vaid,vid,variant,hid,haplotype,gene,phenotype,significance,chemical,sid,biogroup
1451834452,,,PA165819201,CYP3A4*1,CYP3A4,Other,0,nifedipine,1451834455.0,Unknown
1451834452,,,PA165819239,CYP3A4*17,CYP3A4,Other,0,nifedipine,1451834455.0,Unknown
1451834452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,nifedipine,1451834455.0,Unknown
1451834452,,,PA165819239,CYP3A4*17,CYP3A4,Metabolism/PK,0,nifedipine,1451834455.0,Unknown
1451159680,PA166155422,rs5031016,,,CYP2A6,Dosage,-1,warfarin,1451159685.0,East Asian
1451159680,PA166155422,rs5031016,,,CYP2A6,Dosage,-1,warfarin,1451159685.0,East Asian
1451306860,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,0,warfarin,1451306864.0,African American/Afro-Caribbean
1448997750,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448997762.0,Multiple groups
1448997750,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,efavirenz,1448997762.0,Multiple groups
1448631821,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,clomipramine,,
1448631821,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,clomipramine,,
1448631821,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,desmethyl clomipramine,,
1448631821,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,desmethyl clomipramine,,
1451159740,PA166157235,rs371194629,,,HLA-G,,-1,methotrexate,1451159745.0,
1451159740,PA166157235,rs371194629,,,HLA-G,,-1,methotrexate,1451159745.0,
982047744,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,codeine,982047750.0,Unknown
982047744,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,codeine,982047750.0,Unknown
1449191920,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1449191926.0,Unknown
1449192330,PA166162705,rs74551128,,,CFTR,Efficacy,0,ivacaftor / lumacaftor,1449192332.0,"Custom, Not applicable - study was carried out using rectal organoids"
1183632366,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,1183632368.0,Unknown
1183632366,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,codeine,1183632368.0,Unknown
982047720,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,codeine,982047730.0,Unknown
982047720,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,0,codeine,982047730.0,Unknown
1449192352,PA166157525,rs113993960,,,CFTR,Efficacy,0,ivacaftor / lumacaftor,1449192354.0,"Custom, Not applicable - study was carried out using rectal organoids"
827566506,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,codeine,827566508.0,European
827566506,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,codeine,827566508.0,European
827566506,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,codeine,827566508.0,European
1451307925,PA166227802,rs9839376,,,KCNMB2,Efficacy,1,ritodrine,1451307929.0,Unknown
1451307920,PA166227801,rs7624046,,,KCNMB2,Efficacy,1,ritodrine,1451307924.0,Unknown
1451307920,PA166227801,rs7624046,,,KCNMB2,Efficacy,1,ritodrine,1451307924.0,Unknown
1451307920,PA166227801,rs7624046,,,KCNMB2,Efficacy,1,ritodrine,1451307924.0,Unknown
1183960706,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1183960708.0,Unknown
1183960706,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1183960708.0,Unknown
1183960706,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1183960708.0,Unknown
1183960706,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1183960708.0,Unknown
1183960706,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1183960708.0,Unknown
1183960706,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1183960708.0,Unknown
1451161780,PA166157284,rs1045642,,,ABCB1,Dosage,-1,methadone,1451161800.0,European
1451330400,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,propafenone,1451330343.0,East Asian
1451330400,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,propafenone,1451330343.0,East Asian
1451330363,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,propafenone,1451330380.0,East Asian
1451330363,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,propafenone,1451330380.0,East Asian
1449716526,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,fentanyl,1449716538.0,East Asian
1449716526,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,fentanyl,1449716538.0,East Asian
1449716734,PA166157288,rs1128503,,,ABCB1,Dosage,1,fentanyl,1449716741.0,East Asian
1449716742,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716744.0,East Asian
1449716742,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716744.0,East Asian
1449716742,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716744.0,East Asian
1451161820,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,methadone,1451161840.0,European
1451153720,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153740.0,Unknown
1451153720,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153741.0,Unknown
1451153720,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153740.0,Unknown
1451153720,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153741.0,Unknown
1451153720,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153740.0,Unknown
1451153720,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153741.0,Unknown
1451153720,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153740.0,Unknown
1451153720,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153741.0,Unknown
1451153720,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153740.0,Unknown
1451153720,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153741.0,Unknown
1451153720,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153740.0,Unknown
1451153720,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153741.0,Unknown
1451153720,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153740.0,Unknown
1451153720,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153741.0,Unknown
1451153720,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153740.0,Unknown
1451153720,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153741.0,Unknown
1451153720,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153740.0,Unknown
1451153720,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153741.0,Unknown
1451153720,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153740.0,Unknown
1451153720,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153741.0,Unknown
1451153720,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153740.0,Unknown
1451153720,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153741.0,Unknown
1451153720,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153740.0,Unknown
1451153720,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153741.0,Unknown
1451161371,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,methadone,1451161381.0,European
1451161371,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,1,methadone,1451161381.0,European
1451161371,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,methadone,1451161381.0,European
1451161472,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,methadone,1451161479.0,European
1451161472,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,methadone,1451161479.0,European
1451161472,,,PA165988480,CYP2D6*2xN,CYP2D6,Dosage,1,methadone,1451161479.0,European
1451161540,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,methadone,1451161546.0,European
1451161540,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,methadone,1451161546.0,European
1451161540,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,methadone,1451161546.0,European
1451153754,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,methadone,1451153780.0,Unknown
1451153754,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,-1,methadone,1451153780.0,Unknown
1451153754,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,methadone,1451153780.0,Unknown
1451153754,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,methadone,1451153780.0,Unknown
1451153754,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,methadone,1451153780.0,Unknown
1451161360,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,methadone,1451161380.0,European
1451161360,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,methadone,1451161380.0,European
1451161620,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,methadone,1451161640.0,European
1451161620,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,methadone,1451161640.0,European
1451205960,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,tramadol,1451205981.0,Central/South Asian
1451205960,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,tramadol,1451205980.0,Central/South Asian
1184989377,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenytoin,1184989379.0,East Asian
1184989377,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenytoin,1184989379.0,East Asian
1451151724,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,phenytoin,1451151748.0,Unknown
1448994156,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenytoin,1448994187.0,East Asian
1448994156,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenytoin,1448994187.0,East Asian
1184989363,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenytoin,1184989376.0,East Asian
1184989363,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenytoin,1184989376.0,East Asian
981240165,PA166157564,rs1799930,,,NAT2,Toxicity,1,isoniazid,981240173.0,East Asian
981240165,PA166157564,rs1799930,,,NAT2,Metabolism/PK,1,isoniazid,981240173.0,East Asian
1445388514,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,phenytoin,1445390302.0,Latino
1445388514,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,phenytoin,1445390302.0,Latino
1451162800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,raloxifene 6-glucuronide,1451162808.0,European
1451162800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,raloxifene 6-glucuronide,1451162807.0,European
1451162800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,raloxifene 6-glucuronide,1451162820.0,European
1451162800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,raloxifene 6-glucuronide,1451162808.0,European
1451162800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,raloxifene 6-glucuronide,1451162807.0,European
1451162800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,raloxifene 6-glucuronide,1451162820.0,European
1451162800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,raloxifene-4′-glucuronide,1451162808.0,European
1451162800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,raloxifene-4′-glucuronide,1451162807.0,European
1451162800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,raloxifene-4′-glucuronide,1451162820.0,European
1451162800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,raloxifene-4′-glucuronide,1451162808.0,European
1451162800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,raloxifene-4′-glucuronide,1451162807.0,European
1451162800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,raloxifene-4′-glucuronide,1451162820.0,European
1451151829,PA166154675,rs6313,,,HTR2A,Efficacy,1,risperidone,1451151840.0,European
1451151848,PA166154675,rs6313,,,HTR2A,Efficacy,1,olanzapine,1451151853.0,European
1451151860,PA166154675,rs6313,,,HTR2A,Efficacy,1,olanzapine,1451151844.0,European
1451151860,PA166154675,rs6313,,,HTR2A,Efficacy,1,olanzapine,1451151844.0,European
1451151860,PA166154675,rs6313,,,HTR2A,Efficacy,1,olanzapine,1451151844.0,European
1451865260,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1451865280.0,East Asian
1451163180,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atorvastatin,1451163184.0,European
1451163194,PA166155607,rs887829,,,UGT1A1,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A10,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A3,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A4,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A5,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A6,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A7,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A8,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451163194,PA166155607,rs887829,,,UGT1A9,Metabolism/PK,1,atorvastatin,1451163220.0,European
1451154280,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451154280,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451154280,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451154280,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451154280,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451154280,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451154280,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,tramadol,1451154292.0,East Asian
1451163221,PA166213621,rs45446698,,,CYP3A7,Metabolism/PK,1,atorvastatin,1451163225.0,European
1451334662,PA166156061,rs1058164,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334666.0,East Asian
1451206740,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,irinotecan,1451206747.0,European
1451206740,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,irinotecan,1451206748.0,European
1451206740,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,irinotecan,1451206749.0,European
1451206740,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,irinotecan,1451206750.0,European
1451206740,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,irinotecan,1451206747.0,European
1451206740,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,irinotecan,1451206748.0,European
1451206740,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,irinotecan,1451206749.0,European
1451206740,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,irinotecan,1451206750.0,European
1451163505,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,rifampin,1451163540.0,East Asian
1451334680,PA166156145,rs28371699,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334700.0,East Asian
1451334680,PA166156145,rs28371699,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334700.0,East Asian
1451334781,PA166156076,rs1135840,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334820.0,East Asian
1451334860,PA166156147,rs28371702,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334864.0,East Asian
1451334860,PA166156147,rs28371702,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334864.0,East Asian
1451334860,PA166156147,rs28371702,,,CYP2D6,Metabolism/PK,1,aripiprazole,1451334864.0,East Asian
1451335308,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,olanzapine,1451335312.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335308,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,olanzapine,1451335312.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451206861,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,morphine,1451206843.0,Unknown
1451206834,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,codeine,1451206838.0,Unknown
1451206834,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,codeine,1451206940.0,Unknown
1451206834,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1451206838.0,Unknown
1451206834,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1451206940.0,Unknown
1451335158,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335260.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451866940,PA166157284,rs1045642,,,ABCB1,Efficacy,1,atorvastatin,1451866945.0,Central/South Asian
1451866940,PA166157284,rs1045642,,,ABCB1,Efficacy,1,atorvastatin,1451866946.0,Central/South Asian
1451206853,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,codeine,1451206858.0,Unknown
1451206853,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,codeine,1451206857.0,Unknown
1451206853,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,morphine,1451206858.0,Unknown
1451206853,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,morphine,1451206857.0,Unknown
1451335303,PA166157428,rs7787082,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335307.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335460,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,-1,olanzapine,1451335414.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335452,PA166154676,rs6314,,,HTR2A,Metabolism/PK,-1,olanzapine,1451335468.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335520,PA166154726,rs7997012,,,HTR2A,Metabolism/PK,-1,olanzapine,1451335524.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451866947,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,atorvastatin,1451866952.0,Central/South Asian
1451866947,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,atorvastatin,1451866953.0,Central/South Asian
1451206886,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,codeine,1451206900.0,Unknown
1451206886,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,codeine,1451206981.0,Unknown
1451206886,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,morphine,1451206900.0,Unknown
1451206886,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,morphine,1451206981.0,Unknown
1451335447,PA166154261,rs6277,,,DRD2,Metabolism/PK,-1,olanzapine,1451335432.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335416,PA166154339,rs1800497,,,ANKK1,Metabolism/PK,-1,olanzapine,1451335431.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335416,PA166154339,rs1800497,,,DRD2,Metabolism/PK,-1,olanzapine,1451335431.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335433,PA166156277,rs6280,,,DRD3,Metabolism/PK,-1,olanzapine,1451335451.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335582,PA166153626,rs1137101,,,LEPR,Metabolism/PK,-1,olanzapine,1451335586.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451164240,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,atazanavir,1451164244.0,European
1451164240,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,atazanavir,1451164244.0,European
1451317820,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,olanzapine,1451317840.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451317820,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,olanzapine,1451317860.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451317900,PA166154254,rs5128,,,APOC3,Metabolism/PK,-1,olanzapine,1451317904.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451317900,PA166154254,rs5128,,,APOC3,Metabolism/PK,-1,olanzapine,1451317904.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451341440,PA166156748,rs1042713,,,ADRB2,Efficacy,1,salmeterol,1451341445.0,Near Eastern
1451317880,PA166157239,rs3842,,,ABCB1,Metabolism/PK,1,olanzapine,1451317884.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451317880,PA166157239,rs3842,,,ABCB1,Metabolism/PK,1,olanzapine,1451317884.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451155780,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451155786.0,European
1451155780,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1451155786.0,European
1451155780,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,tramadol,1451155786.0,European
1451341447,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,salmeterol,1451341452.0,Near Eastern
1451164700,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,rosuvastatin,1451164720.0,East Asian
1451164700,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,rosuvastatin,1451164704.0,East Asian
1451207688,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,1,irinotecan,1451207604.0,East Asian
1451207688,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,1,irinotecan,1451207604.0,East Asian
1451207688,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,1,irinotecan,1451207604.0,East Asian
1451164800,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,rosuvastatin,1451164761.0,East Asian
1451164800,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,rosuvastatin,1451164761.0,East Asian
1451164800,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,rosuvastatin,1451164761.0,East Asian
1449310660,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,"sulfonamides, urea derivatives",1449310662.0,Latino
1451164966,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,atorvastatin,1451164980.0,East Asian
1451207780,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,dabigatran,1451207768.0,"Multiple groups, Caucasians and Latin Americans"
1451207780,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,dabigatran,1451207768.0,"Multiple groups, Caucasians and Latin Americans"
1451207800,PA166155037,rs2244613,,,CES1,Metabolism/PK,-1,dabigatran,1451207820.0,"Multiple groups, Caucasians and Latin Americans"
1451207800,PA166155037,rs2244613,,,CES1,Metabolism/PK,-1,dabigatran,1451207820.0,"Multiple groups, Caucasians and Latin Americans"
1451843520,PA166274201,rs10787959,,,GRK5,Efficacy,1,Beta Blocking Agents,1451843525.0,European
1451843520,PA166274201,rs10787959,,,GRK5,Efficacy,1,Beta Blocking Agents,1451843526.0,European
1451207769,PA166159104,rs8192935,,,CES1,Metabolism/PK,-1,dabigatran,1451207773.0,"Multiple groups, Caucasians and Latin Americans"
1451156440,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,methadone,1451156480.0,European
1451156440,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,methadone,1451156480.0,European
1451156440,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,methadone,1451156480.0,European
982010069,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,1451338000.0,Near Eastern
982010069,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,982010081.0,Near Eastern
982010069,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,1451338000.0,Near Eastern
982010069,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,982010081.0,Near Eastern
1451156342,PA166155720,rs4124874,,,UGT1A1,Metabolism/PK,-1,SN-38,1451156347.0,East Asian
1451207940,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tramadol,1451207948.0,European
1451207940,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,-1,tramadol,1451207948.0,European
1451207940,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,tramadol,1451207948.0,European
1451207940,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tramadol,1451207948.0,European
1451156580,PA166155720,rs4124874,,,UGT1A1,Metabolism/PK,1,bilirubin,1451156600.0,East Asian
1451156420,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,methadone,1451156424.0,European
1451156500,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,(S)-methadone,1451156520.0,European
1451156500,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,1,(S)-methadone,1451156520.0,European
1451156500,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,(S)-methadone,1451156520.0,European
1451156500,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,1,(S)-methadone,1451156520.0,European
1451862762,PA166274204,rs4752292,,,GRK5,Efficacy,1,Beta Blocking Agents,1451862767.0,European
1451862762,PA166274204,rs4752292,,,GRK5,Efficacy,1,Beta Blocking Agents,1451862768.0,European
1448109809,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methadone,1448109811.0,East Asian
1451339660,PA166156637,rs10011796,,,ABCG2,Efficacy,-1,allopurinol,1451339665.0,Unknown
1451339660,PA166156637,rs10011796,,,ABCG2,Efficacy,-1,allopurinol,1451339666.0,Unknown
1451339660,PA166156637,rs10011796,,,ABCG2,Efficacy,-1,allopurinol,1451339667.0,Unknown
1448104379,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methadone,1448104389.0,European
1451339600,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1451339624.0,Unknown
1451339600,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1451339620.0,Unknown
1451339600,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1451339640.0,Unknown
1451843527,PA166274202,rs3740563,,,GRK5,Efficacy,1,Beta Blocking Agents,1451843532.0,European
1451843527,PA166274202,rs3740563,,,GRK5,Efficacy,1,Beta Blocking Agents,1451843533.0,European
1451156620,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,tramadol,1451156640.0,
1451156620,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,tramadol,1451156640.0,
1451156620,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,tramadol,1451156640.0,
1451156620,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,tramadol,1451156640.0,
1451208380,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451208400.0,Unknown
1451208380,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451208400.0,Unknown
1451208380,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451208400.0,Unknown
1451208380,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451208400.0,Unknown
1451208380,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451208400.0,Unknown
1451339940,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451339962.0,Sub-Saharan African
1451339940,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1451339962.0,Sub-Saharan African
1451156680,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,codeine,1451156684.0,
1451156680,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,0,codeine,1451156684.0,
1451343120,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451343105.0,Unknown
1451343120,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451343132.0,Unknown
1451343120,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451343105.0,Unknown
1451343120,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451343132.0,Unknown
1451340000,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451340005.0,Sub-Saharan African
1451340000,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1451340005.0,Sub-Saharan African
1451868583,PA166154001,rs2230345,,,GRK5,Efficacy,0,Beta Blocking Agents,1451868588.0,East Asian
1451868583,PA166154001,rs2230345,,,GRK5,Efficacy,0,Beta Blocking Agents,1451868588.0,East Asian
1451340007,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451340020.0,Sub-Saharan African
1451340007,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1451340020.0,Sub-Saharan African
1451340040,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451340018.0,Sub-Saharan African
1451340040,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1451340018.0,Sub-Saharan African
1451157920,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451157940.0,European
1451157920,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,tramadol,1451157940.0,European
1451157920,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1451157940.0,European
1451157920,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,tramadol,1451157940.0,European
1451157920,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,tramadol,1451157940.0,European
1451157968,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,tramadol,1451157930.0,European
1451157968,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,-1,tramadol,1451157930.0,European
1451157968,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,-1,tramadol,1451157930.0,European
1451157968,,,PA165816581,CYP2D6*6,CYP2D6,Dosage,-1,tramadol,1451157930.0,European
1451157968,,,PA165948317,CYP2D6*9,CYP2D6,Dosage,-1,tramadol,1451157930.0,European
1451340046,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451340050.0,Sub-Saharan African
1451340046,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451340050.0,Sub-Saharan African
1451340046,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451340050.0,Sub-Saharan African
1444705578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705584.0,Multiple groups
1444705578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1451343285.0,Multiple groups
1444705578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705584.0,Multiple groups
1444705578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1451343285.0,Multiple groups
1451340140,PA166155042,rs2884737,,,VKORC1,Dosage,1,warfarin,1451340129.0,Sub-Saharan African
1451340140,PA166155042,rs2884737,,,VKORC1,Dosage,1,warfarin,1451340129.0,Sub-Saharan African
1451343340,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451343360.0,East Asian
1451343340,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451343360.0,East Asian
1451343340,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451343360.0,East Asian
1451343500,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451343505.0,East Asian
1451340220,,,PA165959980,UGT1A3*1,UGT1A3,Metabolism/PK,1,telmisartan,1451340240.0,European
1451340220,,,PA165959981,UGT1A3*2,UGT1A3,Metabolism/PK,1,telmisartan,1451340240.0,European
1451340220,,,PA165959981,UGT1A3*2,UGT1A3,Metabolism/PK,1,telmisartan,1451340240.0,European
1451208948,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451208955.0,Multiple groups
1451208948,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208955.0,Multiple groups
1451343760,PA166155795,rs10929303,,,MROH2A,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A1,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A10,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A3,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A4,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A5,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A6,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A7,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A8,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A9,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451343760,PA166155795,rs10929303,,,UGT1A9,Metabolism/PK,0,acetaminophen glucuronide,1451343764.0,Central/South Asian
1451208980,,,PA166115841,UGT1A1*1,UGT1A1,Other,1,bilirubin,1451208961.0,Multiple groups
1451208980,,,PA166115842,UGT1A1*28,UGT1A1,Other,1,bilirubin,1451208961.0,Multiple groups
1451342940,PA166155584,rs8330,,,MROH2A,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A1,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A10,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A3,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A4,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A5,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A6,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A7,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A8,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451342940,PA166155584,rs8330,,,UGT1A9,Metabolism/PK,0,acetaminophen glucuronide,1451342980.0,Central/South Asian
1451158440,PA166211542,rs147055479,,,CES1,Dosage,-1,methylphenidate,1451158460.0,Unknown
1451158461,PA166211542,rs147055479,,,CES1,Dosage,-1,methylphenidate,1451158481.0,Unknown
1451158461,PA166211542,rs147055479,,,CES1,Efficacy,-1,methylphenidate,1451158481.0,Unknown
1446898218,PA166156991,rs1799971,,,OPRM1,Efficacy,1,acetaminophen,1446898232.0,East Asian
1446898218,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1446898232.0,East Asian
1446898218,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1446898232.0,East Asian
1446898218,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1446898232.0,East Asian
1451344540,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344580.0,East Asian
1451344540,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344560.0,East Asian
1451344540,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344580.0,East Asian
1451344540,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344560.0,East Asian
1451344540,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344580.0,East Asian
1451344540,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344560.0,East Asian
1451344548,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344601.0,Unknown
1451344548,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344601.0,Unknown
1451344548,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344601.0,Unknown
1451344650,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451344655.0,East Asian
1451344650,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451344663.0,East Asian
1451344650,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1451344655.0,East Asian
1451344650,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1451344663.0,East Asian
1451344650,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,esomeprazole,1451344655.0,East Asian
1451344650,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,esomeprazole,1451344663.0,East Asian
1451344650,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344655.0,East Asian
1451344650,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344663.0,East Asian
1451344650,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344655.0,East Asian
1451344650,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344663.0,East Asian
1451344650,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344655.0,East Asian
1451344650,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344663.0,East Asian
1451209187,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451209202.0,Multiple groups
1451209187,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451209202.0,Multiple groups
1451344640,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344662.0,Unknown
1451344640,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344662.0,Unknown
1451344640,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344662.0,Unknown
1451344640,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344662.0,Unknown
1451344680,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451344700.0,East Asian
1451344680,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451344700.0,East Asian
1451344680,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451344700.0,East Asian
1451209365,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,carvedilol,1451209381.0,East Asian
1451209365,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,carvedilol,1451209381.0,East Asian
1449192125,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192130.0,"Custom, Not applicable - study was carried out in PBE cells"
1449192125,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192130.0,"Custom, Not applicable - study was carried out in PBE cells"
1451209820,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,cisplatin,1451209826.0,East Asian
1451209820,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,cisplatin,1451209826.0,East Asian
1451209820,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451209826.0,East Asian
1451209820,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451209826.0,East Asian
1451209847,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,irinotecan,1451209881.0,East Asian
1451209847,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,irinotecan,1451209881.0,East Asian
1451346608,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451346660.0,Unknown
1451346608,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1451346660.0,Unknown
1451346608,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,esomeprazole,1451346660.0,Unknown
1451346700,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451346705.0,Unknown
1451346700,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1451346705.0,Unknown
1451346700,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,esomeprazole,1451346705.0,Unknown
1451158820,PA166211543,rs36120609,,,GSTM3,Metabolism/PK,1,olanzapine,1451158840.0,
1451346726,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451346740.0,Unknown
1451346726,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1451346740.0,Unknown
1451346726,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,esomeprazole,1451346740.0,Unknown
1451158825,PA166211543,rs36120609,,,GSTM3,Metabolism/PK,1,olanzapine,1451158829.0,
981499235,PA166156748,rs1042713,,,ADRB2,Efficacy,1,salmeterol,981499246.0,Unknown
1451347680,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,combination nicotine replacement therapy,1451347662.0,African American/Afro-Caribbean
1451347701,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,varenicline,1451347706.0,African American/Afro-Caribbean
1451347701,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,varenicline,1451347706.0,African American/Afro-Caribbean
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,buprenorphine,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,buprenorphine,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,dihydrocodeine,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,dihydrocodeine,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,fentanyl,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,fentanyl,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,hydromorphone,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,hydromorphone,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,methadone,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,methadone,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,morphine,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,morphine,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,oxycodone,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,oxycodone,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,piritramide,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,piritramide,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,tilidine,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,tilidine,1183681991.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,tramadol,1183681993.0,European
1183681975,PA166157284,rs1045642,,,ABCB1,Dosage,1,tramadol,1183681991.0,European
1184753725,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1184753732.0,"Multiple groups, Majority Caucasian patients."
1184753725,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1184753732.0,"Multiple groups, Majority Caucasian patients."
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,buprenorphine,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,dihydrocodeine,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,fentanyl,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,hydromorphone,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,oxycodone,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,piritramide,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,tilidine,1451159088.0,European
1451159083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,tramadol,1451159088.0,European
982044075,PA166157267,rs776746,,,CYP3A5,Efficacy,1,atorvastatin,982044092.0,European
982044075,PA166157267,rs776746,,,CYP3A5,Efficacy,1,lovastatin,982044092.0,European
982044075,PA166157267,rs776746,,,CYP3A5,Efficacy,1,simvastatin,982044092.0,European
1451159180,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,oxycodone,1451159200.0,Unknown
1451159180,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,-1,oxycodone,1451159200.0,Unknown
1451159180,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,oxycodone,1451159200.0,Unknown
1451159180,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,oxycodone,1451159200.0,Unknown
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,buprenorphine,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,dihydrocodeine,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,fentanyl,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,hydromorphone,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,methadone,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,oxycodone,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,piritramide,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,tilidine,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,tramadol,1183682032.0,European
1183682029,PA166156024,rs4680,,,COMT,Dosage,-1,tramadol,1183682032.0,European
982037414,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,-1,fluvastatin,982037421.0,Unknown
982043865,PA166155810,rs11887534,,,ABCG8,Efficacy,1,atorvastatin,982043880.0,Unknown
1451888600,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,vortioxetine,1451888618.0,European
1451888600,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,vortioxetine,1451888617.0,European
1451888600,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,vortioxetine,1451888618.0,European
1451888600,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,vortioxetine,1451888617.0,European
1451888600,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,vortioxetine,1451888618.0,European
1451888600,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,vortioxetine,1451888617.0,European
1451888620,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,1,vortioxetine,1451888643.0,European
1451888620,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,1,vortioxetine,1451888643.0,European
1184753631,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1184753636.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184763829,,,PA165987831,HLA-B*58:01,HLA-B,Toxicity,1,allopurinol,1184763839.0,Unknown
978639883,PA166154142,rs11598702,,,NT5C2,Other,1,gemcitabine,978639889.0,European
978639883,PA166154142,rs11598702,,,NT5C2,Metabolism/PK,1,gemcitabine,978639889.0,European
1183959953,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1183959961.0,East Asian
1183959953,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1183959963.0,East Asian
1183959953,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1183959961.0,East Asian
1183959953,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1183959963.0,East Asian
1183959953,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183959961.0,East Asian
1183959953,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183959963.0,East Asian
1183959953,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183959961.0,East Asian
1183959953,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183959963.0,East Asian
1451211740,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,axitinib,1451211760.0,Multiple groups
1451211740,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,axitinib,1451211760.0,Multiple groups
1450376849,PA166156602,rs6551665,,,ADGRL3,Efficacy,0,methylphenidate,1450376855.0,Multiple groups
1450376858,PA166181219,rs1947274,,,ADGRL3,Efficacy,0,methylphenidate,1450376860.0,Multiple groups
982044485,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982044492.0,East Asian
982044493,PA166156644,rs11269124,,,ADRA2C,Efficacy,1,clonidine,982044498.0,East Asian
982044507,PA166155865,rs29000568,,,ADRA2B,Efficacy,-1,clonidine,982044511.0,East Asian
1448257090,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448257092.0,East Asian
1448257090,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448257092.0,East Asian
1448257121,PA166160014,rs41301394,,,POR,Dosage,1,warfarin,1448257123.0,East Asian
1448257131,PA166160016,rs10239977,,,POR,Dosage,-1,warfarin,1448257133.0,East Asian
1043737597,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1043737601.0,Unknown
1451212381,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,carvedilol,1451212389.0,Unknown
1451212381,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,carvedilol,1451212389.0,Unknown
1451212381,,,PA166115844,UGT1A1*37,UGT1A1,Efficacy,-1,carvedilol,1451212389.0,Unknown
1451212381,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,metoprolol,1451212389.0,Unknown
1451212381,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,metoprolol,1451212389.0,Unknown
1451212381,,,PA166115844,UGT1A1*37,UGT1A1,Efficacy,-1,metoprolol,1451212389.0,Unknown
1451212360,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,carvedilol,1451212380.0,Unknown
1451212360,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,carvedilol,1451212368.0,Unknown
1451212360,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,carvedilol,1451212380.0,Unknown
1451212360,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,carvedilol,1451212368.0,Unknown
1451212360,,,PA166115844,UGT1A1*37,UGT1A1,Dosage,-1,carvedilol,1451212380.0,Unknown
1451212360,,,PA166115844,UGT1A1*37,UGT1A1,Dosage,-1,carvedilol,1451212368.0,Unknown
1451212360,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,metoprolol,1451212380.0,Unknown
1451212360,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,metoprolol,1451212368.0,Unknown
1451212360,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,metoprolol,1451212380.0,Unknown
1451212360,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,metoprolol,1451212368.0,Unknown
1451212360,,,PA166115844,UGT1A1*37,UGT1A1,Dosage,-1,metoprolol,1451212380.0,Unknown
1451212360,,,PA166115844,UGT1A1*37,UGT1A1,Dosage,-1,metoprolol,1451212368.0,Unknown
1451893780,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1451893785.0,East Asian
1451893700,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1451893720.0,East Asian
1451893700,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1451893720.0,East Asian
1451893787,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,tacrolimus,1451893792.0,East Asian
1447984881,PA166157519,rs78655421,,,CFTR,Efficacy,0,ivacaftor,1447984887.0,Unknown
1451213020,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,FOLFIRI,1451213040.0,Unknown
1451213020,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,FOLFIRI,1451213040.0,Unknown
1451893960,PA166232961,rs28379954,,,NFIB,Metabolism/PK,0,clozapine,1451893982.0,European
1451350980,PA166156024,rs4680,,,COMT,Dosage,1,opioids,1451351000.0,"Multiple groups, ""White and Other ethnicities"""
1451893986,PA166232961,rs28379954,,,NFIB,Metabolism/PK,0,clozapine,1451893990.0,European
1451213120,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451213140.0,Unknown
1451213120,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451213140.0,Unknown
1451351220,PA166231401,rs79910351,,,OPRM1,Efficacy,0,fentanyl,1451351224.0,Unknown
1451351220,PA166231401,rs79910351,,,OPRM1,Efficacy,0,remifentanil,1451351224.0,Unknown
1451351280,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1451351285.0,Near Eastern
1451351280,PA166190881,rs11322783,,,IFNL4,Efficacy,1,sofosbuvir,1451351285.0,Near Eastern
1451894000,PA166154895,rs2472297,,,CYP1A1,Metabolism/PK,0,clozapine,1451893997.0,Unknown
1451893991,PA166154895,rs2472297,,,CYP1A1,Metabolism/PK,0,clozapine,1451893996.0,European
1451351843,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451351848.0,East Asian
1448997136,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997138.0,East Asian
1451213340,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451213360.0,East Asian
1451213340,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451213360.0,East Asian
1451261560,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1451261565.0,Unknown
1451352120,PA166182219,rs6517442,,,KCNJ6,Dosage,1,opioids,1451352125.0,Unknown
1451352120,PA166182219,rs6517442,,,KCNJ6,Dosage,1,opioids,1451352125.0,Unknown
1451352200,PA166156991,rs1799971,,,OPRM1,Dosage,1,sufentanil,1451352240.0,Unknown
1451213545,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,letermovir,1451213564.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1451213545,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,letermovir,1451213564.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1451352241,PA166157284,rs1045642,,,ABCB1,Dosage,-1,sufentanil,1451352280.0,Unknown
1451352281,PA166157316,rs2032582,,,ABCB1,Dosage,-1,sufentanil,1451352286.0,Unknown
1451895360,PA166157267,rs776746,,,CYP3A5,Other,1,Dihydropyridine derivatives,1451895364.0,"Multiple groups, ""(93%) identified as genetically European"""
1451352404,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,simvastatin,1451352440.0,East Asian
1451352480,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1451352484.0,East Asian
1451895321,PA166154441,rs10898815,,,NUMA1,Other,1,Dihydropyridine derivatives,1451895325.0,"Multiple groups, ""(93%) identified as genetically European"""
1451352500,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,simvastatin acid,1451352504.0,European
1451352522,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,0,rosuvastatin,1451352505.0,European
981755710,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,981755718.0,Unknown
981755710,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,981755719.0,Unknown
981755710,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,981755724.0,Unknown
1451213721,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,tipifarnib,1451213760.0,European
1451213721,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,tipifarnib,1451213760.0,European
1451352820,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atorvastatin,1451352840.0,Central/South Asian
981755725,PA166157525,rs113993960,,,CFTR,Efficacy,0,ivacaftor,981755735.0,Unknown
981755766,PA166157525,rs113993960,,,CFTR,Efficacy,0,ivacaftor,981755774.0,Unknown
981755776,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor,981755786.0,Unknown
1447981017,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1447981024.0,Unknown
1451352842,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,atorvastatin,1451352860.0,East Asian
1451352842,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,atorvastatin,1451352860.0,East Asian
1451352861,PA166154007,rs2273697,,,ABCC2,Efficacy,1,atorvastatin,1451352883.0,East Asian
981755699,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,981755707.0,Unknown
981755699,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,981755709.0,Unknown
981755699,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,981755722.0,Unknown
1451352866,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atorvastatin,1451352884.0,American
1183960702,PA166157537,rs267606723,,,CFTR,Efficacy,1,ivacaftor,1183960704.0,Unknown
981755746,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,981755755.0,Unknown
1451352886,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,atorvastatin,1451352890.0,American
1451353000,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,atorvastatin,1451353020.0,European
981755787,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,981755793.0,Unknown
1451213915,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451213843.0,Multiple groups
1451213915,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451213940.0,Multiple groups
1451213915,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451213843.0,Multiple groups
1451213915,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451213940.0,Multiple groups
1451352900,PA166156997,rs1800629,,,TNF,Metabolism/PK,1,atorvastatin,1451352904.0,American
1183960690,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1183960692.0,Unknown
1451352892,PA166156277,rs6280,,,DRD3,Metabolism/PK,1,atorvastatin,1451352896.0,American
1451352940,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1451352960.0,European
1451214031,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,FOLFIRI,1451214035.0,East Asian
1451214031,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,FOLFIRI,1451213992.0,East Asian
1451214031,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,FOLFIRI,1451214035.0,East Asian
1451214031,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,FOLFIRI,1451213992.0,East Asian
1451214031,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451214035.0,East Asian
1451214031,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451213992.0,East Asian
1451214031,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451214035.0,East Asian
1451214031,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451213992.0,East Asian
1183960714,PA166157534,rs193922525,,,CFTR,Efficacy,1,ivacaftor,1183960716.0,Unknown
1451214044,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,1,warfarin,1451214080.0,European
1451214044,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,1,warfarin,1451214080.0,European
1451353640,PA166156991,rs1799971,,,OPRM1,Efficacy,0,naltrexone,1451353660.0,European
1183960710,PA166157533,rs121909041,,,CFTR,Efficacy,1,ivacaftor,1183960712.0,Unknown
1183960694,PA166157531,rs121909005,,,CFTR,Efficacy,1,ivacaftor,1183960696.0,Unknown
1183960694,PA166157531,rs121909005,,,CFTR,Efficacy,1,ivacaftor,1183960696.0,Unknown
1183960686,PA166157529,rs121908755,,,CFTR,Efficacy,1,ivacaftor,1183960688.0,Unknown
1451354452,PA166232249,rs6010717,,,OPRL1,Dosage,-1,methadone,1451354457.0,Unknown
1451354470,PA166156059,rs933271,,,COMT,Dosage,-1,methadone,1451354475.0,Unknown
1447679054,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447679072.0,European
1447679054,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447679074.0,European
1447679054,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447679076.0,European
1447679054,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447679072.0,European
1447679054,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447679074.0,European
1447679054,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447679076.0,European
1451354446,PA166177932,rs1997794,,,PDYN,Dosage,-1,methadone,1451354451.0,Unknown
1451354160,PA166232205,rs17078877,,,GRM6,Dosage,-1,methadone,1451354165.0,Unknown
1451354268,PA166232231,rs211105,,,TPH1,Dosage,-1,methadone,1451354305.0,Unknown
1451354380,PA166232247,rs2285907,,,GRIN3B,Dosage,-1,methadone,1451354400.0,Unknown
1451354349,PA166232244,rs1487275,,,TPH2,Dosage,-1,methadone,1451354354.0,Unknown
1451354458,PA166232250,rs7271530,,,OPRL1,Dosage,-1,methadone,1451354463.0,Unknown
1451354420,PA166177939,rs910080,,,PDYN,Dosage,-1,methadone,1451354425.0,Unknown
1451354488,PA166156049,rs174699,,,COMT,Dosage,-1,methadone,1451354493.0,Unknown
1451354482,PA166180044,rs5993882,,,COMT,Dosage,-1,methadone,1451354487.0,Unknown
1451354166,PA166232225,rs2067011,,,GRM6,Dosage,-1,methadone,1451354171.0,Unknown
1451354281,PA166154600,rs7305115,,,TPH2,Dosage,-1,methadone,1451354286.0,Unknown
1183699846,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183699848.0,Latino
1183699846,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,tacrolimus,1183699848.0,Latino
1451353780,PA166156953,rs806368,,,CNR1,Dosage,1,methadone,1451353785.0,Unknown
1184515509,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184515513.0,Latino
1184515509,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184515513.0,Latino
1451353806,PA166232221,rs1386493,,,TPH2,Dosage,1,methadone,1451353811.0,Unknown
982043181,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,pravastatin,982043189.0,Unknown
1183697996,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183698000.0,East Asian
1448276612,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,0,tacrolimus,1448281096.0,"Multiple groups, 96% Caucasian"
827861835,PA166155409,rs3745274,,,CYP2B6,Toxicity,0,nevirapine,827861845.0,"Multiple groups, UK: 67% ""Caucasian ethnicity"" 33% ""Black ethnicity"""
827861835,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,nevirapine,827861845.0,"Multiple groups, UK: 67% ""Caucasian ethnicity"" 33% ""Black ethnicity"""
1183699855,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183699857.0,Latino
1183699855,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,tacrolimus,1183699857.0,Latino
1183699824,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1183699832.0,Latino
1183699824,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1183699832.0,Latino
1451353817,PA166177058,rs2229205,,,OPRL1,Dosage,1,methadone,1451353862.0,Unknown
1451353812,PA166232202,rs16974799,,,CYP2B6,Dosage,1,methadone,1451353793.0,Unknown
1447674199,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447674201.0,East Asian
1447674199,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674201.0,East Asian
1451354760,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,hmg coa reductase inhibitors,1451354780.0,Multiple groups
1447947417,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447947429.0,East Asian
1447947417,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447947429.0,East Asian
1451359880,PA166156024,rs4680,,,COMT,Efficacy,-1,propranolol,1451359885.0,European
1451354800,PA166154579,rs4149056,,,SLCO1B1,Efficacy,0,simvastatin,1451354820.0,Multiple groups
1184514878,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514884.0,Central/South Asian
1184514878,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514885.0,Central/South Asian
1184514878,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514886.0,Central/South Asian
1184514878,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514883.0,Central/South Asian
1184514878,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514884.0,Central/South Asian
1184514878,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514885.0,Central/South Asian
1184514878,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514886.0,Central/South Asian
1184514878,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514883.0,Central/South Asian
1184514921,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514926.0,"Multiple groups, Black (n=12), White (n=81), South Asian (n=20), Other (n=5)"
1184514921,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514926.0,"Multiple groups, Black (n=12), White (n=81), South Asian (n=20), Other (n=5)"
1451354845,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,atorvastatin,1451354881.0,Unknown
1449750413,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449750415.0,Multiple groups
1449750413,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449750415.0,Multiple groups
1451354840,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,pravastatin,1451354860.0,Unknown
1449747930,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1449747942.0,Unknown
1449747930,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1449747942.0,Unknown
1451354923,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,simvastatin,1451354940.0,European
827784291,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,827784320.0,Multiple groups
827784291,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827784320.0,Multiple groups
1451354882,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,atorvastatin,1451354850.0,Unknown
1451354882,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,fluvastatin,1451354850.0,Unknown
1451354882,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,lovastatin,1451354850.0,Unknown
1451354882,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,pravastatin,1451354850.0,Unknown
1451354882,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,simvastatin,1451354850.0,Unknown
1184514927,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,0,tacrolimus,1184514932.0,Unknown
1184514927,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,0,tacrolimus,1184514932.0,Unknown
1447946747,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447946784.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1447946747,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447946759.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1447946747,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447946784.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1447946747,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447946759.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1448819488,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448819502.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448819500.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448819502.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448819500.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128233,CYP3A5*6,CYP3A5,Dosage,1,tacrolimus,1448819502.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128233,CYP3A5*6,CYP3A5,Dosage,1,tacrolimus,1448819500.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128234,CYP3A5*7,CYP3A5,Dosage,1,tacrolimus,1448819502.0,"Multiple groups, Predominantly African American (67%)"
1448819488,,,PA166128234,CYP3A5*7,CYP3A5,Dosage,1,tacrolimus,1448819500.0,"Multiple groups, Predominantly African American (67%)"
1451354981,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,atorvastatin,1451354985.0,Unknown
1451354981,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,simvastatin,1451354985.0,Unknown
1183698721,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183698723.0,East Asian
1183698721,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183698724.0,East Asian
1451354947,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,rosuvastatin,1451354951.0,Unknown
1451354953,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,simvastatin,1451354961.0,Unknown
1451355040,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,simvastatin,1451355060.0,Unknown
1184515198,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184515203.0,East Asian
1184515198,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184515203.0,East Asian
1184515210,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184515215.0,East Asian
1184515210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184515215.0,East Asian
1451354962,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,atorvastatin,1451354980.0,Unknown
1451354962,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,simvastatin,1451354980.0,Unknown
1447520652,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447520682.0,East Asian
1447520652,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447520682.0,East Asian
1447520652,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447520682.0,East Asian
1451162940,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451162960.0,"Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants"
1451162940,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451162960.0,"Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants"
1451162940,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,nicotine,1451162960.0,"Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants"
1444694284,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444694290.0,East Asian
1448358416,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448358426.0,East Asian
1448358416,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448358426.0,East Asian
1451355120,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,simvastatin,1451355124.0,European
1449183240,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,cyclosporine,1449183250.0,Unknown
1449183240,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,cyclosporine,1449183250.0,Unknown
1449183240,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1449183250.0,Unknown
1449183240,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1449183250.0,Unknown
1449171475,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1449171484.0,East Asian
1449171475,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1449171484.0,East Asian
1449575706,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,tacrolimus,1449575712.0,European
1451356100,PA166232961,rs28379954,,,NFIB,Metabolism/PK,1,clozapine,1451356140.0,Unknown
1451356100,PA166232961,rs28379954,,,NFIB,Metabolism/PK,1,clozapine,1451356140.0,Unknown
1448104272,,,PA165924719,CYP2A6*2,CYP2A6,Dosage,1,nicotine,1448104284.0,European
1451356341,PA166233022,rs11265549,,,NECTIN4,Dosage,1,methadone,1451356349.0,Unknown
1451356350,PA166233022,rs11265549,,,NECTIN4,Metabolism/PK,1,methadone,1451356355.0,Unknown
1451356350,PA166233022,rs11265549,,,NECTIN4,Metabolism/PK,1,methadone,1451356355.0,Unknown
1451356350,PA166233022,rs11265549,,,NECTIN4,Metabolism/PK,1,methadone,1451356355.0,Unknown
981202028,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,coumarin,981202031.0,East Asian
1451221900,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451221940.0,East Asian
1184515204,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1184515209.0,Unknown
1184515204,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1184515209.0,Unknown
1451230062,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atorvastatin,1451230066.0,East Asian
1184988315,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1184988317.0,Sub-Saharan African
1451221840,PA166153686,rs2260863,,,EPHX1,Dosage,1,warfarin,1451221860.0,East Asian
1451356707,PA166233161,rs17561,,,IL1A,Dosage,-1,sufentanil,1451356720.0,Unknown
1451356727,PA166155587,rs16944,,,IL1B,Dosage,-1,sufentanil,1451356732.0,Unknown
1451356739,PA166156478,rs4073,,,CXCL8,Dosage,-1,sufentanil,1451356744.0,Unknown
1451221905,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1451221923.0,East Asian
1448260935,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,0,belinostat,1448260944.0,Unknown
1448260935,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,belinostat,1448260944.0,Unknown
1448260935,,,PA166115845,UGT1A1*60,UGT1A1,Dosage,0,belinostat,1448260944.0,Unknown
1451356757,PA166153642,rs1800896,,,IL10,Dosage,-1,sufentanil,1451356762.0,Unknown
1451356787,PA166233201,rs842647,,,REL,Dosage,-1,sufentanil,1451356792.0,Unknown
1451356800,PA166203410,rs8904,,,NFKBIA,Dosage,-1,sufentanil,1451356793.0,Unknown
1451229760,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,tramadol,1451229765.0,Unknown
1451229760,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,tramadol,1451229765.0,Unknown
1451356805,PA166159900,rs696,,,NFKBIA,Dosage,1,sufentanil,1451356820.0,Unknown
1451229766,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tramadol,1451229771.0,Unknown
1451229766,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tramadol,1451229771.0,Unknown
1451229766,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tramadol,1451229771.0,Unknown
1451214860,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,moxifloxacin,1451214843.0,"Multiple groups, South African: 56 individuals were Black, one individual white and one individual ""colored"""
1451214860,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,moxifloxacin,1451214843.0,"Multiple groups, South African: 56 individuals were Black, one individual white and one individual ""colored"""
1451214860,,,PA166115843,UGT1A1*36,UGT1A1,Metabolism/PK,1,moxifloxacin,1451214843.0,"Multiple groups, South African: 56 individuals were Black, one individual white and one individual ""colored"""
1451214860,,,PA166115844,UGT1A1*37,UGT1A1,Metabolism/PK,1,moxifloxacin,1451214843.0,"Multiple groups, South African: 56 individuals were Black, one individual white and one individual ""colored"""
1451357220,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,rosuvastatin,1451357224.0,European
1451357220,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,rosuvastatin,1451357224.0,European
1451356980,PA166233341,rs6981827,,,CSMD1,Efficacy,1,anastrozole,1451356985.0,Unknown
1451356980,PA166233341,rs6981827,,,CSMD1,Efficacy,1,anastrozole,1451356985.0,Unknown
1451162952,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,metronidazole,1451162921.0,"Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants"
1451162952,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,metronidazole,1451162921.0,"Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants"
1451162952,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,metronidazole,1451162921.0,"Multiple groups, White, non-Hispanic, Black and Middle-Eastern particicpants"
1451356971,PA166233301,rs2449598,,,DLG2,Efficacy,1,anastrozole,1451356976.0,Unknown
1451356971,PA166233301,rs2449598,,,DLG2,Efficacy,1,anastrozole,1451356976.0,Unknown
1451356971,PA166233301,rs2449598,,,DLG2,Efficacy,1,anastrozole,1451356976.0,Unknown
1446904199,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1446904202.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1446904201.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1446904202.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1446904201.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1446904202.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1446904201.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1446904202.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1446904201.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1446904202.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1446904201.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1446904202.0,East Asian
1446904199,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1446904201.0,East Asian
827847849,PA166156991,rs1799971,,,OPRM1,Dosage,1,alfentanil,1451237707.0,Unknown
827847849,PA166156991,rs1799971,,,OPRM1,Dosage,1,alfentanil,1451237705.0,Unknown
827847849,PA166156991,rs1799971,,,OPRM1,Dosage,1,alfentanil,827847850.0,Unknown
827847849,PA166156991,rs1799971,,,OPRM1,Dosage,1,alfentanil,1451237708.0,Unknown
827847849,PA166156991,rs1799971,,,OPRM1,Dosage,1,alfentanil,1451237706.0,Unknown
827847849,PA166156991,rs1799971,,,OPRM1,Dosage,1,alfentanil,1451237704.0,Unknown
1451358200,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1451358205.0,Unknown
1184654383,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184654385.0,Unknown
1184654383,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184654385.0,Unknown
1184654383,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,1184654385.0,Unknown
1184654383,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,warfarin,1184654385.0,Unknown
1183701514,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183701516.0,"Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic)."
1183701514,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183701516.0,"Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic)."
827919897,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,simvastatin,827919901.0,Unknown
827919897,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,simvastatin,827919901.0,Unknown
827919897,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,simvastatin,827919901.0,Unknown
827919897,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,simvastatin,827919901.0,Unknown
827919897,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827919901.0,Unknown
827919897,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,827919901.0,Unknown
827919897,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,827919901.0,Unknown
827919897,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,827919901.0,Unknown
827919905,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,simvastatin,827919908.0,Unknown
827919905,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,simvastatin,827919908.0,Unknown
827919905,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,simvastatin,827919908.0,Unknown
827919905,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,simvastatin,827919908.0,Unknown
827919905,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,827919908.0,Unknown
827919905,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,827919908.0,Unknown
827919905,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,warfarin,827919908.0,Unknown
827919905,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,warfarin,827919908.0,Unknown
827919924,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827919927.0,Unknown
827919924,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,827919927.0,Unknown
827919924,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,827919927.0,Unknown
827919924,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,827919927.0,Unknown
1451358680,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,rosuvastatin,1451358666.0,East Asian
1451358673,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,-1,rosuvastatin,1451358691.0,East Asian
1451358700,PA166186237,rs4764980,,,NR1H4,Metabolism/PK,-1,rosuvastatin,1451358704.0,East Asian
1451358668,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,rosuvastatin,1451358672.0,East Asian
1448267984,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448267986.0,East Asian
1448267984,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448267986.0,East Asian
1184510026,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184510028.0,East Asian
1184510026,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184510028.0,East Asian
1444693888,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1444693890.0,Multiple groups
827919910,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827919921.0,Unknown
827919910,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,827919921.0,Unknown
827919910,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,827919921.0,Unknown
827919910,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,827919921.0,Unknown
769251002,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,769251005.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769251002,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,769251005.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769251002,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,769251005.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769251002,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,769251005.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769251002,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,769251005.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769251002,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,769251005.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
978614428,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,978614517.0,Central/South Asian
978614428,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,978614519.0,Central/South Asian
978614428,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,0,warfarin,978614517.0,Central/South Asian
978614428,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,0,warfarin,978614519.0,Central/South Asian
1444930897,PA166155468,rs12979860,,,IFNL3,Efficacy,0,daclatasvir,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL4,Efficacy,0,daclatasvir,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2a,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2a,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2b,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2b,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL3,Efficacy,0,ribavirin,1444930903.0,Multiple groups
1444930897,PA166155468,rs12979860,,,IFNL4,Efficacy,0,ribavirin,1444930903.0,Multiple groups
1444706780,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444706782.0,European
1444706780,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444706782.0,European
1444706780,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706782.0,European
1444706780,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706782.0,European
1444706780,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706782.0,European
1444706780,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706782.0,European
1444706780,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706782.0,European
1451241020,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,letrozole,1451241040.0,"Multiple groups, Study carried out in London, Ontario, Canada. The majority of study participants were Caucasian."
1451241020,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,letrozole,1451241040.0,"Multiple groups, Study carried out in London, Ontario, Canada. The majority of study participants were Caucasian."
1451241020,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,letrozole,1451241040.0,"Multiple groups, Study carried out in London, Ontario, Canada. The majority of study participants were Caucasian."
1451241020,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,letrozole,1451241040.0,"Multiple groups, Study carried out in London, Ontario, Canada. The majority of study participants were Caucasian."
981478958,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981478963.0,European
981478958,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981478963.0,European
981478958,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981478963.0,European
981478958,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981478963.0,European
1184756158,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1184756160.0,East Asian
1184756158,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1184756188.0,Unknown
827864554,PA166154176,rs28371686,,,CYP2C9,Dosage,1,warfarin,827864555.0,Near Eastern
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,telaprevir,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL3,Efficacy,1,telaprevir,1444667947.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,telaprevir,1444665875.0,European
1444665865,PA166155468,rs12979860,,,IFNL4,Efficacy,1,telaprevir,1444667947.0,European
827864542,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,827864543.0,European
827864542,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827864543.0,European
1451359472,PA166233886,rs1611114,,,DBH,Dosage,-1,methadone,1451359480.0,East Asian
1183689393,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183689398.0,"Multiple groups, Brazilian."
1451359106,PA166233881,rs10064525,,,SLC6A3,Efficacy,-1,heroin,1451359110.0,East Asian
1451359340,PA166233881,rs10064525,,,SLC6A3,Dosage,-1,heroin,1451359360.0,East Asian
1451359340,PA166233881,rs10064525,,,SLC6A3,Dosage,-1,heroin,1451359360.0,East Asian
1451359340,PA166233881,rs10064525,,,SLC6A3,Dosage,-1,heroin,1451359360.0,East Asian
827704864,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,0,letrozole,827704870.0,East Asian
827704864,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,letrozole,827704870.0,East Asian
827704864,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,letrozole,827704870.0,East Asian
1448255689,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1448255700.0,Unknown
1451359100,PA166233886,rs1611114,,,DBH,Efficacy,-1,heroin,1451359120.0,East Asian
1451359274,PA166233886,rs1611114,,,DBH,Dosage,-1,heroin,1451359279.0,East Asian
1451359481,PA166233881,rs10064525,,,SLC6A3,Dosage,-1,methadone,1451359500.0,East Asian
1451226263,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,pravastatin,1451226273.0,Multiple groups
981754840,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,981754850.0,Near Eastern
982031288,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,982031296.0,Multiple groups
1451359111,PA166208983,rs10770140,,,TH,Efficacy,-1,heroin,1451359115.0,East Asian
982031298,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,982031306.0,Multiple groups
1448276515,,,PA165860687,CYP4F2*3,CYP4F2,Dosage,0,warfarin,1448276517.0,Unknown
1451226420,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,0,atorvastatin,1451226440.0,Unknown
1451226420,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,0,atorvastatin,1451226440.0,Unknown
1446765933,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1446765935.0,East Asian
1448275984,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448275993.0,East Asian
1450370810,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1450370812.0,American
1450370810,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1450370813.0,American
1451359140,PA166156714,rs27072,,,SLC6A3,Efficacy,-1,heroin,1451359121.0,East Asian
1450372683,PA166182096,rs7905446,,,HTR7,Efficacy,1,fluoxetine,1450372685.0,European
1450372683,PA166182096,rs7905446,,,HTR7,Efficacy,1,paroxetine,1450372685.0,European
1451359240,PA166154434,rs10770141,,,TH,Efficacy,-1,heroin,1451359244.0,East Asian
1451359336,PA166233885,rs129882,,,DBH,Dosage,-1,heroin,1451359282.0,East Asian
1451359149,PA166233885,rs129882,,,DBH,Efficacy,-1,heroin,1451359124.0,East Asian
1451359247,PA166209042,rs3842727,,,TH,Efficacy,-1,heroin,1451359251.0,East Asian
1451359269,PA166233887,rs5320,,,DBH,Efficacy,-1,heroin,1451359273.0,East Asian
1451359440,PA166233883,rs11575553,,,DDC,Dosage,-1,heroin,1451359445.0,East Asian
1449750276,,,PA165819268,TPMT*1,TPMT,Dosage,-1,mercaptopurine,1449750278.0,East Asian
1449750276,,,PA165819272,TPMT*3C,TPMT,Dosage,-1,mercaptopurine,1449750278.0,East Asian
1449750276,,,PA165819268,TPMT*1,TPMT,Toxicity,-1,mercaptopurine,1449750278.0,East Asian
1449750276,,,PA165819272,TPMT*3C,TPMT,Toxicity,-1,mercaptopurine,1449750278.0,East Asian
1447682783,PA166156978,rs1142345,,,TPMT,Dosage,1,mercaptopurine,1447682789.0,East Asian
1451359160,PA166156709,rs6347,,,SLC6A3,Efficacy,-1,heroin,1451359164.0,East Asian
1451359200,PA166233884,rs12666409,,,DDC,Efficacy,-1,heroin,1451359220.0,East Asian
1451359260,PA166233883,rs11575553,,,DDC,Efficacy,-1,heroin,1451359264.0,East Asian
1451359460,PA166234021,rs129915,,,DBH,Dosage,-1,heroin,1451359465.0,East Asian
1451359252,PA166154263,rs6356,,,TH,Efficacy,-1,heroin,1451359256.0,East Asian
1451359265,PA166234021,rs129915,,,DBH,Efficacy,-1,heroin,1451359257.0,East Asian
1451359432,PA166154263,rs6356,,,TH,Dosage,-1,heroin,1451359437.0,East Asian
1449140243,PA166154334,rs1799732,,,DRD2,Efficacy,0,aripiprazole,1449140248.0,African American/Afro-Caribbean
827823670,PA166155409,rs3745274,,,CYP2B6,Dosage,1,nevirapine,827823684.0,Sub-Saharan African
827823670,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,827823684.0,Sub-Saharan African
1448576445,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1448576459.0,Latino
1448576445,,,PA165819269,TPMT*2,TPMT,Dosage,1,mercaptopurine,1448576459.0,Latino
1448576445,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1448576459.0,Latino
1333193294,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819269,TPMT*2,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819269,TPMT*2,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819269,TPMT*2,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819279,TPMT*9,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819279,TPMT*9,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819279,TPMT*9,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819291,TPMT*21,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819291,TPMT*21,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819291,TPMT*21,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005224,TPMT*33,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005224,TPMT*33,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005224,TPMT*33,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005225,TPMT*34,TPMT,Dosage,1,mercaptopurine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005225,TPMT*34,TPMT,Dosage,1,mercaptopurine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005225,TPMT*34,TPMT,Dosage,1,mercaptopurine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819269,TPMT*2,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819269,TPMT*2,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819269,TPMT*2,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819270,TPMT*3A,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819270,TPMT*3A,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819270,TPMT*3A,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819272,TPMT*3C,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819272,TPMT*3C,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819272,TPMT*3C,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819279,TPMT*9,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819279,TPMT*9,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819279,TPMT*9,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819291,TPMT*21,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819291,TPMT*21,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA165819291,TPMT*21,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005224,TPMT*33,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005224,TPMT*33,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005224,TPMT*33,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005225,TPMT*34,TPMT,Dosage,1,thioguanine,1333193320.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005225,TPMT*34,TPMT,Dosage,1,thioguanine,1333193318.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1333193294,,,PA166005225,TPMT*34,TPMT,Dosage,1,thioguanine,1351024842.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1296598953,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,0,nevirapine,1296598986.0,Sub-Saharan African
981500472,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,981500484.0,East Asian
981500472,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,981500482.0,East Asian
981500472,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,981500484.0,East Asian
981500472,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,981500482.0,East Asian
827861853,PA166155478,rs28399499,,,CYP2B6,Toxicity,0,nevirapine,827861863.0,Unknown
827861853,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,0,nevirapine,827861863.0,Unknown
827861853,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,0,nevirapine,827861863.0,Unknown
1451902012,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,diazepam,1451902023.0,"Multiple groups, ""11 were Caucasian (33,67 %) and 19; were Latin-American (63.33 %)."""
1451228555,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,rosuvastatin,1451228566.0,East Asian
1451902007,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,diazepam,1451902011.0,"Multiple groups, ""11 were Caucasian (33,67 %) and 19; were Latin-American (63.33 %)."""
1451390700,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,atorvastatin,1451390720.0,European
1451228580,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,rosuvastatin,1451228584.0,East Asian
1184747085,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1184747096.0,East Asian
1184747085,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,1,SN-38,1184747096.0,East Asian
1184747085,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1184747096.0,East Asian
1184747085,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,1,SN-38,1184747096.0,East Asian
1451390620,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,atorvastatin,1451390624.0,Multiple groups
1451228860,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,simvastatin,1451228865.0,East Asian
981794068,PA166155721,rs4148323,,,UGT1A1,Dosage,1,SN-38,981794111.0,East Asian
1451902026,PA166157564,rs1799930,,,NAT2,Metabolism/PK,-1,diazepam,1451902016.0,"Multiple groups, ""11 were Caucasian (33,67 %) and 19; were Latin-American (63.33 %)."""
1448634666,PA166156528,rs1870377,,,KDR,Efficacy,1,carfilzomib,1448634669.0,Unknown
1448634666,PA166156528,rs1870377,,,KDR,Efficacy,1,dexamethasone,1448634669.0,Unknown
1448634666,PA166156528,rs1870377,,,KDR,Efficacy,1,lenalidomide,1448634669.0,Unknown
1446897938,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,cytarabine,1446897940.0,East Asian
1446897938,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,cytarabine,1446897941.0,East Asian
1446897938,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,daunorubicin,1446897940.0,East Asian
1446897938,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,daunorubicin,1446897941.0,East Asian
1446897938,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,dexrazoxane,1446897940.0,East Asian
1446897938,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,dexrazoxane,1446897941.0,East Asian
1448995122,PA166157239,rs3842,,,ABCB1,Metabolism/PK,-1,dolutegravir,1448995124.0,East Asian
1448601898,PA166163155,rs11178998,,,TPH2,Efficacy,-1,venlafaxine,1448601900.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1451902060,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,diazepam,1451902064.0,"Multiple groups, ""11 were Caucasian (33,67 %) and 19; were Latin-American (63.33 %)."""
1184471413,PA166155504,rs36118214,,,CYP2B6,Metabolism/PK,1,efavirenz,1184471415.0,African American/Afro-Caribbean
1448257821,PA166160105,rs9648623,,,GLCCI1,Efficacy,-1,corticosteroids,1448257823.0,Unknown
1448601887,PA166163153,rs11178997,,,TPH2,Efficacy,-1,venlafaxine,1448601889.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1448995116,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,dolutegravir,1448995118.0,East Asian
1451141460,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1451141466.0,East Asian
1449716014,PA166180147,rs3845744,,,ATF2,Dosage,-1,fentanyl,1449716016.0,East Asian
1448634646,PA166156958,rs833061,,,VEGFA,Efficacy,1,carfilzomib,1448634654.0,Unknown
1448634646,PA166156958,rs833061,,,VEGFA,Efficacy,1,carfilzomib,1448634656.0,Unknown
1448634646,PA166156958,rs833061,,,VEGFA,Efficacy,1,dexamethasone,1448634654.0,Unknown
1448634646,PA166156958,rs833061,,,VEGFA,Efficacy,1,dexamethasone,1448634656.0,Unknown
1448634646,PA166156958,rs833061,,,VEGFA,Efficacy,1,lenalidomide,1448634654.0,Unknown
1448634646,PA166156958,rs833061,,,VEGFA,Efficacy,1,lenalidomide,1448634656.0,Unknown
1450928480,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1450928485.0,East Asian
1450928480,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1450928485.0,East Asian
1450928480,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1450928485.0,East Asian
1183619415,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183619417.0,East Asian
1183619415,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183619417.0,East Asian
1183619415,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183619417.0,East Asian
1448601874,PA166154340,rs1800532,,,TPH1,Efficacy,-1,venlafaxine,1448601877.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1450813798,PA166184140,rs7164594,,,HYKK,Efficacy,1,varenicline,1450813803.0,European
1451354464,PA166156083,rs2020917,,,COMT,Dosage,-1,methadone,1451354469.0,Unknown
1449716026,PA166180149,rs1982235,,,ATF2,Dosage,-1,fentanyl,1449716028.0,East Asian
1448601868,PA166163150,rs9567746,,,HTR2A,Efficacy,-1,venlafaxine,1448601870.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1449748829,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748844.0,Unknown
1449748829,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748841.0,Unknown
1449748829,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748844.0,Unknown
1449748829,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748841.0,Unknown
1183701311,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1183701319.0,"Multiple groups, 94% White"
1183701311,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1183701319.0,"Multiple groups, 94% White"
1448601851,PA166163147,rs2274639,,,HTR2A,Efficacy,-1,venlafaxine,1448601853.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1448601857,PA166154673,rs6311,,,HTR2A,Efficacy,-1,venlafaxine,1448601859.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1449716072,PA166156991,rs1799971,,,OPRM1,Efficacy,1,fentanyl,1449716078.0,"Multiple groups, Asian and Caucasian participants"
1449732457,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1449732475.0,East Asian
1449732457,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1449732477.0,East Asian
1449732457,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1449732475.0,East Asian
1449732457,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1449732477.0,East Asian
1449732457,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1449732475.0,East Asian
1449732457,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1449732477.0,East Asian
1449732457,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1449732475.0,East Asian
1449732457,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1449732477.0,East Asian
1449716044,PA166157030,rs2275913,,,IL17A,Dosage,1,opioids,1449716052.0,East Asian
1449716044,PA166157030,rs2275913,,,IL17A,Efficacy,1,opioids,1449716052.0,East Asian
1451905400,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,"sulfonamides, urea derivatives",1451905408.0,East Asian
1451905400,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,"sulfonamides, urea derivatives",1451905408.0,East Asian
1451905400,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,"sulfonamides, urea derivatives",1451905408.0,East Asian
1451141440,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,rosuvastatin,1451141449.0,East Asian
1449191784,PA166157534,rs193922525,,,CFTR,Efficacy,1,ivacaftor,1449191786.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1451354440,PA166177940,rs2235751,,,PDYN,Dosage,-1,methadone,1451354445.0,Unknown
1450928448,PA166170406,rs10211,,,CYP3A7,Metabolism/PK,1,tacrolimus,1450928453.0,East Asian
1448601840,PA166156903,rs6296,,,HTR1B,Efficacy,-1,venlafaxine,1448601842.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1183701305,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183701307.0,European
1183701305,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1183701307.0,European
1447520509,PA166156277,rs6280,,,DRD3,Metabolism/PK,1,quetiapine,1447520514.0,European
1449191796,PA166157532,rs121909013,,,CFTR,Efficacy,1,ivacaftor,1449191798.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1448601834,PA166156908,rs130058,,,HTR1B,Efficacy,-1,venlafaxine,1448601836.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1448601828,PA166157174,rs11568817,,,HTR1B,Efficacy,-1,venlafaxine,1448601830.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
769245428,PA166154053,rs4244285,,,CYP2C19,Efficacy,0,aspirin,769245453.0,"Multiple groups, 94 White; 49 African American"
1183701419,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701419,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701419,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701419,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701419,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701419,,,PA165816551,CYP2C9*10,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816551,CYP2C9*10,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816551,CYP2C9*10,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701419,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1183701453.0,"Multiple groups, European-American plus African American"
1183701419,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1183701473.0,European
1183701419,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1183701455.0,African American/Afro-Caribbean
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,carbamazepine,1183701421.0,East Asian
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,gabapentin,1183701421.0,East Asian
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,lamotrigine,1183701421.0,East Asian
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,oxcarbazepine,1183701421.0,East Asian
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,phenytoin,1183701421.0,East Asian
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,topiramate,1183701421.0,East Asian
1183701415,PA166156842,rs6883877,,,GABRA1,Efficacy,-1,valproic acid,1183701421.0,East Asian
1448257758,PA166160091,rs13245462,,,GLCCI1,Efficacy,-1,corticosteroids,1448257760.0,Unknown
1448601816,PA166156708,rs6295,,,HTR1A,Efficacy,-1,venlafaxine,1448601818.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1448634582,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634586.0,Unknown
1448634582,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634584.0,Unknown
1449191818,PA166157511,rs74503330,,,CFTR,Efficacy,1,ivacaftor,1449191820.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
769245444,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,aspirin,769245450.0,"Multiple groups, 94 White;49  African American"
1448257749,PA166160089,rs10243846,,,GLCCI1,Efficacy,-1,corticosteroids,1448257751.0,Unknown
1448601808,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,venlafaxine,1448601810.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1449748855,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748857.0,Unknown
1449748855,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748857.0,Unknown
1449748855,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748857.0,Unknown
1448634570,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634581.0,Unknown
1448634570,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634576.0,Unknown
1448634570,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634578.0,Unknown
1449191831,PA166157529,rs121908755,,,CFTR,Efficacy,1,ivacaftor,1449191833.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
982044019,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,carvedilol,982044026.0,European
769245459,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,aspirin,769245462.0,"Multiple groups, 59 White;  50 African American"
769245459,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,aspirin,769245464.0,"Multiple groups, 59 White; 55 African American"
769245459,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,769245462.0,"Multiple groups, 59 White;  50 African American"
769245459,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,769245464.0,"Multiple groups, 59 White; 55 African American"
1451354476,PA166232251,rs174675,,,COMT,Dosage,-1,methadone,1451354481.0,Unknown
769245456,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,aspirin,769245458.0,"Multiple groups, 59 White; 55 African American"
769245456,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,769245458.0,"Multiple groups, 59 White; 55 African American"
1184471382,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471392.0,East Asian
1184471382,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471392.0,East Asian
1184471393,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471395.0,East Asian
1184471393,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471395.0,East Asian
769245468,PA166154147,rs12248560,,,CYP2C19,,1,aspirin,769245471.0,Multiple groups
769245468,PA166154147,rs12248560,,,CYP2C19,,1,clopidogrel,769245471.0,Multiple groups
1448257731,PA166160085,rs10229643,,,GLCCI1,Efficacy,-1,corticosteroids,1448257733.0,Unknown
1448257722,PA166160083,rs1476823,,,GLCCI1,Efficacy,-1,corticosteroids,1448257724.0,Unknown
1449191837,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449191839.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1450944900,PA166153977,rs1801253,,,ADRB1,Efficacy,1,atenolol,1450944908.0,"Multiple groups, USA Vandebilt, White or Black, ""Subjects reported their ethnicity and that of their parents and grandparents using check-boxes to choose among “Caucasian”, “African-American”, “Hispanic”, “Chinese”, “Japanese”, and “other” (the latter to be specified). Multiple choices were permitted. A subject was assigned to an ethnic group when both parents and at least 3 out of 4 grandparents were of the same ethnicity."""
1449191843,PA166157531,rs121909005,,,CFTR,Efficacy,1,ivacaftor,1449191845.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1184471403,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471405.0,East Asian
1184471403,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471405.0,East Asian
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,aspirin,1450928595.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,aspirin,1450928596.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,aspirin,1450928597.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,clopidogrel,1450928595.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,clopidogrel,1450928596.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,clopidogrel,1450928597.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,prasugrel,1450928595.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,prasugrel,1450928596.0,"Multiple groups, European, African American and East Asian ancestries"
1450928591,PA166153839,rs12041331,,,PEAR1,Efficacy,1,prasugrel,1450928597.0,"Multiple groups, European, African American and East Asian ancestries"
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,carbamazepine,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,gabapentin,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,lamotrigine,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,oxcarbazepine,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,phenytoin,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,topiramate,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,valproic acid,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,valproic acid,1183701470.0,East Asian
1183701468,PA166157861,rs1112122,,,GABRA3,Efficacy,-1,valproic acid,1183701470.0,East Asian
1448257704,PA166160079,rs2041362,,,GLCCI1,Efficacy,-1,corticosteroids,1448257706.0,Unknown
982044110,PA166153977,rs1801253,,,ADRB1,Dosage,-1,bisoprolol,982044119.0,European
1447962788,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1447962796.0,Unknown
1449748938,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748940.0,East Asian
1449748938,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748940.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,carbamazepine,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,gabapentin,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,lamotrigine,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,oxcarbazepine,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,phenytoin,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,topiramate,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,valproic acid,1183701458.0,East Asian
1183701456,PA166156756,rs1157122,,,GABRA1,Efficacy,-1,valproic acid,1183701458.0,East Asian
1448257686,PA166160075,rs37990,,,GLCCI1,Efficacy,-1,corticosteroids,1448257688.0,Unknown
1451908780,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,atomoxetine,1451908800.0,Central/South Asian
1451908780,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,atomoxetine,1451908820.0,Central/South Asian
1185012234,PA166157316,rs2032582,,,ABCB1,Dosage,1,cyclosporine,1185012236.0,Near Eastern
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,carbamazepine,1183701466.0,East Asian
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,gabapentin,1183701466.0,East Asian
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,lamotrigine,1183701466.0,East Asian
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,oxcarbazepine,1183701466.0,East Asian
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,phenytoin,1183701466.0,East Asian
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,topiramate,1183701466.0,East Asian
1183701464,PA166156857,rs10068980,,,GABRA1,Efficacy,-1,valproic acid,1183701466.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,carbamazepine,1183701462.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,gabapentin,1183701462.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,lamotrigine,1183701462.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,oxcarbazepine,1183701462.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,phenytoin,1183701462.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,topiramate,1183701462.0,East Asian
1183701460,PA166156844,rs6892782,,,GABRA1,Efficacy,-1,valproic acid,1183701462.0,East Asian
1183848923,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183848993.0,East Asian
1183848923,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183863917.0,East Asian
1183848923,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183848993.0,East Asian
1183848923,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183863917.0,East Asian
1183848923,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183848993.0,East Asian
1183848923,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183863917.0,East Asian
1449748921,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748923.0,East Asian
1449748921,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748923.0,East Asian
1451908740,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,methylphenidate,1451908749.0,Central/South Asian
1451908740,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,methylphenidate,1451908745.0,Central/South Asian
1183848916,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183849025.0,East Asian
1183848916,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183848983.0,East Asian
1183848916,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183849025.0,East Asian
1183848916,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183848983.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,carbamazepine,1183701443.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,gabapentin,1183701443.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,lamotrigine,1183701443.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,oxcarbazepine,1183701443.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,phenytoin,1183701443.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,topiramate,1183701443.0,East Asian
1183701441,PA166157877,rs4828696,,,GABRA3,Efficacy,-1,valproic acid,1183701443.0,East Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908755.0,Central/South Asian
1451908750,PA166156076,rs1135840,,,CYP2D6,Efficacy,1,methylphenidate,1451908756.0,Central/South Asian
1185012251,PA166157391,rs4646437,,,CYP3A4,Efficacy,1,cyclosporine,1185012257.0,Near Eastern
1185012251,PA166157391,rs4646437,,,CYP3A4,Efficacy,1,cyclosporine,1185012257.0,Near Eastern
769278040,PA166155477,rs28399468,,,CYP2A6,Other,-1,nicotine,981201932.0,East Asian
769278040,PA166155477,rs28399468,,,CYP2A6,Metabolism/PK,-1,nicotine,981201932.0,East Asian
1451909620,PA166155285,rs2612091,,,ENOSF1,Efficacy,1,fluorouracil,1451909640.0,Near Eastern
769278048,PA166155376,rs1801272,,,CYP2A6,Other,0,coumarin,978636633.0,Unknown
769278048,PA166155376,rs1801272,,,CYP2A6,Metabolism/PK,0,coumarin,978636633.0,Unknown
1144788614,PA166153539,rs699,,,AGT,Efficacy,-1,losartan,1144788649.0,Unknown
769278055,PA166155376,rs1801272,,,CYP2A6,Metabolism/PK,0,coumarin,978636636.0,Unknown
982044093,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,fluvastatin,982044108.0,European
982044093,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,pravastatin,982044108.0,European
769278059,PA166155422,rs5031016,,,CYP2A6,Metabolism/PK,0,nicotine,769278062.0,East Asian
1451909688,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,1451909700.0,Sub-Saharan African
1451909688,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,1451909700.0,Sub-Saharan African
1451909688,,,PA165816552,CYP2C9*11,CYP2C9,Metabolism/PK,1,warfarin,1451909700.0,Sub-Saharan African
1448257646,PA166160067,rs7792118,,,GLCCI1,Efficacy,-1,corticosteroids,1448257648.0,Unknown
1183701537,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,citalopram,1183701545.0,East Asian
1183701537,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,citalopram,1183701545.0,East Asian
1449716224,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1449716239.0,East Asian
1449716224,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1449716237.0,East Asian
1449716224,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1449716239.0,East Asian
1449716224,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1449716237.0,East Asian
1450813969,PA166156024,rs4680,,,COMT,Efficacy,-1,modafinil,1450813974.0,European
1450813969,PA166156024,rs4680,,,COMT,Efficacy,-1,modafinil,1450813974.0,European
1448257635,PA166160065,rs37976,,,GLCCI1,Efficacy,-1,corticosteroids,1448257637.0,Unknown
1183701546,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,citalopram,1183701548.0,East Asian
1183701546,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,citalopram,1183701548.0,East Asian
1451239960,PA166161209,rs2853542,,,TYMS,Efficacy,1,methotrexate,1451239980.0,Unknown
1447946341,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,1447946347.0,European
1451909701,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,hydroxyphenytoin,1451909727.0,Sub-Saharan African
1451909701,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,hydroxyphenytoin,1451909727.0,Sub-Saharan African
1451909701,,,PA165816552,CYP2C9*11,CYP2C9,Metabolism/PK,1,hydroxyphenytoin,1451909727.0,Sub-Saharan African
1449732592,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1449732594.0,East Asian
1450928668,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1450928676.0,East Asian
1450928668,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1450928672.0,East Asian
1450928668,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1450928673.0,East Asian
1450928668,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1450928675.0,East Asian
1450813982,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,modafinil,1450813987.0,"Multiple groups, ""Non-Hispanic Caucasian"" and ""Hispanic Caucasian"" subjects"
1448257622,PA166157244,rs37973,,,GLCCI1,Efficacy,-1,corticosteroids,1448257625.0,Unknown
1451910660,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451910666.0,East Asian
1451910660,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451910665.0,East Asian
1183701528,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1183701530.0,"Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic)."
1451092520,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,piroxicam,1451092511.0,"Multiple groups, Brazilian"
1451092520,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,piroxicam,1451092511.0,"Multiple groups, Brazilian"
982044192,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,digoxin,982044202.0,European
982044192,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,digoxin,982044202.0,European
1448519749,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,fluorouracil,1448519758.0,Multiple groups
1448519749,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,irinotecan,1448519758.0,Multiple groups
1448519749,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,oxaliplatin,1448519758.0,Multiple groups
1183701501,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183701509.0,"Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic)."
1183701501,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183701509.0,"Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic)."
1449716257,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,fentanyl,1449716259.0,East Asian
1450928634,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450928638.0,European
1450928634,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450928640.0,European
1450928634,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450928639.0,European
1450928634,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450928641.0,European
1448257599,PA166160062,rs37972,,,GLCCI1,Efficacy,-1,corticosteroids,1448257621.0,Unknown
1449716264,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,fentanyl,1449716266.0,East Asian
1448601657,PA166156339,rs2046934,,,P2RY12,Efficacy,1,clopidogrel,1448601659.0,East Asian
1185012200,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,cyclosporine,1185012206.0,Near Eastern
1449191978,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,apixaban,1449191980.0,East Asian
1451338240,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1451338245.0,Multiple groups
1451338240,PA166190881,rs11322783,,,IFNL4,Efficacy,1,sofosbuvir,1451338245.0,Multiple groups
1451338240,PA166190881,rs11322783,,,IFNL4,Efficacy,1,sofosbuvir,1451338245.0,Multiple groups
1450814028,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1450814034.0,Unknown
1450814028,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1450814034.0,Unknown
1450814028,,,PA165816569,CYP2C9*24,CYP2C9,Dosage,0,warfarin,1450814034.0,Unknown
1449191990,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,apixaban,1449191992.0,East Asian
1448601648,PA166163131,rs7428575,,,P2RY12,Efficacy,-1,clopidogrel,1448601656.0,East Asian
1449716250,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,fentanyl,1449716252.0,East Asian
1449716250,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,fentanyl,1449716252.0,East Asian
1184471670,,,PA165819171,CYP1A2*1A,CYP1A2,Efficacy,-1,prasugrel,1184471673.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471670,,,PA165819171,CYP1A2*1A,CYP1A2,Efficacy,-1,prasugrel,1184471672.0,Unknown
1184471670,,,PA165819173,CYP1A2*1C,CYP1A2,Efficacy,-1,prasugrel,1184471673.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471670,,,PA165819173,CYP1A2*1C,CYP1A2,Efficacy,-1,prasugrel,1184471672.0,Unknown
1184471670,,,PA165819174,CYP1A2*1D,CYP1A2,Efficacy,-1,prasugrel,1184471673.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471670,,,PA165819174,CYP1A2*1D,CYP1A2,Efficacy,-1,prasugrel,1184471672.0,Unknown
1184471670,,,PA165819175,CYP1A2*1E,CYP1A2,Efficacy,-1,prasugrel,1184471673.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471670,,,PA165819175,CYP1A2*1E,CYP1A2,Efficacy,-1,prasugrel,1184471672.0,Unknown
1184471670,,,PA165988094,CYP1A2*1L,CYP1A2,Efficacy,-1,prasugrel,1184471673.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471670,,,PA165988094,CYP1A2*1L,CYP1A2,Efficacy,-1,prasugrel,1184471672.0,Unknown
1449716295,PA166157288,rs1128503,,,ABCB1,Efficacy,1,fentanyl,1449716297.0,East Asian
982044239,PA166157472,rs17161788,,,CYP3A5,Efficacy,1,atorvastatin,982044250.0,Latino
982044239,PA166157472,rs17161788,,,CYP3A5,Efficacy,1,atorvastatin,982044251.0,Sub-Saharan African
1183849063,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1183849098.0,East Asian
1183849063,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1183849091.0,East Asian
1183849063,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1183849098.0,East Asian
1183849063,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1183849091.0,East Asian
1183849063,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183849098.0,East Asian
1183849063,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183849091.0,East Asian
1183849063,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183849098.0,East Asian
1183849063,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183849091.0,East Asian
1451092564,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,meloxicam,1451092580.0,Multiple groups
1451092564,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,meloxicam,1451092580.0,Multiple groups
1451092564,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,meloxicam,1451092580.0,Multiple groups
1183619689,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,paroxetine,1183619691.0,Multiple groups
1449191984,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,apixaban,1449191986.0,East Asian
1185012360,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1185012362.0,East Asian
1449192000,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1449192006.0,Near Eastern
1450928686,PA166156991,rs1799971,,,OPRM1,Other,1,ethanol,1450928690.0,East Asian
769277894,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,769277898.0,European
1183701565,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1183701567.0,European
1183701565,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1183701567.0,European
1450043998,PA166181205,rs35068180,,,MMP3,Efficacy,1,pravastatin,1450044000.0,Unknown
1448257532,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,bupropion,1448257534.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1448257532,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,bupropion,1448257534.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1448257532,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,bupropion,1448257534.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1448257532,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,bupropion,1448257534.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1183701573,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1183701579.0,European
1183701573,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1183701579.0,European
1183849008,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183849040.0,East Asian
1183849008,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183849031.0,East Asian
1183849008,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183849040.0,East Asian
1183849008,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183849031.0,East Asian
1183849008,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183849040.0,East Asian
1183849008,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183849031.0,East Asian
769277912,PA166154977,rs7294,,,PRSS53,Dosage,1,warfarin,769277918.0,East Asian
769277912,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,769277918.0,East Asian
1447520262,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447520264.0,European
1447520262,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447520264.0,European
1447520262,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447520264.0,European
1184471715,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,aspirin,1184471719.0,Unknown
1184471715,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,aspirin,1184471721.0,Unknown
1184471715,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1184471719.0,Unknown
1184471715,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1184471721.0,Unknown
1448257516,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,bupropion,1448257518.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1448257516,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,bupropion,1448257518.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1449732693,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1449732699.0,East Asian
1450814021,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1450814027.0,Unknown
1450814021,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1450814027.0,Unknown
1450814021,,,PA165816569,CYP2C9*24,CYP2C9,Dosage,0,warfarin,1450814027.0,Unknown
1450814021,,,PA165816569,CYP2C9*24,CYP2C9,Dosage,0,warfarin,1450814027.0,Unknown
1450814021,,,PA165816569,CYP2C9*24,CYP2C9,Dosage,0,warfarin,1450814027.0,Unknown
1450814021,,,PA165816569,CYP2C9*24,CYP2C9,Dosage,0,warfarin,1450814027.0,Unknown
982044307,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,1,carvedilol,982044313.0,East Asian
1448257502,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,bupropion,1448257515.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1448257502,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,bupropion,1448257515.0,"Multiple groups, White and hispanic (36%), white and non-hispanic (57%)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,bupropion,1450928796.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,bupropion,1450928797.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,bupropion,1450928794.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,nicotine,1450928796.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,nicotine,1450928797.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,nicotine,1450928794.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,varenicline,1450928796.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,varenicline,1450928797.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928789,PA166185385,rs2472553,,,CHRNA2,Efficacy,-1,varenicline,1450928794.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1183849125,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183849133.0,East Asian
1183849125,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183849133.0,East Asian
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,bupropion,1450928805.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,bupropion,1450928804.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,bupropion,1450928803.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,nicotine,1450928805.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,nicotine,1450928804.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,nicotine,1450928803.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,varenicline,1450928805.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,varenicline,1450928804.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928798,PA166154856,rs1051730,,,CHRNA3,Efficacy,-1,varenicline,1450928803.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1449192069,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192075.0,Unknown
1449192069,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192075.0,Unknown
1183849101,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183849107.0,East Asian
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,bupropion,1450928813.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,bupropion,1450928812.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,bupropion,1450928811.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,nicotine,1450928813.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,nicotine,1450928812.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,nicotine,1450928811.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,varenicline,1450928813.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,varenicline,1450928812.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928806,PA166185388,rs6474413,,,CHRNB3,Efficacy,-1,varenicline,1450928811.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1449716341,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,fentanyl,1449716343.0,East Asian
1444702155,PA166157757,rs2770150,,,TLR4,Efficacy,1,Pertussis vaccines,1444702162.0,Unknown
1183849112,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,paroxetine,1183849124.0,East Asian
1183849112,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1183849124.0,East Asian
1183849112,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1183849124.0,East Asian
1451913100,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,apixaban,1451913140.0,"Multiple groups, Trial was carried out at 1113 study locations globally including sites in North America, South America, Europe, and Asia (NCT00412984)"
1451092600,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,meloxicam,1451092620.0,East Asian
1451092600,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,meloxicam,1451092620.0,East Asian
982044299,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,carvedilol,982044306.0,East Asian
982044299,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,carvedilol,982044306.0,East Asian
982044299,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,carvedilol,982044306.0,East Asian
982044299,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,carvedilol,982044306.0,East Asian
1450928770,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,bupropion,1450928775.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928770,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,nicotine,1450928775.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928770,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,varenicline,1450928775.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1185012329,PA166155187,rs1799752,,,ACE,Dosage,-1,tacrolimus,1185012335.0,East Asian
1185012329,PA166155187,rs1799752,,,ACE,Dosage,-1,tacrolimus,1185012335.0,East Asian
1185012329,PA166155187,rs1799752,,,ACE,Dosage,-1,tacrolimus,1185012335.0,East Asian
1451913560,PA166154070,rs4986893,,,CYP2C19,Dosage,1,warfarin,1451913564.0,Unknown
1449192093,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,1449192099.0,Unknown
1450928777,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,bupropion,1450928782.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928777,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,nicotine,1450928782.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1450928777,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,varenicline,1450928782.0,"Multiple groups, Brazilian subjects (white, black, intermediate, Asian or Amerindian)"
1451141840,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,hydromorphone,1451141844.0,African American/Afro-Caribbean
1451141840,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,0,hydromorphone,1451141844.0,African American/Afro-Caribbean
1183685341,PA166153835,rs11807862,,,PRDM16,Efficacy,-1,atorvastatin,1183685345.0,European
1183685341,PA166153835,rs11807862,,,PRDM16,Efficacy,-1,hmg coa reductase inhibitors,1183685345.0,European
1183685341,PA166153835,rs11807862,,,PRDM16,Efficacy,-1,simvastatin,1183685345.0,European
1451913567,PA166154042,rs3814637,,,CYP2C19,Dosage,1,warfarin,1451913582.0,Unknown
1450814162,PA166156991,rs1799971,,,OPRM1,Dosage,1,ethanol,1450814166.0,"Multiple groups, ""Almost all adolescents (94.1%) lived in households with both parents being Caucasian, the remainder had a least one non-Caucasian parent"""
1449192108,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192114.0,Unknown
1449192108,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192114.0,Unknown
1449716420,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,fentanyl,1449716430.0,"Multiple groups, Malay, Chinese and other"
1449716420,,,PA165819240,CYP3A4*18,CYP3A4,Dosage,-1,fentanyl,1449716430.0,"Multiple groups, Malay, Chinese and other"
982044373,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,982044379.0,European
982044373,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,982044379.0,European
982044373,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,982044379.0,European
982044373,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,982044379.0,European
1451913583,PA166154053,rs4244285,,,CYP2C19,Dosage,-1,warfarin,1451913571.0,Unknown
1451141860,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,0,hydrocodone,1451141864.0,African American/Afro-Caribbean
1451141860,,,PA165816583,CYP2D6*17,CYP2D6,Efficacy,0,hydrocodone,1451141864.0,African American/Afro-Caribbean
1451141860,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,0,tramadol,1451141864.0,African American/Afro-Caribbean
1451141860,,,PA165816583,CYP2D6*17,CYP2D6,Efficacy,0,tramadol,1451141864.0,African American/Afro-Caribbean
1448617859,PA166155721,rs4148323,,,UGT1A1,Efficacy,-1,irinotecan,1448617861.0,East Asian
1448617859,PA166155721,rs4148323,,,UGT1A1,Efficacy,-1,irinotecan,1448617861.0,East Asian
1450814181,PA166180109,rs671531,,,OPRM1,Efficacy,1,highly active antiretroviral therapy (haart),1450814189.0,Latino
1450814181,PA166180109,rs671531,,,OPRM1,Efficacy,1,highly active antiretroviral therapy (haart),1450814190.0,European
1450814181,PA166180109,rs671531,,,OPRM1,Efficacy,1,highly active antiretroviral therapy (haart),1450814191.0,African American/Afro-Caribbean
1448995530,PA166170277,rs8094439,,,CDH2,Efficacy,1,methadone,1448995535.0,East Asian
1449192131,PA166178088,rs121909047,,,CFTR,Efficacy,1,lumacaftor,1449192133.0,"Custom, Not applicable - study was carried out in PBE cells"
982044349,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,982044355.0,European
1451092660,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,meloxicam,1451092670.0,Multiple groups
1451092660,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,meloxicam,1451092670.0,Multiple groups
1451092660,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,meloxicam,1451092670.0,Multiple groups
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995576.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995565.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995578.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995572.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995580.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995574.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995568.0,Unknown
1448995554,PA166154312,rs1062613,,,HTR3A,Efficacy,-1,granisetron,1448995570.0,Unknown
1451092671,,,PA165816542,CYP2C9*1,CYP2C9,PD,1,meloxicam,1451092676.0,East Asian
1451092671,,,PA165816554,CYP2C9*13,CYP2C9,PD,1,meloxicam,1451092676.0,East Asian
1451092671,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,meloxicam,1451092676.0,East Asian
1451092671,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,meloxicam,1451092676.0,East Asian
1449716437,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1449716449.0,East Asian
1449716437,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1449716449.0,East Asian
982044434,PA166153541,rs1205,,,CRP,Efficacy,-1,fenofibrate,982044439.0,European
1448257366,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448257368.0,Unknown
1448257366,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1448257368.0,Unknown
1448257366,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448257368.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995590.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995587.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995589.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995585.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995584.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995586.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995588.0,Unknown
1448995581,PA166154324,rs1176744,,,HTR3B,Efficacy,-1,granisetron,1448995591.0,Unknown
1447520081,PA166155096,rs9934438,,,VKORC1,Dosage,-1,warfarin,1447520083.0,Multiple groups
1448257356,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448257363.0,Unknown
769261454,PA166153643,rs1801131,,,MTHFR,Efficacy,1,oxaliplatin,769261457.0,Unknown
982044407,PA166153735,rs3091244,,,CRP,Efficacy,1,fenofibrate,982044415.0,European
769261461,PA166155406,rs3212948,,,ERCC1,Efficacy,1,fluorouracil,769261464.0,Unknown
769261461,PA166155406,rs3212948,,,ERCC1,Efficacy,1,leucovorin,769261464.0,Unknown
769261461,PA166155406,rs3212948,,,ERCC1,Efficacy,1,oxaliplatin,769261464.0,Unknown
982044398,PA166153630,rs1417938,,,CRP,Efficacy,1,fenofibrate,982044405.0,European
1448995614,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1448995620.0,European
1448995614,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1448995620.0,European
982044416,PA166153735,rs3091244,,,CRP,Efficacy,1,fenofibrate,982044422.0,European
982044416,PA166153735,rs3091244,,,CRP,Efficacy,1,fenofibrate,982044422.0,European
982044500,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,clonidine,982044506.0,East Asian
1183619942,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183619959.0,East Asian
1183619942,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183619944.0,East Asian
1449749318,PA166154761,rs186364861,,,NUDT15,Dosage,1,mercaptopurine,1449749326.0,Unknown
1446897429,PA166157288,rs1128503,,,ABCB1,Efficacy,1,glucocorticoids,1446897437.0,East Asian
1450928984,PA166182408,rs1277441,,,TAOK3,Dosage,-1,opioids,1450928994.0,Unknown
1184471936,PA166156029,rs11479,,,TYMP,Dosage,1,capecitabine,1184471940.0,Unknown
1184471936,PA166156029,rs11479,,,TYMP,Dosage,1,fluorouracil,1184471940.0,Unknown
1446897438,PA166157284,rs1045642,,,ABCB1,Efficacy,1,glucocorticoids,1446897440.0,East Asian
1184471941,PA166153760,rs3918290,,,DPYD,Dosage,1,capecitabine,1184471943.0,Unknown
1184471941,PA166153760,rs3918290,,,DPYD,Dosage,1,fluorouracil,1184471943.0,Unknown
1450928995,PA166182407,rs795484,,,TAOK3,Dosage,1,opioids,1450929001.0,Unknown
1448634130,PA166165139,rs4671393,,,BCL11A,Efficacy,1,hydroxyurea,1448634132.0,Near Eastern
827785745,PA166157267,rs776746,,,CYP3A5,Other,1,vardenafil,827785762.0,East Asian
827785745,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,vardenafil,827785762.0,East Asian
1184471945,PA166153895,rs67376798,,,DPYD,Dosage,1,capecitabine,1184471947.0,Unknown
1184471945,PA166153895,rs67376798,,,DPYD,Dosage,1,fluorouracil,1184471947.0,Unknown
1449749340,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449749350.0,Unknown
1449749340,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449749350.0,Unknown
1447159547,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tropisetron,,
1447159547,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,tropisetron,,
1449192282,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,1449192287.0,Central/South Asian
1449192282,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,1449192289.0,Central/South Asian
1449192273,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449192278.0,Central/South Asian
1449192273,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449192280.0,Central/South Asian
1449192273,PA166155091,rs9923231,,,VKORC1,Other,1,warfarin,1449192278.0,Central/South Asian
1449192273,PA166155091,rs9923231,,,VKORC1,Other,1,warfarin,1449192280.0,Central/South Asian
1449192273,PA166155091,rs9923231,,,VKORC1,Other,1,warfarin,1449192278.0,Central/South Asian
1449192273,PA166155091,rs9923231,,,VKORC1,Other,1,warfarin,1449192280.0,Central/South Asian
1450945340,PA166186981,rs1047303,,,HSD3B1,Efficacy,1,glucocorticoids,1450945345.0,European
1450945340,PA166186981,rs1047303,,,HSD3B1,Efficacy,1,glucocorticoids,1450945346.0,European
1449749328,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1449749330.0,Unknown
1448617711,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617713.0,East Asian
1448617711,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617713.0,East Asian
1448617711,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617713.0,East Asian
982044478,PA166153736,rs3093059,,,CRP,Efficacy,-1,fenofibrate,982044482.0,European
1449192290,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449192292.0,Central/South Asian
1449192290,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449192293.0,Central/South Asian
1448617702,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617704.0,East Asian
1448617702,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617704.0,East Asian
1448257253,PA166160028,rs2288344,,,NEDD4,Dosage,1,warfarin,1448257255.0,"Multiple groups, mostly Caucasians"
1448617690,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617692.0,East Asian
1448617690,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617692.0,East Asian
1448617690,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617692.0,East Asian
1448617678,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617689.0,East Asian
1448617678,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1448617689.0,East Asian
1448634086,PA166154094,rs8187710,,,ABCC2,Metabolism/PK,1,lumefantrine,1448634093.0,Sub-Saharan African
1448634086,PA166154094,rs8187710,,,ABCC2,Metabolism/PK,1,lumefantrine,1448634091.0,Sub-Saharan African
1449192342,PA166162695,rs80034486,,,CFTR,Efficacy,0,ivacaftor,1449192344.0,"Custom, Not applicable - study was carried out using rectal organoids"
1449192342,PA166162695,rs80034486,,,CFTR,Efficacy,0,lumacaftor,1449192344.0,"Custom, Not applicable - study was carried out using rectal organoids"
1449733021,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733023.0,European
1449192347,PA166161186,rs77932196,,,CFTR,Efficacy,0,ivacaftor,1449192349.0,Unknown
1449192347,PA166161186,rs77932196,,,CFTR,Efficacy,0,lumacaftor,1449192349.0,Unknown
1447519925,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447519930.0,"Multiple groups, 98% white"
1448257212,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448257214.0,"Multiple groups, mostly Caucasians"
1448257212,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1448257214.0,"Multiple groups, mostly Caucasians"
1447519944,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1447519946.0,"Multiple groups, 98% white"
1448126131,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,1448126171.0,Latino
1449733005,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733010.0,European
1449733005,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733013.0,East Asian
1449733005,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733015.0,East Asian
1449733005,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733018.0,Central/South Asian
1449749389,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449749391.0,Unknown
982044553,PA166153539,rs699,,,AGT,Efficacy,-1,captopril,982044561.0,Unknown
1448995403,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1448995418.0,Unknown
1448995403,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1448995418.0,Unknown
1183685485,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,voriconazole,1183685487.0,European
1449749395,PA166156352,rs2276707,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449749397.0,Unknown
1450371982,PA166156991,rs1799971,,,OPRM1,Toxicity,-1,ethanol,1450372042.0,European
1450371982,PA166156991,rs1799971,,,OPRM1,Toxicity,-1,ethanol,1450372019.0,European
1450371982,PA166156991,rs1799971,,,OPRM1,Toxicity,-1,ethanol,1450372029.0,European
1450371982,PA166156991,rs1799971,,,OPRM1,Toxicity,-1,ethanol,1450372017.0,European
1447519938,PA166154023,rs2860905,,,CYP2C9,Dosage,1,warfarin,1447519940.0,"Multiple groups, 98% white"
1448617649,PA166163844,rs3212185,,,HNF4A,Efficacy,-1,metformin,1448617651.0,Multiple groups
1448995748,PA166170284,rs2445365,,,ANGPT1,Efficacy,-1,bevacizumab,1448995757.0,European
1448995748,PA166170284,rs2445365,,,ANGPT1,Efficacy,-1,bevacizumab,1448995754.0,African American/Afro-Caribbean
982044541,PA166156276,rs5186,,,AGTR1,Efficacy,1,captopril,982044552.0,Unknown
1447519932,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1447519934.0,"Multiple groups, 98% white"
1448257202,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448257204.0,"Multiple groups, mostly Caucasians"
1448257202,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448257204.0,"Multiple groups, mostly Caucasians"
1184471365,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1184471367.0,African American/Afro-Caribbean
1450814412,PA166153643,rs1801131,,,MTHFR,Efficacy,1,"Vitamin B-complex, Incl. Combinations",1450814417.0,Unknown
1184472053,PA166155402,rs3093105,,,CYP4F2,Efficacy,-1,vitamin e,1184472096.0,Unknown
1184472053,PA166155402,rs3093105,,,CYP4F2,Efficacy,-1,vitamin e,1184472831.0,Unknown
1446897307,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,debrisoquine,1446897314.0,East Asian
1446897307,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,0,debrisoquine,1446897314.0,East Asian
1448995765,PA166170286,rs10102851,,,ANGPT2,Efficacy,-1,bevacizumab,1448995767.0,African American/Afro-Caribbean
1448995765,PA166170286,rs10102851,,,ANGPT2,Efficacy,-1,bevacizumab,1448995768.0,European
1018613244,PA166155187,rs1799752,,,ACE,Efficacy,1,quinapril,1019330733.0,Unknown
1018613244,PA166155187,rs1799752,,,ACE,Efficacy,1,quinapril,1019330733.0,Unknown
1449733067,PA166154648,rs34671512,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733069.0,Sub-Saharan African
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995775.0,European
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995774.0,African American/Afro-Caribbean
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995775.0,European
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995774.0,African American/Afro-Caribbean
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995775.0,European
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995774.0,African American/Afro-Caribbean
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995775.0,European
1448995772,PA166170287,rs2515462,,,ANGPT2,Efficacy,-1,bevacizumab,1448995774.0,African American/Afro-Caribbean
1449716700,PA166156025,rs4818,,,COMT,Dosage,-1,fentanyl,1449716703.0,East Asian
1449716700,PA166156025,rs4818,,,COMT,Dosage,-1,fentanyl,1449716702.0,East Asian
1448995786,PA166170288,rs13269021,,,ANGPT2,Efficacy,-1,bevacizumab,1448995789.0,European
1448995786,PA166170288,rs13269021,,,ANGPT2,Efficacy,-1,bevacizumab,1448995788.0,African American/Afro-Caribbean
1449733085,PA166156453,rs12721616,,,NR1I2,Metabolism/PK,1,rosuvastatin,1449733087.0,Sub-Saharan African
1183701955,PA166155551,rs140471703,,,CYP2A6,Metabolism/PK,1,nicotine,1183701957.0,African American/Afro-Caribbean
1183685564,PA166155113,rs12708954,,,SLC6A2,Efficacy,1,atomoxetine,1183685572.0,Multiple groups
1183685564,PA166155113,rs12708954,,,SLC6A2,Efficacy,1,atomoxetine,1183685568.0,Multiple groups
1449716707,PA166156024,rs4680,,,COMT,Dosage,-1,fentanyl,1449716709.0,East Asian
1449716707,PA166156024,rs4680,,,COMT,Dosage,-1,fentanyl,1449716710.0,East Asian
1450814388,PA166153644,rs1801133,,,MTHFR,Efficacy,0,l-methylfolate,1450814395.0,Unknown
1447945867,PA166154356,rs2237897,,,KCNQ1,Efficacy,-1,gliclazide,1447945932.0,East Asian
1448109703,PA166154195,rs72558189,,,CYP2C9,Dosage,0,warfarin,,
1183701959,PA166155553,rs143690364,,,CYP2A6,Metabolism/PK,1,nicotine,1183701961.0,African American/Afro-Caribbean
1184521242,,,PA165819268,TPMT*1,TPMT,Dosage,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Dosage,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Dosage,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Efficacy,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Efficacy,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Efficacy,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Toxicity,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Toxicity,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Toxicity,1,azathioprine,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Efficacy,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Efficacy,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Efficacy,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Toxicity,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Toxicity,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Toxicity,1,mercaptopurine,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Dosage,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Dosage,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Dosage,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Efficacy,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Efficacy,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Efficacy,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819268,TPMT*1,TPMT,Toxicity,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819270,TPMT*3A,TPMT,Toxicity,1,purine analogues,1184521244.0,Unknown
1184521242,,,PA165819272,TPMT*3C,TPMT,Toxicity,1,purine analogues,1184521244.0,Unknown
1449716684,PA166156027,rs6269,,,COMT,Dosage,-1,fentanyl,1449716692.0,East Asian
1449716684,PA166156027,rs6269,,,COMT,Dosage,-1,fentanyl,1449716690.0,East Asian
1448109681,PA166154176,rs28371686,,,CYP2C9,Dosage,0,warfarin,,
1448109681,PA166154176,rs28371686,,,CYP2C9,Dosage,0,warfarin,,
1450814400,PA166153643,rs1801131,,,MTHFR,Efficacy,0,l-methylfolate,1450814405.0,Unknown
1448109677,PA166153959,rs1057910,,,CYP2C9,Dosage,0,warfarin,,
1183849398,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183849406.0,East Asian
1183849398,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183849406.0,East Asian
1448995807,PA166170291,rs2274755,,,MMP9,Efficacy,-1,bevacizumab,1448995810.0,European
1448995807,PA166170291,rs2274755,,,MMP9,Efficacy,-1,bevacizumab,1448995809.0,African American/Afro-Caribbean
1448257142,PA166160018,rs3815455,,,POR,Dosage,-1,warfarin,1448257144.0,East Asian
1183701942,PA166155579,rs376817657,,,CYP2A6,Metabolism/PK,1,nicotine,1183701954.0,African American/Afro-Caribbean
981848091,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,clopidogrel,981848108.0,Unknown
982044699,PA166154395,rs3135506,,,APOA5,Efficacy,0,fenofibrate,982044711.0,European
1183702049,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,meloxicam,1183702059.0,East Asian
1183702049,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,meloxicam,1183702059.0,East Asian
1448109663,PA166155381,rs2108622,,,CYP4F2,Dosage,0,warfarin,,
1448126046,PA166153646,rs1801159,,,DPYD,Metabolism/PK,-1,fluorouracil,1448126048.0,Unknown
1447945831,PA166154356,rs2237897,,,KCNQ1,Efficacy,1,gliclazide,1447945848.0,East Asian
1447945831,PA166154356,rs2237897,,,KCNQ1,Efficacy,1,gliclazide,1447945865.0,East Asian
1448126052,PA166153895,rs67376798,,,DPYD,Metabolism/PK,-1,fluorouracil,1448126054.0,Unknown
1449749486,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tacrolimus,1449749498.0,East Asian
1449749486,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1449749498.0,East Asian
1449749486,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1449749498.0,East Asian
1448995836,PA166156960,rs833069,,,VEGFA,Efficacy,-1,bevacizumab,1448995839.0,European
1448995836,PA166156960,rs833069,,,VEGFA,Efficacy,-1,bevacizumab,1448995838.0,African American/Afro-Caribbean
1449192458,PA166157530,rs121908757,,,CFTR,Efficacy,0,ivacaftor,1449192464.0,Unknown
1449192458,PA166157530,rs121908757,,,CFTR,Efficacy,0,ivacaftor,1449192464.0,Unknown
1448126039,PA166153645,rs1801158,,,DPYD,Metabolism/PK,-1,fluorouracil,1448126045.0,Unknown
1448995845,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448995856.0,Unknown
1448995845,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448995856.0,Unknown
1446897254,PA166157149,rs9369421,,,VEGFA,Efficacy,1,carboplatin,1446897259.0,Unknown
1446897254,PA166157149,rs9369421,,,VEGFA,Efficacy,1,taxanes,1446897259.0,Unknown
1448257102,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448257104.0,East Asian
1448257102,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448257104.0,East Asian
1448257102,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448257104.0,East Asian
1448257102,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448257104.0,East Asian
1451125741,,,PA165819171,CYP1A2*1A,CYP1A2,Efficacy,-1,clozapine,1451125745.0,"Multiple groups, 56 patients were of European ancestry"
1451125741,,,PA165819176,CYP1A2*1F,CYP1A2,Efficacy,-1,clozapine,1451125745.0,"Multiple groups, 56 patients were of European ancestry"
982044657,PA166155601,rs780094,,,GCKR,Efficacy,0,fenofibrate,982044698.0,European
1449749543,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449749545.0,Multiple groups
1449749543,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449749545.0,Multiple groups
982044655,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,982044675.0,European
982044655,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,982044675.0,European
982044655,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,982044675.0,European
1449192465,PA166157531,rs121909005,,,CFTR,Efficacy,0,ivacaftor,1449192467.0,Unknown
1449192465,PA166157531,rs121909005,,,CFTR,Efficacy,0,ivacaftor,1449192467.0,Unknown
1449749518,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449749530.0,Multiple groups
1449749518,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449749530.0,Multiple groups
1447945779,PA166154510,rs1072388,,,GRIN2B,Efficacy,-1,clozapine,1447945847.0,European
982044677,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,982044679.0,European
982044677,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,982044679.0,European
1448633915,PA166165118,rs1060467,,,CYP4F11,Dosage,1,warfarin,1448633920.0,Multiple groups
1184473257,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184473259.0,East Asian
1451919000,PA166154175,rs28371685,,,CYP2C9,Metabolism/PK,1,warfarin,1451919565.0,Sub-Saharan African
1451919000,PA166154175,rs28371685,,,CYP2C9,Metabolism/PK,1,warfarin,1451919007.0,Sub-Saharan African
1447962916,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,,
1447962916,,,PA165818812,CYP2B6*28,CYP2B6,Metabolism/PK,0,efavirenz,,
1183849453,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183849478.0,Unknown
1183849453,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183849476.0,Unknown
1183849453,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183849478.0,Unknown
1183849453,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1183849476.0,Unknown
1448995871,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448995880.0,Sub-Saharan African
1448995871,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448995880.0,Sub-Saharan African
981848070,PA166155152,rs5918,,,ITGB3,Efficacy,-1,aspirin,981848079.0,"Multiple groups, White, African-American, Asian, and Hispanic origin"
1448633907,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448633912.0,Multiple groups
1451919592,PA166154006,rs2256871,,,CYP2C9,Metabolism/PK,1,warfarin,1451919600.0,Sub-Saharan African
982044755,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,digoxin,982044762.0,East Asian
982044755,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,digoxin,982044764.0,East Asian
982044755,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,digoxin,982044766.0,East Asian
1449192494,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,1449192500.0,Unknown
1449733194,PA166154094,rs8187710,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733196.0,Sub-Saharan African
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,bevacizumab,1448568346.0,Unknown
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,capecitabine,1448568346.0,Unknown
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,cisplatin,1448568346.0,Unknown
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,docetaxel,1448568346.0,Unknown
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,epirubicin,1448568346.0,Unknown
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,oxaliplatin,1448568346.0,Unknown
1448568344,PA166154249,rs1695,,,GSTP1,Efficacy,-1,trastuzumab,1448568346.0,Unknown
1449192520,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor,1449192523.0,Unknown
1449192520,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor,1449192529.0,Unknown
1449192520,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor,1449192522.0,Unknown
1449192520,PA166157525,rs113993960,,,CFTR,Efficacy,-1,lumacaftor,1449192523.0,Unknown
1449192520,PA166157525,rs113993960,,,CFTR,Efficacy,-1,lumacaftor,1449192529.0,Unknown
1449192520,PA166157525,rs113993960,,,CFTR,Efficacy,-1,lumacaftor,1449192522.0,Unknown
1448257049,PA166153977,rs1801253,,,ADRB1,Efficacy,1,Beta Blocking Agents,1448257065.0,East Asian
1448257049,PA166153977,rs1801253,,,ADRB1,Efficacy,1,flecainide,1448257065.0,East Asian
1448995913,PA166155766,rs7574865,,,STAT4,Efficacy,1,etanercept,1448995919.0,European
1449192508,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192515.0,Unknown
1449192508,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192514.0,Unknown
1449192508,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192515.0,Unknown
1449192508,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192514.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,bevacizumab,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,bevacizumab,1448568336.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,capecitabine,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,capecitabine,1448568336.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,cisplatin,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,cisplatin,1448568336.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,docetaxel,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,docetaxel,1448568336.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,epirubicin,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,epirubicin,1448568336.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,oxaliplatin,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,oxaliplatin,1448568336.0,Unknown
1448568334,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,trastuzumab,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,trastuzumab,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,trastuzumab,1448568336.0,Unknown
1448568334,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,trastuzumab,1448568336.0,Unknown
1448995921,PA166155766,rs7574865,,,STAT4,Efficacy,-1,adalimumab,1448995923.0,European
982044767,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044777.0,East Asian
982044767,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044778.0,East Asian
982044767,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044779.0,East Asian
982044767,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044777.0,East Asian
982044767,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044778.0,East Asian
982044767,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044779.0,East Asian
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,bevacizumab,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,bevacizumab,1448568326.0,Unknown
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,capecitabine,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,capecitabine,1448568326.0,Unknown
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,cisplatin,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,cisplatin,1448568326.0,Unknown
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,docetaxel,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,docetaxel,1448568326.0,Unknown
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,epirubicin,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,epirubicin,1448568326.0,Unknown
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,oxaliplatin,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,oxaliplatin,1448568326.0,Unknown
1448568324,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,trastuzumab,1448568326.0,Unknown
1448568324,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,trastuzumab,1448568326.0,Unknown
1183620160,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183620162.0,East Asian
1183620160,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183620162.0,East Asian
1183620160,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183620162.0,East Asian
1450814517,PA166154339,rs1800497,,,DRD2,Dosage,1,ethanol,1450814521.0,Unknown
1446897141,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897143.0,African American/Afro-Caribbean
1446897141,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897143.0,African American/Afro-Caribbean
1446897141,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897143.0,African American/Afro-Caribbean
1184472218,PA166157316,rs2032582,,,ABCB1,Efficacy,1,fluoxetine,1184472234.0,European
1184472218,PA166157316,rs2032582,,,ABCB1,Efficacy,1,fluoxetine,1184472234.0,European
1449750266,PA166154759,rs116855232,,,NUDT15,Dosage,-1,mercaptopurine,1449750275.0,East Asian
1449750266,PA166154759,rs116855232,,,NUDT15,Dosage,-1,mercaptopurine,1449750268.0,East Asian
1449750266,PA166154759,rs116855232,,,NUDT15,Dosage,-1,mercaptopurine,1449750273.0,East Asian
1449750266,PA166154759,rs116855232,,,NUDT15,Toxicity,-1,mercaptopurine,1449750275.0,East Asian
1449750266,PA166154759,rs116855232,,,NUDT15,Toxicity,-1,mercaptopurine,1449750268.0,East Asian
1449750266,PA166154759,rs116855232,,,NUDT15,Toxicity,-1,mercaptopurine,1449750273.0,East Asian
1451918980,PA166154082,rs7900194,,,CYP2C9,Metabolism/PK,1,warfarin,1451919591.0,Sub-Saharan African
1451918980,PA166154082,rs7900194,,,CYP2C9,Metabolism/PK,1,warfarin,1451918987.0,Sub-Saharan African
1450814522,PA166156991,rs1799971,,,OPRM1,Dosage,1,ethanol,1450814526.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,bevacizumab,1448568319.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,capecitabine,1448568319.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,cisplatin,1448568319.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,docetaxel,1448568319.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,epirubicin,1448568319.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,oxaliplatin,1448568319.0,Unknown
1448568317,PA166155343,rs13181,,,ERCC2,Efficacy,1,trastuzumab,1448568319.0,Unknown
769146231,PA166154574,rs4149015,,,SLCO1B1,Efficacy,1,pravastatin,769146233.0,European
769146231,PA166154574,rs4149015,,,SLCO1B1,Metabolism/PK,1,pravastatin,769146233.0,European
1448617460,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,atazanavir,1448617467.0,"Multiple groups, White, African-American"
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,bevacizumab,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,capecitabine,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,cisplatin,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,docetaxel,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,epirubicin,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,oxaliplatin,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,trastuzumab,1448568313.0,Unknown
1448568311,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,trastuzumab,1448568313.0,Unknown
1446897151,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897153.0,African American/Afro-Caribbean
1446897151,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897153.0,African American/Afro-Caribbean
1448995941,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448995947.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,bevacizumab,1448568307.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,capecitabine,1448568307.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,cisplatin,1448568307.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,docetaxel,1448568307.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,epirubicin,1448568307.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,oxaliplatin,1448568307.0,Unknown
1448568304,PA166155342,rs11615,,,ERCC1,Efficacy,1,trastuzumab,1448568307.0,Unknown
1448125943,PA166155024,rs1967309,,,ADCY9,Efficacy,1,dalcetrapib,1448125982.0,European
827704966,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,-1,efavirenz,827704972.0,African American/Afro-Caribbean
1448617452,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,atazanavir,1448617457.0,"Multiple groups, White, African-American"
1449715608,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,alfentanil,1449715610.0,Unknown
1450375846,PA166154276,rs537681,,,PGR,Efficacy,-1,etonogestrel,1450375849.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1450375846,PA166154276,rs537681,,,PGR,Metabolism/PK,-1,etonogestrel,1450375849.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,bevacizumab,1448568300.0,Unknown
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,capecitabine,1448568300.0,Unknown
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,cisplatin,1448568300.0,Unknown
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,docetaxel,1448568300.0,Unknown
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,epirubicin,1448568300.0,Unknown
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,oxaliplatin,1448568300.0,Unknown
1448568298,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,trastuzumab,1448568300.0,Unknown
982032084,PA166154329,rs1491850,,,BDNF,Dosage,-1,methadone,982032087.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
982032084,PA166154329,rs1491850,,,BDNF,Dosage,-1,methadone,982032087.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1449749631,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1449749637.0,East Asian
982044822,PA166157744,rs2230806,,,ABCA1,Efficacy,1,fenofibrate,982044829.0,European
982032418,PA166157773,rs4358872,,,NTRK2,Dosage,-1,methadone,982032424.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
982032418,PA166157773,rs4358872,,,NTRK2,Dosage,-1,methadone,982032425.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European patients."
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,bevacizumab,1448568294.0,Unknown
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,capecitabine,1448568294.0,Unknown
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,cisplatin,1448568294.0,Unknown
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,docetaxel,1448568294.0,Unknown
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,epirubicin,1448568294.0,Unknown
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,oxaliplatin,1448568294.0,Unknown
1448568292,PA166153667,rs2072671,,,CDA,Efficacy,-1,trastuzumab,1448568294.0,Unknown
1450814610,PA166184251,rs363225,,,SLC18A2,Efficacy,1,bupropion,1450814615.0,European
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,bevacizumab,1448568287.0,Unknown
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,capecitabine,1448568287.0,Unknown
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,cisplatin,1448568287.0,Unknown
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,docetaxel,1448568287.0,Unknown
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,epirubicin,1448568287.0,Unknown
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,oxaliplatin,1448568287.0,Unknown
1448568284,PA166156029,rs11479,,,TYMP,Efficacy,-1,trastuzumab,1448568287.0,Unknown
982044812,PA166157744,rs2230806,,,ABCA1,Efficacy,1,fenofibrate,982044821.0,European
1448125906,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,esomeprazole,1448125916.0,Central/South Asian
1448125906,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,esomeprazole,1448125916.0,Central/South Asian
1448125906,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,esomeprazole,1448125916.0,Central/South Asian
1448125906,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1448125916.0,Central/South Asian
1448125906,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,pantoprazole,1448125916.0,Central/South Asian
1448125906,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,pantoprazole,1448125916.0,Central/South Asian
1450814625,PA166184253,rs17614642,,,FKBP5,Efficacy,1,bupropion,1450814630.0,European
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,bevacizumab,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,bevacizumab,1448568283.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,capecitabine,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,capecitabine,1448568283.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,cisplatin,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,cisplatin,1448568283.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,docetaxel,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,docetaxel,1448568283.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,epirubicin,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,epirubicin,1448568283.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,oxaliplatin,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,oxaliplatin,1448568283.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,trastuzumab,1448568278.0,Unknown
1448568276,PA166153644,rs1801133,,,MTHFR,Efficacy,1,trastuzumab,1448568283.0,Unknown
1449749618,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449749630.0,East Asian
1449749618,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449749630.0,East Asian
982032487,PA166157752,rs2378676,,,NTRK2,Dosage,-1,methadone,982032493.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
982047968,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1184134015.0,European
982047968,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,982047978.0,European
982047968,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1184134015.0,European
982047968,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,982047978.0,European
982047968,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1184134015.0,European
982047968,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,982047978.0,European
1448256976,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,aspirin,1448256991.0,East Asian
1448256976,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,aspirin,1448256991.0,East Asian
1448256976,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,aspirin,1448256991.0,East Asian
1448256976,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1448256991.0,East Asian
1448256976,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1448256991.0,East Asian
1448256976,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1448256991.0,East Asian
1448256969,PA166156412,rs6785930,,,P2RY12,Efficacy,-1,ticagrelor,1448256971.0,East Asian
1451920058,PA166155623,rs1105879,,,UGT1A6,Metabolism/PK,-1,valproic acid,1451920083.0,"Custom, Specified ""Han patients with epilepsy."""
1448684682,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,1,levonorgestrel,1448684684.0,Sub-Saharan African
1448633804,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1448633806.0,Near Eastern
1448633804,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,clopidogrel,1448633806.0,Near Eastern
1448633799,PA166157273,rs854560,,,PON1,Efficacy,-1,clopidogrel,1448633801.0,Near Eastern
1451920040,PA166155760,rs6759892,,,UGT1A6,Metabolism/PK,1,valproic acid,1451920048.0,"Custom, Specified ""Han patients with epilepsy."""
1448125884,PA166153895,rs67376798,,,DPYD,Efficacy,-1,fluorouracil,1448125886.0,Multiple groups
1449192603,PA166157519,rs78655421,,,CFTR,Efficacy,1,ivacaftor,1449192609.0,Unknown
1449192588,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192594.0,Unknown
1449192588,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192594.0,Unknown
1448256957,PA166156413,rs6787801,,,P2RY12,Efficacy,-1,ticagrelor,1448256963.0,East Asian
1450814583,PA166184248,rs2770296,,,HTR2A,Efficacy,1,bupropion,1450814588.0,European
982044781,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982044789.0,East Asian
982044781,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982044790.0,East Asian
982044781,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982044791.0,East Asian
1447519665,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1447519692.0,African American/Afro-Caribbean
1447519665,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1447519667.0,European
1448633787,PA166155152,rs5918,,,ITGB3,Efficacy,-1,clopidogrel,1448633790.0,Near Eastern
1448996001,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448996003.0,Multiple groups
1448996001,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,efavirenz,1448996003.0,Multiple groups
1448996001,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,efavirenz,1448996003.0,Multiple groups
1449192615,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192621.0,Unknown
1449192615,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192623.0,Unknown
1449192615,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192626.0,Unknown
1451920049,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,valproic acid,1451920057.0,"Custom, Specified ""Han patients with epilepsy."""
1450814595,PA166184250,rs2873804,,,DBH,Efficacy,1,bupropion,1450814600.0,European
1448633778,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,clopidogrel,1448633780.0,Near Eastern
1448633778,,,PA165818807,CYP2B6*9,CYP2B6,Efficacy,-1,clopidogrel,1448633780.0,Near Eastern
1448996011,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,efavirenz,1448996013.0,Multiple groups
1448996011,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,-1,efavirenz,1448996013.0,Multiple groups
1450814601,PA166156709,rs6347,,,SLC6A3,Efficacy,-1,bupropion,1450814609.0,Unknown
1447519677,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,1447519679.0,European
1447519677,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,1447519699.0,African American/Afro-Caribbean
1446765966,PA166157629,rs10090884,,,GATA4,Dosage,-1,warfarin,1446765968.0,East Asian
1446765971,PA166155044,rs2917670,,,NQO1,Dosage,-1,warfarin,1446765973.0,East Asian
1451920120,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,1,tacrolimus,1451920125.0,"Multiple groups, ""Urdu Speaking, Sindhi, Pathan, Punjabi, Others"""
1451920120,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451920125.0,"Multiple groups, ""Urdu Speaking, Sindhi, Pathan, Punjabi, Others"""
1185002405,PA166156379,rs3772810,,,UMPS,Efficacy,-1,capecitabine,1185002407.0,East Asian
1185002405,PA166156379,rs3772810,,,UMPS,Efficacy,-1,fluorouracil,1185002407.0,East Asian
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192638.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192640.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192644.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192642.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192638.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192640.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192644.0,Unknown
1449192632,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192642.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,bevacizumab,1448568237.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,capecitabine,1448568237.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,cisplatin,1448568237.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,docetaxel,1448568237.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,epirubicin,1448568237.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,oxaliplatin,1448568237.0,Unknown
1448568229,PA166155285,rs2612091,,,ENOSF1,Efficacy,-1,trastuzumab,1448568237.0,Unknown
1448633764,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1448633766.0,Near Eastern
1447814565,PA166156321,rs1516338,,,CHL1,Efficacy,1,antidepressants,1447814575.0,European
1449602225,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,voriconazole,1449602227.0,"Multiple groups, Italy, specified 37.5% Caucasian, 62.5% Other."
1448996021,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,efavirenz,1448996023.0,Multiple groups
1448996021,,,PA165818809,CYP2B6*22,CYP2B6,Metabolism/PK,-1,efavirenz,1448996023.0,Multiple groups
982044907,PA166154486,rs5443,,,GNB3,Efficacy,1,atenolol,1451291020.0,European
982044907,PA166154486,rs5443,,,GNB3,Efficacy,1,atenolol,1451291040.0,European
982044907,PA166154486,rs5443,,,GNB3,Efficacy,1,atenolol,982044922.0,European
982044907,PA166154486,rs5443,,,GNB3,Efficacy,1,atenolol,982044914.0,European
1448633755,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1448633757.0,Near Eastern
1448633755,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1448633757.0,Near Eastern
1449192645,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor,1449192647.0,Unknown
1449192645,PA166157525,rs113993960,,,CFTR,Efficacy,-1,lumacaftor,1449192647.0,Unknown
1447814526,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1447814532.0,East Asian
1448996035,,,PA165956704,HLA-C*01:02:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165956777,HLA-C*02:02:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA166123425,HLA-C*03:02,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957046,HLA-C*04:01:01:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957192,HLA-C*05:01:01:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957372,HLA-C*07:01:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA166123426,HLA-C*08:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957722,HLA-C*12:02:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957818,HLA-C*14:02:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957859,HLA-C*15:02:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957927,HLA-C*16:01:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165957985,HLA-C*17:01:01:01,HLA-C,Efficacy,1,peginterferon alfa-2b,1448996068.0,European
1448996035,,,PA165956704,HLA-C*01:02:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165956777,HLA-C*02:02:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA166123425,HLA-C*03:02,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957046,HLA-C*04:01:01:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957192,HLA-C*05:01:01:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957372,HLA-C*07:01:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA166123426,HLA-C*08:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957722,HLA-C*12:02:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957818,HLA-C*14:02:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957859,HLA-C*15:02:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957927,HLA-C*16:01:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1448996035,,,PA165957985,HLA-C*17:01:01:01,HLA-C,Efficacy,1,ribavirin,1448996068.0,European
1184472326,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,fluvoxamine,1184472328.0,Unknown
1184472326,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluvoxamine,1184472328.0,Unknown
1184472326,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,pindolol,1184472328.0,Unknown
1184472326,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,pindolol,1184472328.0,Unknown
1448617361,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,atazanavir,1448617363.0,European
1448617361,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,atazanavir,1448617368.0,Unknown
1448125834,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,imatinib,1448125836.0,Sub-Saharan African
1448617354,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,-1,atazanavir,1448617360.0,European
1446897010,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,simvastatin,1446897021.0,Multiple groups
1446897010,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,simvastatin,1446897023.0,Multiple groups
1446897010,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,simvastatin,1446897021.0,Multiple groups
1446897010,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,simvastatin,1446897023.0,Multiple groups
1446897010,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,simvastatin acid,1446897021.0,Multiple groups
1446897010,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,simvastatin acid,1446897023.0,Multiple groups
1446897010,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,simvastatin acid,1446897021.0,Multiple groups
1446897010,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,simvastatin acid,1446897023.0,Multiple groups
1446765943,PA166155017,rs1800566,,,NQO1,Dosage,1,warfarin,1446765955.0,East Asian
1446765943,PA166155017,rs1800566,,,NQO1,Dosage,1,warfarin,1446765945.0,East Asian
981848236,PA166156024,rs4680,,,COMT,Efficacy,1,venlafaxine,981848251.0,European
981848236,PA166156024,rs4680,,,COMT,Efficacy,1,venlafaxine,981848254.0,European
1184472345,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1184472370.0,Unknown
1184472345,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1184472370.0,Unknown
1185002399,PA166156378,rs3772809,,,UMPS,Efficacy,-1,capecitabine,1185002401.0,East Asian
1185002399,PA166156378,rs3772809,,,UMPS,Efficacy,-1,fluorouracil,1185002401.0,East Asian
1448633725,PA166165098,rs1267067,,,TANK,Efficacy,1,adalimumab,1448633727.0,Unknown
1184472347,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,aspirin,1184472355.0,Unknown
1184472347,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,aspirin,1184472355.0,Unknown
1184472347,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184472355.0,Unknown
1184472347,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184472355.0,Unknown
1448633723,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1448633740.0,Near Eastern
1448633723,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1448633740.0,Near Eastern
982028484,PA166156487,rs352046,,,CXCL5,Efficacy,1,hmg coa reductase inhibitors,982028490.0,"Multiple groups, 79% White; patients from 2 Kansas City hospitals"
1446765956,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1446765958.0,East Asian
1448633712,PA166165096,rs1126535,,,CD40LG,Efficacy,1,adalimumab,1448633714.0,Unknown
981794208,PA166156947,rs760370,,,SLC29A1,Efficacy,-1,gemcitabine,981794216.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794208,PA166156947,rs760370,,,SLC29A1,Toxicity,-1,gemcitabine,981794216.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1444699419,PA166157736,rs1778929,,,NTRK2,Efficacy,-1,clozapine,1444699427.0,European
1449192671,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192673.0,Unknown
1449192671,PA166157516,rs75527207,,,CFTR,Efficacy,1,tezacaftor,1449192673.0,Unknown
1446765961,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1446765963.0,East Asian
1183620382,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,risperidone,1183620384.0,East Asian
1184472237,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,fluoxetine,1184472256.0,European
1184472237,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,fluoxetine,1184472256.0,European
1184472237,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,fluoxetine,1184472256.0,European
1184472237,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,fluoxetine,1184472256.0,European
1184472237,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,fluoxetine,1184472256.0,European
1183491887,PA166155187,rs1799752,,,ACE,Efficacy,-1,lisinopril,1183491899.0,East Asian
1450814737,PA166153980,rs1885301,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814746.0,Unknown
1450814737,PA166153980,rs1885301,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814745.0,Unknown
1450814737,PA166153980,rs1885301,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814748.0,Unknown
1450814737,PA166153980,rs1885301,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814744.0,Unknown
1450814737,PA166153980,rs1885301,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814743.0,Unknown
1450814737,PA166153980,rs1885301,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814747.0,Unknown
982044949,PA166154636,rs11064426,,,GNB3,Efficacy,1,atenolol,982044954.0,European
982044949,PA166154636,rs11064426,,,GNB3,Efficacy,1,atenolol,982044955.0,European
1448633699,PA166156906,rs25648,,,VEGFA,Efficacy,1,adalimumab,1448633701.0,Unknown
1447814502,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,1447814510.0,Central/South Asian
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192697.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192699.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192703.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192701.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192695.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192697.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192699.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192703.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192701.0,Unknown
1449192689,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192695.0,Unknown
1444668728,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668734.0,European
1444668728,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668791.0,European
1444668735,PA166156997,rs1800629,,,TNF,Efficacy,-1,infliximab,1444668797.0,European
1444668735,PA166156997,rs1800629,,,TNF,Efficacy,-1,infliximab,1444668741.0,European
1450814749,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814756.0,Unknown
1450814749,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814753.0,Unknown
1450814749,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814754.0,Unknown
1450814749,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814755.0,Unknown
1450814749,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814758.0,Unknown
1450814749,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814757.0,Unknown
827816385,PA166157164,rs9479757,,,OPRM1,Dosage,-1,methadone,827816428.0,East Asian
827816385,PA166157164,rs9479757,,,OPRM1,Metabolism/PK,-1,methadone,827816428.0,East Asian
1446765922,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1446765924.0,East Asian
982044965,PA166154486,rs5443,,,GNB3,Efficacy,1,atenolol,982044972.0,European
982044965,PA166154486,rs5443,,,GNB3,Efficacy,1,atenolol,982044974.0,European
1184472258,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,fluoxetine,1184472260.0,European
1184472258,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,fluoxetine,1184472260.0,European
1184472258,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,fluoxetine,1184472260.0,European
1446896996,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,simvastatin,1446897006.0,Multiple groups
1446896996,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,simvastatin,1446897006.0,Multiple groups
982037742,PA166156276,rs5186,,,AGTR1,Efficacy,-1,candesartan,982037751.0,European
982044957,PA166154545,rs2301339,,,GNB3,Efficacy,1,atenolol,982044962.0,European
982044957,PA166154545,rs2301339,,,GNB3,Efficacy,1,atenolol,982044963.0,European
1444668744,PA166156915,rs361525,,,TNF,Efficacy,-1,etanercept,1444668795.0,European
1444668744,PA166156915,rs361525,,,TNF,Efficacy,-1,etanercept,1444668750.0,European
982044923,PA166154636,rs11064426,,,GNB3,Efficacy,1,atenolol,982044929.0,European
982044923,PA166154636,rs11064426,,,GNB3,Efficacy,1,atenolol,982044928.0,European
1448568141,PA166162510,rs10995,,,VASP,Efficacy,1,hydrochlorothiazide,1448568149.0,European
1444668751,PA166156915,rs361525,,,TNF,Efficacy,1,infliximab,1444668793.0,European
1444668751,PA166156915,rs361525,,,TNF,Efficacy,1,infliximab,1444668757.0,European
1184472274,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1184472322.0,Unknown
1184472274,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1184472322.0,Unknown
1450044715,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,ceftriaxone,1450044734.0,Unknown
769146304,PA166154045,rs4086116,,,CYP2C9,Dosage,1,acenocoumarol,769146307.0,European
1447984301,PA166155366,rs1137115,,,CYP2A6,Metabolism/PK,-1,nicotine,1447984303.0,Unknown
1447984301,PA166155366,rs1137115,,,CYP2A6,Metabolism/PK,-1,nicotine,1447984304.0,European
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192735.0,European
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192739.0,Unknown
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192737.0,European
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192727.0,European
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192729.0,European
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192733.0,European
1449192721,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192731.0,European
1448568122,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448568134.0,"Multiple groups, Caucasian and Unknown"
1448568122,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448568134.0,"Multiple groups, Caucasian and Unknown"
1448568122,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448568134.0,"Multiple groups, Caucasian and Unknown"
1448568122,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448568134.0,"Multiple groups, Caucasian and Unknown"
1184226554,PA166156481,rs5522,,,NR3C2,Efficacy,1,enalapril,1184227971.0,East Asian
1450814797,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1450814807.0,Unknown
1450814797,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1450814803.0,Unknown
1450814797,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1450814805.0,Unknown
1450814797,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1450814808.0,Unknown
1450814797,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1450814804.0,Unknown
1450814797,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1450814806.0,Unknown
1449747633,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1449747635.0,Unknown
1449747633,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1449747635.0,Unknown
1450044739,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,ceftriaxone,1450044741.0,Unknown
1450044739,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,ceftriaxone,1450044741.0,Unknown
981502284,PA166153644,rs1801133,,,MTHFR,Efficacy,1,disulfiram,981502293.0,"Multiple groups, Caucasian, African American and Hispanic"
1444706410,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1444706412.0,European
1444706410,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1444706412.0,European
1444706410,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,1444706412.0,European
1444706410,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,1444706412.0,European
1450044745,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,ceftriaxone,1450044747.0,Unknown
1447814438,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447814440.0,East Asian
1447814438,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447814441.0,East Asian
1447814438,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447814440.0,East Asian
1447814438,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447814441.0,East Asian
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192762.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192766.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192756.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192764.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192760.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192768.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192758.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192762.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192766.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192756.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192764.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192760.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192768.0,Unknown
1449192749,PA166157525,rs113993960,,,CFTR,Efficacy,1,lumacaftor,1449192758.0,Unknown
1184472447,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1184472449.0,Multiple groups
1448568092,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,1448568115.0,Unknown
1448568092,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,1448568115.0,Unknown
1448568092,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,1448568115.0,Unknown
1449192774,PA166157529,rs121908755,,,CFTR,Efficacy,0,ivacaftor,1449192780.0,Latino
982042981,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,atenolol,982042985.0,European
982042981,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,atenolol,982042986.0,European
1184472450,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,citalopram,1184472485.0,Unknown
1184472450,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,citalopram,1184472485.0,Unknown
769146005,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,carbamazepine,769146007.0,Central/South Asian
769146005,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,phenobarbital,769146007.0,Central/South Asian
769146005,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,phenytoin,769146007.0,Central/South Asian
769146005,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,valproic acid,769146007.0,Central/South Asian
1184472453,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clopidogrel,1184472482.0,Unknown
1184472453,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clopidogrel,1184472482.0,Unknown
1447679211,PA166154080,rs7094248,,,CHAT,Efficacy,-1,donepezil,1447679213.0,East Asian
1447679211,PA166154080,rs7094248,,,CHAT,Efficacy,-1,galantamine,1447679213.0,East Asian
1447679211,PA166154080,rs7094248,,,CHAT,Efficacy,-1,rivastigmine,1447679213.0,East Asian
1451126120,PA166157334,rs2229109,,,ABCB1,Efficacy,0,temozolomide,1451126140.0,Unknown
1451126120,PA166157334,rs2229109,,,ABCB1,Efficacy,0,temozolomide,1451126141.0,Unknown
1451126120,PA166157334,rs2229109,,,ABCB1,Efficacy,0,temozolomide,1451126125.0,Unknown
1184472455,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184472478.0,Unknown
1184472455,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184472478.0,Unknown
1184472455,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184472478.0,Unknown
1184472455,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1184472478.0,Unknown
1447519521,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447519537.0,European
1447519521,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447519537.0,European
1447519521,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447519537.0,European
769145998,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,carbamazepine,769146000.0,Central/South Asian
769145998,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,phenobarbital,769146000.0,Central/South Asian
769145998,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,phenytoin,769146000.0,Central/South Asian
769145998,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,valproic acid,769146000.0,Central/South Asian
982042973,PA166153546,rs5050,,,AGT,Efficacy,-1,atenolol,982042979.0,European
982042973,PA166153546,rs5050,,,AGT,Efficacy,-1,atenolol,982042978.0,European
1183680176,PA166155594,rs295114,,,SPATS2L,Efficacy,-1,salbutamol,1183680178.0,Latino
1448126187,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1448126189.0,Latino
1451228826,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,methadone,1451228787.0,Unknown
1451228826,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,methadone,1451228787.0,Unknown
1447679196,PA166153983,rs1917818,,,CHAT,Efficacy,-1,donepezil,1447679198.0,East Asian
1447679196,PA166153983,rs1917818,,,CHAT,Efficacy,-1,galantamine,1447679198.0,East Asian
1447679196,PA166153983,rs1917818,,,CHAT,Efficacy,-1,rivastigmine,1447679198.0,East Asian
1451921140,PA166154007,rs2273697,,,ABCC2,Efficacy,1,lacosamide,1451921145.0,"Custom, Ughur"
1183619532,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183619534.0,East Asian
1183619532,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183619534.0,East Asian
1183619532,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183619534.0,East Asian
1183623333,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183623335.0,East Asian
1183619521,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183619531.0,East Asian
1183619521,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183619531.0,East Asian
1183619521,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183619531.0,East Asian
1450814771,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,pitavastatin,1450814778.0,Unknown
1450814771,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,pitavastatin,1450814779.0,Unknown
1450814771,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,pitavastatin,1450814782.0,Unknown
1450814771,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,pitavastatin,1450814780.0,Unknown
1450814771,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,pitavastatin,1450814775.0,Unknown
1450814771,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,pitavastatin,1450814781.0,Unknown
1450044772,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,ceftriaxone,1450044774.0,Unknown
1448568076,PA166162502,rs230504,,,NFKB1,Efficacy,1,flupenthixol,1448568082.0,"Multiple groups, 82 South African Colored (SAC), 13 Xhosa and eight Caucasian individuals"
1447679203,PA166154125,rs11101192,,,CHAT,Efficacy,-1,donepezil,1447679205.0,East Asian
1447679203,PA166154125,rs11101192,,,CHAT,Efficacy,-1,galantamine,1447679205.0,East Asian
1447679203,PA166154125,rs11101192,,,CHAT,Efficacy,-1,rivastigmine,1447679205.0,East Asian
981502261,PA166156318,rs1470579,,,IGF2BP2,Dosage,1,repaglinide,981502269.0,East Asian
981502261,PA166156318,rs1470579,,,IGF2BP2,Efficacy,1,repaglinide,981502269.0,East Asian
1451921146,PA166153953,rs717620,,,ABCC2,Efficacy,1,lacosamide,1451921151.0,"Custom, Ughur"
1447814409,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447814418.0,East Asian
1447814409,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447814431.0,East Asian
1447814409,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447814418.0,East Asian
1447814409,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447814431.0,East Asian
1448617211,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,atazanavir,1448617222.0,European
1447945457,PA166153913,rs78060119,,,DPYD,Efficacy,-1,fluorouracil,1447945463.0,Unknown
982042952,PA166153539,rs699,,,AGT,Efficacy,1,atenolol,982042958.0,European
1450814783,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814788.0,Unknown
1450814783,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814789.0,Unknown
1450814783,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814790.0,Unknown
1450814783,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814793.0,Unknown
1450814783,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814791.0,Unknown
1450814783,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814792.0,Unknown
1450814783,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814788.0,Unknown
1450814783,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814789.0,Unknown
1450814783,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814790.0,Unknown
1450814783,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814793.0,Unknown
1450814783,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814791.0,Unknown
1450814783,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1450814792.0,Unknown
1447679245,PA166154149,rs12264845,,,CHAT,Efficacy,-1,donepezil,1447679247.0,East Asian
1447679245,PA166154149,rs12264845,,,CHAT,Efficacy,-1,galantamine,1447679247.0,East Asian
1447679245,PA166154149,rs12264845,,,CHAT,Efficacy,-1,rivastigmine,1447679247.0,East Asian
1447519494,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447519503.0,East Asian
1447519494,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447519503.0,East Asian
981502270,PA166156398,rs4402960,,,IGF2BP2,Dosage,1,repaglinide,981502276.0,East Asian
981502270,PA166156398,rs4402960,,,IGF2BP2,Efficacy,1,repaglinide,981502276.0,East Asian
1450044751,PA166155677,rs2287622,,,ABCB11,Metabolism/PK,-1,ceftriaxone,1450044753.0,Unknown
1447679252,PA166154075,rs7076926,,,CHAT,Efficacy,-1,donepezil,1447679254.0,East Asian
1447679252,PA166154075,rs7076926,,,CHAT,Efficacy,-1,galantamine,1447679254.0,East Asian
1447679252,PA166154075,rs7076926,,,CHAT,Efficacy,-1,rivastigmine,1447679254.0,East Asian
982042944,PA166153547,rs5051,,,AGT,Efficacy,1,atenolol,982042951.0,European
1183619918,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1183619920.0,East Asian
1183619918,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1183619920.0,East Asian
1183619918,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1183619920.0,East Asian
1450044757,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,ceftriaxone,1450044759.0,Unknown
1446765775,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,-1,bupropion,1446765783.0,Multiple groups
827816415,PA166154313,rs1076560,,,DRD2,Dosage,-1,methadone,827816441.0,East Asian
827816415,PA166154313,rs1076560,,,DRD2,Metabolism/PK,-1,methadone,827816441.0,East Asian
1451921160,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,lacosamide,1451921165.0,"Custom, Ughur"
1183619889,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1183619917.0,East Asian
1183619889,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1183619917.0,East Asian
1183619889,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1183619917.0,East Asian
1451921167,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,lacosamide,1451921154.0,"Custom, Ughur"
1448568038,PA166157006,rs2010963,,,VEGFA,Efficacy,1,pazopanib,1448568040.0,"Multiple groups, 84% white"
1447519445,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447519454.0,Multiple groups
1447519445,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447519454.0,Multiple groups
982044884,PA166156747,rs1042711,,,ADRB2,Efficacy,-1,atenolol,982044889.0,European
1448568032,PA166156938,rs699947,,,VEGFA,Efficacy,1,pazopanib,1448568034.0,"Multiple groups, 84% white"
1447679224,PA166154036,rs3793797,,,CHAT,Efficacy,-1,donepezil,1447679226.0,East Asian
1447679224,PA166154036,rs3793797,,,CHAT,Efficacy,-1,galantamine,1447679226.0,East Asian
1447679224,PA166154036,rs3793797,,,CHAT,Efficacy,-1,rivastigmine,1447679226.0,East Asian
1446765784,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,bupropion,1446765786.0,"Multiple groups, Brazil"
827819994,PA166155190,rs1800012,,,COL1A1,Dosage,1,somatropin recombinant,827820001.0,Unknown
1447679234,PA166154114,rs10776586,,,CHAT,Efficacy,-1,donepezil,1447679236.0,East Asian
1447679234,PA166154114,rs10776586,,,CHAT,Efficacy,-1,galantamine,1447679236.0,East Asian
1447679234,PA166154114,rs10776586,,,CHAT,Efficacy,-1,rivastigmine,1447679236.0,East Asian
1449192838,PA166157334,rs2229109,,,ABCB1,Dosage,-1,methadone,1449192840.0,"Multiple groups, White, Indigenous Australian, Torres Strait Islander and Asian participants"
1450044786,PA166154618,rs10841795,,,SLCO1A2,Metabolism/PK,-1,ceftriaxone,1450044788.0,Unknown
1184505152,PA166154593,rs4570625,,,TPH2,Efficacy,-1,citalopram,1184505154.0,Unknown
981502364,PA166156304,rs1050450,,,GPX1,Efficacy,-1,clozapine,981502376.0,"Multiple groups, 171 White; 45 African American"
1184472389,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1184472403.0,Multiple groups
982043042,PA166153539,rs699,,,AGT,Efficacy,-1,irbesartan,982043049.0,European
982043042,PA166153539,rs699,,,AGT,Efficacy,-1,irbesartan,982043048.0,European
1448617170,PA166157284,rs1045642,,,ABCB1,Other,-1,atazanavir,,
1448617170,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,atazanavir,,
981502377,PA166156900,rs4880,,,SOD2,Efficacy,-1,clozapine,981502387.0,"Multiple groups, 171 White; 45 African American"
1447519456,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447519458.0,Multiple groups
1447519456,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447519458.0,Multiple groups
1449192831,PA166157435,rs9282564,,,ABCB1,Dosage,-1,methadone,1449192837.0,"Multiple groups, White, Indigenous Australian, Torres Strait Islander and Asian participants"
982043003,PA166155145,rs4331,,,ACE,Efficacy,-1,irbesartan,982043012.0,European
982043003,PA166155145,rs4331,,,ACE,Efficacy,-1,irbesartan,982043011.0,European
1183554747,PA166154092,rs7921977,,,CASP7,Efficacy,-1,docetaxel,1183554749.0,East Asian
1183554747,PA166154092,rs7921977,,,CASP7,Efficacy,-1,gemcitabine,1183554749.0,East Asian
1183554747,PA166154092,rs7921977,,,CASP7,Efficacy,-1,paclitaxel,1183554749.0,East Asian
1183554747,PA166154092,rs7921977,,,CASP7,Efficacy,-1,Platinum compounds,1183554749.0,East Asian
1183554747,PA166154092,rs7921977,,,CASP7,Efficacy,-1,vinorelbine,1183554749.0,East Asian
1449192852,PA166157288,rs1128503,,,ABCB1,Dosage,-1,methadone,1449192854.0,"Multiple groups, White, Indigenous Australian, Torres Strait Islander and Asian participants"
1447945405,PA166153760,rs3918290,,,DPYD,Efficacy,1,fluorouracil,1447945407.0,Unknown
1447945405,PA166153760,rs3918290,,,DPYD,Efficacy,1,fluorouracil,1447945407.0,Unknown
1449192858,PA166157316,rs2032582,,,ABCB1,Dosage,-1,methadone,1449192860.0,"Multiple groups, White, Indigenous Australian, Torres Strait Islander and Asian participants"
1446896983,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin,1446896994.0,Multiple groups
1446896983,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1446896994.0,Multiple groups
982042996,PA166153547,rs5051,,,AGT,Efficacy,1,atenolol,982043001.0,European
1451126126,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,temozolomide,1451126142.0,Unknown
1184472404,PA166155384,rs2189784,,,CYP4F2,Dosage,-1,warfarin,1184472406.0,Multiple groups
1449192844,PA166157284,rs1045642,,,ABCB1,Dosage,-1,methadone,1449192846.0,"Multiple groups, White, Indigenous Australian, Torres Strait Islander and Asian participants"
1447679019,PA166154123,rs11101187,,,CHAT,Efficacy,-1,donepezil,1447679021.0,East Asian
1447679019,PA166154123,rs11101187,,,CHAT,Efficacy,-1,galantamine,1447679021.0,East Asian
1447679019,PA166154123,rs11101187,,,CHAT,Efficacy,-1,rivastigmine,1447679021.0,East Asian
1446765748,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,bupropion,1446765754.0,"Multiple groups, Brazil"
1446765748,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,bupropion,1446765759.0,Multiple groups
1446765748,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,bupropion,1446765757.0,Multiple groups
1446765748,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,varenicline,1446765754.0,"Multiple groups, Brazil"
1446765748,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,varenicline,1446765759.0,Multiple groups
1446765748,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,varenicline,1446765757.0,Multiple groups
1184472408,PA166157354,rs2290228,,,CALU,Dosage,-1,warfarin,1184472410.0,Multiple groups
655387637,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,bisoprolol,655387639.0,Unknown
1447945413,PA166153647,rs1801160,,,DPYD,Efficacy,-1,fluorouracil,1447945415.0,Unknown
982042988,PA166153539,rs699,,,AGT,Efficacy,-1,atenolol,982042994.0,European
1447679025,PA166154035,rs3793791,,,CHAT,Efficacy,-1,donepezil,1447679027.0,East Asian
1447679025,PA166154035,rs3793791,,,CHAT,Efficacy,-1,galantamine,1447679027.0,East Asian
1447679025,PA166154035,rs3793791,,,CHAT,Efficacy,-1,rivastigmine,1447679027.0,East Asian
1184472412,PA166155805,rs11676382,,,GGCX,Dosage,-1,warfarin,1184472414.0,Multiple groups
827836346,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,doxorubicin,827836352.0,East Asian
1447814319,PA166153895,rs67376798,,,DPYD,Toxicity,0,fluorouracil,1447814345.0,Unknown
1451922200,PA166159110,rs4148738,,,ABCB1,Metabolism/PK,1,rivaroxaban,1451922220.0,European
1184472416,PA166155134,rs61742245,,,VKORC1,Dosage,-1,warfarin,1184472418.0,Multiple groups
1447678999,PA166154062,rs4838391,,,CHAT,Efficacy,-1,donepezil,1447679001.0,East Asian
1447678999,PA166154062,rs4838391,,,CHAT,Efficacy,-1,galantamine,1447679001.0,East Asian
1447678999,PA166154062,rs4838391,,,CHAT,Efficacy,-1,rivastigmine,1447679001.0,East Asian
1449192875,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,methadone,1449192890.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192875,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,-1,methadone,1449192890.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192875,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,methadone,1449192890.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192875,,,PA165971584,CYP2D6*33,CYP2D6,Metabolism/PK,-1,methadone,1449192890.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1444930780,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2a,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2a,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2b,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2b,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL3,Efficacy,0,ribavirin,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL4,Efficacy,0,ribavirin,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL3,Efficacy,0,simeprevir,1444930811.0,Multiple groups
1444930780,PA166155468,rs12979860,,,IFNL4,Efficacy,0,simeprevir,1444930811.0,Multiple groups
1446765760,PA166155405,rs3211371,,,CYP2B6,Efficacy,-1,bupropion,1446765762.0,"Multiple groups, Brazil"
1451922360,PA166154850,rs762551,,,CYP1A2,,0,ciprofloxacin,1451922380.0,European
1451126149,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,temozolomide,1451126154.0,Unknown
1447679013,PA166154145,rs12246528,,,CHAT,Efficacy,-1,donepezil,1447679015.0,East Asian
1447679013,PA166154145,rs12246528,,,CHAT,Efficacy,-1,galantamine,1447679015.0,East Asian
1447679013,PA166154145,rs12246528,,,CHAT,Efficacy,-1,rivastigmine,1447679015.0,East Asian
1184472424,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184472426.0,Multiple groups
827848020,PA166155393,rs2279343,,,CYP2B6,Toxicity,-1,nevirapine,827848531.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827848020,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,nevirapine,827848531.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
1447681058,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1447681060.0,Unknown
1447681058,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1447681061.0,Unknown
1447681058,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1447681060.0,Unknown
1447681058,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1447681061.0,Unknown
1183682139,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,-1,lamotrigine,1183682141.0,Unknown
1183623314,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623316.0,East Asian
1183623314,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623316.0,East Asian
1183623314,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183623316.0,East Asian
1183623314,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183623316.0,East Asian
1448617122,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,atazanavir,1448617124.0,"Multiple groups, Black, White, Hispanic"
1447716007,PA166157435,rs9282564,,,ABCB1,Toxicity,1,cyclosporine,1447717147.0,Unknown
1447716007,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,1,cyclosporine,1447717147.0,Unknown
981502424,PA166156552,rs2304865,,,FAT1,Efficacy,-1,aripiprazole,981502427.0,East Asian
981502424,PA166156552,rs2304865,,,FAT1,Toxicity,-1,aripiprazole,981502427.0,East Asian
981502424,PA166156552,rs2304865,,,FAT1,Toxicity,-1,aripiprazole,981502427.0,East Asian
981502424,PA166156552,rs2304865,,,FAT1,Toxicity,-1,aripiprazole,981502427.0,East Asian
1444668546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,"interferon alfa-2a, recombinant",1444668554.0,European
1444668546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,"interferon alfa-2a, recombinant",1444668554.0,European
1444668546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,"interferon alfa-2b, recombinant",1444668554.0,European
1444668546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,"interferon alfa-2b, recombinant",1444668554.0,European
1444668546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444668554.0,European
1444668546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444668554.0,European
981502435,PA166155091,rs9923231,,,VKORC1,Efficacy,1,acenocoumarol,981502445.0,European
981502435,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,981502445.0,European
1448617115,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,atazanavir,1448617117.0,"Multiple groups, Black, White, Hispanic"
981502420,PA166156563,rs2637777,,,FAT1,Efficacy,-1,aripiprazole,981502422.0,East Asian
981502420,PA166156563,rs2637777,,,FAT1,Toxicity,-1,aripiprazole,981502422.0,East Asian
982043114,PA166156901,rs5370,,,EDN1,Efficacy,-1,atenolol,982043124.0,European
982043114,PA166156901,rs5370,,,EDN1,Efficacy,-1,irbesartan,982043124.0,European
1450372533,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1450372536.0,East Asian
1450372533,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1450372535.0,East Asian
1450372533,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1450372536.0,East Asian
1450372533,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1450372535.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372536.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372535.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372536.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372535.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372536.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372535.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372536.0,East Asian
1450372533,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372535.0,East Asian
1448617108,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lopinavir,1448617114.0,"Multiple groups, Black, White, Hispanic"
1450814947,PA166156991,rs1799971,,,OPRM1,Toxicity,1,ethanol,1450814952.0,"Multiple groups, White, African American, Asian, Latino and Native American participants."
1450814947,PA166156991,rs1799971,,,OPRM1,Toxicity,1,ethanol,1450814953.0,"Multiple groups, White, African American, Asian, Latino and Native American participants."
1450814947,PA166156991,rs1799971,,,OPRM1,Toxicity,1,ethanol,1450814954.0,"Multiple groups, White, African American, Asian, Latino and Native American participants."
1445143678,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445147647.0,East Asian
1445143678,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445147647.0,East Asian
1446765735,PA166155393,rs2279343,,,CYP2B6,Efficacy,1,bupropion,1446765742.0,"Multiple groups, Brazil"
1448567951,PA166156997,rs1800629,,,TNF,Metabolism/PK,-1,sirolimus,1448567953.0,Unknown
1444668552,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668573.0,European
1444668552,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668575.0,European
1444668552,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668567.0,European
1444668552,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668569.0,European
1448567945,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,sirolimus,1448567947.0,Unknown
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814907.0,East Asian
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814903.0,East Asian
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814905.0,East Asian
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814904.0,East Asian
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814906.0,East Asian
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814909.0,East Asian
1450814898,PA166156331,rs1801282,,,PPARG,Efficacy,1,pioglitazone,1450814908.0,East Asian
982043057,PA166153546,rs5050,,,AGT,Efficacy,-1,irbesartan,982043063.0,European
982043057,PA166153546,rs5050,,,AGT,Efficacy,-1,irbesartan,982043062.0,European
1447519344,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1447519346.0,Central/South Asian
1447519344,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1447519346.0,Central/South Asian
1447519344,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1447519346.0,Central/South Asian
1448567934,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,sirolimus,1448567944.0,Unknown
1448567934,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,sirolimus,1448567944.0,Unknown
769146107,PA166157048,rs2781659,,,ARG1,Efficacy,1,selective beta-2-adrenoreceptor agonists,769146113.0,European
769146107,PA166157048,rs2781659,,,ARG1,Efficacy,1,selective beta-2-adrenoreceptor agonists,769146115.0,European
769146107,PA166157048,rs2781659,,,ARG1,Efficacy,1,selective beta-2-adrenoreceptor agonists,769146111.0,European
769146107,PA166157048,rs2781659,,,ARG1,Efficacy,1,selective beta-2-adrenoreceptor agonists,769146117.0,European
769146107,PA166157048,rs2781659,,,ARG1,Efficacy,1,selective beta-2-adrenoreceptor agonists,769146109.0,European
1449733611,PA166180558,rs61747221,,,BEST3,Efficacy,1,hydrochlorothiazide,1449733617.0,"Multiple groups, European American and African American participants"
1449733611,PA166180558,rs61747221,,,BEST3,Efficacy,1,hydrochlorothiazide,1449733621.0,"Multiple groups, European American and African American participants"
1449733611,PA166180558,rs61747221,,,BEST3,Efficacy,1,hydrochlorothiazide,1449733623.0,"Multiple groups, European American and African American participants"
1449733611,PA166180558,rs61747221,,,BEST3,Efficacy,1,hydrochlorothiazide,1449733619.0,"Multiple groups, European American and African American participants"
1451927120,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1451927140.0,Near Eastern
1451927120,,,PA166048692,CYP2C9*46,CYP2C9,Dosage,-1,warfarin,1451927140.0,Near Eastern
1451927120,,,PA166048692,CYP2C9*46,CYP2C9,Dosage,-1,warfarin,1451927140.0,Near Eastern
1448567928,PA166153642,rs1800896,,,IL10,Metabolism/PK,1,sirolimus,1448567930.0,Unknown
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814916.0,East Asian
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814918.0,East Asian
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814917.0,East Asian
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814921.0,East Asian
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814919.0,East Asian
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814915.0,East Asian
1450814910,PA166184298,rs17584499,,,PTPRD,Efficacy,1,pioglitazone,1450814920.0,East Asian
981502399,PA166153679,rs2228145,,,IL6R,Efficacy,-1,adalimumab,981502410.0,European
981502399,PA166153679,rs2228145,,,IL6R,Efficacy,-1,etanercept,981502410.0,European
981502399,PA166153679,rs2228145,,,IL6R,Efficacy,-1,infliximab,981502410.0,European
981502399,PA166153679,rs2228145,,,IL6R,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981502410.0,European
1448109167,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,3,1448109169.0,European
1448109167,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1448109167,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109169.0,European
1444930731,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2a,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2a,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2b,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2b,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL3,Efficacy,0,ribavirin,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL4,Efficacy,0,ribavirin,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL3,Efficacy,0,simeprevir,1444930737.0,Multiple groups
1444930731,PA166155468,rs12979860,,,IFNL4,Efficacy,0,simeprevir,1444930737.0,Multiple groups
981502411,PA166156555,rs2306987,,,FAT1,Efficacy,-1,aripiprazole,981502415.0,East Asian
981502411,PA166156555,rs2306987,,,FAT1,Toxicity,-1,aripiprazole,981502415.0,East Asian
1444668581,PA166155098,rs9939609,,,FTO,Efficacy,1,"interferon alfa-2a, recombinant",1444668595.0,Unknown
1444668581,PA166155098,rs9939609,,,FTO,Efficacy,1,"interferon alfa-2b, recombinant",1444668595.0,Unknown
1444668581,PA166155098,rs9939609,,,FTO,Efficacy,1,ribavirin,1444668595.0,Unknown
1448567921,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,sirolimus,1448567927.0,Unknown
982043071,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,irbesartan,982043075.0,European
982043071,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,irbesartan,982043076.0,European
1184996788,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,acenocoumarol,1184996799.0,European
1184996788,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,acenocoumarol,1184996799.0,European
1184472493,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clopidogrel,1184472503.0,"Multiple groups, EM:9 Caucasian;1 Chinese (Asian).  PM:2 Caucasian; 5 Chinese and 3 Japanese (8 Asian)."
1184472493,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clopidogrel,1184472503.0,"Multiple groups, EM:9 Caucasian;1 Chinese (Asian).  PM:2 Caucasian; 5 Chinese and 3 Japanese (8 Asian)."
1184472493,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,clopidogrel,1184472503.0,"Multiple groups, EM:9 Caucasian;1 Chinese (Asian).  PM:2 Caucasian; 5 Chinese and 3 Japanese (8 Asian)."
1184472493,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,clopidogrel,1184472503.0,"Multiple groups, EM:9 Caucasian;1 Chinese (Asian).  PM:2 Caucasian; 5 Chinese and 3 Japanese (8 Asian)."
982043158,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,pravastatin,982043166.0,Unknown
1444707037,PA166190881,rs11322783,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1444707041.0,European
1444707037,PA166190881,rs11322783,,,IFNL4,Efficacy,-1,ribavirin,1444707041.0,European
1444707037,PA166190881,rs11322783,,,IFNL4,Efficacy,-1,ribavirin,1444707041.0,European
1447814223,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,1,cotinine,1447814225.0,European
1451927260,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451927283.0,"Multiple groups, meta-analysis one ""Han Chinese"", 2 ""Caucasians"","
1451927260,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451927265.0,East Asian
1451927260,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451927283.0,"Multiple groups, meta-analysis one ""Han Chinese"", 2 ""Caucasians"","
1451927260,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451927265.0,East Asian
1184472513,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,1184472515.0,Unknown
1447814229,PA166154919,rs7170068,,,CHRNA3,Metabolism/PK,1,cotinine,1447814231.0,European
1450373158,PA166179966,rs562859,,,OPRM1,Efficacy,-1,methadone,1450373160.0,East Asian
1450373158,PA166179966,rs562859,,,OPRM1,Efficacy,-1,methadone,1450373292.0,East Asian
1449160191,PA166176136,rs168924,,,SLC6A2,Other,-1,3,1449160196.0,European
1449160191,PA166176136,rs168924,,,SLC6A2,Other,-1,3,1449160198.0,European
1449160191,PA166176136,rs168924,,,SLC6A2,Other,-1,3,1449160200.0,European
1449160191,PA166176136,rs168924,,,SLC6A2,Other,-1,4-methylenedioxymethamphetamine,1449160196.0,European
1449160191,PA166176136,rs168924,,,SLC6A2,Other,-1,4-methylenedioxymethamphetamine,1449160198.0,European
1449160191,PA166176136,rs168924,,,SLC6A2,Other,-1,4-methylenedioxymethamphetamine,1449160200.0,European
1450372589,PA166155582,rs6166,,,FSHR,Toxicity,0,follitropin beta,1450372595.0,Unknown
1450372589,PA166155582,rs6166,,,FSHR,Toxicity,0,urofollitropin,1450372595.0,Unknown
1183690880,PA166157105,rs4715354,,,GSTA5,Metabolism/PK,-1,busulfan,1183690884.0,Unknown
1183690880,PA166157105,rs4715354,,,GSTA5,Metabolism/PK,-1,busulfan,1183690886.0,Unknown
1447679044,PA166154150,rs12266458,,,CHAT,Efficacy,-1,donepezil,1447679046.0,East Asian
1447679044,PA166154150,rs12266458,,,CHAT,Efficacy,-1,galantamine,1447679046.0,East Asian
1447679044,PA166154150,rs12266458,,,CHAT,Efficacy,-1,rivastigmine,1447679046.0,East Asian
1450815015,PA166184308,rs2636697,,,PPA2,Efficacy,1,risperidone,1450815020.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1447814235,PA166154841,rs588765,,,CHRNA5,Metabolism/PK,-1,cotinine,1447814237.0,European
1444668491,PA166155468,rs12979860,,,IFNL3,Efficacy,1,"interferon alfa-2a, recombinant",1444668497.0,Near Eastern
1444668491,PA166155468,rs12979860,,,IFNL4,Efficacy,1,"interferon alfa-2a, recombinant",1444668497.0,Near Eastern
1444668491,PA166155468,rs12979860,,,IFNL3,Efficacy,1,"interferon alfa-2b, recombinant",1444668497.0,Near Eastern
1444668491,PA166155468,rs12979860,,,IFNL4,Efficacy,1,"interferon alfa-2b, recombinant",1444668497.0,Near Eastern
1444668491,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444668497.0,Near Eastern
1444668491,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444668497.0,Near Eastern
651394513,PA166157201,rs35167514,,,SLC22A1,Efficacy,0,Antiemetics And Antinauseants,,
651394513,PA166157201,rs35167514,,,SLC22A1,Metabolism/PK,0,Antiemetics And Antinauseants,,
1184996801,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,acenocoumarol,1184996803.0,European
1184996801,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,acenocoumarol,1184996803.0,European
1447814206,PA166154929,rs10851907,,,CHRNB4,Metabolism/PK,1,cotinine,1447814208.0,European
827816322,PA166155405,rs3211371,,,CYP2B6,Dosage,-1,methadone,827816472.0,East Asian
827816322,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,-1,methadone,827816472.0,East Asian
1451927202,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451927223.0,East Asian
1451927202,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451927224.0,"Multiple groups, meta-analysis one ""Han Chinese"", 2 ""Caucasians"", 1 ""Iranians"""
1451927202,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451927223.0,East Asian
1451927202,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451927224.0,"Multiple groups, meta-analysis one ""Han Chinese"", 2 ""Caucasians"", 1 ""Iranians"""
827816336,PA166154339,rs1800497,,,ANKK1,Dosage,-1,methadone,827816434.0,East Asian
827816336,PA166154339,rs1800497,,,ANKK1,Metabolism/PK,-1,methadone,827816434.0,East Asian
1450044963,PA166181266,rs6961419,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044965.0,Unknown
1444668499,PA166155435,rs8099917,,,IFNL3,Efficacy,1,"interferon alfa-2a, recombinant",1444668501.0,Near Eastern
1444668499,PA166155435,rs8099917,,,IFNL3,Efficacy,1,"interferon alfa-2b, recombinant",1444668501.0,Near Eastern
1444668499,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444668501.0,Near Eastern
982043126,PA166156901,rs5370,,,EDN1,Efficacy,1,atenolol,982043136.0,European
982043126,PA166156901,rs5370,,,EDN1,Efficacy,1,atenolol,982043145.0,European
982043126,PA166156901,rs5370,,,EDN1,Efficacy,1,irbesartan,982043136.0,European
982043126,PA166156901,rs5370,,,EDN1,Efficacy,1,irbesartan,982043145.0,European
1447814214,PA166154955,rs57064725,,,PSMA4,Metabolism/PK,1,cotinine,1447814217.0,European
1449160206,PA166176138,rs47958,,,SLC6A2,Other,-1,3,1449160208.0,European
1449160206,PA166176138,rs47958,,,SLC6A2,Other,-1,3,1449160209.0,European
1449160206,PA166176138,rs47958,,,SLC6A2,Other,-1,3,1449160210.0,European
1449160206,PA166176138,rs47958,,,SLC6A2,Other,-1,4-methylenedioxymethamphetamine,1449160208.0,European
1449160206,PA166176138,rs47958,,,SLC6A2,Other,-1,4-methylenedioxymethamphetamine,1449160209.0,European
1449160206,PA166176138,rs47958,,,SLC6A2,Other,-1,4-methylenedioxymethamphetamine,1449160210.0,European
1450044969,PA166181267,rs6961665,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044971.0,Unknown
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,3,1449160222.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,3,1449160220.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,3,1449160221.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160222.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160220.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160221.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160222.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160220.0,European
1449160218,PA166176140,rs1861647,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160221.0,European
1447945286,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1447945302.0,East Asian
1447945286,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,irinotecan,1447945302.0,East Asian
1447945286,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1447945302.0,East Asian
1448567866,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,sirolimus,1448567915.0,East Asian
982043146,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,pravastatin,982043154.0,Unknown
1449160225,PA166155036,rs2242446,,,SLC6A2,Other,1,3,1449160229.0,European
1449160225,PA166155036,rs2242446,,,SLC6A2,Other,1,3,1449160227.0,European
1449160225,PA166155036,rs2242446,,,SLC6A2,Other,1,3,1449160228.0,European
1449160225,PA166155036,rs2242446,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160229.0,European
1449160225,PA166155036,rs2242446,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160227.0,European
1449160225,PA166155036,rs2242446,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160228.0,European
1451208192,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,fentanyl,1451208200.0,Unknown
1451208192,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,fentanyl,1451208200.0,Unknown
1451208192,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,fentanyl,1451208200.0,Unknown
1444668512,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,1444668531.0,Unknown
1444668512,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,1444668529.0,Unknown
982043138,PA166154574,rs4149015,,,SLCO1B1,Metabolism/PK,1,pravastatin,982043142.0,Unknown
1451126280,PA166202221,rs616147,,,MOBP,Efficacy,1,creatine,1451126285.0,Unknown
1183622736,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183622738.0,East Asian
1183622736,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183622773.0,East Asian
1183622736,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183622771.0,East Asian
1183622736,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183622738.0,East Asian
1183622736,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183622773.0,East Asian
1183622736,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183622771.0,East Asian
1183622736,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183622738.0,East Asian
1183622736,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183622773.0,East Asian
1183622736,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183622771.0,East Asian
827816288,PA166157288,rs1128503,,,ABCB1,Dosage,-1,methadone,827816306.0,East Asian
827816288,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methadone,827816306.0,East Asian
827816288,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methadone,827816306.0,East Asian
827816288,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methadone,827816306.0,East Asian
827816288,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methadone,827816306.0,East Asian
1448567850,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,sirolimus,1448567906.0,East Asian
1448567850,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,sirolimus,1448567906.0,East Asian
982043225,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,pravastatin,982043233.0,Unknown
982043225,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,pravastatin,982043623.0,Unknown
1444930545,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,0,voriconazole,1444930552.0,European
827816293,PA166157316,rs2032582,,,ABCB1,Dosage,-1,methadone,827816304.0,East Asian
827816293,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,methadone,827816304.0,East Asian
1450044988,PA166157380,rs3789243,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044990.0,Unknown
1450815058,PA166184313,rs17742120,,,PDE4D,Efficacy,1,quetiapine,1450815063.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1447519253,PA166154663,rs112445441,,,KRAS,Efficacy,-1,cetuximab,1447519259.0,Unknown
1450045000,PA166157443,rs10276036,,,ABCB1,Metabolism/PK,-1,methotrexate,1450045002.0,Unknown
1444930553,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444930566.0,East Asian
1444930553,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444930566.0,East Asian
1450044994,PA166181269,rs1202171,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044996.0,Unknown
1450815067,PA166184314,rs2164660,,,PDE4D,Efficacy,1,quetiapine,1450815072.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1183620712,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183620714.0,East Asian
1183620712,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183620715.0,East Asian
1183620712,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183620714.0,East Asian
1183620712,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183620715.0,East Asian
1183620712,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183620714.0,East Asian
1183620712,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183620715.0,East Asian
1444668415,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1444668421.0,Unknown
982046695,PA166155642,rs1799809,,,PROC,Dosage,-1,phenprocoumon,982046697.0,European
982046695,PA166155642,rs1799809,,,PROC,Metabolism/PK,-1,phenprocoumon,982046697.0,European
1450815073,PA166184316,rs711355,,,TJP1,Efficacy,1,risperidone,1450815078.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1450372675,PA166182096,rs7905446,,,HTR7,Efficacy,1,paroxetine,1450372682.0,European
982044530,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982044540.0,Unknown
1450044975,PA166157442,rs10267099,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044977.0,Unknown
1450815079,PA166184317,rs785423,,,TJP1,Efficacy,1,risperidone,1450815084.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1444930567,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930569.0,East Asian
1444930567,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930569.0,East Asian
982046684,PA166154680,rs510335,,,F7,Dosage,-1,phenprocoumon,982046686.0,European
982046684,PA166154680,rs510335,,,F7,Metabolism/PK,-1,phenprocoumon,982046686.0,European
1450044982,PA166181268,rs10808071,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044984.0,Unknown
1450372709,PA166182096,rs7905446,,,HTR7,Efficacy,1,Selective serotonin reuptake inhibitors,1450372711.0,European
1450045025,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methotrexate,1450045027.0,Unknown
1450045025,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methotrexate,1450045027.0,Unknown
1444668429,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,1444668434.0,Unknown
1444668429,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668434.0,Unknown
1444668429,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1444668434.0,Unknown
982043191,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,pravastatin,982043201.0,Unknown
982043191,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,pravastatin,982043625.0,Unknown
982046680,PA166154679,rs510317,,,F7,Dosage,-1,phenprocoumon,982046682.0,European
982046680,PA166154679,rs510317,,,F7,Metabolism/PK,-1,phenprocoumon,982046682.0,European
1450815024,PA166184309,rs2636719,,,PPA2,Efficacy,1,risperidone,1450815029.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1450815024,PA166184309,rs2636719,,,PPA2,Efficacy,1,risperidone,1450815029.0,"Multiple groups, European American, African American and 'Other' ethnicities."
1444668437,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,1444668443.0,Unknown
1444668437,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1444668443.0,Unknown
1444668437,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1444668443.0,Unknown
1450372715,PA166182096,rs7905446,,,HTR7,Efficacy,1,escitalopram,1450372717.0,European
1451928000,PA166155506,rs56113850,,,CYP2A6,,0,letrozole,1451928005.0,European
1450045031,PA166154982,rs35592,,,ABCC1,Metabolism/PK,-1,methotrexate,1450045033.0,Unknown
1448125427,PA166153646,rs1801159,,,DPYD,Efficacy,1,capecitabine,1448125433.0,Unknown
1450815036,PA166184311,rs10170310,,,SPOPL,Efficacy,1,olanzapine,1450815044.0,"Multiple groups, European American, African American and 'Other' ethnicities."
981502529,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,981502540.0,European
1450045006,PA166157340,rs2235048,,,ABCB1,Metabolism/PK,-1,methotrexate,1450045008.0,Unknown
1445297534,PA166157284,rs1045642,,,ABCB1,Other,-1,tacrolimus,1445297536.0,East Asian
982043203,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,pravastatin,982043211.0,Unknown
982043203,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,pravastatin,982043621.0,Unknown
1447683061,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,1,lamotrigine,1447683063.0,East Asian
1450815045,PA166184312,rs17382202,,,PDE4D,Efficacy,1,quetiapine,1450815054.0,"Multiple groups, European American, African American and 'Other' ethnicities."
982046688,PA166155822,rs12714145,,,GGCX,Dosage,-1,phenprocoumon,982046690.0,European
982046688,PA166155822,rs12714145,,,GGCX,Metabolism/PK,-1,phenprocoumon,982046690.0,European
1450045012,PA166157385,rs4148737,,,ABCB1,Metabolism/PK,-1,methotrexate,1450045014.0,Unknown
1450045018,PA166181270,rs2235035,,,ABCB1,Metabolism/PK,-1,methotrexate,1450045020.0,Unknown
1444668343,PA166156990,rs1799964,,,TNF,Efficacy,-1,etanercept,1444668353.0,East Asian
1444668343,PA166156990,rs1799964,,,TNF,Efficacy,-1,etanercept,1444668349.0,East Asian
1444668343,PA166156990,rs1799964,,,TNF,Efficacy,-1,etanercept,1444668351.0,East Asian
1448109032,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,3,1448109147.0,European
1448109032,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
1448109032,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448109147.0,European
981502615,PA166156456,rs13064530,,,HRH1,Efficacy,-1,clozapine,981502628.0,East Asian
1448125419,PA166153648,rs1801265,,,DPYD,Efficacy,-1,capecitabine,1448125426.0,Unknown
1450045061,PA166181272,rs4148398,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045063.0,Unknown
1450045037,PA166154991,rs246240,,,ABCC1,Metabolism/PK,-1,methotrexate,1450045039.0,Unknown
1444668354,PA166156998,rs1800630,,,TNF,Efficacy,-1,etanercept,1444668358.0,East Asian
1444668354,PA166156998,rs1800630,,,TNF,Efficacy,-1,etanercept,1444668356.0,East Asian
1444668354,PA166156998,rs1800630,,,TNF,Efficacy,-1,etanercept,1444668357.0,East Asian
1450372728,PA166182096,rs7905446,,,HTR7,Efficacy,-1,escitalopram,1450372730.0,European
1450372728,PA166182096,rs7905446,,,HTR7,Efficacy,-1,nortriptyline,1450372730.0,European
1450045049,PA166155053,rs3784862,,,ABCC1,Metabolism/PK,-1,methotrexate,1450045051.0,Unknown
1444668362,PA166156969,rs1041981,,,LTA,Efficacy,-1,etanercept,1444668366.0,East Asian
1444668362,PA166156969,rs1041981,,,LTA,Efficacy,-1,etanercept,1444668364.0,East Asian
1444668362,PA166156969,rs1041981,,,LTA,Efficacy,-1,etanercept,1444668365.0,East Asian
981502629,PA166154411,rs4938013,,,ANKK1,Efficacy,-1,clozapine,981502636.0,East Asian
1450815085,PA166184318,rs813676,,,TJP1,Efficacy,1,risperidone,1450815090.0,"Multiple groups, European American, African American and 'Other' ethnicities."
827820232,PA166156286,rs324026,,,DRD3,Efficacy,1,duloxetine,827820239.0,European
1183620738,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,famotidine,1183620755.0,East Asian
1183620738,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,famotidine,1183620758.0,East Asian
1183620738,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183620755.0,East Asian
1183620738,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183620758.0,East Asian
1448262090,PA166160426,rs2229193,,,GRIN2A,Efficacy,-1,methylphenidate,1448262092.0,East Asian
1444668370,PA166156915,rs361525,,,TNF,Efficacy,-1,etanercept,1444668374.0,East Asian
1444668370,PA166156915,rs361525,,,TNF,Efficacy,-1,etanercept,1444668372.0,East Asian
1444668370,PA166156915,rs361525,,,TNF,Efficacy,-1,etanercept,1444668373.0,East Asian
1183702665,PA166157434,rs8191992,,,CHRM2,Efficacy,1,fluticasone/salmeterol,1183702889.0,European
827820224,PA166156285,rs324023,,,DRD3,Efficacy,1,duloxetine,827820231.0,European
1184753642,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1184753644.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1448567743,PA166157286,rs1057868,,,POR,Metabolism/PK,1,sirolimus,1448567749.0,Unknown
827820216,PA166156279,rs167770,,,DRD3,Efficacy,1,duloxetine,827820223.0,European
1450045097,PA166181275,rs3740063,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045099.0,Unknown
981502588,PA166155159,rs25531,,,SLC6A4,Efficacy,1,clozapine,981502592.0,European
1183620725,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183620737.0,East Asian
1447945146,,,PA166131619,NUDT15*1,NUDT15,Metabolism/PK,1,mercaptopurine,1447945168.0,Multiple groups
1447945146,,,PA166131619,NUDT15*1,NUDT15,Metabolism/PK,1,mercaptopurine,1447945164.0,East Asian
1447945146,,,PA166131619,NUDT15*1,NUDT15,Metabolism/PK,1,mercaptopurine,1447945166.0,East Asian
1447945146,,,PA166131620,NUDT15*2,NUDT15,Metabolism/PK,1,mercaptopurine,1447945168.0,Multiple groups
1447945146,,,PA166131620,NUDT15*2,NUDT15,Metabolism/PK,1,mercaptopurine,1447945164.0,East Asian
1447945146,,,PA166131620,NUDT15*2,NUDT15,Metabolism/PK,1,mercaptopurine,1447945166.0,East Asian
1447945146,,,PA166131621,NUDT15*3,NUDT15,Metabolism/PK,1,mercaptopurine,1447945168.0,Multiple groups
1447945146,,,PA166131621,NUDT15*3,NUDT15,Metabolism/PK,1,mercaptopurine,1447945164.0,East Asian
1447945146,,,PA166131621,NUDT15*3,NUDT15,Metabolism/PK,1,mercaptopurine,1447945166.0,East Asian
1447945146,,,PA166131623,NUDT15*5,NUDT15,Metabolism/PK,1,mercaptopurine,1447945168.0,Multiple groups
1447945146,,,PA166131623,NUDT15*5,NUDT15,Metabolism/PK,1,mercaptopurine,1447945164.0,East Asian
1447945146,,,PA166131623,NUDT15*5,NUDT15,Metabolism/PK,1,mercaptopurine,1447945166.0,East Asian
1184469950,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,prasugrel,1184469952.0,European
1184469950,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,prasugrel,1184469952.0,European
1184469950,,,PA165816524,CYP2C19*8,CYP2C19,Efficacy,-1,prasugrel,1184469952.0,European
1184469950,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,prasugrel,1184469952.0,European
1184469950,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,prasugrel,1184469952.0,European
1184469950,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,prasugrel,1184469952.0,European
1184469950,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,-1,prasugrel,1184469952.0,European
1184469950,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,prasugrel,1184469952.0,European
1448567727,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,sirolimus,1448567729.0,Unknown
1448567727,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,sirolimus,1448567729.0,Unknown
1450045121,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,methotrexate,1450045123.0,Unknown
827820202,PA166156301,rs963468,,,DRD3,Efficacy,1,duloxetine,827820209.0,European
981502673,PA166153999,rs2227310,,,CASP7,Efficacy,1,paclitaxel,981502686.0,East Asian
981502673,PA166153999,rs2227310,,,CASP7,Efficacy,1,Platinum compounds,981502686.0,East Asian
1450815182,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,venlafaxine,1450815186.0,European
1450815182,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,venlafaxine,1450815186.0,European
1444706639,PA166154623,rs10877012,,,CYP27B1,Efficacy,-1,peginterferon alfa-2b,1444706642.0,European
1444706639,PA166154623,rs10877012,,,CYP27B1,Efficacy,-1,ribavirin,1444706642.0,European
1447682974,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,lamotrigine,1447682980.0,East Asian
1448567714,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,sirolimus,1448567726.0,Unknown
1448567714,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,sirolimus,1448567726.0,Unknown
982043371,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982043383.0,Unknown
982043371,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982043381.0,Unknown
982043371,PA166155187,rs1799752,,,ACE,Efficacy,1,losartan,982043383.0,Unknown
982043371,PA166155187,rs1799752,,,ACE,Efficacy,1,losartan,982043381.0,Unknown
827847951,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,nevirapine,827848519.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827847951,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,nevirapine,827848519.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
1450815197,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,venlafaxine,1450815201.0,European
981502687,PA166153965,rs1127687,,,CASP7,Efficacy,1,paclitaxel,981502696.0,East Asian
981502687,PA166153965,rs1127687,,,CASP7,Efficacy,1,Platinum compounds,981502696.0,East Asian
1450045103,PA166155219,rs4148416,,,ABCC3,Metabolism/PK,-1,methotrexate,1450045105.0,Unknown
1183620822,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183620834.0,East Asian
1451110120,PA166155986,rs1051266,,,SLC19A1,Efficacy,-1,methotrexate,1451110125.0,Unknown
981502697,PA166153965,rs1127687,,,CASP7,Efficacy,1,gemcitabine,981502706.0,East Asian
981502697,PA166153965,rs1127687,,,CASP7,Efficacy,1,Platinum compounds,981502706.0,East Asian
1183679954,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183679956.0,East Asian
1183679954,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183679956.0,East Asian
1183679954,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183679956.0,East Asian
1450045109,PA166154734,rs9516519,,,ABCC4,Metabolism/PK,-1,methotrexate,1450045111.0,Unknown
1450045109,PA166154734,rs9516519,,,ABCC4,Metabolism/PK,-1,methotrexate,1450045111.0,Unknown
1450372838,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450372848.0,American
1450372838,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450372848.0,American
981502641,PA166154152,rs12415607,,,CASP7,Efficacy,1,paclitaxel,981502646.0,East Asian
981502641,PA166154152,rs12415607,,,CASP7,Efficacy,1,Platinum compounds,981502646.0,East Asian
1450045115,PA166181276,rs1564481,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045117.0,Unknown
982046676,PA166157283,rs1043550,,,CALU,Dosage,-1,phenprocoumon,982046678.0,European
982046676,PA166157283,rs1043550,,,CALU,Metabolism/PK,-1,phenprocoumon,982046678.0,European
1450045163,PA166156674,rs17731538,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045165.0,Unknown
981502647,PA166154152,rs12415607,,,CASP7,Efficacy,-1,gemcitabine,981502652.0,East Asian
981502647,PA166154152,rs12415607,,,CASP7,Efficacy,-1,Platinum compounds,981502652.0,East Asian
1450045157,PA166156659,rs12505410,,,ABCG2,Metabolism/PK,1,methotrexate,1450045159.0,Unknown
982043310,PA166155187,rs1799752,,,ACE,Efficacy,1,benazepril,982043320.0,East Asian
1184472851,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184472855.0,Multiple groups
1446896503,PA166156457,rs16846673,,,P2RY12,Efficacy,-1,clopidogrel,1446896505.0,Latino
1450045139,PA166156571,rs3114018,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045141.0,Unknown
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043368.0,East Asian
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043370.0,East Asian
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043364.0,East Asian
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043359.0,East Asian
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043351.0,East Asian
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043349.0,East Asian
982043336,PA166155187,rs1799752,,,ACE,Efficacy,-1,benazepril,982043361.0,East Asian
1448567673,PA166155384,rs2189784,,,CYP4F2,Dosage,1,warfarin,1448567675.0,East Asian
1446896509,PA166156418,rs6809699,,,P2RY12,Efficacy,-1,clopidogrel,1446896512.0,Latino
1450045133,PA166156565,rs2725252,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045135.0,Unknown
1447678993,PA166154040,rs3810950,,,CHAT,Efficacy,-1,donepezil,1447678995.0,East Asian
1447678993,PA166154040,rs3810950,,,CHAT,Efficacy,-1,galantamine,1447678995.0,East Asian
1447678993,PA166154040,rs3810950,,,CHAT,Efficacy,-1,rivastigmine,1447678995.0,East Asian
1185012341,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,1185012343.0,East Asian
981502653,PA166154054,rs4353229,,,CASP7,Efficacy,1,paclitaxel,981502662.0,East Asian
981502653,PA166154054,rs4353229,,,CASP7,Efficacy,1,Platinum compounds,981502662.0,East Asian
1184472866,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1184472868.0,Multiple groups
1184472866,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1184472868.0,Multiple groups
1449275114,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1449275128.0,East Asian
1449275114,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1449275126.0,East Asian
1449275114,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1449275130.0,East Asian
1449275114,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1449275128.0,East Asian
1449275114,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1449275126.0,East Asian
1449275114,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1449275130.0,East Asian
1449275114,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1449275128.0,East Asian
1449275114,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1449275126.0,East Asian
1449275114,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1449275130.0,East Asian
1446896521,PA166156412,rs6785930,,,P2RY12,Efficacy,-1,clopidogrel,1446896523.0,Latino
1450045145,PA166156561,rs2622604,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045147.0,Unknown
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930499.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930497.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930476.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930499.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930497.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930476.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930499.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930497.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930476.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930499.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930497.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930476.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930499.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930497.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444930476.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930499.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930497.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930476.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930499.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930497.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930476.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930499.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930497.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930476.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930499.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930497.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930476.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930499.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930497.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444930476.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930499.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930497.0,East Asian
1444930474,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930476.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930499.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930497.0,East Asian
1444930474,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930476.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930499.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930497.0,East Asian
1444930474,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930476.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930499.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930497.0,East Asian
1444930474,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930476.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930499.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930497.0,East Asian
1444930474,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444930476.0,East Asian
1448567667,PA166153686,rs2260863,,,EPHX1,Dosage,1,warfarin,1448567669.0,East Asian
981502663,PA166154054,rs4353229,,,CASP7,Efficacy,-1,gemcitabine,981502672.0,East Asian
981502663,PA166154054,rs4353229,,,CASP7,Efficacy,-1,Platinum compounds,981502672.0,East Asian
1444668331,PA166154503,rs784888,,,SP1,Metabolism/PK,1,metformin,1444668338.0,Multiple groups
1448567661,PA166155341,rs7412,,,APOE,Dosage,1,warfarin,1448567663.0,East Asian
1448568158,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1448568170.0,"Multiple groups, Caucasian and Unknown"
1448568158,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1448568170.0,"Multiple groups, Caucasian and Unknown"
1450372870,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450372888.0,"Multiple groups, White European and Black African"
1450372870,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450372892.0,"Multiple groups, White European and Black African"
1450372870,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450372890.0,"Multiple groups, White European and Black African"
1450372870,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450372888.0,"Multiple groups, White European and Black African"
1450372870,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450372892.0,"Multiple groups, White European and Black African"
1450372870,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450372890.0,"Multiple groups, White European and Black African"
1446896464,,,PA165988484,CYP2D6*21,CYP2D6,Metabolism/PK,0,debrisoquine,1446896471.0,East Asian
1446896464,,,PA165971589,CYP2D6*36xN,CYP2D6,Metabolism/PK,0,debrisoquine,1446896471.0,East Asian
1451110160,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methotrexate,1451110165.0,Unknown
1447681039,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1447681042.0,Unknown
1447681039,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1447681041.0,Unknown
1447681039,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1447681042.0,Unknown
1447681039,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1447681041.0,Unknown
1450045187,PA166154581,rs4149081,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045189.0,Unknown
1450045181,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045183.0,Unknown
982046672,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,phenprocoumon,982046674.0,European
982046672,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,-1,phenprocoumon,982046674.0,European
1450372874,PA166155937,rs3746544,,,SNAP25,Efficacy,-1,methylphenidate,1450372901.0,Multiple groups
1183620899,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620901.0,East Asian
1183620899,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620902.0,East Asian
1183620899,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620901.0,East Asian
1183620899,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620902.0,East Asian
1183620899,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620901.0,East Asian
1183620899,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620902.0,East Asian
1448567655,PA166157481,rs28371759,,,CYP3A4,Dosage,1,warfarin,1448567657.0,East Asian
981502733,PA166155250,rs12941497,,,NR1D1,Efficacy,-1,lithium,981502739.0,European
1448567649,PA166154874,rs2069514,,,CYP1A2,Dosage,1,warfarin,1448567651.0,East Asian
981502741,PA166155170,rs939347,,,NR1D1,Efficacy,-1,lithium,981502746.0,European
1183620883,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620893.0,East Asian
1183620883,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620895.0,East Asian
1183620883,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620893.0,East Asian
1183620883,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620895.0,East Asian
1183620883,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620893.0,East Asian
1183620883,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620895.0,East Asian
1447945037,,,PA166131619,NUDT15*1,NUDT15,Dosage,1,mercaptopurine,1447945129.0,Multiple groups
1447945037,,,PA166131619,NUDT15*1,NUDT15,Dosage,1,mercaptopurine,1447945104.0,East Asian
1447945037,,,PA166131619,NUDT15*1,NUDT15,Dosage,1,mercaptopurine,1447945106.0,East Asian
1447945037,,,PA166131619,NUDT15*1,NUDT15,Dosage,1,mercaptopurine,1447945102.0,Latino
1447945037,,,PA166131620,NUDT15*2,NUDT15,Dosage,1,mercaptopurine,1447945129.0,Multiple groups
1447945037,,,PA166131620,NUDT15*2,NUDT15,Dosage,1,mercaptopurine,1447945104.0,East Asian
1447945037,,,PA166131620,NUDT15*2,NUDT15,Dosage,1,mercaptopurine,1447945106.0,East Asian
1447945037,,,PA166131620,NUDT15*2,NUDT15,Dosage,1,mercaptopurine,1447945102.0,Latino
1447945037,,,PA166131621,NUDT15*3,NUDT15,Dosage,1,mercaptopurine,1447945129.0,Multiple groups
1447945037,,,PA166131621,NUDT15*3,NUDT15,Dosage,1,mercaptopurine,1447945104.0,East Asian
1447945037,,,PA166131621,NUDT15*3,NUDT15,Dosage,1,mercaptopurine,1447945106.0,East Asian
1447945037,,,PA166131621,NUDT15*3,NUDT15,Dosage,1,mercaptopurine,1447945102.0,Latino
1447945037,,,PA166131622,NUDT15*4,NUDT15,Dosage,1,mercaptopurine,1447945129.0,Multiple groups
1447945037,,,PA166131622,NUDT15*4,NUDT15,Dosage,1,mercaptopurine,1447945104.0,East Asian
1447945037,,,PA166131622,NUDT15*4,NUDT15,Dosage,1,mercaptopurine,1447945106.0,East Asian
1447945037,,,PA166131622,NUDT15*4,NUDT15,Dosage,1,mercaptopurine,1447945102.0,Latino
1447945037,,,PA166131623,NUDT15*5,NUDT15,Dosage,1,mercaptopurine,1447945129.0,Multiple groups
1447945037,,,PA166131623,NUDT15*5,NUDT15,Dosage,1,mercaptopurine,1447945104.0,East Asian
1447945037,,,PA166131623,NUDT15*5,NUDT15,Dosage,1,mercaptopurine,1447945106.0,East Asian
1447945037,,,PA166131623,NUDT15*5,NUDT15,Dosage,1,mercaptopurine,1447945102.0,Latino
1449750257,PA166155915,rs1127354,,,ITPA,Dosage,-1,mercaptopurine,1449750265.0,East Asian
1449750257,PA166155915,rs1127354,,,ITPA,Toxicity,-1,mercaptopurine,1449750265.0,East Asian
1446896476,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1446896481.0,Latino
981502748,PA166154731,rs9315885,,,DGKH,Efficacy,-1,lithium,981502754.0,European
1448567637,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448567639.0,East Asian
1448567637,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448567639.0,East Asian
981502763,PA166154696,rs1170191,,,DGKH,Efficacy,-1,lithium,981502768.0,European
1449275137,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449275150.0,East Asian
1449275137,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449275150.0,East Asian
1448567630,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448567636.0,East Asian
1450045175,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1450045177.0,Unknown
981502756,PA166154691,rs1012053,,,DGKH,Efficacy,-1,lithium,981502761.0,European
651361989,PA166157197,rs34130495,,,SLC22A1,Efficacy,0,Antiemetics And Antinauseants,,
651361989,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,0,Antiemetics And Antinauseants,,
1444668242,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1444668248.0,Unknown
1444668242,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1444668252.0,Unknown
1451110126,PA166155971,rs7499,,,SLC19A1,Efficacy,-1,methotrexate,1451110131.0,Unknown
1450045217,PA166181283,rs4149026,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045219.0,Unknown
1451110132,PA166156004,rs2838956,,,SLC19A1,Efficacy,-1,methotrexate,1451110140.0,Unknown
1444930388,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444930473.0,East Asian
1444930388,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1444930473.0,East Asian
1444930388,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444930473.0,East Asian
1444930388,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444930473.0,East Asian
1444930388,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1444930473.0,East Asian
1450045205,PA166154632,rs11045872,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045207.0,Unknown
981732098,PA166155293,rs4149601,,,NEDD4L,Efficacy,-1,hydrochlorothiazide,981732108.0,African American/Afro-Caribbean
1448567608,PA166162451,rs2230229,,,TNFRSF10A,Efficacy,-1,rituximab,1448567614.0,Unknown
1450045211,PA166181282,rs1463565,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045213.0,Unknown
1450045251,PA166154580,rs4149057,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045253.0,Unknown
1450045245,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045247.0,Unknown
1184407399,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,tacrolimus,1184407403.0,Unknown
1444930299,PA166154841,rs588765,,,CHRNA5,Dosage,-1,nicotine,1444930301.0,European
1447679275,PA166154038,rs3793800,,,CHAT,Efficacy,-1,donepezil,1447679277.0,East Asian
1447679275,PA166154038,rs3793800,,,CHAT,Efficacy,-1,galantamine,1447679277.0,East Asian
1447679275,PA166154038,rs3793800,,,CHAT,Efficacy,-1,rivastigmine,1447679277.0,East Asian
1450372926,PA166155937,rs3746544,,,SNAP25,Efficacy,-1,methylphenidate,1450372932.0,Multiple groups
1450045257,PA166181287,rs4148324,,,UGT1A1,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A10,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A3,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A4,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A5,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A6,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A7,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A8,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1450045257,PA166181287,rs4148324,,,UGT1A9,Metabolism/PK,1,methotrexate,1450045259.0,Unknown
1444930293,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,nicotine,1444930295.0,European
1449750346,,,PA166131619,NUDT15*1,NUDT15,Dosage,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131620,NUDT15*2,NUDT15,Dosage,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131621,NUDT15*3,NUDT15,Dosage,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131623,NUDT15*5,NUDT15,Dosage,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166151814,NUDT15*6,NUDT15,Dosage,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131619,NUDT15*1,NUDT15,Toxicity,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131620,NUDT15*2,NUDT15,Toxicity,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131621,NUDT15*3,NUDT15,Toxicity,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166131623,NUDT15*5,NUDT15,Toxicity,-1,mercaptopurine,1449750362.0,East Asian
1449750346,,,PA166151814,NUDT15*6,NUDT15,Toxicity,-1,mercaptopurine,1449750362.0,East Asian
1447813900,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447813911.0,East Asian
1447813900,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447813911.0,East Asian
1447814077,,,PA165958463,NAT1*3,NAT1,Metabolism/PK,1,mesalazine,1447814089.0,Unknown
1447814077,,,PA165958462,NAT1*4,NAT1,Metabolism/PK,1,mesalazine,1447814089.0,Unknown
1447814077,,,PA165958465,NAT1*10,NAT1,Metabolism/PK,1,mesalazine,1447814089.0,Unknown
1447814077,,,PA165958463,NAT1*3,NAT1,Metabolism/PK,1,thioguanine,1447814089.0,Unknown
1447814077,,,PA165958462,NAT1*4,NAT1,Metabolism/PK,1,thioguanine,1447814089.0,Unknown
1447814077,,,PA165958465,NAT1*10,NAT1,Metabolism/PK,1,thioguanine,1447814089.0,Unknown
1448567570,PA166157545,rs20575,,,TNFRSF10A,Efficacy,-1,rituximab,1448567586.0,Unknown
1447682840,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,azathioprine,1447682860.0,East Asian
1447682840,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,mercaptopurine,1447682860.0,East Asian
1447679282,PA166154039,rs3793801,,,CHAT,Efficacy,-1,donepezil,1447679284.0,East Asian
1447679282,PA166154039,rs3793801,,,CHAT,Efficacy,-1,galantamine,1447679284.0,East Asian
1447679282,PA166154039,rs3793801,,,CHAT,Efficacy,-1,rivastigmine,1447679284.0,East Asian
981501273,PA166155468,rs12979860,,,IFNL3,Dosage,-1,peginterferon alfa-2a,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL4,Dosage,-1,peginterferon alfa-2a,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL3,Dosage,-1,peginterferon alfa-2b,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL4,Dosage,-1,peginterferon alfa-2b,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL3,Dosage,-1,ribavirin,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL4,Dosage,-1,ribavirin,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,981501276.0,African American/Afro-Caribbean
981501273,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,981501276.0,African American/Afro-Caribbean
1444668176,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668188.0,Unknown
1444668176,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1444668216.0,Unknown
1447944969,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,capecitabine,1447944975.0,European
982043442,PA166153644,rs1801133,,,MTHFR,Efficacy,1,benazepril,982043450.0,East Asian
982043442,PA166153644,rs1801133,,,MTHFR,Efficacy,1,benazepril,982043449.0,East Asian
748042563,PA166156664,rs13120400,,,ABCG2,Efficacy,1,methotrexate,748054566.0,Unknown
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,citalopram,981500796.0,European
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,citalopram,981500795.0,Multiple groups
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,fluoxetine,981500796.0,European
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,fluoxetine,981500795.0,Multiple groups
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,mirtazapine,981500796.0,European
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,mirtazapine,981500795.0,Multiple groups
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,paroxetine,981500796.0,European
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,paroxetine,981500795.0,Multiple groups
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,Selective serotonin reuptake inhibitors,981500796.0,European
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,Selective serotonin reuptake inhibitors,981500795.0,Multiple groups
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,venlafaxine,981500796.0,European
981500787,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,venlafaxine,981500795.0,Multiple groups
1447944960,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,adalimumab,1447944962.0,Unknown
1447944960,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,etanercept,1447944962.0,Unknown
1447944960,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,infliximab,1447944962.0,Unknown
1447944960,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447944962.0,Unknown
1183620937,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183620940.0,East Asian
1183620937,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183620939.0,East Asian
1183620937,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183620940.0,East Asian
1183620937,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183620939.0,East Asian
1183620937,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183620940.0,East Asian
1183620937,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183620939.0,East Asian
1183620937,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620940.0,East Asian
1183620937,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620939.0,East Asian
1183620937,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620940.0,East Asian
1183620937,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620939.0,East Asian
1183620937,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620940.0,East Asian
1183620937,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620939.0,East Asian
1445585706,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1445585728.0,Unknown
1444668195,PA166153642,rs1800896,,,IL10,Efficacy,1,etanercept,1444668197.0,Unknown
1444668195,PA166153642,rs1800896,,,IL10,Efficacy,1,etanercept,1444668220.0,Unknown
1183620915,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183620918.0,East Asian
1183620915,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183620917.0,East Asian
1183620915,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183620918.0,East Asian
1183620915,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183620917.0,East Asian
1183620915,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183620918.0,East Asian
1183620915,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183620917.0,East Asian
1183620915,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620918.0,East Asian
1183620915,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183620917.0,East Asian
1183620915,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620918.0,East Asian
1183620915,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183620917.0,East Asian
1183620915,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620918.0,East Asian
1183620915,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183620917.0,East Asian
1447944945,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,oxcarbazepine,1447944947.0,East Asian
1448567540,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,pioglitazone,1448567549.0,East Asian
1448567540,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,pioglitazone,1448567549.0,East Asian
1448108791,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,nevirapine,1448108793.0,Sub-Saharan African
1448108791,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,nevirapine,1448108794.0,Sub-Saharan African
1450045269,PA166155795,rs10929303,,,MROH2A,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A1,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A10,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A3,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A4,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A5,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A6,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A7,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A8,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045269,PA166155795,rs10929303,,,UGT1A9,Metabolism/PK,-1,methotrexate,1450045271.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A1,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A10,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A3,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A4,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A5,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A6,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A7,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A8,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1450045263,PA166181288,rs4148326,,,UGT1A9,Metabolism/PK,-1,methotrexate,1450045265.0,Unknown
1444668201,PA166155374,rs1800471,,,TGFB1,Efficacy,1,etanercept,1444668203.0,Unknown
1444668201,PA166155374,rs1800471,,,TGFB1,Efficacy,1,etanercept,1444668224.0,Unknown
1449750363,,,PA166131619,NUDT15*1,NUDT15,Dosage,-1,mercaptopurine,1449750365.0,East Asian
1449750363,,,PA166131621,NUDT15*3,NUDT15,Dosage,-1,mercaptopurine,1449750365.0,East Asian
1449750363,,,PA166131623,NUDT15*5,NUDT15,Dosage,-1,mercaptopurine,1449750365.0,East Asian
1449750363,,,PA166131619,NUDT15*1,NUDT15,Toxicity,-1,mercaptopurine,1449750365.0,East Asian
1449750363,,,PA166131621,NUDT15*3,NUDT15,Toxicity,-1,mercaptopurine,1449750365.0,East Asian
1449750363,,,PA166131623,NUDT15*5,NUDT15,Toxicity,-1,mercaptopurine,1449750365.0,East Asian
1448567530,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,pioglitazone,1448567539.0,East Asian
1448567530,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,pioglitazone,1448567539.0,East Asian
1447944951,PA166153611,rs1050501,,,FCGR2B,Efficacy,-1,adalimumab,1447944959.0,Unknown
1447944951,PA166153611,rs1050501,,,FCGR2B,Efficacy,-1,etanercept,1447944959.0,Unknown
1447944951,PA166153611,rs1050501,,,FCGR2B,Efficacy,-1,infliximab,1447944959.0,Unknown
1447944951,PA166153611,rs1050501,,,FCGR2B,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447944959.0,Unknown
1447944930,PA166155715,rs3812718,,,SCN1A,Dosage,-1,oxcarbazepine,1447944938.0,East Asian
1447944939,PA166154007,rs2273697,,,ABCC2,Dosage,-1,oxcarbazepine,1447944941.0,East Asian
1449750401,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449750403.0,Multiple groups
1449750401,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449750403.0,Multiple groups
1446896334,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,atorvastatin,1446896342.0,Latino
1444930241,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,nicotine,1444930265.0,European
1444930241,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,nicotine,1444930262.0,European
1444930241,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,varenicline,1444930265.0,European
1444930241,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,varenicline,1444930262.0,European
1448616662,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,methotrexate,1448616675.0,Central/South Asian
1447679267,PA166154037,rs3793798,,,CHAT,Efficacy,-1,donepezil,1447679269.0,East Asian
1447679267,PA166154037,rs3793798,,,CHAT,Efficacy,-1,galantamine,1447679269.0,East Asian
1447679267,PA166154037,rs3793798,,,CHAT,Efficacy,-1,rivastigmine,1447679269.0,East Asian
981502876,PA166154354,rs2237892,,,KCNQ1,Efficacy,1,repaglinide,981502884.0,East Asian
1449750388,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449750400.0,Multiple groups
1449750388,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449750400.0,Multiple groups
1444930247,PA166154841,rs588765,,,CHRNA5,Efficacy,-1,nicotine,1444930269.0,European
1444930247,PA166154841,rs588765,,,CHRNA5,Efficacy,-1,nicotine,1444930267.0,European
1444930247,PA166154841,rs588765,,,CHRNA5,Efficacy,-1,varenicline,1444930269.0,European
1444930247,PA166154841,rs588765,,,CHRNA5,Efficacy,-1,varenicline,1444930267.0,European
1447680330,PA166154486,rs5443,,,GNB3,Efficacy,-1,amlodipine,1447680332.0,East Asian
1447682776,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682782.0,East Asian
1447813823,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,anthracyclines and related substances,1447813825.0,Unknown
1447813823,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,bevacizumab,1447813825.0,Unknown
1447813823,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,cyclophosphamide,1447813825.0,Unknown
1447813823,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,docetaxel,1447813825.0,Unknown
1447813823,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,epirubicin,1447813825.0,Unknown
1447813823,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,taxanes,1447813825.0,Unknown
1448108757,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1448108779.0,Sub-Saharan African
1448108757,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1448108769.0,Sub-Saharan African
1183702193,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183702195.0,Unknown
1183702193,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,risperidone,1183702195.0,Unknown
1183702193,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,risperidone,1183702195.0,Unknown
1183702193,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183702195.0,Unknown
1183702193,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183702195.0,Unknown
1183702193,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,risperidone,1183702195.0,Unknown
982043511,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,amlodipine,982043544.0,East Asian
982043511,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,amlodipine,982043546.0,East Asian
982043511,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,amlodipine,982043550.0,East Asian
982043511,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,amlodipine,982043548.0,East Asian
1444930252,PA166154840,rs578776,,,CHRNA3,Efficacy,-1,nicotine,1444930273.0,European
1444930252,PA166154840,rs578776,,,CHRNA3,Efficacy,-1,nicotine,1444930275.0,European
1444930252,PA166154840,rs578776,,,CHRNA3,Efficacy,-1,varenicline,1444930273.0,European
1444930252,PA166154840,rs578776,,,CHRNA3,Efficacy,-1,varenicline,1444930275.0,European
1447679311,PA166155808,rs11685873,,,SLC5A7,Efficacy,-1,donepezil,1447679313.0,East Asian
1447679311,PA166155808,rs11685873,,,SLC5A7,Efficacy,-1,galantamine,1447679313.0,East Asian
1447679311,PA166155808,rs11685873,,,SLC5A7,Efficacy,-1,rivastigmine,1447679313.0,East Asian
1447679290,PA166155745,rs6542746,,,SLC5A7,Efficacy,-1,donepezil,1447679292.0,East Asian
1447679290,PA166155745,rs6542746,,,SLC5A7,Efficacy,-1,galantamine,1447679292.0,East Asian
1447679290,PA166155745,rs6542746,,,SLC5A7,Efficacy,-1,rivastigmine,1447679292.0,East Asian
1447682735,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1447682741.0,East Asian
1447682735,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682741.0,East Asian
1447813811,PA166155708,rs3768728,,,EPAS1,Efficacy,-1,anthracyclines and related substances,1447813813.0,Unknown
1447813811,PA166155708,rs3768728,,,EPAS1,Efficacy,-1,bevacizumab,1447813813.0,Unknown
1447813811,PA166155708,rs3768728,,,EPAS1,Efficacy,-1,cyclophosphamide,1447813813.0,Unknown
1447813811,PA166155708,rs3768728,,,EPAS1,Efficacy,-1,docetaxel,1447813813.0,Unknown
1447813811,PA166155708,rs3768728,,,EPAS1,Efficacy,-1,epirubicin,1447813813.0,Unknown
1447813811,PA166155708,rs3768728,,,EPAS1,Efficacy,-1,taxanes,1447813813.0,Unknown
1184472932,PA166154078,rs7089580,,,CYP2C9,Dosage,1,warfarin,1184472934.0,Multiple groups
1184472932,PA166154078,rs7089580,,,CYP2C9,Dosage,1,warfarin,1184472934.0,Multiple groups
1447679299,PA166155749,rs6720783,,,SLC5A7,Efficacy,-1,donepezil,1447679301.0,East Asian
1447679299,PA166155749,rs6720783,,,SLC5A7,Efficacy,-1,galantamine,1447679301.0,East Asian
1447679299,PA166155749,rs6720783,,,SLC5A7,Efficacy,-1,rivastigmine,1447679301.0,East Asian
1449144225,PA166171040,rs7959663,,,MYO1H,Efficacy,1,lithium,1449144227.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
982022015,PA166154486,rs5443,,,GNB3,Dosage,-1,risperidone,982022020.0,East Asian
982022015,PA166154486,rs5443,,,GNB3,Efficacy,-1,risperidone,982022020.0,East Asian
1444930282,PA166154938,rs16969968,,,CHRNA5,Dosage,1,nicotine,1444930288.0,European
1183620980,PA166157284,rs1045642,,,ABCB1,Efficacy,1,omeprazole,1183620982.0,European
1183620980,PA166157284,rs1045642,,,ABCB1,Efficacy,1,pantoprazole,1183620982.0,European
699638765,PA166156339,rs2046934,,,P2RY12,Dosage,-1,clopidogrel,699638804.0,"Multiple groups, Caucasian 76; African-American 4; Hispanic origin 29; Asian origin 11.  38 women.  Avg age 65.5 +/- 10.9 .  Patients were at Baylor College of Medicine, Houston,; TX, United States.  Patients were scheduled for elective; percutaneous coronary intervention (PCI). All; patients had received aspirin 81¿325mg daily for; z1week before the PCI and had not received a; thienopyridine or GP IIb/IIIa inhibitor in the week; prior to enrollment"
699638765,PA166156339,rs2046934,,,P2RY12,Dosage,-1,clopidogrel,699638804.0,"Multiple groups, Caucasian 76; African-American 4; Hispanic origin 29; Asian origin 11.  38 women.  Avg age 65.5 +/- 10.9 .  Patients were at Baylor College of Medicine, Houston,; TX, United States.  Patients were scheduled for elective; percutaneous coronary intervention (PCI). All; patients had received aspirin 81¿325mg daily for; z1week before the PCI and had not received a; thienopyridine or GP IIb/IIIa inhibitor in the week; prior to enrollment"
1451929620,PA166155939,rs3787186,,,NFATC2,Efficacy,1,adalimumab,1451929640.0,Unknown
1451929620,PA166155939,rs3787186,,,NFATC2,Efficacy,1,etanercept,1451929640.0,Unknown
1451929620,PA166155939,rs3787186,,,NFATC2,Efficacy,1,infliximab,1451929640.0,Unknown
1446896327,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,atorvastatin,1446896340.0,Latino
1447813817,PA166155634,rs1374749,,,EPAS1,Efficacy,-1,anthracyclines and related substances,1447813819.0,Unknown
1447813817,PA166155634,rs1374749,,,EPAS1,Efficacy,-1,bevacizumab,1447813819.0,Unknown
1447813817,PA166155634,rs1374749,,,EPAS1,Efficacy,-1,cyclophosphamide,1447813819.0,Unknown
1447813817,PA166155634,rs1374749,,,EPAS1,Efficacy,-1,docetaxel,1447813819.0,Unknown
1447813817,PA166155634,rs1374749,,,EPAS1,Efficacy,-1,epirubicin,1447813819.0,Unknown
1447813817,PA166155634,rs1374749,,,EPAS1,Efficacy,-1,taxanes,1447813819.0,Unknown
1447682722,PA166155017,rs1800566,,,NQO1,Dosage,1,warfarin,1447682724.0,Latino
1451930160,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,-1,rasagiline,1451930164.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1451930160,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,-1,rasagiline,1451930164.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1184471333,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,tacrolimus,1184471335.0,European
1184471333,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,-1,tacrolimus,1184471335.0,European
1451928880,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,rasagiline,1451928888.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1451928880,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,rasagiline,1451928888.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1451928660,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,rasagiline,1451928665.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1447682726,PA166154759,rs116855232,,,NUDT15,Toxicity,1,azathioprine,1447682734.0,East Asian
1447682726,PA166154759,rs116855232,,,NUDT15,Toxicity,1,mercaptopurine,1447682734.0,East Asian
1447813803,PA166155737,rs4953344,,,EPAS1,Efficacy,-1,anthracyclines and related substances,1447813806.0,Unknown
1447813803,PA166155737,rs4953344,,,EPAS1,Efficacy,-1,bevacizumab,1447813806.0,Unknown
1447813803,PA166155737,rs4953344,,,EPAS1,Efficacy,-1,cyclophosphamide,1447813806.0,Unknown
1447813803,PA166155737,rs4953344,,,EPAS1,Efficacy,-1,docetaxel,1447813806.0,Unknown
1447813803,PA166155737,rs4953344,,,EPAS1,Efficacy,-1,epirubicin,1447813806.0,Unknown
1447813803,PA166155737,rs4953344,,,EPAS1,Efficacy,-1,taxanes,1447813806.0,Unknown
1183622476,PA166154893,rs2470890,,,CYP1A2,Metabolism/PK,-1,escitalopram,1183622478.0,East Asian
1451928900,PA166156024,rs4680,,,COMT,Metabolism/PK,1,rasagiline,1451928920.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1448108691,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,paroxetine,1448108713.0,East Asian
1448108691,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,paroxetine,1448108713.0,East Asian
1448108691,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,paroxetine,1448108713.0,East Asian
1448108691,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,paroxetine,1448108713.0,East Asian
1447682700,,,PA165860685,CYP4F2*1,CYP4F2,Dosage,1,warfarin,1447682702.0,Latino
1447682700,,,PA165860687,CYP4F2*3,CYP4F2,Dosage,1,warfarin,1447682702.0,Latino
1444668038,PA166156997,rs1800629,,,TNF,Efficacy,-1,infliximab,1444668044.0,Unknown
1183622468,PA166154898,rs2472304,,,CYP1A2,Metabolism/PK,-1,escitalopram,1183622470.0,East Asian
1449144244,PA166171043,rs6728642,,,FAM178B,Efficacy,1,lithium,1449144246.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
1449144244,PA166171043,rs6728642,,,FAM178B,Efficacy,1,lithium,1449144246.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
1451928680,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,rasagiline,1451928700.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1451928620,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,rasagiline,1451928640.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1451928620,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,rasagiline,1451928640.0,"Multiple groups, ""Volunteers mainly self-reported as Caucasian (n = 83) whereas 34 self-reported as Latino-Americans and 1 as Black, who was merged with the Latino-American volunteers in a group called “Mixed” ethnicity. """
1447682688,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447682693.0,Latino
1447682688,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447682695.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,anthracyclines and related substances,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,bevacizumab,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,cyclophosphamide,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,docetaxel,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,epirubicin,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,taxanes,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,taxanes,1447813759.0,Unknown
1447813757,PA166157059,rs3025030,,,VEGFA,Efficacy,-1,taxanes,1447813759.0,Unknown
1449750499,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449750511.0,East Asian
1449750499,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449750511.0,East Asian
1451930261,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,clopidogrel,1451930340.0,East Asian
1447813766,PA166154676,rs6314,,,HTR2A,Efficacy,1,olanzapine,1447813790.0,European
1451399960,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,-1,ibuprofen,1451399967.0,Unknown
1451399960,,,PA165958684,CYP2C8*2,CYP2C8,Efficacy,-1,ibuprofen,1451399967.0,Unknown
1451399960,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,-1,ibuprofen,1451399967.0,Unknown
1451399960,,,PA165958686,CYP2C8*4,CYP2C8,Efficacy,-1,ibuprofen,1451399967.0,Unknown
1446896245,PA166157886,rs7051085,,,PTCHD1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896248.0,Multiple groups
1447813768,PA166154725,rs7995976,,,FLT1,Efficacy,-1,anthracyclines and related substances,1447813771.0,Unknown
1447813768,PA166154725,rs7995976,,,FLT1,Efficacy,-1,bevacizumab,1447813771.0,Unknown
1447813768,PA166154725,rs7995976,,,FLT1,Efficacy,-1,cyclophosphamide,1447813771.0,Unknown
1447813768,PA166154725,rs7995976,,,FLT1,Efficacy,-1,docetaxel,1447813771.0,Unknown
1447813768,PA166154725,rs7995976,,,FLT1,Efficacy,-1,epirubicin,1447813771.0,Unknown
1447813768,PA166154725,rs7995976,,,FLT1,Efficacy,-1,taxanes,1447813771.0,Unknown
982043591,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,amlodipine,982043599.0,African American/Afro-Caribbean
1446896253,PA166156077,rs1210638,,,DGCR5,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896255.0,Multiple groups
1184473116,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473122.0,Unknown
1184473116,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473120.0,Unknown
1447813745,PA166156938,rs699947,,,VEGFA,Efficacy,-1,anthracyclines and related substances,1447813747.0,Unknown
1447813745,PA166156938,rs699947,,,VEGFA,Efficacy,-1,bevacizumab,1447813747.0,Unknown
1447813745,PA166156938,rs699947,,,VEGFA,Efficacy,-1,cyclophosphamide,1447813747.0,Unknown
1447813745,PA166156938,rs699947,,,VEGFA,Efficacy,-1,docetaxel,1447813747.0,Unknown
1447813745,PA166156938,rs699947,,,VEGFA,Efficacy,-1,epirubicin,1447813747.0,Unknown
1447813745,PA166156938,rs699947,,,VEGFA,Efficacy,-1,taxanes,1447813747.0,Unknown
1447813751,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,anthracyclines and related substances,1447813753.0,Unknown
1447813751,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,bevacizumab,1447813753.0,Unknown
1447813751,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,cyclophosphamide,1447813753.0,Unknown
1447813751,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,docetaxel,1447813753.0,Unknown
1447813751,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,epirubicin,1447813753.0,Unknown
1447813751,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,taxanes,1447813753.0,Unknown
1184997409,PA166155352,rs445925,,,None,Efficacy,1,hmg coa reductase inhibitors,1184997418.0,Multiple groups
1184997409,PA166155352,rs445925,,,None,Efficacy,1,hmg coa reductase inhibitors,1184997414.0,Multiple groups
1184997409,PA166155352,rs445925,,,None,Efficacy,1,hmg coa reductase inhibitors,1184997416.0,Multiple groups
1449750524,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1449750530.0,Unknown
1451399980,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,ibuprofen,1451399942.0,Unknown
1451399980,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,ibuprofen,1451399942.0,Unknown
1451399980,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,ibuprofen,1451399942.0,Unknown
1451930259,PA166153953,rs717620,,,ABCC2,Efficacy,1,clopidogrel,1451930304.0,East Asian
1183619642,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183619666.0,European
1183619642,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183619666.0,European
1183619642,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183619666.0,European
1451930254,PA166154070,rs4986893,,,CYP2C19,Efficacy,1,clopidogrel,1451930260.0,East Asian
1451930254,PA166154070,rs4986893,,,CYP2C19,Efficacy,1,clopidogrel,1451930260.0,East Asian
827704679,PA166157284,rs1045642,,,ABCB1,Efficacy,0,efavirenz,827704690.0,"Multiple groups, not stated for the individuals genotyped, full cohort was a mixed population"
827704679,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,0,efavirenz,827704690.0,"Multiple groups, not stated for the individuals genotyped, full cohort was a mixed population"
1451930360,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,clopidogrel,1451930365.0,East Asian
1447813735,PA166154313,rs1076560,,,DRD2,Efficacy,1,olanzapine,1447813782.0,Unknown
1446896213,PA166153572,rs506546,,,CSMD2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896216.0,Multiple groups
982043660,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,amlodipine,982043669.0,African American/Afro-Caribbean
982043660,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,amlodipine,982043666.0,African American/Afro-Caribbean
827704671,PA166157284,rs1045642,,,ABCB1,Efficacy,0,efavirenz,827704688.0,"Multiple groups, not stated for the individuals genotyped, full cohort was a mixed population"
827704671,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,0,efavirenz,827704688.0,"Multiple groups, not stated for the individuals genotyped, full cohort was a mixed population"
1447682637,PA166154759,rs116855232,,,NUDT15,Other,-1,mercaptopurine,1447682654.0,East Asian
1451930248,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1451930253.0,East Asian
1183620333,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183620335.0,East Asian
1183620333,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183620335.0,East Asian
1183620333,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183620335.0,East Asian
1183620333,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1183620335.0,East Asian
1183620333,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,risperidone,1183620335.0,East Asian
1446896227,PA166153904,rs72772787,,,None,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896229.0,Multiple groups
982043687,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043695.0,African American/Afro-Caribbean
982043687,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043696.0,African American/Afro-Caribbean
982043687,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043695.0,African American/Afro-Caribbean
982043687,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043696.0,African American/Afro-Caribbean
1449717747,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,metoprolol,1449717756.0,"Multiple groups, Caucasian and African American patients."
1449717747,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,metoprolol,1449717756.0,"Multiple groups, Caucasian and African American patients."
1446896233,PA166157741,rs2043144,,,None,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896235.0,Multiple groups
1446896179,PA166156895,rs74378198,,,OSMR,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896182.0,Multiple groups
1446896179,PA166156895,rs74378198,,,OSMR,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896182.0,Multiple groups
1450979360,PA166155119,rs17708472,,,VKORC1,Dosage,1,warfarin,1450979380.0,Unknown
1447682626,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682632.0,East Asian
1447682626,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682632.0,East Asian
1451930520,PA166157284,rs1045642,,,ABCB1,Efficacy,1,cannabinoids,1451930525.0,European
1451159544,PA166157228,rs144854329,,,VEGFA,Efficacy,1,cetuximab,1451159580.0,Unknown
1451159544,PA166157228,rs144854329,,,VEGFA,Efficacy,1,cetuximab,1451159581.0,Unknown
1451159544,PA166157228,rs144854329,,,VEGFA,Efficacy,1,cetuximab,1451159580.0,Unknown
1451159544,PA166157228,rs144854329,,,VEGFA,Efficacy,1,cetuximab,1451159581.0,Unknown
1450373150,PA166180106,rs675026,,,OPRM1,Efficacy,-1,methadone,1450373152.0,East Asian
1450373150,PA166180106,rs675026,,,OPRM1,Efficacy,-1,methadone,1450373302.0,East Asian
1447682605,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447682655.0,Latino
1447682605,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447682664.0,Latino
1447682605,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447682687.0,Latino
1447682605,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447682655.0,Latino
1447682605,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447682664.0,Latino
1447682605,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447682687.0,Latino
1447682605,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447682655.0,Latino
1447682605,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447682664.0,Latino
1447682605,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447682687.0,Latino
1447682605,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1447682655.0,Latino
1447682605,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1447682664.0,Latino
1447682605,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1447682687.0,Latino
1446896199,PA166157685,rs113889867,,,STMN2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896202.0,Multiple groups
1451930586,PA166156617,rs7438135,,,UGT2B7,Efficacy,1,cannabinoids,1451930591.0,European
1446896143,PA166157102,rs4615376,,,PHACTR1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896146.0,Multiple groups
1450373190,PA166182129,rs2236258,,,OPRM1,Efficacy,-1,methadone,1450373192.0,East Asian
1450373190,PA166182129,rs2236258,,,OPRM1,Efficacy,-1,methadone,1450373324.0,East Asian
1451208780,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451208750.0,European
1451208780,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451208761.0,European
1451208780,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451208800.0,European
1451208780,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451208751.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208750.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208761.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208800.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208751.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208750.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208761.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208800.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208751.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208750.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208761.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208800.0,European
1451208780,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208751.0,European
1183621225,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183621227.0,Unknown
1183621225,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183621227.0,Unknown
1183621225,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183621227.0,Unknown
1450373183,PA166182128,rs2236257,,,OPRM1,Efficacy,-1,methadone,1450373185.0,East Asian
1450373183,PA166182128,rs2236257,,,OPRM1,Efficacy,-1,methadone,1450373322.0,East Asian
1450373183,PA166182128,rs2236257,,,OPRM1,Efficacy,-1,methadone,1450373185.0,East Asian
1450373183,PA166182128,rs2236257,,,OPRM1,Efficacy,-1,methadone,1450373322.0,East Asian
1450373183,PA166182128,rs2236257,,,OPRM1,Efficacy,-1,methadone,1450373185.0,East Asian
1450373183,PA166182128,rs2236257,,,OPRM1,Efficacy,-1,methadone,1450373322.0,East Asian
1450373174,PA166182127,rs2236256,,,OPRM1,Efficacy,-1,methadone,1450373176.0,East Asian
1450373174,PA166182127,rs2236256,,,OPRM1,Efficacy,-1,methadone,1450373320.0,East Asian
1446896157,PA166156965,rs910039,,,CAP2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896160.0,Multiple groups
1183621202,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183621204.0,Unknown
1183621202,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183621204.0,Unknown
1183621202,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183621204.0,Unknown
1183621202,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183621204.0,Unknown
1183621202,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183621204.0,Unknown
1183621202,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183621204.0,Unknown
1183621202,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183621204.0,Unknown
1183621202,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183621204.0,Unknown
1183621202,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183621204.0,Unknown
1183621202,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183621204.0,Unknown
827787027,PA166154771,rs1046428,,,GSTZ1,Toxicity,-1,dichloroacetic acid,827787040.0,Unknown
827787027,PA166154771,rs1046428,,,POMT2,Toxicity,-1,dichloroacetic acid,827787040.0,Unknown
827787027,PA166154771,rs1046428,,,GSTZ1,Metabolism/PK,-1,dichloroacetic acid,827787040.0,Unknown
827787027,PA166154771,rs1046428,,,POMT2,Metabolism/PK,-1,dichloroacetic acid,827787040.0,Unknown
1448616465,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1448616467.0,Unknown
1448616465,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1448616467.0,Unknown
1448616465,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,voriconazole,1448616467.0,Unknown
1448616465,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1448616467.0,Unknown
1448616465,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1448616467.0,Unknown
1446896165,PA166157186,rs17068112,,,REPS1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896168.0,Multiple groups
1446896165,PA166157186,rs17068112,,,REPS1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896168.0,Multiple groups
827787019,PA166154764,rs7972,,,GSTZ1,Toxicity,-1,dichloroacetic acid,827787038.0,Unknown
827787019,PA166154764,rs7972,,,POMT2,Toxicity,-1,dichloroacetic acid,827787038.0,Unknown
827787019,PA166154764,rs7972,,,GSTZ1,Metabolism/PK,-1,dichloroacetic acid,827787038.0,Unknown
827787019,PA166154764,rs7972,,,POMT2,Metabolism/PK,-1,dichloroacetic acid,827787038.0,Unknown
1447682561,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,ibuprofen,1447682563.0,Multiple groups
1447682561,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,ibuprofen,1447682563.0,Multiple groups
1184997529,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,atazanavir,1184997535.0,European
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373317.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373267.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373317.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373267.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373317.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373267.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373317.0,East Asian
1450373168,PA166177786,rs6912029,,,OPRM1,Efficacy,-1,methadone,1450373267.0,East Asian
1183621191,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183621193.0,Unknown
1183621191,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183621193.0,Unknown
1183621191,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183621193.0,Unknown
1183621191,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183621193.0,Unknown
1183621191,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183621193.0,Unknown
1183621191,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183621193.0,Unknown
1183621191,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183621193.0,Unknown
1183621191,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183621193.0,Unknown
1183621191,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183621193.0,Unknown
1448616451,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1448616464.0,Unknown
1448616451,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1448616464.0,Unknown
1448616451,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,voriconazole,1448616464.0,Unknown
1448616451,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1448616464.0,Unknown
982043698,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043706.0,African American/Afro-Caribbean
982043698,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043707.0,African American/Afro-Caribbean
982043698,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043706.0,African American/Afro-Caribbean
982043698,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043707.0,African American/Afro-Caribbean
982043698,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043706.0,African American/Afro-Caribbean
982043698,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043707.0,African American/Afro-Caribbean
1184473237,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473239.0,East Asian
1447682570,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,ibuprofen,1447682572.0,Multiple groups
1450373217,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,methadone,1450373341.0,East Asian
1450373217,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,methadone,1450373219.0,East Asian
1446896129,PA166155871,rs35806662,,,None,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896131.0,Multiple groups
1183621166,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183621179.0,Unknown
1183621166,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183621179.0,Unknown
1183621166,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183621179.0,Unknown
1183621166,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183621179.0,Unknown
1183621166,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183621179.0,Unknown
1183621166,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183621179.0,Unknown
1183621166,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183621179.0,Unknown
1183621166,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183621179.0,Unknown
1183621166,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183621179.0,Unknown
1451934500,,,PA165951493,HLA-DRB1*04:01:01,HLA-DRB1,Efficacy,1,adalimumab,1451934489.0,Unknown
1451934500,,,PA165951493,HLA-DRB1*04:01:01,HLA-DRB1,Efficacy,1,etanercept,1451934489.0,Unknown
1451934500,,,PA165951493,HLA-DRB1*04:01:01,HLA-DRB1,Efficacy,1,infliximab,1451934489.0,Unknown
1184473245,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473247.0,East Asian
1450373204,PA166182131,rs6902403,,,OPRM1,Efficacy,-1,methadone,1450373330.0,East Asian
1450373204,PA166182131,rs6902403,,,OPRM1,Efficacy,-1,methadone,1450373206.0,East Asian
1184473249,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473251.0,East Asian
1450373211,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methadone,1450373213.0,East Asian
1450373211,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methadone,1450373334.0,East Asian
827786999,PA166154765,rs7975,,,GSTZ1,Toxicity,-1,dichloroacetic acid,827787036.0,Unknown
827786999,PA166154765,rs7975,,,POMT2,Toxicity,-1,dichloroacetic acid,827787036.0,Unknown
827786999,PA166154765,rs7975,,,GSTZ1,Metabolism/PK,-1,dichloroacetic acid,827787036.0,Unknown
827786999,PA166154765,rs7975,,,POMT2,Metabolism/PK,-1,dichloroacetic acid,827787036.0,Unknown
1184473253,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473255.0,East Asian
982043719,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982043735.0,African American/Afro-Caribbean
982043719,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982043734.0,African American/Afro-Caribbean
1447682551,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,ibuprofen,1447682560.0,Multiple groups
1447682551,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,ibuprofen,1447682560.0,Multiple groups
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373199.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373326.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373199.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373326.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373199.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373326.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373199.0,East Asian
1450373197,PA166182130,rs2236259,,,OPRM1,Efficacy,-1,methadone,1450373326.0,East Asian
982043709,PA166157346,rs2246709,,,CYP3A4,Efficacy,-1,amlodipine,982043717.0,African American/Afro-Caribbean
1446896135,PA166156894,rs73069924,,,MTMR12,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896138.0,Multiple groups
827786987,PA166154771,rs1046428,,,GSTZ1,Other,1,dichloroacetic acid,827786998.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786987,PA166154771,rs1046428,,,POMT2,Other,1,dichloroacetic acid,827786998.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786987,PA166154771,rs1046428,,,GSTZ1,Metabolism/PK,1,dichloroacetic acid,827786998.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786987,PA166154771,rs1046428,,,POMT2,Metabolism/PK,1,dichloroacetic acid,827786998.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
1184997431,PA166153583,rs646776,,,CELSR2,Efficacy,1,hmg coa reductase inhibitors,1184997435.0,Multiple groups
1184997431,PA166153583,rs646776,,,CELSR2,Efficacy,1,hmg coa reductase inhibitors,1184997433.0,Multiple groups
1184997431,PA166153583,rs646776,,,CELSR2,Efficacy,1,hmg coa reductase inhibitors,1184997434.0,Multiple groups
1446896077,PA166155283,rs2377898,,,MTCL1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896080.0,Multiple groups
1184997420,PA166157168,rs10455872,,,LPA,Efficacy,1,hmg coa reductase inhibitors,1184997424.0,Multiple groups
1184997420,PA166157168,rs10455872,,,LPA,Efficacy,1,hmg coa reductase inhibitors,1184997423.0,Multiple groups
1184997420,PA166157168,rs10455872,,,LPA,Efficacy,1,hmg coa reductase inhibitors,1184997422.0,Multiple groups
827786978,PA166154764,rs7972,,,GSTZ1,Other,1,dichloroacetic acid,827786996.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786978,PA166154764,rs7972,,,POMT2,Other,1,dichloroacetic acid,827786996.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786978,PA166154764,rs7972,,,GSTZ1,Metabolism/PK,1,dichloroacetic acid,827786996.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786978,PA166154764,rs7972,,,POMT2,Metabolism/PK,1,dichloroacetic acid,827786996.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
1446896085,PA166157192,rs17220479,,,BRD2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896088.0,Multiple groups
1450373248,PA166153889,rs56038477,,,DPYD,Dosage,0,capecitabine,1450373250.0,Multiple groups
1450373248,PA166153889,rs56038477,,,DPYD,Dosage,0,capecitabine,1450373250.0,Multiple groups
1450373242,PA166153895,rs67376798,,,DPYD,Dosage,0,capecitabine,1450373244.0,Multiple groups
1450373242,PA166153895,rs67376798,,,DPYD,Dosage,0,capecitabine,1450373244.0,Multiple groups
1184473155,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,1,efavirenz,1184473158.0,Unknown
1183621271,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183621273.0,Unknown
1183621271,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183621273.0,Unknown
1183621271,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183621273.0,Unknown
1450373232,PA166153760,rs3918290,,,DPYD,Dosage,0,capecitabine,1450373238.0,Multiple groups
827786955,PA166154765,rs7975,,,GSTZ1,Other,1,dichloroacetic acid,827786977.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786955,PA166154765,rs7975,,,POMT2,Other,1,dichloroacetic acid,827786977.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786955,PA166154765,rs7975,,,GSTZ1,Metabolism/PK,1,dichloroacetic acid,827786977.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
827786955,PA166154765,rs7975,,,POMT2,Metabolism/PK,1,dichloroacetic acid,827786977.0,"Multiple groups, 2 Black, 1 Asian, 9 Whites"
1184473161,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473163.0,Unknown
1183621246,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183621248.0,Unknown
1183621246,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183621248.0,Unknown
1183621246,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183621248.0,Unknown
1184473165,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473167.0,Unknown
1449750688,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,thioguanine,1449750696.0,East Asian
1449750688,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,thioguanine,1449750696.0,East Asian
1449750688,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,thioguanine,1449750696.0,East Asian
1449750688,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,thioguanine,1449750696.0,East Asian
1449750688,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,thioguanine,1449750696.0,East Asian
1449750688,PA166154759,rs116855232,,,NUDT15,Metabolism/PK,-1,thioguanine,1449750696.0,East Asian
981483665,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,methotrexate,1451401540.0,Multiple groups
981483665,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,methotrexate,981483681.0,Multiple groups
981483665,PA166154547,rs2306283,,,SLCO1B1,Toxicity,1,methotrexate,1451401540.0,Multiple groups
981483665,PA166154547,rs2306283,,,SLCO1B1,Toxicity,1,methotrexate,981483681.0,Multiple groups
981483665,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401540.0,Multiple groups
981483665,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483681.0,Multiple groups
1451934880,PA166156932,rs622342,,,SLC22A1,Efficacy,1,metformin,1451934900.0,East Asian
1446896047,PA166154862,rs1470108,,,MIR7-2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896049.0,Multiple groups
1449717924,PA166156991,rs1799971,,,OPRM1,Efficacy,1,Opioid anesthetics,1449717929.0,Unknown
1449717924,PA166156991,rs1799971,,,OPRM1,Efficacy,1,Other general anesthetics,1449717929.0,Unknown
1449717924,PA166156991,rs1799971,,,OPRM1,Efficacy,1,volatile anesthetics,1449717929.0,Unknown
1450373276,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1450373295.0,Unknown
1450373276,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1450373295.0,Unknown
981483656,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Toxicity,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Toxicity,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483683.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401590.0,Multiple groups
981483656,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483683.0,Multiple groups
1449717930,PA166156544,rs2231142,,,ABCG2,Efficacy,1,Opioid anesthetics,1449717932.0,Unknown
1449717930,PA166156544,rs2231142,,,ABCG2,Efficacy,1,Other general anesthetics,1449717932.0,Unknown
1449717930,PA166156544,rs2231142,,,ABCG2,Efficacy,1,volatile anesthetics,1449717932.0,Unknown
1446896054,PA166153836,rs11811628,,,ATF3,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896057.0,Multiple groups
1447682476,PA166155191,rs1801689,,,APOH,Efficacy,-1,boceprevir,1447682478.0,European
1447682476,PA166155191,rs1801689,,,APOH,Efficacy,-1,peginterferon alfa-2a,1447682478.0,European
1447682476,PA166155191,rs1801689,,,APOH,Efficacy,-1,peginterferon alfa-2b,1447682478.0,European
1447682476,PA166155191,rs1801689,,,APOH,Efficacy,-1,ribavirin,1447682478.0,European
1447682476,PA166155191,rs1801689,,,APOH,Efficacy,-1,telaprevir,1447682478.0,European
1447682476,PA166155191,rs1801689,,,APOH,Efficacy,-1,telaprevir,1447682478.0,European
1451934940,PA166154450,rs11212617,,,ATM,Efficacy,1,metformin,1451934945.0,East Asian
1447682483,PA166155263,rs52797880,,,APOH,Efficacy,-1,boceprevir,1447682485.0,European
1447682483,PA166155263,rs52797880,,,APOH,Efficacy,-1,peginterferon alfa-2a,1447682485.0,European
1447682483,PA166155263,rs52797880,,,APOH,Efficacy,-1,peginterferon alfa-2b,1447682485.0,European
1447682483,PA166155263,rs52797880,,,APOH,Efficacy,-1,ribavirin,1447682485.0,European
1447682483,PA166155263,rs52797880,,,APOH,Efficacy,-1,telaprevir,1447682485.0,European
1451208840,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451208847.0,Unknown
1451208840,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208847.0,Unknown
1451208840,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451208847.0,Unknown
1447682490,PA166155236,rs8178822,,,APOH,Efficacy,-1,boceprevir,1447682492.0,European
1447682490,PA166155236,rs8178822,,,APOH,Efficacy,-1,peginterferon alfa-2a,1447682492.0,European
1447682490,PA166155236,rs8178822,,,APOH,Efficacy,-1,peginterferon alfa-2b,1447682492.0,European
1447682490,PA166155236,rs8178822,,,APOH,Efficacy,-1,ribavirin,1447682492.0,European
1447682490,PA166155236,rs8178822,,,APOH,Efficacy,-1,telaprevir,1447682492.0,European
1183703264,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,lornoxicam,1183703290.0,East Asian
1183703264,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,lornoxicam,1183703290.0,East Asian
982043772,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,pravastatin,982043782.0,East Asian
1183620172,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183620183.0,East Asian
1183620172,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1451253540.0,East Asian
1183620172,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183620183.0,East Asian
1183620172,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1451253540.0,East Asian
1183620172,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183620183.0,East Asian
1183620172,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1451253540.0,East Asian
1183620224,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183620364.0,East Asian
1183620224,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183620237.0,East Asian
1183620224,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183620239.0,East Asian
1183620224,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1451253580.0,East Asian
1183620224,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1451253581.0,East Asian
1183620224,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1451253600.0,East Asian
1183620224,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183620364.0,East Asian
1183620224,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183620237.0,East Asian
1183620224,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183620239.0,East Asian
1183620224,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1451253580.0,East Asian
1183620224,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1451253581.0,East Asian
1183620224,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1451253600.0,East Asian
1183620224,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183620364.0,East Asian
1183620224,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183620237.0,East Asian
1183620224,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183620239.0,East Asian
1183620224,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1451253580.0,East Asian
1183620224,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1451253581.0,East Asian
1183620224,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1451253600.0,East Asian
1451401880,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methadone,1451401863.0,Unknown
1183620365,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183620369.0,East Asian
1183620365,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183620367.0,East Asian
1183620365,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183620368.0,East Asian
1183620365,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183620369.0,East Asian
1183620365,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183620367.0,East Asian
1183620365,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183620368.0,East Asian
1183620365,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183620369.0,East Asian
1183620365,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183620367.0,East Asian
1183620365,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183620368.0,East Asian
1184473325,PA166153700,rs2307424,,,NR1I3,Metabolism/PK,1,efavirenz,1184473327.0,Latino
1451401900,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methadone,1451401864.0,Unknown
1451401904,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,methadone,1451401884.0,Unknown
1183619844,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183619854.0,East Asian
1183619844,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183619854.0,East Asian
1183619844,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183619854.0,East Asian
1183621341,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183621343.0,Unknown
1183621341,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183621343.0,Unknown
1183621341,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183621343.0,Unknown
1184473329,PA166153700,rs2307424,,,NR1I3,Metabolism/PK,1,efavirenz,1184473331.0,Latino
1447682467,PA166155192,rs1801690,,,APOH,Efficacy,-1,boceprevir,1447682470.0,European
1447682467,PA166155192,rs1801690,,,APOH,Efficacy,-1,peginterferon alfa-2a,1447682470.0,European
1447682467,PA166155192,rs1801690,,,APOH,Efficacy,-1,peginterferon alfa-2b,1447682470.0,European
1447682467,PA166155192,rs1801690,,,APOH,Efficacy,-1,ribavirin,1447682470.0,European
1447682467,PA166155192,rs1801690,,,APOH,Efficacy,-1,telaprevir,1447682470.0,European
1447682467,PA166155192,rs1801690,,,APOH,Efficacy,-1,telaprevir,1447682470.0,European
1184473333,PA166155447,rs8192726,,,CYP2A6,Metabolism/PK,-1,efavirenz,1184473335.0,Latino
1446896021,PA166154550,rs2453488,,,RND1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896024.0,Multiple groups
1183621354,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183621356.0,Unknown
1183621354,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183621356.0,Unknown
1183621354,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183621356.0,Unknown
1184473341,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,efavirenz,1184473343.0,Latino
1184473341,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,efavirenz,1184473343.0,Latino
827704987,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,pilocarpine,827705002.0,East Asian
827704987,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,pilocarpine,827705004.0,East Asian
827704987,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,pilocarpine,827705002.0,East Asian
827704987,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,pilocarpine,827705004.0,East Asian
827704987,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,pilocarpine,827705002.0,East Asian
827704987,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,pilocarpine,827705004.0,East Asian
1184473345,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,-1,efavirenz,1184473347.0,Latino
1183621329,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183621331.0,Unknown
1183621329,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183621331.0,Unknown
1183621329,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183621331.0,Unknown
1183703247,PA166157422,rs6962027,,,CHRM2,Efficacy,1,fluticasone/salmeterol,1183703249.0,European
1183703257,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,lornoxicam,1183703286.0,East Asian
1183703257,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,lornoxicam,1183703286.0,East Asian
1446896040,PA166155978,rs239022,,,LINC00478,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896042.0,Multiple groups
1447682452,PA166155468,rs12979860,,,IFNL3,Efficacy,1,boceprevir,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL4,Efficacy,1,boceprevir,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL3,Efficacy,1,telaprevir,1447682458.0,European
1447682452,PA166155468,rs12979860,,,IFNL4,Efficacy,1,telaprevir,1447682458.0,European
1451126960,PA166156299,rs901865,,,HRH1,Efficacy,-1,desloratadine,1451126965.0,Unknown
1183703229,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,lornoxicam,1183703237.0,East Asian
1183703229,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,lornoxicam,1183703237.0,East Asian
1450979500,PA166155096,rs9934438,,,VKORC1,Dosage,0,acenocoumarol,1450979520.0,European
1183621319,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183621321.0,Unknown
1183621319,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183621321.0,Unknown
1183621319,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183621321.0,Unknown
1183621319,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183621321.0,Unknown
1183703238,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,lornoxicam,1183703275.0,East Asian
1183703238,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,lornoxicam,1183703275.0,East Asian
1183703328,PA166157286,rs1057868,,,POR,Metabolism/PK,1,nicotine,1183703330.0,Sub-Saharan African
1183703328,PA166157286,rs1057868,,,POR,Metabolism/PK,1,nicotine,1183703330.0,Sub-Saharan African
1183703328,PA166157286,rs1057868,,,POR,Metabolism/PK,1,nicotine,1183703330.0,Sub-Saharan African
1449259246,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449259248.0,East Asian
1449259246,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449259249.0,East Asian
1449259246,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449259250.0,East Asian
1446895961,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,1446895966.0,Unknown
1446895961,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,1446895968.0,Unknown
1449718023,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,aspirin,1449718040.0,Unknown
1449718023,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,aspirin,1449718040.0,Unknown
1449718023,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,clopidogrel,1449718040.0,Unknown
1449718023,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,clopidogrel,1449718040.0,Unknown
1184473273,PA166153613,rs1051741,,,EPHX1,Dosage,1,warfarin,1184473277.0,European
1184473273,PA166153613,rs1051741,,,EPHX1,Dosage,1,warfarin,1184473277.0,European
1184473261,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184473263.0,East Asian
1448997108,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448997114.0,Sub-Saharan African
1449750794,PA166180924,rs2303377,,,NCAM1,Efficacy,1,duloxetine,1449750797.0,European
1449750794,PA166180924,rs2303377,,,NCAM1,Efficacy,1,duloxetine,1449750796.0,European
1447944531,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,adalimumab,1447944539.0,European
1447682410,PA166155915,rs1127354,,,ITPA,Dosage,-1,mercaptopurine,1447682418.0,East Asian
1183703313,PA166155193,rs1876828,,,CRHR1,Efficacy,1,fluticasone propionate,1183703315.0,European
1450373368,PA166154259,rs6265,,,BDNF,Efficacy,-1,antipsychotics,1450373375.0,Multiple groups
1448997129,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997135.0,East Asian
1445585200,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1445585208.0,European
982043099,PA166154574,rs4149015,,,SLCO1B1,Metabolism/PK,1,pravastatin,982043113.0,Unknown
1446895979,PA166157637,rs11989215,,,ANGPT2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446895982.0,Multiple groups
1446895979,PA166157637,rs11989215,,,ANGPT2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446895988.0,Multiple groups
1446895979,PA166157637,rs11989215,,,ANGPT2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446895982.0,Multiple groups
1446895979,PA166157637,rs11989215,,,ANGPT2,Efficacy,-1,Selective serotonin reuptake inhibitors,1446895988.0,Multiple groups
1447682392,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682400.0,East Asian
1447682392,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682402.0,East Asian
1447682392,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1447682398.0,East Asian
1183703319,PA166153688,rs2266782,,,FMO3,Metabolism/PK,-1,nicotine,1183703324.0,Sub-Saharan African
1447960897,PA166154334,rs1799732,,,DRD2,Efficacy,1,nicotine,1447960903.0,European
1449750812,PA166180928,rs117986340,,,KMT2E,Efficacy,1,duloxetine,1449750814.0,European
1183703293,PA166155165,rs739645,,,CRHR1,Efficacy,1,fluticasone propionate,1183703295.0,European
1451340012,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451340017.0,Sub-Saharan African
1451340012,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1451340017.0,Sub-Saharan African
1183703305,PA166155195,rs1876831,,,CRHR1,Efficacy,1,fluticasone propionate,1183703307.0,European
1183621387,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183621389.0,Unknown
1183621387,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183621389.0,Unknown
1183621387,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183621389.0,Unknown
1448255788,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448255790.0,Unknown
1448255788,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448255790.0,Unknown
1183621366,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183621368.0,Unknown
1183621366,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183621368.0,Unknown
1183621366,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183621368.0,Unknown
1184473309,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473313.0,Latino
1448997148,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997157.0,
1183703276,PA166157422,rs6962027,,,CHRM2,Efficacy,1,fluticasone/salmeterol,1183703278.0,European
1447960889,PA166154334,rs1799732,,,DRD2,Efficacy,1,bupropion,1447960895.0,European
1450373388,PA166156991,rs1799971,,,OPRM1,Dosage,1,morphine,1450373394.0,"Multiple groups, Chinese, Malay and Indian self-reported ethnicities."
1450373388,PA166156991,rs1799971,,,OPRM1,Efficacy,1,morphine,1450373394.0,"Multiple groups, Chinese, Malay and Indian self-reported ethnicities."
1184473321,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473323.0,Latino
1451258120,PA166155733,rs4673993,,,ATIC,Efficacy,1,methotrexate,1451258140.0,European
1449718041,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,aspirin,1449718043.0,Unknown
1449718041,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,aspirin,1449718043.0,Unknown
1449718041,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1449718043.0,Unknown
1449718041,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,clopidogrel,1449718043.0,Unknown
1449713980,PA166156991,rs1799971,,,OPRM1,Dosage,-1,fentanyl,1449713986.0,East Asian
1183699298,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1183699305.0,Unknown
1183699298,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1183699366.0,Unknown
1448112425,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1448112427.0,European
1448112425,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448112427.0,European
1448112417,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,-1,tacrolimus,1448112423.0,European
1448112417,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1448112423.0,European
1448276267,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1448276278.0,European
1448276267,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448276278.0,European
1448423713,PA166156027,rs6269,,,COMT,Efficacy,1,quetiapine,1448423719.0,East Asian
827690019,PA166154536,rs2239179,,,VDR,Efficacy,1,selective beta-2-adrenoreceptor agonists,827690026.0,European
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811747.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811750.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811752.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811741.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811748.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811753.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811739.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811740.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811742.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811743.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811749.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811751.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811746.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811745.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811735,PA166183858,rs1461773,,,OPRM1,Efficacy,1,ethanol,1450811744.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1184764277,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184764283.0,European
1184764277,,,PA165971560,CYP2D6*8,CYP2D6,Metabolism/PK,0,sparteine,1184764283.0,European
1183617359,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,venlafaxine,1183617361.0,Unknown
1183617359,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,venlafaxine,1183617361.0,Unknown
1183617359,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,venlafaxine,1183617361.0,Unknown
1183617359,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,venlafaxine,1183617361.0,Unknown
1449713965,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,alfentanil,1449713977.0,"Multiple groups, 25 black/African American, 4 Asian, 2 North American Native, 68 Hispanic and Non-Hispanic white."
1449713965,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,alfentanil,1449713977.0,"Multiple groups, 25 black/African American, 4 Asian, 2 North American Native, 68 Hispanic and Non-Hispanic white."
1183699283,PA166157304,rs1800795,,,IL6,Efficacy,1,adalimumab,1183699300.0,Unknown
1183699283,PA166157304,rs1800795,,,IL6,Efficacy,1,etanercept,1183699300.0,Unknown
1183699283,PA166157304,rs1800795,,,IL6,Efficacy,1,infliximab,1183699300.0,Unknown
1451838520,PA166156991,rs1799971,,,OPRM1,Dosage,-1,sufentanil,1451838525.0,East Asian
981419348,PA166157316,rs2032582,,,ABCB1,Efficacy,1,paroxetine,981419360.0,East Asian
1448603925,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1448603927.0,Unknown
1448603925,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1448603927.0,Unknown
1184764290,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184764292.0,European
1184764290,,,PA165971564,CYP2D6*11,CYP2D6,Metabolism/PK,0,sparteine,1184764292.0,European
827690011,PA166154515,rs1540339,,,VDR,Efficacy,1,selective beta-2-adrenoreceptor agonists,827690018.0,European
981501278,PA166155941,rs3787430,,,HRH3,Efficacy,1,risperidone,981501286.0,East Asian
981501278,PA166155941,rs3787430,,,HRH3,Efficacy,1,risperidone,981501284.0,East Asian
1184764284,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184764286.0,European
1184764284,,,PA165971565,CYP2D6*12,CYP2D6,Metabolism/PK,0,sparteine,1184764286.0,European
1448112396,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,warfarin,1448112398.0,European
981501287,PA166155940,rs3787429,,,HRH3,Efficacy,1,risperidone,981501293.0,East Asian
981501287,PA166155940,rs3787429,,,HRH3,Efficacy,1,risperidone,981502119.0,East Asian
1451838540,PA166157345,rs2242480,,,CYP3A4,Dosage,1,sufentanil,1451838545.0,East Asian
1447948565,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,gefitinib,1447948567.0,Unknown
1447948565,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,gefitinib,1447948567.0,Unknown
1447948565,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,-1,gefitinib,1447948567.0,Unknown
1183699285,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183699297.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1183699285,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183699297.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1184747909,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,propofol,1184747919.0,European
1184747909,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,propofol,1184747919.0,European
1183699264,PA166154465,rs12422149,,,SLCO2B1,Metabolism/PK,-1,montelukast,1183699266.0,Unknown
1449714013,PA166157316,rs2032582,,,ABCB1,Dosage,-1,fentanyl,1449714015.0,East Asian
1448636679,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,everolimus,1448636681.0,European
1448603912,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1448603914.0,Unknown
1448603912,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1448603914.0,Unknown
981501231,,,PA165819268,TPMT*1,TPMT,Dosage,-1,mercaptopurine,981501235.0,East Asian
981501231,,,PA165819270,TPMT*3A,TPMT,Dosage,-1,mercaptopurine,981501235.0,East Asian
981501231,,,PA165819268,TPMT*1,TPMT,Dosage,-1,methotrexate,981501235.0,East Asian
981501231,,,PA165819270,TPMT*3A,TPMT,Dosage,-1,methotrexate,981501235.0,East Asian
1449714020,PA166157316,rs2032582,,,ABCB1,Dosage,-1,fentanyl,1449714022.0,East Asian
1184764302,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184764308.0,Unknown
1184764302,,,PA165971614,CYP2D6*59,CYP2D6,Metabolism/PK,0,sparteine,1184764308.0,Unknown
1183699272,PA166154381,rs2712807,,,SLCO2B1,Metabolism/PK,-1,montelukast,1183699279.0,Unknown
1183699272,PA166154381,rs2712807,,,SLCO2B1,Metabolism/PK,-1,montelukast,1183699274.0,Unknown
1447948553,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,gefitinib,1447948555.0,Unknown
1447948553,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,gefitinib,1447948555.0,Unknown
1183699268,PA166154472,rs35199625,,,SLCO2B1,Metabolism/PK,-1,montelukast,1183699270.0,Unknown
1451843594,PA166153977,rs1801253,,,ADRB1,Efficacy,0,Beta Blocking Agents,1451843599.0,East Asian
1448112390,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,1,warfarin,1448112395.0,European
1447948529,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,gefitinib,1447948531.0,Unknown
1448276214,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,1448276345.0,East Asian
1448276214,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,1448276345.0,East Asian
1184747936,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,gepirone hydrochloride,1184747945.0,European
1184747936,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,gepirone hydrochloride,1184747945.0,European
1449173340,PA166157316,rs2032582,,,ABCB1,Dosage,-1,morphine,1449173343.0,European
1449173340,PA166157316,rs2032582,,,ABCB1,Dosage,-1,morphine,1449173342.0,European
1449713997,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,fentanyl,1449713999.0,East Asian
1449713997,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,fentanyl,1449713999.0,East Asian
1183699250,PA166154367,rs2306168,,,SLCO2B1,Metabolism/PK,-1,montelukast,1183699257.0,Unknown
1448603895,PA166157748,rs2289656,,,NTRK2,Efficacy,-1,antidepressants,1448603897.0,"Multiple groups, 92% Caucasian"
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811725.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811730.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811728.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811726.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811731.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811719.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811720.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811717.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811718.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811721.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811727.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811729.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811723.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811724.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811713,PA166183856,rs3778148,,,OPRM1,Efficacy,1,ethanol,1450811722.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1448636661,PA166154140,rs11572080,,,CYP2C8,Metabolism/PK,-1,everolimus,1448636663.0,European
1451404160,PA166236261,rs7967354,,,SLCO1A2,Dosage,1,rocuronium,1451404220.0,Unknown
1451404160,PA166236261,rs7967354,,,SLCO1A2,Dosage,1,rocuronium,1451404180.0,Unknown
1447981305,PA166156582,rs4148157,,,ABCG2,Metabolism/PK,1,topotecan,1447981311.0,Unknown
1183699255,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,quetiapine,1183699280.0,East Asian
1184747946,,,PA165959981,UGT1A3*2,UGT1A3,Metabolism/PK,-1,gepirone hydrochloride,1184747948.0,European
1449714007,PA166157284,rs1045642,,,ABCB1,Dosage,-1,fentanyl,1449714009.0,East Asian
1447948535,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,gefitinib,1447948537.0,Unknown
1184747824,PA166156936,rs683369,,,SLC22A1,Metabolism/PK,1,imatinib,1184747829.0,Unknown
1185012370,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1185023103.0,"Multiple groups, White, Black, Asian, Unknown"
1185012370,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1185012373.0,"Multiple groups, White, Black, Asian, Unknown"
1185012370,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1185012378.0,"Multiple groups, White, Black, Asian, Unknown"
1451843560,PA166274203,rs11198893,,,GRK5,Efficacy,1,Beta Blocking Agents,1451843565.0,European
1451843560,PA166274203,rs11198893,,,GRK5,Efficacy,1,Beta Blocking Agents,1451843566.0,European
1451404202,PA166236262,rs11045995,,,IAPP,Dosage,1,rocuronium,1451404207.0,Unknown
1451404202,PA166236262,rs11045995,,,IAPP,Dosage,1,rocuronium,1451404206.0,Unknown
1451404202,PA166236262,rs11045995,,,SLCO1A2,Dosage,1,rocuronium,1451404207.0,Unknown
1451404202,PA166236262,rs11045995,,,SLCO1A2,Dosage,1,rocuronium,1451404206.0,Unknown
1448603878,PA166163351,rs2289657,,,NTRK2,Efficacy,-1,antidepressants,1448603880.0,"Multiple groups, 92% Caucasian"
1448603878,PA166163351,rs2289657,,,NTRK2,Efficacy,-1,antidepressants,1448603880.0,"Multiple groups, 92% Caucasian"
1451843550,PA166156031,rs16947,,,CYP2D6,Efficacy,-1,Beta Blocking Agents,1451843555.0,European
1183617444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183617469.0,Unknown
1183617444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183617469.0,Unknown
1183617444,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183617469.0,Unknown
1183617444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183617469.0,Unknown
1183617444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183617469.0,Unknown
1183617444,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183617469.0,Unknown
1451863980,PA166154001,rs2230345,,,GRK5,Efficacy,1,Beta Blocking Agents,1451864000.0,Unknown
1451863980,PA166154001,rs2230345,,,GRK5,Efficacy,1,Beta Blocking Agents,1451863988.0,Unknown
1447948516,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,gefitinib,1447948522.0,Unknown
1448423646,PA166161166,rs177852,,,TTC6,Efficacy,1,hydrochlorothiazide,1448423648.0,Unknown
1184747838,PA166157150,rs9370867,,,MYLIP,Efficacy,1,atorvastatin,1184747845.0,"Multiple groups, Brazilian"
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811813.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811819.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811809.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811810.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811822.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811820.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811812.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811821.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811808.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811818.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811811.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811816.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811815.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811817.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811814.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811813.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811819.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811809.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811810.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811822.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811820.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811812.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811821.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811808.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811818.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811811.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811816.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811815.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811817.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811814.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811813.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811819.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811809.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811810.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811822.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811820.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811812.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811821.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811808.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811818.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811811.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811816.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811815.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811817.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811804,PA166176243,rs648893,,,OPRM1,Efficacy,-1,ethanol,1450811814.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1449173387,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,morphine,1449173389.0,European
1449173387,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,morphine,1449173390.0,European
1449566589,PA166153675,rs2165870,,,CHRM3,Efficacy,0,dexamethasone,1449566599.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,citalopram,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,citalopram,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,citalopram,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,citalopram,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,escitalopram,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,escitalopram,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,escitalopram,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,escitalopram,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,fluoxetine,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,fluoxetine,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,fluoxetine,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,fluoxetine,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,fluvoxamine,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,fluvoxamine,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,fluvoxamine,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,fluvoxamine,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,paroxetine,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,paroxetine,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,paroxetine,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,paroxetine,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,sertraline,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,sertraline,1183617436.0,European
1183617434,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,sertraline,1183617436.0,European
1183617434,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,sertraline,1183617436.0,European
1184747846,PA166154313,rs1076560,,,DRD2,Efficacy,-1,venlafaxine,1184747852.0,"Multiple groups, European Americans, African Americans, Other"
1448603851,PA166157749,rs2289658,,,NTRK2,Efficacy,-1,antidepressants,1448603853.0,"Multiple groups, 92% Caucasian"
1448603851,PA166157749,rs2289658,,,NTRK2,Efficacy,-1,antidepressants,1448603853.0,"Multiple groups, 92% Caucasian"
1448603851,PA166157749,rs2289658,,,NTRK2,Efficacy,-1,antidepressants,1448603853.0,"Multiple groups, 92% Caucasian"
1449714076,PA166179865,rs4912522,,,HTR3E,Dosage,-1,opioids,1449714078.0,European
1449714076,PA166179865,rs4912522,,,HTR3E,Dosage,-1,opioids,1449714079.0,European
1448603849,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448603870.0,Unknown
1448603849,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448603870.0,Unknown
1183699325,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,1183699327.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1449714083,PA166153975,rs1800545,,,ADRA2A,Dosage,-1,opioids,1449714085.0,European
1449714083,PA166153975,rs1800545,,,ADRA2A,Dosage,-1,opioids,1449714086.0,European
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811771.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811780.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811776.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811768.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811777.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811778.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811779.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811770.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811775.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811773.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811774.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811782.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811781.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811772.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811764,PA166183860,rs506247,,,OPRM1,Efficacy,-1,ethanol,1450811769.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1451106680,PA166156890,rs28363170,,,SLC6A3,Efficacy,1,disulfiram,1451106703.0,"Multiple groups, ""Primarily Caucasian"""
1451106680,PA166156890,rs28363170,,,SLC6A3,Efficacy,1,disulfiram,1451106704.0,"Multiple groups, ""Primarily Caucasian"""
1184747866,PA166154339,rs1800497,,,DRD2,Efficacy,-1,venlafaxine,1184747868.0,"Multiple groups, European Americans, African Americans, Other"
1449157016,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,efavirenz,1449157018.0,European
1449157016,,,PA165818753,CYP2B6*2,CYP2B6,Metabolism/PK,-1,efavirenz,1449157018.0,European
1184469338,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1185235664.0,Central/South Asian
1184469338,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184469347.0,Central/South Asian
1184469338,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1185235664.0,Central/South Asian
1184469338,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184469347.0,Central/South Asian
981501315,PA166155810,rs11887534,,,ABCG8,Efficacy,-1,atorvastatin,981501324.0,Central/South Asian
1449714090,PA166154133,rs11195419,,,ADRA2A,Dosage,-1,opioids,1449714092.0,European
1449714090,PA166154133,rs11195419,,,ADRA2A,Dosage,-1,opioids,1449714093.0,European
1183699310,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183699312.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1183699310,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183699312.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1449173405,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,morphine,1449173407.0,European
1449173405,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,morphine,1449173408.0,European
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811799.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811790.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811798.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811794.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811789.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811800.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811797.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811796.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811791.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811787.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811793.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811788.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811795.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811792.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811783,PA166177796,rs563649,,,OPRM1,Efficacy,-1,ethanol,1450811801.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1448603822,PA166163345,rs1778933,,,NTRK2,Efficacy,-1,antidepressants,1448603824.0,"Multiple groups, 92% Caucasian"
1184747882,PA166156890,rs28363170,,,SLC6A3,Efficacy,-1,venlafaxine,1184747884.0,"Multiple groups, European Americans, African Americans, Other"
1448423603,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,rilpivirine,1448423605.0,Unknown
1449173414,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1449173454.0,European
1449173414,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1449173417.0,European
1448423597,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,rilpivirine,1448423599.0,Unknown
1451812280,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,ketoprofen,1451812300.0,European
1451812280,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,ketoprofen,1451814721.0,European
1451812280,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,ketoprofen,1451814720.0,European
1451812280,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,ketoprofen,1451814704.0,European
1451812280,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,ketoprofen,1451814703.0,European
981501391,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981501396.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981501396.0,European
981501391,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981501396.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981501396.0,European
981501391,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981501396.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981501396.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981501398.0,European
981501391,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981501396.0,European
982042071,PA166155187,rs1799752,,,ACE,Efficacy,1,benazepril,982042086.0,East Asian
982042071,PA166155187,rs1799752,,,ACE,Efficacy,1,perindopril,982042086.0,East Asian
1449173422,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1449173424.0,European
1449173422,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1449173425.0,European
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811868.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811863.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811862.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811861.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811869.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811873.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811871.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811860.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811872.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811867.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811864.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811865.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811870.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811856,PA166157015,rs2075572,,,OPRM1,Efficacy,1,ethanol,1450811866.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
982025681,PA166156024,rs4680,,,COMT,Efficacy,1,entacapone,982025697.0,Unknown
1449173430,PA166156024,rs4680,,,COMT,Metabolism/PK,-1,morphine,1449173432.0,European
1449173430,PA166156024,rs4680,,,COMT,Metabolism/PK,-1,morphine,1449173433.0,European
1449191908,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,1449191914.0,Unknown
1449192481,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192487.0,Unknown
1449714123,PA166156107,rs4646312,,,COMT,Dosage,-1,opioids,1449714125.0,European
1449714123,PA166156107,rs4646312,,,COMT,Dosage,-1,opioids,1449714126.0,European
1449714123,PA166156107,rs4646312,,,COMT,Dosage,-1,opioids,1449714125.0,European
1449714123,PA166156107,rs4646312,,,COMT,Dosage,-1,opioids,1449714126.0,European
1451406248,PA166153559,rs20417,,,PTGS2,Efficacy,-1,ibuprofen,1451406256.0,European
1451406248,PA166153559,rs20417,,,PTGS2,Efficacy,-1,ibuprofen,1451406255.0,European
1451406248,PA166153559,rs20417,,,PTGS2,Efficacy,-1,ibuprofen,1451406254.0,European
1451406248,PA166153559,rs20417,,,PTGS2,Efficacy,-1,ibuprofen,1451406253.0,European
1449192439,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192451.0,Unknown
1449192439,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192451.0,Unknown
1449714097,PA166179866,rs4274224,,,DRD2,Dosage,-1,opioids,1449714099.0,European
1449714097,PA166179866,rs4274224,,,DRD2,Dosage,-1,opioids,1449714100.0,European
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811881.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811893.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811879.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811880.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811882.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811883.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811888.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811892.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811890.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811889.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811887.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811884.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811891.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811885.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811875,PA166179967,rs548646,,,OPRM1,Efficacy,1,ethanol,1450811886.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1448423579,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,rilpivirine,1448423596.0,Unknown
1451406160,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,ibuprofen,1451406165.0,European
1451406160,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,ibuprofen,1451406166.0,European
1451406160,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,ibuprofen,1451406168.0,European
1451406160,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,ibuprofen,1451406167.0,European
1451406160,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,ibuprofen,1451406165.0,European
1451406160,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,ibuprofen,1451406166.0,European
1451406160,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,ibuprofen,1451406168.0,European
1451406160,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,ibuprofen,1451406167.0,European
1449192576,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192582.0,Unknown
1183699417,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183699419.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183699420.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183699421.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183699422.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,risperidone,1183699419.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,risperidone,1183699420.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,risperidone,1183699421.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,risperidone,1183699422.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183699419.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183699420.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183699421.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183699422.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183699419.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183699420.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183699421.0,"Multiple groups, Caucasian, African, Unknown"
1183699417,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1183699422.0,"Multiple groups, Caucasian, African, Unknown"
1449714104,PA166154451,rs11214763,,,HTR3B,Dosage,-1,opioids,1449714106.0,European
1449714104,PA166154451,rs11214763,,,HTR3B,Dosage,-1,opioids,1449714107.0,European
1448665545,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1448665547.0,Sub-Saharan African
1451406180,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,ibuprofen,1451406170.0,European
1451406180,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,ibuprofen,1451406169.0,European
1451406180,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,ibuprofen,1451406172.0,European
1451406180,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,ibuprofen,1451406171.0,European
1451406180,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,ibuprofen,1451406170.0,European
1451406180,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,ibuprofen,1451406169.0,European
1451406180,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,ibuprofen,1451406172.0,European
1451406180,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,ibuprofen,1451406171.0,European
1449192055,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192061.0,Unknown
1449192055,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1449192061.0,Unknown
1449714143,PA166179882,rs533123,,,OPRD1,Dosage,-1,opioids,1449714146.0,European
1449714143,PA166179882,rs533123,,,OPRD1,Dosage,-1,opioids,1449714145.0,European
981501360,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,sulfasalazine,981501385.0,East Asian
981501360,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,sulfasalazine,981501385.0,East Asian
981501360,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,sulfasalazine,981501385.0,East Asian
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811832.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811828.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811838.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811829.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811841.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811831.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811827.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811837.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811839.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811830.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811840.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811836.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811835.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811834.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811823,PA166183863,rs642489,,,OPRM1,Efficacy,-1,ethanol,1450811833.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1448276106,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448276108.0,Multiple groups
1448276106,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448276108.0,Multiple groups
982009266,PA166157289,rs1137617,,,KCNH2,Efficacy,0,atenolol,982009312.0,East Asian
982009266,PA166157289,rs1137617,,,KCNH2,Efficacy,0,bisoprolol,982009312.0,East Asian
982009266,PA166157289,rs1137617,,,KCNH2,Efficacy,0,celiprolol,982009312.0,East Asian
982009266,PA166157289,rs1137617,,,KCNH2,Efficacy,0,doxazosin,982009312.0,East Asian
1448276095,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448276104.0,Multiple groups
1448276095,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1448276104.0,Multiple groups
981861811,PA166157304,rs1800795,,,IL6,Efficacy,1,peginterferon alfa-2a,981861816.0,European
1449714151,PA166175994,rs678849,,,OPRD1,Dosage,-1,opioids,1449714154.0,European
1449714151,PA166175994,rs678849,,,OPRD1,Dosage,-1,opioids,1449714153.0,European
1447948420,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,gefitinib,1447948422.0,East Asian
1447948400,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,gefitinib,1447948402.0,East Asian
981501374,PA166156277,rs6280,,,DRD3,Efficacy,1,paroxetine,981501388.0,East Asian
981501374,PA166156277,rs6280,,,DRD3,Efficacy,1,paroxetine,981502134.0,East Asian
981501374,PA166156277,rs6280,,,DRD3,Efficacy,1,paroxetine,981501390.0,East Asian
1449714130,PA166156024,rs4680,,,COMT,Dosage,-1,opioids,1449714132.0,European
1449714130,PA166156024,rs4680,,,COMT,Dosage,-1,opioids,1449714133.0,European
1449157093,,,PA165819268,TPMT*1,TPMT,Metabolism/PK,1,thioguanine,1449157110.0,Unknown
1449157093,,,PA165819270,TPMT*3A,TPMT,Metabolism/PK,1,thioguanine,1449157110.0,Unknown
1449157093,,,PA165819272,TPMT*3C,TPMT,Metabolism/PK,1,thioguanine,1449157110.0,Unknown
1448276076,PA166160965,rs9332098,,,CYP2C9,Dosage,1,warfarin,1448276078.0,East Asian
1447948406,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,gefitinib,1447948408.0,East Asian
1451406260,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,tramadol,1451406268.0,European
1451406260,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,tramadol,1451406271.0,European
1451406260,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,tramadol,1451406270.0,European
1451406260,PA166155409,rs3745274,,,CYP2A7P1,Efficacy,-1,tramadol,1451406269.0,European
1451406260,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,tramadol,1451406268.0,European
1451406260,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,tramadol,1451406271.0,European
1451406260,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,tramadol,1451406270.0,European
1451406260,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,tramadol,1451406269.0,European
1184747953,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,paroxetine,1184747973.0,East Asian
1184747953,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,paroxetine,1184747973.0,East Asian
1184747953,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,paroxetine,1184747973.0,East Asian
1184747953,,,PA166001447,CYP2D6*39,CYP2D6,Metabolism/PK,-1,paroxetine,1184747973.0,East Asian
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811924.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811931.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811936.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811923.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811922.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811925.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811935.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811926.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811930.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811932.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811933.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811927.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811934.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811928.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811918,PA166183871,rs681243,,,OPRM1,Efficacy,1,ethanol,1450811929.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1449173486,PA166156024,rs4680,,,COMT,Dosage,1,opioids,1449173492.0,"Multiple groups, Participants were of Hispanic, Caucasian or African American ethnicity."
1449173486,PA166156024,rs4680,,,COMT,Dosage,1,opioids,1449173492.0,"Multiple groups, Participants were of Hispanic, Caucasian or African American ethnicity."
1448603755,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,pantoprazole,1448603766.0,Near Eastern
1444704305,PA166153620,rs1061631,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704307.0,European
1444704305,PA166153620,rs1061631,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704308.0,European
1447948394,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,gefitinib,1447948396.0,East Asian
1183945249,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1183950365.0,European
1183945249,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1183950365.0,European
1449173493,PA166156025,rs4818,,,COMT,Dosage,-1,opioids,1449173495.0,"Multiple groups, Participants were of Hispanic, Caucasian or African American ethnicity."
1449173493,PA166156025,rs4818,,,COMT,Dosage,-1,opioids,1449173495.0,"Multiple groups, Participants were of Hispanic, Caucasian or African American ethnicity."
1451406341,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,tramadol,1451406348.0,European
1451406341,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,tramadol,1451406330.0,European
1451406341,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,tramadol,1451406347.0,European
1451406341,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,tramadol,1451406329.0,European
1451406341,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,tramadol,1451406348.0,European
1451406341,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,tramadol,1451406330.0,European
1451406341,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,tramadol,1451406347.0,European
1451406341,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,tramadol,1451406329.0,European
1448276066,PA166160963,rs9332092,,,CYP2C9,Dosage,1,warfarin,1448276068.0,East Asian
1444704313,PA166153619,rs1061624,,,TNFRSF1B,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704316.0,European
1444704313,PA166153619,rs1061624,,,TNFRSF1B,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704315.0,European
1451406389,PA166156024,rs4680,,,COMT,Efficacy,-1,tramadol,1451406402.0,European
1451406389,PA166156024,rs4680,,,COMT,Efficacy,-1,tramadol,1451406401.0,European
1451406389,PA166156024,rs4680,,,COMT,Efficacy,-1,tramadol,1451406394.0,European
1451406389,PA166156024,rs4680,,,COMT,Efficacy,-1,tramadol,1451406400.0,European
1449714159,PA166179883,rs2236857,,,OPRD1,Dosage,-1,opioids,1449714162.0,European
1449714159,PA166179883,rs2236857,,,OPRD1,Dosage,-1,opioids,1449714161.0,European
1183699481,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,risperidone,1183699483.0,"Multiple groups, Caucasian, African, Unknown"
1043859504,PA166153977,rs1801253,,,ADRB1,Efficacy,1,metoprolol,1043859508.0,Unknown
1183699477,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,risperidone,1183699479.0,"Multiple groups, Caucasian, African, Unknown"
1451406380,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1451406351.0,European
1451406380,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1451406388.0,European
1451406380,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1451406350.0,European
1451406380,PA166156991,rs1799971,,,OPRM1,Efficacy,1,tramadol,1451406349.0,European
1449173508,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1449173514.0,Unknown
1449173523,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,tacrolimus,1449173656.0,European
1449173523,,,PA165819244,CYP3A4*20,CYP3A4,Dosage,-1,tacrolimus,1449173656.0,European
1448423497,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,proguanil,1448423562.0,Oceanian
1448423497,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,proguanil,1448423562.0,Oceanian
1448423497,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,proguanil,1448423562.0,Oceanian
1184747986,PA166154918,rs6494223,,,CHRNA7,Efficacy,1,donepezil,1184747991.0,"Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)"
1184747986,PA166154918,rs6494223,,,CHRNA7,Efficacy,1,galantamine,1184747991.0,"Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)"
1184747986,PA166154918,rs6494223,,,CHRNA7,Efficacy,1,rivastigmine,1184747991.0,"Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)"
1449191776,PA166157537,rs267606723,,,CFTR,Efficacy,1,ivacaftor,1449191782.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1184518608,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1184518630.0,Unknown
1184518608,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1184518630.0,Unknown
1184518608,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1184518630.0,Unknown
1448112188,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,1,tamoxifen-n-glucuronide,1448112194.0,"Multiple groups, Chinese, Malay, Indian"
1183699464,,,PA165948045,CYP3A7*1A,CYP3A7,Metabolism/PK,-1,risperidone,1183699466.0,"Multiple groups, Caucasian, African, Unknown"
1183699464,,,PA165948047,CYP3A7*1C,CYP3A7,Metabolism/PK,-1,risperidone,1183699466.0,"Multiple groups, Caucasian, African, Unknown"
1449191825,PA166157533,rs121909041,,,CFTR,Efficacy,1,ivacaftor,1449191827.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1183699460,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,risperidone,1183699462.0,"Multiple groups, Caucasian, African, Unknown"
982044204,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,digoxin,982044212.0,European
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811903.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811910.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811901.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811915.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811914.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811904.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811900.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811912.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811905.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811909.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811906.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811911.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811913.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811907.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811896,PA166183869,rs648007,,,OPRM1,Efficacy,1,ethanol,1450811908.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1449191790,PA166157521,rs80282562,,,CFTR,Efficacy,1,ivacaftor,1449191792.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
1451406403,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,tramadol,1451406411.0,European
1451406403,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,tramadol,1451406410.0,European
1451406403,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,tramadol,1451406409.0,European
1451406403,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,tramadol,1451406408.0,European
982025734,PA166156722,rs265976,,,DRD1,Efficacy,1,clozapine,982025739.0,African American/Afro-Caribbean
982025734,PA166156722,rs265976,,,DRD1,Efficacy,1,clozapine,982025741.0,European
1448489015,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,exemestane,1448489762.0,Multiple groups
1448489015,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,exemestane,1448489762.0,Multiple groups
1451406420,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,tramadol,1451406460.0,European
1451406420,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,tramadol,1451406441.0,European
1451406420,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,tramadol,1451406440.0,European
1451406420,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,tramadol,1451406425.0,European
982042116,PA166156523,rs1800591,,,MTTP,Efficacy,1,atorvastatin,982042134.0,Unknown
1333193034,PA166154899,rs2606345,,,CYP1A1,Metabolism/PK,1,deferasirox,1333193040.0,"Multiple groups, Mainly Caucasian (Italy)"
1333193034,PA166154899,rs2606345,,,CYP1A1,Metabolism/PK,1,deferasirox,1333193067.0,"Multiple groups, Mainly Caucasian (Italy)"
1448603685,PA166163331,rs3116149,,,SLC5A2,Efficacy,-1,empagliflozin,1448603687.0,Unknown
1449157166,PA166153574,rs529520,,,OPRD1,Efficacy,-1,buprenorphine,1449157168.0,African American/Afro-Caribbean
1449157166,PA166153574,rs529520,,,OPRD1,Efficacy,-1,buprenorphine,1449157200.0,European
982025810,PA166156024,rs4680,,,COMT,Efficacy,-1,antipsychotics,982025826.0,Central/South Asian
1333193025,PA166155607,rs887829,,,UGT1A1,Metabolism/PK,1,deferasirox,1333193031.0,"Multiple groups, Mainly Caucasian (Italy)"
982042188,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982042198.0,East Asian
1449157174,PA166153578,rs581111,,,OPRD1,Efficacy,-1,buprenorphine,1449157202.0,European
1449157174,PA166153578,rs581111,,,OPRD1,Efficacy,-1,buprenorphine,1449157176.0,African American/Afro-Caribbean
981501538,PA166156734,rs460000,,,SLC6A3,Dosage,-1,amphetamine,981501545.0,European
981501538,PA166156734,rs460000,,,SLC6A3,Efficacy,-1,amphetamine,981501545.0,European
1451123305,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,lumefantrine,1451123340.0,Unknown
1451123305,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,lumefantrine,1451123340.0,Unknown
1451406461,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406469.0,European
1451406461,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406468.0,European
1451406461,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406467.0,European
1451406461,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406466.0,European
1451123300,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,artemether,1451123320.0,Unknown
1451123300,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,artemether,1451123320.0,Unknown
1451123300,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,artemether,1451123320.0,Unknown
1447948288,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,gefitinib,1447948300.0,East Asian
1447948288,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,gefitinib,1447948300.0,East Asian
1447948288,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,gefitinib,1447948300.0,East Asian
1448603665,PA166163326,rs9924771,,,SLC5A2,Efficacy,-1,empagliflozin,1448603672.0,Unknown
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,adalimumab,1183699534.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,adalimumab,1183699547.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,adalimumab,1183699549.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,etanercept,1183699534.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,etanercept,1183699547.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,etanercept,1183699549.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1183699534.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1183699547.0,European
1183699530,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1183699549.0,European
1448275978,PA166155598,rs699664,,,GGCX,Dosage,1,warfarin,1448275983.0,East Asian
1444704274,PA166153542,rs3397,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704284.0,European
1444704274,PA166153542,rs3397,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704282.0,European
1444704274,PA166153542,rs3397,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704284.0,European
1444704274,PA166153542,rs3397,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704282.0,European
982025774,PA166156706,rs4532,,,DRD1,Efficacy,-1,clozapine,982025779.0,African American/Afro-Caribbean
982025774,PA166156706,rs4532,,,DRD1,Efficacy,-1,clozapine,982025780.0,European
1183699525,PA166156423,rs7643645,,,NR1I2,Metabolism/PK,-1,risperidone,1183699529.0,"Multiple groups, Caucasian, African, Unknown"
1333193055,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,deferasirox,1333193061.0,"Multiple groups, Mainly Caucasian (Italy)"
1444704286,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704289.0,European
1444704286,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704288.0,European
1449157205,PA166175994,rs678849,,,OPRD1,Efficacy,-1,buprenorphine,1449157208.0,European
1451406470,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406480.0,European
1451406470,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406477.0,European
1451406470,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406476.0,European
1451406470,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,tramadol,1451406475.0,European
1333193048,PA166154893,rs2470890,,,CYP1A2,Metabolism/PK,1,deferasirox,1333193054.0,"Multiple groups, Mainly Caucasian (Italy)"
1333193048,PA166154893,rs2470890,,,CYP1A2,Metabolism/PK,1,deferasirox,1333193071.0,"Multiple groups, Mainly Caucasian (Italy)"
982025799,PA166156023,rs4633,,,COMT,Efficacy,-1,antipsychotics,982025809.0,Central/South Asian
982042181,PA166156523,rs1800591,,,MTTP,Efficacy,-1,atorvastatin,982042186.0,Unknown
1184748190,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,citalopram,1184748314.0,"Multiple groups, Asian and White"
1184748190,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,citalopram,1184748314.0,"Multiple groups, Asian and White"
1184748190,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,citalopram,1184748314.0,"Multiple groups, Asian and White"
1184748190,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1184748314.0,"Multiple groups, Asian and White"
1184748190,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,escitalopram,1184748314.0,"Multiple groups, Asian and White"
1184748190,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,escitalopram,1184748314.0,"Multiple groups, Asian and White"
1449157212,PA166153606,rs1042114,,,OPRD1,Efficacy,-1,buprenorphine,1449157215.0,European
1000539548,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,vincristine,1000539555.0,European
1000539548,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,vincristine,1000539555.0,European
1333193041,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,deferasirox,1333193047.0,"Multiple groups, Mainly Caucasian (Italy)"
1450041941,PA166156064,rs1080985,,,CYP2D6,Metabolism/PK,1,thioridazine,1450041946.0,European
1447981047,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1447981049.0,European
1449714260,PA166179896,rs6725334,,,TACR1,Dosage,-1,opioids,1449714262.0,European
1449714260,PA166179896,rs6725334,,,TACR1,Dosage,-1,opioids,1449714263.0,European
1449157221,PA166153606,rs1042114,,,OPRD1,Efficacy,-1,methadone,1449157224.0,European
1444704297,PA166153542,rs3397,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444704300.0,European
982042172,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982042180.0,East Asian
1448423400,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,0,citalopram,1448423418.0,Unknown
1447981032,PA166153644,rs1801133,,,MTHFR,Efficacy,1,methotrexate,1447981039.0,European
982025895,PA166156723,rs265981,,,DRD1,Efficacy,-1,clozapine,982025900.0,African American/Afro-Caribbean
982025895,PA166156723,rs265981,,,DRD1,Efficacy,-1,clozapine,982025901.0,European
1448423402,PA166161141,rs12436663,,,PRORP,Efficacy,1,zileuton,1448423430.0,Multiple groups
1449714306,PA166179910,rs346070,,,HRH1,Dosage,-1,opioids,1449714308.0,European
1449714306,PA166179910,rs346070,,,HRH1,Dosage,-1,opioids,1449714309.0,European
981239462,PA166155137,rs104894539,,,VKORC1,Dosage,0,warfarin,1184136137.0,Unknown
1184469575,PA166155331,rs45445694,,,TYMS,Efficacy,-1,fluorouracil,,
1449157257,PA166153574,rs529520,,,OPRD1,Efficacy,-1,methadone,1449157260.0,European
1449157257,PA166153574,rs529520,,,OPRD1,Efficacy,-1,methadone,1449157259.0,African American/Afro-Caribbean
1449714290,PA166179909,rs346076,,,HRH1,Dosage,-1,opioids,1449714292.0,European
1449714290,PA166179909,rs346076,,,HRH1,Dosage,-1,opioids,1449714293.0,European
1449714297,PA166156299,rs901865,,,HRH1,Dosage,-1,opioids,1449714300.0,European
1449714297,PA166156299,rs901865,,,HRH1,Dosage,-1,opioids,1449714299.0,European
1448993424,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,antipsychotics,1448993559.0,European
1448993424,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,antipsychotics,1448993559.0,European
1448993424,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,aripiprazole,1448993559.0,European
1448993424,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,aripiprazole,1448993559.0,European
1448993424,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,haloperidol,1448993559.0,European
1448993424,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,haloperidol,1448993559.0,European
1448993424,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,pimozide,1448993559.0,European
1448993424,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,pimozide,1448993559.0,European
1448993424,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,risperidone,1448993559.0,European
1448993424,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,risperidone,1448993559.0,European
1449157264,PA166153578,rs581111,,,OPRD1,Efficacy,-1,methadone,1449157266.0,African American/Afro-Caribbean
1449157264,PA166153578,rs581111,,,OPRD1,Efficacy,-1,methadone,1449157267.0,European
1448112064,PA166153751,rs3766355,,,PTGFR,Efficacy,1,latanoprost,1448112082.0,East Asian
1184469584,PA166154147,rs12248560,,,CYP2C19,Dosage,1,clopidogrel,1184469590.0,Unknown
1184469584,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,clopidogrel,1184469590.0,Unknown
1449714333,PA166179917,rs9817063,,,DRD3,Dosage,-1,opioids,1449714335.0,European
1449714333,PA166179917,rs9817063,,,DRD3,Dosage,-1,opioids,1449714336.0,European
1183699582,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1183699586.0,East Asian
1449190032,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,n-desmethylclozapine,1449190043.0,"Multiple groups, 64% were Caucasian, 13% Asian, 10% Pacific Islander and 13% others"
1449190032,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,n-desmethylclozapine,1449190043.0,"Multiple groups, 64% were Caucasian, 13% Asian, 10% Pacific Islander and 13% others"
1449714347,PA166156301,rs963468,,,DRD3,Dosage,-1,opioids,1449714349.0,European
1449714347,PA166156301,rs963468,,,DRD3,Dosage,-1,opioids,1449714350.0,European
1448603574,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1448603574,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,oxymorphone,1448603576.0,Unknown
1448603574,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,oxymorphone,1448603577.0,Unknown
1449190044,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clozapine,1449190046.0,Multiple groups
1449714340,PA166179918,rs3732790,,,DRD3,Dosage,-1,opioids,1449714343.0,European
1449714340,PA166179918,rs3732790,,,DRD3,Dosage,-1,opioids,1449714342.0,European
1447980961,PA166155206,rs2289669,,,SLC47A1,Efficacy,1,metformin,1447980963.0,East Asian
1000539639,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1000539651.0,Multiple groups
1449714326,PA166179916,rs2399496,,,DRD3,Dosage,-1,opioids,1449714328.0,European
1449714326,PA166179916,rs2399496,,,DRD3,Dosage,-1,opioids,1449714329.0,European
1449714368,PA166156277,rs6280,,,DRD3,Dosage,-1,opioids,1449714371.0,European
1449714368,PA166156277,rs6280,,,DRD3,Dosage,-1,opioids,1449714370.0,European
982025943,PA166156938,rs699947,,,VEGFA,Efficacy,1,ranibizumab,982025949.0,Unknown
981239505,PA166155139,rs104894541,,,VKORC1,Dosage,0,warfarin,,
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699680.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699679.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699680.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699679.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699680.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699679.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699680.0,East Asian
1183699677,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183699679.0,East Asian
1448603555,PA166153640,rs1800872,,,IL10,Metabolism/PK,-1,tacrolimus,1448603557.0,East Asian
1448993465,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,efavirenz,1448993472.0,Central/South Asian
1183699689,PA166154107,rs10490924,,,ARMS2,Dosage,-1,bevacizumab,1183699691.0,East Asian
1449714375,PA166156286,rs324026,,,DRD3,Dosage,-1,opioids,1449714378.0,European
1449714375,PA166156286,rs324026,,,DRD3,Dosage,-1,opioids,1449714377.0,European
981239514,PA166155138,rs104894540,,,VKORC1,Dosage,0,warfarin,,
1183699684,PA166153617,rs1061170,,,CFH,Dosage,1,bevacizumab,1183699688.0,East Asian
1448603549,PA166153642,rs1800896,,,IL10,Metabolism/PK,1,tacrolimus,1448603551.0,East Asian
981239523,PA166155137,rs104894539,,,VKORC1,Dosage,0,warfarin,,
1448603543,PA166154344,rs1946518,,,IL18,Metabolism/PK,1,tacrolimus,1448603545.0,East Asian
1448603535,PA166154416,rs5744247,,,IL18,Metabolism/PK,1,tacrolimus,1448603537.0,East Asian
982025950,PA166156985,rs1570360,,,VEGFA,Efficacy,-1,ranibizumab,982025954.0,Unknown
1448993476,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448993483.0,Central/South Asian
1183699670,PA166154107,rs10490924,,,ARMS2,Efficacy,1,bevacizumab,1183699672.0,East Asian
1183699670,PA166154107,rs10490924,,,ARMS2,Efficacy,1,bevacizumab,1183699673.0,East Asian
1447980951,PA166156930,rs594709,,,SLC22A1,Efficacy,1,metformin,1447980959.0,East Asian
1449157325,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cyclophosphamide,1449157339.0,East Asian
1449157325,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cyclophosphamide,1449157339.0,East Asian
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407446.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407448.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407445.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407443.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407447.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407444.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407420,PA166156991,rs1799971,,,OPRM1,Efficacy,0,morphine,1451407440.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407464.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407481.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407466.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407480.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407467.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407465.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407460,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,morphine,1451407500.0,"Multiple groups, Participants were African American or non-Hispanic white"
1183699659,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183699669.0,East Asian
1183699659,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183699667.0,East Asian
1183699659,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183699663.0,East Asian
1183699659,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183699665.0,East Asian
1184748315,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,citalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,citalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,citalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,citalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,escitalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,escitalopram,1184748317.0,"Multiple groups, Asian and White"
1184748315,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,escitalopram,1184748317.0,"Multiple groups, Asian and White"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407511.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407508.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407509.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407560.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407544.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407510.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407539,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1451407543.0,"Multiple groups, Participants were African American or non-Hispanic white"
1449714407,PA166179928,rs939334,,,HTR3D,Dosage,-1,opioids,1449714409.0,European
1449714407,PA166179928,rs939334,,,HTR3D,Dosage,-1,opioids,1449714410.0,European
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407535.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407536.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407507.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407537.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407538.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407533.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407529,PA166156024,rs4680,,,COMT,Efficacy,0,morphine,1451407534.0,"Multiple groups, Participants were African American or non-Hispanic white"
1448603519,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,pantoprazole,1448603521.0,Near Eastern
981239480,PA166155138,rs104894540,,,VKORC1,Dosage,0,warfarin,1184136143.0,Unknown
1183699633,PA166155796,rs10931910,,,AOX1,Metabolism/PK,-1,XK469,1183699635.0,European
1448111986,PA166154566,rs3794271,,,SLCO1C1,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448111993.0,European
1183699628,PA166155796,rs10931910,,,AOX1,Metabolism/PK,1,XK469,1183699632.0,European
981239489,PA166155140,rs104894542,,,VKORC1,Dosage,0,warfarin,1184136141.0,Unknown
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407840.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407807.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407820.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407805.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407808.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407806.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407800,PA166183555,rs702764,,,OPRK1,Efficacy,-1,butorphanol,1451407804.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407814.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407815.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407813.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407816.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407819.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407817.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407809,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,butorphanol,1451407818.0,"Multiple groups, Participants were African American or non-Hispanic white"
1449157340,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cyclophosphamide,1449157342.0,East Asian
1449157340,,,PA166117272,CYP2B6*30,CYP2B6,Metabolism/PK,1,cyclophosphamide,1449157342.0,East Asian
1184748329,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,citalopram,1184748331.0,"Multiple groups, Asian and White"
1184748329,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,citalopram,1184748331.0,"Multiple groups, Asian and White"
1184748329,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1184748331.0,"Multiple groups, Asian and White"
1184748329,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,escitalopram,1184748331.0,"Multiple groups, Asian and White"
1184469799,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,aspirin,1184469807.0,East Asian
1184469799,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,aspirin,1184469807.0,East Asian
1184469799,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,aspirin,1184469807.0,East Asian
1184469799,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,aspirin,1184469807.0,East Asian
1184469799,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,aspirin,1184469807.0,East Asian
1184469799,,,PA165980636,CYP2C19*3,CYP2C19,Toxicity,-1,aspirin,1184469807.0,East Asian
1184469799,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1184469807.0,East Asian
1184469799,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,clopidogrel,1184469807.0,East Asian
1184469799,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1184469807.0,East Asian
1184469799,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,clopidogrel,1184469807.0,East Asian
1184469799,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,clopidogrel,1184469807.0,East Asian
1184469799,,,PA165980636,CYP2C19*3,CYP2C19,Toxicity,-1,clopidogrel,1184469807.0,East Asian
981239497,PA166155140,rs104894542,,,VKORC1,Dosage,0,warfarin,,
1449157351,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cyclophosphamide,1449157353.0,East Asian
1449157351,,,PA165818813,CYP2B6*29,CYP2B6,Metabolism/PK,1,cyclophosphamide,1449157353.0,East Asian
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407497.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407502.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407499.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407498.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407503.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407496.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407520.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407497.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407502.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407499.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407498.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407503.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407496.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407492,PA166184295,rs16918875,,,OPRK1,Efficacy,-1,morphine,1451407520.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407501.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407487.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407488.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407486.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407489.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407490.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407482,PA166183555,rs702764,,,OPRK1,Efficacy,-1,morphine,1451407491.0,"Multiple groups, Participants were African American or non-Hispanic white"
1448993523,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,efavirenz,1448993529.0,Multiple groups
1448993523,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,non-nucleoside reverse transcriptase inhibitors,1448993529.0,Multiple groups
1183617822,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183617837.0,Unknown
1183617822,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183617837.0,Unknown
1183617822,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183617837.0,Unknown
1183617822,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183617837.0,Unknown
1183617822,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183617837.0,Unknown
1183617822,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183617837.0,Unknown
1184174889,PA166157415,rs6946062,,,NT5C3A,Metabolism/PK,-1,gemcitabine,1184174901.0,Unknown
981862168,PA166156129,rs7287550,,,COMT,Dosage,1,morphine,981862174.0,European
981862168,PA166156129,rs7287550,,,TXNRD2,Dosage,1,morphine,981862174.0,European
981862168,PA166156129,rs7287550,,,COMT,Efficacy,1,morphine,981862174.0,European
981862168,PA166156129,rs7287550,,,TXNRD2,Efficacy,1,morphine,981862174.0,European
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407528.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407526.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407505.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407504.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407525.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407506.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407521,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1451407527.0,"Multiple groups, Participants were African American or non-Hispanic white"
981747482,PA166155267,rs292449,,,NEDD4L,Efficacy,-1,atenolol,981747494.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Dosage,1,cyclosporine,1446899562.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Dosage,1,cyclosporine,1446899559.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,1446899562.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,1446899559.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1446899562.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1446899559.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1446899562.0,European
1446899545,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1446899559.0,European
1446899532,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,debrisoquine,1446899541.0,Latino
1446899532,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1446899541.0,Latino
1184174886,PA166156945,rs747199,,,SLC29A1,Metabolism/PK,-1,gemcitabine,1184174899.0,Unknown
981862160,PA166156056,rs737866,,,COMT,Dosage,1,morphine,981862166.0,European
981862160,PA166156056,rs737866,,,COMT,Efficacy,1,morphine,981862166.0,European
1333193325,,,PA165958685,CYP2C8*3,CYP2C8,Dosage,1,rosiglitazone,1333193327.0,European
1333193325,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,rosiglitazone,1333193327.0,European
1333193325,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,rosiglitazone,1333193327.0,European
1450664704,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,prasugrel,1450664713.0,East Asian
1450664704,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,prasugrel,1450664713.0,East Asian
1450664704,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,prasugrel,1450664713.0,East Asian
1043859264,PA166153977,rs1801253,,,ADRB1,Dosage,1,catecholamines,1043859268.0,European
1448993530,PA166155478,rs28399499,,,CYP2B6,Efficacy,-1,efavirenz,1448993532.0,Multiple groups
1448993530,PA166155478,rs28399499,,,CYP2B6,Efficacy,-1,non-nucleoside reverse transcriptase inhibitors,1448993532.0,Multiple groups
1449157368,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,cyclophosphamide,1449157370.0,East Asian
1449157368,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,cyclophosphamide,1449157370.0,East Asian
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407517.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407547.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407546.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407516.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407545.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407518.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407512,PA166156027,rs6269,,,COMT,Efficacy,0,morphine,1451407548.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407702.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407701.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407703.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407666.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407700.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407704.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,butorphanol,1451407720.0,"Multiple groups, Participants were African American or non-Hispanic white"
982009615,PA166154259,rs6265,,,BDNF,Efficacy,-1,mirtazapine,982009661.0,Multiple groups
1000539568,PA166155187,rs1799752,,,ACE,Efficacy,1,quinapril,1000539572.0,Unknown
1184174878,PA166153610,rs1048977,,,CDA,Metabolism/PK,1,gemcitabine,1184174885.0,Unknown
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407763.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407740.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407764.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407741.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407760.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407762.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407705,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,butorphanol,1451407761.0,"Multiple groups, Participants were African American or non-Hispanic white"
1184174881,PA166154142,rs11598702,,,NT5C2,Metabolism/PK,1,gemcitabine,1184174907.0,Unknown
981862185,PA166156057,rs740603,,,COMT,Dosage,1,morphine,981862192.0,European
981862185,PA166156057,rs740603,,,COMT,Efficacy,1,morphine,981862192.0,European
1448993538,PA166155486,rs34097093,,,CYP2B6,Efficacy,-1,efavirenz,1448993540.0,Multiple groups
1448993538,PA166155486,rs34097093,,,CYP2B6,Efficacy,-1,non-nucleoside reverse transcriptase inhibitors,1448993540.0,Multiple groups
1446899553,PA166157267,rs776746,,,CYP3A5,Dosage,1,cyclosporine,1446899573.0,European
1446899553,PA166157267,rs776746,,,CYP3A5,Dosage,1,cyclosporine,1446899571.0,Unknown
1446899553,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,1446899573.0,European
1446899553,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,1446899571.0,Unknown
1446899553,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1446899573.0,European
1446899553,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1446899571.0,Unknown
1446899553,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1446899573.0,European
1446899553,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1446899571.0,Unknown
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407770.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407742.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407780.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407769.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407744.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407781.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407765,PA166156025,rs4818,,,COMT,Efficacy,-1,butorphanol,1451407743.0,"Multiple groups, Participants were African American or non-Hispanic white"
1450664694,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clopidogrel,1450664703.0,East Asian
1450664694,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clopidogrel,1450664703.0,East Asian
1450664694,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,clopidogrel,1450664703.0,East Asian
981747496,PA166155276,rs1008899,,,NEDD4L,Efficacy,-1,hydrochlorothiazide,981747507.0,European
981862176,PA166156116,rs5746849,,,COMT,Dosage,1,morphine,981862183.0,European
981862176,PA166156116,rs5746849,,,COMT,Efficacy,1,morphine,981862183.0,European
1448993544,PA166155360,rs1042389,,,CYP2B6,Efficacy,-1,efavirenz,1448993546.0,Multiple groups
1448993544,PA166155360,rs1042389,,,CYP2B6,Efficacy,-1,non-nucleoside reverse transcriptase inhibitors,1448993546.0,Multiple groups
1449157385,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,cyclophosphamide,1449157387.0,East Asian
1449157385,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,cyclophosphamide,1449157387.0,East Asian
1449714421,PA166177550,rs6443930,,,HTR3D,Dosage,-1,opioids,1449714424.0,European
1449714421,PA166177550,rs6443930,,,HTR3D,Dosage,-1,opioids,1449714423.0,European
1449714421,PA166177550,rs6443930,,,HTR3D,Dosage,-1,opioids,1449714424.0,European
1449714421,PA166177550,rs6443930,,,HTR3D,Dosage,-1,opioids,1449714423.0,European
1449714421,PA166177550,rs6443930,,,HTR3D,Dosage,-1,opioids,1449714424.0,European
1449714421,PA166177550,rs6443930,,,HTR3D,Dosage,-1,opioids,1449714423.0,European
1449714463,PA166179936,rs6807670,,,HTR3C,Dosage,-1,opioids,1449714465.0,European
1449714463,PA166179936,rs6807670,,,HTR3C,Dosage,-1,opioids,1449714466.0,European
981501734,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,carbamazepine,981501742.0,"Multiple groups, African Americans and Caucasians"
981501734,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,carbamazepine,981501746.0,European
981501734,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,carbamazepine,981501744.0,African American/Afro-Caribbean
1447964483,PA166154826,rs12050217,,,BDKRB1,Efficacy,1,perindopril,1447964486.0,European
1448259403,PA166155351,rs429358,,,APOE,Dosage,1,acenocoumarol,1448259410.0,Unknown
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407824.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407821.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407842.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407841.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407823.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407880.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407860,PA166156023,rs4633,,,COMT,Efficacy,1,butorphanol,1451407822.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407884.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407881.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407882.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407885.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407883.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407886.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407825,PA166156024,rs4680,,,COMT,Efficacy,-1,butorphanol,1451407843.0,"Multiple groups, Participants were African American or non-Hispanic white"
1448993550,PA166155442,rs8192709,,,CYP2B6,Efficacy,-1,efavirenz,1448993552.0,Multiple groups
1448993550,PA166155442,rs8192709,,,CYP2B6,Efficacy,-1,non-nucleoside reverse transcriptase inhibitors,1448993552.0,Multiple groups
1447980873,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,carbamazepine,1447980886.0,European
1447980873,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,carbamazepine,1447980886.0,European
1449566994,PA166179496,rs241692,,,FHIT,Efficacy,-1,bevacizumab,1449566996.0,Multiple groups
1449566994,PA166179496,rs241692,,,FHIT,Efficacy,-1,bevacizumab,1449566997.0,Multiple groups
1449566994,PA166179496,rs241692,,,FHIT,Efficacy,-1,bevacizumab,1449566998.0,Multiple groups
1449566994,PA166179496,rs241692,,,FHIT,Efficacy,-1,ranibizumab,1449566996.0,Multiple groups
1449566994,PA166179496,rs241692,,,FHIT,Efficacy,-1,ranibizumab,1449566997.0,Multiple groups
1449566994,PA166179496,rs241692,,,FHIT,Efficacy,-1,ranibizumab,1449566998.0,Multiple groups
981419765,PA166156094,rs2284018,,,CACNG2,Efficacy,1,lithium,981419777.0,European
981419765,PA166156094,rs2284018,,,CACNG2,Efficacy,1,lithium,981419775.0,European
1448603457,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,pantoprazole,1448603459.0,Near Eastern
1448603457,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,pantoprazole,1448603459.0,Near Eastern
1448603457,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,pantoprazole,1448603459.0,Near Eastern
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407891.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407888.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407900.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407889.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407890.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407901.0,"Multiple groups, Participants were African American or non-Hispanic white"
1451407844,PA166156027,rs6269,,,COMT,Efficacy,1,butorphanol,1451407887.0,"Multiple groups, Participants were African American or non-Hispanic white"
1449714449,PA166177545,rs6766410,,,HTR3C,Dosage,-1,opioids,1449714452.0,European
1449714449,PA166177545,rs6766410,,,HTR3C,Dosage,-1,opioids,1449714451.0,European
1450664729,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,prasugrel,1450664740.0,East Asian
1450664729,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,prasugrel,1450664740.0,East Asian
1450664729,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,prasugrel,1450664740.0,East Asian
1448259384,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1448259386.0,Unknown
1448259384,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1448259386.0,Unknown
1448259384,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1448259386.0,Unknown
1451956000,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1451956005.0,East Asian
981862151,PA166156085,rs2075507,,,COMT,Dosage,1,morphine,981862159.0,European
981862151,PA166156085,rs2075507,,,COMT,Efficacy,1,morphine,981862159.0,European
1447520463,,,PA165819171,CYP1A2*1A,CYP1A2,Metabolism/PK,1,quetiapine,1447520474.0,European
1447520463,,,PA165819173,CYP1A2*1C,CYP1A2,Metabolism/PK,1,quetiapine,1447520474.0,European
1447520463,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,1,quetiapine,1447520474.0,European
1451956020,PA166153639,rs1800871,,,IL10,Metabolism/PK,1,tacrolimus,1451956025.0,East Asian
1451956020,PA166153639,rs1800871,,,IL10,Metabolism/PK,1,tacrolimus,1451956025.0,East Asian
1451956020,PA166153639,rs1800871,,,IL10,Metabolism/PK,1,tacrolimus,1451956025.0,East Asian
1449714456,PA166177547,rs6807362,,,HTR3C,Dosage,-1,opioids,1449714459.0,European
1449714456,PA166177547,rs6807362,,,HTR3C,Dosage,-1,opioids,1449714458.0,European
981501779,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,-1,carbamazepine,981501788.0,"Multiple groups, African Americans and Caucasians"
981501779,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,-1,carbamazepine,981501790.0,European
981501779,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,-1,carbamazepine,981501789.0,African American/Afro-Caribbean
1448993587,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,haloperidol,1448993606.0,Unknown
1448993587,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,haloperidol,1448993617.0,Unknown
1184748403,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,1,ritonavir,1184748408.0,"Multiple groups, 30 Caucasian, 5 African"
981862234,PA166156089,rs2239393,,,COMT,Dosage,1,morphine,981862242.0,European
981862234,PA166156089,rs2239393,,,COMT,Efficacy,1,morphine,981862242.0,European
1184748409,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,1,ritonavir,1184748414.0,"Multiple groups, 30 Caucasian, 5 African"
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107180.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107242.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107241.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107260.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107220.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107240.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107200.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,1451107181.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107180.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107242.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107241.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107260.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107220.0,European
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107240.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107200.0,African American/Afro-Caribbean
1451107160,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,1451107181.0,European
1449157431,PA166155393,rs2279343,,,CYP2B6,Efficacy,1,cyclophosphamide,1449157433.0,East Asian
1451956843,PA166154726,rs7997012,,,HTR2A,Efficacy,1,fluoxetine,1451956848.0,Unknown
1451956843,PA166154726,rs7997012,,,HTR2A,Efficacy,1,fluoxetine,1451956848.0,Unknown
981501792,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,carbamazepine,981501798.0,African American/Afro-Caribbean
981501792,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,carbamazepine,981501799.0,European
1447980818,,,PA166117588,UGT1A4*1a,UGT1A4,Efficacy,1,testosterone,1447980820.0,"Custom, Non human cell line"
1447980818,,,PA166117598,UGT1A4*3a,UGT1A4,Efficacy,1,testosterone,1447980820.0,"Custom, Non human cell line"
1447980818,,,PA166117588,UGT1A4*1a,UGT1A4,Metabolism/PK,1,testosterone,1447980820.0,"Custom, Non human cell line"
1447980818,,,PA166117598,UGT1A4*3a,UGT1A4,Metabolism/PK,1,testosterone,1447980820.0,"Custom, Non human cell line"
981419860,PA166155017,rs1800566,,,NQO1,Efficacy,1,epirubicin,981419872.0,Unknown
981419860,PA166155017,rs1800566,,,NQO1,Toxicity,1,epirubicin,981419872.0,Unknown
1451962640,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,n-desmethyltamoxifen,1451962783.0,Unknown
981862244,PA166156049,rs174699,,,ARVCF,Dosage,1,morphine,981862252.0,European
981862244,PA166156049,rs174699,,,COMT,Dosage,1,morphine,981862252.0,European
981862244,PA166156049,rs174699,,,ARVCF,Efficacy,1,morphine,981862252.0,European
981862244,PA166156049,rs174699,,,COMT,Efficacy,1,morphine,981862252.0,European
981862244,PA166156049,rs174699,,,COMT,Efficacy,1,morphine,981862252.0,European
1448636182,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,0,efavirenz,1448636184.0,Sub-Saharan African
1449157437,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,cyclophosphamide,1449157439.0,East Asian
1449157437,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,cyclophosphamide,1449157439.0,East Asian
981501801,PA166157386,rs4148739,,,ABCB1,Metabolism/PK,1,carbamazepine,981501806.0,African American/Afro-Caribbean
981501801,PA166157386,rs4148739,,,ABCB1,Metabolism/PK,1,carbamazepine,981501807.0,European
981501801,PA166157386,rs4148739,,,ABCB1,Metabolism/PK,1,carbamazepine,981501806.0,African American/Afro-Caribbean
981501801,PA166157386,rs4148739,,,ABCB1,Metabolism/PK,1,carbamazepine,981501807.0,European
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,atenolol,1451107133.0,Latino
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,atenolol,1451107131.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,atenolol,1451107132.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,atenolol,1451107129.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,atenolol,1451107130.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,metoprolol,1451107133.0,Latino
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,metoprolol,1451107131.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,metoprolol,1451107132.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,metoprolol,1451107129.0,African American/Afro-Caribbean
1451107121,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,metoprolol,1451107130.0,African American/Afro-Caribbean
1184469900,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,prasugrel,1184469902.0,European
1184469900,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,prasugrel,1184469902.0,European
1184469900,,,PA165816524,CYP2C19*8,CYP2C19,Efficacy,-1,prasugrel,1184469902.0,European
1184469900,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,prasugrel,1184469902.0,European
1184469900,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,prasugrel,1184469902.0,European
1184469900,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,prasugrel,1184469902.0,European
1184469900,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,-1,prasugrel,1184469902.0,European
1184469900,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,prasugrel,1184469902.0,European
1451408820,PA166156111,rs5030655,,,CYP2D6,Efficacy,-1,atorvastatin,1451408824.0,Unknown
1451408820,PA166156111,rs5030655,,,CYP2D6,Efficacy,-1,rosuvastatin,1451408824.0,Unknown
1451408820,PA166156111,rs5030655,,,CYP2D6,Efficacy,-1,simvastatin,1451408824.0,Unknown
1451408825,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,atorvastatin,1451408829.0,Unknown
1451408825,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,rosuvastatin,1451408829.0,Unknown
1451408825,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,simvastatin,1451408829.0,Unknown
1451962920,PA166154465,rs12422149,,,SLCO2B1,Metabolism/PK,1,tamoxifen,1451962940.0,Unknown
1448259332,PA166155341,rs7412,,,APOE,Dosage,0,acenocoumarol,1448259351.0,Unknown
981862203,PA166156024,rs4680,,,COMT,Dosage,1,morphine,981862216.0,European
981862203,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,981862216.0,European
1447980797,,,PA166117588,UGT1A4*1a,UGT1A4,Efficacy,-1,tamoxifen,1447980799.0,"Custom, Non human cell line"
1447980797,,,PA166117597,UGT1A4*2,UGT1A4,Efficacy,-1,tamoxifen,1447980799.0,"Custom, Non human cell line"
1447980797,,,PA166117598,UGT1A4*3a,UGT1A4,Efficacy,-1,tamoxifen,1447980799.0,"Custom, Non human cell line"
1447980797,,,PA166117588,UGT1A4*1a,UGT1A4,Metabolism/PK,-1,tamoxifen,1447980799.0,"Custom, Non human cell line"
1447980797,,,PA166117597,UGT1A4*2,UGT1A4,Metabolism/PK,-1,tamoxifen,1447980799.0,"Custom, Non human cell line"
1447980797,,,PA166117598,UGT1A4*3a,UGT1A4,Metabolism/PK,-1,tamoxifen,1447980799.0,"Custom, Non human cell line"
1184748428,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,1,ethanol,1184748432.0,"Multiple groups, Caucasian (n=27), Asian (n=3), East Indian (n=3), Black (n=2), Native North American (n=1), mixed race (n=4)"
1184748428,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,1,ethanol,1184748434.0,"Multiple groups, Caucasian (n=27), Asian (n=3), East Indian (n=3), Black (n=2), Native North American (n=1), mixed race (n=4)"
1184748428,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,1,ethanol,1184748453.0,"Multiple groups, Caucasian (n=27), Asian (n=3), East Indian (n=3), Black (n=2), Native North American (n=1), mixed race (n=4)"
1448259338,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1448259353.0,Unknown
1448259338,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1448259353.0,Unknown
1449714526,PA166179949,rs2551038,,,HINT1,Dosage,-1,opioids,1449714528.0,European
1449714526,PA166179949,rs2551038,,,HINT1,Dosage,-1,opioids,1449714529.0,European
1451408830,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,atorvastatin,1451408834.0,Unknown
1451408830,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,rosuvastatin,1451408834.0,Unknown
1451408830,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,simvastatin,1451408834.0,Unknown
981501753,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,981501763.0,African American/Afro-Caribbean
981501753,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,981501764.0,European
981862194,PA166156027,rs6269,,,COMT,Dosage,1,morphine,981862201.0,European
981862194,PA166156027,rs6269,,,COMT,Efficacy,1,morphine,981862201.0,European
1448259328,PA166155381,rs2108622,,,CYP4F2,Dosage,0,acenocoumarol,1448259349.0,Unknown
1447980787,,,PA166117588,UGT1A4*1a,UGT1A4,Efficacy,-1,testosterone,1447980789.0,"Custom, Non human cell line"
1447980787,,,PA166117597,UGT1A4*2,UGT1A4,Efficacy,-1,testosterone,1447980789.0,"Custom, Non human cell line"
1447980787,,,PA166117588,UGT1A4*1a,UGT1A4,Metabolism/PK,-1,testosterone,1447980789.0,"Custom, Non human cell line"
1447980787,,,PA166117597,UGT1A4*2,UGT1A4,Metabolism/PK,-1,testosterone,1447980789.0,"Custom, Non human cell line"
981862218,PA166156025,rs4818,,,COMT,Dosage,1,morphine,981862232.0,European
981862218,PA166156025,rs4818,,,COMT,Efficacy,1,morphine,981862232.0,European
1446735619,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,sunitinib,1446736703.0,"Multiple groups, Chinese, Indian, Malay"
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,atorvastatin,1451408100.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,atorvastatin,1451408620.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,atorvastatin,1451408140.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,atorvastatin,1451408142.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,atorvastatin,1451408621.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,rosuvastatin,1451408100.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,rosuvastatin,1451408620.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,rosuvastatin,1451408140.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,rosuvastatin,1451408142.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,rosuvastatin,1451408621.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,simvastatin,1451408100.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,simvastatin,1451408620.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,simvastatin,1451408140.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,simvastatin,1451408142.0,Unknown
1451408080,PA166157744,rs2230806,,,ABCA1,Efficacy,1,simvastatin,1451408621.0,Unknown
1446899452,PA166155135,rs71647871,,,CES1,Metabolism/PK,-1,quinapril,1446899455.0,European
1446899452,PA166155135,rs71647871,,,CES1,Metabolism/PK,-1,quinapril,1446899454.0,European
1446899465,PA166155135,rs71647871,,,CES1,Metabolism/PK,-1,quinapril,1446899467.0,European
1451408101,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,atorvastatin,1451408105.0,Unknown
1451408101,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,rosuvastatin,1451408105.0,Unknown
1451408101,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,simvastatin,1451408105.0,Unknown
1449714519,PA166179948,rs3852209,,,HINT1,Dosage,-1,opioids,1449714522.0,European
1449714519,PA166179948,rs3852209,,,HINT1,Dosage,-1,opioids,1449714521.0,European
1184174892,PA166154933,rs11853372,,,SLC28A1,Metabolism/PK,-1,gemcitabine,1184174909.0,Unknown
981747522,PA166155276,rs1008899,,,NEDD4L,Efficacy,-1,atenolol,981747533.0,European
981747522,PA166155276,rs1008899,,,NEDD4L,Efficacy,-1,atenolol,981747533.0,European
1184174895,PA166157777,rs4877831,,,SLC28A3,Metabolism/PK,-1,gemcitabine,1184174903.0,Unknown
981501842,PA166154047,rs4148386,,,ABCC2,Metabolism/PK,1,carbamazepine,981501848.0,African American/Afro-Caribbean
981501842,PA166154047,rs4148386,,,ABCC2,Metabolism/PK,1,carbamazepine,981501849.0,European
1184748337,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,citalopram,1184748339.0,"Multiple groups, Asian and White"
1184748337,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,citalopram,1184748339.0,"Multiple groups, Asian and White"
1184748337,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1184748339.0,"Multiple groups, Asian and White"
1184748337,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,escitalopram,1184748339.0,"Multiple groups, Asian and White"
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,atorvastatin,1451408160.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,atorvastatin,1451408141.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,atorvastatin,1451408110.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,rosuvastatin,1451408160.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,rosuvastatin,1451408141.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,rosuvastatin,1451408110.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,simvastatin,1451408160.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,simvastatin,1451408141.0,Unknown
1451408106,PA166156167,rs35742686,,,CYP2D6,Efficacy,-1,simvastatin,1451408110.0,Unknown
1451156368,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,quetiapine,1451156400.0,European
1451156368,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,-1,quetiapine,1451156400.0,European
1451156368,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,quetiapine,1451156400.0,European
1451156368,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,-1,quetiapine,1451156400.0,European
1447964381,PA166156283,rs275651,,,AGTR1,Efficacy,1,perindopril,1447964440.0,European
1448993645,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,-1,haloperidol,1448993651.0,European
981501851,PA166156423,rs7643645,,,NR1I2,Metabolism/PK,1,carbamazepine,981501858.0,"Multiple groups, African Americans and Caucasians"
1451408180,PA166154993,rs708272,,,CETP,Efficacy,1,rosuvastatin,1451408740.0,Unknown
1451408180,PA166154993,rs708272,,,CETP,Efficacy,1,rosuvastatin,1451408161.0,Unknown
1451408180,PA166154993,rs708272,,,CETP,Efficacy,1,rosuvastatin,1451408760.0,Unknown
1451408800,PA166154975,rs5882,,,CETP,Efficacy,1,rosuvastatin,1451408805.0,Unknown
1451408800,PA166154975,rs5882,,,CETP,Efficacy,1,rosuvastatin,1451408804.0,Unknown
1449714559,PA166179955,rs4264931,,,HTR4,Dosage,-1,opioids,1449714561.0,European
1449714559,PA166179955,rs4264931,,,HTR4,Dosage,-1,opioids,1449714562.0,European
1449714559,PA166179955,rs4264931,,,HTR4,Dosage,-1,opioids,1449714561.0,European
1449714559,PA166179955,rs4264931,,,HTR4,Dosage,-1,opioids,1449714562.0,European
1449714566,PA166179956,rs2068190,,,HTR4,Dosage,-1,opioids,1449714569.0,European
1449714566,PA166179956,rs2068190,,,HTR4,Dosage,-1,opioids,1449714568.0,European
1447980777,,,PA166117588,UGT1A4*1a,UGT1A4,Efficacy,1,lamotrigine,1447980779.0,"Custom, Non human cell line"
1447980777,,,PA166117597,UGT1A4*2,UGT1A4,Efficacy,1,lamotrigine,1447980779.0,"Custom, Non human cell line"
1447980777,,,PA166117598,UGT1A4*3a,UGT1A4,Efficacy,1,lamotrigine,1447980779.0,"Custom, Non human cell line"
1447980777,,,PA166117588,UGT1A4*1a,UGT1A4,Metabolism/PK,1,lamotrigine,1447980779.0,"Custom, Non human cell line"
1447980777,,,PA166117597,UGT1A4*2,UGT1A4,Metabolism/PK,1,lamotrigine,1447980779.0,"Custom, Non human cell line"
1447980777,,,PA166117598,UGT1A4*3a,UGT1A4,Metabolism/PK,1,lamotrigine,1447980779.0,"Custom, Non human cell line"
1448259292,PA166157143,rs9340799,,,ESR1,Efficacy,-1,raloxifene,1448259294.0,Unknown
982042511,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982042519.0,East Asian
1451409400,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,phenytoin,1451409406.0,Latino
1451409400,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,phenytoin,1451409406.0,Latino
1451409400,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,phenytoin,1451409406.0,Latino
1447980773,PA166157518,rs77010898,,,CFTR,Efficacy,1,curcumin,,
1447980773,PA166157518,rs77010898,,,CFTR,Efficacy,1,ivacaftor,,
1448259299,PA166157000,rs1801132,,,ESR1,Efficacy,-1,raloxifene,1448259301.0,Unknown
981862284,PA166155134,rs61742245,,,VKORC1,Dosage,1,warfarin,981862295.0,Near Eastern
1450664831,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1450664841.0,European
1450664831,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1450664841.0,European
1184748352,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,ritonavir,1184748357.0,"Multiple groups, 30 Caucasian, 5 African"
1184748352,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,ritonavir,1184748371.0,"Multiple groups, 30 Caucasian, 5 African"
1450812316,PA166154261,rs6277,,,DRD2,Efficacy,1,nicotine,1450812320.0,European
1450812316,PA166154261,rs6277,,,DRD2,Efficacy,1,nicotine,1450812327.0,European
1448993666,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,efavirenz,1448993668.0,East Asian
1451409502,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451409520.0,Unknown
1451409502,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451409520.0,Unknown
1448308434,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448308436.0,East Asian
981501862,PA166156357,rs2461817,,,NR1I2,Metabolism/PK,1,carbamazepine,981501869.0,"Multiple groups, African Americans and Caucasians"
1450943400,PA166154367,rs2306168,,,SLCO2B1,Metabolism/PK,-1,atenolol,1450943420.0,Unknown
1449714552,PA166179954,rs1971431,,,HTR4,Dosage,-1,opioids,1449714554.0,European
1449714552,PA166179954,rs1971431,,,HTR4,Dosage,-1,opioids,1449714555.0,European
1449714552,PA166179954,rs1971431,,,HTR4,Dosage,-1,opioids,1449714554.0,European
1449714552,PA166179954,rs1971431,,,HTR4,Dosage,-1,opioids,1449714555.0,European
1451409603,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,3-hydroxycotinine,1451409640.0,Unknown
1451409603,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,3-hydroxycotinine,1451409640.0,Unknown
1451409712,PA166238022,rs12471326,,,UGT1A9,Metabolism/PK,1,cotinine glucuronide,1451409716.0,Unknown
1451409712,PA166238022,rs12471326,,,UGT1A9,Metabolism/PK,1,cotinine glucuronide,1451409716.0,Unknown
1184469836,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,aspirin,1184469838.0,East Asian
1184469836,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,aspirin,1184469838.0,East Asian
1184469836,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,aspirin,1184469838.0,East Asian
1184469836,,,PA165980636,CYP2C19*3,CYP2C19,Toxicity,-1,aspirin,1184469838.0,East Asian
1184469836,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,clopidogrel,1184469838.0,East Asian
1184469836,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1184469838.0,East Asian
1184469836,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,clopidogrel,1184469838.0,East Asian
1184469836,,,PA165980636,CYP2C19*3,CYP2C19,Toxicity,-1,clopidogrel,1184469838.0,East Asian
981862265,PA166156948,rs760761,,,DTNBP1,Efficacy,-1,citalopram,981862274.0,European
1449714590,PA166179962,rs12720071,,,CNR1,Dosage,-1,opioids,1449714593.0,European
1449714590,PA166179962,rs12720071,,,CNR1,Dosage,-1,opioids,1449714592.0,European
981501809,PA166157387,rs4148740,,,ABCB1,Metabolism/PK,1,carbamazepine,981501814.0,African American/Afro-Caribbean
981501809,PA166157387,rs4148740,,,ABCB1,Metabolism/PK,1,carbamazepine,981501815.0,European
1183634307,PA166157463,rs13223171,,,CNTNAP2,Efficacy,-1,diuretics,1183634309.0,European
1183634307,PA166157463,rs13223171,,,CNTNAP2,Efficacy,-1,diuretics,1183634310.0,European
1183634307,PA166157463,rs13223171,,,CNTNAP2,Efficacy,-1,hydrochlorothiazide,1183634309.0,European
1183634307,PA166157463,rs13223171,,,CNTNAP2,Efficacy,-1,hydrochlorothiazide,1183634310.0,European
1183634307,PA166157463,rs13223171,,,CNTNAP2,Efficacy,-1,"Thiazides, plain",1183634309.0,European
1183634307,PA166157463,rs13223171,,,CNTNAP2,Efficacy,-1,"Thiazides, plain",1183634310.0,European
1451409700,PA166238001,rs145014075,,,CYP2A6,Metabolism/PK,1,nicotine,1451409704.0,Unknown
1451409980,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,everolimus,1451410000.0,Unknown
1183699837,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183699845.0,Latino
1183699837,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1183699845.0,Latino
981747566,PA166155333,rs75982813,,,NEDD4L,Efficacy,1,hydrochlorothiazide,981747569.0,European
982035504,PA166154993,rs708272,,,CETP,Efficacy,1,atorvastatin,982035511.0,Multiple groups
1183634313,PA166157712,rs689979,,,ERCC6L2,Efficacy,-1,diuretics,1183634315.0,European
1183634313,PA166157712,rs689979,,,ERCC6L2,Efficacy,-1,diuretics,1183634316.0,European
1183634313,PA166157712,rs689979,,,ERCC6L2,Efficacy,-1,hydrochlorothiazide,1183634315.0,European
1183634313,PA166157712,rs689979,,,ERCC6L2,Efficacy,-1,hydrochlorothiazide,1183634316.0,European
1183634313,PA166157712,rs689979,,,ERCC6L2,Efficacy,-1,"Thiazides, plain",1183634315.0,European
1183634313,PA166157712,rs689979,,,ERCC6L2,Efficacy,-1,"Thiazides, plain",1183634316.0,European
981501817,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,carbamazepine,981501825.0,European
981501817,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,carbamazepine,981501824.0,African American/Afro-Caribbean
981862254,PA166156047,rs165728,,,ARVCF,Dosage,1,morphine,981862263.0,European
981862254,PA166156047,rs165728,,,COMT,Dosage,1,morphine,981862263.0,European
981862254,PA166156047,rs165728,,,ARVCF,Efficacy,1,morphine,981862263.0,European
981862254,PA166156047,rs165728,,,COMT,Efficacy,1,morphine,981862263.0,European
1451410001,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,everolimus,1451410008.0,Unknown
1448259252,PA166155614,rs1042597,,,UGT1A8,Efficacy,1,raloxifene,1448259276.0,Unknown
1449714573,PA166179957,rs1862342,,,HTR4,Dosage,-1,opioids,1449714575.0,European
1449714573,PA166179957,rs1862342,,,HTR4,Dosage,-1,opioids,1449714576.0,European
1446897275,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1446897277.0,Unknown
1446897275,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1446897277.0,Unknown
1446897275,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1446897277.0,Unknown
1447947949,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,atenolol,1447947951.0,European
1447947949,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,atenolol,1447947952.0,European
1451966240,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,rivaroxaban,1451966245.0,East Asian
1184469857,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184469881.0,European
1184469857,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184469881.0,European
1184469857,,,PA165816524,CYP2C19*8,CYP2C19,Efficacy,1,clopidogrel,1184469881.0,European
1184469857,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1184469881.0,European
1184469857,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1184469881.0,European
1184469857,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1184469881.0,European
1184469857,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,1,clopidogrel,1184469881.0,European
1184469857,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,clopidogrel,1184469881.0,European
981501834,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,carbamazepine,981501839.0,"Multiple groups, African American and Caucasian."
1448259259,PA166155091,rs9923231,,,VKORC1,Dosage,0,acenocoumarol,1448259266.0,Unknown
1448259259,PA166155091,rs9923231,,,VKORC1,Dosage,0,acenocoumarol,1448259264.0,Unknown
1448259259,PA166155091,rs9923231,,,VKORC1,Dosage,0,phenprocoumon,1448259266.0,Unknown
1448259259,PA166155091,rs9923231,,,VKORC1,Dosage,0,phenprocoumon,1448259264.0,Unknown
1448993707,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1448993709.0,Central/South Asian
1451156360,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,quetiapine,1451156380.0,European
1451156360,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,quetiapine,1451156380.0,European
1451156360,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,quetiapine,1451156380.0,European
1450812294,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,nicotine,1450812298.0,European
1450812294,PA166154339,rs1800497,,,DRD2,Efficacy,-1,nicotine,1450812298.0,European
1449714583,PA166156953,rs806368,,,CNR1,Dosage,-1,opioids,1449714585.0,European
1449714583,PA166156953,rs806368,,,CNR1,Dosage,-1,opioids,1449714586.0,European
1450664844,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1450664854.0,European
1450664844,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1450664854.0,European
1451270680,PA166156024,rs4680,,,COMT,Efficacy,1,bupropion,1451270685.0,"Multiple groups, USA: 86% white"
981501905,PA166156110,rs4823613,,,PPARA,Efficacy,-1,simvastatin,981501911.0,East Asian
1449714623,PA166156991,rs1799971,,,OPRM1,Dosage,-1,opioids,1449714626.0,European
1449714623,PA166156991,rs1799971,,,OPRM1,Dosage,-1,opioids,1449714625.0,European
1450812368,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,nimodipine,1450812372.0,Unknown
982042579,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982042600.0,East Asian
1184470005,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1184470009.0,European
1449714630,PA166157164,rs9479757,,,OPRM1,Dosage,-1,opioids,1449714633.0,European
1449714630,PA166157164,rs9479757,,,OPRM1,Dosage,-1,opioids,1449714632.0,European
1448308386,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,tacrolimus,1448308394.0,Unknown
1450812373,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,nimodipine,1450812377.0,Unknown
1449157557,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1449157566.0,East Asian
1449157557,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1449157566.0,East Asian
1449157557,,,PA165971603,CYP2D6*49,CYP2D6,Metabolism/PK,1,dextromethorphan,1449157566.0,East Asian
1184748535,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1184748537.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748535,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1184748537.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748535,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1184748537.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748535,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1184748537.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184470013,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,1184470015.0,European
1449157567,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,dextromethorphan,1449157574.0,East Asian
1449157567,,,PA165971603,CYP2D6*49,CYP2D6,Metabolism/PK,-1,dextromethorphan,1449157574.0,East Asian
1449157567,,,PA165971603,CYP2D6*49,CYP2D6,Metabolism/PK,-1,dextromethorphan,1449157574.0,East Asian
1450812385,PA166154534,rs2239050,,,CACNA1C,Efficacy,1,nimodipine,1450812389.0,Unknown
1450812390,PA166154533,rs2238032,,,CACNA1C,Efficacy,-1,nimodipine,1450812394.0,Unknown
1449157575,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,dextromethorphan,1449157586.0,East Asian
1449157575,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,dextromethorphan,1449157586.0,East Asian
1449157575,,,PA165971603,CYP2D6*49,CYP2D6,Metabolism/PK,0,dextromethorphan,1449157586.0,East Asian
1449157575,,,PA165971606,CYP2D6*52,CYP2D6,Metabolism/PK,0,dextromethorphan,1449157586.0,East Asian
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107272.0,African American/Afro-Caribbean
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107273.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107271.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107274.0,African American/Afro-Caribbean
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107307.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107320.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,atenolol,1451107270.0,African American/Afro-Caribbean
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107272.0,African American/Afro-Caribbean
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107273.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107271.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107274.0,African American/Afro-Caribbean
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107307.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107320.0,European
1451107302,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,metoprolol,1451107270.0,African American/Afro-Caribbean
1449157587,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1449157596.0,East Asian
1449157587,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1449157596.0,East Asian
1449157587,,,PA165971603,CYP2D6*49,CYP2D6,Metabolism/PK,1,dextromethorphan,1449157596.0,East Asian
1448308356,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448308368.0,Unknown
1448308356,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448308368.0,Unknown
1451156401,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,quetiapine,1451156405.0,European
981501871,PA166156402,rs4688040,,,NR1I2,Metabolism/PK,1,carbamazepine,981501878.0,"Multiple groups, African Americans and Caucasians"
1447964285,PA166156491,rs734644,,,ADGRL3,Efficacy,1,methylphenidate,1447964287.0,"Multiple groups, European-Brazilian and African-Brazilian"
1184470036,PA166154053,rs4244285,,,CYP2C19,Dosage,1,clopidogrel,1184470051.0,"Multiple groups, out of an initial 40 patients(2 of whom did not complete the study), there were 35 Caucasian,2 Maori,2 Fijian Indian and 1 Chinese from the Australian New Zealand Clinical Trials registry."
1184470036,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1184470051.0,"Multiple groups, out of an initial 40 patients(2 of whom did not complete the study), there were 35 Caucasian,2 Maori,2 Fijian Indian and 1 Chinese from the Australian New Zealand Clinical Trials registry."
1447947908,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,irbesartan,1447947944.0,European
1447947908,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,irbesartan,1447947947.0,European
1449714658,PA166179968,rs1323042,,,OPRM1,Dosage,-1,opioids,1449714660.0,European
1449714658,PA166179968,rs1323042,,,OPRM1,Dosage,-1,opioids,1449714661.0,European
1184175032,PA166153667,rs2072671,,,CDA,Metabolism/PK,1,gemcitabine,1184175040.0,Unknown
1451254722,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,citalopram,1451254740.0,East Asian
1451254722,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,citalopram,1451254740.0,East Asian
1451254722,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,fluoxetine,1451254740.0,East Asian
1451254722,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluoxetine,1451254740.0,East Asian
1451254722,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,paroxetine,1451254740.0,East Asian
1451254722,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1451254740.0,East Asian
981501889,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,1,carbamazepine,981501893.0,African American/Afro-Caribbean
981501889,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,1,carbamazepine,981501894.0,European
1449714665,PA166179969,rs618207,,,OPRM1,Dosage,-1,opioids,1449714667.0,European
1449714665,PA166179969,rs618207,,,OPRM1,Dosage,-1,opioids,1449714668.0,European
1449714637,PA166178596,rs540825,,,OPRM1,Dosage,-1,opioids,1449714639.0,European
1449714637,PA166178596,rs540825,,,OPRM1,Dosage,-1,opioids,1449714640.0,European
1451973946,PA166156339,rs2046934,,,P2RY12,Efficacy,-1,clopidogrel,1451973951.0,East Asian
1043859096,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165948317,CYP2D6*9,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165816582,CYP2D6*10,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165816583,CYP2D6*17,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165948318,CYP2D6*29,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165988489,CYP2D6*45,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165971600,CYP2D6*46,CYP2D6,Toxicity,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165988489,CYP2D6*45,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859096,,,PA165971600,CYP2D6*46,CYP2D6,Metabolism/PK,1,metoprolol,1043859098.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107266.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107269.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107300.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107281.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107268.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107280.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107301.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,1451107267.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107266.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107269.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107300.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107281.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107268.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107280.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107301.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107267.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107266.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107269.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107300.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107281.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107268.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107280.0,African American/Afro-Caribbean
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107301.0,European
1451107261,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,1451107267.0,European
1451973700,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1451973740.0,East Asian
1451973700,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1451973740.0,East Asian
1447964271,PA166156510,rs1355368,,,ADGRL3,Efficacy,1,methylphenidate,1447964273.0,"Multiple groups, European-Brazilian and African-Brazilian"
1451973760,PA166156418,rs6809699,,,P2RY12,Efficacy,1,clopidogrel,1451973741.0,East Asian
1451973760,PA166156418,rs6809699,,,P2RY12,Efficacy,1,clopidogrel,1451973741.0,East Asian
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107340.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107324.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107341.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107308.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107310.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107325.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107311.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,atenolol,1451107309.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107340.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107324.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107341.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107308.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107310.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107325.0,European
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107311.0,African American/Afro-Caribbean
1451107275,PA166154486,rs5443,,,GNB3,Efficacy,-1,metoprolol,1451107309.0,European
1449714644,PA166179966,rs562859,,,OPRM1,Dosage,-1,opioids,1449714646.0,European
1449714644,PA166179966,rs562859,,,OPRM1,Dosage,-1,opioids,1449714647.0,European
1451140040,PA166182404,rs2153628,,,CYP2C9,Efficacy,1,indomethacin,1451140060.0,Multiple groups
981419976,PA166157316,rs2032582,,,ABCB1,Efficacy,0,antipsychotics,981419986.0,Central/South Asian
1451411060,PA166238462,rs1051792,,,MICA,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451411068.0,European
1183634361,PA166155885,rs56294817,,,HES6,Efficacy,-1,citalopram,1183634363.0,Unknown
1183634361,PA166155885,rs56294817,,,HES6,Efficacy,-1,fluoxetine,1183634363.0,Unknown
1183634361,PA166155885,rs56294817,,,HES6,Efficacy,-1,paroxetine,1183634363.0,Unknown
1449714651,PA166179967,rs548646,,,OPRM1,Dosage,-1,opioids,1449714653.0,European
1449714651,PA166179967,rs548646,,,OPRM1,Dosage,-1,opioids,1449714654.0,European
1451973940,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1451973921.0,East Asian
1451973940,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1451973921.0,East Asian
1447964257,PA166156607,rs6813183,,,ADGRL3,Efficacy,1,methylphenidate,1447964259.0,"Multiple groups, European-Brazilian and African-Brazilian"
1184469934,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184469936.0,European
1184469934,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184469936.0,European
1184469934,,,PA165816524,CYP2C19*8,CYP2C19,Efficacy,1,clopidogrel,1184469936.0,European
1184469934,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1184469936.0,European
1184469934,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1184469936.0,European
1184469934,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1184469936.0,European
1184469934,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,1,clopidogrel,1184469936.0,European
1184469934,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,clopidogrel,1184469936.0,European
1451411069,PA166238462,rs1051792,,,MICA,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451411074.0,European
1183699996,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1183700016.0,"Multiple groups, 93% White"
1183699996,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,escitalopram,1183700016.0,"Multiple groups, 93% White"
1183699996,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,escitalopram,1183700016.0,"Multiple groups, 93% White"
1183699996,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,escitalopram,1183700016.0,"Multiple groups, 93% White"
1183699996,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,escitalopram,1183700016.0,"Multiple groups, 93% White"
1144135755,PA166156276,rs5186,,,AGTR1,Efficacy,1,losartan,1144583577.0,Unknown
1450812440,PA166156991,rs1799971,,,OPRM1,Dosage,-1,opioids,1450812446.0,Multiple groups
1450812440,PA166156991,rs1799971,,,OPRM1,Dosage,-1,opioids,1450812446.0,Multiple groups
1184748470,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1184748491.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748470,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1184748491.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748470,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1184748491.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748470,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1184748491.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1447947879,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,irbesartan,1447947889.0,East Asian
1447947879,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,irbesartan,1447947891.0,East Asian
1447947879,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,irbesartan,1447947887.0,East Asian
1447947879,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,irbesartan,1447947885.0,East Asian
1449714698,PA166157284,rs1045642,,,ABCB1,Dosage,-1,opioids,1449714701.0,European
1449714698,PA166157284,rs1045642,,,ABCB1,Dosage,-1,opioids,1449714700.0,European
1183699984,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183699986.0,Multiple groups
1183699984,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1183699986.0,Multiple groups
1449747466,PA166155096,rs9934438,,,VKORC1,Dosage,1,phenprocoumon,1449747471.0,"Multiple groups, Netherlands, describe cohort as 85.4% ""European ethnicity"""
1449747466,PA166155096,rs9934438,,,VKORC1,Dosage,1,phenprocoumon,1449747471.0,"Multiple groups, Netherlands, describe cohort as 85.4% ""European ethnicity"""
1447964243,PA166156531,rs1947275,,,ADGRL3,Efficacy,-1,methylphenidate,1447964245.0,"Multiple groups, European-Brazilian and African-Brazilian"
1447964243,PA166156531,rs1947275,,,ADGRL3,Efficacy,-1,methylphenidate,1447964245.0,"Multiple groups, European-Brazilian and African-Brazilian"
1451411280,PA166238581,rs3781727,,,SLCO2B1,Metabolism/PK,0,voriconazole,1451411300.0,Unknown
1451411342,PA166156099,rs2298383,,,ADORA2A,Efficacy,-1,methotrexate,1451411347.0,Unknown
1445585209,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1445585215.0,European
1451411348,PA166156088,rs2236624,,,ADORA2A,Efficacy,-1,methotrexate,1451411360.0,Unknown
1451411377,PA166176812,rs1544223,,,ADORA3,Efficacy,-1,methotrexate,1451411422.0,Unknown
1450812447,PA166156991,rs1799971,,,OPRM1,Dosage,0,opioids,1450812452.0,Multiple groups
1184175124,PA166156554,rs2306744,,,DCK,Efficacy,1,cytarabine,1184175126.0,Unknown
1184175124,PA166156554,rs2306744,,,DCK,Efficacy,1,cytarabine,1184472875.0,Unknown
1184175124,PA166156554,rs2306744,,,DCK,Efficacy,1,idarubicin,1184175126.0,Unknown
1184175124,PA166156554,rs2306744,,,DCK,Efficacy,1,idarubicin,1184472875.0,Unknown
1184175124,PA166156554,rs2306744,,,DCK,Efficacy,1,idarubicin,1184175126.0,Unknown
1184175124,PA166156554,rs2306744,,,DCK,Efficacy,1,idarubicin,1184472875.0,Unknown
1444668324,PA166156988,rs1799724,,,TNF,Efficacy,1,etanercept,1444668330.0,East Asian
1447947867,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947875.0,East Asian
1447947867,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947878.0,East Asian
1451411361,PA166156118,rs5751876,,,ADORA2A,Efficacy,-1,methotrexate,1451411380.0,Unknown
1444703814,,,PA165980638,CYP2C19*5,CYP2C19,Metabolism/PK,-1,mephenytoin,,
1444703814,,,PA165980638,CYP2C19*5,CYP2C19,Metabolism/PK,-1,tolbutamide,,
1444703814,,,PA165980638,CYP2C19*5,CYP2C19,Metabolism/PK,-1,tolbutamide,,
1451159760,PA166157235,rs371194629,,,HLA-G,Efficacy,1,methotrexate,1451159765.0,
1043859051,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816578,CYP2D6*3,CYP2D6,Toxicity,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165948092,CYP2D6*5,CYP2D6,Toxicity,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816581,CYP2D6*6,CYP2D6,Toxicity,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859051,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,metoprolol,1043859053.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1451411372,PA166176808,rs2298191,,,ADORA3,Efficacy,-1,methotrexate,1451411386.0,Unknown
1451411423,PA166176809,rs3393,,,ADORA3,Efficacy,-1,methotrexate,1451411428.0,Unknown
1449714679,PA166179971,rs497976,,,OPRM1,Dosage,-1,opioids,1449714681.0,European
1449714679,PA166179971,rs497976,,,OPRM1,Dosage,-1,opioids,1449714682.0,European
1451159800,PA166211523,rs67624739,,,CHRNA5,Efficacy,-1,bupropion,1451159787.0,European
1451159800,PA166211523,rs67624739,,,CHRNA5,Efficacy,-1,nicotine,1451159787.0,European
1451159800,PA166211523,rs67624739,,,CHRNA5,Efficacy,-1,varenicline,1451159787.0,European
1451159800,PA166211523,rs67624739,,,CHRNA5,Efficacy,-1,varenicline,1451159787.0,European
1451205300,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451205340.0,"Multiple groups, Asian (n=126) and Caucasian (n=455)"
1451205300,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451205307.0,European
1451205300,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1451205320.0,"Multiple groups, Asian (n=126) and Caucasian (n=71)"
1451205300,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451205340.0,"Multiple groups, Asian (n=126) and Caucasian (n=455)"
1451205300,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451205307.0,European
1451205300,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451205320.0,"Multiple groups, Asian (n=126) and Caucasian (n=71)"
1451205300,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451205340.0,"Multiple groups, Asian (n=126) and Caucasian (n=455)"
1451205300,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451205307.0,European
1451205300,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1451205320.0,"Multiple groups, Asian (n=126) and Caucasian (n=71)"
1184748497,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,voriconazole,1184748499.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748497,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,-1,voriconazole,1184748499.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748497,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1184748499.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748497,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,voriconazole,1184748499.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1449714719,PA166157337,rs2235033,,,ABCB1,Dosage,-1,opioids,1449714722.0,European
1449714719,PA166157337,rs2235033,,,ABCB1,Dosage,-1,opioids,1449714721.0,European
1447947839,PA166154194,rs72558187,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947841.0,East Asian
1450320924,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,morphine,1450320926.0,Unknown
1450320924,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,morphine-3-glucuronide,1450320926.0,Unknown
1450320924,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,morphine-6-glucuronide,1450320926.0,Unknown
1451411381,PA166238642,rs17004921,,,ADORA2A-AS1,Efficacy,1,methotrexate,1451411503.0,Unknown
1451411381,PA166238642,rs17004921,,,ADORA2A-AS1,Efficacy,1,methotrexate,1451411371.0,Unknown
1451273761,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1451273820.0,Unknown
1451273761,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,esomeprazole,1451273820.0,Unknown
1451273860,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451273880.0,Unknown
1451273860,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,esomeprazole,1451273880.0,Unknown
1449714726,PA166157288,rs1128503,,,ABCB1,Dosage,-1,opioids,1449714729.0,European
1449714726,PA166157288,rs1128503,,,ABCB1,Dosage,-1,opioids,1449714728.0,European
1451273890,PA166224541,rs1059513,,,STAT6,Efficacy,1,esomeprazole,1451273900.0,Unknown
1183699973,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183699983.0,Multiple groups
1183699973,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1183699983.0,Multiple groups
1184748512,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1184748514.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748512,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1184748514.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748512,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1184748514.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1184748512,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1184748514.0,"Multiple groups, African (n=6), European (n=23), Hispanic (n=2), multiple race (n=2)"
1450320917,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,morphine,1450320923.0,Unknown
1450320917,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,morphine-3-glucuronide,1450320923.0,Unknown
1450320917,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,morphine-6-glucuronide,1450320923.0,Unknown
1447945228,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,1,irinotecan,1447945240.0,East Asian
1447945228,,,PA166115858,UGT1A1*6,UGT1A1,Dosage,1,irinotecan,1447945240.0,East Asian
1447945228,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,1,irinotecan,1447945240.0,East Asian
1449714705,PA166179981,rs4437575,,,ABCB1,Dosage,-1,opioids,1449714708.0,European
1449714705,PA166179981,rs4437575,,,ABCB1,Dosage,-1,opioids,1449714707.0,European
982042629,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982042641.0,East Asian
1449747475,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,phenprocoumon,1449747477.0,"Multiple groups, Netherlands, describe cohort as 85.4% ""European ethnicity"""
1449747475,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,phenprocoumon,1449747477.0,"Multiple groups, Netherlands, describe cohort as 85.4% ""European ethnicity"""
1449747475,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenprocoumon,1449747477.0,"Multiple groups, Netherlands, describe cohort as 85.4% ""European ethnicity"""
1449192662,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449192668.0,Unknown
1449192662,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449192668.0,Unknown
1451157820,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451157794.0,Unknown
1451157820,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,tramadol,1451157794.0,Unknown
1451208680,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,SN-38,1451208720.0,"Multiple groups, USA ""49 White, 18 Black, 7 Other"""
1451208680,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,SN-38,1451208720.0,"Multiple groups, USA ""49 White, 18 Black, 7 Other"""
1446899262,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1446899269.0,European
1446899262,,,PA165971614,CYP2D6*59,CYP2D6,Metabolism/PK,0,dextromethorphan,1446899269.0,European
1447947832,PA166154194,rs72558187,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947834.0,East Asian
1449714712,PA166157335,rs2235013,,,ABCB1,Dosage,-1,opioids,1449714715.0,European
1449714712,PA166157335,rs2235013,,,ABCB1,Dosage,-1,opioids,1449714714.0,European
1449157673,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449157675.0,East Asian
1450812426,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450812434.0,Unknown
1450812426,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450812432.0,Unknown
1450812426,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450812433.0,Unknown
1446899270,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,dextromethorphan,1446899277.0,European
1446899270,,,PA165971614,CYP2D6*59,CYP2D6,Metabolism/PK,0,dextromethorphan,1446899277.0,European
1184470125,PA166154255,rs5215,,,KCNJ11,Dosage,-1,gliclazide,1184470175.0,European
1184470125,PA166154255,rs5215,,,KCNJ11,Dosage,-1,glimepiride,1184470175.0,European
1184470125,PA166154255,rs5215,,,KCNJ11,Dosage,-1,glipizide,1184470175.0,European
1184470125,PA166154255,rs5215,,,KCNJ11,Dosage,-1,gliquidone,1184470175.0,European
1184470125,PA166154255,rs5215,,,KCNJ11,Dosage,-1,glyburide,1184470175.0,European
1183700066,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700091.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";1216 were *1/*2 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1183700066,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700091.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";1216 were *1/*2 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1451416180,PA166154673,rs6311,,,HTR2A,Efficacy,-1,antidepressants,1451416200.0,Unknown
1451414380,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1451414400.0,European
1451414380,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1451414400.0,European
1451414380,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,pantoprazole,1451414400.0,European
1184470130,PA166154256,rs5219,,,KCNJ11,Dosage,-1,gliclazide,1184470165.0,European
1184470130,PA166154256,rs5219,,,KCNJ11,Dosage,-1,glimepiride,1184470165.0,European
1184470130,PA166154256,rs5219,,,KCNJ11,Dosage,-1,glipizide,1184470165.0,European
1184470130,PA166154256,rs5219,,,KCNJ11,Dosage,-1,gliquidone,1184470165.0,European
1184470130,PA166154256,rs5219,,,KCNJ11,Dosage,-1,glyburide,1184470165.0,European
1451414440,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,pantoprazole,1451414445.0,European
1451416269,PA166154675,rs6313,,,HTR2A,Efficacy,1,antidepressants,1451416280.0,Unknown
1451416269,PA166154675,rs6313,,,HTR2A,Efficacy,1,antidepressants,1451416276.0,Unknown
1451414463,PA166155630,rs1143634,,,IL1B,Efficacy,-1,pantoprazole,1451414468.0,European
1451414540,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1451414560.0,East Asian
1451414540,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1451414560.0,East Asian
1451414540,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,pantoprazole,1451414560.0,East Asian
1448125824,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,imatinib,1448125830.0,Sub-Saharan African
1448125824,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,imatinib,1451280900.0,Sub-Saharan African
1451416321,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,antidepressants,1451416380.0,Unknown
1451414561,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,pantoprazole,1451414580.0,East Asian
1447947817,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947819.0,East Asian
1447947817,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947820.0,East Asian
1448259324,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1448259347.0,Unknown
1451415203,PA166157316,rs2032582,,,ABCB1,Dosage,-1,lamotrigine,1451415208.0,Latino
1451415192,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451415145.0,Latino
1451415180,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451415185.0,Latino
1451415152,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451415274.0,Latino
1451415186,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451415191.0,Latino
1451415146,PA166157284,rs1045642,,,ABCB1,Dosage,-1,lamotrigine,1451415151.0,Latino
1451415140,PA166157288,rs1128503,,,ABCB1,Dosage,-1,lamotrigine,1451415160.0,Latino
1451415220,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,lamotrigine,1451415225.0,Latino
1451415246,PA166156572,rs3114020,,,ABCG2,Dosage,-1,lamotrigine,1451415251.0,Latino
1451415252,PA166156572,rs3114020,,,ABCG2,Metabolism/PK,-1,lamotrigine,1451415257.0,Latino
1451415197,PA166157316,rs2032582,,,ABCB1,Dosage,-1,lamotrigine,1451415202.0,Latino
1184473220,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1184473230.0,East Asian
1184473220,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1184473230.0,East Asian
1451415263,PA166156933,rs628031,,,SLC22A1,Dosage,-1,lamotrigine,1451415268.0,Latino
1451415080,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,-1,lamotrigine,1451415085.0,Latino
1451417063,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temozolomide,1451417080.0,Central/South Asian
1451415240,PA166156544,rs2231142,,,ABCG2,Dosage,-1,lamotrigine,1451415245.0,Latino
1451415258,PA166156933,rs628031,,,SLC22A1,Metabolism/PK,-1,lamotrigine,1451415280.0,Latino
1451415086,PA166156677,rs28365063,,,UGT2B7,Dosage,-1,lamotrigine,1451415091.0,Latino
1451414900,,,PA166117588,UGT1A4*1a,UGT1A4,Metabolism/PK,1,lamotrigine,1451414890.0,Latino
1451414900,,,PA166117589,UGT1A4*1b,UGT1A4,Metabolism/PK,1,lamotrigine,1451414890.0,Latino
1451415020,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,-1,lamotrigine,1451415040.0,Latino
1451414860,PA166156625,rs7668258,,,UGT2B7,Dosage,1,lamotrigine,1451414866.0,Latino
1451414860,PA166156625,rs7668258,,,UGT2B7,Dosage,1,lamotrigine,1451414865.0,Latino
1451415500,PA166157367,rs2740574,,,CYP3A,Metabolism/PK,1,tacrolimus,1451415505.0,Near Eastern
1451415500,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451415505.0,Near Eastern
1183629904,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183629906.0,East Asian
1183629904,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,haloperidol,1183629906.0,East Asian
1183629904,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,haloperidol,1183629906.0,East Asian
1451415506,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,1,tacrolimus,1451415514.0,Near Eastern
1451415506,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451415514.0,Near Eastern
1451415515,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1451415520.0,Near Eastern
1451415515,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1451415520.0,Near Eastern
1183622259,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183622280.0,European
1183622259,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,haloperidol,1183622280.0,European
1183622259,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,haloperidol,1183622280.0,European
1183623024,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183623026.0,East Asian
1183623024,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,haloperidol,1183623026.0,East Asian
1183623024,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,haloperidol,1183623026.0,East Asian
1451430400,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430460.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430385.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430386.0,European
1451430400,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1451430461.0,European
1451431406,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431411.0,European
1451431240,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431245.0,European
1451431260,PA166153571,rs396991,,,FCGR3A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431268.0,European
1451431289,PA166156915,rs361525,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431324.0,European
1451431360,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431380.0,European
1451431360,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431382.0,European
1451431360,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431381.0,European
1451431400,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451431405.0,European
1448255587,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,,
1448255587,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,,
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,antipsychotics,1451432080.0,Near Eastern
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,chlorpromazine,1451432080.0,Near Eastern
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,clozapine,1451432080.0,Near Eastern
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,haloperidol,1451432080.0,Near Eastern
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,olanzapine,1451432080.0,Near Eastern
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,quetiapine,1451432080.0,Near Eastern
1451432060,PA166153644,rs1801133,,,MTHFR,Efficacy,1,risperidone,1451432080.0,Near Eastern
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,cyclosporine,1451436968.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,cyclosporine,1451437005.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,cyclosporine,1451437006.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,cyclosporine,1451437020.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451436968.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451437005.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451437006.0,European
1451437000,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451437020.0,European
1451436960,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,cyclosporine,1451436980.0,Unknown
1448519775,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,fluorouracil,1448519777.0,Multiple groups
1448519775,,,PA165819221,CYP3A4*3,CYP3A4,Efficacy,-1,fluorouracil,1448519777.0,Multiple groups
1448519775,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,irinotecan,1448519777.0,Multiple groups
1448519775,,,PA165819221,CYP3A4*3,CYP3A4,Efficacy,-1,irinotecan,1448519777.0,Multiple groups
1448519775,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,oxaliplatin,1448519777.0,Multiple groups
1448519775,,,PA165819221,CYP3A4*3,CYP3A4,Efficacy,-1,oxaliplatin,1448519777.0,Multiple groups
1451437220,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,phenprocoumon,1451437240.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1183698704,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183698718.0,East Asian
1183698704,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,1,tacrolimus,1183698718.0,East Asian
1183698757,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,cyclosporine,1183698767.0,East Asian
1183698757,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,cyclosporine,1183698772.0,East Asian
1183698757,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,1,cyclosporine,1183698767.0,East Asian
1183698757,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,1,cyclosporine,1183698772.0,East Asian
1449715317,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449715320.0,East Asian
1449715317,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449715319.0,East Asian
1449715317,,,PA165819240,CYP3A4*18,CYP3A4,Dosage,1,fentanyl,1449715320.0,East Asian
1449715317,,,PA165819240,CYP3A4*18,CYP3A4,Dosage,1,fentanyl,1449715319.0,East Asian
1449715317,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,fentanyl,1449715320.0,East Asian
1449715317,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,fentanyl,1449715319.0,East Asian
1449715317,,,PA165819240,CYP3A4*18,CYP3A4,Efficacy,1,fentanyl,1449715320.0,East Asian
1449715317,,,PA165819240,CYP3A4*18,CYP3A4,Efficacy,1,fentanyl,1449715319.0,East Asian
1449715329,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,fentanyl,1449715331.0,East Asian
1449715329,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,fentanyl,1451348720.0,East Asian
1449715329,,,PA165819240,CYP3A4*18,CYP3A4,Dosage,-1,fentanyl,1449715331.0,East Asian
1449715329,,,PA165819240,CYP3A4*18,CYP3A4,Dosage,-1,fentanyl,1451348720.0,East Asian
1444843685,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,cyclosporine,1444843694.0,East Asian
1444843685,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,1,cyclosporine,1444843694.0,East Asian
1451439620,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,vincristine,1451439605.0,European
1451439700,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451439705.0,Near Eastern
1451439740,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,acenocoumarol,1451439747.0,Unknown
1451439740,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,acenocoumarol,1451439748.0,Unknown
1451439740,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,phenprocoumon,1451439747.0,Unknown
1451439740,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,phenprocoumon,1451439748.0,Unknown
1451439780,PA166157367,rs2740574,,,CYP3A4,Dosage,1,phenprocoumon,1451439784.0,"Multiple groups, Netherlands, describe cohort as 85.4% ""European ethnicity"""
1451440360,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,buprenorphine,1451440372.0,African American/Afro-Caribbean
1451440440,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,risperidone,1451440445.0,"Multiple groups, Caucasian, African, Unknown"
1451440480,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,(S)-methadone,1451440485.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1451440540,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,everolimus,1451440545.0,"Multiple groups, Mainly Caucasian, 2 Hispanic, 1 African-American and 1 American Indian"
1451440560,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,fentanyl,1451440580.0,Unknown
1449576542,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,montelukast,1449576544.0,European
1449576542,,,PA165958686,CYP2C8*4,CYP2C8,Metabolism/PK,1,montelukast,1449576544.0,European
1184166991,,,PA166242948,CYP2C8*1,CYP2C8,Dosage,-1,everolimus,1184167001.0,Unknown
1184166991,,,PA165958685,CYP2C8*3,CYP2C8,Dosage,-1,everolimus,1184167001.0,Unknown
1451335353,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,-1,olanzapine,1451335366.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335353,,,PA165958684,CYP2C8*2,CYP2C8,Metabolism/PK,-1,olanzapine,1451335366.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335353,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,olanzapine,1451335366.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1449576530,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,montelukast,1449576532.0,European
1449576530,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,montelukast,1449576532.0,European
1449171705,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,tacrolimus,1449171713.0,Unknown
1449171705,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,tacrolimus,1449171713.0,Unknown
1449713492,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,-1,pioglitazone,1449713503.0,European
1449713492,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,pioglitazone,1449713503.0,European
1449713480,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,-1,pioglitazone,1449713491.0,European
1449713480,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,pioglitazone,1449713491.0,European
1450367891,,,PA166242948,CYP2C8*1,CYP2C8,Dosage,1,ibuprofen,1450367898.0,Unknown
1450367891,,,PA165958685,CYP2C8*3,CYP2C8,Dosage,1,ibuprofen,1450367898.0,Unknown
1450935194,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,rosiglitazone,1450935199.0,European
1450935194,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,rosiglitazone,1450935199.0,European
1183680757,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,-1,celecoxib,1183680780.0,"Multiple groups, 23 White and 1 Black"
1183680757,,,PA165958684,CYP2C8*2,CYP2C8,Metabolism/PK,-1,celecoxib,1183680780.0,"Multiple groups, 23 White and 1 Black"
1183680757,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,celecoxib,1183680780.0,"Multiple groups, 23 White and 1 Black"
1183680757,,,PA165958686,CYP2C8*4,CYP2C8,Metabolism/PK,-1,celecoxib,1183680780.0,"Multiple groups, 23 White and 1 Black"
1450935268,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,ibuprofen,1450935273.0,European
1450935268,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,ibuprofen,1450935273.0,European
1450935112,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,-1,rosiglitazone,1450935118.0,Unknown
1450935112,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,rosiglitazone,1450935118.0,Unknown
1449713452,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,-1,pioglitazone,1449713463.0,European
1449713452,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,-1,pioglitazone,1449713463.0,European
1451111440,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,-1,hydroxychloroquine,1451111467.0,Unknown
1451111440,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,-1,hydroxychloroquine,1451111467.0,Unknown
1451111440,,,PA165958686,CYP2C8*4,CYP2C8,Efficacy,-1,hydroxychloroquine,1451111467.0,Unknown
1451454162,PA166176852,rs1319501,,,NAMPT,Efficacy,1,nitric oxide,1451454170.0,"Multiple groups, Brazil, 70.5% White"
1451440801,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,cyclosporine,1451440806.0,Unknown
1451441660,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451441669.0,Multiple groups
1451443220,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1451443225.0,Latino
1449258301,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449258991.0,East Asian
1449258301,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449258368.0,East Asian
1449258301,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449258528.0,East Asian
1451353463,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,methadone,1451353480.0,"Multiple groups, Patients reported race of 'White', 'Black or African American' or 'Other' and ethnicity of 'Non-Hispanic or Latino' or 'Hispanic or Latino'"
1451353463,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,1,methadone,1451353480.0,"Multiple groups, Patients reported race of 'White', 'Black or African American' or 'Other' and ethnicity of 'Non-Hispanic or Latino' or 'Hispanic or Latino'"
1451353463,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,methadone,1451353480.0,"Multiple groups, Patients reported race of 'White', 'Black or African American' or 'Other' and ethnicity of 'Non-Hispanic or Latino' or 'Hispanic or Latino'"
1451353463,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,1,methadone,1451353480.0,"Multiple groups, Patients reported race of 'White', 'Black or African American' or 'Other' and ethnicity of 'Non-Hispanic or Latino' or 'Hispanic or Latino'"
1451353463,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,methadone,1451353480.0,"Multiple groups, Patients reported race of 'White', 'Black or African American' or 'Other' and ethnicity of 'Non-Hispanic or Latino' or 'Hispanic or Latino'"
1451463720,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,methotrexate,1451463725.0,"Multiple groups, Patients of Malay, Chinese and Indian ethnicities."
1451463760,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451463780.0,"Multiple groups, Patients of Malay, Chinese and Indian ethnicities."
1451444938,PA166153974,rs1800544,,,ADRA2A,Dosage,-1,dexmedetomidine,1451444942.0,Unknown
1451463726,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,-1,methotrexate,1451463731.0,"Multiple groups, Patients of Malay, Chinese and Indian ethnicities."
1183703309,PA166155194,rs1876829,,,CRHR1,Efficacy,1,fluticasone propionate,1183703311.0,European
1451445120,PA166154016,rs2484516,,,ADRA2A,Dosage,-1,dexmedetomidine,1451445140.0,Unknown
1451463740,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451463745.0,"Multiple groups, Patients of Malay, Chinese and Indian ethnicities."
1451445125,PA166170852,rs3750625,,,ADRA2A,Dosage,-1,dexmedetomidine,1451445160.0,Unknown
1451445141,PA166153975,rs1800545,,,ADRA2A,Dosage,-1,dexmedetomidine,1451445124.0,Unknown
1451445180,PA166179993,rs553668,,,ADRA2A,Dosage,-1,dexmedetomidine,1451445184.0,Unknown
982025903,PA166156705,rs686,,,DRD1,Efficacy,-1,clozapine,982025908.0,African American/Afro-Caribbean
982025903,PA166156705,rs686,,,DRD1,Efficacy,-1,clozapine,982025909.0,European
1451443460,PA166157367,rs2740574,,,CYP3A4,Dosage,1,tacrolimus,1451443465.0,Near Eastern
1451465029,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451465034.0,Unknown
1451465038,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,-1,methotrexate,1451465043.0,Unknown
1451465080,PA166154581,rs4149081,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451465085.0,Unknown
1451446260,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,sufentanil,1451446280.0,Unknown
1451446260,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,sufentanil,1451446280.0,Unknown
1451446281,PA166156024,rs4680,,,COMT,Dosage,-1,sufentanil,1451446285.0,Unknown
1451465052,PA166155196,rs1979277,,,SHMT1,Metabolism/PK,-1,methotrexate,1451465060.0,Unknown
1451465061,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,methotrexate,1451465066.0,Unknown
1451465067,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1451465072.0,Unknown
1451447380,PA166154465,rs12422149,,,SLCO2B1,Efficacy,1,rosuvastatin,1451447384.0,East Asian
1451465086,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451465091.0,Unknown
1451465086,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451465092.0,Unknown
1451447393,PA166156100,rs2413739,,,PACSIN2,Efficacy,1,azathioprine,1451447398.0,Unknown
1451447480,,,PA165981641,SLCO1B1*1,SLCO1B1,Efficacy,-1,rosuvastatin,1451447486.0,East Asian
1451447480,,,PA165819265,SLCO1B1*15,SLCO1B1,Efficacy,-1,rosuvastatin,1451447486.0,East Asian
1451447501,PA166156544,rs2231142,,,ABCG2,Efficacy,1,rosuvastatin,1451447505.0,East Asian
1451447487,PA166154367,rs2306168,,,SLCO2B1,Efficacy,-1,rosuvastatin,1451447491.0,East Asian
1451448720,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atorvastatin,1451448740.0,Unknown
1451448720,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atorvastatin,1451448740.0,Unknown
1451448741,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,atorvastatin,1451448761.0,Unknown
1451448741,,,PA165819255,SLCO1B1*5,SLCO1B1,Metabolism/PK,1,atorvastatin,1451448761.0,Unknown
1451450560,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,pravastatin,1451450564.0,Unknown
1451450580,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,pravastatin,1451450584.0,Unknown
1451450620,,,PA165981641,SLCO1B1*1,SLCO1B1,Efficacy,1,pravastatin,1451450640.0,Unknown
1451450620,,,PA165819265,SLCO1B1*15,SLCO1B1,Efficacy,1,pravastatin,1451450640.0,Unknown
1451256960,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,atorvastatin,1451256945.0,East Asian
1451256960,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,hmg coa reductase inhibitors,1451256945.0,East Asian
1451256960,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,pravastatin,1451256945.0,East Asian
1451256960,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,simvastatin,1451256945.0,East Asian
981962878,PA166156905,rs20455,,,KIF6,Efficacy,1,pravastatin,981964706.0,"Multiple groups, mostly White, with some African American,Asian Pacific Islander,Hispanic, and other."
1451451060,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pravastatin,1451451064.0,European
1451451060,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pravastatin,1451451064.0,European
1451451080,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pitavastatin,1451451100.0,East Asian
1451451080,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1451451100.0,East Asian
1451451080,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,pravastatin,1451451100.0,East Asian
1451451080,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pravastatin,1451451100.0,East Asian
1451451102,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,-1,fluvastatin,1451451085.0,East Asian
1451451102,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,-1,fluvastatin,1451451085.0,East Asian
1451451120,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,pravastatin,1451451124.0,East Asian
1451451140,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,pravastatin,1451451144.0,East Asian
1451451180,PA166245122,rs2296651,,,SLC10A1,Metabolism/PK,1,pravastatin,1451451184.0,East Asian
1451451700,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,pitavastatin,1451451720.0,East Asian
1451451706,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,pitavastatin,1451451721.0,East Asian
1451474460,PA166154789,rs2236225,,,MTHFD1,Efficacy,1,cisplatin,1451474465.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474460,PA166154789,rs2236225,,,MTHFD1,Efficacy,1,doxorubicin,1451474465.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474460,PA166154789,rs2236225,,,MTHFD1,Efficacy,1,methotrexate,1451474465.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474540,PA166153953,rs717620,,,ABCC2,Efficacy,1,cisplatin,1451474545.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474540,PA166153953,rs717620,,,ABCC2,Efficacy,1,doxorubicin,1451474545.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474540,PA166153953,rs717620,,,ABCC2,Efficacy,1,methotrexate,1451474545.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474540,PA166153953,rs717620,,,ABCC2,Efficacy,1,methotrexate,1451474545.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474580,PA166154249,rs1695,,,GSTP1,Efficacy,1,cisplatin,1451474600.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474580,PA166154249,rs1695,,,GSTP1,Efficacy,1,doxorubicin,1451474600.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451474580,PA166154249,rs1695,,,GSTP1,Efficacy,1,methotrexate,1451474600.0,"Multiple groups, Caucasian, Afro-Caribbean, Indian/Asian"
1451487800,PA166165249,rs25678,,,CBR1,Metabolism/PK,-1,daunorubicin,1451487820.0,Central/South Asian
1451491077,,,PA166131619,NUDT15*1,NUDT15,Efficacy,1,acyclovir,1451491180.0,East Asian
1451491077,,,PA166131620,NUDT15*2,NUDT15,Efficacy,1,acyclovir,1451491180.0,East Asian
1451491077,,,PA166131621,NUDT15*3,NUDT15,Efficacy,1,acyclovir,1451491180.0,East Asian
1451491077,,,PA166131623,NUDT15*5,NUDT15,Efficacy,1,acyclovir,1451491180.0,East Asian
1451489140,PA166153865,rs16851030,,,ADORA1,Efficacy,1,caffeine,1451489160.0,Unknown
1451489140,PA166153865,rs16851030,,,ADORA1,Efficacy,1,caffeine,1451489161.0,Unknown
1451493500,PA166153545,rs4762,,,AGT,Efficacy,1,atenolol,1451493508.0,European
1451493500,PA166153545,rs4762,,,AGT,Efficacy,1,irbesartan,1451493508.0,European
1451493546,PA166153539,rs699,,,AGT,Efficacy,-1,atenolol,1451493551.0,European
1451493540,PA166153539,rs699,,,AGT,Efficacy,1,irbesartan,1451493545.0,European
1451493552,PA166155187,rs1799752,,,ACE,Efficacy,-1,atenolol,1451493557.0,European
1451493552,PA166155187,rs1799752,,,ACE,Efficacy,-1,irbesartan,1451493557.0,European
1451493560,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,atenolol,1451493558.0,European
1451493560,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,irbesartan,1451493558.0,European
1451493586,PA166156276,rs5186,,,AGTR1,Efficacy,-1,atenolol,1451493591.0,European
1451493580,PA166156276,rs5186,,,AGTR1,Efficacy,1,irbesartan,1451493585.0,European
981954745,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,ondansetron,981954751.0,East Asian
981954745,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,ondansetron,981954753.0,East Asian
981954745,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,ondansetron,981954751.0,East Asian
981954745,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,ondansetron,981954753.0,East Asian
1451499146,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,praziquantel,1451499154.0,African American/Afro-Caribbean
1451499146,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,praziquantel,1451499163.0,African American/Afro-Caribbean
1451499146,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,praziquantel,1451499154.0,African American/Afro-Caribbean
1451499146,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,praziquantel,1451499163.0,African American/Afro-Caribbean
1451499146,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,praziquantel,1451499154.0,African American/Afro-Caribbean
1451499146,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,praziquantel,1451499163.0,African American/Afro-Caribbean
1451499146,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,praziquantel,1451499154.0,African American/Afro-Caribbean
1451499146,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,praziquantel,1451499163.0,African American/Afro-Caribbean
1451503480,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,fluoxetine,1451503492.0,Latino
1451503480,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,fluoxetine,1451503491.0,Latino
1451503480,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,fluoxetine,1451503492.0,Latino
1451503480,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,fluoxetine,1451503491.0,Latino
1451503480,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,fluoxetine,1451503492.0,Latino
1451503480,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,fluoxetine,1451503491.0,Latino
1451516060,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,1451516080.0,European
1451516060,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1451516080.0,European
1451516060,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,1451516080.0,European
1451516060,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1451516080.0,European
1451516060,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1451516080.0,European
1451516060,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1451516080.0,European
1444707881,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,1451516268.0,Unknown
1444707881,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,1444707892.0,Unknown
1444707881,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1451516268.0,Unknown
1444707881,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1444707892.0,Unknown
1444707881,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,1451516268.0,Unknown
1444707881,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,1444707892.0,Unknown
1451503688,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,teneligliptin,1451503724.0,East Asian
1451499280,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,fluoxetine,1451499680.0,Unknown
1451516560,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,(R)-methadone,1451516580.0,East Asian
1451503720,PA166153688,rs2266782,,,FMO3,Metabolism/PK,1,teneligliptin,1451503704.0,East Asian
1451499681,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,fluoxetine,1451499687.0,Unknown
1451503700,PA166162580,rs909530,,,FMO3,Metabolism/PK,1,teneligliptin,1451503683.0,East Asian
1451503760,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,teneligliptin,1451503705.0,East Asian
1451516600,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,0,(S)-methadone,1451516581.0,East Asian
1451516606,PA166153700,rs2307424,,,NR1I3,Metabolism/PK,1,(R)-methadone,1451516611.0,East Asian
1451516640,PA166153729,rs3003596,,,NR1I3,Metabolism/PK,1,(R)-methadone,1451516645.0,East Asian
1450935228,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,-1,rosiglitazone,1450935236.0,European
1450935228,,,PA165819255,SLCO1B1*5,SLCO1B1,Metabolism/PK,-1,rosiglitazone,1450935236.0,European
1450935228,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,-1,rosiglitazone,1450935236.0,European
1450935228,,,PA165949164,SLCO1B1*16,SLCO1B1,Metabolism/PK,-1,rosiglitazone,1450935236.0,European
1450935228,,,PA165949164,SLCO1B1*16,SLCO1B1,Metabolism/PK,-1,rosiglitazone,1450935236.0,European
1451504060,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,3-hydroxycotinine,1451504080.0,American
1451504060,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,3-hydroxycotinine,1451504080.0,American
1451504060,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,3-hydroxycotinine,1451504080.0,American
1451504060,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,3-hydroxycotinine,1451504080.0,American
1451504060,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,3-hydroxycotinine glucuronide,1451504080.0,American
1451504060,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,3-hydroxycotinine glucuronide,1451504080.0,American
1451504060,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,3-hydroxycotinine glucuronide,1451504080.0,American
1451499840,,,PA165981617,CYP2E1*1,CYP2E1,Metabolism/PK,1,acetaminophen sulfate,1451499847.0,Near Eastern
1451499840,,,PA165948040,CYP2E1*5B,CYP2E1,Metabolism/PK,1,acetaminophen sulfate,1451499847.0,Near Eastern
1184748435,,,PA165981641,SLCO1B1*1,SLCO1B1,Efficacy,1,fluvastatin,1184748450.0,European
1184748435,,,PA165981641,SLCO1B1*1,SLCO1B1,Efficacy,1,fluvastatin,1184748448.0,European
1184748435,,,PA165819264,SLCO1B1*14,SLCO1B1,Efficacy,1,fluvastatin,1184748450.0,European
1184748435,,,PA165819264,SLCO1B1*14,SLCO1B1,Efficacy,1,fluvastatin,1184748448.0,European
1451477260,,,PA165818762,CYP2B6*6,CYP2B6,Toxicity,0,methadone,1451477280.0,"Multiple groups, ""majority of the participants were Caucasians (87%)"""
1184747049,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,methotrexate,1184747051.0,Multiple groups
1184747049,,,PA165947872,SLCO1B1*31,SLCO1B1,Metabolism/PK,1,methotrexate,1184747051.0,Multiple groups
1184747049,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747051.0,Multiple groups
1184747071,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,methotrexate,1184747073.0,Multiple groups
1184747071,,,PA165988676,SLCO1B1*20,SLCO1B1,Metabolism/PK,1,methotrexate,1184747073.0,Multiple groups
1184747071,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747073.0,Multiple groups
1184747038,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,methotrexate,1184747040.0,Multiple groups
1184747038,,,PA165947864,SLCO1B1*23,SLCO1B1,Metabolism/PK,1,methotrexate,1184747040.0,Multiple groups
1184747038,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747040.0,Multiple groups
1184747038,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747040.0,Multiple groups
1451477620,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,,
1451502800,PA166249261,rs72846714,,,NT5C2,Metabolism/PK,1,mercaptopurine,1451502766.0,Multiple groups
1451502800,PA166249261,rs72846714,,,NT5C2,Metabolism/PK,1,mercaptopurine,1451502765.0,Multiple groups
1451477585,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,,
1451477582,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,,
1451502880,PA166249301,rs58700372,,,CNNM2,Metabolism/PK,1,mercaptopurine,1451502900.0,Multiple groups
1451502880,PA166249301,rs58700372,,,CNNM2,Metabolism/PK,1,mercaptopurine,1451502920.0,Multiple groups
1451504420,PA166154789,rs2236225,,,MTHFD1,Efficacy,-1,methotrexate,1451504440.0,Unknown
1451531660,PA166156322,rs1523127,,,NR1I2,Efficacy,1,efavirenz,1451531680.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531660,PA166156322,rs1523127,,,NR1I2,Efficacy,1,nevirapine,1451531680.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451504441,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1451504480.0,Unknown
1451531684,PA166153729,rs3003596,,,NR1I3,Efficacy,1,efavirenz,1451531690.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531684,PA166153729,rs3003596,,,NR1I3,Efficacy,1,efavirenz,1451531689.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531684,PA166153729,rs3003596,,,NR1I3,Efficacy,1,efavirenz,1451531740.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531684,PA166153729,rs3003596,,,NR1I3,Efficacy,1,nevirapine,1451531690.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531684,PA166153729,rs3003596,,,NR1I3,Efficacy,1,nevirapine,1451531689.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531684,PA166153729,rs3003596,,,NR1I3,Efficacy,1,nevirapine,1451531740.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531760,PA166153700,rs2307424,,,NR1I3,Efficacy,1,efavirenz,1451531765.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451531760,PA166153700,rs2307424,,,NR1I3,Efficacy,1,nevirapine,1451531765.0,"Multiple groups, From table 1, Ancestry: 72% European, 23% African, 5% Native American"
1451504503,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1451504520.0,Unknown
1184747027,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,methotrexate,1184747029.0,Multiple groups
1184747027,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,methotrexate,1184747029.0,Multiple groups
1184747027,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747029.0,Multiple groups
982043808,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,rosuvastatin,982043810.0,East Asian
982043808,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,rosuvastatin,982043810.0,East Asian
1451504580,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1451504585.0,Unknown
1451504521,PA166155331,rs45445694,,,TYMS,Efficacy,-1,methotrexate,1451504560.0,Unknown
1451511420,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1451511425.0,Unknown
1451505380,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1451505389.0,East Asian
1451505380,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1451505397.0,East Asian
1451505380,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,escitalopram,1451505389.0,East Asian
1451505380,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,escitalopram,1451505397.0,East Asian
1451505380,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,escitalopram,1451505389.0,East Asian
1451505380,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,escitalopram,1451505397.0,East Asian
1451505540,PA166249941,rs4646453,,,CYP3A5,Metabolism/PK,1,sirolimus,1451505560.0,East Asian
1451505550,PA166157243,rs15524,,,CYP3A5,Metabolism/PK,1,sirolimus,1451505555.0,East Asian
1451533063,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,atorvastatin,1451533046.0,East Asian
1451533063,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,atorvastatin,1451533046.0,East Asian
1451165020,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,atorvastatin,1451165028.0,East Asian
1451165020,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,atorvastatin,1451165028.0,East Asian
1451165020,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,atorvastatin,1451165028.0,East Asian
1451533240,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,atrasentan,1451533250.0,Unknown
1451533240,,,PA165819264,SLCO1B1*14,SLCO1B1,Metabolism/PK,1,atrasentan,1451533250.0,Unknown
1451533240,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,atrasentan,1451533250.0,Unknown
1451533240,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,atrasentan,1451533250.0,Unknown
1451535103,PA166157634,rs11545078,,,GGH,Toxicity,1,methotrexate,1451535108.0,Unknown
1451535140,PA166153953,rs717620,,,ABCC2,Toxicity,1,methotrexate,1451535160.0,Unknown
1451535480,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1451535487.0,"Multiple groups, Michigan. ""Most patients were Caucasian (92.3%)"""
1451535480,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1451535487.0,"Multiple groups, Michigan. ""Most patients were Caucasian (92.3%)"""
1451535660,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,bisoprolol,1451535641.0,East Asian
1451535660,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,bisoprolol,1451535641.0,East Asian
1451535660,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,bisoprolol,1451535641.0,East Asian
1451544786,PA166153977,rs1801253,,,ADRB1,Efficacy,1,Beta Blocking Agents,1451544791.0,"Multiple groups, White, Black and 'other' ethnicities"
1451581400,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,3,1451581420.0,Unknown
1451581400,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,3,1451581420.0,Unknown
1451581400,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,4-dehydrocilostazol,1451581420.0,Unknown
1451581400,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,4-dehydrocilostazol,1451581420.0,Unknown
1451506220,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,1451506240.0,Unknown
1451544780,PA166156691,rs61767072,,,ADRA2C,Efficacy,1,Beta Blocking Agents,1451544785.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544780,PA166156691,rs61767072,,,ADRA2C,Efficacy,1,Beta Blocking Agents,1451544785.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544780,PA166156691,rs61767072,,,ADRA2C,Efficacy,1,Beta Blocking Agents,1451544785.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544780,PA166156691,rs61767072,,,ADRA2C,Efficacy,1,Beta Blocking Agents,1451544785.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451544792,PA166156748,rs1042713,,,ADRB2,Efficacy,1,Beta Blocking Agents,1451544797.0,"Multiple groups, White, Black and 'other' ethnicities"
1451506360,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,0,methotrexate,1451506347.0,Unknown
1451506360,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,0,methotrexate,1451506347.0,Unknown
1451506360,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,0,methotrexate,1451506347.0,Unknown
1451506360,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,0,methotrexate,1451506347.0,Unknown
1451506260,PA166153644,rs1801133,,,MTHFR,Efficacy,1,methotrexate,1451506265.0,Unknown
1451582502,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,hydroxybupropion,1451582505.0,"Multiple groups, Studies in paper were from USA (4), China (4), Germany (1), Australia (1), Korea (1), Canada (1)"
1451506300,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1451506320.0,Unknown
1451506300,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1451506320.0,Unknown
1451506467,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1451506500.0,Unknown
1451506600,PA166154633,rs11045879,,,SLCO1B1,Efficacy,-1,methotrexate,1451506606.0,Unknown
1451506520,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1451506580.0,Unknown
1451506620,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,methotrexate,1451506626.0,Unknown
1451546960,PA166155684,rs2372536,,,ATIC,Metabolism/PK,-1,methotrexate,1451546965.0,Unknown
1451546960,PA166155684,rs2372536,,,ATIC,Metabolism/PK,-1,methotrexate,1451546965.0,Unknown
1448104442,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,methadone,1448104444.0,East Asian
1451547000,PA166153644,rs1801133,,,CLCN6,Metabolism/PK,-1,methotrexate,1451547005.0,Unknown
1451547000,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451547005.0,Unknown
1451547020,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,1,methotrexate,1451547015.0,Unknown
1451547020,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,1,methotrexate,1451547015.0,Unknown
1451547020,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,1,methotrexate,1451547015.0,Unknown
1451547006,PA166153643,rs1801131,,,C1orf167,Metabolism/PK,-1,methotrexate,1451547011.0,Unknown
1451547006,PA166153643,rs1801131,,,CLCN6,Metabolism/PK,-1,methotrexate,1451547011.0,Unknown
1451547006,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,-1,methotrexate,1451547011.0,Unknown
981239905,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,981239913.0,Near Eastern
981239887,PA166155134,rs61742245,,,VKORC1,Dosage,1,warfarin,981239897.0,Near Eastern
1451589723,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451589727.0,Near Eastern
1451547383,PA166157731,rs1544105,,,FPGS,Metabolism/PK,1,methotrexate,1451547400.0,Unknown
1451547383,PA166157731,rs1544105,,,FPGS,Metabolism/PK,1,methotrexate,1451547420.0,Unknown
1451589728,PA166155134,rs61742245,,,VKORC1,Dosage,1,warfarin,1451589732.0,Near Eastern
1451547391,PA166157731,rs1544105,,,FPGS,Efficacy,1,methotrexate,1451547396.0,Unknown
1451589737,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,1451589744.0,Near Eastern
1451589745,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1451589761.0,Near Eastern
1451548140,PA166154639,rs11568563,,,SLCO1A2,Metabolism/PK,1,celiprolol,1451548144.0,European
1451589740,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1451589760.0,Near Eastern
1451589825,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,1451589840.0,Near Eastern
1451589820,PA166254923,rs188009042,,,VKORC1,Dosage,-1,warfarin,1451589824.0,Near Eastern
1451548145,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,celiprolol,1451548149.0,European
1451589762,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1451589766.0,Near Eastern
1451548305,PA166252581,rs4149009,,,SLCO1A2,Dosage,-1,methotrexate,1451548310.0,Unknown
1451548340,PA166252581,rs4149009,,,SLCO1A2,Metabolism/PK,1,methotrexate,1451548311.0,Unknown
1451548340,PA166252581,rs4149009,,,SLCO1A2,Metabolism/PK,1,methotrexate,1451548316.0,Unknown
1184510128,PA166155134,rs61742245,,,VKORC1,Dosage,1,warfarin,1184510132.0,Multiple groups
1451592449,PA166254982,rs7858836,,,ASTN2,Dosage,1,fentanyl,1451592462.0,Unknown
1451592449,PA166254982,rs7858836,,,ASTN2,Dosage,1,fentanyl,1451592461.0,Unknown
1451592449,PA166254982,rs7858836,,,ASTN2,Dosage,1,fentanyl,1451592463.0,Unknown
1451592449,PA166254982,rs7858836,,,ASTN2,Dosage,1,fentanyl,1451592460.0,Unknown
1451548506,PA166153644,rs1801133,,,CLCN6,Metabolism/PK,-1,methotrexate,1451548544.0,Unknown
1451548506,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451548544.0,Unknown
1451592467,PA166254981,rs958804,,,ASTN2,Dosage,1,fentanyl,1451592474.0,Unknown
1451592467,PA166254981,rs958804,,,ASTN2,Dosage,1,fentanyl,1451592473.0,Unknown
1451592467,PA166254981,rs958804,,,ASTN2,Dosage,1,fentanyl,1451592472.0,Unknown
1451592467,PA166254981,rs958804,,,ASTN2,Dosage,1,fentanyl,1451592475.0,Unknown
1451511100,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1451511120.0,Near Eastern
1451511100,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1451511105.0,Near Eastern
1451511100,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1451511106.0,Near Eastern
1451511100,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1451511107.0,Near Eastern
1451511160,PA166157593,rs3758149,,,GGH,Metabolism/PK,1,methotrexate,1451511142.0,Unknown
1451548621,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,aripiprazole,1451548624.0,Unknown
1451548621,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,aripiprazole,1451548624.0,Unknown
1451511171,PA166153644,rs1801133,,,CLCN6,Metabolism/PK,-1,methotrexate,1451511176.0,Unknown
1451511171,PA166153644,rs1801133,,,CLCN6,Metabolism/PK,-1,methotrexate,1451511180.0,Unknown
1451511171,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451511176.0,Unknown
1451511171,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451511180.0,Unknown
1451511164,PA166157731,rs1544105,,,FPGS,Metabolism/PK,-1,methotrexate,1451511170.0,Unknown
1451511164,PA166157731,rs1544105,,,FPGS,Metabolism/PK,-1,methotrexate,1451511169.0,Unknown
1451548640,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451548640,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,aripiprazole,1451548643.0,Unknown
1451511320,PA166155987,rs1051296,,,SLC19A1,Metabolism/PK,1,methotrexate,1451511340.0,Unknown
1451511320,PA166155987,rs1051296,,,SLC19A1,Metabolism/PK,1,methotrexate,1451511325.0,Unknown
1451550232,PA166252969,rs39339,,,RELN,Efficacy,-1,aripiprazole,1451550237.0,East Asian
1451550232,PA166252969,rs39339,,,RELN,Efficacy,-1,olanzapine,1451550237.0,East Asian
1451550232,PA166252969,rs39339,,,RELN,Efficacy,-1,perphenazine,1451550237.0,East Asian
1451550232,PA166252969,rs39339,,,RELN,Efficacy,-1,quetiapine,1451550237.0,East Asian
1451550232,PA166252969,rs39339,,,RELN,Efficacy,-1,risperidone,1451550237.0,East Asian
1451550247,PA166252964,rs3808035,,,RELN,Efficacy,-1,aripiprazole,1451550252.0,East Asian
1451550247,PA166252964,rs3808035,,,RELN,Efficacy,-1,olanzapine,1451550252.0,East Asian
1451550247,PA166252964,rs3808035,,,RELN,Efficacy,-1,perphenazine,1451550252.0,East Asian
1451550247,PA166252964,rs3808035,,,RELN,Efficacy,-1,quetiapine,1451550252.0,East Asian
1451550247,PA166252964,rs3808035,,,RELN,Efficacy,-1,risperidone,1451550252.0,East Asian
1451550226,PA166252966,rs7341475,,,RELN,Efficacy,-1,aripiprazole,1451550231.0,East Asian
1451550226,PA166252966,rs7341475,,,RELN,Efficacy,-1,olanzapine,1451550231.0,East Asian
1451550226,PA166252966,rs7341475,,,RELN,Efficacy,-1,perphenazine,1451550231.0,East Asian
1451550226,PA166252966,rs7341475,,,RELN,Efficacy,-1,quetiapine,1451550231.0,East Asian
1451550226,PA166252966,rs7341475,,,RELN,Efficacy,-1,risperidone,1451550231.0,East Asian
1451550301,PA166252961,rs362726,,,RELN,Efficacy,-1,aripiprazole,1451550306.0,East Asian
1451550301,PA166252961,rs362726,,,RELN,Efficacy,-1,olanzapine,1451550306.0,East Asian
1451550301,PA166252961,rs362726,,,RELN,Efficacy,-1,perphenazine,1451550306.0,East Asian
1451550301,PA166252961,rs362726,,,RELN,Efficacy,-1,quetiapine,1451550306.0,East Asian
1451550301,PA166252961,rs362726,,,RELN,Efficacy,-1,risperidone,1451550306.0,East Asian
1451550220,PA166252921,rs362719,,,RELN,Efficacy,-1,aripiprazole,1451550225.0,East Asian
1451550220,PA166252921,rs362719,,,RELN,Efficacy,-1,olanzapine,1451550225.0,East Asian
1451550220,PA166252921,rs362719,,,RELN,Efficacy,-1,perphenazine,1451550225.0,East Asian
1451550220,PA166252921,rs362719,,,RELN,Efficacy,-1,quetiapine,1451550225.0,East Asian
1451550220,PA166252921,rs362719,,,RELN,Efficacy,-1,risperidone,1451550225.0,East Asian
1451550253,PA166252924,rs2535764,,,RELN,Efficacy,-1,aripiprazole,1451550258.0,East Asian
1451550253,PA166252924,rs2535764,,,RELN,Efficacy,-1,olanzapine,1451550258.0,East Asian
1451550253,PA166252924,rs2535764,,,RELN,Efficacy,-1,perphenazine,1451550258.0,East Asian
1451550253,PA166252924,rs2535764,,,RELN,Efficacy,-1,quetiapine,1451550258.0,East Asian
1451550253,PA166252924,rs2535764,,,RELN,Efficacy,-1,risperidone,1451550258.0,East Asian
1451550265,PA166252923,rs2237628,,,RELN,Efficacy,-1,aripiprazole,1451550270.0,East Asian
1451550265,PA166252923,rs2237628,,,RELN,Efficacy,-1,olanzapine,1451550270.0,East Asian
1451550265,PA166252923,rs2237628,,,RELN,Efficacy,-1,perphenazine,1451550270.0,East Asian
1451550265,PA166252923,rs2237628,,,RELN,Efficacy,-1,quetiapine,1451550270.0,East Asian
1451550265,PA166252923,rs2237628,,,RELN,Efficacy,-1,risperidone,1451550270.0,East Asian
1451550241,PA166252965,rs3819479,,,RELN,Efficacy,-1,aripiprazole,1451550246.0,East Asian
1451550241,PA166252965,rs3819479,,,RELN,Efficacy,-1,olanzapine,1451550246.0,East Asian
1451550241,PA166252965,rs3819479,,,RELN,Efficacy,-1,perphenazine,1451550246.0,East Asian
1451550241,PA166252965,rs3819479,,,RELN,Efficacy,-1,quetiapine,1451550246.0,East Asian
1451550241,PA166252965,rs3819479,,,RELN,Efficacy,-1,risperidone,1451550246.0,East Asian
1451550259,PA166252967,rs12705169,,,RELN,Efficacy,-1,aripiprazole,1451550264.0,East Asian
1451550259,PA166252967,rs12705169,,,RELN,Efficacy,-1,olanzapine,1451550264.0,East Asian
1451550259,PA166252967,rs12705169,,,RELN,Efficacy,-1,perphenazine,1451550264.0,East Asian
1451550259,PA166252967,rs12705169,,,RELN,Efficacy,-1,quetiapine,1451550264.0,East Asian
1451550259,PA166252967,rs12705169,,,RELN,Efficacy,-1,risperidone,1451550264.0,East Asian
1451550271,PA166252925,rs362626,,,RELN,Efficacy,-1,aripiprazole,1451550276.0,East Asian
1451550271,PA166252925,rs362626,,,RELN,Efficacy,-1,olanzapine,1451550276.0,East Asian
1451550271,PA166252925,rs362626,,,RELN,Efficacy,-1,perphenazine,1451550276.0,East Asian
1451550271,PA166252925,rs362626,,,RELN,Efficacy,-1,quetiapine,1451550276.0,East Asian
1451550271,PA166252925,rs362626,,,RELN,Efficacy,-1,risperidone,1451550276.0,East Asian
1451550280,PA166252963,rs362814,,,RELN,Efficacy,-1,aripiprazole,1451550285.0,East Asian
1451550280,PA166252963,rs362814,,,RELN,Efficacy,-1,olanzapine,1451550285.0,East Asian
1451550280,PA166252963,rs362814,,,RELN,Efficacy,-1,perphenazine,1451550285.0,East Asian
1451550280,PA166252963,rs362814,,,RELN,Efficacy,-1,quetiapine,1451550285.0,East Asian
1451550280,PA166252963,rs362814,,,RELN,Efficacy,-1,risperidone,1451550285.0,East Asian
1451550286,PA166252968,rs362813,,,RELN,Efficacy,-1,aripiprazole,1451550291.0,East Asian
1451550286,PA166252968,rs362813,,,RELN,Efficacy,-1,olanzapine,1451550291.0,East Asian
1451550286,PA166252968,rs362813,,,RELN,Efficacy,-1,perphenazine,1451550291.0,East Asian
1451550286,PA166252968,rs362813,,,RELN,Efficacy,-1,quetiapine,1451550291.0,East Asian
1451550286,PA166252968,rs362813,,,RELN,Efficacy,-1,risperidone,1451550291.0,East Asian
1451550292,PA166252962,rs362731,,,RELN,Efficacy,-1,aripiprazole,1451550300.0,East Asian
1451550292,PA166252962,rs362731,,,RELN,Efficacy,-1,olanzapine,1451550300.0,East Asian
1451550292,PA166252962,rs362731,,,RELN,Efficacy,-1,perphenazine,1451550300.0,East Asian
1451550292,PA166252962,rs362731,,,RELN,Efficacy,-1,quetiapine,1451550300.0,East Asian
1451550292,PA166252962,rs362731,,,RELN,Efficacy,-1,risperidone,1451550300.0,East Asian
1451551143,PA166155342,rs11615,,,ERCC1,Efficacy,1,cisplatin,1451551148.0,Unknown
1451551246,PA166253321,rs3212964,,,ERCC1,Efficacy,-1,cisplatin,1451551280.0,Unknown
1451551320,PA166253341,rs3212961,,,ERCC1,Efficacy,-1,cisplatin,1451551325.0,Unknown
1183700726,PA166155342,rs11615,,,ERCC1,Efficacy,1,cisplatin,1183700728.0,European
1183700726,PA166155342,rs11615,,,ERCC1,Efficacy,1,gemcitabine,1183700728.0,European
1451551220,PA166155356,rs735482,,,ERCC1,Efficacy,-1,cisplatin,1451551225.0,Unknown
1451551177,PA166253286,rs3212980,,,ERCC1,Efficacy,-1,cisplatin,1451551202.0,Unknown
1451551340,PA166169975,rs2298881,,,ERCC1,Efficacy,-1,cisplatin,1451551345.0,Unknown
1451551149,PA166155407,rs3212986,,,ERCC1,Efficacy,1,cisplatin,1451551154.0,Unknown
1451608120,PA166153989,rs1937840,,,AKR1C3,Efficacy,1,docetaxel,1451608125.0,Multiple groups
1451608120,PA166153989,rs1937840,,,AKR1C3,Efficacy,1,docetaxel,1451608126.0,Multiple groups
1451608120,PA166153989,rs1937840,,,AKR1C3,Efficacy,1,doxorubicin,1451608125.0,Multiple groups
1451608120,PA166153989,rs1937840,,,AKR1C3,Efficacy,1,doxorubicin,1451608126.0,Multiple groups
1451551163,PA166253284,rs2336219,,,ERCC1,Efficacy,-1,cisplatin,1451551168.0,Unknown
1451551163,PA166253284,rs2336219,,,ERCC1,Efficacy,-1,cisplatin,1451551169.0,Unknown
1451551742,PA166157634,rs11545078,,,GGH,Efficacy,-1,methotrexate,1451551747.0,Unknown
1451551800,PA166253503,rs11545076,,,GGH,Efficacy,1,methotrexate,1451551820.0,Unknown
1451610560,PA166155048,rs3213422,,,DHODH,Efficacy,1,leflunomide,1451610620.0,Near Eastern
1451610560,PA166155048,rs3213422,,,DHODH,Efficacy,1,leflunomide,1451610640.0,Near Eastern
1451551760,PA166157567,rs1800909,,,GGH,Efficacy,-1,methotrexate,1451551765.0,Unknown
1451551766,PA166157633,rs11545077,,,GGH,Efficacy,1,methotrexate,1451551771.0,Unknown
1451551777,PA166157593,rs3758149,,,GGH,Efficacy,1,methotrexate,1451551821.0,Unknown
1451610661,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,leflunomide,1451610666.0,Near Eastern
1451610667,PA166154053,rs4244285,,,CYP2C19,Efficacy,-1,leflunomide,1451610672.0,Near Eastern
1451552300,PA166156288,rs352139,,,TLR9,Efficacy,1,adalimumab,1451552308.0,East Asian
1451552300,PA166156288,rs352139,,,TLR9,Efficacy,1,etanercept,1451552308.0,East Asian
1451552300,PA166156288,rs352139,,,TLR9,Efficacy,1,infliximab,1451552308.0,East Asian
1451552300,PA166156288,rs352139,,,TLR9,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451552308.0,East Asian
1451552561,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,tramadol,1451552547.0,European
1451552540,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451552560.0,European
1451552540,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1451552560.0,European
1451552540,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,tramadol,1451552560.0,European
1451552548,PA166156024,rs4680,,,COMT,Metabolism/PK,-1,tramadol,1451552580.0,European
1451552752,PA166155331,rs45445694,,,TYMS,Metabolism/PK,-1,methotrexate,1451552757.0,Unknown
1451614884,PA166256486,rs4696,,,HINT1,Efficacy,-1,daclatasvir,1451614889.0,Near Eastern
1451614884,PA166256486,rs4696,,,HINT1,Efficacy,-1,sofosbuvir,1451614889.0,Near Eastern
1451552723,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1451552728.0,Unknown
1451614766,PA166256481,rs7728773,,,HINT1,Efficacy,1,daclatasvir,1451614771.0,Near Eastern
1451614766,PA166256481,rs7728773,,,HINT1,Efficacy,1,sofosbuvir,1451614771.0,Near Eastern
1451614773,PA166155468,rs12979860,,,IFNL3,Efficacy,1,daclatasvir,1451614820.0,Near Eastern
1451614773,PA166155468,rs12979860,,,IFNL3,Efficacy,1,sofosbuvir,1451614820.0,Near Eastern
1451614846,PA166256484,rs3760468,,,NME1,Efficacy,-1,daclatasvir,1451614860.0,Near Eastern
1451614846,PA166256484,rs3760468,,,NME1,Efficacy,-1,sofosbuvir,1451614860.0,Near Eastern
1451614846,PA166256484,rs3760468,,,NME1,Efficacy,-1,sofosbuvir,1451614860.0,Near Eastern
1451553125,PA166253761,rs12539,,,AOC1,Efficacy,1,cannabidiol,1451553140.0,Multiple groups
1451614958,PA166155028,rs2074087,,,ABCC1,Metabolism/PK,-1,methotrexate,1451614963.0,Unknown
1451614946,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,methotrexate,1451614951.0,Unknown
1451553150,PA166253781,rs1339067,,,SLC15A1,Efficacy,1,cannabidiol,1451553155.0,Multiple groups
1451614940,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1451614945.0,Unknown
1451615000,PA166155053,rs3784862,,,ABCC1,Metabolism/PK,-1,methotrexate,1451615005.0,Unknown
1451615006,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,methotrexate,1451615011.0,Unknown
1451615012,PA166154027,rs3740065,,,ABCC2,Metabolism/PK,-1,methotrexate,1451615017.0,Unknown
1451615018,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,methotrexate,1451615023.0,Unknown
1451552740,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,1,methotrexate,1451552745.0,Unknown
1451614952,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methotrexate,1451614957.0,Unknown
1451614974,PA166256505,rs2230671,,,ABCC1,Metabolism/PK,-1,methotrexate,1451614979.0,Unknown
1451615024,PA166154709,rs2274407,,,ABCC4,Metabolism/PK,-1,methotrexate,1451615029.0,Unknown
1451465044,PA166155331,rs45445694,,,TYMS,Metabolism/PK,-1,methotrexate,1451465049.0,Unknown
1451553338,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1451553363.0,Unknown
1451553420,PA166159618,rs3749442,,,ABCC5,Efficacy,1,cannabidiol,1451553440.0,Multiple groups
1451615120,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451615125.0,Unknown
1451615128,PA166154581,rs4149081,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451615133.0,Unknown
1451553370,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methotrexate,1451553342.0,Unknown
1451613242,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451613247.0,Unknown
1451613242,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451613248.0,Unknown
1451613242,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451614920.0,Unknown
1451553540,PA166157284,rs1045642,,,ABCB1,Efficacy,1,methotrexate,1451553560.0,Unknown
1451553466,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,-1,methotrexate,1451553442.0,Unknown
1451615134,PA166252581,rs4149009,,,SLCO1A2,Metabolism/PK,-1,methotrexate,1451615139.0,Unknown
1451615140,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1451615145.0,Unknown
1451553460,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,methotrexate,1451553465.0,Unknown
1451615146,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,-1,methotrexate,1451615151.0,Unknown
1451615216,PA166256563,rs10464903,,,GGH,Metabolism/PK,-1,methotrexate,1451615261.0,Unknown
1451615152,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,1451615157.0,Unknown
1451553477,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1451553502.0,Unknown
1451615306,PA166157567,rs1800909,,,GGH,Metabolism/PK,-1,methotrexate,1451615311.0,Unknown
1451615343,PA166157731,rs1544105,,,FPGS,Metabolism/PK,-1,methotrexate,1451615348.0,Unknown
1451615160,PA166155684,rs2372536,,,ATIC,Metabolism/PK,-1,methotrexate,1451615180.0,Unknown
1451615200,PA166156770,rs1650697,,,DHFR,Metabolism/PK,-1,methotrexate,1451615205.0,Unknown
1451554360,PA166156991,rs1799971,,,OPRM1,Dosage,1,morphine,1451554380.0,Unknown
1451615317,PA166157548,rs719235,,,GGH,Metabolism/PK,-1,methotrexate,1451615342.0,Unknown
1451554440,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1451554447.0,Near Eastern
1451554440,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1451554460.0,Near Eastern
1451554440,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1451554447.0,Near Eastern
1451554440,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1451554460.0,Near Eastern
1451615300,PA166157640,rs12681874,,,GGH,Metabolism/PK,-1,methotrexate,1451615305.0,Unknown
1451615349,PA166154264,rs9344,,,CCND1,Metabolism/PK,-1,methotrexate,1451615354.0,Unknown
1451564980,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,salbutamol,1451565000.0,"Multiple groups, See Table 1"
1451564980,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,salbutamol,1451565020.0,"Multiple groups, See Table 1"
1451564980,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,salbutamol,1451565021.0,"Multiple groups, See Table 1"
1451493920,PA166156748,rs1042713,,,ADRB2,PD,1,salbutamol,1451493940.0,Unknown
1451564962,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1451565060.0,"Multiple groups, See Table 1"
1451564962,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1451564967.0,"Multiple groups, See Table 1"
1451564962,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1451565040.0,"Multiple groups, See Table 1"
1451565700,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,n-desmethyltramadol,1451565720.0,Unknown
1451565700,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,n-desmethyltramadol,1451565720.0,Unknown
1451565700,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,n-desmethyltramadol,1451565720.0,Unknown
1451565700,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,n-desmethyltramadol,1451565720.0,Unknown
1449715484,PA166156626,rs7668282,,,UGT2B7,Efficacy,-1,fentanyl,1449715486.0,East Asian
1451566720,PA166154339,rs1800497,,,ANKK1,Efficacy,1,bupropion,1451566740.0,"Multiple groups, White, Black, Asian or Hispanic ethnicities"
1451566720,PA166154339,rs1800497,,,DRD2,Efficacy,1,bupropion,1451566740.0,"Multiple groups, White, Black, Asian or Hispanic ethnicities"
1451566720,PA166154339,rs1800497,,,ANKK1,Efficacy,1,naltrexone,1451566740.0,"Multiple groups, White, Black, Asian or Hispanic ethnicities"
1451566720,PA166154339,rs1800497,,,DRD2,Efficacy,1,naltrexone,1451566740.0,"Multiple groups, White, Black, Asian or Hispanic ethnicities"
1451566720,PA166154339,rs1800497,,,DRD2,Efficacy,1,naltrexone,1451566740.0,"Multiple groups, White, Black, Asian or Hispanic ethnicities"
1451569080,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,methadone,1451569100.0,European
1451569101,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,methadone,1451569106.0,European
1451569107,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,-1,methadone,1451569112.0,European
1451569620,PA166155810,rs11887534,,,ABCG8,Efficacy,1,atorvastatin,1451569625.0,European
1451569620,PA166155810,rs11887534,,,ABCG8,Efficacy,1,simvastatin,1451569625.0,European
982009313,PA166157289,rs1137617,,,KCNH2,Efficacy,0,candesartan,982009328.0,East Asian
982009313,PA166157289,rs1137617,,,KCNH2,Efficacy,0,imidapril,982009328.0,East Asian
982009313,PA166157289,rs1137617,,,KCNH2,Efficacy,0,irbesartan,982009328.0,East Asian
981502416,PA166156556,rs2306990,,,FAT1,Efficacy,-1,aripiprazole,981502418.0,East Asian
981502416,PA166156556,rs2306990,,,FAT1,Toxicity,-1,aripiprazole,981502418.0,East Asian
1451635420,PA166175994,rs678849,,,OPRD1,Efficacy,1,disulfiram,1451635443.0,"Multiple groups, Self-reported African American, Hispanic and Caucasian ethnicities."
1451635420,PA166175994,rs678849,,,OPRD1,Efficacy,1,disulfiram,1451635443.0,"Multiple groups, Self-reported African American, Hispanic and Caucasian ethnicities."
1451638466,PA166258303,rs2376805,,,GABRD,Efficacy,-1,methadone,1451638471.0,East Asian
1451638460,PA166258302,rs4481796,,,GABRD,Efficacy,-1,methadone,1451638465.0,East Asian
1451638472,PA166258304,rs2229110,,,GABRD,Efficacy,-1,methadone,1451638477.0,East Asian
1451638720,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1451638762.0,Unknown
1451638720,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1451638740.0,Unknown
1451638720,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1451638763.0,Unknown
1451638720,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1451638764.0,Unknown
1451638720,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1451638761.0,Unknown
1451638720,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1451638760.0,Unknown
1451638720,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,tramadol,1451638762.0,Unknown
1451638720,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,tramadol,1451638740.0,Unknown
1451638720,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,tramadol,1451638763.0,Unknown
1451638720,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,tramadol,1451638764.0,Unknown
1451638720,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,tramadol,1451638761.0,Unknown
1451638720,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,tramadol,1451638760.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638804.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638783.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638821.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638784.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638782.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638820.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638860.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638823.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638822.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638840.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638787.0,Unknown
1451638800,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,ketorolac,1451638788.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638804.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638783.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638821.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638784.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638782.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638820.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638860.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638823.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638822.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638840.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638787.0,Unknown
1451638800,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,ketorolac,1451638788.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638804.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638783.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638821.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638784.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638782.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638820.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638860.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638823.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638822.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638840.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638787.0,Unknown
1451638800,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,ketorolac,1451638788.0,Unknown
1451639680,PA166157367,rs2740574,,,CYP3A,Metabolism/PK,-1,erythromycin,1451639700.0,African American/Afro-Caribbean
1451639680,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,erythromycin,1451639700.0,African American/Afro-Caribbean
1451639740,PA166157367,rs2740574,,,CYP3A,Metabolism/PK,-1,nifedipine,1451639760.0,African American/Afro-Caribbean
1451639740,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,nifedipine,1451639760.0,African American/Afro-Caribbean
1451126306,PA166202201,rs12608932,,,UNC13A,Efficacy,-1,creatine,1451126311.0,Unknown
1451639883,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,pazopanib,1451639900.0,Unknown
1451639920,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pazopanib,1451639940.0,Unknown
1451639980,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,pazopanib,1451640000.0,Unknown
1451640080,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tenofovir alafenamide,1451640100.0,"Custom, HIV-negative males or non-pregnant and non-lactating females, aged between 18 and 60 years"
1451640080,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tenofovir alafenamide,1451640100.0,"Custom, HIV-negative males or non-pregnant and non-lactating females, aged between 18 and 60 years"
1451640080,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tenofovir alafenamide,1451640100.0,"Custom, HIV-negative males or non-pregnant and non-lactating females, aged between 18 and 60 years"
1451643100,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,0,tacrolimus,,
1451643100,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,0,tacrolimus,,
1451648260,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,endoxifen,1451648267.0,"Multiple groups, Caucasian (n=178), Middle Eastern (n=2), Asian (n=5), Other (n=4)."
1451648260,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,endoxifen,1451648267.0,"Multiple groups, Caucasian (n=178), Middle Eastern (n=2), Asian (n=5), Other (n=4)."
1451642920,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,0,tacrolimus,,
1451642920,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,0,tacrolimus,,
1451642920,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,0,tacrolimus,,
1451643200,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,midazolam,1451643240.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451643200,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,midazolam,1451643240.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451643200,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,midazolam,1451643240.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451643241,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,docetaxel,1451643260.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451643241,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,docetaxel,1451643260.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451643241,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,docetaxel,1451643260.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451643241,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,docetaxel,1451643260.0,"Multiple groups, Chinese 28; Malays 3; Indian 1"
1451647605,PA166259903,rs756770,,,ADAMTSL2,Efficacy,1,buprenorphine,1451647576.0,Unknown
1451643262,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,citalopram,1451643270.0,Unknown
1451643262,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,citalopram,1451643270.0,Unknown
1451643262,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,escitalopram,1451643270.0,Unknown
1451643262,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,escitalopram,1451643270.0,Unknown
1451643262,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,sertraline,1451643270.0,Unknown
1451643262,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,sertraline,1451643270.0,Unknown
1451643262,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,sertraline,1451643270.0,Unknown
1451643250,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,citalopram,1451643261.0,Unknown
1451643250,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,citalopram,1451643261.0,Unknown
1451643250,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,citalopram,1451643261.0,Unknown
1451643250,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,escitalopram,1451643261.0,Unknown
1451643250,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,escitalopram,1451643261.0,Unknown
1451643250,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,escitalopram,1451643261.0,Unknown
1451643250,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,sertraline,1451643261.0,Unknown
1451643250,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,sertraline,1451643261.0,Unknown
1451643250,,,PA165816533,CYP2C19*17,CYP2C19,Toxicity,-1,sertraline,1451643261.0,Unknown
1451648462,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,quetiapine,1451648453.0,Unknown
1451648462,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,quetiapine,1451648453.0,Unknown
1451643140,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643140,,,PA165816577,CYP2D6*2,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643140,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643140,,,PA165948092,CYP2D6*5,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643140,,,PA165948317,CYP2D6*9,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643140,,,PA165816582,CYP2D6*10,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643140,,,PA165816584,CYP2D6*41,CYP2D6,Toxicity,-1,paroxetine,1451643180.0,Unknown
1451643611,PA166157288,rs1128503,,,ABCB1,Dosage,-1,methadone,1451643616.0,East Asian
1451648760,PA166157196,rs34059508,,,SLC22A1,Dosage,-1,morphine,1451648765.0,European
1451643605,PA166157284,rs1045642,,,ABCB1,Dosage,-1,methadone,1451643610.0,East Asian
1451643540,PA166157316,rs2032582,,,ABCB1,Dosage,1,methadone,1451643545.0,East Asian
1451643586,PA166155393,rs2279343,,,CYP2B6,Dosage,1,methadone,1451643600.0,East Asian
1451648769,PA166157216,rs72552763,,,SLC22A1,Dosage,-1,morphine,1451648780.0,European
1451648640,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,-1,morphine,1451648660.0,European
1451643580,PA166155409,rs3745274,,,CYP2B6,Dosage,1,methadone,1451643585.0,East Asian
1451643617,PA166156062,rs1065852,,,CYP2D6,Dosage,-1,methadone,1451643622.0,East Asian
1451648740,PA166157178,rs12208357,,,SLC22A1,Dosage,-1,morphine,1451648745.0,Unknown
1451648703,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,-1,morphine,1451648708.0,European
1451643703,PA166156105,rs4253728,,,PPARA,Metabolism/PK,1,2-hydroxyatorvastatin,1451643720.0,"Custom, HTCR (Human Tissue and Cell Research)"
1451643703,PA166156105,rs4253728,,,PPARA,Metabolism/PK,1,2-hydroxyatorvastatin,1451643727.0,European
1451648709,PA166157216,rs72552763,,,SLC22A1,Metabolism/PK,-1,morphine,1451648714.0,European
1451644760,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,1,2-hydroxyatorvastatin,1451644780.0,European
1451644760,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,2-hydroxyatorvastatin,1451644780.0,European
1451648830,PA166156507,rs1229984,,,ADH1B,Efficacy,-1,naltrexone,1451648920.0,Multiple groups
1451648927,PA166156476,rs698,,,ADH1C,Efficacy,1,naltrexone,1451648932.0,Multiple groups
1451648927,PA166156476,rs698,,,ADH1C,Efficacy,1,naltrexone,1451648932.0,Multiple groups
1451644868,PA166259561,rs3733260,,,PGRMC2,Metabolism/PK,-1,2-hydroxyatorvastatin,1451644872.0,"Custom, HTCR (Human Tissue and Cell Research)"
1451644868,PA166259561,rs3733260,,,PGRMC2,Metabolism/PK,-1,2-hydroxyatorvastatin,1451644873.0,European
1451648933,PA166154482,rs671,,,ALDH2,Efficacy,1,naltrexone,1451648938.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451648921,PA166156533,rs2066702,,,ADH1B,Efficacy,1,naltrexone,1451648926.0,Multiple groups
1451649100,PA166156991,rs1799971,,,OPRM1,Dosage,1,morphine,1451649106.0,East Asian
1451645240,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451645320.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451645340,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451645346.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451645407,PA166157284,rs1045642,,,ABCB1,Dosage,-1,methadone,1451645413.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451645368,PA166157288,rs1128503,,,ABCB1,Dosage,-1,methadone,1451645380.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451645400,PA166157316,rs2032582,,,ABCB1,Dosage,-1,methadone,1451645381.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451646320,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,tamoxifen,1451646340.0,Unknown
1451646320,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,tamoxifen,1451646340.0,Unknown
1451645382,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,methadone,1451645392.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451645347,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,methadone,1451645367.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451646240,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,n-desmethyltamoxifen,1451646243.0,Unknown
1451646240,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,n-desmethyltamoxifen,1451646243.0,Unknown
1451646392,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,tamoxifen,1451646421.0,Unknown
1451646392,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,tamoxifen,1451646421.0,Unknown
1451645393,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methadone,1451645406.0,"Multiple groups, ""Predominantly Caucasian"" cohort"
1451646480,PA166157487,rs35599367,,,CYP3A4,Efficacy,-1,atorvastatin,1451646485.0,European
1451646480,PA166157487,rs35599367,,,CYP3A4,Efficacy,-1,simvastatin,1451646485.0,European
1451652220,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1451652227.0,Unknown
1451652220,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1451652227.0,Unknown
1451646560,PA166156707,rs5326,,,DRD1,Dosage,1,methadone,1451646565.0,East Asian
1451652240,PA166155748,rs6714486,,,UGT1A9,Metabolism/PK,1,mycophenolic acid,1451652245.0,Unknown
1451652240,PA166155748,rs6714486,,,UGT1A9,Metabolism/PK,1,mycophenolic acid,1451652245.0,Unknown
1451652240,PA166155748,rs6714486,,,UGT1A9,Metabolism/PK,1,mycophenolic acid,1451652245.0,Unknown
1451647340,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,oxycodone,1451647380.0,"Multiple groups, Caucasian and African American ancestries"
1451647340,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,oxycodone,1451647380.0,"Multiple groups, Caucasian and African American ancestries"
1451678271,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,fentanyl,1451678320.0,Multiple groups
1451678271,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,fentanyl,1451678320.0,Multiple groups
1451678340,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,fentanyl,1451678360.0,Multiple groups
1451678262,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1451678300.0,Multiple groups
1451678262,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1451678300.0,Multiple groups
1451678262,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,fentanyl,1451678300.0,Multiple groups
1451679100,PA166155409,rs3745274,,,CYP2B6,Dosage,-1,methadone,1451679105.0,European
1451679040,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,methadone,1451679060.0,European
1451679040,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,methadone,1451679060.0,European
1451679040,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,methadone,1451679060.0,European
1451679146,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451679280.0,European
1451679146,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1451679151.0,European
1451660364,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,midazolam,1451660400.0,Unknown
1451660364,,,PA165819244,CYP3A4*20,CYP3A4,Metabolism/PK,-1,midazolam,1451660400.0,Unknown
1451679200,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1451679116.0,European
1451679260,PA166161944,rs10485058,,,OPRM1,Dosage,-1,methadone,1451679205.0,European
1451679300,PA166161944,rs10485058,,,OPRM1,Efficacy,-1,methadone,1451679309.0,European
1451679300,PA166161944,rs10485058,,,OPRM1,Efficacy,-1,methadone,1451679308.0,European
1451679529,PA166263684,rs55944529,,,DAO,Metabolism/PK,1,methadone,1451679534.0,Unknown
1451679535,PA166263681,rs11114083,,,DAO,Metabolism/PK,-1,methadone,1451679540.0,Unknown
1451679523,PA166263684,rs55944529,,,DAO,Dosage,1,methadone,1451679528.0,Unknown
1451679541,PA166263681,rs11114083,,,DAO,Dosage,-1,methadone,1451679546.0,Unknown
1451679553,PA166263682,rs2070586,,,DAO,Metabolism/PK,-1,methadone,1451679558.0,Unknown
1451679559,PA166263683,rs2070587,,,DAO,Metabolism/PK,-1,methadone,1451679564.0,Unknown
1451679547,PA166263682,rs2070586,,,DAO,Dosage,-1,methadone,1451679552.0,Unknown
1451679565,PA166263683,rs2070587,,,DAO,Dosage,-1,methadone,1451679570.0,Unknown
1451681600,PA166154895,rs2472297,,,CYP1A1,Metabolism/PK,1,clozapine,1451681640.0,European
1451682560,PA166156690,rs61750900,,,UGT2B10,Metabolism/PK,1,n-desmethylclozapine,1451682565.0,European
1451682566,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,1,n-desmethylclozapine,1451682580.0,European
1451682620,PA166156690,rs61750900,,,UGT2B10,Metabolism/PK,1,clozapine,1451682625.0,European
1451682582,PA166263902,rs1126545,,,CYP2C18,Metabolism/PK,1,clozapine,1451682680.0,European
1451682582,PA166263902,rs1126545,,,CYP2C18,Metabolism/PK,1,clozapine,1451682680.0,European
1451682582,PA166263902,rs1126545,,,CYP2C18,Metabolism/PK,1,clozapine,1451682680.0,European
1451683380,PA166263961,rs523349,,,SRD5A2,Efficacy,1,abiraterone,1451683385.0,Unknown
1451683600,PA166161401,rs743572,,,CYP17A1,Efficacy,-1,abiraterone,1451683605.0,Unknown
1451683680,PA166153943,rs12529,,,AKR1C3,Efficacy,-1,abiraterone,1451683663.0,Unknown
1451683620,PA166263962,rs2486758,,,CYP17A1,Efficacy,-1,abiraterone,1451683640.0,Unknown
1451663080,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,0,nicotine,1451663100.0,Unknown
1450823491,PA166184831,rs58310495,,,SLCO1B1,Metabolism/PK,1,fluvastatin,1450823495.0,European
1451664500,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,duloxetine,1451664483.0,European
1451664500,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,duloxetine,1451664483.0,European
1451664485,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,desvenlafaxine,1451664490.0,European
1451664485,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,desvenlafaxine,1451664490.0,European
1451664492,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,desvenlafaxine,1451664497.0,European
1451664492,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,desvenlafaxine,1451664497.0,European
1451684880,PA166264141,rs2075748,,,CHRM1,Dosage,1,clozapine,1451684920.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451684940,PA166264181,rs1942499,,,CHRM1,Dosage,1,clozapine,1451684945.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451684940,PA166264181,rs1942499,,,CHRM1,Dosage,1,clozapine,1451684945.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451664820,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451664860.0,"Multiple groups, White, Black, HIspanic, Asian and Other ethnicities."
1451664820,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451664860.0,"Multiple groups, White, Black, HIspanic, Asian and Other ethnicities."
1451664820,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451664860.0,"Multiple groups, White, Black, HIspanic, Asian and Other ethnicities."
1451664820,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451664860.0,"Multiple groups, White, Black, HIspanic, Asian and Other ethnicities."
1451664820,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451664860.0,"Multiple groups, White, Black, HIspanic, Asian and Other ethnicities."
1451664820,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451664860.0,"Multiple groups, White, Black, HIspanic, Asian and Other ethnicities."
1451664980,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,coumarin,1451665000.0,East Asian
1451664980,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,coumarin,1451665000.0,East Asian
1451664980,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,coumarin,1451665000.0,East Asian
1451664980,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,coumarin,1451665000.0,East Asian
1451664980,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,coumarin,1451665000.0,East Asian
1451664980,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,1451665000.0,East Asian
1451664980,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451665000.0,East Asian
1451664980,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,1,nicotine,1451665000.0,East Asian
1451685290,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,0,clozapine,1451685300.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451685290,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,0,clozapine,1451685300.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451685290,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,0,clozapine,1451685300.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451665040,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,0,coumarin,1451665060.0,East Asian
1451665040,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,coumarin,1451665060.0,East Asian
1451665040,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,coumarin,1451665060.0,East Asian
1451665040,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,coumarin,1451665060.0,East Asian
1451665040,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,0,nicotine,1451665060.0,East Asian
1451665040,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,nicotine,1451665060.0,East Asian
1451685223,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,clozapine,1451685246.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451685223,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,clozapine,1451685246.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451685223,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,clozapine,1451685246.0,"Multiple groups, Centre for Addictions and Mental Health (CAMH) in the Greater Toronto Area, 21–70 years age range, 78% white and 22% non-white, although one participant’s ethnicity is unknown"
1451686520,PA166154176,rs28371686,,,CYP2C9,Dosage,1,warfarin,1451686540.0,"Multiple groups, multi-site USA"
1451686520,PA166154176,rs28371686,,,CYP2C9,Dosage,1,warfarin,1451686541.0,African American/Afro-Caribbean
1451686520,PA166154176,rs28371686,,,CYP2C9,Dosage,1,warfarin,1451686540.0,"Multiple groups, multi-site USA"
1451686520,PA166154176,rs28371686,,,CYP2C9,Dosage,1,warfarin,1451686541.0,African American/Afro-Caribbean
1451665780,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924752,CYP2A6*23,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924752,CYP2A6*23,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924755,CYP2A6*25,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924756,CYP2A6*26,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924757,CYP2A6*27,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165924757,CYP2A6*27,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451665780,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451665761.0,African American/Afro-Caribbean
1451686760,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1451686820.0,Sub-Saharan African
1451686940,PA166264401,rs115629050,,,CES1,Efficacy,-1,sofosbuvir,1451686946.0,European
1451686940,PA166264401,rs115629050,,,CES1,Efficacy,-1,sofosbuvir,1451686945.0,European
1451686950,PA166264402,rs4513095,,,CES1,Efficacy,1,sofosbuvir,1451686955.0,Unknown
1451686950,PA166264402,rs4513095,,,CES1,Efficacy,1,sofosbuvir,1451686956.0,Unknown
1451686950,PA166264402,rs4513095,,,CES1,Efficacy,1,sofosbuvir,1451686955.0,Unknown
1451686950,PA166264402,rs4513095,,,CES1,Efficacy,1,sofosbuvir,1451686956.0,Unknown
1451666180,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451666240.0,African American/Afro-Caribbean
1451666180,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451666200.0,African American/Afro-Caribbean
1451666180,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,nicotine,1451666240.0,African American/Afro-Caribbean
1451666180,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,nicotine,1451666200.0,African American/Afro-Caribbean
1451666180,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451666240.0,African American/Afro-Caribbean
1451666180,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451666200.0,African American/Afro-Caribbean
1451666180,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451666240.0,African American/Afro-Caribbean
1451666180,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451666200.0,African American/Afro-Caribbean
1451666225,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,0,nicotine,1451666230.0,African American/Afro-Caribbean
982043792,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,rosuvastatin,982043799.0,East Asian
982043792,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,rosuvastatin,982043799.0,East Asian
1451692484,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1451692490.0,Unknown
1451666680,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,fluvastatin,1451666685.0,East Asian
1451666680,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,fluvastatin,1451666685.0,East Asian
1451692560,PA166155621,rs1056836,,,CYP1B1,Efficacy,1,codeine,1451692620.0,European
1451692560,PA166155621,rs1056836,,,CYP1B1,Efficacy,1,tramadol,1451692620.0,European
1451140100,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,indomethacin,1451140120.0,Multiple groups
1451692660,PA166264581,rs1056837,,,CYP1B1,Efficacy,1,codeine,1451692683.0,European
1451692660,PA166264581,rs1056837,,,CYP1B1,Efficacy,1,tramadol,1451692683.0,European
1451666721,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,fluvastatin,1451666726.0,East Asian
1451666721,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,fluvastatin,1451666726.0,East Asian
1451692692,PA166264621,rs76026520,,,MACROD2,Efficacy,1,hydrocodone,1451692697.0,European
1451692692,PA166264621,rs76026520,,,MACROD2,Efficacy,1,oxycodone,1451692697.0,European
1451667320,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672860,PA166155551,rs140471703,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451692704,PA166156167,rs35742686,,,CYP2D6,Efficacy,1,hydrocodone,1451692741.0,European
1451692704,PA166156167,rs35742686,,,CYP2D6,Efficacy,1,oxycodone,1451692741.0,European
1451672680,PA166262001,rs199515342,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451692802,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,clozapine,1451692820.0,Unknown
1451672684,PA166261982,rs571335587,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672700,PA166262002,rs61605570,,,CYP2A6,Metabolism/PK,0,nicotine,,
1447964201,PA166156602,rs6551665,,,ADGRL3,Efficacy,-1,methylphenidate,1447964234.0,"Multiple groups, European-Brazilian and African-Brazilian"
1451672704,PA166261983,rs768416963,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672720,PA166261984,rs1302192284,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672764,PA166262021,rs114558780,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451697420,PA166157375,rs3735451,,,CYP3A4,Metabolism/PK,1,hydroxychloroquine,1451697440.0,Unknown
1451672740,PA166261985,rs111869995,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672760,PA166262003,rs137904044,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451673060,PA166262101,rs150247689,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672768,PA166262004,rs200554095,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672772,PA166262005,rs772964366,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672820,PA166262006,rs138978736,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672824,PA166262007,rs761666827,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451673040,PA166262081,rs143841823,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672880,PA166262008,rs758479488,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672884,PA166262009,rs145157460,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672960,PA166262022,rs148693084,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672964,PA166262041,rs1303839356,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451672968,PA166262042,rs778019189,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451674400,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,pitavastatin,1451674406.0,East Asian
1451674400,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,pitavastatin,1451674406.0,East Asian
1451674420,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1451674440.0,East Asian
1451674420,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,pitavastatin,1451674440.0,East Asian
1451700080,PA166156492,rs835309,,,UGT2B10,Metabolism/PK,-1,nicotine,1451700100.0,Multiple groups
1451672980,PA166262043,rs374515279,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451700101,PA166156651,rs11726322,,,UGT2B10,Metabolism/PK,-1,nicotine,1451700084.0,Multiple groups
1451700120,PA166163174,rs2942857,,,UGT2B10,Metabolism/PK,-1,nicotine,1451700124.0,Multiple groups
1451673000,PA166262061,rs145308399,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451673020,PA166262062,rs777098658,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451673080,PA166155422,rs5031016,,,CYP2A6,Metabolism/PK,0,nicotine,,
1451674520,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,pitavastatin,1451674524.0,East Asian
1451674540,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,pitavastatin,1451674560.0,East Asian
1451674540,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,pitavastatin,1451674560.0,East Asian
1451674540,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,pitavastatin,1451674560.0,East Asian
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675720,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675720,,,PA165924741,CYP2A6*14,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA165924741,CYP2A6*14,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA165924741,CYP2A6*14,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA165924741,CYP2A6*14,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA165924741,CYP2A6*14,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA165924741,CYP2A6*14,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675760.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675781.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675783.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675820.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675800.0,European
1451675720,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675782.0,European
1451675840,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675860.0,European
1451675840,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675880.0,European
1451675840,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675861.0,European
1451675840,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451675843.0,European
1451675840,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451675860.0,European
1451675840,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451675880.0,European
1451675840,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451675861.0,European
1451675840,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451675843.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675860.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675880.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675861.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675843.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675860.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675880.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675861.0,European
1451675840,,,PA166117264,CYP2A6*38,CYP2A6,Metabolism/PK,1,nicotine,1451675843.0,European
1451676000,PA166175994,rs678849,,,OPRD1,Efficacy,1,buprenorphine,1451676180.0,European
1451701983,PA166156286,rs324026,,,DRD3,Efficacy,1,olanzapine,1451701988.0,East Asian
1451701983,PA166156286,rs324026,,,DRD3,Efficacy,1,olanzapine,1451702000.0,East Asian
1451676184,PA166175994,rs678849,,,OPRD1,Efficacy,-1,buprenorphine,1451676189.0,African American/Afro-Caribbean
1451676184,PA166175994,rs678849,,,OPRD1,Efficacy,-1,buprenorphine,1451676189.0,African American/Afro-Caribbean
1449714757,PA166179993,rs553668,,,ADRA2A,Dosage,-1,opioids,1449714759.0,European
1449714757,PA166179993,rs553668,,,ADRA2A,Dosage,-1,opioids,1449714760.0,European
1184470133,PA166154301,rs757110,,,ABCC8,Dosage,-1,gliclazide,1184470152.0,European
1184470133,PA166154301,rs757110,,,ABCC8,Dosage,-1,glimepiride,1184470152.0,European
1184470133,PA166154301,rs757110,,,ABCC8,Dosage,-1,glipizide,1184470152.0,European
1184470133,PA166154301,rs757110,,,ABCC8,Dosage,-1,gliquidone,1184470152.0,European
1184470133,PA166154301,rs757110,,,ABCC8,Dosage,-1,glyburide,1184470152.0,European
1451707240,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,-1,efavirenz,1451707260.0,Sub-Saharan African
1451707240,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,-1,efavirenz,1451707261.0,Sub-Saharan African
1451714340,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1451714345.0,European
1451714340,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1451714345.0,European
1451707041,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1451707047.0,Sub-Saharan African
1451707041,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1451707061.0,Sub-Saharan African
1451714346,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,1,tacrolimus,1451714351.0,European
1451714346,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451714351.0,European
1451706780,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1451706800.0,Sub-Saharan African
1451706780,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1451706801.0,Sub-Saharan African
1451715780,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,citalopram,1451715800.0,Unknown
1451707340,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1451707360.0,Sub-Saharan African
1451707340,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1451707361.0,Sub-Saharan African
1451707346,PA166155444,rs8192719,,,CYP2B6,Metabolism/PK,1,efavirenz,1451707271.0,Sub-Saharan African
1451707346,PA166155444,rs8192719,,,CYP2B6,Metabolism/PK,1,efavirenz,1451707351.0,Sub-Saharan African
1451715786,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,citalopram,1451715792.0,Unknown
1451719580,PA166232961,rs28379954,,,NFIB,Metabolism/PK,1,paliperidone,1451719660.0,European
1451719580,PA166232961,rs28379954,,,NFIB,Metabolism/PK,1,risperidone,1451719660.0,European
1451720320,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,clozapine,1451720326.0,Unknown
1451720380,PA166153644,rs1801133,,,MTHFR,Dosage,1,capecitabine,1451720440.0,Unknown
1451720380,PA166153644,rs1801133,,,MTHFR,Dosage,1,capecitabine,1451720400.0,Unknown
1451720380,PA166153644,rs1801133,,,MTHFR,Dosage,1,fluorouracil,1451720440.0,Unknown
1451720380,PA166153644,rs1801133,,,MTHFR,Dosage,1,fluorouracil,1451720400.0,Unknown
1451722660,PA166266961,rs12199316,,,TPMT,Dosage,1,mercaptopurine,1451722665.0,"Multiple groups, St Judes"
1451722660,PA166266961,rs12199316,,,TPMT,Dosage,1,mercaptopurine,1451722666.0,"Multiple groups, St Judes"
1451725060,PA166267001,rs73189762,,,NUDT15,Dosage,1,mercaptopurine,1451725068.0,"Multiple groups, St Judes"
1451725060,PA166267001,rs73189762,,,NUDT15,Dosage,1,mercaptopurine,1451725069.0,"Multiple groups, St Judes"
1449157689,PA166154583,rs4149117,,,SLCO1B3,Dosage,1,warfarin,1449157691.0,East Asian
1451144740,PA166157487,rs35599367,,,CYP3A4,Efficacy,1,alprazolam,1451144746.0,Unknown
1451144700,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,alprazolam,1451144706.0,Unknown
1451144700,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,alprazolam,1451144706.0,Unknown
1451726355,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,docetaxel,1451726400.0,Unknown
1451726355,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,paclitaxel,1451726400.0,Unknown
1451726202,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,paclitaxel,1451726206.0,Unknown
1451726202,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,paclitaxel,1451726206.0,Unknown
1451726920,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451726908.0,European
1451726260,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,docetaxel,1451726219.0,Unknown
1451726260,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,docetaxel,1451726219.0,Unknown
1451726360,PA166155759,rs6755571,,,UGT1A4,Metabolism/PK,1,lamotrigine,1451726365.0,European
1451726360,PA166155759,rs6755571,,,UGT1A4,Metabolism/PK,1,lamotrigine,1451726348.0,European
1451726491,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,lamotrigine,1451726623.0,European
1451726280,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,docetaxel,1451726300.0,Unknown
1451726280,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,docetaxel,1451726300.0,Unknown
1451726778,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,lamotrigine,1451726860.0,European
1451726778,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,lamotrigine,1451726880.0,European
1451726420,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,-1,paclitaxel,1451726440.0,Unknown
1451726420,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,-1,paclitaxel,1451726440.0,Unknown
1451726420,,,PA165958686,CYP2C8*4,CYP2C8,Efficacy,-1,paclitaxel,1451726440.0,Unknown
1451726901,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451726906.0,European
1451726901,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451726906.0,European
1451726901,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,lamotrigine,1451726906.0,European
1451727960,PA166153911,rs77235035,,,PEAR1,Metabolism/PK,-1,ticagrelor,1451727964.0,East Asian
1449748460,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,tacrolimus,1449748470.0,East Asian
1449748460,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,tacrolimus,1449748470.0,East Asian
1447948367,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,gefitinib,1447948369.0,East Asian
1447948367,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,gefitinib,1447948369.0,East Asian
1451134880,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,sufentanil,1451134861.0,East Asian
1451134880,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,sufentanil,1451134861.0,East Asian
1450824004,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,clopidogrel,1450824010.0,European
1450824004,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,clopidogrel,1450824010.0,European
1450823962,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1450823969.0,East Asian
1450823962,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1450823969.0,East Asian
1447520683,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1447520695.0,East Asian
1447520683,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1447520695.0,East Asian
1447948541,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,gefitinib,1447948543.0,Unknown
1447948541,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,gefitinib,1447948543.0,Unknown
1449715407,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,sufentanil,1449715409.0,Unknown
1449715407,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,sufentanil,1449715409.0,Unknown
1448633769,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,clopidogrel,1448633771.0,Near Eastern
1448633769,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,clopidogrel,1448633771.0,Near Eastern
1183689729,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689737.0,East Asian
1183689729,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689737.0,East Asian
1451134740,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,sufentanil,1451134760.0,East Asian
1451134740,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,sufentanil,1451134760.0,East Asian
827812461,,,PA165819201,CYP3A4*1,CYP3A4,Other,1,tacrolimus,827812466.0,East Asian
827812461,,,PA165819201,CYP3A4*1,CYP3A4,Other,1,tacrolimus,827812466.0,East Asian
827812461,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,827812466.0,East Asian
827812461,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,827812466.0,East Asian
1450928466,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1450928472.0,East Asian
1450928466,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1450928472.0,East Asian
1450823997,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,clopidogrel,1450824003.0,European
1450823997,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,clopidogrel,1450824003.0,European
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689780.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1451331564.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689781.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1451331620.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689805.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689780.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1451331564.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689781.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1451331620.0,East Asian
1183689778,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1183689805.0,East Asian
981843814,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,981843834.0,East Asian
981843814,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1451331560.0,East Asian
981843814,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,981843834.0,East Asian
981843814,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1451331560.0,East Asian
1445584912,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1445584924.0,East Asian
1445584912,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1445584924.0,East Asian
1449715394,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,sufentanil,1449715406.0,Unknown
1449715394,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,sufentanil,1449715406.0,Unknown
1449716632,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716644.0,East Asian
1449716632,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716644.0,East Asian
1451729080,PA166153960,rs1057911,,,CYP2C9,Metabolism/PK,-1,AR-C124910XX,1451729084.0,East Asian
1451729080,PA166153960,rs1057911,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451729084.0,East Asian
1451729097,PA166267582,rs9332245,,,CYP2C9,Metabolism/PK,-1,AR-C124910XX,1451729121.0,East Asian
1451729097,PA166267582,rs9332245,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451729121.0,East Asian
1451729123,PA166155392,rs2279342,,,CYP2B6,Metabolism/PK,-1,AR-C124910XX,1451729127.0,East Asian
1451729123,PA166155392,rs2279342,,,CYP2B6,Metabolism/PK,-1,ticagrelor,1451729127.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,AR-C124910XX,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451727971,PA166267562,rs17847029,,,CYP2C9,Metabolism/PK,-1,ticagrelor,1451727975.0,East Asian
1451729281,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,AR-C124910XX,1451729300.0,East Asian
1451729281,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,ticagrelor,1451729300.0,East Asian
1451729346,PA166157481,rs28371759,,,CYP3A4,Metabolism/PK,-1,AR-C124910XX,1451729350.0,East Asian
1451729346,PA166157481,rs28371759,,,CYP3A4,Metabolism/PK,-1,ticagrelor,1451729350.0,East Asian
1451729240,PA166154156,rs12769205,,,CYP2C19,Metabolism/PK,-1,AR-C124910XX,1451729260.0,East Asian
1451729240,PA166154156,rs12769205,,,CYP2C19,Metabolism/PK,-1,ticagrelor,1451729260.0,East Asian
1451729340,PA166154032,rs3758580,,,CYP2C19,Metabolism/PK,-1,AR-C124910XX,1451729344.0,East Asian
1451729340,PA166154032,rs3758580,,,CYP2C19,Metabolism/PK,-1,ticagrelor,1451729344.0,East Asian
1451729352,PA166157243,rs15524,,,CYP3A5,Metabolism/PK,-1,AR-C124910XX,1451729356.0,East Asian
1451729352,PA166157243,rs15524,,,CYP3A5,Metabolism/PK,-1,ticagrelor,1451729356.0,East Asian
1451729358,PA166249941,rs4646453,,,CYP3A5,Metabolism/PK,-1,AR-C124910XX,1451729380.0,East Asian
1451729358,PA166249941,rs4646453,,,CYP3A5,Metabolism/PK,-1,ticagrelor,1451729380.0,East Asian
1451729373,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,-1,AR-C124910XX,1451729401.0,East Asian
1451729373,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,-1,ticagrelor,1451729401.0,East Asian
1451729393,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,AR-C124910XX,1451729448.0,East Asian
1451729393,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ticagrelor,1451729448.0,East Asian
1451729393,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ticagrelor,1451729448.0,East Asian
1451729393,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ticagrelor,1451729448.0,East Asian
1450930992,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,tacrolimus,1450930997.0,
1451732680,PA166157306,rs1800797,,,IL6,Dosage,1,opioids,1451732686.0,European
1444935523,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,carbamazepine,1444935534.0,East Asian
1444935523,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,carbamazepine,1444935557.0,East Asian
1449269443,PA166157345,rs2242480,,,CYP3A4,Efficacy,-1,oxycodone,1449269445.0,East Asian
1451732688,PA166156997,rs1800629,,,TNF,Dosage,1,opioids,1451732694.0,European
1451732760,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,rosuvastatin,1451732764.0,"Multiple groups, Three of them were conducted in China, two in the U.S.A., one in Canada, one in Finland, and one in Korea. Six of them were cohort studies, and two were randomized controlled trials."
1451734000,PA166157398,rs4728709,,,ABCB1,Metabolism/PK,0,rivaroxaban,1451734005.0,East Asian
1451734503,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,diazepam,1451734520.0,"Custom, "" Russian"""
1451734560,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,diazepam,1451734550.0,"Custom, "" Russian"""
1451735260,PA166157487,rs35599367,,,CYP3A,Efficacy,1,diazepam,1451735265.0,Unknown
1451735260,PA166157487,rs35599367,,,CYP3A4,Efficacy,1,diazepam,1451735265.0,Unknown
1451735420,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,1,voriconazole,1451735424.0,East Asian
1451735380,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,voriconazole,1451735400.0,East Asian
1451735460,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,-1,voriconazole,1451735480.0,East Asian
1451735563,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,voriconazole,1451735544.0,East Asian
1451740000,PA166202681,rs163184,,,KCNQ1,Efficacy,1,exenatide,1451740020.0,East Asian
1184510805,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,diclofenac,1451740280.0,"Multiple groups, 84 Cuban-Mestizo, 76 Cuban-White"
1184510805,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,diclofenac,1184510814.0,"Multiple groups, 84 Cuban-Mestizo, 76 Cuban-White"
1184510805,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,diclofenac,1451740280.0,"Multiple groups, 84 Cuban-Mestizo, 76 Cuban-White"
1184510805,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,diclofenac,1184510814.0,"Multiple groups, 84 Cuban-Mestizo, 76 Cuban-White"
1184510805,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,1,diclofenac,1451740280.0,"Multiple groups, 84 Cuban-Mestizo, 76 Cuban-White"
1184510805,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,1,diclofenac,1184510814.0,"Multiple groups, 84 Cuban-Mestizo, 76 Cuban-White"
1450375583,PA166182334,rs4148155,,,ABCG2,Efficacy,-1,allopurinol,1450375585.0,European
1450375583,PA166182334,rs4148155,,,ABCG2,Efficacy,-1,allopurinol,1450375632.0,"Multiple groups, Non-Hispanic White, Asian, African American and Latino"
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,diuretics,1183632052.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,diuretics,1183632056.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,diuretics,1183632070.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,diuretics,1183632072.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,hydrochlorothiazide,1183632052.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,hydrochlorothiazide,1183632056.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,hydrochlorothiazide,1183632070.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,hydrochlorothiazide,1183632072.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632052.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632056.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632070.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632072.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632052.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632056.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632070.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632072.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632052.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632056.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632070.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632072.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632052.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632056.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632070.0,European
1183631253,PA166155256,rs16960228,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632072.0,European
769257715,PA166157284,rs1045642,,,ABCB1,Other,-1,carbamazepine,769257717.0,East Asian
769257715,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,carbamazepine,769257717.0,East Asian
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,diuretics,1183631269.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,diuretics,1183632066.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,diuretics,1183632068.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,hydrochlorothiazide,1183631269.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,hydrochlorothiazide,1183632066.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,hydrochlorothiazide,1183632068.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,"Thiazides, plain",1183631269.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,"Thiazides, plain",1183632066.0,European
1183631267,PA166155924,rs2273359,,,NELFCD,Efficacy,-1,"Thiazides, plain",1183632068.0,European
1183632046,PA166155948,rs4815273,,,None,Efficacy,1,diuretics,1183632048.0,European
1183632046,PA166155948,rs4815273,,,None,Efficacy,1,diuretics,1183633628.0,European
1183632046,PA166155948,rs4815273,,,None,Efficacy,1,hydrochlorothiazide,1183632048.0,European
1183632046,PA166155948,rs4815273,,,None,Efficacy,1,hydrochlorothiazide,1183633628.0,European
1183632046,PA166155948,rs4815273,,,None,Efficacy,1,"Thiazides, plain",1183632048.0,European
1183632046,PA166155948,rs4815273,,,None,Efficacy,1,"Thiazides, plain",1183633628.0,European
1183632057,PA166155224,rs4791040,,,PRKCA,Efficacy,1,diuretics,1183632059.0,European
1183632057,PA166155224,rs4791040,,,PRKCA,Efficacy,1,diuretics,1183632062.0,European
1183632057,PA166155224,rs4791040,,,PRKCA,Efficacy,1,hydrochlorothiazide,1183632059.0,European
1183632057,PA166155224,rs4791040,,,PRKCA,Efficacy,1,hydrochlorothiazide,1183632062.0,European
1183632057,PA166155224,rs4791040,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632059.0,European
1183632057,PA166155224,rs4791040,,,PRKCA,Efficacy,1,"Thiazides, plain",1183632062.0,European
1451774660,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,dolutegravir,1451774665.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451774741,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,dolutegravir,1451774800.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451774741,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,1,dolutegravir,1451774800.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451774741,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,dolutegravir,1451774800.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451775480,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,dolutegravir,1451775485.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451775480,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,dolutegravir,1451775485.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451775480,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,dolutegravir,1451775485.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1451775480,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,dolutegravir,1451775485.0,"Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other."
1183634117,PA166155095,rs9933692,,,HS3ST4,Efficacy,-1,diuretics,1183634119.0,European
1183634117,PA166155095,rs9933692,,,HS3ST4,Efficacy,-1,diuretics,1183634120.0,European
1183634117,PA166155095,rs9933692,,,HS3ST4,Efficacy,-1,hydrochlorothiazide,1183634119.0,European
1183634117,PA166155095,rs9933692,,,HS3ST4,Efficacy,-1,hydrochlorothiazide,1183634120.0,European
1183634117,PA166155095,rs9933692,,,HS3ST4,Efficacy,-1,"Thiazides, plain",1183634119.0,European
1183634117,PA166155095,rs9933692,,,HS3ST4,Efficacy,-1,"Thiazides, plain",1183634120.0,European
1183634138,PA166155059,rs4074471,,,HS3ST4,Efficacy,-1,diuretics,1183634140.0,European
1183634138,PA166155059,rs4074471,,,HS3ST4,Efficacy,-1,diuretics,1183634141.0,European
1183634138,PA166155059,rs4074471,,,HS3ST4,Efficacy,-1,hydrochlorothiazide,1183634140.0,European
1183634138,PA166155059,rs4074471,,,HS3ST4,Efficacy,-1,hydrochlorothiazide,1183634141.0,European
1183634138,PA166155059,rs4074471,,,HS3ST4,Efficacy,-1,"Thiazides, plain",1183634140.0,European
1183634138,PA166155059,rs4074471,,,HS3ST4,Efficacy,-1,"Thiazides, plain",1183634141.0,European
1451775982,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,tacrolimus,1451776020.0,Unknown
1451775982,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,tacrolimus,1451776020.0,Unknown
1451775982,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,1,tacrolimus,1451776020.0,Unknown
1451775982,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tacrolimus,1451776020.0,Unknown
1451775982,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,tacrolimus,1451776020.0,Unknown
1451775982,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,tacrolimus,1451776020.0,Unknown
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,diuretics,1183634270.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,diuretics,1183634271.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,hydrochlorothiazide,1183634270.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,hydrochlorothiazide,1183634271.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634270.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634271.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634270.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634271.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634270.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634271.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634270.0,European
1183634268,PA166155956,rs6083538,,,None,Efficacy,-1,"Thiazides, plain",1183634271.0,European
1451781260,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818807,CYP2B6*9,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1451781260,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,(S)-methadone,1451781268.0,Unknown
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,diuretics,1183634303.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,diuretics,1183634304.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,hydrochlorothiazide,1183634303.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,hydrochlorothiazide,1183634304.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,"Thiazides, plain",1183634303.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,"Thiazides, plain",1183634304.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,"Thiazides, plain",1183634303.0,European
1183634301,PA166157451,rs11763492,,,CNTNAP2,Efficacy,-1,"Thiazides, plain",1183634304.0,European
1356539101,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1357775027.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1356539101,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1357775027.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1356539101,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1357775027.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1356539101,,,PA165819272,TPMT*3C,TPMT,Dosage,1,thioguanine,1357775027.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1451782460,PA166154855,rs1048943,,,CYP1A1,Efficacy,1,nilotinib,1451782466.0,Central/South Asian
1451782460,PA166154855,rs1048943,,,CYP1A1,Efficacy,1,nilotinib,1451782465.0,Central/South Asian
1451782480,PA166154249,rs1695,,,GSTP1,Efficacy,1,nilotinib,1451782501.0,Central/South Asian
1451782480,PA166154249,rs1695,,,GSTP1,Efficacy,1,nilotinib,1451782520.0,Central/South Asian
1451782480,PA166154249,rs1695,,,GSTP1,Efficacy,1,nilotinib,1451782500.0,Central/South Asian
1353450854,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1353451337.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1353451277.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1353451345.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1353451337.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1353451277.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1353451345.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1353451337.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1353451277.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819268,TPMT*1,TPMT,Dosage,1,thioguanine,1353451345.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819270,TPMT*3A,TPMT,Dosage,1,thioguanine,1353451337.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819270,TPMT*3A,TPMT,Dosage,1,thioguanine,1353451277.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
1353450854,,,PA165819270,TPMT*3A,TPMT,Dosage,1,thioguanine,1353451345.0,"Multiple groups, White, Asian (Indian sub-continent), mixed, Black, Oriental, unknown"
981501641,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,sulfapyridine,981501645.0,East Asian
981501641,,,PA165949099,NAT2*5A,NAT2,Metabolism/PK,1,sulfapyridine,981501645.0,East Asian
981501641,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501645.0,East Asian
981501641,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,1,sulfapyridine,981501645.0,East Asian
981501641,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,sulfapyridine,981501645.0,East Asian
1451793682,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949099,NAT2*5A,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949101,NAT2*5C,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949102,NAT2*5D,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949138,NAT2*12A,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949138,NAT2*12A,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165981639,NAT2*13,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451793682,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,0,caffeine,1451793694.0,European
1451788360,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1451788365.0,Central/South Asian
1451788360,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451788365.0,Central/South Asian
1451788400,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1451788405.0,Central/South Asian
1451788400,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1451788405.0,Central/South Asian
1451788440,PA166153959,rs1057910,,,CYP2C9,Dosage,1,acenocoumarol,1451788410.0,Central/South Asian
1451788440,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1451788410.0,Central/South Asian
1451788412,PA166153972,rs1799853,,,CYP2C9,Dosage,-1,acenocoumarol,1451788445.0,Central/South Asian
1451788412,PA166153972,rs1799853,,,CYP2C9,Dosage,-1,warfarin,1451788445.0,Central/South Asian
1183680038,PA166157133,rs8191725,,,IGF2R,Efficacy,1,salbutamol,1183680042.0,Latino
1183680038,PA166157133,rs8191725,,,IGF2R,Efficacy,1,salbutamol,1183680046.0,Latino
1183680038,PA166157133,rs8191725,,,IGF2R,Efficacy,1,salbutamol,1183680044.0,Latino
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753820.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753821.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753805.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753820.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753821.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753805.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753820.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753821.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753805.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753820.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753821.0,East Asian
1451753800,PA166156463,rs17026688,,,GADL1,Efficacy,1,lithium,1451753805.0,East Asian
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,donepezil,1183703675.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,donepezil,1183703667.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,donepezil,1183703671.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,galantamine,1183703675.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,galantamine,1183703667.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,galantamine,1183703671.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,rivastigmine,1183703675.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,rivastigmine,1183703667.0,European
1183703663,PA166155750,rs6720975,,,PRKCE,Efficacy,1,rivastigmine,1183703671.0,European
1444703337,PA166156978,rs1142345,,,TPMT,Dosage,1,mercaptopurine,1444703357.0,Multiple groups
1444703337,PA166156978,rs1142345,,,TPMT,Dosage,1,mercaptopurine,1444703359.0,Multiple groups
1444703361,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1444703363.0,Multiple groups
1444703361,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1444703364.0,Multiple groups
1451139042,,,PA165949102,NAT2*5D,NAT2,Metabolism/PK,1,dipyrone,1451139060.0,European
1451139042,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,1,dipyrone,1451139060.0,European
1451139042,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,dipyrone,1451139060.0,European
1451139042,,,PA165949150,NAT2*14A,NAT2,Metabolism/PK,1,dipyrone,1451139060.0,European
1451136500,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,0,hydralazine,1451136507.0,Unknown
1451136500,,,PA165949102,NAT2*5D,NAT2,Metabolism/PK,0,hydralazine,1451136507.0,Unknown
1451136500,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,0,hydralazine,1451136507.0,Unknown
1451136500,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,0,hydralazine,1451136507.0,Unknown
1184174568,,,PA165949098,NAT2*4,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
1184174568,,,PA165949102,NAT2*5D,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
1184174568,,,PA165949116,NAT2*6B,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
1184174568,,,PA165949130,NAT2*7A,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
1184174568,,,PA165949138,NAT2*12A,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
1184174568,,,PA165949148,NAT2*13A,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
1184174568,,,PA165949150,NAT2*14A,NAT2,Efficacy,-1,hydralazine,1184174570.0,Unknown
981851641,,,PA165949098,NAT2*4,NAT2,Dosage,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949098,NAT2*4,NAT2,Dosage,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949102,NAT2*5D,NAT2,Dosage,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949102,NAT2*5D,NAT2,Dosage,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949116,NAT2*6B,NAT2,Dosage,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949116,NAT2*6B,NAT2,Dosage,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949130,NAT2*7A,NAT2,Dosage,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949130,NAT2*7A,NAT2,Dosage,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Dosage,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Dosage,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Dosage,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Dosage,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949102,NAT2*5D,NAT2,Metabolism/PK,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949102,NAT2*5D,NAT2,Metabolism/PK,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Metabolism/PK,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Metabolism/PK,1,isoniazid,981851645.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Metabolism/PK,1,isoniazid,1448261901.0,East Asian
981851641,,,PA165949150,NAT2*14A,NAT2,Metabolism/PK,1,isoniazid,981851645.0,East Asian
1183702439,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1183702441.0,Unknown
1183702439,,,PA165949099,NAT2*5A,NAT2,Metabolism/PK,1,isoniazid,1183702441.0,Unknown
1183702439,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,1,isoniazid,1183702441.0,Unknown
1183702439,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,isoniazid,1183702441.0,Unknown
1183702439,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,isoniazid,1183702441.0,Unknown
1183702439,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,isoniazid,1183702441.0,Unknown
1451760640,PA166154874,rs2069514,,,CYP1A2,Metabolism/PK,-1,clozapine,1451760645.0,Unknown
1451760610,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,clozapine,1451760620.0,Unknown
1451760660,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,clozapine,1451760680.0,Unknown
1451760997,PA166154713,rs3742106,,,ABCC4,Toxicity,1,tenofovir,1451761002.0,Unknown
1451760997,PA166154713,rs3742106,,,ABCC4,Toxicity,1,tenofovir,1451761020.0,Unknown
1451760997,PA166154713,rs3742106,,,ABCC4,Toxicity,1,tenofovir,1451761021.0,Unknown
1451807080,PA166271681,rs7627954,,,TNIK,Efficacy,1,risperidone,1451807100.0,East Asian
1451761040,PA166154702,rs1751034,,,ABCC4,Toxicity,1,tenofovir,1451761060.0,Unknown
1451761040,PA166154702,rs1751034,,,ABCC4,Toxicity,1,tenofovir,1451761080.0,Unknown
1451761040,PA166154702,rs1751034,,,ABCC4,Toxicity,1,tenofovir,1451761081.0,Unknown
1451806987,PA166271661,rs2088885,,,TNIK,Efficacy,1,risperidone,1451807040.0,East Asian
1451807340,PA166271642,rs11188059,,,CYP2C18,Metabolism/PK,1,escitalopram,1451807344.0,European
1451807320,PA166271641,rs2860840,,,CYP2C18,Metabolism/PK,1,escitalopram,1451807324.0,European
981476160,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
981476160,,,PA165949099,NAT2*5A,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
981476160,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
981476160,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
981476160,,,PA165949138,NAT2*12A,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
981476160,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
981476160,,,PA165949150,NAT2*14A,NAT2,Metabolism/PK,0,isoniazid,981476162.0,Unknown
1451804900,PA166156900,rs4880,,,SOD2,Toxicity,1,bilirubin,1451804920.0,"Multiple groups, Los Angeles, Hispanic (n = 89), Non-Hispanic (n = 54), age of patients ranged from < 1–20 years"
1451804900,PA166156900,rs4880,,,SOD2,Toxicity,1,bilirubin,1451804921.0,"Multiple groups, Los Angeles, Hispanic (n = 89), Non-Hispanic (n = 54), age of patients ranged from < 1–20 years"
1451804900,PA166156900,rs4880,,,SOD2,Toxicity,1,bilirubin,1451804922.0,"Multiple groups, Los Angeles, Hispanic (n = 89), Non-Hispanic (n = 54), age of patients ranged from < 1–20 years"
1448099582,PA166158905,rs112936952,,,GGCX,Dosage,-1,warfarin,1448099587.0,East Asian
1451799880,PA166271161,rs2292596,,,AHRR,Efficacy,0,methotrexate,1451799912.0,European
1451809180,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,-1,morphine,1451809200.0,European
1451809220,PA166157197,rs34130495,,,SLC22A1,Dosage,-1,morphine,1451809240.0,European
1451809220,PA166157197,rs34130495,,,SLC22A1,Dosage,-1,morphine,1451809240.0,European
981747792,PA166155721,rs4148323,,,UGT1A1,Dosage,1,SN-38,981747816.0,"Multiple groups, Chinese (n=36), Malay (n=8) and Other (n=1)"
981747792,PA166155721,rs4148323,,,UGT1A1,Dosage,1,SN-38,981747814.0,"Multiple groups, Chinese (n=36), Malay (n=8) and Other (n=1)"
981747792,PA166155721,rs4148323,,,UGT1A1,Dosage,1,SN-38,981747812.0,"Multiple groups, Chinese (n=36), Malay (n=8) and Other (n=1)"
1451768280,PA166156765,rs1532268,,,MTRR,Metabolism/PK,1,methotrexate,1451768300.0,East Asian
1451768380,PA166154759,rs116855232,,,NUDT15,Dosage,-1,mercaptopurine,1451768400.0,Latino
1451769040,PA166156992,rs1800460,,,TPMT,Dosage,-1,mercaptopurine,1451769045.0,Latino
1451769140,PA166154313,rs1076560,,,DRD2,Efficacy,-1,methylphenidate,1451769160.0,European
1451769162,PA166154339,rs1800497,,,DRD2,Efficacy,-1,methylphenidate,1451769180.0,European
1449157684,PA166176076,rs1143672,,,SLC15A2,Dosage,1,warfarin,1449157686.0,East Asian
1451814760,PA166157804,rs10306135,,,PTGS1,Efficacy,-1,ketoprofen,1451814765.0,European
1451814780,PA166157837,rs12353214,,,PTGS1,Efficacy,-1,ketoprofen,1451814766.0,European
1451769360,PA166270041,rs17004785,,,SLC19A1,Metabolism/PK,1,methotrexate,1451769365.0,East Asian
1451814800,PA166153559,rs20417,,,PTGS2,Efficacy,-1,ketoprofen,1451814820.0,European
1451769300,PA166155219,rs4148416,,,ABCC3,Metabolism/PK,1,methotrexate,1451769305.0,East Asian
1451770120,PA166179993,rs553668,,,ADRA2A,Dosage,-1,doxazosin,1451770126.0,"Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab"
1451770120,PA166179993,rs553668,,,ADRA2A,Dosage,-1,phenoxybenzamine,1451770126.0,"Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab"
1451770080,PA166270081,rs10515807,,,ADRA1B,Dosage,-1,doxazosin,1451770100.0,"Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab"
1451770080,PA166270081,rs10515807,,,ADRA1B,Dosage,-1,phenoxybenzamine,1451770100.0,"Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab"
1451770141,PA166270141,rs521674,,,ADRA2A,Dosage,-1,doxazosin,1451770147.0,"Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab"
1451770141,PA166270141,rs521674,,,ADRA2A,Dosage,-1,phenoxybenzamine,1451770147.0,"Multiple groups, Ethnicity: 93% European, 3% Asian, 1.5% African, 1.5% Latin American, 1% Arab"
1451770441,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,clozapine 5-N-glucuronide,1451770460.0,Unknown
1451770441,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,clozapine 5-N-glucuronide,1451770460.0,Unknown
1451770441,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,clozapine 5-N-glucuronide,1451770460.0,Unknown
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Other,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Other,1,nicotine,1451817946.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Other,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Other,1,nicotine,1451817946.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Other,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Other,1,nicotine,1451817946.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,1451817946.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,1451817946.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,1451817946.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,981202008.0,East Asian
981201993,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,1451817946.0,East Asian
1451822580,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924736,CYP2A6*11,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924740,CYP2A6*13,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924742,CYP2A6*15,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924748,CYP2A6*19,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451822580,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,0,nicotine,1451822583.0,Multiple groups
1451811083,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,ketoprofen,1451811100.0,European
1451811083,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,ketoprofen,1451812360.0,European
1451811083,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,ketoprofen,1451812320.0,European
1451811083,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,ketoprofen,1451812340.0,European
1451811083,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,ketoprofen,1451812341.0,European
1449714733,PA166179982,rs1202170,,,ABCB1,Dosage,-1,opioids,1449714736.0,European
1449714733,PA166179982,rs1202170,,,ABCB1,Dosage,-1,opioids,1449714735.0,European
1184174554,,,PA165949098,NAT2*4,NAT2,Efficacy,-1,hydralazine,1184174556.0,Unknown
1184174554,,,PA165949138,NAT2*12A,NAT2,Efficacy,-1,hydralazine,1184174556.0,Unknown
1184174554,,,PA165949148,NAT2*13A,NAT2,Efficacy,-1,hydralazine,1184174556.0,Unknown
1184174554,,,PA165949148,NAT2*13A,NAT2,Efficacy,-1,hydralazine,1184174556.0,Unknown
1184174554,,,PA165949148,NAT2*13A,NAT2,Efficacy,-1,hydralazine,1184174556.0,Unknown
1451216440,,,PA165924736,CYP2A6*11,CYP2A6,Metabolism/PK,0,tegafur,1451216460.0,Unknown
1451216440,,,PA165924736,CYP2A6*11,CYP2A6,Metabolism/PK,0,tegafur,1451216460.0,Unknown
827864375,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165924752,CYP2A6*23,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165924752,CYP2A6*23,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
827864375,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,letrozole,827864378.0,Multiple groups
827864375,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,letrozole,1451331975.0,Multiple groups
1448104167,,,PA165924729,CYP2A6*5,CYP2A6,Metabolism/PK,0,coumarin,1448104182.0,Unknown
1448104167,,,PA165924729,CYP2A6*5,CYP2A6,Metabolism/PK,0,coumarin,1448104182.0,Unknown
1448104167,,,PA165924729,CYP2A6*5,CYP2A6,Metabolism/PK,0,coumarin,1448104182.0,Unknown
1448104167,,,PA165924729,CYP2A6*5,CYP2A6,Metabolism/PK,0,coumarin,1448104182.0,Unknown
1448104167,,,PA165924729,CYP2A6*5,CYP2A6,Metabolism/PK,0,coumarin,1448104182.0,Unknown
1451665300,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924752,CYP2A6*23,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924752,CYP2A6*23,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924755,CYP2A6*25,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924756,CYP2A6*26,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924757,CYP2A6*27,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165924757,CYP2A6*27,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451665300,,,PA165980920,CYP2A6*35,CYP2A6,Metabolism/PK,1,nicotine,1451665760.0,African American/Afro-Caribbean
1451821000,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,buprenorphine,1451829800.0,European
1451821000,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,buprenorphine,1451821023.0,European
1451821080,PA166156621,rs7662029,,,UGT2B7,Metabolism/PK,1,buprenorphine,1451821085.0,European
1451821080,PA166156621,rs7662029,,,UGT2B7,Metabolism/PK,1,buprenorphine,1451829780.0,European
1184514558,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514560.0,European
1184514558,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514560.0,European
1184514552,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514554.0,"Multiple groups, 72 Caucasian, 7 African-American, 1 Indian"
1184515373,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184515375.0,European
1184515373,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515375.0,European
1448603528,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448603534.0,East Asian
1448635746,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448635753.0,Unknown
1296598965,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1296598982.0,Sub-Saharan African
1448257830,PA166160107,rs13242904,,,GLCCI1,Efficacy,-1,corticosteroids,1448257832.0,Unknown
982044010,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,carvedilol,982044018.0,European
1448257812,PA166160103,rs6969971,,,GLCCI1,Efficacy,-1,corticosteroids,1448257814.0,Unknown
1183701330,PA166155096,rs9934438,,,VKORC1,Dosage,0,warfarin,1183701332.0,"Multiple groups, 94% White"
1449716020,PA166180148,rs268214,,,ATF2,Dosage,-1,fentanyl,1449716022.0,East Asian
1448257803,PA166160101,rs13222222,,,GLCCI1,Efficacy,-1,corticosteroids,1448257805.0,Unknown
1448257794,PA166160099,rs10226865,,,GLCCI1,Efficacy,-1,corticosteroids,1448257796.0,Unknown
1448257785,PA166160097,rs4725061,,,GLCCI1,Efficacy,-1,corticosteroids,1448257787.0,Unknown
1446897929,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,cytarabine,1446897932.0,East Asian
1446897929,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,cytarabine,1446897931.0,East Asian
1446897929,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,daunorubicin,1446897932.0,East Asian
1446897929,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,daunorubicin,1446897931.0,East Asian
1446897929,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,dexrazoxane,1446897932.0,East Asian
1446897929,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,dexrazoxane,1446897931.0,East Asian
1183701300,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183701304.0,European
1183701300,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1183701304.0,European
1448257776,PA166160095,rs7801924,,,GLCCI1,Efficacy,-1,corticosteroids,1448257778.0,Unknown
1448257767,PA166160093,rs10435183,,,GLCCI1,Efficacy,-1,corticosteroids,1448257769.0,Unknown
1448257740,PA166160087,rs13239966,,,GLCCI1,Efficacy,-1,corticosteroids,1448257742.0,Unknown
1448257713,PA166160081,rs17141876,,,GLCCI1,Efficacy,-1,corticosteroids,1448257715.0,Unknown
982044028,PA166156749,rs1042714,,,ADRB2,Efficacy,1,carvedilol,982044036.0,European
1185012207,PA166157316,rs2032582,,,ABCB1,Dosage,1,cyclosporine,1185012225.0,Near Eastern
1448257677,PA166160073,rs7800750,,,GLCCI1,Efficacy,-1,corticosteroids,1448257679.0,Unknown
982044124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,simvastatin,982044141.0,Unknown
1448257668,PA166160071,rs12537880,,,GLCCI1,Efficacy,-1,corticosteroids,1448257670.0,Unknown
1449732574,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1449732580.0,East Asian
1449732581,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1449732583.0,East Asian
1449732581,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1449732583.0,East Asian
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371559.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371644.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371617.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371599.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371640.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371603.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371642.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371601.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371621.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371619.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371629.0,European
1450371553,PA166153571,rs396991,,,FCGR3A,Efficacy,1,tocilizumab,1450371631.0,European
1448257657,PA166160069,rs715377,,,GLCCI1,Efficacy,-1,corticosteroids,1448257659.0,Unknown
1185012151,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1185012287.0,East Asian
1185012151,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1185012153.0,East Asian
982044179,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,digoxin,982044191.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371593.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371581.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371580.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371587.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371589.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371646.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371690.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371648.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371591.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371678.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371680.0,European
1450371578,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,rituximab,1450371682.0,European
1183701524,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183701526.0,"Multiple groups, 94% were White (all were patients at Ottawa Hospital Thrombosis Clinic)."
982044142,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,simvastatin,982044157.0,Unknown
1449191972,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,apixaban,1449191974.0,East Asian
1449716240,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,fentanyl,1449716242.0,East Asian
1185012354,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,1185012356.0,East Asian
982044219,PA166157267,rs776746,,,CYP3A5,Efficacy,1,atorvastatin,982044236.0,Latino
982044219,PA166157267,rs776746,,,CYP3A5,Efficacy,1,atorvastatin,982044238.0,Sub-Saharan African
769277903,PA166154977,rs7294,,,PRSS53,Dosage,1,warfarin,769277906.0,European
769277903,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,769277906.0,European
982044271,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044284.0,European
1449192081,PA166164949,rs397508442,,,CFTR,Efficacy,0,ivacaftor,1449192087.0,Unknown
982044285,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982044297.0,European
1449192136,PA166162695,rs80034486,,,CFTR,Efficacy,-1,lumacaftor,1449192138.0,"Custom, Not applicable - study was carried out in PBE cells"
1448995536,PA166170278,rs17446819,,,CDH2,Efficacy,1,methadone,1448995538.0,East Asian
1447520074,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447520079.0,Multiple groups
1183849199,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,paroxetine,1183849203.0,European
1450928977,PA166182408,rs1277441,,,TAOK3,Dosage,1,opioids,1450928983.0,Unknown
1448634144,PA166165143,rs6545816,,,BCL11A,Efficacy,-1,hydroxyurea,1448634146.0,Near Eastern
1450929002,PA166182407,rs795484,,,TAOK3,Dosage,1,opioids,1450929008.0,Unknown
1184471949,PA166153906,rs75017182,,,DPYD,Dosage,1,capecitabine,1184471951.0,Unknown
1184471949,PA166153906,rs75017182,,,DPYD,Dosage,1,fluorouracil,1184471951.0,Unknown
1448634124,PA166165138,rs766432,,,BCL11A,Efficacy,1,hydroxyurea,1448634126.0,Near Eastern
1449733034,PA166180498,rs11045854,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733040.0,Sub-Saharan African
1448995758,PA166170285,rs2515409,,,ANGPT2,Efficacy,-1,bevacizumab,1448995761.0,European
1448995758,PA166170285,rs2515409,,,ANGPT2,Efficacy,-1,bevacizumab,1448995760.0,African American/Afro-Caribbean
1448617627,PA166163842,rs11868513,,,HNF1B,Efficacy,1,metformin,1448617635.0,Unknown
1448617627,PA166163842,rs11868513,,,HNF1B,Efficacy,1,metformin,1448617632.0,Multiple groups
1449733045,PA166180500,rs12305884,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733047.0,Sub-Saharan African
1448617616,PA166163840,rs11086926,,,HNF4A,Efficacy,-1,metformin,1448617621.0,Multiple groups
1448995793,PA166170289,rs1375668,,,ANGPT2,Efficacy,-1,bevacizumab,1448995796.0,European
1448995793,PA166170289,rs1375668,,,ANGPT2,Efficacy,-1,bevacizumab,1448995795.0,African American/Afro-Caribbean
1448995793,PA166170289,rs1375668,,,ANGPT2,Efficacy,-1,bevacizumab,1448995796.0,European
1448995793,PA166170289,rs1375668,,,ANGPT2,Efficacy,-1,bevacizumab,1448995795.0,African American/Afro-Caribbean
1448995800,PA166170290,rs1960669,,,FGF2,Efficacy,-1,bevacizumab,1448995803.0,European
1448995800,PA166170290,rs1960669,,,FGF2,Efficacy,-1,bevacizumab,1448995802.0,African American/Afro-Caribbean
1448995822,PA166170294,rs17577,,,MMP9,Efficacy,-1,bevacizumab,1448995825.0,European
1448995822,PA166170294,rs17577,,,MMP9,Efficacy,-1,bevacizumab,1448995824.0,African American/Afro-Caribbean
1448995829,PA166170295,rs833068,,,VEGFA,Efficacy,-1,bevacizumab,1448995832.0,European
1448995829,PA166170295,rs833068,,,VEGFA,Efficacy,-1,bevacizumab,1448995831.0,African American/Afro-Caribbean
1184471369,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184471371.0,African American/Afro-Caribbean
827654491,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827657312.0,Unknown
1449733176,PA166180527,rs7899457,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733178.0,Sub-Saharan African
1449733103,PA166180511,rs8187692,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733105.0,Sub-Saharan African
1449733115,PA166180514,rs7579275,,,ABCB11,Metabolism/PK,1,rosuvastatin,1449733117.0,Sub-Saharan African
1184472014,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184472018.0,East Asian
1184472014,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184472016.0,East Asian
1449733142,PA166180520,rs1805343,,,RXRA,Metabolism/PK,1,rosuvastatin,1449733144.0,Sub-Saharan African
1449733184,PA166180529,rs8187706,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733186.0,Sub-Saharan African
1448995927,PA166170321,rs33980500,,,TRAF3IP2,Efficacy,-1,adalimumab,1448995929.0,European
1448995933,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448995940.0,Unknown
1450373239,PA166182126,rs3192723,,,OPRM1,Efficacy,-1,methadone,1450373269.0,East Asian
1450373239,PA166182126,rs3192723,,,OPRM1,Efficacy,-1,methadone,1450373241.0,East Asian
1448995949,PA166170321,rs33980500,,,TRAF3IP2,Efficacy,-1,etanercept,1448995951.0,European
1448995977,PA166170320,rs7234029,,,PTPN2,Efficacy,-1,etanercept,1448995979.0,European
1448684688,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448684690.0,Sub-Saharan African
1184515224,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1184515226.0,Unknown
1448633692,PA166165093,rs2230926,,,TNFAIP3,Efficacy,1,adalimumab,1448633698.0,Unknown
1444694676,PA166154977,rs7294,,,VKORC1,Dosage,-1,warfarin,1444694682.0,East Asian
982044899,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,atenolol,982044905.0,European
1184472429,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184472431.0,Multiple groups
1184472436,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1184472438.0,Multiple groups
1448568086,PA166162504,rs230493,,,NFKB1,Efficacy,1,flupenthixol,1448568088.0,"Multiple groups, 82 South African Colored (SAC), 13 Xhosa and eight Caucasian individuals"
769146001,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,carbamazepine,769146003.0,Central/South Asian
769146001,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenobarbital,769146003.0,Central/South Asian
769146001,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenytoin,769146003.0,Central/South Asian
769146001,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,valproic acid,769146003.0,Central/South Asian
1447945392,PA166153648,rs1801265,,,DPYD,Efficacy,1,fluorouracil,1447945404.0,Unknown
1451126143,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,temozolomide,1451126148.0,Unknown
1184472420,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,1184472422.0,Multiple groups
1446765769,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,bupropion,1446765771.0,"Multiple groups, Brazil"
1448617129,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,lopinavir,1448617131.0,"Multiple groups, Black, White, Hispanic"
1448633511,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448633517.0,Multiple groups
1448256681,PA166159968,rs8192675,,,SLC2A2,Efficacy,1,metformin,1448256687.0,European
1450044955,PA166181265,rs10264990,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044957.0,Unknown
1450044948,PA166181264,rs13233308,,,ABCB1,Metabolism/PK,-1,methotrexate,1450044954.0,Unknown
982043213,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,pravastatin,982043223.0,Unknown
982043213,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,pravastatin,982043627.0,Unknown
1450372702,PA166182096,rs7905446,,,HTR7,Efficacy,1,atomoxetine,1450372704.0,European
1450372702,PA166182096,rs7905446,,,HTR7,Efficacy,1,desvenlafaxine,1450372704.0,European
1450372702,PA166182096,rs7905446,,,HTR7,Efficacy,1,duloxetine,1450372704.0,European
1450372702,PA166182096,rs7905446,,,HTR7,Efficacy,1,Selective serotonin reuptake inhibitors,1450372704.0,European
1450372702,PA166182096,rs7905446,,,HTR7,Efficacy,1,venlafaxine,1450372704.0,European
1446847493,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1446848370.0,East Asian
1450045055,PA166181271,rs2002042,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045057.0,Unknown
1450045043,PA166176636,rs11075291,,,ABCC1,Metabolism/PK,-1,methotrexate,1450045045.0,Unknown
1450372722,PA166182096,rs7905446,,,HTR7,Efficacy,-1,nortriptyline,1450372724.0,European
1448996513,PA166170356,rs185430475,,,ZNF536,Metabolism/PK,-1,nicotine,1448996515.0,African American/Afro-Caribbean
1448996513,PA166170356,rs185430475,,,ZNF536,Metabolism/PK,-1,nicotine,1448996515.0,African American/Afro-Caribbean
1450979020,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1450979025.0,Unknown
1450979020,PA166155096,rs9934438,,,VKORC1,Efficacy,1,warfarin,1450979025.0,Unknown
1450045127,PA166181277,rs13137622,,,ABCG2,Metabolism/PK,1,methotrexate,1450045129.0,Unknown
1450045151,PA166181278,rs2622621,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045153.0,Unknown
1450045193,PA166181280,rs4149034,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045195.0,Unknown
1449295831,PA166178588,rs4455491,,,UGT2B7,Dosage,-1,morphine,1449295833.0,Unknown
1449295831,PA166178588,rs4455491,,,UGT2B7,Efficacy,-1,morphine,1449295833.0,Unknown
1450372908,PA166170589,rs1051312,,,SNAP25,Efficacy,-1,methylphenidate,1450372914.0,Multiple groups
1450045169,PA166181279,rs6857600,,,ABCG2,Metabolism/PK,-1,methotrexate,1450045171.0,Unknown
1448567620,PA166162453,rs12488654,,,TNFSF10,Efficacy,-1,rituximab,1448567626.0,Unknown
1448567593,PA166162449,rs20576,,,TNFRSF10A,Efficacy,-1,rituximab,1448567599.0,Unknown
1450372933,PA166170589,rs1051312,,,SNAP25,Efficacy,-1,methylphenidate,1450372939.0,Multiple groups
1450045275,PA166181289,rs4148328,,,UGT1A1,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A10,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A3,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A4,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A5,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A6,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A7,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A8,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
1450045275,PA166181289,rs4148328,,,UGT1A9,Metabolism/PK,-1,methotrexate,1450045277.0,Unknown
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043564.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043565.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043567.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043566.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043564.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043565.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043567.0,East Asian
982043554,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,amlodipine,982043566.0,East Asian
1450979180,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450979200.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1450979180,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450979200.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
1449144219,PA166171039,rs61123830,,,GRAMD1B,Efficacy,1,lithium,1449144221.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
1449144213,PA166171038,rs59724122,,,EPHX2,Efficacy,1,lithium,1449144215.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
1448255569,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,,
1450979280,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1450979284.0,Unknown
982043600,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982043619.0,African American/Afro-Caribbean
982043600,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982043617.0,African American/Afro-Caribbean
1448616510,PA166162248,rs3761548,,,FOXP3,Other,1,methotrexate,1448616518.0,Central/South Asian
1448616510,PA166162248,rs3761548,,,FOXP3,Other,1,methotrexate,1448616516.0,Central/South Asian
982043737,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982043752.0,African American/Afro-Caribbean
982043737,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982043753.0,African American/Afro-Caribbean
1449750599,PA166180907,rs558614,,,LATS2,Efficacy,-1,cetuximab,1449750601.0,Unknown
1449750580,PA166180904,rs2073498,,,RASSF1,Efficacy,-1,cetuximab,1449750586.0,Unknown
1450373223,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,methadone,1450373225.0,East Asian
1450373223,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,methadone,1450373337.0,East Asian
1184473241,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473243.0,East Asian
1449750606,PA166180908,rs3811715,,,WWTR1,Efficacy,-1,cetuximab,1449750608.0,Unknown
1449750780,PA166177108,rs4261893,,,ZNF385D,Efficacy,1,duloxetine,1449750788.0,European
1449750780,PA166177108,rs4261893,,,ZNF385D,Efficacy,1,duloxetine,1449750786.0,European
1448259816,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1448259826.0,Central/South Asian
1448259816,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1448259822.0,Central/South Asian
1448259816,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1448259828.0,Central/South Asian
1448259816,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salbutamol,1448259824.0,Central/South Asian
1448112349,PA166159478,rs772583466,,,BCHE,Efficacy,0,succinylcholine,1448112354.0,Unknown
1448112362,PA166159480,rs755648929,,,BCHE,Efficacy,0,mivacurium,1448112367.0,Unknown
1447948523,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,gefitinib,1447948525.0,Unknown
1449714054,PA166179864,rs7432211,,,HTR3E,Dosage,-1,opioids,1449714073.0,European
1449714054,PA166179864,rs7432211,,,HTR3E,Dosage,-1,opioids,1449714075.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,atenolol,1451107080.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,atenolol,1451106980.0,Unknown
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,atenolol,1451106800.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,atenolol,1451107000.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451107080.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451106980.0,Unknown
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451106800.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451107000.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451107080.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451106980.0,Unknown
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451106800.0,European
1451106720,PA166156749,rs1042714,,,ADRB2,Efficacy,1,metoprolol,1451107000.0,European
1448276164,PA166160972,rs3784943,,,CDH13,Efficacy,1,amphetamine,1448276178.0,Multiple groups
1449714116,PA166179868,rs7943062,,,HTR3B,Dosage,-1,opioids,1449714118.0,European
1449714116,PA166179868,rs7943062,,,HTR3B,Dosage,-1,opioids,1449714119.0,European
1448603809,PA166163343,rs1187352,,,NTRK2,Efficacy,-1,antidepressants,1448603811.0,"Multiple groups, 92% Caucasian"
1183699485,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,risperidone,1183699487.0,"Multiple groups, Caucasian, African, Unknown"
1449714210,PA166179889,rs4439987,,,TACR1,Dosage,-1,opioids,1449714213.0,European
1449714210,PA166179889,rs4439987,,,TACR1,Dosage,-1,opioids,1449714212.0,European
1449157145,PA166175994,rs678849,,,OPRD1,Efficacy,1,buprenorphine,1449157151.0,African American/Afro-Caribbean
1449714217,PA166179890,rs6546952,,,TACR1,Dosage,-1,opioids,1449714219.0,European
1449714217,PA166179890,rs6546952,,,TACR1,Dosage,-1,opioids,1449714220.0,European
1448603703,PA166163335,rs3813008,,,SLC5A2,Efficacy,-1,empagliflozin,1448603705.0,Unknown
1449157158,PA166175996,rs10753331,,,None,Efficacy,-1,buprenorphine,1449157195.0,European
1449157158,PA166175996,rs10753331,,,None,Efficacy,-1,buprenorphine,1449157160.0,African American/Afro-Caribbean
1448603694,PA166163333,rs3116150,,,SLC5A2,Efficacy,-1,empagliflozin,1448603696.0,Unknown
1449714203,PA166179888,rs881,,,TACR1,Dosage,-1,opioids,1449714206.0,European
1449714203,PA166179888,rs881,,,TACR1,Dosage,-1,opioids,1449714205.0,European
1449714238,PA166179893,rs3771836,,,TACR1,Dosage,-1,opioids,1449714240.0,European
1449714238,PA166179893,rs3771836,,,TACR1,Dosage,-1,opioids,1449714241.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,adalimumab,1183699552.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,adalimumab,1183699554.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,adalimumab,1183699553.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,etanercept,1183699552.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,etanercept,1183699554.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,etanercept,1183699553.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,infliximab,1183699552.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,infliximab,1183699554.0,European
1183699550,PA166153571,rs396991,,,FCGR3A,Efficacy,1,infliximab,1183699553.0,European
1449714246,PA166179894,rs10191107,,,TACR1,Dosage,-1,opioids,1449714249.0,European
1449714246,PA166179894,rs10191107,,,TACR1,Dosage,-1,opioids,1449714248.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,adalimumab,1183699560.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,adalimumab,1183699559.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,adalimumab,1183699561.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,adalimumab,1183699558.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,etanercept,1183699560.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,etanercept,1183699559.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,etanercept,1183699561.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,etanercept,1183699558.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,infliximab,1183699560.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,infliximab,1183699559.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,infliximab,1183699561.0,European
1183699556,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,infliximab,1183699558.0,European
1449714224,PA166179891,rs2160652,,,TACR1,Dosage,-1,opioids,1449714226.0,European
1449714224,PA166179891,rs2160652,,,TACR1,Dosage,-1,opioids,1449714227.0,European
1449157181,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,buprenorphine,1449157183.0,African American/Afro-Caribbean
1449157181,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,buprenorphine,1449157204.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,adalimumab,1183699545.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,adalimumab,1183699541.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,adalimumab,1183699543.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,adalimumab,1183699537.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,etanercept,1183699545.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,etanercept,1183699541.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,etanercept,1183699543.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,etanercept,1183699537.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,infliximab,1183699545.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,infliximab,1183699541.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,infliximab,1183699543.0,European
1183699535,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,infliximab,1183699537.0,European
1449714231,PA166179892,rs12475818,,,TACR1,Dosage,-1,opioids,1449714233.0,European
1449714231,PA166179892,rs12475818,,,TACR1,Dosage,-1,opioids,1449714234.0,European
982042159,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,982042171.0,East Asian
1449714283,PA166179908,rs2606731,,,HRH1,Dosage,-1,opioids,1449714286.0,European
1449714283,PA166179908,rs2606731,,,HRH1,Dosage,-1,opioids,1449714285.0,European
1449714253,PA166179895,rs12713837,,,TACR1,Dosage,-1,opioids,1449714255.0,European
1449714253,PA166179895,rs12713837,,,TACR1,Dosage,-1,opioids,1449714256.0,European
1449714267,PA166179897,rs2024512,,,TACR1,Dosage,-1,opioids,1449714269.0,European
1449714267,PA166179897,rs2024512,,,TACR1,Dosage,-1,opioids,1449714270.0,European
1449157237,PA166175994,rs678849,,,OPRD1,Efficacy,1,methadone,1449157239.0,African American/Afro-Caribbean
1449157250,PA166175996,rs10753331,,,None,Efficacy,-1,methadone,1449157252.0,African American/Afro-Caribbean
1449157250,PA166175996,rs10753331,,,None,Efficacy,-1,methadone,1449157253.0,European
1449157244,PA166175994,rs678849,,,OPRD1,Efficacy,-1,methadone,1449157246.0,European
1448423378,PA166161139,rs11591741,,,CHUK,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448423384.0,European
1449157271,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,methadone,1449157273.0,African American/Afro-Caribbean
1449157271,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,methadone,1449157274.0,European
982009519,PA166154259,rs6265,,,BDNF,Efficacy,1,paroxetine,982009570.0,Multiple groups
1449714414,PA166179929,rs6792482,,,HTR3D,Dosage,-1,opioids,1449714416.0,European
1449714414,PA166179929,rs6792482,,,HTR3D,Dosage,-1,opioids,1449714417.0,European
1448259376,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1448259383.0,Unknown
1449567006,PA166179500,rs2237435,,,INHBA,Efficacy,-1,bevacizumab,1449567008.0,Multiple groups
1449567006,PA166179500,rs2237435,,,INHBA,Efficacy,-1,bevacizumab,1449567010.0,Multiple groups
1449567006,PA166179500,rs2237435,,,INHBA,Efficacy,-1,bevacizumab,1449567009.0,Multiple groups
1449567006,PA166179500,rs2237435,,,INHBA,Efficacy,-1,ranibizumab,1449567008.0,Multiple groups
1449567006,PA166179500,rs2237435,,,INHBA,Efficacy,-1,ranibizumab,1449567010.0,Multiple groups
1449567006,PA166179500,rs2237435,,,INHBA,Efficacy,-1,ranibizumab,1449567009.0,Multiple groups
1449714478,PA166179941,rs6443950,,,HTR3E,Dosage,-1,opioids,1449714481.0,European
1449714478,PA166179941,rs6443950,,,HTR3E,Dosage,-1,opioids,1449714480.0,European
1448636173,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448636179.0,Sub-Saharan African
1446765916,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1446765921.0,East Asian
1448275994,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1448275999.0,East Asian
1184748358,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,ritonavir,1184748360.0,"Multiple groups, 30 Caucasian, 5 African"
1184748358,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,ritonavir,1184748381.0,"Multiple groups, 30 Caucasian, 5 African"
1449714672,PA166179970,rs639855,,,OPRM1,Dosage,-1,opioids,1449714674.0,European
1449714672,PA166179970,rs639855,,,OPRM1,Dosage,-1,opioids,1449714675.0,European
1449275102,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1449275109.0,"Multiple groups, Tanzania, Mozambique, South Africa, Uganda, Rwanda, Ethiopia, India, Thailand, Cambodia"
1184473123,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473126.0,Unknown
1184473123,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473125.0,Unknown
1444707052,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444707058.0,East Asian
1444707052,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444707058.0,East Asian
1444707052,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444707058.0,East Asian
1043858925,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,nifedipine,1043858927.0,East Asian
1449714747,PA166179984,rs13229143,,,ABCB1,Dosage,-1,opioids,1449714750.0,European
1449714747,PA166179984,rs13229143,,,ABCB1,Dosage,-1,opioids,1449714749.0,European
1449714827,PA166179998,rs17601612,,,DRD2,Dosage,-1,opioids,1449714830.0,European
1449714827,PA166179998,rs17601612,,,DRD2,Dosage,-1,opioids,1449714829.0,European
1448635798,PA166165281,rs2454727,,,HCAR2,Efficacy,-1,niacin,1448635800.0,European
1449714869,PA166180010,rs7103572,,,HTR3B,Dosage,-1,opioids,1449714872.0,European
1449714869,PA166180010,rs7103572,,,HTR3B,Dosage,-1,opioids,1449714871.0,European
1448635792,PA166165281,rs2454727,,,HCAR2,Efficacy,1,niacin,1448635797.0,European
827804302,PA166157316,rs2032582,,,ABCB1,Other,-1,antiepileptics,827804458.0,Multiple groups
1449714925,PA166180019,rs1176719,,,HTR3A,Dosage,-1,opioids,1449714927.0,European
1449714925,PA166180019,rs1176719,,,HTR3A,Dosage,-1,opioids,1449714928.0,European
1184470217,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184470221.0,Unknown
1449715002,PA166180031,rs3783641,,,GCH1,Dosage,-1,opioids,1449715004.0,European
1449715002,PA166180031,rs3783641,,,GCH1,Dosage,-1,opioids,1449715005.0,European
1449715020,PA166180035,rs4790693,,,ARRB2,Dosage,-1,opioids,1449715023.0,European
1449715020,PA166180035,rs4790693,,,ARRB2,Dosage,-1,opioids,1449715022.0,European
1448635633,PA166165266,rs79419059,,,NUP107,Efficacy,1,Platinum compounds,1448635639.0,Multiple groups
1449747838,PA166176608,rs4646450,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449747840.0,East Asian
1449715082,PA166180045,rs165722,,,COMT,Dosage,-1,opioids,1449715084.0,European
1449715082,PA166180045,rs165722,,,COMT,Dosage,-1,opioids,1449715085.0,European
1184748906,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184748908.0,Unknown
1183684051,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684055.0,"Multiple groups, Asian, Black, Caucasian, Other"
981483977,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,981483985.0,East Asian
981483977,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,981483985.0,East Asian
1448258575,PA166160239,rs165815,,,COMT,Efficacy,-1,antipsychotics,1448258577.0,European
1184749219,PA166156748,rs1042713,,,ADRB2,Efficacy,1,tiotropium,1184749224.0,Unknown
1448994415,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448994417.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1183684255,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684258.0,East Asian
1183684255,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684257.0,East Asian
1183684248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684254.0,East Asian
1183684248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684252.0,East Asian
981500585,PA166154977,rs7294,,,VKORC1,Dosage,-1,warfarin,981500608.0,European
981500585,PA166154977,rs7294,,,VKORC1,Efficacy,-1,warfarin,981500608.0,European
827642001,PA166155096,rs9934438,,,PRSS53,Dosage,1,warfarin,827642013.0,African American/Afro-Caribbean
827642001,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827642013.0,African American/Afro-Caribbean
981500592,PA166155119,rs17708472,,,VKORC1,Dosage,-1,warfarin,981500632.0,European
981500592,PA166155119,rs17708472,,,VKORC1,Efficacy,-1,warfarin,981500632.0,European
1450370821,PA166181975,rs3093153,,,CYP4F2,Dosage,-1,warfarin,1450370823.0,American
1450370821,PA166181975,rs3093153,,,CYP4F2,Dosage,-1,warfarin,1450370824.0,American
1450370821,PA166181975,rs3093153,,,CYP4F2,Dosage,-1,warfarin,1450370823.0,American
1450370821,PA166181975,rs3093153,,,CYP4F2,Dosage,-1,warfarin,1450370824.0,American
1448258393,PA166160221,rs1800547,,,MAPT,Efficacy,-1,corticosteroids,1448258395.0,Unknown
1448258375,PA166160217,rs4640231,,,CRHR1,Efficacy,-1,corticosteroids,1448258377.0,Unknown
1448258375,PA166160217,rs4640231,,,CRHR1,Efficacy,-1,corticosteroids,1448258377.0,Unknown
1448258375,PA166160217,rs4640231,,,CRHR1,Efficacy,-1,corticosteroids,1448258377.0,Unknown
1448258324,PA166160206,rs16940674,,,CRHR1,Efficacy,-1,corticosteroids,1448258326.0,Unknown
1449715511,PA166180080,rs4587017,,,UGT2B7,Efficacy,-1,fentanyl,1449715513.0,East Asian
1448258305,PA166160202,rs16940665,,,CRHR1,Efficacy,-1,corticosteroids,1448258307.0,Unknown
1448635132,PA166165231,rs746071566,,,NUDT15,Dosage,0,mercaptopurine,1448635139.0,Multiple groups
1448635132,PA166165231,rs746071566,,,NUDT15,Toxicity,0,mercaptopurine,1448635139.0,Multiple groups
1448258293,PA166160200,rs75638861,,,CRHR1,Efficacy,-1,corticosteroids,1448258295.0,Unknown
1448258265,PA166160194,rs1912151,,,CRHR1,Efficacy,-1,corticosteroids,1448258267.0,Unknown
1448569538,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448569540.0,East Asian
1448569538,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448569549.0,East Asian
1448569532,PA166162580,rs909530,,,FMO3,Metabolism/PK,1,tacrolimus,1448569534.0,East Asian
1448258221,PA166160185,rs171440,,,CRHR1,Efficacy,-1,corticosteroids,1448258223.0,Unknown
1448258191,PA166160180,rs12103667,,,CRHR1,Efficacy,-1,corticosteroids,1448258193.0,Unknown
1448258176,PA166160177,rs4792887,,,CRHR1,Efficacy,-1,corticosteroids,1448258178.0,Unknown
1448258158,PA166160173,rs9892359,,,CRHR1,Efficacy,-1,corticosteroids,1448258160.0,Unknown
1447520859,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,sirolimus,1447520861.0,East Asian
1447520859,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447520861.0,East Asian
1447520859,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447520861.0,East Asian
981501007,PA166154259,rs6265,,,BDNF,Efficacy,-1,fluoxetine,981501053.0,East Asian
1448994861,PA166170232,rs200707504,,,CES1,Metabolism/PK,-1,oseltamivir,1448994866.0,East Asian
1448258091,PA166160160,rs11607165,,,STIP1,Efficacy,-1,corticosteroids,1448258093.0,Unknown
1448258070,PA166160156,rs6591838,,,STIP1,Efficacy,-1,corticosteroids,1448258072.0,Unknown
1183701155,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183701157.0,European
1448258025,PA166160147,rs3751123,,,STIP1,Efficacy,-1,corticosteroids,1448258027.0,Unknown
1447520720,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,methadone,1447520743.0,East Asian
1444702654,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702658.0,European
1444702654,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702657.0,European
1185011784,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1185012275.0,East Asian
1185011784,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1185012148.0,East Asian
1448257965,PA166160135,rs1468594,,,GLCCI1,Efficacy,-1,corticosteroids,1448257967.0,Unknown
1448602034,PA166163170,rs2295490,,,TRIB3,Efficacy,-1,indapamide,1448602042.0,East Asian
1448602034,PA166163170,rs2295490,,,TRIB3,Efficacy,-1,perindopril,1448602042.0,East Asian
981861657,PA166154259,rs6265,,,BDNF,Efficacy,1,citalopram,981861701.0,European
1449715969,PA166180146,rs2302663,,,ATF2,Efficacy,-1,fentanyl,1449715971.0,East Asian
1448995055,PA166170253,rs2307418,,,NR1I3,Metabolism/PK,-1,tacrolimus,1448995057.0,European
1448257884,PA166160119,rs4236406,,,GLCCI1,Efficacy,-1,corticosteroids,1448257886.0,Unknown
1183701268,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1183701270.0,European
1448257875,PA166160117,rs11976862,,,GLCCI1,Efficacy,-1,corticosteroids,1448257877.0,Unknown
1450928424,PA166157347,rs2257401,,,CYP3A7,Metabolism/PK,1,tacrolimus,1450928429.0,East Asian
1448110402,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1448110412.0,Sub-Saharan African
1448110402,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1448110412.0,Sub-Saharan African
1448257866,PA166160115,rs2191318,,,GLCCI1,Efficacy,-1,corticosteroids,1448257868.0,Unknown
1448257857,PA166160113,rs16872488,,,GLCCI1,Efficacy,-1,corticosteroids,1448257859.0,Unknown
1448601916,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1448602256.0,Sub-Saharan African
1449715987,PA166180149,rs1982235,,,ATF2,Efficacy,-1,fentanyl,1449715989.0,East Asian
1448995110,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,dolutegravir,1448995112.0,East Asian
1449163079,PA166176382,rs117937072,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449163081.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1183697213,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183697215.0,European
1183697213,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183697216.0,European
1183697222,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1183697225.0,European
1183697222,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1183697224.0,European
1450375552,PA166182332,rs1934341,,,GREM2,Efficacy,1,allopurinol,1450375554.0,"Multiple groups, Non-Hispanic White, Asian, African American and Latino"
1450375552,PA166182332,rs1934341,,,GREM2,Efficacy,1,allopurinol,1450375560.0,Multiple groups
1450375552,PA166182332,rs1934341,,,GREM2,Efficacy,1,allopurinol,1450375564.0,European
1450981800,PA166155119,rs17708472,,,VKORC1,Dosage,0,warfarin,1450981806.0,Central/South Asian
1450981800,PA166155119,rs17708472,,,VKORC1,Dosage,0,warfarin,1450981820.0,Central/South Asian
1450981800,PA166155119,rs17708472,,,VKORC1,Metabolism/PK,0,warfarin,1450981806.0,Central/South Asian
1450981800,PA166155119,rs17708472,,,VKORC1,Metabolism/PK,0,warfarin,1450981820.0,Central/South Asian
1450375622,PA166182339,rs2725215,,,PKD2,Efficacy,-1,allopurinol,1450375624.0,European
1450375658,PA166182352,rs76979899,,,ABCG2,Efficacy,-1,allopurinol,1450375660.0,European
1449163228,PA166176403,rs2237991,,,ABCC8,Metabolism/PK,-1,tacrolimus,1449163230.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1448261536,PA166160393,rs3816877,,,APEH,Metabolism/PK,1,valproic acid,1448261552.0,East Asian
1444935560,PA166157267,rs776746,,,CYP3A5,Dosage,1,carbamazepine,1444935566.0,East Asian
1449753275,PA166181111,rs12060765,,,CACNA1E,Efficacy,1,antipsychotics,1449753277.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1183697701,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1183697703.0,European
1449753373,PA166181119,rs982003,,,CACNB2,Efficacy,1,antipsychotics,1449753375.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1449147171,PA166171194,rs2464196,,,HNF1A,Efficacy,-1,metformin,1449147173.0,European
1449147171,PA166171194,rs2464196,,,HNF1A,Efficacy,-1,metformin,1449147174.0,European
1449147171,PA166171194,rs2464196,,,HNF1A,Efficacy,-1,metformin,1449147175.0,European
1449147171,PA166171194,rs2464196,,,HNF1A,Efficacy,-1,metformin,1449147176.0,European
1449147171,PA166171194,rs2464196,,,HNF1A,Efficacy,-1,metformin,1449147177.0,European
1183533917,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1183533921.0,Multiple groups
1449753409,PA166181127,rs1277733,,,CACNB2,Efficacy,1,antipsychotics,1449753411.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1449753418,PA166181129,rs4237348,,,CACNB2,Efficacy,1,antipsychotics,1449753420.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1449753391,PA166181123,rs1859204,,,CACNG3,Efficacy,1,antipsychotics,1449753393.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1183533912,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183533916.0,Unknown
1449163647,PA166176618,rs258751,,,NR3C1,Efficacy,1,prednisone,1449163653.0,East Asian
1449163673,PA166176617,rs6196,,,NR3C1,Efficacy,1,prednisone,1449163675.0,East Asian
1183697782,PA166154259,rs6265,,,BDNF,Efficacy,1,antipsychotics,1183697784.0,European
1183697782,PA166154259,rs6265,,,BDNF,Efficacy,1,antipsychotics,1183697785.0,European
1183697782,PA166154259,rs6265,,,BDNF,Efficacy,1,antipsychotics,1183697784.0,European
1183697782,PA166154259,rs6265,,,BDNF,Efficacy,1,antipsychotics,1183697785.0,European
1448097420,PA166159102,rs10934498,,,NR1I2,Toxicity,1,irinotecan,1448097428.0,Unknown
1448097420,PA166159102,rs10934498,,,NR1I2,Metabolism/PK,1,irinotecan,1448097428.0,Unknown
1448097420,PA166159102,rs10934498,,,NR1I2,Metabolism/PK,1,irinotecan,1448097428.0,Unknown
1449164008,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,6beta-hydroxycortisol,1449164014.0,Unknown
1449164026,PA166176700,rs4760658,,,VDR,Dosage,1,warfarin,1449164031.0,European
1449311485,PA166178816,rs11030101,,,BDNF-AS,Efficacy,-1,escitalopram,1449311491.0,East Asian
1450376500,PA166181214,rs3785157,,,SLC6A2,Efficacy,-1,methylphenidate,1450376502.0,Unknown
1450376506,PA166181215,rs7194256,,,SLC6A2,Efficacy,-1,methylphenidate,1450376508.0,Unknown
1450376553,PA166181225,rs1868790,,,ADGRL3,Efficacy,1,methylphenidate,1450376559.0,European
1450376553,PA166181225,rs1868790,,,ADGRL3,Efficacy,1,methylphenidate,1450376559.0,European
1450376553,PA166181225,rs1868790,,,ADGRL3,Efficacy,1,methylphenidate,1450376559.0,European
1450376598,PA166182269,rs3792452,,,GRM7,Efficacy,-1,methylphenidate,1450376600.0,European
1450376638,PA166170120,rs2652511,,,SLC6A3,Efficacy,-1,methylphenidate,1450376640.0,European
1449164214,PA166154259,rs6265,,,BDNF,Efficacy,-1,methadone,1449164220.0,"Multiple groups, 85% of participants were of European ethnicity"
1450376843,PA166181224,rs6858066,,,ADGRL3,Efficacy,0,methylphenidate,1450376845.0,Unknown
1183682206,PA166156748,rs1042713,,,ADRB2,Efficacy,1,methacholine,1183682233.0,"Multiple groups, African American and White"
1183682206,PA166156748,rs1042713,,,ADRB2,Efficacy,1,methacholine,1183682230.0,"Multiple groups, African American and White"
1183682206,PA166156748,rs1042713,,,ADRB2,Efficacy,1,methacholine,1183682233.0,"Multiple groups, African American and White"
1183682206,PA166156748,rs1042713,,,ADRB2,Efficacy,1,methacholine,1183682230.0,"Multiple groups, African American and White"
1183682206,PA166156748,rs1042713,,,ADRB2,Efficacy,1,methacholine,1183682233.0,"Multiple groups, African American and White"
1183682206,PA166156748,rs1042713,,,ADRB2,Efficacy,1,methacholine,1183682230.0,"Multiple groups, African American and White"
1450180271,PA166181377,rs202201137,,,CYP2C9,Dosage,-1,warfarin,1450180278.0,African American/Afro-Caribbean
1450376883,PA166181219,rs1947274,,,ADGRL3,Efficacy,-1,methylphenidate,1450376885.0,Unknown
1450180328,PA166181219,rs1947274,,,ADGRL3,Efficacy,-1,methylphenidate,1450180330.0,Multiple groups
1448522617,PA166161846,rs2916205,,,PGLYRP4,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448522623.0,European
1448820454,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820456.0,East Asian
1448820454,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820458.0,East Asian
1448820454,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820459.0,East Asian
1448820454,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820457.0,East Asian
1448820497,PA166169847,rs10052999,,,C6,Metabolism/PK,-1,tacrolimus,1448820499.0,East Asian
1448820497,PA166169847,rs10052999,,,C6,Metabolism/PK,-1,tacrolimus,1448820502.0,East Asian
1448820497,PA166169847,rs10052999,,,C6,Metabolism/PK,-1,tacrolimus,1448820501.0,East Asian
1448820497,PA166169847,rs10052999,,,C6,Metabolism/PK,-1,tacrolimus,1448820500.0,East Asian
1450376988,PA166154259,rs6265,,,BDNF,Efficacy,1,methylphenidate,1450376994.0,Unknown
1450376988,PA166154259,rs6265,,,BDNF,Efficacy,1,methylphenidate,1450376998.0,Unknown
1450376988,PA166154259,rs6265,,,BDNF,Efficacy,1,methylphenidate,1450376996.0,Unknown
1448820506,PA166169847,rs10052999,,,C6,Metabolism/PK,1,tacrolimus,1448820511.0,East Asian
1448820506,PA166169847,rs10052999,,,C6,Metabolism/PK,1,tacrolimus,1448820510.0,East Asian
1448820506,PA166169847,rs10052999,,,C6,Metabolism/PK,1,tacrolimus,1448820509.0,East Asian
1448820506,PA166169847,rs10052999,,,C6,Metabolism/PK,1,tacrolimus,1448820508.0,East Asian
1183698750,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,1183698754.0,East Asian
1183698750,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,1183698756.0,East Asian
1183698750,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,1183698754.0,East Asian
1183698750,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,1183698756.0,East Asian
1448424016,PA166161197,rs17268282,,,ABCC4,Efficacy,1,furosemide,1448424024.0,"Multiple groups, Majority Caucasian"
1449295885,PA166178593,rs1319339,,,OPRM1,Dosage,-1,morphine,1449295887.0,European
1449295885,PA166178593,rs1319339,,,OPRM1,Efficacy,-1,morphine,1449295887.0,European
1449295951,PA166178599,rs174696,,,COMT,Dosage,-1,morphine,1449295953.0,European
1449295951,PA166178599,rs174696,,,COMT,Efficacy,-1,morphine,1449295953.0,European
982047897,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982047901.0,European
1448604135,PA166163375,rs3212217,,,IL12B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604142.0,Unknown
1448604135,PA166163375,rs3212217,,,IL12B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604144.0,Unknown
1448604135,PA166163375,rs3212217,,,IL12B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604137.0,Unknown
1449295981,PA166178600,rs4986936,,,ESR1,Dosage,-1,morphine,1449295983.0,European
1449295981,PA166178600,rs4986936,,,ESR1,Efficacy,-1,morphine,1449295983.0,European
1183699109,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1183699113.0,East Asian
982015093,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,982015107.0,Central/South Asian
1448423843,PA166161188,rs121909011,,,CFTR,Efficacy,1,ivacaftor,1448423845.0,Unknown
982047927,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,1,fluindione,982047941.0,European
1448112462,PA166159490,rs4910008,,,GALNT18,Efficacy,1,tocilizumab,1448112468.0,European
1451114760,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,lopinavir,1451114800.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114760,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,ritonavir,1451114800.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1448423725,PA166161174,rs5993883,,,COMT,Efficacy,1,quetiapine,1448423727.0,East Asian
1448423725,PA166161174,rs5993883,,,COMT,Efficacy,1,quetiapine,1448423727.0,East Asian
1448997232,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997238.0,European
1448263914,PA166160547,rs3213094,,,IL12B,Efficacy,-1,etanercept,1448263916.0,Unknown
1448997239,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997245.0,East Asian
1448526029,PA166161944,rs10485058,,,OPRM1,Efficacy,-1,buprenorphine,1448526031.0,European
1184514388,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,imatinib,1184514396.0,Unknown
1448526016,PA166161944,rs10485058,,,OPRM1,Efficacy,1,methadone,1448526026.0,European
1448526016,PA166161944,rs10485058,,,OPRM1,Efficacy,1,methadone,1448526022.0,European
1184514540,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514542.0,East Asian
1184514543,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514545.0,"Multiple groups, 38 white, 4 black, 2 asian"
1184514549,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514551.0,"Multiple groups, Study classified ethnicity as African-American and Non-African American"
1184514555,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514557.0,Unknown
1184514561,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514563.0,"Multiple groups, Black n=23, White n=119, Middle Eastern n=12, South Asian n=26"
1184514567,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514569.0,European
1184514570,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514572.0,"Multiple groups, 57 Caucasian, 2 African"
1184514573,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514577.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514576.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514575.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514578.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514577.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514576.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514575.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514573,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514578.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184514582,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514584.0,"Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3)."
1184514582,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514584.0,"Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3)."
1184514585,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514587.0,European
1184514585,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514587.0,European
1184514507,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514509.0,Multiple groups
1184514507,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514509.0,Multiple groups
1184514516,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514518.0,Central/South Asian
1448997399,PA166170406,rs10211,,,CYP3A7,Metabolism/PK,1,cyclosporine,1448997401.0,East Asian
1184514690,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514692.0,East Asian
1184514690,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514692.0,East Asian
1184514534,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514536.0,East Asian
1448263689,PA166160525,rs4420638,,,APOC1,Efficacy,1,hmg coa reductase inhibitors,1448263696.0,European
1448997489,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997495.0,East Asian
1448263620,PA166160516,rs4909237,,,MIR595,Other,-1,methotrexate,1448263622.0,European
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373789.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373792.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373796.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373794.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,remifentanil,1450373789.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,remifentanil,1450373792.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,remifentanil,1450373796.0,Unknown
1450373783,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,remifentanil,1450373794.0,Unknown
1448099742,PA166159103,rs3814995,,,NPHS1,Efficacy,-1,losartan,1448099767.0,European
1184514802,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514804.0,East Asian
1184514808,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514810.0,"Multiple groups, Mainly Caucasian, remainder unspecified"
1184514811,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514813.0,European
1450373806,PA166182219,rs6517442,,,KCNJ6,Efficacy,-1,remifentanil,1450373808.0,Unknown
1184514829,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514831.0,Multiple groups
1184514832,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514834.0,Multiple groups
1296599155,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1296599161.0,Unknown
1296599155,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1296599167.0,Unknown
1296599155,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1296599171.0,Unknown
1296599155,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1296599173.0,Unknown
1296599155,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1296599169.0,Unknown
1296599155,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1296599165.0,Unknown
1184514850,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514852.0,East Asian
1184514853,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514855.0,"Multiple groups, Caucasians n=82, African n=2, South Asian n=1"
1184514859,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514861.0,Unknown
1449161507,PA166176243,rs648893,,,OPRM1,Efficacy,-1,nalmefene,1449161509.0,European
1449161513,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,nalmefene,1449161515.0,European
1184514793,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514795.0,European
1448997691,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448997703.0,Sub-Saharan African
1449161532,PA166176247,rs963549,,,OPRK1,Efficacy,-1,nalmefene,1449161534.0,European
1184514865,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514867.0,"Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3)."
1184514865,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514867.0,"Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3)."
1448997743,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997749.0,Multiple groups
1184514871,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514873.0,European
1184514874,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514876.0,East Asian
1184514874,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1449754434.0,East Asian
1184514874,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514877.0,East Asian
1184515019,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515021.0,Unknown
1450374111,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,(R)-methadone,1450374117.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1450374111,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,(R)-methadone,1450374120.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1448263253,PA166156749,rs1042714,,,ADRB2,Metabolism/PK,-1,ephedrine,1448263255.0,European
1448263253,PA166156749,rs1042714,,,ADRB2,Metabolism/PK,-1,phenylephrine,1448263255.0,European
1184515004,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515006.0,East Asian
1450374130,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,methadone,1450374132.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1450374130,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,methadone,1450374133.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1184515016,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,tacrolimus,1184515018.0,Central/South Asian
1184515022,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515025.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1184515022,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515024.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
982030345,PA166157873,rs3810651,,,GABRQ,Efficacy,1,venlafaxine,982030353.0,East Asian
1184515184,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515186.0,East Asian
827922834,PA166155621,rs1056836,,,CYP1B1,Efficacy,-1,paclitaxel,827922842.0,"Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5."
1444707792,PA166155040,rs2359612,,,VKORC1,Efficacy,1,phenprocoumon,1444707797.0,Unknown
1184515163,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515165.0,European
1184515166,PA166157267,rs776746,,,CYP3A5,Other,1,tacrolimus,1184515168.0,East Asian
1184515166,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515168.0,East Asian
1444707634,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1444707636.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1184515273,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515275.0,Multiple groups
1184515288,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515290.0,East Asian
1448426745,PA166161209,rs2853542,,,TYMS,Efficacy,-1,capecitabine,1448426747.0,"Multiple groups, Majority Caucasian"
1448426745,PA166161209,rs2853542,,,TYMS,Efficacy,-1,fluorouracil,1448426747.0,"Multiple groups, Majority Caucasian"
1450980680,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1450980700.0,"Multiple groups, Vanderbilt USA: 89.2% White, 9.8% Black, 1% Hispanic"
1185023279,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023287.0,"Multiple groups, Mostly Caucasian and Asian"
1184482753,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184482758.0,East Asian
1183532526,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183532534.0,European
1450931709,PA166160473,rs1042718,,,ADRB2,PD,-1,fentanyl,1450931713.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1448639517,PA166169465,rs6746030,,,SCN9A,Other,1,propofol,1448639522.0,East Asian
1450374888,PA166175927,rs2070762,,,TH,Efficacy,1,methylphenidate,1450374894.0,Unknown
1450374888,PA166175927,rs2070762,,,TH,Efficacy,1,methylphenidate,1450374904.0,Unknown
1444707128,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,1444707133.0,European
1444707128,PA166155096,rs9934438,,,VKORC1,Efficacy,1,acenocoumarol,1444707133.0,European
1450932012,PA166157316,rs2032582,,,ABCB1,Dosage,1,sufentanil,1450932018.0,East Asian
982045496,PA166157316,rs2032582,,,ABCB1,Efficacy,1,atorvastatin,982045506.0,European
982045496,PA166157316,rs2032582,,,ABCB1,Efficacy,1,atorvastatin,982045509.0,European
608431255,PA166153720,rs2842030,,,RGS4,Efficacy,0,risperidone,608431257.0,European
1448998839,PA166170509,rs1023574,,,HTR2C,Efficacy,1,risperidone,1448998841.0,East Asian
1448998848,PA166170511,rs9698290,,,HTR2C,Efficacy,1,risperidone,1448998850.0,East Asian
1448639061,PA166169445,rs2231198,,,AKR7A3,Metabolism/PK,-1,bupropion,1448639063.0,Unknown
1445296586,PA166157316,rs2032582,,,ABCB1,Efficacy,1,imatinib,1445296604.0,"Multiple groups, Asian, American, African, European"
699639139,PA166154259,rs6265,,,BDNF,Efficacy,0,lithium,699639142.0,East Asian
699639139,PA166154259,rs6265,,,BDNF-AS,Efficacy,0,lithium,699639142.0,East Asian
1448262073,PA166160424,rs2284411,,,GRIN2B,Efficacy,1,methylphenidate,1448262081.0,East Asian
827825723,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cyclophosphamide,827825732.0,East Asian
827825723,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,doxorubicin,827825732.0,East Asian
827825723,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,paclitaxel,827825732.0,East Asian
827825723,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,trastuzumab,827825732.0,East Asian
1444694293,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1444694299.0,East Asian
1449576802,PA166178426,rs149212925,,,FBXO21,Efficacy,-1,cyclophosphamide,1449576804.0,Central/South Asian
1449576802,PA166178426,rs149212925,,,FBXO21,Efficacy,-1,doxorubicin,1449576804.0,Central/South Asian
1447676154,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,cyclophosphamide,1447676193.0,East Asian
1447676154,PA166157267,rs776746,,,CYP3A5,Toxicity,-1,cyclophosphamide,1447676193.0,East Asian
1447676154,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclophosphamide,1447676193.0,East Asian
1447954649,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,docetaxel,1447954651.0,Central/South Asian
1447954649,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,paclitaxel,1447954651.0,Central/South Asian
1447954614,PA166155621,rs1056836,,,CYP1B1,Efficacy,-1,docetaxel,1447954616.0,Central/South Asian
1447954614,PA166155621,rs1056836,,,CYP1B1,Efficacy,-1,paclitaxel,1447954616.0,Central/South Asian
1444694176,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444694206.0,"Multiple groups, 17 Caucasian, 2 Black"
1183693340,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183693342.0,East Asian
1444694110,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1444694116.0,"Multiple groups, Mostly White"
827925294,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,digoxin,827925305.0,East Asian
1444693994,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1444694000.0,"Multiple groups, White, Asian"
1449577151,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1449577157.0,East Asian
1449577151,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1449577161.0,East Asian
1449577151,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1449577163.0,East Asian
1449577151,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1449577173.0,East Asian
1449577174,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1449577176.0,East Asian
1449577174,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1449577184.0,East Asian
1449167736,PA166177103,rs4971678,,,NRXN1,Efficacy,1,duloxetine,1449167738.0,European
827925119,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827925128.0,East Asian
981954427,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,981954437.0,Central/South Asian
1449167770,PA166177109,rs4334661,,,ZNF385D,Efficacy,1,duloxetine,1449167772.0,European
1449167764,PA166177107,rs13093500,,,ZNF385D,Efficacy,1,duloxetine,1449167766.0,European
1449167785,PA166177112,rs7616119,,,ZNF385D,Efficacy,1,duloxetine,1449167787.0,European
1449167803,PA166177115,rs9310657,,,ZNF385D,Efficacy,1,duloxetine,1449167805.0,European
1449167809,PA166177116,rs9310658,,,ZNF385D,Efficacy,1,duloxetine,1449167811.0,European
1449167815,PA166177117,rs9819548,,,ZNF385D,Efficacy,1,duloxetine,1449167817.0,European
981954525,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,ondansetron,981954545.0,Multiple groups
981954525,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,ondansetron,981954542.0,"Multiple groups, 139 Caucasians, 2 Black Africans"
1449167827,PA166177119,rs9873889,,,ZNF385D,Efficacy,1,duloxetine,1449167829.0,European
1449167821,PA166177118,rs9824595,,,ZNF385D,Efficacy,1,duloxetine,1449167823.0,European
1449167833,PA166177120,rs9879065,,,ZNF385D,Efficacy,1,duloxetine,1449167835.0,European
1449167833,PA166177120,rs9879065,,,ZNF385D,Efficacy,1,duloxetine,1449167835.0,European
1449167833,PA166177120,rs9879065,,,ZNF385D,Efficacy,1,duloxetine,1449167835.0,European
1449167833,PA166177120,rs9879065,,,ZNF385D,Efficacy,1,duloxetine,1449167835.0,European
982036522,PA166156749,rs1042714,,,ADRB2,Efficacy,1,atenolol,982036530.0,European
982036522,PA166156749,rs1042714,,,ADRB2,Efficacy,1,enalapril,982036530.0,European
982036522,PA166156749,rs1042714,,,ADRB2,Efficacy,1,enalapril,982036530.0,European
1449167894,PA166177130,rs10989064,,,TEX10,Efficacy,1,duloxetine,1449167896.0,European
1449167900,PA166177131,rs6479008,,,TEX10,Efficacy,1,duloxetine,1449167902.0,European
1449167936,PA166177139,rs56355515,,,MIEF2,Efficacy,1,duloxetine,1449167938.0,European
1449167942,PA166177140,rs58042962,,,None,Efficacy,1,duloxetine,1449167944.0,European
1184169091,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184169107.0,East Asian
1184169091,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184169095.0,East Asian
1184988306,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184988314.0,Sub-Saharan African
1184988306,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184988314.0,Sub-Saharan African
1184988306,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184988314.0,Sub-Saharan African
1446905193,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1446905207.0,Sub-Saharan African
1449168137,PA166177183,rs13204353,,,TREML4,Efficacy,1,duloxetine,1449168139.0,European
1449168143,PA166177184,rs9369266,,,TREML4,Efficacy,1,duloxetine,1449168145.0,European
981954805,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,carbamazepine,981954815.0,Central/South Asian
981954805,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenobarbital,981954815.0,Central/South Asian
981954805,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenytoin,981954815.0,Central/South Asian
981954805,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,valproic acid,981954815.0,Central/South Asian
1449168149,PA166177185,rs3124955,,,FCN2,Efficacy,1,duloxetine,1449168151.0,European
1449168149,PA166177185,rs3124955,,,FCN2,Efficacy,1,duloxetine,1449168151.0,European
1449004322,PA166170798,rs2371108,,,EOMES,Efficacy,1,glatiramer acetate,1449004328.0,European
981954817,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,carbamazepine,981954827.0,Central/South Asian
981954817,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenobarbital,981954827.0,Central/South Asian
981954817,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenytoin,981954827.0,Central/South Asian
981954817,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,valproic acid,981954827.0,Central/South Asian
981954817,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,valproic acid,981954827.0,Central/South Asian
981954817,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,valproic acid,981954827.0,Central/South Asian
1449004340,PA166157574,rs2114358,,,PVT1,Efficacy,1,glatiramer acetate,1449004342.0,European
1448494366,PA166161794,rs1043657,,,AKR7A2,Metabolism/PK,-1,exemestane,1448494368.0,Multiple groups
982034790,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,benazepril,982034842.0,East Asian
982034790,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,benazepril,982034829.0,East Asian
1448428823,PA166161452,rs75995567,,,AOX1,Dosage,1,allopurinol,1448428825.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428823,PA166161452,rs75995567,,,AOX1,Dosage,1,febuxostat,1448428825.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1449577793,PA166155079,rs7196161,,,VKORC1,Dosage,0,warfarin,1449577800.0,"Multiple groups, Chinese, Indian and Malay participants in Singapore"
1449168199,PA166177191,rs17724464,,,ANO2,Efficacy,1,duloxetine,1449168201.0,European
1449168205,PA166177192,rs17724494,,,ANO2,Efficacy,1,duloxetine,1449168207.0,European
1449577814,PA166155079,rs7196161,,,VKORC1,Dosage,0,warfarin,1449577816.0,"Multiple groups, Singapore: Chinese, Malay, Indian, Other"
1449168258,PA166177200,rs61908406,,,ANO2,Efficacy,1,duloxetine,1449168260.0,European
1449168264,PA166177201,rs61908407,,,ANO2,Efficacy,1,duloxetine,1449168266.0,European
1449168271,PA166177202,rs61908408,,,ANO2,Efficacy,1,duloxetine,1449168273.0,European
1449168283,PA166177204,rs61908410,,,ANO2,Efficacy,1,duloxetine,1449168285.0,European
1449168289,PA166177205,rs61908411,,,ANO2,Efficacy,1,duloxetine,1449168291.0,European
613978995,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,Beta Blocking Agents,613978998.0,European
1449168301,PA166177209,rs78615940,,,ANO2,Efficacy,1,duloxetine,1449168303.0,European
1451134420,PA166157316,rs2032582,,,ABCB1,,-1,lamotrigine,1451134425.0,Unknown
1448100925,PA166159110,rs4148738,,,ABCB1,Metabolism/PK,-1,dabigatran,1448100927.0,European
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807143.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807130.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicitites. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807133.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807131.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807132.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807141.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807143.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807130.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicitites. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807133.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807131.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807132.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807128,PA166170103,rs1137070,,,MAOA,Dosage,1,nicotine,1450807141.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1185234900,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1185234928.0,Sub-Saharan African
1448264077,PA166160571,rs17716942,,,KCNH7,Efficacy,-1,etanercept,1448264079.0,Unknown
1448264083,PA166160571,rs17716942,,,KCNH7,Efficacy,-1,adalimumab,1448264085.0,Unknown
1449005283,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449005290.0,Multiple groups
1184514346,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,imatinib,1184514350.0,Unknown
1448264031,PA166160563,rs240993,,,REV3L,Efficacy,-1,etanercept,1448264033.0,Unknown
1448267977,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1448267983.0,East Asian
1184756163,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1184756165.0,East Asian
1184756163,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1184756198.0,East Asian
1449165313,PA166176855,rs3801266,,,NAMPT,Efficacy,-1,Antihypertensives,1449165316.0,Multiple groups
1449165313,PA166176855,rs3801266,,,NAMPT,Efficacy,-1,Antihypertensives,1449165318.0,Multiple groups
1449165313,PA166176855,rs3801266,,,NAMPT,Efficacy,-1,Antihypertensives,1449165317.0,Multiple groups
1449165313,PA166176855,rs3801266,,,NAMPT,Efficacy,-1,Antihypertensives,1449165315.0,Multiple groups
1450934903,PA166170701,rs10841753,,,SLCO1B1,Efficacy,1,estrone sulfate,1450934908.0,"Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other."
827567282,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827567312.0,European
827862165,PA166157316,rs2032582,,,ABCB1,Efficacy,1,atorvastatin,827862187.0,Multiple groups
827845768,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827845775.0,East Asian
1449001741,PA166170572,rs2078267,,,SLC22A11,Efficacy,-1,furosemide,1449001743.0,"Multiple groups, Maori, Pacific Islanders and Caucasians"
1449001741,PA166170572,rs2078267,,,SLC22A11,Efficacy,-1,furosemide,1449001749.0,"Multiple groups, Maori, Pacific Islander and Caucasian"
1043818250,PA166154977,rs7294,,,VKORC1,Dosage,-1,phenprocoumon,1043818252.0,European
1445400136,PA166153648,rs1801265,,,DPYD,Metabolism/PK,1,fluorouracil,1445400138.0,Unknown
1449165839,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449165841.0,East Asian
1184511092,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,donepezil,1184511094.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184511092,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,donepezil,1184511094.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1448594916,PA166162770,rs848,,,IL13,Efficacy,1,ustekinumab,1448594918.0,European
1449165997,PA166176935,rs10413455,,,ZNF134,Efficacy,-1,methylphenidate,1449165999.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
982034642,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,benazepril,982034663.0,East Asian
982034642,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,benazepril,982034737.0,East Asian
982034642,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,benazepril,982034739.0,East Asian
982034642,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,benazepril,982034761.0,East Asian
1449166044,PA166176940,rs2886059,,,ALDH1L1,Efficacy,-1,methylphenidate,1449166046.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166057,PA166176942,rs4805162,,,ZNF565,Efficacy,-1,methylphenidate,1449166059.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166082,PA166176946,rs12409352,,,PIGM,Efficacy,-1,methylphenidate,1449166084.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166076,PA166176945,rs2799018,,,ARHGAP12,Efficacy,-1,methylphenidate,1449166078.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166076,PA166176945,rs2799018,,,ARHGAP12,Efficacy,-1,methylphenidate,1449166078.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166100,PA166176948,rs4627790,,,CMTM8,Efficacy,-1,methylphenidate,1449166102.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166122,PA166176951,rs751655,,,OPCML,Efficacy,-1,methylphenidate,1449166124.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166269,PA166176956,rs11552708,,,SENP3,Efficacy,-1,methylphenidate,1449166271.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166147,PA166176955,rs9032,,,STRBP,Efficacy,-1,methylphenidate,1449166149.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166147,PA166176955,rs9032,,,STRBP,Efficacy,-1,methylphenidate,1449166149.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166191,PA166177008,rs17300741,,,SLC22A11,Dosage,-1,allopurinol,1449166193.0,Unknown
827813802,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,827813818.0,"Multiple groups, Predominantly Caucasian cohort"
827813802,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827813818.0,"Multiple groups, Predominantly Caucasian cohort"
827830139,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,827830163.0,Multiple groups
827830139,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,827830279.0,European
827830139,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827830163.0,Multiple groups
827830139,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827830279.0,European
1449166319,PA166176958,rs11553441,,,RRP7A,Efficacy,-1,methylphenidate,1449166321.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166331,PA166176960,rs757978,,,FARP2,Efficacy,-1,methylphenidate,1449166333.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166325,PA166176959,rs362272,,,HTT,Efficacy,-1,methylphenidate,1449166327.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1448266816,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,carbamazepine,1448266818.0,East Asian
1449166371,PA166176964,rs2013169,,,PURA,Efficacy,-1,methylphenidate,1449166373.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1450378806,PA166182585,rs587783672,,,KCNJ11,Efficacy,0,"sulfonamides, urea derivatives",1450378811.0,Near Eastern
1184511615,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184511619.0,East Asian
1184511615,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184511619.0,East Asian
1448266687,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,carbamazepine,1448266689.0,East Asian
769250129,PA166157267,rs776746,,,CYP3A5,Dosage,1,sirolimus,769250135.0,Multiple groups
769250129,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,sirolimus,769250135.0,Multiple groups
769250136,PA166157267,rs776746,,,CYP3A5,Dosage,1,sirolimus,769250370.0,European
769250136,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,sirolimus,769250370.0,European
1450985160,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,ritonavir,1450985156.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985160,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,ritonavir,1450985180.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985160,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,ritonavir,1450985157.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985160,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,ritonavir,1450985164.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1448266567,PA166160807,rs7301582,,,KLRC1,Efficacy,1,adalimumab,1448266569.0,European
1448266567,PA166160807,rs7301582,,,KLRC1,Efficacy,1,certolizumab pegol,1448266569.0,European
1448266567,PA166160807,rs7301582,,,KLRC1,Efficacy,1,etanercept,1448266569.0,European
1448266567,PA166160807,rs7301582,,,KLRC1,Efficacy,1,glucocorticoids,1448266569.0,European
1448266567,PA166160807,rs7301582,,,KLRC1,Efficacy,1,infliximab,1448266569.0,European
1448266567,PA166160807,rs7301582,,,KLRC1,Efficacy,1,methotrexate,1448266569.0,European
1444694728,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,1,warfarin,1444694730.0,East Asian
1444694686,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1444694688.0,East Asian
827698530,PA166157267,rs776746,,,CYP3A,Efficacy,1,tacrolimus,827698571.0,"Multiple groups, Mostly White, non-African American"
827698530,PA166157267,rs776746,,,CYP3A,Efficacy,1,tacrolimus,827698569.0,African American/Afro-Caribbean
827698530,PA166157267,rs776746,,,CYP3A5,Efficacy,1,tacrolimus,827698571.0,"Multiple groups, Mostly White, non-African American"
827698530,PA166157267,rs776746,,,CYP3A5,Efficacy,1,tacrolimus,827698569.0,African American/Afro-Caribbean
827698530,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,827698571.0,"Multiple groups, Mostly White, non-African American"
827698530,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,827698569.0,African American/Afro-Caribbean
827698530,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827698571.0,"Multiple groups, Mostly White, non-African American"
827698530,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827698569.0,African American/Afro-Caribbean
1448266309,PA166160763,rs7703002,,,RICTOR,Efficacy,-1,platinum,1448266311.0,East Asian
1184511950,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184511954.0,"Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)"
1449576503,PA166179590,rs7604115,,,UGT1A3,Metabolism/PK,1,montelukast,1449576510.0,European
637880240,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,637880242.0,Unknown
1448531970,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,ticagrelor,1448531972.0,East Asian
981345407,PA166156749,rs1042714,,,ADRB2,Metabolism/PK,1,terbutaline,981345415.0,Unknown
981417521,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,adalimumab,981417697.0,European
981417521,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,etanercept,981417697.0,European
981417521,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,infliximab,981417697.0,European
981417521,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417697.0,European
1184754595,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184754605.0,East Asian
1184754595,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184754601.0,East Asian
1184754595,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184754603.0,East Asian
1449155460,PA166163371,rs5744174,,,TLR5,Efficacy,1,ustekinumab,1449155462.0,Unknown
769249039,PA166154082,rs7900194,,,CYP2C9,Other,1,phenytoin,769249068.0,Sub-Saharan African
769249039,PA166154082,rs7900194,,,CYP2C9,Metabolism/PK,1,phenytoin,769249068.0,Sub-Saharan African
1184754659,PA166155091,rs9923231,,,VKORC1,Dosage,0,acenocoumarol,1184754663.0,European
1449188400,PA166177790,rs499796,,,OPRM1,Metabolism/PK,-1,cotinine,1449188402.0,East Asian
1449188400,PA166177790,rs499796,,,OPRM1,Metabolism/PK,-1,cotinine,1449188402.0,East Asian
1449270340,PA166178385,rs2477134,,,PADI4,Metabolism/PK,1,uric acid,1449270342.0,European
1184754859,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,simvastatin,1184754863.0,Unknown
1448926344,PA166169975,rs2298881,,,ERCC1,Efficacy,1,fluorouracil,1448926350.0,East Asian
1448926344,PA166169975,rs2298881,,,ERCC1,Efficacy,1,fluorouracil,1448926379.0,East Asian
1448926344,PA166169975,rs2298881,,,ERCC1,Efficacy,1,Platinum compounds,1448926350.0,East Asian
1448926344,PA166169975,rs2298881,,,ERCC1,Efficacy,1,Platinum compounds,1448926379.0,East Asian
1448926344,PA166169975,rs2298881,,,ERCC1,Efficacy,1,radiotherapy,1448926350.0,East Asian
1448926344,PA166169975,rs2298881,,,ERCC1,Efficacy,1,radiotherapy,1448926379.0,East Asian
637879816,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,637879818.0,"Multiple groups, Asians (n = 1103), blacks (n = 670), and whites (n = 3113)"
1448926366,PA166169979,rs2075685,,,XRCC4,Efficacy,1,fluorouracil,1448926368.0,East Asian
1448926366,PA166169979,rs2075685,,,XRCC4,Efficacy,1,fluorouracil,1448926377.0,East Asian
1448926366,PA166169979,rs2075685,,,XRCC4,Efficacy,1,Platinum compounds,1448926368.0,East Asian
1448926366,PA166169979,rs2075685,,,XRCC4,Efficacy,1,Platinum compounds,1448926377.0,East Asian
1448926366,PA166169979,rs2075685,,,XRCC4,Efficacy,1,radiotherapy,1448926368.0,East Asian
1448926366,PA166169979,rs2075685,,,XRCC4,Efficacy,1,radiotherapy,1448926377.0,East Asian
1448926454,PA166159977,rs50872,,,ERCC2,Efficacy,-1,fluorouracil,1448926456.0,East Asian
1448926454,PA166159977,rs50872,,,ERCC2,Efficacy,-1,Platinum compounds,1448926456.0,East Asian
1448926454,PA166159977,rs50872,,,ERCC2,Efficacy,-1,radiotherapy,1448926456.0,East Asian
1183690021,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183690025.0,Unknown
1448613214,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448613216.0,East Asian
1448613179,PA166163546,rs181781,,,IL3,Metabolism/PK,1,tacrolimus,1448613185.0,East Asian
1183690054,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183690058.0,Unknown
1184755018,PA166154259,rs6265,,,BDNF,Efficacy,1,paroxetine,1184755023.0,East Asian
1448926610,PA166170020,rs1052133,,,OGG1,Efficacy,-1,fluorouracil,1448926612.0,East Asian
1448926610,PA166170020,rs1052133,,,OGG1,Efficacy,-1,Platinum compounds,1448926612.0,East Asian
1448926610,PA166170020,rs1052133,,,OGG1,Efficacy,-1,radiotherapy,1448926612.0,East Asian
1448926619,PA166170022,rs293795,,,OGG1,Efficacy,-1,fluorouracil,1448926621.0,East Asian
1448926619,PA166170022,rs293795,,,OGG1,Efficacy,-1,Platinum compounds,1448926621.0,East Asian
1448926619,PA166170022,rs293795,,,OGG1,Efficacy,-1,radiotherapy,1448926621.0,East Asian
1449155990,PA166175850,rs503464,,,CHRNA5,Efficacy,1,bupropion,1449155992.0,European
1449155990,PA166175850,rs503464,,,CHRNA5,Efficacy,1,nicotine,1449155992.0,European
1449155990,PA166175850,rs503464,,,CHRNA5,Efficacy,1,varenicline,1449155992.0,European
1448268958,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1448268965.0,Multiple groups
1448926649,PA166170028,rs26279,,,MSH3,Efficacy,-1,fluorouracil,1448926651.0,East Asian
1448926649,PA166170028,rs26279,,,MSH3,Efficacy,-1,Platinum compounds,1448926651.0,East Asian
1448926649,PA166170028,rs26279,,,MSH3,Efficacy,-1,radiotherapy,1448926651.0,East Asian
1448926669,PA166170032,rs2725335,,,WRN,Efficacy,-1,fluorouracil,1448926671.0,East Asian
1448926669,PA166170032,rs2725335,,,WRN,Efficacy,-1,Platinum compounds,1448926671.0,East Asian
1448926669,PA166170032,rs2725335,,,WRN,Efficacy,-1,radiotherapy,1448926671.0,East Asian
1448926689,PA166170036,rs7180135,,,RAD51,Efficacy,-1,fluorouracil,1448926691.0,East Asian
1448926689,PA166170036,rs7180135,,,RAD51,Efficacy,-1,Platinum compounds,1448926691.0,East Asian
1448926689,PA166170036,rs7180135,,,RAD51,Efficacy,-1,radiotherapy,1448926691.0,East Asian
769248362,PA166157316,rs2032582,,,ABCB1,Other,-1,tipifarnib,769248364.0,European
769248362,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tipifarnib,769248364.0,European
827848956,PA166155409,rs3745274,,,CYP2B6,Toxicity,1,nevirapine,827848971.0,Multiple groups
827848956,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,827848971.0,Multiple groups
1448104695,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448104700.0,East Asian
1450827404,PA166154259,rs6265,,,BDNF,Toxicity,-1,heroin,1450827408.0,East Asian
1448432589,PA166161547,rs8187843,,,ABCC1,Metabolism/PK,-1,SN-38,1448432591.0,"Multiple groups, Caucasian and African-American"
827848906,PA166157316,rs2032582,,,ABCB1,Toxicity,-1,nevirapine,827848977.0,Multiple groups
827848906,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,nevirapine,827848977.0,Multiple groups
1451138781,PA166176247,rs963549,,,OPRK1,Dosage,-1,heroin,1451138769.0,East Asian
981858994,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859030.0,East Asian
981858994,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859032.0,East Asian
981858994,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859020.0,East Asian
981858994,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859026.0,East Asian
981858994,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859017.0,East Asian
1450942220,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450942227.0,East Asian
1184509863,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184509865.0,Near Eastern
1449713634,PA166179818,rs2070096,,,BARD1,Efficacy,1,carboplatin,1449713636.0,Unknown
1449713634,PA166179818,rs2070096,,,BARD1,Efficacy,1,docetaxel,1449713636.0,Unknown
1449713634,PA166179818,rs2070096,,,BARD1,Efficacy,1,trastuzumab,1449713636.0,Unknown
982023222,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,982023241.0,"Multiple groups, Caucasian, Black, Asian"
982023222,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,982023243.0,"Multiple groups, Caucasian, Black, Asian"
982023222,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,982023245.0,"Multiple groups, Caucasian, Black, Asian"
982023222,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,982023250.0,"Multiple groups, Caucasian, Black, Asian"
982023222,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,982023247.0,"Multiple groups, Caucasian, Black, Asian"
982023222,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,982023239.0,"Multiple groups, Caucasian, Black, Asian"
1448109670,PA166153972,rs1799853,,,CYP2C9,Dosage,0,warfarin,,
1184510103,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184510107.0,Latino
1184510103,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184510107.0,Latino
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811678.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811683.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811687.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811688.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811677.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811684.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811689.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811675.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811676.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811679.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811685.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811686.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811681.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811680.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811671,PA166177789,rs553202,,,OPRM1,Efficacy,1,ethanol,1450811853.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1184998300,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998306.0,Near Eastern
1184998408,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998414.0,East Asian
1184998408,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998414.0,East Asian
1184998516,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998522.0,Unknown
1184998516,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998522.0,Unknown
1184998516,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998522.0,Unknown
1450415278,PA166155091,rs9923231,,,VKORC1,Dosage,-1,acenocoumarol,1450415283.0,European
1450415278,PA166155091,rs9923231,,,VKORC1,Dosage,-1,acenocoumarol,1450415283.0,European
1449170332,PA166177554,rs6715729,,,TACR1,Efficacy,-1,granisetron,1449170335.0,East Asian
1449170332,PA166177554,rs6715729,,,TACR1,Efficacy,-1,granisetron,1449170334.0,East Asian
1449170332,PA166177554,rs6715729,,,TACR1,Efficacy,-1,palonosetron,1449170335.0,East Asian
1449170332,PA166177554,rs6715729,,,TACR1,Efficacy,-1,palonosetron,1449170334.0,East Asian
1451120169,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1451120142.0,Unknown
1448614987,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,anastrozole,1448614993.0,European
1444666410,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444666415.0,East Asian
1448106998,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1448107005.0,European
1450415747,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,atazanavir / ritonavir,1450415755.0,Unknown
1450415747,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,atazanavir / ritonavir,1450415753.0,Unknown
1450415747,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,atazanavir / ritonavir,1450415755.0,Unknown
1450415747,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,atazanavir / ritonavir,1450415753.0,Unknown
1448614774,PA166163600,rs3834939,,,SLCO1A2,Metabolism/PK,1,rocuronium,1448614797.0,Unknown
1448614774,PA166163600,rs3834939,,,SLCO1A2,Metabolism/PK,1,rocuronium,1448614779.0,Unknown
1448106854,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448106866.0,European
1183704904,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1185235424.0,Central/South Asian
1183704904,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1183704908.0,Central/South Asian
1448532419,PA166162418,rs1049174,,,KLRK1,Efficacy,1,peginterferon alfa-2b,1448532426.0,Unknown
1448532419,PA166162418,rs1049174,,,KLRK1,Efficacy,1,ribavirin,1448532426.0,Unknown
1448601675,PA166163134,rs3732759,,,P2RY12,Efficacy,1,clopidogrel,1448601677.0,East Asian
1448634152,PA166165144,rs6706648,,,BCL11A,Efficacy,-1,hydroxyurea,1448634154.0,Near Eastern
1449713987,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,fentanyl,1449713989.0,East Asian
1449713987,,,PA165819240,CYP3A4*18,CYP3A4,Dosage,-1,fentanyl,1449713989.0,East Asian
1449716539,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716541.0,East Asian
1449716539,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1449716541.0,East Asian
1451125720,,,PA165819171,CYP1A2*1A,CYP1A2,Metabolism/PK,-1,clozapine,1451125740.0,"Multiple groups, 56 patients were of European ancestry"
1451125720,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,-1,clozapine,1451125740.0,"Multiple groups, 56 patients were of European ancestry"
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371577.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371572.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371699.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371609.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371607.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371605.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371694.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371650.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371652.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371654.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371684.0,European
1450371570,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1450371688.0,European
1448684673,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,levonorgestrel,1448684681.0,Sub-Saharan African
1447947794,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947799.0,East Asian
1449714740,PA166179983,rs7802773,,,ABCB1,Dosage,-1,opioids,1449714743.0,European
1449714740,PA166179983,rs7802773,,,ABCB1,Dosage,-1,opioids,1449714742.0,European
1449714740,PA166179983,rs7802773,,,ABCB1,Dosage,-1,opioids,1449714743.0,European
1449714740,PA166179983,rs7802773,,,ABCB1,Dosage,-1,opioids,1449714742.0,European
1449714740,PA166179983,rs7802773,,,ABCB1,Dosage,-1,opioids,1449714743.0,European
1449714740,PA166179983,rs7802773,,,ABCB1,Dosage,-1,opioids,1449714742.0,European
981502054,PA166153999,rs2227310,,,CASP7,Efficacy,1,docetaxel,981502067.0,East Asian
981502054,PA166153999,rs2227310,,,CASP7,Efficacy,1,gemcitabine,981502067.0,East Asian
981502054,PA166153999,rs2227310,,,CASP7,Efficacy,1,paclitaxel,981502067.0,East Asian
981502054,PA166153999,rs2227310,,,CASP7,Efficacy,1,Platinum compounds,981502067.0,East Asian
981502054,PA166153999,rs2227310,,,CASP7,Efficacy,1,vinorelbine,981502067.0,East Asian
1043858930,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,nifedipine,1043858932.0,East Asian
769258956,PA166153953,rs717620,,,ABCC2,Other,1,erythromycin,769258959.0,European
769258956,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,erythromycin,769258959.0,European
769258956,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,erythromycin,769258959.0,European
1444703756,PA166154758,rs77876672,,,DIAPH3,Efficacy,-1,hydrochlorothiazide,1444703759.0,European
1448422916,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1448422928.0,Unknown
1448422916,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,irinotecan,1448422928.0,Unknown
1448422916,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1448422928.0,Unknown
1448422916,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1448422928.0,Unknown
1447964156,PA166157519,rs78655421,,,CFTR,Efficacy,0,ivacaftor,1447964171.0,European
1447947784,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447947790.0,Near Eastern
1447947784,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447947790.0,Near Eastern
1447947784,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447947790.0,Near Eastern
1447947784,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447947790.0,Near Eastern
1449714790,PA166154262,rs6279,,,DRD2,Dosage,-1,opioids,1449714792.0,European
1449714790,PA166154262,rs6279,,,DRD2,Dosage,-1,opioids,1449714793.0,European
1449714790,PA166154262,rs6279,,,DRD2,Dosage,-1,opioids,1449714792.0,European
1449714790,PA166154262,rs6279,,,DRD2,Dosage,-1,opioids,1449714793.0,European
1449714790,PA166154262,rs6279,,,DRD2,Dosage,-1,opioids,1449714792.0,European
1449714790,PA166154262,rs6279,,,DRD2,Dosage,-1,opioids,1449714793.0,European
1447947763,PA166155914,rs1059150,,,ATP5F1E,Efficacy,1,adalimumab,1447947766.0,European
1447947763,PA166155914,rs1059150,,,ATP5F1E,Efficacy,1,certolizumab pegol,1447947766.0,European
1447947763,PA166155914,rs1059150,,,ATP5F1E,Efficacy,1,etanercept,1447947766.0,European
1447947763,PA166155914,rs1059150,,,ATP5F1E,Efficacy,1,glucocorticoids,1447947766.0,European
1447947763,PA166155914,rs1059150,,,ATP5F1E,Efficacy,1,infliximab,1447947766.0,European
1447947763,PA166155914,rs1059150,,,ATP5F1E,Efficacy,1,methotrexate,1447947766.0,European
1448259064,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448259066.0,Multiple groups
1448259064,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448259067.0,Multiple groups
1183863853,PA166155301,rs6506569,,,PTPRM,Efficacy,-1,methotrexate,1183863855.0,Central/South Asian
1451156540,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,(R)-methadone,1451156508.0,European
1451156540,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,-1,(R)-methadone,1451156508.0,European
1451156540,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,(R)-methadone,1451156508.0,European
1451156540,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,-1,(R)-methadone,1451156508.0,European
1451156540,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,-1,(R)-methadone,1451156508.0,European
1451156540,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,-1,(R)-methadone,1451156508.0,European
699642186,PA166154625,rs10879346,,,TPH2,Efficacy,1,antidepressants,699642188.0,European
699642186,PA166154625,rs10879346,,,TPH2,Efficacy,1,antidepressants,699642188.0,European
981502104,PA166154272,rs286913,,,EHF,Dosage,1,ziprasidone,981502110.0,"Multiple groups, White/European American; Black/African American; other"
981502104,PA166154272,rs286913,,,EHF,Efficacy,1,ziprasidone,981502110.0,"Multiple groups, White/European American; Black/African American; other"
1450812567,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,dextropropoxyphene,1450812575.0,Unknown
1450812567,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,dextropropoxyphene,1450812575.0,Unknown
1450812567,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,dextropropoxyphene,1450812575.0,Unknown
1450812567,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,nordextropropoxyphene,1450812575.0,Unknown
1450812567,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,nordextropropoxyphene,1450812575.0,Unknown
1450812567,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,nordextropropoxyphene,1450812575.0,Unknown
1444703675,PA166156827,rs4431329,,,FBXL17,Efficacy,-1,hydrochlorothiazide,1444703677.0,European
1449747593,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449747612.0,Unknown
1449747593,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449747612.0,Unknown
1183700136,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183700144.0,European
1449714797,PA166154260,rs6275,,,DRD2,Dosage,-1,opioids,1449714799.0,European
1449714797,PA166154260,rs6275,,,DRD2,Dosage,-1,opioids,1449714800.0,European
1183700115,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700117.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";81 were *2/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1183700115,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700117.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";81 were *2/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1183700115,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700117.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";81 were *2/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
981502111,PA166153823,rs11240594,,,SLC26A9,Dosage,1,olanzapine,981502116.0,"Multiple groups, White/European American; Black/African American; other"
981502111,PA166153823,rs11240594,,,SLC26A9,Efficacy,1,olanzapine,981502116.0,"Multiple groups, White/European American; Black/African American; other"
1447964109,PA166157525,rs113993960,,,CFTR,Efficacy,1,cysteamine,1447964135.0,Unknown
1184175254,PA166154309,rs1042858,,,RRM1,Efficacy,-1,carboplatin,1184175323.0,East Asian
1184175254,PA166154309,rs1042858,,,RRM1,Efficacy,-1,gemcitabine,1184175323.0,East Asian
1449714804,PA166154319,rs1125394,,,DRD2,Dosage,-1,opioids,1449714807.0,European
1449714804,PA166154319,rs1125394,,,DRD2,Dosage,-1,opioids,1449714806.0,European
1445391811,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,phenytoin,1445396092.0,Latino
1448635857,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,escitalopram,1448635869.0,East Asian
1448635857,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,escitalopram,1448635869.0,East Asian
1448635857,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,escitalopram,1448635869.0,East Asian
1450812582,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,dextropropoxyphene,1450812587.0,Unknown
1450812582,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,dextropropoxyphene,1450812587.0,Unknown
982010017,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,982010027.0,Near Eastern
981502120,PA166155806,rs11677416,,,IL1A,Dosage,1,olanzapine,981502123.0,"Multiple groups, White/European American; Black/African American; other"
981502120,PA166155806,rs11677416,,,IL1A,Efficacy,1,olanzapine,981502123.0,"Multiple groups, White/European American; Black/African American; other"
1183700123,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700125.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";24 were *3/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1183700123,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700125.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";24 were *3/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1444703691,PA166156846,rs7706429,,,FBXL17,Efficacy,-1,hydrochlorothiazide,1444703693.0,European
1184175245,PA166154468,rs12806698,,,RRM1,Efficacy,1,carboplatin,1184175265.0,East Asian
1184175245,PA166154468,rs12806698,,,RRM1,Efficacy,1,gemcitabine,1184175265.0,East Asian
1183700096,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700098.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";759 were *1/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1183700096,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700098.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";759 were *1/*3 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1448603080,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,felodipine,1448603082.0,East Asian
1448603080,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,felodipine,1448603082.0,East Asian
1448993933,PA166155442,rs8192709,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448993946.0,East Asian
1449714811,PA166179996,rs7131440,,,DRD2,Dosage,-1,opioids,1449714813.0,European
1449714811,PA166179996,rs7131440,,,DRD2,Dosage,-1,opioids,1449714814.0,European
1043858918,PA166157550,rs1048101,,,ADRA1A,Efficacy,1,nifedipine,1043858922.0,East Asian
1448603074,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,felodipine,1448603079.0,East Asian
699642204,PA166154465,rs12422149,,,SLCO2B1,Efficacy,1,montelukast,699642206.0,"Multiple groups, white, black, hispanic"
699642204,PA166154465,rs12422149,,,SLCO2B1,Metabolism/PK,1,montelukast,699642206.0,"Multiple groups, white, black, hispanic"
1183700106,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700108.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";78 were *2/*2 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1183700106,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700108.0,"Multiple groups, For all genotypes, there were 7907 subjects.  5749 were ""*1/*1"";78 were *2/*2 (the rest were other genotypes). 12 studies were performed in Asia,13 in the Americas and 14 in Europe."
1449747623,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1449747625.0,Unknown
1449747623,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1449747625.0,Unknown
747943548,PA166155034,rs2238476,,,ABCC1,Efficacy,1,methotrexate,747960550.0,Unknown
981502071,PA166154152,rs12415607,,,CASP7,Efficacy,1,docetaxel,981502078.0,East Asian
981502071,PA166154152,rs12415607,,,CASP7,Efficacy,1,gemcitabine,981502078.0,East Asian
981502071,PA166154152,rs12415607,,,CASP7,Efficacy,1,paclitaxel,981502078.0,East Asian
981502071,PA166154152,rs12415607,,,CASP7,Efficacy,1,Platinum compounds,981502078.0,East Asian
981502071,PA166154152,rs12415607,,,CASP7,Efficacy,1,vinorelbine,981502078.0,East Asian
1043858910,PA166155187,rs1799752,,,ACE,Efficacy,-1,nifedipine,1043858914.0,Unknown
1448603069,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,sirolimus,1448603071.0,Unknown
769259039,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,1,zidovudine,769259061.0,Sub-Saharan African
982009991,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,982009999.0,Multiple groups
981502079,PA166154054,rs4353229,,,CASP7,Efficacy,1,docetaxel,981502088.0,East Asian
981502079,PA166154054,rs4353229,,,CASP7,Efficacy,1,gemcitabine,981502088.0,East Asian
981502079,PA166154054,rs4353229,,,CASP7,Efficacy,1,paclitaxel,981502088.0,East Asian
981502079,PA166154054,rs4353229,,,CASP7,Efficacy,1,Platinum compounds,981502088.0,East Asian
981502079,PA166154054,rs4353229,,,CASP7,Efficacy,1,vinorelbine,981502088.0,East Asian
1448993954,PA166170101,rs8100458,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448993956.0,East Asian
1448993954,PA166170101,rs8100458,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448993956.0,East Asian
1449714836,PA166154423,rs7131056,,,DRD2,Dosage,-1,opioids,1449714838.0,European
1449714836,PA166154423,rs7131056,,,DRD2,Dosage,-1,opioids,1449714839.0,European
1450943622,PA166186661,rs2364349,,,SNX9,PD,1,atenolol,1450943627.0,African American/Afro-Caribbean
1450943622,PA166186661,rs2364349,,,SNX9,PD,1,metoprolol,1450943627.0,African American/Afro-Caribbean
981502089,PA166154092,rs7921977,,,CASP7,Efficacy,1,docetaxel,981502098.0,East Asian
981502089,PA166154092,rs7921977,,,CASP7,Efficacy,1,gemcitabine,981502098.0,East Asian
981502089,PA166154092,rs7921977,,,CASP7,Efficacy,1,paclitaxel,981502098.0,East Asian
981502089,PA166154092,rs7921977,,,CASP7,Efficacy,1,Platinum compounds,981502098.0,East Asian
981502089,PA166154092,rs7921977,,,CASP7,Efficacy,1,vinorelbine,981502098.0,East Asian
1448603056,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,sirolimus,1448603065.0,Unknown
1448603056,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,sirolimus,1448603065.0,Unknown
1444703722,PA166154744,rs9590353,,,UGGT2,Efficacy,-1,hydrochlorothiazide,1444703725.0,European
1444703722,PA166154744,rs9590353,,,UGGT2,Efficacy,-1,hydrochlorothiazide,1444703725.0,European
1447947702,PA166156981,rs1264457,,,HLA-E,Efficacy,1,adalimumab,1447947760.0,European
1447947702,PA166156981,rs1264457,,,HLA-E,Efficacy,1,certolizumab pegol,1447947760.0,European
1447947702,PA166156981,rs1264457,,,HLA-E,Efficacy,1,etanercept,1447947760.0,European
1447947702,PA166156981,rs1264457,,,HLA-E,Efficacy,1,glucocorticoids,1447947760.0,European
1447947702,PA166156981,rs1264457,,,HLA-E,Efficacy,1,infliximab,1447947760.0,European
1447947702,PA166156981,rs1264457,,,HLA-E,Efficacy,1,methotrexate,1447947760.0,European
1449714843,PA166154409,rs4648317,,,DRD2,Dosage,-1,opioids,1449714846.0,European
1449714843,PA166154409,rs4648317,,,DRD2,Dosage,-1,opioids,1449714845.0,European
1444703599,PA166157638,rs11993031,,,CSMD1,Efficacy,-1,hydrochlorothiazide,1444703601.0,European
1449714876,PA166154324,rs1176744,,,HTR3B,Dosage,-1,opioids,1449714878.0,European
1449714876,PA166154324,rs1176744,,,HTR3B,Dosage,-1,opioids,1449714879.0,European
1449714876,PA166154324,rs1176744,,,HTR3B,Dosage,-1,opioids,1449714878.0,European
1449714876,PA166154324,rs1176744,,,HTR3B,Dosage,-1,opioids,1449714879.0,European
1183700190,PA166154332,rs1561876,,,RRM1,Efficacy,1,cladribine,1183700198.0,Multiple groups
1183700190,PA166154332,rs1561876,,,RRM1,Efficacy,1,cladribine,1183700194.0,Multiple groups
1183700190,PA166154332,rs1561876,,,RRM1,Efficacy,1,cladribine,1183700196.0,Multiple groups
1183700190,PA166154332,rs1561876,,,RRM1,Efficacy,1,cytarabine,1183700198.0,Multiple groups
1183700190,PA166154332,rs1561876,,,RRM1,Efficacy,1,cytarabine,1183700194.0,Multiple groups
1183700190,PA166154332,rs1561876,,,RRM1,Efficacy,1,cytarabine,1183700196.0,Multiple groups
1184175334,,,PA165819268,TPMT*1,TPMT,Dosage,1,azathioprine,1184175346.0,"Multiple groups, Cases:  Recipients of  kidney transplants at the Oxford Transplant Centre.  95% were Caucasian.  The *1/*3C patient was of Afro-Caribbean ancestry.  The controls were UK Caucasian cadavers (renal allograft donors)."
1184175334,,,PA165819270,TPMT*3A,TPMT,Dosage,1,azathioprine,1184175346.0,"Multiple groups, Cases:  Recipients of  kidney transplants at the Oxford Transplant Centre.  95% were Caucasian.  The *1/*3C patient was of Afro-Caribbean ancestry.  The controls were UK Caucasian cadavers (renal allograft donors)."
1184175334,,,PA165819272,TPMT*3C,TPMT,Dosage,1,azathioprine,1184175346.0,"Multiple groups, Cases:  Recipients of  kidney transplants at the Oxford Transplant Centre.  95% were Caucasian.  The *1/*3C patient was of Afro-Caribbean ancestry.  The controls were UK Caucasian cadavers (renal allograft donors)."
1449714883,PA166154360,rs2276307,,,HTR3B,Dosage,-1,opioids,1449714885.0,European
1449714883,PA166154360,rs2276307,,,HTR3B,Dosage,-1,opioids,1449714886.0,European
1450812627,PA166183950,rs2337980,,,CHRNA7,Efficacy,1,nicotine,1450812631.0,Unknown
769160740,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,769160742.0,Multiple groups
1444703605,PA166156850,rs9285669,,,None,Efficacy,-1,hydrochlorothiazide,1444703607.0,European
1444703611,PA166154128,rs11189015,,,SLIT1,Efficacy,-1,hydrochlorothiazide,1444703614.0,European
1444703611,PA166154128,rs11189015,,,SLIT1,Efficacy,-1,hydrochlorothiazide,1444703614.0,European
1183700199,PA166154310,rs1042919,,,RRM1,Efficacy,1,cladribine,1183700202.0,Multiple groups
1183700199,PA166154310,rs1042919,,,RRM1,Efficacy,1,cladribine,1183700203.0,Multiple groups
1183700199,PA166154310,rs1042919,,,RRM1,Efficacy,1,cytarabine,1183700202.0,Multiple groups
1183700199,PA166154310,rs1042919,,,RRM1,Efficacy,1,cytarabine,1183700203.0,Multiple groups
1447947686,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,-1,atazanavir,1447947688.0,"Multiple groups, South African, Peruvians, American."
1448635810,PA166165284,rs7314976,,,HCAR2,Efficacy,-1,niacin,1448635812.0,European
1449714862,PA166180009,rs11606194,,,HTR3B,Dosage,-1,opioids,1449714864.0,European
1449714862,PA166180009,rs11606194,,,HTR3B,Dosage,-1,opioids,1449714865.0,European
982010090,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,982010096.0,Near Eastern
982010090,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,982010096.0,Near Eastern
1448993987,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448994000.0,Multiple groups
1448993987,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448994000.0,Multiple groups
827804313,PA166157284,rs1045642,,,ABCB1,Other,-1,antiepileptics,827804518.0,Unknown
827804313,PA166157284,rs1045642,,,ABCB1,Other,-1,antiepileptics,827804518.0,Unknown
1447947662,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,atazanavir,1447947664.0,"Multiple groups, South African, Peruvians, American."
981731560,PA166155293,rs4149601,,,NEDD4L,Efficacy,-1,atenolol,981731570.0,European
1444933003,PA166155409,rs3745274,,,CYP2B6,Dosage,1,propofol,1444933013.0,"Multiple groups, 69% white"
1444933003,PA166155409,rs3745274,,,CYP2B6,Dosage,1,propofol,1444933013.0,"Multiple groups, 69% white"
1447947668,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,atazanavir,1447947670.0,"Multiple groups, South African, Peruvians, American."
1444703625,PA166155242,rs9915451,,,ANKFN1,Efficacy,-1,hydrochlorothiazide,1444703628.0,European
1184470283,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,cyclosporine,1184470285.0,Unknown
1450812588,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,nordextropropoxyphene,1450812593.0,Unknown
1450812588,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,nordextropropoxyphene,1450812593.0,Unknown
1184470287,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,cyclosporine,1184470293.0,Unknown
1449714911,PA166154312,rs1062613,,,HTR3A,Dosage,-1,opioids,1449714914.0,European
1449714911,PA166154312,rs1062613,,,HTR3A,Dosage,-1,opioids,1449714913.0,European
982010039,PA166155091,rs9923231,,,VKORC1,Dosage,-1,acenocoumarol,982010052.0,Near Eastern
981502125,PA166156812,rs2975226,,,SLC6A3,Dosage,1,clozapine,981502131.0,East Asian
981502125,PA166156812,rs2975226,,,SLC6A3,Efficacy,1,clozapine,981502131.0,East Asian
1184470291,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184470306.0,East Asian
1184470291,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184470306.0,East Asian
1184470291,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1184470306.0,East Asian
1449714918,PA166154358,rs2276302,,,HTR3A,Dosage,-1,opioids,1449714920.0,European
1449714918,PA166154358,rs2276302,,,HTR3A,Dosage,-1,opioids,1449714921.0,European
1446899066,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1446899077.0,Unknown
1446899066,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1446899077.0,Unknown
1446899066,,,PA165980637,CYP2C19*4,CYP2C19,Efficacy,1,clopidogrel,1446899077.0,Unknown
1446899066,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1446899077.0,Unknown
1184748821,PA166155836,rs16853826,,,ATIC,Toxicity,1,methotrexate,1184748856.0,Unknown
981239992,PA166153976,rs1801252,,,ADRB1,Efficacy,1,metoprolol,981240000.0,"Multiple groups, 29 White, 10 African American,and 1; 'Hispanic"""
1447947654,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,atazanavir,1447947656.0,"Multiple groups, South African, Peruvians, American."
982010028,PA166155091,rs9923231,,,VKORC1,Dosage,-1,acenocoumarol,982010038.0,Near Eastern
1449239780,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1449240338.0,"Multiple groups, Caucasian, black and biracial participants"
1449157859,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,nicotine,1449157870.0,Unknown
1449157859,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,nicotine,1449157868.0,Unknown
1449157859,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,nicotine,1449157866.0,Unknown
1449157859,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,nicotine,1449157872.0,Unknown
1449157859,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,nicotine,1449157864.0,Unknown
1184470301,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1184470303.0,Unknown
699642395,PA166156943,rs742105,,,DTNBP1,Efficacy,1,clozapine,699642397.0,African American/Afro-Caribbean
699642395,PA166156943,rs742105,,,DTNBP1,Efficacy,1,clozapine,699642401.0,European
1449714892,PA166180011,rs3782025,,,HTR3B,Dosage,-1,opioids,1449714895.0,European
1449714892,PA166180011,rs3782025,,,HTR3B,Dosage,-1,opioids,1449714894.0,European
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,citalopram,981502279.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,citalopram,981502231.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,fluoxetine,981502279.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,fluoxetine,981502231.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,paroxetine,981502279.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,paroxetine,981502231.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,sertraline,981502279.0,East Asian
981502225,PA166156736,rs495794,,,SRP19,Efficacy,1,sertraline,981502231.0,East Asian
1446899027,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1446899029.0,European
1446899027,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,debrisoquine,1446899029.0,European
1446899027,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1446899029.0,European
1446899027,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1446899029.0,European
1446899027,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1446899029.0,European
1449714901,PA166180012,rs1672717,,,HTR3B,Dosage,-1,opioids,1449714903.0,European
1449714901,PA166180012,rs1672717,,,HTR3B,Dosage,-1,opioids,1449714904.0,European
1184470313,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184470326.0,Unknown
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,citalopram,981502238.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,citalopram,981502281.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,fluoxetine,981502238.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,fluoxetine,981502281.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,paroxetine,981502238.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,paroxetine,981502281.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,sertraline,981502238.0,East Asian
981502232,PA166156716,rs153549,,,REEP5,Efficacy,1,sertraline,981502281.0,East Asian
1448602976,PA166155915,rs1127354,,,ITPA,Dosage,1,ribavirin,1448602983.0,East Asian
1450812696,PA166183961,rs12072348,,,CHRNB2,Efficacy,-1,nicotine,1450812700.0,Unknown
1449714950,PA166176329,rs3024971,,,STAT6,Dosage,-1,opioids,1449714952.0,European
1449714950,PA166176329,rs3024971,,,STAT6,Dosage,-1,opioids,1449714953.0,European
1449714950,PA166176329,rs3024971,,,STAT6,Dosage,-1,opioids,1449714952.0,European
1449714950,PA166176329,rs3024971,,,STAT6,Dosage,-1,opioids,1449714953.0,European
1184748726,PA166153875,rs17421511,,,MTHFR,Efficacy,-1,methotrexate,1184748733.0,Unknown
1450812701,PA166183962,rs2304297,,,CHRNB3,Efficacy,-1,nicotine,1450812705.0,Unknown
1449157889,PA166155928,rs2585428,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157927.0,Multiple groups
1449157889,PA166155928,rs2585428,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157919.0,Multiple groups
1449157889,PA166155928,rs2585428,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157921.0,Multiple groups
1449157889,PA166155928,rs2585428,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157895.0,Multiple groups
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,citalopram,981502245.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,citalopram,981502283.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,fluoxetine,981502245.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,fluoxetine,981502283.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,paroxetine,981502245.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,paroxetine,981502283.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,sertraline,981502245.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,sertraline,981502283.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,sertraline,981502245.0,East Asian
981502239,PA166156717,rs153560,,,REEP5,Efficacy,1,sertraline,981502283.0,East Asian
1184748734,PA166153631,rs1476413,,,MTHFR,Efficacy,-1,methotrexate,1184748736.0,Unknown
1448635733,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,apixaban,1448635739.0,East Asian
1448635726,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,apixaban,1448635732.0,East Asian
1449714939,PA166154505,rs841718,,,STAT6,Dosage,-1,opioids,1449714943.0,European
1449714939,PA166154505,rs841718,,,STAT6,Dosage,-1,opioids,1449714942.0,European
827804237,PA166157288,rs1128503,,,ABCB1,Other,-1,antiepileptics,827804324.0,Multiple groups
981502189,PA166156024,rs4680,,,COMT,Dosage,-1,fluoxetine,981502204.0,"Multiple groups, probably White (Spanish mental health center)."
981502189,PA166156024,rs4680,,,COMT,Efficacy,-1,fluoxetine,981502204.0,"Multiple groups, probably White (Spanish mental health center)."
1183700223,PA166155740,rs5030743,,,RRM2,Efficacy,1,cladribine,1183700225.0,Multiple groups
1183700223,PA166155740,rs5030743,,,RRM2,Efficacy,1,cytarabine,1183700225.0,Multiple groups
1449157896,PA166170863,rs2248359,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157902.0,Multiple groups
1449157896,PA166170863,rs2248359,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157931.0,Multiple groups
1444703568,PA166156660,rs12505746,,,TET2,Efficacy,-1,hydrochlorothiazide,1444703590.0,European
1184175360,PA166154468,rs12806698,,,RRM1,Efficacy,1,gemcitabine,1184175366.0,Unknown
1450812661,PA166183954,rs2273502,,,CHRNA4,Efficacy,-1,nicotine,1450812665.0,Unknown
982010097,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,982010099.0,Near Eastern
982010097,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,acenocoumarol,982010099.0,Near Eastern
1184748761,PA166156768,rs1643650,,,DHFR,Efficacy,-1,methotrexate,1184748763.0,Unknown
1451205881,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tramadol,1451205900.0,Unknown
1450812666,PA166183955,rs2217732,,,CHRNA6,Efficacy,-1,nicotine,1450812670.0,Unknown
1450812666,PA166183955,rs2217732,,,CHRNA6,Efficacy,-1,nicotine,1450812670.0,Unknown
1183700211,PA166157554,rs1265138,,,RRM2B,Efficacy,1,cladribine,1183700213.0,Multiple groups
1183700211,PA166157554,rs1265138,,,RRM2B,Efficacy,1,cytarabine,1183700213.0,Multiple groups
1450812671,PA166183956,rs1072003,,,CHRNA6,Efficacy,-1,nicotine,1450812675.0,Unknown
1449714987,PA166180029,rs752688,,,GCH1,Dosage,-1,opioids,1449714990.0,European
1449714987,PA166180029,rs752688,,,GCH1,Dosage,-1,opioids,1449714989.0,European
1449714957,PA166176331,rs167769,,,STAT6,Dosage,-1,opioids,1449714959.0,European
1449714957,PA166176331,rs167769,,,STAT6,Dosage,-1,opioids,1449714960.0,European
1184175348,PA166154447,rs11030918,,,RRM1,Efficacy,1,gemcitabine,1184175364.0,Unknown
1183700205,PA166154392,rs2898950,,,RRM1,Efficacy,1,cladribine,1183700207.0,Multiple groups
1183700205,PA166154392,rs2898950,,,RRM1,Efficacy,1,cytarabine,1183700207.0,Multiple groups
981502205,PA166155159,rs25531,,,SLC6A4,Dosage,-1,fluoxetine,981502209.0,"Multiple groups, probably White (Spanish mental health center)."
981502205,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,fluoxetine,981502209.0,"Multiple groups, probably White (Spanish mental health center)."
1444703591,PA166157626,rs7387065,,,CSMD1,Efficacy,-1,hydrochlorothiazide,1444703594.0,European
1449714964,PA166154674,rs6312,,,HTR2A,Dosage,-1,opioids,1449714966.0,European
1449714964,PA166154674,rs6312,,,HTR2A,Dosage,-1,opioids,1449714967.0,European
1450812676,PA166183957,rs883473,,,CHRNA7,Efficacy,-1,nicotine,1450812680.0,Unknown
1183700217,PA166155627,rs1130609,,,RRM2,Efficacy,1,cladribine,1183700219.0,African American/Afro-Caribbean
1183700217,PA166155627,rs1130609,,,RRM2,Efficacy,1,cytarabine,1183700219.0,African American/Afro-Caribbean
1183700217,PA166155627,rs1130609,,,RRM2,Efficacy,1,cytarabine,1183700219.0,African American/Afro-Caribbean
1446899019,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1446899021.0,European
1446899019,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,dextromethorphan,1446899021.0,European
1446899019,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1446899021.0,European
1446899019,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,sparteine,1446899021.0,European
1450812681,PA166183958,rs2741868,,,CHRNA10,Efficacy,-1,nicotine,1450812685.0,Unknown
1183700215,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,0,Vitamin K,1183700226.0,"Custom, in vitro"
1449714971,PA166154673,rs6311,,,HTR2A,Dosage,-1,opioids,1449714974.0,European
1449714971,PA166154673,rs6311,,,HTR2A,Dosage,-1,opioids,1449714973.0,European
1184470380,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1184470385.0,Unknown
827641894,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,827641902.0,Unknown
827641894,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,1,warfarin,827641902.0,Unknown
1444687084,PA166156915,rs361525,,,TNF,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444687086.0,East Asian
1449157937,PA166176111,rs927650,,,CYP24A1,Metabolism/PK,1,deferasirox,1449157940.0,Multiple groups
1449190712,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449190718.0,Near Eastern
1449190712,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449190723.0,Near Eastern
1449190712,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449190727.0,Near Eastern
1449190712,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449190721.0,Near Eastern
1449190712,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449190725.0,Near Eastern
1449190712,PA166157530,rs121908757,,,CFTR,Efficacy,1,ivacaftor,1449190729.0,Near Eastern
1444687090,PA166156990,rs1799964,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444687092.0,East Asian
1184470386,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,cyclosporine,1184470388.0,Unknown
827641885,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,827641893.0,Unknown
1444687098,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444687100.0,East Asian
1184748929,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184748931.0,Unknown
1444687104,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,cytarabine,1444687107.0,East Asian
1444687104,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,cytarabine,1444687106.0,East Asian
1444687104,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,daunorubicin,1444687107.0,East Asian
1444687104,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,daunorubicin,1444687106.0,East Asian
1444687104,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,dexrazoxane,1444687107.0,East Asian
1444687104,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,dexrazoxane,1444687106.0,East Asian
981483879,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981483884.0,East Asian
981483879,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981483884.0,East Asian
981483879,PA166155435,rs8099917,,,IFNL3,Efficacy,1,telaprevir,981483884.0,East Asian
1043858728,PA166155942,rs3787554,,,CYP24A1,Efficacy,-1,calcitriol,1043858730.0,European
1043858728,PA166155942,rs3787554,,,CYP24A1,Efficacy,-1,calcitriol,1043858731.0,European
1043858728,PA166155942,rs3787554,,,CYP24A1,Efficacy,-1,cisplatin,1043858730.0,European
1043858728,PA166155942,rs3787554,,,CYP24A1,Efficacy,-1,cisplatin,1043858731.0,European
1043858728,PA166155942,rs3787554,,,CYP24A1,Efficacy,-1,docetaxel,1043858730.0,European
1043858728,PA166155942,rs3787554,,,CYP24A1,Efficacy,-1,docetaxel,1043858731.0,European
981483823,PA166154342,rs1813443,,,CNTN5,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981483828.0,European
1449714994,PA166180030,rs4411417,,,GCH1,Dosage,-1,opioids,1449714997.0,European
1449714994,PA166180030,rs4411417,,,GCH1,Dosage,-1,opioids,1449714996.0,European
1449715041,PA166155174,rs1045280,,,ARRB2,Dosage,-1,opioids,1449715043.0,European
1449715041,PA166155174,rs1045280,,,ARRB2,Dosage,-1,opioids,1449715044.0,European
1449747816,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449747823.0,East Asian
1449747816,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449747823.0,East Asian
1448422658,PA166161119,rs7166737,,,SIN3A,Efficacy,1,hydroxyurea,1448426915.0,European
1449715048,PA166180037,rs2271167,,,ARRB2,Dosage,-1,opioids,1449715050.0,European
1449715048,PA166180037,rs2271167,,,ARRB2,Dosage,-1,opioids,1449715051.0,European
1043858711,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,calcitriol,1043858715.0,European
1043858711,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,calcitriol,1043858727.0,European
1043858711,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,cisplatin,1043858715.0,European
1043858711,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,cisplatin,1043858727.0,European
1043858711,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,docetaxel,1043858715.0,European
1043858711,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,docetaxel,1043858727.0,European
981483837,PA166153664,rs2072658,,,CHRNB2,Other,1,nicotine,981483843.0,"Multiple groups, 79.6% Caucasian;8.8% Hispanic;3.3% Asian;2.8% African-American; 5.2% undisclosed. Subjects were from the Denver/Boulder, CO metropolitan area.  About half the samples were from unrelated individuals and the other half were dizygotic twin and sib-pairs."
1449715027,PA166155215,rs3786047,,,ARRB2,Dosage,-1,opioids,1449715029.0,European
1449715027,PA166155215,rs3786047,,,ARRB2,Dosage,-1,opioids,1449715030.0,European
981483844,PA166155922,rs2229959,,,CHRNA4,Other,1,nicotine,981483849.0,"Multiple groups, 79.6% Caucasian;8.8% Hispanic;3.3% Asian;2.8% African-American; 5.2% undisclosed. Subjects were from the Denver/Boulder, CO metropolitan area.  About half the samples were from unrelated individuals and the other half were dizygotic twin and sib-pairs."
1449715068,PA166156083,rs2020917,,,COMT,Dosage,-1,opioids,1449715070.0,European
1449715068,PA166156083,rs2020917,,,COMT,Dosage,-1,opioids,1449715071.0,European
1449715068,PA166156083,rs2020917,,,TXNRD2,Dosage,-1,opioids,1449715070.0,European
1449715068,PA166156083,rs2020917,,,TXNRD2,Dosage,-1,opioids,1449715071.0,European
1184175529,PA166154734,rs9516519,,,ABCC4,Metabolism/PK,-1,methotrexate,1184175531.0,East Asian
1184175525,PA166154027,rs3740065,,,ABCC2,Metabolism/PK,-1,methotrexate,1184175527.0,East Asian
1449190777,PA166155805,rs11676382,,,GGCX,Dosage,-1,acenocoumarol,1449190779.0,European
1449190777,PA166155805,rs11676382,,,GGCX,Metabolism/PK,-1,acenocoumarol,1449190779.0,European
1449190777,PA166155805,rs11676382,,,GGCX,Dosage,-1,warfarin,1449190779.0,European
1449190777,PA166155805,rs11676382,,,GGCX,Metabolism/PK,-1,warfarin,1449190779.0,European
1449190764,PA166155341,rs7412,,,APOE,Dosage,-1,acenocoumarol,1449190770.0,European
1449190764,PA166155341,rs7412,,,APOE,Dosage,-1,warfarin,1449190770.0,European
1449190764,PA166155341,rs7412,,,APOE,Dosage,-1,warfarin,1449190770.0,European
1449715075,PA166180044,rs5993882,,,COMT,Dosage,-1,opioids,1449715077.0,European
1449715075,PA166180044,rs5993882,,,COMT,Dosage,-1,opioids,1449715078.0,European
1184175517,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,methotrexate,1184175521.0,East Asian
1449190771,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,1449190773.0,European
1449190771,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449190773.0,European
1449715055,PA166155198,rs2036657,,,ARRB2,Dosage,-1,opioids,1449715057.0,European
1449715055,PA166155198,rs2036657,,,ARRB2,Dosage,-1,opioids,1449715058.0,European
1184470327,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,1184470329.0,Unknown
1449747849,PA166180804,rs3800959,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1449747855.0,East Asian
1184175504,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,methotrexate,1184175508.0,East Asian
1447963867,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,codeine,1447963875.0,African American/Afro-Caribbean
1449747832,PA166157243,rs15524,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449747834.0,East Asian
1449190785,PA166157284,rs1045642,,,ABCB1,Dosage,-1,acenocoumarol,1449190787.0,European
1449190785,PA166157284,rs1045642,,,ABCB1,Dosage,-1,warfarin,1449190787.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Dosage,1,amantadine,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Efficacy,1,amantadine,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Dosage,1,Anticholinergics,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Efficacy,1,Anticholinergics,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Dosage,1,levodopa,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Efficacy,1,levodopa,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Dosage,1,selegiline,981483947.0,European
981483940,PA166156932,rs622342,,,SLC22A1,Efficacy,1,selegiline,981483947.0,European
1449747826,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449747828.0,East Asian
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684011.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684013.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684015.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250684.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684009.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250683.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250685.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250686.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250700.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684017.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684004.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250720.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684011.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684013.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684015.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250684.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684009.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250683.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250685.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250686.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250700.0,Multiple groups
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684017.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1183684004.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183683991,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,1451250720.0,Multiple groups
1184748897,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184748903.0,Unknown
1183618419,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183618435.0,East Asian
1183618419,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183618437.0,East Asian
1183618419,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183618431.0,East Asian
1183618419,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183618433.0,East Asian
1183618419,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183618435.0,East Asian
1183618419,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183618437.0,East Asian
1183618419,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183618431.0,East Asian
1183618419,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183618433.0,East Asian
1183618419,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183618435.0,East Asian
1183618419,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183618437.0,East Asian
1183618419,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183618431.0,East Asian
1183618419,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183618433.0,East Asian
1449715100,PA166180050,rs3788339,,,GNAZ,Dosage,-1,opioids,1449715102.0,European
1449715100,PA166180050,rs3788339,,,GNAZ,Dosage,-1,opioids,1449715103.0,European
1449715100,PA166180050,rs3788339,,,RSPH14,Dosage,-1,opioids,1449715102.0,European
1449715100,PA166180050,rs3788339,,,RSPH14,Dosage,-1,opioids,1449715103.0,European
1444687074,PA166156997,rs1800629,,,TNF,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444687083.0,East Asian
1449715089,PA166156023,rs4633,,,COMT,Dosage,-1,opioids,1449715092.0,European
1449715089,PA166156023,rs4633,,,COMT,Dosage,-1,opioids,1449715091.0,European
1449715089,PA166156023,rs4633,,,COMT,Dosage,-1,opioids,1449715092.0,European
1449715089,PA166156023,rs4633,,,COMT,Dosage,-1,opioids,1449715091.0,European
1449747856,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,tacrolimus,1449747858.0,East Asian
1184470375,PA166156110,rs4823613,,,PPARA,Metabolism/PK,-1,cyclosporine,1184470377.0,Unknown
1444703466,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1444703472.0,European
1447947447,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1447947449.0,East Asian
1447947447,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1447947449.0,East Asian
981238152,PA166157288,rs1128503,,,ABCB1,Efficacy,1,antipsychotics,981238158.0,Central/South Asian
1451124102,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,rosuvastatin,1451124106.0,East Asian
1451124102,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,rosuvastatin,1451124112.0,East Asian
981483987,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,981483993.0,East Asian
981483987,PA166154977,rs7294,,,VKORC1,Efficacy,1,warfarin,981483993.0,East Asian
1447947435,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447947437.0,East Asian
1447947435,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447947437.0,East Asian
1451124180,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,rosuvastatin,1451124119.0,East Asian
1451124180,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,rosuvastatin,1451124200.0,East Asian
982041062,PA166156523,rs1800591,,,MTTP,Efficacy,0,pravastatin,982043784.0,Unknown
1450370504,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450370760.0,American
1450370504,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450370509.0,American
1448994222,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448994228.0,East Asian
1183684058,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183684062.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684058,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183684062.0,"Multiple groups, Asian, Black, Caucasian, Other"
981238190,PA166157284,rs1045642,,,ABCB1,Efficacy,1,antipsychotics,981238201.0,Central/South Asian
1043858602,PA166156276,rs5186,,,AGTR1,Efficacy,1,nitrendipine,1043858604.0,European
981238245,PA166157316,rs2032582,,,ABCB1,Dosage,1,antipsychotics,981238256.0,Central/South Asian
981238245,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,antipsychotics,981238256.0,Central/South Asian
1184470543,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,prasugrel,1184470546.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470543,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,prasugrel,1184470545.0,Unknown
1184470543,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,prasugrel,1184470546.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470543,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,prasugrel,1184470545.0,Unknown
1184470543,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,prasugrel,1184470546.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470543,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,prasugrel,1184470545.0,Unknown
1184470543,,,PA165816547,CYP2C9*6,CYP2C9,Efficacy,-1,prasugrel,1184470546.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470543,,,PA165816547,CYP2C9*6,CYP2C9,Efficacy,-1,prasugrel,1184470545.0,Unknown
1184470543,,,PA165816552,CYP2C9*11,CYP2C9,Efficacy,-1,prasugrel,1184470546.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470543,,,PA165816552,CYP2C9*11,CYP2C9,Efficacy,-1,prasugrel,1184470545.0,Unknown
1184470543,,,PA165816553,CYP2C9*12,CYP2C9,Efficacy,-1,prasugrel,1184470546.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470543,,,PA165816553,CYP2C9*12,CYP2C9,Efficacy,-1,prasugrel,1184470545.0,Unknown
1043858597,PA166156276,rs5186,,,AGTR1,Efficacy,1,perindopril,1043858601.0,European
1450812854,PA166156991,rs1799971,,,OPRM1,Efficacy,1,ethanol,1450812858.0,Unknown
1183618501,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,famotidine,1183618527.0,East Asian
1183618501,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,famotidine,1183618527.0,East Asian
1183618501,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,famotidine,1183618527.0,East Asian
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684039.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684040.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250760.0,Multiple groups
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684043.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684041.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684038.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250761.0,Multiple groups
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684042.0,"Multiple groups, Asian, Black, Caucasian, Other"
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250783.0,Multiple groups
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250781.0,Multiple groups
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250782.0,Multiple groups
1183684036,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250780.0,Multiple groups
981483967,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,981483976.0,East Asian
981483967,PA166155381,rs2108622,,,CYP4F2,Efficacy,1,warfarin,981483976.0,East Asian
827789173,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183624198.0,European
827789173,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183624200.0,European
827789173,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,827789210.0,European
827789173,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183624179.0,European
827789173,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183624198.0,European
827789173,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183624200.0,European
827789173,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,827789210.0,European
827789173,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183624179.0,European
1184175537,PA166154687,rs868853,,,ABCC4,Metabolism/PK,-1,methotrexate,1184175539.0,East Asian
827789167,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1183624294.0,European
827789167,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,827789171.0,European
827789167,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1183624294.0,European
827789167,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,827789171.0,European
1450042840,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1450042846.0,"Multiple groups, 194 African Americans, 57 whites, 53 Latinos"
1450042840,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1450042850.0,European
1450042840,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1450042848.0,African American/Afro-Caribbean
1450042840,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1450042852.0,Latino
1184175533,PA166154709,rs2274407,,,ABCC4,Metabolism/PK,-1,methotrexate,1184175535.0,East Asian
1184175533,PA166154709,rs2274407,,,ABCC4,Metabolism/PK,-1,methotrexate,1184175535.0,East Asian
1184175533,PA166154709,rs2274407,,,ABCC4,Metabolism/PK,-1,methotrexate,1184175535.0,East Asian
981238217,PA166157284,rs1045642,,,ABCB1,Dosage,1,antipsychotics,981238226.0,Central/South Asian
981238217,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,antipsychotics,981238226.0,Central/South Asian
1183864353,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1183864365.0,European
1183864353,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1183864365.0,European
1183864353,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1183864365.0,European
1448602730,PA166154747,rs11568658,,,ABCC4,Dosage,-1,mercaptopurine,1448602733.0,East Asian
1448602730,PA166154747,rs11568658,,,ABCC4,Dosage,-1,mercaptopurine,1448602732.0,East Asian
1183618588,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,famotidine,1183618590.0,East Asian
1183618588,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,famotidine,1183618590.0,East Asian
1183618588,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,famotidine,1183618590.0,East Asian
1444703280,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,tenofovir,1444703282.0,East Asian
1450812948,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,bupropion,1450812956.0,Unknown
1450812948,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,bupropion,1450812955.0,Unknown
1450812948,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,bupropion,1450812956.0,Unknown
1450812948,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,bupropion,1450812955.0,Unknown
1450812948,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,bupropion,1450812956.0,Unknown
1450812948,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,bupropion,1450812955.0,Unknown
1448602719,PA166154709,rs2274407,,,ABCC4,Dosage,1,mercaptopurine,1448602722.0,East Asian
1448602719,PA166154709,rs2274407,,,ABCC4,Dosage,1,mercaptopurine,1448602721.0,East Asian
1183618600,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,famotidine,1183618602.0,East Asian
1183618600,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,famotidine,1183618602.0,East Asian
1183618600,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,famotidine,1183618602.0,East Asian
1183684112,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183684116.0,East Asian
1448258646,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1448258651.0,European
1448258646,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1448258648.0,European
1448258646,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1448258650.0,European
1448258646,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1448258649.0,European
1450812962,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,nortriptyline,1450812969.0,"Multiple groups, Study was carried out in the Netherlands so authors expect ""that virtually all participants are Caucasians"". However, this is not confirmed."
1450812962,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,nortriptyline,1450812968.0,Unknown
1450812962,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,nortriptyline,1450812969.0,"Multiple groups, Study was carried out in the Netherlands so authors expect ""that virtually all participants are Caucasians"". However, this is not confirmed."
1450812962,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,nortriptyline,1450812968.0,Unknown
1183618576,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,famotidine,1183618586.0,East Asian
1183618576,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,famotidine,1183618586.0,East Asian
1183618576,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,famotidine,1183618586.0,East Asian
1444703296,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,tenofovir,1444703298.0,East Asian
1444703303,PA166154702,rs1751034,,,ABCC4,Metabolism/PK,-1,tenofovir,1444703305.0,East Asian
1448258637,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,clopidogrel,1448258641.0,European
1448258637,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,clopidogrel,1448258639.0,European
1448258637,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,clopidogrel,1448258640.0,European
1448258637,PA166153959,rs1057910,,,CYP2C9,Efficacy,-1,clopidogrel,1448258642.0,European
1043858478,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1043858482.0,European
1043858478,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1043858484.0,European
1043858478,PA166155091,rs9923231,,,VKORC1,Toxicity,1,phenprocoumon,1043858482.0,European
1043858478,PA166155091,rs9923231,,,VKORC1,Toxicity,1,phenprocoumon,1043858484.0,European
1183684117,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183684119.0,East Asian
1450812970,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,nortriptyline,1450812975.0,Unknown
1450812970,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,nortriptyline,1450812976.0,Unknown
1448602706,PA166154714,rs3765534,,,ABCC4,Dosage,-1,mercaptopurine,1448602716.0,East Asian
1448602706,PA166154714,rs3765534,,,ABCC4,Dosage,-1,mercaptopurine,1448602714.0,East Asian
747926545,PA166155126,rs28364006,,,ABCC1,Efficacy,1,methotrexate,747939547.0,Unknown
1448258628,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,clopidogrel,1448258633.0,European
1448258628,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,clopidogrel,1448258631.0,European
1448258628,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,clopidogrel,1448258630.0,European
1448258628,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,clopidogrel,1448258632.0,European
1449190935,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449190941.0,European
1447947325,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1447947345.0,European
1447947325,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1447947345.0,European
1043858529,PA166155822,rs12714145,,,GGCX,Dosage,-1,phenprocoumon,1043858531.0,European
1043858529,PA166155822,rs12714145,,,GGCX,Dosage,-1,phenprocoumon,1043858532.0,European
1043858529,PA166155822,rs12714145,,,GGCX,Efficacy,-1,phenprocoumon,1043858531.0,European
1043858529,PA166155822,rs12714145,,,GGCX,Efficacy,-1,phenprocoumon,1043858532.0,European
1183618564,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1183618566.0,East Asian
1183618564,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183618566.0,East Asian
1183618564,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,1183618566.0,East Asian
1447947333,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1447947343.0,European
1447947333,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1447947343.0,European
1043858523,PA166154680,rs510335,,,F7,Dosage,-1,phenprocoumon,1043858525.0,European
1043858523,PA166154680,rs510335,,,F7,Dosage,-1,phenprocoumon,1043858526.0,European
1043858523,PA166154680,rs510335,,,F7,Efficacy,-1,phenprocoumon,1043858525.0,European
1043858523,PA166154680,rs510335,,,F7,Efficacy,-1,phenprocoumon,1043858526.0,European
1449190950,PA166155351,rs429358,,,APOE,Dosage,1,acenocoumarol,1449190956.0,European
1449715215,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,fentanyl,1449715220.0,"Multiple groups, Caucasian, Asian or other ethnic background"
1447947314,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1447947324.0,European
1447947314,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,pantoprazole,1447947324.0,European
1183618547,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1183618560.0,East Asian
1183618547,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183618560.0,East Asian
1183618547,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,1183618560.0,East Asian
1183684103,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684107.0,East Asian
1183684103,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684109.0,East Asian
1183684103,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684111.0,East Asian
1043858518,PA166154679,rs510317,,,F7,Dosage,-1,phenprocoumon,1043858520.0,European
1043858518,PA166154679,rs510317,,,F7,Dosage,-1,phenprocoumon,1043858521.0,European
1043858518,PA166154679,rs510317,,,F7,Efficacy,-1,phenprocoumon,1043858520.0,European
1043858518,PA166154679,rs510317,,,F7,Efficacy,-1,phenprocoumon,1043858521.0,European
1448258619,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,1448258621.0,European
1448258619,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,1448258624.0,European
1448258619,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,1448258623.0,European
1448258619,PA166154147,rs12248560,,,CYP2C19,Efficacy,-1,clopidogrel,1448258622.0,European
1450812933,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,nicotine,1450812937.0,European
1449715221,PA166156024,rs4680,,,COMT,Efficacy,-1,fentanyl,1449715223.0,"Multiple groups, Caucasian, Asian or other ethnic background"
1448258608,PA166154070,rs4986893,,,CYP2C19,Efficacy,-1,clopidogrel,1448258612.0,European
1448258608,PA166154070,rs4986893,,,CYP2C19,Efficacy,-1,clopidogrel,1448258611.0,European
1448258608,PA166154070,rs4986893,,,CYP2C19,Efficacy,-1,clopidogrel,1448258610.0,European
1448258608,PA166154070,rs4986893,,,CYP2C19,Efficacy,-1,clopidogrel,1448258613.0,European
1448635431,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448635444.0,Unknown
1448635431,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448635453.0,Unknown
1448635431,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448635444.0,Unknown
1448635431,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448635453.0,Unknown
1183700587,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700609.0,European
1183700587,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700609.0,European
1183700587,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,1183700609.0,European
1183700587,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,warfarin,1183700609.0,European
1448258595,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1448258605.0,European
1448258595,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1448258601.0,European
1448258595,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1448258603.0,European
1448258595,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1448258607.0,European
1448635420,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1448635430.0,Unknown
1448635420,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1448635430.0,Unknown
1183848019,PA166157844,rs56040400,,,C5,Efficacy,0,eculizumab,1183848023.0,East Asian
1184749184,PA166153952,rs363390,,,SLC18A2,Efficacy,-1,citalopram,1184749186.0,European
1184749184,PA166153952,rs363390,,,SLC18A2,Efficacy,-1,citalopram,1184749187.0,African American/Afro-Caribbean
1448258581,PA166156024,rs4680,,,COMT,Efficacy,-1,antipsychotics,1448258583.0,European
1449748012,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748024.0,East Asian
1449748012,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748024.0,East Asian
1451124322,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,morphine,1451124340.0,East Asian
1183618644,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183618650.0,Unknown
1183618651,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183618653.0,Unknown
1449748025,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,everolimus,1449748047.0,East Asian
1449748025,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,everolimus,1449748047.0,East Asian
1184749190,PA166153950,rs363343,,,SLC18A2,Efficacy,-1,citalopram,1184749192.0,European
1184749190,PA166153950,rs363343,,,SLC18A2,Efficacy,-1,citalopram,1184749193.0,African American/Afro-Caribbean
1184749202,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,citalopram,1184749204.0,European
1184749202,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,citalopram,1184749205.0,African American/Afro-Caribbean
1184749196,PA166153957,rs929493,,,SLC18A2,Efficacy,-1,citalopram,1184749198.0,European
1184749196,PA166153957,rs929493,,,SLC18A2,Efficacy,-1,citalopram,1184749199.0,African American/Afro-Caribbean
1448994381,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,efavirenz,1448994408.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1449748065,PA166156905,rs20455,,,KIF6,Efficacy,-1,simvastatin,1449748073.0,Unknown
1449748065,PA166156905,rs20455,,,KIF6,Efficacy,-1,simvastatin,1449748136.0,Unknown
1450812977,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,bupropion,1450812982.0,Unknown
1450812977,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,bupropion,1450812983.0,Unknown
1183618626,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,aripiprazole,1183618668.0,Unknown
1183618626,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,aripiprazole,1183618668.0,Unknown
1183618626,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,aripiprazole,1183618668.0,Unknown
1183618626,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,aripiprazole,1183618668.0,Unknown
1183618624,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183618640.0,Unknown
1183618624,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183618640.0,Unknown
1183618624,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183618640.0,Unknown
1448258556,PA166154334,rs1799732,,,DRD2,Efficacy,-1,antipsychotics,1448258558.0,European
1447947268,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,,
1447947268,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,,
1447947268,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,lansoprazole,,
1447947268,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,,
1447947268,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,,
1447947268,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,omeprazole,,
1450812984,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,nortriptyline,1450812990.0,"Multiple groups, Study was carried out in the Netherlands so authors expect ""that virtually all participants are Caucasians"". However, this is not confirmed."
1450812984,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,nortriptyline,1450812989.0,Unknown
1449748074,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,1449748076.0,Unknown
1449748074,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,1449748081.0,Unknown
1449748074,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,1449748139.0,Unknown
1448258562,PA166156277,rs6280,,,DRD3,Efficacy,-1,antipsychotics,1448258564.0,European
1449715307,PA166156991,rs1799971,,,OPRM1,Dosage,-1,fentanyl,1449715314.0,East Asian
1449715307,PA166156991,rs1799971,,,OPRM1,Dosage,-1,fentanyl,1449715316.0,East Asian
1449715307,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,fentanyl,1449715314.0,East Asian
1449715307,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,fentanyl,1449715316.0,East Asian
827920220,PA166156606,rs6811453,,,ADH1A,Efficacy,1,cytarabine,827920225.0,Unknown
827920220,PA166156606,rs6811453,,,ADH1A,Efficacy,1,fludarabine,827920225.0,Unknown
827920220,PA166156606,rs6811453,,,ADH1A,Efficacy,1,gemtuzumab ozogamicin,827920225.0,Unknown
827920220,PA166156606,rs6811453,,,ADH1A,Efficacy,1,idarubicin,827920225.0,Unknown
1448258550,PA166154341,rs1801028,,,DRD2,Efficacy,-1,antipsychotics,1448258552.0,European
1450812991,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,bupropion,1450812996.0,Unknown
1450812991,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,bupropion,1450812997.0,Unknown
1183864366,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1183864377.0,European
1183864366,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1183864377.0,European
1183864366,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1183864377.0,European
1184749213,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,citalopram,1184749215.0,European
1184749213,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,citalopram,1184749216.0,African American/Afro-Caribbean
1444703265,PA166154713,rs3742106,,,ABCC4,Metabolism/PK,1,tenofovir,1444703271.0,East Asian
827920229,PA166156527,rs1826909,,,ADH1A,Efficacy,1,cytarabine,827920234.0,Unknown
827920229,PA166156527,rs1826909,,,ADH1A,Efficacy,1,fludarabine,827920234.0,Unknown
827920229,PA166156527,rs1826909,,,ADH1A,Efficacy,1,gemtuzumab ozogamicin,827920234.0,Unknown
827920229,PA166156527,rs1826909,,,ADH1A,Efficacy,1,idarubicin,827920234.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250622.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250640.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250641.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250663.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684152.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250620.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250623.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250642.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250662.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1183684151.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250621.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250661.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250643.0,Unknown
1183684149,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1451250660.0,Unknown
1448258544,PA166156707,rs5326,,,DRD1,Efficacy,-1,antipsychotics,1448258546.0,European
1450944140,PA166156062,rs1065852,,,CYP2D6,Metabolism/PK,1,metoprolol,1450944160.0,East Asian
1449748095,PA166156905,rs20455,,,KIF6,Efficacy,-1,atorvastatin,1449748097.0,Unknown
1449748095,PA166156905,rs20455,,,KIF6,Efficacy,-1,rosuvastatin,1449748097.0,Unknown
1449748095,PA166156905,rs20455,,,KIF6,Efficacy,-1,simvastatin,1449748097.0,Unknown
1448258537,PA166156706,rs4532,,,DRD1,Efficacy,-1,antipsychotics,1448258543.0,European
1447947241,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1447947252.0,Unknown
1447947241,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,omeprazole,1447947252.0,Unknown
1447947241,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,omeprazole,1447947252.0,Unknown
1447963626,PA166154249,rs1695,,,GSTP1,Efficacy,1,dimethyl fumarate,1447963633.0,Unknown
1450944144,PA166156031,rs16947,,,CYP2D6,Metabolism/PK,-1,alpha-hydroxymetoprolol,1450944148.0,East Asian
1449748103,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,1449748105.0,Unknown
1449748103,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,1449748133.0,Unknown
1449748103,PA166156905,rs20455,,,KIF6,Efficacy,1,simvastatin,1449748105.0,Unknown
1449748103,PA166156905,rs20455,,,KIF6,Efficacy,1,simvastatin,1449748133.0,Unknown
1448994422,PA166155496,rs35303484,,,CYP2B6,Metabolism/PK,1,efavirenz,1448994424.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1451124380,PA166156658,rs12233719,,,UGT2B7,Dosage,-1,morphine,1451124386.0,East Asian
1448994431,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448994433.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1447521252,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,silibinin,1447521282.0,East Asian
1183684260,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684263.0,East Asian
1183684260,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183684262.0,East Asian
1449748084,PA166156905,rs20455,,,KIF6,Efficacy,1,rosuvastatin,1449748121.0,Unknown
1449748084,PA166156905,rs20455,,,KIF6,Efficacy,1,rosuvastatin,1449748087.0,Unknown
1449748084,PA166156905,rs20455,,,KIF6,Efficacy,1,rosuvastatin,1449748086.0,Unknown
1448994443,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448994445.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1447947227,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1447947240.0,Unknown
1447947227,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1447947240.0,Unknown
1447947227,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,pantoprazole,1447947240.0,Unknown
1448635343,PA166165249,rs25678,,,CBR1,Metabolism/PK,1,daunorubicin,1448635349.0,Central/South Asian
1448994437,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,efavirenz,1448994439.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1448994449,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448994451.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1447586737,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447586746.0,Near Eastern
1447586737,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447586746.0,Near Eastern
1447586737,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447586746.0,Near Eastern
1448635326,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,anthracyclines and related substances,1448635328.0,Multiple groups
1448635326,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,anthracyclines and related substances,1448635328.0,Multiple groups
1448635326,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,capecitabine,1448635328.0,Multiple groups
1448635326,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,capecitabine,1448635328.0,Multiple groups
1448635326,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,cyclophosphamide,1448635328.0,Multiple groups
1448635326,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,cyclophosphamide,1448635328.0,Multiple groups
1448635326,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,fluorouracil,1448635328.0,Multiple groups
1448635326,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,fluorouracil,1448635328.0,Multiple groups
1448635326,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,taxanes,1448635328.0,Multiple groups
1448635326,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,taxanes,1448635328.0,Multiple groups
1450944120,PA166156062,rs1065852,,,CYP2D6,Metabolism/PK,1,alpha-hydroxymetoprolol,1450944124.0,East Asian
1448994455,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448994457.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1448994455,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448994457.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1448994467,PA166157239,rs3842,,,ABCB1,Metabolism/PK,-1,efavirenz,1448994469.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1448994467,PA166157239,rs3842,,,ABCB1,Metabolism/PK,-1,efavirenz,1448994469.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1448635319,PA166154249,rs1695,,,GSTP1,Efficacy,1,anthracyclines and related substances,1448635325.0,Multiple groups
1448994461,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,efavirenz,1448994463.0,"Multiple groups, 30/36 patients were of African origin (countries of origin: Burundi, Eritrea, Ethiopia, Sudan, Ivory Coast, Kenya, Liberia, Rwanda, Somalia, Tanzania and Uganda), 4/36 were of Asian origin (countries of origin: India, Philippines, Thailand and Uzbekistan) and 2/36 were of Latin American origin (countries of origin: Chile and Honduras)"
1447586752,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1447586754.0,Near Eastern
1447586752,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1447586754.0,Near Eastern
1446898629,PA166153644,rs1801133,,,MTHFR,Toxicity,1,methotrexate,1446898636.0,Near Eastern
1446898629,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1446898636.0,Near Eastern
1184749158,PA166153951,rs363371,,,SLC18A2,Efficacy,-1,citalopram,1184749172.0,European
1184749158,PA166153951,rs363371,,,SLC18A2,Efficacy,-1,citalopram,1184749174.0,African American/Afro-Caribbean
1450944125,PA166156031,rs16947,,,CYP2D6,Metabolism/PK,-1,metoprolol,1450944129.0,East Asian
1183618781,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183618791.0,Unknown
1183618781,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183618791.0,Unknown
1183618781,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183618791.0,Unknown
1183700701,PA166153667,rs2072671,,,CDA,Efficacy,1,cisplatin,1183700705.0,European
1183700701,PA166153667,rs2072671,,,CDA,Efficacy,1,gemcitabine,1183700705.0,European
1450370763,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1450370766.0,American
1450370763,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1450370765.0,American
1449748162,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748210.0,Unknown
1449748162,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748210.0,Unknown
1451124440,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,morphine,1451124446.0,East Asian
827642014,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827642021.0,European
1448635296,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,1,sorafenib,1448635306.0,Unknown
1183618795,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183618797.0,Unknown
1183618795,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183618797.0,Unknown
1183618795,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183618797.0,Unknown
827642007,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,coumarin,981240248.0,"Multiple groups, African-American, Caucasian, Chinese and Korean"
1448994492,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1448994498.0,East Asian
1184470790,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470794.0,East Asian
1184470790,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470792.0,East Asian
1184470790,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470793.0,East Asian
1184470790,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470796.0,East Asian
1184470790,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470795.0,East Asian
1184470790,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470794.0,East Asian
1184470790,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470792.0,East Asian
1184470790,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470793.0,East Asian
1184470790,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470796.0,East Asian
1184470790,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470795.0,East Asian
1451124400,PA166156619,rs7439366,,,UGT2B7,Efficacy,1,morphine,1451124420.0,East Asian
1448635273,PA166157284,rs1045642,,,ABCB1,Efficacy,1,imatinib,1448635275.0,European
1448258444,PA166160232,rs758391,,,None,Efficacy,-1,corticosteroids,1448258446.0,Unknown
1184470804,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184470814.0,East Asian
1184470804,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184470818.0,East Asian
1184470804,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184470816.0,East Asian
1184470804,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184470814.0,East Asian
1184470804,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184470818.0,East Asian
1184470804,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184470816.0,East Asian
1447586674,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1447586685.0,Unknown
1447586674,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1447586685.0,Unknown
1447586674,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1447586685.0,Unknown
981500599,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,981500634.0,European
981500599,PA166155381,rs2108622,,,CYP4F2,Efficacy,-1,warfarin,981500634.0,European
1450370787,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1450370790.0,American
1450370787,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1450370789.0,American
1450370787,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1450370790.0,American
1450370787,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1450370789.0,American
827641986,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,nicotine,827641994.0,East Asian
1184503573,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,citalopram,1184504733.0,Unknown
1184503573,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,citalopram,1184504733.0,Unknown
1449715433,PA166156619,rs7439366,,,UGT2B7,Efficacy,1,fentanyl,1449715439.0,East Asian
1448635262,PA166156936,rs683369,,,SLC22A1,Efficacy,1,imatinib,1448635270.0,European
1447979910,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tolperisone,1447979929.0,European
1447979910,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tolperisone,1447983854.0,European
1447979910,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tolperisone,1447979936.0,European
1447979910,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tolperisone,1447983850.0,European
1447979910,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tolperisone,1447983852.0,European
1447979910,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tolperisone,1447979929.0,European
1447979910,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tolperisone,1447983854.0,European
1447979910,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tolperisone,1447979936.0,European
1447979910,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tolperisone,1447983850.0,European
1447979910,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tolperisone,1447983852.0,European
1447979910,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tolperisone,1447979929.0,European
1447979910,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tolperisone,1447983854.0,European
1447979910,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tolperisone,1447979936.0,European
1447979910,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tolperisone,1447983850.0,European
1447979910,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tolperisone,1447983852.0,European
1450370774,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1450370776.0,American
1450370774,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1450370777.0,American
1450370774,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1450370776.0,American
1450370774,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1450370777.0,American
1448602490,PA166163208,rs187941554,,,RAD18,Metabolism/PK,-1,clopidogrel thiol metabolite H4,1448602492.0,Unknown
1447586694,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1447586696.0,Unknown
1183684270,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183684274.0,East Asian
1183684270,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183684276.0,East Asian
1449748185,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tacrolimus,1449748214.0,Unknown
1449748185,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1449748214.0,Unknown
1183700770,PA166156064,rs1080985,,,CYP2D6,Metabolism/PK,1,debrisoquine,1183700804.0,Unknown
1448258426,PA166160228,rs1528072,,,KANSL1,Efficacy,-1,corticosteroids,1448258428.0,Unknown
1448258426,PA166160228,rs1528072,,,KANSL1,Efficacy,-1,corticosteroids,1448258428.0,Unknown
1447521111,PA166157851,rs179008,,,TLR7,Efficacy,1,imiquimod,1447521119.0,Unknown
1447521111,PA166157851,rs179008,,,TLR7,Efficacy,1,imiquimod,1447521125.0,Unknown
1447521111,PA166157851,rs179008,,,TLR7,Efficacy,1,imiquimod,1447521127.0,Unknown
1447521111,PA166157851,rs179008,,,TLR7,Efficacy,1,imiquimod,1447521119.0,Unknown
1447521111,PA166157851,rs179008,,,TLR7,Efficacy,1,imiquimod,1447521125.0,Unknown
1447521111,PA166157851,rs179008,,,TLR7,Efficacy,1,imiquimod,1447521127.0,Unknown
1183700775,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700805.0,European
1183700775,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700805.0,European
1183700775,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700805.0,European
1183618830,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1183618832.0,Unknown
1183618830,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183618832.0,Unknown
1183618830,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,1183618832.0,Unknown
1450370804,PA166155384,rs2189784,,,CYP4F2,Dosage,-1,warfarin,1450370807.0,American
1450370804,PA166155384,rs2189784,,,CYP4F2,Dosage,-1,warfarin,1450370806.0,American
1183700748,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700750.0,"Multiple groups, 84.4% Caucasian;9.8% African ancestry;2.9% Asian;2.9% other."
1183700748,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700750.0,"Multiple groups, 84.4% Caucasian;9.8% African ancestry;2.9% Asian;2.9% other."
1449715442,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,fentanyl,1449715444.0,East Asian
1449715442,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,fentanyl,1449715444.0,East Asian
1450370798,PA166155805,rs11676382,,,GGCX,Dosage,-1,warfarin,1450370801.0,American
1450370798,PA166155805,rs11676382,,,GGCX,Dosage,-1,warfarin,1450370800.0,American
1183700756,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183700758.0,"Multiple groups, 84.4% Caucasian;9.8% African ancestry;2.9% Asian;2.9% other."
827641940,PA166156104,rs3892097,,,CYP2D6,Metabolism/PK,0,codeine,827641991.0,Unknown
1184749254,PA166156001,rs2832407,,,GRIK1,Metabolism/PK,1,topiramate,1184749259.0,"Multiple groups, Mostly Caucasian"
1184749254,PA166156001,rs2832407,,,GRIK1,Metabolism/PK,1,topiramate,1184749259.0,"Multiple groups, Mostly Caucasian"
1448569672,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448569709.0,Multiple groups
1448569672,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448569709.0,Multiple groups
1448258384,PA166160219,rs16940686,,,CRHR1,Efficacy,-1,corticosteroids,1448258386.0,Unknown
1451124467,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,-1,morphine,1451124480.0,East Asian
1184470735,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184470743.0,Unknown
1184470735,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184470743.0,Unknown
1184749261,PA166156001,rs2832407,,,GRIK1,Efficacy,1,topiramate,1184749266.0,"Multiple groups, 90% Caucasian"
1448994572,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1448994575.0,Unknown
1448994572,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1448994575.0,Unknown
1451124460,PA166156658,rs12233719,,,UGT2B7,Efficacy,-1,morphine,1451124466.0,East Asian
1448635204,,,PA166131619,NUDT15*1,NUDT15,Dosage,-1,mercaptopurine,1448635214.0,
1448635204,,,PA166131620,NUDT15*2,NUDT15,Dosage,-1,mercaptopurine,1448635214.0,
1448635204,,,PA166131619,NUDT15*1,NUDT15,Toxicity,-1,mercaptopurine,1448635214.0,
1448635204,,,PA166131620,NUDT15*2,NUDT15,Toxicity,-1,mercaptopurine,1448635214.0,
1449715490,PA166180071,rs6851533,,,UGT2B7,Efficacy,-1,fentanyl,1449715492.0,East Asian
1449748260,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748272.0,Multiple groups
1449748260,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748272.0,Multiple groups
1447521075,PA166153644,rs1801133,,,MTHFR,Efficacy,1,capecitabine,1447521086.0,Unknown
1447521075,PA166153644,rs1801133,,,MTHFR,Efficacy,1,fluorouracil,1447521086.0,Unknown
1447521075,PA166153644,rs1801133,,,MTHFR,Efficacy,1,leucovorin,1447521086.0,Unknown
1447521075,PA166153644,rs1801133,,,MTHFR,Efficacy,1,oxaliplatin,1447521086.0,Unknown
981959406,PA166156277,rs6280,,,DRD3,Efficacy,-1,aripiprazole,981960030.0,East Asian
981959406,PA166156277,rs6280,,,DRD3,Efficacy,-1,aripiprazole,981960030.0,East Asian
1183684336,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,imipramine,1183684352.0,European
1183684336,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,imipramine,1183684352.0,European
1183684336,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,imipramine,1183684352.0,European
1183684336,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,imipramine,1183684352.0,European
1448258366,PA166160215,rs4525537,,,CRHR1,Efficacy,-1,corticosteroids,1448258368.0,Unknown
1183700722,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,cisplatin,1183700724.0,European
1183700722,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,gemcitabine,1183700724.0,European
1183700717,PA166155343,rs13181,,,ERCC2,Efficacy,-1,cisplatin,1183700721.0,European
1183700717,PA166155343,rs13181,,,ERCC2,Efficacy,-1,gemcitabine,1183700721.0,European
827641903,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827641911.0,Unknown
827641903,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,warfarin,827641911.0,Unknown
1448258357,PA166160213,rs878888,,,CRHR1,Efficacy,-1,corticosteroids,1448258359.0,Unknown
1183618805,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1183618828.0,Unknown
1183618805,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183618828.0,Unknown
1183618805,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,1183618828.0,Unknown
1448258348,PA166160211,rs878887,,,CRHR1,Efficacy,-1,corticosteroids,1448258350.0,Unknown
1184470893,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470896.0,Latino
1184470893,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470895.0,Latino
1184470893,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470896.0,Latino
1184470893,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470895.0,Latino
1446767372,PA166153882,rs35822937,,,MIA3,Metabolism/PK,-1,vancomycin,1446767374.0,European
1446767377,PA166153871,rs17163429,,,AIDA,Metabolism/PK,-1,vancomycin,1446767379.0,European
1450370833,PA166181978,rs8104361,,,CYP4F11,Dosage,-1,warfarin,1450370835.0,American
1450370833,PA166181978,rs8104361,,,CYP4F11,Dosage,-1,warfarin,1450370836.0,American
1446767382,PA166153599,rs904323,,,MIA3,Metabolism/PK,-1,vancomycin,1446767384.0,European
1447521040,PA166153758,rs3917412,,,SELE,Efficacy,1,capecitabine,1447521072.0,Unknown
1447521040,PA166153758,rs3917412,,,SELE,Efficacy,1,fluorouracil,1447521072.0,Unknown
1447521040,PA166153758,rs3917412,,,SELE,Efficacy,1,leucovorin,1447521072.0,Unknown
1447521040,PA166153758,rs3917412,,,SELE,Efficacy,1,oxaliplatin,1447521072.0,Unknown
1184470904,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1184470906.0,Latino
1447947045,PA166153833,rs11591147,,,PCSK9,Efficacy,1,hmg coa reductase inhibitors,1447947051.0,African American/Afro-Caribbean
1446767387,PA166153728,rs3002145,,,MIA3,Metabolism/PK,-1,vancomycin,1446767389.0,European
731493498,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,731512500.0,European
1449715526,PA166180083,rs10028494,,,UGT2B7,Efficacy,1,fentanyl,1449715528.0,East Asian
1184470908,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,tacrolimus,1184470910.0,Latino
1183700819,PA166156906,rs25648,,,VEGFA,Efficacy,1,cisplatin,1183700827.0,Unknown
1183700819,PA166156906,rs25648,,,VEGFA,Efficacy,1,cisplatin,1183700848.0,Unknown
1183700819,PA166156906,rs25648,,,VEGFA,Efficacy,1,fluorouracil,1183700827.0,Unknown
1183700819,PA166156906,rs25648,,,VEGFA,Efficacy,1,fluorouracil,1183700848.0,Unknown
1183700819,PA166156906,rs25648,,,VEGFA,Efficacy,1,oxaliplatin,1183700827.0,Unknown
1183700819,PA166156906,rs25648,,,VEGFA,Efficacy,1,oxaliplatin,1183700848.0,Unknown
981500768,PA166155597,rs676210,,,APOB,Efficacy,1,fenofibrate,981500776.0,European
1448258339,PA166160209,rs878886,,,CRHR1,Efficacy,-1,corticosteroids,1448258341.0,Unknown
1449748273,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,1,tacrolimus,1449748279.0,Multiple groups
1446767392,PA166153866,rs17011686,,,AIDA,Metabolism/PK,-1,vancomycin,1446767394.0,European
1448258330,PA166155193,rs1876828,,,CRHR1,Efficacy,-1,corticosteroids,1448258332.0,Unknown
1183700824,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,1183700826.0,European
1183700824,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,1183700826.0,European
1183700824,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,1183700826.0,European
1184470912,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,tacrolimus,1184470914.0,Latino
1448635155,PA166154677,rs17655,,,ERCC5,Efficacy,1,platinum,1448635259.0,East Asian
1451124585,PA166201321,rs13338697,,,WWOX,Efficacy,-1,cisplatin,1451124590.0,Unknown
1451124585,PA166201321,rs13338697,,,WWOX,Efficacy,-1,fluorouracil,1451124590.0,Unknown
1451124585,PA166201321,rs13338697,,,WWOX,Efficacy,-1,mitoxantrone,1451124590.0,Unknown
1447979801,PA166155056,rs3785161,,,CES1P1,Efficacy,-1,trandolapril,1447979809.0,African American/Afro-Caribbean
1447979801,PA166155056,rs3785161,,,CES1P1,Efficacy,-1,trandolapril,1447979811.0,Latino
1447979801,PA166155056,rs3785161,,,CES1P1,Efficacy,-1,trandolapril,1447979807.0,European
1446767397,PA166153702,rs2378597,,,AIDA,Metabolism/PK,-1,vancomycin,1446767399.0,European
1184470918,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470926.0,Unknown
1184470918,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470926.0,Unknown
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,citalopram,981500784.0,Multiple groups
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,citalopram,981500786.0,European
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,fluoxetine,981500784.0,Multiple groups
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,fluoxetine,981500786.0,European
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,mirtazapine,981500784.0,Multiple groups
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,mirtazapine,981500786.0,European
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,paroxetine,981500784.0,Multiple groups
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,paroxetine,981500786.0,European
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,Selective serotonin reuptake inhibitors,981500784.0,Multiple groups
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,Selective serotonin reuptake inhibitors,981500786.0,European
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,venlafaxine,981500784.0,Multiple groups
981500777,PA166157104,rs4713916,,,FKBP5,Efficacy,1,venlafaxine,981500786.0,European
1444702987,PA166157780,rs4986790,,,TLR4,Efficacy,1,Pertussis vaccines,1444702997.0,Unknown
1446767402,PA166153670,rs2088514,,,MIA3,Metabolism/PK,-1,vancomycin,1446767404.0,European
1450944360,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,1450944380.0,Near Eastern
1450944360,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,1450944384.0,Near Eastern
1450944360,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,1450944385.0,Near Eastern
1449731933,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,sertraline,1449731940.0,Unknown
1184470927,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1184470931.0,Unknown
1446767340,PA166153870,rs17163303,,,MIA3,Metabolism/PK,-1,vancomycin,1446767342.0,European
1451255600,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255609.0,European
1451255600,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255620.0,European
1451255600,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255609.0,European
1451255600,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255620.0,European
1451255600,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255609.0,European
1451255600,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255620.0,European
1451255600,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255609.0,European
1451255600,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255620.0,European
1451255600,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255609.0,European
1451255600,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,fluoxetine,1451255620.0,European
1447521014,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1447521023.0,East Asian
1447521014,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1447521023.0,East Asian
1296667136,PA166155704,rs3738948,,,ERCC3,Efficacy,1,Platinum compounds,1296667142.0,Unknown
1446767345,PA166153787,rs7414551,,,PLEKHN1,Metabolism/PK,-1,vancomycin,1446767348.0,European
1447963391,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1447963400.0,East Asian
1447963391,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,mephenytoin,1447963400.0,East Asian
1449715552,PA166180080,rs4587017,,,UGT2B7,Dosage,-1,fentanyl,1449715554.0,East Asian
1449731942,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,trazodone,1449731944.0,Unknown
1449715558,PA166156626,rs7668282,,,UGT2B7,Dosage,-1,fentanyl,1449715560.0,East Asian
1296667143,PA166155016,rs1799801,,,ERCC4,Efficacy,1,Platinum compounds,1296667149.0,Unknown
1446767352,PA166153908,rs75328711,,,MIA3,Metabolism/PK,-1,vancomycin,1446767354.0,European
1448258314,PA166160204,rs17689966,,,CRHR1,Efficacy,-1,corticosteroids,1448258316.0,Unknown
1184470941,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,everolimus,1184470982.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,everolimus,1184470980.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,everolimus,1184470982.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,everolimus,1184470980.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1184470982.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1184470980.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1184470982.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470941,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1184470980.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1446767357,PA166153924,rs142155704,,,MIA3,Metabolism/PK,-1,vancomycin,1446767359.0,European
1444703011,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,mianserin,1444703023.0,East Asian
1444703011,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,mianserin,1444703023.0,East Asian
1444703011,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,mianserin,1444703023.0,East Asian
1444703011,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,mianserin,1444703023.0,East Asian
1446767362,PA166153614,rs1053316,,,MIA3,Metabolism/PK,-1,vancomycin,1446767364.0,European
1451206460,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451206441.0,Unknown
1451206460,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451206441.0,Unknown
1183618864,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,aripiprazole,1183618929.0,East Asian
1183618864,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,aripiprazole,1183618929.0,East Asian
1183618864,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,aripiprazole,1183618929.0,East Asian
1183618864,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,aripiprazole,1183618929.0,East Asian
1448602351,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,tacrolimus,1448602353.0,Unknown
1448602351,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,tacrolimus,1448602353.0,Unknown
1296667129,PA166155342,rs11615,,,ERCC1,Efficacy,1,Platinum compounds,1296667135.0,Unknown
1296667129,PA166155342,rs11615,,,ERCC1,Efficacy,1,Platinum compounds,1296667187.0,Unknown
1296667129,PA166155342,rs11615,,,ERCC1,Efficacy,1,Platinum compounds,1296667135.0,Unknown
1296667129,PA166155342,rs11615,,,ERCC1,Efficacy,1,Platinum compounds,1296667187.0,Unknown
827919981,PA166153588,rs800292,,,CFH,Efficacy,1,bevacizumab,827919993.0,East Asian
1449731965,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,olanzapine,1449731967.0,Unknown
1447963360,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1447963369.0,East Asian
1447963360,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,mephenytoin,1447963369.0,East Asian
1447963360,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,mephenytoin,1447963369.0,East Asian
1448635118,PA166165228,rs766023281,,,NUDT15,Dosage,-1,mercaptopurine,1448635124.0,East Asian
1448635118,PA166165228,rs766023281,,,NUDT15,Toxicity,-1,mercaptopurine,1448635124.0,East Asian
1446767314,PA166153747,rs3748631,,,AIDA,Metabolism/PK,-1,vancomycin,1446767316.0,European
1184749358,PA166156185,rs74966855,,,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184749362.0,East Asian
1447946975,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447946984.0,East Asian
1447946975,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447946984.0,East Asian
1449731970,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,quetiapine,1449731972.0,Unknown
1450944400,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1450944421.0,Near Eastern
1450944400,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1450944420.0,Near Eastern
1450944400,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1450944405.0,Near Eastern
1448258283,PA166160198,rs17763086,,,CRHR1,Efficacy,-1,corticosteroids,1448258285.0,Unknown
1446767319,PA166153733,rs3008610,,,MIA3,Metabolism/PK,-1,vancomycin,1446767321.0,European
1447946985,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,tacrolimus,1447946987.0,East Asian
1448602336,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1448602346.0,Unknown
1448602336,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1448602346.0,Unknown
1449731979,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,paliperidone,1449731981.0,Unknown
1449731979,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,risperidone,1449731981.0,Unknown
1451124640,PA166155774,rs9679162,,,GALNT14,Efficacy,1,cisplatin,1451124596.0,Unknown
1451124640,PA166155774,rs9679162,,,GALNT14,Efficacy,1,fluorouracil,1451124596.0,Unknown
1451124640,PA166155774,rs9679162,,,GALNT14,Efficacy,1,mitoxantrone,1451124596.0,Unknown
1449715564,PA166180083,rs10028494,,,UGT2B7,Dosage,-1,fentanyl,1449715566.0,East Asian
827919998,PA166154135,rs11200638,,,HTRA1,Efficacy,1,bevacizumab,827920003.0,East Asian
1447946963,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447946974.0,East Asian
1447946963,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447946974.0,East Asian
1446767325,PA166153734,rs3008634,,,AIDA,Metabolism/PK,-1,vancomycin,1446767327.0,European
1446767325,PA166153734,rs3008634,,,AIDA,Metabolism/PK,-1,vancomycin,1446767327.0,European
981238689,PA166157249,rs221253,,,PTPRN2,Efficacy,1,olanzapine,981238700.0,European
1449731955,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,agomelatine,1449731957.0,Unknown
827920004,PA166154107,rs10490924,,,ARMS2,Efficacy,1,bevacizumab,827920011.0,East Asian
1446767335,PA166153803,rs10495197,,,MIA3,Metabolism/PK,-1,vancomycin,1446767337.0,European
1451206568,PA166155187,rs1799752,,,ACE,Efficacy,1,salvianolic acid b,1451206580.0,East Asian
1447520990,PA166153709,rs2494262,,,FCER1A,Efficacy,-1,desloratadine,1447521005.0,East Asian
1447520990,PA166153709,rs2494262,,,FCER1A,Efficacy,-1,mizolastine,1447521005.0,East Asian
1449715570,PA166180071,rs6851533,,,UGT2B7,Dosage,-1,fentanyl,1449715572.0,East Asian
1449731960,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,citalopram,1449731962.0,Unknown
1448258256,PA166160192,rs242936,,,CRHR1,Efficacy,-1,corticosteroids,1448258258.0,Unknown
1448258256,PA166160192,rs242936,,,CRHR1,Efficacy,-1,corticosteroids,1448258258.0,Unknown
1448258256,PA166160192,rs242936,,,CRHR1,Efficacy,-1,corticosteroids,1448258258.0,Unknown
1448258247,PA166160190,rs12150390,,,CRHR1,Efficacy,-1,corticosteroids,1448258249.0,Unknown
827920021,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,827920047.0,East Asian
827920021,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,827920047.0,East Asian
1447963315,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,mephenytoin,1447963326.0,European
1447963315,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,mephenytoin,1447963328.0,East Asian
1447963315,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,mephenytoin,1447963326.0,European
1447963315,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,mephenytoin,1447963328.0,East Asian
827920030,PA166153810,rs10801555,,,CFH,Efficacy,-1,bevacizumab,827920052.0,East Asian
1446767299,PA166153879,rs35684750,,,AIDA,Metabolism/PK,-1,vancomycin,1446767301.0,European
1449715602,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,alfentanil,1449715607.0,Unknown
1184470883,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184470885.0,Latino
1184470883,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184470885.0,Latino
1449731988,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,aripiprazole,1449731990.0,Unknown
1449731988,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,dehydroaripiprazole,1449731990.0,Unknown
981238661,PA166157027,rs2247408,,,PLAGL1,Efficacy,1,olanzapine,981238674.0,European
1448258232,PA166160187,rs16940655,,,CRHR1,Efficacy,-1,corticosteroids,1448258234.0,Unknown
1447520961,PA166153812,rs10908703,,,FCER1A,Efficacy,-1,desloratadine,1447520987.0,East Asian
1447520961,PA166153812,rs10908703,,,FCER1A,Efficacy,-1,mizolastine,1447520987.0,East Asian
1448569520,PA166162578,rs1800822,,,FMO3,Metabolism/PK,1,tacrolimus,1448569526.0,East Asian
827920041,PA166153629,rs1410996,,,CFH,Efficacy,-1,bevacizumab,827920057.0,East Asian
1446767304,PA166153881,rs35762933,,,None,Metabolism/PK,-1,vancomycin,1446767306.0,European
1448258212,PA166155163,rs242941,,,CRHR1,Efficacy,-1,corticosteroids,1448258214.0,Unknown
1448258212,PA166155163,rs242941,,,CRHR1,Efficacy,-1,corticosteroids,1448258214.0,Unknown
981238732,PA166156643,rs11100483,,,MAML3,Efficacy,1,perphenazine,981238737.0,European
981238738,PA166153945,rs35793,,,KCNMA1,Efficacy,1,quetiapine,981238747.0,European
981238738,PA166153945,rs35793,,,KCNMA1,Efficacy,1,quetiapine,981238747.0,European
1183700959,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,cisplatin,1183700961.0,Unknown
1183700959,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,fluorouracil,1183700961.0,Unknown
1183700959,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,oxaliplatin,1183700961.0,Unknown
1183700959,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,oxaliplatin,1183700961.0,Unknown
1183700971,PA166156958,rs833061,,,VEGFA,Efficacy,-1,cisplatin,1183700973.0,Unknown
1183700971,PA166156958,rs833061,,,VEGFA,Efficacy,-1,fluorouracil,1183700973.0,Unknown
1183700971,PA166156958,rs833061,,,VEGFA,Efficacy,-1,oxaliplatin,1183700973.0,Unknown
1183700971,PA166156958,rs833061,,,VEGFA,Efficacy,-1,oxaliplatin,1183700973.0,Unknown
827920061,PA166156960,rs833069,,,VEGFA,Efficacy,-1,bevacizumab,827920131.0,East Asian
1448635034,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,valproic acid,1448635050.0,East Asian
1448635034,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,valproic acid,1448635054.0,East Asian
1448635034,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,valproic acid,1448635052.0,East Asian
1448635034,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,valproic acid,1448635058.0,East Asian
1448635034,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,valproic acid,1448635056.0,East Asian
1448635034,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,valproic acid,1448635050.0,East Asian
1448635034,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,valproic acid,1448635054.0,East Asian
1448635034,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,valproic acid,1448635052.0,East Asian
1448635034,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,valproic acid,1448635058.0,East Asian
1448635034,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,valproic acid,1448635056.0,East Asian
1448635034,,,PA166117625,UGT1A6*3a,UGT1A6,Metabolism/PK,1,valproic acid,1448635050.0,East Asian
1448635034,,,PA166117625,UGT1A6*3a,UGT1A6,Metabolism/PK,1,valproic acid,1448635054.0,East Asian
1448635034,,,PA166117625,UGT1A6*3a,UGT1A6,Metabolism/PK,1,valproic acid,1448635052.0,East Asian
1448635034,,,PA166117625,UGT1A6*3a,UGT1A6,Metabolism/PK,1,valproic acid,1448635058.0,East Asian
1448635034,,,PA166117625,UGT1A6*3a,UGT1A6,Metabolism/PK,1,valproic acid,1448635056.0,East Asian
1448635034,,,PA166117627,UGT1A6*4a,UGT1A6,Metabolism/PK,1,valproic acid,1448635050.0,East Asian
1448635034,,,PA166117627,UGT1A6*4a,UGT1A6,Metabolism/PK,1,valproic acid,1448635054.0,East Asian
1448635034,,,PA166117627,UGT1A6*4a,UGT1A6,Metabolism/PK,1,valproic acid,1448635052.0,East Asian
1448635034,,,PA166117627,UGT1A6*4a,UGT1A6,Metabolism/PK,1,valproic acid,1448635058.0,East Asian
1448635034,,,PA166117627,UGT1A6*4a,UGT1A6,Metabolism/PK,1,valproic acid,1448635056.0,East Asian
1448635034,,,PA166117633,UGT1A6*8,UGT1A6,Metabolism/PK,1,valproic acid,1448635050.0,East Asian
1448635034,,,PA166117633,UGT1A6*8,UGT1A6,Metabolism/PK,1,valproic acid,1448635054.0,East Asian
1448635034,,,PA166117633,UGT1A6*8,UGT1A6,Metabolism/PK,1,valproic acid,1448635052.0,East Asian
1448635034,,,PA166117633,UGT1A6*8,UGT1A6,Metabolism/PK,1,valproic acid,1448635058.0,East Asian
1448635034,,,PA166117633,UGT1A6*8,UGT1A6,Metabolism/PK,1,valproic acid,1448635056.0,East Asian
1448258206,PA166160182,rs3785877,,,CRHR1,Efficacy,-1,corticosteroids,1448258208.0,Unknown
1183700964,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,cisplatin,1183700966.0,Unknown
1183700964,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,fluorouracil,1183700966.0,Unknown
1183700964,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,oxaliplatin,1183700966.0,Unknown
1450928092,PA166155747,rs6706232,,,UGT1A3,Efficacy,-1,risperidone,1450928097.0,East Asian
981238748,PA166155585,rs9713,,,PSMD14,Efficacy,1,risperidone,981238753.0,European
1450928098,PA166155620,rs1056827,,,CYP1B1,Efficacy,-1,risperidone,1450928103.0,East Asian
981238754,PA166155605,rs874295,,,LRP1B,Efficacy,1,risperidone,981238759.0,European
1448602262,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1448602264.0,Sub-Saharan African
1448602262,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1448602264.0,Sub-Saharan African
1449748405,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748417.0,Unknown
1449748405,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748417.0,Unknown
1446767269,PA166153878,rs35397194,,,MIA3,Metabolism/PK,-1,vancomycin,1446767272.0,European
1183700949,PA166156904,rs10434,,,VEGFA,Efficacy,-1,cisplatin,1183700951.0,Unknown
1183700949,PA166156904,rs10434,,,VEGFA,Efficacy,-1,fluorouracil,1183700951.0,Unknown
1183700949,PA166156904,rs10434,,,VEGFA,Efficacy,-1,oxaliplatin,1183700951.0,Unknown
1447946904,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447946910.0,Unknown
1450928104,PA166155586,rs10012,,,CYP1B1,Efficacy,-1,risperidone,1450928109.0,East Asian
1447963286,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,mephenytoin,1447963295.0,European
1447963286,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,mephenytoin,1447963295.0,European
1447963286,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1447963295.0,European
1447963286,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1447963295.0,European
1448258182,PA166155160,rs110402,,,CRHR1,Efficacy,-1,corticosteroids,1448258184.0,Unknown
1449748447,PA166157288,rs1128503,,,ABCB1,Efficacy,1,tacrolimus,1449748453.0,East Asian
981238707,PA166155676,rs2278773,,,PRKCE,Efficacy,1,perphenazine,981238712.0,European
827920081,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,bevacizumab,827920136.0,East Asian
1448635009,,,PA166117614,UGT1A6*1a,UGT1A6,Dosage,1,valproic acid,1448635025.0,East Asian
1448635009,,,PA166117614,UGT1A6*1a,UGT1A6,Dosage,1,valproic acid,1448635029.0,East Asian
1448635009,,,PA166117614,UGT1A6*1a,UGT1A6,Dosage,1,valproic acid,1448635027.0,East Asian
1448635009,,,PA166117614,UGT1A6*1a,UGT1A6,Dosage,1,valproic acid,1448635031.0,East Asian
1448635009,,,PA166117614,UGT1A6*1a,UGT1A6,Dosage,1,valproic acid,1448635033.0,East Asian
1448635009,,,PA166117621,UGT1A6*2a,UGT1A6,Dosage,1,valproic acid,1448635025.0,East Asian
1448635009,,,PA166117621,UGT1A6*2a,UGT1A6,Dosage,1,valproic acid,1448635029.0,East Asian
1448635009,,,PA166117621,UGT1A6*2a,UGT1A6,Dosage,1,valproic acid,1448635027.0,East Asian
1448635009,,,PA166117621,UGT1A6*2a,UGT1A6,Dosage,1,valproic acid,1448635031.0,East Asian
1448635009,,,PA166117621,UGT1A6*2a,UGT1A6,Dosage,1,valproic acid,1448635033.0,East Asian
1448635009,,,PA166117625,UGT1A6*3a,UGT1A6,Dosage,1,valproic acid,1448635025.0,East Asian
1448635009,,,PA166117625,UGT1A6*3a,UGT1A6,Dosage,1,valproic acid,1448635029.0,East Asian
1448635009,,,PA166117625,UGT1A6*3a,UGT1A6,Dosage,1,valproic acid,1448635027.0,East Asian
1448635009,,,PA166117625,UGT1A6*3a,UGT1A6,Dosage,1,valproic acid,1448635031.0,East Asian
1448635009,,,PA166117625,UGT1A6*3a,UGT1A6,Dosage,1,valproic acid,1448635033.0,East Asian
1448635009,,,PA166117627,UGT1A6*4a,UGT1A6,Dosage,1,valproic acid,1448635025.0,East Asian
1448635009,,,PA166117627,UGT1A6*4a,UGT1A6,Dosage,1,valproic acid,1448635029.0,East Asian
1448635009,,,PA166117627,UGT1A6*4a,UGT1A6,Dosage,1,valproic acid,1448635027.0,East Asian
1448635009,,,PA166117627,UGT1A6*4a,UGT1A6,Dosage,1,valproic acid,1448635031.0,East Asian
1448635009,,,PA166117627,UGT1A6*4a,UGT1A6,Dosage,1,valproic acid,1448635033.0,East Asian
1448635009,,,PA166117633,UGT1A6*8,UGT1A6,Dosage,1,valproic acid,1448635025.0,East Asian
1448635009,,,PA166117633,UGT1A6*8,UGT1A6,Dosage,1,valproic acid,1448635029.0,East Asian
1448635009,,,PA166117633,UGT1A6*8,UGT1A6,Dosage,1,valproic acid,1448635027.0,East Asian
1448635009,,,PA166117633,UGT1A6*8,UGT1A6,Dosage,1,valproic acid,1448635031.0,East Asian
1448635009,,,PA166117633,UGT1A6*8,UGT1A6,Dosage,1,valproic acid,1448635033.0,East Asian
1448635002,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,0,valproic acid,1448635008.0,East Asian
1449748454,PA166157316,rs2032582,,,ABCB1,Efficacy,1,tacrolimus,1449748456.0,East Asian
1183700910,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700918.0,African American/Afro-Caribbean
1183700910,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1183700918.0,African American/Afro-Caribbean
981238720,PA166155029,rs2116971,,,CDH13,Efficacy,1,perphenazine,981238725.0,European
1448634995,PA166153959,rs1057910,,,CYP2C9,Dosage,0,valproic acid,1448635001.0,East Asian
981238726,PA166155315,rs9952628,,,SKOR2,Efficacy,1,perphenazine,981238731.0,European
1451124680,PA166201321,rs13338697,,,WWOX,Efficacy,-1,cisplatin,1451124720.0,Unknown
1451124680,PA166201321,rs13338697,,,WWOX,Efficacy,-1,fluorouracil,1451124720.0,Unknown
1448258167,PA166160175,rs4792886,,,CRHR1,Efficacy,-1,corticosteroids,1448258169.0,Unknown
1448258167,PA166160175,rs4792886,,,CRHR1,Efficacy,-1,corticosteroids,1448258169.0,Unknown
1448634988,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,0,valproic acid,1448634994.0,East Asian
1447946849,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447946851.0,Unknown
1447946849,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447946851.0,Unknown
827920108,PA166154308,rs1005510,,,SERPING1,Efficacy,-1,bevacizumab,827920141.0,East Asian
1296666974,PA166155657,rs2003569,,,UGT1A9,Efficacy,1,simvastatin,1296666979.0,"Multiple groups, 75% white, 20% black, 5% asian"
981238796,PA166156465,rs17194378,,,CNTN4,Efficacy,1,ziprasidone,981238802.0,European
1183701027,PA166156729,rs307822,,,FLT4,Efficacy,-1,cisplatin,1183701029.0,Unknown
1183701027,PA166156729,rs307822,,,FLT4,Efficacy,-1,fluorouracil,1183701029.0,Unknown
1183701027,PA166156729,rs307822,,,FLT4,Efficacy,-1,oxaliplatin,1183701029.0,Unknown
1451354134,PA166232204,rs2071247,,,GRM6,Dosage,-1,methadone,1451354139.0,Unknown
981238803,PA166154743,rs9585618,,,NALCN,Efficacy,1,ziprasidone,981238808.0,European
1184470962,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,cyclosporine,1184470972.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black, Other"
1184470962,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,cyclosporine,1184470972.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black, Other"
1450928144,PA166156025,rs4818,,,COMT,Efficacy,-1,risperidone,1450928149.0,East Asian
1448634981,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,valproic acid,1448634987.0,East Asian
1183701023,PA166156624,rs7667298,,,KDR,Efficacy,-1,cisplatin,1183701025.0,Unknown
1183701023,PA166156624,rs7667298,,,KDR,Efficacy,-1,fluorouracil,1183701025.0,Unknown
1183701023,PA166156624,rs7667298,,,KDR,Efficacy,-1,oxaliplatin,1183701025.0,Unknown
1447520853,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,sirolimus,1447520855.0,East Asian
1447520853,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447520855.0,East Asian
1447946859,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1447946861.0,Unknown
1447946859,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1447946861.0,Unknown
1183701035,PA166156840,rs6877011,,,FLT4,Efficacy,-1,cisplatin,1183701037.0,Unknown
1183701035,PA166156840,rs6877011,,,FLT4,Efficacy,-1,fluorouracil,1183701037.0,Unknown
1183701035,PA166156840,rs6877011,,,FLT4,Efficacy,-1,oxaliplatin,1183701037.0,Unknown
1296666983,PA166155811,rs12052787,,,UGT1A9,Efficacy,1,simvastatin,1296666985.0,"Multiple groups, 75% white, 20% black, 5% asian"
827920120,PA166155387,rs2230205,,,C3,Efficacy,-1,bevacizumab,827920148.0,East Asian
1450960920,PA166153888,rs55886062,,,DPYD,Dosage,0,capecitabine,,
1450960920,PA166153888,rs55886062,,,DPYD,Dosage,0,fluorouracil,,
1451354128,PA166232203,rs17078853,,,GRM6,Dosage,-1,methadone,1451354133.0,Unknown
1451354128,PA166232203,rs17078853,,,GRM6,Dosage,-1,methadone,1451354133.0,Unknown
827920125,PA166155389,rs2250656,,,C3,Efficacy,-1,bevacizumab,827920153.0,East Asian
827920125,PA166155389,rs2250656,,,C3,Efficacy,-1,bevacizumab,827920153.0,East Asian
1450928156,PA166156024,rs4680,,,COMT,Efficacy,-1,risperidone,1450928161.0,East Asian
1446898274,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,icotinib,1446898286.0,East Asian
1446898274,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,icotinib,1446898286.0,East Asian
1446898274,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,icotinib,1446898286.0,East Asian
1447946834,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447946844.0,Unknown
1447946834,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447946844.0,Unknown
1448634968,PA166157430,rs7793837,,,CRHR2,Efficacy,-1,salbutamol,1448634970.0,European
1448634968,PA166157430,rs7793837,,,CRHR2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1448634970.0,European
1450928162,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,risperidone,1450928169.0,East Asian
1450928162,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,risperidone,1450928168.0,East Asian
1450928162,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,risperidone,1450928167.0,East Asian
1448258137,PA166160169,rs1011219,,,None,Efficacy,-1,corticosteroids,1448258139.0,Unknown
1447520868,PA166153699,rs2298805,,,FCER1A,Efficacy,1,desloratadine,1447520940.0,East Asian
1447520868,PA166153699,rs2298805,,,FCER1A,Efficacy,1,mizolastine,1447520940.0,East Asian
1183684634,PA166155900,rs72551330,,,UGT1A9,Metabolism/PK,1,sulfinpyrazone,1183684638.0,Unknown
1183701018,PA166156553,rs2305948,,,KDR,Efficacy,-1,cisplatin,1183701020.0,Unknown
1183701018,PA166156553,rs2305948,,,KDR,Efficacy,-1,fluorouracil,1183701020.0,Unknown
1183701018,PA166156553,rs2305948,,,KDR,Efficacy,-1,oxaliplatin,1183701020.0,Unknown
1449748471,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tacrolimus,1449748479.0,East Asian
1449748471,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1449748479.0,East Asian
1183701007,PA166156537,rs2071559,,,KDR,Efficacy,-1,cisplatin,1183701009.0,Unknown
1183701007,PA166156537,rs2071559,,,KDR,Efficacy,-1,fluorouracil,1183701009.0,Unknown
1183701007,PA166156537,rs2071559,,,KDR,Efficacy,-1,oxaliplatin,1183701009.0,Unknown
1448258128,PA166160167,rs2070232,,,STIP1,Efficacy,-1,corticosteroids,1448258130.0,Unknown
981238767,PA166154780,rs1315115,,,NPAS3,Efficacy,1,risperidone,981238776.0,European
1183700993,PA166154724,rs7993418,,,FLT1,Efficacy,-1,cisplatin,1183700995.0,Unknown
1183700993,PA166154724,rs7993418,,,FLT1,Efficacy,-1,fluorouracil,1183700995.0,Unknown
1183700993,PA166154724,rs7993418,,,FLT1,Efficacy,-1,oxaliplatin,1183700995.0,Unknown
1448634953,PA166157353,rs2284220,,,CRHR2,Efficacy,-1,salbutamol,1448634955.0,European
1183700989,PA166154683,rs664393,,,FLT1,Efficacy,-1,cisplatin,1183700991.0,Unknown
1183700989,PA166154683,rs664393,,,FLT1,Efficacy,-1,fluorouracil,1183700991.0,Unknown
1183700989,PA166154683,rs664393,,,FLT1,Efficacy,-1,oxaliplatin,1183700991.0,Unknown
1444932172,PA166157016,rs2076828,,,SLC22A3,Efficacy,1,metformin,1444932181.0,Unknown
1448258117,PA166160165,rs2236648,,,STIP1,Efficacy,-1,corticosteroids,1448258119.0,Unknown
1450928113,PA166156277,rs6280,,,DRD3,Efficacy,-1,risperidone,1450928118.0,East Asian
1450043422,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1450043459.0,Multiple groups
1450043422,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1450043463.0,Multiple groups
1450043422,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1450043465.0,Multiple groups
1450043422,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1450043461.0,Multiple groups
1447520814,PA166155398,rs2396185,,,INSR,Efficacy,-1,topiramate,1447520824.0,European
981238777,PA166155703,rs3738883,,,TMEFF2,Efficacy,1,risperidone,981238782.0,European
1450928121,PA166185304,rs362267,,,HTT,Efficacy,-1,risperidone,1450928126.0,East Asian
1183700999,PA166156528,rs1870377,,,KDR,Efficacy,-1,cisplatin,1183701001.0,Unknown
1183700999,PA166156528,rs1870377,,,KDR,Efficacy,-1,fluorouracil,1183701001.0,Unknown
1183700999,PA166156528,rs1870377,,,KDR,Efficacy,-1,oxaliplatin,1183701001.0,Unknown
981238783,PA166155949,rs4925300,,,CDH4,Efficacy,1,ziprasidone,981238788.0,European
1446767165,PA166154980,rs10517,,,NQO1,Dosage,1,warfarin,1446767168.0,East Asian
1446767165,PA166154980,rs10517,,,NQO1,Dosage,1,warfarin,1446767167.0,East Asian
1183700979,PA166156623,rs7664413,,,VEGFA,Efficacy,-1,cisplatin,1183700981.0,Unknown
1183700979,PA166156623,rs7664413,,,VEGFA,Efficacy,-1,fluorouracil,1183700981.0,Unknown
1183700979,PA166156623,rs7664413,,,VEGFA,Efficacy,-1,oxaliplatin,1183700981.0,Unknown
1444702812,PA166157284,rs1045642,,,ABCB1,Efficacy,1,phenobarbital,1444702818.0,East Asian
1296666927,PA166154747,rs11568658,,,ABCC4,Efficacy,1,latanoprost,1296666929.0,East Asian
1296666927,PA166154747,rs11568658,,,ABCC4,Efficacy,1,latanoprost,1296666960.0,East Asian
1296666927,PA166154747,rs11568658,,,ABCC4,Efficacy,1,latanoprost,1444666171.0,East Asian
1296666927,PA166154747,rs11568658,,,ABCC4,Efficacy,1,latanoprost,1444666173.0,East Asian
1450928129,PA166185306,rs362306,,,HTT,Efficacy,-1,risperidone,1450928134.0,East Asian
1450928129,PA166185306,rs362306,,,HTT,Efficacy,-1,risperidone,1450928134.0,East Asian
1450928129,PA166185306,rs362306,,,HTT,Efficacy,-1,risperidone,1450928134.0,East Asian
1447520795,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,sirolimus,1447520810.0,East Asian
1447520795,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,sirolimus,1447520818.0,East Asian
1447520795,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,sirolimus,1447520810.0,East Asian
1447520795,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,sirolimus,1447520818.0,East Asian
1447520795,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447520810.0,East Asian
1447520795,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447520818.0,East Asian
1447520795,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447520810.0,East Asian
1447520795,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447520818.0,East Asian
827641636,PA166155346,rs25487,,,XRCC1,Efficacy,1,carboplatin,827641642.0,East Asian
827641636,PA166155346,rs25487,,,XRCC1,Efficacy,1,cisplatin,827641642.0,East Asian
827641636,PA166155346,rs25487,,,XRCC1,Efficacy,1,fluorouracil,827641642.0,East Asian
827919665,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,827919745.0,"Multiple groups, Chinese, Malay, Indian mixed population."
1450928135,PA166154017,rs2515641,,,CYP2E1,Efficacy,-1,risperidone,1450928143.0,East Asian
1450928209,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,risperidone,1450928216.0,East Asian
1450928209,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,risperidone,1450928215.0,East Asian
1450928209,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,risperidone,1450928214.0,East Asian
827641630,PA166155973,rs12659,,,SLC19A1,Efficacy,1,carboplatin,827641635.0,East Asian
827641630,PA166155973,rs12659,,,SLC19A1,Efficacy,1,cisplatin,827641635.0,East Asian
827641630,PA166155973,rs12659,,,SLC19A1,Efficacy,1,fluorouracil,827641635.0,East Asian
1449191473,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1449191479.0,Near Eastern
1449748555,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1449748567.0,Unknown
1449748555,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1449748567.0,Unknown
1451124822,PA166155774,rs9679162,,,GALNT14,Efficacy,1,sorafenib,1451124795.0,Unknown
1183619151,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183619153.0,East Asian
1183619151,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183619153.0,East Asian
1183619151,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183619153.0,East Asian
1183619151,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183619153.0,East Asian
1183619151,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183619153.0,East Asian
1183619151,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183619153.0,East Asian
1447946767,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447946798.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1447946767,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447946777.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1447946767,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447946798.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1447946767,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447946777.0,"Multiple groups, Caucasian, East Asian, South Asian, Black, Other"
1450928233,PA166154801,rs3803300,,,AKT1,Efficacy,-1,risperidone,1450928240.0,East Asian
1450928233,PA166154801,rs3803300,,,AKT1,Efficacy,-1,risperidone,1450928239.0,East Asian
1450928233,PA166154801,rs3803300,,,AKT1,Efficacy,-1,risperidone,1450928238.0,East Asian
1446898161,PA166155204,rs2252281,,,SLC47A1,Metabolism/PK,-1,metformin,1446898163.0,Unknown
1446898156,PA166155206,rs2289669,,,SLC47A1,Metabolism/PK,-1,metformin,1446898158.0,Unknown
1183619140,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183619150.0,East Asian
1183619140,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183619150.0,East Asian
1183619140,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183619150.0,East Asian
1183619140,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183619150.0,East Asian
1183619140,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183619150.0,East Asian
1183619140,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183619150.0,East Asian
827641603,PA166155990,rs1131596,,,SLC19A1,,0,methotrexate,827641613.0,Unknown
1451124789,PA166155774,rs9679162,,,GALNT14,Efficacy,-1,sorafenib,1451124794.0,Unknown
1446898166,PA166155251,rs12943590,,,SLC47A2,Metabolism/PK,-1,metformin,1446898168.0,Unknown
827789050,PA166156015,rs11702779,,,RUNX1,Other,1,methacholine chloride,827789056.0,Unknown
1451124803,PA166155774,rs9679162,,,GALNT14,Efficacy,1,cisplatin,1451124776.0,Unknown
1451124803,PA166155774,rs9679162,,,GALNT14,Efficacy,1,fluorouracil,1451124776.0,Unknown
1451354183,PA166232206,rs11746675,,,GRM6,Dosage,-1,methadone,1451354200.0,Unknown
1450928193,PA166154337,rs1799978,,,DRD2,Efficacy,-1,risperidone,1450928200.0,East Asian
1450928193,PA166154337,rs1799978,,,DRD2,Efficacy,-1,risperidone,1450928199.0,East Asian
1450928193,PA166154337,rs1799978,,,DRD2,Efficacy,-1,risperidone,1450928198.0,East Asian
1183848503,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183848535.0,East Asian
1183848503,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183848535.0,East Asian
1183848503,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1183848535.0,East Asian
1447520749,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,methadone,1447520797.0,East Asian
1451354262,PA166232228,rs3983721,,,GRIN3A,Dosage,-1,methadone,1451354280.0,Unknown
1448602085,PA166156690,rs61750900,,,UGT2B10,Metabolism/PK,-1,nicotine,1448602087.0,African American/Afro-Caribbean
1450928272,PA166155296,rs4483927,,,HRH4,Efficacy,-1,risperidone,1450928279.0,East Asian
1450928272,PA166155296,rs4483927,,,HRH4,Efficacy,-1,risperidone,1450928277.0,East Asian
1450928272,PA166155296,rs4483927,,,HRH4,Efficacy,-1,risperidone,1450928278.0,East Asian
1444702644,PA166153818,rs10919563,,,PTPRC,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702648.0,European
1444702644,PA166153818,rs10919563,,,PTPRC,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702647.0,European
1448258035,PA166160149,rs3751122,,,STIP1,Efficacy,-1,corticosteroids,1448258037.0,Unknown
1451354254,PA166232229,rs6583954,,,CYP2C19,Dosage,-1,methadone,1451354267.0,Unknown
1448602077,PA166156690,rs61750900,,,UGT2B10,Metabolism/PK,-1,cotinine,1448602079.0,African American/Afro-Caribbean
1451354259,PA166232230,rs11528090,,,CYP2C19,Dosage,-1,methadone,1451354304.0,Unknown
827690712,PA166157405,rs4986910,,,CYP3A,Metabolism/PK,-1,nifedipine,827690722.0,Unknown
827690712,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,nifedipine,827690722.0,Unknown
827690712,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,nifedipine,827690722.0,Unknown
1450928280,PA166154259,rs6265,,,BDNF,Efficacy,-1,risperidone,1450928287.0,East Asian
1450928280,PA166154259,rs6265,,,BDNF,Efficacy,-1,risperidone,1450928286.0,East Asian
1450928280,PA166154259,rs6265,,,BDNF,Efficacy,-1,risperidone,1450928285.0,East Asian
1451288740,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,Selective serotonin reuptake inhibitors,1451288746.0,European
1451288740,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,Selective serotonin reuptake inhibitors,1451288746.0,European
1450928288,PA166156708,rs6295,,,HTR1A,Efficacy,-1,risperidone,1450928295.0,East Asian
1450928288,PA166156708,rs6295,,,HTR1A,Efficacy,-1,risperidone,1450928293.0,East Asian
1450928288,PA166156708,rs6295,,,HTR1A,Efficacy,-1,risperidone,1450928294.0,East Asian
1448258007,PA166160143,rs4725068,,,GLCCI1,Efficacy,-1,corticosteroids,1448258009.0,Unknown
1448602071,PA166163174,rs2942857,,,UGT2B10,Metabolism/PK,1,cotinine,1448602073.0,African American/Afro-Caribbean
1451354273,PA166232210,rs623580,,,TPH1,Dosage,-1,methadone,1451354278.0,Unknown
1450928296,PA166154673,rs6311,,,HTR2A,Efficacy,-1,risperidone,1450928303.0,East Asian
1450928296,PA166154673,rs6311,,,HTR2A,Efficacy,-1,risperidone,1450928302.0,East Asian
1450928296,PA166154673,rs6311,,,HTR2A,Efficacy,-1,risperidone,1450928301.0,East Asian
1446898150,PA166156913,rs316019,,,SLC22A2,Metabolism/PK,-1,metformin,1446898155.0,Unknown
1444702671,PA166153684,rs2240340,,,PADI4,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702674.0,European
1444702671,PA166153684,rs2240340,,,PADI4,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702675.0,European
827690697,PA166157406,rs4986913,,,CYP3A,Metabolism/PK,-1,nifedipine,827690706.0,Unknown
827690697,PA166157406,rs4986913,,,CYP3A4,Metabolism/PK,-1,nifedipine,827690706.0,Unknown
1448602065,PA166163174,rs2942857,,,UGT2B10,Metabolism/PK,-1,nicotine,1448602067.0,African American/Afro-Caribbean
1448257998,PA166160141,rs929509,,,GLCCI1,Efficacy,-1,corticosteroids,1448258000.0,Unknown
1448602059,PA166163174,rs2942857,,,UGT2B10,Metabolism/PK,-1,nicotine,1448602061.0,African American/Afro-Caribbean
1447520696,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1447520715.0,East Asian
1451354231,PA166232227,rs1983812,,,GRIN3A,Dosage,-1,methadone,1451354247.0,Unknown
1183701116,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183701118.0,European
1450928241,PA166155940,rs3787429,,,HRH3,Efficacy,-1,risperidone,1450928253.0,East Asian
1450928241,PA166155940,rs3787429,,,HRH3,Efficacy,-1,risperidone,1450928252.0,East Asian
1450928241,PA166155940,rs3787429,,,HRH3,Efficacy,-1,risperidone,1450928249.0,East Asian
1451354220,PA166232207,rs806380,,,CNR1,Dosage,-1,methadone,1451354240.0,Unknown
827919768,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,827919795.0,"Multiple groups, Chinese, Malay, Indian mixed population."
1448602052,PA166163174,rs2942857,,,UGT2B10,Metabolism/PK,1,cotinine,1448602058.0,African American/Afro-Caribbean
1444702681,PA166155828,rs13031237,,,REL,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702684.0,European
1444702681,PA166155828,rs13031237,,,REL,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702685.0,European
1451354226,PA166232226,rs7030238,,,GRIN3A,Dosage,-1,methadone,1451354246.0,Unknown
1450928254,PA166157874,rs3813928,,,HTR2C,Efficacy,-1,risperidone,1450928261.0,East Asian
1450928254,PA166157874,rs3813928,,,HTR2C,Efficacy,-1,risperidone,1450928260.0,East Asian
1450928254,PA166157874,rs3813928,,,HTR2C,Efficacy,-1,risperidone,1450928259.0,East Asian
1451354248,PA166232209,rs10512285,,,GRIN3A,Dosage,-1,methadone,1451354253.0,Unknown
1448257987,PA166160139,rs12668352,,,GLCCI1,Efficacy,-1,corticosteroids,1448257989.0,Unknown
1448257975,PA166160137,rs10257285,,,GLCCI1,Efficacy,-1,corticosteroids,1448257977.0,Unknown
1451354236,PA166232208,rs942142,,,GRIN3A,Dosage,-1,methadone,1451354261.0,Unknown
1444702693,PA166157169,rs10499194,,,None,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702695.0,European
1444702693,PA166157169,rs10499194,,,None,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702696.0,European
1183701108,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183701114.0,European
1451354241,PA166184293,rs6473799,,,OPRK1,Dosage,-1,methadone,1451354225.0,Unknown
1450928264,PA166185322,rs3818929,,,SLC44A3,Efficacy,-1,risperidone,1450928271.0,East Asian
1450928264,PA166185322,rs3818929,,,SLC44A3,Efficacy,-1,risperidone,1450928270.0,East Asian
1450928264,PA166185322,rs3818929,,,SLC44A3,Efficacy,-1,risperidone,1450928269.0,East Asian
1447520701,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447520707.0,East Asian
827788970,PA166156015,rs11702779,,,RUNX1,Other,1,methacholine chloride,827788993.0,Unknown
1451206866,PA166156692,rs62298861,,,UGT2B7,Metabolism/PK,-1,codeine,1451206852.0,Unknown
1451206866,PA166156692,rs62298861,,,UGT2B7,Metabolism/PK,-1,codeine,1451206960.0,Unknown
1451206866,PA166156692,rs62298861,,,UGT2B7,Metabolism/PK,-1,morphine,1451206852.0,Unknown
1451206866,PA166156692,rs62298861,,,UGT2B7,Metabolism/PK,-1,morphine,1451206960.0,Unknown
1144953742,PA166155187,rs1799752,,,ACE,Efficacy,-1,losartan,1144953781.0,Unknown
1451354316,PA166232241,rs10506645,,,TPH2,Dosage,-1,methadone,1451354341.0,Unknown
1450928340,PA166155471,rs28399433,,,CYP2A6,Efficacy,-1,varenicline,1450928345.0,
981239001,PA166155390,rs2269879,,,DOT1L,Efficacy,-1,hydrochlorothiazide,981239006.0,European
981239001,PA166155390,rs2269879,,,DOT1L,Efficacy,-1,hydrochlorothiazide,981239008.0,African American/Afro-Caribbean
1447946656,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1447946666.0,East Asian
1447946656,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,1,tacrolimus,1447946666.0,East Asian
1448257954,PA166160132,rs6956039,,,GLCCI1,Efficacy,-1,corticosteroids,1448257956.0,Unknown
981501152,PA166155930,rs2740204,,,OXT,Efficacy,1,clozapine,981501158.0,Unknown
1451206881,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,codeine,1451206844.0,Unknown
1451206881,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,codeine,1451206980.0,Unknown
1451206881,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1451206844.0,Unknown
1451206881,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,morphine,1451206980.0,Unknown
1448257940,PA166160130,rs6964558,,,GLCCI1,Efficacy,-1,corticosteroids,1448257942.0,Unknown
1451354342,PA166232242,rs4760820,,,TPH2,Dosage,-1,methadone,1451354347.0,Unknown
827919808,PA166154070,rs4986893,,,CYP2C19,Efficacy,1,clopidogrel,827919815.0,"Multiple groups, Chinese, Malay, Indian mixed population."
1448995005,PA166156383,rs3814055,,,NR1I2,Dosage,1,tacrolimus,1448995011.0,European
981861603,PA166154421,rs7124442,,,BDNF,Efficacy,1,citalopram,981861632.0,European
981501160,PA166153802,rs10494366,,,NOS1AP,Dosage,1,repaglinide,981501168.0,East Asian
981501160,PA166153802,rs10494366,,,NOS1AP,Efficacy,1,repaglinide,981501168.0,East Asian
827919816,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,clopidogrel,827919823.0,"Multiple groups, Chinese, Malay, Indian mixed population."
1448995012,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,tacrolimus,1448995014.0,European
1448995012,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,tacrolimus,1448995024.0,European
1447520668,PA166155136,rs72547529,,,VKORC1,Efficacy,0,warfarin,1447520711.0,Sub-Saharan African
1448995025,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,-1,tacrolimus,1448995034.0,European
1446898032,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,tramadol,1446898045.0,East Asian
1446898032,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,tramadol,1446898047.0,East Asian
1446898032,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,tramadol,1446898045.0,East Asian
1446898032,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,tramadol,1446898047.0,East Asian
1446898032,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1446898045.0,East Asian
1446898032,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tramadol,1446898047.0,East Asian
1446898032,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,tramadol,1446898045.0,East Asian
1446898032,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,tramadol,1446898047.0,East Asian
1451354292,PA166154909,rs4646425,,,CYP1A2,Dosage,-1,methadone,1451354297.0,Unknown
1184471312,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184471314.0,African American/Afro-Caribbean
1450928304,PA166154675,rs6313,,,HTR2A,Efficacy,-1,risperidone,1450928311.0,East Asian
1450928304,PA166154675,rs6313,,,HTR2A,Efficacy,-1,risperidone,1450928310.0,East Asian
1450928304,PA166154675,rs6313,,,HTR2A,Efficacy,-1,risperidone,1450928309.0,East Asian
1451354298,PA166232245,rs2240158,,,GRIN3B,Dosage,-1,methadone,1451354363.0,Unknown
1184471318,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471332.0,European
1184471318,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471330.0,European
1184471318,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471328.0,European
1184471318,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184471326.0,European
1184471318,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471332.0,European
1184471318,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471330.0,European
1184471318,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471328.0,European
1184471318,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184471326.0,European
1444702613,PA166154836,rs4646,,,CYP19A1,Efficacy,1,anastrozole,1444702622.0,East Asian
1444702613,PA166154836,rs4646,,,CYP19A1,Efficacy,1,letrozole,1444702622.0,East Asian
1444702613,PA166154836,rs4646,,,CYP19A1,Efficacy,1,tamoxifen,1444702622.0,East Asian
1448995035,PA166156352,rs2276707,,,NR1I2,Metabolism/PK,-1,tacrolimus,1448995037.0,European
1448257931,PA166160128,rs10952084,,,GLCCI1,Efficacy,-1,corticosteroids,1448257933.0,Unknown
1451354287,PA166232243,rs9325202,,,TPH2,Dosage,-1,methadone,1451354348.0,Unknown
1447946634,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447946644.0,East Asian
1447946634,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447946644.0,East Asian
1444702623,PA166154836,rs4646,,,CYP19A1,Efficacy,1,anastrozole,1444702625.0,East Asian
1444702623,PA166154836,rs4646,,,CYP19A1,Efficacy,1,letrozole,1444702625.0,East Asian
1444702623,PA166154836,rs4646,,,CYP19A1,Efficacy,1,tamoxifen,1444702625.0,East Asian
827788923,PA166155251,rs12943590,,,SLC47A2,Efficacy,1,metformin,827788929.0,European
827788923,PA166155251,rs12943590,,,SLC47A2,Metabolism/PK,1,metformin,827788929.0,European
827690618,PA166153625,rs1131873,,,EPHX1,Dosage,-1,warfarin,827690625.0,Unknown
1448257922,PA166160126,rs10253260,,,GLCCI1,Efficacy,-1,corticosteroids,1448257924.0,Unknown
1451354311,PA166232212,rs2171363,,,TPH2,Dosage,-1,methadone,1451354320.0,Unknown
981238979,PA166155390,rs2269879,,,DOT1L,Efficacy,1,hydrochlorothiazide,981238984.0,European
981238979,PA166155390,rs2269879,,,DOT1L,Efficacy,1,hydrochlorothiazide,981238984.0,European
1448257913,PA166160124,rs17142727,,,GLCCI1,Efficacy,-1,corticosteroids,1448257915.0,Unknown
1451206845,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451206885.0,European
1451206845,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1451206865.0,European
1451206845,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451206885.0,European
1451206845,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1451206865.0,European
1444702631,PA166157763,rs3761847,,,TRAF1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702639.0,European
1444702631,PA166157763,rs3761847,,,TRAF1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444702641.0,European
1448601968,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lovastatin acid,1448601970.0,East Asian
1448601968,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lovastatin acid,1448601971.0,East Asian
1451354306,PA166232211,rs2129575,,,TPH2,Dosage,-1,methadone,1451354279.0,Unknown
1448257902,PA166160122,rs17142716,,,GLCCI1,Efficacy,-1,corticosteroids,1448257904.0,Unknown
1448601959,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,lovastatin,1448601961.0,East Asian
1448601959,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,lovastatin,1448601962.0,East Asian
1449732350,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,0,voriconazole,1449732358.0,European
1449732350,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,0,voriconazole,1449732358.0,European
1447946591,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,1447946593.0,European
1450928402,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1450928408.0,East Asian
1448601953,PA166156110,rs4823613,,,PPARA,Metabolism/PK,-1,lovastatin acid,1448601956.0,East Asian
1448601953,PA166156110,rs4823613,,,PPARA,Metabolism/PK,-1,lovastatin acid,1448601955.0,East Asian
1448995061,PA166153700,rs2307424,,,NR1I3,Metabolism/PK,-1,tacrolimus,1448995063.0,European
1183701285,PA166154042,rs3814637,,,CYP2C19,Dosage,1,warfarin,1183701287.0,European
1447979364,PA166156657,rs11947402,,,TSPAN5,Efficacy,-1,citalopram,1447979368.0,European
1447979364,PA166156657,rs11947402,,,TSPAN5,Efficacy,-1,citalopram,1447979367.0,Unknown
1447979364,PA166156657,rs11947402,,,TSPAN5,Efficacy,-1,citalopram,1447979366.0,Unknown
1447979364,PA166156657,rs11947402,,,TSPAN5,Efficacy,-1,escitalopram,1447979368.0,European
1447979364,PA166156657,rs11947402,,,TSPAN5,Efficacy,-1,escitalopram,1447979367.0,Unknown
1447979364,PA166156657,rs11947402,,,TSPAN5,Efficacy,-1,escitalopram,1447979366.0,Unknown
1451157780,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1451157780,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1451157780,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1451157780,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1451157780,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1451157780,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1451157780,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,tramadol,1451157800.0,Unknown
1447946579,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,1447946581.0,European
747991835,PA166156674,rs17731538,,,ABCG2,Efficacy,1,methotrexate,748001556.0,Unknown
1448110413,PA166154850,rs762551,,,CYP1A2,Efficacy,1,nevirapine,1448110415.0,Sub-Saharan African
1448601940,PA166156110,rs4823613,,,PPARA,Metabolism/PK,1,lovastatin,1448601948.0,East Asian
1448601940,PA166156110,rs4823613,,,PPARA,Metabolism/PK,1,lovastatin,1448601946.0,East Asian
1449732339,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,0,voriconazole,1449732347.0,European
1449732339,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,0,voriconazole,1449732347.0,European
1447946585,PA166157316,rs2032582,,,ABCB1,Dosage,1,tacrolimus,1447946587.0,European
1183701274,PA166154066,rs4917639,,,CYP2C9,Dosage,1,warfarin,1183701276.0,European
1447979349,PA166153829,rs11580409,,,ERICH3,Efficacy,1,citalopram,1447979360.0,Unknown
1447979349,PA166153829,rs11580409,,,ERICH3,Efficacy,1,citalopram,1447979357.0,Unknown
1447979349,PA166153829,rs11580409,,,ERICH3,Efficacy,1,citalopram,1447979362.0,European
1447979349,PA166153829,rs11580409,,,ERICH3,Efficacy,1,escitalopram,1447979360.0,Unknown
1447979349,PA166153829,rs11580409,,,ERICH3,Efficacy,1,escitalopram,1447979357.0,Unknown
1447979349,PA166153829,rs11580409,,,ERICH3,Efficacy,1,escitalopram,1447979362.0,European
1451354401,PA166232248,rs3760657,,,CYP2B6,Dosage,-1,methadone,1451354406.0,Unknown
981419300,PA166156046,rs165599,,,COMT,Efficacy,1,bupropion,981419312.0,European
1448995097,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,dolutegravir,1448995103.0,East Asian
1448995097,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,dolutegravir,1448995103.0,East Asian
1448995097,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,dolutegravir,1448995103.0,East Asian
1447979333,PA166153586,rs696692,,,ERICH3,Other,1,serotonin,1447979339.0,European
1447979333,PA166153586,rs696692,,,ERICH3,Other,1,serotonin,1447979343.0,European
1447979333,PA166153586,rs696692,,,ERICH3,Other,1,serotonin,1447979341.0,European
1448995092,PA166157288,rs1128503,,,ABCB1,Efficacy,1,clopidogrel,1448995094.0,East Asian
827657784,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,827658367.0,Unknown
1449716007,PA166180146,rs2302663,,,ATF2,Dosage,-1,fentanyl,1449716009.0,East Asian
1449715981,PA166180148,rs268214,,,ATF2,Efficacy,-1,fentanyl,1449715983.0,East Asian
1447520587,PA166156399,rs4533622,,,CTNNB1,Efficacy,1,thalidomide,1447520593.0,Unknown
1448995104,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,dolutegravir,1448995106.0,East Asian
1447520580,PA166156394,rs4135385,,,CTNNB1,Efficacy,1,cyclophosphamide,1447520586.0,Unknown
1447520580,PA166156394,rs4135385,,,CTNNB1,Efficacy,1,dexamethasone,1447520586.0,Unknown
1447520580,PA166156394,rs4135385,,,CTNNB1,Efficacy,1,thalidomide,1447520586.0,Unknown
981861633,PA166154418,rs7103411,,,BDNF,Efficacy,1,citalopram,981861655.0,European
1451354364,PA166232246,rs2285906,,,GRIN3B,Dosage,-1,methadone,1451354369.0,Unknown
1448257848,PA166160111,rs6463755,,,GLCCI1,Efficacy,-1,corticosteroids,1448257850.0,Unknown
1296667190,PA166157737,rs1800975,,,XPA,Efficacy,1,Platinum compounds,1296667196.0,Unknown
1448601904,PA166154593,rs4570625,,,TPH2,Efficacy,-1,venlafaxine,1448601906.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1447979316,PA166156657,rs11947402,,,TSPAN5,Other,1,serotonin,1447979326.0,European
1447979316,PA166156657,rs11947402,,,TSPAN5,Other,1,serotonin,1447979328.0,European
1447979316,PA166156657,rs11947402,,,TSPAN5,Other,1,serotonin,1447979330.0,European
1448257839,PA166160109,rs11978165,,,GLCCI1,Efficacy,-1,corticosteroids,1448257841.0,Unknown
1448257839,PA166160109,rs11978165,,,GLCCI1,Efficacy,-1,corticosteroids,1448257841.0,Unknown
1183697248,PA166153986,rs1934969,,,CYP2C9,Metabolism/PK,1,losartan,1183697260.0,European
1183697248,PA166153986,rs1934969,,,CYP2C9,Metabolism/PK,1,losartan,1183697262.0,East Asian
1450375492,PA166157167,rs10305420,,,GLP1R,Efficacy,1,exenatide,1450375500.0,Unknown
1450375492,PA166157167,rs10305420,,,GLP1R,Efficacy,1,exenatide,1450375498.0,Unknown
1449163057,PA166157340,rs2235048,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449163059.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1445296375,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,leflunomide,1445296381.0,European
655387115,PA166153603,rs951436,,,RGS4,Efficacy,-1,antipsychotics,655387118.0,European
982048083,PA166155150,rs4363,,,ACE,Efficacy,-1,ramipril,982048085.0,African American/Afro-Caribbean
1446902041,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,imipramine,1446902051.0,European
1446902041,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,imipramine,1446902053.0,European
1446902041,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,imipramine,1446902051.0,European
1446902041,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,imipramine,1446902053.0,European
982048078,PA166155149,rs4359,,,ACE,Efficacy,1,ramipril,982048080.0,African American/Afro-Caribbean
982048078,PA166155149,rs4359,,,ACE,Efficacy,1,ramipril,982048080.0,African American/Afro-Caribbean
1447983378,PA166156328,rs1799852,,,TF,Efficacy,-1,adalimumab,1447983381.0,European
655387086,PA166155337,rs688,,,LDLR,Efficacy,-1,atenolol,655387088.0,European
1449163067,PA166159110,rs4148738,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449163069.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1448573201,PA166157370,rs2868177,,,POR,Metabolism/PK,-1,tacrolimus,1448573203.0,Multiple groups
655387074,PA166155632,rs1367117,,,APOB,Efficacy,1,irbesartan,655387081.0,European
1448573195,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1448573197.0,Multiple groups
655387073,PA166155632,rs1367117,,,APOB,Efficacy,1,irbesartan,655387079.0,European
655387073,PA166155632,rs1367117,,,APOB,Metabolism/PK,1,irbesartan,655387079.0,European
1445296386,PA166153706,rs2476601,,,PTPN22,Toxicity,-1,leflunomide,1445296392.0,European
1183680834,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,efavirenz,1183680836.0,"Multiple groups, Brazilian."
1183680834,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,lamivudine,1183680836.0,"Multiple groups, Brazilian."
1183680834,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,lopinavir,1183680836.0,"Multiple groups, Brazilian."
1183680834,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,nevirapine,1183680836.0,"Multiple groups, Brazilian."
1183680834,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,ritonavir,1183680836.0,"Multiple groups, Brazilian."
1183680834,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,zidovudine,1183680836.0,"Multiple groups, Brazilian."
1447983363,PA166157009,rs2071303,,,HFE,Efficacy,1,adalimumab,1447983376.0,European
1450375524,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1450375558.0,Multiple groups
1450375524,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1450375526.0,European
1450375524,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1450375540.0,"Multiple groups, Non-Hispanic whites, Asians, African Americans and Latinos"
1450375524,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1450375562.0,European
1183680830,PA166154864,rs1517618,,,SLCO3A1,Efficacy,-1,efavirenz,1183680832.0,"Multiple groups, Brazilian."
1183680830,PA166154864,rs1517618,,,SLCO3A1,Efficacy,-1,lamivudine,1183680832.0,"Multiple groups, Brazilian."
1183680830,PA166154864,rs1517618,,,SLCO3A1,Efficacy,-1,nevirapine,1183680832.0,"Multiple groups, Brazilian."
1183680830,PA166154864,rs1517618,,,SLCO3A1,Efficacy,-1,zidovudine,1183680832.0,"Multiple groups, Brazilian."
1448573188,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448573194.0,Multiple groups
655387083,PA166155337,rs688,,,LDLR,Efficacy,-1,atenolol,655387085.0,European
827921493,PA166157527,rs121434568,,,EGFR,Efficacy,1,erlotinib,827921500.0,European
827921493,PA166157527,rs121434568,,,EGFR,Efficacy,1,erlotinib,827921500.0,European
1448573185,PA166155072,rs4889606,,,STX1B,Dosage,1,warfarin,1448573217.0,African American/Afro-Caribbean
1448573185,PA166155072,rs4889606,,,STX1B,Dosage,1,warfarin,1448573219.0,African American/Afro-Caribbean
1448573185,PA166155072,rs4889606,,,STX1B,Dosage,1,warfarin,1448573217.0,African American/Afro-Caribbean
1448573185,PA166155072,rs4889606,,,STX1B,Dosage,1,warfarin,1448573219.0,African American/Afro-Caribbean
1183680813,PA166154987,rs212091,,,ABCC1,Efficacy,1,lamivudine,1183680815.0,"Multiple groups, Brazilian."
1183680813,PA166154987,rs212091,,,ABCC1,Efficacy,1,lopinavir,1183680815.0,"Multiple groups, Brazilian."
1183680813,PA166154987,rs212091,,,ABCC1,Efficacy,1,ritonavir,1183680815.0,"Multiple groups, Brazilian."
1183680813,PA166154987,rs212091,,,ABCC1,Efficacy,1,zidovudine,1183680815.0,"Multiple groups, Brazilian."
1445296421,PA166154675,rs6313,,,HTR2A,Efficacy,1,antidepressants,1445296427.0,"Multiple groups, Caucasian and Asian"
1449163102,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449163104.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
982048069,PA166154205,rs113646094,,,ABCC2,Metabolism/PK,1,pravastatin,982048082.0,European
1184483749,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,antidepressants,1184483760.0,European
1184483749,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,antidepressants,1184483760.0,European
1184483749,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,antidepressants,1184483760.0,European
1449163113,PA166157373,rs3213619,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449163115.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1183680826,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,efavirenz,1183680828.0,"Multiple groups, Brazilian."
1183680826,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,lamivudine,1183680828.0,"Multiple groups, Brazilian."
1183680826,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,nevirapine,1183680828.0,"Multiple groups, Brazilian."
1183680826,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,zidovudine,1183680828.0,"Multiple groups, Brazilian."
982048062,PA166155148,rs4344,,,ACE,Efficacy,1,ramipril,982048076.0,African American/Afro-Caribbean
1183680822,PA166155049,rs3743527,,,ABCC1,Efficacy,-1,lamivudine,1183680824.0,"Multiple groups, Brazilian."
1183680822,PA166155049,rs3743527,,,ABCC1,Efficacy,-1,lopinavir,1183680824.0,"Multiple groups, Brazilian."
1183680822,PA166155049,rs3743527,,,ABCC1,Efficacy,-1,ritonavir,1183680824.0,"Multiple groups, Brazilian."
1183680822,PA166155049,rs3743527,,,ABCC1,Efficacy,-1,zidovudine,1183680824.0,"Multiple groups, Brazilian."
1449310581,PA166155857,rs17868323,,,UGT1A7,Metabolism/PK,1,axitinib,1449310588.0,East Asian
1449163120,PA166157738,rs1927907,,,TLR4,Metabolism/PK,-1,tacrolimus,1449163122.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1450375507,PA166182323,rs3765467,,,GLP1R,Efficacy,-1,exenatide,1450375510.0,Unknown
1450375507,PA166182323,rs3765467,,,GLP1R,Efficacy,-1,exenatide,1450375509.0,Unknown
1447983326,PA166157359,rs2299267,,,PON2,Efficacy,1,antidepressants,1447983329.0,East Asian
1444935867,PA166153596,rs846910,,,HSD11B1,Metabolism/PK,1,tacrolimus,1444935869.0,East Asian
769257718,PA166157288,rs1128503,,,ABCB1,Other,-1,carbamazepine,769257720.0,East Asian
769257718,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,carbamazepine,769257720.0,East Asian
1447983338,PA166155383,rs2112460,,,CACNA1A,Efficacy,1,antidepressants,1447983341.0,East Asian
1444935875,PA166153776,rs4844880,,,HSD11B1,Metabolism/PK,1,tacrolimus,1444935877.0,East Asian
769257721,PA166157316,rs2032582,,,ABCB1,Other,-1,carbamazepine,769257723.0,East Asian
769257721,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,carbamazepine,769257723.0,East Asian
1184483645,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,escitalopram,1184483647.0,European
1184483645,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,escitalopram,1184483647.0,European
1449310596,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,axitinib,1449310598.0,East Asian
1447983310,PA166154121,rs10997242,,,CTNNA3,Efficacy,1,antidepressants,1447983313.0,East Asian
655387163,PA166154140,rs11572080,,,CYP2C8,Dosage,1,repaglinide,655387165.0,European
655387163,PA166154140,rs11572080,,,CYP2C8,Metabolism/PK,1,repaglinide,655387165.0,European
1450375544,PA166182330,rs77567654,,,GREM2,Efficacy,1,allopurinol,1450375546.0,European
1450375534,PA166182328,rs45499402,,,ABCG2,Efficacy,1,allopurinol,1450375536.0,European
1449310590,PA166155718,rs3832043,,,UGT1A10,Metabolism/PK,1,axitinib,1449310592.0,East Asian
1449310590,PA166155718,rs3832043,,,UGT1A8,Metabolism/PK,1,axitinib,1449310592.0,East Asian
1449310590,PA166155718,rs3832043,,,UGT1A9,Metabolism/PK,1,axitinib,1449310592.0,East Asian
655387159,PA166154110,rs10509681,,,CYP2C8,Dosage,1,repaglinide,655387161.0,European
655387159,PA166154110,rs10509681,,,CYP2C8,Metabolism/PK,1,repaglinide,655387161.0,European
1447983318,PA166157467,rs16873129,,,RAPGEF5,Efficacy,1,antidepressants,1447983320.0,East Asian
1447983318,PA166157467,rs16873129,,,RAPGEF5,Efficacy,1,antidepressants,1447983320.0,East Asian
1184483660,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,escitalopram,1184483662.0,European
1184483660,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,escitalopram,1184483662.0,European
655387138,PA166153604,rs951439,,,RGS4,Efficacy,0,quetiapine,655387140.0,Unknown
655387138,PA166153604,rs951439,,,RGS4,Efficacy,0,ziprasidone,655387140.0,Unknown
1450129827,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1450129829.0,East Asian
1449163153,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,tacrolimus,1449163155.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
655387136,PA166153815,rs10917670,,,RGS4,Efficacy,-1,risperidone,,
655387136,PA166153815,rs10917670,,,RGS4,Efficacy,-1,risperidone,,
1450375594,PA166182336,rs10802887,,,GREM2,Efficacy,-1,allopurinol,1450375630.0,"Multiple groups, Non-Hispanic White, Asian, African American, Latino"
1450375594,PA166182336,rs10802887,,,GREM2,Efficacy,-1,allopurinol,1450375596.0,European
1444706513,PA166157592,rs3735814,,,GATA4,Dosage,1,acenocoumarol,1444706520.0,Multiple groups
1444706513,PA166157592,rs3735814,,,GATA4,Dosage,1,acenocoumarol,1444706522.0,Multiple groups
982015348,PA166157349,rs2270007,,,CRHR2,Efficacy,1,citalopram,982015354.0,European
655387147,PA166154110,rs10509681,,,CYP2C8,Dosage,1,rosiglitazone,655387149.0,European
655387147,PA166154110,rs10509681,,,CYP2C8,Metabolism/PK,1,rosiglitazone,655387149.0,European
1184483668,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,nortriptyline,1184483670.0,European
1184483668,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,nortriptyline,1184483670.0,European
1445296333,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1445296339.0,East Asian
1445296333,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1445296339.0,East Asian
1449310608,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,axitinib,1449310610.0,East Asian
1445296361,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,dactinomycin,1445296367.0,"Multiple groups, White British and mixed other"
1447983283,PA166156278,rs49411,,,FHIT,Efficacy,1,antidepressants,1447983285.0,East Asian
1447983276,PA166154551,rs2532560,,,PARP11,Efficacy,1,antidepressants,1447983278.0,East Asian
1183697263,PA166154098,rs9332104,,,CYP2C9,Metabolism/PK,-1,losartan,1183697265.0,European
1183697263,PA166154098,rs9332104,,,CYP2C9,Metabolism/PK,-1,losartan,1183697266.0,East Asian
1445296356,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,dactinomycin,1445296369.0,"Multiple groups, White British and mixed other"
1184467298,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467304.0,East Asian
1184467298,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467302.0,East Asian
1184467298,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1451344760.0,East Asian
1184467298,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1451344724.0,East Asian
1183697273,PA166154103,rs9332174,,,CYP2C9,Metabolism/PK,-1,losartan,1183697276.0,East Asian
1183697273,PA166154103,rs9332174,,,CYP2C9,Metabolism/PK,-1,losartan,1183697275.0,European
1448261806,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,0,irinotecan,1448261818.0,Unknown
1448261806,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1448261818.0,Unknown
1183697268,PA166154099,rs9332120,,,CYP2C9,Metabolism/PK,-1,losartan,1183697270.0,European
1183697268,PA166154099,rs9332120,,,CYP2C9,Metabolism/PK,-1,losartan,1183697271.0,East Asian
1449310621,PA166178735,rs35305980,,,OR2B11,Metabolism/PK,1,axitinib,1449310623.0,East Asian
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449146795.0,East Asian
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449146794.0,East Asian
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449146804.0,European
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449146806.0,European
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,trifluridine,1449146795.0,East Asian
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,trifluridine,1449146794.0,East Asian
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,trifluridine,1449146804.0,European
1449146792,PA166157157,rs9394992,,,SLC29A1,Efficacy,1,trifluridine,1449146806.0,European
1184467305,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467307.0,East Asian
1184467305,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467308.0,East Asian
1445296351,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,dactinomycin,1445296371.0,"Multiple groups, White British and mixed other"
1451293140,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,bupropion,1451293160.0,
1451293140,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,hydroxybupropion,1451293160.0,
1184467438,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1184467461.0,Unknown
1184467438,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1184467442.0,European
1184467438,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1184467444.0,European
1447983260,PA166156951,rs766127,,,MTRF1L,Efficacy,1,antidepressants,1447983263.0,East Asian
1449163182,PA166154153,rs12571421,,,CYP2C19,Metabolism/PK,-1,tacrolimus,1449163184.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1184467445,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1184467448.0,European
1184467445,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1184467447.0,European
1449310639,PA166154256,rs5219,,,KCNJ11,Efficacy,1,"sulfonamides, urea derivatives",1449310641.0,Latino
1447983268,PA166157606,rs4737771,,,CRH,Efficacy,1,antidepressants,1447983270.0,East Asian
1296666538,PA166156642,rs10213440,,,PPARGC1A,Efficacy,-1,metformin,1296666541.0,Unknown
1296666538,PA166156642,rs10213440,,,PPARGC1A,Efficacy,-1,metformin,1296666540.0,European
1450981840,PA166154977,rs7294,,,VKORC1,Dosage,0,warfarin,1450981860.0,Central/South Asian
1450981840,PA166154977,rs7294,,,VKORC1,Dosage,0,warfarin,1450981844.0,Central/South Asian
1450981840,PA166154977,rs7294,,,VKORC1,Metabolism/PK,0,warfarin,1450981860.0,Central/South Asian
1450981840,PA166154977,rs7294,,,VKORC1,Metabolism/PK,0,warfarin,1450981844.0,Central/South Asian
1450375616,PA166156637,rs10011796,,,ABCG2,Efficacy,-1,allopurinol,1450375628.0,"Multiple groups, Non-Hispanic White, Asian, African American and Latino"
1450375616,PA166156637,rs10011796,,,ABCG2,Efficacy,-1,allopurinol,1450375618.0,European
1449163202,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,tacrolimus,1449163204.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1448261782,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,0,irinotecan,1448261794.0,European
1448261782,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1448261794.0,European
1449310666,PA166154255,rs5215,,,KCNJ11,Efficacy,-1,"sulfonamides, urea derivatives",1449310668.0,Latino
1449163209,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,tacrolimus,1449163211.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1449163209,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,tacrolimus,1449163211.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1450375609,PA166182338,rs79663562,,,MYT1L,Efficacy,-1,allopurinol,1450375611.0,European
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,tipiracil hydrochloride,1449146827.0,European
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,tipiracil hydrochloride,1449146826.0,East Asian
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,tipiracil hydrochloride,1449146825.0,East Asian
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,tipiracil hydrochloride,1449146828.0,European
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,trifluridine,1449146827.0,European
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,trifluridine,1449146826.0,East Asian
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,trifluridine,1449146825.0,East Asian
1449146823,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,trifluridine,1449146828.0,European
1184467466,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1184467468.0,European
1184467466,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1184467469.0,European
1184467466,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1184467470.0,Unknown
1449163216,PA166153993,rs2070673,,,CYP2E1,Metabolism/PK,-1,tacrolimus,1449163218.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1449163216,PA166153993,rs2070673,,,DUX1,Metabolism/PK,-1,tacrolimus,1449163218.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1449753015,PA166181074,rs11568634,,,SLC22A6,Other,-1,adefovir dipivoxil,1449753020.0,Unknown
1449753015,PA166181074,rs11568634,,,SLC22A6,Other,-1,adefovir dipivoxil,1449753020.0,Unknown
1447983231,PA166154730,rs9315310,,,NBEA,Efficacy,1,antidepressants,1447983237.0,East Asian
655386940,PA166157430,rs7793837,,,CRHR2,Efficacy,1,salbutamol,655386943.0,European
655386940,PA166157430,rs7793837,,,CRHR2,Efficacy,1,selective beta-2-adrenoreceptor agonists,655386943.0,European
1184467478,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1184467482.0,Unknown
1184467478,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1184467481.0,European
1184467478,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1184467480.0,European
1444935833,PA166157286,rs1057868,,,POR,Efficacy,1,atorvastatin,1444935839.0,European
1444935833,PA166157286,rs1057868,,,POR,Efficacy,1,atorvastatin,1444935841.0,European
1445296275,PA166157303,rs1799983,,,NOS3,Efficacy,1,salvianolic acid b,1445296288.0,East Asian
1449753059,PA166175994,rs678849,,,OPRD1,Efficacy,1,buprenorphine,1449753069.0,African American/Afro-Caribbean
1449753059,PA166175994,rs678849,,,OPRD1,Efficacy,1,buprenorphine,1449753065.0,African American/Afro-Caribbean
1449310672,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,"sulfonamides, urea derivatives",1449310674.0,Latino
1447983239,PA166156935,rs672170,,,RGS17,Efficacy,1,antidepressants,1447983242.0,East Asian
1449163235,PA166154416,rs5744247,,,IL18,Metabolism/PK,-1,tacrolimus,1449163237.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1451358660,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1451358664.0,East Asian
769257569,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,769257571.0,East Asian
769257569,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,769257571.0,East Asian
769257569,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,769257571.0,East Asian
655386935,PA166157430,rs7793837,,,CRHR2,Efficacy,1,salbutamol,655386939.0,European
655386935,PA166157430,rs7793837,,,CRHR2,Efficacy,1,selective beta-2-adrenoreceptor agonists,655386939.0,European
1449310690,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,"sulfonamides, urea derivatives",1449310692.0,Latino
1296666461,PA166155946,rs4810083,,,PCK1,Efficacy,-1,metformin,1296666464.0,Unknown
1296666461,PA166155946,rs4810083,,,PCK1,Efficacy,-1,metformin,1296666463.0,European
982015513,PA166153979,rs1880676,,,CHAT,Dosage,1,olanzapine,982015527.0,European
982015513,PA166153979,rs1880676,,,CHAT,Efficacy,1,olanzapine,982015527.0,European
769257578,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,769257580.0,European
1449163258,PA166154583,rs4149117,,,SLCO1B3,Metabolism/PK,-1,tacrolimus,1449163260.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1183697450,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,axitinib,1183697452.0,Multiple groups
1183697450,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,-1,axitinib,1183697452.0,Multiple groups
1183697450,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,-1,axitinib,1183697452.0,Multiple groups
827822943,PA166154608,rs7975232,,,VDR,Efficacy,-1,zoledronate,827822952.0,Unknown
769257594,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,769257596.0,East Asian
1449163245,PA166176406,rs1946519,,,IL18,Metabolism/PK,-1,tacrolimus,1449163247.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1446901857,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,trimipramine,1446901871.0,Unknown
1446901857,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,trimipramine,1446901859.0,Unknown
1446901857,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,trimipramine,1446901871.0,Unknown
1446901857,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,trimipramine,1446901859.0,Unknown
1446901857,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,trimipramine,1446901871.0,Unknown
1446901857,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,trimipramine,1446901859.0,Unknown
1446901857,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,trimipramine,1446901871.0,Unknown
1446901857,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,trimipramine,1446901859.0,Unknown
1446901857,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,trimipramine,1446901871.0,Unknown
1446901857,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,trimipramine,1446901859.0,Unknown
1449163265,PA166154602,rs7311358,,,SLCO1B3,Metabolism/PK,-1,tacrolimus,1449163267.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1444706370,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706376.0,European
1444706370,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706376.0,European
1444706370,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706376.0,European
1444706370,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706376.0,European
1183697423,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,axitinib,1183697427.0,Multiple groups
1449146891,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1449146903.0,Near Eastern
1449146891,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1449146903.0,Near Eastern
1449146891,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1449146903.0,Near Eastern
1449753070,PA166175994,rs678849,,,OPRD1,Efficacy,-1,methadone,1449753072.0,African American/Afro-Caribbean
1450375663,PA166182353,rs4659982,,,GREM2,Efficacy,-1,allopurinol,1450375665.0,European
769257608,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,antiepileptics,769257613.0,East Asian
1444608072,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1444608081.0,European
1444608072,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1444608081.0,European
1444706377,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1444706379.0,European
1444706377,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,ribavirin,1444706379.0,European
769257609,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,antiepileptics,769257615.0,East Asian
1183697411,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1183697413.0,East Asian
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1444935772.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1444935774.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1444935776.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1444935772.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1444935774.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1444935776.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,omeprazole,1444935772.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,omeprazole,1444935774.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,omeprazole,1444935776.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1444935772.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1444935774.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1444935776.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1444935772.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1444935774.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1444935776.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,pantoprazole,1444935772.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,pantoprazole,1444935774.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,pantoprazole,1444935776.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1444935772.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1444935774.0,European
1444935760,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1444935776.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1444935772.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1444935774.0,European
1444935760,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1444935776.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,rabeprazole,1444935772.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,rabeprazole,1444935774.0,European
1444935760,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,rabeprazole,1444935776.0,European
1448261705,PA166156387,rs3842689,,,NR1I2,Efficacy,1,corticosteroids,1448261710.0,Unknown
1449163277,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,tacrolimus,1449163279.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1444706391,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706409.0,European
1444706391,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444706409.0,European
1184483798,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184483808.0,East Asian
1184483798,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184483808.0,East Asian
1183681035,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,venlafaxine,1183681041.0,Unknown
1183681035,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,venlafaxine,1183681041.0,Unknown
1183697415,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,1183697417.0,East Asian
1449163284,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,tacrolimus,1449163286.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1449163299,PA166156089,rs2239393,,,COMT,Metabolism/PK,-1,tacrolimus,1449163301.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
827822903,PA166154516,rs1544410,,,VDR,Efficacy,-1,zoledronate,827822910.0,Unknown
1184483809,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184483811.0,East Asian
1183697400,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1183697410.0,East Asian
1183697400,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1183697410.0,East Asian
1451293180,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,bupropion,1451293185.0,
1451293180,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,hydroxybupropion,1451293185.0,
1184483813,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184483815.0,East Asian
827921704,PA166155193,rs1876828,,,CRHR1,Efficacy,1,glucocorticoids,827921715.0,European
827921704,PA166155193,rs1876828,,,CRHR1,Efficacy,1,glucocorticoids,827921713.0,European
1296666425,PA166156720,rs249429,,,PRKAA1,Efficacy,-1,metformin,1296666427.0,Unknown
1296666425,PA166156720,rs249429,,,PRKAA1,Efficacy,-1,metformin,1296666428.0,Unknown
1449163292,PA166155409,rs3745274,,,CYP2A7P1,Metabolism/PK,-1,tacrolimus,1449163294.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1449163292,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,tacrolimus,1449163294.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1446901830,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,trimipramine,1446901843.0,Unknown
1446901830,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,trimipramine,1446901843.0,Unknown
1446901830,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,trimipramine,1446901843.0,Unknown
1446901830,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,trimipramine,1446901843.0,Unknown
1446901830,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,trimipramine,1446901843.0,Unknown
1450932816,PA166154500,rs731236,,,VDR,Efficacy,1,deferasirox,1450932821.0,"Multiple groups, Caucasian and 'Other' ethnicities."
1448261674,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,0,irinotecan,1448261684.0,European
1448261674,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1448261684.0,European
1450932822,PA166154516,rs1544410,,,VDR,Efficacy,1,deferasirox,1450932827.0,"Multiple groups, Caucasian and 'Other' ethnicities."
827807008,PA166153671,rs2106089,,,SPTA1,Efficacy,1,benazepril,827807018.0,Unknown
827807008,PA166153671,rs2106089,,,SPTA1,Efficacy,1,benazepril,827807018.0,Unknown
827807008,PA166153671,rs2106089,,,SPTA1,Efficacy,1,benazepril,827807018.0,Unknown
982015564,PA166157542,rs4950,,,CHRNB3,Efficacy,1,nicotine,982015570.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015564,PA166157542,rs4950,,,CHRNB3,Efficacy,1,nicotine,982015572.0,"Multiple groups, Caucasian: 69%, African American: 20%, Asian: 7.7%, Native American: 1.7% and Unknown: 1.9%."
982015564,PA166157542,rs4950,,,CHRNB3,Other,1,nicotine,982015570.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015564,PA166157542,rs4950,,,CHRNB3,Other,1,nicotine,982015572.0,"Multiple groups, Caucasian: 69%, African American: 20%, Asian: 7.7%, Native American: 1.7% and Unknown: 1.9%."
1447983120,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1447983126.0,Unknown
1184565887,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,mephenytoin,1184642649.0,Unknown
1184565887,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,mephenytoin,1184642651.0,Unknown
1184565887,,,PA165816540,CYP2C19*26,CYP2C19,Metabolism/PK,1,mephenytoin,1184642649.0,Unknown
1184565887,,,PA165816540,CYP2C19*26,CYP2C19,Metabolism/PK,1,mephenytoin,1184642651.0,Unknown
1184565887,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1184642649.0,Unknown
1184565887,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1184642651.0,Unknown
1184565887,,,PA165816540,CYP2C19*26,CYP2C19,Metabolism/PK,1,omeprazole,1184642649.0,Unknown
1184565887,,,PA165816540,CYP2C19*26,CYP2C19,Metabolism/PK,1,omeprazole,1184642651.0,Unknown
1183615565,PA166155187,rs1799752,,,ACE,Efficacy,-1,atenolol,1183615569.0,European
1183697486,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,aripiprazole,1183697498.0,East Asian
1183697486,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,aripiprazole,1183697498.0,East Asian
1183697486,,,PA165988484,CYP2D6*21,CYP2D6,Metabolism/PK,0,aripiprazole,1183697498.0,East Asian
1449179722,PA166156936,rs683369,,,SLC22A1,Efficacy,1,imatinib,1449179724.0,Unknown
1183697499,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,aripiprazole,1183697501.0,East Asian
1183697499,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,aripiprazole,1183697501.0,East Asian
1183697499,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,aripiprazole,1183697501.0,East Asian
1183697499,,,PA165988484,CYP2D6*21,CYP2D6,Metabolism/PK,0,aripiprazole,1183697501.0,East Asian
982015580,PA166157542,rs4950,,,CHRNB3,Dosage,-1,ethanol,982015584.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015580,PA166157542,rs4950,,,CHRNB3,Efficacy,-1,ethanol,982015584.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
827806987,PA166153545,rs4762,,,AGT,Efficacy,1,benazepril,827807020.0,East Asian
655387327,PA166157288,rs1128503,,,ABCB1,Efficacy,1,risperidone,655387329.0,"Multiple groups, Portugal: 44 white, 1 African"
1296666880,PA166157030,rs2275913,,,IL17A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296667031.0,European
1296666880,PA166157030,rs2275913,,,IL17A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666882.0,European
1449179728,PA166157267,rs776746,,,CYP3A5,Efficacy,1,imatinib,1449179730.0,"Multiple groups, Mixed Asian"
655387331,PA166157284,rs1045642,,,ABCB1,Other,-1,efavirenz,655387333.0,"Multiple groups, No other associations between CYP2B6 or ABCB1 genotype and any other treatment response end points were observed overall and among white, black, or Hispanic participants analyzed separately"
655387331,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,efavirenz,655387333.0,"Multiple groups, No other associations between CYP2B6 or ABCB1 genotype and any other treatment response end points were observed overall and among white, black, or Hispanic participants analyzed separately"
982015543,PA166154040,rs3810950,,,CHAT,Dosage,-1,olanzapine,982015561.0,European
982015543,PA166154040,rs3810950,,,CHAT,Efficacy,-1,olanzapine,982015561.0,European
1183615560,PA166155187,rs1799752,,,ACE,Efficacy,1,irbesartan,1183615564.0,European
1450932798,PA166155607,rs887829,,,UGT1A1,Efficacy,1,deferasirox,1450932803.0,"Multiple groups, Caucasian and 'Other' ethnicities."
1296666866,PA166155724,rs4251961,,,IL1RN,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666868.0,European
1444706343,PA166156076,rs1135840,,,CYP2D6,Metabolism/PK,-1,clozapine,1444706348.0,East Asian
1446901759,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,trimipramine,1446901761.0,Unknown
1446901759,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,trimipramine,1446901775.0,Unknown
1446901759,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,trimipramine,1446901761.0,Unknown
1446901759,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,trimipramine,1446901775.0,Unknown
1446901759,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,trimipramine,1446901761.0,Unknown
1446901759,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,trimipramine,1446901775.0,Unknown
1446901759,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,trimipramine,1446901761.0,Unknown
1446901759,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,trimipramine,1446901775.0,Unknown
1446901759,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,trimipramine,1446901761.0,Unknown
1446901759,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,trimipramine,1446901775.0,Unknown
1450932804,PA166155655,rs1983023,,,UGT1A3,Efficacy,1,deferasirox,1450932809.0,"Multiple groups, Caucasian and 'Other' ethnicities."
1450932810,PA166154623,rs10877012,,,CYP27B1,Efficacy,1,deferasirox,1450932815.0,"Multiple groups, Caucasian and 'Other' ethnicities."
1296666874,PA166157448,rs10499563,,,IL6,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296667026.0,European
1296666874,PA166157448,rs10499563,,,IL6,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666876.0,European
1296666869,PA166157803,rs10306114,,,PTGS1,Efficacy,-1,latanoprost,1444666161.0,East Asian
1296666869,PA166157803,rs10306114,,,PTGS1,Efficacy,-1,latanoprost,1296666956.0,East Asian
1296666869,PA166157803,rs10306114,,,PTGS1,Efficacy,-1,latanoprost,1296666918.0,East Asian
827921263,PA166156480,rs4961,,,ADD1,Efficacy,-1,hydrochlorothiazide,827921292.0,"Multiple groups, 291 unrelated non-Hispanic African American adults (150 women and 141 men) from Atlanta, GA, and 294 unrelated non-Hispanic white adults (126 women and 168 men) from Rochester, MN"
1296666850,PA166157119,rs6927172,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296667008.0,European
1296666850,PA166157119,rs6927172,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666852.0,European
981474970,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,methotrexate,981474977.0,Unknown
1183632042,PA166157695,rs238,,,None,Efficacy,1,diuretics,1183632044.0,European
1183632042,PA166157695,rs238,,,None,Efficacy,1,diuretics,1183632213.0,European
1183632042,PA166157695,rs238,,,None,Efficacy,1,hydrochlorothiazide,1183632044.0,European
1183632042,PA166157695,rs238,,,None,Efficacy,1,hydrochlorothiazide,1183632213.0,European
1183632042,PA166157695,rs238,,,None,Efficacy,1,"Thiazides, plain",1183632044.0,European
1183632042,PA166157695,rs238,,,None,Efficacy,1,"Thiazides, plain",1183632213.0,European
982032025,PA166154437,rs10835210,,,BDNF,Dosage,-1,methadone,982032053.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European patients."
982032025,PA166154437,rs10835210,,,BDNF,Dosage,-1,methadone,982032051.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1296666859,PA166155735,rs4848306,,,IL1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296667016.0,European
1296666859,PA166155735,rs4848306,,,IL1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666861.0,European
827921276,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,hydrochlorothiazide,827921296.0,"Multiple groups, 291 unrelated non-Hispanic African American adults (150 women and 141 men) from Atlanta, GA, and 294 unrelated non-Hispanic white adults (126 women and 168 men) from Rochester, MN"
1184467517,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,efavirenz,1184467521.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1184467517,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,efavirenz,1184467525.0,European
1184467517,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,efavirenz,1184467529.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1184467517,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,efavirenz,1184467523.0,African American/Afro-Caribbean
1184467517,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,1,efavirenz,1184467527.0,Latino
1296666832,PA166156805,rs2569190,,,CD14,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666834.0,European
827921283,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,hydrochlorothiazide,827921294.0,"Multiple groups, 291 unrelated non-Hispanic African American adults (150 women and 141 men) from Atlanta, GA, and 294 unrelated non-Hispanic white adults (126 women and 168 men) from Rochester, MN"
1446901738,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,trimipramine,1446901740.0,Unknown
1446901738,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,trimipramine,1446901740.0,Unknown
1184467530,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,1,efavirenz,1184467532.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1184467530,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,1,efavirenz,1184467536.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1184467530,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,1,efavirenz,1184467533.0,African American/Afro-Caribbean
1184467530,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,1,efavirenz,1184467534.0,European
1184467530,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,1,efavirenz,1184467535.0,Latino
1449753246,PA166181105,rs2229949,,,CACNA1B,Efficacy,1,antipsychotics,1449753252.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1451293300,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,bupropion,1451293305.0,European
1451293300,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,bupropion,1451293305.0,European
1451293300,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,hydroxybupropion,1451293305.0,European
1451293300,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,hydroxybupropion,1451293305.0,European
1184467538,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467544.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1184467538,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467544.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1184467538,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1184467544.0,"Multiple groups, Self-identified as Black, White or Hispanic."
1296666820,PA166157732,rs1554973,,,CNPY4,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666822.0,European
1183615597,PA166154352,rs2229437,,,PRCP,Efficacy,1,benazepril,1183615599.0,East Asian
1183615597,PA166154352,rs2229437,,,PRCP,Efficacy,1,benazepril,1183615600.0,East Asian
1183615597,PA166154352,rs2229437,,,PRCP,Efficacy,1,benazepril,1183615601.0,East Asian
1183697523,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,capecitabine,1183697525.0,East Asian
1183697523,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,fluorouracil,1183697525.0,East Asian
1183697523,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,irinotecan,1183697525.0,East Asian
1183697523,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,leucovorin,1183697525.0,East Asian
1183697518,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,capecitabine,1183697522.0,East Asian
1183697518,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,fluorouracil,1183697522.0,East Asian
1183697518,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,irinotecan,1183697522.0,East Asian
1183697518,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,leucovorin,1183697522.0,East Asian
1183615604,PA166154001,rs2230345,,,GRK5,Efficacy,-1,atenolol,1183615608.0,"Multiple groups, 85 White and 69 Black individuals"
1183615604,PA166154001,rs2230345,,,GRK5,Efficacy,-1,atenolol,1183615606.0,"Multiple groups, 85 White and 69 Black individuals"
1183615604,PA166154001,rs2230345,,,GRK5,Efficacy,-1,atenolol,1183615607.0,"Multiple groups, 85 White and 69 Black individuals"
1450375830,,,PA165948045,CYP3A7*1A,CYP3A7,Efficacy,-1,etonogestrel,1450375842.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1450375830,,,PA165948047,CYP3A7*1C,CYP3A7,Efficacy,-1,etonogestrel,1450375842.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1450375830,,,PA165948045,CYP3A7*1A,CYP3A7,Metabolism/PK,-1,etonogestrel,1450375842.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1450375830,,,PA165948047,CYP3A7*1C,CYP3A7,Metabolism/PK,-1,etonogestrel,1450375842.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1448261553,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1448261555.0,East Asian
1444706282,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1444706294.0,Central/South Asian
1444706282,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1444706294.0,Central/South Asian
1183697527,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,capecitabine,1183697529.0,East Asian
1183697527,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,fluorouracil,1183697529.0,East Asian
1183697527,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,irinotecan,1183697529.0,East Asian
1183697527,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,leucovorin,1183697529.0,East Asian
1296666811,PA166156654,rs11938228,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666813.0,European
1296666811,PA166156654,rs11938228,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666913.0,European
1296666780,PA166156526,rs1816702,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666782.0,European
655387233,PA166154673,rs6311,,,HTR2A,Efficacy,1,risperidone,655387236.0,"Multiple groups, Portugal: 44 white, 1 african"
1444935535,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,carbamazepine,1444935538.0,East Asian
655387241,PA166157874,rs3813928,,,HTR2C,Efficacy,1,risperidone,655387244.0,"Multiple groups, Portugal: 44 white, 1 african"
1296666792,PA166154549,rs2430561,,,IFNG,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666794.0,European
1296666792,PA166154549,rs2430561,,,IFNG,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296667038.0,European
655387218,PA166156277,rs6280,,,DRD3,Efficacy,1,risperidone,655387220.0,"Multiple groups, Portugal: 44 white, 1 african"
1296666768,PA166157782,rs5030728,,,TLR4,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666770.0,European
1296666768,PA166157782,rs5030728,,,TLR4,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666926.0,European
1296666768,PA166157782,rs5030728,,,TLR4,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666924.0,European
1296666774,PA166156580,rs3804099,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666901.0,European
1296666774,PA166156580,rs3804099,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666776.0,European
1296666774,PA166156580,rs3804099,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296667049.0,European
1449753264,PA166181108,rs2238087,,,CACNA1C,Efficacy,1,antipsychotics,1449753266.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1450375853,PA166156357,rs2461817,,,NR1I2,Efficacy,-1,etonogestrel,1450375855.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1450375853,PA166156357,rs2461817,,,NR1I2,Metabolism/PK,-1,etonogestrel,1450375855.0,"Multiple groups, USA, Colorado. ""The most frequent self-reported race was white (Caucasian) (46.6% [163/350]) and 51.4% (180/350) of participants reported Hispanic or Latina ethnicity."""
1450932911,PA166157061,rs3025039,,,VEGFA,PD,1,salbutamol,1450932917.0,Unknown
1449310935,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1449310941.0,European
1449310935,PA166157284,rs1045642,,,ABCB1,Other,1,clopidogrel,1449310941.0,European
1444935567,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,1444935573.0,East Asian
1444935567,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,1444935575.0,East Asian
982032054,PA166154427,rs7934165,,,BDNF,Dosage,-1,methadone,982032063.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1449163468,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1449163481.0,Unknown
1449163468,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,escitalopram,1449163481.0,Unknown
1449163468,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,escitalopram,1449163481.0,Unknown
1449163468,,,PA165980637,CYP2C19*4,CYP2C19,Metabolism/PK,1,escitalopram,1449163481.0,Unknown
1296666759,PA166154585,rs4149570,,,TNFRSF1A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666893.0,European
1296666759,PA166154585,rs4149570,,,TNFRSF1A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666765.0,European
1450932921,PA166185757,rs3809324,,,COL2A1,PD,1,salbutamol,1450932926.0,Unknown
1449753292,PA166181113,rs4505744,,,CACNA2D3,Efficacy,1,antipsychotics,1449753294.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
981475009,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,methotrexate,981475016.0,Unknown
1449163487,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,escitalopram,1449163489.0,Unknown
1449163487,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,escitalopram,1449163489.0,Unknown
1449310952,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,clopidogrel,1449310954.0,European
1449310952,PA166154147,rs12248560,,,CYP2C19,Other,1,clopidogrel,1449310954.0,European
981475017,PA166154094,rs8187710,,,ABCC2,Metabolism/PK,-1,methotrexate,981475025.0,Unknown
1296666743,PA166156596,rs4696480,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666752.0,European
1449753301,PA166181115,rs10741058,,,CACNB2,Efficacy,1,antipsychotics,1449753303.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1296666726,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666728.0,East Asian
1296666726,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666735.0,East Asian
1296666726,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666730.0,East Asian
1296666726,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666729.0,East Asian
1296666702,PA166157413,rs6467136,,,PAX4,Efficacy,-1,repaglinide,1296666704.0,East Asian
1448819433,PA166169828,rs3730251,,,PPP3CA,Efficacy,-1,tacrolimus,1448819439.0,"Multiple groups, Brazilian"
1448819433,PA166169828,rs3730251,,,PPP3CA,Toxicity,-1,tacrolimus,1448819439.0,"Multiple groups, Brazilian"
1448819442,PA166169828,rs3730251,,,PPP3CA,Metabolism/PK,-1,tacrolimus,1448819448.0,"Multiple groups, Brazilian"
1448819453,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448819465.0,"Multiple groups, Caucasian, Asian, Latino"
1448819453,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448819465.0,"Multiple groups, Caucasian, Asian, Latino"
1183697679,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183697689.0,European
1183697679,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183697689.0,European
1183697679,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183697689.0,European
1450933031,PA166156931,rs610604,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1450933037.0,Unknown
1450933031,PA166156931,rs610604,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1450933038.0,Unknown
1296666710,PA166157436,rs10229583,,,PAX4,Efficacy,-1,repaglinide,1296666712.0,East Asian
1296666710,PA166157436,rs10229583,,,PAX4,Efficacy,-1,rosiglitazone,1296666712.0,East Asian
1183697690,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183697692.0,European
1448819466,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448819468.0,"Multiple groups, Caucasian, Asian, Latino"
1448819466,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448819468.0,"Multiple groups, Caucasian, Asian, Latino"
1449147143,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1449147145.0,European
1449147143,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1449147146.0,European
1449147143,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1449147147.0,European
1449147143,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1449147148.0,European
1449147143,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1449147149.0,European
1444935495,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,carbamazepine,1444935514.0,East Asian
1444935495,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,carbamazepine,1444935517.0,East Asian
1296666686,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666692.0,East Asian
1296666686,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666700.0,East Asian
1296666686,PA166157413,rs6467136,,,PAX4,Efficacy,1,rosiglitazone,1296666696.0,East Asian
1449147153,PA166154512,rs1169288,,,HNF1A,Efficacy,-1,metformin,1449147156.0,European
1449147153,PA166154512,rs1169288,,,HNF1A,Efficacy,-1,metformin,1449147157.0,European
1449147153,PA166154512,rs1169288,,,HNF1A,Efficacy,-1,metformin,1449147158.0,European
1449147153,PA166154512,rs1169288,,,HNF1A,Efficacy,-1,metformin,1449147159.0,European
1449147153,PA166154512,rs1169288,,,HNF1A,Efficacy,-1,metformin,1449147160.0,European
1449556763,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,simvastatin acid,1449556765.0,"Multiple groups, Patients were of Caucasian, Hispanic or African American ethnicity"
1449556763,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,simvastatin acid,1449556765.0,"Multiple groups, Patients were of Caucasian, Hispanic or African American ethnicity"
1451129580,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,efavirenz,1451129583.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1451129580,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,efavirenz,1451129583.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1449311002,PA166154293,rs662799,,,APOA5,Efficacy,1,simvastatin,1449311016.0,East Asian
1449311002,PA166154293,rs662799,,,APOA5,Efficacy,1,simvastatin,1449311010.0,East Asian
1449311002,PA166154293,rs662799,,,APOA5,Efficacy,1,simvastatin,1449311013.0,East Asian
1449311002,PA166154293,rs662799,,,APOA5,Efficacy,1,simvastatin,1449311018.0,East Asian
1446901561,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,amitriptyline,1446901563.0,East Asian
1446901561,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,amitriptyline,1446901563.0,East Asian
1446901561,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,amitriptyline,1446901563.0,East Asian
1449556752,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1449556757.0,"Multiple groups, Patients were of Caucasian, Hispanic or African American ethnicity"
1451129593,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,efavirenz,1451129597.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1450932983,PA166185751,rs7041,,,GC,Efficacy,1,deferasirox,1450932988.0,"Multiple groups, Caucasian and 'Other' ethnicities."
1444706133,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1444706161.0,East Asian
1444706133,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1444706161.0,East Asian
1451129589,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,efavirenz,1451129605.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1449753382,PA166181121,rs12245847,,,CACNB2,Efficacy,1,antipsychotics,1449753384.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1449163542,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1449163545.0,European
1449163542,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1449163544.0,African American/Afro-Caribbean
1449163542,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449163545.0,European
1449163542,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449163544.0,African American/Afro-Caribbean
1451129601,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,efavirenz,1451129623.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1449163553,PA166157347,rs2257401,,,CYP3A7,Metabolism/PK,1,tacrolimus,1449163556.0,European
1449163553,PA166157347,rs2257401,,,CYP3A7,Metabolism/PK,1,tacrolimus,1449163555.0,African American/Afro-Caribbean
1449311019,PA166154293,rs662799,,,APOA5,Efficacy,1,atorvastatin,1449311022.0,East Asian
1449311019,PA166154293,rs662799,,,APOA5,Efficacy,1,atorvastatin,1449311023.0,East Asian
1449311019,PA166154293,rs662799,,,APOA5,Efficacy,1,atorvastatin,1449311021.0,East Asian
1449311019,PA166154293,rs662799,,,APOA5,Efficacy,1,atorvastatin,1449311024.0,East Asian
978639673,PA166155595,rs295137,,,SPATS2L,Efficacy,-1,salbutamol,978639689.0,European
978639673,PA166155595,rs295137,,,SPATS2L,Efficacy,-1,salbutamol,978639677.0,European
1183697658,,,PA165984975,UGT2B15*1,UGT2B15,Efficacy,1,sipoglitazar,1183697668.0,Unknown
1183697658,,,PA165984976,UGT2B15*2,UGT2B15,Efficacy,1,sipoglitazar,1183697668.0,Unknown
1183697658,,,PA165984975,UGT2B15*1,UGT2B15,Metabolism/PK,1,sipoglitazar,1183697668.0,Unknown
1183697658,,,PA165984976,UGT2B15*2,UGT2B15,Metabolism/PK,1,sipoglitazar,1183697668.0,Unknown
1449163561,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449163564.0,European
1449163561,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449163563.0,African American/Afro-Caribbean
1447573274,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447573378.0,Multiple groups
1447573274,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447573378.0,Multiple groups
1447573274,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447573378.0,Multiple groups
1449163570,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449163573.0,European
1449163570,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449163572.0,African American/Afro-Caribbean
1449311028,PA166154293,rs662799,,,APOA5,Efficacy,1,rosuvastatin,1449311030.0,East Asian
1449311028,PA166154293,rs662799,,,APOA5,Efficacy,1,rosuvastatin,1449311031.0,East Asian
1449311028,PA166154293,rs662799,,,APOA5,Efficacy,1,rosuvastatin,1449311032.0,East Asian
1449311028,PA166154293,rs662799,,,APOA5,Efficacy,1,rosuvastatin,1449311033.0,East Asian
1451129606,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,efavirenz,1451129610.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1449163578,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,1,tacrolimus,1449163581.0,European
1449163578,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449163581.0,European
1183697770,PA166154444,rs11030104,,,BDNF,Efficacy,1,antipsychotics,1183697774.0,European
1183697770,PA166154444,rs11030104,,,BDNF,Efficacy,1,antipsychotics,1183697776.0,European
655387624,PA166154337,rs1799978,,,DRD2,Other,1,risperidone,655387628.0,East Asian
1444706036,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444706098.0,European
1444706036,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444706121.0,European
1444706036,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444706118.0,European
1444706036,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444706098.0,European
1444706036,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444706121.0,European
1444706036,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444706118.0,European
1444706036,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706098.0,European
1444706036,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706121.0,European
1444706036,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706118.0,European
1444706036,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706098.0,European
1444706036,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706121.0,European
1444706036,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706118.0,European
1183533922,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183533926.0,Latino
1183533922,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184135924.0,Latino
655387621,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,irinotecan,655387625.0,East Asian
1449163587,PA166157367,rs2740574,,,CYP3A,Metabolism/PK,1,tacrolimus,1449163590.0,European
1449163587,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449163590.0,European
1449311045,PA166154293,rs662799,,,APOA5,Other,1,atorvastatin,1449311058.0,East Asian
1449311045,PA166154293,rs662799,,,APOA5,Other,1,rosuvastatin,1449311058.0,East Asian
1449311045,PA166154293,rs662799,,,APOA5,Other,1,simvastatin,1449311058.0,East Asian
1448605470,PA166163444,rs8450,,,CRTC2,Toxicity,1,hdl cholesterol,1448605476.0,European
1447950096,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,sertraline,1447950099.0,Unknown
1447950096,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,sertraline,1447950098.0,Unknown
1447950096,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,sertraline,1447950099.0,Unknown
1447950096,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,sertraline,1447950098.0,Unknown
1447950096,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,sertraline,1447950099.0,Unknown
1447950096,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,sertraline,1447950098.0,Unknown
1183959898,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183959908.0,Unknown
1183959898,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183959908.0,Unknown
1183533900,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183533904.0,Unknown
1444706053,PA166154416,rs5744247,,,IL18,Metabolism/PK,1,tacrolimus,1444706063.0,East Asian
1446901546,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,nortriptyline,1446901548.0,East Asian
1446901546,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,nortriptyline,1446901548.0,East Asian
1446901546,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,nortriptyline,1446901548.0,East Asian
1449311061,PA166156978,rs1142345,,,TPMT,Dosage,-1,mercaptopurine,1449311069.0,Near Eastern
1449311061,PA166156978,rs1142345,,,TPMT,Dosage,-1,mercaptopurine,1449311067.0,Near Eastern
1449311061,PA166156978,rs1142345,,,TPMT,Dosage,-1,methotrexate,1449311069.0,Near Eastern
1449311061,PA166156978,rs1142345,,,TPMT,Dosage,-1,methotrexate,1449311067.0,Near Eastern
1449753400,PA166181125,rs7427395,,,CACNA2D3,Efficacy,1,antipsychotics,1449753402.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
982015800,PA166156083,rs2020917,,,COMT,Efficacy,1,risperidone,982015808.0,East Asian
1449163596,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1449163598.0,African American/Afro-Caribbean
1183959875,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,tacrolimus,1183959897.0,Unknown
1183959875,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,tacrolimus,1183959897.0,Unknown
982015818,PA166156134,rs9606186,,,COMT,Efficacy,1,risperidone,982015823.0,East Asian
1183533891,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183533895.0,East Asian
1183533896,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183533898.0,East Asian
1183959864,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,tacrolimus,1183959894.0,Unknown
1183959864,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,tacrolimus,1183959894.0,Unknown
1449311080,PA166156443,rs11706052,,,IMPDH2,Dosage,-1,mercaptopurine,1449311083.0,Near Eastern
1449311080,PA166156443,rs11706052,,,IMPDH2,Dosage,-1,mercaptopurine,1449311082.0,Near Eastern
1449311080,PA166156443,rs11706052,,,IMPDH2,Dosage,-1,methotrexate,1449311083.0,Near Eastern
1449311080,PA166156443,rs11706052,,,IMPDH2,Dosage,-1,methotrexate,1449311082.0,Near Eastern
1447950063,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,sertraline,1447950079.0,Unknown
1447950063,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,sertraline,1447950077.0,Unknown
1447950063,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,sertraline,1447950079.0,Unknown
1447950063,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,sertraline,1447950077.0,Unknown
1447950063,,,PA165818807,CYP2B6*9,CYP2B6,Metabolism/PK,1,sertraline,1447950079.0,Unknown
1447950063,,,PA165818807,CYP2B6*9,CYP2B6,Metabolism/PK,1,sertraline,1447950077.0,Unknown
655387565,PA166153972,rs1799853,,,CYP2C9,Dosage,-1,warfarin,655387567.0,Multiple groups
982015810,PA166156059,rs933271,,,COMT,Efficacy,1,risperidone,982015816.0,East Asian
1449753427,PA166181131,rs3768652,,,CACNB4,Efficacy,1,antipsychotics,1449753429.0,"Multiple groups, 80% South African Coloured, 12% Xhosa, 8% European"
1449311070,PA166156993,rs1800462,,,TPMT,Dosage,-1,mercaptopurine,1449311072.0,Near Eastern
1449311070,PA166156993,rs1800462,,,TPMT,Dosage,-1,mercaptopurine,1449311073.0,Near Eastern
1449311070,PA166156993,rs1800462,,,TPMT,Dosage,-1,methotrexate,1449311072.0,Near Eastern
1449311070,PA166156993,rs1800462,,,TPMT,Dosage,-1,methotrexate,1449311073.0,Near Eastern
1450933135,PA166156024,rs4680,,,COMT,Efficacy,1,opioids,1450933139.0,Unknown
1450933135,PA166156024,rs4680,,,COMT,Efficacy,1,opioids,1450933140.0,Unknown
1183959975,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,fluvoxamine,1183959984.0,East Asian
1183959975,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,fluvoxamine,1183959977.0,East Asian
1183959975,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluvoxamine,1183959984.0,East Asian
1183959975,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluvoxamine,1183959977.0,East Asian
1449311094,PA166153643,rs1801131,,,MTHFR,Dosage,-1,mercaptopurine,1449311096.0,Near Eastern
1449311094,PA166153643,rs1801131,,,MTHFR,Dosage,-1,mercaptopurine,1449311097.0,Near Eastern
1449311094,PA166153643,rs1801131,,,MTHFR,Dosage,-1,methotrexate,1449311096.0,Near Eastern
1449311094,PA166153643,rs1801131,,,MTHFR,Dosage,-1,methotrexate,1449311097.0,Near Eastern
1183959964,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,paroxetine,1183959974.0,East Asian
1183959964,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1183959974.0,East Asian
1449311087,PA166153644,rs1801133,,,MTHFR,Dosage,-1,mercaptopurine,1449311089.0,Near Eastern
1449311087,PA166153644,rs1801133,,,MTHFR,Dosage,-1,mercaptopurine,1449311090.0,Near Eastern
1449311087,PA166153644,rs1801133,,,MTHFR,Dosage,-1,methotrexate,1449311089.0,Near Eastern
1449311087,PA166153644,rs1801133,,,MTHFR,Dosage,-1,methotrexate,1449311090.0,Near Eastern
1449311109,PA166155964,rs7270101,,,ITPA,Dosage,-1,mercaptopurine,1449311111.0,Near Eastern
1449311109,PA166155964,rs7270101,,,ITPA,Dosage,-1,mercaptopurine,1449311112.0,Near Eastern
1449311109,PA166155964,rs7270101,,,ITPA,Dosage,-1,methotrexate,1449311111.0,Near Eastern
1449311109,PA166155964,rs7270101,,,ITPA,Dosage,-1,methotrexate,1449311112.0,Near Eastern
1448999809,PA166157216,rs72552763,,,SLC22A1,Metabolism/PK,1,metformin,1448999811.0,Unknown
1451359144,PA166233882,rs1042098,,,SLC6A3,Efficacy,-1,heroin,1451359148.0,East Asian
1446901471,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,clomipramine,1446901481.0,European
1446901471,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,clomipramine,1446901481.0,European
1444705991,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,cyclosporine,1444705999.0,"Multiple groups, White, Black, Asian"
1444705991,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,cyclosporine,1444706001.0,"Multiple groups, White, Black, Asian"
1449311101,PA166155915,rs1127354,,,ITPA,Dosage,-1,mercaptopurine,1449311104.0,Near Eastern
1449311101,PA166155915,rs1127354,,,ITPA,Dosage,-1,mercaptopurine,1449311103.0,Near Eastern
1449311101,PA166155915,rs1127354,,,ITPA,Dosage,-1,methotrexate,1449311104.0,Near Eastern
1449311101,PA166155915,rs1127354,,,ITPA,Dosage,-1,methotrexate,1449311103.0,Near Eastern
1447950037,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,venlafaxine,1447950048.0,East Asian
1447950037,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,venlafaxine,1447950048.0,East Asian
1447950037,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,venlafaxine,1447950048.0,East Asian
1005117719,PA166154993,rs708272,,,CETP,Efficacy,-1,simvastatin,1005117782.0,Unknown
1448605395,PA166163448,rs12117078,,,CRTC2,Toxicity,-1,glucose,1448605397.0,European
1450376100,PA166182407,rs795484,,,TAOK3,Dosage,1,morphine,1450376114.0,European
1450376100,PA166182407,rs795484,,,TAOK3,Dosage,1,morphine,1450376109.0,European
1450376100,PA166182407,rs795484,,,TAOK3,Dosage,1,morphine,1450376111.0,"Multiple groups, European Caucasian and African American patients"
1450376100,PA166182407,rs795484,,,TAOK3,Dosage,1,morphine,1450376107.0,European
1450376100,PA166182407,rs795484,,,TAOK3,Efficacy,1,morphine,1450376114.0,European
1450376100,PA166182407,rs795484,,,TAOK3,Efficacy,1,morphine,1450376109.0,European
1450376100,PA166182407,rs795484,,,TAOK3,Efficacy,1,morphine,1450376111.0,"Multiple groups, European Caucasian and African American patients"
1450376100,PA166182407,rs795484,,,TAOK3,Efficacy,1,morphine,1450376107.0,European
827806149,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,0,tamoxifen,827806158.0,East Asian
827806149,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,0,tamoxifen,827806158.0,East Asian
827806149,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,tamoxifen,827806158.0,East Asian
827806149,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,tamoxifen,827806158.0,East Asian
1448097468,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1448097478.0,East Asian
1448097468,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1448097478.0,East Asian
1449311116,PA166156100,rs2413739,,,PACSIN2,Dosage,-1,mercaptopurine,1449311118.0,Near Eastern
1449311116,PA166156100,rs2413739,,,PACSIN2,Dosage,-1,mercaptopurine,1449311119.0,Near Eastern
1449311116,PA166156100,rs2413739,,,PACSIN2,Dosage,-1,methotrexate,1449311118.0,Near Eastern
1449311116,PA166156100,rs2413739,,,PACSIN2,Dosage,-1,methotrexate,1449311119.0,Near Eastern
1449311123,PA166154714,rs3765534,,,ABCC4,Dosage,-1,mercaptopurine,1449311126.0,Near Eastern
1449311123,PA166154714,rs3765534,,,ABCC4,Dosage,-1,mercaptopurine,1449311125.0,Near Eastern
1449311123,PA166154714,rs3765534,,,ABCC4,Dosage,-1,methotrexate,1449311126.0,Near Eastern
1449311123,PA166154714,rs3765534,,,ABCC4,Dosage,-1,methotrexate,1449311125.0,Near Eastern
1449163663,PA166176620,rs10052957,,,NR3C1,Efficacy,1,prednisone,1449163665.0,East Asian
655387634,PA166154337,rs1799978,,,DRD2,Efficacy,1,risperidone,655387636.0,East Asian
1183697777,PA166154431,rs10501087,,,BDNF-AS,Efficacy,1,antipsychotics,1183697779.0,European
1183697777,PA166154431,rs10501087,,,BDNF-AS,Efficacy,1,antipsychotics,1183697780.0,European
1183959926,PA166157373,rs3213619,,,ABCB1,Dosage,-1,tacrolimus,1183959928.0,Unknown
1444706019,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1444706029.0,"Multiple groups, 74% Caucasian"
1444706019,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1444706035.0,"Multiple groups, 74% Caucasian"
1444706019,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1444706029.0,"Multiple groups, 74% Caucasian"
1444706019,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1444706035.0,"Multiple groups, 74% Caucasian"
1183959930,PA166156544,rs2231142,,,ABCG2,Dosage,-1,tacrolimus,1183959932.0,Unknown
1446901449,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,clomipramine,1446901460.0,European
1446901449,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,clomipramine,1446901460.0,European
1450933130,PA166156024,rs4680,,,COMT,Dosage,1,opioids,1450933134.0,Unknown
1449311146,PA166178794,rs146708960,,,ABCC4,Dosage,-1,mercaptopurine,1449311148.0,Near Eastern
1449311146,PA166178794,rs146708960,,,ABCC4,Dosage,-1,mercaptopurine,1449311149.0,Near Eastern
1449311146,PA166178794,rs146708960,,,ABCC4,Dosage,-1,methotrexate,1449311148.0,Near Eastern
1449311146,PA166178794,rs146708960,,,ABCC4,Dosage,-1,methotrexate,1449311149.0,Near Eastern
1448605357,PA166163444,rs8450,,,CRTC2,Toxicity,1,glucose,1448605363.0,European
1446901389,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,nortriptyline,1446901403.0,European
1446901389,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,nortriptyline,1446901403.0,European
827658659,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827659117.0,Unknown
1449311153,PA166154579,rs4149056,,,SLCO1B1,Dosage,1,mercaptopurine,1449311161.0,Near Eastern
1449311153,PA166154579,rs4149056,,,SLCO1B1,Dosage,1,mercaptopurine,1449311159.0,Near Eastern
1449311153,PA166154579,rs4149056,,,SLCO1B1,Dosage,1,methotrexate,1449311161.0,Near Eastern
1449311153,PA166154579,rs4149056,,,SLCO1B1,Dosage,1,methotrexate,1449311159.0,Near Eastern
1451146199,PA166209221,rs1800035,,,ADRA2A,Efficacy,1,dexmedetomidine,1451146220.0,East Asian
1451146199,PA166209221,rs1800035,,,ADRA2A,Efficacy,1,dexmedetomidine,1451146221.0,East Asian
1450376124,PA166182408,rs1277441,,,TAOK3,Dosage,1,morphine,1450376129.0,European
1450376124,PA166182408,rs1277441,,,TAOK3,Dosage,1,morphine,1450376127.0,European
1450376124,PA166182408,rs1277441,,,TAOK3,Dosage,1,morphine,1450376128.0,"Multiple groups, European Caucasian and African American patients"
1450376124,PA166182408,rs1277441,,,TAOK3,Dosage,1,morphine,1450376126.0,European
1450376124,PA166182408,rs1277441,,,TAOK3,Efficacy,1,morphine,1450376129.0,European
1450376124,PA166182408,rs1277441,,,TAOK3,Efficacy,1,morphine,1450376127.0,European
1450376124,PA166182408,rs1277441,,,TAOK3,Efficacy,1,morphine,1450376128.0,"Multiple groups, European Caucasian and African American patients"
1450376124,PA166182408,rs1277441,,,TAOK3,Efficacy,1,morphine,1450376126.0,European
982032363,PA166157749,rs2289658,,,NTRK2,Dosage,-1,methadone,982032369.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
982032363,PA166157749,rs2289658,,,NTRK2,Dosage,-1,methadone,982032370.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European patients."
1451146204,PA166209222,rs201376588,,,ADRA2A,Efficacy,1,dexmedetomidine,1451146209.0,East Asian
1451146204,PA166209222,rs201376588,,,ADRA2A,Efficacy,1,dexmedetomidine,1451146210.0,East Asian
1450933220,PA166156543,rs2231137,,,ABCG2,Dosage,1,imatinib,1450933244.0,Unknown
1450933220,PA166156543,rs2231137,,,ABCG2,Dosage,1,imatinib,1450933225.0,Unknown
1444705930,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444705944.0,Unknown
1444705930,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444705944.0,Unknown
1448261257,,,PA165818750,CYP2B6*1,CYP2B6,Dosage,0,efavirenz,1448261269.0,"Multiple groups, Japanese, other Asian or ""other"""
1448261257,,,PA165818762,CYP2B6*6,CYP2B6,Dosage,0,efavirenz,1448261269.0,"Multiple groups, Japanese, other Asian or ""other"""
1448261257,,,PA165818788,CYP2B6*26,CYP2B6,Dosage,0,efavirenz,1448261269.0,"Multiple groups, Japanese, other Asian or ""other"""
982032312,PA166157742,rs2120266,,,NTRK2,Dosage,-1,methadone,982032321.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European patients."
982032312,PA166157742,rs2120266,,,NTRK2,Dosage,-1,methadone,982032320.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1445164685,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,tacrolimus,1445164699.0,East Asian
1445164685,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,tacrolimus,1445164699.0,East Asian
1444705951,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444705953.0,Unknown
1444705951,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444705953.0,Unknown
1448097395,PA166153953,rs717620,,,ABCC2,Efficacy,1,tamoxifen,1448097401.0,East Asian
1446901379,,,PA165988479,CYP2D6*1xN,CYP2D6,Dosage,0,nortriptyline,1446901387.0,European
1446901379,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,0,nortriptyline,1446901387.0,European
1446901379,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,0,nortriptyline,1446901387.0,European
1446901379,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,0,nortriptyline,1446901387.0,European
1183959993,PA166154673,rs6311,,,HTR2A,Efficacy,1,fluvoxamine,1183960003.0,East Asian
1183959993,PA166154673,rs6311,,,HTR2A,Efficacy,1,fluvoxamine,1183959997.0,East Asian
1183959993,PA166154673,rs6311,,,HTR2A,Efficacy,1,fluvoxamine,1183960001.0,East Asian
1183959993,PA166154673,rs6311,,,HTR2A,Efficacy,1,fluvoxamine,1183959999.0,East Asian
1447982703,PA166154473,rs35705950,,,MUC5B,Efficacy,-1,acetylcysteine,1447982705.0,European
1446901329,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,clomipramine,1446901341.0,European
1446901329,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,clomipramine,1446901341.0,European
1449147375,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,clozapine,1449147383.0,East Asian
1450376200,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450376208.0,Multiple groups
1448261213,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,0,clopidogrel,1448261224.0,East Asian
1448261213,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,0,clopidogrel,1448261224.0,East Asian
1448261213,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,0,clopidogrel,1448261224.0,East Asian
1448261213,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,0,prasugrel,1448261224.0,East Asian
1448261213,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,0,prasugrel,1448261224.0,East Asian
1448261213,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,0,prasugrel,1448261224.0,East Asian
655387562,PA166153959,rs1057910,,,CYP2C9,Dosage,-1,warfarin,655387564.0,Multiple groups
1183697961,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183697965.0,East Asian
1444705842,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1444705844.0,Unknown
1447982696,PA166154413,rs5743854,,,TOLLIP,Efficacy,-1,acetylcysteine,1447982698.0,European
1444935225,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444935233.0,European
1451211800,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,SN-38,1451211807.0,Unknown
1451211800,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,SN-38,1451211807.0,Unknown
1183697956,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183697960.0,East Asian
1445164614,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,tacrolimus,1445164620.0,East Asian
1447982668,PA166154415,rs5743894,,,TOLLIP,Efficacy,-1,acetylcysteine,1447982670.0,European
1447982668,PA166154415,rs5743894,,,TOLLIP,Efficacy,-1,acetylcysteine,1447982670.0,European
1449147388,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,clozapine,1449147396.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697943.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697945.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697947.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697949.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697951.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697953.0,East Asian
1183697938,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183697955.0,East Asian
1447982682,PA166154414,rs5743890,,,TOLLIP,Efficacy,-1,acetylcysteine,1447982684.0,European
1449147400,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,clozapine,1449147402.0,East Asian
1449147400,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,clozapine,1449147402.0,East Asian
1449147400,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,clozapine,1449147402.0,East Asian
1449311234,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,repaglinide,1449311239.0,East Asian
1449311234,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,repaglinide,1449311241.0,East Asian
1451129840,PA166156708,rs6295,,,HTR1A,Efficacy,1,lurasidone,1451129861.0,European
1451129840,PA166156708,rs6295,,,HTR1A,Efficacy,1,lurasidone,1451129860.0,European
1183697916,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,axitinib,1183697920.0,Multiple groups
1445164635,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,tacrolimus,1445164637.0,East Asian
1451097080,PA166157761,rs3132291,,,RXRA,Metabolism/PK,1,docetaxel,1451097042.0,East Asian
1451097080,PA166157761,rs3132291,,,RXRA,Metabolism/PK,1,docetaxel,1451097085.0,East Asian
1451097080,PA166157761,rs3132291,,,RXRA,Metabolism/PK,1,docetaxel,1451097100.0,East Asian
1451097080,PA166157761,rs3132291,,,RXRA,Metabolism/PK,1,docetaxel,1451097042.0,East Asian
1451097080,PA166157761,rs3132291,,,RXRA,Metabolism/PK,1,docetaxel,1451097085.0,East Asian
1451097080,PA166157761,rs3132291,,,RXRA,Metabolism/PK,1,docetaxel,1451097100.0,East Asian
1448261184,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,0,clopidogrel,,
1448261184,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,0,clopidogrel,,
1448261184,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,0,clopidogrel,,
1445164625,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1445164627.0,East Asian
1445164625,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1445164627.0,East Asian
1445164647,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445164659.0,East Asian
1445164647,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445164659.0,East Asian
1450376218,PA166153848,rs12083537,,,IL6R,Efficacy,1,tocilizumab,1450376224.0,Unknown
1450376218,PA166153848,rs12083537,,,IL6R,Efficacy,1,tocilizumab,1450376228.0,Multiple groups
1450933245,PA166156544,rs2231142,,,ABCG2,Dosage,-1,imatinib,1450933250.0,Unknown
1450933245,PA166156544,rs2231142,,,ABCG2,Dosage,-1,imatinib,1450933251.0,Unknown
1450933245,PA166156544,rs2231142,,,ABCG2,Dosage,-1,imatinib,1450933252.0,Unknown
1446901309,,,PA165988479,CYP2D6*1xN,CYP2D6,Dosage,0,clomipramine,1446901328.0,European
1446901309,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,0,clomipramine,1446901328.0,European
1446901309,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,0,clomipramine,1446901328.0,European
1446901309,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,0,clomipramine,1446901328.0,European
981344263,PA166157829,rs11144870,,,RFK,Efficacy,-1,citalopram,981344269.0,European
981344263,PA166157829,rs11144870,,,RFK,Efficacy,-1,citalopram,981344280.0,European
981344263,PA166157829,rs11144870,,,RFK,Efficacy,-1,escitalopram,981344269.0,European
981344263,PA166157829,rs11144870,,,RFK,Efficacy,-1,escitalopram,981344280.0,European
1451129862,PA166156708,rs6295,,,HTR1A,Efficacy,-1,lurasidone,1451129867.0,African American/Afro-Caribbean
1451129862,PA166156708,rs6295,,,HTR1A,Efficacy,-1,lurasidone,1451129868.0,African American/Afro-Caribbean
1444705777,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1444705779.0,European
1444705777,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1444705779.0,European
1444705777,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,1444705779.0,European
1444705777,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,1444705779.0,European
1447982629,PA166154399,rs3750920,,,TOLLIP,Efficacy,1,acetylcysteine,1447982649.0,European
1450933341,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,sertraline,1450933347.0,European
1450933341,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,sertraline,1450933347.0,European
1450933341,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,sertraline,1450933347.0,European
1451293800,PA166226741,rs885814,,,ALPL,Efficacy,1,adalimumab,1451293805.0,European
1451293800,PA166226741,rs885814,,,ALPL,Efficacy,1,certolizumab pegol,1451293805.0,European
1451293800,PA166226741,rs885814,,,ALPL,Efficacy,1,etanercept,1451293805.0,European
1451293800,PA166226741,rs885814,,,ALPL,Efficacy,1,infliximab,1451293805.0,European
1451293800,PA166226741,rs885814,,,ALPL,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451293805.0,European
1451097180,PA166155011,rs1136703,,,SULT1A2,Metabolism/PK,1,4-hydroxytamoxifen,1451097185.0,Unknown
1451097180,PA166155011,rs1136703,,,SULT1A2,Metabolism/PK,1,4-hydroxytamoxifen,1451097200.0,Unknown
1451097180,PA166155011,rs1136703,,,SULT1A2,Metabolism/PK,1,endoxifen,1451097185.0,Unknown
1451097180,PA166155011,rs1136703,,,SULT1A2,Metabolism/PK,1,endoxifen,1451097200.0,Unknown
1451359324,PA166156714,rs27072,,,SLC6A3,Dosage,-1,heroin,1451359329.0,East Asian
1450933348,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,sertraline,1450933353.0,European
1450933348,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,sertraline,1450933353.0,European
655387863,PA166157460,rs12721627,,,CYP3A,Dosage,-1,paclitaxel,655387868.0,East Asian
655387863,PA166157460,rs12721627,,,CYP3A4,Dosage,-1,paclitaxel,655387868.0,East Asian
655387863,PA166157460,rs12721627,,,CYP3A,Metabolism/PK,-1,paclitaxel,655387868.0,East Asian
655387863,PA166157460,rs12721627,,,CYP3A4,Metabolism/PK,-1,paclitaxel,655387868.0,East Asian
1451359330,PA166233882,rs1042098,,,SLC6A3,Dosage,-1,heroin,1451359335.0,East Asian
1444705804,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444705810.0,Latino
1444705804,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444705810.0,Latino
1444705804,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705810.0,Latino
1444705804,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705810.0,Latino
1296666368,PA166155711,rs3792269,,,CAPN10,Efficacy,1,metformin,1296666379.0,Unknown
1296666368,PA166155711,rs3792269,,,CAPN10,Efficacy,1,metformin,1296666385.0,Unknown
1183698005,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1183698009.0,East Asian
1183698005,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1183698009.0,East Asian
1447982613,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,nicotine,1447982623.0,African American/Afro-Caribbean
1447982613,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,0,nicotine,1447982623.0,African American/Afro-Caribbean
1447982613,,,PA165924756,CYP2A6*26,CYP2A6,Metabolism/PK,0,nicotine,1447982623.0,African American/Afro-Caribbean
1450933302,PA166156808,rs2631372,,,SLC22A5,Dosage,-1,imatinib,1450933309.0,Unknown
1450933302,PA166156808,rs2631372,,,SLC22A5,Dosage,-1,imatinib,1450933308.0,Unknown
1450933302,PA166156808,rs2631372,,,SLC22A5,Dosage,-1,imatinib,1450933307.0,Unknown
1448261123,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1448261123,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,endoxifen,1448261125.0,Multiple groups
1451359283,PA166233884,rs12666409,,,DDC,Dosage,-1,heroin,1451359288.0,East Asian
1450933310,PA166156933,rs628031,,,SLC22A1,Dosage,-1,imatinib,1450933317.0,Unknown
1450933310,PA166156933,rs628031,,,SLC22A1,Dosage,-1,imatinib,1450933316.0,Unknown
1450933310,PA166156933,rs628031,,,SLC22A1,Dosage,-1,imatinib,1450933315.0,Unknown
1449163874,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,1449163895.0,Multiple groups
1449163874,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,1449163882.0,Multiple groups
1449163874,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,1449163879.0,Multiple groups
1449163874,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,1449163893.0,Multiple groups
1449163874,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,1449163899.0,Multiple groups
1449163874,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,1449163897.0,Multiple groups
981934126,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,981934134.0,Unknown
1296666350,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1296666357.0,European
1183697971,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183697975.0,East Asian
1184468132,,,PA165955500,HLA-B*38:01:01,HLA-B,Efficacy,1,peginterferon alfa-2a,1184468138.0,Near Eastern
1184468132,,,PA165955500,HLA-B*38:01:01,HLA-B,Efficacy,1,peginterferon alfa-2b,1184468138.0,Near Eastern
1184468132,,,PA165955500,HLA-B*38:01:01,HLA-B,Efficacy,1,ribavirin,1184468138.0,Near Eastern
1450933318,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,sertraline,1450933328.0,European
1450933318,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,sertraline,1450933328.0,European
1450933318,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,sertraline,1450933328.0,European
1451359381,PA166156709,rs6347,,,SLC6A3,Dosage,-1,heroin,1451359366.0,East Asian
1183681696,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681702.0,Unknown
1183681696,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681716.0,Unknown
1183681696,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681718.0,Unknown
1444705709,PA166154333,rs1792774,,,CARD16,Efficacy,1,peginterferon alfa-2b,1444705711.0,Multiple groups
1444705709,PA166154333,rs1792774,,,CARD16,Efficacy,1,ribavirin,1444705711.0,Multiple groups
1450376330,PA166154972,rs5569,,,SLC6A2,Efficacy,1,methylphenidate,1450376336.0,East Asian
1450933392,PA166157284,rs1045642,,,ABCB1,Dosage,-1,imatinib,1450933399.0,Unknown
1450933392,PA166157284,rs1045642,,,ABCB1,Dosage,-1,imatinib,1450933398.0,Unknown
1450933392,PA166157284,rs1045642,,,ABCB1,Dosage,-1,imatinib,1450933397.0,Unknown
1444705718,PA166157842,rs17461620,,,TUT7,Efficacy,1,peginterferon alfa-2b,1444705721.0,Multiple groups
1444705718,PA166157842,rs17461620,,,TUT7,Efficacy,1,ribavirin,1444705721.0,Multiple groups
1296666342,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,1,methotrexate,1296666349.0,European
1296666342,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,1,methotrexate,1296666349.0,European
1296666342,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,1,methotrexate,1296666349.0,European
1296666342,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,1,methotrexate,1296666349.0,European
1296666342,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,1,methotrexate,1296666349.0,European
1296666342,PA166154069,rs4948496,,,ARID5B,Metabolism/PK,1,methotrexate,1296666349.0,European
1444672955,PA166154249,rs1695,,,GSTP1,Efficacy,-1,imatinib,1444672957.0,Unknown
1447982567,PA166156637,rs10011796,,,ABCG2,Efficacy,-1,allopurinol,1447982569.0,"Multiple groups, 53% White, 42% Polynesian (Maori), 5% Asian"
1450933400,PA166157279,rs868755,,,ABCB1,Dosage,-1,imatinib,1450933407.0,Unknown
1450933400,PA166157279,rs868755,,,ABCB1,Dosage,-1,imatinib,1450933405.0,Unknown
1450933400,PA166157279,rs868755,,,ABCB1,Dosage,-1,imatinib,1450933406.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681710.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681705.0,Unknown
1183681703,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,methotrexate,1183681714.0,Unknown
1449147520,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,buprenorphine,1449147564.0,Unknown
1450933408,PA166156750,rs1050152,,,SLC22A4,Dosage,-1,imatinib,1450933414.0,Unknown
1450933408,PA166156750,rs1050152,,,SLC22A4,Dosage,-1,imatinib,1450933415.0,Unknown
1450933408,PA166156750,rs1050152,,,SLC22A4,Dosage,-1,imatinib,1450933413.0,Unknown
1449163901,PA166154874,rs2069514,,,CYP1A2,Metabolism/PK,-1,caffeine,1449163907.0,Multiple groups
1447982552,PA166156544,rs2231142,,,ABCG2,Efficacy,1,allopurinol,1447982558.0,"Multiple groups, 53% White, 42% Polynesian (Maori), 5% Asian"
1183960204,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,1183960206.0,Unknown
1449163913,PA166154877,rs2069526,,,CYP1A2,Metabolism/PK,-1,caffeine,1449163915.0,Multiple groups
1450933416,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,imatinib,1450933421.0,Unknown
1450933416,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,imatinib,1450933422.0,Unknown
1450933416,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,imatinib,1450933423.0,Unknown
1183960210,PA166156544,rs2231142,,,ABCG2,Dosage,-1,tacrolimus,1183960212.0,Unknown
1449163908,PA166154944,rs35694136,,,CYP1A2,Metabolism/PK,-1,caffeine,1449163910.0,Multiple groups
1449163908,PA166154944,rs35694136,,,CYP1A2,Metabolism/PK,-1,caffeine,1449163910.0,Multiple groups
1449163908,PA166154944,rs35694136,,,CYP1A2,Metabolism/PK,-1,caffeine,1449163910.0,Multiple groups
1451097203,PA166154367,rs2306168,,,SLCO2B1,Dosage,-1,glyburide,1451097226.0,East Asian
1451097203,PA166154367,rs2306168,,,SLCO2B1,Dosage,-1,rosuvastatin,1451097226.0,East Asian
1451097203,PA166154367,rs2306168,,,SLCO2B1,Dosage,-1,sulfasalazine,1451097226.0,East Asian
982032504,PA166157779,rs4877900,,,NTRK2,Dosage,-1,methadone,982032510.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1183960200,PA166157373,rs3213619,,,ABCB1,Dosage,-1,tacrolimus,1183960202.0,Unknown
1183960200,PA166157373,rs3213619,,,ABCB1,Dosage,-1,tacrolimus,1183960202.0,Unknown
1447949757,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1447949759.0,East Asian
1447949757,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1447949759.0,East Asian
1449163918,PA166154893,rs2470890,,,CYP1A2,Metabolism/PK,-1,caffeine,1449163920.0,Multiple groups
1448261067,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1448261067,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1448261122.0,Multiple groups
1447359923,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,,
1447359923,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,,
1447359923,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,clopidogrel,,
1449000085,PA166156991,rs1799971,,,OPRM1,Dosage,1,oxycodone,1449000091.0,Unknown
1447949770,PA166157267,rs776746,,,CYP3A5,Efficacy,1,clopidogrel,1447949772.0,East Asian
1447949744,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1447949746.0,East Asian
1447949744,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1447949746.0,East Asian
1183960183,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1183960185.0,Unknown
1444705756,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705762.0,European
1444705756,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705762.0,European
1444705756,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705762.0,European
1444705756,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705762.0,European
1444705763,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705765.0,European
1444705763,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705765.0,European
1444705763,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705765.0,European
1444705763,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705765.0,European
1444935134,PA166156932,rs622342,,,SLC22A1,Efficacy,1,metformin,1444935140.0,Central/South Asian
982032521,PA166154420,rs7118900,,,ANKK1,Dosage,-1,methadone,982032528.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European patients."
982032521,PA166154420,rs7118900,,,ANKK1,Dosage,-1,methadone,982032527.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1183960187,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1183960189.0,Unknown
1450376345,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376351.0,Unknown
1448261039,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1448261041.0,European
1448261039,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1448261041.0,European
1448261039,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1448261041.0,European
1448261039,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1448261041.0,European
1448261039,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1448261041.0,European
1448261039,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1448261041.0,European
1450376338,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376344.0,Multiple groups
1451359361,PA166208983,rs10770140,,,TH,Dosage,-1,heroin,1451359380.0,East Asian
1183960177,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,1183960179.0,Unknown
1451097220,PA166155007,rs1059491,,,SULT1A2,Metabolism/PK,1,4-hydroxytamoxifen,1451097201.0,Unknown
1451097220,PA166155007,rs1059491,,,SULT1A2,Metabolism/PK,1,4-hydroxytamoxifen,1451097225.0,Unknown
1451097220,PA166155007,rs1059491,,,SULT1A2,Metabolism/PK,1,endoxifen,1451097201.0,Unknown
1451097220,PA166155007,rs1059491,,,SULT1A2,Metabolism/PK,1,endoxifen,1451097225.0,Unknown
1450933384,PA166185803,rs6935207,,,SLC22A1,Dosage,-1,imatinib,1450933391.0,Unknown
1450933384,PA166185803,rs6935207,,,SLC22A1,Dosage,-1,imatinib,1450933389.0,Unknown
1450933384,PA166185803,rs6935207,,,SLC22A1,Dosage,-1,imatinib,1450933390.0,Unknown
1447949731,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,clopidogrel,1447949733.0,East Asian
1447949731,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,clopidogrel,1447949733.0,East Asian
1449147567,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,buprenorphine,1449147569.0,Unknown
1450376393,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376399.0,Unknown
1450376393,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376399.0,Unknown
1450376393,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376399.0,Unknown
1450376393,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376399.0,Unknown
1450376393,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376399.0,Unknown
1449311406,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,repaglinide,1449311413.0,East Asian
1449311406,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,repaglinide,1449311450.0,East Asian
1449311406,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,repaglinide,1449311452.0,East Asian
1451097300,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,morphine,1451097306.0,"Multiple groups, ""majority Central Europeans, 9 subjects from Turkey, and 1 subject each from the Ukraine, Syria, Tunisia, Dubai, and Asia"""
1450376375,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376381.0,Multiple groups
1450376375,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376381.0,Multiple groups
1450933468,PA166185815,rs1800812,,,PDGFRA,Dosage,-1,imatinib,1450933474.0,Unknown
1450933468,PA166185815,rs1800812,,,PDGFRA,Dosage,-1,imatinib,1450933475.0,Unknown
1450933468,PA166185815,rs1800812,,,PDGFRA,Dosage,-1,imatinib,1450933473.0,Unknown
1451097314,PA166157206,rs55918055,,,SLC22A1,Metabolism/PK,1,morphine,1451097340.0,"Multiple groups, ""majority Central Europeans, 9 subjects from Turkey, and 1 subject each from the Ukraine, Syria, Tunisia, Dubai, and Asia"""
1444705660,PA166154330,rs1503391,,,CARD16,Efficacy,1,peginterferon alfa-2b,1444705663.0,Multiple groups
1444705660,PA166154330,rs1503391,,,CARD16,Efficacy,1,ribavirin,1444705663.0,Multiple groups
1451097308,PA166157216,rs72552763,,,SLC22A1,Metabolism/PK,1,morphine,1451097320.0,"Multiple groups, ""majority Central Europeans, 9 subjects from Turkey, and 1 subject each from the Ukraine, Syria, Tunisia, Dubai, and Asia"""
1447949708,PA166157345,rs2242480,,,CYP3A4,Efficacy,-1,clopidogrel,1447949714.0,East Asian
1448261019,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1448261019,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1448261019,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1448261019,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1448261019,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1448261019,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1448261019,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1448261021.0,European
1449147581,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,buprenorphine,1449147583.0,Unknown
1449311435,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,conjugated estrogens,1449311437.0,Unknown
1451359466,PA166233887,rs5320,,,DBH,Dosage,-1,heroin,1451359471.0,East Asian
1450933478,PA166185817,rs1800813,,,PDGFRA,Dosage,-1,imatinib,1450933484.0,Unknown
1450933478,PA166185817,rs1800813,,,PDGFRA,Dosage,-1,imatinib,1450933483.0,Unknown
1450933478,PA166185817,rs1800813,,,PDGFRA,Dosage,-1,imatinib,1450933485.0,Unknown
1444672903,PA166156455,rs13064411,,,CFAP44,Efficacy,1,hmg coa reductase inhibitors,1444672908.0,Unknown
1447949723,PA166153987,rs1934980,,,CYP2C8,Efficacy,-1,clopidogrel,1447949725.0,East Asian
1447949723,PA166153987,rs1934980,,,CYP2C8,Efficacy,-1,clopidogrel,1447949725.0,East Asian
1447949723,PA166153987,rs1934980,,,CYP2C8,Efficacy,-1,clopidogrel,1447949725.0,East Asian
1451293920,PA166155829,rs13393173,,,CERS6,Efficacy,1,adalimumab,1451293867.0,European
1451293920,PA166155829,rs13393173,,,CERS6,Efficacy,1,certolizumab pegol,1451293867.0,European
1451293920,PA166155829,rs13393173,,,CERS6,Efficacy,1,etanercept,1451293867.0,European
1451293920,PA166155829,rs13393173,,,CERS6,Efficacy,1,infliximab,1451293867.0,European
1451293920,PA166155829,rs13393173,,,CERS6,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451293867.0,European
1449147591,PA166156619,rs7439366,,,UGT2B7,Efficacy,-1,buprenorphine,1449147593.0,Unknown
1444705674,PA166154278,rs557905,,,CASP1,Efficacy,1,peginterferon alfa-2b,1444705677.0,Multiple groups
1444705674,PA166154278,rs557905,,,CASP1,Efficacy,1,ribavirin,1444705677.0,Multiple groups
1447949716,PA166154160,rs17110453,,,CYP2C8,Efficacy,-1,clopidogrel,1447949718.0,East Asian
1451113700,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451113720.0,"Multiple groups, Caucasian, African American and Other ethnicities."
655387714,PA166154127,rs11188072,,,CYP2C19,Dosage,1,mephenytoin,655387716.0,Sub-Saharan African
655387714,PA166154127,rs11188072,,,CYP2C19,Metabolism/PK,1,mephenytoin,655387716.0,Sub-Saharan African
655387711,PA166154127,rs11188072,,,CYP2C19,Dosage,1,omeprazole,655387713.0,European
655387711,PA166154127,rs11188072,,,CYP2C19,Metabolism/PK,1,omeprazole,655387713.0,European
1444705683,PA166154280,rs568910,,,CASP1,Efficacy,1,peginterferon alfa-2b,1444705685.0,Multiple groups
1444705683,PA166154280,rs568910,,,CASP1,Efficacy,1,ribavirin,1444705685.0,Multiple groups
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935099.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935056.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444935057.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935099.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935056.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444935057.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935099.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935056.0,Unknown
1444935054,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444935057.0,Unknown
1450933424,PA166157286,rs1057868,,,POR,Dosage,-1,imatinib,1450933431.0,Unknown
1450933424,PA166157286,rs1057868,,,POR,Dosage,-1,imatinib,1450933430.0,Unknown
1450933424,PA166157286,rs1057868,,,POR,Dosage,-1,imatinib,1450933429.0,Unknown
1451293868,PA166226862,rs17301249,,,EYA4,Efficacy,1,adalimumab,1451293873.0,European
1451293868,PA166226862,rs17301249,,,EYA4,Efficacy,1,certolizumab pegol,1451293873.0,European
1451293868,PA166226862,rs17301249,,,EYA4,Efficacy,1,etanercept,1451293873.0,European
1451293868,PA166226862,rs17301249,,,EYA4,Efficacy,1,infliximab,1451293873.0,European
1451293868,PA166226862,rs17301249,,,EYA4,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451293873.0,European
1450376415,PA166154972,rs5569,,,SLC6A2,Efficacy,0,methylphenidate,1450376421.0,Unknown
1448260990,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1448261018.0,European
1448260990,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1448261018.0,European
1448260990,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1448261018.0,European
1448260990,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1448261018.0,European
1448260990,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1448261018.0,European
1448260990,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1448261018.0,European
655387719,PA166154147,rs12248560,,,CYP2C19,Dosage,1,mephenytoin,655387723.0,Sub-Saharan African
655387719,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,1,mephenytoin,655387723.0,Sub-Saharan African
1444705691,PA166155047,rs3093390,,,IL21R,Efficacy,1,peginterferon alfa-2b,1444705694.0,Multiple groups
1444705691,PA166155047,rs3093390,,,IL21R,Efficacy,1,ribavirin,1444705694.0,Multiple groups
655387718,PA166154147,rs12248560,,,CYP2C19,Dosage,1,omeprazole,655387721.0,European
655387718,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,1,omeprazole,655387721.0,European
1444672922,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,1,imatinib,1444672932.0,Unknown
1444672922,,,PA166048678,GSTT1 null,GSTT1,Efficacy,1,imatinib,1444672932.0,Unknown
1449311443,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,conjugated estrogens,1449311445.0,Unknown
1450933432,PA166153953,rs717620,,,ABCC2,Dosage,-1,imatinib,1450933439.0,Unknown
1450933432,PA166153953,rs717620,,,ABCC2,Dosage,-1,imatinib,1450933438.0,Unknown
1450933432,PA166153953,rs717620,,,ABCC2,Dosage,-1,imatinib,1450933437.0,Unknown
1450933432,PA166153953,rs717620,,,ABCC2,Dosage,-1,imatinib,1450933439.0,Unknown
1450933432,PA166153953,rs717620,,,ABCC2,Dosage,-1,imatinib,1450933438.0,Unknown
1450933432,PA166153953,rs717620,,,ABCC2,Dosage,-1,imatinib,1450933437.0,Unknown
1450933440,PA166154855,rs1048943,,,CYP1A1,Dosage,-1,imatinib,1450933446.0,Unknown
1450933440,PA166154855,rs1048943,,,CYP1A1,Dosage,-1,imatinib,1450933445.0,Unknown
1450933440,PA166154855,rs1048943,,,CYP1A1,Dosage,-1,imatinib,1450933447.0,Unknown
1449311453,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,glucose,1449311456.0,East Asian
1449311453,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,glucose,1449311457.0,East Asian
1449311453,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,glucose,1449311455.0,East Asian
1451359420,PA166154434,rs10770141,,,TH,Dosage,-1,heroin,1451359425.0,East Asian
982032576,PA166154364,rs2283265,,,DRD2,Dosage,-1,methadone,982032582.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1449311464,PA166154259,rs6265,,,BDNF,Efficacy,-1,escitalopram,1449311470.0,East Asian
1449311464,PA166154259,rs6265,,,BDNF,Efficacy,-1,escitalopram,1449311472.0,East Asian
1444672939,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,imatinib,1444672941.0,Unknown
1444672939,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,imatinib,1444672941.0,Unknown
1450933448,PA166154583,rs4149117,,,SLCO1B3,Dosage,-1,imatinib,1450933453.0,Unknown
1450933448,PA166154583,rs4149117,,,SLCO1B3,Dosage,-1,imatinib,1450933454.0,Unknown
1450933448,PA166154583,rs4149117,,,SLCO1B3,Dosage,-1,imatinib,1450933455.0,Unknown
1451359426,PA166209042,rs3842727,,,TH,Dosage,-1,heroin,1451359431.0,East Asian
655387811,PA166155290,rs2853539,,,TYMS,Efficacy,1,methotrexate,655387814.0,Central/South Asian
655387811,PA166155290,rs2853539,,,TYMS,Efficacy,1,methotrexate,655387814.0,Central/South Asian
1447949684,PA166157316,rs2032582,,,ABCB1,Efficacy,1,atorvastatin,1447949686.0,Central/South Asian
1451097360,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,morphine,1451097319.0,"Multiple groups, ""majority Central Europeans, 9 subjects from Turkey, and 1 subject each from the Ukraine, Syria, Tunisia, Dubai, and Asia"""
1447949667,PA166157595,rs3808607,,,CYP7A1,Efficacy,1,atorvastatin,1447949675.0,Central/South Asian
1444934961,PA166156617,rs7438135,,,UGT2B7,Metabolism/PK,1,morphine,1444934966.0,Unknown
1444607282,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,1444607288.0,European
1444607282,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,1444607288.0,European
1450933522,PA166156553,rs2305948,,,KDR,Dosage,-1,imatinib,1450933527.0,Unknown
1450933522,PA166156553,rs2305948,,,KDR,Dosage,-1,imatinib,1450933528.0,Unknown
1444705585,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705587.0,Multiple groups
1444705585,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705587.0,Multiple groups
1451359501,PA166156714,rs27072,,,SLC6A3,Dosage,-1,methadone,1451359520.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,amisulpride,981476195.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,amisulpride,981476197.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,amisulpride,981475613.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,antipsychotics,981476195.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,antipsychotics,981476197.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,antipsychotics,981475613.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,olanzapine,981476195.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,olanzapine,981476197.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,olanzapine,981475613.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,quetiapine,981476195.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,quetiapine,981476197.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,quetiapine,981475613.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,risperidone,981476195.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,risperidone,981476197.0,East Asian
981475608,PA166156855,rs10042486,,,HTR1A,Efficacy,1,risperidone,981475613.0,East Asian
1449311473,PA166154418,rs7103411,,,BDNF,Efficacy,-1,escitalopram,1449311475.0,East Asian
1449311473,PA166154418,rs7103411,,,BDNF,Efficacy,-1,escitalopram,1449311476.0,East Asian
1450933529,PA166156985,rs1570360,,,VEGFA,Dosage,-1,imatinib,1450933535.0,Unknown
1450933529,PA166156985,rs1570360,,,VEGFA,Dosage,-1,imatinib,1450933536.0,Unknown
1450933529,PA166156985,rs1570360,,,VEGFA,Dosage,-1,imatinib,1450933534.0,Unknown
1449311492,PA166154329,rs1491850,,,None,Efficacy,-1,escitalopram,1449311494.0,East Asian
1451113763,PA166198081,rs1294092,,,OPRM1,Efficacy,-1,naltrexone,1451113780.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1450933537,PA166157006,rs2010963,,,VEGFA,Dosage,-1,imatinib,1450933544.0,Unknown
1450933537,PA166157006,rs2010963,,,VEGFA,Dosage,-1,imatinib,1450933543.0,Unknown
1450933537,PA166157006,rs2010963,,,VEGFA,Dosage,-1,imatinib,1450933542.0,Unknown
1451343133,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1451343140.0,Unknown
1451343133,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1451343141.0,Unknown
1451343133,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1451343140.0,Unknown
1451343133,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1451343141.0,Unknown
1451359521,PA166233885,rs129882,,,DBH,Dosage,-1,methadone,1451359526.0,East Asian
1450933545,PA166156906,rs25648,,,VEGFA,Dosage,-1,imatinib,1450933550.0,Unknown
1450933545,PA166156906,rs25648,,,VEGFA,Dosage,-1,imatinib,1450933551.0,Unknown
1450933545,PA166156906,rs25648,,,VEGFA,Dosage,-1,imatinib,1450933552.0,Unknown
1449164032,PA166176701,rs11168292,,,VDR,Dosage,1,warfarin,1449164034.0,European
1450376486,PA166155036,rs2242446,,,SLC6A2,Efficacy,-1,methylphenidate,1450376492.0,Unknown
981475566,PA166155631,rs1344706,,,ZNF804A,Efficacy,1,antipsychotics,981475580.0,European
981475566,PA166155631,rs1344706,,,ZNF804A,Efficacy,1,antipsychotics,981476211.0,European
1450933489,PA166185819,rs2228230,,,PDGFRA,Dosage,-1,imatinib,1450933494.0,Unknown
1450933489,PA166185819,rs2228230,,,PDGFRA,Dosage,-1,imatinib,1450933495.0,Unknown
1450933489,PA166185819,rs2228230,,,PDGFRA,Dosage,-1,imatinib,1450933496.0,Unknown
1450376478,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376484.0,Unknown
1451113721,PA166184699,rs10485057,,,OPRM1,Efficacy,-1,naltrexone,1451113740.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1449147673,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1449147681.0,Unknown
1450933497,PA166156682,rs35597368,,,PDGFRA,Dosage,-1,imatinib,1450933502.0,Unknown
1450933497,PA166156682,rs35597368,,,PDGFRA,Dosage,-1,imatinib,1450933503.0,Unknown
1450933497,PA166156682,rs35597368,,,PDGFRA,Dosage,-1,imatinib,1450933504.0,Unknown
982032649,PA166156928,rs558025,,,OPRM1,Dosage,-1,methadone,982032654.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1183960311,PA166157529,rs121908755,,,CFTR,Efficacy,0,ivacaftor,1183960315.0,Unknown
1448604982,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,0,dextromethorphan,1448604984.0,Unknown
1448604982,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,0,dextromethorphan,1448604984.0,Unknown
1450933505,PA166156528,rs1870377,,,KDR,Dosage,-1,imatinib,1450933512.0,Unknown
1450933505,PA166156528,rs1870377,,,KDR,Dosage,-1,imatinib,1450933511.0,Unknown
1450933505,PA166156528,rs1870377,,,KDR,Dosage,-1,imatinib,1450933510.0,Unknown
1450933505,PA166156528,rs1870377,,,KDR,Dosage,-1,imatinib,1450933512.0,Unknown
1450933505,PA166156528,rs1870377,,,KDR,Dosage,-1,imatinib,1450933511.0,Unknown
1450933505,PA166156528,rs1870377,,,KDR,Dosage,-1,imatinib,1450933510.0,Unknown
1450376462,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376470.0,Unknown
1449164073,PA166153711,rs2501873,,,NR1I3,Dosage,-1,warfarin,1449164079.0,European
1448604972,,,PA165971565,CYP2D6*12,CYP2D6,Metabolism/PK,0,dextromethorphan,1448604979.0,Unknown
1448604972,,,PA166123324,CYP2D6*84,CYP2D6,Metabolism/PK,0,dextromethorphan,1448604979.0,Unknown
1450933513,PA166156537,rs2071559,,,KDR,Dosage,-1,imatinib,1450933518.0,Unknown
1450933513,PA166156537,rs2071559,,,KDR,Dosage,-1,imatinib,1450933519.0,Unknown
1450933513,PA166156537,rs2071559,,,KDR,Dosage,-1,imatinib,1450933520.0,Unknown
982047065,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,982047067.0,Near Eastern
982047065,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,982047067.0,Near Eastern
1451359577,PA166154263,rs6356,,,TH,Dosage,-1,methadone,1451359622.0,East Asian
982047062,PA166156969,rs1041981,,,LTA,Efficacy,-1,rituximab,982047075.0,European
827807783,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,827807786.0,Multiple groups
827807783,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,827807786.0,Multiple groups
827807783,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,827807786.0,Multiple groups
827807783,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,827807786.0,Multiple groups
827807783,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,827807786.0,Multiple groups
827807783,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,827807786.0,Multiple groups
827807783,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,827807786.0,Multiple groups
827807783,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,827807786.0,Multiple groups
827807783,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,827807786.0,Multiple groups
827807783,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,827807786.0,Multiple groups
827807783,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,827807786.0,Multiple groups
827807783,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,827807786.0,Multiple groups
827807783,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,827807786.0,Multiple groups
827807783,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,827807786.0,Multiple groups
827807783,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,827807786.0,Multiple groups
1444705520,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705522.0,East Asian
1444705520,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705522.0,East Asian
1450933585,PA166153973,rs1799939,,,RET,Dosage,-1,imatinib,1450933591.0,Unknown
1450933585,PA166153973,rs1799939,,,RET,Dosage,-1,imatinib,1450933590.0,Unknown
1450933585,PA166153973,rs1799939,,,RET,Dosage,-1,imatinib,1450933592.0,Unknown
1450376521,PA166179993,rs553668,,,ADRA2A,Efficacy,-1,methylphenidate,1450376523.0,Unknown
1451113806,PA166157015,rs2075572,,,OPRM1,Efficacy,-1,naltrexone,1451113811.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1444705526,PA166155429,rs7248668,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705528.0,East Asian
1444705526,PA166155429,rs7248668,,,IFNL3,Efficacy,1,ribavirin,1444705528.0,East Asian
1451113819,PA166183702,rs524731,,,OPRM1,Efficacy,-1,naltrexone,1451113831.0,"Multiple groups, Caucasian, African American and Other ethnicities."
982047056,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,982047064.0,Near Eastern
982047056,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,lansoprazole,982047064.0,Near Eastern
1451359566,PA166154434,rs10770141,,,TH,Dosage,-1,methadone,1451359600.0,East Asian
1450376514,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376520.0,Unknown
1451113812,PA166183703,rs3823010,,,OPRM1,Efficacy,-1,naltrexone,1451113817.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1451359571,PA166209042,rs3842727,,,TH,Dosage,-1,methadone,1451359576.0,East Asian
1450933593,PA166154705,rs1933437,,,FLT3,Dosage,-1,imatinib,1450933598.0,Unknown
1450933593,PA166154705,rs1933437,,,FLT3,Dosage,-1,imatinib,1450933600.0,Unknown
1450933593,PA166154705,rs1933437,,,FLT3,Dosage,-1,imatinib,1450933599.0,Unknown
1451113825,PA166183701,rs511435,,,OPRM1,Efficacy,-1,naltrexone,1451113830.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1449164097,PA166157607,rs4841588,,,GATA4,Dosage,-1,warfarin,1449164099.0,European
1449164097,PA166157607,rs4841588,,,GATA4,Dosage,-1,warfarin,1449164099.0,European
1449164097,PA166157607,rs4841588,,,GATA4,Dosage,-1,warfarin,1449164099.0,European
1449164085,PA166176711,rs2472682,,,NR1I2,Dosage,-1,warfarin,1449164087.0,European
1451359593,PA166233887,rs5320,,,DBH,Dosage,-1,methadone,1451359624.0,East Asian
1183944026,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1183944050.0,Unknown
1183944026,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1183944050.0,Unknown
982047076,PA166156963,rs909253,,,LTA,Efficacy,-1,rituximab,982047078.0,European
1451113820,PA166177792,rs495491,,,OPRM1,Efficacy,-1,naltrexone,1451113818.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1448604948,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1448604951.0,Multiple groups
1448604948,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1448604950.0,"Multiple groups, White, African American, Asian"
1448604948,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1448604951.0,Multiple groups
1448604948,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1448604950.0,"Multiple groups, White, African American, Asian"
1448604948,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1448604951.0,Multiple groups
1448604948,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1448604950.0,"Multiple groups, White, African American, Asian"
1450933601,PA166154724,rs7993418,,,FLT1,Dosage,-1,imatinib,1450933607.0,Unknown
1450933601,PA166154724,rs7993418,,,FLT1,Dosage,-1,imatinib,1450933606.0,Unknown
1450933601,PA166154724,rs7993418,,,FLT1,Dosage,-1,imatinib,1450933608.0,Unknown
1451359581,PA166233884,rs12666409,,,DDC,Dosage,-1,methadone,1451359586.0,East Asian
1450376493,PA166155055,rs3785143,,,SLC6A2,Efficacy,-1,methylphenidate,1450376499.0,Unknown
1451343200,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451343220.0,East Asian
1451343200,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451343220.0,East Asian
1451113832,PA166179967,rs548646,,,OPRM1,Efficacy,-1,naltrexone,1451113837.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1451359587,PA166233883,rs11575553,,,DDC,Dosage,-1,methadone,1451359623.0,East Asian
1183944019,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1183944040.0,Unknown
1183944019,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1183944040.0,Unknown
1444705544,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444705553.0,Central/South Asian
1444705544,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444705553.0,Central/South Asian
1448260868,PA166157284,rs1045642,,,ABCB1,Dosage,1,atazanavir,1448260870.0,Unknown
1451359540,PA166208983,rs10770140,,,TH,Dosage,-1,methadone,1451359560.0,East Asian
1184468366,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,paroxetine,1184468378.0,Multiple groups
1184468366,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,paroxetine,1184468378.0,Multiple groups
1184468366,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,paroxetine,1184468378.0,Multiple groups
1184468366,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,paroxetine,1184468378.0,Multiple groups
1444705555,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444705557.0,Central/South Asian
1444705555,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444705557.0,Central/South Asian
1449311576,PA166156332,rs1803274,,,BCHE,Efficacy,1,donepezil,1449311585.0,European
1449311576,PA166156332,rs1803274,,,BCHE,Efficacy,1,donepezil,1449311582.0,European
1449311576,PA166156332,rs1803274,,,BCHE,Efficacy,1,donepezil,1449311587.0,European
1450933553,PA166157061,rs3025039,,,VEGFA,Dosage,-1,imatinib,1450933560.0,Unknown
1450933553,PA166157061,rs3025039,,,VEGFA,Dosage,-1,imatinib,1450933559.0,Unknown
1450933553,PA166157061,rs3025039,,,VEGFA,Dosage,-1,imatinib,1450933558.0,Unknown
1444934938,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,rocuronium,1444934943.0,East Asian
1451097400,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,morphine,1451097404.0,"Multiple groups, ""majority Central Europeans, 9 subjects from Turkey, and 1 subject each from the Ukraine, Syria, Tunisia, Dubai, and Asia"""
1448604929,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1448604947.0,Multiple groups
1448604929,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1448604945.0,"Multiple groups, White, African American, Asian"
1448604929,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1448604947.0,Multiple groups
1448604929,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1448604945.0,"Multiple groups, White, African American, Asian"
1448604929,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1448604947.0,Multiple groups
1448604929,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1448604945.0,"Multiple groups, White, African American, Asian"
1450376546,PA166155937,rs3746544,,,SNAP25,Efficacy,1,methylphenidate,1450376552.0,Unknown
1451294020,PA166226881,rs1800139,,,LRP1,Dosage,1,warfarin,1451294043.0,Unknown
1296600073,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,hydromorphone,1296600075.0,East Asian
1444934944,PA166157288,rs1128503,,,ABCB1,Efficacy,1,rocuronium,1444934946.0,East Asian
1451359561,PA166156709,rs6347,,,SLC6A3,Dosage,-1,methadone,1451359580.0,East Asian
1444705565,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1444705567.0,Central/South Asian
1450376539,PA166156802,rs2550948,,,SLC6A3,Efficacy,1,methylphenidate,1450376545.0,European
1444672801,,,PA165819268,TPMT*1,TPMT,Other,-1,thioguanine,1444672825.0,East Asian
1444672801,,,PA166005223,TPMT*32,TPMT,Other,-1,thioguanine,1444672825.0,East Asian
1448260859,PA166156358,rs2472677,,,NR1I2,Dosage,1,atazanavir,1448260867.0,Unknown
1450933569,PA166156958,rs833061,,,VEGFA,Dosage,-1,imatinib,1450933576.0,Unknown
1450933569,PA166156958,rs833061,,,VEGFA,Dosage,-1,imatinib,1450933575.0,Unknown
1450933569,PA166156958,rs833061,,,VEGFA,Dosage,-1,imatinib,1450933574.0,Unknown
827824114,PA166157284,rs1045642,,,ABCB1,Dosage,-1,carbamazepine,827824226.0,East Asian
827824114,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,carbamazepine,827824226.0,East Asian
982047043,PA166155374,rs1800471,,,TGFB1,Efficacy,1,rituximab,1043858793.0,European
982047043,PA166155374,rs1800471,,,TGFB1,Efficacy,1,rituximab,982047047.0,European
1444934955,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1444934955,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1444935052.0,Unknown
1444934955,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1444935050.0,Unknown
1450376527,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1450376529.0,Unknown
1451113800,PA166183704,rs1381376,,,OPRM1,Efficacy,-1,naltrexone,1451113805.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1184746917,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,simvastatin,1184746927.0,European
1184746917,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,simvastatin,1184746927.0,European
982047038,PA166155373,rs1800470,,,TGFB1,Efficacy,1,rituximab,982047042.0,European
982047038,PA166155373,rs1800470,,,TGFB1,Efficacy,1,rituximab,1043858791.0,European
1448820072,PA166154140,rs11572080,,,CYP2C8,Efficacy,0,piroxicam,1448820077.0,"Multiple groups, Brazil"
1448820078,PA166153972,rs1799853,,,CYP2C9,Efficacy,0,piroxicam,1448820080.0,"Multiple groups, Brazil"
655388193,PA166153961,rs1058930,,,CYP2C8,Other,-1,paclitaxel,655388196.0,European
655388193,PA166153961,rs1058930,,,CYP2C8,Metabolism/PK,-1,paclitaxel,655388196.0,European
1450376581,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,1450376583.0,European
1183681948,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,atorvastatin,1183681950.0,East Asian
1183681948,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,simvastatin,1183681950.0,East Asian
1451097485,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,morphine,1451097466.0,"Multiple groups, Caucasian and African-American children."
1448820083,PA166153972,rs1799853,,,CYP2C9,Efficacy,0,piroxicam,1448820085.0,"Multiple groups, Brazil"
1450376587,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1450376589.0,European
1451359640,PA166234021,rs129915,,,DBH,Dosage,-1,methadone,1451359592.0,East Asian
655388190,PA166154140,rs11572080,,,CYP2C8,Other,-1,paclitaxel,655388192.0,European
655388190,PA166154140,rs11572080,,,CYP2C8,Metabolism/PK,-1,paclitaxel,655388192.0,European
655388203,PA166155635,rs1402467,,,SULT1C4,Efficacy,1,docetaxel,655388205.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388203,PA166155635,rs1402467,,,SULT1C4,Efficacy,1,thalidomide,655388205.0,"Multiple groups, 43 white, 3 african american, 1 asian"
982047122,PA166156996,rs1800610,,,TNF,Efficacy,-1,rituximab,982047124.0,European
1449557367,PA166179050,rs6031587,,,HNF4A,Metabolism/PK,-1,irinotecan,1449557373.0,European
982047118,PA166157114,rs6920220,,,TNFAIP3,Efficacy,-1,rituximab,982047120.0,European
1448820088,PA166153959,rs1057910,,,CYP2C9,Efficacy,0,piroxicam,1448820090.0,"Multiple groups, Brazil"
1449311620,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,propofol,1449311622.0,Unknown
1449311620,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,remifentanil,1449311622.0,Unknown
1448820093,PA166154110,rs10509681,,,CYP2C8,Efficacy,0,piroxicam,1448820095.0,"Multiple groups, Brazil"
1451113880,PA166176243,rs648893,,,OPRM1,Efficacy,-1,naltrexone,1451113900.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1449557385,PA166179071,rs3767344,,,RXRG,Metabolism/PK,-1,irinotecan,1449557391.0,European
655388186,PA166157284,rs1045642,,,ABCB1,Other,-1,paclitaxel,655388188.0,European
655388186,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,paclitaxel,655388188.0,European
1444705477,PA166155417,rs4803219,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705483.0,East Asian
1444705477,PA166155417,rs4803219,,,IFNL3,Efficacy,1,ribavirin,1444705483.0,East Asian
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,bevacizumab,1444934889.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,bevacizumab,1444934865.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,fluorouracil,1444934889.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,fluorouracil,1444934865.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,irinotecan,1444934889.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,irinotecan,1444934865.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,leucovorin,1444934889.0,Unknown
1444934857,PA166155268,rs329007,,,RALBP1,Efficacy,1,leucovorin,1444934865.0,Unknown
1449311625,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,propofol,1449311627.0,Unknown
1449311625,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,remifentanil,1449311627.0,Unknown
827824080,PA166157288,rs1128503,,,ABCB1,Dosage,-1,carbamazepine,827824214.0,East Asian
827824080,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,carbamazepine,827824214.0,East Asian
827824085,PA166157316,rs2032582,,,ABCB1,Dosage,-1,carbamazepine,827824218.0,East Asian
827824085,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,carbamazepine,827824218.0,East Asian
1449557376,PA166179043,rs12717991,,,VDR,Metabolism/PK,-1,irinotecan,1449557382.0,European
1449311615,PA166157288,rs1128503,,,ABCB1,Efficacy,1,propofol,1449311617.0,Unknown
1449311615,PA166157288,rs1128503,,,ABCB1,Efficacy,1,remifentanil,1449311617.0,Unknown
655388183,PA166154141,rs11572103,,,CYP2C8,Dosage,-1,paclitaxel,655388185.0,European
655388183,PA166154141,rs11572103,,,CYP2C8,Metabolism/PK,-1,paclitaxel,655388185.0,European
1451359651,PA166233882,rs1042098,,,SLC6A3,Dosage,-1,methadone,1451359665.0,East Asian
982047098,PA166155766,rs7574865,,,STAT4,Efficacy,-1,rituximab,982047100.0,European
1450376612,PA166156602,rs6551665,,,ADGRL3,Efficacy,-1,methylphenidate,1450376614.0,European
1444705484,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705486.0,East Asian
1444705484,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705486.0,East Asian
1444705484,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705486.0,East Asian
1444705484,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705486.0,East Asian
1450376560,PA166181224,rs6858066,,,ADGRL3,Efficacy,-1,methylphenidate,1450376568.0,European
1450376618,PA166156607,rs6813183,,,ADGRL3,Efficacy,-1,methylphenidate,1450376620.0,European
982047094,PA166156988,rs1799724,,,TNF,Efficacy,-1,rituximab,982047096.0,European
1451113838,PA166183707,rs609148,,,OPRM1,Efficacy,-1,naltrexone,1451113863.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1451294060,PA166226901,rs1800154,,,LRP1,Dosage,1,warfarin,1451294047.0,Unknown
982047088,PA166153642,rs1800896,,,IL10,Efficacy,-1,rituximab,982047090.0,European
1449311630,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,propofol,1449311632.0,Unknown
1449311630,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,remifentanil,1449311632.0,Unknown
1451097460,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,morphine,1451097465.0,"Multiple groups, Caucasian and African-American children."
827824060,PA166155842,rs17183814,,,SCN2A,Dosage,-1,carbamazepine,827824261.0,East Asian
827824060,PA166155842,rs17183814,,,SCN2A,Metabolism/PK,-1,carbamazepine,827824261.0,East Asian
982047114,PA166156977,rs1081848,,,TRAF1,Efficacy,-1,rituximab,982047116.0,European
1444705502,PA166155462,rs11881222,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705504.0,East Asian
1444705502,PA166155462,rs11881222,,,IFNL3,Efficacy,1,ribavirin,1444705504.0,East Asian
982047084,PA166153706,rs2476601,,,PTPN22,Efficacy,-1,rituximab,982047086.0,European
1451343240,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451343245.0,East Asian
1451343240,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451343245.0,East Asian
1451343240,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451343245.0,East Asian
982047110,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,-1,rituximab,982047112.0,European
1451097480,PA166157216,rs72552763,,,SLC22A1,Metabolism/PK,1,morphine,1451097500.0,"Multiple groups, Caucasian and African-American children."
1444705508,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705510.0,East Asian
1444705508,PA166155469,rs12980275,,,IFNL3,Efficacy,1,ribavirin,1444705510.0,East Asian
1444705514,PA166155438,rs8105790,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705516.0,East Asian
1444705514,PA166155438,rs8105790,,,IFNL3,Efficacy,1,ribavirin,1444705516.0,East Asian
827824050,PA166155680,rs2298771,,,SCN1A,Dosage,-1,carbamazepine,827824250.0,East Asian
827824050,PA166155680,rs2298771,,,SCN1A,Metabolism/PK,-1,carbamazepine,827824250.0,East Asian
827824050,PA166155680,rs2298771,,,SCN1A,Metabolism/PK,-1,carbamazepine,827824250.0,East Asian
827824037,PA166153612,rs1051740,,,EPHX1,Dosage,1,carbamazepine,827824049.0,East Asian
827824037,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,827824049.0,East Asian
655388010,PA166155351,rs429358,,,APOC1,Efficacy,-1,acitretin,655388012.0,"Multiple groups, Responders: White 95 (89%) Black African 1 (1) Indian 5 (5) Chinese 1 (1) Asian other 3 (3) Egyptian 1 (1);Nonresponders: White 75 (89%) Black Caribbean 1 (1) Black African 1 (1) Indian 1 (1) Asian other 5 (6) Egyptian 1 (1).  The frequency of e4 carriers was higher in the nonresponder group, but this was not significant.  When just the white patients were compared, the results were the same."
655388010,PA166155351,rs429358,,,APOE,Efficacy,-1,acitretin,655388012.0,"Multiple groups, Responders: White 95 (89%) Black African 1 (1) Indian 5 (5) Chinese 1 (1) Asian other 3 (3) Egyptian 1 (1);Nonresponders: White 75 (89%) Black Caribbean 1 (1) Black African 1 (1) Indian 1 (1) Asian other 5 (6) Egyptian 1 (1).  The frequency of e4 carriers was higher in the nonresponder group, but this was not significant.  When just the white patients were compared, the results were the same."
1296599948,PA166153643,rs1801131,,,MTHFR,Toxicity,-1,methotrexate,1296600050.0,"Multiple groups, Mixed, Caucasian, Egyptian"
1296599948,PA166153643,rs1801131,,,MTHFR,Toxicity,-1,methotrexate,1296600017.0,"Multiple groups, Caucasian, Egyptian"
1296599948,PA166153643,rs1801131,,,MTHFR,Toxicity,-1,methotrexate,1296599950.0,"Multiple groups, Caucasian, Egyptian, Mixed"
827824027,PA166153612,rs1051740,,,EPHX1,Dosage,1,carbamazepine,827824047.0,East Asian
827824027,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,827824047.0,East Asian
1449164221,PA166154337,rs1799978,,,DRD2,Efficacy,-1,methadone,1449164223.0,"Multiple groups, 85% of participants were of European ethnicity"
982047201,PA166156024,rs4680,,,COMT,Efficacy,1,nicotine,982047205.0,East Asian
1450376632,PA166181216,rs3758653,,,DRD4,Efficacy,-1,methylphenidate,1450376634.0,European
1450376626,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376628.0,European
1447949461,PA166156529,rs1875705,,,GRID2,Efficacy,1,risperidone,1447949464.0,Multiple groups
1184747012,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,methotrexate,1184747022.0,Multiple groups
1184747012,,,PA165819255,SLCO1B1*5,SLCO1B1,Metabolism/PK,1,methotrexate,1184747022.0,Multiple groups
1184747012,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747022.0,Multiple groups
1183960529,PA166153766,rs4492666,,,CMPK1,Efficacy,1,cisplatin,1183960594.0,East Asian
1183960529,PA166153766,rs4492666,,,CMPK1,Efficacy,1,gemcitabine,1183960594.0,East Asian
1184468489,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,nortriptyline,1184468497.0,East Asian
1184468489,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,nortriptyline,1184468497.0,East Asian
982047196,PA166156693,rs66878317,,,DCK,Metabolism/PK,1,gemcitabine,982047200.0,Unknown
1451097520,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,morphine,1451097501.0,"Multiple groups, Caucasian and African-American children."
1444705420,PA166157316,rs2032582,,,ABCB1,Efficacy,1,paclitaxel,1444705426.0,Unknown
1446900845,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,imipramine,1446900895.0,European
1446900845,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,imipramine,1446900895.0,European
1446900845,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,imipramine,1446900895.0,European
1446900845,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,imipramine,1446900895.0,European
1184468498,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904552.0,European
1184468498,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1184468506.0,East Asian
1184468498,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904550.0,East Asian
1184468498,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,nortriptyline,1446904552.0,European
1184468498,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,nortriptyline,1184468506.0,East Asian
1184468498,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,nortriptyline,1446904550.0,East Asian
1450376668,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376674.0,Unknown
827823998,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,827824008.0,East Asian
827823998,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,1,carbamazepine,827824008.0,East Asian
1444705431,PA166157316,rs2032582,,,ABCB1,Efficacy,1,paclitaxel,1444705438.0,East Asian
1450376675,PA166153974,rs1800544,,,ADRA2A,Efficacy,0,methylphenidate,1450376681.0,Multiple groups
1450376675,PA166153974,rs1800544,,,ADRA2A,Efficacy,0,methylphenidate,1450376685.0,Multiple groups
1447949447,PA166156341,rs2069062,,,GRM7,Efficacy,1,risperidone,1447949457.0,Multiple groups
982047178,PA166157267,rs776746,,,CYP3A5,Dosage,-1,tacrolimus,982047182.0,European
827823984,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,827824006.0,East Asian
827823984,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,1,carbamazepine,827824006.0,East Asian
1450376659,PA166156024,rs4680,,,COMT,Efficacy,0,methylphenidate,1450376665.0,Unknown
1183682080,PA166157303,rs1799983,,,NOS3,Efficacy,-1,salbutamol,1183682085.0,Central/South Asian
1184746928,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,simvastatin,1184746930.0,African American/Afro-Caribbean
1184746928,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,simvastatin,1184746930.0,African American/Afro-Caribbean
1451114002,PA166153606,rs1042114,,,OPRD1,Efficacy,-1,naltrexone,1451114007.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1444607027,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1444607039.0,East Asian
1444607027,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1444607041.0,East Asian
1444607027,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1444607039.0,East Asian
1444607027,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1444607041.0,East Asian
1450376712,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376718.0,Unknown
1451114009,PA166198162,rs2298896,,,OPRD1,Efficacy,-1,naltrexone,1451114045.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1183944224,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,nortriptyline,1183944232.0,Unknown
1183944224,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,nortriptyline,1183944232.0,Unknown
1183944224,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,paroxetine,1183944232.0,Unknown
1183944224,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1183944232.0,Unknown
1183682086,PA166157325,rs2070744,,,NOS3,Efficacy,-1,salbutamol,1183682088.0,Central/South Asian
1183960596,PA166153822,rs11211524,,,CMPK1,Efficacy,1,cisplatin,1183960600.0,East Asian
1183960596,PA166153822,rs11211524,,,CMPK1,Efficacy,1,gemcitabine,1183960600.0,East Asian
1183960611,PA166154271,rs232043,,,RRM1,Efficacy,1,cisplatin,1183960615.0,East Asian
1183960611,PA166154271,rs232043,,,RRM1,Efficacy,1,gemcitabine,1183960615.0,East Asian
1450376695,PA166156024,rs4680,,,COMT,Efficacy,0,methylphenidate,1450376707.0,Unknown
1450376695,PA166156024,rs4680,,,COMT,Efficacy,0,methylphenidate,1450376701.0,Unknown
1450376695,PA166156024,rs4680,,,COMT,Efficacy,0,methylphenidate,1450376705.0,Unknown
1183682066,PA166156960,rs833069,,,VEGFA,Efficacy,-1,ranibizumab,1183682068.0,East Asian
1183682066,PA166156960,rs833069,,,VEGFA,Efficacy,-1,ranibizumab,1183682069.0,East Asian
1183960601,PA166154365,rs2284449,,,RRM1,Efficacy,1,cisplatin,1183960607.0,East Asian
1183960601,PA166154365,rs2284449,,,RRM1,Efficacy,1,gemcitabine,1183960607.0,East Asian
1444607043,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,clopidogrel,1444607045.0,East Asian
1444607043,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,clopidogrel,1444607046.0,East Asian
1446900828,PA166154881,rs2242046,,,SLC28A1,Metabolism/PK,-1,gemcitabine,1446900830.0,Unknown
1451114014,PA166198163,rs16918941,,,OPRK1,Efficacy,-1,naltrexone,1451114019.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1450376686,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376694.0,Multiple groups
1450376686,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376692.0,Multiple groups
1183682073,PA166156960,rs833069,,,VEGFA,Efficacy,1,ranibizumab,1183682079.0,East Asian
1183682073,PA166156960,rs833069,,,VEGFA,Efficacy,1,ranibizumab,1183682077.0,East Asian
827922697,PA166155342,rs11615,,,ERCC1,Efficacy,1,Platinum compounds,827922707.0,East Asian
1446900839,PA166154857,rs1060896,,,SLC28A2,Metabolism/PK,-1,gemcitabine,1446900841.0,Unknown
1451114020,PA166157164,rs9479757,,,OPRM1,Efficacy,-1,naltrexone,1451114001.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1444607054,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1444607056.0,East Asian
1444607054,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1444607057.0,East Asian
827807563,PA166154130,rs11191439,,,AS3MT,Toxicity,1,arsenite,827807569.0,Latino
827807563,PA166154130,rs11191439,,,AS3MT,Metabolism/PK,1,arsenite,827807569.0,Latino
1446900787,,,PA166048676,GSTM1 non-null,GSTM1,Metabolism/PK,-1,gemcitabine,1446900789.0,Unknown
1446900787,,,PA166048675,GSTM1 null,GSTM1,Metabolism/PK,-1,gemcitabine,1446900789.0,Unknown
1183682045,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183682049.0,East Asian
1183682045,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183682048.0,East Asian
1183682045,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183682047.0,East Asian
1183682045,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183682050.0,East Asian
1183944189,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluvoxamine,1183944199.0,Unknown
1183944189,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1183944199.0,Unknown
1183944189,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1183944199.0,Unknown
1183944189,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183944199.0,Unknown
1444934745,PA166156024,rs4680,,,COMT,Toxicity,1,glucose,1444934747.0,Multiple groups
1183682059,PA166156537,rs2071559,,,KDR,Efficacy,-1,ranibizumab,1183682063.0,East Asian
1183682059,PA166156537,rs2071559,,,KDR,Efficacy,-1,ranibizumab,1183682061.0,East Asian
1183682059,PA166156537,rs2071559,,,KDR,Efficacy,-1,ranibizumab,1183682062.0,East Asian
1183682059,PA166156537,rs2071559,,,KDR,Efficacy,-1,ranibizumab,1183682064.0,East Asian
1183682052,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183682056.0,East Asian
1183682052,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183682055.0,East Asian
1183682052,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183682054.0,East Asian
1183682052,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183682057.0,East Asian
1444607066,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1444607068.0,East Asian
1444607066,PA166157284,rs1045642,,,ABCB1,Efficacy,1,clopidogrel,1444607069.0,East Asian
1450376738,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376744.0,European
1450376738,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450376744.0,European
1183682034,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183682038.0,East Asian
1183682034,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183682040.0,East Asian
1183682034,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183682042.0,East Asian
1183682034,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183682044.0,East Asian
1450376730,PA166153974,rs1800544,,,ADRA2A,Efficacy,0,methylphenidate,1450376736.0,Unknown
1451113980,PA166183706,rs9322447,,,OPRM1,Efficacy,-1,naltrexone,1451114000.0,"Multiple groups, Caucasian, African American and Other ethnicities."
655388013,PA166155341,rs7412,,,APOC1,Efficacy,-1,acitretin,655388015.0,"Multiple groups, acitretin responders (106) and acitretin nonresponders (84). Responders: White 95; Black African 1; Indian 5; Chinese 1 ; Asian other 3; Egyptian 1 ; Non-responders White 75; Black Caribbean 1; Black African 1; Indian 1; Asian other 5; Egyptian 1 ."
655388013,PA166155341,rs7412,,,APOE,Efficacy,-1,acitretin,655388015.0,"Multiple groups, acitretin responders (106) and acitretin nonresponders (84). Responders: White 95; Black African 1; Indian 5; Chinese 1 ; Asian other 3; Egyptian 1 ; Non-responders White 75; Black Caribbean 1; Black African 1; Indian 1; Asian other 5; Egyptian 1 ."
655388013,PA166155341,rs7412,,,APOE,Efficacy,-1,acitretin,655388015.0,"Multiple groups, acitretin responders (106) and acitretin nonresponders (84). Responders: White 95; Black African 1; Indian 5; Chinese 1 ; Asian other 3; Egyptian 1 ; Non-responders White 75; Black Caribbean 1; Black African 1; Indian 1; Asian other 5; Egyptian 1 ."
1450376719,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1450376725.0,Unknown
1444607076,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1444607078.0,East Asian
1444607076,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1444607079.0,East Asian
1444607076,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1444607078.0,East Asian
1444607076,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1444607079.0,East Asian
1449164327,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,sildenafil,1449164337.0,European
1449164327,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,sildenafil,1449164339.0,Multiple groups
1449164327,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,sildenafil,1449164337.0,European
1449164327,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,sildenafil,1449164339.0,Multiple groups
1183616504,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1183616510.0,East Asian
1448260658,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1448260668.0,Near Eastern
1448260658,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1448260668.0,Near Eastern
1450180162,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,1450180168.0,East Asian
1450180162,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,1450180170.0,East Asian
1184747123,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1184747125.0,East Asian
1184747123,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1184747125.0,East Asian
1451261520,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1451261540.0,Unknown
1451114066,PA166198164,rs997917,,,OPRK1,Efficacy,-1,naltrexone,1451114071.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1451114060,PA166185233,rs6985606,,,OPRK1,Efficacy,-1,naltrexone,1451114065.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1183960682,PA166157521,rs80282562,,,CFTR,Efficacy,1,ivacaftor,1183960684.0,Unknown
1448260651,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1448260657.0,Near Eastern
1450376776,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1450376782.0,Unknown
1450376776,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1450376784.0,Unknown
1183944291,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1183944297.0,Sub-Saharan African
651406997,PA166157206,rs55918055,,,SLC22A1,Efficacy,0,Antiemetics And Antinauseants,,
651406997,PA166157206,rs55918055,,,SLC22A1,Metabolism/PK,0,Antiemetics And Antinauseants,,
1447949328,PA166157815,rs10793902,,,ASS1,Efficacy,1,hydroxyurea,1447949330.0,European
1450376762,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1450376768.0,Unknown
1450376762,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1450376775.0,Unknown
1444705281,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705287.0,Latino
1444705281,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705287.0,Latino
1183682143,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,lamotrigine,1183682145.0,Unknown
1446900777,PA166153667,rs2072671,,,CDA,Metabolism/PK,1,gemcitabine,1446900783.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1449164423.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1449164390.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1449164419.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1449164423.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1449164390.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1449164419.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1449164423.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1449164390.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1449164419.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1449164423.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1449164390.0,Unknown
1449164359,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1449164419.0,Unknown
1450376755,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1450376761.0,Unknown
1183682134,PA166156625,rs7668258,,,UGT2B7,Dosage,1,lamotrigine,1183682138.0,Unknown
1183682134,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,lamotrigine,1183682138.0,Unknown
1444705288,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705290.0,Latino
1444705288,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705290.0,Latino
1444705288,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705290.0,Latino
1444705288,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705290.0,Latino
1183960644,PA166154299,rs725518,,,RRM1,Efficacy,-1,cisplatin,1183960651.0,East Asian
1183960644,PA166154299,rs725518,,,RRM1,Efficacy,-1,gemcitabine,1183960651.0,East Asian
1449164371,PA166156140,rs13058338,,,RAC2,Efficacy,1,idarubicin,1449164373.0,European
1184468622,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,1184468627.0,Unknown
1183960647,PA166154428,rs7940013,,,RRM1,Efficacy,-1,cisplatin,1183960653.0,East Asian
1183960647,PA166154428,rs7940013,,,RRM1,Efficacy,-1,gemcitabine,1183960653.0,East Asian
769174406,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,cisplatin,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,TYMS,Toxicity,-1,cisplatin,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,cyclophosphamide,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,TYMS,Toxicity,-1,cyclophosphamide,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,dactinomycin,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,TYMS,Toxicity,-1,dactinomycin,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,doxorubicin,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,TYMS,Toxicity,-1,doxorubicin,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,methotrexate,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,TYMS,Toxicity,-1,methotrexate,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,vincristine,1451240280.0,Unknown
769174406,PA166155331,rs45445694,,,TYMS,Toxicity,-1,vincristine,1451240280.0,Unknown
1450376805,PA166179993,rs553668,,,ADRA2A,Efficacy,-1,methylphenidate,1450376811.0,Unknown
1449164364,PA166156080,rs1883112,,,NCF4,Efficacy,1,idarubicin,1449164370.0,European
1450376798,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1450376804.0,Unknown
1447949320,PA166157821,rs10901080,,,ASS1,Efficacy,1,hydroxyurea,1447949327.0,European
1183960639,PA166154468,rs12806698,,,RRM1,Efficacy,-1,cisplatin,1183960643.0,East Asian
1183960639,PA166154468,rs12806698,,,RRM1,Efficacy,-1,gemcitabine,1183960643.0,East Asian
1184747164,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,bilirubin,1184747166.0,East Asian
1184747164,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,1,bilirubin,1184747166.0,East Asian
1183960634,PA166154447,rs11030918,,,RRM1,Efficacy,-1,cisplatin,1183960638.0,East Asian
1183960634,PA166154447,rs11030918,,,RRM1,Efficacy,-1,gemcitabine,1183960638.0,East Asian
1444705313,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705321.0,East Asian
1444705313,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705321.0,East Asian
1451114046,PA166183884,rs6473797,,,OPRK1,Efficacy,-1,naltrexone,1451114025.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1451228747,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,methadone,1451228760.0,Unknown
1451228747,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,methadone,1451228760.0,Unknown
1451228747,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,methadone,1451228760.0,Unknown
1183960621,PA166153849,rs12090346,,,CMPK1,Efficacy,-1,cisplatin,1183960625.0,East Asian
1183960621,PA166153849,rs12090346,,,CMPK1,Efficacy,-1,gemcitabine,1183960625.0,East Asian
1184747179,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,bilirubin,1184747181.0,East Asian
1184747179,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,bilirubin,1184747181.0,East Asian
1450376787,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1450376793.0,Unknown
1450376787,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1450376797.0,Unknown
1183960626,PA166153608,rs1044457,,,CMPK1,Efficacy,-1,cisplatin,1183960630.0,East Asian
1183960626,PA166153608,rs1044457,,,CMPK1,Efficacy,-1,gemcitabine,1183960630.0,East Asian
1444934692,PA166155342,rs11615,,,ERCC1,Efficacy,1,capecitabine,1444934695.0,Unknown
1444934692,PA166155342,rs11615,,,ERCC1,Efficacy,1,radiotherapy,1444934695.0,Unknown
1451228740,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,methadone,1451228746.0,Unknown
1451228740,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,methadone,1451228746.0,Unknown
1444934576,PA166155621,rs1056836,,,CYP1B1,Efficacy,1,cyclophosphamide,1444934584.0,Unknown
1444934576,PA166155621,rs1056836,,,CYP1B1,Efficacy,1,epirubicin,1444934584.0,Unknown
1444934576,PA166155621,rs1056836,,,CYP1B1,Efficacy,1,fluorouracil,1444934584.0,Unknown
1450180222,PA166154972,rs5569,,,SLC6A2,Efficacy,1,methylphenidate,1450180224.0,Multiple groups
1451261580,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1451261600.0,Unknown
1450376837,PA166181226,rs2345039,,,ADGRL3,Efficacy,0,methylphenidate,1450376839.0,Unknown
1184468532,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,nortriptyline,1184468540.0,East Asian
1184468532,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,nortriptyline,1184468540.0,East Asian
1444934586,PA166153633,rs1563828,,,MDM4,Efficacy,1,docetaxel,1444934594.0,Unknown
1444934586,PA166153633,rs1563828,,,MDM4,Efficacy,1,epirubicin,1444934594.0,Unknown
1450376831,PA166181219,rs1947274,,,ADGRL3,Efficacy,0,methylphenidate,1450376833.0,Unknown
1451228820,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,methadone,1451228786.0,Unknown
1451228820,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,methadone,1451228786.0,Unknown
1451228820,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,methadone,1451228786.0,Unknown
1043880889,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,1043880895.0,Near Eastern
1043880889,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,losartan,1043880895.0,Near Eastern
1184747060,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,methotrexate,1184747062.0,Multiple groups
1184747060,,,PA165819264,SLCO1B1*14,SLCO1B1,Metabolism/PK,1,methotrexate,1184747062.0,Multiple groups
1184747060,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,methotrexate,1184747062.0,Multiple groups
1451261601,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,efavirenz,1451261574.0,Unknown
655388432,PA166157083,rs3800373,,,FKBP5,Efficacy,1,antidepressants,655388434.0,European
655388432,PA166157083,rs3800373,,,FKBP5,Efficacy,1,antidepressants,655388436.0,European
1450376824,PA166156602,rs6551665,,,ADGRL3,Efficacy,0,methylphenidate,1450376830.0,Unknown
982047396,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,982047402.0,Multiple groups
982047396,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,982047402.0,Multiple groups
982047396,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,982047402.0,Multiple groups
655388442,PA166157104,rs4713916,,,FKBP5,Efficacy,1,antidepressants,655388445.0,European
655388442,PA166157104,rs4713916,,,FKBP5,Efficacy,1,antidepressants,655388447.0,European
1450376812,PA166153975,rs1800545,,,ADRA2A,Efficacy,-1,methylphenidate,1450376818.0,Unknown
655388437,PA166156983,rs1360780,,,FKBP5,Efficacy,1,antidepressants,655388439.0,European
655388437,PA166156983,rs1360780,,,FKBP5,Efficacy,1,antidepressants,655388441.0,European
1450376870,PA166156602,rs6551665,,,ADGRL3,Efficacy,-1,methylphenidate,1450376876.0,Unknown
827922320,PA166153667,rs2072671,,,CDA,Toxicity,0,cytarabine,827922326.0,Unknown
827922320,PA166153667,rs2072671,,,CDA,Metabolism/PK,0,cytarabine,827922326.0,Unknown
1449164430,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,hydroxyurea,1449164432.0,Unknown
1449164430,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,hydroxyurea,1449164434.0,Unknown
1449164430,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,hydroxyurea,1449164433.0,Unknown
1449164430,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,hydroxyurea,1449164432.0,Unknown
1449164430,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,hydroxyurea,1449164434.0,Unknown
1449164430,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,hydroxyurea,1449164433.0,Unknown
1451228780,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,methadone,1451228800.0,Unknown
1451228780,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,methadone,1451228800.0,Unknown
1451228780,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,methadone,1451228800.0,Unknown
1183682182,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1183682187.0,East Asian
655388402,PA166156983,rs1360780,,,FKBP5,Efficacy,1,antidepressants,655388404.0,European
1450376864,PA166181224,rs6858066,,,ADGRL3,Efficacy,0,methylphenidate,1450376866.0,Multiple groups
1451228801,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,methadone,1451228811.0,Unknown
1451228801,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,methadone,1451228810.0,Unknown
1451228801,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,methadone,1451228811.0,Unknown
1451228801,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,methadone,1451228810.0,Unknown
1451228801,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,methadone,1451228811.0,Unknown
1451228801,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,methadone,1451228810.0,Unknown
1451228801,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,methadone,1451228811.0,Unknown
1451228801,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,methadone,1451228810.0,Unknown
1451228801,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,methadone,1451228811.0,Unknown
1451228801,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,methadone,1451228810.0,Unknown
1183960698,PA166157532,rs121909013,,,CFTR,Efficacy,1,ivacaftor,1183960700.0,Unknown
1184747113,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1184747115.0,East Asian
1184747113,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,1,SN-38,1184747115.0,East Asian
1444705254,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705261.0,European
1444705254,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705261.0,European
1444705254,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705261.0,European
1183616635,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,clomipramine,1183616650.0,European
1183616635,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,clomipramine,1183616650.0,European
655388405,PA166157083,rs3800373,,,FKBP5,Efficacy,1,antidepressants,655388407.0,European
1183944307,PA166157239,rs3842,,,ABCB1,Metabolism/PK,1,efavirenz,1183944314.0,Sub-Saharan African
1450180291,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1450180293.0,Multiple groups
655388257,PA166154050,rs4148945,,,CHST3,Efficacy,1,docetaxel,655388259.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388257,PA166154050,rs4148945,,,CHST3,Efficacy,1,thalidomide,655388259.0,"Multiple groups, 43 white, 3 african american, 1 asian"
982047450,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,982047460.0,East Asian
1449164464,PA166154525,rs2069502,,,CDK4,Efficacy,1,somatropin recombinant,1449164470.0,Unknown
1451228880,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,simvastatin,1451228885.0,East Asian
655388254,PA166154049,rs4148943,,,CHST3,Efficacy,1,docetaxel,655388256.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388254,PA166154049,rs4148943,,,CHST3,Efficacy,1,thalidomide,655388256.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1043880833,PA166155187,rs1799752,,,ACE,Efficacy,-1,losartan,1043880850.0,European
655388265,PA166157267,rs776746,,,CYP3A5,Dosage,1,cyclosporine,655388270.0,"Multiple groups, France, the Netherlands, Belgium, United States, Germany, China, India ,Singapore and Malaysia"
655388265,PA166157267,rs776746,,,CYP3A5,Dosage,1,cyclosporine,655388268.0,"Multiple groups, France, the Netherlands, Belgium, United States, Germany, China, India ,Singapore and Malaysia"
655388265,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,655388270.0,"Multiple groups, France, the Netherlands, Belgium, United States, Germany, China, India ,Singapore and Malaysia"
655388265,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,655388268.0,"Multiple groups, France, the Netherlands, Belgium, United States, Germany, China, India ,Singapore and Malaysia"
1444705141,PA166155468,rs12979860,,,IFNL3,Efficacy,1,interferon alfa-n1,1444705143.0,Unknown
1444705141,PA166155468,rs12979860,,,IFNL4,Efficacy,1,interferon alfa-n1,1444705143.0,Unknown
1444705141,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705143.0,Unknown
1444705141,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705143.0,Unknown
1444705141,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705143.0,Unknown
1444705141,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705143.0,Unknown
982047439,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,paroxetine,982047445.0,Multiple groups
982047439,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,paroxetine,982047445.0,Multiple groups
1444705147,PA166155435,rs8099917,,,IFNL3,Efficacy,1,interferon alfa-n1,1444705149.0,Unknown
1444705147,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705149.0,Unknown
1444705147,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705149.0,Unknown
1449164471,PA166154538,rs2270777,,,CDK4,Efficacy,1,somatropin recombinant,1449164473.0,Unknown
1183682259,PA166153667,rs2072671,,,CDA,Metabolism/PK,-1,capecitabine,1183682284.0,"Multiple groups, Caucasian, Black, Other"
1183682259,PA166153667,rs2072671,,,CDA,Metabolism/PK,-1,capecitabine,1183682291.0,"Multiple groups, Caucasian, Black, Other"
1183682259,PA166153667,rs2072671,,,CDA,Metabolism/PK,-1,capecitabine,1183682279.0,"Multiple groups, Caucasian, Black, Other"
1183682259,PA166153667,rs2072671,,,CDA,Metabolism/PK,-1,capecitabine,1183682289.0,"Multiple groups, Caucasian, Black, Other"
1448522650,PA166161851,rs11126740,,,CTNNA2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448522652.0,European
1447949199,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447949237.0,European
982047462,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,nateglinide,982047464.0,East Asian
655388236,PA166157007,rs2016520,,,PPARD,Efficacy,1,docetaxel,655388238.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388236,PA166157007,rs2016520,,,PPARD,Efficacy,1,thalidomide,655388238.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1184468739,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1184468747.0,East Asian
1184468739,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1184468747.0,East Asian
1184468739,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1184468747.0,East Asian
655388251,PA166157077,rs3734254,,,PPARD,Efficacy,1,docetaxel,655388253.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388251,PA166157077,rs3734254,,,PPARD,Efficacy,1,thalidomide,655388253.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1450376889,PA166155937,rs3746544,,,SNAP25,Efficacy,-1,methylphenidate,1450376897.0,Unknown
1450376889,PA166155937,rs3746544,,,SNAP25,Efficacy,-1,methylphenidate,1450376895.0,Unknown
1451130600,PA166203235,rs4774388,,,RORA,Efficacy,1,interferon beta-1a,1451130620.0,Unknown
1451130600,PA166203235,rs4774388,,,RORA,Efficacy,1,interferon beta-1a,1451130622.0,Unknown
1451130600,PA166203235,rs4774388,,,RORA,Efficacy,1,interferon beta-1a,1451130621.0,Unknown
1451228900,PA166154590,rs4363657,,,SLCO1B1,Efficacy,-1,simvastatin,1451228905.0,East Asian
1450180321,PA166156602,rs6551665,,,ADGRL3,Efficacy,-1,methylphenidate,1450180323.0,Multiple groups
827807881,PA166155381,rs2108622,,,CYP4F2,Dosage,1,phenprocoumon,827807889.0,Unknown
1450376877,PA166181226,rs2345039,,,ADGRL3,Efficacy,-1,methylphenidate,1450376879.0,Unknown
655388232,PA166153978,rs1871450,,,CHST3,Efficacy,1,docetaxel,655388234.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388232,PA166153978,rs1871450,,,CHST3,Efficacy,1,thalidomide,655388234.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1183764170,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1183771505.0,Sub-Saharan African
1183764170,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1183944331.0,Sub-Saharan African
1183764170,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1183771505.0,Sub-Saharan African
1183764170,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1183944331.0,Sub-Saharan African
1450376929,PA166156602,rs6551665,,,ADGRL3,Efficacy,0,methylphenidate,1450376935.0,Unknown
1448820435,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820441.0,East Asian
1448820435,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820449.0,East Asian
1448820435,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820453.0,East Asian
1448820435,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448820451.0,East Asian
655388209,PA166157128,rs7769719,,,PPARD,Efficacy,1,docetaxel,655388211.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388209,PA166157128,rs7769719,,,PPARD,Efficacy,1,thalidomide,655388211.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388206,PA166157116,rs6922548,,,PPARD,Efficacy,1,docetaxel,655388208.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388206,PA166157116,rs6922548,,,PPARD,Efficacy,1,thalidomide,655388208.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1450180302,PA166156024,rs4680,,,COMT,Efficacy,1,methylphenidate,1450180304.0,Multiple groups
827807860,PA166154045,rs4086116,,,CYP2C9,Dosage,1,phenprocoumon,827807880.0,Unknown
655388216,PA166153942,rs12418,,,CHST3,Efficacy,1,docetaxel,655388218.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388216,PA166153942,rs12418,,,CHST3,Efficacy,1,thalidomide,655388218.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388213,PA166157003,rs1883322,,,PPARD,Efficacy,1,docetaxel,655388215.0,"Multiple groups, 43 white, 3 african american, 1 asian"
655388213,PA166157003,rs1883322,,,PPARD,Efficacy,1,thalidomide,655388215.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1451294486,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,-1,irinotecan,1451294491.0,
1451294486,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,-1,irinotecan,1451294491.0,
827807849,PA166155102,rs10871454,,,STX4,Dosage,1,phenprocoumon,827807854.0,Unknown
1183682339,PA166157032,rs2282143,,,SLC22A1,Metabolism/PK,1,metformin,1183682341.0,East Asian
1183682339,PA166157032,rs2282143,,,SLC22A1,Metabolism/PK,1,metformin,1183682342.0,East Asian
1184468657,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
1184468657,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
1184468657,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
1184468657,,,PA165948317,CYP2D6*9,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
1184468657,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
1184468657,,,PA165816583,CYP2D6*17,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
1184468657,,,PA165816584,CYP2D6*41,CYP2D6,Dosage,1,venlafaxine,1184468659.0,Unknown
827643999,PA166154053,rs4244285,,,CYP2C19,Dosage,1,valproic acid,827644008.0,Unknown
827643999,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,valproic acid,827644008.0,Unknown
1183682344,PA166155251,rs12943590,,,SLC47A2,Metabolism/PK,-1,metformin,1183682346.0,East Asian
1183682344,PA166155251,rs12943590,,,SLC47A2,Metabolism/PK,-1,metformin,1183682347.0,East Asian
1444705077,PA166155437,rs8103142,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705079.0,European
1444705077,PA166155437,rs8103142,,,IFNL3,Efficacy,1,ribavirin,1444705079.0,European
1448820472,PA166169844,rs9200,,,C6,Metabolism/PK,1,tacrolimus,1448820474.0,East Asian
1448820472,PA166169844,rs9200,,,C6,Metabolism/PK,1,tacrolimus,1448820475.0,East Asian
1448820472,PA166169844,rs9200,,,C6,Metabolism/PK,1,tacrolimus,1448820476.0,East Asian
1448820472,PA166169844,rs9200,,,C6,Metabolism/PK,1,tacrolimus,1448820477.0,East Asian
1444705084,PA166155479,rs28416813,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705086.0,European
1444705084,PA166155479,rs28416813,,,IFNL3,Efficacy,1,ribavirin,1444705086.0,European
827807830,PA166155341,rs7412,,,APOE,Efficacy,1,atorvastatin,827807840.0,"Multiple groups, 82.4% white"
827807830,PA166155341,rs7412,,,APOE,Efficacy,1,pravastatin,827807840.0,"Multiple groups, 82.4% white"
827807830,PA166155341,rs7412,,,APOE,Efficacy,1,simvastatin,827807840.0,"Multiple groups, 82.4% white"
1450180334,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,paclitaxel,1450186357.0,"Multiple groups, ""93.2% Caucasian"""
827824206,PA166153953,rs717620,,,ABCC2,Dosage,-1,carbamazepine,827824269.0,East Asian
827824206,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,carbamazepine,827824269.0,East Asian
827807823,PA166157834,rs12003906,,,ABCA1,Efficacy,1,atorvastatin,827807838.0,"Multiple groups, 82.4% white"
827807823,PA166157834,rs12003906,,,ABCA1,Efficacy,1,atorvastatin,827807829.0,"Multiple groups, 82.4% white"
827807823,PA166157834,rs12003906,,,ABCA1,Efficacy,1,pravastatin,827807838.0,"Multiple groups, 82.4% white"
827807823,PA166157834,rs12003906,,,ABCA1,Efficacy,1,pravastatin,827807829.0,"Multiple groups, 82.4% white"
827807823,PA166157834,rs12003906,,,ABCA1,Efficacy,1,simvastatin,827807838.0,"Multiple groups, 82.4% white"
827807823,PA166157834,rs12003906,,,ABCA1,Efficacy,1,simvastatin,827807829.0,"Multiple groups, 82.4% white"
1183682327,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,labetalol,1183682329.0,East Asian
1444705100,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705102.0,European
1444705100,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705102.0,European
1444705100,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705102.0,European
1444705100,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705102.0,European
1448820481,PA166169844,rs9200,,,C6,Metabolism/PK,-1,tacrolimus,1448820483.0,East Asian
1448820481,PA166169844,rs9200,,,C6,Metabolism/PK,-1,tacrolimus,1448820484.0,East Asian
1448820481,PA166169844,rs9200,,,C6,Metabolism/PK,-1,tacrolimus,1448820485.0,East Asian
1448820481,PA166169844,rs9200,,,C6,Metabolism/PK,-1,tacrolimus,1448820486.0,East Asian
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376959.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376961.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376963.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376959.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376961.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376963.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376959.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376961.0,Unknown
1450376953,PA166182269,rs3792452,,,GRM7,Efficacy,0,methylphenidate,1450376963.0,Unknown
827824194,PA166154007,rs2273697,,,ABCC2,Dosage,-1,carbamazepine,827824245.0,East Asian
827824194,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,carbamazepine,827824245.0,East Asian
1444705115,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705117.0,European
1444705115,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705117.0,European
982047471,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,pantoprazole,982047479.0,Multiple groups
982047471,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,pantoprazole,982047479.0,Multiple groups
827824191,PA166156617,rs7438135,,,UGT2B7,Dosage,-1,carbamazepine,827824243.0,East Asian
827824191,PA166156617,rs7438135,,,UGT2B7,Metabolism/PK,-1,carbamazepine,827824243.0,East Asian
1183682310,PA166154886,rs2290272,,,SLC28A1,Metabolism/PK,-1,capecitabine,1183682315.0,"Multiple groups, Caucasian, Black, Other"
1183682310,PA166154886,rs2290272,,,SLC28A1,Metabolism/PK,-1,capecitabine,1183682312.0,"Multiple groups, Caucasian, Black, Other"
1183682310,PA166154886,rs2290272,,,SLC28A1,Metabolism/PK,-1,capecitabine,1183682314.0,"Multiple groups, Caucasian, Black, Other"
1183682310,PA166154886,rs2290272,,,SLC28A1,Metabolism/PK,-1,capecitabine,1183682313.0,"Multiple groups, Caucasian, Black, Other"
827824186,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,carbamazepine,827824238.0,East Asian
827824186,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,carbamazepine,827824238.0,East Asian
982047492,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clobazam,982047499.0,East Asian
982047492,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clobazam,982047499.0,East Asian
982047492,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clobazam,982047499.0,East Asian
1449754388,PA166156114,rs5030865,,,CYP2D6,Metabolism/PK,1,dextromethorphan,1449754393.0,East Asian
827824178,PA166156625,rs7668258,,,UGT2B7,Dosage,-1,carbamazepine,827824231.0,East Asian
827824178,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,-1,carbamazepine,827824231.0,East Asian
827807793,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183624021.0,Multiple groups
827807793,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183624019.0,Multiple groups
827807793,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183623798.0,Multiple groups
1183682299,PA166153646,rs1801159,,,DPYD,Metabolism/PK,-1,capecitabine,1183682304.0,"Multiple groups, Caucasian, Black, Other"
1183682299,PA166153646,rs1801159,,,DPYD,Metabolism/PK,-1,capecitabine,1183682303.0,"Multiple groups, Caucasian, Black, Other"
1183682299,PA166153646,rs1801159,,,DPYD,Metabolism/PK,-1,capecitabine,1183682301.0,"Multiple groups, Caucasian, Black, Other"
1183682299,PA166153646,rs1801159,,,DPYD,Metabolism/PK,-1,capecitabine,1183682302.0,"Multiple groups, Caucasian, Black, Other"
1444705124,PA166155468,rs12979860,,,IFNL3,Efficacy,1,interferon alfa-n1,1444705130.0,Unknown
1444705124,PA166155468,rs12979860,,,IFNL4,Efficacy,1,interferon alfa-n1,1444705130.0,Unknown
1444705124,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705130.0,Unknown
1444705124,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705130.0,Unknown
1444705124,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705130.0,Unknown
1444705124,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705130.0,Unknown
1183682292,PA166155103,rs11075646,,,CES2,Metabolism/PK,-1,capecitabine,1183682297.0,"Multiple groups, Caucasian, Black, Other"
1183682292,PA166155103,rs11075646,,,CES2,Metabolism/PK,-1,capecitabine,1183682296.0,"Multiple groups, Caucasian, Black, Other"
1183682292,PA166155103,rs11075646,,,CES2,Metabolism/PK,-1,capecitabine,1183682295.0,"Multiple groups, Caucasian, Black, Other"
1183682292,PA166155103,rs11075646,,,CES2,Metabolism/PK,-1,capecitabine,1183682294.0,"Multiple groups, Caucasian, Black, Other"
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,"adrenergics, inhalants",1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,"adrenergics, inhalants",1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,"adrenergics, inhalants",1183698957.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,beclomethasone,1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,beclomethasone,1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,beclomethasone,1183698957.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,budesonide,1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,budesonide,1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,budesonide,1183698957.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,corticosteroids,1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,corticosteroids,1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,corticosteroids,1183698957.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,fluticasone propionate,1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,fluticasone propionate,1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,fluticasone propionate,1183698957.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,fluticasone/salmeterol,1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,fluticasone/salmeterol,1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,fluticasone/salmeterol,1183698957.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,salbutamol,1183698959.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,salbutamol,1183698961.0,European
1183698784,PA166155410,rs3752120,,,ZNF432,Efficacy,1,salbutamol,1183698957.0,European
827921971,PA166154938,rs16969968,,,CHRNA3,Other,1,Drugs used in nicotine dependence,827921995.0,Unknown
827921971,PA166154938,rs16969968,,,CHRNA5,Other,1,Drugs used in nicotine dependence,827921995.0,Unknown
1449262882,PA166153972,rs1799853,,,CYP2C9,Dosage,-1,warfarin,1449262884.0,Near Eastern
1183682400,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,labetalol,1183682402.0,East Asian
1451294540,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,propafenone,1451294560.0,East Asian
1451294540,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,propafenone,1451294560.0,East Asian
1451294540,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,propafenone,1451294560.0,East Asian
1451294540,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,propafenone,1451294560.0,East Asian
1451294540,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,1,propafenone,1451294560.0,East Asian
1449754439,PA166155293,rs4149601,,,NEDD4L,Efficacy,1,hydrochlorothiazide,1449754445.0,East Asian
1451097940,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,proguanil,1451097944.0,Unknown
1183682406,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,labetalol,1183682408.0,East Asian
827921983,PA166154845,rs680244,,,CHRNA5,Other,1,Drugs used in nicotine dependence,827921993.0,Unknown
769174170,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,769174172.0,European
769174170,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,769174172.0,European
1184468863,PA166155718,rs3832043,,,UGT1A9,Efficacy,-1,cisplatin,1184468878.0,East Asian
1184468863,PA166155718,rs3832043,,,UGT1A9,Efficacy,-1,irinotecan,1184468878.0,East Asian
1451097949,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,cycloguanil,1451097953.0,Unknown
1447949071,PA166156899,rs3077,,,HLA-DPA1,Efficacy,1,peginterferon alfa-2b,1447949079.0,East Asian
1447949081,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1447949083.0,East Asian
1447949081,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1447949083.0,East Asian
769174162,PA166156744,rs881152,,,DUSP1,Efficacy,0,salbutamol,769174164.0,African American/Afro-Caribbean
982031201,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,982031212.0,Unknown
982031201,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,982031210.0,European
1449164615,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1449164619.0,Unknown
1449164615,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1449164617.0,Unknown
1449164615,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1449164618.0,Unknown
1449164615,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1449164619.0,Unknown
1449164615,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1449164617.0,Unknown
1449164615,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1449164618.0,Unknown
1183682389,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,labetalol,1183682391.0,East Asian
1043880685,,,PA165818757,CYP2B6*4,CYP2B6,Other,1,bupropion,1043880687.0,European
1043880685,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,bupropion,1043880687.0,European
827921996,PA166154938,rs16969968,,,CHRNA3,Other,1,Drugs used in nicotine dependence,827922009.0,Unknown
827921996,PA166154938,rs16969968,,,CHRNA5,Other,1,Drugs used in nicotine dependence,827922009.0,Unknown
1449754461,PA166155342,rs11615,,,ERCC1,Efficacy,1,fluorouracil,1449754467.0,East Asian
1449754461,PA166155342,rs11615,,,ERCC1,Efficacy,1,fluorouracil,1449754469.0,East Asian
1449754461,PA166155342,rs11615,,,ERCC1,Efficacy,1,leucovorin,1449754467.0,East Asian
1449754461,PA166155342,rs11615,,,ERCC1,Efficacy,1,leucovorin,1449754469.0,East Asian
1449754461,PA166155342,rs11615,,,ERCC1,Efficacy,1,oxaliplatin,1449754467.0,East Asian
1449754461,PA166155342,rs11615,,,ERCC1,Efficacy,1,oxaliplatin,1449754469.0,East Asian
1448820555,PA166169851,rs3805715,,,C6,Metabolism/PK,-1,tacrolimus,1448820561.0,East Asian
1449164623,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449164625.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449164627.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449164626.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449164625.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449164627.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449164626.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1449164625.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1449164627.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1449164626.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1449164625.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1449164627.0,Unknown
1449164623,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1449164626.0,Unknown
827922003,PA166154845,rs680244,,,CHRNA5,Other,1,Drugs used in nicotine dependence,827922011.0,Unknown
1451130680,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451130700.0,Near Eastern
1451130680,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1451130700.0,Near Eastern
1451130680,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1451130700.0,Near Eastern
1184468885,PA166155720,rs4124874,,,UGT1A1,Efficacy,-1,cisplatin,1184468891.0,East Asian
1184468885,PA166155720,rs4124874,,,UGT1A1,Efficacy,-1,irinotecan,1184468891.0,East Asian
1448820562,PA166169852,rs3805716,,,C6,Metabolism/PK,-1,tacrolimus,1448820564.0,East Asian
1449164633,PA166155646,rs1801278,,,IRS1,Efficacy,1,Drugs Used In Diabetes,1449164641.0,Unknown
1449164633,PA166155646,rs1801278,,,IRS1,Efficacy,1,Drugs Used In Diabetes,1449164639.0,Unknown
1451130683,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1451130687.0,Near Eastern
1444705048,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705054.0,European
1444705048,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444705054.0,European
1444705048,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444705054.0,European
1444705048,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444705054.0,European
1448820570,PA166169853,rs6865420,,,C6,Metabolism/PK,-1,tacrolimus,1448820572.0,East Asian
1444705057,PA166155416,rs4803217,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705069.0,European
1444705057,PA166155416,rs4803217,,,IFNL3,Efficacy,1,ribavirin,1444705069.0,European
1449754452,PA166155346,rs25487,,,XRCC1,Efficacy,1,fluorouracil,1449754458.0,East Asian
1449754452,PA166155346,rs25487,,,XRCC1,Efficacy,1,fluorouracil,1449754460.0,East Asian
1449754452,PA166155346,rs25487,,,XRCC1,Efficacy,1,leucovorin,1449754458.0,East Asian
1449754452,PA166155346,rs25487,,,XRCC1,Efficacy,1,leucovorin,1449754460.0,East Asian
1449754452,PA166155346,rs25487,,,XRCC1,Efficacy,1,oxaliplatin,1449754458.0,East Asian
1449754452,PA166155346,rs25487,,,XRCC1,Efficacy,1,oxaliplatin,1449754460.0,East Asian
827807210,PA166156626,rs7668282,,,UGT2B7,Metabolism/PK,1,morphine,1449271358.0,Unknown
1448820578,PA166169854,rs7443562,,,C6,Metabolism/PK,-1,tacrolimus,1448820580.0,East Asian
1448820578,PA166169854,rs7443562,,,C6,Metabolism/PK,-1,tacrolimus,1448820580.0,East Asian
827823590,PA166154549,rs2430561,,,IFNG,Efficacy,-1,glatiramer acetate,827823615.0,European
827823586,PA166157717,rs1051922,,,IFNB1,Efficacy,-1,glatiramer acetate,827823613.0,European
1451360140,PA166155063,rs4240803,,,SLC7A5,Efficacy,1,gabapentin,1451360180.0,"Multiple groups, Participants were of the following ethnicities: Punjabi, Pathan, Urdu Speaking, Kashmiri and Others"
1451360140,PA166155063,rs4240803,,,SLC7A5,Efficacy,1,pregabalin,1451360180.0,"Multiple groups, Participants were of the following ethnicities: Punjabi, Pathan, Urdu Speaking, Kashmiri and Others"
1449557869,PA166156776,rs1801394,,,MTRR,Efficacy,1,methotrexate,1449557876.0,European
1449557869,PA166156776,rs1801394,,,MTRR,Efficacy,1,methotrexate,1449557878.0,European
1448820606,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448820618.0,East Asian
1448820606,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448820618.0,East Asian
1448604375,PA166156339,rs2046934,,,P2RY12,Efficacy,-1,clopidogrel,1448604381.0,Near Eastern
1450950560,PA166153760,rs3918290,,,DPYD,Metabolism/PK,1,fluorouracil,1450950583.0,Unknown
982031268,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,982031276.0,Multiple groups
827823570,PA166156845,rs6897932,,,IL7R,Efficacy,-1,glatiramer acetate,827823611.0,European
1449557891,PA166154982,rs35592,,,ABCC1,Efficacy,-1,methotrexate,1449558065.0,European
1449557891,PA166154982,rs35592,,,ABCC1,Efficacy,-1,methotrexate,1449557894.0,European
981785504,PA166153610,rs1048977,,,CDA,Efficacy,1,gemcitabine,981785508.0,East Asian
1449557915,PA166155823,rs12995526,,,ATIC,Efficacy,-1,methotrexate,1449558071.0,European
1449557915,PA166155823,rs12995526,,,ATIC,Efficacy,-1,methotrexate,1449557917.0,European
1184468811,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,1184468813.0,Multiple groups
1451294582,PA166227021,rs2290910,,,ADCY2,Efficacy,-1,lithium,1451294587.0,
1184468815,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,1184468817.0,Multiple groups
982031223,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,infliximab,982031230.0,European
1183616898,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,clomipramine,1183616900.0,European
1183616898,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,clomipramine,1183616900.0,European
1183616898,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,clomipramine,1183616900.0,European
1449557909,PA166179154,rs4673990,,,ATIC,Efficacy,-1,methotrexate,1449558069.0,European
1449557909,PA166179154,rs4673990,,,ATIC,Efficacy,-1,methotrexate,1449557911.0,European
1184468819,PA166157395,rs4646458,,,None,Dosage,1,tacrolimus,1184468821.0,Multiple groups
769174083,PA166156744,rs881152,,,DUSP1,Efficacy,1,salbutamol,769174113.0,Latino
1446900410,PA166156985,rs1570360,,,VEGFA,Efficacy,-1,enalapril,1446900413.0,Unknown
1446900410,PA166156985,rs1570360,,,VEGFA,Efficacy,-1,enalapril,1446900412.0,"Multiple groups, Brazil"
1183616907,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,clomipramine,1183616909.0,European
1183616907,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,clomipramine,1183616909.0,European
1183616907,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,clomipramine,1183616909.0,European
1184468824,PA166157394,rs4646457,,,None,Dosage,1,tacrolimus,1184468826.0,Multiple groups
982031213,PA166154566,rs3794271,,,SLCO1C1,Efficacy,-1,adalimumab,982031220.0,European
1448820632,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448820634.0,East Asian
827823546,PA166155985,rs1012335,,,IFNAR1,Efficacy,1,glatiramer acetate,827823551.0,European
1183682419,PA166155266,rs80338792,,,SCN4A,Efficacy,0,flecainide,1183682434.0,Unknown
1451097980,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,proguanil,1451097904.0,Unknown
1449557927,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,1449558075.0,European
1449557927,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,1449557929.0,European
1184468834,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184468836.0,"Multiple groups, Caucasian n=44, African-American n=13, Hispanic n=30, Asian n=6, Other n=2."
981785480,PA166153667,rs2072671,,,CDA,Efficacy,-1,gemcitabine,981785487.0,East Asian
827823538,PA166156273,rs333,,,CCR5,Efficacy,1,glatiramer acetate,827823545.0,European
1449557921,PA166155837,rs16853834,,,ATIC,Efficacy,-1,methotrexate,1449557923.0,European
1449557921,PA166155837,rs16853834,,,ATIC,Efficacy,-1,methotrexate,1449558073.0,European
827807155,,,PA165980634,CYP2C19*1,CYP2C19,Other,-1,carvedilol,827807169.0,Multiple groups
827807155,,,PA165980635,CYP2C19*2,CYP2C19,Other,-1,carvedilol,827807169.0,Multiple groups
827807155,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,carvedilol,827807169.0,Multiple groups
827807155,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,carvedilol,827807169.0,Multiple groups
827807152,,,PA165980635,CYP2C19*2,CYP2C19,Other,-1,carvedilol,827807167.0,Multiple groups
827807152,,,PA165816533,CYP2C19*17,CYP2C19,Other,-1,carvedilol,827807167.0,Multiple groups
827807152,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,carvedilol,827807167.0,Multiple groups
827807152,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,carvedilol,827807167.0,Multiple groups
1184468838,PA166157454,rs12333983,,,CYP3A4,Dosage,1,tacrolimus,1184468840.0,Multiple groups
1448358573,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,cyclosporine,1448358575.0,Unknown
1448358573,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,cyclosporine,1448358575.0,Unknown
982031232,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,etanercept,982031239.0,European
827807149,,,PA165980634,CYP2C19*1,CYP2C19,Other,-1,carvedilol,827807165.0,Multiple groups
827807149,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,carvedilol,827807165.0,Multiple groups
827807146,,,PA165980634,CYP2C19*1,CYP2C19,Other,-1,carvedilol,827807163.0,Multiple groups
827807146,,,PA165816533,CYP2C19*17,CYP2C19,Other,-1,carvedilol,827807163.0,Multiple groups
827807146,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,carvedilol,827807163.0,Multiple groups
827807146,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,carvedilol,827807163.0,Multiple groups
827807146,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,carvedilol,827807163.0,Multiple groups
1449557945,PA166155915,rs1127354,,,ITPA,Efficacy,-1,methotrexate,1449558081.0,European
1449557945,PA166155915,rs1127354,,,ITPA,Efficacy,-1,methotrexate,1449557947.0,European
1444934259,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1444934266.0,Multiple groups
1448637103,PA166165398,rs3888190,,,SH2B1,Other,1,low density lipoprotein,1448637108.0,Unknown
1448637103,PA166165398,rs3888190,,,SH2B1,Other,1,low density lipoprotein,1448637110.0,European
1451294680,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451294688.0,East Asian
1451294680,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451294720.0,East Asian
1451294680,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1451294688.0,East Asian
1451294680,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1451294720.0,East Asian
1451294680,,,PA165816554,CYP2C9*13,CYP2C9,Dosage,1,warfarin,1451294688.0,East Asian
1451294680,,,PA165816554,CYP2C9*13,CYP2C9,Dosage,1,warfarin,1451294720.0,East Asian
1451294680,,,PA165816557,CYP2C9*16,CYP2C9,Dosage,1,warfarin,1451294688.0,East Asian
1451294680,,,PA165816557,CYP2C9*16,CYP2C9,Dosage,1,warfarin,1451294720.0,East Asian
1451294680,,,PA166128211,CYP2C9*60,CYP2C9,Dosage,1,warfarin,1451294688.0,East Asian
1451294680,,,PA166128211,CYP2C9*60,CYP2C9,Dosage,1,warfarin,1451294720.0,East Asian
1451360216,PA166155063,rs4240803,,,SLC7A5,Dosage,-1,pregabalin,1451360221.0,"Multiple groups, Participants were of the following ethnicities: Punjabi, Pathan, Urdu Speaking, Kashmiri and Others"
981785551,PA166154274,rs487989,,,POLA2,Efficacy,-1,gemcitabine,981785556.0,East Asian
1444934267,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1444934276.0,Multiple groups
1444934267,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1444934276.0,Multiple groups
1449295802,PA166178583,rs2162145,,,CPA6,Efficacy,1,metformin,1449295804.0,European
1449295791,PA166178547,rs254271,,,PRPF31,Efficacy,1,metformin,1449295793.0,Multiple groups
1448522397,PA166155342,rs11615,,,ERCC1,Efficacy,-1,fluorouracil,1448522399.0,Multiple groups
1448522397,PA166155342,rs11615,,,ERCC1,Efficacy,-1,irinotecan,1448522399.0,Multiple groups
1448522397,PA166155342,rs11615,,,ERCC1,Efficacy,-1,oxaliplatin,1448522399.0,Multiple groups
1183698918,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,sertraline,1183698932.0,East Asian
1183698918,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,sertraline,1183698932.0,East Asian
1183698918,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,sertraline,1183698932.0,East Asian
1448358561,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1448358563.0,Unknown
1448358561,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1448358563.0,Unknown
1451360210,PA166155063,rs4240803,,,SLC7A5,Dosage,1,gabapentin,1451360215.0,"Multiple groups, Participants were of the following ethnicities: Punjabi, Pathan, Urdu Speaking, Kashmiri and Others"
1451098080,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,sumatriptan,1451098084.0,Unknown
1444704894,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL3,Efficacy,1,telaprevir,1444704896.0,East Asian
1444704894,PA166155468,rs12979860,,,IFNL4,Efficacy,1,telaprevir,1444704896.0,East Asian
655388494,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,655388496.0,Unknown
1184747519,PA166156358,rs2472677,,,NR1I2,Toxicity,-1,atazanavir,1184747521.0,"Multiple groups, 80% Caucasian"
1184747519,PA166156358,rs2472677,,,NR1I2,Toxicity,-1,ritonavir,1184747521.0,"Multiple groups, 80% Caucasian"
981785567,PA166154447,rs11030918,,,RRM1,Efficacy,-1,gemcitabine,981785571.0,East Asian
981785567,PA166154447,rs11030918,,,STIM1,Efficacy,-1,gemcitabine,981785571.0,East Asian
1184174034,,,PA165819268,TPMT*1,TPMT,Dosage,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819270,TPMT*3A,TPMT,Dosage,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819272,TPMT*3C,TPMT,Dosage,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819268,TPMT*1,TPMT,Efficacy,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819270,TPMT*3A,TPMT,Efficacy,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819272,TPMT*3C,TPMT,Efficacy,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819268,TPMT*1,TPMT,Toxicity,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819270,TPMT*3A,TPMT,Toxicity,0,azathioprine,1184174036.0,Unknown
1184174034,,,PA165819272,TPMT*3C,TPMT,Toxicity,0,azathioprine,1184174036.0,Unknown
1446900395,PA166156938,rs699947,,,VEGFA,Efficacy,1,enalapril,1446900406.0,"Multiple groups, Brazil"
1446900395,PA166156938,rs699947,,,VEGFA,Efficacy,1,enalapril,1446900404.0,Unknown
1446900395,PA166156938,rs699947,,,VEGFA,Efficacy,1,enalapril,1446900402.0,"Multiple groups, Brazil"
1449295811,PA166156024,rs4680,,,COMT,Dosage,1,morphine,1449295819.0,Unknown
1449295811,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1449295819.0,Unknown
1449557951,PA166154789,rs2236225,,,MTHFD1,Efficacy,-1,methotrexate,1449557953.0,European
1449557951,PA166154789,rs2236225,,,MTHFD1,Efficacy,-1,methotrexate,1449558083.0,European
1451098086,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,fenoterol,1451098126.0,Unknown
1184174025,,,PA165819268,TPMT*1,TPMT,Dosage,0,azathioprine,1184174033.0,Unknown
1184174025,,,PA165819270,TPMT*3A,TPMT,Dosage,0,azathioprine,1184174033.0,Unknown
1184174025,,,PA165819268,TPMT*1,TPMT,Efficacy,0,azathioprine,1184174033.0,Unknown
1184174025,,,PA165819270,TPMT*3A,TPMT,Efficacy,0,azathioprine,1184174033.0,Unknown
1184174025,,,PA165819268,TPMT*1,TPMT,Toxicity,0,azathioprine,1184174033.0,Unknown
1184174025,,,PA165819270,TPMT*3A,TPMT,Toxicity,0,azathioprine,1184174033.0,Unknown
982047671,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,phenobarbital,982047681.0,Unknown
982047671,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,phenobarbital,982047681.0,Unknown
982047671,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,phenobarbital,982047681.0,Unknown
827823495,PA166155372,rs1800469,,,TGFB1,Efficacy,1,glatiramer acetate,827823501.0,European
827823495,PA166155372,rs1800469,,,TGFB1,Efficacy,1,glatiramer acetate,827823501.0,European
1449295820,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449295822.0,Unknown
1449295820,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1449295822.0,Unknown
981785517,PA166156578,rs3775289,,,DCK,Efficacy,-1,gemcitabine,981785522.0,East Asian
1444934293,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1444934301.0,Multiple groups
1448522360,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,fluorouracil,1448522362.0,Multiple groups
1448522360,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,irinotecan,1448522362.0,Multiple groups
1448522360,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,oxaliplatin,1448522362.0,Multiple groups
1448358522,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,cyclosporine,1448358524.0,Unknown
1448358522,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,cyclosporine,1448358524.0,Unknown
1184747551,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747579.0,Unknown
1184747551,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747576.0,Unknown
1184747551,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747574.0,Unknown
1184747551,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747572.0,Unknown
1449295851,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449295857.0,European
1449295851,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1449295857.0,European
981785534,PA166156479,rs4742,,,DCTD,Efficacy,-1,gemcitabine,981785542.0,"Multiple groups, 43 subjects (81%) were Chinese and 10 (19%) were Malay"
981785534,PA166156479,rs4742,,,DCTD,Efficacy,-1,gemcitabine,981785542.0,"Multiple groups, 43 subjects (81%) were Chinese and 10 (19%) were Malay"
1449164775,PA166155986,rs1051266,,,SLC19A1,Toxicity,1,methotrexate,1449164781.0,European
1449164775,PA166155986,rs1051266,,,SLC19A1,Toxicity,1,methotrexate,1449164781.0,European
982047769,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,982047789.0,Multiple groups
982047769,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,982047789.0,Multiple groups
982047769,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,982047789.0,Multiple groups
982047769,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,1,lansoprazole,982047789.0,Multiple groups
982047769,,,PA165816525,CYP2C19*9,CYP2C19,Metabolism/PK,1,lansoprazole,982047789.0,Multiple groups
1448522347,PA166155346,rs25487,,,XRCC1,Efficacy,-1,fluorouracil,1448522349.0,Multiple groups
1448522347,PA166155346,rs25487,,,XRCC1,Efficacy,-1,irinotecan,1448522349.0,Multiple groups
1448522347,PA166155346,rs25487,,,XRCC1,Efficacy,-1,oxaliplatin,1448522349.0,Multiple groups
1184468912,PA166155721,rs4148323,,,UGT1A1,Efficacy,1,cisplatin,1184468919.0,East Asian
1184468912,PA166155721,rs4148323,,,UGT1A1,Efficacy,1,irinotecan,1184468919.0,East Asian
1184468912,PA166155721,rs4148323,,,UGT1A1,Efficacy,1,irinotecan,1184468919.0,East Asian
1451098127,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,fenoterol,1451098109.0,Unknown
1444934203,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1444934215.0,Latino
1444934203,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1444934215.0,Latino
1449164791,PA166157288,rs1128503,,,ABCB1,Toxicity,-1,methotrexate,1449164797.0,European
1449246724,PA166157283,rs1043550,,,CALU,Dosage,-1,warfarin,1449246777.0,Central/South Asian
1449246724,PA166157283,rs1043550,,,CALU,Dosage,-1,warfarin,1449246777.0,Central/South Asian
1449164801,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,methotrexate,1449164803.0,European
1449164801,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,methotrexate,1449164803.0,European
1448522322,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,fluorouracil,1448522324.0,Multiple groups
1448522322,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,fluorouracil,1448522324.0,Multiple groups
1448522322,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,irinotecan,1448522324.0,Multiple groups
1448522322,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,irinotecan,1448522324.0,Multiple groups
1448522322,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,oxaliplatin,1448522324.0,Multiple groups
1448522322,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,oxaliplatin,1448522324.0,Multiple groups
1449164807,PA166154579,rs4149056,,,SLCO1B1,Toxicity,-1,methotrexate,1449164809.0,European
1183698962,PA166155409,rs3745274,,,CYP2B6,Dosage,1,methadone,1183698966.0,"Multiple groups, Israeli - European, Middle Eastern and Asian mixed ancestry"
1183698967,PA166155393,rs2279343,,,CYP2B6,Dosage,1,methadone,1183698969.0,"Multiple groups, Israeli - European, Middle Eastern and Asian mixed ancestry"
1444704847,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444704888.0,East Asian
1444704847,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444704888.0,East Asian
1444704847,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444704888.0,East Asian
1444704847,PA166155435,rs8099917,,,IFNL3,Efficacy,1,telaprevir,1444704888.0,East Asian
1449164819,PA166154547,rs2306283,,,SLCO1B1,Toxicity,-1,methotrexate,1449164821.0,European
981785594,PA166154940,rs17215836,,,SLC28A1,Efficacy,-1,gemcitabine,981785599.0,East Asian
1449164813,PA166154633,rs11045879,,,SLCO1B1,Toxicity,-1,methotrexate,1449164815.0,European
1449558039,PA166155301,rs6506569,,,PTPRM,Efficacy,-1,methotrexate,1449558103.0,European
1449558039,PA166155301,rs6506569,,,PTPRM,Efficacy,-1,methotrexate,1449558041.0,European
1449295897,PA166177796,rs563649,,,OPRM1,Dosage,-1,morphine,1449295899.0,European
1449295897,PA166177796,rs563649,,,OPRM1,Efficacy,-1,morphine,1449295899.0,European
1451098094,PA166157206,rs55918055,,,SLC22A1,Metabolism/PK,1,fenoterol,1451098098.0,Unknown
1451098104,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,sumatriptan,1451098121.0,Unknown
1449164825,PA166156543,rs2231137,,,ABCG2,Toxicity,-1,methotrexate,1449164827.0,European
981785580,PA166154468,rs12806698,,,RRM1,Efficacy,-1,gemcitabine,981785585.0,East Asian
981785580,PA166154468,rs12806698,,,STIM1,Efficacy,-1,gemcitabine,981785585.0,East Asian
1449558033,PA166179184,rs162040,,,MTRR,Efficacy,-1,methotrexate,1449558101.0,European
1449558033,PA166179184,rs162040,,,MTRR,Efficacy,-1,methotrexate,1449558035.0,European
1449558033,PA166179184,rs162040,,,MTRR,Efficacy,-1,methotrexate,1449558101.0,European
1449558033,PA166179184,rs162040,,,MTRR,Efficacy,-1,methotrexate,1449558035.0,European
1444934243,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1444934251.0,East Asian
1449295891,PA166178595,rs7776341,,,OPRM1,Dosage,-1,morphine,1449295893.0,European
1449295891,PA166178595,rs7776341,,,OPRM1,Efficacy,-1,morphine,1449295893.0,European
1448522297,PA166154249,rs1695,,,GSTP1,Efficacy,-1,fluorouracil,1448522299.0,Multiple groups
1448522297,PA166154249,rs1695,,,GSTP1,Efficacy,-1,irinotecan,1448522299.0,Multiple groups
1448522297,PA166154249,rs1695,,,GSTP1,Efficacy,-1,oxaliplatin,1448522299.0,Multiple groups
1449558056,PA166155288,rs2847153,,,TYMS,Efficacy,-1,methotrexate,1449558058.0,European
1449558056,PA166155288,rs2847153,,,TYMS,Efficacy,-1,methotrexate,1449558107.0,European
1449164833,PA166156544,rs2231142,,,ABCG2,Toxicity,-1,methotrexate,1449164835.0,European
1184747485,PA166154688,rs899494,,,ABCC4,Toxicity,-1,tenofovir,1184747490.0,"Multiple groups, 80% Caucasian"
1449295909,PA166178596,rs540825,,,OPRM1,Dosage,-1,morphine,1449295911.0,European
1449295909,PA166178596,rs540825,,,OPRM1,Efficacy,-1,morphine,1449295911.0,European
1448604213,PA166163378,rs2234711,,,IFNGR1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604215.0,Unknown
827807029,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,827807035.0,East Asian
981785608,PA166154886,rs2290272,,,SLC28A1,Efficacy,-1,gemcitabine,981785613.0,East Asian
1184747497,PA166153953,rs717620,,,ABCC2,Toxicity,-1,tenofovir,1184747499.0,"Multiple groups, 80% Caucasian"
1449295903,PA166157015,rs2075572,,,OPRM1,Dosage,-1,morphine,1449295905.0,European
1449295903,PA166157015,rs2075572,,,OPRM1,Efficacy,-1,morphine,1449295905.0,European
1451098122,PA166157206,rs55918055,,,SLC22A1,Metabolism/PK,1,sumatriptan,1451098085.0,Unknown
1449295915,PA166178597,rs677830,,,OPRM1,Dosage,-1,morphine,1449295917.0,European
1449295915,PA166178597,rs677830,,,OPRM1,Efficacy,-1,morphine,1449295917.0,European
1449164839,PA166154021,rs2804402,,,ABCC2,Toxicity,-1,methotrexate,1449164841.0,European
827807021,PA166156359,rs2640543,,,AGTR1,Efficacy,1,benazepril,827807038.0,East Asian
1449164851,PA166154007,rs2273697,,,ABCC2,Toxicity,-1,methotrexate,1449164853.0,European
1448358439,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tacrolimus,1448358449.0,East Asian
1448358439,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1448358449.0,East Asian
1449558050,PA166179188,rs2244500,,,TYMS,Efficacy,-1,methotrexate,1449558105.0,European
1449558050,PA166179188,rs2244500,,,TYMS,Efficacy,-1,methotrexate,1449558052.0,European
1448604207,PA166163385,rs10754558,,,NLRP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604209.0,Unknown
1450934350,PA166185904,rs398123217,,,GLA,Efficacy,0,migalastat,1450934355.0,Unknown
1183699042,PA166157725,rs1318383,,,KCNT1,Efficacy,-1,antiepileptics,1183699044.0,East Asian
1449295927,PA166156027,rs6269,,,COMT,Dosage,-1,morphine,1449295929.0,European
1449295927,PA166156027,rs6269,,,COMT,Efficacy,-1,morphine,1449295929.0,European
1445556737,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1445556746.0,Unknown
1445556737,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1445556746.0,Unknown
1183699038,PA166157827,rs11103182,,,KCNT1,Efficacy,-1,antiepileptics,1183699040.0,East Asian
1449164845,PA166153953,rs717620,,,ABCC2,Toxicity,-1,methotrexate,1449164847.0,European
1449164845,PA166153953,rs717620,,,ABCC2,Toxicity,-1,methotrexate,1449164847.0,European
827921716,PA166157244,rs37973,,,GLCCI1,Efficacy,1,glucocorticoids,827921722.0,European
827921716,PA166157244,rs37973,,,GLCCI1,Efficacy,1,glucocorticoids,827921720.0,European
1448604196,PA166163375,rs3212217,,,IL12B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604198.0,Unknown
982015058,PA166154304,rs964184,,,APOA1,Efficacy,1,fenofibrate,982015065.0,European
982015058,PA166154304,rs964184,,,APOA1,Efficacy,1,fenofibrate,982015067.0,European
982015058,PA166154304,rs964184,,,APOA1,Efficacy,1,fenofibrate,982030073.0,Latino
982015058,PA166154304,rs964184,,,APOA1,Efficacy,1,fenofibrate,982030075.0,Latino
1183699050,PA166157814,rs10776850,,,KCNT1,Efficacy,-1,antiepileptics,1183699052.0,East Asian
1183699050,PA166157814,rs10776850,,,KCNT1,Efficacy,-1,antiepileptics,1183699052.0,East Asian
1450934356,PA166185905,rs397515874,,,GLA,Efficacy,0,migalastat,1450934361.0,Unknown
1451098202,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,o-desmethyltramadol,1451098191.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1450934362,PA166185906,rs727505292,,,GLA,Efficacy,0,migalastat,1450934367.0,Unknown
1183699046,PA166157813,rs10776845,,,KCNT1,Efficacy,-1,antiepileptics,1183699048.0,East Asian
1448604190,PA166163382,rs12343867,,,JAK2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604192.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,amitriptyline,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,citalopram,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,escitalopram,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,nortriptyline,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,paroxetine,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,Selective serotonin reuptake inhibitors,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,sertraline,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,trimipramine,1448276514.0,Unknown
1448276512,PA166157336,rs2235015,,,ABCB1,Efficacy,-1,venlafaxine,1448276514.0,Unknown
1184747648,PA166156544,rs2231142,,,ABCG2,Efficacy,1,sulfasalazine,1184747653.0,Multiple groups
1448276503,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1448276505.0,Unknown
1448276503,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448276505.0,Unknown
981785702,PA166154857,rs1060896,,,SLC28A2,Efficacy,1,gemcitabine,981785709.0,East Asian
1183699026,PA166157808,rs10735239,,,KCNT1,Efficacy,-1,antiepileptics,1183699028.0,East Asian
1184469118,PA166157734,rs1611115,,,DBH,Efficacy,1,levodopa,1184469149.0,Unknown
1184469118,PA166157734,rs1611115,,,DBH,Efficacy,1,levodopa,1184469149.0,Unknown
1445556721,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1445556730.0,European
1445556721,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1445556730.0,European
1449295945,PA166178598,rs165774,,,COMT,Dosage,-1,morphine,1449295947.0,European
1449295945,PA166178598,rs165774,,,COMT,Efficacy,-1,morphine,1449295947.0,European
1183699022,PA166157713,rs755722,,,KCNT1,Efficacy,-1,antiepileptics,1183699024.0,East Asian
1450934368,PA166185907,rs869312399,,,GLA,Efficacy,0,migalastat,1450934373.0,Unknown
1449295933,PA166156023,rs4633,,,COMT,Dosage,-1,morphine,1449295935.0,European
1449295933,PA166156023,rs4633,,,COMT,Efficacy,-1,morphine,1449295935.0,European
1448423959,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448423961.0,Latino
1448604179,PA166163380,rs17250932,,,TBX21,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604181.0,Unknown
1450934374,PA166185908,rs104894828,,,GLA,Efficacy,0,migalastat,1450934379.0,Unknown
1183699034,PA166157800,rs10118746,,,KCNT1,Efficacy,-1,antiepileptics,1183699036.0,East Asian
1448112663,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1448115791.0,European
1448112663,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1448115791.0,European
1183699030,PA166157826,rs11103167,,,KCNT1,Efficacy,-1,antiepileptics,1183699032.0,East Asian
1449295939,PA166156025,rs4818,,,COMT,Dosage,-1,morphine,1449295941.0,European
1449295939,PA166156025,rs4818,,,COMT,Efficacy,-1,morphine,1449295941.0,European
981785654,PA166154882,rs2242047,,,SLC28A1,Efficacy,-1,gemcitabine,981785659.0,East Asian
1183699010,PA166157709,rs498618,,,KCNT1,Efficacy,-1,antiepileptics,1183699012.0,East Asian
1183699006,PA166157710,rs498974,,,KCNT1,Efficacy,-1,antiepileptics,1183699008.0,East Asian
827921746,PA166153953,rs717620,,,ABCC2,Efficacy,1,antiepileptics,827921752.0,East Asian
1449164880,PA166176805,rs3394,,,ADORA3,Toxicity,-1,methotrexate,1449164882.0,European
1449246811,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1449246813.0,Central/South Asian
1183699018,PA166157791,rs7855716,,,KCNT1,Efficacy,-1,antiepileptics,1183699020.0,East Asian
827921753,PA166154028,rs3740066,,,ABCC2,Efficacy,1,antiepileptics,827921759.0,East Asian
1448604165,PA166163378,rs2234711,,,IFNGR1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604167.0,Unknown
1183699014,PA166157729,rs1537416,,,KCNT1,Efficacy,-1,antiepileptics,1183699016.0,East Asian
1449295975,PA166156626,rs7668282,,,UGT2B7,Dosage,-1,morphine,1449295977.0,European
1449295975,PA166156626,rs7668282,,,UGT2B7,Efficacy,-1,morphine,1449295977.0,European
981785668,PA166154881,rs2242046,,,SLC28A1,Efficacy,-1,gemcitabine,981785673.0,East Asian
827921760,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,antiepileptics,827921767.0,East Asian
1183698989,PA166157711,rs546120,,,KCNT1,Efficacy,-1,antiepileptics,1183698993.0,East Asian
1448604149,PA166154344,rs1946518,,,IL18,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604155.0,Unknown
1448604149,PA166154344,rs1946518,,,IL18,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604157.0,Unknown
1183699002,PA166157721,rs1165016,,,KCNT1,Efficacy,-1,antiepileptics,1183699004.0,East Asian
1450934341,PA166185903,rs398123212,,,GLA,Efficacy,0,migalastat,1450934346.0,Unknown
827921768,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,827921777.0,East Asian
1449164906,PA166176808,rs2298191,,,ADORA3,Toxicity,-1,methotrexate,1449164908.0,European
1183698998,PA166157706,rs487750,,,KCNT1,Efficacy,-1,antiepileptics,1183699000.0,East Asian
1184747687,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,methotrexate,1184747692.0,Unknown
1448636905,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1448636911.0,European
1448636905,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1448636911.0,European
1448636905,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1448636911.0,European
1448276458,PA166155381,rs2108622,,,CYP4F2,Dosage,0,warfarin,1448276460.0,Multiple groups
1448276453,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1448276455.0,Multiple groups
1449295993,PA166157143,rs9340799,,,ESR1,Dosage,-1,morphine,1449295995.0,European
1449295993,PA166157143,rs9340799,,,ESR1,Efficacy,-1,morphine,1449295995.0,European
1451098252,PA166157206,rs55918055,,,SLC22A1,Metabolism/PK,1,o-desmethyltramadol,1451098257.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1450950800,PA166153760,rs3918290,,,DPYD,Efficacy,-1,FOLFIRI,1450950781.0,Multiple groups
1450950800,PA166153760,rs3918290,,,DPYD,Efficacy,-1,FOLFOX,1450950781.0,Multiple groups
1450950800,PA166153760,rs3918290,,,DPYD,Efficacy,-1,irinotecan,1450950781.0,Multiple groups
1450950800,PA166153760,rs3918290,,,DPYD,Efficacy,-1,oxaliplatin,1450950781.0,Multiple groups
1183699114,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183699116.0,East Asian
1183699114,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183699116.0,East Asian
827823838,PA166156323,rs1523130,,,NR1I2,Dosage,-1,nevirapine,827823848.0,Sub-Saharan African
827823838,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,-1,nevirapine,827823848.0,Sub-Saharan African
1451098261,PA166157206,rs55918055,,,SLC22A1,Dosage,1,tramadol,1451098266.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1449295987,PA166157026,rs2234693,,,ESR1,Dosage,-1,morphine,1449295989.0,European
1449295987,PA166157026,rs2234693,,,ESR1,Efficacy,-1,morphine,1449295989.0,European
1449295987,PA166157026,rs2234693,,,ESR1,Efficacy,-1,morphine,1449295989.0,European
1448820856,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1448820867.0,Unknown
1448820856,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1448820867.0,Unknown
1448820856,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,voriconazole,1448820867.0,Unknown
1448820856,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1448820867.0,Unknown
1450934425,PA166185911,rs869312136,,,GLA,Efficacy,0,migalastat,1450934430.0,Unknown
1448423903,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448423917.0,Latino
1448423903,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448423917.0,Latino
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,amitriptyline,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,citalopram,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,escitalopram,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,nortriptyline,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,paroxetine,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,Selective serotonin reuptake inhibitors,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,sertraline,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,trimipramine,1448276501.0,Unknown
1448276439,PA166157317,rs2032583,,,ABCB1,Efficacy,-1,venlafaxine,1448276501.0,Unknown
1448604122,PA166163373,rs8126756,,,IFNGR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604124.0,Unknown
1449164930,PA166153644,rs1801133,,,MTHFR,Toxicity,-1,methotrexate,1449164932.0,European
1450934431,PA166185912,rs28935195,,,GLA,Efficacy,0,migalastat,1450934436.0,Unknown
1184747580,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747585.0,Unknown
1184747580,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747582.0,Unknown
1184747580,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747584.0,Unknown
1184747580,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,antineoplastic agents,1184747583.0,Unknown
1448276436,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,pioglitazone,1448276438.0,Unknown
1448423892,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448423915.0,Latino
1448423892,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448423915.0,Latino
1448423892,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448423915.0,Latino
1448423892,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448423915.0,Latino
1450950820,PA166153646,rs1801159,,,DPYD,Efficacy,-1,FOLFIRI,1450950825.0,Multiple groups
1450950820,PA166153646,rs1801159,,,DPYD,Efficacy,-1,FOLFOX,1450950825.0,Multiple groups
1450950820,PA166153646,rs1801159,,,DPYD,Efficacy,-1,irinotecan,1450950825.0,Multiple groups
1450950820,PA166153646,rs1801159,,,DPYD,Efficacy,-1,oxaliplatin,1450950825.0,Multiple groups
1451098283,PA166157178,rs12208357,,,SLC22A1,Dosage,1,tramadol,1451098288.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
827823825,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827823836.0,"Multiple groups, 91 Malays;96 Chinese;46 Indians."
1184747595,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,antineoplastic agents,1184747597.0,Unknown
1184747595,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,antineoplastic agents,1184747600.0,Unknown
1184747595,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,antineoplastic agents,1184747599.0,Unknown
1184747595,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,antineoplastic agents,1184747598.0,Unknown
1449164924,PA166176812,rs1544223,,,ADORA3,Toxicity,-1,methotrexate,1449164926.0,European
1449164936,PA166153643,rs1801131,,,MTHFR,Toxicity,-1,methotrexate,1449164938.0,European
1450934437,PA166185913,rs104894827,,,GLA,Efficacy,0,migalastat,1450934442.0,Unknown
1451114666,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451114671.0,"Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)"
1451114666,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114671.0,"Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)"
1450934443,PA166185914,rs869312138,,,GLA,Efficacy,0,migalastat,1450934448.0,Unknown
1451114660,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114665.0,"Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)"
981785718,PA166157820,rs10868138,,,SLC28A3,Efficacy,-1,gemcitabine,981785723.0,East Asian
827823816,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,827823824.0,"Multiple groups, 91 Malays;96 Chinese;46 Indians."
1450934380,PA166185909,rs398123226,,,GLA,Efficacy,0,migalastat,1450934385.0,Unknown
1448604108,PA166163371,rs5744174,,,TLR5,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448604116.0,Unknown
1184747603,PA166156544,rs2231142,,,ABCG2,Efficacy,1,antineoplastic agents,1184747605.0,Unknown
1184747603,PA166156544,rs2231142,,,ABCG2,Efficacy,1,antineoplastic agents,1184747606.0,Unknown
1184747603,PA166156544,rs2231142,,,ABCG2,Efficacy,1,antineoplastic agents,1184747607.0,Unknown
1184747603,PA166156544,rs2231142,,,ABCG2,Efficacy,1,antineoplastic agents,1184747608.0,Unknown
1450934386,PA166185909,rs398123226,,,GLA,Efficacy,0,migalastat,1450934391.0,Unknown
1449164942,PA166153654,rs1805087,,,MTR,Toxicity,-1,methotrexate,1449164944.0,European
1448276427,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,rosiglitazone,1448276429.0,Unknown
982015087,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,982015089.0,Central/South Asian
1184469080,PA166154891,rs2412459,,,EIF2AK4,Efficacy,-1,haloperidol,1184469082.0,European
827823804,PA166157284,rs1045642,,,ABCB1,Dosage,-1,nevirapine,827823813.0,Sub-Saharan African
827823804,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,nevirapine,827823813.0,Sub-Saharan African
1450934392,PA166185910,rs727504348,,,GLA,Efficacy,0,migalastat,1450934397.0,Unknown
1449164948,PA166156776,rs1801394,,,MTRR,Toxicity,-1,methotrexate,1449164950.0,European
1448604092,PA166155017,rs1800566,,,NQO1,Efficacy,0,warfarin,1448604098.0,Latino
1451098240,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,o-desmethyltramadol,1451098245.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1183699054,PA166157819,rs10858173,,,KCNT1,Efficacy,-1,antiepileptics,1183699056.0,East Asian
1449164956,PA166155331,rs45445694,,,TYMS,Toxicity,-1,methotrexate,1449164958.0,European
1184469093,PA166154891,rs2412459,,,EIF2AK4,Efficacy,-1,olanzapine,1184469095.0,Unknown
1184469093,PA166154891,rs2412459,,,EIF2AK4,Efficacy,-1,quetiapine,1184469095.0,Unknown
1184469093,PA166154891,rs2412459,,,EIF2AK4,Efficacy,-1,risperidone,1184469095.0,Unknown
1184469093,PA166154891,rs2412459,,,EIF2AK4,Efficacy,-1,ziprasidone,1184469095.0,Unknown
1184747623,PA166155778,rs10188577,,,SCN1A,Efficacy,1,antiepileptics,1184747628.0,European
1448276404,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,-1,pioglitazone,1448276406.0,Unknown
1448276404,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,-1,pioglitazone,1448276406.0,Unknown
827823796,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827823815.0,"Multiple groups, 91 Malays;96 Chinese;46 Indians."
1183699169,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,cyclophosphamide,1183699171.0,Unknown
1450934476,PA166185918,rs398123223,,,GLA,Efficacy,0,migalastat,1450934481.0,Unknown
1183699164,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,cyclophosphamide,1183699166.0,Unknown
1448604071,PA166157525,rs113993960,,,CFTR,Efficacy,1,cavosonstat,1448604079.0,Unknown
1448112545,PA166159499,rs10964552,,,MLLT3,Efficacy,1,cisplatin,1448112547.0,Unknown
1448112545,PA166159499,rs10964552,,,MLLT3,Efficacy,1,cisplatin,1448112548.0,Unknown
1448604066,PA166157525,rs113993960,,,CFTR,Efficacy,-1,cavosonstat,,
1449164986,PA166155684,rs2372536,,,ATIC,Toxicity,-1,methotrexate,1449164988.0,European
1183699173,PA166154794,rs2494750,,,AKT1,Efficacy,-1,carboplatin,1183699175.0,East Asian
1183699173,PA166154794,rs2494750,,,AKT1,Efficacy,-1,cisplatin,1183699175.0,East Asian
1450950867,PA166153648,rs1801265,,,DPYD,Efficacy,-1,FOLFIRI,1450950872.0,Multiple groups
1450950867,PA166153648,rs1801265,,,DPYD,Efficacy,-1,FOLFOX,1450950872.0,Multiple groups
1450950867,PA166153648,rs1801265,,,DPYD,Efficacy,-1,irinotecan,1450950872.0,Multiple groups
1450950867,PA166153648,rs1801265,,,DPYD,Efficacy,-1,oxaliplatin,1450950872.0,Multiple groups
827807389,PA166154792,rs2401863,,,TDP1,Efficacy,1,irinotecan,827807396.0,European
1450934488,PA166185920,rs28935490,,,GLA,Efficacy,0,migalastat,1450934493.0,Unknown
1449164980,PA166153876,rs17602729,,,AMPD1,Toxicity,-1,methotrexate,1449164982.0,European
1451262164,PA166223581,rs10493112,,,YBX1,Efficacy,1,abiraterone,1451262180.0,Unknown
1451262164,PA166223581,rs10493112,,,YBX1,Efficacy,1,abiraterone,1451262169.0,Unknown
1451262164,PA166223581,rs10493112,,,YBX1,Efficacy,1,abiraterone,1451262170.0,Unknown
982047979,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,fluindione,982047990.0,European
982047979,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,fluindione,982047990.0,European
1183699152,PA166154796,rs2498786,,,AKT1,Efficacy,-1,carboplatin,1183699167.0,East Asian
1183699152,PA166154796,rs2498786,,,AKT1,Efficacy,-1,cisplatin,1183699167.0,East Asian
982015210,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,982015217.0,Unknown
1448604057,PA166163365,rs12535512,,,ABCB1,Efficacy,1,risperidone,1448604059.0,East Asian
1449164992,PA166155915,rs1127354,,,ITPA,Toxicity,-1,methotrexate,1449164994.0,European
1448276377,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,1,rosiglitazone,1448276389.0,Unknown
1448276377,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,1,rosiglitazone,1448276389.0,Unknown
982015200,PA166155381,rs2108622,,,CYP4F2,Dosage,1,phenprocoumon,982015209.0,Unknown
1448112528,PA166159497,rs7937567,,,GALNT18,Efficacy,1,cisplatin,1448112530.0,Unknown
1448112528,PA166159497,rs7937567,,,GALNT18,Efficacy,1,cisplatin,1448112535.0,Unknown
827823764,PA166157267,rs776746,,,CYP3A5,Dosage,-1,nevirapine,827823780.0,Sub-Saharan African
827823764,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,nevirapine,827823780.0,Sub-Saharan African
1449164998,PA166154789,rs2236225,,,MTHFD1,Toxicity,-1,methotrexate,1449165000.0,European
1451098289,PA166157197,rs34130495,,,SLC22A1,Dosage,1,tramadol,1451098294.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1451114672,PA166154628,rs11045819,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451114677.0,"Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)"
1451114672,PA166154628,rs11045819,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114677.0,"Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)"
1448423827,PA166161186,rs77932196,,,CFTR,Efficacy,1,ivacaftor,1448423833.0,Unknown
1448276358,PA166160991,rs3759467,,,None,Efficacy,1,rituximab,1448276368.0,Unknown
1448276358,PA166160991,rs3759467,,,None,Efficacy,1,rituximab,1448276366.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,cetuximab,1184747801.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,cetuximab,1184747795.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,cetuximab,1184747797.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,cetuximab,1184747799.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,irinotecan,1184747801.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,irinotecan,1184747795.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,irinotecan,1184747797.0,Unknown
1184747790,PA166158794,rs11568315,,,EGFR,Efficacy,-1,irinotecan,1184747799.0,Unknown
1448604036,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,risperidone,1448604038.0,East Asian
1450934449,PA166185915,rs1569304898,,,GLA,Efficacy,0,migalastat,1450934454.0,Unknown
827823747,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,nevirapine,827823763.0,Sub-Saharan African
827823747,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,nevirapine,827823763.0,Sub-Saharan African
1450934455,PA166185916,rs372966991,,,GLA,Efficacy,0,migalastat,1450934460.0,Unknown
1448604030,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,risperidone,1448604032.0,East Asian
1450934461,PA166185917,rs869312146,,,GLA,Efficacy,0,migalastat,1450934466.0,Unknown
1451098303,PA166157196,rs34059508,,,SLC22A1,Dosage,1,tramadol,1451098295.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1450934470,PA166185937,rs397515870,,,GLA,Efficacy,0,migalastat,1450934475.0,Unknown
1448276340,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1448276342.0,East Asian
1183699129,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1183699131.0,East Asian
1184747818,PA166156936,rs683369,,,SLC22A1,Metabolism/PK,1,imatinib,1184747823.0,Unknown
1448276332,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448276339.0,East Asian
982047936,PA166153539,rs699,,,AGT,Efficacy,1,quinapril,982047987.0,East Asian
1448604016,PA166157340,rs2235048,,,ABCB1,Efficacy,1,risperidone,1448604029.0,East Asian
1183699124,PA166156938,rs699947,,,VEGFA,Efficacy,-1,cyclophosphamide,1183699128.0,Unknown
1445556633,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1445556642.0,European
1445556633,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1445556640.0,"Multiple groups, Caucasian (n=48), African-American (n=4), Hispanics (n=2)"
1444704559,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1444704589.0,European
1444704559,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1444704653.0,European
1444704559,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1444704589.0,European
1444704559,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1444704653.0,European
1444704559,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,clopidogrel,1444704589.0,European
1444704559,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,clopidogrel,1444704653.0,European
1451114771,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lopinavir,1451114784.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114771,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,ritonavir,1451114784.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1448112500,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448112506.0,European
1448112479,PA166159492,rs11052877,,,CD69,Efficacy,1,tocilizumab,1448112481.0,European
1184747694,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,1,methotrexate,1184747696.0,Unknown
1184747694,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,1,methotrexate,1184747696.0,Unknown
1451114766,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lopinavir,1451114825.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114766,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,ritonavir,1451114825.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
982015252,PA166155912,rs1044396,,,CHRNA4,Efficacy,-1,methylphenidate,982015259.0,Unknown
982048014,PA166157284,rs1045642,,,ABCB1,Efficacy,1,atorvastatin,982048018.0,"Multiple groups, Majority White patients."
1448603998,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1448604000.0,Unknown
1448603998,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1448604000.0,Unknown
1296599629,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1296599641.0,East Asian
1296599629,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1296599641.0,East Asian
982048012,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,982048028.0,East Asian
982048012,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,982048028.0,East Asian
982048012,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,982048028.0,East Asian
982048012,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,982048028.0,East Asian
1183699216,PA166153853,rs12139042,,,MTOR,Efficacy,-1,carboplatin,1183699218.0,East Asian
1183699216,PA166153853,rs12139042,,,MTOR,Efficacy,-1,cisplatin,1183699218.0,East Asian
827823698,PA166156151,rs28371706,,,CYP2D6,Dosage,1,nevirapine,827823718.0,Sub-Saharan African
827823698,PA166156151,rs28371706,,,CYP2D6,Dosage,1,nevirapine,827823736.0,Sub-Saharan African
827823698,PA166156151,rs28371706,,,CYP2D6,Metabolism/PK,1,nevirapine,827823718.0,Sub-Saharan African
827823698,PA166156151,rs28371706,,,CYP2D6,Metabolism/PK,1,nevirapine,827823736.0,Sub-Saharan African
982048034,PA166155460,rs11666735,,,FCAR,Efficacy,1,pravastatin,982048042.0,European
827921925,PA166154400,rs3758785,,,GPR83,Efficacy,1,candesartan,827921934.0,European
1451147560,PA166157405,rs4986910,,,CYP3A,Metabolism/PK,-1,ambrisentan,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,ambrisentan,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A,Metabolism/PK,-1,aripiprazole,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,aripiprazole,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A,Metabolism/PK,-1,atorvastatin,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,atorvastatin,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A,Metabolism/PK,-1,donepezil,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,donepezil,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A,Metabolism/PK,-1,olanzapine,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147560,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,-1,olanzapine,1451147564.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1183617300,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,zuclopenthixol,1183617302.0,European
1183617300,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,zuclopenthixol,1183617302.0,European
827921929,PA166154400,rs3758785,,,GPR83,Efficacy,1,hydrochlorothiazide,827921939.0,European
982015260,PA166155957,rs6090384,,,CHRNA4,Efficacy,-1,methylphenidate,982015265.0,Unknown
827823690,PA166156387,rs3842689,,,NR1I2,Dosage,1,nevirapine,827823697.0,Sub-Saharan African
827823690,PA166156387,rs3842689,,,NR1I2,Metabolism/PK,1,nevirapine,827823697.0,Sub-Saharan African
1449165062,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,-1,warfarin,1449165067.0,Unknown
1448423752,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1448423761.0,Unknown
1444704590,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,prasugrel,1444704592.0,European
1444704590,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,prasugrel,1444704592.0,European
1444704590,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,prasugrel,1444704592.0,European
982047993,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,-1,warfarin,982047997.0,European
1184747730,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,clopidogrel,1184747747.0,Unknown
1184747730,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1184747747.0,Unknown
982031608,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,982031611.0,European
982031608,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,982031611.0,European
982031608,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,ribavirin,982031611.0,European
1448112449,PA166159488,rs244898,,,RARS,Efficacy,1,cisplatin,1448112455.0,Unknown
1448112449,PA166159488,rs244898,,,RARS,Efficacy,1,cisplatin,1448112537.0,Unknown
1184747724,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,1184747729.0,European
1183699207,PA166155515,rs62107593,,,AKT2,Efficacy,-1,carboplatin,1183699209.0,East Asian
1183699207,PA166155515,rs62107593,,,AKT2,Efficacy,-1,cisplatin,1183699209.0,East Asian
1447948592,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1447948592,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,gefitinib,1447948599.0,European
1449165069,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,-1,warfarin,1449165071.0,Unknown
1448276279,PA166155096,rs9934438,,,VKORC1,Dosage,0,warfarin,1448276281.0,European
982048008,PA166156276,rs5186,,,AGTR1,Efficacy,-1,quinapril,982048010.0,East Asian
1451229440,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1451229444.0,Unknown
1451229440,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,tramadol,1451229444.0,Unknown
1451229440,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,tramadol,1451229444.0,Unknown
982015239,PA166157487,rs35599367,,,CYP3A4,Dosage,-1,acenocoumarol,982015248.0,Unknown
982015239,PA166157487,rs35599367,,,CYP3A4,Dosage,-1,acenocoumarol,982015250.0,Unknown
982015239,PA166157487,rs35599367,,,CYP3A4,Dosage,-1,phenprocoumon,982015248.0,Unknown
982015239,PA166157487,rs35599367,,,CYP3A4,Dosage,-1,phenprocoumon,982015250.0,Unknown
982031621,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,982031624.0,European
982031621,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,982031624.0,European
982031621,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,ribavirin,982031624.0,European
982048004,PA166155187,rs1799752,,,ACE,Efficacy,-1,quinapril,982048006.0,East Asian
1448423731,PA166156025,rs4818,,,COMT,Efficacy,1,quetiapine,1448423733.0,East Asian
1183699188,PA166155490,rs34716810,,,AKT2,Efficacy,-1,carboplatin,1183699190.0,East Asian
1183699188,PA166155490,rs34716810,,,AKT2,Efficacy,-1,cisplatin,1183699190.0,East Asian
699638917,PA166156046,rs165599,,,COMT,Efficacy,1,risperidone,699638920.0,"Multiple groups, 78 African American and 65 white patients"
699638922,PA166157264,rs724226,,,GRM3,Efficacy,1,risperidone,699638924.0,"Multiple groups, 78 African American and 65 white patients"
769173671,PA166155915,rs1127354,,,ITPA,Efficacy,-1,methotrexate,769173677.0,European
769173669,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,769173679.0,European
769173669,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,769173679.0,European
769173669,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,769173679.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750890.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750892.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750901.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750903.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750907.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750917.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750895.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750897.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750905.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750911.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750913.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750909.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750915.0,European
1449750851,PA166154147,rs12248560,,,CYP2C19,Efficacy,1,phenazepam,1449750899.0,European
1449718085,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,aspirin,1449718087.0,Unknown
1449718085,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,aspirin,1449718087.0,Unknown
1449718085,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1449718087.0,Unknown
1449718085,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1449718087.0,Unknown
1451094360,PA166153977,rs1801253,,,ADRB1,Efficacy,1,carvedilol,1451094347.0,Multiple groups
1185235308,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1185235310.0,East Asian
1185235308,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1185235390.0,East Asian
1185235308,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,irinotecan,1185235310.0,East Asian
1185235308,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,irinotecan,1185235390.0,East Asian
981751120,PA166155842,rs17183814,,,SCN2A,Efficacy,1,carbamazepine,981751132.0,Central/South Asian
981751120,PA166155842,rs17183814,,,SCN2A,Efficacy,1,phenobarbital,981751132.0,Central/South Asian
981751120,PA166155842,rs17183814,,,SCN2A,Efficacy,1,phenytoin,981751132.0,Central/South Asian
981751120,PA166155842,rs17183814,,,SCN2A,Efficacy,1,valproic acid,981751132.0,Central/South Asian
1450930521,PA166185405,rs7606603,,,XIRP2,Dosage,-1,atenolol,1450930526.0,African American/Afro-Caribbean
769173660,PA166155915,rs1127354,,,ITPA,Efficacy,1,folic acid,769173662.0,"Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients."
769173660,PA166155915,rs1127354,,,ITPA,Efficacy,1,methotrexate,769173662.0,"Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients."
1448263959,PA166156931,rs610604,,,TNFAIP3,Efficacy,-1,adalimumab,1448263961.0,Unknown
1447674129,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447674141.0,East Asian
1447674129,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674141.0,East Asian
1451340124,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,1451340128.0,Sub-Saharan African
769173649,PA166153876,rs17602729,,,AMPD1,Efficacy,1,folic acid,769173651.0,"Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients."
769173649,PA166153876,rs17602729,,,AMPD1,Efficacy,1,methotrexate,769173651.0,"Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients."
1448263953,PA166156931,rs610604,,,TNFAIP3,Efficacy,-1,etanercept,1448263955.0,Unknown
1448263953,PA166156931,rs610604,,,TNFAIP3,Efficacy,-1,etanercept,1448263955.0,Unknown
1445396733,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,phenytoin,1445396735.0,Latino
1451340084,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1451340105.0,Sub-Saharan African
1451127146,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1451127125.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
769173642,PA166156118,rs5751876,,,ADORA2A,Efficacy,1,methotrexate,769173645.0,Central/South Asian
1448263941,PA166156931,rs610604,,,TNFAIP3,Efficacy,-1,ustekinumab,1448263944.0,Unknown
1450930479,PA166185466,rs3784921,,,TXNDC11,Efficacy,1,hydrochlorothiazide,1450930484.0,European
1451258160,PA166153644,rs1801133,,,MTHFR,Efficacy,1,methotrexate,1451258180.0,European
769173638,PA166155907,rs244076,,,ADA,Efficacy,1,methotrexate,769173641.0,Central/South Asian
981505339,PA166154592,rs4516035,,,VDR,Metabolism/PK,1,midazolam,981505345.0,European
1451340080,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1451340051.0,Sub-Saharan African
1450930491,PA166185405,rs7606603,,,XIRP2,Efficacy,1,atenolol,1450930499.0,African American/Afro-Caribbean
1296599021,PA166155259,rs28364032,,,CRHR1,Efficacy,1,antidepressants,1296599027.0,East Asian
1448427775,PA166157284,rs1045642,,,ABCB1,Efficacy,1,granisetron,1448427777.0,East Asian
1449718123,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,aspirin,1449718125.0,Unknown
1449718123,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,aspirin,1449718125.0,Unknown
1449718123,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1449718125.0,Unknown
1449718123,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,clopidogrel,1449718125.0,Unknown
1448427766,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,palonosetron,1448427768.0,East Asian
1448526070,PA166153765,rs4329505,,,IL6R,Efficacy,-1,tocilizumab,1448526072.0,European
1450979640,PA166154977,rs7294,,,VKORC1,Dosage,0,acenocoumarol,1450979660.0,European
1450979640,PA166154977,rs7294,,,VKORC1,Dosage,0,acenocoumarol,1450979660.0,European
1448526064,PA166153679,rs2228145,,,IL6R,Efficacy,-1,tocilizumab,1448526066.0,European
1450930506,PA166185466,rs3784921,,,TXNDC11,Dosage,-1,hydrochlorothiazide,1450930511.0,European
1448427759,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,granisetron,1448427761.0,East Asian
1448427759,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,palonosetron,1448427761.0,East Asian
1447952609,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1447952618.0,European
1447952609,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1447952616.0,Multiple groups
1447952609,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1447952620.0,African American/Afro-Caribbean
1448997225,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448997231.0,Multiple groups
1448263922,PA166160547,rs3213094,,,IL12B,Efficacy,1,ustekinumab,1448263924.0,Unknown
1451127180,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,efavirenz,1451127200.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
699638857,PA166154793,rs2494732,,,AKT1,Efficacy,1,risperidone,699638859.0,East Asian
1450373502,PA166155630,rs1143634,,,IL1B,Dosage,1,morphine,1450373504.0,"Multiple groups, Chinese and Indian self-reported ethnicities."
1450373502,PA166155630,rs1143634,,,IL1B,Efficacy,1,morphine,1450373504.0,"Multiple groups, Chinese and Indian self-reported ethnicities."
1450373508,PA166176322,rs3804100,,,TLR2,Dosage,1,morphine,1450373510.0,"Multiple groups, Chinese, Malay and Indian self-reported ethnicities."
1450373508,PA166176322,rs3804100,,,TLR2,Efficacy,1,morphine,1450373510.0,"Multiple groups, Chinese, Malay and Indian self-reported ethnicities."
1448526058,PA166161950,rs11265618,,,IL6R,Efficacy,1,tocilizumab,1448526060.0,European
608431827,PA166155102,rs10871454,,,STX4,Dosage,1,warfarin,608431829.0,European
1448526046,PA166153848,rs12083537,,,IL6R,Efficacy,1,tocilizumab,1448526052.0,European
1450930590,PA166185407,rs3743075,,,CHRNA3,Other,-1,nicotine,1450930596.0,East Asian
1448263892,PA166153781,rs6427528,,,CD84,Efficacy,-1,ustekinumab,1448263894.0,Unknown
1450373495,PA166155630,rs1143634,,,IL1B,Dosage,1,morphine,1450373497.0,"Multiple groups, Chinese and Indian self-reported ethnicities."
1450373495,PA166155630,rs1143634,,,IL1B,Efficacy,1,morphine,1450373497.0,"Multiple groups, Chinese and Indian self-reported ethnicities."
1448263903,PA166160547,rs3213094,,,IL12B,Efficacy,-1,adalimumab,1448263905.0,Unknown
1448427729,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,granisetron,1448427741.0,East Asian
1448427729,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,palonosetron,1448427741.0,East Asian
1448263886,PA166153781,rs6427528,,,CD84,Efficacy,-1,adalimumab,1448263888.0,Unknown
1450930597,PA166185408,rs3743074,,,CHRNA3,Other,-1,nicotine,1450930601.0,East Asian
1448263877,PA166153781,rs6427528,,,CD84,Efficacy,1,etanercept,1448263885.0,Unknown
1448997257,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997263.0,Sub-Saharan African
1184514375,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,imatinib,1184514383.0,Unknown
1448997264,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997266.0,Sub-Saharan African
608431797,PA166157254,rs339097,,,CALU,Dosage,1,warfarin,608431799.0,
1451127150,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,1,efavirenz,1451127126.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
608431789,PA166154175,rs28371685,,,CYP2C9,Dosage,1,warfarin,608431791.0,African American/Afro-Caribbean
1451340144,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1451340148.0,Sub-Saharan African
608431793,PA166154176,rs28371686,,,CYP2C9,Dosage,1,warfarin,608431795.0,African American/Afro-Caribbean
1448997270,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997272.0,Sub-Saharan African
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,antipsychotics,1448997290.0,European
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,aripiprazole,1448997290.0,European
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,clozapine,1448997290.0,European
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,haloperidol,1448997290.0,European
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,olanzapine,1448997290.0,European
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,quetiapine,1448997290.0,European
1448997283,PA166157260,rs680055,,,CYP3A43,Efficacy,1,risperidone,1448997290.0,European
827661232,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827661812.0,East Asian
699638861,PA166154801,rs3803300,,,AKT1,Efficacy,1,risperidone,699638863.0,East Asian
982046080,PA166154870,rs1800588,,,LIPC,Efficacy,1,pravastatin,982046087.0,Unknown
1448100012,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,mycophenolic acid,1448100014.0,European
1448640683,PA166155039,rs2307240,,,CES1,Efficacy,1,clopidogrel,1448640689.0,East Asian
1448640683,PA166155039,rs2307240,,,CES1,Efficacy,1,clopidogrel,1448640691.0,East Asian
1448640683,PA166155039,rs2307240,,,CES1,Efficacy,1,clopidogrel,1448640693.0,East Asian
608431766,PA166153686,rs2260863,,,EPHX1,Dosage,-1,warfarin,,
1448100023,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,mycophenolic acid,1448100025.0,European
1450979720,PA166155119,rs17708472,,,VKORC1,Dosage,0,acenocoumarol,1450979740.0,European
1450930637,PA166154845,rs680244,,,CHRNA5,Other,-1,nicotine,1450930641.0,East Asian
1450930642,PA166185485,rs692780,,,CHRNA5,Other,-1,nicotine,1450930646.0,East Asian
1184514546,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514548.0,European
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903955.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903963.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903967.0,Unknown
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903965.0,Unknown
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903953.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903954.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903969.0,Unknown
1446903951,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903960.0,Unknown
608431768,PA166153625,rs1131873,,,EPHX1,Dosage,1,warfarin,608431770.0,European
1448997292,PA166157257,rs472660,,,CYP3A,Efficacy,-1,antipsychotics,1448997294.0,European
1448997292,PA166157257,rs472660,,,CYP3A43,Efficacy,-1,antipsychotics,1448997294.0,European
1448997292,PA166157257,rs472660,,,CYP3A,Efficacy,-1,clozapine,1448997294.0,European
1448997292,PA166157257,rs472660,,,CYP3A43,Efficacy,-1,clozapine,1448997294.0,European
1450930647,PA166154841,rs588765,,,CHRNA5,Other,-1,nicotine,1450930651.0,East Asian
608431758,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,608431760.0,European
1296598928,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1296598930.0,East Asian
1296598928,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1296598931.0,East Asian
1183613417,PA166155842,rs17183814,,,SCN2A,Efficacy,-1,carbamazepine,1183613419.0,Multiple groups
1183613417,PA166155842,rs17183814,,,SCN2A,Efficacy,-1,valproic acid,1183613419.0,Multiple groups
1451340242,PA166230183,rs60140950,,,SLCO1B3,Metabolism/PK,1,telmisartan,1451340246.0,European
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,aspirin,1184989708.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,aspirin,1184989710.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,aspirin,1184989712.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,aspirin,1184989706.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,clopidogrel,1184989708.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,clopidogrel,1184989710.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,clopidogrel,1184989712.0,Unknown
1184989701,PA166155152,rs5918,,,ITGB3,Efficacy,-1,clopidogrel,1184989706.0,Unknown
1450930652,PA166185486,rs6495306,,,CHRNA5,Other,-1,nicotine,1450930656.0,East Asian
1043880054,PA166154586,rs4238001,,,SCARB1,Efficacy,-1,atorvastatin,1043880056.0,"Multiple groups, European and African Brazilian subjects."
1448525969,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1448525987.0,East Asian
1448525969,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1448525987.0,East Asian
1448525969,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1448525987.0,East Asian
1450930662,PA166185487,rs514743,,,CHRNA5,Other,-1,nicotine,1450930668.0,East Asian
608431781,PA166154082,rs7900194,,,CYP2C9,Dosage,1,warfarin,608431783.0,African American/Afro-Caribbean
608431774,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,608431776.0,European
608431772,PA166153772,rs4653436,,,EPHX1,Dosage,-1,warfarin,,
1043880045,PA166154488,rs5888,,,SCARB1,Efficacy,1,atorvastatin,1043880051.0,"Multiple groups, European and African Brazilian subjects."
1043880045,PA166154488,rs5888,,,SCARB1,Efficacy,1,atorvastatin,1043880049.0,"Multiple groups, European and African Brazilian subjects."
1043880045,PA166154488,rs5888,,,SCARB1,Efficacy,1,atorvastatin,1043880071.0,"Multiple groups, European and African Brazilian subjects."
608431778,PA166154493,rs216013,,,CACNA1C,Dosage,-1,warfarin,982032939.0,European
608431778,PA166154493,rs216013,,,CACNA1C,Dosage,-1,warfarin,982032944.0,European
1184514564,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514566.0,East Asian
1446903975,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor / lumacaftor,1446903977.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903975,PA166157525,rs113993960,,,CFTR,Efficacy,-1,ivacaftor / lumacaftor,1446903978.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
608431735,PA166154140,rs11572080,,,CYP2C8,Other,0,paclitaxel,608431739.0,
608431735,PA166154140,rs11572080,,,CYP2C8,Metabolism/PK,0,paclitaxel,608431739.0,
1449161170,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1449161175.0,European
1449161170,PA166156991,rs1799971,,,OPRM1,Toxicity,-1,ethanol,1449161175.0,European
1450930607,PA166185480,rs3743077,,,CHRNA3,Other,-1,nicotine,1450930611.0,East Asian
608431738,PA166157242,rs11653,,,CALU,Dosage,-1,warfarin,,
608431738,PA166157242,rs11653,,,OPN1SW,Dosage,-1,warfarin,,
1446903928,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,amitriptyline,1446903941.0,European
1446903928,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,amitriptyline,1446903941.0,European
1446903928,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,nortriptyline,1446903941.0,European
1446903928,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,nortriptyline,1446903941.0,European
1450930612,PA166154844,rs660652,,,CHRNA3,Other,-1,nicotine,1450930616.0,East Asian
1447673991,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1447674001.0,European
1447673991,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1447674001.0,European
1184514579,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514581.0,"Multiple groups, Chinese, Malay, Indian"
1448099974,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448099976.0,European
608431730,PA166153612,rs1051740,,,EPHX1,Dosage,-1,warfarin,,
1451127220,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,-1,efavirenz,1451127240.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1185235470,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1185235479.0,East Asian
1185235470,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1185235481.0,East Asian
1185235470,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,1,SN-38,1185235479.0,East Asian
1185235470,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,1,SN-38,1185235481.0,East Asian
1185235470,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1185235479.0,East Asian
1185235470,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1185235481.0,East Asian
1450930617,PA166185481,rs2869546,,,CHRNA3,Other,-1,nicotine,1450930621.0,East Asian
608431751,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,655388291.0,European
608431749,PA166155664,rs2069919,,,PROC,Dosage,-1,warfarin,,
699639067,PA166156885,rs17238540,,,HMGCR,Efficacy,-1,pravastatin,699639069.0,European
1296598918,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,-1,methotrexate,1296598921.0,East Asian
1296598918,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,-1,methotrexate,1296598920.0,East Asian
1450930627,PA166185483,rs555018,,,CHRNA5,Other,-1,nicotine,1450930631.0,East Asian
608431753,PA166156690,rs61750900,,,UGT2B10,Other,0,nicotine,608431755.0,
608431753,PA166156690,rs61750900,,,UGT2B10,Metabolism/PK,0,nicotine,608431755.0,
1184514597,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514603.0,Central/South Asian
1184514597,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514604.0,Central/South Asian
1184514597,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514605.0,Central/South Asian
1184514597,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514602.0,Central/South Asian
1184514597,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514603.0,Central/South Asian
1184514597,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514604.0,Central/South Asian
1184514597,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514605.0,Central/South Asian
1184514597,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514602.0,Central/South Asian
1184514588,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514590.0,European
1184514588,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514590.0,European
1448099963,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1448099973.0,European
608431743,PA166157735,rs1687390,,,ORM1,,-1,warfarin,,
608431743,PA166157735,rs1687390,,,ORM2,,-1,warfarin,,
1448640623,PA166156119,rs5758550,,,WBP2NL,Metabolism/PK,-1,4-hydroxytamoxifen,1448640679.0,Unknown
1448640623,PA166156119,rs5758550,,,WBP2NL,Metabolism/PK,-1,endoxifen,1448640679.0,Unknown
1448640623,PA166156119,rs5758550,,,WBP2NL,Metabolism/PK,-1,n-desmethyltamoxifen,1448640679.0,Unknown
1448640623,PA166156119,rs5758550,,,WBP2NL,Metabolism/PK,-1,tamoxifen,1448640679.0,Unknown
1451340224,,,PA165959980,UGT1A3*1,UGT1A3,Metabolism/PK,1,telmisartan,1451340241.0,European
1451340224,,,PA165959982,UGT1A3*3,UGT1A3,Metabolism/PK,1,telmisartan,1451340241.0,European
1450930632,PA166185484,rs621849,,,CHRNA5,Other,-1,nicotine,1450930636.0,East Asian
608431745,PA166154110,rs10509681,,,CYP2C8,Other,0,paclitaxel,608431747.0,
608431745,PA166154110,rs10509681,,,CYP2C8,Metabolism/PK,0,paclitaxel,608431747.0,
1184514481,PA166153635,rs1741981,,,HDAC1,Efficacy,1,Corticosteroids For Systemic Use,1184514485.0,Unknown
699638975,PA166154051,rs4148947,,,CHST3,Efficacy,1,docetaxel,699638977.0,"Multiple groups, 43 white, 3 african american, 1 asian"
699638975,PA166154051,rs4148947,,,CHST3,Efficacy,1,thalidomide,699638977.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1184514486,PA166153635,rs1741981,,,HDAC1,Efficacy,1,corticosteroids,1184514488.0,Unknown
1446903892,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,amitriptyline,1446903894.0,Unknown
1446903892,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,amitriptyline,1446903894.0,Unknown
1446903892,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,amitriptyline,1446903894.0,Unknown
1446903892,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,nortriptyline,1446903894.0,Unknown
1446903892,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,nortriptyline,1446903894.0,Unknown
1446903892,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,nortriptyline,1446903894.0,Unknown
1451094560,PA166154482,rs671,,,ALDH2,Metabolism/PK,1,nitroglycerin,1451094566.0,East Asian
1184137748,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,phenobarbital,1184137750.0,Unknown
1184137748,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,phenobarbital,1184137750.0,Unknown
1184137748,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,phenobarbital,1184137750.0,Unknown
699638971,PA166154052,rs4148950,,,CHST3,Efficacy,1,docetaxel,699638974.0,"Multiple groups, 43 white, 3 african american, 1 asian"
699638971,PA166154052,rs4148950,,,CHST3,Efficacy,1,thalidomide,699638974.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1296598882,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methotrexate,1296598884.0,East Asian
982046240,,,PA165819201,CYP3A4*1,CYP3A4,Other,-1,tacrolimus,982046242.0,Unknown
982046240,,,PA166048680,CYP3A4*22,CYP3A4,Other,-1,tacrolimus,982046242.0,Unknown
699638963,PA166153954,rs730720,,,CHST3,Efficacy,1,docetaxel,699638966.0,"Multiple groups, 43 white, 3 african american, 1 asian"
699638963,PA166153954,rs730720,,,CHST3,Efficacy,1,thalidomide,699638966.0,"Multiple groups, 43 white, 3 african american, 1 asian"
1446903908,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,amitriptyline,1446903910.0,Unknown
1446903908,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,-1,amitriptyline,1446903910.0,Unknown
1446903908,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,-1,amitriptyline,1446903910.0,Unknown
1446903908,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,-1,amitriptyline,1446903910.0,Unknown
1446903908,,,PA165816581,CYP2D6*6,CYP2D6,Dosage,-1,amitriptyline,1446903910.0,Unknown
1184514504,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514506.0,East Asian
1184514504,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514506.0,East Asian
982046202,PA166156447,rs12487736,,,SCAP,Efficacy,-1,atorvastatin,982046204.0,Multiple groups
1450930669,PA166185488,rs647041,,,CHRNA5,Other,-1,nicotine,1450930673.0,East Asian
1450930679,PA166185489,rs7178270,,,CHRNB4,Other,-1,nicotine,1450930683.0,East Asian
1451094520,PA166154482,rs671,,,ALDH2,Efficacy,1,nitroglycerin,1451094540.0,East Asian
1184514513,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514515.0,European
1184514513,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514515.0,European
982046193,PA166156087,rs2228314,,,SREBF2,Efficacy,-1,simvastatin,982046195.0,European
1296598832,PA166155271,rs520210,,,NEDD4L,Efficacy,1,citalopram,1296598844.0,"Multiple groups, non-HIspanic Caucasian, African-American, Hispanic Caucasian"
1296598832,PA166155271,rs520210,,,NEDD4L,Efficacy,1,citalopram,1296598875.0,"Multiple groups, non-Hispanic and Hispanic Caucasian"
1296598832,PA166155271,rs520210,,,NEDD4L,Efficacy,1,citalopram,1296598879.0,European
982046189,PA166155265,rs60282872,,,SREBF1,Efficacy,-1,simvastatin,982046191.0,European
1448624188,PA166155607,rs887829,,,UGT1A1,Dosage,-1,warfarin,1448624190.0,East Asian
1184514519,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514521.0,East Asian
1296598859,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,phenprocoumon,1296598906.0,"Multiple groups, mostly White (81%)"
1296598859,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,-1,phenprocoumon,1296598906.0,"Multiple groups, mostly White (81%)"
1446903873,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446903890.0,European
1446903873,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446903890.0,European
982046215,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,tacrolimus,1451251064.0,Unknown
982046215,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,tacrolimus,982046221.0,Unknown
982046215,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,1,tacrolimus,1451251064.0,Unknown
982046215,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,1,tacrolimus,982046221.0,Unknown
1447952428,PA166157524,rs113993959,,,CFTR,Efficacy,1,ataluren,1447952430.0,Unknown
1446903870,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903889.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903870,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903907.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1446903870,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1446903926.0,"Multiple groups, Australia, Belgium, Germany, New Zealand, USA CF centers"
1450930689,PA166185490,rs950776,,,CHRNB4,Other,-1,nicotine,1450930693.0,East Asian
1450930684,PA166181364,rs1948,,,CHRNB4,Other,-1,nicotine,1450930688.0,East Asian
1448624178,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448624180.0,East Asian
1296598845,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1296598878.0,East Asian
1296598845,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1296598873.0,East Asian
1448525865,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,edoxaban,1448525867.0,Multiple groups
1448263716,PA166160529,rs2072183,,,NPC1L1,Efficacy,1,hmg coa reductase inhibitors,1448263718.0,European
1448624168,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1448624170.0,East Asian
1183629922,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183630105.0,East Asian
1183629922,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,haloperidol,1183630105.0,East Asian
1448116253,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,1448116255.0,European
1451356763,PA166156997,rs1800629,,,TNF,Dosage,-1,sufentanil,1451356768.0,Unknown
1184989819,PA166157487,rs35599367,,,CYP3A4,Dosage,-1,tacrolimus,1184989821.0,European
1184514676,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184514681.0,East Asian
1184514676,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184514681.0,East Asian
1184514668,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1184514670.0,Near Eastern
1185235569,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185235575.0,Unknown
1185235569,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185235638.0,Unknown
1448525859,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,edoxaban,1448525864.0,Multiple groups
1451356751,PA166153640,rs1800872,,,IL10,Dosage,-1,sufentanil,1451356756.0,Unknown
1184989808,PA166157286,rs1057868,,,POR,Dosage,1,tacrolimus,1184989810.0,European
1184989808,PA166157286,rs1057868,,,POR,Dosage,1,tacrolimus,1184989810.0,European
1184989808,PA166157286,rs1057868,,,POR,Dosage,1,tacrolimus,1184989810.0,European
1447952420,PA166157513,rs74767530,,,CFTR,Efficacy,-1,ataluren,1447952422.0,Unknown
1448624157,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448624167.0,East Asian
1184514687,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514689.0,East Asian
1184514687,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514689.0,East Asian
1448263702,PA166160527,rs629301,,,SORT1,Efficacy,1,hmg coa reductase inhibitors,1448263704.0,European
1449161276,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1449161286.0,Unknown
1449161276,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1449161286.0,Unknown
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,amitriptyline,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,amitriptyline,1446903859.0,European
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,clomipramine,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,clomipramine,1446903859.0,European
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,doxepin,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,doxepin,1446903859.0,European
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,imipramine,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,imipramine,1446903859.0,European
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,maprotiline,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,maprotiline,1446903859.0,European
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,nortriptyline,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,nortriptyline,1446903859.0,European
1446903849,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,opipramol,1446903859.0,European
1446903849,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,-1,opipramol,1446903859.0,European
1447952408,PA166157524,rs113993959,,,CFTR,Efficacy,-1,ataluren,1447952410.0,Unknown
1185235587,PA166156332,rs1803274,,,BCHE,Efficacy,-1,donepezil,1185235589.0,Unknown
1185235587,PA166156332,rs1803274,,,BCHE,Efficacy,-1,donepezil,1185235602.0,Unknown
1451356769,PA166159897,rs28362491,,,NFKB1,Dosage,-1,sufentanil,1451356780.0,Unknown
1448099841,PA166156902,rs5985,,,F13A1,Efficacy,1,photodynamic therapy,1448099897.0,European
1446903789,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1446903811.0,European
1446903789,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1446903820.0,European
1446903789,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1446903816.0,European
1446903789,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1446903818.0,European
1446903789,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1446903822.0,European
1184514696,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514698.0,East Asian
1449718371,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Metabolism/PK,-1,sertraline,1449718383.0,Multiple groups
1449718371,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Metabolism/PK,-1,sertraline,1449718383.0,Multiple groups
1296599283,PA166153953,rs717620,,,ABCC2,Efficacy,-1,carbamazepine,1296599292.0,Unknown
1296599283,PA166153953,rs717620,,,ABCC2,Efficacy,-1,carbamazepine,1296599290.0,Unknown
1446903799,,,PA165951644,HLA-DRB1*07:01:01:01,HLA-DRB1,Efficacy,1,Hepatitis vaccines,1446903810.0,"Multiple groups, Black, White, Other"
1446903799,,,PA165951644,HLA-DRB1*07:01:01:01,HLA-DRB1,Efficacy,1,Hepatitis vaccines,1446903827.0,"Multiple groups, White, Black, Other"
1451356721,PA166161586,rs1800587,,,IL1A,Dosage,-1,sufentanil,1451356726.0,Unknown
1184514710,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1184514712.0,Near Eastern
1184989861,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1184989881.0,"Multiple groups, mainly White"
1184989861,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1184989881.0,"Multiple groups, mainly White"
1184989861,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clopidogrel,1184989881.0,"Multiple groups, mainly White"
1184989861,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,1,clopidogrel,1184989881.0,"Multiple groups, mainly White"
1184989861,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,clopidogrel,1184989881.0,"Multiple groups, mainly White"
1296599306,PA166154029,rs3740067,,,ABCC2,Efficacy,-1,carbamazepine,1296599308.0,Unknown
1296599306,PA166154029,rs3740067,,,ABCC2,Efficacy,-1,carbamazepine,1296599309.0,Unknown
1448997469,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,efavirenz,1448997471.0,Unknown
1449718352,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,sertraline,1449718362.0,Multiple groups
1449718352,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,sertraline,1449718368.0,Multiple groups
1449718352,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,sertraline,1449718370.0,Multiple groups
1449718352,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,sertraline,1449718362.0,Multiple groups
1449718352,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,sertraline,1449718368.0,Multiple groups
1449718352,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,sertraline,1449718370.0,Multiple groups
1451356745,PA166153639,rs1800871,,,IL10,Dosage,-1,sufentanil,1451356750.0,Unknown
1184514722,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514724.0,East Asian
1451356733,PA166233162,rs419598,,,IL1RN,Dosage,-1,sufentanil,1451356738.0,Unknown
1296599297,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,carbamazepine,1296599300.0,Unknown
1296599297,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,carbamazepine,1296599299.0,Unknown
982046272,PA166156933,rs628031,,,SLC22A1,Metabolism/PK,1,imatinib,982046285.0,East Asian
982046274,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,982046276.0,Unknown
1448997483,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997488.0,"Multiple groups, Black, mixed-race and white participants"
982046361,PA166157238,rs662,,,PON1,Efficacy,1,simvastatin,982046365.0,East Asian
699638591,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,699638594.0,Unknown
699638591,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,699638594.0,Unknown
699638591,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,699638594.0,Unknown
699638591,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,699638594.0,Unknown
1446903764,,,PA165956201,HLA-B*51:01:01,HLA-B,Efficacy,1,Measles vaccines,1446903766.0,"Multiple groups, Caucasian, Asian, Native American, Other"
1447952362,PA166157518,rs77010898,,,CFTR,Efficacy,-1,ataluren,1447952406.0,Unknown
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,alemtuzumab,1448099824.0,European
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,chlorambucil,1448099824.0,European
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,cyclophosphamide,1448099824.0,European
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,fludarabine,1448099824.0,European
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,prednisone,1448099824.0,European
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,rituximab,1448099824.0,European
1448099807,PA166159131,rs1801157,,,CXCL12,Efficacy,1,vincristine,1448099824.0,European
982046373,PA166156691,rs61767072,,,ADRA2C,Efficacy,1,bucindolol,982046375.0,Multiple groups
982046368,PA166153977,rs1801253,,,ADRB1,Efficacy,1,bucindolol,982046372.0,Multiple groups
1451111080,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1451111085.0,African American/Afro-Caribbean
1451111080,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1451111100.0,European
1451111080,PA166181200,rs73208473,,,SORCS2,Metabolism/PK,1,atazanavir,1451111101.0,Latino
1451356781,PA166233181,rs3774932,,,NFKB1,Dosage,-1,sufentanil,1451356786.0,Unknown
1184514654,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184514659.0,Near Eastern
1184514654,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184514659.0,Near Eastern
1448099774,PA166159082,rs2514036,,,ACY3,Efficacy,1,bisoprolol,1448099777.0,European
1450373797,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373799.0,Unknown
1450373797,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373800.0,Unknown
1450373797,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373801.0,Unknown
1450373797,PA166182219,rs6517442,,,KCNJ6,Efficacy,1,morphine,1450373802.0,Unknown
1446903740,,,PA165954366,HLA-B*07:02:01,HLA-B,Efficacy,1,Measles vaccines,1446903747.0,"Multiple groups, Caucasian, Asian, Native American, Other"
1446903740,,,PA165954366,HLA-B*07:02:01,HLA-B,Efficacy,1,Measles vaccines,1446903747.0,"Multiple groups, Caucasian, Asian, Native American, Other"
699638607,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,699638609.0,European
699638607,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,699638611.0,European
699638607,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,699638613.0,European
1446903755,,,PA165954643,HLA-B*13:01:01,HLA-B,Efficacy,1,Measles vaccines,1446903757.0,"Multiple groups, Caucasian, Asian, Native American, Other"
1448263608,PA166160514,rs56292801,,,MIR5189,Other,-1,methotrexate,1448263615.0,European
1446903748,,,PA165954547,HLA-B*08:01:01,HLA-B,Efficacy,1,Measles vaccines,1446903750.0,"Multiple groups, Caucasian, Asian, Native American, Other"
982046427,PA166155342,rs11615,,,ERCC1,Efficacy,-1,Platinum compounds,982046434.0,"Multiple groups, Asian and Caucasian"
1450373834,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373836.0,Unknown
1450373834,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373839.0,Unknown
1450373834,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373837.0,Unknown
1450373834,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373838.0,Unknown
1184514796,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514798.0,European
982046419,PA166157288,rs1128503,,,ABCB1,Efficacy,1,simvastatin,982046423.0,European
1450373824,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373827.0,Unknown
1450373824,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373828.0,Unknown
1450373824,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373826.0,Unknown
1450373824,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373829.0,Unknown
1296599211,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,Platinum compounds,1296599213.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373817.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373818.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373819.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1450373820.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373817.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373818.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373819.0,Unknown
1450373815,PA166156024,rs4680,,,COMT,Efficacy,1,remifentanil,1450373820.0,Unknown
1185235722,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1185235733.0,"Multiple groups, White, African-American, Hispanic, Other"
1185235722,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1185235733.0,"Multiple groups, White, African-American, Hispanic, Other"
1185235722,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1185235733.0,"Multiple groups, White, African-American, Hispanic, Other"
1185235722,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1185235733.0,"Multiple groups, White, African-American, Hispanic, Other"
1451143900,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451143882.0,"Multiple groups, Caucasian, Native American/Alaska Native and Asian participants."
1451143900,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451143920.0,"Multiple groups, Caucasian, Native American/Alaska Native and Asian participants."
1451143900,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451143905.0,"Multiple groups, Caucasian, Native American/Alaska Native and Asian participants."
1451143900,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451143906.0,"Multiple groups, Caucasian, Native American/Alaska Native and Asian participants."
1184514817,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514819.0,European
1185235716,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1185235721.0,"Multiple groups, White, African-American, Hispanic, Other"
1446903708,,,PA165951644,HLA-DRB1*07:01:01:01,HLA-DRB1,Efficacy,1,Influenza vaccines,1446903715.0,European
1296599205,PA166155349,rs238406,,,ERCC2,Efficacy,-1,Platinum compounds,1296599207.0,Unknown
982046436,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,simvastatin,982046438.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,insulin recombinant,1296599962.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,insulin recombinant,1296599319.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,insulin recombinant,1296599976.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,insulin recombinant,1296666188.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,zinc acetate,1296599962.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,zinc acetate,1296599319.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,zinc acetate,1296599976.0,European
1296599203,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,zinc acetate,1296666188.0,European
1446903723,,,PA165951968,HLA-DRB1*13:01:01,HLA-DRB1,Efficacy,1,Influenza vaccines,1446903725.0,European
1446903716,,,PA165958180,HLA-DQB1*03:03:02:01,HLA-DQB1,Efficacy,1,Influenza vaccines,1446903718.0,European
982046429,PA166157316,rs2032582,,,ABCB1,Efficacy,1,simvastatin,982046431.0,European
1184514826,PA166157267,rs776746,,,CYP3A5,Dosage,0,tacrolimus,1184514828.0,Multiple groups
699638814,PA166156339,rs2046934,,,P2RY12,Efficacy,0,clopidogrel,699638825.0,Unknown
1183679177,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679193.0,Unknown
1183679177,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679193.0,Unknown
1183679177,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679193.0,Unknown
1448263559,PA166160504,rs3212183,,,HNF4A,Efficacy,-1,lamotrigine,1448263561.0,East Asian
1445379985,PA166153986,rs1934969,,,CYP2C9,Metabolism/PK,1,phenytoin,1445381814.0,Latino
1448263553,PA166155919,rs2071197,,,HNF4A,Efficacy,-1,lamotrigine,1448263555.0,East Asian
1447952261,PA166157514,rs75039782,,,CFTR,Efficacy,1,ataluren,1447952263.0,Unknown
1448263541,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,lamotrigine,1448263543.0,East Asian
1184514838,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514840.0,East Asian
699638805,PA166156339,rs2046934,,,P2RY12,Efficacy,0,clopidogrel,699638807.0,Unknown
1448263547,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,lamotrigine,1448263549.0,East Asian
1448997609,PA166155355,rs707265,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997611.0,Unknown
1448997596,PA166170429,rs3181842,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997598.0,Unknown
1448263533,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,lamotrigine,1448263535.0,East Asian
1183679160,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679176.0,Unknown
1183679160,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679176.0,Unknown
1183679160,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679176.0,Unknown
1183679160,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679176.0,Unknown
1183679160,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679176.0,Unknown
1183679160,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183679176.0,Unknown
1185235744,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1185235749.0,"Multiple groups, White, African-American, Hispanic, Other"
1447952247,PA166157518,rs77010898,,,CFTR,Efficacy,1,ataluren,1447952249.0,Unknown
1448997604,PA166170431,rs7246465,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997606.0,Unknown
699638724,PA166154962,rs72547516,,,CYP1A2,,0,clozapine,,
1448263524,PA166157032,rs2282143,,,SLC22A1,Efficacy,-1,lamotrigine,1448263526.0,East Asian
699638728,PA166154963,rs72547517,,,CYP1A2,,0,clozapine,,
1184989883,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,prasugrel,1184989885.0,"Multiple groups, mainly White"
1184989883,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,prasugrel,1184989885.0,"Multiple groups, mainly White"
1184989883,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,prasugrel,1184989885.0,"Multiple groups, mainly White"
1184989883,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,-1,prasugrel,1184989885.0,"Multiple groups, mainly White"
1184989883,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,prasugrel,1184989885.0,"Multiple groups, mainly White"
1448492904,PA166161790,rs9332978,,,CYP4A11,Metabolism/PK,-1,exemestane,1448492906.0,Multiple groups
982046488,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,Platinum compounds,982046490.0,East Asian
1448997614,PA166155360,rs1042389,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997616.0,Unknown
1296599123,PA166155370,rs1799782,,,XRCC1,Efficacy,-1,Platinum compounds,1296599129.0,Unknown
1446903640,,,PA165951292,HLA-DQA1*02:01,HLA-DQA1,Efficacy,1,Measles vaccines,1446903642.0,"Multiple groups, Caucasian, Asian, Native American, Other"
1444708148,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,1444708153.0,Central/South Asian
1448263518,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,lamotrigine,1448263520.0,East Asian
982046480,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,simvastatin,982046482.0,European
1444708155,PA166155805,rs11676382,,,GGCX,Dosage,-1,acenocoumarol,1444708157.0,Central/South Asian
1448263511,PA166160504,rs3212183,,,HNF4A,Metabolism/PK,-1,lamotrigine,1448263513.0,East Asian
699638721,PA166156339,rs2046934,,,P2RY12,Efficacy,0,clopidogrel,699638727.0,European
1448263500,PA166155919,rs2071197,,,HNF4A,Metabolism/PK,-1,lamotrigine,1448263502.0,East Asian
982046476,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,Platinum compounds,982046478.0,East Asian
982046476,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,Platinum compounds,982046510.0,European
982046503,PA166154249,rs1695,,,GSTP1,Efficacy,-1,Platinum compounds,982046505.0,East Asian
982046503,PA166154249,rs1695,,,GSTP1,Efficacy,-1,Platinum compounds,982046508.0,European
699638701,PA166156886,rs17244841,,,HMGCR,Efficacy,-1,fluvastatin,699639074.0,"Multiple groups, White 97.00%,; Asian 2.30%,; Black 0.40%; other 0.30%"
1448263492,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,lamotrigine,1448263494.0,East Asian
982046456,PA166155343,rs13181,,,ERCC2,Efficacy,-1,Platinum compounds,982046458.0,"Multiple groups, Asian and Caucasian"
982046452,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,Platinum compounds,982046454.0,"Multiple groups, Asian and Caucasian"
1296599089,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1296599101.0,Unknown
699638755,PA166156339,rs2046934,,,P2RY12,Efficacy,0,clopidogrel,699638764.0,Unknown
1450930986,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,1450930991.0,
1450930986,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1450930991.0,
1449161492,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,nalmefene,1449161499.0,European
1448263476,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,lamotrigine,1448263478.0,East Asian
982046473,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,simvastatin,982046475.0,European
1446903619,,,PA166123430,HLA-DRB1*03:01,HLA-DRB1,Efficacy,1,Measles vaccines,1446903626.0,"Multiple groups, Caucasian, Asian, Native American, Other"
982046469,PA166155346,rs25487,,,XRCC1,Efficacy,-1,Platinum compounds,982046471.0,"Multiple groups, Asian and Caucasian"
1184514776,PA166157267,rs776746,,,CYP3A5,Dosage,-1,tacrolimus,1184514778.0,East Asian
1296599109,PA166155361,rs1052555,,,ERCC2,Efficacy,1,Platinum compounds,1296599111.0,Unknown
1448263482,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,lamotrigine,1448263484.0,East Asian
1444708196,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,1444708213.0,European
1444708196,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1444708213.0,European
1444708196,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,1444708213.0,European
982046461,PA166154693,rs1047768,,,ERCC5,Efficacy,-1,Platinum compounds,982046463.0,"Multiple groups, Asian and Caucasian"
1448997672,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997678.0,Central/South Asian
1448997672,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997678.0,Central/South Asian
1184990075,PA166153681,rs2235544,,,DIO1,Dosage,-1,levothyroxine,1184990081.0,"Multiple groups, Brazilian."
1447673635,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447673688.0,European
1447673635,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447673688.0,European
1448263466,PA166157032,rs2282143,,,SLC22A1,Metabolism/PK,-1,lamotrigine,1448263468.0,East Asian
1449161519,PA166175994,rs678849,,,OPRD1,Efficacy,-1,nalmefene,1449161521.0,European
1448997679,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997685.0,"Multiple groups, ""Study subjects were predominantly Black men"""
1448263457,PA166156933,rs628031,,,SLC22A1,Metabolism/PK,1,lamotrigine,1448263465.0,East Asian
1449161538,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1449161545.0,European
1449161538,,,PA165819244,CYP3A4*20,CYP3A4,Metabolism/PK,1,tacrolimus,1449161545.0,European
1448525595,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448525607.0,East Asian
1448525595,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448525607.0,East Asian
982046569,PA166156913,rs316019,,,SLC22A2,Metabolism/PK,1,l-tryptophan,982046573.0,Unknown
1184990088,PA166154767,rs225014,,,DIO2,Dosage,-1,levothyroxine,1184990090.0,"Multiple groups, Brazilian."
1184990082,PA166153820,rs11206244,,,DIO1,Dosage,-1,levothyroxine,1184990084.0,"Multiple groups, Brazilian."
1447984897,PA166157519,rs78655421,,,CFTR,Efficacy,1,ivacaftor,1447984903.0,Unknown
1448997712,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,efavirenz,,
1451143980,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine,1451144000.0,Unknown
1451143980,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine,1451144020.0,Unknown
1449161549,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1449161551.0,European
1449161549,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1449161551.0,European
1184990094,PA166154828,rs12885300,,,DIO2,Dosage,-1,levothyroxine,1184990096.0,"Multiple groups, Brazilian."
1450931001,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1450931006.0,
827824632,PA166153760,rs3918290,,,DPYD,Other,1,fluorouracil,827824638.0,Unknown
827824632,PA166153760,rs3918290,,,DPYD,Metabolism/PK,1,fluorouracil,827824638.0,Unknown
1184514962,PA166157267,rs776746,,,CYP3A5,Dosage,-1,tacrolimus,1184514964.0,Near Eastern
1184514968,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514970.0,East Asian
1448263407,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,oxaliplatin,1448263417.0,Multiple groups
1448263407,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,oxaliplatin,1448263417.0,Multiple groups
1448640236,,,PA165819269,TPMT*2,TPMT,Efficacy,-1,cisplatin,1448640238.0,Central/South Asian
1448640236,,,PA165819269,TPMT*2,TPMT,Efficacy,-1,fluorouracil,1448640238.0,Central/South Asian
769255152,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,769255158.0,East Asian
1183679401,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679403.0,Multiple groups
1183679401,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679403.0,Multiple groups
1183679401,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679403.0,Multiple groups
1184514862,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514864.0,"Multiple groups, Asian (n=8), Black (n=7), Caucasian (n=120)"
1447952104,PA166157524,rs113993959,,,CFTR,Efficacy,1,ataluren,1447952172.0,Unknown
769255159,PA166154053,rs4244285,,,CYP2C19,Efficacy,-1,ticlopidine,769255161.0,East Asian
769255162,PA166154070,rs4986893,,,CYP2C19,Efficacy,1,clopidogrel,769255170.0,East Asian
1185235759,PA166157747,rs2250242,,,ORM2,Metabolism/PK,1,docetaxel,1185235765.0,"Multiple groups, Caucasian (primarily), and African-American"
1184514868,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514870.0,East Asian
1184514868,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514870.0,East Asian
1184514868,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514870.0,East Asian
1448997763,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448997765.0,Multiple groups
1448997763,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448997765.0,Multiple groups
1451291560,PA166153729,rs3003596,,,NR1I3,Metabolism/PK,-1,efavirenz,1451291580.0,European
1183679374,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679376.0,Multiple groups
1183679374,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679376.0,Multiple groups
1183679374,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679376.0,Multiple groups
1183679374,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183679376.0,Multiple groups
1183679374,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183679376.0,Multiple groups
1448640212,,,PA165819272,TPMT*3C,TPMT,Efficacy,1,cisplatin,1448640214.0,Central/South Asian
1448640212,,,PA165819272,TPMT*3C,TPMT,Efficacy,1,fluorouracil,1448640214.0,Central/South Asian
1184514887,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514892.0,Unknown
1184514887,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514892.0,Unknown
1448115929,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1448115931.0,European
1183679387,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679389.0,Multiple groups
1183679387,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679389.0,Multiple groups
1183679387,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679389.0,Multiple groups
1183679387,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679389.0,Multiple groups
1183679387,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183679389.0,Multiple groups
1184514893,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514897.0,European
1184514893,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514899.0,European
1184514893,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514900.0,European
1184514893,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514898.0,European
1184514893,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514897.0,European
1184514893,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514899.0,European
1184514893,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514900.0,European
1184514893,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514898.0,European
1448640203,,,PA165819271,TPMT*3B,TPMT,Efficacy,1,cisplatin,1448640211.0,Central/South Asian
1448640203,,,PA165819271,TPMT*3B,TPMT,Efficacy,1,fluorouracil,1448640211.0,Central/South Asian
1183679361,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679373.0,Multiple groups
1183679361,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679373.0,Multiple groups
1183679361,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679373.0,Multiple groups
1183679361,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679373.0,Multiple groups
1183679361,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183679373.0,Multiple groups
1184990042,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184990044.0,East Asian
1184990042,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1184990044.0,East Asian
1451291500,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,efavirenz,1451291520.0,European
1448115914,,,PA165819176,CYP1A2*1F,CYP1A2,Efficacy,-1,clopidogrel,1448115916.0,European
1184990030,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184990040.0,East Asian
1184990030,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184990040.0,East Asian
1448997777,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997779.0,Multiple groups
1448525501,PA166161882,rs648743,,,CTH,Metabolism/PK,-1,busulfan,1448525507.0,"Multiple groups, Caucasian (n=60), African (n=11), Asian (n=3), American Indian (n=2)"
1446903476,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,-1,amitriptyline,1446903483.0,European
1184514907,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514912.0,"Multiple groups, White, African American, Asian, Unknown"
1184514907,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514912.0,"Multiple groups, White, African American, Asian, Unknown"
1185235790,PA166154256,rs5219,,,KCNJ11,Efficacy,1,gliclazide,1185235796.0,East Asian
1446903489,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,amitriptyline,1446903500.0,European
1446903489,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,amitriptyline,1446903496.0,European
1446903489,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,amitriptyline,1446903498.0,European
1184990053,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,1184990055.0,East Asian
1448115887,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,clopidogrel,1448115889.0,European
1448115887,,,PA165818760,CYP2B6*5,CYP2B6,Efficacy,-1,clopidogrel,1448115889.0,European
1448525496,PA166161880,rs1021737,,,CTH,Metabolism/PK,-1,busulfan,1448525509.0,"Multiple groups, Caucasian (n=60), African (n=11), Asian (n=3), American Indian (n=2)"
1448115897,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,clopidogrel,1448115899.0,European
1448115897,,,PA165818807,CYP2B6*9,CYP2B6,Efficacy,-1,clopidogrel,1448115899.0,European
1183679456,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679458.0,Multiple groups
1183679456,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679458.0,Multiple groups
1183679456,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679458.0,Multiple groups
1446903440,PA166153669,rs2076322,,,None,Efficacy,-1,metformin,1446903442.0,Unknown
1448997797,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997803.0,Multiple groups
1450374079,PA166156530,rs1902023,,,UGT2B15,Efficacy,1,acetaminophen,1450374081.0,European
769173279,PA166157767,rs3842787,,,PTGS1,Efficacy,-1,aspirin,769173281.0,European
982046699,PA166155641,rs1799808,,,PROC,Dosage,1,phenprocoumon,982046701.0,European
982046699,PA166155641,rs1799808,,,PROC,Metabolism/PK,1,phenprocoumon,982046701.0,European
1449161667,PA166154339,rs1800497,,,DRD2,Efficacy,-1,buprenorphine,1449161673.0,"Multiple groups, Participants were of Caucasian, Indigenous Australian, Torres Strait Islander, Asian, Indian or Turkish ethnicity."
1449161667,PA166154339,rs1800497,,,DRD2,Efficacy,-1,methadone,1449161673.0,"Multiple groups, Participants were of Caucasian, Indigenous Australian, Torres Strait Islander, Asian, Indian or Turkish ethnicity."
827808153,PA166153818,rs10919563,,,PTPRC,Efficacy,1,adalimumab,827808160.0,Multiple groups
827808153,PA166153818,rs10919563,,,PTPRC,Efficacy,1,etanercept,827808160.0,Multiple groups
827808153,PA166153818,rs10919563,,,PTPRC,Efficacy,1,infliximab,827808160.0,Multiple groups
1183679442,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679444.0,Multiple groups
1183679442,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679444.0,Multiple groups
1183679442,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679444.0,Multiple groups
1450374073,PA166182236,rs224534,,,TRPV1,Efficacy,1,acetaminophen,1450374078.0,European
1450374073,PA166182236,rs224534,,,TRPV1,Efficacy,1,acetaminophen,1450374078.0,European
827808147,PA166154321,rs1150226,,,HTR3A,Efficacy,1,clozapine,827808152.0,Multiple groups
1451111400,PA166156076,rs1135840,,,CYP2D6,Metabolism/PK,1,desethyl hydroxychloroquine,1451111405.0,East Asian
1448115863,PA166156418,rs6809699,,,P2RY12,Efficacy,-1,clopidogrel,1448115865.0,European
769156875,PA166157267,rs776746,,,CYP3A,Dosage,-1,risperidone,769156877.0,European
769156875,PA166157267,rs776746,,,CYP3A5,Dosage,-1,risperidone,769156877.0,European
769156875,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,risperidone,769156877.0,European
769156875,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,risperidone,769156877.0,European
827808138,PA166154358,rs2276302,,,HTR3A,Efficacy,1,clozapine,827808146.0,Multiple groups
982046650,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,982046654.0,European
1184515084,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1184515089.0,"Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% ""other""."
1184515084,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1184515089.0,"Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% ""other""."
1447951996,PA166153868,rs17111584,,,USP24,Efficacy,1,rosuvastatin,1447951999.0,European
1448115838,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,clopidogrel,1448115840.0,European
1448115838,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,clopidogrel,1448115840.0,European
1183679423,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183679425.0,Multiple groups
1183679423,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183679425.0,Multiple groups
1183679423,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183679425.0,Multiple groups
769156872,PA166157316,rs2032582,,,ABCB1,Dosage,-1,risperidone,769156874.0,European
769156872,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,risperidone,769156874.0,European
1450374121,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,(S)-methadone,1450374123.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1450374121,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,(S)-methadone,1450374124.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1184515103,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184515108.0,East Asian
1184515103,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184515108.0,East Asian
827808121,PA166154312,rs1062613,,,HTR3A,Efficacy,1,clozapine,827808129.0,Multiple groups
1447951982,PA166155341,rs7412,,,APOE,Efficacy,1,rosuvastatin,1447951984.0,European
1451291581,PA166153700,rs2307424,,,NR1I3,Metabolism/PK,-1,efavirenz,1451291586.0,European
982046656,PA166153612,rs1051740,,,EPHX1,Dosage,1,phenprocoumon,982046658.0,European
982046656,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,phenprocoumon,982046658.0,European
1446903431,PA166153791,rs7541245,,,FMO5,Efficacy,1,metformin,1446903439.0,Unknown
1447951990,PA166156515,rs1481012,,,ABCG2,Efficacy,1,rosuvastatin,1447951992.0,European
1448115828,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1448115830.0,European
1448115828,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,clopidogrel,1448115830.0,European
982046747,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,calcitriol,982046751.0,European
982046747,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,cisplatin,982046751.0,European
982046747,PA166155932,rs2762939,,,CYP24A1,Efficacy,-1,docetaxel,982046751.0,European
1184514988,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514992.0,European
1184514988,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514992.0,European
1447951965,PA166157168,rs10455872,,,LPA,Efficacy,1,rosuvastatin,1447951967.0,European
982046742,PA166154740,rs9561765,,,ABCC4,Efficacy,1,imatinib,982046746.0,European
827808098,PA166155125,rs17886199,,,PRSS53,Dosage,1,warfarin,827808105.0,African American/Afro-Caribbean
827808098,PA166155125,rs17886199,,,VKORC1,Dosage,1,warfarin,827808105.0,African American/Afro-Caribbean
982030355,PA166157853,rs502434,,,GRIA3,Efficacy,1,Selective serotonin reuptake inhibitors,982030361.0,East Asian
982030355,PA166157853,rs502434,,,GRIA3,Efficacy,1,venlafaxine,982030361.0,East Asian
982030355,PA166157853,rs502434,,,GRIA3,Efficacy,1,venlafaxine,982030361.0,East Asian
1448263271,PA166160480,rs1042719,,,ADRB2,Metabolism/PK,-1,ephedrine,1448263273.0,European
1448263271,PA166160480,rs1042719,,,ADRB2,Metabolism/PK,-1,phenylephrine,1448263273.0,European
1183679530,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679533.0,Multiple groups
1183679530,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679534.0,Multiple groups
1183679530,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679532.0,Multiple groups
1183679530,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679533.0,Multiple groups
1183679530,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679534.0,Multiple groups
1183679530,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679532.0,Multiple groups
1448115817,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,clopidogrel,1448115819.0,European
1448115817,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,clopidogrel,1448115819.0,European
1184515001,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,tacrolimus,1184515003.0,Multiple groups
1447951974,PA166155517,rs71352238,,,APOE,Efficacy,1,rosuvastatin,1447951977.0,European
1447951974,PA166155517,rs71352238,,,APOE,Efficacy,1,rosuvastatin,1447951977.0,European
982030375,PA166157871,rs3761554,,,GRIA3,Efficacy,1,Selective serotonin reuptake inhibitors,982030379.0,East Asian
982030375,PA166157871,rs3761554,,,GRIA3,Efficacy,1,venlafaxine,982030379.0,East Asian
1448263265,PA166160473,rs1042718,,,ADRB2,Metabolism/PK,-1,ephedrine,1448263267.0,European
1448263265,PA166160473,rs1042718,,,ADRB2,Metabolism/PK,-1,phenylephrine,1448263267.0,European
1444707906,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenprocoumon,1444707921.0,Unknown
1444707906,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,phenprocoumon,1444707921.0,Unknown
1444707906,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenprocoumon,1444707921.0,Unknown
1444707906,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenprocoumon,1444707921.0,Unknown
1448263259,PA166156773,rs1800888,,,ADRB2,Metabolism/PK,-1,ephedrine,1448263261.0,European
1448263259,PA166156773,rs1800888,,,ADRB2,Metabolism/PK,-1,phenylephrine,1448263261.0,European
982046754,PA166153953,rs717620,,,ABCC2,Efficacy,-1,antiepileptics,982046775.0,Unknown
1184515013,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515015.0,Multiple groups
827824467,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,antiepileptics,827824477.0,European
1447951958,PA166157575,rs2199939,,,ABCG2,Efficacy,1,rosuvastatin,1447951963.0,European
827824458,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,antiepileptics,827824475.0,European
982046752,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982046762.0,Multiple groups
1446903345,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,amitriptyline,1446903369.0,European
1446903345,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,amitriptyline,1446903367.0,European
1446903345,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,amitriptyline,1446903369.0,European
1446903345,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,amitriptyline,1446903367.0,European
1446903345,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,amitriptyline,1446903369.0,European
1446903345,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,amitriptyline,1446903367.0,European
1446903345,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,amitriptyline,1446903369.0,European
1446903345,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,amitriptyline,1446903367.0,European
1446903345,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,amitriptyline,1446903369.0,European
1446903345,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,amitriptyline,1446903367.0,European
1446903345,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,amitriptyline,1446903369.0,European
1446903345,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,amitriptyline,1446903367.0,European
1448525387,PA166161870,rs879577,,,IL17RA,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448525389.0,European
982030327,PA166154345,rs1954787,,,GRIK4,Efficacy,-1,Selective serotonin reuptake inhibitors,982030333.0,East Asian
982030327,PA166154345,rs1954787,,,GRIK4,Efficacy,-1,venlafaxine,982030333.0,East Asian
1451095020,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1451095025.0,Unknown
1451095020,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1451095025.0,Unknown
827824453,PA166153953,rs717620,,,ABCC2,Efficacy,-1,antiepileptics,827824473.0,European
769173180,PA166155996,rs2070995,,,KCNJ6,,-1,opioids,769173182.0,European
982046731,PA166156807,rs2631367,,,SLC22A5,Efficacy,1,imatinib,982046733.0,European
769173176,PA166155996,rs2070995,,,KCNJ6,,1,methadone,769173179.0,European
1184515026,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184515028.0,"Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3)."
1184515026,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515028.0,"Multiple groups, Caucasian (n=120), African (n=12), Asia (n=3)."
982046726,PA166156750,rs1050152,,,SLC22A4,Efficacy,1,imatinib,982046730.0,European
1183679469,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183679471.0,Multiple groups
1183679469,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183679471.0,Multiple groups
1183679469,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183679471.0,Multiple groups
1451111420,PA166156062,rs1065852,,,CYP2D6,Metabolism/PK,1,desethyl hydroxychloroquine,1451111425.0,East Asian
1451111420,PA166156062,rs1065852,,,CYP2D6,Metabolism/PK,1,desethyl hydroxychloroquine,1451111426.0,East Asian
982030334,PA166156853,rs10036156,,,GABRP,Efficacy,-1,Selective serotonin reuptake inhibitors,982030338.0,East Asian
982030334,PA166156853,rs10036156,,,GABRP,Efficacy,-1,venlafaxine,982030338.0,East Asian
982046809,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,982046811.0,East Asian
982046809,PA166157284,rs1045642,,,ABCB1,Dosage,1,tacrolimus,982046812.0,East Asian
1449260063,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1449260065.0,East Asian
1449260063,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1449260066.0,East Asian
1449260063,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1449260067.0,East Asian
1448427044,PA166155802,rs11563250,,,MROH2A,Dosage,-1,levothyroxine,,
1448427044,PA166155802,rs11563250,,,UGT1A,Dosage,-1,levothyroxine,,
1451111500,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,hydroxychloroquine,1451111529.0,Unknown
1451111500,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,hydroxychloroquine,1451111529.0,Unknown
1451111500,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,hydroxychloroquine,1451111529.0,Unknown
1451111500,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,hydroxychloroquine,1451111529.0,Unknown
982046804,PA166153642,rs1800896,,,IL10,Dosage,1,tacrolimus,982046806.0,East Asian
982046804,PA166153642,rs1800896,,,IL10,Dosage,1,tacrolimus,982046807.0,East Asian
1448525354,PA166161868,rs4819554,,,IL17RA,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448525365.0,European
1448525354,PA166161868,rs4819554,,,IL17RA,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448525361.0,European
1448525354,PA166161868,rs4819554,,,IL17RA,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448525367.0,European
1184515192,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1184515197.0,Unknown
1184515192,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1184515197.0,Unknown
1448640030,PA166155346,rs25487,,,XRCC1,Efficacy,1,platinum,1448640036.0,"Multiple groups, White, Asian"
1448640030,PA166155346,rs25487,,,XRCC1,Efficacy,1,platinum,1448640038.0,"Multiple groups, White, Asian"
1448640030,PA166155346,rs25487,,,XRCC1,Efficacy,1,platinum,1448640040.0,"Multiple groups, White, Asian"
1450980440,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1450980462.0,Central/South Asian
1446903324,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,amitriptyline,1446903331.0,European
1185023114,PA166157286,rs1057868,,,POR,Metabolism/PK,1,cyclosporine,1185023122.0,"Multiple groups, White, Black, Asian, Unknown"
827922747,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,Platinum compounds,827922756.0,East Asian
1446903336,PA166155506,rs56113850,,,CYP2A6,Metabolism/PK,1,nicotine,1446903386.0,European
1446903336,PA166155506,rs56113850,,,CYP2A6,Metabolism/PK,1,nicotine,1446903349.0,European
1446903336,PA166155506,rs56113850,,,CYP2A6,Metabolism/PK,1,nicotine,1446903351.0,European
1446903336,PA166155506,rs56113850,,,CYP2A6,Metabolism/PK,1,nicotine,1446903347.0,European
1183679579,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679599.0,East Asian
1183679579,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679599.0,East Asian
1183679579,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679599.0,East Asian
1448640016,PA166155370,rs1799782,,,XRCC1,Efficacy,1,Platinum compounds,1448640022.0,East Asian
1448640016,PA166155370,rs1799782,,,XRCC1,Efficacy,1,Platinum compounds,1448640027.0,East Asian
1448640016,PA166155370,rs1799782,,,XRCC1,Efficacy,1,Platinum compounds,1448640025.0,East Asian
982046815,PA166154030,rs3740556,,,EIF3A,Efficacy,1,carboplatin,982046819.0,East Asian
982046815,PA166154030,rs3740556,,,EIF3A,Efficacy,1,cisplatin,982046819.0,East Asian
1447951892,PA166155435,rs8099917,,,IFNL3,Efficacy,1,interferons,1447951894.0,European
1447951892,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1447951894.0,European
1447951874,PA166155959,rs6108160,,,PLCB1,Efficacy,1,Selective serotonin reuptake inhibitors,1447951882.0,Unknown
1449243739,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,morphine,1449243741.0,"Multiple groups, Caucasian, black and biracial participants"
982046771,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,antiepileptics,982046781.0,Unknown
1444707861,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,phenprocoumon,1444707863.0,Unknown
1444707861,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,phenprocoumon,1444707863.0,Unknown
1444707861,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,phenprocoumon,1444707863.0,Unknown
1447951883,PA166155468,rs12979860,,,IFNL3,Efficacy,1,interferons,1447951889.0,European
1447951883,PA166155468,rs12979860,,,IFNL4,Efficacy,1,interferons,1447951889.0,European
1447951883,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447951889.0,European
1447951883,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447951889.0,European
1444707853,PA166155091,rs9923231,,,VKORC1,Dosage,0,phenprocoumon,1444707858.0,Unknown
1445297704,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1445297728.0,Unknown
1445297704,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1445297728.0,Unknown
1445297704,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,voriconazole,1445297728.0,Unknown
1445117476,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1445117485.0,East Asian
1445117476,,,PA166128210,CYP2C9*59,CYP2C9,Dosage,0,warfarin,1445117485.0,East Asian
1184515235,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515237.0,East Asian
1184515235,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515237.0,East Asian
1184515243,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515245.0,East Asian
1445297594,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,tacrolimus,1445297596.0,East Asian
1446903250,PA166154646,rs17109924,,,LGR5,Efficacy,1,fluorouracil,1446903258.0,Unknown
1444707757,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1444707762.0,"Multiple groups, Mostly white"
1183614112,PA166155842,rs17183814,,,SCN2A,Efficacy,-1,carbamazepine,1183614114.0,"Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese)."
1183614112,PA166155842,rs17183814,,,SCN2A,Efficacy,-1,valproic acid,1183614114.0,"Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese)."
1445297581,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tacrolimus,1445297593.0,East Asian
1445297581,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1445297593.0,East Asian
982046888,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,infliximab,982046892.0,European
1451226268,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,methadone,1451226281.0,Unknown
1451226268,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,methadone,1451226280.0,Unknown
1451226268,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,methadone,1451226281.0,Unknown
1451226268,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,methadone,1451226280.0,Unknown
1448639952,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639968.0,"Multiple groups, Black, White"
1448639952,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639957.0,"Multiple groups, White, Black"
1448639952,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639959.0,"Multiple groups, White, Black"
1448639975,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,acetaminophen,1448639977.0,"Multiple groups, Black, White"
982046877,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,adalimumab,982046886.0,European
982046877,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,etanercept,982046886.0,European
982046877,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,infliximab,982046886.0,European
982046879,PA166153639,rs1800871,,,IL10,Dosage,-1,tacrolimus,982046881.0,East Asian
982046879,PA166153639,rs1800871,,,IL10,Dosage,-1,tacrolimus,982046882.0,East Asian
1448426957,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448426959.0,European
982046834,PA166154030,rs3740556,,,EIF3A,Efficacy,1,carboplatin,982046842.0,East Asian
982046834,PA166154030,rs3740556,,,EIF3A,Efficacy,1,cisplatin,982046842.0,East Asian
827922843,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,paclitaxel,827922850.0,"Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5."
1446706623,PA166154705,rs1933437,,,FLT3,Efficacy,-1,sunitinib,1446708702.0,"Multiple groups, Chinese, Indian, Malay"
1448426950,PA166153571,rs396991,,,FCGR3A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448426956.0,European
1448426950,PA166153571,rs396991,,,FCGR3A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448426968.0,European
1447673266,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,belinostat,1447673277.0,"Multiple groups, White, African American, Hispanic, Asian"
1448639925,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639932.0,"Multiple groups, White, Black"
1448639925,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639936.0,"Multiple groups, White, Black"
1448639925,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639964.0,"Multiple groups, Black, White"
1448639925,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639966.0,"Multiple groups, Black, White"
1448639925,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639930.0,"Multiple groups, White, Black"
1448639925,PA166156530,rs1902023,,,UGT2B15,Metabolism/PK,1,acetaminophen,1448639934.0,"Multiple groups, White, Black"
827922851,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,paclitaxel,827922860.0,"Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5."
1296598723,PA166155420,rs4803419,,,CYP2B6,Efficacy,-1,efavirenz,1296598725.0,Unknown
769172782,PA166154334,rs1799732,,,DRD2,Efficacy,1,chlorpromazine,769172785.0,East Asian
982046845,PA166153640,rs1800872,,,IL10,Dosage,-1,tacrolimus,982046847.0,East Asian
982046845,PA166153640,rs1800872,,,IL10,Dosage,-1,tacrolimus,982046848.0,East Asian
1448426926,,,PA165954745,HLA-B*15:01:01:01,HLA-B,Efficacy,1,interferon beta-1a,1448426928.0,Near Eastern
1296598716,PA166155478,rs28399499,,,CYP2B6,Efficacy,-1,efavirenz,1296598718.0,Unknown
1451226244,,,PA165818750,CYP2B6*1,CYP2B6,Dosage,-1,methadone,1451226247.0,Unknown
1451226244,,,PA165818762,CYP2B6*6,CYP2B6,Dosage,-1,methadone,1451226247.0,Unknown
982046937,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,codeine,982046939.0,African American/Afro-Caribbean
982046937,,,PA165971594,CYP2D6*40,CYP2D6,Efficacy,1,codeine,982046939.0,African American/Afro-Caribbean
827922861,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,paclitaxel,827922872.0,"Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5."
1184515311,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1184515316.0,"Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% ""other""."
1184515311,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1184515316.0,"Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% ""other""."
1448426917,,,PA165951493,HLA-DRB1*04:01:01,HLA-DRB1,Efficacy,1,interferon beta-1a,1448426925.0,Near Eastern
982046931,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,codeine,982046933.0,African American/Afro-Caribbean
982046931,,,PA165816583,CYP2D6*17,CYP2D6,Efficacy,1,codeine,982046933.0,African American/Afro-Caribbean
1445297523,,,PA166128213,CYP3A5*1,CYP3A5,Other,1,tacrolimus,1445297533.0,East Asian
1445297523,,,PA166128219,CYP3A5*3,CYP3A5,Other,1,tacrolimus,1445297533.0,East Asian
982046925,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,codeine,982046927.0,African American/Afro-Caribbean
982046925,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,1,codeine,982046927.0,African American/Afro-Caribbean
1183958243,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,tacrolimus,1183959846.0,East Asian
1183958243,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183959846.0,East Asian
982046951,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,adalimumab,982046955.0,European
982046951,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,etanercept,982046955.0,European
982046951,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,infliximab,982046955.0,European
1296598692,PA166157547,rs374527,,,None,Efficacy,-1,efavirenz,1296598698.0,Unknown
982046944,PA166157545,rs20575,,,TNFRSF10A,Efficacy,-1,adalimumab,982046948.0,European
982046944,PA166157545,rs20575,,,TNFRSF10A,Efficacy,-1,etanercept,982046948.0,European
982046944,PA166157545,rs20575,,,TNFRSF10A,Efficacy,-1,infliximab,982046948.0,European
1450980580,PA166155042,rs2884737,,,VKORC1,Dosage,1,warfarin,1450980600.0,"Multiple groups, Vanderbilt USA: 89.2% White, 9.8% Black, 1% Hispanic"
982046905,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,codeine,982046917.0,African American/Afro-Caribbean
982046905,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,codeine,982046917.0,African American/Afro-Caribbean
1446903149,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,clomipramine,1446903151.0,Unknown
1446903149,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,clomipramine,1446903152.0,Unknown
1446903149,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,clomipramine,1446903151.0,Unknown
1446903149,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,clomipramine,1446903152.0,Unknown
1446903149,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,clomipramine,1446903151.0,Unknown
1446903149,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,clomipramine,1446903152.0,Unknown
982046893,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,982046895.0,East Asian
982046893,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,982046896.0,East Asian
769172985,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,Drugs used in nicotine dependence,,
1449751756,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,aspirin,1449751798.0,Unknown
1449751756,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,aspirin,1449751782.0,Unknown
1449751756,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,aspirin,1449751800.0,Unknown
1449751756,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,aspirin,1449751798.0,Unknown
1449751756,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,aspirin,1449751782.0,Unknown
1449751756,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,aspirin,1449751800.0,Unknown
1449751756,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,aspirin,1449751798.0,Unknown
1449751756,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,aspirin,1449751782.0,Unknown
1449751756,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,aspirin,1449751800.0,Unknown
1449751756,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,aspirin,1449751798.0,Unknown
1449751756,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,aspirin,1449751782.0,Unknown
1449751756,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,aspirin,1449751800.0,Unknown
1449751756,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1449751798.0,Unknown
1449751756,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1449751782.0,Unknown
1449751756,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1449751800.0,Unknown
1449751756,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1449751798.0,Unknown
1449751756,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1449751782.0,Unknown
1449751756,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1449751800.0,Unknown
1449751756,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1449751798.0,Unknown
1449751756,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1449751782.0,Unknown
1449751756,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1449751800.0,Unknown
1449751756,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1449751798.0,Unknown
1449751756,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1449751782.0,Unknown
1449751756,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1449751800.0,Unknown
1450980540,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450980544.0,"Multiple groups, Vanderbilt USA: 89.2% White, 9.8% Black, 1% Hispanic"
982046919,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,codeine,982046921.0,African American/Afro-Caribbean
982046919,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,codeine,982046921.0,African American/Afro-Caribbean
1451226300,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,methadone,1451226282.0,Unknown
1451226300,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,methadone,1451226305.0,Unknown
1451226300,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,methadone,1451226282.0,Unknown
1451226300,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,methadone,1451226305.0,Unknown
1448426866,,,PA165860672,CYP1A1*1,CYP1A1,Metabolism/PK,1,granisetron,1448426868.0,Unknown
1448426866,,,PA165860673,CYP1A1*2A,CYP1A1,Metabolism/PK,1,granisetron,1448426868.0,Unknown
1446903175,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,clomipramine,1446903177.0,Unknown
1446903175,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,clomipramine,1446903178.0,Unknown
1446903175,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,clomipramine,1446903177.0,Unknown
1446903175,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,clomipramine,1446903178.0,Unknown
1446903175,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,clomipramine,1446903177.0,Unknown
1446903175,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,clomipramine,1446903178.0,Unknown
1446903175,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,clomipramine,1446903177.0,Unknown
1446903175,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,clomipramine,1446903178.0,Unknown
1446903175,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,clomipramine,1446903177.0,Unknown
1446903175,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,clomipramine,1446903178.0,Unknown
655385762,PA166153946,rs290487,,,TCF7L2,Efficacy,1,repaglinide,655385768.0,East Asian
982046912,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,982046914.0,East Asian
982046912,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,982046915.0,East Asian
1445297465,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445297498.0,East Asian
1445297465,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445297484.0,East Asian
1445297465,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445297498.0,East Asian
1445297465,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445297484.0,East Asian
655385756,PA166154256,rs5219,,,KCNJ11,Efficacy,1,repaglinide,655385760.0,East Asian
1448426850,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,granisetron,1448426864.0,Unknown
1448426850,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,granisetron,1448426864.0,Unknown
655385769,PA166153695,rs2297480,,,FDPS,Efficacy,-1,Bisphosphonates,655385771.0,European
655385769,PA166153695,rs2297480,,,PKLR,Efficacy,-1,Bisphosphonates,655385771.0,European
1184515246,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515248.0,East Asian
1450980620,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1450980642.0,"Multiple groups, Vanderbilt USA: 89.2% White, 9.8% Black, 1% Hispanic"
1451226403,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,0,pitavastatin,1451226460.0,Unknown
1451226403,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,0,pitavastatin,1451226460.0,Unknown
1446903139,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clomipramine,1446903141.0,Unknown
1446903139,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clomipramine,1446903141.0,Unknown
1185023177,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1185023189.0,"Multiple groups, Malay, Chinese, Indian"
1185023177,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1185023189.0,"Multiple groups, Malay, Chinese, Indian"
1445297476,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1445297482.0,East Asian
1445297476,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1445297522.0,East Asian
1444707640,PA166155096,rs9934438,,,VKORC1,Dosage,1,phenprocoumon,1444707642.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1444707646,PA166154977,rs7294,,,VKORC1,Dosage,1,phenprocoumon,1444707648.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1450980643,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,1450980647.0,"Multiple groups, Vanderbilt USA: 89.2% White, 9.8% Black, 1% Hispanic"
981489956,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,981489965.0,"Multiple groups, 99 Chinese, 12 Malaysian, 13 Indians"
981489956,PA166155381,rs2108622,,,CYP4F2,Efficacy,1,warfarin,981489965.0,"Multiple groups, 99 Chinese, 12 Malaysian, 13 Indians"
1444707660,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,1444707662.0,Unknown
1444707660,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1444707662.0,Unknown
1444707660,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,1444707662.0,Unknown
1444707652,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1444707657.0,Unknown
1184515279,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515281.0,East Asian
1445297499,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,tacrolimus,1445297511.0,East Asian
1445297499,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,tacrolimus,1445297511.0,East Asian
1185023192,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1185023198.0,"Multiple groups, Malay, Chinese, Indian"
982046966,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,infliximab,982046970.0,European
982046966,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,infliximab,982046972.0,European
769172931,PA166154261,rs6277,,,DRD2,Efficacy,-1,methadone,769172953.0,European
1296598578,PA166153547,rs5051,,,AGT,Efficacy,1,benazepril,1296598584.0,East Asian
1296598578,PA166153547,rs5051,,,AGT,Efficacy,1,imidapril,1296598584.0,East Asian
982046956,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,adalimumab,982046958.0,European
982046956,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,etanercept,982046958.0,European
982046956,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,infliximab,982046958.0,European
655385715,PA166154486,rs5443,,,GNB3,Efficacy,1,sumatriptan,655385748.0,European
1185023205,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1185023207.0,"Multiple groups, Malay, Chinese, Indian"
1445297512,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1445297518.0,East Asian
1448426810,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,antiepileptics,1448426812.0,Multiple groups
1449162016,,,PA166115842,UGT1A1*28,UGT1A1,Toxicity,1,hmg coa reductase inhibitors,1449162024.0,European
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385712,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385714.0,Unknown
655385709,PA166153972,rs1799853,,,CYP2C9,Efficacy,1,"sulfonamides, urea derivatives",655385711.0,Unknown
1449162025,PA166156447,rs12487736,,,SCAP,Efficacy,1,rosuvastatin,1449162256.0,European
1446903052,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,sunitinib,1446903076.0,"Multiple groups, Caucasian, African, Asian"
1447984401,PA166157239,rs3842,,,ABCB1,Metabolism/PK,0,efavirenz,1447984414.0,Sub-Saharan African
1185023364,PA166156352,rs2276707,,,NR1I2,Metabolism/PK,1,tacrolimus,1185023366.0,European
1185023364,PA166156352,rs2276707,,,NR1I2,Metabolism/PK,1,tacrolimus,1185023414.0,European
1185023364,PA166156352,rs2276707,,,NR1I2,Metabolism/PK,1,tacrolimus,1185023412.0,European
1185023199,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1185023201.0,"Multiple groups, Malay, Chinese, Indian"
1451226461,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,0,rosuvastatin,1451226409.0,Unknown
1451226461,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,0,rosuvastatin,1451226409.0,Unknown
1185023357,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1185023363.0,European
1185023357,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1185023426.0,European
1185023357,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1185023428.0,European
1444707589,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,phenprocoumon,1444707604.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1444707589,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,phenprocoumon,1444707604.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1444707589,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenprocoumon,1444707604.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1445297413,PA166156748,rs1042713,,,ADRB2,Dosage,1,phenylephrine,1445297418.0,"Multiple groups, White, Hispanic, Black, Asian, Other"
1184515460,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515462.0,"Multiple groups, French study: Caucasian, Black and Other"
1446903079,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446903081.0,Unknown
1446903079,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446903098.0,Unknown
1446903079,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,nortriptyline,1446903081.0,Unknown
1446903079,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,nortriptyline,1446903098.0,Unknown
1446903079,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446903081.0,Unknown
1446903079,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446903098.0,Unknown
1446903079,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446903081.0,Unknown
1446903079,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446903098.0,Unknown
1446903079,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,nortriptyline,1446903081.0,Unknown
1446903079,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,nortriptyline,1446903098.0,Unknown
1446903025,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446903027.0,Unknown
1446903025,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446903027.0,Unknown
982044983,PA166154545,rs2301339,,,GNB3,Efficacy,1,atenolol,982044988.0,European
982044983,PA166154545,rs2301339,,,GNB3,Efficacy,1,atenolol,982044989.0,European
1447984382,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1447984400.0,Sub-Saharan African
1447984382,,,PA165818770,CYP2B6*11,CYP2B6,Metabolism/PK,0,efavirenz,1447984400.0,Sub-Saharan African
651306365,PA166157178,rs12208357,,,SLC22A1,Efficacy,0,Antiemetics And Antinauseants,,
651306365,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,0,Antiemetics And Antinauseants,,
1185023373,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1185023379.0,European
1185023373,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1185023385.0,European
982044975,PA166154636,rs11064426,,,GNB3,Efficacy,1,atenolol,982044980.0,European
982044975,PA166154636,rs11064426,,,GNB3,Efficacy,1,atenolol,982044981.0,European
1444707618,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,phenprocoumon,1444707620.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1444707618,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,phenprocoumon,1444707620.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1444707618,,,PA166128233,CYP3A5*6,CYP3A5,Dosage,-1,phenprocoumon,1444707620.0,"Multiple groups, southern Brazilian population, 81% of European ancestry"
1447984366,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1447984381.0,Sub-Saharan African
1447984366,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1447984381.0,Sub-Saharan African
1451226441,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,0,fluvastatin,1451226426.0,Unknown
1451226441,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,0,fluvastatin,1451226426.0,Unknown
1184515480,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515482.0,"Multiple groups, 38 white, 4 black, 2 asian"
1444707507,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,acenocoumarol,1444707518.0,Unknown
1444707507,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,acenocoumarol,1444707518.0,Unknown
1444707507,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,acenocoumarol,1444707518.0,Unknown
982028694,PA166154675,rs6313,,,HTR2A,Efficacy,-1,antidepressants,982028701.0,Multiple groups
1448099051,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1448099057.0,European
1451144600,PA166155944,rs3918242,,,MMP9,Efficacy,1,ulinastatin,1451144620.0,Unknown
1448426721,PA166155331,rs45445694,,,TYMS,Efficacy,1,capecitabine,1448426727.0,"Multiple groups, Majority Caucasian"
1448426721,PA166155331,rs45445694,,,TYMS,Efficacy,1,capecitabine,1448426766.0,"Multiple groups, Majority Caucasian"
1448426721,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,1448426727.0,"Multiple groups, Majority Caucasian"
1448426721,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,1448426766.0,"Multiple groups, Majority Caucasian"
1446903003,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446903005.0,Unknown
1446903003,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446903005.0,Unknown
1183679914,PA166155587,rs16944,,,IL1B,Efficacy,-1,lansoprazole,1183679919.0,Unknown
1183679914,PA166155587,rs16944,,,IL1B,Efficacy,-1,omeprazole,1183679919.0,Unknown
1183679914,PA166155587,rs16944,,,IL1B,Efficacy,-1,rabeprazole,1183679919.0,Unknown
1184548150,,,PA165819268,TPMT*1,TPMT,Dosage,-1,azathioprine,1184548152.0,Near Eastern
1184548150,,,PA165819272,TPMT*3C,TPMT,Dosage,-1,azathioprine,1184548152.0,Near Eastern
1450931614,PA166185597,rs9349379,,,PHACTR1,Efficacy,-1,Selective serotonin (5HT1) agonists,1450931619.0,Unknown
1450931614,PA166185597,rs9349379,,,PHACTR1,Efficacy,-1,Selective serotonin (5HT1) agonists,1450931619.0,Unknown
1448099032,PA166157117,rs6923761,,,GLP1R,Efficacy,1,sitagliptin,1448099040.0,European
1448099032,PA166157117,rs6923761,,,GLP1R,Efficacy,1,vildagliptin,1448099040.0,European
982028703,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,antidepressants,982028709.0,Multiple groups
1450931626,PA166185599,rs6478241,,,ASTN2,Efficacy,-1,Selective serotonin (5HT1) agonists,1450931631.0,Unknown
1183679894,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183679896.0,Unknown
1183679894,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183679896.0,Unknown
1183679894,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183679896.0,Unknown
1183679894,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183679896.0,Unknown
1183679894,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183679896.0,Unknown
1183679894,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183679896.0,Unknown
1183679894,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679896.0,Unknown
1183679894,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183679896.0,Unknown
1183679894,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183679896.0,Unknown
1444707532,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,acenocoumarol,1444707541.0,Unknown
1444707532,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,acenocoumarol,1444707541.0,Unknown
982028661,PA166156708,rs6295,,,HTR1A,Efficacy,-1,antidepressants,982028666.0,Multiple groups
1446902958,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,nortriptyline,1446902972.0,Unknown
1446902958,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,nortriptyline,1446902996.0,Unknown
1446902958,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,nortriptyline,1446902972.0,Unknown
1446902958,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,nortriptyline,1446902996.0,Unknown
1446902958,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,nortriptyline,1446902972.0,Unknown
1446902958,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,nortriptyline,1446902996.0,Unknown
1183679880,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679893.0,Unknown
1183679880,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679893.0,Unknown
1183679880,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679893.0,Unknown
1183679880,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679893.0,Unknown
1183679880,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679893.0,Unknown
1183679880,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679893.0,Unknown
1183679880,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679893.0,Unknown
1183679880,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679893.0,Unknown
1183679880,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183679893.0,Unknown
1444707543,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444707556.0,Unknown
1444707543,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444707556.0,Unknown
1444707543,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444707556.0,Unknown
1451144564,PA166154989,rs243865,,,MMP2,Efficacy,1,ulinastatin,1451144580.0,Unknown
1446902977,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,amitriptyline,1446902979.0,Unknown
1446902977,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,amitriptyline,1446902989.0,Unknown
1446902977,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,amitriptyline,1446902979.0,Unknown
1446902977,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,amitriptyline,1446902989.0,Unknown
1447984307,PA166155418,rs4803381,,,CYP2A6,Efficacy,1,bupropion,1447984313.0,Unknown
1447984307,PA166155418,rs4803381,,,CYP2A6,Efficacy,1,Drugs used in nicotine dependence,1447984313.0,Unknown
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023356.0,European
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023348.0,European
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023338.0,European
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023350.0,European
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023340.0,European
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023352.0,European
1185023332,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1185023344.0,European
1448098990,PA166156357,rs2461817,,,NR1I2,Metabolism/PK,-1,lamotrigine,1448098992.0,East Asian
1444707558,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,1444707560.0,Unknown
1444707558,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,1444707560.0,Unknown
982028673,PA166154673,rs6311,,,HTR2A,Efficacy,-1,antidepressants,982028677.0,Multiple groups
1448099002,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,-1,lamotrigine,1448099004.0,East Asian
1448098996,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,-1,lamotrigine,1448098998.0,East Asian
1447984289,PA166155418,rs4803381,,,CYP2A6,Metabolism/PK,1,nicotine,1447984296.0,European
1447984289,PA166155418,rs4803381,,,CYP2A6,Metabolism/PK,1,nicotine,1447984294.0,Unknown
1450931660,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,fentanyl,1450931665.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931660,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,fentanyl,1450931666.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931660,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,fentanyl,1450931665.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931660,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,fentanyl,1450931666.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1444936816,PA166155802,rs11563250,,,UGT1A,Metabolism/PK,1,bilirubin,1444936822.0,Unknown
1449751996,PA166160283,rs4643786,,,DCK,Metabolism/PK,1,ara-CTP,1449752005.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1444707442,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,acenocoumarol,1444707453.0,Unknown
1444707442,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,acenocoumarol,1444707453.0,Unknown
1444707442,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,acenocoumarol,1444707453.0,Unknown
982028756,PA166156024,rs4680,,,COMT,Efficacy,-1,antidepressants,982028769.0,Multiple groups
1184482805,PA166154042,rs3814637,,,CYP2C19,Dosage,1,warfarin,1184482809.0,East Asian
1449752006,PA166154933,rs11853372,,,SLC28A1,Metabolism/PK,1,ara-CTP,1449752008.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1450931669,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,fentanyl,1450931678.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931669,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,fentanyl,1450931678.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1184482810,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1184482812.0,East Asian
1448098981,PA166156692,rs62298861,,,UGT2B7,Metabolism/PK,-1,lamotrigine,1448098983.0,East Asian
827793307,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827793314.0,Unknown
827793307,PA166154249,rs1695,,,GSTP1,Efficacy,1,oxaliplatin,827793314.0,Unknown
1450931679,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,fentanyl,1450931689.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931679,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,fentanyl,1450931690.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931679,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,fentanyl,1450931691.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1445297288,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,doxorubicin,1445297290.0,"Multiple groups, >95% Nordic Caucasian"
1445297288,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,methotrexate,1445297290.0,"Multiple groups, >95% Nordic Caucasian"
1445297288,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,prednisolone,1445297290.0,"Multiple groups, >95% Nordic Caucasian"
1445297288,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,vincristine,1445297290.0,"Multiple groups, >95% Nordic Caucasian"
1184482814,PA166155598,rs699664,,,GGCX,Dosage,1,warfarin,1184482816.0,East Asian
827826067,PA166154084,rs7903146,,,TCF7L2,Efficacy,1,"sulfonamides, urea derivatives",827826079.0,Unknown
1448098969,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lamotrigine,1448098971.0,East Asian
1448998341,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,oxcarbazepine,1448998356.0,East Asian
1445297279,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,doxorubicin,1445297287.0,"Multiple groups, >95% Nordic Caucasian"
1445297279,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,methotrexate,1445297287.0,"Multiple groups, >95% Nordic Caucasian"
1445297279,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,prednisolone,1445297287.0,"Multiple groups, >95% Nordic Caucasian"
1445297279,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,vincristine,1445297287.0,"Multiple groups, >95% Nordic Caucasian"
982028731,PA166154340,rs1800532,,,TPH1,Efficacy,-1,antidepressants,982028736.0,Multiple groups
1451357620,PA166233521,rs6990851,,,CSMD1,Efficacy,1,anastrozole,1451357700.0,Unknown
1448098944,PA166156562,rs2622628,,,ABCG2,Metabolism/PK,-1,lamotrigine,1448098946.0,East Asian
1447984258,PA166155655,rs1983023,,,UGT1A3,Metabolism/PK,1,deferasirox,1447984260.0,European
1450931632,PA166185600,rs11172113,,,LRP1,Efficacy,-1,Selective serotonin (5HT1) agonists,1450931637.0,Unknown
982028725,PA166153653,rs1805054,,,HTR6,Efficacy,-1,antidepressants,982028729.0,Multiple groups
982028725,PA166153653,rs1805054,,,HTR6,Efficacy,-1,antidepressants,982028729.0,Multiple groups
1448998357,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,oxcarbazepine,1448998359.0,East Asian
1183679942,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679944.0,East Asian
1183679942,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679944.0,East Asian
1183679942,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679944.0,East Asian
1449752036,PA166180992,rs11577910,,,CTPS1,Metabolism/PK,1,ara-CTP,1449752038.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1449752012,PA166156479,rs4742,,,DCTD,Metabolism/PK,1,ara-CTP,1449752014.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1447984241,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,deferasirox,1447984247.0,European
982028745,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,antidepressants,982028754.0,Multiple groups
1448098929,PA166155919,rs2071197,,,HNF4A,Metabolism/PK,1,lamotrigine,1448098931.0,East Asian
1448098929,PA166155919,rs2071197,,,HNF4A,Metabolism/PK,1,lamotrigine,1448098931.0,East Asian
1448998365,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,oxcarbazepine,1448998367.0,East Asian
827826043,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,827826052.0,Central/South Asian
827826043,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,0,warfarin,827826052.0,Central/South Asian
1444707494,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,acenocoumarol,1444707505.0,Unknown
1444707494,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,acenocoumarol,1444707505.0,Unknown
1444707494,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,acenocoumarol,1444707505.0,Unknown
1183679931,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679941.0,East Asian
1183679931,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679941.0,East Asian
1183679931,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679941.0,East Asian
982028827,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,antidepressants,982028834.0,Multiple groups
982028827,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,antidepressants,982028834.0,Multiple groups
1183680034,PA166155587,rs16944,,,IL1B,Efficacy,1,lansoprazole,1183680036.0,East Asian
1183680034,PA166155587,rs16944,,,IL1B,Efficacy,1,omeprazole,1183680036.0,East Asian
1183680034,PA166155587,rs16944,,,IL1B,Efficacy,1,rabeprazole,1183680036.0,East Asian
1449752025,PA166180989,rs4364871,,,CTPS1,Metabolism/PK,1,ara-CTP,1449752027.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1449752060,PA166180997,rs12404655,,,CDA,Metabolism/PK,1,ara-CTP,1449752062.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1448098912,PA166156572,rs3114020,,,ABCG2,Metabolism/PK,1,lamotrigine,1448098922.0,East Asian
1448998381,PA166155919,rs2071197,,,HNF4A,Metabolism/PK,-1,oxcarbazepine,1448998383.0,East Asian
1183680029,PA166155587,rs16944,,,IL1B,Efficacy,1,lansoprazole,1183680033.0,East Asian
1183680029,PA166155587,rs16944,,,IL1B,Efficacy,1,omeprazole,1183680033.0,East Asian
1183680029,PA166155587,rs16944,,,IL1B,Efficacy,1,rabeprazole,1183680033.0,East Asian
1450931728,,,PA166048680,CYP3A4*22,CYP3A4,PD,-1,fentanyl,1450931732.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931728,,,PA166048680,CYP3A4*22,CYP3A4,PD,-1,fentanyl,1450931732.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1448098923,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,lamotrigine,1448098925.0,East Asian
1447984232,PA166155712,rs3806596,,,UGT1A3,Efficacy,1,deferasirox,1447984238.0,European
1447984232,PA166155712,rs3806596,,,UGT1A3,Metabolism/PK,1,deferasirox,1447984238.0,European
982028817,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,antidepressants,982028825.0,Multiple groups
982045201,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,1,carvedilol,982045209.0,Unknown
982045201,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,carvedilol,982045209.0,Unknown
982045201,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,carvedilol,982045209.0,Unknown
1450931733,,,PA166128219,CYP3A5*3,CYP3A5,PD,-1,fentanyl,1450931737.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1448998389,PA166157284,rs1045642,,,ABCB1,Efficacy,1,oxcarbazepine,1448998395.0,East Asian
1450931738,PA166157284,rs1045642,,,ABCB1,PD,-1,fentanyl,1450931742.0,"Multiple groups, Volunteers of European or Latino ethnicity."
982045227,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,carvedilol,982045289.0,Unknown
982045227,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,carvedilol,982045289.0,Unknown
982045227,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,carvedilol,982045289.0,Unknown
982045227,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,metoprolol,982045289.0,Unknown
982045227,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,metoprolol,982045289.0,Unknown
982045227,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,metoprolol,982045289.0,Unknown
1183680019,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183680021.0,East Asian
1183680019,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183680021.0,East Asian
1183680019,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183680021.0,East Asian
1183680019,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183680021.0,East Asian
1183680019,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183680021.0,East Asian
1183680019,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183680021.0,East Asian
1183680019,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183680021.0,East Asian
1183680019,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183680021.0,East Asian
1183680019,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183680021.0,East Asian
1448998396,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,oxcarbazepine,1448998398.0,East Asian
982028836,PA166157083,rs3800373,,,FKBP5,Efficacy,1,antidepressants,982028843.0,European
982045219,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,carvedilol,982045269.0,Unknown
982045219,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,982045269.0,Unknown
982045219,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,982045269.0,Unknown
1448998411,PA166155919,rs2071197,,,HNF4A,Efficacy,-1,oxcarbazepine,1448998417.0,East Asian
1448998405,PA166156619,rs7439366,,,UGT2B7,Efficacy,1,oxcarbazepine,1448998407.0,East Asian
1450931752,PA166157316,rs2032582,,,ABCB1,PD,-1,fentanyl,1450931756.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1184482762,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184482764.0,East Asian
1184482762,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184482764.0,East Asian
1444707400,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444707402.0,Unknown
1444707400,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444707402.0,Unknown
1444707400,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444707402.0,Unknown
982028793,PA166154486,rs5443,,,GNB3,Efficacy,-1,antidepressants,982028798.0,Multiple groups
1450931692,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,fentanyl,1450931698.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1183679996,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679998.0,Unknown
1183679996,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679998.0,Unknown
1183679996,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679998.0,Unknown
982045173,PA166153977,rs1801253,,,ADRB1,Dosage,1,carvedilol,982045190.0,Unknown
1184482772,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184482774.0,East Asian
1444707419,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,1444707421.0,Unknown
1444707419,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,1444707421.0,Unknown
1444707419,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,1444707421.0,Unknown
1183680006,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183680018.0,East Asian
1183680006,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183680018.0,East Asian
1183680006,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183680018.0,East Asian
1183680006,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183680018.0,East Asian
1183680006,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183680018.0,East Asian
1183680006,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183680018.0,East Asian
1183680006,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183680018.0,East Asian
1183680006,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183680018.0,East Asian
1183680006,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183680018.0,East Asian
1450931699,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,fentanyl,1450931703.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1184482780,PA166157286,rs1057868,,,POR,Dosage,-1,warfarin,1184482782.0,East Asian
1184482784,PA166157370,rs2868177,,,POR,Dosage,-1,warfarin,1184482786.0,East Asian
982028807,PA166156983,rs1360780,,,FKBP5,Efficacy,1,antidepressants,982028815.0,European
1450931704,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,fentanyl,1450931708.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1449752077,PA166181000,rs17343066,,,SLC28A3,Metabolism/PK,1,ara-CTP,1449752079.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1449752077,PA166181000,rs17343066,,,SLC28A3,Metabolism/PK,1,ara-CTP,1449752079.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
1183679983,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183679995.0,Unknown
1183679983,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183679995.0,Unknown
1183679983,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183679995.0,Unknown
1450931716,PA166156991,rs1799971,,,OPRM1,PD,-1,fentanyl,1450931720.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1184482790,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1184482798.0,East Asian
1184482790,,,PA166122566,CYP2C9*58,CYP2C9,Dosage,0,warfarin,1184482798.0,East Asian
982028800,PA166154486,rs5443,,,GNB3,Efficacy,1,antidepressants,982028805.0,East Asian
982028800,PA166154486,rs5443,,,GNB3,Efficacy,1,antidepressants,982028805.0,East Asian
1450931721,PA166156024,rs4680,,,COMT,PD,-1,fentanyl,1450931725.0,"Multiple groups, Volunteers of European or Latino ethnicity."
981750357,PA166155170,rs939347,,,NR1D1,Efficacy,-1,lithium,981750362.0,European
1183680098,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183680100.0,Unknown
982045270,PA166157026,rs2234693,,,ESR1,Efficacy,-1,atorvastatin,982045290.0,Unknown
981750351,PA166155250,rs12941497,,,NR1D1,Efficacy,-1,lithium,981750355.0,European
1444936699,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,sunitinib,1444936711.0,"Multiple groups, Chinese, Malay, Indian"
1444936699,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,sunitinib,1444936711.0,"Multiple groups, Chinese, Malay, Indian"
1449162297,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,voriconazole,1449162308.0,Unknown
1449162297,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,voriconazole,1449162306.0,Unknown
1449162297,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,voriconazole,1449162308.0,Unknown
1449162297,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,voriconazole,1449162306.0,Unknown
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,doxorubicin,1445297171.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,doxorubicin,1445297247.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,methotrexate,1445297171.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,methotrexate,1445297247.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,prednisolone,1445297171.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,prednisolone,1445297247.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,vincristine,1445297171.0,"Multiple groups, >95% Nordic Caucasian"
1445297161,PA166157334,rs2229109,,,ABCB1,Efficacy,1,vincristine,1445297247.0,"Multiple groups, >95% Nordic Caucasian"
1449244207,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,morphine,1449244209.0,"Multiple groups, Caucasian, black and biracial participants"
1183630925,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183630933.0,Multiple groups
1183630925,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,haloperidol,1183630933.0,Multiple groups
1448998466,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448998472.0,Unknown
1183680064,PA166156990,rs1799964,,,TNF,Efficacy,-1,lansoprazole,1183680066.0,East Asian
1183680064,PA166156990,rs1799964,,,TNF,Efficacy,-1,omeprazole,1183680066.0,East Asian
1183680064,PA166156990,rs1799964,,,TNF,Efficacy,-1,rabeprazole,1183680066.0,East Asian
981865016,PA166153759,rs3917643,,,F3,Efficacy,1,simvastatin,981865023.0,European
981750325,PA166155226,rs4794826,,,NR1D1,Efficacy,-1,lithium,981750330.0,European
981750325,PA166155226,rs4794826,,,THRA,Efficacy,-1,lithium,981750330.0,European
1448998482,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448998488.0,Multiple groups
981750364,PA166155200,rs2071570,,,NR1D1,Efficacy,-1,lithium,981750367.0,European
1445297172,PA166157284,rs1045642,,,ABCB1,Efficacy,1,doxorubicin,1445297178.0,"Multiple groups, >95% Nordic Caucasian"
1445297172,PA166157284,rs1045642,,,ABCB1,Efficacy,1,methotrexate,1445297178.0,"Multiple groups, >95% Nordic Caucasian"
1445297172,PA166157284,rs1045642,,,ABCB1,Efficacy,1,prednisolone,1445297178.0,"Multiple groups, >95% Nordic Caucasian"
1445297172,PA166157284,rs1045642,,,ABCB1,Efficacy,1,vincristine,1445297178.0,"Multiple groups, >95% Nordic Caucasian"
1445297172,PA166157284,rs1045642,,,ABCB1,Efficacy,1,vincristine,1445297178.0,"Multiple groups, >95% Nordic Caucasian"
981750318,PA166155208,rs2314339,,,NR1D1,Efficacy,1,lithium,981750324.0,European
981750318,PA166155208,rs2314339,,,THRA,Efficacy,1,lithium,981750324.0,European
981750318,PA166155208,rs2314339,,,THRA,Efficacy,1,lithium,981750324.0,European
1450931757,PA166157316,rs2032582,,,ABCB1,PD,-1,fentanyl,1450931761.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1448998489,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448998495.0,East Asian
1448639490,PA166156794,rs2279020,,,GABRA1,Other,1,propofol,1448639497.0,East Asian
1448639490,PA166156794,rs2279020,,,GABRA1,Other,1,propofol,1448639499.0,East Asian
1183680069,PA166154480,rs77149876,,,None,Efficacy,1,salbutamol,1183680071.0,Latino
1446902772,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1446902772,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1446902772,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1446902772,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1446902772,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1446902772,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1446902772,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,-1,amitriptyline,1446902774.0,European
1451243060,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1451243083.0,Multiple groups
1451243060,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1451243083.0,Multiple groups
1451243060,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1451243083.0,Multiple groups
1448639482,PA166154675,rs6313,,,HTR2A,Dosage,1,propofol,1448639489.0,East Asian
1448639482,PA166154675,rs6313,,,HTR2A,Dosage,1,propofol,1448639487.0,East Asian
982045253,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,982045284.0,Unknown
1183680053,PA166153912,rs77977790,,,PAPPA2,Efficacy,1,salbutamol,1183680055.0,Latino
1183680053,PA166153912,rs77977790,,,PAPPA2,Efficacy,1,salbutamol,1183680057.0,Latino
1183680053,PA166153912,rs77977790,,,PAPPA2,Efficacy,1,salbutamol,1183680056.0,Latino
1183680059,PA166156988,rs1799724,,,TNF,Efficacy,-1,lansoprazole,1183680063.0,East Asian
1183680059,PA166156988,rs1799724,,,TNF,Efficacy,-1,omeprazole,1183680063.0,East Asian
1183680059,PA166156988,rs1799724,,,TNF,Efficacy,-1,rabeprazole,1183680063.0,East Asian
1183680047,PA166154834,rs77441273,,,SLC24A4,Efficacy,1,salbutamol,1183680049.0,Latino
1183680047,PA166154834,rs77441273,,,SLC24A4,Efficacy,1,salbutamol,1183680051.0,Latino
1183680047,PA166154834,rs77441273,,,SLC24A4,Efficacy,1,salbutamol,1183680050.0,Latino
981750332,PA166155199,rs2071427,,,NR1D1,Efficacy,-1,lithium,981750336.0,European
981750332,PA166155199,rs2071427,,,THRA,Efficacy,-1,lithium,981750336.0,European
981750338,PA166155205,rs2269457,,,NR1D1,Efficacy,-1,lithium,981750342.0,European
981750338,PA166155205,rs2269457,,,THRA,Efficacy,-1,lithium,981750342.0,European
1183680162,PA166157508,rs73294475,,,CRHR2,Efficacy,1,salbutamol,1183680164.0,Latino
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,bumetanide,982045343.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,bumetanide,982045421.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,bumetanide,982045345.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,furosemide,982045343.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,furosemide,982045421.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,furosemide,982045345.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,torasemide,982045343.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,torasemide,982045421.0,European
982045336,PA166154486,rs5443,,,GNB3,Efficacy,1,torasemide,982045345.0,European
1183680156,PA166155142,rs144315541,,,ADCY9,Efficacy,1,salbutamol,1183680158.0,Latino
1448639460,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,remifentanil,1448639462.0,East Asian
1448639460,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,sevoflurane,1448639462.0,East Asian
1183680170,PA166155595,rs295137,,,SPATS2L,Efficacy,-1,salbutamol,1183680172.0,Latino
1448639468,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,remifentanil,1448639470.0,East Asian
1448639468,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,sevoflurane,1448639470.0,East Asian
1183680146,PA166157226,rs116551936,,,None,Efficacy,1,salbutamol,1183680148.0,Latino
1444936640,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,sunitinib,1444936646.0,"Multiple groups, Chinese, Malay, Indian"
1183680142,PA166155969,rs115501901,,,NCOA3,Efficacy,1,salbutamol,1183680144.0,Latino
982045346,PA166153548,rs5063,,,NPPA-AS1,Efficacy,1,bumetanide,982045355.0,European
982045346,PA166153548,rs5063,,,NPPA-AS1,Efficacy,1,furosemide,982045355.0,European
982045346,PA166153548,rs5063,,,NPPA-AS1,Efficacy,1,torasemide,982045355.0,European
1449260681,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449260685.0,East Asian
1449260681,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449260683.0,East Asian
1449260681,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449260684.0,East Asian
981865125,PA166155091,rs9923231,,,VKORC1,Efficacy,1,acenocoumarol,981865135.0,European
1183680154,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183680175.0,East Asian
1448262608,PA166156978,rs1142345,,,TPMT,Metabolism/PK,1,azathioprine,1448262617.0,Unknown
1448262608,PA166156978,rs1142345,,,TPMT,Metabolism/PK,1,azathioprine,1448262614.0,Unknown
1448262608,PA166156978,rs1142345,,,TPMT,Metabolism/PK,1,azathioprine,1448262617.0,Unknown
1448262608,PA166156978,rs1142345,,,TPMT,Metabolism/PK,1,azathioprine,1448262614.0,Unknown
1449752221,PA166153876,rs17602729,,,AMPD1,Efficacy,-1,methotrexate,1449752223.0,European
1444936658,PA166157284,rs1045642,,,ABCB1,Efficacy,1,sunitinib,1444936666.0,"Multiple groups, Chinese, Malay, Indian"
1183680131,PA166155587,rs16944,,,IL1B,Efficacy,-1,omeprazole,1183680133.0,East Asian
1183680131,PA166155587,rs16944,,,IL1B,Efficacy,-1,omeprazole,1183680134.0,East Asian
1183680131,PA166155587,rs16944,,,IL1B,Efficacy,-1,rabeprazole,1183680133.0,East Asian
1183680131,PA166155587,rs16944,,,IL1B,Efficacy,-1,rabeprazole,1183680134.0,East Asian
1449752227,PA166155915,rs1127354,,,ITPA,Efficacy,-1,methotrexate,1449752229.0,European
1183680137,PA166155630,rs1143634,,,IL1B,Efficacy,-1,omeprazole,1183680140.0,East Asian
1183680137,PA166155630,rs1143634,,,IL1B,Efficacy,-1,omeprazole,1183680139.0,East Asian
1183680137,PA166155630,rs1143634,,,IL1B,Efficacy,-1,rabeprazole,1183680140.0,East Asian
1183680137,PA166155630,rs1143634,,,IL1B,Efficacy,-1,rabeprazole,1183680139.0,East Asian
1448639423,PA166157288,rs1128503,,,ABCB1,Efficacy,1,remifentanil,1448639430.0,East Asian
1448639423,PA166157288,rs1128503,,,ABCB1,Efficacy,1,remifentanil,1448639445.0,East Asian
1448639423,PA166157288,rs1128503,,,ABCB1,Efficacy,1,remifentanil,1448639448.0,East Asian
1448639423,PA166157288,rs1128503,,,ABCB1,Efficacy,1,sevoflurane,1448639430.0,East Asian
1448639423,PA166157288,rs1128503,,,ABCB1,Efficacy,1,sevoflurane,1448639445.0,East Asian
1448639423,PA166157288,rs1128503,,,ABCB1,Efficacy,1,sevoflurane,1448639448.0,East Asian
1450342045,PA166181403,rs4148412,,,ABCC3,Metabolism/PK,1,morphine-3-glucuronide,1450342052.0,"Multiple groups, USA: 267 Caucasian and 49 African American children"
1450342045,PA166181403,rs4148412,,,ABCC3,Metabolism/PK,1,morphine-3-glucuronide,1450342060.0,"Multiple groups, 79% Caucasian"
1449752233,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,1449752235.0,European
982045293,PA166157143,rs9340799,,,ESR1,Efficacy,-1,atorvastatin,982045301.0,Unknown
1183680115,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183680123.0,East Asian
1183680115,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183680121.0,East Asian
1451112060,,,PA165860685,CYP4F2*1,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112080.0,Unknown
1451112060,,,PA165860685,CYP4F2*1,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112102.0,Unknown
1451112060,,,PA165860685,CYP4F2*1,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112101.0,Unknown
1451112060,,,PA165860685,CYP4F2*1,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112100.0,Unknown
1451112060,,,PA165860687,CYP4F2*3,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112080.0,Unknown
1451112060,,,PA165860687,CYP4F2*3,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112102.0,Unknown
1451112060,,,PA165860687,CYP4F2*3,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112101.0,Unknown
1451112060,,,PA165860687,CYP4F2*3,CYP4F2,Metabolism/PK,1,Vitamin K1,1451112100.0,Unknown
827826357,PA166156933,rs628031,,,SLC22A1,Efficacy,1,metformin,827826366.0,East Asian
1449752214,PA166154789,rs2236225,,,MTHFD1,Efficacy,-1,methotrexate,1449752220.0,European
1446902725,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1446902725,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1446902725,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1446902725,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1446902725,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1446902725,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1446902725,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,nortriptyline,1446902755.0,European
1448998564,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,metformin,1448998570.0,European
1448998564,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,metformin,1448998572.0,European
1448998564,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,metformin,1448998574.0,European
1448998564,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,metformin,1448998576.0,European
1448998564,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,metformin,1448998581.0,European
1447148428,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tropisetron,1447156146.0,East Asian
1447148428,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,tropisetron,1447156146.0,East Asian
1447148428,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,tropisetron,1447156146.0,East Asian
982045391,PA166155187,rs1799752,,,ACE,Efficacy,1,bumetanide,982045403.0,European
982045391,PA166155187,rs1799752,,,ACE,Efficacy,1,furosemide,982045403.0,European
982045391,PA166155187,rs1799752,,,ACE,Efficacy,1,torasemide,982045403.0,European
1449752258,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449752265.0,Unknown
1449752258,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449752267.0,Unknown
1449752258,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449752281.0,Unknown
1448998582,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,metformin,1448998584.0,European
1448998582,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,metformin,1448998585.0,European
1448998582,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,metformin,1448998586.0,European
1448998582,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,metformin,1448998587.0,European
1448998582,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,metformin,1448998588.0,European
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-3-glucuronide,1450342063.0,"Multiple groups, USA: 267 Caucasian and 49 African American children"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-3-glucuronide,1450342070.0,"Multiple groups, USA: 267 Caucasian and 49 African American children"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-3-glucuronide,1450342064.0,"Multiple groups, 79% Caucasian"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-3-glucuronide,1450342072.0,"Multiple groups, 79% Caucasian"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-6-glucuronide,1450342063.0,"Multiple groups, USA: 267 Caucasian and 49 African American children"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-6-glucuronide,1450342070.0,"Multiple groups, USA: 267 Caucasian and 49 African American children"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-6-glucuronide,1450342064.0,"Multiple groups, 79% Caucasian"
1450342061,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine-6-glucuronide,1450342072.0,"Multiple groups, 79% Caucasian"
1448998602,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,metformin,1448998604.0,European
1448998602,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,metformin,1448998605.0,European
1448998602,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,metformin,1448998606.0,European
1448998602,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,metformin,1448998607.0,European
1448998602,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,metformin,1448998608.0,European
1450931941,PA166185165,rs45476395,,,GNB3,Efficacy,-1,sertraline,1450931947.0,Near Eastern
1184483081,PA166157284,rs1045642,,,ABCB1,Efficacy,1,cyclosporine,1184483085.0,European
982045404,PA166156480,rs4961,,,ADD1,Efficacy,1,bumetanide,982045419.0,European
982045404,PA166156480,rs4961,,,ADD1,Efficacy,1,furosemide,982045419.0,European
982045404,PA166156480,rs4961,,,ADD1,Efficacy,1,torasemide,982045419.0,European
1449244338,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,morphine,1449244340.0,"Multiple groups, Caucasian, black and biracial participants"
1184483086,PA166157373,rs3213619,,,ABCB1,Efficacy,-1,cyclosporine,1184483090.0,European
982045366,PA166153549,rs5065,,,NPPA-AS1,Efficacy,1,bumetanide,982045375.0,European
982045366,PA166153549,rs5065,,,NPPA-AS1,Efficacy,1,furosemide,982045375.0,European
982045366,PA166153549,rs5065,,,NPPA-AS1,Efficacy,1,torasemide,982045375.0,European
1450342120,PA166153953,rs717620,,,ABCC2,Efficacy,-1,doxorubicin,1450342126.0,European
1184483091,PA166157334,rs2229109,,,ABCB1,Efficacy,-1,cyclosporine,1184483093.0,European
1448998619,PA166155204,rs2252281,,,SLC47A1,Efficacy,-1,metformin,1448998621.0,European
1448998619,PA166155204,rs2252281,,,SLC47A1,Efficacy,-1,metformin,1448998622.0,European
1448998619,PA166155204,rs2252281,,,SLC47A1,Efficacy,-1,metformin,1448998623.0,European
1448998619,PA166155204,rs2252281,,,SLC47A1,Efficacy,-1,metformin,1448998624.0,European
1448998619,PA166155204,rs2252281,,,SLC47A1,Efficacy,-1,metformin,1448998625.0,European
1184483095,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,cyclosporine,1184483097.0,European
1183680197,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,benzbromarone,1183680199.0,East Asian
1183680197,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,benzbromarone,1183680199.0,East Asian
1447984004,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,0,voriconazole,1447984014.0,Unknown
1447984004,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,0,voriconazole,1447984014.0,Unknown
982045356,PA166153549,rs5065,,,NPPA-AS1,Efficacy,1,bumetanide,982045365.0,European
982045356,PA166153549,rs5065,,,NPPA-AS1,Efficacy,1,furosemide,982045365.0,European
982045356,PA166153549,rs5065,,,NPPA-AS1,Efficacy,1,torasemide,982045365.0,European
1449752269,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,cetuximab,1449752283.0,Unknown
1449752269,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,cetuximab,1449752275.0,Unknown
1449752269,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,cetuximab,1449752277.0,Unknown
1184515869,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,tacrolimus,1184515875.0,East Asian
1184515869,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,tacrolimus,1184515874.0,East Asian
1184515869,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,tacrolimus,1184515875.0,East Asian
1184515869,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,tacrolimus,1184515874.0,East Asian
827777144,PA166154790,rs2273623,,,PPM1A,Efficacy,1,nortriptyline,827777150.0,European
1447672688,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447672711.0,East Asian
1447672688,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447672711.0,East Asian
1447672688,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1447672711.0,East Asian
749069601,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,atazanavir,749233590.0,"Multiple groups, 3 cohorts:A(75 self-reported Caucasions- Turin, Italy); B(42 self-reported Caucasians- Madrid, Spain); C(65 unknown, but probably mostly Caucasian since from Liverpool Therapeutic Drug Monitoring Registry)."
982028994,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,982029004.0,Unknown
1447148415,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tropisetron,1447148430.0,East Asian
1447148415,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,tropisetron,1447148430.0,East Asian
1449244383,PA166156619,rs7439366,,,UGT2B7,Efficacy,-1,morphine,1449244385.0,"Multiple groups, Caucasian, black and biracial participants"
1448998629,PA166155251,rs12943590,,,SLC47A2,Efficacy,-1,metformin,1448998631.0,European
1448998629,PA166155251,rs12943590,,,SLC47A2,Efficacy,-1,metformin,1448998632.0,European
1448998629,PA166155251,rs12943590,,,SLC47A2,Efficacy,-1,metformin,1448998633.0,European
1448998629,PA166155251,rs12943590,,,SLC47A2,Efficacy,-1,metformin,1448998634.0,European
1448998629,PA166155251,rs12943590,,,SLC47A2,Efficacy,-1,metformin,1448998635.0,European
1447672698,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447672713.0,East Asian
1447672698,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447672713.0,East Asian
1447672698,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1447672713.0,East Asian
1446902609,PA166156619,rs7439366,,,UGT2B7,Dosage,1,codeine,1446902614.0,Multiple groups
1450374923,PA166156024,rs4680,,,COMT,Efficacy,1,methylphenidate,1450374929.0,European
1450374923,PA166156024,rs4680,,,COMT,Efficacy,1,methylphenidate,1450374931.0,European
1445296945,PA166155607,rs887829,,,UGT1A1,Toxicity,1,atazanavir,1445296959.0,"Multiple groups, White, Black, Hispanic"
1445296945,PA166155607,rs887829,,,UGT1A1,Toxicity,1,atazanavir,1445296955.0,European
1445296945,PA166155607,rs887829,,,UGT1A1,Toxicity,1,atazanavir,1445296951.0,African American/Afro-Caribbean
1445296945,PA166155607,rs887829,,,UGT1A1,Toxicity,1,atazanavir,1445296957.0,Latino
1444936497,PA166156864,rs10512734,,,PTGER4,Efficacy,-1,adalimumab,1444936499.0,European
1444936506,PA166155082,rs8049439,,,IL27,Efficacy,-1,adalimumab,1444936508.0,European
1444870968,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ledipasvir,1444870974.0,Multiple groups
1444870968,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ledipasvir,1444870974.0,Multiple groups
1444870968,PA166155468,rs12979860,,,IFNL3,Efficacy,1,sofosbuvir,1444870974.0,Multiple groups
1444870968,PA166155468,rs12979860,,,IFNL4,Efficacy,1,sofosbuvir,1444870974.0,Multiple groups
1450931989,PA166156991,rs1799971,,,OPRM1,Dosage,1,sufentanil,1450931995.0,East Asian
1444707135,PA166157283,rs1043550,,,CALU,Dosage,-1,acenocoumarol,1444707142.0,European
1450931998,PA166185653,rs1323040,,,OPRM1,Dosage,1,sufentanil,1450932004.0,East Asian
1449752300,PA166155407,rs3212986,,,ERCC1,Efficacy,1,Platinum compounds,1449752307.0,Unknown
982029098,PA166154177,rs28399504,,,CYP2C19,Metabolism/PK,1,mephenytoin,982029107.0,Unknown
1446902626,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446902642.0,Unknown
1446902626,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446902648.0,Unknown
1446902626,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446902645.0,Unknown
1446902626,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446902642.0,Unknown
1446902626,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446902648.0,Unknown
1446902626,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446902645.0,Unknown
1444936514,PA166154425,rs7927894,,,EMSY,Efficacy,-1,adalimumab,1444936516.0,European
1449752308,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1449752310.0,Unknown
982045474,PA166155066,rs4783961,,,CETP,Efficacy,1,fluvastatin,982045480.0,Unknown
1184515781,PA166157267,rs776746,,,CYP3A5,Toxicity,-1,tacrolimus,1184515783.0,Unknown
1450374950,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,1450374956.0,Unknown
1444936520,PA166154158,rs12777960,,,CCNY,Efficacy,-1,adalimumab,1444936522.0,European
1450931954,PA166185647,rs5441,,,GNB3,Efficacy,1,sertraline,1450931959.0,Near Eastern
1444936532,PA166156759,rs1295686,,,IL13,Efficacy,-1,adalimumab,1444936535.0,European
982045422,PA166157284,rs1045642,,,ABCB1,Efficacy,0,lamivudine,982045443.0,East Asian
982045422,PA166157284,rs1045642,,,ABCB1,Efficacy,0,nevirapine,982045443.0,East Asian
982045433,PA166155014,rs1529927,,,SLC12A3,Efficacy,1,bumetanide,982045457.0,European
982045433,PA166155014,rs1529927,,,SLC12A3,Efficacy,1,furosemide,982045457.0,European
982045433,PA166155014,rs1529927,,,SLC12A3,Efficacy,1,torasemide,982045457.0,European
1444936526,PA166156384,rs3814057,,,NR1I2,Efficacy,-1,adalimumab,1444936528.0,European
1450374932,PA166156024,rs4680,,,COMT,Efficacy,1,methylphenidate,1450374938.0,Unknown
1450374939,PA166156024,rs4680,,,COMT,Efficacy,0,methylphenidate,1450374945.0,Unknown
1445296998,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1445297004.0,Unknown
1445296998,PA166154566,rs3794271,,,SLCO1C1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1445297004.0,Unknown
1450112795,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1450112797.0,Unknown
1446902603,PA166156991,rs1799971,,,OPRM1,Dosage,1,codeine,1446902608.0,Multiple groups
1444707179,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1444707184.0,Unknown
1444936434,PA166155785,rs10210302,,,ATG16L1,Efficacy,1,adalimumab,1444936454.0,European
1446902544,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,imipramine,1446902556.0,East Asian
1446902544,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,imipramine,1446902556.0,East Asian
1446902544,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,imipramine,1446902556.0,East Asian
1450931972,PA166157345,rs2242480,,,CYP3A4,Efficacy,1,fentanyl,1450931977.0,East Asian
1447148309,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447148322.0,Unknown
1447148309,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447148322.0,Unknown
1447148309,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447148322.0,Unknown
982045529,PA166155341,rs7412,,,APOE,Efficacy,1,atorvastatin,982045536.0,European
1451226960,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,simvastatin,1451226980.0,East Asian
1444707059,PA166155915,rs1127354,,,ITPA,Efficacy,-1,peginterferon alfa-2b,1444707061.0,East Asian
1444707059,PA166155915,rs1127354,,,ITPA,Efficacy,-1,ribavirin,1444707061.0,East Asian
1449752387,PA166155342,rs11615,,,ERCC1,Efficacy,-1,Platinum compounds,1449752393.0,Unknown
982045523,PA166154870,rs1800588,,,LIPC,Efficacy,-1,pravastatin,982045527.0,European
982045517,PA166154870,rs1800588,,,LIPC,Efficacy,1,simvastatin,982045521.0,European
1448998711,PA166157849,rs6318,,,HTR2C,Efficacy,1,clozapine,1448998717.0,European
1451128662,PA166154950,rs56107638,,,CYP1A2,Toxicity,-1,clozapine,1451128682.0,European
1451128662,PA166154950,rs56107638,,,CYP1A2,Metabolism/PK,-1,clozapine,1451128682.0,European
982045547,PA166154576,rs4149036,,,SLCO1B1,Efficacy,1,atorvastatin,982045552.0,European
1447148324,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1447148326.0,Unknown
1447148324,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1447148326.0,Unknown
1450374964,PA166156803,rs2550956,,,SLC6A3,Efficacy,-1,methylphenidate,1450374970.0,European
1451161440,PA166180936,rs11280056,,,TYMS,Toxicity,-1,methotrexate,1451161478.0,European
1444707079,PA166157130,rs7772821,,,TAAR6,Efficacy,1,corticosteroids,1444707089.0,East Asian
1446902570,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,imipramine,1446902587.0,East Asian
1446902570,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,imipramine,1446902587.0,East Asian
1446902570,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,imipramine,1446902587.0,East Asian
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,bevacizumab,1446902536.0,Multiple groups
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,bevacizumab,1446902520.0,"Multiple groups, Caucasian, East Asian, Undeclared"
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,bevacizumab,1446902522.0,European
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,bevacizumab,1446902531.0,East Asian
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902536.0,Multiple groups
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902520.0,"Multiple groups, Caucasian, East Asian, Undeclared"
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902522.0,European
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902531.0,East Asian
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902536.0,Multiple groups
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902520.0,"Multiple groups, Caucasian, East Asian, Undeclared"
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902522.0,European
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902531.0,East Asian
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902536.0,Multiple groups
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902520.0,"Multiple groups, Caucasian, East Asian, Undeclared"
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902522.0,European
1446902514,PA166153617,rs1061170,,,CFH,Efficacy,1,ranibizumab,1446902531.0,East Asian
1450932019,PA166157284,rs1045642,,,ABCB1,Dosage,-1,sufentanil,1450932029.0,East Asian
1449752421,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,Platinum compounds,1449752423.0,Unknown
1451161400,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,methadone,1451161420.0,European
1451161400,,,PA165818757,CYP2B6*4,CYP2B6,Efficacy,-1,methadone,1451161420.0,European
1451161400,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,-1,methadone,1451161420.0,European
1449752415,PA166181026,rs1470383,,,MDM2,Efficacy,-1,Platinum compounds,1449752417.0,Unknown
1184483225,PA166153848,rs12083537,,,IL6R,Efficacy,1,tocilizumab,1184483229.0,Unknown
1450932030,PA166177796,rs563649,,,OPRM1,Dosage,-1,sufentanil,1450932040.0,East Asian
608431344,PA166156093,rs2284017,,,CACNG2,Efficacy,0,lithium,608431346.0,European
1449752396,PA166155343,rs13181,,,ERCC2,Efficacy,-1,Platinum compounds,1449752398.0,Unknown
655386544,PA166154334,rs1799732,,,DRD2,Efficacy,-1,antipsychotics,655386546.0,East Asian
1444936470,PA166153767,rs4645983,,,CASP9,Efficacy,-1,adalimumab,1444936473.0,European
1444936470,PA166153767,rs4645983,,,CASP9,Efficacy,-1,adalimumab,1444936481.0,European
982045510,PA166154870,rs1800588,,,LIPC,Efficacy,1,fluvastatin,982045514.0,European
1184483234,PA166153765,rs4329505,,,IL6R,Efficacy,1,tocilizumab,1184483236.0,Unknown
1449752404,PA166155371,rs1799793,,,ERCC2,Efficacy,-1,Platinum compounds,1449752406.0,Unknown
1444707113,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444707126.0,European
1444707113,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444707126.0,European
1444707113,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444707126.0,European
1444707113,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444707126.0,European
1451161488,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methadone,1451161471.0,European
1447983837,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1447983842.0,"Multiple groups, Most studies were in Chinese patients but 5 were not (2 Japanese, 1 Korean, 1 Indian, 1 Turkish) and one was in a non-specific ""Asian"" population"
1447983837,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1447983845.0,"Multiple groups, Most studies were in Chinese patients but 5 were not (2 Japanese, 1 Korean, 1 Indian, 1 Turkish) and one was in a non-specific ""Asian"" population"
1448818544,PA166156024,rs4680,,,COMT,Dosage,1,opioids,1448818679.0,Unknown
1451227020,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,simvastatin,1451227040.0,East Asian
1451161493,,,PA165818750,CYP2B6*1,CYP2B6,Dosage,-1,methadone,1451161503.0,European
1451161493,,,PA165818762,CYP2B6*6,CYP2B6,Dosage,-1,methadone,1451161503.0,European
1449752428,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,Platinum compounds,1449752430.0,Unknown
1449752434,PA166155370,rs1799782,,,XRCC1,Efficacy,-1,Platinum compounds,1449752436.0,Unknown
982045604,PA166157405,rs4986910,,,CYP3A4,Efficacy,1,fluvastatin,982045612.0,European
1445296829,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1445296835.0,European
1445296829,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1445296835.0,European
1445296829,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1445296835.0,European
1445296829,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1445296835.0,European
1445296829,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,1445296835.0,European
1445296829,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,1445296835.0,European
1444707026,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444707032.0,European
1444707026,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444707034.0,European
1444707026,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444707032.0,European
1444707026,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444707034.0,European
699639389,PA166154148,rs12255372,,,TCF7L2,Efficacy,1,"sulfonamides, urea derivatives",699639391.0,Unknown
1451161460,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,methadone,1451161480.0,European
1451161460,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,methadone,1451161480.0,European
1451161460,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,methadone,1451161480.0,European
982045554,PA166157267,rs776746,,,CYP3A5,Efficacy,1,atorvastatin,982045569.0,European
982045571,PA166155337,rs688,,,LDLR,Efficacy,1,lovastatin,982045577.0,European
1444707045,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444707051.0,Unknown
1444707045,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444707051.0,Unknown
1444707045,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444707051.0,Unknown
1451161481,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,methadone,1451161470.0,European
1451161481,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,methadone,1451161470.0,European
1444706925,PA166155102,rs10871454,,,STX4,Dosage,1,acenocoumarol,1444706927.0,European
1448998827,PA166157854,rs518147,,,HTR2C,Efficacy,1,risperidone,1448998833.0,East Asian
1451128780,PA166157117,rs6923761,,,GLP1R,Efficacy,1,sitagliptin,1451128742.0,European
1451128780,PA166157117,rs6923761,,,GLP1R,Efficacy,1,vildagliptin,1451128742.0,European
1444936314,PA166153841,rs12044852,,,CD58,Efficacy,1,interferon beta-1a,1444936320.0,Near Eastern
1444936314,PA166153841,rs12044852,,,CD58,Efficacy,1,interferon beta-1b,1444936320.0,Near Eastern
1444706936,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1444706938.0,European
1449244619,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,morphine,1449244621.0,Unknown
982045665,PA166157539,rs328,,,LPL,Efficacy,1,pravastatin,982045672.0,European
608431246,PA166153720,rs2842030,,,RGS4,Efficacy,0,olanzapine,608431248.0,Unknown
608431246,PA166153720,rs2842030,,,RGS4,Efficacy,0,perphenazine,608431248.0,Unknown
1449179077,PA166156933,rs628031,,,SLC22A1,Efficacy,1,imatinib,1449179548.0,Unknown
1448998855,PA166157875,rs3813929,,,HTR2C,Efficacy,-1,risperidone,1448998857.0,East Asian
1444936324,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444936329.0,East Asian
1444706957,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,1444706959.0,Unknown
1444706957,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,1444706959.0,Unknown
1451128748,PA166202681,rs163184,,,KCNQ1,Efficacy,-1,sitagliptin,1451128753.0,European
1451128748,PA166202681,rs163184,,,KCNQ1,Efficacy,-1,vildagliptin,1451128753.0,European
655386443,PA166154449,rs11042725,,,ADM,Efficacy,1,paroxetine,655386446.0,Unknown
1444706967,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1444706969.0,Unknown
1445296785,PA166156991,rs1799971,,,OPRM1,Efficacy,1,morphine,1445296790.0,"Multiple groups, White, African-American, Other"
982045615,PA166155340,rs5925,,,LDLR,Efficacy,1,lovastatin,982045621.0,European
1448639101,PA166156024,rs4680,,,COMT,Efficacy,-1,venlafaxine,1448639111.0,Unknown
1445296808,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1445296814.0,European
1445296808,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1445296814.0,European
1445296808,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1445296814.0,European
1444936352,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,aspirin,1444936354.0,Unknown
1444936352,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,aspirin,1444936354.0,Unknown
1444936352,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1444936354.0,Unknown
1444936352,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,clopidogrel,1444936354.0,Unknown
1444706973,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,1444706978.0,European
1444706973,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,1444706978.0,European
1444706981,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444706983.0,European
1444706981,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444706983.0,European
1444706981,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444706983.0,European
982045631,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,fluvastatin,982045639.0,European
1449162725,PA166153640,rs1800872,,,IL10,Metabolism/PK,-1,tacrolimus,1449162727.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1184483370,,,PA166117652,UGT1A8*1a,UGT1A8,Metabolism/PK,1,raloxifene,1184483384.0,Unknown
1184483370,,,PA166117652,UGT1A8*1a,UGT1A8,Metabolism/PK,1,raloxifene,1184483386.0,Unknown
1184483370,,,PA166117652,UGT1A8*1a,UGT1A8,Metabolism/PK,1,raloxifene,1184483382.0,Unknown
1184483370,,,PA166117654,UGT1A8*2,UGT1A8,Metabolism/PK,1,raloxifene,1184483384.0,Unknown
1184483370,,,PA166117654,UGT1A8*2,UGT1A8,Metabolism/PK,1,raloxifene,1184483386.0,Unknown
1184483370,,,PA166117654,UGT1A8*2,UGT1A8,Metabolism/PK,1,raloxifene,1184483382.0,Unknown
1184483370,,,PA166117655,UGT1A8*3,UGT1A8,Metabolism/PK,1,raloxifene,1184483384.0,Unknown
1184483370,,,PA166117655,UGT1A8*3,UGT1A8,Metabolism/PK,1,raloxifene,1184483386.0,Unknown
1184483370,,,PA166117655,UGT1A8*3,UGT1A8,Metabolism/PK,1,raloxifene,1184483382.0,Unknown
1448639083,PA166169449,rs2013249,,,AKR7A3,Metabolism/PK,-1,bupropion,1448639085.0,Unknown
1449162739,PA166153642,rs1800896,,,IL10,Metabolism/PK,-1,tacrolimus,1449162741.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1444936241,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444936243.0,East Asian
1444936241,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444936243.0,East Asian
1444936241,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444936243.0,East Asian
1444936241,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444936243.0,East Asian
1444936241,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444936243.0,East Asian
1444936241,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444936243.0,East Asian
1450948626,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,phenazepam,1450948660.0,Unknown
1450948626,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,phenazepam,1450948680.0,Unknown
1450948626,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,phenazepam,1450948660.0,Unknown
1450948626,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,phenazepam,1450948680.0,Unknown
981750809,PA166153653,rs1805054,,,HTR6,Efficacy,-1,citalopram,981750813.0,European
981750809,PA166153653,rs1805054,,,HTR6,Efficacy,-1,fluoxetine,981750813.0,European
981750809,PA166153653,rs1805054,,,HTR6,Efficacy,-1,paroxetine,981750813.0,European
1445296694,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1445296697.0,European
1445296694,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1445296696.0,Multiple groups
1445296694,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1445296698.0,African American/Afro-Caribbean
1449162732,PA166153639,rs1800871,,,IL10,Metabolism/PK,-1,tacrolimus,1449162734.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
982045714,PA166155340,rs5925,,,LDLR,Efficacy,-1,fluvastatin,982045720.0,European
981750801,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,citalopram,981750807.0,European
981750801,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,fluoxetine,981750807.0,European
981750801,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,paroxetine,981750807.0,European
1451341865,PA166156480,rs4961,,,ADD1,Efficacy,1,hydrochlorothiazide,1451341869.0,"Multiple groups, France, Italy, Finland"
981750815,PA166154340,rs1800532,,,TPH1,Efficacy,-1,citalopram,981750820.0,European
981750815,PA166154340,rs1800532,,,TPH1,Efficacy,-1,fluoxetine,981750820.0,European
981750815,PA166154340,rs1800532,,,TPH1,Efficacy,-1,paroxetine,981750820.0,European
1449162751,PA166176344,rs16840252,,,CTLA4,Metabolism/PK,-1,tacrolimus,1449162753.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1451161642,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1451161642,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,methadone,1451161667.0,European
1449162758,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,tramadol,1449162763.0,Unknown
608431157,PA166156579,rs3775291,,,TLR3,Efficacy,1,Measles vaccines,608431159.0,European
1449162769,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tramadol,1449162771.0,Unknown
1448639049,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,bupropion,1448639051.0,Unknown
1451161580,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,(S)-methadone,1451161586.0,European
1451161580,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,(S)-methadone,1451161586.0,European
1451161580,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,(S)-methadone,1451161586.0,European
1184483284,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1184483292.0,European
1184483284,,,PA165816553,CYP2C9*12,CYP2C9,Dosage,0,warfarin,1184483292.0,European
982045682,PA166155146,rs4341,,,ACE,Efficacy,1,pravastatin,982045690.0,European
982045682,PA166155146,rs4341,,,ACE,Efficacy,1,pravastatin,982045690.0,European
1448639039,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,bupropion,1448639041.0,Unknown
1448639039,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,bupropion,1448639041.0,Unknown
1448639039,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,bupropion,1448639041.0,Unknown
827809082,PA166154972,rs5569,,,SLC6A2,Efficacy,1,methylphenidate,827809093.0,East Asian
1449162764,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,tramadol,1449162766.0,Unknown
1449162764,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,tramadol,1449162766.0,Unknown
1448639028,PA166155442,rs8192709,,,CYP2B6,Metabolism/PK,-1,bupropion,1448639033.0,Unknown
1445296737,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296739.0,Multiple groups
1445296737,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296741.0,African American/Afro-Caribbean
1445296737,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1445296739.0,Multiple groups
1445296737,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1445296741.0,African American/Afro-Caribbean
1445296737,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1445296739.0,Multiple groups
1445296737,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1445296741.0,African American/Afro-Caribbean
1445296737,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1445296739.0,Multiple groups
1445296737,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1445296741.0,African American/Afro-Caribbean
981750780,PA166156708,rs6295,,,HTR1A,Efficacy,-1,citalopram,981750785.0,European
981750780,PA166156708,rs6295,,,HTR1A,Efficacy,-1,fluoxetine,981750785.0,European
981750780,PA166156708,rs6295,,,HTR1A,Efficacy,-1,paroxetine,981750785.0,European
1448589873,PA166155331,rs45445694,,,TYMS,Efficacy,1,methotrexate,1448589875.0,"Multiple groups, non-Caucasian."
1448639034,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,bupropion,1448639036.0,Unknown
981750786,PA166154675,rs6313,,,HTR2A,Efficacy,-1,citalopram,981750793.0,European
981750786,PA166154675,rs6313,,,HTR2A,Efficacy,-1,fluoxetine,981750793.0,European
981750786,PA166154675,rs6313,,,HTR2A,Efficacy,-1,paroxetine,981750793.0,European
982045692,PA166154993,rs708272,,,CETP,Efficacy,1,lovastatin,982045697.0,European
1444608497,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,valproic acid,1444608515.0,East Asian
1444608497,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,valproic acid,1444608515.0,East Asian
1444608497,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,valproic acid,1444608515.0,East Asian
1183680618,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,codeine,1183680620.0,European
1183680618,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,codeine,1183680620.0,European
1184483446,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,sertraline,1184483471.0,Unknown
1184483446,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,sertraline,1184483471.0,Unknown
699639165,PA166157348,rs2267715,,,CRHR2,Efficacy,-1,salbutamol,699639171.0,European
1183680612,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,codeine,1183680614.0,European
1183680612,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,codeine,1183680614.0,European
1451161687,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,methadone,1451161694.0,European
1451161687,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,methadone,1451161694.0,European
655386834,PA166157329,rs2227631,,,SERPINE1,Efficacy,1,citalopram,655386837.0,East Asian
655386834,PA166157329,rs2227631,,,SERPINE1,Efficacy,1,fluoxetine,655386837.0,East Asian
1183680593,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,codeine,1183680605.0,European
1184467070,PA166154675,rs6313,,,HTR2A,Efficacy,-1,fluvoxamine,1184467074.0,"Multiple groups, Japanese and Italian"
1184467070,PA166154675,rs6313,,,HTR2A,Efficacy,-1,paroxetine,1184467074.0,"Multiple groups, Japanese and Italian"
1184483457,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184483459.0,East Asian
1184483457,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184483459.0,East Asian
1451161695,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,methadone,1451161627.0,European
1451161695,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,methadone,1451161627.0,European
1447983631,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,1,lamotrigine,1447983633.0,European
1184467075,PA166154675,rs6313,,,HTR2A,Efficacy,-1,fluvoxamine,1184467077.0,East Asian
1184467075,PA166154675,rs6313,,,HTR2A,Efficacy,-1,paroxetine,1184467077.0,East Asian
699639151,PA166156093,rs2284017,,,CACNG2,Efficacy,0,lithium,699639155.0,European
699639154,PA166157348,rs2267715,,,CRHR2,Efficacy,1,salbutamol,699639162.0,European
1448589833,PA166155733,rs4673993,,,ATIC,Efficacy,1,methotrexate,1448589835.0,European
699639210,PA166156723,rs265981,,,DRD1,Dosage,0,lithium,699639216.0,European
1184483473,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,0,dolutegravir,1184483495.0,"Multiple groups, African-American (n=37), European-American (n=46), Asian (n=5), Unknown (n=1)."
1184483473,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,0,dolutegravir,1184483495.0,"Multiple groups, African-American (n=37), European-American (n=46), Asian (n=5), Unknown (n=1)."
1184483473,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,0,dolutegravir,1184483495.0,"Multiple groups, African-American (n=37), European-American (n=46), Asian (n=5), Unknown (n=1)."
1184483473,,,PA166115843,UGT1A1*36,UGT1A1,Metabolism/PK,0,dolutegravir,1184483495.0,"Multiple groups, African-American (n=37), European-American (n=46), Asian (n=5), Unknown (n=1)."
1184483473,,,PA166115844,UGT1A1*37,UGT1A1,Metabolism/PK,0,dolutegravir,1184483495.0,"Multiple groups, African-American (n=37), European-American (n=46), Asian (n=5), Unknown (n=1)."
827793156,PA166154020,rs2804400,,,ABCC2,Efficacy,-1,antiepileptics,827793163.0,East Asian
827793156,PA166154020,rs2804400,,,NANOGP6,Efficacy,-1,antiepileptics,827793163.0,East Asian
1447983614,PA166156933,rs628031,,,SLC22A1,Metabolism/PK,-1,lamotrigine,1447983622.0,European
1184467092,PA166154675,rs6313,,,HTR2A,Efficacy,-1,fluvoxamine,1184467094.0,European
1184467092,PA166154675,rs6313,,,HTR2A,Efficacy,-1,paroxetine,1184467094.0,European
699639199,PA166156706,rs4532,,,DRD1,Efficacy,0,lithium,699639208.0,European
1448573444,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,3,1448573470.0,European
1448573444,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,4-methylenedioxymethamphetamine,1448573470.0,European
1447983624,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,lamotrigine,1447983626.0,European
1449162841,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449162843.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
655386824,PA166153893,rs60369023,,,CDA,Other,1,gemcitabine,655386826.0,East Asian
655386824,PA166153893,rs60369023,,,CDA,Metabolism/PK,1,gemcitabine,655386826.0,East Asian
1444706841,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706847.0,East Asian
1444706841,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706847.0,East Asian
1444706841,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706847.0,East Asian
1444706841,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706847.0,East Asian
1451161652,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,methadone,1451161682.0,European
1451161652,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,methadone,1451161682.0,European
1451161652,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,methadone,1451161682.0,European
1445296652,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1445296654.0,Multiple groups
1445296652,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1445296655.0,European
1445296652,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1445296656.0,African American/Afro-Caribbean
699639201,PA166157250,rs255100,,,CRHR2,Efficacy,1,salbutamol,699639205.0,European
655386820,PA166153667,rs2072671,,,CDA,Toxicity,-1,gemcitabine,655386823.0,East Asian
655386820,PA166153667,rs2072671,,,CDA,Metabolism/PK,-1,gemcitabine,655386823.0,East Asian
1449162849,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449162851.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
699639192,PA166157353,rs2284220,,,CRHR2,Efficacy,-1,salbutamol,699639197.0,European
1451161660,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,methadone,1451161641.0,European
1451161660,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,methadone,1451161641.0,European
1444706848,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706850.0,East Asian
1444706848,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444706850.0,East Asian
699639182,PA166156024,rs4680,,,COMT,Efficacy,0,lithium,699639190.0,European
827793137,PA166156277,rs6280,,,DRD3,Efficacy,1,clozapine,827793149.0,European
1449162856,PA166156384,rs3814057,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449162858.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
699639185,PA166157353,rs2284220,,,CRHR2,Efficacy,1,salbutamol,699639191.0,European
827923820,PA166155135,rs71647871,,,CES1,Dosage,1,methylphenidate,827923846.0,European
827923820,PA166155135,rs71647871,,,CES1,Metabolism/PK,1,methylphenidate,827923846.0,European
1445296571,PA166154611,rs10161126,,,MVK,Efficacy,1,alendronate,1445296578.0,East Asian
1446902225,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,imipramine,1446902227.0,European
1446902225,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,imipramine,1446902255.0,European
1446902225,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,imipramine,1446902246.0,European
1446902225,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,imipramine,1446902227.0,European
1446902225,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,imipramine,1446902255.0,European
1446902225,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,imipramine,1446902246.0,European
1446902225,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,imipramine,1446902227.0,European
1446902225,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,imipramine,1446902255.0,European
1446902225,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,imipramine,1446902246.0,European
1446902225,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,1,imipramine,1446902227.0,European
1446902225,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,1,imipramine,1446902255.0,European
1446902225,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,1,imipramine,1446902246.0,European
982045842,PA166155145,rs4331,,,ACE,Efficacy,-1,fluvastatin,982045850.0,European
827923830,PA166155135,rs71647871,,,CES1,Efficacy,-1,methylphenidate,827923841.0,European
1448818810,PA166156991,rs1799971,,,OPRM1,Dosage,-1,opioids,1448818812.0,Unknown
1183631503,PA166155293,rs4149601,,,NEDD4L,Efficacy,1,Aldosterone antagonists,1183631505.0,European
1183631503,PA166155293,rs4149601,,,NEDD4L,Efficacy,1,amiloride,1183631505.0,European
1444706755,PA166155915,rs1127354,,,ITPA,Efficacy,1,peginterferon alfa-2b,1444706761.0,East Asian
1444706755,PA166155915,rs1127354,,,ITPA,Efficacy,1,ribavirin,1444706761.0,East Asian
827793107,PA166156705,rs686,,,DRD1,Efficacy,1,clozapine,827793114.0,European
1444706762,PA166155344,rs14158,,,LDLR,Efficacy,1,peginterferon alfa-2a,1444706769.0,European
1444706762,PA166155344,rs14158,,,LDLR,Efficacy,1,peginterferon alfa-2b,1444706769.0,European
1444706762,PA166155344,rs14158,,,LDLR,Efficacy,1,ribavirin,1444706769.0,European
1444706762,PA166155344,rs14158,,,LDLR,Efficacy,1,ribavirin,1444706769.0,European
1448573389,PA166157284,rs1045642,,,ABCB1,Efficacy,0,tacrolimus,1448573391.0,East Asian
1449752734,PA166155173,rs1042522,,,TP53,Efficacy,1,oxaliplatin,1449752743.0,Unknown
1449752734,PA166155173,rs1042522,,,TP53,Efficacy,1,oxaliplatin,1449752750.0,Unknown
1449752734,PA166155173,rs1042522,,,TP53,Efficacy,1,oxaliplatin,1449752748.0,Unknown
1183631485,PA166155293,rs4149601,,,NEDD4L,Efficacy,1,"Beta blocking agents, selective",1183631489.0,European
1183631485,PA166155293,rs4149601,,,NEDD4L,Efficacy,1,diuretics,1183631489.0,European
1183631490,PA166155293,rs4149601,,,NEDD4L,Efficacy,-1,diltiazem,1183631492.0,European
1448573382,PA166157316,rs2032582,,,ABCB1,Efficacy,0,tacrolimus,1448573384.0,East Asian
1446902201,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,imipramine,1446902224.0,European
1446902201,,,PA165988479,CYP2D6*1xN,CYP2D6,Dosage,1,imipramine,1446902224.0,European
1446902201,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,imipramine,1446902224.0,European
1446902201,,,PA165988480,CYP2D6*2xN,CYP2D6,Dosage,1,imipramine,1446902224.0,European
1450375324,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,nicotine,1450375333.0,"Custom, in vitro"
1450375324,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,nicotine,1450375333.0,"Custom, in vitro"
1444706772,PA166155344,rs14158,,,LDLR,Efficacy,-1,peginterferon alfa-2a,1444706775.0,European
1444706772,PA166155344,rs14158,,,LDLR,Efficacy,-1,peginterferon alfa-2b,1444706775.0,European
1444706772,PA166155344,rs14158,,,LDLR,Efficacy,-1,ribavirin,1444706775.0,European
699639135,PA166156748,rs1042713,,,ADRB2,Efficacy,1,salmeterol,699639140.0,Unknown
699639132,PA166154259,rs6265,,,BDNF,Efficacy,0,lithium,699639137.0,"Multiple groups, Brazilian"
699639132,PA166154259,rs6265,,,BDNF-AS,Efficacy,0,lithium,699639137.0,"Multiple groups, Brazilian"
1445296591,PA166157284,rs1045642,,,ABCB1,Efficacy,1,imatinib,1445296602.0,Unknown
1184467037,,,PA165819270,TPMT*3A,TPMT,Dosage,0,mercaptopurine,1184467043.0,European
1184467037,,,PA165819272,TPMT*3C,TPMT,Dosage,0,mercaptopurine,1184467043.0,European
1184467037,,,PA165819270,TPMT*3A,TPMT,Efficacy,0,mercaptopurine,1184467043.0,European
1184467037,,,PA165819272,TPMT*3C,TPMT,Efficacy,0,mercaptopurine,1184467043.0,European
1184467037,,,PA165819270,TPMT*3A,TPMT,Toxicity,0,mercaptopurine,1184467043.0,European
1184467037,,,PA165819272,TPMT*3C,TPMT,Toxicity,0,mercaptopurine,1184467043.0,European
608431045,PA166156277,rs6280,,,DRD3,Efficacy,0,clozapine,608431049.0,"Multiple groups, Caucasian; African American"
982045832,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,pravastatin,982045840.0,European
699639130,PA166155779,rs10192566,,,LPIN1,Efficacy,1,rosiglitazone,699639134.0,East Asian
1449162909,PA166157299,rs1524107,,,IL6,Metabolism/PK,-1,tacrolimus,1449162911.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1184467044,,,PA165819270,TPMT*3A,TPMT,Dosage,0,mercaptopurine,1184467050.0,American
1184467044,,,PA165819270,TPMT*3A,TPMT,Efficacy,0,mercaptopurine,1184467050.0,American
1184467044,,,PA165819270,TPMT*3A,TPMT,Toxicity,0,mercaptopurine,1184467050.0,American
1043763662,PA166154306,rs1001179,,,CAT,Efficacy,-1,atorvastatin,1043764130.0,European
1449146532,,,PA165819176,CYP1A2*1F,CYP1A2,Dosage,-1,clozapine,1449146548.0,European
1449146532,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,-1,clozapine,1449146548.0,European
982045915,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,pravastatin,982045923.0,European
1444706671,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706708.0,Unknown
1448573355,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448573363.0,East Asian
1183680733,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,celecoxib,1183680735.0,"Multiple groups, 23 White and 1 African"
1183680733,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,celecoxib,1183680735.0,"Multiple groups, 23 White and 1 African"
982029525,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,venlafaxine,982029527.0,European
982029525,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,venlafaxine,982029527.0,European
982029525,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,venlafaxine,982029527.0,European
982029525,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,venlafaxine,982029527.0,European
1448262059,,,PA166048676,GSTM1 non-null,GSTM1,Metabolism/PK,1,azathioprine,1448262606.0,Unknown
1448262059,,,PA166048676,GSTM1 non-null,GSTM1,Metabolism/PK,1,azathioprine,1448262511.0,Unknown
1448262059,,,PA166048675,GSTM1 null,GSTM1,Metabolism/PK,1,azathioprine,1448262606.0,Unknown
1448262059,,,PA166048675,GSTM1 null,GSTM1,Metabolism/PK,1,azathioprine,1448262511.0,Unknown
1184483570,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,sertraline,1184483600.0,Unknown
1184483570,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,sertraline,1184483600.0,Unknown
1449310381,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,paroxetine,1449310411.0,East Asian
1449310381,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,paroxetine,1449310411.0,East Asian
1449310381,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,paroxetine,1449310411.0,East Asian
1449310381,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,paroxetine,1449310411.0,East Asian
1449310381,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,0,paroxetine,1449310411.0,East Asian
1449588912,PA166154583,rs4149117,,,SLCO1B3,Metabolism/PK,1,voriconazole,1449592561.0,"Multiple groups, Italy, specified 37.5% Caucasian, 62.5% Other."
1451178201,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,aripiprazole,1451178220.0,European
1446902165,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,desipramine,1446905480.0,European
1446902165,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,desipramine,1446902194.0,European
1446902165,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,desipramine,1446902184.0,European
1446902165,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,desipramine,1446905480.0,European
1446902165,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,desipramine,1446902194.0,European
1446902165,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,desipramine,1446902184.0,European
1446902165,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,imipramine,1446905480.0,European
1446902165,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,imipramine,1446902194.0,European
1446902165,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,imipramine,1446902184.0,European
1446902165,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,imipramine,1446905480.0,European
1446902165,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,imipramine,1446902194.0,European
1446902165,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,imipramine,1446902184.0,European
1448573342,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448573354.0,East Asian
1448573342,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448573354.0,East Asian
1449162934,PA166156619,rs7439366,,,UGT2B7,Dosage,1,morphine,1449162953.0,Unknown
699639287,PA166154335,rs1799913,,,TPH1,Efficacy,0,lithium,699639325.0,European
1449162946,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1449162948.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
699639285,PA166154340,rs1800532,,,TPH1,Efficacy,0,lithium,699639323.0,European
982045927,PA166154247,rs670,,,APOA1,Efficacy,-1,pravastatin,982045931.0,European
1183697100,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183697210.0,European
1183697100,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183697212.0,European
1183697100,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183697210.0,European
1183697100,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183697212.0,European
1183697100,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183697210.0,European
1183697100,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183697212.0,European
1183697100,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183697210.0,European
1183697100,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183697212.0,European
1449162954,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449162956.0,Unknown
699639277,PA166157723,rs1187327,,,NTRK2,Efficacy,0,lithium,699639313.0,European
699639283,PA166156559,rs2433322,,,PDLIM5,Efficacy,0,lithium,699639321.0,European
1183680725,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,celecoxib,1183680727.0,"Multiple groups, 23 White and 1 African"
1183680725,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,celecoxib,1183680727.0,"Multiple groups, 23 White and 1 African"
1451178160,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,aripiprazole,1451178180.0,European
1445296539,PA166156706,rs4532,,,DRD1,Efficacy,-1,risperidone,1445296553.0,East Asian
1445296532,PA166156836,rs4867798,,,DRD1,Efficacy,-1,risperidone,1445296551.0,East Asian
1183615168,PA166156276,rs5186,,,AGTR1,Efficacy,-1,atenolol,1183615172.0,European
1183615168,PA166156276,rs5186,,,AGTR1,Efficacy,-1,irbesartan,1183615172.0,European
1448573312,PA166157288,rs1128503,,,ABCB1,Efficacy,1,tacrolimus,1448573320.0,East Asian
1448573312,PA166157288,rs1128503,,,ABCB1,Efficacy,1,tacrolimus,1448573584.0,East Asian
1448573312,PA166157288,rs1128503,,,ABCB1,Efficacy,1,tacrolimus,1448573586.0,East Asian
1448573312,PA166157288,rs1128503,,,ABCB1,Efficacy,1,tacrolimus,1448573318.0,East Asian
1444706715,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706721.0,European
1444706715,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706721.0,European
1444706715,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706721.0,European
1444706715,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706721.0,European
1449162966,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449162968.0,Unknown
1183680709,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,celecoxib,1183680719.0,"Multiple groups, 23 White and 1 African"
1183680709,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,celecoxib,1183680719.0,"Multiple groups, 23 White and 1 African"
1445296525,PA166156707,rs5326,,,DRD1,Efficacy,-1,risperidone,1445296555.0,East Asian
1445296525,PA166156707,rs5326,,,DRD1,Efficacy,-1,risperidone,1445296555.0,East Asian
1445296525,PA166156707,rs5326,,,DRD1,Efficacy,-1,risperidone,1445296555.0,East Asian
982045899,PA166157405,rs4986910,,,CYP3A4,Efficacy,-1,atorvastatin,982045907.0,European
1449162979,PA166157334,rs2229109,,,ABCB1,Dosage,-1,morphine,1449162981.0,Unknown
699639316,PA166156558,rs2433320,,,PDLIM5,Efficacy,0,lithium,699639319.0,European
1183615155,PA166153539,rs699,,,AGT,Efficacy,-1,atenolol,1183615159.0,European
1183615155,PA166153539,rs699,,,AGT,Efficacy,-1,irbesartan,1183615159.0,European
1184483616,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,escitalopram,1184483641.0,European
1184483616,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,escitalopram,1184483641.0,European
827661941,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827663186.0,East Asian
827661941,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,warfarin,827663186.0,East Asian
1444706722,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706728.0,"Multiple groups, Caucasian, African American, Hispanic"
1444706722,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706728.0,"Multiple groups, Caucasian, African American, Hispanic"
1444706722,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706728.0,"Multiple groups, Caucasian, African American, Hispanic"
1444706722,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706728.0,"Multiple groups, Caucasian, African American, Hispanic"
1449162972,PA166157334,rs2229109,,,ABCB1,Dosage,-1,morphine,1449162974.0,Unknown
1449162985,PA166157288,rs1128503,,,ABCB1,Dosage,-1,morphine,1449162987.0,Unknown
1183615160,PA166153545,rs4762,,,AGT,Efficacy,-1,atenolol,1183615165.0,European
1183615160,PA166153545,rs4762,,,AGT,Efficacy,-1,irbesartan,1183615165.0,European
1449162993,PA166157288,rs1128503,,,ABCB1,Dosage,-1,morphine,1449162995.0,Unknown
1449163001,PA166157316,rs2032582,,,ABCB1,Dosage,-1,morphine,1449163003.0,Unknown
1445296437,PA166154673,rs6311,,,HTR2A,Efficacy,-1,antidepressants,1445296439.0,"Multiple groups, Caucasian and Asian"
699639240,PA166156939,rs706895,,,FYN,Efficacy,0,lithium,699639243.0,European
982045968,PA166155018,rs1800775,,,CETP,Efficacy,-1,atorvastatin,982045972.0,European
699639234,PA166154486,rs5443,,,GNB3,Efficacy,1,sildenafil,699639239.0,European
1450375434,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tramadol,1450375439.0,Unknown
1450375434,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tramadol,1450375441.0,Unknown
1450375434,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tramadol,1450375443.0,Unknown
1445296428,PA166154726,rs7997012,,,HTR2A,Efficacy,1,antidepressants,1445296430.0,"Multiple groups, Caucasian and Asian"
699639235,PA166156277,rs6280,,,DRD3,Efficacy,0,lithium,699639238.0,European
699639221,PA166154339,rs1800497,,,ANKK1,Efficacy,0,lithium,699639223.0,European
1446902114,,,PA165819268,TPMT*1,TPMT,Other,1,mercaptopurine,1446902129.0,Unknown
1446902114,,,PA165819270,TPMT*3A,TPMT,Other,1,mercaptopurine,1446902129.0,Unknown
1446902114,,,PA165819272,TPMT*3C,TPMT,Other,1,mercaptopurine,1446902129.0,Unknown
1445296452,PA166157644,rs13253389,,,NAT1,Metabolism/PK,1,cotinine,1445296459.0,European
1444706626,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444706632.0,European
1444706626,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444706632.0,European
1444706626,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706632.0,European
1444706626,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706632.0,European
1449163009,PA166157316,rs2032582,,,ABCB1,Dosage,-1,morphine,1449163011.0,Unknown
1449163018,PA166157284,rs1045642,,,ABCB1,Dosage,-1,morphine,1449163020.0,Unknown
699639212,PA166157250,rs255100,,,CRHR2,Efficacy,-1,salbutamol,699639215.0,European
1448589644,PA166157284,rs1045642,,,ABCB1,Efficacy,1,methotrexate,1448589646.0,European
699639217,PA166154260,rs6275,,,DRD2,Efficacy,0,lithium,699639220.0,European
982045947,PA166155146,rs4341,,,ACE,Efficacy,-1,fluvastatin,982045955.0,European
827825747,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,trastuzumab,827825762.0,East Asian
699639271,PA166157727,rs1387923,,,NTRK2,Efficacy,0,lithium,699639307.0,European
1449163026,PA166157284,rs1045642,,,ABCB1,Dosage,-1,morphine,1449163028.0,Unknown
1448573256,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448573259.0,African American/Afro-Caribbean
1448573256,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448573258.0,African American/Afro-Caribbean
1448573256,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1448573259.0,African American/Afro-Caribbean
1448573256,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1448573258.0,African American/Afro-Caribbean
1448573256,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448573259.0,African American/Afro-Caribbean
1448573256,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448573258.0,African American/Afro-Caribbean
1448573256,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1448573259.0,African American/Afro-Caribbean
1448573256,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1448573258.0,African American/Afro-Caribbean
1448573256,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1448573259.0,African American/Afro-Caribbean
1448573256,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1448573258.0,African American/Afro-Caribbean
1448573256,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1448573259.0,African American/Afro-Caribbean
1448573256,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1448573258.0,African American/Afro-Caribbean
699639269,PA166155275,rs971363,,,IMPA2,Efficacy,0,lithium,699639327.0,European
699639275,PA166157748,rs2289656,,,NTRK2,Efficacy,0,lithium,699639311.0,European
1446902063,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,desipramine,1446902078.0,European
1446902063,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,desipramine,1446902076.0,European
1446902063,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,desipramine,1446902078.0,European
1446902063,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,desipramine,1446902076.0,European
699639273,PA166157722,rs1187326,,,NTRK2,Efficacy,0,lithium,699639309.0,European
1448261958,PA166160417,rs3734703,,,SLC29A1,Efficacy,1,cytarabine,1448261964.0,East Asian
982045940,PA166154993,rs708272,,,CETP,Efficacy,-1,atorvastatin,982045945.0,European
699639262,PA166154483,rs890,,,GRIN2B,Efficacy,0,lithium,699639297.0,European
699639262,PA166154483,rs890,,,GRIN2B,Efficacy,0,lithium,699639297.0,European
699639260,PA166155613,rs1019358,,,NBAS,Efficacy,0,lithium,699639295.0,European
981505272,PA166154516,rs1544410,,,VDR,Metabolism/PK,1,midazolam,981505283.0,European
699639267,PA166156377,rs3755557,,,GSK3B,Efficacy,0,lithium,699639305.0,"Multiple groups, Brazilian"
1448573250,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448573253.0,African American/Afro-Caribbean
1448573250,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448573252.0,African American/Afro-Caribbean
1450375453,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,o-desmethyltramadol,,
1450375453,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tramadol,,
699639264,PA166156287,rs334558,,,GSK3B,Efficacy,0,lithium,699639299.0,European
699639264,PA166156287,rs334558,,,GSK3B,Efficacy,0,lithium,699639301.0,European
1446902080,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,imipramine,1446902082.0,European
1446902080,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,imipramine,1446902083.0,European
1446902080,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,imipramine,1446902082.0,European
1446902080,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,imipramine,1446902083.0,European
1450375444,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,o-desmethyltramadol,1450375446.0,Unknown
1450375444,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,o-desmethyltramadol,1450375447.0,Unknown
1450375444,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,o-desmethyltramadol,1450375452.0,Unknown
1450375444,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,o-desmethyltramadol,1450375448.0,Unknown
1448261943,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,sunitinib,1448261950.0,"Multiple groups, Singapore: Chinese (85%), Malay, Indian"
699639253,PA166157113,rs6917661,,,CNKSR3,Efficacy,0,lithium,699639293.0,European
982045958,PA166155810,rs11887534,,,ABCG8,Efficacy,-1,atorvastatin,982045965.0,European
1450932486,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,0,toremifene,,
699639257,PA166154599,rs7301408,,,None,Efficacy,0,lithium,699639291.0,European
699639244,PA166157076,rs3730353,,,FYN,Efficacy,0,lithium,699639247.0,European
1444694255,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444694266.0,Unknown
1444694255,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444694280.0,Unknown
1447983413,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methylphenidate,1447983425.0,European
1184233832,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184233837.0,East Asian
1184233832,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184233842.0,East Asian
1449576762,PA166157443,rs10276036,,,ABCB1,Efficacy,-1,cyclophosphamide,1449576764.0,Central/South Asian
1449576762,PA166157443,rs10276036,,,ABCB1,Efficacy,-1,doxorubicin,1449576764.0,Central/South Asian
981478735,PA166157174,rs11568817,,,HTR1B,Efficacy,-1,methylphenidate,981478793.0,European
1449576756,PA166154249,rs1695,,,GSTP1,Efficacy,-1,cyclophosphamide,1449576761.0,Central/South Asian
1449576756,PA166154249,rs1695,,,GSTP1,Efficacy,-1,doxorubicin,1449576761.0,Central/South Asian
1449560375,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,lamotrigine,1449560377.0,European
1447954729,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,primaquine,1447954772.0,Unknown
1447954729,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,primaquine,1447954769.0,Unknown
1447954729,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,primaquine,1447954772.0,Unknown
1447954729,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,primaquine,1447954769.0,Unknown
1447954729,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,primaquine,1447954772.0,Unknown
1447954729,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,primaquine,1447954769.0,Unknown
1447954729,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,1,primaquine,1447954772.0,Unknown
1447954729,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,1,primaquine,1447954769.0,Unknown
1447954729,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,primaquine,1447954772.0,Unknown
1447954729,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,primaquine,1447954769.0,Unknown
1447954729,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,primaquine,1447954772.0,Unknown
1447954729,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,primaquine,1447954769.0,Unknown
1449560369,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,-1,lamotrigine,1449560371.0,European
1449003329,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1449003335.0,East Asian
1449576777,PA166157334,rs2229109,,,ABCB1,Efficacy,-1,cyclophosphamide,1449576779.0,Central/South Asian
1449576777,PA166157334,rs2229109,,,ABCB1,Efficacy,-1,doxorubicin,1449576779.0,Central/South Asian
827810841,PA166155173,rs1042522,,,TP53,Efficacy,1,cisplatin,827810855.0,East Asian
827810841,PA166155173,rs1042522,,,TP53,Efficacy,1,paclitaxel,827810855.0,East Asian
1447676175,PA166154741,rs9561778,,,ABCC4,Efficacy,-1,cyclophosphamide,1447676199.0,East Asian
1447676175,PA166154741,rs9561778,,,ABCC4,Toxicity,-1,cyclophosphamide,1447676199.0,East Asian
1447676175,PA166154741,rs9561778,,,ABCC4,Metabolism/PK,-1,cyclophosphamide,1447676199.0,East Asian
1450936672,PA166186238,rs17376019,,,SRPRB,Metabolism/PK,1,ethanol,1450936676.0,East Asian
982035812,PA166154534,rs2239050,,,CACNA1C,Efficacy,1,amlodipine,982035857.0,European
982035812,PA166154534,rs2239050,,,CACNA1C,Efficacy,1,felodipine,982035857.0,European
1449003337,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1449003339.0,East Asian
1184512384,PA166157267,rs776746,,,CYP3A5,Dosage,-1,tacrolimus,,
1184512384,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,,
1447676180,PA166157094,rs3957357,,,GSTA1,Efficacy,-1,cyclophosphamide,1447676191.0,East Asian
1447676180,PA166157094,rs3957357,,,GSTA1,Toxicity,-1,cyclophosphamide,1447676191.0,East Asian
1447676180,PA166157094,rs3957357,,,GSTA1,Metabolism/PK,-1,cyclophosphamide,1447676191.0,East Asian
1184512390,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184512394.0,"Multiple groups, Caucasian, Black and Asian patients."
1450936677,PA166154482,rs671,,,ALDH2,Metabolism/PK,1,ethanol,1450936681.0,East Asian
1449560381,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,lamotrigine,1449560383.0,European
1447676185,PA166154249,rs1695,,,GSTP1,Efficacy,-1,cyclophosphamide,1447676197.0,East Asian
1447676185,PA166154249,rs1695,,,GSTP1,Toxicity,-1,cyclophosphamide,1447676197.0,East Asian
1447676185,PA166154249,rs1695,,,GSTP1,Metabolism/PK,-1,cyclophosphamide,1447676197.0,East Asian
1449576792,PA166157385,rs4148737,,,ABCB1,Efficacy,-1,cyclophosphamide,1449576794.0,Central/South Asian
1449576792,PA166157385,rs4148737,,,ABCB1,Efficacy,-1,doxorubicin,1449576794.0,Central/South Asian
1448265990,PA166157518,rs77010898,,,CFTR,Efficacy,1,ivacaftor,1448265996.0,Unknown
1449576767,PA166178427,rs112783657,,,DOP1B,Efficacy,-1,cyclophosphamide,1449576769.0,Central/South Asian
1449576767,PA166178427,rs112783657,,,DOP1B,Efficacy,-1,doxorubicin,1449576769.0,Central/South Asian
1446906094,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906097.0,East Asian
1446906094,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906096.0,East Asian
1446906094,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906099.0,East Asian
1446906094,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906098.0,East Asian
1446906094,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906097.0,East Asian
1446906094,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906096.0,East Asian
1446906094,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906099.0,East Asian
1446906094,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,clopidogrel,1446906098.0,East Asian
1449576787,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,cyclophosphamide,1449576789.0,Central/South Asian
1449576787,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,doxorubicin,1449576789.0,Central/South Asian
1447676170,PA166155060,rs4148350,,,ABCC1,Efficacy,-1,cyclophosphamide,1447676203.0,East Asian
1447676170,PA166155060,rs4148350,,,ABCC1,Toxicity,-1,cyclophosphamide,1447676203.0,East Asian
1447676170,PA166155060,rs4148350,,,ABCC1,Metabolism/PK,-1,cyclophosphamide,1447676203.0,East Asian
1449003343,PA166170701,rs10841753,,,SLCO1B1,Metabolism/PK,1,methotrexate,1449003345.0,East Asian
1449003351,PA166155986,rs1051266,,,SLC19A1,Metabolism/PK,-1,methotrexate,1449003353.0,East Asian
827892732,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,cisplatin,827892733.0,Unknown
827892732,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,fluorouracil,827892733.0,Unknown
769171579,PA166156287,rs334558,,,GSK3B,Efficacy,1,citalopram,769171581.0,East Asian
769171579,PA166156287,rs334558,,,GSK3B,Efficacy,1,fluoxetine,769171581.0,East Asian
1444710685,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710835.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710833.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710695.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710835.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710833.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710695.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710835.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710833.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710695.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710835.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710833.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710695.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710835.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710833.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710695.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710835.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710833.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710685,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710695.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
827892728,PA166156339,rs2046934,,,P2RY12,Efficacy,0,clopidogrel,827892729.0,European
1449576807,PA166155467,rs12721655,,,CYP2B6,Efficacy,-1,cyclophosphamide,1449576809.0,Central/South Asian
1449576807,PA166155467,rs12721655,,,CYP2B6,Efficacy,-1,doxorubicin,1449576809.0,Central/South Asian
1449003369,PA166155990,rs1131596,,,SLC19A1,Metabolism/PK,-1,methotrexate,1449003371.0,East Asian
1447676150,PA166154053,rs4244285,,,CYP2C19,Efficacy,-1,cyclophosphamide,1447676195.0,East Asian
1447676150,PA166154053,rs4244285,,,CYP2C19,Toxicity,-1,cyclophosphamide,1447676195.0,East Asian
1447676150,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,cyclophosphamide,1447676195.0,East Asian
1449576797,PA166157303,rs1799983,,,NOS3,Efficacy,-1,cyclophosphamide,1449576799.0,Central/South Asian
1449576797,PA166157303,rs1799983,,,NOS3,Efficacy,-1,doxorubicin,1449576799.0,Central/South Asian
1447954657,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,docetaxel,1447954659.0,Central/South Asian
1447954657,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,paclitaxel,1447954659.0,Central/South Asian
1449003357,PA166170691,rs3788200,,,SLC19A1,Metabolism/PK,-1,methotrexate,1449003359.0,East Asian
1450936718,PA166154482,rs671,,,ALDH2,Metabolism/PK,1,acetaldehyde,1450936722.0,East Asian
1450936723,PA166186239,rs4643,,,PGM1,Metabolism/PK,1,acetaldehyde,1450936729.0,East Asian
1450822034,PA166156991,rs1799971,,,OPRM1,Other,1,ethanol,1450822039.0,Unknown
1449576822,PA166155442,rs8192709,,,CYP2B6,Efficacy,-1,cyclophosphamide,1449576824.0,Central/South Asian
1449576822,PA166155442,rs8192709,,,CYP2B6,Efficacy,-1,doxorubicin,1449576824.0,Central/South Asian
1449576817,PA166155405,rs3211371,,,CYP2B6,Efficacy,-1,cyclophosphamide,1449576819.0,Central/South Asian
1449576817,PA166155405,rs3211371,,,CYP2B6,Efficacy,-1,doxorubicin,1449576819.0,Central/South Asian
981478810,PA166154520,rs1843809,,,TPH2,Efficacy,-1,methylphenidate,981478815.0,European
1449003375,PA166170682,rs2838958,,,SLC19A1,Metabolism/PK,-1,methotrexate,1449003377.0,East Asian
1449003387,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,methotrexate,1449003389.0,East Asian
1450936730,PA166156507,rs1229984,,,ADH1B,Metabolism/PK,1,acetaldehyde,1450936734.0,East Asian
1449576812,PA166155415,rs4802101,,,CYP2B6,Efficacy,-1,cyclophosphamide,1449576814.0,Central/South Asian
1449576812,PA166155415,rs4802101,,,CYP2B6,Efficacy,-1,doxorubicin,1449576814.0,Central/South Asian
1449003393,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,methotrexate,1449003395.0,East Asian
1447954643,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,docetaxel,1447954645.0,Central/South Asian
1447954643,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,paclitaxel,1447954645.0,Central/South Asian
981478817,PA166154593,rs4570625,,,TPH2,Efficacy,-1,methylphenidate,981478821.0,European
1446906082,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,clopidogrel,1446906084.0,East Asian
1446906082,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,clopidogrel,1446906085.0,East Asian
1446906082,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,clopidogrel,1446906084.0,East Asian
1446906082,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,clopidogrel,1446906085.0,East Asian
827810774,PA166155906,rs7121,,,GNAS,Efficacy,1,cisplatin,827810787.0,Unknown
827810774,PA166155906,rs7121,,,GNAS,Efficacy,1,fluorouracil,827810787.0,Unknown
1449576839,PA166157112,rs6907567,,,SLC22A16,Efficacy,-1,cyclophosphamide,1449576841.0,Central/South Asian
1449576839,PA166157112,rs6907567,,,SLC22A16,Efficacy,-1,doxorubicin,1449576841.0,Central/South Asian
1447676115,PA166155393,rs2279343,,,CYP2B6,Efficacy,-1,cyclophosphamide,1447676205.0,East Asian
1447676115,PA166155393,rs2279343,,,CYP2B6,Toxicity,-1,cyclophosphamide,1447676205.0,East Asian
1447676115,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,cyclophosphamide,1447676205.0,East Asian
1444694209,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444694215.0,Unknown
1449576834,PA166156941,rs723685,,,SLC22A16,Efficacy,-1,cyclophosphamide,1449576836.0,Central/South Asian
1449576834,PA166156941,rs723685,,,SLC22A16,Efficacy,-1,doxorubicin,1449576836.0,Central/South Asian
981478823,PA166157734,rs1611115,,,DBH,Efficacy,-1,methylphenidate,981478827.0,European
1449003399,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,methotrexate,1449003401.0,East Asian
827843529,PA166154264,rs9344,,,CCND1,Efficacy,-1,cetuximab,827843535.0,European
1447954627,PA166154110,rs10509681,,,CYP2C8,Efficacy,-1,docetaxel,1447954629.0,Central/South Asian
1447954627,PA166154110,rs10509681,,,CYP2C8,Efficacy,-1,paclitaxel,1447954629.0,Central/South Asian
1450936684,PA166156506,rs1229976,,,ADH1A,Metabolism/PK,-1,ethanol,1450936688.0,East Asian
1449576829,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,cyclophosphamide,1449576831.0,Central/South Asian
1449576829,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,doxorubicin,1449576831.0,Central/South Asian
1449576859,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,cyclophosphamide,1449576861.0,Central/South Asian
1449576859,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,doxorubicin,1449576861.0,Central/South Asian
769171526,PA166156991,rs1799971,,,OPRM1,Efficacy,1,naltrexone,769171530.0,Unknown
1449576854,PA166156979,rs1143684,,,NQO2,Efficacy,-1,cyclophosphamide,1449576856.0,Central/South Asian
1449576854,PA166156979,rs1143684,,,NQO2,Efficacy,-1,doxorubicin,1449576856.0,Central/South Asian
1450936689,PA166186239,rs4643,,,PGM1,Metabolism/PK,1,ethanol,1450936695.0,East Asian
1447987401,PA166153890,rs56160474,,,DPYD,Efficacy,-1,capecitabine,1447987403.0,East Asian
1447987401,PA166153890,rs56160474,,,DPYD,Efficacy,-1,fluorouracil,1447987403.0,East Asian
1447987401,PA166153890,rs56160474,,,DPYD,Efficacy,-1,tegafur / gimeracil / oteracil,1447987403.0,East Asian
1449576844,PA166157179,rs12210538,,,SLC22A16,Efficacy,-1,cyclophosphamide,1449576846.0,Central/South Asian
1449576844,PA166157179,rs12210538,,,SLC22A16,Efficacy,-1,doxorubicin,1449576846.0,Central/South Asian
1450936696,PA166156507,rs1229984,,,ADH1B,Metabolism/PK,-1,ethanol,1450936700.0,East Asian
1447987376,PA166153647,rs1801160,,,DPYD,Efficacy,-1,capecitabine,1447987378.0,East Asian
1447987376,PA166153647,rs1801160,,,DPYD,Efficacy,-1,fluorouracil,1447987378.0,East Asian
1447987376,PA166153647,rs1801160,,,DPYD,Efficacy,-1,tegafur / gimeracil / oteracil,1447987378.0,East Asian
1450822015,PA166156991,rs1799971,,,OPRM1,Toxicity,-1,heroin,1450822020.0,European
827892661,PA166153895,rs67376798,,,DPYD,Toxicity,1,fluorouracil,827892668.0,European
827892661,PA166153895,rs67376798,,,DPYD,Metabolism/PK,1,fluorouracil,827892668.0,European
1447954607,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,docetaxel,1447954609.0,Central/South Asian
1447954607,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,paclitaxel,1447954609.0,Central/South Asian
1447987385,PA166153696,rs2297595,,,DPYD,Efficacy,-1,capecitabine,1447987387.0,East Asian
1447987385,PA166153696,rs2297595,,,DPYD,Efficacy,-1,fluorouracil,1447987387.0,East Asian
1447987385,PA166153696,rs2297595,,,DPYD,Efficacy,-1,tegafur / gimeracil / oteracil,1447987387.0,East Asian
981478794,PA166157184,rs13212041,,,HTR1B,Efficacy,-1,methylphenidate,981478799.0,European
981478794,PA166157184,rs13212041,,,HTR1B,Efficacy,-1,methylphenidate,981478799.0,European
981478794,PA166157184,rs13212041,,,HTR1B,Efficacy,-1,methylphenidate,981478799.0,European
1449576869,PA166178425,rs181501757,,,TOP2A,Efficacy,-1,cyclophosphamide,1449576871.0,Central/South Asian
1449576869,PA166178425,rs181501757,,,TOP2A,Efficacy,-1,doxorubicin,1449576871.0,Central/South Asian
1449576864,PA166157094,rs3957357,,,GSTA1,Efficacy,-1,cyclophosphamide,1449576866.0,Central/South Asian
1449576864,PA166157094,rs3957357,,,GSTA1,Efficacy,-1,doxorubicin,1449576866.0,Central/South Asian
1450936711,PA166156506,rs1229976,,,ADH1A,Metabolism/PK,1,acetaldehyde,1450936715.0,East Asian
1447987361,PA166153646,rs1801159,,,DPYD,Efficacy,1,capecitabine,1447987369.0,East Asian
1447987361,PA166153646,rs1801159,,,DPYD,Efficacy,1,fluorouracil,1447987369.0,East Asian
1447987361,PA166153646,rs1801159,,,DPYD,Efficacy,1,tegafur / gimeracil / oteracil,1447987369.0,East Asian
827892647,PA166153760,rs3918290,,,DPYD,Toxicity,1,fluorouracil,827892653.0,European
827892647,PA166153760,rs3918290,,,DPYD,Metabolism/PK,1,fluorouracil,827892653.0,European
981741019,PA166155267,rs292449,,,NEDD4L,Efficacy,-1,hydrochlorothiazide,981741032.0,African American/Afro-Caribbean
1184987641,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184987650.0,East Asian
1184987641,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184987650.0,East Asian
1449003438,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1449003440.0,East Asian
981954002,PA166154363,rs2279287,,,ARNTL,Efficacy,-1,lithium,981954013.0,European
1451133400,PA166204081,rs9909004,,,PRKCA,Efficacy,-1,"Ace Inhibitors, Plain",1451133421.0,"Multiple groups, White and African American patients"
1451133400,PA166204081,rs9909004,,,PRKCA,Efficacy,-1,"Ace Inhibitors, Plain",1451133420.0,"Multiple groups, White and African American patients"
1451133400,PA166204081,rs9909004,,,PRKCA,Efficacy,-1,Angiotensin II Antagonists,1451133421.0,"Multiple groups, White and African American patients"
1451133400,PA166204081,rs9909004,,,PRKCA,Efficacy,-1,Angiotensin II Antagonists,1451133420.0,"Multiple groups, White and African American patients"
1451133400,PA166204081,rs9909004,,,PRKCA,Efficacy,-1,Beta Blocking Agents,1451133421.0,"Multiple groups, White and African American patients"
1451133400,PA166204081,rs9909004,,,PRKCA,Efficacy,-1,Beta Blocking Agents,1451133420.0,"Multiple groups, White and African American patients"
1444694133,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,1444694139.0,"Multiple groups, Mostly White"
1447954597,PA166157267,rs776746,,,CYP3A5,Efficacy,1,docetaxel,1447954603.0,Central/South Asian
1447954597,PA166157267,rs776746,,,CYP3A5,Efficacy,1,paclitaxel,1447954603.0,Central/South Asian
1184512509,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513244.0,Unknown
1184512509,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513250.0,Unknown
1184512509,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513248.0,Unknown
1184512509,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513255.0,Unknown
1450822109,PA166156924,rs510769,,,OPRM1,Dosage,-1,nicotine,1450822113.0,European
1184512515,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184512522.0,Unknown
1447987342,PA166157496,rs56324128,,,CYP3A4,Metabolism/PK,1,ticagrelor,1447987344.0,European
981954014,PA166154347,rs1982350,,,ARNTL,Efficacy,-1,lithium,981954020.0,European
1449003454,PA166170701,rs10841753,,,SLCO1B1,Efficacy,-1,methotrexate,1449003456.0,East Asian
1184512524,PA166156664,rs13120400,,,ABCG2,Efficacy,1,imatinib,1184512526.0,Unknown
1184512528,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184512530.0,Unknown
981478829,PA166156024,rs4680,,,COMT,Efficacy,-1,methylphenidate,981478842.0,European
981953971,PA166154312,rs1062613,,,HTR3A,Efficacy,1,clozapine,981954197.0,Central/South Asian
1184987661,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184987670.0,East Asian
1184987661,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1184987670.0,East Asian
1184512532,PA166156373,rs3732356,,,NR1I2,Metabolism/PK,-1,efavirenz,1184512534.0,Sub-Saharan African
1184512536,PA166156453,rs12721616,,,NR1I2,Metabolism/PK,-1,efavirenz,1184512538.0,Sub-Saharan African
1447676042,PA166157093,rs3957356,,,GSTA1,Efficacy,1,cyclophosphamide,1447676114.0,East Asian
1447676042,PA166157093,rs3957356,,,GSTA1,Toxicity,1,cyclophosphamide,1447676114.0,East Asian
1447676042,PA166157093,rs3957356,,,GSTA1,Metabolism/PK,1,cyclophosphamide,1447676114.0,East Asian
1447741578,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,1447746260.0,"Multiple groups, Han Chinese, Indian, Malay in Singapore"
1447741578,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,tamoxifen,1447746260.0,"Multiple groups, Han Chinese, Indian, Malay in Singapore"
981478851,PA166155908,rs363020,,,SNAP25,Efficacy,-1,methylphenidate,981478856.0,European
748396572,PA166153977,rs1801253,,,ADRB1,Efficacy,1,metoprolol,748401135.0,"Multiple groups, white, African; American, and Hispanic men and women with hypertension"
1450822078,PA166156991,rs1799971,,,OPRM1,Dosage,1,ethanol,1450822082.0,European
1448265859,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448265865.0,"Multiple groups, 22 white, 8 black"
1450822083,PA166156991,rs1799971,,,OPRM1,Dosage,-1,nicotine,1450822087.0,European
1184512548,PA166156316,rs1464602,,,NR1I2,Metabolism/PK,-1,efavirenz,1184512550.0,Sub-Saharan African
1184512552,PA166153712,rs2502815,,,NR1I3,Metabolism/PK,-1,efavirenz,1184512554.0,Sub-Saharan African
1444694062,PA166156872,rs11959113,,,None,Dosage,1,fentanyl,1444694064.0,East Asian
1444694062,PA166156872,rs11959113,,,None,Efficacy,1,fentanyl,1444694064.0,East Asian
1449003493,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,lumefantrine,1449003500.0,Sub-Saharan African
1449003493,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,lumefantrine,1449003500.0,Sub-Saharan African
1184512440,PA166157516,rs75527207,,,CFTR,Efficacy,1,ivacaftor,1184512444.0,European
1449003506,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,lumefantrine,1449003508.0,Sub-Saharan African
981954070,PA166155096,rs9934438,,,VKORC1,Efficacy,1,acenocoumarol,981954117.0,Unknown
1447987282,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,ticagrelor,1447987284.0,European
981954089,PA166153565,rs228697,,,PER3,Efficacy,-1,lithium,981954094.0,European
1447987289,PA166156689,rs61361928,,,UGT2B7,Metabolism/PK,1,ticagrelor,1447987291.0,European
1183693336,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183693338.0,East Asian
981954083,PA166153564,rs228666,,,PER3,Efficacy,-1,lithium,981954087.0,European
1449576962,PA166179651,rs3828743,,,TSPYL1,Efficacy,1,abiraterone,1449576968.0,Unknown
1449576962,PA166179651,rs3828743,,,TSPYL1,Efficacy,1,prednisolone,1449576968.0,Unknown
1183693332,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183693334.0,East Asian
827777870,PA166156699,rs113420705,,,CASP3,Efficacy,1,Immunoglobulins,827777876.0,East Asian
827777870,PA166156699,rs113420705,,,CASP3,Efficacy,1,Immunoglobulins,827777874.0,East Asian
827777870,PA166156699,rs113420705,,,PRIMPOL,Efficacy,1,Immunoglobulins,827777876.0,East Asian
827777870,PA166156699,rs113420705,,,PRIMPOL,Efficacy,1,Immunoglobulins,827777874.0,East Asian
1449003524,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,1,lumefantrine,1449003526.0,Sub-Saharan African
981954077,PA166153563,rs228642,,,PER3,Efficacy,-1,lithium,981954081.0,European
827777860,PA166155480,rs28493229,,,COQ8B,Efficacy,1,Immunoglobulins,827777869.0,East Asian
827777860,PA166155480,rs28493229,,,ITPKC,Efficacy,1,Immunoglobulins,827777869.0,East Asian
1444694094,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444694100.0,"Multiple groups, Mostly White"
1451133423,PA166204101,rs9303504,,,PRKCA,Efficacy,-1,"Ace Inhibitors, Plain",1451133440.0,"Multiple groups, White and African American patients"
1451133423,PA166204101,rs9303504,,,PRKCA,Efficacy,-1,"Ace Inhibitors, Plain",1451133428.0,"Multiple groups, White and African American patients"
1451133423,PA166204101,rs9303504,,,PRKCA,Efficacy,-1,Angiotensin II Antagonists,1451133440.0,"Multiple groups, White and African American patients"
1451133423,PA166204101,rs9303504,,,PRKCA,Efficacy,-1,Angiotensin II Antagonists,1451133428.0,"Multiple groups, White and African American patients"
1451133423,PA166204101,rs9303504,,,PRKCA,Efficacy,-1,Beta Blocking Agents,1451133440.0,"Multiple groups, White and African American patients"
1451133423,PA166204101,rs9303504,,,PRKCA,Efficacy,-1,Beta Blocking Agents,1451133428.0,"Multiple groups, White and African American patients"
1449003535,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,lumefantrine,1449003537.0,Sub-Saharan African
1449003545,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,lumefantrine,1449003547.0,Sub-Saharan African
1183693321,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183693331.0,East Asian
1183693321,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1183693331.0,East Asian
1450822133,PA166184699,rs10485057,,,OPRM1,Dosage,1,ethanol,1450822140.0,European
1450822133,PA166184699,rs10485057,,,OPRM1,Dosage,1,ethanol,1450822137.0,European
1447987275,PA166154664,rs113681054,,,SLCO1B1,Metabolism/PK,1,ticagrelor,1447987281.0,European
981954029,PA166154361,rs2278749,,,ARNTL,Efficacy,-1,lithium,981954035.0,European
827695929,PA166153959,rs1057910,,,CYP2C9,Dosage,-1,glimepiride,827695938.0,Unknown
827695929,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,-1,glimepiride,827695938.0,Unknown
1184512470,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1184512474.0,Sub-Saharan African
1450822141,PA166184699,rs10485057,,,OPRM1,Dosage,-1,nicotine,1450822147.0,European
981954051,PA166156681,rs34897046,,,CLOCK,Efficacy,-1,lithium,981954056.0,European
981954045,PA166156574,rs3736544,,,CLOCK,Efficacy,-1,lithium,981954049.0,European
769171370,PA166155190,rs1800012,,,COL1A1,Efficacy,1,etidronic acid,769171372.0,Unknown
827811113,PA166157367,rs2740574,,,CYP3A4,Other,-1,midazolam,827811120.0,European
827811113,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,midazolam,827811120.0,European
827811113,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,midazolam,827811120.0,European
981954134,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,acenocoumarol,981954136.0,Unknown
651336346,PA166157196,rs34059508,,,SLC22A1,Efficacy,0,Antiemetics And Antinauseants,,
651336346,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,0,Antiemetics And Antinauseants,,
1446905879,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905894.0,European
1446905879,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446906591.0,European
1446905879,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446906593.0,European
1446905879,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905896.0,European
1446905879,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905892.0,European
1446905879,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,doxepin,1446905894.0,European
1446905879,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,doxepin,1446906591.0,European
1446905879,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,doxepin,1446906593.0,European
1446905879,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,doxepin,1446905896.0,European
1446905879,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,doxepin,1446905892.0,European
1446905879,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,doxepin,1446905894.0,European
1446905879,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,doxepin,1446906591.0,European
1446905879,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,doxepin,1446906593.0,European
1446905879,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,doxepin,1446905896.0,European
1446905879,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,doxepin,1446905892.0,European
1446905879,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,doxepin,1446905894.0,European
1446905879,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,doxepin,1446906591.0,European
1446905879,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,doxepin,1446906593.0,European
1446905879,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,doxepin,1446905896.0,European
1446905879,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,doxepin,1446905892.0,European
1448265747,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,azithromycin,1448265749.0,East Asian
1444694003,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1444694005.0,"Multiple groups, White, Asian"
1444694003,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1444694005.0,"Multiple groups, White, Asian"
981954104,PA166153713,rs2640909,,,PER3,Efficacy,-1,lithium,981954109.0,European
981954096,PA166153723,rs2859388,,,PER3,Efficacy,-1,lithium,981954100.0,European
1444694036,PA166153757,rs3845446,,,CACNA1E,Dosage,-1,fentanyl,1444694038.0,East Asian
1444694036,PA166153757,rs3845446,,,CACNA1E,Efficacy,-1,fentanyl,1444694038.0,East Asian
981478966,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981478969.0,European
981478966,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981478969.0,European
981478966,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981478969.0,European
981478966,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981478969.0,European
1449003619,PA166157239,rs3842,,,ABCB1,Metabolism/PK,-1,lumefantrine,1449003621.0,Sub-Saharan African
1444694034,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1444694046.0,"Multiple groups, Mostly White"
981478976,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981478982.0,European
981478976,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981478982.0,European
981478976,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981478982.0,European
981478976,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981478982.0,European
981478976,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981478982.0,European
981478976,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981478982.0,European
1444694050,PA166156003,rs2835859,,,KCNJ6,Dosage,1,fentanyl,1444694052.0,East Asian
1444694050,PA166156003,rs2835859,,,KCNJ6,Efficacy,1,fentanyl,1444694052.0,East Asian
1450822217,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1450822217,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,mephedrone,1450822255.0,Unknown
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987192.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987193.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987191.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987190.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987192.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987193.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987191.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987190.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987192.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987193.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987191.0,East Asian
1447987188,PA166157126,rs7756992,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987190.0,East Asian
1184512556,PA166153700,rs2307424,,,NR1I3,Metabolism/PK,-1,efavirenz,1184512558.0,Sub-Saharan African
981954198,PA166154358,rs2276302,,,HTR3A,Efficacy,1,clozapine,981954207.0,Central/South Asian
1450822293,PA166154938,rs16969968,,,CHRNA3,Efficacy,-1,varenicline,1450822298.0,European
1450822293,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,varenicline,1450822298.0,European
1447987173,PA166157125,rs7754840,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987185.0,East Asian
1447987173,PA166157125,rs7754840,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987187.0,East Asian
1447987173,PA166157125,rs7754840,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987183.0,East Asian
1447987173,PA166157125,rs7754840,,,CDKAL1,Efficacy,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,1447987181.0,East Asian
1449003637,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,lumefantrine,1449003644.0,Sub-Saharan African
1450822299,PA166154938,rs16969968,,,CHRNA3,Efficacy,1,nicotine,1450822305.0,European
1450822299,PA166154938,rs16969968,,,CHRNA3,Efficacy,1,nicotine,1450822304.0,European
1450822299,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,nicotine,1450822305.0,European
1450822299,PA166154938,rs16969968,,,CHRNA5,Efficacy,1,nicotine,1450822304.0,European
769171288,PA166155331,rs45445694,,,C18orf56,Efficacy,-1,methotrexate,769171290.0,Unknown
769171288,PA166155331,rs45445694,,,TYMS,Efficacy,-1,methotrexate,769171290.0,Unknown
769171288,PA166155331,rs45445694,,,TYMS,Efficacy,-1,methotrexate,769171290.0,Unknown
769171288,PA166155331,rs45445694,,,TYMS,Efficacy,-1,methotrexate,769171290.0,Unknown
1448265676,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1448265701.0,Unknown
1448265676,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1448265701.0,Unknown
1449003652,PA166155478,rs28399499,,,CYP2B6,Efficacy,-1,lumefantrine,1449003654.0,Sub-Saharan African
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,bevacizumab,1184168598.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,bevacizumab,1184168593.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,bevacizumab,1184168595.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,pegaptanib,1184168598.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,pegaptanib,1184168593.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,pegaptanib,1184168595.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,ranibizumab,1184168598.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,ranibizumab,1184168593.0,East Asian
1184168589,PA166157006,rs2010963,,,VEGFA,Efficacy,1,ranibizumab,1184168595.0,East Asian
1449003645,PA166155409,rs3745274,,,CYP2B6,Efficacy,-1,lumefantrine,1449003647.0,Sub-Saharan African
1449003659,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,lumefantrine,1449003661.0,Sub-Saharan African
1449003666,PA166157441,rs10264272,,,CYP3A5,Efficacy,-1,lumefantrine,1449003668.0,Sub-Saharan African
1449003666,PA166157441,rs10264272,,,ZSCAN25,Efficacy,-1,lumefantrine,1449003668.0,Sub-Saharan African
1446905772,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1446905772,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,doxepin,1446905793.0,European
1446905772,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,doxepin,1446905814.0,European
1446905772,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,doxepin,1446905791.0,European
1446905772,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,doxepin,1446906556.0,European
1446905772,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,doxepin,1446905787.0,European
1446905772,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,doxepin,1446905789.0,European
1449003673,PA166157490,rs41303343,,,CYP3A5,Efficacy,-1,lumefantrine,1449003675.0,Sub-Saharan African
1449003673,PA166157490,rs41303343,,,ZSCAN25,Efficacy,-1,lumefantrine,1449003675.0,Sub-Saharan African
1184168575,PA166157229,rs145450955,,,SLC22A2,Metabolism/PK,-1,lamivudine,1184168579.0,East Asian
1184987748,,,PA165980634,CYP2C19*1,CYP2C19,Other,1,clopidogrel,1184987762.0,"Multiple groups, Chinese, Korean, French"
1184987748,,,PA165980634,CYP2C19*1,CYP2C19,Other,1,clopidogrel,1184987772.0,"Multiple groups, Korean, Chinese, French"
1184987748,,,PA165980634,CYP2C19*1,CYP2C19,Other,1,clopidogrel,1184987774.0,"Multiple groups, Korean, Chinese, French"
1184987748,,,PA165980635,CYP2C19*2,CYP2C19,Other,1,clopidogrel,1184987762.0,"Multiple groups, Chinese, Korean, French"
1184987748,,,PA165980635,CYP2C19*2,CYP2C19,Other,1,clopidogrel,1184987772.0,"Multiple groups, Korean, Chinese, French"
1184987748,,,PA165980635,CYP2C19*2,CYP2C19,Other,1,clopidogrel,1184987774.0,"Multiple groups, Korean, Chinese, French"
1444693964,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444693974.0,"Multiple groups, White, Asian, Other"
1449003680,PA166157239,rs3842,,,ABCB1,Efficacy,-1,lumefantrine,1449003682.0,Sub-Saharan African
769171257,PA166156893,rs70991108,,,DHFR,Efficacy,-1,folic acid,769171259.0,European
769171257,PA166156893,rs70991108,,,DHFR,Efficacy,-1,hydroxychloroquine,769171259.0,European
769171257,PA166156893,rs70991108,,,DHFR,Efficacy,-1,methotrexate,769171259.0,European
769171257,PA166156893,rs70991108,,,DHFR,Efficacy,-1,sulfasalazine,769171259.0,European
769171254,PA166155196,rs1979277,,,SHMT1,Efficacy,-1,folic acid,769171256.0,European
769171254,PA166155196,rs1979277,,,SHMT1,Efficacy,-1,hydroxychloroquine,769171256.0,European
769171254,PA166155196,rs1979277,,,SHMT1,Efficacy,-1,methotrexate,769171256.0,European
769171254,PA166155196,rs1979277,,,SHMT1,Efficacy,-1,sulfasalazine,769171256.0,European
769171251,PA166155684,rs2372536,,,ATIC,Efficacy,-1,folic acid,769171253.0,European
769171251,PA166155684,rs2372536,,,ATIC,Efficacy,-1,hydroxychloroquine,769171253.0,European
769171251,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,769171253.0,European
769171251,PA166155684,rs2372536,,,ATIC,Efficacy,-1,sulfasalazine,769171253.0,European
769171245,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,folic acid,769171247.0,European
769171245,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,hydroxychloroquine,769171247.0,European
769171245,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,769171247.0,European
769171245,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,sulfasalazine,769171247.0,European
1444693992,PA166157155,rs9384179,,,OPRM1,Dosage,1,fentanyl,1444694029.0,East Asian
1444693992,PA166157155,rs9384179,,,OPRM1,Efficacy,1,fentanyl,1444694029.0,East Asian
1450117776,PA166164927,rs2254638,,,N6AMT1,Efficacy,1,clopidogrel,1450121157.0,East Asian
1451117264,PA166199001,rs1275988,,,KCNK3,Efficacy,1,candesartan,1451117320.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1444693880,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1444693886.0,Multiple groups
981954279,PA166155944,rs3918242,,,MMP9,Efficacy,-1,lithium,981954291.0,European
1444693893,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,0,rosuvastatin,1444693895.0,Multiple groups
1444693893,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,0,rosuvastatin,1444693895.0,Multiple groups
1184168659,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ustekinumab,1184168664.0,Unknown
1184168659,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ustekinumab,1184168662.0,Unknown
982036189,PA166154535,rs2239128,,,CACNA1C,Efficacy,-1,lacidipine,982036218.0,European
982036189,PA166154535,rs2239128,,,CACNA1C,Efficacy,-1,nifedipine,982036218.0,European
982036189,PA166154535,rs2239128,,,CACNA1C,Efficacy,-1,nitrendipine,982036218.0,European
1184987905,PA166155409,rs3745274,,,CYP2B6,Dosage,0,efavirenz,1184987910.0,"Multiple groups, Caucasian, Black, Hispanic/Latin."
1184987905,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1184987910.0,"Multiple groups, Caucasian, Black, Hispanic/Latin."
1184168650,PA166156931,rs610604,,,TNFAIP3,Efficacy,-1,ustekinumab,1184168654.0,Unknown
769171459,PA166157284,rs1045642,,,ABCB1,Other,-1,loperamide,769171461.0,European
769171459,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,loperamide,769171461.0,European
1444693914,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1444693920.0,"Multiple groups, White, Asian, Other"
981954223,PA166157733,rs1565445,,,NTRK2,Efficacy,-1,lithium,981954235.0,East Asian
981954223,PA166157733,rs1565445,,,NTRK2,Efficacy,-1,valproic acid,981954235.0,East Asian
981954223,PA166157733,rs1565445,,,NTRK2,Efficacy,-1,valproic acid,981954235.0,East Asian
1449577166,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1449577813.0,"Multiple groups, Singapore: Chinese, Malay, Indian, Other"
1449577192,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1449577792.0,"Multiple groups, Chinese, Indian and Malay participants in Singapore"
981954249,PA166157727,rs1387923,,,NTRK2,Efficacy,-1,lithium,981954254.0,East Asian
1451346620,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1451346625.0,Unknown
1451346620,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1451346625.0,Unknown
1451346620,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,esomeprazole,1451346625.0,Unknown
1449593570,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,voriconazole,1449593572.0,"Multiple groups, Italy, specified 37.5% Caucasian, 62.5% Other."
1184168621,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ustekinumab,1184168637.0,Unknown
1184168621,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ustekinumab,1184168642.0,Unknown
1184168621,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ustekinumab,1184168639.0,Unknown
1184168621,,,PA165957286,HLA-C*06:02:01:01,HLA-C,Efficacy,1,ustekinumab,1184168635.0,Unknown
1447675769,PA166156921,rs465646,,,REV3L,Efficacy,-1,cisplatin,1447675777.0,European
982036156,PA166154535,rs2239128,,,CACNA1C,Efficacy,1,amlodipine,982036188.0,European
982036156,PA166154535,rs2239128,,,CACNA1C,Efficacy,1,felodipine,982036188.0,European
1446905682,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,doxepin,1446905689.0,European
1446905682,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,doxepin,1446905689.0,European
1444693810,PA166156915,rs361525,,,TNF,Efficacy,1,adalimumab,1444693812.0,European
1451100940,PA166195401,rs28375964,,,UGT2B7,Metabolism/PK,-1,morphine,1451100960.0,"Multiple groups, Caucasian, African American, Asian and multiracial patients"
1447675747,PA166155695,rs3087399,,,REV1,Efficacy,-1,cisplatin,1447675753.0,European
1447675754,PA166157073,rs3204953,,,REV3L,Efficacy,-1,cisplatin,1447675764.0,European
982036265,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,benazepril,982036280.0,East Asian
982036265,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,benazepril,982036278.0,East Asian
982036265,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,imidapril,982036280.0,East Asian
982036265,PA166157566,rs1799998,,,CYP11B2,Efficacy,-1,imidapril,982036278.0,East Asian
1451117340,PA166154861,rs1378942,,,CSK,Efficacy,1,hydrochlorothiazide,1451117345.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1184512708,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,venlafaxine,1184512710.0,East Asian
1184512708,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,venlafaxine,1184512710.0,East Asian
1447675738,PA166155694,rs3087386,,,REV1,Efficacy,-1,cisplatin,1447675746.0,European
1447675738,PA166155694,rs3087386,,,REV1,Efficacy,-1,cisplatin,1447675746.0,European
1451133680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1451133700.0,European
1451133680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,nortriptyline,1451133700.0,European
1184168705,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1184985893.0,European
1184168705,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1184985891.0,European
1184168705,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1184985893.0,European
1184168705,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1184985891.0,European
982036232,PA166157566,rs1799998,,,CYP11B2,Efficacy,1,benazepril,982036264.0,East Asian
982036232,PA166157566,rs1799998,,,CYP11B2,Efficacy,1,benazepril,982036262.0,East Asian
982036232,PA166157566,rs1799998,,,CYP11B2,Efficacy,1,imidapril,982036264.0,East Asian
982036232,PA166157566,rs1799998,,,CYP11B2,Efficacy,1,imidapril,982036262.0,East Asian
1447675704,PA166155696,rs3087403,,,REV1,Efficacy,1,cisplatin,1447675710.0,European
827647045,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827648879.0,European
982036220,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,verapamil,982036230.0,East Asian
1184136041,PA166156092,rs2269577,,,XBP1,Efficacy,-1,Platinum compounds,1184136043.0,East Asian
1451117391,PA166199007,rs932764,,,PLCE1,Efficacy,1,hydrochlorothiazide,1451117396.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1451117401,PA166199005,rs10995311,,,ADO,Efficacy,1,hydrochlorothiazide,1451117406.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1183611749,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,carbamazepine,1183611751.0,"Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese)."
1183611749,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,valproic acid,1183611751.0,"Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese)."
1448265505,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,phenytoin,1448265531.0,East Asian
1448265505,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,1,phenytoin,1448265531.0,East Asian
1184168799,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,methylphenidate,1184168801.0,Unknown
1184168799,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,methylphenidate,1184168801.0,Unknown
1451101020,PA166154837,rs10046,,,CYP19A1,PD,-1,exemestane,1451101040.0,Unknown
1451117407,PA166199008,rs740406,,,DOT1L,Efficacy,1,candesartan,1451117398.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1451117407,PA166199008,rs740406,,,PLEKHJ1,Efficacy,1,candesartan,1451117398.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1184168791,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,clozapine,1184168793.0,European
1184168791,,,PA166117147,SLC6A4 L allele-rs25531C,SLC6A4,Efficacy,1,clozapine,1184168793.0,European
1184168791,,,PA166117146,SLC6A4 L allele-rs25531T,SLC6A4,Efficacy,1,clozapine,1184168793.0,European
1448265498,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenytoin,1448265533.0,East Asian
1451117412,PA166199041,rs757081,,,NUCB2,Efficacy,1,hydrochlorothiazide,1451117417.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1444693768,PA166156988,rs1799724,,,TNF,Efficacy,-1,adalimumab,1444693774.0,European
1184168783,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Dosage,-1,fluoxetine,1184168785.0,"Multiple groups, probably White (Spanish mental health center)."
1184168783,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Dosage,-1,fluoxetine,1184168785.0,"Multiple groups, probably White (Spanish mental health center)."
1184168783,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,fluoxetine,1184168785.0,"Multiple groups, probably White (Spanish mental health center)."
1184168783,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluoxetine,1184168785.0,"Multiple groups, probably White (Spanish mental health center)."
1451117360,PA166199002,rs6722745,,,SULT1C3,Efficacy,1,candesartan,1451117346.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1451133746,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,morphine,1451133751.0,European
1451133746,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,nortriptyline,1451133751.0,European
1451117356,PA166199004,rs4387287,,,STN1,Efficacy,1,atenolol,1451117365.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1446905582,PA166155964,rs7270101,,,ITPA,Efficacy,-1,peginterferon alfa-2a,1446905584.0,European
1446905582,PA166155964,rs7270101,,,ITPA,Efficacy,-1,peginterferon alfa-2b,1446905584.0,European
1446905582,PA166155964,rs7270101,,,ITPA,Efficacy,-1,ribavirin,1446905584.0,European
1451100985,PA166195441,rs62296959,,,UGT2B7,Metabolism/PK,-1,morphine,1451100989.0,"Multiple groups, Caucasian, African American, Asian and multiracial patients"
1451100985,PA166195441,rs62296959,,,UGT2B7,Metabolism/PK,-1,morphine,1451100989.0,"Multiple groups, Caucasian, African American, Asian and multiracial patients"
1451100985,PA166195441,rs62296959,,,UGT2B7,Metabolism/PK,-1,morphine,1451100989.0,"Multiple groups, Caucasian, African American, Asian and multiracial patients"
1444693781,PA166156915,rs361525,,,TNF,Efficacy,-1,adalimumab,1444693783.0,European
1444693787,PA166156988,rs1799724,,,TNF,Efficacy,1,adalimumab,1444693795.0,European
1451100980,PA166195421,rs10006452,,,UGT2B7,Metabolism/PK,-1,morphine,1451100984.0,"Multiple groups, Caucasian, African American, Asian and multiracial patients"
1184168762,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,antipsychotics,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,antipsychotics,1184168764.0,European
1184168762,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,haloperidol,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,haloperidol,1184168764.0,European
1184168762,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,olanzapine,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,olanzapine,1184168764.0,European
1184168762,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,risperidone,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,risperidone,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,risperidone,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,risperidone,1184168764.0,European
1184168762,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,risperidone,1184168764.0,European
1444693800,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,1444693806.0,European
1184168874,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,1184168876.0,East Asian
1184988061,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184988079.0,East Asian
1184988061,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184988079.0,East Asian
1184168867,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1184168869.0,East Asian
981954447,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,acenocoumarol,981954458.0,Central/South Asian
1451117460,PA166199022,rs12521868,,,C5orf56,Efficacy,1,hydrochlorothiazide,1451117372.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1184168856,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1184168858.0,East Asian
1184168856,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1184168858.0,East Asian
1448265433,PA166154593,rs4570625,,,TPH2,Efficacy,1,fluoxetine,1448265435.0,European
1451117480,PA166154560,rs3184504,,,SH2B3,Efficacy,1,candesartan,1451117378.0,"Multiple groups, See Figure 1A for genetic ancestry data"
1184168844,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184168846.0,East Asian
1184168844,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184168846.0,East Asian
1184168844,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1184168846.0,East Asian
1446905573,PA166155915,rs1127354,,,ITPA,Efficacy,-1,peginterferon alfa-2a,1446905579.0,European
1446905573,PA166155915,rs1127354,,,ITPA,Efficacy,-1,peginterferon alfa-2b,1446905579.0,European
1446905573,PA166155915,rs1127354,,,ITPA,Efficacy,-1,ribavirin,1446905579.0,European
1446905573,PA166155915,rs1127354,,,ITPA,Efficacy,-1,ribavirin,1446905579.0,European
827925134,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,827925142.0,East Asian
1448265419,PA166156908,rs130058,,,HTR1B,Efficacy,1,fluoxetine,1448265428.0,European
1184168830,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184168840.0,East Asian
1184168830,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184168840.0,East Asian
1449167758,PA166177145,rs12630569,,,ZNF385D,Efficacy,1,duloxetine,1449167760.0,European
1451101060,PA166154836,rs4646,,,CYP19A1,PD,-1,exemestane,1451101065.0,Unknown
769171242,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,folic acid,769171244.0,European
769171242,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,hydroxychloroquine,769171244.0,European
769171242,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,769171244.0,European
769171242,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,sulfasalazine,769171244.0,European
1450970060,PA166186146,rs1042028,,,SULT1A1,Efficacy,1,tamoxifen,1450970023.0,"Multiple groups, 81.6% Caucasian, 18.4% African-America"
1450970060,PA166186146,rs1042028,,,SULT1A1,Efficacy,1,tamoxifen,1450970024.0,Multiple groups
982036359,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,amlodipine,982036381.0,East Asian
982036359,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,amlodipine,982036982.0,East Asian
982036359,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,amlodipine,982036393.0,East Asian
827925168,PA166156773,rs1800888,,,ADRB2,Efficacy,1,terbutaline,827925176.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,folic acid,1451240624.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,folic acid,769171239.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,folic acid,1451240624.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,folic acid,769171239.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,hydroxychloroquine,1451240624.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,hydroxychloroquine,769171239.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,hydroxychloroquine,1451240624.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,hydroxychloroquine,769171239.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,methotrexate,1451240624.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,methotrexate,769171239.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,methotrexate,1451240624.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,methotrexate,769171239.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,sulfasalazine,1451240624.0,European
769171237,PA166155331,rs45445694,,,C18orf56,Efficacy,1,sulfasalazine,769171239.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,sulfasalazine,1451240624.0,European
769171237,PA166155331,rs45445694,,,TYMS,Efficacy,1,sulfasalazine,769171239.0,European
769171236,PA166153654,rs1805087,,,MTR,Efficacy,1,folic acid,769171241.0,European
769171236,PA166153654,rs1805087,,,MTR,Efficacy,1,hydroxychloroquine,769171241.0,European
769171236,PA166153654,rs1805087,,,MTR,Efficacy,1,methotrexate,769171241.0,European
769171236,PA166153654,rs1805087,,,MTR,Efficacy,1,sulfasalazine,769171241.0,European
769171231,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,folic acid,769171234.0,European
769171231,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,hydroxychloroquine,769171234.0,European
769171231,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,769171234.0,European
769171231,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,sulfasalazine,769171234.0,European
769171231,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,sulfasalazine,769171234.0,European
1451101160,PA166195561,rs184199168,,,RGL4,Metabolism/PK,0,tramadol,1451101164.0,Unknown
1451101160,PA166195561,rs184199168,,,RGL4,Metabolism/PK,0,tramadol,1451101165.0,Unknown
1449167797,PA166177114,rs7653345,,,ZNF385D,Efficacy,1,duloxetine,1449167799.0,European
1448101515,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,clopidogrel,1448101521.0,Unknown
769171199,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,769171206.0,European
1446905463,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,imipramine,1446905465.0,East Asian
1446905463,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,imipramine,1446905465.0,East Asian
1446905463,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,-1,imipramine,1446905465.0,East Asian
1448101486,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clopidogrel,1448101501.0,Unknown
1448101486,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clopidogrel,1448101499.0,Unknown
1448101486,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clopidogrel,1448101501.0,Unknown
1448101486,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clopidogrel,1448101499.0,Unknown
1450806291,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,ticagrelor,1450806300.0,European
1450806291,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,ticagrelor,1450806300.0,European
769171171,PA166156994,rs1800562,,,HFE,Dosage,1,epoetin alfa,769171177.0,European
769171171,PA166156994,rs1800562,,,HFE,Metabolism/PK,1,epoetin alfa,769171177.0,European
769171171,PA166156994,rs1800562,,,HFE,Metabolism/PK,1,epoetin alfa,769171177.0,European
769171171,PA166156994,rs1800562,,,HFE,Metabolism/PK,1,epoetin alfa,769171177.0,European
982036494,PA166155187,rs1799752,,,ACE,Efficacy,1,fluvastatin,982036507.0,Multiple groups
982036494,PA166155187,rs1799752,,,ACE,Efficacy,1,fluvastatin,982036505.0,Multiple groups
982036494,PA166155187,rs1799752,,,ACE,Efficacy,1,fluvastatin,982036509.0,Multiple groups
1450806301,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,ticagrelor,1450806303.0,European
1450806301,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,ticagrelor,1450806303.0,European
1450806311,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,clopidogrel,1450806313.0,European
1450806311,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,clopidogrel,1450806313.0,European
1451101220,PA166195565,rs9384825,,,RFPL4B,Metabolism/PK,0,tramadol,1451101185.0,Unknown
1451101220,PA166195565,rs9384825,,,RFPL4B,Metabolism/PK,0,tramadol,1451101224.0,Unknown
1451101220,PA166195565,rs9384825,,,RFPL4B,Metabolism/PK,0,tramadol,1451101185.0,Unknown
1451101220,PA166195565,rs9384825,,,RFPL4B,Metabolism/PK,0,tramadol,1451101224.0,Unknown
827826504,PA166153551,rs5273,,,PTGS2,Efficacy,0,celecoxib,827826512.0,European
769171145,PA166156989,rs1799945,,,HFE,Dosage,1,epoetin alfa,769171175.0,European
769171145,PA166156989,rs1799945,,,HFE,Metabolism/PK,1,epoetin alfa,769171175.0,European
1449167881,PA166177127,rs10123866,,,INVS,Efficacy,1,duloxetine,1449167883.0,European
981954547,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,ondansetron,981954555.0,"Multiple groups, 139 Caucasian, 2 Black African"
981954547,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,ondansetron,981954557.0,Multiple groups
981954547,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,ondansetron,981954555.0,"Multiple groups, 139 Caucasian, 2 Black African"
981954547,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,ondansetron,981954557.0,Multiple groups
1451101180,PA166195563,rs62435418,,,ICA1,Metabolism/PK,0,tramadol,1451101174.0,Unknown
1451101180,PA166195563,rs62435418,,,ICA1,Metabolism/PK,0,tramadol,1451101184.0,Unknown
1449167888,PA166177128,rs10124893,,,TEX10,Efficacy,1,duloxetine,1449167890.0,European
827925284,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,827925293.0,East Asian
827695410,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,nelfinavir,827695419.0,Multiple groups
827695410,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,nelfinavir,827695421.0,European
827695410,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,nelfinavir,827695423.0,African American/Afro-Caribbean
827695410,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,nelfinavir,827695425.0,Latino
769171119,PA166156443,rs11706052,,,IMPDH2,Efficacy,0,mycophenolic acid,769171124.0,Unknown
769171119,PA166156443,rs11706052,,,IMPDH2,Efficacy,0,mycophenolic acid,769171124.0,Unknown
982036476,PA166156749,rs1042714,,,ADRB2,Efficacy,1,enalapril,982036484.0,European
1449167912,PA166177133,rs7472,,,TEX10,Efficacy,1,duloxetine,1449167914.0,European
769170859,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,769170862.0,European
1450822736,PA166156991,rs1799971,,,OPRM1,Other,-1,nicotine,1450822741.0,"Multiple groups, Some participants were of non-European ancestry."
1450822736,PA166156991,rs1799971,,,OPRM1,Other,-1,nicotine,1450822742.0,"Multiple groups, Some participants were of non-European ancestry."
1450822736,PA166156991,rs1799971,,,OPRM1,Other,-1,nicotine,1450822743.0,"Multiple groups, Some participants were of non-European ancestry."
982036564,PA166156079,rs1800206,,,PPARA,Efficacy,-1,fenofibrate,982036573.0,Unknown
982036564,PA166156079,rs1800206,,,PPARA,Efficacy,-1,fenofibrate,982036574.0,Unknown
1451134040,PA166204281,rs61734410,,,CACNA1H,Efficacy,1,ethosuximide,1451134045.0,"Multiple groups, USA: 20% Black, 70% white, 9% other; NCT00088452"
769170846,PA166154383,rs2727786,,,APOA1,Efficacy,1,fenofibrate,769170852.0,East Asian
769170844,PA166157538,rs320,,,LPL,Efficacy,1,fenofibrate,769170854.0,East Asian
1449167918,PA166177136,rs12595802,,,ATP10A,Efficacy,1,duloxetine,1449167920.0,European
1451134046,PA166204301,rs3747178,,,CACNA1I,Efficacy,1,ethosuximide,1451134051.0,"Multiple groups, USA: 20% Black, 70% white, 9% other; NCT00088452"
1184349257,,,PA165955891,HLA-B*44:02:01:01,HLA-B,Efficacy,1,"interferon alfa-2a, recombinant",1184349263.0,Unknown
1184349257,,,PA165955891,HLA-B*44:02:01:01,HLA-B,Efficacy,1,ribavirin,1184349263.0,Unknown
1449167924,PA166177137,rs12603700,,,MIEF2,Efficacy,1,duloxetine,1449167926.0,European
1450806336,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,prasugrel,1450806338.0,European
1450806336,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,prasugrel,1450806338.0,European
1450806345,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,prasugrel,1450806347.0,European
1450806345,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,prasugrel,1450806347.0,European
981954714,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,ondansetron,981954725.0,Unknown
981954714,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,ondansetron,981954731.0,Unknown
981954714,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,ondansetron,981954725.0,Unknown
981954714,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,ondansetron,981954731.0,Unknown
981954714,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tropisetron,981954725.0,Unknown
981954714,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,tropisetron,981954731.0,Unknown
981954714,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,tropisetron,981954725.0,Unknown
981954714,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,tropisetron,981954731.0,Unknown
1448101346,PA166154911,rs4646903,,,CYP1A1,Metabolism/PK,-1,deferasirox,1448101348.0,"Multiple groups, Italy"
769170794,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,769170796.0,East Asian
1448101363,PA166159130,rs887929,,,UGT1A1,Metabolism/PK,-1,deferasirox,1448101365.0,"Multiple groups, Italy"
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1449004162.0,European
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1449004160.0,European
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1449004158.0,Unknown
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1449004156.0,European
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1449004162.0,European
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1449004160.0,European
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1449004158.0,Unknown
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1449004156.0,European
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449004162.0,European
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449004160.0,European
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449004158.0,Unknown
1449004146,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449004156.0,European
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449004162.0,European
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449004160.0,European
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449004158.0,Unknown
1449004146,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449004156.0,European
982036630,PA166155647,rs1801701,,,APOB,Efficacy,1,irbesartan,982036646.0,European
1451101326,PA166155690,rs2741049,,,UGT1A9,Efficacy,-1,azathioprine,1451101331.0,"Multiple groups, White and Non-White patients"
1451101326,PA166155690,rs2741049,,,UGT1A9,Efficacy,-1,mycophenolic acid,1451101331.0,"Multiple groups, White and Non-White patients"
1451134105,PA166204361,rs2753326,,,CACNA1H,Efficacy,1,lamotrigine,1451134086.0,"Multiple groups, USA: 20% Black, 70% white, 9% other; NCT00088452"
1184349348,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1184349352.0,East Asian
1448101354,PA166154899,rs2606345,,,CYP1A1,Metabolism/PK,-1,deferasirox,1448101356.0,"Multiple groups, Italy"
769170786,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,769170790.0,East Asian
1451101338,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,azathioprine,1451101360.0,"Multiple groups, White and Non-White patients"
1451101338,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,mycophenolic acid,1451101360.0,"Multiple groups, White and Non-White patients"
1451101332,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,azathioprine,1451101337.0,"Multiple groups, White and Non-White patients"
1451101332,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,mycophenolic acid,1451101337.0,"Multiple groups, White and Non-White patients"
982036621,PA166153539,rs699,,,AGT,Efficacy,1,irbesartan,982036629.0,European
1448101330,PA166154893,rs2470890,,,CYP1A2,Metabolism/PK,-1,deferasirox,1448101332.0,"Multiple groups, Italy"
769170776,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,769170792.0,East Asian
1448101336,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,-1,deferasirox,1448101338.0,"Multiple groups, Italy"
1448576460,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,1448576463.0,European
982036636,PA166155187,rs1799752,,,ACE,Efficacy,1,pravastatin,982036664.0,Unknown
1184169096,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1184169102.0,East Asian
1184169096,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1184169100.0,East Asian
1448101324,PA166156076,rs1135840,,,CYP2D6,Metabolism/PK,-1,deferasirox,1448101326.0,"Multiple groups, Italy"
1448101311,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,deferasirox,1448101313.0,"Multiple groups, Italy"
1448101296,PA166155712,rs3806596,,,UGT1A3,Metabolism/PK,1,deferasirox,1448101302.0,"Multiple groups, Italy"
1451134060,PA166157316,rs2032582,,,ABCB1,Efficacy,1,lamotrigine,1451134080.0,"Multiple groups, USA: 20% Black, 70% white, 9% other; NCT00088452"
1448428998,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,everolimus,1448429004.0,European
1449577638,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577656.0,East Asian
1449577638,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577656.0,East Asian
1449577638,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577656.0,East Asian
1449577638,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577656.0,East Asian
1451101320,PA166155614,rs1042597,,,UGT1A8,Efficacy,-1,azathioprine,1451101325.0,"Multiple groups, White and Non-White patients"
1451101320,PA166155614,rs1042597,,,UGT1A8,Efficacy,-1,mycophenolic acid,1451101325.0,"Multiple groups, White and Non-White patients"
1448101303,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,deferasirox,1448101305.0,"Multiple groups, Italy"
1448576430,,,PA166131619,NUDT15*1,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
1448576430,,,PA166131620,NUDT15*2,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
1448576430,,,PA166131621,NUDT15*3,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
1448576430,,,PA166131622,NUDT15*4,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
1448576430,,,PA166151814,NUDT15*6,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
1448576430,,,PA166151814,NUDT15*6,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
1448576430,,,PA166151814,NUDT15*6,NUDT15,Dosage,1,mercaptopurine,1448576457.0,Latino
982036689,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,982036696.0,Near Eastern
1448576417,PA166153876,rs17602729,,,AMPD1,Efficacy,1,methotrexate,1448576423.0,Multiple groups
1448576417,PA166153876,rs17602729,,,AMPD1,Efficacy,1,methotrexate,1448576425.0,European
981479639,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981479642.0,East Asian
981479639,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981479642.0,East Asian
981479639,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981479642.0,East Asian
981954791,PA166156867,rs11134178,,,MIR4278,Dosage,-1,methylphenidate,981954794.0,"Multiple groups, White, non-Latino: 56%;White, Latino:18%;African American: 14%;Other: 12%."
981954791,PA166156867,rs11134178,,,MIR4278,Efficacy,-1,methylphenidate,981954794.0,"Multiple groups, White, non-Latino: 56%;White, Latino:18%;African American: 14%;Other: 12%."
982036710,PA166154184,rs56165452,,,CYP2C9,Dosage,1,warfarin,982036716.0,Near Eastern
1448592786,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,propofol,1448592791.0,Unknown
1448592786,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,propofol,1448592791.0,Unknown
1448592786,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,propofol,1448592791.0,Unknown
1184349397,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,efavirenz,1184349399.0,East Asian
1184349397,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,efavirenz,1184349400.0,East Asian
1184349397,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,nevirapine,1184349399.0,East Asian
1184349397,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,nevirapine,1184349400.0,East Asian
1449577681,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577698.0,East Asian
1449577681,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577698.0,East Asian
1449577681,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577698.0,East Asian
1449577681,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,-1,fluvoxamine,1449577698.0,East Asian
1446905210,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1446905212.0,Sub-Saharan African
982036653,PA166153975,rs1800545,,,ADRA2A,Efficacy,1,atenolol,982036660.0,European
769170937,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,769170939.0,East Asian
1446905219,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,1,efavirenz,1446905228.0,Sub-Saharan African
1446905219,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,1,efavirenz,1446905221.0,Sub-Saharan African
769170930,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,etoposide,769170932.0,"Multiple groups, Black(25) and White (77) Children"
1184349357,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184349359.0,East Asian
1184349357,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184349363.0,East Asian
1184349357,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,nevirapine,1184349359.0,East Asian
1184349357,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,nevirapine,1184349363.0,East Asian
1184349357,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,nevirapine,1184349359.0,East Asian
1184349357,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,nevirapine,1184349363.0,East Asian
982036670,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982036680.0,Near Eastern
981479695,PA166157257,rs472660,,,CYP3A43,Dosage,1,olanzapine,981479706.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479695,PA166157257,rs472660,,,CYP3A43,Efficacy,1,olanzapine,981479706.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479695,PA166157257,rs472660,,,CYP3A43,Toxicity,1,olanzapine,981479706.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479695,PA166157257,rs472660,,,CYP3A43,Metabolism/PK,1,olanzapine,981479706.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
769170918,PA166156480,rs4961,,,ADD1,Efficacy,0,benazepril,769170920.0,East Asian
1184988338,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1184988340.0,Sub-Saharan African
981479707,PA166157257,rs472660,,,CYP3A43,Metabolism/PK,-1,ziprasidone,981479716.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1184988346,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1184988348.0,Sub-Saharan African
1184988346,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,efavirenz,1184988348.0,Sub-Saharan African
981954839,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,carbamazepine,981954849.0,Central/South Asian
981954839,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenobarbital,981954849.0,Central/South Asian
981954839,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,phenytoin,981954849.0,Central/South Asian
981954839,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,valproic acid,981954849.0,Central/South Asian
769170906,PA166153539,rs699,,,AGT,Efficacy,0,Antihypertensives,769170908.0,European
769170898,PA166154397,rs3736228,,,LRP5,,0,risedronate,,
981954851,PA166156024,rs4680,,,COMT,Efficacy,1,paroxetine,981955667.0,European
1449168131,PA166177182,rs4639250,,,TTC37,Efficacy,1,duloxetine,1449168133.0,European
1449168125,PA166177181,rs12657120,,,TTC37,Efficacy,1,duloxetine,1449168127.0,European
1184988354,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1184988356.0,Sub-Saharan African
1184988354,,,PA165818807,CYP2B6*9,CYP2B6,Metabolism/PK,1,efavirenz,1184988356.0,Sub-Saharan African
981479718,PA166154897,rs2472300,,,CYP1A2,Metabolism/PK,-1,olanzapine,981479722.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
769170891,PA166155879,rs55754655,,,AOX1,Efficacy,1,azathioprine,769170894.0,Multiple groups
1184513231,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluoxetine,1184513239.0,East Asian
1184513231,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1184513239.0,East Asian
1184513231,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,sertraline,1184513239.0,East Asian
1184513231,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,sertraline,1184513239.0,East Asian
769170882,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,769170885.0,Unknown
1184513240,PA166158926,rs57098334,,,SLC6A4,Efficacy,1,fluoxetine,1184513242.0,East Asian
1184513240,PA166158926,rs57098334,,,SLC6A4,Efficacy,1,sertraline,1184513242.0,East Asian
1449168155,PA166177186,rs3128624,,,FCN2,Efficacy,1,duloxetine,1449168157.0,European
1450806529,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1450806555.0,European
1450806529,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1450806555.0,European
1450806529,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1450806555.0,European
1450806529,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1450806555.0,European
981479677,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981479682.0,East Asian
981479677,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981479682.0,East Asian
981479690,PA166155435,rs8099917,,,IFNL3,Other,-1,peginterferon alfa-2b,981479693.0,East Asian
981479690,PA166155435,rs8099917,,,IFNL3,Other,-1,ribavirin,981479693.0,East Asian
1184349427,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,efavirenz,1184349429.0,East Asian
1184349427,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,efavirenz,1184349430.0,East Asian
1184349427,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,nevirapine,1184349429.0,East Asian
1184349427,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,nevirapine,1184349430.0,East Asian
1448592688,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1448592690.0,"Multiple groups, non-Caucasian."
982036737,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,1,carvedilol,982036760.0,East Asian
982036737,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,1,carvedilol,982036760.0,East Asian
1449266489,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,methadone,1449266491.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266489,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,methadone,1449266491.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
613978984,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,Beta Blocking Agents,613978991.0,European
1449266478,,,PA165819172,CYP1A2*1B,CYP1A2,Metabolism/PK,-1,methadone,1449266480.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266478,,,PA165819172,CYP1A2*1B,CYP1A2,Metabolism/PK,-1,methadone,1449266480.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266478,,,PA165819172,CYP1A2*1B,CYP1A2,Metabolism/PK,-1,methadone,1449266480.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1448428834,PA166161454,rs1884725,,,XDH,Dosage,1,allopurinol,1448428836.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428834,PA166161454,rs1884725,,,XDH,Dosage,1,febuxostat,1448428836.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1449266505,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,methadone,1449266507.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449168191,PA166177190,rs17724452,,,ANO2,Efficacy,1,duloxetine,1449168193.0,European
1446905073,PA166156759,rs1295686,,,IL13,Efficacy,1,Hepatitis vaccines,1446905078.0,East Asian
981477680,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,acetaminophen,981477687.0,European
1449266520,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,1,methadone,1449266522.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1448428814,PA166161450,rs3731722,,,AOX1,Dosage,1,allopurinol,1448428816.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428814,PA166161450,rs3731722,,,AOX1,Dosage,1,febuxostat,1448428816.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1449266512,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methadone,1449266514.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266539,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,methadone,1449266541.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709570.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709572.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709560.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709562.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709570.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709572.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709560.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444709562.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444709570.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444709572.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444709560.0,East Asian
1444709550,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444709562.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444709570.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444709572.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444709560.0,East Asian
1444709550,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444709562.0,East Asian
1448428803,PA166161448,rs11678615,,,AOX1,Dosage,1,allopurinol,1448428809.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428803,PA166161448,rs11678615,,,AOX1,Dosage,1,febuxostat,1448428809.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1449168233,PA166177196,rs61908402,,,ANO2,Efficacy,1,duloxetine,1449168235.0,European
1184136618,PA166155760,rs6759892,,,UGT1A6,Efficacy,-1,deferiprone,1184136620.0,Central/South Asian
1184136611,PA166155665,rs2070959,,,UGT1A6,Efficacy,1,deferiprone,1184136613.0,Central/South Asian
1449266547,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,(S)-methadone,1449266549.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266547,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,(S)-methadone,1449266549.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
981477795,PA166153977,rs1801253,,,ADRB1,Efficacy,1,metoprolol,981477804.0,"Multiple groups, 68% Caucasian, 32% African American"
1449168240,PA166177197,rs61908403,,,ANO2,Efficacy,1,duloxetine,1449168242.0,European
1449168240,PA166177197,rs61908403,,,ANO2,Efficacy,1,duloxetine,1449168242.0,European
1184136603,PA166155760,rs6759892,,,UGT1A6,Efficacy,1,deferiprone,1184136605.0,Central/South Asian
1184136603,PA166155760,rs6759892,,,UGT1A6,Efficacy,1,deferiprone,1184136605.0,Central/South Asian
1184136590,PA166155665,rs2070959,,,UGT1A6,Efficacy,1,deferiprone,1184136595.0,Central/South Asian
1184136590,PA166155665,rs2070959,,,UGT1A6,Efficacy,1,deferiprone,1184136595.0,Central/South Asian
613979015,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,Beta Blocking Agents,613979017.0,European
613979010,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,Beta Blocking Agents,613979012.0,European
1445151949,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1445151959.0,East Asian
1445151949,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1445151959.0,East Asian
981477763,PA166156691,rs61767072,,,ADRA2C,Efficacy,1,metoprolol,981477779.0,"Multiple groups, 68% Caucasian, 32% African American"
613979002,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,Beta Blocking Agents,613979006.0,European
1449168277,PA166177203,rs61908409,,,ANO2,Efficacy,1,duloxetine,1449168279.0,European
1184988665,PA166154528,rs2160733,,,GRIN2B,Efficacy,-1,acamprosate,1184988667.0,European
1184988665,PA166154528,rs2160733,,,GRIN2B,Efficacy,-1,acamprosate,1184988668.0,European
1450823121,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,endoxifen,1450823139.0,Unknown
1450823121,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,endoxifen,1450823139.0,Unknown
1449168295,PA166177208,rs78482393,,,ANO2,Efficacy,1,duloxetine,1449168297.0,European
1449168295,PA166177208,rs78482393,,,ANO2,Efficacy,1,duloxetine,1449168297.0,European
1184988683,PA166154529,rs2160734,,,GRIN2B,Efficacy,-1,acamprosate,1184988685.0,European
1184988683,PA166154529,rs2160734,,,GRIN2B,Efficacy,-1,acamprosate,1184988686.0,European
1450806762,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1450806771.0,African American/Afro-Caribbean
1450806762,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,omeprazole,1450806771.0,African American/Afro-Caribbean
981477860,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,-1,sulfamethoxazole,981477867.0,East Asian
1447986304,PA166155050,rs3751664,,,CACNA1H,Efficacy,-1,antiepileptics,1447986306.0,East Asian
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234605.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234601.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234609.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234603.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234607.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234595.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234597.0,European
1185234452,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,midazolam,1185234599.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234605.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234601.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234609.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234603.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234607.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234595.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234597.0,European
1185234452,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,midazolam,1185234599.0,European
1451134380,PA166204381,rs2753325,,,CACNA1H,Efficacy,1,lamotrigine,1451134400.0,"Multiple groups, USA: 20% Black, 70% white, 9% other; NCT00088452"
1447986312,PA166157519,rs78655421,,,CFTR,Efficacy,1,ivacaftor,1447986314.0,Unknown
1447675015,PA166153738,rs3215400,,,CDA,Efficacy,-1,azacitidine,1447675021.0,European
1450806712,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450806725.0,East Asian
1450806712,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450806725.0,East Asian
1450806712,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450806725.0,East Asian
982034860,PA166155187,rs1799752,,,ACE,Efficacy,-1,verapamil,982034868.0,European
1185234468,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,tacrolimus,1185234496.0,European
1185234468,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,tacrolimus,1185234485.0,European
1185234468,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,1,tacrolimus,1185234496.0,European
1185234468,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,1,tacrolimus,1185234485.0,European
1185234468,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,1,tacrolimus,1185234496.0,European
1185234468,,,PA166048680,CYP3A4*22,CYP3A4,Dosage,1,tacrolimus,1185234485.0,European
1184136634,PA166155623,rs1105879,,,UGT1A6,Efficacy,-1,deferiprone,1184136636.0,Central/South Asian
1447986286,PA166155057,rs3794619,,,CACNA1H,Efficacy,-1,antiepileptics,1447986288.0,East Asian
1447986298,PA166155105,rs11640796,,,CACNA1H,Efficacy,-1,antiepileptics,1447986300.0,East Asian
1185234460,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234504.0,European
1185234460,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234502.0,European
1185234460,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234504.0,European
1185234460,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234502.0,European
982034878,PA166155187,rs1799752,,,ACE,Efficacy,-1,norepinephrine,982034886.0,European
1447986292,PA166155077,rs7191246,,,CACNA1H,Efficacy,-1,antiepileptics,1447986294.0,East Asian
1447986272,PA166154642,rs12813888,,,CACNA1C,Efficacy,-1,antiepileptics,1447986274.0,East Asian
1450823183,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1450823188.0,Unknown
1450823183,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1450823189.0,Unknown
1447986278,PA166155005,rs1054645,,,CACNA1H,Efficacy,-1,antiepileptics,1447986281.0,East Asian
1447674959,PA166156889,rs17671591,,,HMGCR,Efficacy,1,atorvastatin,1447674964.0,Latino
1447674959,PA166156889,rs17671591,,,HMGCR,Efficacy,1,atorvastatin,1447674998.0,Latino
1447674959,PA166156889,rs17671591,,,HMGCR,Efficacy,1,atorvastatin,1447674996.0,Latino
1184513472,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513474.0,Unknown
1184513472,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513476.0,Unknown
1184513472,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513475.0,Unknown
1184513472,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513477.0,Unknown
982034981,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,982034995.0,Unknown
1447986254,PA166154491,rs215976,,,CACNA1C,Efficacy,-1,antiepileptics,1447986256.0,East Asian
1447986266,PA166154492,rs216008,,,CACNA1C,Efficacy,-1,antiepileptics,1447986268.0,East Asian
1447986266,PA166154492,rs216008,,,CACNA1C,Efficacy,-1,antiepileptics,1447986268.0,East Asian
1447986260,PA166154604,rs7316246,,,CACNA1C,Efficacy,-1,antiepileptics,1447986262.0,East Asian
1184513485,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513487.0,Unknown
1184513485,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513489.0,Unknown
1184513485,PA166156659,rs12505410,,,ABCG2,Efficacy,1,imatinib,1184513488.0,Unknown
1448100931,PA166155037,rs2244613,,,CES1,Metabolism/PK,1,dabigatran,1448100933.0,European
1448100931,PA166155037,rs2244613,,,CES1,Metabolism/PK,1,dabigatran,1448100933.0,European
1447986242,PA166155388,rs2248069,,,CACNA1A,Efficacy,-1,antiepileptics,1447986244.0,East Asian
1447986236,PA166155345,rs16030,,,CACNA1A,Efficacy,-1,antiepileptics,1447986238.0,East Asian
981477870,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,citalopram,981477878.0,European
981477870,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,citalopram,981477880.0,African American/Afro-Caribbean
981477870,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,citalopram,981477876.0,Latino
1447986248,PA166154535,rs2239128,,,CACNA1C,Efficacy,-1,antiepileptics,1447986250.0,East Asian
1184988627,PA166154524,rs2058878,,,GRIN2B,Efficacy,1,acamprosate,1184988637.0,European
1184988627,PA166154524,rs2058878,,,GRIN2B,Efficacy,1,acamprosate,1184988639.0,European
1447986224,PA166155452,rs10416717,,,CACNA1A,Efficacy,-1,antiepileptics,1447986226.0,East Asian
1184513500,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,antidepressants,1184513509.0,European
1184513500,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,antidepressants,1184513509.0,European
1184988646,PA166156672,rs17035723,,,GLRB,Efficacy,-1,acamprosate,1184988661.0,European
1184988646,PA166156672,rs17035723,,,GLRB,Efficacy,-1,acamprosate,1184988648.0,European
1184988646,PA166156672,rs17035723,,,GLRB,Efficacy,-1,acamprosate,1184988649.0,European
1449004578,PA166154702,rs1751034,,,ABCC4,Metabolism/PK,0,tenofovir,1449004586.0,East Asian
827664180,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827664596.0,"Multiple groups, mostly white"
1450806785,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450806802.0,East Asian
1450806785,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450806802.0,East Asian
1450806785,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450806802.0,East Asian
1447986230,PA166155431,rs7254351,,,CACNA1A,Efficacy,-1,antiepileptics,1447986232.0,East Asian
982035028,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,982035051.0,Unknown
982035028,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,982035049.0,Unknown
982035028,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,982035056.0,Unknown
982035028,PA166153977,rs1801253,,,ADRB1,Efficacy,1,dobutamine,982035054.0,Unknown
1449004602,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,trazodone,1449004607.0,European
1447674916,PA166157323,rs2066992,,,IL6,Efficacy,-1,duloxetine,1447674937.0,European
1450823255,PA166157284,rs1045642,,,ABCB1,Dosage,-1,opioids,1450823260.0,Unknown
1447986214,PA166155379,rs2074880,,,CACNA1A,Efficacy,-1,antiepileptics,1447986220.0,East Asian
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,cisplatin,827812119.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,cisplatin,827812115.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,cisplatin,827812117.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,fluorouracil,827812119.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,fluorouracil,827812115.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,fluorouracil,827812117.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,mitoxantrone,827812119.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,mitoxantrone,827812115.0,Unknown
827812110,PA166155774,rs9679162,,,GALNT14,Efficacy,1,mitoxantrone,827812117.0,Unknown
1447986196,PA166155380,rs2075650,,,TOMM40,Efficacy,1,hmg coa reductase inhibitors,1447986198.0,European
1447986178,PA166156544,rs2231142,,,ABCG2,Efficacy,1,hmg coa reductase inhibitors,1447986185.0,European
613979204,PA166153715,rs2661319,,,RGS4,Efficacy,1,risperidone,613979206.0,East Asian
1450806845,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1450806860.0,East Asian
1450806845,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1450806860.0,East Asian
1450806845,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,1450806860.0,East Asian
1447674863,PA166153668,rs2076222,,,LAMB3,Dosage,1,fentanyl,1447674871.0,East Asian
1447674863,PA166153668,rs2076222,,,LAMB3,Efficacy,1,fentanyl,1447674871.0,East Asian
1184513697,PA166157204,rs41271330,,,BMP5,Efficacy,1,escitalopram,1184513709.0,European
1184513697,PA166157204,rs41271330,,,BMP5,Efficacy,1,escitalopram,1184513706.0,European
981478035,PA166154120,rs10994982,,,ARID5B,Metabolism/PK,1,methotrexate,981478069.0,European
1447986147,PA166157475,rs17171676,,,SUGCT,Efficacy,-1,hmg coa reductase inhibitors,1447986156.0,European
1447986147,PA166157475,rs17171676,,,SUGCT,Efficacy,-1,hmg coa reductase inhibitors,1447986154.0,European
1447674849,PA166156985,rs1570360,,,VEGFA,Efficacy,1,cetuximab,1447674859.0,Unknown
1447674849,PA166156985,rs1570360,,,VEGFA,Efficacy,1,cetuximab,1447674851.0,Unknown
1447986129,PA166154578,rs4149045,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1447986131.0,Sub-Saharan African
613979290,PA166154339,rs1800497,,,ANKK1,Efficacy,1,risperidone,613979292.0,East Asian
613979290,PA166154339,rs1800497,,,ANKK1,Efficacy,1,risperidone,613979292.0,East Asian
982035107,PA166156106,rs4253778,,,PPARA,Efficacy,1,fenofibrate,982035124.0,Unknown
1447986136,PA166154580,rs4149057,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1447986138.0,Sub-Saharan African
608178665,PA166156964,rs909706,,,DTNBP1,Efficacy,-1,haloperidol,608178667.0,African American/Afro-Caribbean
1183612568,PA166155680,rs2298771,,,SCN1A,Efficacy,-1,carbamazepine,1183612570.0,Multiple groups
1183612568,PA166155680,rs2298771,,,SCN1A,Efficacy,-1,valproic acid,1183612570.0,Multiple groups
1447674843,PA166156958,rs833061,,,VEGFA,Efficacy,1,cetuximab,1447674845.0,Unknown
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234538.0,European
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234534.0,European
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234542.0,European
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234536.0,European
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234540.0,European
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234544.0,European
1185234522,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234546.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234538.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234534.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234542.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234536.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234540.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234544.0,European
1185234522,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234546.0,European
1447986111,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1447986113.0,Sub-Saharan African
1451118200,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1451118240.0,Multiple groups
1451118200,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1451118240.0,Multiple groups
1451118200,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,tacrolimus,1451118240.0,Multiple groups
1451118200,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,tacrolimus,1451118240.0,Multiple groups
982035057,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,dobutamine,982035082.0,Unknown
982035057,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,dobutamine,982035078.0,Unknown
982035057,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,dobutamine,982035080.0,Unknown
982035057,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,dobutamine,982035067.0,Unknown
1447986122,PA166154577,rs4149044,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1447986124.0,Sub-Saharan African
1185234509,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1185234521.0,European
1185234509,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tacrolimus,1185234521.0,European
1447986096,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1447986098.0,Sub-Saharan African
1448100784,PA166159104,rs8192935,,,CES1,Metabolism/PK,1,dabigatran,1448100825.0,European
1447986105,PA166154086,rs7910642,,,ABCC2,Metabolism/PK,-1,lopinavir,1447986107.0,Sub-Saharan African
1451216520,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,"sulfonamides, urea derivatives",1451216525.0,Latino
1184513638,PA166153578,rs581111,,,OPRD1,Efficacy,1,buprenorphine,1184513718.0,"Multiple groups, European American - mainly White but some Latino/White."
1184513638,PA166153578,rs581111,,,OPRD1,Efficacy,1,buprenorphine,1184513710.0,"Multiple groups, European American - mainly White but some Latino/White."
1184513638,PA166153578,rs581111,,,OPRD1,Efficacy,1,buprenorphine,1184513696.0,"Multiple groups, European American - mainly White but some Latino/White."
1184513638,PA166153578,rs581111,,,OPRD1,Efficacy,1,buprenorphine,1184513716.0,"Multiple groups, European American - mainly White but some Latino/White."
1446904772,,,PA165955249,HLA-B*35:03:01,HLA-B,Efficacy,1,Rubella vaccines,1446904789.0,"Multiple groups, Mainly Caucasian (93.3%)"
1446904778,,,PA165957859,HLA-C*15:02:01,HLA-C,Efficacy,1,Rubella vaccines,1446904791.0,"Multiple groups, Mainly Caucasian (93.3%)"
1446904778,,,PA165957859,HLA-C*15:02:01,HLA-C,Efficacy,1,Rubella vaccines,1446904791.0,"Multiple groups, Mainly Caucasian (93.3%)"
982035158,PA166156079,rs1800206,,,PPARA,Efficacy,-1,fenofibrate,982035169.0,Unknown
1451134681,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,sufentanil,1451134686.0,East Asian
1447986089,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,lopinavir,1447986095.0,Sub-Saharan African
1007118673,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,vincristine,1007754857.0,Multiple groups
1007118673,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,vincristine,1007754857.0,Multiple groups
1450823384,PA166156991,rs1799971,,,OPRM1,Other,0,ethanol,1450823389.0,"Multiple groups, Caucasian and African American participants"
1450823384,PA166156991,rs1799971,,,OPRM1,Other,0,ethanol,1450823389.0,"Multiple groups, Caucasian and African American participants"
1447674771,PA166155789,rs10490162,,,NRXN1,Efficacy,1,antipsychotics,1447674779.0,European
1450823396,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1450823398.0,Unknown
1450823396,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1450823398.0,Unknown
1450823396,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1450823398.0,Unknown
1450823396,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1450823398.0,Unknown
1184513812,PA166155685,rs2592551,,,GGCX,Dosage,1,warfarin,1184513820.0,East Asian
1184513812,PA166155685,rs2592551,,,GGCX,Dosage,1,warfarin,1184513822.0,East Asian
1184513812,PA166155685,rs2592551,,,GGCX,Dosage,1,warfarin,1184513824.0,East Asian
1447674758,PA166155812,rs12467557,,,NRXN1,Efficacy,1,antipsychotics,1447674777.0,European
982035143,PA166154993,rs708272,,,CETP,Efficacy,-1,fenofibrate,982035157.0,Unknown
1451118280,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451118276.0,Multiple groups
1451118280,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451118276.0,Multiple groups
1448100703,PA166153617,rs1061170,,,CFH,Efficacy,1,bevacizumab,1448100725.0,"Multiple groups, Brazilian"
1184513712,PA166157204,rs41271330,,,BMP5,Efficacy,0,escitalopram,1184513714.0,European
1184513712,PA166157204,rs41271330,,,BMP5,Efficacy,0,escitalopram,1184513715.0,European
1450823445,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1450823447.0,Unknown
1450823445,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1450823447.0,Unknown
1450823445,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1450823447.0,Unknown
1450823445,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1450823447.0,Unknown
1184513727,PA166153574,rs529520,,,OPRD1,Efficacy,-1,buprenorphine,1184513731.0,"Multiple groups, European American - Mainly White with some Latino/White"
1184513727,PA166153574,rs529520,,,OPRD1,Efficacy,-1,methadone,1184513731.0,"Multiple groups, European American - Mainly White with some Latino/White"
981478172,PA166153617,rs1061170,,,CFH,Efficacy,-1,photodynamic therapy,981478183.0,Unknown
1450823459,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1450823461.0,Unknown
1450823459,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1450823461.0,Unknown
1450823459,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1450823461.0,Unknown
1450823459,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1450823461.0,Unknown
1184513732,PA166153578,rs581111,,,OPRD1,Efficacy,-1,buprenorphine,1184513734.0,"Multiple groups, European American - Mainly White with some Latino/White"
1184513732,PA166153578,rs581111,,,OPRD1,Efficacy,-1,methadone,1184513734.0,"Multiple groups, European American - Mainly White with some Latino/White"
1184169737,PA166153971,rs1786929,,,None,Efficacy,1,fluticasone propionate,1184169739.0,Unknown
1184169737,PA166153971,rs1786929,,,None,Efficacy,1,montelukast,1184169739.0,Unknown
1043737399,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,phenprocoumon,1043737405.0,European
1043737399,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,phenprocoumon,1043737405.0,European
1043737399,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenprocoumon,1043737405.0,European
1450823408,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,endoxifen,1450823410.0,Unknown
1450823408,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,endoxifen,1450823410.0,Unknown
1450823408,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,endoxifen,1450823410.0,Unknown
1450823408,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,endoxifen,1450823410.0,Unknown
1447674691,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447674704.0,Near Eastern
1447674691,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674704.0,Near Eastern
982035187,PA166155153,rs6065,,,GP1BA,Efficacy,1,aspirin,982035198.0,East Asian
608178490,PA166157284,rs1045642,,,ABCB1,Other,1,lansoprazole,608178492.0,East Asian
608178490,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,lansoprazole,608178492.0,East Asian
608178498,PA166156708,rs6295,,,HTR1A,Efficacy,1,fluvoxamine,608178501.0,East Asian
608178498,PA166156708,rs6295,,,HTR1A,Efficacy,1,milnacipran,608178501.0,East Asian
608178498,PA166156708,rs6295,,,HTR1A,Efficacy,1,paroxetine,608178501.0,East Asian
608178494,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,0,indinavir,608178496.0,"Multiple groups, African and Caucasian"
982035206,PA166155203,rs2243093,,,GP1BA,Efficacy,-1,aspirin,982035213.0,East Asian
608178504,PA166156855,rs10042486,,,HTR1A,Efficacy,1,fluvoxamine,608178506.0,East Asian
608178504,PA166156855,rs10042486,,,HTR1A,Efficacy,1,milnacipran,608178506.0,East Asian
608178504,PA166156855,rs10042486,,,HTR1A,Efficacy,1,paroxetine,608178506.0,East Asian
1450823431,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1450823433.0,Unknown
1450823431,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1450823433.0,Unknown
1450823431,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1450823433.0,Unknown
1450823431,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1450823433.0,Unknown
1184169710,PA166155171,rs967676,,,CA10,Efficacy,1,fluticasone propionate,1184169736.0,Unknown
1184169710,PA166155171,rs967676,,,CA10,Efficacy,1,montelukast,1184169736.0,Unknown
1184169832,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1184169843.0,European
1184169832,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1184169843.0,European
827827752,PA166156024,rs4680,,,None,Efficacy,-1,clomipramine,827827766.0,Unknown
1446904589,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,nortriptyline,1446904597.0,Central/South Asian
1446904589,,,PA166123321,CYP2D6*81,CYP2D6,Metabolism/PK,0,nortriptyline,1446904597.0,Central/South Asian
827827743,PA166154672,rs6305,,,None,Efficacy,-1,clomipramine,827827751.0,Unknown
827827736,PA166154763,rs6113,,,None,Efficacy,-1,clomipramine,827827742.0,Unknown
1183612769,PA166155680,rs2298771,,,SCN1A,Efficacy,-1,carbamazepine,1183612771.0,"Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese)."
1183612769,PA166155680,rs2298771,,,SCN1A,Efficacy,-1,valproic acid,1183612771.0,"Multiple groups, 701 patients from Malaysia (Malay, Chinese or Indian), 803 patients from Hong Kong (Han Chinese)."
1184989053,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,dextromethorphan,1184989085.0,"Central/South Asian, African American/Afro-Caribbean"
1184989053,,,PA166123340,CYP2D6*100,CYP2D6,Metabolism/PK,0,dextromethorphan,1184989085.0,"Central/South Asian, African American/Afro-Caribbean"
827827729,PA166156903,rs6296,,,None,Efficacy,-1,clomipramine,827827735.0,Unknown
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234839.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234841.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234839.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234841.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234839.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234841.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234839.0,"Multiple groups, UK, Spain, Italy"
1185234819,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185234841.0,"Multiple groups, UK, Spain, Italy"
1450823485,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,fluvastatin,1450823490.0,European
1450823485,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,fluvastatin,1450823490.0,European
1451134780,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,oxycodone,1451134840.0,East Asian
1451134780,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,oxycodone,1451134840.0,East Asian
1448624885,PA166164933,rs12456693,,,SLC14A2,Metabolism/PK,-1,clopidogrel,1448624887.0,East Asian
1184989087,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,dextromethorphan,1184989089.0,"Central/South Asian, African American/Afro-Caribbean"
1184989087,,,PA166123341,CYP2D6*101,CYP2D6,Metabolism/PK,0,dextromethorphan,1184989089.0,"Central/South Asian, African American/Afro-Caribbean"
1185234844,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234847.0,"Multiple groups, UK, Spain, Italy"
1185234844,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234846.0,"Multiple groups, UK, Spain, Italy"
1185234844,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234847.0,"Multiple groups, UK, Spain, Italy"
1185234844,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234846.0,"Multiple groups, UK, Spain, Italy"
1450807114,PA166157701,rs77905,,,DBH,Dosage,1,nicotine,1450807124.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807114,PA166157701,rs77905,,,DBH,Dosage,1,nicotine,1450807126.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1450807114,PA166157701,rs77905,,,DBH,Dosage,1,nicotine,1450807120.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicitites. 13 participants did not give an ethnicity."
1450807114,PA166157701,rs77905,,,DBH,Dosage,1,nicotine,1450807122.0,"Multiple groups, Participants were of Caucasian, Asian, Afro-Caribbean or Other ethnicities. 13 participants did not give an ethnicity."
1447674588,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,sirolimus,1447674594.0,"Multiple groups, White, Hispanic, Asian/Pacific Islander, Other"
1450971020,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA165971569,CYP2D6*18,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165971569,CYP2D6*18,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1450971020,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,1,methamphetamine,1450971040.0,Unknown
1450971020,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,1,methamphetamine,1450971037.0,Unknown
1448624865,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1448624867.0,East Asian
1448624865,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1448624867.0,East Asian
827926134,PA166157527,rs121434568,,,EGFR,Efficacy,0,gefitinib,,
1449004923,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,cyclophosphamide,1449004929.0,Central/South Asian
1449004932,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,cyclophosphamide,1449004934.0,Central/South Asian
1449004938,PA166154249,rs1695,,,GSTP1,Efficacy,-1,cyclophosphamide,1449004940.0,Central/South Asian
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904509.0,European
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904513.0,European
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904511.0,European
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904515.0,European
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904517.0,European
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904519.0,European
1446904494,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904521.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904509.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904513.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904511.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904515.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904517.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904519.0,European
1446904494,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,nortriptyline,1446904521.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904509.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904513.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904511.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904515.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904517.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904519.0,European
1446904494,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904521.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904509.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904513.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904511.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904515.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904517.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904519.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904521.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904509.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904513.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904511.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904515.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904517.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904519.0,European
1446904494,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904521.0,European
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Other,0,coumarin,827827659.0,Unknown
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Other,0,coumarin,827827659.0,Unknown
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,0,coumarin,827827659.0,Unknown
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,0,coumarin,827827659.0,Unknown
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Other,0,nicotine,827827659.0,Unknown
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Other,0,nicotine,827827659.0,Unknown
827827654,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,0,nicotine,827827659.0,Unknown
1449004944,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,4-hydroxycyclophosphamide,1449004950.0,Central/South Asian
1448116927,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,clopidogrel,1448116929.0,European
1450971000,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA165971569,CYP2D6*18,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1450971000,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,-1,amphetamine,1450971017.0,Unknown
1449004961,PA166156024,rs4680,,,COMT,Efficacy,-1,clozapine,1449004967.0,Central/South Asian
1449004961,PA166156024,rs4680,,,COMT,Efficacy,-1,clozapine,1449004967.0,Central/South Asian
1449004961,PA166156024,rs4680,,,COMT,Efficacy,-1,clozapine,1449004967.0,Central/South Asian
1448428210,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,valproic acid,1448428212.0,Unknown
1448428210,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,-1,valproic acid,1448428212.0,Unknown
613978599,PA166153972,rs1799853,,,CYP2C9,Dosage,-1,phenytoin,,
613978599,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,-1,phenytoin,,
613978601,PA166155715,rs3812718,,,SCN1A,Dosage,1,phenytoin,613978605.0,European
1448428199,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,valproic acid,1448428201.0,Unknown
1448428199,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,-1,valproic acid,1448428201.0,Unknown
1448428199,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,-1,valproic acid,1448428201.0,Unknown
827827639,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,0,nicotine,827827642.0,African American/Afro-Caribbean
827827639,,,PA165924749,CYP2A6*20,CYP2A6,Metabolism/PK,0,nicotine,827827642.0,African American/Afro-Caribbean
1185234929,PA166155496,rs35303484,,,CYP2B6,Metabolism/PK,1,efavirenz,1185234931.0,Sub-Saharan African
613978592,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,613978595.0,European
1448428186,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,valproic acid,1448428188.0,Unknown
1448428186,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,valproic acid,1448428188.0,Unknown
613978582,PA166153959,rs1057910,,,CYP2C9,Dosage,1,phenytoin,613978586.0,European
613978582,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,phenytoin,613978586.0,European
613978577,PA166157284,rs1045642,,,ABCB1,Dosage,-1,carbamazepine,,
613978577,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,carbamazepine,,
1449004981,PA166170863,rs2248359,,,CYP24A1,Metabolism/PK,0,deferasirox,1449004987.0,Unknown
1449004990,PA166154608,rs7975232,,,VDR,Metabolism/PK,1,deferasirox,1449004992.0,Unknown
613978575,PA166157284,rs1045642,,,ABCB1,Dosage,-1,phenytoin,,
613978575,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,phenytoin,,
1185234940,PA166157239,rs3842,,,ABCB1,Metabolism/PK,1,efavirenz,1185234942.0,Sub-Saharan African
1448428173,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,valproic acid,1448428175.0,Unknown
1448428173,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,valproic acid,1448428175.0,Unknown
1448641165,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448641167.0,"Multiple groups, Caucasian and African American"
1448641165,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448641168.0,"Multiple groups, Caucasian and African American"
1448641165,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448641167.0,"Multiple groups, Caucasian and African American"
1448641165,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448641168.0,"Multiple groups, Caucasian and African American"
1449004998,PA166154531,rs2228570,,,VDR,Metabolism/PK,1,deferasirox,1449005011.0,Unknown
1449004998,PA166154531,rs2228570,,,VDR,Metabolism/PK,1,deferasirox,1449005000.0,Unknown
1449004998,PA166154531,rs2228570,,,VDR,Metabolism/PK,1,deferasirox,1449005015.0,Unknown
1144910963,PA166153545,rs4762,,,AGT,Efficacy,-1,losartan,1144911002.0,Unknown
1448641151,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448641154.0,"Multiple groups, Caucasian and African American"
1448641151,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448641153.0,"Multiple groups, Caucasian and African American"
1185234957,PA166156332,rs1803274,,,BCHE,Efficacy,1,memantine,1185234959.0,East Asian
1185234957,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234959.0,East Asian
1448428159,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,valproic acid,1448428161.0,Unknown
1448428159,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,valproic acid,1448428161.0,Unknown
1448428159,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,valproic acid,1448428161.0,Unknown
1448641138,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1448641140.0,"Multiple groups, Caucasian and African American"
1448641138,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1448641141.0,"Multiple groups, Caucasian and African American"
1448641138,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1448641140.0,"Multiple groups, Caucasian and African American"
1448641138,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1448641141.0,"Multiple groups, Caucasian and African American"
1184169928,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1184169935.0,Unknown
1184169928,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1184169935.0,Unknown
1184169928,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1184169935.0,Unknown
1184169928,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,infliximab,1184169935.0,Unknown
1448624746,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1448624761.0,Unknown
1448624746,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1448624757.0,"Multiple groups, Black, White"
1448624746,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,simvastatin,1448624761.0,Unknown
1448624746,,,PA166048680,CYP3A4*22,CYP3A4,Efficacy,-1,simvastatin,1448624757.0,"Multiple groups, Black, White"
1447674471,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1447674477.0,Central/South Asian
1448624736,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,simvastatin,1448624763.0,"Multiple groups, Black, White"
1448624736,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,simvastatin,1448624745.0,"Multiple groups, Black, White"
1448624736,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,simvastatin,1448624763.0,"Multiple groups, Black, White"
1448624736,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,simvastatin,1448624745.0,"Multiple groups, Black, White"
982035499,PA166157304,rs1800795,,,IL6,Efficacy,1,fenofibrate,982035514.0,Unknown
1185234889,PA166153986,rs1934969,,,CYP2C9,Metabolism/PK,1,losartan,1185234895.0,Latino
1183629335,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,1183629339.0,Unknown
827811153,PA166157284,rs1045642,,,ABCB1,Other,-1,midazolam,827811162.0,European
827811153,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,midazolam,827811162.0,European
1446904423,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,nortriptyline,1446904489.0,"Multiple groups, mostly White"
1446904423,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,nortriptyline,1446904451.0,"Multiple groups, mostly White"
1446904423,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,nortriptyline,1446904489.0,"Multiple groups, mostly White"
1446904423,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,1,nortriptyline,1446904451.0,"Multiple groups, mostly White"
1446904423,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,1,nortriptyline,1446904489.0,"Multiple groups, mostly White"
1446904423,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,1,nortriptyline,1446904451.0,"Multiple groups, mostly White"
1446904423,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,nortriptyline,1446904489.0,"Multiple groups, mostly White"
1446904423,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,nortriptyline,1446904451.0,"Multiple groups, mostly White"
1446904423,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,1,nortriptyline,1446904489.0,"Multiple groups, mostly White"
1446904423,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,1,nortriptyline,1446904451.0,"Multiple groups, mostly White"
1446904423,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,nortriptyline,1446904489.0,"Multiple groups, mostly White"
1446904423,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,1,nortriptyline,1446904451.0,"Multiple groups, mostly White"
1451134960,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,oxycodone,1451134964.0,Unknown
1451134960,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,oxycodone,1451134980.0,Unknown
1451134960,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,oxycodone,1451134964.0,Unknown
1451134960,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,oxycodone,1451134980.0,Unknown
1451134960,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,sufentanil,1451134964.0,Unknown
1451134960,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,sufentanil,1451134980.0,Unknown
1451134960,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,sufentanil,1451134964.0,Unknown
1451134960,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,sufentanil,1451134980.0,Unknown
1185234906,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234932.0,East Asian
1185234906,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234953.0,East Asian
1185234906,PA166156332,rs1803274,,,BCHE,Efficacy,1,rivastigmine,1185234924.0,East Asian
1184514020,PA166154759,rs116855232,,,NUDT15,Toxicity,1,azathioprine,1184514025.0,East Asian
1450807298,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450807306.0,Sub-Saharan African
1450807298,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450807306.0,Sub-Saharan African
1450807298,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450807306.0,Sub-Saharan African
1450807307,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450807309.0,Sub-Saharan African
1450807307,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450807309.0,Sub-Saharan African
1450807307,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450807309.0,Sub-Saharan African
1450807373,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450807391.0,European
1450807373,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450807391.0,European
1450807373,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450807391.0,European
827811136,PA166157267,rs776746,,,CYP3A5,Other,-1,midazolam,827811152.0,European
827811136,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,midazolam,827811152.0,European
769169833,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,0,nicotine,769169835.0,Unknown
1446904338,,,PA165955891,HLA-B*44:02:01:01,HLA-B,Efficacy,1,Measles vaccines,1446904366.0,"Multiple groups, Caucasian, Asian, Native American, Other"
1451118680,PA166157284,rs1045642,,,ABCB1,Dosage,1,remifentanil,1451118684.0,East Asian
1451118680,PA166157284,rs1045642,,,ABCB1,Dosage,1,remifentanil,1451118684.0,East Asian
1444708852,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444708890.0,Multiple groups
1444708852,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444708854.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708852,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1444708890.0,Multiple groups
1444708852,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1444708854.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708852,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1444708890.0,Multiple groups
1444708852,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1444708854.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708852,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444708890.0,Multiple groups
1444708852,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444708854.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708852,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1444708890.0,Multiple groups
1444708852,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1444708854.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1446904346,,,PA165951320,HLA-DRB1*01:01:01,HLA-DRB1,Efficacy,1,Measles vaccines,1446904372.0,"Multiple groups, Caucasian, Asian, Native American, Other"
769169820,PA166157346,rs2246709,,,CYP3A4,Efficacy,1,amlodipine,769169825.0,African American/Afro-Caribbean
982035563,PA166154534,rs2239050,,,CACNA1C,Efficacy,1,calcium channel blockers,982035592.0,European
1446904352,,,PA165951669,HLA-DRB1*08:01:01,HLA-DRB1,Efficacy,1,Measles vaccines,1446904374.0,"Multiple groups, Caucasian, Asian, Native American, Other"
1451118687,PA166157284,rs1045642,,,ABCB1,Dosage,-1,remifentanil,1451118691.0,East Asian
769169810,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,paclitaxel,769169813.0,European
1185235079,PA166156315,rs1355534,,,BCHE,Efficacy,-1,rivastigmine,1185235081.0,Unknown
1451118697,PA166157284,rs1045642,,,ABCB1,Efficacy,1,remifentanil,1451118703.0,East Asian
1451118697,PA166157284,rs1045642,,,ABCB1,Efficacy,1,remifentanil,1451118701.0,East Asian
1451118697,PA166157284,rs1045642,,,ABCB1,Efficacy,1,remifentanil,1451118702.0,East Asian
1185235073,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185235075.0,Unknown
1185235073,PA166156332,rs1803274,,,BCHE,Efficacy,-1,rivastigmine,1185235075.0,Unknown
1451118692,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,remifentanil,1451118696.0,East Asian
769169804,PA166153959,rs1057910,,,CYP2C9,Other,0,acenocoumarol,769169809.0,"Multiple groups, 230 white subjects and 33 nonwhite subjects"
827778829,PA166157288,rs1128503,,,ABCB1,Efficacy,0,dexamethasone,827778835.0,European
827778829,PA166157288,rs1128503,,,ABCB1,Efficacy,0,diphenhydramine,827778835.0,European
827778829,PA166157288,rs1128503,,,ABCB1,Efficacy,0,paclitaxel,827778835.0,European
827778829,PA166157288,rs1128503,,,ABCB1,Efficacy,0,ranitidine,827778835.0,European
1446904358,,,PA165951284,HLA-DQA1*01:04:01:01,HLA-DQA1,Efficacy,1,Measles vaccines,1446904368.0,"Multiple groups, Caucasian, Asian, Native American, Other"
769235406,PA166154850,rs762551,,,CYP1A2,Other,-1,leflunomide,769235408.0,European
769235406,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,-1,leflunomide,769235408.0,European
1451135020,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,oxycodone,1451135040.0,Unknown
1451135020,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,oxycodone,1451135040.0,Unknown
1451135020,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,sufentanil,1451135040.0,Unknown
1451135020,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,sufentanil,1451135040.0,Unknown
769235409,PA166154935,rs12720461,,,CYP1A2,Other,-1,leflunomide,769235412.0,European
769235409,PA166154935,rs12720461,,,CYP1A2,Metabolism/PK,-1,leflunomide,769235412.0,European
1185235091,PA166157364,rs2571598,,,ACHE,Efficacy,-1,donepezil,1185235093.0,Unknown
1185235085,PA166153997,rs2177369,,,CHAT,Efficacy,-1,rivastigmine,1185235087.0,Unknown
1185235112,PA166153997,rs2177369,,,CHAT,Efficacy,-1,donepezil,1185235114.0,Unknown
1444708893,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,endoxifen,1444708905.0,"Multiple groups, mostly White"
1444708893,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,endoxifen,1444708905.0,"Multiple groups, mostly White"
1444708893,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,endoxifen,1444708905.0,"Multiple groups, mostly White"
1444708893,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,tamoxifen,1444708905.0,"Multiple groups, mostly White"
1444708893,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,tamoxifen,1444708905.0,"Multiple groups, mostly White"
1444708893,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,tamoxifen,1444708905.0,"Multiple groups, mostly White"
1449250920,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1449250922.0,Central/South Asian
1446904319,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,nortriptyline,1446904321.0,European
1446904319,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,nortriptyline,1446904321.0,European
1448641012,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448641135.0,"Multiple groups, Caucasian and African American"
1448641012,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448641137.0,"Multiple groups, Caucasian and African American"
1448641012,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448641135.0,"Multiple groups, Caucasian and African American"
1448641012,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448641137.0,"Multiple groups, Caucasian and African American"
1185235106,PA166156315,rs1355534,,,BCHE,Efficacy,-1,donepezil,1185235108.0,Unknown
1449005162,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449005164.0,East Asian
1185235100,PA166156332,rs1803274,,,BCHE,Efficacy,-1,donepezil,1185235102.0,Unknown
751884916,PA166156111,rs5030655,,,CYP2D6,Efficacy,1,metoprolol,751919644.0,European
1449005156,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1449005161.0,East Asian
1449005167,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1449005169.0,East Asian
1450807446,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,amoxicillin,1450807448.0,East Asian
1450807446,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,amoxicillin,1450807448.0,East Asian
1450807446,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,amoxicillin,1450807448.0,East Asian
1450807446,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807448.0,East Asian
1450807446,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807448.0,East Asian
1450807446,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807448.0,East Asian
981478561,PA166153617,rs1061170,,,CFH,Efficacy,1,photodynamic therapy,981478572.0,Unknown
981478561,PA166153617,rs1061170,,,CFH,Efficacy,1,photodynamic therapy,981478574.0,Unknown
1184759874,,,PA165987831,HLA-B*58:01,HLA-B,Toxicity,1,allopurinol,1184761194.0,Unknown
1449005177,PA166170884,rs10950022,,,VKORC1L1,Dosage,-1,warfarin,1449005179.0,East Asian
1449005177,PA166170884,rs10950022,,,VKORC1L1,Metabolism/PK,-1,warfarin,1449005179.0,East Asian
1449005185,PA166170886,rs4072879,,,VKORC1L1,Dosage,1,warfarin,1449005187.0,East Asian
1444708801,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,tamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,tamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,tamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1444708801,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,-1,tamoxifen,1444708829.0,"Multiple groups,  majority (~93%) of the subjects enrolled in this study were white"
1450807458,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,amoxicillin,1450807460.0,East Asian
1450807458,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,amoxicillin,1450807460.0,East Asian
1450807458,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,amoxicillin,1450807460.0,East Asian
1450807458,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807460.0,East Asian
1450807458,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807460.0,East Asian
1450807458,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807460.0,East Asian
1184137368,PA166154924,rs8027174,,,SLCO3A1,Metabolism/PK,0,darunavir,1184137372.0,European
1448624596,,,PA166131619,NUDT15*1,NUDT15,Toxicity,1,mercaptopurine,1448624598.0,East Asian
1448624596,,,PA166131620,NUDT15*2,NUDT15,Toxicity,1,mercaptopurine,1448624598.0,East Asian
1448624596,,,PA166131621,NUDT15*3,NUDT15,Toxicity,1,mercaptopurine,1448624598.0,East Asian
1449005190,PA166153656,rs1877724,,,EPHX1,Dosage,-1,warfarin,1449005192.0,East Asian
1448624581,,,PA166131619,NUDT15*1,NUDT15,Toxicity,1,mercaptopurine,1448624595.0,East Asian
1448624581,,,PA166131620,NUDT15*2,NUDT15,Toxicity,1,mercaptopurine,1448624595.0,East Asian
1448624581,,,PA166131621,NUDT15*3,NUDT15,Toxicity,1,mercaptopurine,1448624595.0,East Asian
1448624581,,,PA166131623,NUDT15*5,NUDT15,Toxicity,1,mercaptopurine,1448624595.0,East Asian
1448640957,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448640959.0,East Asian
1448640957,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448640959.0,East Asian
1447674287,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447674295.0,Unknown
1449005213,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1449005215.0,East Asian
1185235045,PA166157364,rs2571598,,,ACHE,Efficacy,1,rivastigmine,1185235070.0,Unknown
1449005203,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1449005210.0,East Asian
1450954880,PA166153646,rs1801159,,,DPYD,Metabolism/PK,1,fluorouracil,1450954862.0,"Multiple groups, Malay, Chinese, Indian"
1450954880,PA166153646,rs1801159,,,DPYD,Metabolism/PK,1,fluorouracil,1450954861.0,"Multiple groups, Malay, Chinese, Indian"
1184137325,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,paroxetine,1184137338.0,East Asian
1184137325,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,paroxetine,1184137338.0,East Asian
1184137325,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,paroxetine,1184137338.0,East Asian
1450807430,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,amoxicillin,1450807445.0,East Asian
1450807430,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,amoxicillin,1450807445.0,East Asian
1450807430,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,amoxicillin,1450807445.0,East Asian
1450807430,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807445.0,East Asian
1450807430,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807445.0,East Asian
1450807430,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807445.0,East Asian
1448640944,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448640956.0,East Asian
1448640944,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448640956.0,East Asian
1449005223,PA166154608,rs7975232,,,VDR,Dosage,-1,warfarin,1449005225.0,East Asian
1446904209,PA166155825,rs13015258,,,DPP4,Efficacy,-1,peginterferon alfa-2a,1446904212.0,East Asian
1446904209,PA166155825,rs13015258,,,DPP4,Efficacy,-1,peginterferon alfa-2b,1446904212.0,East Asian
1449005229,PA166154531,rs2228570,,,VDR,Dosage,-1,warfarin,1449005231.0,East Asian
1446904218,PA166155848,rs17848916,,,DPP4,Efficacy,-1,peginterferon alfa-2a,1446904220.0,East Asian
1446904218,PA166155848,rs17848916,,,DPP4,Efficacy,-1,peginterferon alfa-2b,1446904220.0,East Asian
1448116648,PA166157345,rs2242480,,,CYP3A4,Efficacy,-1,clopidogrel,1448116650.0,European
827827881,PA166157553,rs1128397,,,GFRA2,Efficacy,-1,clozapine,827827891.0,"Multiple groups, USA, Caucasians (n = 114) and Africanâ¿¿American (n = 26)"
1446904224,PA166155588,rs17574,,,DPP4,Efficacy,-1,peginterferon alfa-2a,1446904226.0,East Asian
1446904224,PA166155588,rs17574,,,DPP4,Efficacy,-1,peginterferon alfa-2b,1446904226.0,East Asian
1449005259,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,risperidone,1449005303.0,European
1184137425,PA166155370,rs1799782,,,XRCC1,Efficacy,1,Platinum compounds,1184137429.0,Unknown
1184137425,PA166155370,rs1799782,,,XRCC1,Efficacy,1,Platinum compounds,1184137494.0,Unknown
1448264089,PA166160571,rs17716942,,,KCNH7,Efficacy,-1,ustekinumab,1448264091.0,Unknown
1447674267,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447674277.0,Unknown
1447674267,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447674277.0,Unknown
1447674267,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447674277.0,Unknown
1447674267,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674277.0,Unknown
1447952771,PA166157514,rs75039782,,,CFTR,Efficacy,1,ataluren,1447952773.0,Unknown
1447952765,PA166157518,rs77010898,,,CFTR,Efficacy,1,ataluren,1447952767.0,Unknown
981478575,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,photodynamic therapy,981478584.0,Unknown
1448264060,PA166160567,rs27524,,,ERAP1,Efficacy,-1,adalimumab,1448264062.0,Unknown
1449169100,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169112.0,"Multiple groups, Asian"
1449169100,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169110.0,"Multiple groups, Mostly Asian"
1449169100,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169115.0,"Multiple groups, Mostly Asian"
1449169100,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169106.0,"Multiple groups, Mostly Asian"
1449169116,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169119.0,"Multiple groups, Mostly Asian"
1449169116,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169120.0,"Multiple groups, Asian"
1449169116,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169118.0,"Multiple groups, Mostly Asian"
1449169116,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169166.0,Multiple groups
1449169116,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169121.0,"Multiple groups, Mostly Asian"
1448264066,PA166160567,rs27524,,,ERAP1,Efficacy,-1,ustekinumab,1448264068.0,Unknown
1448264054,PA166160567,rs27524,,,ERAP1,Efficacy,-1,etanercept,1448264056.0,Unknown
1449005291,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1449005293.0,Multiple groups
1449005291,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1449005293.0,Multiple groups
1449005291,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1449005293.0,Multiple groups
1450823878,PA166156991,rs1799971,,,OPRM1,Other,1,nicotine,1450823882.0,"Multiple groups, Asian and Caucasian subjects"
1450823878,PA166156991,rs1799971,,,OPRM1,Other,1,nicotine,1450823885.0,European
1450823878,PA166156991,rs1799971,,,OPRM1,Other,1,nicotine,1450823886.0,East Asian
1449169125,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169128.0,"Multiple groups, Mostly Asian"
1449169125,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169127.0,"Multiple groups, Mostly Asian"
1449169125,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169170.0,"Multiple groups, Mostly Asian"
1451249860,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1451249864.0,Unknown
1447952758,PA166157524,rs113993959,,,CFTR,Efficacy,1,ataluren,1447952764.0,Unknown
1450807565,PA166157564,rs1799930,,,NAT2,Metabolism/PK,1,isoniazid,1450807571.0,Sub-Saharan African
1449169135,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169138.0,"Multiple groups, Mostly Asian"
1449169135,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169144.0,"Multiple groups, Mostly Asian"
1449169135,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169137.0,"Multiple groups, Mostly Asian"
1449169145,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169478.0,"Multiple groups, Mostly Asian"
1449169145,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169147.0,"Multiple groups, Mostly Asian"
1449169145,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,1,valproic acid,1449169148.0,"Multiple groups, Mostly Asian"
1448264037,PA166160563,rs240993,,,REV3L,Efficacy,-1,adalimumab,1448264039.0,Unknown
1448264043,PA166160563,rs240993,,,REV3L,Efficacy,-1,ustekinumab,1448264045.0,Unknown
1184137507,PA166154003,rs2234767,,,FAS,Efficacy,-1,Platinum compounds,1184137509.0,Unknown
1449005313,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,midazolam,1449005322.0,East Asian
1449005313,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,midazolam,1449005324.0,East Asian
1449005313,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,midazolam,1449005326.0,East Asian
1449005313,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,midazolam,1449005328.0,East Asian
1449005313,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,midazolam,1449005330.0,East Asian
1449005313,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,midazolam,1449005322.0,East Asian
1449005313,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,midazolam,1449005324.0,East Asian
1449005313,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,midazolam,1449005326.0,East Asian
1449005313,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,midazolam,1449005328.0,East Asian
1449005313,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,midazolam,1449005330.0,East Asian
769218940,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,paroxetine,769218943.0,East Asian
1448264020,PA166160559,rs11209026,,,IL23R,Efficacy,-1,ustekinumab,1448264022.0,Unknown
1449169153,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169481.0,"Multiple groups, Mostly Asian"
1449169153,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169155.0,"Multiple groups, Mostly Asian"
1449169153,PA166156658,rs12233719,,,UGT2B7,Metabolism/PK,-1,valproic acid,1449169156.0,"Multiple groups, Mostly Asian"
1184137499,PA166153587,rs763110,,,FASLG,Efficacy,-1,Platinum compounds,1184137503.0,Unknown
982035751,PA166154533,rs2238032,,,CACNA1C,Efficacy,1,amlodipine,982035780.0,European
982035751,PA166154533,rs2238032,,,CACNA1C,Efficacy,1,felodipine,982035780.0,European
1450807585,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,1,isoniazid,1450807587.0,Sub-Saharan African
1450807585,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,1,isoniazid,1450807587.0,Sub-Saharan African
1450807585,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,1,isoniazid,1450807587.0,Sub-Saharan African
1450807585,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,1,isoniazid,1450807587.0,Sub-Saharan African
1450807585,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,1,isoniazid,1450807587.0,Sub-Saharan African
1183629572,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,debrisoquine,1183629574.0,Unknown
1183629572,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1183629574.0,Unknown
1183629572,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629574.0,Unknown
1183629572,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629574.0,Unknown
1448264014,PA166160559,rs11209026,,,IL23R,Efficacy,-1,adalimumab,1448264016.0,Unknown
1448264008,PA166160559,rs11209026,,,IL23R,Efficacy,-1,etanercept,1448264010.0,Unknown
1451135223,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,hydralazine,1451135240.0,"Multiple groups, 7 non-Hispanic white, 3 Asian, and 2 native Hawaiian/other Pacific Islander"
1451135223,,,PA165981634,NAT2*5,NAT2,Metabolism/PK,1,hydralazine,1451135240.0,"Multiple groups, 7 non-Hispanic white, 3 Asian, and 2 native Hawaiian/other Pacific Islander"
1451135223,,,PA165981635,NAT2*6,NAT2,Metabolism/PK,1,hydralazine,1451135240.0,"Multiple groups, 7 non-Hispanic white, 3 Asian, and 2 native Hawaiian/other Pacific Islander"
1451135223,,,PA165981636,NAT2*7,NAT2,Metabolism/PK,1,hydralazine,1451135240.0,"Multiple groups, 7 non-Hispanic white, 3 Asian, and 2 native Hawaiian/other Pacific Islander"
1183629548,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1183629550.0,Unknown
1183629548,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,debrisoquine,1183629550.0,Unknown
1183629548,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629550.0,Unknown
1183629548,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629550.0,Unknown
1183629554,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,debrisoquine,1183629556.0,Unknown
1183629554,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,debrisoquine,1183629556.0,Unknown
1183629554,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629556.0,Unknown
1183629554,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629556.0,Unknown
827827767,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,clomipramine,827827777.0,Unknown
1447674165,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447674179.0,East Asian
1447674165,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674179.0,East Asian
1447674165,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674179.0,East Asian
1448263986,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1448264000.0,Unknown
1448263986,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1448264000.0,Unknown
1451147601,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,ambrisentan,1451147570.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147601,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,aripiprazole,1451147570.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147601,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,atorvastatin,1451147570.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147601,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,donepezil,1451147570.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147601,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,olanzapine,1451147570.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
827698212,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,827698228.0,Unknown
827698212,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,827698228.0,Unknown
1184510322,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184510338.0,European
1184510322,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184510338.0,European
1184510322,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184510338.0,European
981755213,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,981755228.0,European
1451163993,,,PA166115841,UGT1A1*1,UGT1A1,Toxicity,1,atazanavir / ritonavir,1451164040.0,Latino
1451163993,,,PA166115842,UGT1A1*28,UGT1A1,Toxicity,1,atazanavir / ritonavir,1451164040.0,Latino
1451163993,,,PA166115843,UGT1A1*36,UGT1A1,Toxicity,1,atazanavir / ritonavir,1451164040.0,Latino
1446908186,PA166157527,rs121434568,,,EGFR,Efficacy,1,erlotinib,1446908188.0,Unknown
1446908186,PA166157527,rs121434568,,,EGFR,Efficacy,1,erlotinib,1446908189.0,Unknown
1447678220,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,1,carbamazepine,1447678223.0,European
1447678220,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,1,carbamazepine,1447678222.0,European
1448268060,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1448268062.0,East Asian
1444696319,PA166155135,rs71647871,,,CES1,Efficacy,1,clopidogrel,1444696321.0,European
981755237,PA166156938,rs699947,,,VEGFA,Efficacy,-1,ranibizumab,981755241.0,European
1449165120,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,metformin,1449165125.0,"Multiple groups, Brazilian mixed cohort"
981755243,PA166156938,rs699947,,,VEGFA,Efficacy,-1,ranibizumab,981755247.0,European
1184756094,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1184756106.0,European
1184756094,,,PA165971568,CYP2D6*15,CYP2D6,Metabolism/PK,0,debrisoquine,1184756106.0,European
1184756094,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756106.0,European
1184756094,,,PA165971568,CYP2D6*15,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756106.0,European
1450934625,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,estrone sulfate,1450934630.0,"Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other."
1450934625,,,PA165819255,SLCO1B1*5,SLCO1B1,Metabolism/PK,1,estrone sulfate,1450934630.0,"Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other."
1184510339,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184510341.0,European
1451147625,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,fesoterodine,1451147628.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147625,,,PA165819221,CYP3A4*3,CYP3A4,Metabolism/PK,0,fesoterodine,1451147628.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147625,,,PA165819244,CYP3A4*20,CYP3A4,Metabolism/PK,0,fesoterodine,1451147628.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147625,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,fesoterodine,1451147628.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
981755229,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,981755235.0,European
1448268037,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448268039.0,East Asian
1450934575,PA166154628,rs11045819,,,SLCO1B1,PD,1,grazoprevir,1450934580.0,"Multiple groups, This is a retrospective pharmacogenetic analysis of a pooled dataset of selected HCV GT1- or GT4-infected participants enrolled in ten Phase II/III clinical trials of EBR/GZR: C-WORTHY (MSD Protocol, 5172-035; ClinicalTrials. gov identifier NCT01717326), C-SCAPE (5172-047; NCT01932762), C-SALVAGE (5172-048; NCT02105454), C-SURFER (5172-052; NCT02092350), Japan Phase II/III study (5172-058; NCT02203149), C-SALT (5172-059; NCT02115321), C-EDGE Treatment-Naive (5172-060; NCT02105467), C-EDGE CO-INFECTION (5172-061; NCT02105662), C-EDGE CO-STAR (5172-062; NCT02105688), C-EDGE Treatment-Experienced (5172-068; NCT02105701)"
1450934575,PA166154628,rs11045819,,,SLCO1B1,PD,1,grazoprevir,1450934581.0,"Multiple groups, This is a retrospective pharmacogenetic analysis of a pooled dataset of selected HCV GT1- or GT4-infected participants enrolled in ten Phase II/III clinical trials of EBR/GZR: C-WORTHY (MSD Protocol, 5172-035; ClinicalTrials. gov identifier NCT01717326), C-SCAPE (5172-047; NCT01932762), C-SALVAGE (5172-048; NCT02105454), C-SURFER (5172-052; NCT02092350), Japan Phase II/III study (5172-058; NCT02203149), C-SALT (5172-059; NCT02115321), C-EDGE Treatment-Naive (5172-060; NCT02105467), C-EDGE CO-INFECTION (5172-061; NCT02105662), C-EDGE CO-STAR (5172-062; NCT02105688), C-EDGE Treatment-Experienced (5172-068; NCT02105701)"
1451114801,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,lopinavir,1451114765.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114801,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,ritonavir,1451114765.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1448268043,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448268045.0,East Asian
1448268043,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448268045.0,East Asian
1451229484,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n,1451229520.0,Unknown
1451229484,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,n,1451229520.0,Unknown
1451229484,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,n,1451229520.0,Unknown
1451229484,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,n,1451229520.0,Unknown
1451229484,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,o-didesmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,o-didesmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,o-didesmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,o-didesmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,o-desmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,o-desmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,o-desmethyltramadol,1451229520.0,Unknown
1451229484,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,o-desmethyltramadol,1451229520.0,Unknown
1450934582,PA166154547,rs2306283,,,SLCO1B1,PD,-1,grazoprevir,1450934590.0,"Multiple groups, This is a retrospective pharmacogenetic analysis of a pooled dataset of selected HCV GT1- or GT4-infected participants enrolled in ten Phase II/III clinical trials of EBR/GZR: C-WORTHY (MSD Protocol, 5172-035; ClinicalTrials. gov identifier NCT01717326), C-SCAPE (5172-047; NCT01932762), C-SALVAGE (5172-048; NCT02105454), C-SURFER (5172-052; NCT02092350), Japan Phase II/III study (5172-058; NCT02203149), C-SALT (5172-059; NCT02115321), C-EDGE Treatment-Naive (5172-060; NCT02105467), C-EDGE CO-INFECTION (5172-061; NCT02105662), C-EDGE CO-STAR (5172-062; NCT02105688), C-EDGE Treatment-Experienced (5172-068; NCT02105701)"
1184756122,PA166154066,rs4917639,,,CYP2C9,Dosage,1,warfarin,1184756156.0,East Asian
1184756122,PA166154066,rs4917639,,,CYP2C9,Dosage,1,warfarin,1184756174.0,East Asian
1451147565,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,ambrisentan,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,ambrisentan,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,aripiprazole,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,aripiprazole,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,atorvastatin,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,atorvastatin,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,donepezil,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,donepezil,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,olanzapine,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147565,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,olanzapine,1451147569.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1449165132,PA166176843,rs1867351,,,SLC22A1,Metabolism/PK,-1,metformin,1449165137.0,"Multiple groups, Brazil"
1444712725,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,paroxetine,1444712752.0,East Asian
1444712725,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,paroxetine,1444712754.0,East Asian
1444712725,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,paroxetine,1444712752.0,East Asian
1444712725,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,paroxetine,1444712754.0,East Asian
1444712725,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,paroxetine,1444712752.0,East Asian
1444712725,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,paroxetine,1444712754.0,East Asian
1444712725,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,paroxetine,1444712752.0,East Asian
1444712725,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,paroxetine,1444712754.0,East Asian
1444712725,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,paroxetine,1444712752.0,East Asian
1444712725,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,paroxetine,1444712754.0,East Asian
1444712725,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,paroxetine,1444712752.0,East Asian
1444712725,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,paroxetine,1444712754.0,East Asian
1449165143,PA166157216,rs72552763,,,SLC22A1,Metabolism/PK,-1,metformin,1449165145.0,"Multiple groups, Brazil"
1451147572,PA166157502,rs67666821,,,CYP3A4,Metabolism/PK,-1,ambrisentan,1451147576.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147572,PA166157502,rs67666821,,,CYP3A4,Metabolism/PK,-1,aripiprazole,1451147576.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147572,PA166157502,rs67666821,,,CYP3A4,Metabolism/PK,-1,atorvastatin,1451147576.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147572,PA166157502,rs67666821,,,CYP3A4,Metabolism/PK,-1,donepezil,1451147576.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147572,PA166157502,rs67666821,,,CYP3A4,Metabolism/PK,-1,olanzapine,1451147576.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1449165153,PA166156913,rs316019,,,SLC22A2,Metabolism/PK,-1,metformin,1449165155.0,"Multiple groups, Brazil"
1184510363,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1184510367.0,Unknown
1184510363,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1184510369.0,Unknown
1451147580,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,-1,ambrisentan,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,ambrisentan,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,-1,aripiprazole,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,aripiprazole,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,-1,atorvastatin,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,atorvastatin,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,-1,donepezil,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,donepezil,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A,Metabolism/PK,-1,olanzapine,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147580,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,olanzapine,1451147600.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1446908159,PA166157527,rs121434568,,,EGFR,Efficacy,1,gefitinib,1446908181.0,Unknown
1446908159,PA166157527,rs121434568,,,EGFR,Efficacy,1,gefitinib,1446908184.0,Unknown
1449165148,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,-1,metformin,1449165150.0,"Multiple groups, Brazil"
1451114826,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lopinavir,1451114783.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114826,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,ritonavir,1451114783.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1184510377,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1184510381.0,East Asian
1451114820,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,lopinavir,1451114840.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114820,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,ritonavir,1451114840.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1184166190,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,bleomycin,1184166200.0,Unknown
1184166190,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,bleomycin,1184166200.0,Unknown
1184166190,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,dacarbazine,1184166200.0,Unknown
1184166190,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,dacarbazine,1184166200.0,Unknown
1184166190,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,doxorubicin,1184166200.0,Unknown
1184166190,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,doxorubicin,1184166200.0,Unknown
1184166190,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,vinblastine,1184166200.0,Unknown
1184166190,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,vinblastine,1184166200.0,Unknown
1184756016,PA166154601,rs7305534,,,AQP2,Efficacy,-1,platinum,1184756018.0,East Asian
1448431851,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,celecoxib,1448431869.0,East Asian
1448431851,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,celecoxib,1448431869.0,East Asian
1448431851,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,celecoxib,1448431869.0,East Asian
1444843695,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1444843704.0,East Asian
1444843695,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1444843704.0,East Asian
1451114894,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114899.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1184510263,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184510277.0,Sub-Saharan African
1184510263,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184510277.0,Sub-Saharan African
1184510263,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1184510277.0,Sub-Saharan African
1184510263,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1184510277.0,Sub-Saharan African
1184510263,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1184510277.0,Sub-Saharan African
1451114900,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451114882.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114900,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114882.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1447678164,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,1,carbamazepine,1447678177.0,European
1447678164,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,1,carbamazepine,1447678182.0,European
1451114920,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451114940.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114920,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114940.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
981755292,PA166156960,rs833069,,,VEGFA,Efficacy,-1,ranibizumab,981755312.0,European
1184510278,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184510278,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184510278,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184510278,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184510278,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184510278,,,PA165816550,CYP2C9*9,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184510278,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1184510280.0,Sub-Saharan African
1184756042,PA166154562,rs3759126,,,AQP2,Efficacy,-1,platinum,1184756044.0,East Asian
1449296254,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1449296261.0,European
1444843717,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1444843719.0,East Asian
1444843717,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1444843719.0,East Asian
1451114866,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,lopinavir,1451114871.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114866,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,ritonavir,1451114871.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1184756047,PA166154603,rs7314734,,,AQP2,Efficacy,-1,platinum,1184756049.0,East Asian
1184756047,PA166154603,rs7314734,,,AQP2,Efficacy,-1,platinum,1184756049.0,East Asian
1451147640,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,fentanyl,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819221,CYP3A4*3,CYP3A4,Metabolism/PK,0,fentanyl,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819244,CYP3A4*20,CYP3A4,Metabolism/PK,0,fentanyl,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,fentanyl,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,imatinib,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819221,CYP3A4*3,CYP3A4,Metabolism/PK,0,imatinib,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819244,CYP3A4*20,CYP3A4,Metabolism/PK,0,imatinib,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,imatinib,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,0,quetiapine,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819221,CYP3A4*3,CYP3A4,Metabolism/PK,0,quetiapine,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA165819244,CYP3A4*20,CYP3A4,Metabolism/PK,0,quetiapine,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147640,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,quetiapine,1451147660.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451114860,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,lopinavir,1451114865.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114860,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,ritonavir,1451114865.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114872,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,lopinavir,1451114877.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114872,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,ritonavir,1451114877.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1184756052,PA166154621,rs10875989,,,AQP2,Efficacy,-1,platinum,1184756054.0,East Asian
981755270,PA166156960,rs833069,,,VEGFA,Efficacy,-1,ranibizumab,981755290.0,European
1449165218,PA166154503,rs784888,,,SP1,Metabolism/PK,-1,metformin,1449165220.0,"Multiple groups, Brazil"
1451114883,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451114888.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114883,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114888.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1184756063,PA166154871,rs1867380,,,AQP9,Efficacy,-1,platinum,1184756065.0,East Asian
1449165213,PA166155251,rs12943590,,,SLC47A2,Metabolism/PK,-1,metformin,1449165215.0,"Multiple groups, Brazil"
1449296299,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,0,folic acid,1449296304.0,Unknown
1184756073,PA166154865,rs1554203,,,AQP9,Efficacy,-1,platinum,1184756075.0,East Asian
1451114889,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lopinavir,1451114941.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1447678134,PA166157801,rs10120688,,,CDKN2B-AS1,Efficacy,-1,Platinum compounds,1447678136.0,East Asian
827812782,PA166156521,rs1799883,,,FABP2,Dosage,-1,valproic acid,827812791.0,East Asian
827812782,PA166156521,rs1799883,,,FABP2,Metabolism/PK,-1,valproic acid,827812791.0,East Asian
1184756068,PA166154863,rs1516400,,,AQP9,Efficacy,-1,platinum,1184756070.0,East Asian
1447678108,PA166157382,rs3807598,,,HOTTIP,Efficacy,-1,Platinum compounds,1447678111.0,East Asian
1444843635,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1444843637.0,Multiple groups
1444843635,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1444843637.0,Multiple groups
1444843635,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1444843637.0,Multiple groups
1444843635,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1444843637.0,Multiple groups
1444843635,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,1444843637.0,Multiple groups
1444843635,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,1444843637.0,Multiple groups
1184510446,PA166155184,rs1136287,,,SERPINF1,Efficacy,-1,ranibizumab,1184510448.0,East Asian
827812774,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,valproic acid,827812780.0,East Asian
827812774,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,valproic acid,827812780.0,East Asian
981755354,PA166154397,rs3736228,,,LRP5,Efficacy,-1,ranibizumab,981755360.0,European
1184510450,PA166154488,rs5888,,,SCARB1,Efficacy,-1,ranibizumab,1184510452.0,East Asian
1448267942,PA166155096,rs9934438,,,VKORC1,Dosage,0,warfarin,1448267947.0,East Asian
1446908047,PA166154643,rs12817819,,,ATP2B1,Efficacy,1,Antihypertensives,1446908089.0,Multiple groups
1446908047,PA166154643,rs12817819,,,ATP2B1,Efficacy,1,Antihypertensives,1446908062.0,Multiple groups
1446908047,PA166154643,rs12817819,,,ATP2B1,Efficacy,1,Antihypertensives,1446908060.0,Latino
1446908047,PA166154643,rs12817819,,,ATP2B1,Efficacy,1,Antihypertensives,1446908058.0,European
1446908047,PA166154643,rs12817819,,,ATP2B1,Efficacy,1,Antihypertensives,1446908087.0,European
1447678116,PA166157409,rs5883064,,,HOTTIP,Efficacy,-1,Platinum compounds,1447678118.0,East Asian
827812768,PA166156676,rs28365062,,,UGT2B7,Dosage,-1,valproic acid,827812773.0,East Asian
827812768,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,-1,valproic acid,827812773.0,East Asian
981755340,PA166154440,rs10898563,,,FZD4,Efficacy,-1,ranibizumab,981755345.0,European
1444843642,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843648.0,"Multiple groups, mostly white"
1444843642,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444843648.0,"Multiple groups, mostly white"
1444843642,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843648.0,"Multiple groups, mostly white"
1444843642,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444843648.0,"Multiple groups, mostly white"
1444843642,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444843648.0,"Multiple groups, mostly white"
1444843642,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444843648.0,"Multiple groups, mostly white"
981755347,PA166154440,rs10898563,,,FZD4,Efficacy,-1,ranibizumab,981755352.0,European
1449296305,PA166153643,rs1801131,,,MTHFR,Metabolism/PK,0,folic acid,1449296307.0,Unknown
1447678122,PA166157311,rs1859168,,,HOTTIP,Efficacy,-1,Platinum compounds,1447678124.0,East Asian
1451114966,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114980.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
827812759,PA166156625,rs7668258,,,UGT2B7,Dosage,-1,valproic acid,827812763.0,East Asian
827812759,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,-1,valproic acid,827812763.0,East Asian
981755370,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,981755379.0,European
1444843653,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444843655.0,"Multiple groups, mostly white"
1444843653,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444843655.0,"Multiple groups, mostly white"
1444843653,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444843655.0,"Multiple groups, mostly white"
981755362,PA166154397,rs3736228,,,LRP5,Efficacy,-1,ranibizumab,981755368.0,European
1449165252,PA166156544,rs2231142,,,ABCG2,Dosage,1,allopurinol,1449165258.0,Unknown
1449181636,PA166156991,rs1799971,,,OPRM1,Efficacy,1,naltrexone,1449181642.0,Multiple groups
827812746,PA166155690,rs2741049,,,UGT1A10,Dosage,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A7,Dosage,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A8,Dosage,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A9,Dosage,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A10,Metabolism/PK,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A7,Metabolism/PK,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A8,Metabolism/PK,-1,valproic acid,827812755.0,East Asian
827812746,PA166155690,rs2741049,,,UGT1A9,Metabolism/PK,-1,valproic acid,827812755.0,East Asian
1444843667,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444843673.0,East Asian
1444843667,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444843673.0,East Asian
1444843667,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444843673.0,East Asian
1451114925,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451114942.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1451114925,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1451114942.0,"Multiple groups, Majority of patients were African American, 3 patients of African origin, 1 Asian patient , 1 Caucasian patient and 2 Hispanic patients."
1447678081,PA166154594,rs4759314,,,HOTAIR,Efficacy,-1,Platinum compounds,1447678083.0,East Asian
1448267909,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1448267914.0,East Asian
1448267915,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448267917.0,East Asian
1448267915,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448267917.0,East Asian
981755320,PA166156537,rs2071559,,,KDR,Efficacy,-1,ranibizumab,981755324.0,European
1445400722,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1445400739.0,Unknown
1445400722,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1445400739.0,Unknown
1445400722,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1445400739.0,Unknown
1445400722,,,PA165971560,CYP2D6*8,CYP2D6,Metabolism/PK,1,endoxifen,1445400739.0,Unknown
1446908024,PA166157411,rs6465084,,,GRM3,Toxicity,1,antipsychotics,1446908030.0,"Multiple groups, White, Black, other"
1444843675,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444843677.0,East Asian
1444843675,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444843677.0,East Asian
1444843675,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444843677.0,East Asian
1444843675,PA166190881,rs11322783,,,IFNL4,Efficacy,1,telaprevir,1444843677.0,East Asian
981755314,PA166156537,rs2071559,,,KDR,Efficacy,-1,ranibizumab,981755318.0,European
827812732,PA166155754,rs6731242,,,UGT1A10,Dosage,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A7,Dosage,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A8,Dosage,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A9,Dosage,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A10,Metabolism/PK,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A7,Metabolism/PK,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A8,Metabolism/PK,-1,valproic acid,827812740.0,East Asian
827812732,PA166155754,rs6731242,,,UGT1A9,Metabolism/PK,-1,valproic acid,827812740.0,East Asian
1447678060,PA166154351,rs2107425,,,None,Efficacy,-1,Platinum compounds,1447678062.0,East Asian
981755333,PA166156627,rs7671745,,,KDR,Efficacy,-1,ranibizumab,981755338.0,European
1184510497,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,efavirenz,1184510507.0,Unknown
1184510497,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,efavirenz,1184510507.0,Unknown
981755326,PA166156627,rs7671745,,,KDR,Efficacy,-1,ranibizumab,981755331.0,European
827812721,PA166154508,rs1019385,,,GRIN2B,Dosage,1,valproic acid,827812725.0,East Asian
827812721,PA166154508,rs1019385,,,GRIN2B,Metabolism/PK,1,valproic acid,827812725.0,East Asian
1448267884,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448267889.0,East Asian
1448267890,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1448267892.0,East Asian
1448267890,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448267892.0,East Asian
827812715,PA166154508,rs1019385,,,GRIN2B,Dosage,1,valproic acid,827812720.0,East Asian
827812715,PA166154508,rs1019385,,,GRIN2B,Metabolism/PK,1,valproic acid,827812720.0,East Asian
769169634,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,losartan,769169639.0,European
1448267876,PA166160922,rs2954625,,,CSMD1,Efficacy,1,metformin,1448267878.0,Multiple groups
1184510386,PA166153749,rs3753394,,,CFH,Efficacy,-1,ranibizumab,1184510388.0,East Asian
1184510390,PA166153629,rs1410996,,,CFH,Efficacy,-1,ranibizumab,1184510392.0,East Asian
1444843578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843584.0,East Asian
1444843578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843584.0,East Asian
1444843578,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444843584.0,East Asian
1184510394,PA166153628,rs1329428,,,CFH,Efficacy,-1,ranibizumab,1184510396.0,East Asian
1449165300,PA166176852,rs1319501,,,NAMPT,Efficacy,-1,Antihypertensives,1449165310.0,Multiple groups
1449165300,PA166176852,rs1319501,,,NAMPT,Efficacy,-1,Antihypertensives,1449165306.0,Multiple groups
1449165300,PA166176852,rs1319501,,,NAMPT,Efficacy,-1,Antihypertensives,1449165312.0,Multiple groups
1449165300,PA166176852,rs1319501,,,NAMPT,Efficacy,-1,Antihypertensives,1449165308.0,Multiple groups
1184510398,PA166153804,rs10737680,,,CFH,Efficacy,-1,ranibizumab,1184510400.0,East Asian
827812695,PA166155623,rs1105879,,,UGT1A6,Dosage,1,valproic acid,827812708.0,East Asian
827812695,PA166155623,rs1105879,,,UGT1A6,Metabolism/PK,1,valproic acid,827812708.0,East Asian
769169620,PA166154887,rs2290573,,,ULK3,Efficacy,1,imatinib,769169627.0,Multiple groups
1184510406,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1184510408.0,East Asian
1184510410,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1184510412.0,East Asian
1184510414,PA166156917,rs429608,,,SKIV2L,Efficacy,-1,ranibizumab,1184510416.0,East Asian
1451229680,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,n,1451229720.0,Unknown
1451229680,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,o-didesmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1451229680,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,o-desmethyltramadol,1451229720.0,Unknown
1444843596,PA166155462,rs11881222,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843598.0,East Asian
1444843596,PA166155462,rs11881222,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843598.0,East Asian
1444843596,PA166155462,rs11881222,,,IFNL3,Efficacy,1,ribavirin,1444843598.0,East Asian
1448267848,PA166160920,rs2617102,,,CSMD1,Efficacy,1,metformin,1448267850.0,Multiple groups
1451164140,,,PA166115841,UGT1A1*1,UGT1A1,Toxicity,1,atazanavir / ritonavir,1451164146.0,"Multiple groups, 80% Caucasian"
1451164140,,,PA166115842,UGT1A1*28,UGT1A1,Toxicity,1,atazanavir / ritonavir,1451164146.0,"Multiple groups, 80% Caucasian"
1184510418,PA166156934,rs641153,,,CFB,Efficacy,-1,ranibizumab,1184510420.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A10,Dosage,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A6,Dosage,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A7,Dosage,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A8,Dosage,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A9,Dosage,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A10,Metabolism/PK,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A6,Metabolism/PK,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A7,Metabolism/PK,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A8,Metabolism/PK,1,valproic acid,827812688.0,East Asian
827812675,PA166155665,rs2070959,,,UGT1A9,Metabolism/PK,1,valproic acid,827812688.0,East Asian
1184510422,PA166157140,rs9332739,,,C2,Efficacy,-1,ranibizumab,1184510424.0,East Asian
1444712539,PA166155206,rs2289669,,,SLC47A1,Efficacy,1,metformin,1444712545.0,East Asian
1449165334,PA166154264,rs9344,,,CCND1,Efficacy,-1,cetuximab,1449165342.0,Unknown
1449165334,PA166154264,rs9344,,,CCND1,Efficacy,-1,panitumumab,1449165342.0,Unknown
1184510426,PA166156640,rs10033900,,,CFI,Efficacy,-1,ranibizumab,1184510428.0,East Asian
1449165345,PA166153559,rs20417,,,PTGS2,Efficacy,-1,cetuximab,1449165347.0,Unknown
1449165345,PA166153559,rs20417,,,PTGS2,Efficacy,-1,panitumumab,1449165347.0,Unknown
1184510430,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,ranibizumab,1184510432.0,East Asian
1451164161,,,PA166115841,UGT1A1*1,UGT1A1,Toxicity,-1,atazanavir / ritonavir,1451164180.0,"Multiple groups, 80% Caucasian"
1451164161,,,PA166115842,UGT1A1*28,UGT1A1,Toxicity,-1,atazanavir / ritonavir,1451164180.0,"Multiple groups, 80% Caucasian"
1444712547,PA166155206,rs2289669,,,SLC47A1,Metabolism/PK,1,metformin,1444712549.0,East Asian
1447678000,PA166154606,rs7958904,,,HOTAIR,Efficacy,1,Platinum compounds,1447678002.0,East Asian
1184510434,PA166156937,rs699946,,,VEGFA,Efficacy,-1,ranibizumab,1184510436.0,East Asian
1444843627,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843633.0,Multiple groups
1444843627,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444843633.0,Multiple groups
1444843627,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843633.0,Multiple groups
1444843627,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444843633.0,Multiple groups
1444843627,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444843633.0,Multiple groups
1444843627,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444843633.0,Multiple groups
1449296415,PA166157284,rs1045642,,,ABCB1,Dosage,1,fentanyl,1449296421.0,Unknown
1449296415,PA166157284,rs1045642,,,ABCB1,Efficacy,1,fentanyl,1449296421.0,Unknown
1184510438,PA166156938,rs699947,,,VEGFA,Efficacy,-1,ranibizumab,1184510440.0,East Asian
1449165351,PA166156588,rs4444903,,,EGF,Efficacy,-1,cetuximab,1449165354.0,Unknown
1449165351,PA166156588,rs4444903,,,EGF,Efficacy,-1,panitumumab,1449165354.0,Unknown
827812655,PA166155760,rs6759892,,,UGT1A10,Dosage,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A6,Dosage,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A7,Dosage,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A8,Dosage,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A9,Dosage,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A10,Metabolism/PK,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A6,Metabolism/PK,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A7,Metabolism/PK,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A8,Metabolism/PK,1,valproic acid,827812668.0,East Asian
827812655,PA166155760,rs6759892,,,UGT1A9,Metabolism/PK,1,valproic acid,827812668.0,East Asian
1184510442,PA166156958,rs833061,,,VEGFA,Efficacy,-1,ranibizumab,1184510444.0,East Asian
1447677984,PA166154388,rs2839698,,,H19,Efficacy,1,Platinum compounds,1447677986.0,East Asian
1449165359,PA166157262,rs712829,,,EGFR,Efficacy,-1,cetuximab,1449165361.0,Unknown
1449165359,PA166157262,rs712829,,,EGFR,Efficacy,-1,panitumumab,1449165361.0,Unknown
827845924,PA166154194,rs72558187,,,CYP2C9,Dosage,-1,warfarin,827845932.0,East Asian
1184756346,,,PA165971569,CYP2D6*18,CYP2D6,Metabolism/PK,0,debrisoquine,1184756442.0,East Asian
1184756346,,,PA165988484,CYP2D6*21,CYP2D6,Metabolism/PK,0,debrisoquine,1184756442.0,East Asian
1448267827,PA166160917,rs316009,,,SLC22A2,Efficacy,1,metformin,1448267840.0,Multiple groups
1447677992,PA166154287,rs619586,,,MALAT1,Efficacy,1,Platinum compounds,1447677994.0,East Asian
1449165367,PA166157331,rs2227983,,,EGFR,Efficacy,-1,cetuximab,1449165373.0,Unknown
1449165367,PA166157331,rs2227983,,,EGFR,Efficacy,-1,panitumumab,1449165373.0,Unknown
827845911,PA166157284,rs1045642,,,ABCB1,Dosage,-1,warfarin,827845920.0,East Asian
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,carbamazepine,1448821341.0,European
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,clobazam,1448821341.0,European
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,ethosuximide,1448821341.0,European
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,lamotrigine,1448821341.0,European
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,levetiracetam,1448821341.0,European
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,oxcarbazepine,1448821341.0,European
1448821318,PA166155680,rs2298771,,,SCN1A,Efficacy,1,valproic acid,1448821341.0,European
1450934891,,,PA165981641,SLCO1B1*1,SLCO1B1,Efficacy,1,estrone,1450934898.0,"Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other."
1450934891,,,PA165819255,SLCO1B1*5,SLCO1B1,Efficacy,1,estrone,1450934898.0,"Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other."
1449165374,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,cetuximab,1449165376.0,Unknown
1449165374,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,panitumumab,1449165376.0,Unknown
769152908,PA166155400,rs2738466,,,LDLR,Efficacy,0,pravastatin,769152914.0,European
769152906,PA166155367,rs1433099,,,LDLR,Efficacy,0,pravastatin,769152912.0,European
1449165394,PA166154658,rs61764370,,,KRAS,Efficacy,-1,cetuximab,1449165396.0,Unknown
1449165394,PA166154658,rs61764370,,,KRAS,Efficacy,-1,panitumumab,1449165396.0,Unknown
1451147820,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ketamine,1451147841.0,Unknown
1451147820,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ketamine,1451147840.0,Unknown
1449165380,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,cetuximab,1449165382.0,Unknown
1449165380,PA166153571,rs396991,,,FCGR3A,Efficacy,-1,panitumumab,1449165382.0,Unknown
827567370,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,metoprolol,827567380.0,Unknown
1446907885,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,cyclophosphamide,1446907887.0,East Asian
1449165388,PA166156478,rs4073,,,CXCL8,Efficacy,-1,cetuximab,1449165390.0,Unknown
1449165388,PA166156478,rs4073,,,CXCL8,Efficacy,-1,panitumumab,1449165390.0,Unknown
1449165400,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,cetuximab,1449165402.0,Unknown
1449165400,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,panitumumab,1449165402.0,Unknown
827845885,PA166157405,rs4986910,,,CYP3A4,Dosage,-1,warfarin,827845894.0,East Asian
827845885,PA166157405,rs4986910,,,CYP3A4,Dosage,-1,warfarin,827845894.0,East Asian
1184510620,PA166155822,rs12714145,,,GGCX,Dosage,1,warfarin,1184510624.0,East Asian
1446907901,PA166154249,rs1695,,,GSTP1,Metabolism/PK,-1,cyclophosphamide,1446907903.0,East Asian
827567352,PA166155822,rs12714145,,,GGCX,Dosage,1,warfarin,827567360.0,European
827567361,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827567378.0,East Asian
827567361,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,1,warfarin,827567378.0,East Asian
827567343,PA166153977,rs1801253,,,ADRB1,Efficacy,0,metoprolol,827567369.0,East Asian
1184510631,PA166156663,rs13104811,,,AREG,Efficacy,1,cetuximab,1184510635.0,Unknown
1184510631,PA166156663,rs13104811,,,AREG,Efficacy,1,panitumumab,1184510635.0,Unknown
1184510631,PA166156663,rs13104811,,,AREG,Efficacy,1,panitumumab,1184510635.0,Unknown
1450934857,PA166184626,rs1718125,,,P2RX7,Dosage,1,fentanyl,1450934863.0,East Asian
1450951310,PA166153760,rs3918290,,,DPYD,Efficacy,-1,fluorouracil,1450951272.0,Multiple groups
982034073,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982034098.0,Unknown
982034073,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982034103.0,Unknown
982034073,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982034081.0,Unknown
982034073,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982034105.0,Unknown
982034073,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982034142.0,Unknown
982034073,PA166154486,rs5443,,,GNB3,Efficacy,1,clonidine,982034080.0,Unknown
1184510511,PA166156707,rs5326,,,DRD1,Efficacy,1,methylphenidate,1184510515.0,Multiple groups
827845864,PA166155463,rs12460590,,,CYP2A6,Dosage,-1,warfarin,827845874.0,East Asian
1184756280,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184756283.0,East Asian
1184756280,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184756282.0,East Asian
1184510516,PA166156836,rs4867798,,,DRD1,Efficacy,1,methylphenidate,1184510518.0,Multiple groups
1184510520,PA166156277,rs6280,,,DRD3,Efficacy,1,methylphenidate,1184510522.0,Multiple groups
1184510524,PA166154456,rs11246226,,,DRD4,Efficacy,1,methylphenidate,1184510526.0,Multiple groups
1184510528,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,methylphenidate,1184510530.0,Multiple groups
827845844,PA166154850,rs762551,,,CYP1A2,Dosage,-1,warfarin,827845852.0,East Asian
1184510536,PA166156024,rs4680,,,COMT,Efficacy,1,methylphenidate,1184510538.0,Multiple groups
827567329,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,827567336.0,European
1450820267,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450820273.0,European
1450820267,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450820275.0,European
1450820267,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450820272.0,European
1450820267,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450820271.0,European
1450820267,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450820274.0,European
827845835,PA166154874,rs2069514,,,CYP1A2,Dosage,-1,warfarin,827845840.0,East Asian
769169217,PA166155331,rs45445694,,,TYMS,Efficacy,0,fluorouracil,,
1447989193,PA166154759,rs116855232,,,NUDT15,Dosage,0,azathioprine,1447989198.0,East Asian
1447989193,PA166154759,rs116855232,,,NUDT15,Dosage,0,mercaptopurine,1447989198.0,East Asian
827567313,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,827567320.0,European
1444843476,PA166157089,rs3828913,,,MICB,Efficacy,1,peginterferon alfa-2a,1444843484.0,East Asian
1444843476,PA166157089,rs3828913,,,MICB,Efficacy,1,peginterferon alfa-2b,1444843484.0,East Asian
1444843476,PA166157089,rs3828913,,,MICB,Efficacy,1,ribavirin,1444843484.0,East Asian
827845820,PA166154855,rs1048943,,,CYP1A1,Dosage,-1,warfarin,827845828.0,East Asian
827845815,PA166154100,rs9332127,,,CYP2C9,Dosage,-1,warfarin,827845826.0,East Asian
982034052,PA166155187,rs1799752,,,ACE,Efficacy,-1,candesartan,982034062.0,Unknown
1444843486,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843488.0,East Asian
1444843486,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843488.0,East Asian
1444843486,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444843488.0,East Asian
1450934909,PA166170701,rs10841753,,,SLCO1B1,Metabolism/PK,1,estrone sulfate,1450934914.0,"Multiple groups, USA Michigan and Indiana Universities, 88% white, 9% black, 3% other."
1449165490,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,0,dihydrocodeine,1449165503.0,East Asian
1449165490,,,PA165816582,CYP2D6*10,CYP2D6,Toxicity,0,dihydrocodeine,1449165503.0,East Asian
1449165490,,,PA165988488,CYP2D6*36,CYP2D6,Toxicity,0,dihydrocodeine,1449165503.0,East Asian
1449165490,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,dihydrocodeine,1449165503.0,East Asian
1449165490,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,dihydrocodeine,1449165503.0,East Asian
1449165490,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,0,dihydrocodeine,1449165503.0,East Asian
1448431531,PA166155720,rs4124874,,,UGT1A1,Dosage,-1,warfarin,1448431533.0,East Asian
827845798,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827845806.0,East Asian
1448431525,PA166155721,rs4148323,,,UGT1A1,Dosage,-1,warfarin,1448431527.0,East Asian
769169443,PA166154338,rs1800169,,,CNTF,Efficacy,1,iloperidone,769169446.0,"Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients"
769169443,PA166154338,rs1800169,,,CNTF,Efficacy,1,iloperidone,769169450.0,"Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients"
769169443,PA166154338,rs1800169,,,CNTF,Efficacy,1,iloperidone,769169448.0,"Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients"
769169443,PA166154338,rs1800169,,,ZFP91-CNTF,Efficacy,1,iloperidone,769169446.0,"Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients"
769169443,PA166154338,rs1800169,,,ZFP91-CNTF,Efficacy,1,iloperidone,769169450.0,"Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients"
769169443,PA166154338,rs1800169,,,ZFP91-CNTF,Efficacy,1,iloperidone,769169448.0,"Multiple groups, The three ethnic/racial groups with the largest number of genotyped patients were blacks (n = 211, 50.6%), whites (n = 143, 34.3%) and Asians (n = 39, 9.4%). Additional ethnic/racial groups that included American Indians, Native Alaskans, Native Hawaiians, Pacific Islanders or others, contained only 24 (5.7%) genotyped patients"
1184756472,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756483.0,East Asian
1184756472,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756483.0,East Asian
1184756472,,,PA165971597,CYP2D6*44,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756483.0,East Asian
1447677865,PA166155072,rs4889606,,,STX1B,Dosage,1,warfarin,1447677868.0,European
1447677865,PA166155072,rs4889606,,,STX1B,Dosage,1,warfarin,1447677869.0,Near Eastern
1448431519,PA166155607,rs887829,,,UGT1A1,Dosage,1,warfarin,1448431521.0,East Asian
1448431513,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448431515.0,East Asian
1448267671,PA166155915,rs1127354,,,ITPA,Metabolism/PK,1,azathioprine,1448267677.0,East Asian
1448267671,PA166155915,rs1127354,,,ITPA,Metabolism/PK,1,mercaptopurine,1448267677.0,East Asian
827862175,PA166157316,rs2032582,,,ABCB1,Efficacy,1,atorvastatin,827862189.0,Multiple groups
1451148002,PA166156059,rs933271,,,COMT,Efficacy,1,methadone,1451148007.0,East Asian
1184510725,PA166157262,rs712829,,,EGFR,Efficacy,-1,cetuximab,1184510733.0,Unknown
1184510725,PA166157262,rs712829,,,EGFR,Efficacy,-1,panitumumab,1184510733.0,Unknown
1448431507,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1448431509.0,East Asian
1446907760,PA166154000,rs2229935,,,NRP1,Efficacy,-1,ranibizumab,1446907762.0,Unknown
1184510737,PA166157331,rs2227983,,,EGFR,Efficacy,-1,cetuximab,1184510739.0,Unknown
1184510737,PA166157331,rs2227983,,,EGFR,Efficacy,-1,panitumumab,1184510739.0,Unknown
769169412,PA166153748,rs3753380,,,PTGFR,Efficacy,1,latanoprost,769169415.0,East Asian
1184510741,PA166156600,rs6533485,,,EGF,Efficacy,-1,cetuximab,1184510743.0,Unknown
1184510741,PA166156600,rs6533485,,,EGF,Efficacy,-1,panitumumab,1184510743.0,Unknown
1446907768,PA166154005,rs2247383,,,NRP1,Efficacy,-1,ranibizumab,1446907770.0,Unknown
1447677830,PA166157792,rs7856096,,,FPGS,Dosage,-1,warfarin,1447677832.0,European
1447677830,PA166157792,rs7856096,,,FPGS,Dosage,-1,warfarin,1447677833.0,Near Eastern
1450984121,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,atazanavir,1450984125.0,"Multiple groups, White, African-American"
1184510749,PA166156597,rs4698803,,,EGF,Efficacy,-1,cetuximab,1184510751.0,Unknown
1184510749,PA166156597,rs4698803,,,EGF,Efficacy,-1,panitumumab,1184510751.0,Unknown
827845755,PA166156582,rs4148157,,,ABCG2,Efficacy,-1,antiepileptics,827845760.0,East Asian
1184510753,PA166156588,rs4444903,,,EGF,Efficacy,-1,cetuximab,1184510755.0,Unknown
1184510753,PA166156588,rs4444903,,,EGF,Efficacy,-1,panitumumab,1184510755.0,Unknown
1184510753,PA166156588,rs4444903,,,EGF,Efficacy,-1,panitumumab,1184510755.0,Unknown
1446907775,PA166154022,rs2804495,,,NRP1,Efficacy,-1,ranibizumab,1446907777.0,Unknown
1448431482,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1448431506.0,East Asian
827812982,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,indacaterol,827812989.0,"Multiple groups, Mostly Caucasian, some Black, Asian, Other"
1184510757,PA166156645,rs11568972,,,EGF,Efficacy,-1,cetuximab,1184510759.0,Unknown
1184510757,PA166156645,rs11568972,,,EGF,Efficacy,-1,panitumumab,1184510759.0,Unknown
827845746,PA166156545,rs2231148,,,ABCG2,Efficacy,-1,antiepileptics,827845751.0,East Asian
1184756523,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756525.0,East Asian
1184756523,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756525.0,East Asian
1184756523,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756525.0,East Asian
1184756523,,,PA165988484,CYP2D6*21,CYP2D6,Metabolism/PK,0,dextromethorphan,1184756525.0,East Asian
1184510761,PA166156495,rs929446,,,EGF,Efficacy,-1,cetuximab,1184510763.0,Unknown
1184510761,PA166156495,rs929446,,,EGF,Efficacy,-1,panitumumab,1184510763.0,Unknown
1447677818,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1447677828.0,Near Eastern
1447677818,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1447677826.0,European
827812974,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,indacaterol,827812981.0,"Multiple groups, Mostly Caucasian, some Black, Asian, Other"
1446907782,PA166156820,rs3846662,,,HMGCR,Efficacy,1,hmg coa reductase inhibitors,1446907797.0,Unknown
1448821487,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,tenofovir,1448821493.0,"Multiple groups, Majority African American (n=55)"
827845737,PA166156562,rs2622628,,,ABCG2,Efficacy,-1,antiepileptics,827845742.0,East Asian
1450984205,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,atazanavir,1450984220.0,"Multiple groups, White, African-American"
1184985784,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,bupropion,1184985799.0,Multiple groups
1184985784,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,bupropion,1184985799.0,Multiple groups
1184510640,PA166156656,rs11942466,,,AREG,Efficacy,1,cetuximab,1184510642.0,Unknown
1184510640,PA166156656,rs11942466,,,AREG,Efficacy,1,panitumumab,1184510642.0,Unknown
1184510644,PA166156635,rs9996584,,,AREG,Efficacy,1,cetuximab,1184510646.0,Unknown
1184510644,PA166156635,rs9996584,,,AREG,Efficacy,1,panitumumab,1184510646.0,Unknown
1446907736,PA166155304,rs7231887,,,TNFRSF11A,Efficacy,-1,alendronate,1446907742.0,East Asian
827845728,PA166156566,rs2725256,,,ABCG2,Efficacy,-1,antiepileptics,827845733.0,East Asian
1184510648,PA166156509,rs1353295,,,AREG,Efficacy,1,cetuximab,1184510650.0,Unknown
1184510648,PA166156509,rs1353295,,,AREG,Efficacy,1,panitumumab,1184510650.0,Unknown
769169373,PA166156932,rs622342,,,SLC22A1,Efficacy,1,metformin,769169375.0,European
1449181943,PA166177727,rs8636,,,SNAP25,Efficacy,1,amisulpride,1449181973.0,East Asian
1449181943,PA166177727,rs8636,,,SNAP25,Efficacy,1,amisulpride,1449181975.0,East Asian
981755665,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,981755677.0,European
981755665,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,981755673.0,European
981755665,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,981755675.0,European
1446907744,PA166153991,rs2070296,,,NRP1,Efficacy,1,ranibizumab,1446907752.0,Unknown
769169370,PA166156932,rs622342,,,SLC22A1,Efficacy,-1,metformin,769169372.0,European
769169367,PA166156932,rs622342,,,SLC22A1,Efficacy,-1,metformin,769169369.0,European
981755678,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,981755686.0,"Multiple groups, 98% non-Hispanic or White"
1449001719,PA166170568,rs11942223,,,SLC2A9,Efficacy,-1,furosemide,1449001724.0,"Multiple groups, Maori, other Pacific Islander, and Caucasian"
1449001719,PA166170568,rs11942223,,,SLC2A9,Efficacy,-1,furosemide,1449001747.0,"Multiple groups, Maori and Pacific Islander, and Caucasian"
1451115303,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lopinavir,1451115320.0,European
1450361636,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,fluvastatin,1450361641.0,Unknown
827845705,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,antiepileptics,827845722.0,East Asian
1451148012,PA166156056,rs737866,,,COMT,Efficacy,-1,methadone,1451148060.0,East Asian
1450361642,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,fluvastatin,1450361647.0,Unknown
1446907707,PA166155433,rs7254579,,,CYP2B6,Metabolism/PK,1,cyclophosphamide,1446907709.0,East Asian
1450820343,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1450820349.0,Unknown
1450820343,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1450820349.0,Unknown
1451148020,PA166156024,rs4680,,,COMT,Efficacy,-1,methadone,1451148011.0,East Asian
1184985811,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,bupropion,1184985813.0,Multiple groups
1184985811,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,bupropion,1184985813.0,Multiple groups
1446907702,PA166155281,rs1805034,,,TNFRSF11A,Efficacy,-1,alendronate,1446907713.0,East Asian
1449001754,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1449001762.0,East Asian
1449001754,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,1449001760.0,East Asian
1446907715,PA166155309,rs8083511,,,TNFRSF11A,Efficacy,-1,alendronate,1446907726.0,East Asian
1444843357,PA166154991,rs246240,,,ABCC1,Efficacy,1,methotrexate,1444843360.0,Multiple groups
827845684,PA166156674,rs17731538,,,ABCG2,Efficacy,-1,antiepileptics,827845692.0,East Asian
1184985821,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,bupropion,1184985832.0,African American/Afro-Caribbean
1184985821,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,bupropion,1184985832.0,African American/Afro-Caribbean
1184985821,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,bupropion,1184985832.0,African American/Afro-Caribbean
1447677749,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1447677751.0,East Asian
1447677749,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,haloperidol,1447677751.0,East Asian
827698232,PA166153643,rs1801131,,,MTHFR,Dosage,-1,methotrexate,827698240.0,Unknown
1446907717,PA166156454,rs13059232,,,NR1I2,Metabolism/PK,-1,cyclophosphamide,1446907719.0,East Asian
1446907717,PA166156454,rs13059232,,,NR1I2,Metabolism/PK,-1,cyclophosphamide,1446907719.0,East Asian
1444843366,PA166155054,rs3784864,,,ABCC1,Efficacy,1,methotrexate,1444843368.0,Multiple groups
827566630,PA166156549,rs2276332,,,ADH1A,Toxicity,1,ethanol,827566636.0,European
827566630,PA166156549,rs2276332,,,ADH1A,Metabolism/PK,1,ethanol,827566636.0,European
1446907665,PA166155306,rs7239261,,,TNFRSF11A,Efficacy,-1,alendronate,1446907671.0,East Asian
1450984200,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,atazanavir,1450984204.0,"Multiple groups, White, African-American"
769250992,PA166155437,rs8103142,,,IFNL3,Efficacy,1,peginterferon alfa-2a,769251009.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769250992,PA166155437,rs8103142,,,IFNL3,Efficacy,1,peginterferon alfa-2b,769251009.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769250992,PA166155437,rs8103142,,,IFNL3,Efficacy,1,ribavirin,769251009.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
827566623,PA166156506,rs1229976,,,ADH1A,Toxicity,1,ethanol,827566629.0,European
827566623,PA166156506,rs1229976,,,ADH1A,Metabolism/PK,1,ethanol,827566629.0,European
769250998,PA166155479,rs28416813,,,IFNL3,Efficacy,1,peginterferon alfa-2a,769251007.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769250998,PA166155479,rs28416813,,,IFNL3,Efficacy,1,peginterferon alfa-2b,769251007.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
769250998,PA166155479,rs28416813,,,IFNL3,Efficacy,1,ribavirin,769251007.0,"Multiple groups, European-Americans: 871; African-Americans: 191; Hispanics: 75."
1450361662,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,fluvastatin,1450361675.0,Unknown
1450361662,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,fluvastatin,1450361675.0,Unknown
1450361662,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,fluvastatin,1450361675.0,Unknown
1447677736,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1447677748.0,East Asian
1447677736,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,haloperidol,1447677748.0,East Asian
1043818234,PA166155091,rs9923231,,,VKORC1,Dosage,1,phenprocoumon,1043818249.0,European
1446907679,PA166155292,rs3826619,,,TNFRSF11A,Efficacy,-1,alendronate,1446907697.0,East Asian
827566611,PA166156504,rs1154461,,,ADH7,Toxicity,1,ethanol,827566617.0,European
827566611,PA166156504,rs1154461,,,ADH7,Metabolism/PK,1,ethanol,827566617.0,European
1446907684,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,cyclophosphamide,1446907686.0,East Asian
1448821568,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448821584.0,East Asian
1449165643,PA166176908,rs237025,,,SUMO4,Metabolism/PK,1,tacrolimus,1449165649.0,Unknown
1449165643,PA166176908,rs237025,,,SUMO4,Metabolism/PK,1,tacrolimus,1449165665.0,Unknown
1449165650,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cyclosporine,1449165672.0,Unknown
1449165650,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cyclosporine,1449165672.0,Unknown
827845129,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,antiepileptics,827845135.0,East Asian
827845123,PA166156570,rs3109823,,,ABCG2,Efficacy,-1,antiepileptics,827845128.0,East Asian
1185002388,PA166156353,rs2291078,,,UMPS,Efficacy,-1,capecitabine,1185002396.0,East Asian
1185002388,PA166156353,rs2291078,,,UMPS,Efficacy,-1,fluorouracil,1185002396.0,East Asian
982034232,PA166155096,rs9934438,,,VKORC1,Dosage,0,warfarin,,
1444712210,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1444712210,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712212.0,"Multiple groups, mostly White"
1450951476,PA166153760,rs3918290,,,DPYD,Efficacy,1,cisplatin,1450951496.0,Central/South Asian
1450951476,PA166153760,rs3918290,,,DPYD,Efficacy,1,fluorouracil,1450951496.0,Central/South Asian
1184510873,,,PA166115845,UGT1A1*60,UGT1A1,Efficacy,1,irinotecan,1184510879.0,Unknown
1184510873,,,PA166115845,UGT1A1*60,UGT1A1,Efficacy,1,oxaliplatin,1184510879.0,Unknown
1184510873,,,PA166115845,UGT1A1*60,UGT1A1,Efficacy,1,tegafur / gimeracil / oteracil,1184510879.0,Unknown
1184756628,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756663.0,East Asian
1184756628,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756663.0,East Asian
1444843284,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,0,sulfasalazine,1444843305.0,East Asian
1446907636,PA166155415,rs4802101,,,CYP2B6,Metabolism/PK,1,cyclophosphamide,1446907638.0,East Asian
827845117,PA166156675,rs17731799,,,ABCG2,Efficacy,-1,antiepileptics,827845122.0,East Asian
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449146810.0,East Asian
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449146808.0,East Asian
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449001822.0,European
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,tipiracil hydrochloride,1449001820.0,European
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,trifluridine,1449146810.0,East Asian
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,trifluridine,1449146808.0,East Asian
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,trifluridine,1449001822.0,European
1449001814,PA166156947,rs760370,,,SLC29A1,Efficacy,1,trifluridine,1449001820.0,European
827845112,PA166156573,rs3219191,,,ABCG2,Efficacy,-1,antiepileptics,827845116.0,East Asian
1444695840,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,1444695851.0,African American/Afro-Caribbean
1444695840,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,1,warfarin,1444695851.0,African American/Afro-Caribbean
827845107,PA166156572,rs3114020,,,ABCG2,Efficacy,-1,antiepileptics,827845111.0,East Asian
982034243,PA166154977,rs7294,,,VKORC1,Dosage,0,warfarin,,
1444843306,PA166156694,rs72552713,,,ABCG2,Metabolism/PK,0,sulfasalazine,1444843308.0,East Asian
1448267502,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1448267504.0,Multiple groups
1448267502,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448267504.0,Multiple groups
1449165670,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449165677.0,Unknown
1449165670,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449165690.0,Unknown
1449165670,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449165766.0,Unknown
1449165670,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449165768.0,Unknown
1184510765,PA166156538,rs2074390,,,EGF,Efficacy,-1,cetuximab,1184510767.0,Unknown
1184510765,PA166156538,rs2074390,,,EGF,Efficacy,-1,panitumumab,1184510767.0,Unknown
1450820493,PA166153757,rs3845446,,,CACNA1E,Dosage,1,fentanyl,1450820498.0,Unknown
1184510769,PA166156615,rs6850557,,,EGF,Efficacy,-1,cetuximab,1184510771.0,Unknown
1184510769,PA166156615,rs6850557,,,EGF,Efficacy,-1,panitumumab,1184510771.0,Unknown
1449165678,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,0,cyclosporine,1449165680.0,Unknown
1448267496,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1448267501.0,Multiple groups
1184985914,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1184985917.0,European
1184985914,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1184985916.0,European
1184985914,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1184985917.0,European
1184985914,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1184985916.0,European
1184985914,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1184985917.0,European
1184985914,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1184985916.0,European
1184985914,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1184985917.0,European
1184985914,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1184985916.0,European
769168996,PA166154275,rs533556,,,SIK3,Efficacy,1,hmg coa reductase inhibitors,769168999.0,Unknown
769168996,PA166154275,rs533556,,,SIK3,Efficacy,1,hmg coa reductase inhibitors,769169001.0,Unknown
1184510773,PA166156581,rs3913032,,,AREG,Efficacy,-1,cetuximab,1184510775.0,Unknown
1184510773,PA166156581,rs3913032,,,AREG,Efficacy,-1,panitumumab,1184510775.0,Unknown
1184510777,PA166156599,rs6447003,,,AREG,Efficacy,-1,cetuximab,1184510779.0,Unknown
1184510777,PA166156599,rs6447003,,,AREG,Efficacy,-1,panitumumab,1184510779.0,Unknown
769168989,PA166155015,rs1532624,,,CETP,Efficacy,1,hmg coa reductase inhibitors,769168992.0,Unknown
769168989,PA166155015,rs1532624,,,CETP,Efficacy,1,hmg coa reductase inhibitors,769168994.0,Unknown
1184510781,PA166156641,rs10034692,,,AREG,Efficacy,-1,cetuximab,1184510783.0,Unknown
1184510781,PA166156641,rs10034692,,,AREG,Efficacy,-1,panitumumab,1184510783.0,Unknown
1444712127,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
1444712127,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1444712129.0,"Multiple groups, mostly White"
769168986,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,antipsychotics,769168988.0,"Multiple groups, China, Germany, Japan, USA, Korea, Taiwan"
769168983,PA166154334,rs1799732,,,DRD2,Efficacy,1,antipsychotics,769168985.0,"Multiple groups, China, Germany, Japan, USA, Korea, Taiwan"
1184510785,PA166156650,rs11725706,,,AREG,Efficacy,-1,cetuximab,1184510787.0,Unknown
1184510785,PA166156650,rs11725706,,,AREG,Efficacy,-1,panitumumab,1184510787.0,Unknown
1185002313,PA166155131,rs55894764,,,VKORC1,Dosage,1,acenocoumarol,1185002318.0,European
1449165693,PA166157286,rs1057868,,,POR,Metabolism/PK,1,cyclosporine,1449165695.0,Unknown
827845075,PA166156302,rs1000002,,,ABCC5,Efficacy,-1,antiepileptics,827845079.0,East Asian
1184510789,PA166156539,rs2132065,,,AREG,Efficacy,-1,cetuximab,1184510791.0,Unknown
1184510789,PA166156539,rs2132065,,,AREG,Efficacy,-1,panitumumab,1184510791.0,Unknown
1184134029,,,PA165819268,TPMT*1,TPMT,Dosage,0,azathioprine,1184134060.0,European
1184134029,,,PA165819269,TPMT*2,TPMT,Dosage,0,azathioprine,1184134060.0,European
1184134029,,,PA165819270,TPMT*3A,TPMT,Dosage,0,azathioprine,1184134060.0,European
1184134029,,,PA165819271,TPMT*3B,TPMT,Dosage,0,azathioprine,1184134060.0,European
1184134029,,,PA165819272,TPMT*3C,TPMT,Dosage,0,azathioprine,1184134060.0,European
1184134029,,,PA165819268,TPMT*1,TPMT,Dosage,0,mercaptopurine,1184134060.0,European
1184134029,,,PA165819269,TPMT*2,TPMT,Dosage,0,mercaptopurine,1184134060.0,European
1184134029,,,PA165819270,TPMT*3A,TPMT,Dosage,0,mercaptopurine,1184134060.0,European
1184134029,,,PA165819271,TPMT*3B,TPMT,Dosage,0,mercaptopurine,1184134060.0,European
1184134029,,,PA165819272,TPMT*3C,TPMT,Dosage,0,mercaptopurine,1184134060.0,European
1184134029,,,PA165819268,TPMT*1,TPMT,Dosage,0,purine analogues,1184134060.0,European
1184134029,,,PA165819269,TPMT*2,TPMT,Dosage,0,purine analogues,1184134060.0,European
1184134029,,,PA165819270,TPMT*3A,TPMT,Dosage,0,purine analogues,1184134060.0,European
1184134029,,,PA165819271,TPMT*3B,TPMT,Dosage,0,purine analogues,1184134060.0,European
1184134029,,,PA165819272,TPMT*3C,TPMT,Dosage,0,purine analogues,1184134060.0,European
1184510793,PA166156498,rs1017733,,,EREG,Efficacy,-1,cetuximab,1184510795.0,Unknown
1184510793,PA166156498,rs1017733,,,EREG,Efficacy,-1,panitumumab,1184510795.0,Unknown
1446907621,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,cyclophosphamide,1446907631.0,East Asian
981477286,PA166155022,rs1805010,,,IL4R,Efficacy,1,pitrakinra,981477296.0,European
827845069,PA166156427,rs8180093,,,ABCC5,Efficacy,-1,antiepileptics,827845074.0,East Asian
982034333,PA166153654,rs1805087,,,MTR,Efficacy,1,benazepril,982034348.0,East Asian
1184510797,PA166156631,rs7687621,,,EREG,Efficacy,-1,cetuximab,1184510799.0,Unknown
1184510797,PA166156631,rs7687621,,,EREG,Efficacy,-1,panitumumab,1184510799.0,Unknown
1446907570,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,simvastatin,1446907579.0,East Asian
1446907570,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,simvastatin,1446907579.0,East Asian
827845063,PA166156344,rs2139560,,,ABCC5,Efficacy,-1,antiepileptics,827845068.0,East Asian
1448267466,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448267483.0,Multiple groups
1448267466,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448267483.0,Multiple groups
1448267453,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,tacrolimus,1448267461.0,"Multiple groups, Netherlands"
981477242,PA166154978,rs8832,,,IL4R,Efficacy,1,pitrakinra,981477268.0,European
981477242,PA166154978,rs8832,,,IL4R,Efficacy,1,pitrakinra,981477753.0,European
981477242,PA166154978,rs8832,,,IL4R,Efficacy,1,pitrakinra,981477755.0,European
981477242,PA166154978,rs8832,,,IL4R,Efficacy,1,pitrakinra,981477249.0,European
981477242,PA166154978,rs8832,,,IL4R,Efficacy,1,pitrakinra,981477254.0,European
827845057,PA166156382,rs3805111,,,ABCC5,Efficacy,-1,antiepileptics,827845062.0,East Asian
1450820473,PA166156991,rs1799971,,,OPRM1,Efficacy,0,ethanol,1450820478.0,"Multiple groups, Caucasian and African American participants"
769168957,PA166155805,rs11676382,,,GGCX,Dosage,1,warfarin,769168961.0,"Multiple groups, predominantly white"
827845051,PA166156381,rs3792581,,,ABCC5,Efficacy,-1,antiepileptics,827845056.0,East Asian
1446907580,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1446907601.0,East Asian
827845045,PA166156355,rs2293001,,,ABCC5,Efficacy,-1,antiepileptics,827845050.0,East Asian
1450984320,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,atazanavir,1450984340.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450984320,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,atazanavir,1450984360.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
827566510,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,827566512.0,European
827566510,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,codeine,827566512.0,European
827566510,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,codeine,827566512.0,European
981739388,PA166155267,rs292449,,,NEDD4L,Efficacy,1,hydrochlorothiazide,981739401.0,European
827566514,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,827566516.0,European
827566514,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,codeine,827566516.0,European
827566514,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,codeine,827566516.0,European
827566514,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,codeine,827566516.0,European
827566514,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,codeine,827566516.0,European
827845039,PA166156355,rs2293001,,,ABCC5,Efficacy,-1,antiepileptics,827845044.0,East Asian
1447677624,PA166153760,rs3918290,,,DPYD,Toxicity,-1,capecitabine,1447989295.0,Unknown
1450951563,PA166153645,rs1801158,,,DPYD,Efficacy,-1,cisplatin,1450951568.0,Central/South Asian
1450951563,PA166153645,rs1801158,,,DPYD,Efficacy,-1,fluorouracil,1450951568.0,Central/South Asian
1184985954,PA166154768,rs861539,,,XRCC3,Efficacy,1,cisplatin,1184985959.0,Unknown
1184985954,PA166154768,rs861539,,,XRCC3,Efficacy,1,docetaxel,1184985959.0,Unknown
1184985954,PA166154768,rs861539,,,XRCC3,Efficacy,1,irinotecan,1184985959.0,Unknown
827566502,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,827566504.0,European
827566502,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,codeine,827566504.0,European
827566502,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,codeine,827566504.0,European
827845032,PA166156396,rs4148572,,,ABCC5,Efficacy,-1,antiepileptics,827845038.0,East Asian
1185002489,PA166157471,rs17160359,,,ABCB1,Efficacy,0,capecitabine,1185002491.0,East Asian
1185002489,PA166157471,rs17160359,,,ABCB1,Efficacy,0,fluorouracil,1185002491.0,East Asian
827845025,PA166156395,rs4148557,,,ABCC5,Efficacy,-1,antiepileptics,827845031.0,East Asian
769250871,PA166157006,rs2010963,,,VEGFA,Efficacy,1,capecitabine,769250881.0,European
769250871,PA166157006,rs2010963,,,VEGFA,Efficacy,1,oxaliplatin,769250881.0,European
769250871,PA166157006,rs2010963,,,VEGFA,Efficacy,1,oxaliplatin,769250881.0,European
769250871,PA166157006,rs2010963,,,VEGFA,Efficacy,1,oxaliplatin,769250881.0,European
1184510958,,,PA165924731,CYP2A6*7,CYP2A6,Efficacy,1,irinotecan,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,irinotecan,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,irinotecan,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,irinotecan,1184510960.0,Unknown
1184510958,,,PA165924731,CYP2A6*7,CYP2A6,Efficacy,1,oxaliplatin,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,oxaliplatin,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,oxaliplatin,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,oxaliplatin,1184510960.0,Unknown
1184510958,,,PA165924731,CYP2A6*7,CYP2A6,Efficacy,1,tegafur / gimeracil / oteracil,1184510960.0,Unknown
1184510958,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,1,tegafur / gimeracil / oteracil,1184510960.0,Unknown
1450935251,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,0,ibuprofen,1450935256.0,European
1450935251,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,0,ibuprofen,1450935256.0,European
982034384,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,benazepril,982034395.0,East Asian
1185002481,PA166154880,rs2236722,,,CYP19A1,Efficacy,0,capecitabine,1185002483.0,East Asian
1185002481,PA166154880,rs2236722,,,CYP19A1,Efficacy,0,fluorouracil,1185002483.0,East Asian
827566496,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,827566499.0,European
827566496,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,codeine,827566499.0,European
827566496,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,codeine,827566499.0,European
1184510970,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,donepezil,1184511016.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184510970,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,donepezil,1184511016.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1450935257,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,ibuprofen,1450935262.0,European
1450935257,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,0,ibuprofen,1450935262.0,European
1450935257,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,ibuprofen,1450935262.0,European
1184986118,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1184986124.0,European
1184986118,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,0,debrisoquine,1184986124.0,European
1184756733,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1184756744.0,African American/Afro-Caribbean
1184756733,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,0,debrisoquine,1184756744.0,African American/Afro-Caribbean
1043818101,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,1043818104.0,European
1043818101,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,1043818103.0,European
1043818101,PA166155096,rs9934438,,,VKORC1,Dosage,1,phenprocoumon,1043818104.0,European
1043818101,PA166155096,rs9934438,,,VKORC1,Dosage,1,phenprocoumon,1043818103.0,European
827812238,PA166157864,rs1734791,,,MECP2,Efficacy,1,cisplatin,827812245.0,Unknown
827812238,PA166157864,rs1734791,,,MECP2,Efficacy,1,fluorouracil,827812245.0,Unknown
827812238,PA166157864,rs1734791,,,MECP2,Efficacy,1,mitoxantrone,827812245.0,Unknown
769250889,PA166154339,rs1800497,,,ANKK1,Efficacy,1,aripiprazole,769250898.0,East Asian
769250889,PA166154339,rs1800497,,,ANKK1,Efficacy,1,aripiprazole,827832231.0,East Asian
981477298,PA166155035,rs2239347,,,IL4R,Efficacy,1,pitrakinra,981477304.0,European
1184756755,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1184756762.0,European
1184756755,,,PA165971592,CYP2D6*38,CYP2D6,Metabolism/PK,0,debrisoquine,1184756762.0,European
827845000,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,antiepileptics,827845006.0,East Asian
982034360,PA166154486,rs5443,,,GNB3,Efficacy,-1,clonidine,982034369.0,Unknown
982034360,PA166154486,rs5443,,,GNB3,Efficacy,-1,clonidine,982034367.0,Unknown
982034360,PA166154486,rs5443,,,GNB3,Efficacy,-1,clonidine,982034373.0,Unknown
982034360,PA166154486,rs5443,,,GNB3,Efficacy,-1,clonidine,982034371.0,Unknown
827812230,PA166157863,rs1734787,,,MECP2,Efficacy,1,cisplatin,827812237.0,Unknown
827812230,PA166157863,rs1734787,,,MECP2,Efficacy,1,fluorouracil,827812237.0,Unknown
827812230,PA166157863,rs1734787,,,MECP2,Efficacy,1,mitoxantrone,827812237.0,Unknown
827812230,PA166157863,rs1734787,,,MECP2,Efficacy,1,mitoxantrone,827812237.0,Unknown
1184134089,,,PA165819268,TPMT*1,TPMT,Dosage,1,azathioprine,1184134099.0,European
1184134089,,,PA165819269,TPMT*2,TPMT,Dosage,1,azathioprine,1184134099.0,European
1184134089,,,PA165819270,TPMT*3A,TPMT,Dosage,1,azathioprine,1184134099.0,European
1184134089,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1184134099.0,European
1184134089,,,PA165819269,TPMT*2,TPMT,Dosage,1,mercaptopurine,1184134099.0,European
1184134089,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1184134099.0,European
1184134089,,,PA165819268,TPMT*1,TPMT,Dosage,1,purine analogues,1184134099.0,European
1184134089,,,PA165819269,TPMT*2,TPMT,Dosage,1,purine analogues,1184134099.0,European
1184134089,,,PA165819270,TPMT*3A,TPMT,Dosage,1,purine analogues,1184134099.0,European
769250900,PA166154261,rs6277,,,DRD2,Efficacy,1,aripiprazole,769250904.0,East Asian
769250900,PA166154261,rs6277,,,DRD2,Efficacy,1,aripiprazole,827832229.0,East Asian
981477306,PA166155004,rs1029489,,,IL4R,Efficacy,1,pitrakinra,981477757.0,European
981477306,PA166155004,rs1029489,,,IL4R,Efficacy,1,pitrakinra,981477310.0,European
827844993,PA166154031,rs3758395,,,ABCC2,Efficacy,-1,antiepileptics,827844999.0,East Asian
982034351,PA166153654,rs1805087,,,MTR,Efficacy,-1,benazepril,982034359.0,East Asian
827812222,PA166157850,rs17435,,,MECP2,Efficacy,1,cisplatin,827812229.0,Unknown
827812222,PA166157850,rs17435,,,MECP2,Efficacy,1,fluorouracil,827812229.0,Unknown
827812222,PA166157850,rs17435,,,MECP2,Efficacy,1,mitoxantrone,827812229.0,Unknown
827812222,PA166157850,rs17435,,,MECP2,Efficacy,1,mitoxantrone,827812229.0,Unknown
769169148,PA166154260,rs6275,,,DRD2,,1,methadone,769169152.0,European
769169148,PA166154260,rs6275,,,DRD2,,1,methadone,769169150.0,European
769250907,PA166154334,rs1799732,,,DRD2,Efficacy,-1,aripiprazole,769250909.0,East Asian
769250907,PA166154334,rs1799732,,,DRD2,Efficacy,-1,aripiprazole,769250909.0,East Asian
769250907,PA166154334,rs1799732,,,DRD2,Efficacy,-1,aripiprazole,769250909.0,East Asian
769250907,PA166154334,rs1799732,,,DRD2,Efficacy,-1,aripiprazole,769250909.0,East Asian
1451099074,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,fentanyl,1451099100.0,Unknown
1451099074,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,fentanyl,1451099100.0,Unknown
982034374,PA166153644,rs1801133,,,MTHFR,Efficacy,1,benazepril,982034383.0,East Asian
827812210,PA166157884,rs5934731,,,None,Efficacy,1,cisplatin,827812216.0,Unknown
827812210,PA166157884,rs5934731,,,None,Efficacy,1,fluorouracil,827812216.0,Unknown
827812210,PA166157884,rs5934731,,,None,Efficacy,1,mitoxantrone,827812216.0,Unknown
1184986142,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
1184986142,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
1184986142,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
1184986142,,,PA166123456,CYP2D6*10x2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
1184986142,,,PA166123456,CYP2D6*10x2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
1184986142,,,PA166123456,CYP2D6*10x2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
1184986142,,,PA166123456,CYP2D6*10x2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184986157.0,East Asian
827844971,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,antiepileptics,827844978.0,East Asian
1445400123,PA166153696,rs2297595,,,DPYD,Metabolism/PK,1,fluorouracil,1445400129.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001980.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001974.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001978.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001976.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001980.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001974.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001978.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001976.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001980.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001974.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001978.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001976.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001980.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001974.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001978.0,Unknown
1449001968,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,atorvastatin,1449001976.0,Unknown
1444711981,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444711981,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,endoxifen,1444711983.0,"Multiple groups, mostly White"
1444695597,PA166155805,rs11676382,,,GGCX,Dosage,1,warfarin,1444695602.0,Multiple groups
1184986040,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986046.0,African American/Afro-Caribbean
1184986040,,,PA165988494,CYP2D6*56,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986046.0,African American/Afro-Caribbean
1448267368,PA166154980,rs10517,,,NQO1,Dosage,1,warfarin,1448267370.0,East Asian
1185002426,PA166155234,rs8071253,,,TK1,Efficacy,-1,capecitabine,,
1185002426,PA166155234,rs8071253,,,TK1,Efficacy,-1,fluorouracil,,
1185002426,PA166155234,rs8071253,,,TK1,Efficacy,-1,fluorouracil,,
1185002426,PA166155234,rs8071253,,,TK1,Efficacy,-1,fluorouracil,,
1185002426,PA166155234,rs8071253,,,TK1,Efficacy,-1,fluorouracil,,
1185002413,PA166157075,rs3218592,,,REV3L,Efficacy,-1,capecitabine,1185002421.0,East Asian
1185002413,PA166157075,rs3218592,,,REV3L,Efficacy,-1,capecitabine,1185002425.0,East Asian
1185002413,PA166157075,rs3218592,,,REV3L,Efficacy,-1,fluorouracil,1185002421.0,East Asian
1185002413,PA166157075,rs3218592,,,REV3L,Efficacy,-1,fluorouracil,1185002425.0,East Asian
1449165818,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449165820.0,East Asian
1449165818,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449165820.0,East Asian
1184756664,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184756666.0,East Asian
1184756664,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184756666.0,East Asian
1444695604,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444695606.0,Multiple groups
1444695604,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444695606.0,Multiple groups
1444695604,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444695606.0,Multiple groups
1444695604,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444695606.0,Multiple groups
1185002437,PA166155270,rs501415,,,WDR7,Efficacy,-1,capecitabine,,
1185002437,PA166155270,rs501415,,,WDR7,Efficacy,-1,fluorouracil,,
769169111,PA166156544,rs2231142,,,ABCG2,Other,1,imatinib,769169113.0,Unknown
769169111,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,imatinib,769169113.0,Unknown
1184986056,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986062.0,African American/Afro-Caribbean
1184986056,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986062.0,African American/Afro-Caribbean
1445400112,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,phenytoin,1445400114.0,Latino
1449001981,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,atorvastatin,1449001984.0,Unknown
1449001981,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,atorvastatin,1449001983.0,Unknown
1449001981,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,atorvastatin,1449001985.0,Unknown
1449001981,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,atorvastatin,1449001986.0,Unknown
1450984482,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,atazanavir,1450984486.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450984482,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,atazanavir,1450984487.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
827812178,PA166155818,rs12613732,,,GALNT14,Efficacy,1,cisplatin,827812183.0,Unknown
827812178,PA166155818,rs12613732,,,GALNT14,Efficacy,1,fluorouracil,827812183.0,Unknown
827812178,PA166155818,rs12613732,,,GALNT14,Efficacy,1,mitoxantrone,827812183.0,Unknown
1445400130,PA166153760,rs3918290,,,DPYD,Metabolism/PK,1,fluorouracil,1445400132.0,Unknown
1449165830,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449165836.0,East Asian
1448267343,PA166160869,rs72800847,,,STX1B,Dosage,1,warfarin,1448267345.0,East Asian
1448496718,PA166155620,rs1056827,,,CYP1B1,Metabolism/PK,-1,exemestane,1448496720.0,Multiple groups
1184986069,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986083.0,Latino
1184986069,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986083.0,Latino
827812166,PA166155758,rs6752303,,,GALNT14,Efficacy,1,cisplatin,827812171.0,Unknown
827812166,PA166155758,rs6752303,,,GALNT14,Efficacy,1,fluorouracil,827812171.0,Unknown
827812166,PA166155758,rs6752303,,,GALNT14,Efficacy,1,mitoxantrone,827812171.0,Unknown
1184756685,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,metoprolol,1184756691.0,Unknown
1184756685,,,PA165971582,CYP2D6*31,CYP2D6,Metabolism/PK,0,metoprolol,1184756691.0,Unknown
1448267332,PA166160867,rs3826041,,,CYP1A1,Dosage,1,warfarin,1448267334.0,East Asian
769250961,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,doxorubicin,769250972.0,Unknown
1447677505,PA166155340,rs5925,,,LDLR,Efficacy,-1,atorvastatin,1447677514.0,American
1449001996,PA166155860,rs28898617,,,UGT1A10,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A3,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A4,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A5,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A6,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A7,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A8,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1449001996,PA166155860,rs28898617,,,UGT1A9,Metabolism/PK,1,valproic acid,1449002003.0,East Asian
1185002444,PA166154010,rs2289310,,,DLG5,Efficacy,0,capecitabine,1185002456.0,East Asian
1185002444,PA166154010,rs2289310,,,DLG5,Efficacy,0,fluorouracil,1185002456.0,East Asian
1444712023,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165988487,CYP2D6*35,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1444712023,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444712025.0,"Multiple groups, mostly White"
1449165851,PA166156387,rs3842689,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449165853.0,East Asian
1184510932,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,irinotecan,1184510938.0,Unknown
1184510932,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,oxaliplatin,1184510938.0,Unknown
1184510932,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,tegafur / gimeracil / oteracil,1184510938.0,Unknown
827812160,PA166155784,rs10209881,,,GALNT14,Efficacy,1,cisplatin,827812165.0,Unknown
827812160,PA166155784,rs10209881,,,GALNT14,Efficacy,1,fluorouracil,827812165.0,Unknown
827812160,PA166155784,rs10209881,,,GALNT14,Efficacy,1,mitoxantrone,827812165.0,Unknown
1445400142,PA166153647,rs1801160,,,DPYD,Metabolism/PK,1,fluorouracil,1445400144.0,Unknown
1448821786,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,efavirenz,1448821788.0,East Asian
1444843105,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methotrexate,,
1449165845,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449165847.0,East Asian
827812154,PA166155824,rs12999804,,,GALNT14,Efficacy,1,cisplatin,827812159.0,Unknown
827812154,PA166155824,rs12999804,,,GALNT14,Efficacy,1,fluorouracil,827812159.0,Unknown
827812154,PA166155824,rs12999804,,,GALNT14,Efficacy,1,mitoxantrone,827812159.0,Unknown
1184986084,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986087.0,Latino
1184986084,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,dextromethorphan,1184986087.0,Latino
769250973,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,doxorubicin,769250975.0,Unknown
1184510940,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1184510942.0,Unknown
1184510940,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,oxaliplatin,1184510942.0,Unknown
1184510940,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,tegafur / gimeracil / oteracil,1184510942.0,Unknown
1444695646,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,mephenytoin,,
1444695646,,,PA165816523,CYP2C19*7,CYP2C19,Metabolism/PK,-1,mephenytoin,,
769169082,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,769169084.0,Unknown
1448821794,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,efavirenz,1448821796.0,East Asian
1185002474,PA166154164,rs17431184,,,PTEN,Efficacy,0,capecitabine,1185002476.0,East Asian
1185002474,PA166154164,rs17431184,,,PTEN,Efficacy,0,fluorouracil,1185002476.0,East Asian
1184510946,,,PA166117621,UGT1A6*2a,UGT1A6,Efficacy,-1,irinotecan,1184510948.0,Unknown
1184510946,,,PA166117621,UGT1A6*2a,UGT1A6,Efficacy,-1,oxaliplatin,1184510948.0,Unknown
1184510946,,,PA166117621,UGT1A6*2a,UGT1A6,Efficacy,-1,tegafur / gimeracil / oteracil,1184510948.0,Unknown
1448267319,PA166160865,rs2304429,,,DNMT3A,Dosage,1,warfarin,1448267326.0,East Asian
1450820613,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450820617.0,Unknown
1184756714,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184756720.0,European
1184756714,,,PA165971582,CYP2D6*31,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184756720.0,European
1184510952,,,PA166117639,UGT1A7*3,UGT1A7,Efficacy,-1,irinotecan,1184510954.0,Unknown
1184510952,,,PA166117639,UGT1A7*3,UGT1A7,Efficacy,-1,oxaliplatin,1184510954.0,Unknown
1184510952,,,PA166117639,UGT1A7*3,UGT1A7,Efficacy,-1,tegafur / gimeracil / oteracil,1184510954.0,Unknown
1185002465,PA166153609,rs1047840,,,EXO1,Efficacy,0,capecitabine,1185002467.0,East Asian
1185002465,PA166153609,rs1047840,,,EXO1,Efficacy,0,fluorouracil,1185002467.0,East Asian
1450984448,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,atazanavir,1450984460.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450984448,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,atazanavir,1450984461.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450820618,PA166154339,rs1800497,,,DRD2,Dosage,-1,ethanol,1450820622.0,Unknown
1448821806,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,lopinavir,1448821808.0,East Asian
1184511084,PA166156423,rs7643645,,,NR1I2,Metabolism/PK,-1,donepezil,1184511086.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184986233,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,sparteine,1184986235.0,European
1184986233,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,sparteine,1184986235.0,European
1184986233,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184986235.0,European
1184986233,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184986235.0,European
1184986233,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,sparteine,1184986235.0,European
1451131980,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1451131968.0,Multiple groups
1448821800,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,lopinavir,1448821802.0,East Asian
1184986221,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184986223.0,European
1184986221,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184986223.0,European
1184986221,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,sparteine,1184986223.0,European
827812640,PA166155623,rs1105879,,,UGT1A6,Dosage,1,valproic acid,827812654.0,East Asian
827812640,PA166155623,rs1105879,,,UGT1A6,Metabolism/PK,1,valproic acid,827812654.0,East Asian
1448821812,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1448821814.0,East Asian
1184511096,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,donepezil,1184511098.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
769250751,PA166156938,rs699947,,,VEGFA,Efficacy,1,capecitabine,769250818.0,European
769250751,PA166156938,rs699947,,,VEGFA,Efficacy,1,oxaliplatin,769250818.0,European
1448821818,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,ritonavir,1448821820.0,East Asian
1184756863,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1184756874.0,Sub-Saharan African
1184756863,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,debrisoquine,1184756874.0,Sub-Saharan African
1448821824,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,ritonavir,1448821826.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A10,Dosage,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A6,Dosage,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A7,Dosage,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A8,Dosage,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A9,Dosage,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A10,Metabolism/PK,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A6,Metabolism/PK,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A7,Metabolism/PK,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A8,Metabolism/PK,1,valproic acid,827812639.0,East Asian
827812626,PA166155665,rs2070959,,,UGT1A9,Metabolism/PK,1,valproic acid,827812639.0,East Asian
1448821830,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,ritonavir,1448821832.0,East Asian
1444843016,PA166157167,rs10305420,,,GLP1R,Efficacy,1,liraglutide,1444843018.0,Unknown
1184756875,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1184756877.0,Sub-Saharan African
1184756875,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1184756877.0,Sub-Saharan African
1184756875,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,debrisoquine,1184756877.0,Sub-Saharan African
1184511110,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,fluvoxamine,1184511118.0,Unknown
1184511110,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluvoxamine,1184511118.0,Unknown
981477479,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,981477488.0,"Multiple groups, 93.2% White;2.4% Asian;1.0 % Black; 3.4% other."
1451132005,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,progesterone,1451132027.0,Unknown
1451132005,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,progesterone,1451132027.0,Unknown
1451132005,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,progesterone,1451132027.0,Unknown
1184166985,PA166156610,rs6822844,,,IL2,Efficacy,1,rituximab,1184166987.0,European
1184166985,PA166156610,rs6822844,,,IL2,Efficacy,1,rituximab,1184166990.0,European
1184511121,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,escitalopram,1184511129.0,European
1184511121,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,escitalopram,1184511129.0,European
827812612,PA166155760,rs6759892,,,UGT1A10,Dosage,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A6,Dosage,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A7,Dosage,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A8,Dosage,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A9,Dosage,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A10,Metabolism/PK,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A6,Metabolism/PK,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A7,Metabolism/PK,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A8,Metabolism/PK,1,valproic acid,827812625.0,East Asian
827812612,PA166155760,rs6759892,,,UGT1A9,Metabolism/PK,1,valproic acid,827812625.0,East Asian
1451131960,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,progesterone,1451132000.0,Unknown
1451131960,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,progesterone,1451132000.0,Unknown
1451131960,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,progesterone,1451132000.0,Unknown
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034505.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034490.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034503.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034484.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034510.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034508.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034488.0,European
982034477,PA166155674,rs2241883,,,FABP1,Efficacy,1,fenofibrate,982034486.0,European
1184511132,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,venlafaxine,1184511134.0,"Multiple groups, Caucasian, White"
1184511132,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,venlafaxine,1184511134.0,"Multiple groups, Caucasian, White"
1449182301,PA166157551,rs1051660,,,OPRK1,Dosage,1,morphine,1449182309.0,Near Eastern
1449182301,PA166157551,rs1051660,,,OPRK1,Efficacy,1,morphine,1449182309.0,Near Eastern
1448267244,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1448267256.0,African American/Afro-Caribbean
1448267244,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,0,tacrolimus,1448267256.0,African American/Afro-Caribbean
1448267244,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,0,tacrolimus,1448267256.0,African American/Afro-Caribbean
1184511142,PA166158926,rs57098334,,,None,Efficacy,-1,escitalopram,1184511144.0,"Multiple groups, Caucasian, White"
1184511142,PA166158926,rs57098334,,,None,Efficacy,-1,escitalopram,1184511149.0,"Multiple groups, Caucasian and White"
1184511142,PA166158926,rs57098334,,,None,Efficacy,-1,venlafaxine,1184511144.0,"Multiple groups, Caucasian, White"
1184511142,PA166158926,rs57098334,,,None,Efficacy,-1,venlafaxine,1184511149.0,"Multiple groups, Caucasian and White"
1184756902,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1184756912.0,Sub-Saharan African
1184756902,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1184756940.0,Sub-Saharan African
1184756902,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,debrisoquine,1184756912.0,Sub-Saharan African
1184756902,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,debrisoquine,1184756940.0,Sub-Saharan African
1184756902,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1184756912.0,Sub-Saharan African
1184756902,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1184756940.0,Sub-Saharan African
1184756902,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756912.0,Sub-Saharan African
1184756902,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756940.0,Sub-Saharan African
1184756902,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756912.0,Sub-Saharan African
1184756902,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756940.0,Sub-Saharan African
1184756902,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756912.0,Sub-Saharan African
1184756902,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756940.0,Sub-Saharan African
1184756902,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1184756912.0,Sub-Saharan African
1184756902,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1184756940.0,Sub-Saharan African
1184756902,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,metoprolol,1184756912.0,Sub-Saharan African
1184756902,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,metoprolol,1184756940.0,Sub-Saharan African
1184756902,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,metoprolol,1184756912.0,Sub-Saharan African
1184756902,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,metoprolol,1184756940.0,Sub-Saharan African
1184167080,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,chlorambucil,1184167082.0,Unknown
1184167080,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,-1,chlorambucil,1184167082.0,Unknown
1449182322,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449182324.0,Near Eastern
1449182322,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1449182324.0,Near Eastern
1444695471,PA166157267,rs776746,,,CYP3A5,Dosage,-1,methadone,1444695473.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1444695477,PA166154127,rs11188072,,,CYP2C19,Dosage,-1,methadone,1444695479.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1184511033,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,donepezil,1184511035.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184511033,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,1,donepezil,1184511035.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1447677393,PA166154836,rs4646,,,CYP19A1,Other,1,hdl cholesterol,1447677395.0,Unknown
1448594903,PA166157714,rs774359,,,C9orf72,Efficacy,1,ustekinumab,1448594906.0,European
1449182316,PA166177735,rs17174629,,,OPRM1,Dosage,-1,morphine,1449182318.0,Near Eastern
1449182316,PA166177735,rs17174629,,,OPRM1,Efficacy,-1,morphine,1449182318.0,Near Eastern
1451213980,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,labetalol,1451213989.0,East Asian
1451213980,,,PA166115858,UGT1A1*6,UGT1A1,Metabolism/PK,-1,labetalol,1451213989.0,East Asian
1451213980,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,labetalol,1451213989.0,East Asian
1451213980,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,-1,labetalol,1451213989.0,East Asian
1451099305,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,risperidone,1451099340.0,Unknown
1451099305,,,PA165816577,CYP2D6*2,CYP2D6,Dosage,-1,risperidone,1451099340.0,Unknown
1451099305,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,-1,risperidone,1451099340.0,Unknown
1184511048,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,donepezil,1184511050.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1448594895,PA166156750,rs1050152,,,SLC22A4,Efficacy,1,ustekinumab,1448594898.0,European
1184511052,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,donepezil,1184511054.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
981477489,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,981477498.0,"Multiple groups, 94% ""Caucasian""; 6% ""Chinese or Asian"""
1449182334,PA166177739,rs1799972,,,OPRM1,Dosage,-1,morphine,1449182336.0,Near Eastern
1449182334,PA166177739,rs1799972,,,OPRM1,Efficacy,-1,morphine,1449182336.0,Near Eastern
1447677374,PA166154912,rs4775936,,,CYP19A1,Other,1,triglycerides,1447677376.0,Unknown
1451230320,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,atorvastatin,1451230325.0,European
1184167044,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,cyclophosphamide,1184167058.0,Unknown
1184167044,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,cyclophosphamide,1184167063.0,Unknown
1184167044,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,cyclophosphamide,1184167065.0,Unknown
1184167044,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,cyclophosphamide,1184167058.0,Unknown
1184167044,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,cyclophosphamide,1184167063.0,Unknown
1184167044,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,cyclophosphamide,1184167065.0,Unknown
1184167044,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,fludarabine,1184167058.0,Unknown
1184167044,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,fludarabine,1184167063.0,Unknown
1184167044,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,fludarabine,1184167065.0,Unknown
1184167044,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,fludarabine,1184167058.0,Unknown
1184167044,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,fludarabine,1184167063.0,Unknown
1184167044,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,fludarabine,1184167065.0,Unknown
1184511056,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,-1,donepezil,1184511058.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1448594887,PA166155766,rs7574865,,,STAT4,Efficacy,1,ustekinumab,1448594890.0,European
1448594887,PA166155766,rs7574865,,,STAT4,Efficacy,1,ustekinumab,1448594890.0,European
1449182349,PA166156024,rs4680,,,COMT,Dosage,-1,morphine,1449182351.0,Near Eastern
1449182349,PA166156024,rs4680,,,COMT,Efficacy,-1,morphine,1449182351.0,Near Eastern
769250837,PA166156958,rs833061,,,VEGFA,Efficacy,-1,capecitabine,769250870.0,European
769250837,PA166156958,rs833061,,,VEGFA,Efficacy,-1,oxaliplatin,769250870.0,European
1184511064,,,PA165948045,CYP3A7*1A,CYP3A7,Metabolism/PK,-1,donepezil,1184511066.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184511064,,,PA165948047,CYP3A7*1C,CYP3A7,Metabolism/PK,-1,donepezil,1184511066.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1450820732,PA166155468,rs12979860,,,IFNL3,Efficacy,1,atorvastatin,,
1450820732,PA166155468,rs12979860,,,IFNL4,Efficacy,1,atorvastatin,,
1184986212,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184986220.0,European
1184986212,,,PA165971559,CYP2D6*7,CYP2D6,Metabolism/PK,0,sparteine,1184986220.0,European
1184986212,,,PA165971560,CYP2D6*8,CYP2D6,Metabolism/PK,0,sparteine,1184986220.0,European
1184511060,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,donepezil,1184511062.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
981477503,PA166155202,rs2240017,,,TBX21,Efficacy,1,corticosteroids,981477510.0,European
981477503,PA166155202,rs2240017,,,TBX21,Efficacy,1,corticosteroids,981477510.0,European
1184511072,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,donepezil,1184511074.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1447677364,PA166154847,rs700518,,,CYP19A1,Other,1,triglycerides,1447677366.0,Unknown
1449165982,PA166176933,rs17685420,,,PEBP4,Efficacy,1,methylphenidate,1449165988.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1184511076,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,-1,donepezil,1184511078.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
981477511,PA166154676,rs6314,,,HTR2A,Efficacy,1,antidepressants,981477522.0,European
1184511080,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,-1,donepezil,1184511082.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1451230340,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,atorvastatin,1451230360.0,European
1449165990,PA166176934,rs3210967,,,ZDHHC7,Efficacy,-1,methylphenidate,1449165992.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1184167146,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1184167154.0,European
1184167146,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1184167154.0,European
1450820814,PA166157551,rs1051660,,,OPRK1,Efficacy,-1,buprenorphine,1450820819.0,European
981477583,PA166155438,rs8105790,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981477588.0,East Asian
981477583,PA166155438,rs8105790,,,IFNL3,Efficacy,1,ribavirin,981477588.0,East Asian
1184167140,PA166154421,rs7124442,,,BDNF,Efficacy,-1,antidepressants,1184167142.0,European
1451099341,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1451099348.0,Unknown
1451099341,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,risperidone,1451099348.0,Unknown
1451099341,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,risperidone,1451099348.0,Unknown
1449166003,PA166176936,rs2071421,,,ARSA,Efficacy,-1,methylphenidate,1449166005.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449002171,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,clopidogrel,1449002173.0,European
1449002171,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,clopidogrel thiol metabolite H4,1449002173.0,European
981477593,PA166155462,rs11881222,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981477597.0,East Asian
981477593,PA166155462,rs11881222,,,IFNL3,Efficacy,1,ribavirin,981477597.0,East Asian
1184167136,PA166154259,rs6265,,,BDNF,Efficacy,-1,antidepressants,1184167138.0,European
1450820823,PA166154339,rs1800497,,,ANKK1,Efficacy,1,prochlorperazine,1450820828.0,Unknown
1450820823,PA166154339,rs1800497,,,DRD2,Efficacy,1,prochlorperazine,1450820828.0,Unknown
1444695419,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1444695425.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1449002165,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,clopidogrel thiol metabolite H4,1449002170.0,European
1449166009,PA166176937,rs12302749,,,SPSB2,Efficacy,-1,methylphenidate,1449166011.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1451099349,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,paliperidone,1451099356.0,Unknown
1451099349,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,paliperidone,1451099356.0,Unknown
1451099349,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,paliperidone,1451099356.0,Unknown
1447677354,PA166154903,rs3759811,,,CYP19A1,Other,1,triglycerides,1447677356.0,Unknown
1450820829,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,prochlorperazine,1450820834.0,Unknown
1450820829,PA166154339,rs1800497,,,DRD2,Efficacy,-1,prochlorperazine,1450820834.0,Unknown
1184167131,PA166154418,rs7103411,,,BDNF,Efficacy,-1,antidepressants,1184167135.0,European
981477599,PA166155437,rs8103142,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981477604.0,East Asian
981477599,PA166155437,rs8103142,,,IFNL3,Efficacy,1,ribavirin,981477604.0,East Asian
1444695427,PA166154339,rs1800497,,,ANKK1,Dosage,-1,methadone,1444695429.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1450820835,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,prochlorperazine,1450820840.0,Unknown
981477611,PA166155417,rs4803219,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981477613.0,East Asian
981477611,PA166155417,rs4803219,,,IFNL3,Efficacy,1,ribavirin,981477613.0,East Asian
1184757003,PA166157354,rs2290228,,,CALU,Dosage,-1,warfarin,1184757005.0,East Asian
1449002186,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,clopidogrel,1449002188.0,European
1449002186,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,clopidogrel thiol metabolite H4,1449002188.0,European
1449166015,PA166176938,rs10420097,,,ZNF211,Efficacy,-1,methylphenidate,1449166017.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1444695435,PA166154261,rs6277,,,DRD2,Dosage,-1,methadone,1444695437.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1449002181,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,-1,clopidogrel,1449002183.0,European
1449002181,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,-1,clopidogrel thiol metabolite H4,1449002183.0,European
981477606,PA166155479,rs28416813,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981477609.0,East Asian
981477606,PA166155479,rs28416813,,,IFNL3,Efficacy,1,ribavirin,981477609.0,East Asian
1185002754,PA166156679,rs34231037,,,KDR,Efficacy,1,pazopanib,1185002760.0,Unknown
1444695442,PA166156024,rs4680,,,None,Dosage,-1,methadone,1444695444.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1446907247,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,cilostazol,1446907258.0,East Asian
1446907247,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,cilostazol,1446907262.0,East Asian
1446907247,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,cilostazol,1446907260.0,East Asian
1446907247,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,cilostazol,1446907258.0,East Asian
1446907247,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,cilostazol,1446907262.0,East Asian
1446907247,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,cilostazol,1446907260.0,East Asian
1446907247,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,cilostazol,1446907258.0,East Asian
1446907247,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,cilostazol,1446907262.0,East Asian
1446907247,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,cilostazol,1446907260.0,East Asian
1449002191,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,clopidogrel,1449002193.0,European
1449166032,PA166176939,rs3810818,,,CORO7,Efficacy,-1,methylphenidate,1449166034.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1451230380,,,PA165981641,SLCO1B1*1,SLCO1B1,Efficacy,-1,atorvastatin,1451230400.0,European
1451230380,,,PA165819265,SLCO1B1*15,SLCO1B1,Efficacy,-1,atorvastatin,1451230400.0,European
981477559,PA166154602,rs7311358,,,SLCO1B3,Metabolism/PK,1,mycophenolate mofetil,981477566.0,Unknown
981477559,PA166154602,rs7311358,,,SLCO1B3,Metabolism/PK,1,mycophenolate mofetil,981477566.0,Unknown
981477559,PA166154602,rs7311358,,,SLCO1B3,Metabolism/PK,1,mycophenolate mofetil,981477566.0,Unknown
1184757013,PA166154100,rs9332127,,,CYP2C9,Dosage,-1,warfarin,1184757015.0,East Asian
1444695451,PA166157284,rs1045642,,,ABCB1,Dosage,-1,methadone,1444695453.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1184511256,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,paroxetine,1184511272.0,East Asian
1184511256,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1184511272.0,East Asian
1444842903,PA166157117,rs6923761,,,GLP1R,Efficacy,-1,liraglutide,1444843009.0,Unknown
1184134324,,,PA165819268,TPMT*1,TPMT,Efficacy,-1,methotrexate,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819269,TPMT*2,TPMT,Efficacy,-1,methotrexate,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819270,TPMT*3A,TPMT,Efficacy,-1,methotrexate,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819272,TPMT*3C,TPMT,Efficacy,-1,methotrexate,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819268,TPMT*1,TPMT,Efficacy,-1,purine analogues,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819269,TPMT*2,TPMT,Efficacy,-1,purine analogues,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819270,TPMT*3A,TPMT,Efficacy,-1,purine analogues,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
1184134324,,,PA165819272,TPMT*3C,TPMT,Efficacy,-1,purine analogues,1184134336.0,"Multiple groups, All patients were from Russian hospitals.  Racial breakdown is given for the group of all pediatric cancer patients (a superset of the ALL patients).  White: 413;Asian:6;Ural:3;Other:21."
981477567,PA166154602,rs7311358,,,SLCO1B3,Metabolism/PK,-1,mycophenolate mofetil,981477574.0,Unknown
1184757023,PA166154053,rs4244285,,,CYP2C19,Dosage,-1,warfarin,1184757025.0,East Asian
1444695457,PA166155393,rs2279343,,,CYP2B6,Dosage,-1,methadone,1444695459.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1449166050,PA166176941,rs9901675,,,FXR2,Efficacy,-1,methylphenidate,1449166052.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1184757033,PA166157254,rs339097,,,CALU,Dosage,-1,warfarin,1184757035.0,East Asian
981477575,PA166154583,rs4149117,,,SLCO1B3,Metabolism/PK,-1,mycophenolate mofetil,981477582.0,Unknown
1184757028,PA166154070,rs4986893,,,CYP2C19,Dosage,-1,warfarin,1184757030.0,East Asian
827812467,PA166157267,rs776746,,,CYP3A5,Other,1,tacrolimus,827812484.0,East Asian
827812467,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827812484.0,East Asian
1447677307,PA166154837,rs10046,,,CYP19A1,Other,1,triglycerides,1447677309.0,Unknown
1444695465,PA166155409,rs3745274,,,CYP2B6,Dosage,-1,methadone,1444695467.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,1184756935.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,codeine,1184756915.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,codeine,1184756935.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,codeine,1184756915.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,codeine,1184756935.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,codeine,1184756915.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1184756935.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1184756915.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,debrisoquine,1184756935.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,debrisoquine,1184756915.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1184756935.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1184756915.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756935.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756915.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756935.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756915.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756935.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756915.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1184756935.0,Sub-Saharan African
1184756913,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1184756915.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,metoprolol,1184756935.0,Sub-Saharan African
1184756913,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,metoprolol,1184756915.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,metoprolol,1184756935.0,Sub-Saharan African
1184756913,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,metoprolol,1184756915.0,Sub-Saharan African
1451148561,PA166154259,rs6265,,,BDNF,Efficacy,-1,escitalopram,1451148548.0,Multiple groups
827566695,PA166156485,rs283416,,,ADH1C,Toxicity,1,ethanol,827566701.0,European
827566695,PA166156485,rs283416,,,ADH1C,Metabolism/PK,1,ethanol,827566701.0,European
1447677286,PA166154884,rs2289105,,,CYP19A1,Other,1,triglycerides,1447677288.0,Unknown
1451148571,PA166154675,rs6313,,,HTR2A,Efficacy,-1,escitalopram,1451148581.0,Multiple groups
1449166063,PA166176943,rs4562,,,ELP5,Efficacy,-1,methylphenidate,1449166065.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
827566688,PA166156484,rs283411,,,ADH1C,Toxicity,1,ethanol,827566694.0,European
827566688,PA166156484,rs283411,,,ADH1C,Metabolism/PK,1,ethanol,827566694.0,European
1446907223,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1446907234.0,East Asian
1446907223,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1446907236.0,East Asian
1446907223,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1446907238.0,East Asian
1446907223,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clopidogrel,1446907240.0,East Asian
1446907223,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1446907234.0,East Asian
1446907223,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1446907236.0,East Asian
1446907223,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1446907238.0,East Asian
1446907223,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clopidogrel,1446907240.0,East Asian
1446907223,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clopidogrel,1446907234.0,East Asian
1446907223,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clopidogrel,1446907236.0,East Asian
1446907223,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clopidogrel,1446907238.0,East Asian
1446907223,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clopidogrel,1446907240.0,East Asian
1451148566,PA166154673,rs6311,,,HTR2A,Efficacy,-1,escitalopram,1451148580.0,Multiple groups
1451148576,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,escitalopram,1451148620.0,Multiple groups
1449166070,PA166176944,rs17712523,,,CDH23,Efficacy,-1,methylphenidate,1449166072.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1451164960,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atorvastatin,1451164965.0,East Asian
827566681,PA166156519,rs1662060,,,ADH1C,Toxicity,1,ethanol,827566687.0,European
827566681,PA166156519,rs1662060,,,ADH1C,Metabolism/PK,1,ethanol,827566687.0,European
1451164971,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,atorvastatin,1451164981.0,East Asian
1447677275,PA166154837,rs10046,,,CYP19A1,Other,1,hdl cholesterol,1447677277.0,Unknown
1450820844,PA166154315,rs1079597,,,DRD2,Efficacy,1,prochlorperazine,1450820849.0,Unknown
827566660,PA166156483,rs17033,,,ADH1B,Toxicity,1,ethanol,827566666.0,European
827566660,PA166156483,rs17033,,,ADH1B,Metabolism/PK,1,ethanol,827566666.0,European
1446907186,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,sorafenib,1446907200.0,Multiple groups
1446907186,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,sorafenib,1446907198.0,Multiple groups
1446907186,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,sorafenib,1446907200.0,Multiple groups
1446907186,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,sorafenib,1446907198.0,Multiple groups
981477615,PA166155429,rs7248668,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981477618.0,East Asian
981477615,PA166155429,rs7248668,,,IFNL3,Efficacy,1,ribavirin,981477618.0,East Asian
1450935595,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1450935600.0,East Asian
1184756941,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756944.0,Sub-Saharan African
1184756941,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756944.0,Sub-Saharan African
1184756941,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,dextromethorphan,1184756944.0,Sub-Saharan African
1184756941,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,metoprolol,1184756944.0,Sub-Saharan African
1184756941,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,metoprolol,1184756944.0,Sub-Saharan African
1184756941,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,metoprolol,1184756944.0,Sub-Saharan African
827566667,PA166156508,rs1229985,,,ADH1B,Toxicity,1,ethanol,827566673.0,European
827566667,PA166156508,rs1229985,,,ADH1B,Metabolism/PK,1,ethanol,827566673.0,European
1450820850,PA166154315,rs1079597,,,DRD2,Efficacy,-1,prochlorperazine,1450820855.0,Unknown
1184756952,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,codeine,1184756954.0,Sub-Saharan African
1184756952,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,codeine,1184756954.0,Sub-Saharan African
1184756952,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,-1,codeine,1184756954.0,Sub-Saharan African
1184756952,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,debrisoquine,1184756954.0,Sub-Saharan African
1184756952,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,debrisoquine,1184756954.0,Sub-Saharan African
1184756952,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,-1,debrisoquine,1184756954.0,Sub-Saharan African
1449166094,PA166163170,rs2295490,,,TRIB3,Efficacy,-1,methylphenidate,1449166096.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
827566652,PA166156496,rs931635,,,ADH1A,Toxicity,1,ethanol,827566659.0,European
827566652,PA166156496,rs931635,,,ADH1A,Metabolism/PK,1,ethanol,827566659.0,European
1184167161,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,clopidogrel,1184167163.0,European
1449166106,PA166176949,rs1048786,,,PDIA2,Efficacy,-1,methylphenidate,1449166108.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1447677231,PA166154858,rs1062033,,,CYP19A1,Other,1,hdl cholesterol,1447677233.0,Unknown
1447677238,PA166154854,rs1008805,,,CYP19A1,Other,1,hdl cholesterol,1447677240.0,Unknown
1449166112,PA166176950,rs9901673,,,SENP3,Efficacy,-1,methylphenidate,1449166114.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
827566637,PA166156505,rs1229967,,,ADH1A,Toxicity,1,ethanol,827566646.0,European
827566637,PA166156505,rs1229967,,,ADH1A,Metabolism/PK,1,ethanol,827566646.0,European
1184134384,,,PA165819268,TPMT*1,TPMT,Dosage,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819269,TPMT*2,TPMT,Dosage,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819270,TPMT*3A,TPMT,Dosage,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819271,TPMT*3B,TPMT,Dosage,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819268,TPMT*1,TPMT,Toxicity,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819269,TPMT*2,TPMT,Toxicity,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819270,TPMT*3A,TPMT,Toxicity,0,mercaptopurine,1184134396.0,European
1184134384,,,PA165819271,TPMT*3B,TPMT,Toxicity,0,mercaptopurine,1184134396.0,European
827813931,PA166157490,rs41303343,,,CYP3A5,Dosage,-1,cyclosporine,827813976.0,"Multiple groups, Brazilian"
827813931,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827813976.0,"Multiple groups, Brazilian"
1184511344,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluoxetine,1184511354.0,East Asian
1184511344,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1184511354.0,East Asian
1444695287,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clobazam,1444695289.0,East Asian
1444695287,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clobazam,1444695289.0,East Asian
1444695287,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clobazam,1444695289.0,East Asian
1184756965,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,debrisoquine,1184756967.0,Sub-Saharan African
1184756965,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,-1,debrisoquine,1184756967.0,Sub-Saharan African
1447677221,PA166154849,rs749292,,,CYP19A1,Other,1,triglycerides,1447677223.0,Unknown
1184757110,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1184757127.0,African American/Afro-Caribbean
1184757110,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,dextromethorphan,1184757127.0,African American/Afro-Caribbean
1449166134,PA166176953,rs7858,,,NFIB,Efficacy,-1,methylphenidate,1449166136.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1184511361,PA166156708,rs6295,,,HTR1A,Efficacy,1,fluoxetine,1184511363.0,East Asian
1184757117,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184757129.0,African American/Afro-Caribbean
1184757117,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,-1,dextromethorphan,1184757129.0,African American/Afro-Caribbean
1451115880,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,amprenavir,1451115900.0,European
827813909,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,827813930.0,"Multiple groups, Brazilian"
827813909,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827813930.0,"Multiple groups, Brazilian"
1184511375,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,fluoxetine,1184511377.0,East Asian
827813894,PA166157490,rs41303343,,,CYP3A5,Dosage,1,tacrolimus,827813926.0,"Multiple groups, Brazilian"
827813894,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,1,tacrolimus,827813926.0,"Multiple groups, Brazilian"
1184511379,PA166154675,rs6313,,,HTR2A,Efficacy,-1,fluoxetine,1184511381.0,East Asian
1450935601,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1450935606.0,East Asian
1450935601,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1450935606.0,East Asian
827813880,PA166157441,rs10264272,,,CYP3A5,Dosage,1,tacrolimus,827813928.0,"Multiple groups, Brazilian"
827813880,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,1,tacrolimus,827813928.0,"Multiple groups, Brazilian"
981475658,PA166157705,rs430397,,,HSPA5,Efficacy,1,Platinum compounds,981475666.0,East Asian
1449166160,PA166170568,rs11942223,,,SLC2A9,Dosage,-1,allopurinol,1449166166.0,Unknown
827830252,PA166157284,rs1045642,,,ABCB1,Dosage,-1,cyclosporine,827830261.0,Multiple groups
827830252,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,cyclosporine,827830261.0,Multiple groups
1184757043,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1184757045.0,East Asian
981344658,PA166155211,rs2872507,,,ORMDL3,Efficacy,1,fluticasone propionate,981344665.0,European
981344658,PA166155211,rs2872507,,,ORMDL3,Efficacy,1,fluticasone propionate,981344663.0,European
981344658,PA166155211,rs2872507,,,ORMDL3,Efficacy,1,fluticasone propionate,981344667.0,European
1450935696,PA166186015,rs771237265,,,CYP2C9,Metabolism/PK,1,tolbutamide,1450935700.0,
1184757038,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1184757040.0,East Asian
1449166180,PA166177005,rs1183201,,,SLC17A1,Dosage,-1,allopurinol,1449166182.0,Unknown
1184757050,PA166156577,rs3756009,,,F11,Dosage,-1,warfarin,1184757052.0,East Asian
1450935701,PA166186016,rs761895497,,,CYP2C9,Metabolism/PK,1,tolbutamide,1450935705.0,
827830235,PA166157405,rs4986910,,,CYP3A4,Dosage,1,tacrolimus,827830244.0,Multiple groups
827830235,PA166157405,rs4986910,,,CYP3A4,Metabolism/PK,1,tacrolimus,827830244.0,Multiple groups
827813847,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,tacrolimus,827813861.0,"Multiple groups, Predominantly Caucasian cohort"
827813847,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,tacrolimus,827813861.0,"Multiple groups, Predominantly Caucasian cohort"
1450935713,PA166186018,rs144928727,,,CYP2C19,Metabolism/PK,-1,mephenytoin,1450935717.0,
1449166202,PA166177011,rs3825018,,,SLC22A12,Dosage,-1,allopurinol,1449166204.0,Unknown
1184757065,PA166155916,rs1415774,,,PROCR,Dosage,-1,warfarin,1184757067.0,East Asian
981934499,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981934507.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934499,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981934507.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934499,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981934507.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934499,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981934507.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934499,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981934507.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934499,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981934507.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
1184757060,PA166154396,rs3136516,,,F2,Dosage,-1,warfarin,1184757062.0,East Asian
1450935720,PA166154217,rs145119820,,,CYP2C19,Metabolism/PK,1,mephenytoin,1450935724.0,
827813837,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,827813859.0,"Multiple groups, Predominantly Caucasian cohort"
827813837,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,827813859.0,"Multiple groups, Predominantly Caucasian cohort"
1444695245,PA166157286,rs1057868,,,POR,Metabolism/PK,0,clobazam,1444695251.0,East Asian
1184757070,PA166153844,rs12065184,,,MPZ,Dosage,-1,warfarin,1184757072.0,East Asian
827830210,PA166157367,rs2740574,,,CYP3A4,Dosage,-1,cyclosporine,827830219.0,Multiple groups
827830210,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,cyclosporine,827830219.0,Multiple groups
1444842712,PA166157367,rs2740574,,,CYP3A4,Dosage,1,tacrolimus,1444842722.0,Multiple groups
1444842712,PA166157367,rs2740574,,,CYP3A4,Dosage,1,tacrolimus,1444842724.0,Multiple groups
1444842712,PA166157367,rs2740574,,,CYP3A4,Dosage,1,tacrolimus,1444842720.0,Multiple groups
827617217,PA166154850,rs762551,,,CYP1A2,Other,1,caffeine,827617223.0,European
827617217,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,827617223.0,European
827830204,PA166157367,rs2740574,,,CYP3A4,Dosage,1,tacrolimus,827830217.0,Multiple groups
827830204,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,827830217.0,Multiple groups
827813827,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,827813857.0,"Multiple groups, Predominantly Caucasian cohort"
827813827,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,827813857.0,"Multiple groups, Predominantly Caucasian cohort"
827617207,PA166154850,rs762551,,,CYP1A2,Other,1,caffeine,827617213.0,European
827617207,PA166154850,rs762551,,,CYP1A2,Other,1,caffeine,827617215.0,European
827617207,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,827617213.0,European
827617207,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,827617215.0,European
827813819,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,827813855.0,"Multiple groups, Predominantly Caucasian cohort"
827813819,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,827813855.0,"Multiple groups, Predominantly Caucasian cohort"
1449575844,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1449575852.0,Unknown
1449575844,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1449575850.0,East Asian
1449575844,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1449575852.0,Unknown
1449575844,PA166154759,rs116855232,,,NUDT15,Dosage,1,mercaptopurine,1449575850.0,East Asian
1444842728,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1444842884.0,Multiple groups
1444842728,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1444842888.0,Multiple groups
1444695268,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clobazam,1444695286.0,East Asian
1444695268,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clobazam,1444695286.0,East Asian
1444695268,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clobazam,1444695286.0,East Asian
1449166259,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1449166268.0,Unknown
1449166259,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1449166268.0,Unknown
1449166259,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,omeprazole,1449166268.0,Unknown
981475790,PA166157033,rs2305089,,,TBXT,Efficacy,1,flunisolide,981475798.0,European
981475790,PA166157033,rs2305089,,,TBXT,Efficacy,1,flunisolide,981476177.0,European
1184511472,PA166156136,rs9621532,,,SYN3,Efficacy,-1,ranibizumab,1184511474.0,East Asian
827813794,PA166157286,rs1057868,,,POR,Dosage,1,tacrolimus,827813801.0,"Multiple groups, Predominantly Caucasian cohort"
827813794,PA166157286,rs1057868,,,POR,Metabolism/PK,1,tacrolimus,827813801.0,"Multiple groups, Predominantly Caucasian cohort"
982032850,PA166155187,rs1799752,,,ACE,Efficacy,1,atenolol,982032922.0,Unknown
982032850,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982032922.0,Unknown
981344731,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,warfarin,981344735.0,European
981344731,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,warfarin,981344735.0,European
981344731,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,warfarin,981344735.0,European
981344731,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,warfarin,981344735.0,European
1444842618,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1444842625.0,Central/South Asian
1444842618,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1444842625.0,Central/South Asian
827699103,PA166155342,rs11615,,,ERCC1,Efficacy,-1,carboplatin,827699117.0,European
827699103,PA166155342,rs11615,,,ERCC1,Efficacy,-1,pemetrexed,827699117.0,European
1449166275,PA166176957,rs1061735,,,ESYT2,Efficacy,-1,methylphenidate,1449166277.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1451116000,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,lopinavir,1451115982.0,European
1451116000,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,lopinavir,1451115982.0,European
1184282060,,,PA165819268,TPMT*1,TPMT,Dosage,1,mercaptopurine,1184282667.0,Central/South Asian
1184282060,,,PA165819269,TPMT*2,TPMT,Dosage,1,mercaptopurine,1184282667.0,Central/South Asian
1184282060,,,PA165819270,TPMT*3A,TPMT,Dosage,1,mercaptopurine,1184282667.0,Central/South Asian
1184282060,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1184282667.0,Central/South Asian
1184282060,,,PA165819272,TPMT*3C,TPMT,Dosage,1,mercaptopurine,1184282667.0,Central/South Asian
981934519,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981934527.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934519,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981934527.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
981934519,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981934527.0,"Multiple groups, Caucasian, Asian, Latvian, Chilean, African-American"
1448496262,PA166155586,rs10012,,,CYP1B1,Metabolism/PK,-1,exemestane,1448496264.0,Multiple groups
1450935734,PA166186020,rs183701923,,,CYP2C19,Metabolism/PK,1,mephenytoin,1450935738.0,
1444695194,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clobazam,1444695212.0,Unknown
1444695194,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clobazam,1444695212.0,Unknown
1444695194,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clobazam,1444695212.0,Unknown
1450935739,PA166154212,rs140278421,,,CYP2C19,Metabolism/PK,1,mephenytoin,1450935743.0,
1447988337,PA166156923,rs510432,,,ATG5,Efficacy,1,adalimumab,1447988339.0,Unknown
1450935745,PA166186021,rs1187513719,,,CYP2C19,Metabolism/PK,-1,mephenytoin,1450935749.0,
1451115963,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,lopinavir,1451115968.0,African American/Afro-Caribbean
1451115963,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,lopinavir,1451115983.0,Latino
1451115963,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,lopinavir,1451115968.0,African American/Afro-Caribbean
1451115963,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,lopinavir,1451115983.0,Latino
1447988322,PA166155879,rs55754655,,,AOX1,Dosage,1,azathioprine,1447988328.0,Unknown
827830124,PA166157267,rs776746,,,CYP3A5,Dosage,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
827830124,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827830161.0,Multiple groups
1447988304,PA166153624,rs1130864,,,CRP,Efficacy,1,adalimumab,1447988316.0,Unknown
1444695105,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695123.0,East Asian
1444695105,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695123.0,East Asian
1444695105,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695123.0,East Asian
982032925,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033023.0,Unknown
1449166337,PA166176961,rs17279558,,,GGH,Efficacy,-1,methylphenidate,1449166339.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1450821104,PA166184563,rs3890011,,,CYP4A11,Efficacy,1,spironolactone,1450821109.0,African American/Afro-Caribbean
1450821112,PA166184563,rs3890011,,,CYP4A11,Efficacy,-1,amiloride,1450821117.0,African American/Afro-Caribbean
1449166351,PA166176963,rs1061115,,,PYROXD2,Efficacy,-1,methylphenidate,1449166353.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166351,PA166176963,rs1061115,,,PYROXD2,Efficacy,-1,methylphenidate,1449166353.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449166351,PA166176963,rs1061115,,,PYROXD2,Efficacy,-1,methylphenidate,1449166353.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
982032876,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,982032878.0,Multiple groups
1448266807,PA166157243,rs15524,,,CYP3A5,Metabolism/PK,1,carbamazepine,1448266809.0,East Asian
1447676959,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676979.0,East Asian
1447676959,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676977.0,East Asian
1447676959,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676979.0,East Asian
1447676959,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676977.0,East Asian
1447676959,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1447676979.0,East Asian
1447676959,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1447676977.0,East Asian
1449002543,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1449002548.0,"Multiple groups, Studies include Asian, Caucasian, Hispanic, Polynesian participants and participants of unreported ethnicity."
1449002543,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1449002548.0,"Multiple groups, Studies include Asian, Caucasian, Hispanic, Polynesian participants and participants of unreported ethnicity."
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,amprenavir,1451116040.0,European
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,amprenavir,1451116048.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,amprenavir,1451116045.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,amprenavir,1451116044.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,amprenavir,1451116046.0,European
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,amprenavir,1451116047.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amprenavir,1451116040.0,European
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amprenavir,1451116048.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amprenavir,1451116045.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amprenavir,1451116044.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amprenavir,1451116046.0,European
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amprenavir,1451116047.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,saquinavir,1451116040.0,European
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,saquinavir,1451116048.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,saquinavir,1451116045.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,saquinavir,1451116044.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,saquinavir,1451116046.0,European
1451116020,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,saquinavir,1451116047.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,saquinavir,1451116040.0,European
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,saquinavir,1451116048.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,saquinavir,1451116045.0,Latino
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,saquinavir,1451116044.0,African American/Afro-Caribbean
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,saquinavir,1451116046.0,European
1451116020,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,saquinavir,1451116047.0,African American/Afro-Caribbean
1449166382,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,omeprazole,1449166389.0,Unknown
1451165260,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,selumetinib,1451165300.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1451165260,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,selumetinib,1451165264.0,Multiple groups
1451165260,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,selumetinib,1451165263.0,Unknown
1451165260,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,selumetinib,1451165280.0,European
1451165260,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,selumetinib,1451165300.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1451165260,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,selumetinib,1451165264.0,Multiple groups
1451165260,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,selumetinib,1451165263.0,Unknown
1451165260,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,selumetinib,1451165280.0,European
827863330,PA166154789,rs2236225,,,MTHFD1,Efficacy,-1,methotrexate,827863340.0,European
1451116120,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,lopinavir,1451116106.0,Unknown
1451116120,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,lopinavir,1451116127.0,Unknown
1451116120,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,lopinavir,1451116106.0,Unknown
1451116120,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,lopinavir,1451116127.0,Unknown
1447676944,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,amisulpride,1447676946.0,East Asian
1447676944,PA166154339,rs1800497,,,DRD2,Efficacy,-1,amisulpride,1447676946.0,East Asian
1449002556,PA166157284,rs1045642,,,ABCB1,Dosage,-1,opioids,1449002558.0,"Multiple groups, Studies include Asian, Caucasian, African-American, Hispanic and Polynesian participants and participants of unreported ethnicity."
1449002556,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,opioids,1449002558.0,"Multiple groups, Studies include Asian, Caucasian, African-American, Hispanic and Polynesian participants and participants of unreported ethnicity."
1444695041,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clobazam,1444695049.0,East Asian
1444695041,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clobazam,1444695049.0,East Asian
1444695041,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,clobazam,1444695049.0,East Asian
827863316,PA166153876,rs17602729,,,AMPD1,Efficacy,-1,methotrexate,827863329.0,European
1184511620,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1184511622.0,East Asian
1184511624,PA166157578,rs2645400,,,GATA4,Dosage,1,warfarin,1184511626.0,East Asian
1444695050,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695058.0,East Asian
1444695050,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695071.0,East Asian
1444695050,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695073.0,East Asian
1444695050,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695058.0,East Asian
1444695050,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695071.0,East Asian
1444695050,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695073.0,East Asian
1444695050,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695058.0,East Asian
1444695050,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695071.0,East Asian
1444695050,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695073.0,East Asian
1184511628,PA166157607,rs4841588,,,GATA4,Dosage,1,warfarin,1184511630.0,East Asian
827863300,PA166155684,rs2372536,,,ATIC,Efficacy,-1,methotrexate,827863308.0,European
827863280,PA166155915,rs1127354,,,ITPA,Efficacy,-1,methotrexate,827863291.0,European
827863280,PA166155915,rs1127354,,,ITPA,Efficacy,-1,methotrexate,827863291.0,European
1448594435,PA166162755,rs2787094,,,ADAM33,Efficacy,1,ustekinumab,1448594437.0,European
1447676920,PA166154315,rs1079597,,,DRD2,Efficacy,1,amisulpride,1447676936.0,East Asian
1444695080,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695084.0,East Asian
1444695080,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695083.0,East Asian
1444695080,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clobazam,1444695082.0,East Asian
1444695080,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695084.0,East Asian
1444695080,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695083.0,East Asian
1444695080,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clobazam,1444695082.0,East Asian
1444695080,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695084.0,East Asian
1444695080,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695083.0,East Asian
1444695080,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clobazam,1444695082.0,East Asian
982033050,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982033060.0,East Asian
982033050,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982033076.0,East Asian
1448594411,PA166154673,rs6311,,,HTR2A,Efficacy,1,ustekinumab,1448594413.0,European
1451230861,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,siponimod,1451230867.0,Unknown
1451230861,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,0,siponimod,1451230867.0,Unknown
1451230861,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,siponimod,1451230867.0,Unknown
1448266716,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,carbamazepine,1448266718.0,East Asian
1444694964,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clobazam,1444694976.0,Unknown
1444694964,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clobazam,1444694976.0,Unknown
1451116180,PA166198781,rs55663133,,,IL1RN,Efficacy,-1,anakinra,1451116185.0,Unknown
1451116180,PA166198781,rs55663133,,,IL1RN,Efficacy,-1,anakinra,1451116186.0,Unknown
1451116180,PA166198781,rs55663133,,,IL1RN,Efficacy,-1,canakinumab,1451116185.0,Unknown
1451116180,PA166198781,rs55663133,,,IL1RN,Efficacy,-1,canakinumab,1451116186.0,Unknown
1448266710,PA166157243,rs15524,,,CYP3A5,Metabolism/PK,-1,carbamazepine,1448266712.0,East Asian
1448594399,PA166161139,rs11591741,,,CHUK,Efficacy,1,ustekinumab,1448594401.0,European
1448594392,PA166162749,rs191190,,,AGBL4,Efficacy,1,ustekinumab,1448594398.0,European
1451148962,PA166155172,rs1042173,,,SLC6A4,Dosage,1,morphine,1451148968.0,Unknown
1184511557,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1184511559.0,European
1184511557,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1184511559.0,European
1184511557,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1184511559.0,European
827699412,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,827699414.0,East Asian
827699412,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1451252580.0,East Asian
1447676885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676892.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676914.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1447676892.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1447676914.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676892.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676914.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447676892.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447676914.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447676892.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447676914.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447676892.0,Near Eastern
1447676885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447676914.0,Near Eastern
1451116200,PA166198801,rs62158853,,,IL1RN,Efficacy,-1,anakinra,1451116206.0,Unknown
1451116200,PA166198801,rs62158853,,,IL1RN,Efficacy,-1,anakinra,1451116205.0,Unknown
1451116200,PA166198801,rs62158853,,,IL1RN,Efficacy,-1,canakinumab,1451116206.0,Unknown
1451116200,PA166198801,rs62158853,,,IL1RN,Efficacy,-1,canakinumab,1451116205.0,Unknown
1184511552,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184511556.0,European
1444842443,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444842454.0,European
1444842443,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444842454.0,European
1184511561,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184511563.0,European
1184511561,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184511563.0,European
1184511561,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184511563.0,European
1448266704,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,carbamazepine,1448266706.0,East Asian
1444694988,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clobazam,1444694999.0,Unknown
1444694988,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clobazam,1444694999.0,Unknown
827814086,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,clopidogrel,827814099.0,European
1448266698,PA166160823,rs10234411,,,ABCB1,Metabolism/PK,-1,carbamazepine,1448266700.0,East Asian
1184511577,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184511579.0,European
1184511581,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1184511583.0,European
827814073,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,827814097.0,European
1444695013,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,clobazam,1444695023.0,Unknown
1444695013,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,clobazam,1444695023.0,Unknown
1448266671,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,carbamazepine,1448266677.0,East Asian
827814062,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,827814071.0,European
1450935925,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,fluticasone propionate,1450935930.0,
1450935925,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,salmeterol,1450935930.0,
1450935931,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,fluticasone propionate,1450935936.0,
1450935931,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,salmeterol,1450935936.0,
1184511592,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,1184511594.0,European
1184511592,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,1184511594.0,European
1184511592,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,acenocoumarol,1184511594.0,European
1444694895,PA166157303,rs1799983,,,NOS3,Efficacy,0,epirubicin,1444694897.0,East Asian
1444694895,PA166157303,rs1799983,,,NOS3,Efficacy,0,fluorouracil,1444694897.0,East Asian
1444694895,PA166157303,rs1799983,,,NOS3,Efficacy,0,oxaliplatin,1444694897.0,East Asian
1447676829,PA166155468,rs12979860,,,IFNL3,Efficacy,1,boceprevir,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL4,Efficacy,1,boceprevir,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL3,Efficacy,1,telaprevir,1447676864.0,Multiple groups
1447676829,PA166155468,rs12979860,,,IFNL4,Efficacy,1,telaprevir,1447676864.0,Multiple groups
1184233189,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233207.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233211.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233209.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233220.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233222.0,Latino
1184233189,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233224.0,Latino
1184511738,PA166155025,rs2002577,,,CES1,Dosage,-1,methylphenidate,1184511740.0,Unknown
1444842369,PA166157061,rs3025039,,,VEGFA,Efficacy,1,bevacizumab,1444842387.0,"Multiple groups, Asian and Caucasians were studied"
1444842369,PA166157061,rs3025039,,,VEGFA,Efficacy,1,capecitabine,1444842387.0,"Multiple groups, Asian and Caucasians were studied"
1444842369,PA166157061,rs3025039,,,VEGFA,Efficacy,1,fluorouracil,1444842387.0,"Multiple groups, Asian and Caucasians were studied"
1444842369,PA166157061,rs3025039,,,VEGFA,Efficacy,1,irinotecan,1444842387.0,"Multiple groups, Asian and Caucasians were studied"
1444842369,PA166157061,rs3025039,,,VEGFA,Efficacy,1,leucovorin,1444842387.0,"Multiple groups, Asian and Caucasians were studied"
1444842369,PA166157061,rs3025039,,,VEGFA,Efficacy,1,oxaliplatin,1444842387.0,"Multiple groups, Asian and Caucasians were studied"
982033131,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033179.0,Unknown
982033131,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033177.0,Unknown
982033131,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033151.0,Unknown
827551899,PA166155477,rs28399468,,,CYP2A6,Metabolism/PK,0,nicotine,827551907.0,East Asian
1184511746,PA166155039,rs2307240,,,CES1,Dosage,-1,methylphenidate,1184511748.0,Unknown
1451116267,PA166198784,rs7580634,,,IL1RN,Efficacy,-1,anakinra,1451116273.0,Unknown
1451116267,PA166198784,rs7580634,,,IL1RN,Efficacy,-1,anakinra,1451116272.0,Unknown
1451116267,PA166198784,rs7580634,,,IL1RN,Efficacy,-1,canakinumab,1451116273.0,Unknown
1451116267,PA166198784,rs7580634,,,IL1RN,Efficacy,-1,canakinumab,1451116272.0,Unknown
1184511750,PA166155111,rs12443580,,,CES1,Dosage,-1,methylphenidate,1184511752.0,Unknown
1451116260,PA166198783,rs55709272,,,IL1RN,Efficacy,-1,anakinra,1451116266.0,Unknown
1451116260,PA166198783,rs55709272,,,IL1RN,Efficacy,-1,anakinra,1451116265.0,Unknown
1451116260,PA166198783,rs55709272,,,IL1RN,Efficacy,-1,canakinumab,1451116266.0,Unknown
1451116260,PA166198783,rs55709272,,,IL1RN,Efficacy,-1,canakinumab,1451116265.0,Unknown
1447676797,PA166156442,rs11313667,,,LRRC15,Efficacy,1,atenolol,1447676807.0,African American/Afro-Caribbean
1447676797,PA166156442,rs11313667,,,LRRC15,Efficacy,1,hydrochlorothiazide,1447676807.0,African American/Afro-Caribbean
1447676797,PA166156442,rs11313667,,,LRRC15,Efficacy,1,metoprolol,1447676807.0,African American/Afro-Caribbean
1184511758,PA166154768,rs861539,,,XRCC3,Efficacy,0,Platinum compounds,1184511784.0,Multiple groups
1184511758,PA166154768,rs861539,,,XRCC3,Efficacy,0,Platinum compounds,1184511786.0,Multiple groups
769250131,PA166157367,rs2740574,,,CYP3A4,Dosage,1,sirolimus,769250133.0,Multiple groups
769250131,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,sirolimus,769250133.0,Multiple groups
1184511766,PA166155025,rs2002577,,,CES1,Dosage,-1,methylphenidate,1184511768.0,Unknown
1450985140,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,ritonavir,1450985145.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985140,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,ritonavir,1450985144.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985140,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,ritonavir,1450985147.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985140,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,ritonavir,1450985146.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
827814015,PA166157284,rs1045642,,,ABCB1,Dosage,-1,cyclosporine,827814024.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Dosage,-1,cyclosporine,827814026.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,cyclosporine,827814024.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,cyclosporine,827814026.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,827814024.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,827814026.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,827814024.0,"Multiple groups, Brazilian"
827814015,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,827814026.0,"Multiple groups, Brazilian"
1447676810,PA166157555,rs1367094,,,ZMAT4,Efficacy,1,atenolol,1447676818.0,African American/Afro-Caribbean
1447676810,PA166157555,rs1367094,,,ZMAT4,Efficacy,1,metoprolol,1447676818.0,African American/Afro-Caribbean
1184511770,PA166155037,rs2244613,,,CES1,Dosage,-1,methylphenidate,1184511772.0,Unknown
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,bevacizumab,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,capecitabine,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,fluorouracil,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,irinotecan,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,leucovorin,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,oxaliplatin,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1444842390,PA166156938,rs699947,,,VEGFA,Efficacy,1,oxaliplatin,1444842392.0,"Multiple groups, Asian and Caucasians were studied"
1451116220,PA166198782,rs62158854,,,IL1RN,Efficacy,-1,anakinra,1451116240.0,Unknown
1451116220,PA166198782,rs62158854,,,IL1RN,Efficacy,-1,anakinra,1451116241.0,Unknown
1451116220,PA166198782,rs62158854,,,IL1RN,Efficacy,-1,canakinumab,1451116240.0,Unknown
1451116220,PA166198782,rs62158854,,,IL1RN,Efficacy,-1,canakinumab,1451116241.0,Unknown
1184511778,PA166155039,rs2307240,,,CES1,Dosage,-1,methylphenidate,1184511780.0,Unknown
827814000,PA166157288,rs1128503,,,ABCB1,Dosage,-1,cyclosporine,827814032.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Dosage,-1,cyclosporine,827814034.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,cyclosporine,827814032.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,cyclosporine,827814034.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,827814032.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,827814034.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,827814032.0,"Multiple groups, Brazilian"
827814000,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,827814034.0,"Multiple groups, Brazilian"
1444842405,PA166156958,rs833061,,,VEGFA,Efficacy,-1,bevacizumab,1444842407.0,"Multiple groups, Asian and Caucasians were studied"
1444842405,PA166156958,rs833061,,,VEGFA,Efficacy,-1,capecitabine,1444842407.0,"Multiple groups, Asian and Caucasians were studied"
1444842405,PA166156958,rs833061,,,VEGFA,Efficacy,-1,fluorouracil,1444842407.0,"Multiple groups, Asian and Caucasians were studied"
1444842405,PA166156958,rs833061,,,VEGFA,Efficacy,-1,irinotecan,1444842407.0,"Multiple groups, Asian and Caucasians were studied"
1444842405,PA166156958,rs833061,,,VEGFA,Efficacy,-1,leucovorin,1444842407.0,"Multiple groups, Asian and Caucasians were studied"
1444842405,PA166156958,rs833061,,,VEGFA,Efficacy,-1,oxaliplatin,1444842407.0,"Multiple groups, Asian and Caucasians were studied"
827814005,PA166157316,rs2032582,,,ABCB1,Dosage,-1,cyclosporine,827814028.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Dosage,-1,cyclosporine,827814030.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,cyclosporine,827814028.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,cyclosporine,827814030.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,827814028.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,827814030.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,827814028.0,"Multiple groups, Brazilian"
827814005,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,827814030.0,"Multiple groups, Brazilian"
1444694834,PA166157238,rs662,,,PON1,Efficacy,1,epirubicin,1444694841.0,East Asian
1444694834,PA166157238,rs662,,,PON1,Efficacy,1,epirubicin,1444694845.0,East Asian
1444694834,PA166157238,rs662,,,PON1,Efficacy,1,fluorouracil,1444694841.0,East Asian
1444694834,PA166157238,rs662,,,PON1,Efficacy,1,fluorouracil,1444694845.0,East Asian
1444694834,PA166157238,rs662,,,PON1,Efficacy,1,oxaliplatin,1444694841.0,East Asian
1444694834,PA166157238,rs662,,,PON1,Efficacy,1,oxaliplatin,1444694845.0,East Asian
1447676770,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676779.0,East Asian
1447676770,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676779.0,East Asian
1447676770,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1447676779.0,East Asian
1447676770,PA166155435,rs8099917,,,IFNL3,Efficacy,1,simeprevir,1447676779.0,East Asian
1447676770,PA166155435,rs8099917,,,IFNL3,Efficacy,1,simeprevir,1447676779.0,East Asian
769250167,PA166154159,rs12782374,,,CYP2C9,Other,0,phenytoin,,
769250167,PA166154159,rs12782374,,,CYP2C9,Metabolism/PK,0,phenytoin,,
769250168,PA166154159,rs12782374,,,CYP2C9,Dosage,1,phenytoin,769250170.0,European
769250168,PA166154159,rs12782374,,,CYP2C9,Metabolism/PK,1,phenytoin,769250170.0,European
1448266589,PA166160811,rs2734440,,,KLRC1,Efficacy,-1,adalimumab,1448266591.0,European
1448266589,PA166160811,rs2734440,,,KLRC1,Efficacy,-1,certolizumab pegol,1448266591.0,European
1448266589,PA166160811,rs2734440,,,KLRC1,Efficacy,-1,etanercept,1448266591.0,European
1448266589,PA166160811,rs2734440,,,KLRC1,Efficacy,-1,glucocorticoids,1448266591.0,European
1448266589,PA166160811,rs2734440,,,KLRC1,Efficacy,-1,infliximab,1448266591.0,European
1448266589,PA166160811,rs2734440,,,KLRC1,Efficacy,-1,methotrexate,1448266591.0,European
769250171,PA166154191,rs71486745,,,CYP2C9,Dosage,1,phenytoin,769250173.0,European
769250171,PA166154191,rs71486745,,,CYP2C9,Metabolism/PK,1,phenytoin,769250173.0,European
981754640,PA166154302,rs948854,,,GAL,Efficacy,1,antidepressants,981754645.0,European
981754640,PA166154302,rs948854,,,GAL,Efficacy,1,benzodiazepine derivatives,981754645.0,European
981754640,PA166154302,rs948854,,,GAL,Efficacy,1,mirtazapine,981754645.0,European
981754640,PA166154302,rs948854,,,GAL,Efficacy,1,Selective serotonin reuptake inhibitors,981754645.0,European
769250174,PA166154159,rs12782374,,,CYP2C9,Dosage,-1,warfarin,769250176.0,East Asian
769250174,PA166154159,rs12782374,,,CYP2C9,Metabolism/PK,-1,warfarin,769250176.0,East Asian
1447676752,PA166156703,rs201279313,,,SLC25A31,Efficacy,1,atenolol,1447676809.0,African American/Afro-Caribbean
1447676752,PA166156703,rs201279313,,,SLC25A31,Efficacy,1,hydrochlorothiazide,1447676809.0,African American/Afro-Caribbean
1447676752,PA166156703,rs201279313,,,SLC25A31,Efficacy,1,metoprolol,1447676809.0,African American/Afro-Caribbean
769250177,PA166154191,rs71486745,,,CYP2C9,Dosage,-1,warfarin,769250179.0,East Asian
769250177,PA166154191,rs71486745,,,CYP2C9,Metabolism/PK,-1,warfarin,769250179.0,East Asian
1444694848,PA166154980,rs10517,,,NQO1,Efficacy,0,epirubicin,1444694855.0,East Asian
1444694848,PA166154980,rs10517,,,NQO1,Efficacy,0,fluorouracil,1444694855.0,East Asian
1444694848,PA166154980,rs10517,,,NQO1,Efficacy,0,oxaliplatin,1444694855.0,East Asian
1184511673,PA166155409,rs3745274,,,CYP2B6,Dosage,-1,efavirenz,1184511696.0,European
1184511673,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184511696.0,European
1450821413,PA166156991,rs1799971,,,OPRM1,Dosage,1,ethanol,1450821417.0,"Multiple groups, 97.3% of participants were of ""Dutch origin""."
1451165480,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tramadol,1451165540.0,Unknown
1447676759,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447676765.0,Multiple groups
1447676759,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1447676765.0,Multiple groups
1447676759,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447676765.0,Multiple groups
1447676759,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447676765.0,Multiple groups
1447676759,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1447676765.0,Multiple groups
1447676759,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1447676765.0,Multiple groups
1184233225,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949101,NAT2*5C,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949124,NAT2*6J,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949129,NAT2*6O,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA166115839,NAT2*7G,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949138,NAT2*12A,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1184233225,,,PA165949148,NAT2*13A,NAT2,Metabolism/PK,1,isoniazid,1184233229.0,Latino
1448266578,PA166160809,rs2734414,,,KLRC1,Efficacy,-1,adalimumab,1448266580.0,European
1448266578,PA166160809,rs2734414,,,KLRC1,Efficacy,-1,certolizumab pegol,1448266580.0,European
1448266578,PA166160809,rs2734414,,,KLRC1,Efficacy,-1,etanercept,1448266580.0,European
1448266578,PA166160809,rs2734414,,,KLRC1,Efficacy,-1,glucocorticoids,1448266580.0,European
1448266578,PA166160809,rs2734414,,,KLRC1,Efficacy,-1,infliximab,1448266580.0,European
1448266578,PA166160809,rs2734414,,,KLRC1,Efficacy,-1,methotrexate,1448266580.0,European
1451116274,PA166155724,rs4251961,,,IL1RN,Efficacy,-1,anakinra,1451116279.0,Unknown
1451116274,PA166155724,rs4251961,,,IL1RN,Efficacy,-1,anakinra,1451116280.0,Unknown
1451116274,PA166155724,rs4251961,,,IL1RN,Efficacy,-1,canakinumab,1451116279.0,Unknown
1451116274,PA166155724,rs4251961,,,IL1RN,Efficacy,-1,canakinumab,1451116280.0,Unknown
1184511697,PA166155393,rs2279343,,,CYP2B6,Dosage,-1,efavirenz,1184511699.0,European
1184511697,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1184511699.0,European
1450985200,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,ritonavir,1450985205.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985200,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,ritonavir,1450985204.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985200,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,ritonavir,1450985207.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1450985200,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,ritonavir,1450985206.0,"Multiple groups, USA, Colorado : African-American,  Hispanic, Asian, Caucasian"
1444694872,PA166157273,rs854560,,,PON1,Efficacy,0,epirubicin,1444694874.0,East Asian
1444694872,PA166157273,rs854560,,,PON1,Efficacy,0,fluorouracil,1444694874.0,East Asian
1444694872,PA166157273,rs854560,,,PON1,Efficacy,0,oxaliplatin,1444694874.0,East Asian
827813946,PA166157441,rs10264272,,,CYP3A5,Dosage,-1,cyclosporine,827813978.0,"Multiple groups, Brazilian"
827813946,PA166157441,rs10264272,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827813978.0,"Multiple groups, Brazilian"
982033139,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982033147.0,East Asian
1444842336,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444842338.0,European
1444842336,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444842338.0,European
1444842336,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1444842338.0,European
1444694886,PA166156090,rs2266637,,,GSTT1,Efficacy,0,epirubicin,1444694888.0,East Asian
1444694886,PA166156090,rs2266637,,,GSTT1,Efficacy,0,fluorouracil,1444694888.0,East Asian
1444694886,PA166156090,rs2266637,,,GSTT1,Efficacy,0,oxaliplatin,1444694888.0,East Asian
1447676729,PA166157284,rs1045642,,,ABCB1,Efficacy,1,agomelatine,1447676751.0,European
1447676729,PA166157284,rs1045642,,,ABCB1,Efficacy,1,Melatonin receptor agonists,1447676751.0,European
1447676729,PA166157284,rs1045642,,,ABCB1,Efficacy,1,Selective serotonin reuptake inhibitors,1447676751.0,European
1447676729,PA166157284,rs1045642,,,ABCB1,Efficacy,1,venlafaxine,1447676751.0,European
1447676729,PA166157284,rs1045642,,,ABCB1,Efficacy,1,venlafaxine,1447676751.0,European
1448266553,PA166160715,rs2302489,,,KLRD1,Efficacy,1,adalimumab,1448266561.0,European
1448266553,PA166160715,rs2302489,,,KLRD1,Efficacy,1,certolizumab pegol,1448266561.0,European
1448266553,PA166160715,rs2302489,,,KLRD1,Efficacy,1,etanercept,1448266561.0,European
1448266553,PA166160715,rs2302489,,,KLRD1,Efficacy,1,glucocorticoids,1448266561.0,European
1448266553,PA166160715,rs2302489,,,KLRD1,Efficacy,1,infliximab,1448266561.0,European
1448266553,PA166160715,rs2302489,,,KLRD1,Efficacy,1,methotrexate,1448266561.0,European
1184135014,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,-1,axitinib,1184135020.0,Multiple groups
1451116369,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451116374.0,European
1451116369,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451116375.0,European
982033238,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033266.0,Unknown
982033238,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033261.0,Unknown
982033238,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033268.0,Unknown
1448266539,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,risperidone,1448266541.0,"Multiple groups, 81% Caucasian"
1448266539,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,risperidone,1448266541.0,"Multiple groups, 81% Caucasian"
1450821470,PA166184627,rs208293,,,P2RX7,Efficacy,-1,fentanyl,1450821475.0,Unknown
982033246,PA166156480,rs4961,,,ADD1,Efficacy,-1,atenolol,982033276.0,"Multiple groups, 11% Black, 47% Hispanic, 41% White"
982033246,PA166156480,rs4961,,,ADD1,Efficacy,-1,verapamil,982033276.0,"Multiple groups, 11% Black, 47% Hispanic, 41% White"
1448266512,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,-1,risperidone,1448266514.0,"Multiple groups, 81% Caucasian"
1450821482,PA166184629,rs7132846,,,P2RX7,Efficacy,-1,fentanyl,1450821487.0,Unknown
1451214640,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,0,irinotecan,1451214645.0,"Multiple groups, 94% white, 6% Black or African American"
1451214640,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1451214645.0,"Multiple groups, 94% white, 6% Black or African American"
1451214640,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1451214645.0,"Multiple groups, 94% white, 6% Black or African American"
1451214640,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1451214645.0,"Multiple groups, 94% white, 6% Black or African American"
1450821424,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1450821430.0,Unknown
1450821424,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1450821429.0,Unknown
1448266492,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,risperidone,1448266495.0,"Multiple groups, 81% Caucasian"
1448266492,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,risperidone,1448266495.0,"Multiple groups, 81% Caucasian"
1451116340,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lopinavir,1451116361.0,European
1451116340,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lopinavir,1451116360.0,European
827698684,PA166157267,rs776746,,,CYP3A5,Efficacy,0,tacrolimus,827698700.0,Unknown
827698684,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,tacrolimus,827698700.0,Unknown
1447676673,PA166155628,rs1143623,,,IL1B,Efficacy,1,metformin,1447676680.0,East Asian
1447676673,PA166155628,rs1143623,,,IL1B,Efficacy,1,metformin,1447676687.0,East Asian
1447676673,PA166155628,rs1143623,,,IL1B,Efficacy,1,metformin,1447676680.0,East Asian
1447676673,PA166155628,rs1143623,,,IL1B,Efficacy,1,metformin,1447676687.0,East Asian
1447676673,PA166155628,rs1143623,,,IL1B,Efficacy,1,metformin,1447676680.0,East Asian
1447676673,PA166155628,rs1143623,,,IL1B,Efficacy,1,metformin,1447676687.0,East Asian
827698683,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,0,tegafur,827698702.0,Unknown
827698683,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,tegafur,827698702.0,Unknown
827698683,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,0,tegafur,827698702.0,Unknown
827698683,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,0,tegafur,827698702.0,Unknown
827698683,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,0,tegafur,827698702.0,Unknown
981345098,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,warfarin,981345102.0,European
1448266483,PA166156423,rs7643645,,,NR1I2,Metabolism/PK,-1,risperidone,1448266485.0,"Multiple groups, 81% Caucasian"
1450821451,PA166184626,rs1718125,,,P2RX7,Efficacy,-1,fentanyl,1450821456.0,Unknown
769250028,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,1,phenytoin,769250030.0,Unknown
1184511789,PA166154768,rs861539,,,XRCC3,Efficacy,0,Platinum compounds,1184511791.0,Multiple groups
1444694702,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,-1,warfarin,1444694708.0,East Asian
769250031,PA166153959,rs1057910,,,CYP2C9,Other,0,phenytoin,769250033.0,Unknown
769250031,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,0,phenytoin,769250033.0,Unknown
827813351,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,827813360.0,Unknown
827813351,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,827813354.0,Unknown
827813351,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,827813356.0,Unknown
1448266465,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,risperidone,1448266467.0,"Multiple groups, 81% Caucasian"
1448594141,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,imatinib,1448594143.0,Multiple groups
1448594141,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,imatinib,1448594143.0,Multiple groups
1448594134,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,imatinib,1448594136.0,Multiple groups
1449183103,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1449183115.0,African American/Afro-Caribbean
1449183103,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1449183115.0,African American/Afro-Caribbean
1449183103,,,PA166128233,CYP3A5*6,CYP3A5,Dosage,1,tacrolimus,1449183115.0,African American/Afro-Caribbean
1449183103,,,PA166128234,CYP3A5*7,CYP3A5,Dosage,1,tacrolimus,1449183115.0,African American/Afro-Caribbean
1450821537,PA166180936,rs11280056,,,TYMS,Efficacy,-1,folic acid,1450821542.0,European
1450821537,PA166180936,rs11280056,,,TYMS,Efficacy,-1,hydroxychloroquine,1450821542.0,European
1450821537,PA166180936,rs11280056,,,TYMS,Efficacy,-1,methotrexate,1450821542.0,European
1450821537,PA166180936,rs11280056,,,TYMS,Efficacy,-1,sulfasalazine,1450821542.0,European
1448266456,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,risperidone,1448266458.0,"Multiple groups, 81% Caucasian"
1444694721,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1444694726.0,East Asian
1448266447,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,risperidone,1448266449.0,"Multiple groups, 81% Caucasian"
1448594125,PA166156544,rs2231142,,,ABCG2,Efficacy,1,imatinib,1448594128.0,East Asian
1448594125,PA166156544,rs2231142,,,ABCG2,Efficacy,1,imatinib,1448594127.0,Multiple groups
1448594125,PA166156544,rs2231142,,,ABCG2,Efficacy,1,imatinib,1448594130.0,East Asian
1448594125,PA166156544,rs2231142,,,ABCG2,Efficacy,1,imatinib,1448594129.0,Multiple groups
1448266438,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,risperidone,1448266440.0,"Multiple groups, 81% Caucasian"
982033269,PA166153959,rs1057910,,,CYP2C9,Dosage,0,warfarin,982033291.0,Unknown
982033269,PA166153959,rs1057910,,,CYP2C9,Efficacy,0,warfarin,982033291.0,Unknown
982033269,PA166153959,rs1057910,,,CYP2C9,Toxicity,0,warfarin,982033291.0,Unknown
1448594115,PA166157316,rs2032582,,,ABCB1,Efficacy,1,imatinib,1448594120.0,East Asian
1448594115,PA166157316,rs2032582,,,ABCB1,Efficacy,1,imatinib,1448594119.0,Multiple groups
1449002901,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,methotrexate,1449002913.0,East Asian
1448266420,PA166156352,rs2276707,,,NR1I2,Metabolism/PK,1,risperidone,1448266422.0,"Multiple groups, 81% Caucasian"
827813298,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,tamoxifen,827813302.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,tamoxifen,827813304.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,tamoxifen,827813302.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,tamoxifen,827813304.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,827813302.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,827813304.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,tamoxifen,827813302.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,tamoxifen,827813304.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,tamoxifen,827813302.0,"Multiple groups, >95% were Caucasian patients."
827813298,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,tamoxifen,827813304.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,antineoplastic agents,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,antineoplastic agents,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,antineoplastic agents,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,antineoplastic agents,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,tamoxifen,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,tamoxifen,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,827813296.0,"Multiple groups, >95% were Caucasian patients."
827813293,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,tamoxifen,827813296.0,"Multiple groups, >95% were Caucasian patients."
1449576353,PA166170105,rs1799836,,,MAOB,Dosage,-1,levodopa,1449576355.0,Latino
1444694638,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1444694648.0,East Asian
981754835,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,981754839.0,Near Eastern
981754835,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,981754839.0,Near Eastern
981754835,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,981754839.0,Near Eastern
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,tamoxifen,827813288.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,tamoxifen,827813282.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,tamoxifen,827813284.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,tamoxifen,827813286.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,tamoxifen,827813288.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,tamoxifen,827813282.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,tamoxifen,827813284.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,tamoxifen,827813286.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,827813288.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,827813282.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,827813284.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,tamoxifen,827813286.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,tamoxifen,827813288.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,tamoxifen,827813282.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,tamoxifen,827813284.0,"Multiple groups, >95% were Caucasian patients."
827813279,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,tamoxifen,827813286.0,"Multiple groups, >95% were Caucasian patients."
1444694650,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444694652.0,East Asian
1448266403,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,1,risperidone,1448266411.0,"Multiple groups, 81% Caucasian"
1449002928,PA166170682,rs2838958,,,SLC19A1,Efficacy,1,methotrexate,1449002930.0,East Asian
1449576366,PA166156024,rs4680,,,COMT,Dosage,-1,levodopa,1449576368.0,Latino
1448266389,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,risperidone,1448266394.0,"Multiple groups, 81% caucasian"
982033386,PA166155187,rs1799752,,,ACE,Efficacy,-1,lisinopril,982033398.0,Unknown
982033386,PA166155187,rs1799752,,,ACE,Efficacy,-1,lisinopril,982033396.0,Unknown
1184085972,PA166156945,rs747199,,,SLC29A1,Efficacy,-1,gemcitabine,1184085981.0,East Asian
1184085972,PA166156945,rs747199,,,SLC29A1,Efficacy,-1,paclitaxel,1184085981.0,East Asian
1449002940,PA166154633,rs11045879,,,SLCO1B1,Efficacy,-1,methotrexate,1449002942.0,East Asian
1444694656,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1444694658.0,East Asian
982033375,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033385.0,Unknown
982033375,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,982033400.0,Unknown
981754851,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,981754858.0,Near Eastern
1184512008,PA166153689,rs2274567,,,CR1,Efficacy,1,eculizumab,1184512012.0,Unknown
1184512008,PA166153689,rs2274567,,,CR1,Efficacy,1,eculizumab,1184512014.0,Unknown
1184085969,PA166157795,rs7867504,,,SLC28A3,Efficacy,-1,gemcitabine,1184085990.0,East Asian
1184085969,PA166157795,rs7867504,,,SLC28A3,Efficacy,-1,paclitaxel,1184085990.0,East Asian
1184085969,PA166157795,rs7867504,,,SLC28A3,Efficacy,-1,paclitaxel,1184085990.0,East Asian
1184512015,PA166153753,rs3811381,,,CR1,Efficacy,-1,eculizumab,1184512017.0,Unknown
1184512015,PA166153753,rs3811381,,,CR1,Efficacy,-1,eculizumab,1184512018.0,Unknown
1449576387,PA166170105,rs1799836,,,MAOB,Dosage,-1,levodopa,1449576389.0,Latino
1449576387,PA166170105,rs1799836,,,MAOB,Dosage,-1,levodopa,1449576389.0,Latino
1184512020,PA166155386,rs2230199,,,C3,Efficacy,-1,eculizumab,1184512022.0,Unknown
1184512020,PA166155386,rs2230199,,,C3,Efficacy,-1,eculizumab,1184512023.0,Unknown
1184512020,PA166155386,rs2230199,,,C3,Efficacy,-1,eculizumab,1184512022.0,Unknown
1184512020,PA166155386,rs2230199,,,C3,Efficacy,-1,eculizumab,1184512023.0,Unknown
1449576398,,,PA165924744,CYP2A6*17,CYP2A6,Metabolism/PK,-1,metronidazole,1449576421.0,Multiple groups
1449002970,PA166155986,rs1051266,,,SLC19A1,Efficacy,-1,methotrexate,1449002972.0,East Asian
1449002964,PA166154547,rs2306283,,,SLCO1B1,Efficacy,-1,methotrexate,1449002966.0,East Asian
982033349,PA166155187,rs1799752,,,ACE,Efficacy,-1,enalapril,982033359.0,Unknown
1444694693,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1444694699.0,East Asian
1449002987,PA166155990,rs1131596,,,SLC19A1,Efficacy,-1,methotrexate,1449002989.0,East Asian
1185003550,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,trastuzumab,1185003552.0,Unknown
1450821649,PA166180936,rs11280056,,,TYMS,Efficacy,-1,capecitabine,1450821654.0,European
1450821649,PA166180936,rs11280056,,,TYMS,Efficacy,-1,fluorouracil,1450821654.0,European
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,bevacizumab,1450821660.0,Unknown
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,capecitabine,1450821660.0,Unknown
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,cisplatin,1450821660.0,Unknown
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,docetaxel,1450821660.0,Unknown
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,epirubicin,1450821660.0,Unknown
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,oxaliplatin,1450821660.0,Unknown
1450821655,PA166180936,rs11280056,,,TYMS,Efficacy,-1,trastuzumab,1450821660.0,Unknown
1449002998,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,methotrexate,1449003000.0,East Asian
1449003010,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,methotrexate,1449003012.0,East Asian
1449002981,PA166170691,rs3788200,,,SLC19A1,Efficacy,-1,methotrexate,1449002983.0,East Asian
1449003004,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methotrexate,1449003006.0,East Asian
1184511945,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,1184511949.0,"Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)"
1184511945,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,1184511949.0,"Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)"
1184511945,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,1184511949.0,"Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)"
1184511945,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,1,warfarin,1184511949.0,"Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)"
1447676504,PA166156950,rs763780,,,IL17F,Efficacy,-1,adalimumab,1447676511.0,European
1447676504,PA166156950,rs763780,,,IL17F,Efficacy,-1,adalimumab,1447676509.0,European
1447676504,PA166156950,rs763780,,,IL17F,Efficacy,-1,etanercept,1447676511.0,European
1447676504,PA166156950,rs763780,,,IL17F,Efficacy,-1,etanercept,1447676509.0,European
1447676504,PA166156950,rs763780,,,IL17F,Efficacy,-1,infliximab,1447676511.0,European
1447676504,PA166156950,rs763780,,,IL17F,Efficacy,-1,infliximab,1447676509.0,European
1447676481,PA166156950,rs763780,,,IL17F,Efficacy,1,infliximab,1447676489.0,European
1447676481,PA166156950,rs763780,,,IL17F,Efficacy,1,infliximab,1447676487.0,European
1184511955,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,1,warfarin,1184511959.0,"Multiple groups, White (n=21), Black (n=3), Asian (n=3), Indian (n=3)"
1448266301,PA166160762,rs7719775,,,RICTOR,Efficacy,-1,platinum,1448266303.0,East Asian
981754860,PA166153625,rs1131873,,,EPHX1,Dosage,-1,warfarin,981754866.0,Near Eastern
1447676490,PA166156950,rs763780,,,IL17F,Efficacy,1,adalimumab,1447676501.0,European
1447676490,PA166156950,rs763780,,,IL17F,Efficacy,1,adalimumab,1447676499.0,European
1450821634,PA166180936,rs11280056,,,TYMS,Efficacy,-1,fluorouracil,1450821640.0,Unknown
1450821634,PA166180936,rs11280056,,,TYMS,Efficacy,-1,leucovorin,1450821640.0,Unknown
1450821634,PA166180936,rs11280056,,,TYMS,Efficacy,-1,oxaliplatin,1450821640.0,Unknown
1449003038,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,oxycodone,1449003080.0,Unknown
1449003038,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,oxycodone,1449003080.0,Unknown
1448495665,,,PA165860672,CYP1A1*1,CYP1A1,Metabolism/PK,-1,exemestane,1448495667.0,Multiple groups
1448495665,,,PA165860673,CYP1A1*2A,CYP1A1,Metabolism/PK,-1,exemestane,1448495667.0,Multiple groups
1447676470,PA166156950,rs763780,,,IL17F,Efficacy,1,ustekinumab,1447676480.0,European
1447676470,PA166156950,rs763780,,,IL17F,Efficacy,1,ustekinumab,1447676478.0,European
1448266279,PA166160760,rs6878291,,,RICTOR,Efficacy,1,platinum,1448266285.0,East Asian
1450936406,PA166186146,rs1042028,,,SULT1A1,Metabolism/PK,-1,acetaminophen,1450936410.0,"Multiple groups, White, Black"
1450936406,PA166186146,rs1042028,,,SULT1A1,Metabolism/PK,-1,acetaminophen,1450936411.0,"Multiple groups, White, Black"
1450936406,PA166186146,rs1042028,,,SULT1A1,Metabolism/PK,-1,acetaminophen,1450936412.0,"Multiple groups, Black, White"
1444710914,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,4-hydroxytamoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,4-hydroxytamoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,endoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,endoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,n-desmethyltamoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,n-desmethyltamoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710914,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamoxifen,1444710916.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
982033507,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982033524.0,East Asian
1444841988,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444842015.0,East Asian
1444841988,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444842015.0,East Asian
1444841988,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1444842015.0,East Asian
1444841988,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1444842015.0,East Asian
1449576511,,,PA165959980,UGT1A3*1,UGT1A3,Metabolism/PK,1,montelukast,1449576513.0,European
1449576511,,,PA165959981,UGT1A3*2,UGT1A3,Metabolism/PK,1,montelukast,1449576513.0,European
1444710925,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,4-hydroxytamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,4-hydroxytamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,4-hydroxytamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,4-hydroxytamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,endoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,endoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,endoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,endoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,n-desmethyltamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,n-desmethyltamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,n-desmethyltamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,n-desmethyltamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,tamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,tamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,tamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710925,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,tamoxifen,1444710927.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1448102401,PA166155143,rs4291,,,ACE,Efficacy,-1,sertraline,1448102403.0,Near Eastern
1449003091,PA166156991,rs1799971,,,OPRM1,Dosage,-1,oxycodone,1449003093.0,Unknown
1449003085,PA166157284,rs1045642,,,ABCB1,Dosage,-1,oxycodone,1449003087.0,Unknown
1449576525,PA166179594,rs704212,,,ABCC9,Metabolism/PK,1,montelukast,1449576527.0,European
1450969140,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenytoin,1450969145.0,"Multiple groups, White, non-Hispanic; Asian; BlackWhite, Hispanic"
1450969140,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,phenytoin,1450969145.0,"Multiple groups, White, non-Hispanic; Asian; BlackWhite, Hispanic"
1450821690,PA166180936,rs11280056,,,TYMS,Efficacy,1,fluorouracil,1450821697.0,Unknown
1450821690,PA166180936,rs11280056,,,TYMS,Efficacy,1,fluorouracil,1450821695.0,Unknown
1450821690,PA166180936,rs11280056,,,TYMS,Efficacy,1,fluorouracil,1450821696.0,Unknown
1184512158,PA166156985,rs1570360,,,VEGFA,Efficacy,1,docetaxel,1184512162.0,Unknown
1444710945,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,4-hydroxytamoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,4-hydroxytamoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,endoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,endoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,n-desmethyltamoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,n-desmethyltamoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,tamoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710945,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,tamoxifen,1444710947.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1447676403,PA166157093,rs3957356,,,GSTA1,Metabolism/PK,1,busulfan,1447676409.0,East Asian
1183954989,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183958240.0,East Asian
1183954989,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1183958240.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,chlorpromazine,1447987759.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,clozapine,1447987759.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,haloperidol,1447987759.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,olanzapine,1447987759.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,quetiapine,1447987759.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,risperidone,1447987759.0,East Asian
1447987701,PA166156984,rs1415744,,,EPM2A,Efficacy,1,trifluoperazine,1447987759.0,East Asian
1450936394,PA166186146,rs1042028,,,SULT1A1,Efficacy,1,acetaminophen,1450936398.0,European
827698925,PA166155944,rs3918242,,,MMP9,Efficacy,1,Antihypertensives,827698930.0,"Multiple groups, Brazil, 73% White other ethnicities not described"
827698925,PA166155944,rs3918242,,,MMP9,Efficacy,1,hydralazine,827698930.0,"Multiple groups, Brazil, 73% White other ethnicities not described"
827698925,PA166155944,rs3918242,,,MMP9,Efficacy,1,Methyldopa,827698930.0,"Multiple groups, Brazil, 73% White other ethnicities not described"
827698925,PA166155944,rs3918242,,,MMP9,Efficacy,1,nifedipine,827698930.0,"Multiple groups, Brazil, 73% White other ethnicities not described"
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,amitriptyline,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,amitriptyline,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,clomipramine,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,clomipramine,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,doxepin,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,doxepin,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,imipramine,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,imipramine,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,maprotiline,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,maprotiline,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,nortriptyline,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,nortriptyline,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Dosage,1,opipramol,981476433.0,European
981476423,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,opipramol,981476433.0,European
1450936460,PA166186212,rs28362731,,,AQP1,Efficacy,-1,cisplatin,1450936466.0,Unknown
1450936460,PA166186212,rs28362731,,,AQP1,Efficacy,-1,cisplatin,1450936465.0,Unknown
1450936460,PA166186212,rs28362731,,,AQP1,Efficacy,-1,cisplatin,1450936467.0,Unknown
982033561,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,982033568.0,Unknown
1448266217,PA166155823,rs12995526,,,ATIC,Efficacy,1,methotrexate,1448266219.0,European
827698919,PA166155944,rs3918242,,,MMP9,Efficacy,1,Methyldopa,827698924.0,"Multiple groups, Brazil, 73.3% White other ethnicities not documented"
1450936468,PA166186213,rs1049305,,,AQP1,Efficacy,-1,cisplatin,1450936474.0,Unknown
1450936468,PA166186213,rs1049305,,,AQP1,Efficacy,-1,cisplatin,1450936473.0,Unknown
1450936468,PA166186213,rs1049305,,,AQP1,Efficacy,-1,cisplatin,1450936475.0,Unknown
1448266210,PA166155761,rs7563206,,,ATIC,Efficacy,1,methotrexate,1448266212.0,European
1447676364,PA166154375,rs2514218,,,DRD2,Efficacy,1,clozapine,1447676372.0,Multiple groups
1447676364,PA166154375,rs2514218,,,DRD2,Efficacy,1,clozapine,1447676370.0,European
1184086177,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,gemcitabine,1184086182.0,East Asian
1184086177,PA166157316,rs2032582,,,ABCB1,Toxicity,-1,gemcitabine,1184086182.0,East Asian
1184086177,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,paclitaxel,1184086182.0,East Asian
1184086177,PA166157316,rs2032582,,,ABCB1,Toxicity,-1,paclitaxel,1184086182.0,East Asian
1448266196,PA166155684,rs2372536,,,ATIC,Efficacy,1,methotrexate,1448266198.0,European
981345436,PA166156568,rs2960306,,,GRK4,Efficacy,1,atenolol,981345449.0,"Multiple groups, mostly Whites and Blacks."
1448266203,PA166155733,rs4673993,,,ATIC,Efficacy,1,methotrexate,1448266205.0,European
981345450,PA166156499,rs1024323,,,GRK4,Efficacy,1,atenolol,981345461.0,"Multiple groups, mostly Whites and Blacks."
1447676351,PA166156537,rs2071559,,,KDR,Efficacy,1,ranibizumab,1447676357.0,Unknown
1447676351,PA166156537,rs2071559,,,KDR,Efficacy,1,ranibizumab,1447676359.0,Unknown
1447954876,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,primaquine,1447954878.0,Multiple groups
1447954876,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,1,primaquine,1447954878.0,Multiple groups
1447954876,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,primaquine,1447954878.0,Multiple groups
1447954876,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,1,primaquine,1447954878.0,Multiple groups
1447954876,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,primaquine,1447954878.0,Multiple groups
1447954876,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,primaquine,1447954878.0,Multiple groups
1448266186,PA166156776,rs1801394,,,FASTKD3,Efficacy,1,methotrexate,1448266188.0,European
1448266186,PA166156776,rs1801394,,,MTRR,Efficacy,1,methotrexate,1448266188.0,European
1450969200,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenytoin,1450969208.0,"Multiple groups, White, non-Hispanic; Asian; Black; White, Hispanic"
1450969200,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,phenytoin,1450969208.0,"Multiple groups, White, non-Hispanic; Asian; Black; White, Hispanic"
1450969200,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenytoin,1450969208.0,"Multiple groups, White, non-Hispanic; Asian; Black; White, Hispanic"
1451198580,PA166154895,rs2472297,,,CYP1A1,Metabolism/PK,1,caffeine,1451198584.0,European
1447676333,PA166156478,rs4073,,,CXCL8,Efficacy,1,ranibizumab,1447676348.0,Unknown
1447676333,PA166156478,rs4073,,,CXCL8,Efficacy,1,ranibizumab,1447676345.0,Unknown
1447676333,PA166156478,rs4073,,,CXCL8,Efficacy,1,ranibizumab,1447676339.0,Unknown
1447676333,PA166156478,rs4073,,,CXCL8,Efficacy,1,ranibizumab,1447676350.0,Unknown
1448102319,PA166155187,rs1799752,,,ACE,Efficacy,1,sertraline,1448102367.0,Near Eastern
1448102319,PA166155187,rs1799752,,,ACE,Efficacy,1,sertraline,1448102383.0,Near Eastern
1448102319,PA166155187,rs1799752,,,ACE,Efficacy,1,sertraline,1448102367.0,Near Eastern
1448102319,PA166155187,rs1799752,,,ACE,Efficacy,1,sertraline,1448102383.0,Near Eastern
1450969293,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,phenytoin,1450969320.0,Multiple groups
1450969293,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,phenytoin,1450969320.0,Multiple groups
1450969293,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenytoin,1450969320.0,Multiple groups
1448266150,PA166153654,rs1805087,,,MTR,Efficacy,1,methotrexate,1448266153.0,European
1184086250,PA166156950,rs763780,,,IL17F,Efficacy,-1,gemcitabine,1184086252.0,East Asian
1184086250,PA166156950,rs763780,,,IL17F,Toxicity,-1,gemcitabine,1184086252.0,East Asian
1184086250,PA166156950,rs763780,,,IL17F,Efficacy,-1,paclitaxel,1184086252.0,East Asian
1184086250,PA166156950,rs763780,,,IL17F,Toxicity,-1,paclitaxel,1184086252.0,East Asian
1184086238,PA166157828,rs11141915,,,DAPK1,Efficacy,-1,gemcitabine,1184086240.0,East Asian
1184086238,PA166157828,rs11141915,,,DAPK1,Toxicity,-1,gemcitabine,1184086240.0,East Asian
1184086238,PA166157828,rs11141915,,,DAPK1,Efficacy,-1,paclitaxel,1184086240.0,East Asian
1184086238,PA166157828,rs11141915,,,DAPK1,Toxicity,-1,paclitaxel,1184086240.0,East Asian
1184233704,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,0,efavirenz,1184233706.0,Unknown
1003775005,PA166154975,rs5882,,,CETP,Efficacy,1,simvastatin,1004987508.0,Unknown
1184086242,PA166156662,rs12648166,,,DCK,Efficacy,-1,gemcitabine,1184086244.0,East Asian
1184086242,PA166156662,rs12648166,,,DCK,Toxicity,-1,gemcitabine,1184086244.0,East Asian
1184086242,PA166156662,rs12648166,,,DCK,Efficacy,-1,paclitaxel,1184086244.0,East Asian
1184086242,PA166156662,rs12648166,,,DCK,Toxicity,-1,paclitaxel,1184086244.0,East Asian
1184233697,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1184233702.0,Unknown
1184086228,PA166157481,rs28371759,,,CYP3A4,Efficacy,-1,gemcitabine,1184086230.0,East Asian
1184086228,PA166157481,rs28371759,,,CYP3A4,Toxicity,-1,gemcitabine,1184086230.0,East Asian
1184086228,PA166157481,rs28371759,,,CYP3A4,Efficacy,-1,paclitaxel,1184086230.0,East Asian
1184086228,PA166157481,rs28371759,,,CYP3A4,Toxicity,-1,paclitaxel,1184086230.0,East Asian
1444710781,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444710783.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710781,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444710803.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710781,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444710783.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710781,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,n-desmethyltamoxifen,1444710803.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1184086220,PA166155621,rs1056836,,,CYP1B1,Efficacy,-1,gemcitabine,1184086222.0,East Asian
1184086220,PA166155621,rs1056836,,,CYP1B1,Toxicity,-1,gemcitabine,1184086222.0,East Asian
1184086220,PA166155621,rs1056836,,,CYP1B1,Efficacy,-1,paclitaxel,1184086222.0,East Asian
1184086220,PA166155621,rs1056836,,,CYP1B1,Toxicity,-1,paclitaxel,1184086222.0,East Asian
1184086220,PA166155621,rs1056836,,,CYP1B1,Toxicity,-1,paclitaxel,1184086222.0,East Asian
1447954841,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,tafenoquine,1447954943.0,Multiple groups
1447954841,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,tafenoquine,1447954875.0,Multiple groups
1447954841,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,tafenoquine,1447954943.0,Multiple groups
1447954841,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,tafenoquine,1447954875.0,Multiple groups
1447954841,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,tafenoquine,1447954943.0,Multiple groups
1447954841,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,tafenoquine,1447954875.0,Multiple groups
1447954841,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,-1,tafenoquine,1447954943.0,Multiple groups
1447954841,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,-1,tafenoquine,1447954875.0,Multiple groups
1447954841,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,tafenoquine,1447954943.0,Multiple groups
1447954841,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,tafenoquine,1447954875.0,Multiple groups
1447954841,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,-1,tafenoquine,1447954943.0,Multiple groups
1447954841,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,-1,tafenoquine,1447954875.0,Multiple groups
1184086224,PA166153766,rs4492666,,,CMPK1,Efficacy,-1,gemcitabine,1184086226.0,East Asian
1184086224,PA166153766,rs4492666,,,CMPK1,Toxicity,-1,gemcitabine,1184086226.0,East Asian
1184086224,PA166153766,rs4492666,,,CMPK1,Efficacy,-1,paclitaxel,1184086226.0,East Asian
1184086224,PA166153766,rs4492666,,,CMPK1,Toxicity,-1,paclitaxel,1184086226.0,East Asian
1184086224,PA166153766,rs4492666,,,CMPK1,Toxicity,-1,paclitaxel,1184086226.0,East Asian
1184086212,PA166153590,rs818194,,,CDA,Efficacy,-1,gemcitabine,1184086214.0,East Asian
1184086212,PA166153590,rs818194,,,CDA,Toxicity,-1,gemcitabine,1184086214.0,East Asian
1184086212,PA166153590,rs818194,,,CDA,Efficacy,-1,paclitaxel,1184086214.0,East Asian
1184086212,PA166153590,rs818194,,,CDA,Toxicity,-1,paclitaxel,1184086214.0,East Asian
1184086216,PA166153822,rs11211524,,,CMPK1,Efficacy,-1,gemcitabine,1184086218.0,East Asian
1184086216,PA166153822,rs11211524,,,CMPK1,Toxicity,-1,gemcitabine,1184086218.0,East Asian
1184086216,PA166153822,rs11211524,,,CMPK1,Efficacy,-1,paclitaxel,1184086218.0,East Asian
1184086216,PA166153822,rs11211524,,,CMPK1,Toxicity,-1,paclitaxel,1184086218.0,East Asian
1447954815,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,primaquine,1447954817.0,Unknown
1447954815,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,primaquine,1447954817.0,Unknown
1447954815,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,primaquine,1447954817.0,Unknown
1447954815,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,primaquine,1447954817.0,Unknown
1447954815,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,primaquine,1447954817.0,Unknown
1447954815,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,primaquine,1447954817.0,Unknown
1444710805,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,4-hydroxytamoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,endoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,endoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,n-desmethyltamoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710805,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,tamoxifen,1444710807.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1448266111,PA166153644,rs1801133,,,CLCN6,Efficacy,1,methotrexate,1448266113.0,European
1448266111,PA166153644,rs1801133,,,MTHFR,Efficacy,1,methotrexate,1448266113.0,European
981476533,PA166153976,rs1801252,,,ADRB1,Efficacy,1,metoprolol,981476542.0,East Asian
981345462,PA166156524,rs1801058,,,GRK4,Efficacy,-1,atenolol,981345474.0,"Multiple groups, mostly Blacks, Whites"
1184086196,PA166153610,rs1048977,,,CDA,Efficacy,-1,gemcitabine,1184086201.0,East Asian
1184086196,PA166153610,rs1048977,,,CDA,Toxicity,-1,gemcitabine,1184086201.0,East Asian
1184086196,PA166153610,rs1048977,,,CDA,Efficacy,-1,paclitaxel,1184086201.0,East Asian
1184086196,PA166153610,rs1048977,,,CDA,Toxicity,-1,paclitaxel,1184086201.0,East Asian
1447987564,PA166154836,rs4646,,,CYP19A1,Efficacy,1,tamoxifen,1447987640.0,East Asian
1448266104,PA166153643,rs1801131,,,C1orf167,Efficacy,1,methotrexate,1448266110.0,European
1448266104,PA166153643,rs1801131,,,CLCN6,Efficacy,1,methotrexate,1448266110.0,European
1448266104,PA166153643,rs1801131,,,MTHFR,Efficacy,1,methotrexate,1448266110.0,European
1184086203,PA166153667,rs2072671,,,CDA,Efficacy,-1,gemcitabine,1184086207.0,East Asian
1184086203,PA166153667,rs2072671,,,CDA,Toxicity,-1,gemcitabine,1184086207.0,East Asian
1184086203,PA166153667,rs2072671,,,CDA,Efficacy,-1,paclitaxel,1184086207.0,East Asian
1184086203,PA166153667,rs2072671,,,CDA,Toxicity,-1,paclitaxel,1184086207.0,East Asian
1184086188,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,gemcitabine,1184086192.0,East Asian
1184086188,PA166157288,rs1128503,,,ABCB1,Toxicity,-1,gemcitabine,1184086192.0,East Asian
1184086188,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,paclitaxel,1184086192.0,East Asian
1184086188,PA166157288,rs1128503,,,ABCB1,Toxicity,-1,paclitaxel,1184086192.0,East Asian
1184348458,,,PA165819268,TPMT*1,TPMT,Dosage,0,mercaptopurine,1184348460.0,"Multiple groups, Three Whites and One Malaysian from Singapore"
1184348458,,,PA165819272,TPMT*3C,TPMT,Dosage,0,mercaptopurine,1184348460.0,"Multiple groups, Three Whites and One Malaysian from Singapore"
1184348458,,,PA165819268,TPMT*1,TPMT,Toxicity,0,mercaptopurine,1184348460.0,"Multiple groups, Three Whites and One Malaysian from Singapore"
1184348458,,,PA165819272,TPMT*3C,TPMT,Toxicity,0,mercaptopurine,1184348460.0,"Multiple groups, Three Whites and One Malaysian from Singapore"
1446906191,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,0,voriconazole,1446906201.0,European
1450821908,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450821912.0,Unknown
1450821908,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450821913.0,Unknown
827698783,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,-1,tegafur,827698789.0,East Asian
1184348438,,,PA165819268,TPMT*1,TPMT,Dosage,0,mercaptopurine,1184348444.0,"Multiple groups, Two Whites and One Chinese from Singapore"
1184348438,,,PA165819270,TPMT*3A,TPMT,Dosage,0,mercaptopurine,1184348444.0,"Multiple groups, Two Whites and One Chinese from Singapore"
1184348438,,,PA165819268,TPMT*1,TPMT,Toxicity,0,mercaptopurine,1184348444.0,"Multiple groups, Two Whites and One Chinese from Singapore"
1184348438,,,PA165819270,TPMT*3A,TPMT,Toxicity,0,mercaptopurine,1184348444.0,"Multiple groups, Two Whites and One Chinese from Singapore"
1446906210,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cilostazol,1446906214.0,East Asian
1446906210,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cilostazol,1446906215.0,East Asian
1446906210,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cilostazol,1446906213.0,East Asian
1446906210,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,cilostazol,1446906212.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906214.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906215.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906213.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906212.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906214.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906215.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906213.0,East Asian
1446906210,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,cilostazol,1446906212.0,East Asian
1447954774,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,primaquine,1447954776.0,Unknown
1447954774,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,primaquine,1447954776.0,Unknown
1447954774,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,primaquine,1447954776.0,Unknown
1447954774,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,primaquine,1447954776.0,Unknown
1447954774,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,primaquine,1447954776.0,Unknown
1447954774,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,primaquine,1447954776.0,Unknown
827813451,PA166153646,rs1801159,,,DPYD,Efficacy,-1,fluorouracil,827813458.0,European
827813447,PA166155331,rs45445694,,,TYMS,Efficacy,-1,fluorouracil,827813450.0,European
1449576724,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tamsulosin,1449576726.0,East Asian
1449576724,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tamsulosin,1449576727.0,East Asian
1449576724,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tamsulosin,1449576728.0,East Asian
1449576724,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tamsulosin,1449576729.0,East Asian
1449576724,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tamsulosin,1449576730.0,East Asian
1449576724,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tamsulosin,1449576731.0,East Asian
1449576724,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tamsulosin,1449576726.0,East Asian
1449576724,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tamsulosin,1449576727.0,East Asian
1449576724,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tamsulosin,1449576728.0,East Asian
1449576724,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tamsulosin,1449576729.0,East Asian
1449576724,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tamsulosin,1449576730.0,East Asian
1449576724,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tamsulosin,1449576731.0,East Asian
1449560343,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,lamotrigine,1449560349.0,European
1449560343,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,lamotrigine,1449560352.0,European
1449560343,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,lamotrigine,1449560355.0,European
1184086271,PA166156947,rs760370,,,SLC29A1,Efficacy,1,gemcitabine,1184086273.0,East Asian
1184086271,PA166156947,rs760370,,,SLC29A1,Efficacy,1,paclitaxel,1184086273.0,East Asian
827698754,PA166155446,rs8192725,,,CYP2A6,Metabolism/PK,-1,tegafur,827698761.0,East Asian
827813437,PA166156052,rs470119,,,IMPDH2,Efficacy,-1,fluorouracil,827813446.0,European
1444710751,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444710753.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710751,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444710894.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710751,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444710753.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710751,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444710894.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710751,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444710753.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1444710751,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444710894.0,"Multiple groups, Chinese, Indian and Malay from Singapore"
1449560363,PA166155759,rs6755571,,,UGT1A4,Metabolism/PK,-1,lamotrigine,1449560365.0,European
1449576742,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,cyclophosphamide,1449576748.0,Central/South Asian
1449576742,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,doxorubicin,1449576748.0,Central/South Asian
827698736,PA166155445,rs8192720,,,CYP2A6,Metabolism/PK,1,tegafur,827698743.0,East Asian
1447676212,PA166155238,rs9904341,,,BIRC5,Efficacy,1,methotrexate,1447676220.0,European
1184086254,PA166153842,rs12046844,,,PDE4B,Efficacy,-1,gemcitabine,1184086256.0,East Asian
1184086254,PA166153842,rs12046844,,,PDE4B,Toxicity,-1,gemcitabine,1184086256.0,East Asian
1184086254,PA166153842,rs12046844,,,PDE4B,Efficacy,-1,paclitaxel,1184086256.0,East Asian
1184086254,PA166153842,rs12046844,,,PDE4B,Toxicity,-1,paclitaxel,1184086256.0,East Asian
981794132,PA166154857,rs1060896,,,SLC28A2,Efficacy,-1,gemcitabine,981794139.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794132,PA166154857,rs1060896,,,SLC28A2,Toxicity,-1,gemcitabine,981794139.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1451153742,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153738.0,Unknown
1451153742,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153739.0,Unknown
1451153742,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153738.0,Unknown
1451153742,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153739.0,Unknown
1451153742,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153738.0,Unknown
1451153742,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153739.0,Unknown
1451153742,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153738.0,Unknown
1451153742,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153739.0,Unknown
1451153742,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153738.0,Unknown
1451153742,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(R)-methadone,1451153739.0,Unknown
1451153742,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153738.0,Unknown
1451153742,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153739.0,Unknown
1451153742,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153738.0,Unknown
1451153742,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153739.0,Unknown
1451153742,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153738.0,Unknown
1451153742,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153739.0,Unknown
1451153742,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153738.0,Unknown
1451153742,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153739.0,Unknown
1451153742,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153738.0,Unknown
1451153742,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,(S)-methadone,1451153739.0,Unknown
1183689066,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,busulfan,1183689070.0,Unknown
827864092,PA166156524,rs1801058,,,GRK4,Efficacy,-1,metoprolol,827864108.0,African American/Afro-Caribbean
1449154881,PA166155607,rs887829,,,UGT1A1,Toxicity,1,atazanavir,1449154888.0,European
1449154881,PA166155607,rs887829,,,UGT1A1,Toxicity,1,atazanavir,1449154886.0,Multiple groups
1447680294,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,venlafaxine,1447680296.0,Unknown
1447680268,PA166157316,rs2032582,,,ABCB1,Efficacy,1,modafinil,1447680270.0,Unknown
1447680274,PA166157284,rs1045642,,,ABCB1,Efficacy,1,modafinil,1447680276.0,Unknown
1447680283,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,venlafaxine,1447680285.0,Unknown
1449154896,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154899.0,African American/Afro-Caribbean
981794102,PA166154926,rs8187758,,,SLC28A1,Efficacy,-1,gemcitabine,981794107.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794102,PA166154926,rs8187758,,,SLC28A1,Toxicity,-1,gemcitabine,981794107.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794096,PA166154883,rs2242048,,,SLC28A1,Efficacy,-1,gemcitabine,981794100.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794096,PA166154883,rs2242048,,,SLC28A1,Toxicity,-1,gemcitabine,981794100.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1184999830,PA166155680,rs2298771,,,SCN1A,Efficacy,-1,carbamazepine,1184999832.0,East Asian
1184999830,PA166155680,rs2298771,,,SCN1A,Efficacy,-1,oxcarbazepine,1184999832.0,East Asian
1450809654,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1450809656.0,East Asian
1450809654,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1450809656.0,East Asian
1450809654,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1450809656.0,East Asian
1450809654,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1450809656.0,East Asian
1450809654,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1450809656.0,East Asian
1450809654,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1450809656.0,East Asian
1449171287,PA166156991,rs1799971,,,OPRM1,Dosage,1,sufentanil,1449171293.0,Unknown
1449154902,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154904.0,Multiple groups
1449154902,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154909.0,African American/Afro-Caribbean
1449154902,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154905.0,European
1449154902,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154904.0,Multiple groups
1449154902,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154909.0,African American/Afro-Caribbean
1449154902,PA166155607,rs887829,,,UGT1A1,Toxicity,-1,atazanavir,1449154905.0,European
1447680238,PA166156915,rs361525,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447680240.0,Multiple groups
1447680238,PA166156915,rs361525,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447680241.0,European
1449171296,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,tacrolimus,1449171302.0,European
1184999851,PA166155682,rs2304016,,,SCN2A,Efficacy,-1,carbamazepine,1184999853.0,East Asian
1184999851,PA166155682,rs2304016,,,SCN2A,Efficacy,-1,oxcarbazepine,1184999853.0,East Asian
981794112,PA166155718,rs3832043,,,UGT1A9,Dosage,1,SN-38,981794119.0,East Asian
827864047,PA166156499,rs1024323,,,GRK4,Efficacy,1,metoprolol,827864062.0,African American/Afro-Caribbean
827864047,PA166156499,rs1024323,,,GRK4,Efficacy,1,metoprolol,827864058.0,African American/Afro-Caribbean
827864047,PA166156499,rs1024323,,,GRK4,Efficacy,1,metoprolol,827864064.0,African American/Afro-Caribbean
827864047,PA166156499,rs1024323,,,GRK4,Efficacy,1,metoprolol,827864066.0,African American/Afro-Caribbean
827864047,PA166156499,rs1024323,,,GRK4,Efficacy,1,metoprolol,827864060.0,African American/Afro-Caribbean
1184999842,PA166155842,rs17183814,,,SCN2A,Efficacy,-1,carbamazepine,1184999844.0,East Asian
1184999842,PA166155842,rs17183814,,,SCN2A,Efficacy,-1,oxcarbazepine,1184999844.0,East Asian
1447680222,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447680237.0,European
1447680222,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447680231.0,Multiple groups
1448106204,PA166153825,rs11264359,,,FDPS,Efficacy,1,Bisphosphonates,1448106206.0,European
981794195,PA166157795,rs7867504,,,SLC28A3,Efficacy,-1,gemcitabine,981794199.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794195,PA166157795,rs7867504,,,SLC28A3,Toxicity,-1,gemcitabine,981794199.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1447680234,PA166157288,rs1128503,,,ABCB1,Efficacy,1,modafinil,1447680267.0,Unknown
1449154934,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449154949.0,European
1449154934,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449154953.0,European
1449154934,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449154949.0,European
1449154934,PA166153652,rs1801274,,,FCGR2A,Efficacy,1,cetuximab,1449154953.0,European
1184999741,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,carbamazepine,1184999743.0,East Asian
1184999741,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,oxcarbazepine,1184999743.0,East Asian
1449154943,PA166153571,rs396991,,,FCGR3A,Efficacy,1,cetuximab,1449154951.0,European
1449154943,PA166153571,rs396991,,,FCGR3A,Efficacy,1,cetuximab,1449154955.0,European
1449171337,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,celecoxib,1449171339.0,East Asian
1449171337,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,celecoxib,1449171339.0,East Asian
1447680216,PA166157602,rs4645974,,,MYC,Dosage,1,warfarin,1447680218.0,East Asian
1447680216,PA166157602,rs4645974,,,MYC,Dosage,1,warfarin,1447680218.0,East Asian
981794170,PA166157790,rs7853758,,,SLC28A3,Efficacy,-1,gemcitabine,981794174.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794170,PA166157790,rs7853758,,,SLC28A3,Toxicity,-1,gemcitabine,981794174.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1448532160,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,rivaroxaban,1448532162.0,Unknown
1449171352,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449171364.0,Multiple groups
1449171352,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449171364.0,Multiple groups
1448532176,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,rivaroxaban,1448532178.0,Unknown
1447680201,PA166157601,rs4645962,,,MYC,Dosage,1,warfarin,1447680209.0,East Asian
1183689095,PA166156750,rs1050152,,,SLC22A4,Metabolism/PK,-1,busulfan,1183689097.0,Unknown
1451104640,PA166196165,rs3781719,,,CALCA,Efficacy,1,botulinum toxin type a,1451104660.0,European
1451121027,PA166153578,rs581111,,,OPRD1,Efficacy,-1,oxycodone,1451121031.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
1183689075,PA166154806,rs7141505,,,SLC7A8,Metabolism/PK,-1,busulfan,1183689077.0,Unknown
1451121020,PA166153578,rs581111,,,OPRD1,Efficacy,1,oxycodone,1451121024.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
1448106156,PA166153695,rs2297480,,,FDPS,Efficacy,1,Bisphosphonates,1448106174.0,European
1448532144,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,dabigatran,1448532146.0,Unknown
1451153800,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165988479,CYP2D6*1xN,CYP2D6,Dosage,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165988479,CYP2D6*1xN,CYP2D6,Dosage,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816578,CYP2D6*3,CYP2D6,Dosage,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816581,CYP2D6*6,CYP2D6,Dosage,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816581,CYP2D6*6,CYP2D6,Dosage,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,methadone,1451153820.0,Unknown
1451153800,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,methadone,1451153808.0,Unknown
1451153800,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,methadone,1451153820.0,Unknown
1183623652,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183623662.0,East Asian
1183623652,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183623662.0,East Asian
1183623652,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183623662.0,East Asian
1183623652,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183623662.0,East Asian
1183623652,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183623662.0,East Asian
1183623652,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183623662.0,East Asian
1449171382,,,PA165948045,CYP3A7*1A,CYP3A7,Metabolism/PK,1,tacrolimus,1449171392.0,Multiple groups
1449171382,,,PA165948047,CYP3A7*1C,CYP3A7,Metabolism/PK,1,tacrolimus,1449171392.0,Multiple groups
1449171398,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1449171404.0,Multiple groups
1449171411,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449171413.0,Multiple groups
1449171405,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449171407.0,Multiple groups
1449171405,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449171407.0,Multiple groups
981794226,PA166156914,rs324148,,,SLC29A1,Efficacy,-1,gemcitabine,981794234.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794226,PA166156914,rs324148,,,SLC29A1,Toxicity,-1,gemcitabine,981794234.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1449171419,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449171421.0,Multiple groups
1449171419,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449171421.0,Multiple groups
1450809796,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,cotinine,1450809804.0,Unknown
1450809796,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,cotinine,1450809804.0,Unknown
1450809796,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,cotinine,1450809804.0,Unknown
1450809796,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,cotinine,1450809804.0,Unknown
1450809796,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,cotinine,1450809804.0,Unknown
1450809796,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1450809804.0,Unknown
1450809796,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,nicotine,1450809804.0,Unknown
1450809796,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,nicotine,1450809804.0,Unknown
1450809796,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,1,nicotine,1450809804.0,Unknown
982023623,PA166156024,rs4680,,,COMT,Efficacy,1,venlafaxine,982023638.0,Unknown
981794238,PA166157157,rs9394992,,,SLC29A1,Efficacy,-1,gemcitabine,981794246.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
827814765,PA166153972,rs1799853,,,CYP2C9,Dosage,0,acenocoumarol,827814773.0,Near Eastern
827814765,PA166153972,rs1799853,,,CYP2C9,Dosage,0,warfarin,827814773.0,Near Eastern
1444698157,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,ketamine,1444698166.0,European
1444698157,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,ketamine,1444698170.0,European
1444698157,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,ketamine,1444698166.0,European
1444698157,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,ketamine,1444698170.0,European
981417489,PA166155693,rs3087243,,,CTLA4,Efficacy,-1,adalimumab,981417707.0,European
981417489,PA166155693,rs3087243,,,CTLA4,Efficacy,-1,etanercept,981417707.0,European
981417489,PA166155693,rs3087243,,,CTLA4,Efficacy,-1,infliximab,981417707.0,European
981417489,PA166155693,rs3087243,,,CTLA4,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417707.0,European
981417494,PA166155766,rs7574865,,,STAT4,Efficacy,-1,adalimumab,981417705.0,European
981417494,PA166155766,rs7574865,,,STAT4,Efficacy,-1,etanercept,981417705.0,European
981417494,PA166155766,rs7574865,,,STAT4,Efficacy,-1,infliximab,981417705.0,European
981417494,PA166155766,rs7574865,,,STAT4,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417705.0,European
1184999857,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,carbamazepine,1184999859.0,East Asian
1184999857,PA166154028,rs3740066,,,ABCC2,Efficacy,-1,oxcarbazepine,1184999859.0,East Asian
827814749,PA166153959,rs1057910,,,CYP2C9,Dosage,-1,acenocoumarol,827814757.0,Near Eastern
981417506,PA166155828,rs13031237,,,REL,Efficacy,-1,adalimumab,981417703.0,European
981417506,PA166155828,rs13031237,,,REL,Efficacy,-1,etanercept,981417703.0,European
981417506,PA166155828,rs13031237,,,REL,Efficacy,-1,infliximab,981417703.0,European
981417506,PA166155828,rs13031237,,,REL,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417703.0,European
981417500,PA166157763,rs3761847,,,TRAF1,Efficacy,-1,adalimumab,981417721.0,European
981417500,PA166157763,rs3761847,,,TRAF1,Efficacy,-1,etanercept,981417721.0,European
981417500,PA166157763,rs3761847,,,TRAF1,Efficacy,-1,infliximab,981417721.0,European
981417500,PA166157763,rs3761847,,,TRAF1,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417721.0,European
1447680083,PA166154501,rs758723,,,CACNA1C,Efficacy,-1,olanzapine,1447680085.0,East Asian
1447680083,PA166154501,rs758723,,,CACNA1C,Efficacy,-1,quetiapine,1447680085.0,East Asian
1447680083,PA166154501,rs758723,,,CACNA1C,Efficacy,-1,risperidone,1447680085.0,East Asian
1447680089,PA166154620,rs10848635,,,CACNA1C,Efficacy,-1,olanzapine,1447680091.0,East Asian
1447680089,PA166154620,rs10848635,,,CACNA1C,Efficacy,-1,quetiapine,1447680091.0,East Asian
1447680089,PA166154620,rs10848635,,,CACNA1C,Efficacy,-1,risperidone,1447680091.0,East Asian
1450973680,PA166155351,rs429358,,,APOE,Efficacy,-1,ranibizumab,1450973685.0,East Asian
981417467,PA166153818,rs10919563,,,PTPRC,Efficacy,-1,adalimumab,981417701.0,European
981417467,PA166153818,rs10919563,,,PTPRC,Efficacy,-1,etanercept,981417701.0,European
981417467,PA166153818,rs10919563,,,PTPRC,Efficacy,-1,infliximab,981417701.0,European
981417467,PA166153818,rs10919563,,,PTPRC,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417701.0,European
827814729,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,827814739.0,Near Eastern
1447991368,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1447991399.0,East Asian
1447991368,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,debrisoquine,1447991399.0,East Asian
1183623689,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183623691.0,East Asian
1183623663,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183623665.0,East Asian
1183623663,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183623665.0,East Asian
1183623663,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183623665.0,East Asian
1183623663,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183623665.0,East Asian
1183623663,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183623665.0,East Asian
1183623663,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183623665.0,East Asian
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,adalimumab,981417596.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,adalimumab,981417594.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,etanercept,981417596.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,etanercept,981417594.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,infliximab,981417596.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,infliximab,981417594.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417596.0,European
981417474,PA166157758,rs2812378,,,CCL21,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417594.0,European
981417482,PA166155947,rs4810485,,,CD40,Efficacy,-1,adalimumab,981417727.0,European
981417482,PA166155947,rs4810485,,,CD40,Efficacy,-1,etanercept,981417727.0,European
981417482,PA166155947,rs4810485,,,CD40,Efficacy,-1,infliximab,981417727.0,European
981417482,PA166155947,rs4810485,,,CD40,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417727.0,European
827814719,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827814728.0,Near Eastern
827814719,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827814728.0,Near Eastern
981417478,PA166153831,rs11586238,,,GAPDHP64,Efficacy,-1,adalimumab,981417699.0,European
981417478,PA166153831,rs11586238,,,GAPDHP64,Efficacy,-1,etanercept,981417699.0,European
981417478,PA166153831,rs11586238,,,GAPDHP64,Efficacy,-1,infliximab,981417699.0,European
981417478,PA166153831,rs11586238,,,GAPDHP64,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417699.0,European
1183623774,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183623776.0,Multiple groups
1183623774,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183623776.0,Multiple groups
1183623774,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183623776.0,Multiple groups
1183623774,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183623776.0,Multiple groups
1183623774,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183623776.0,Multiple groups
1183623774,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183623776.0,Multiple groups
1183623774,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183623776.0,Multiple groups
1183623774,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183623776.0,Multiple groups
1183689314,PA166154341,rs1801028,,,DRD2,Efficacy,-1,olanzapine,1183689316.0,Central/South Asian
827847979,PA166155475,rs28399454,,,CYP2A6,Toxicity,-1,nevirapine,827848525.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827847979,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,-1,nevirapine,827848525.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
1451104844,PA166196164,rs6691840,,,GRIK3,Efficacy,-1,botulinum toxin type a,1451104849.0,European
1183689310,PA166156277,rs6280,,,DRD3,Efficacy,-1,olanzapine,1183689312.0,Central/South Asian
981417561,PA166156926,rs548234,,,PRDM1,Efficacy,-1,adalimumab,981417711.0,European
981417561,PA166156926,rs548234,,,PRDM1,Efficacy,-1,etanercept,981417711.0,European
981417561,PA166156926,rs548234,,,PRDM1,Efficacy,-1,infliximab,981417711.0,European
981417561,PA166156926,rs548234,,,PRDM1,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417711.0,European
1183623786,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,esomeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183623788.0,Multiple groups
1183623786,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183623788.0,Multiple groups
1183623786,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183623788.0,Multiple groups
1183623786,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183623788.0,Multiple groups
1183623786,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183623788.0,Multiple groups
1183623786,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183623788.0,Multiple groups
1183623786,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183623788.0,Multiple groups
1183623786,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183623788.0,Multiple groups
981417569,PA166156610,rs6822844,,,IL2,Efficacy,-1,adalimumab,981417709.0,European
981417569,PA166156610,rs6822844,,,IL2,Efficacy,-1,etanercept,981417709.0,European
981417569,PA166156610,rs6822844,,,IL2,Efficacy,-1,infliximab,981417709.0,European
981417569,PA166156610,rs6822844,,,IL2,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417709.0,European
1184754301,PA166155346,rs25487,,,XRCC1,Efficacy,1,cisplatin,1184754319.0,East Asian
1184754301,PA166155346,rs25487,,,XRCC1,Efficacy,1,cisplatin,1184754312.0,East Asian
1184754301,PA166155346,rs25487,,,XRCC1,Efficacy,1,cisplatin,1184754310.0,East Asian
1184754301,PA166155346,rs25487,,,XRCC1,Efficacy,1,radiotherapy,1184754319.0,East Asian
1184754301,PA166155346,rs25487,,,XRCC1,Efficacy,1,radiotherapy,1184754312.0,East Asian
1184754301,PA166155346,rs25487,,,XRCC1,Efficacy,1,radiotherapy,1184754310.0,East Asian
981417578,PA166157114,rs6920220,,,SH3BP2,Efficacy,-1,adalimumab,981417715.0,European
981417578,PA166157114,rs6920220,,,SH3BP2,Efficacy,-1,etanercept,981417715.0,European
981417578,PA166157114,rs6920220,,,SH3BP2,Efficacy,-1,infliximab,981417715.0,European
981417578,PA166157114,rs6920220,,,SH3BP2,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417715.0,European
1183689306,PA166154675,rs6313,,,HTR2A,Efficacy,-1,olanzapine,1183689308.0,Central/South Asian
1451104875,PA166196168,rs6627221,,,GABRA3,Efficacy,-1,botulinum toxin type a,1451104880.0,European
1448531977,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,dabigatran,1448532133.0,Unknown
981417573,PA166156102,rs3218253,,,IL2RB,Efficacy,-1,adalimumab,981417729.0,European
981417573,PA166156102,rs3218253,,,IL2RB,Efficacy,-1,etanercept,981417729.0,European
981417573,PA166156102,rs3218253,,,IL2RB,Efficacy,-1,infliximab,981417729.0,European
981417573,PA166156102,rs3218253,,,IL2RB,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417729.0,European
1450973740,PA166155351,rs429358,,,APOE,Efficacy,1,atorvastatin,1450973745.0,American
981417516,PA166154057,rs4750316,,,PRKCQ,Efficacy,-1,adalimumab,981417725.0,European
981417516,PA166154057,rs4750316,,,PRKCQ,Efficacy,-1,etanercept,981417725.0,European
981417516,PA166154057,rs4750316,,,PRKCQ,Efficacy,-1,infliximab,981417725.0,European
981417516,PA166154057,rs4750316,,,PRKCQ,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417725.0,European
1183705675,PA166157859,rs1050828,,,G6PD,Efficacy,-1,artemisinin and derivatives,1183705680.0,Sub-Saharan African
637880249,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,637880255.0,Multiple groups
1183623748,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,esomeprazole,1183623758.0,East Asian
1183623748,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,esomeprazole,1183623760.0,East Asian
1183623748,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,esomeprazole,1183623758.0,East Asian
1183623748,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,esomeprazole,1183623760.0,East Asian
1183623748,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,esomeprazole,1183623758.0,East Asian
1183623748,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,esomeprazole,1183623760.0,East Asian
1451104826,PA166185600,rs11172113,,,LRP1,Efficacy,-1,botulinum toxin type a,1451104831.0,European
1448531965,PA166157345,rs2242480,,,CYP3A4,Efficacy,-1,ticagrelor,1448531967.0,East Asian
1451104820,PA166196161,rs1050316,,,MEF2D,Efficacy,-1,botulinum toxin type a,1451104825.0,European
1448417273,,,PA165819171,CYP1A2*1A,CYP1A2,Efficacy,0,clomipramine,1448417322.0,Unknown
1448417273,,,PA165819176,CYP1A2*1F,CYP1A2,Efficacy,0,clomipramine,1448417322.0,Unknown
637880237,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,637880239.0,Unknown
637880237,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,637880239.0,Unknown
1448531959,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,ticagrelor,1448531961.0,East Asian
1448531959,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,ticagrelor,1448531961.0,East Asian
981417547,PA166156916,rs394581,,,TAGAP,Efficacy,-1,adalimumab,981417717.0,European
981417547,PA166156916,rs394581,,,TAGAP,Efficacy,-1,etanercept,981417717.0,European
981417547,PA166156916,rs394581,,,TAGAP,Efficacy,-1,infliximab,981417717.0,European
981417547,PA166156916,rs394581,,,TAGAP,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417717.0,European
1448417266,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,0,clomipramine,1448417334.0,Unknown
1448417266,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,0,clomipramine,1448417334.0,Unknown
1447679991,PA166154540,rs2283271,,,CACNA1C,Efficacy,-1,olanzapine,1447679993.0,East Asian
1447679991,PA166154540,rs2283271,,,CACNA1C,Efficacy,-1,quetiapine,1447679993.0,East Asian
1447679991,PA166154540,rs2283271,,,CACNA1C,Efficacy,-1,risperidone,1447679993.0,East Asian
637880256,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,637880262.0,European
1448531954,PA166154664,rs113681054,,,SLCO1B1,Efficacy,-1,ticagrelor,1448531956.0,East Asian
1451104838,PA166196163,rs4354668,,,SLC1A2,Efficacy,-1,botulinum toxin type a,1451104843.0,European
981417541,PA166153995,rs2104286,,,IL2RA,Efficacy,-1,adalimumab,981417723.0,European
981417541,PA166153995,rs2104286,,,IL2RA,Efficacy,-1,etanercept,981417723.0,European
981417541,PA166153995,rs2104286,,,IL2RA,Efficacy,-1,infliximab,981417723.0,European
981417541,PA166153995,rs2104286,,,IL2RA,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417723.0,European
1183689377,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1183689380.0,Multiple groups
1183689377,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1183689379.0,"Multiple groups, Not stated: studies in Denmark, Czech, China and Greece."
1183689377,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1183689381.0,Multiple groups
1448417258,PA166156064,rs1080985,,,CYP2D6,Efficacy,0,clomipramine,1448417320.0,Unknown
1448531946,PA166154664,rs113681054,,,SLCO1B1,Metabolism/PK,-1,ticagrelor,1448531948.0,East Asian
1448531937,PA166154664,rs113681054,,,SLCO1B1,Metabolism/PK,-1,AR-C124910XX,1448531944.0,East Asian
981565071,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,981565075.0,Unknown
981565071,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,981565075.0,Unknown
1448417245,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,0,clomipramine,1448417329.0,Unknown
1448417245,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,0,clomipramine,1448417329.0,Unknown
1183623820,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183623822.0,Multiple groups
1183623820,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183623822.0,Multiple groups
1183623820,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183623822.0,Multiple groups
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,adalimumab,981417590.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,adalimumab,981417592.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,etanercept,981417590.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,etanercept,981417592.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,infliximab,981417590.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,infliximab,981417592.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417590.0,European
981417582,PA166155654,rs1980422,,,CD28,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417592.0,European
1183623810,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183623812.0,Multiple groups
1183623810,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183623812.0,Multiple groups
1183623810,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183623812.0,Multiple groups
1444698070,PA166155532,rs118192161,,,RYR1,Other,1,halothane,1444698080.0,Unknown
981565062,PA166154640,rs11568820,,,VDR,Metabolism/PK,1,midazolam,981565066.0,European
1451104900,PA166196170,rs734784,,,KCNS1,Efficacy,-1,botulinum toxin type a,1451104920.0,European
1451104887,PA166169465,rs6746030,,,SCN9A,Efficacy,-1,botulinum toxin type a,1451104892.0,European
1448531887,PA166156677,rs28365063,,,UGT2B7,Metabolism/PK,-1,morphine,1448531889.0,European
1444697966,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1444698010.0,"Multiple groups, 95 European"
1448531882,PA166156617,rs7438135,,,UGT2B7,Metabolism/PK,-1,morphine,1448531884.0,European
1450973900,PA166155351,rs429358,,,APOE,Efficacy,1,hmg coa reductase inhibitors,1450973920.0,"Multiple groups, ""White and black or African American"" subjects"
1450973900,PA166155351,rs429358,,,APOE,Efficacy,1,hmg coa reductase inhibitors,1450973940.0,"Multiple groups, ""White and black or African American"" subjects"
1447679904,PA166153571,rs396991,,,FCGR3A,Efficacy,1,rituximab,1447679975.0,East Asian
1451104973,PA166157875,rs3813929,,,HTR2C,Efficacy,-1,botulinum toxin type a,1451104978.0,European
1184754414,PA166154727,rs7999812,,,ATP7B,Efficacy,-1,Platinum compounds,1184754416.0,East Asian
1448531875,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,morphine,1448531881.0,European
1451105001,PA166196175,rs222741,,,TRPV1,Efficacy,-1,botulinum toxin type a,1451105009.0,European
1451104940,PA166196171,rs2230912,,,P2RX7,Efficacy,-1,botulinum toxin type a,1451104960.0,European
1448531842,PA166153859,rs12566888,,,PEAR1,Efficacy,1,ticagrelor,1448531844.0,East Asian
1448531836,PA166153839,rs12041331,,,PEAR1,Efficacy,1,ticagrelor,1448531838.0,East Asian
827602050,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,827602193.0,Multiple groups
1449171668,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,tacrolimus,1449171683.0,Unknown
1448105842,PA166155206,rs2289669,,,SLC47A1,Efficacy,1,metformin,1448105848.0,European
1183623852,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183623854.0,Multiple groups
1183623852,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183623854.0,Multiple groups
1183623852,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183623854.0,Multiple groups
1448531830,PA166153839,rs12041331,,,PEAR1,Efficacy,1,ticagrelor,1448531835.0,East Asian
1183623865,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623867.0,Multiple groups
1183623865,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623867.0,Multiple groups
1183623865,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183623867.0,Multiple groups
1451104967,PA166154339,rs1800497,,,DRD2,Efficacy,-1,botulinum toxin type a,1451104972.0,European
1183689399,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183689401.0,"Multiple groups, Brazilian."
1183689399,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183689401.0,"Multiple groups, Brazilian."
1183689399,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183689401.0,"Multiple groups, Brazilian."
1450957580,PA166153760,rs3918290,,,DPYD,Dosage,0,capecitabine,,
1450957580,PA166153760,rs3918290,,,DPYD,Dosage,0,fluorouracil,,
1450957580,PA166153760,rs3918290,,,DPYD,Dosage,0,fluorouracil,,
1449171694,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,tacrolimus,1449171700.0,Unknown
1449171694,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,tacrolimus,1449171700.0,Unknown
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826521.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826524.0,European
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826523.0,European
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826530.0,European
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826522.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826528.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826529.0,European
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826527.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826517,PA166156890,rs28363170,,,SLC6A3,Other,1,ethanol,1450826544.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
827815008,PA166154259,rs6265,,,BDNF,Efficacy,-1,paroxetine,827815053.0,East Asian
827815008,PA166154259,rs6265,,,BDNF,Efficacy,-1,sertraline,827815053.0,East Asian
1444697908,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1444697908,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1444697908,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1444697908,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1444697908,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1444697908,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1444697908,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,endoxifen,1444697932.0,Multiple groups
1183689490,PA166157485,rs28401781,,,ABCB1,Efficacy,-1,citalopram,1183689526.0,East Asian
1183689490,PA166157485,rs28401781,,,ABCB1,Efficacy,-1,fluoxetine,1183689526.0,East Asian
1183689490,PA166157485,rs28401781,,,ABCB1,Efficacy,-1,paroxetine,1183689526.0,East Asian
1183689490,PA166157485,rs28401781,,,ABCB1,Efficacy,-1,sertraline,1183689526.0,East Asian
1449171720,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,tacrolimus,1449171722.0,Unknown
1451105010,PA166196176,rs7217270,,,TRPV3,Efficacy,-1,botulinum toxin type a,1451105018.0,European
1183689468,,,PA165984975,UGT2B15*1,UGT2B15,Metabolism/PK,1,sipoglitazar,1183689573.0,European
1183689468,,,PA165984976,UGT2B15*2,UGT2B15,Metabolism/PK,1,sipoglitazar,1183689573.0,European
1450826481,PA166156890,rs28363170,,,SLC6A3,Toxicity,1,ethanol,1450826485.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826481,PA166156890,rs28363170,,,SLC6A3,Toxicity,1,ethanol,1450826486.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826481,PA166156890,rs28363170,,,SLC6A3,Toxicity,1,ethanol,1450826487.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1451105019,PA166196181,rs10166942,,,TRPM8,Efficacy,-1,botulinum toxin type a,1451105024.0,European
1450826488,PA166156991,rs1799971,,,OPRM1,Toxicity,1,ethanol,1450826494.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826488,PA166156991,rs1799971,,,OPRM1,Toxicity,1,ethanol,1450826492.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1450826488,PA166156991,rs1799971,,,OPRM1,Toxicity,1,ethanol,1450826493.0,Unknown
1184754389,PA166154736,rs9535826,,,ATP7B,Efficacy,1,Platinum compounds,1184754402.0,East Asian
827864125,PA166156568,rs2960306,,,GRK4,Efficacy,-1,metoprolol,827864135.0,African American/Afro-Caribbean
1451105025,PA166196182,rs734312,,,WFS1,Efficacy,-1,botulinum toxin type a,1451105033.0,European
1447991084,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,brivaracetam,1447991101.0,East Asian
1447991084,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,brivaracetam,1447991101.0,East Asian
1447991084,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,brivaracetam,1447991101.0,East Asian
1449155370,PA166156288,rs352139,,,TLR9,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155378.0,Unknown
1184754410,PA166154695,rs1061472,,,ATP7B,Efficacy,-1,Platinum compounds,1184754412.0,East Asian
827864109,PA166156524,rs1801058,,,GRK4,Efficacy,1,metoprolol,827864120.0,African American/Afro-Caribbean
1184754406,PA166154737,rs9535828,,,ATP7B,Efficacy,1,Platinum compounds,1184754408.0,East Asian
637880191,PA166154320,rs1138272,,,GSTP1,Toxicity,-1,oxaliplatin,637880216.0,"Multiple groups, 92% White, 6% African, 2% Asian; French"
637880191,PA166154320,rs1138272,,,GSTP1,Metabolism/PK,-1,oxaliplatin,637880216.0,"Multiple groups, 92% White, 6% African, 2% Asian; French"
769248943,PA166155715,rs3812718,,,SCN1A,Dosage,-1,phenytoin,769248945.0,East Asian
1451105100,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,letermovir,1451105104.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1448105757,PA166155134,rs61742245,,,VKORC1,Dosage,1,warfarin,1448105763.0,Unknown
1449155387,PA166155628,rs1143623,,,IL1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155395.0,Unknown
1449155387,PA166155628,rs1143623,,,IL1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155439.0,Unknown
1449155387,PA166155628,rs1143623,,,IL1B,Efficacy,1,ustekinumab,1449155395.0,Unknown
1449155387,PA166155628,rs1143623,,,IL1B,Efficacy,1,ustekinumab,1449155439.0,Unknown
1451105113,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,1,letermovir,1451105140.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1450826585,PA166157284,rs1045642,,,ABCB1,Dosage,1,fentanyl,1450826589.0,"Multiple groups, Black and white patients"
1450826585,PA166157284,rs1045642,,,ABCB1,Dosage,1,fentanyl,1450826589.0,"Multiple groups, Black and white patients"
1183689554,PA166157377,rs3747802,,,ABCB1,Efficacy,-1,citalopram,1183689556.0,East Asian
1183689554,PA166157377,rs3747802,,,ABCB1,Efficacy,-1,fluoxetine,1183689556.0,East Asian
1183689554,PA166157377,rs3747802,,,ABCB1,Efficacy,-1,paroxetine,1183689556.0,East Asian
1183689554,PA166157377,rs3747802,,,ABCB1,Efficacy,-1,sertraline,1183689556.0,East Asian
1450826590,PA166157288,rs1128503,,,ABCB1,Dosage,-1,fentanyl,1450826594.0,"Multiple groups, Black and white patients"
1450826590,PA166157288,rs1128503,,,ABCB1,Dosage,-1,fentanyl,1450826594.0,"Multiple groups, Black and white patients"
1450826590,PA166157288,rs1128503,,,ABCB1,Dosage,-1,fentanyl,1450826594.0,"Multiple groups, Black and white patients"
1450826590,PA166157288,rs1128503,,,ABCB1,Dosage,-1,fentanyl,1450826594.0,"Multiple groups, Black and white patients"
1450826590,PA166157288,rs1128503,,,ABCB1,Dosage,-1,fentanyl,1450826594.0,"Multiple groups, Black and white patients"
1450826595,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,fentanyl,1450826599.0,"Multiple groups, Black and white patients"
1449155401,PA166155629,rs1143627,,,IL1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155403.0,Unknown
1449155401,PA166155629,rs1143627,,,IL1B,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155443.0,Unknown
1449155401,PA166155629,rs1143627,,,IL1B,Efficacy,1,ustekinumab,1449155403.0,Unknown
1449155401,PA166155629,rs1143627,,,IL1B,Efficacy,1,ustekinumab,1449155443.0,Unknown
1183689563,PA166155975,rs182694,,,ABCG1,Efficacy,-1,citalopram,1183689565.0,East Asian
1183689563,PA166155975,rs182694,,,ABCG1,Efficacy,-1,fluoxetine,1183689565.0,East Asian
1183689563,PA166155975,rs182694,,,ABCG1,Efficacy,-1,paroxetine,1183689565.0,East Asian
1183689563,PA166155975,rs182694,,,ABCG1,Efficacy,-1,sertraline,1183689565.0,East Asian
1450826600,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,fentanyl,1450826606.0,"Multiple groups, Black and white patients"
637880031,PA166157331,rs2227983,,,EGFR,Efficacy,-1,cetuximab,637880033.0,"Multiple groups, Thirty-one (79%) patients were Caucasian, six (15%) were Asian and two (5%) were Hispanic."
1183689538,PA166155626,rs1109867,,,ABCB6,Efficacy,-1,citalopram,1183689540.0,East Asian
1183689538,PA166155626,rs1109867,,,ABCB6,Efficacy,-1,fluoxetine,1183689540.0,East Asian
1183689538,PA166155626,rs1109867,,,ABCB6,Efficacy,-1,paroxetine,1183689540.0,East Asian
1183689538,PA166155626,rs1109867,,,ABCB6,Efficacy,-1,sertraline,1183689540.0,East Asian
1183689534,PA166155625,rs1109866,,,ABCB6,Efficacy,-1,citalopram,1183689536.0,East Asian
1183689534,PA166155625,rs1109866,,,ABCB6,Efficacy,-1,fluoxetine,1183689536.0,East Asian
1183689534,PA166155625,rs1109866,,,ABCB6,Efficacy,-1,paroxetine,1183689536.0,East Asian
1183689534,PA166155625,rs1109866,,,ABCB6,Efficacy,-1,sertraline,1183689536.0,East Asian
1184754574,PA166156351,rs2276706,,,NR1I2,Metabolism/PK,1,repaglinide,1184754576.0,East Asian
981417773,PA166154367,rs2306168,,,SLCO2B1,Efficacy,-1,montelukast,981417784.0,Multiple groups
1183689546,PA166155705,rs3755047,,,ABCB6,Efficacy,-1,citalopram,1183689548.0,East Asian
1183689546,PA166155705,rs3755047,,,ABCB6,Efficacy,-1,fluoxetine,1183689548.0,East Asian
1183689546,PA166155705,rs3755047,,,ABCB6,Efficacy,-1,paroxetine,1183689548.0,East Asian
1183689546,PA166155705,rs3755047,,,ABCB6,Efficacy,-1,sertraline,1183689548.0,East Asian
1183689542,PA166155698,rs3731885,,,ABCB6,Efficacy,-1,citalopram,1183689544.0,East Asian
1183689542,PA166155698,rs3731885,,,ABCB6,Efficacy,-1,fluoxetine,1183689544.0,East Asian
1183689542,PA166155698,rs3731885,,,ABCB6,Efficacy,-1,paroxetine,1183689544.0,East Asian
1183689542,PA166155698,rs3731885,,,ABCB6,Efficacy,-1,sertraline,1183689544.0,East Asian
1449155420,PA166156654,rs11938228,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155423.0,Unknown
1183689529,PA166157386,rs4148739,,,ABCB1,Efficacy,-1,citalopram,1183689531.0,East Asian
1183689529,PA166157386,rs4148739,,,ABCB1,Efficacy,-1,fluoxetine,1183689531.0,East Asian
1183689529,PA166157386,rs4148739,,,ABCB1,Efficacy,-1,paroxetine,1183689531.0,East Asian
1183689529,PA166157386,rs4148739,,,ABCB1,Efficacy,-1,sertraline,1183689531.0,East Asian
1183689529,PA166157386,rs4148739,,,ABCB1,Efficacy,-1,sertraline,1183689531.0,East Asian
1449155414,PA166175796,rs11465996,,,LY96,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155416.0,Unknown
1449155430,PA166156596,rs4696480,,,TLR2,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1449155432.0,Unknown
1450810253,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1450810265.0,Multiple groups
1450810253,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1450810265.0,Multiple groups
1450810253,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1450810265.0,Multiple groups
1450810253,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1450810265.0,Multiple groups
769249016,PA166154176,rs28371686,,,CYP2C9,Other,1,phenytoin,769249059.0,Sub-Saharan African
769249016,PA166154176,rs28371686,,,CYP2C9,Metabolism/PK,1,phenytoin,769249059.0,Sub-Saharan African
1183624077,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183624079.0,Unknown
1183624077,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183624079.0,Unknown
1183624077,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183624079.0,Unknown
1450810272,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1450810274.0,Multiple groups
1450810272,PA166155435,rs8099917,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1450810274.0,Multiple groups
1450810272,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1450810274.0,Multiple groups
1450810272,PA166155435,rs8099917,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1450810274.0,Multiple groups
1447679700,PA166153889,rs56038477,,,DPYD,Dosage,0,capecitabine,,
1447679700,PA166153889,rs56038477,,,DPYD,Dosage,0,fluorouracil,,
1450974113,PA166155341,rs7412,,,APOE,Efficacy,1,fenofibrate,1450974141.0,Unknown
1451137960,PA166205741,rs3762555,,,GAD1,Dosage,1,methadone,1451137965.0,East Asian
1451137960,PA166205741,rs3762555,,,GAD1,Dosage,1,methadone,1451137965.0,East Asian
1183624062,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183624076.0,Unknown
1183624062,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183624076.0,Unknown
1183624062,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183624076.0,Unknown
769249040,PA166154175,rs28371685,,,CYP2C9,Other,1,phenytoin,769249055.0,Sub-Saharan African
769249040,PA166154175,rs28371685,,,CYP2C9,Metabolism/PK,1,phenytoin,769249055.0,Sub-Saharan African
769249041,PA166154102,rs9332131,,,CYP2C9,Other,1,phenytoin,769249070.0,Sub-Saharan African
769249041,PA166154102,rs9332131,,,CYP2C9,Metabolism/PK,1,phenytoin,769249070.0,Sub-Saharan African
1448105661,PA166155974,rs20572,,,CBR1,Metabolism/PK,1,doxorubicin,1448105663.0,"Multiple groups, Chinese; Malay; Indian"
978614975,PA166154450,rs11212617,,,C11orf65,Efficacy,-1,metformin,978615177.0,"Multiple groups, Genotyped: 1669 White, 609 African American, 497 Hispanic, 127 Asian, 82 American Indian."
978614975,PA166154450,rs11212617,,,C11orf65,Metabolism/PK,-1,metformin,978615177.0,"Multiple groups, Genotyped: 1669 White, 609 African American, 497 Hispanic, 127 Asian, 82 American Indian."
1184754523,PA166156351,rs2276706,,,NR1I2,Metabolism/PK,1,repaglinide,1184754567.0,East Asian
1184754523,PA166156351,rs2276706,,,NR1I2,Metabolism/PK,1,repaglinide,1184754581.0,East Asian
1184754523,PA166156351,rs2276706,,,NR1I2,Metabolism/PK,1,repaglinide,1184754528.0,East Asian
1185000272,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,acetaminophen,1185000282.0,East Asian
1185000272,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,acetaminophen,1185000282.0,East Asian
1447679688,PA166153895,rs67376798,,,DPYD,Dosage,0,capecitabine,,
1447679688,PA166153895,rs67376798,,,DPYD,Dosage,0,fluorouracil,,
1184754529,PA166156385,rs3814058,,,NR1I2,Metabolism/PK,1,repaglinide,1184754571.0,East Asian
1184754529,PA166156385,rs3814058,,,NR1I2,Metabolism/PK,1,repaglinide,1184754573.0,East Asian
1184754529,PA166156385,rs3814058,,,NR1I2,Metabolism/PK,1,repaglinide,1184754531.0,East Asian
1450826625,PA166156991,rs1799971,,,OPRM1,Other,-1,nicotine,1450826726.0,"Multiple groups, Caucasian, African American and 'other'"
1185000284,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,acetaminophen,1185000293.0,European
1185000284,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,acetaminophen,1185000293.0,European
1448105654,PA166155974,rs20572,,,CBR1,Metabolism/PK,1,doxorubicin,1448105656.0,"Multiple groups, Chinese; Malay; Indian"
1448531631,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1448531638.0,Multiple groups
1448531631,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1448531638.0,Multiple groups
1448531631,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1448531638.0,Multiple groups
1448531631,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1448531638.0,Multiple groups
1449188274,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1449188276.0,Near Eastern
1449188274,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1449188276.0,Near Eastern
1183689699,PA166157099,rs4248163,,,TNF,Efficacy,-1,infliximab,1183689701.0,European
1185000439,,,PA166117614,UGT1A6*1a,UGT1A6,Metabolism/PK,1,acetaminophen,1185000471.0,Unknown
1185000439,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,acetaminophen,1185000471.0,Unknown
1185000439,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,acetaminophen,1185000471.0,Unknown
1185000439,,,PA166117621,UGT1A6*2a,UGT1A6,Metabolism/PK,1,acetaminophen,1185000471.0,Unknown
1183689695,PA166157062,rs3093548,,,TNF,Efficacy,-1,infliximab,1183689697.0,European
1183689707,PA166157205,rs55634887,,,TNF,Efficacy,-1,infliximab,1183689709.0,European
981237722,PA166153608,rs1044457,,,CMPK1,Efficacy,1,gemcitabine,981237766.0,East Asian
981237722,PA166153608,rs1044457,,,CMPK1,Efficacy,1,gemcitabine,981237737.0,East Asian
1183689703,PA166157207,rs55994001,,,TNF,Efficacy,-1,infliximab,1183689705.0,European
1449188291,PA166157283,rs1043550,,,CALU,Dosage,1,acenocoumarol,1449188293.0,Near Eastern
1449188291,PA166157283,rs1043550,,,CALU,Dosage,1,acenocoumarol,1449188293.0,Near Eastern
1449188291,PA166157283,rs1043550,,,CALU,Dosage,1,acenocoumarol,1449188293.0,Near Eastern
1183689683,PA166157097,rs4248159,,,TNF,Efficacy,-1,infliximab,1183689685.0,European
1183689679,PA166157107,rs4987086,,,TNF,Efficacy,-1,infliximab,1183689681.0,European
1449188284,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1449188290.0,Near Eastern
981843937,PA166155718,rs3832043,,,UGT1A9,Metabolism/PK,1,SN-38,981843948.0,East Asian
981843937,PA166155718,rs3832043,,,UGT1A9,Metabolism/PK,1,SN-38,981843946.0,East Asian
1448613522,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,deferasirox,1448613524.0,"Multiple groups, 95% Caucasian (Italy)"
1448613522,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,deferasirox,1448613524.0,"Multiple groups, 95% Caucasian (Italy)"
1448613522,PA166156664,rs13120400,,,ABCG2,Metabolism/PK,1,deferasirox,1448613524.0,"Multiple groups, 95% Caucasian (Italy)"
1451121640,PA166156024,rs4680,,,COMT,Efficacy,-1,oxycodone,1451121660.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
1183689691,PA166157098,rs4248160,,,TNF,Efficacy,-1,infliximab,1183689693.0,European
1451138021,PA166205743,rs3791878,,,GAD1,Dosage,-1,methadone,1451138026.0,East Asian
1183689687,PA166157046,rs2736195,,,TNF,Efficacy,-1,infliximab,1183689689.0,European
1448105620,PA166155972,rs9024,,,CBR1,Metabolism/PK,1,doxorubicin,1448105622.0,"Multiple groups, Chinese; Malay; Indian"
1183689667,PA166156998,rs1800630,,,TNF,Efficacy,-1,infliximab,1183689669.0,European
1449155535,PA166153619,rs1061624,,,TNFRSF1B,Efficacy,1,adalimumab,1449155537.0,European
1449155535,PA166153619,rs1061624,,,TNFRSF1B,Efficacy,1,infliximab,1449155537.0,European
1449155529,PA166175826,rs645544,,,SLC9A8,Efficacy,1,adalimumab,1449155531.0,European
1449155529,PA166175826,rs645544,,,SLC9A8,Efficacy,1,infliximab,1449155531.0,European
1449270232,PA166157284,rs1045642,,,ABCB1,Efficacy,1,methotrexate,1449270234.0,Unknown
1185000474,,,PA165984975,UGT2B15*1,UGT2B15,Metabolism/PK,1,acetaminophen,1185000476.0,Unknown
1185000474,,,PA165984976,UGT2B15*2,UGT2B15,Metabolism/PK,1,acetaminophen,1185000476.0,Unknown
1183689663,PA166157103,rs4647198,,,TNF,Efficacy,-1,infliximab,1183689665.0,European
1448105610,PA166155972,rs9024,,,CBR1,Metabolism/PK,1,doxorubicin,1448105618.0,"Multiple groups, Chinese; Malay; Indian"
1183689675,PA166157096,rs4248158,,,TNF,Efficacy,-1,infliximab,1183689677.0,European
1449270224,PA166153644,rs1801133,,,MTHFR,Efficacy,1,methotrexate,1449270231.0,Unknown
1183689671,PA166156988,rs1799724,,,TNF,Efficacy,-1,infliximab,1183689673.0,European
1448613498,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613502.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613498,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613501.0,Unknown
1448613498,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613500.0,European
1448613498,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613503.0,Multiple groups
1451121600,PA166156024,rs4680,,,COMT,Efficacy,1,oxycodone,1451121620.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
981843914,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,1,SN-38,981843934.0,East Asian
981843914,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,1,SN-38,981843936.0,East Asian
1451137980,PA166205742,rs3762556,,,GAD1,Dosage,1,methadone,1451137969.0,East Asian
1448597114,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448597116.0,Unknown
1448613490,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613493.0,Unknown
1448613490,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613494.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613490,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613495.0,Multiple groups
1448613490,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613492.0,European
1183689659,PA166156990,rs1799964,,,TNF,Efficacy,-1,infliximab,1183689661.0,European
1449270240,PA166157288,rs1128503,,,ABCB1,Efficacy,1,methotrexate,1449270242.0,Unknown
1183689654,PA166155630,rs1143634,,,IL1B,Efficacy,1,infliximab,1183689658.0,European
1448613482,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613487.0,Multiple groups
1448613482,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613486.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613482,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613484.0,European
1448613482,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613485.0,Unknown
1449270251,PA166178369,rs12231740,,,SLC16A7,Efficacy,1,methotrexate,1449270253.0,Unknown
1448597107,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1448597113.0,Unknown
981483535,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981483540.0,"Multiple groups, Brazilian (African Americans and Whites)."
981483535,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981483540.0,"Multiple groups, Brazilian (African Americans and Whites)."
981483535,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981483540.0,"Multiple groups, Brazilian (African Americans and Whites)."
981483535,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981483540.0,"Multiple groups, Brazilian (African Americans and Whites)."
981237777,PA166156661,rs12507552,,,DCTD,Efficacy,1,gemcitabine,981237780.0,East Asian
1184754606,PA166157738,rs1927907,,,TLR4,Metabolism/PK,1,tacrolimus,1184754608.0,East Asian
1184754606,PA166157738,rs1927907,,,TLR4,Metabolism/PK,1,tacrolimus,1184754609.0,East Asian
1448613474,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613476.0,European
1448613474,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613478.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613474,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613477.0,Unknown
1448613474,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613479.0,Multiple groups
981237781,PA166157080,rs3778504,,,SLC29A1,Efficacy,-1,gemcitabine,981237787.0,East Asian
1449270257,PA166154563,rs3763980,,,SLC16A7,Efficacy,1,methotrexate,1449270259.0,Unknown
1451121685,PA166156046,rs165599,,,COMT,Efficacy,-1,oxycodone,1451121700.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
981843981,PA166155720,rs4124874,,,UGT1A1,Dosage,-1,irinotecan,981843998.0,East Asian
1183624234,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183624242.0,East Asian
1183624234,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,haloperidol,1183624242.0,East Asian
1445402159,PA166153665,rs2072660,,,CHRNB2,Efficacy,-1,varenicline,1445402162.0,Multiple groups
981483541,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981483546.0,East Asian
981483541,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981483546.0,East Asian
1449155573,PA166153574,rs529520,,,OPRD1,Dosage,1,methadone,1449155582.0,East Asian
1449155573,PA166153574,rs529520,,,OPRD1,Dosage,1,methadone,1449155584.0,East Asian
1448105573,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,escitalopram,1448105579.0,"Multiple groups, 8 African American, 1 African American/Hispanic, 2 Asian, 7 Caucasian/Hispanic, 26 Caucasian/Non-Hispanic"
1449270277,PA166156776,rs1801394,,,MTRR,Efficacy,1,methotrexate,1449270279.0,Unknown
1448613466,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613470.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613466,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613471.0,Multiple groups
1448613466,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613468.0,European
1448613466,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613469.0,Unknown
1451138080,PA166205801,rs2839669,,,GAD2,Dosage,-1,methadone,1451138085.0,East Asian
981237788,PA166156724,rs274713,,,TENT4A,Efficacy,1,gemcitabine,981237794.0,East Asian
1449188355,PA166177785,rs1074287,,,OPRM1,Metabolism/PK,1,cotinine,1449188361.0,East Asian
981237795,PA166156725,rs274717,,,TENT4A,Efficacy,-1,gemcitabine,981237801.0,East Asian
1451121699,PA166176247,rs963549,,,OPRK1,Efficacy,-1,oxycodone,1451121740.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
981844004,PA166155721,rs4148323,,,UGT1A1,Dosage,-1,irinotecan,981844024.0,East Asian
981483548,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981483551.0,East Asian
1451121694,PA166183884,rs6473797,,,OPRK1,Efficacy,-1,oxycodone,1451121698.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
1449188362,PA166177786,rs6912029,,,OPRM1,Metabolism/PK,1,cotinine,1449188364.0,East Asian
1450367980,PA166181773,rs5333,,,EDNRA,Efficacy,1,prednisone,1450367986.0,Unknown
1451121701,PA166175996,rs10753331,,,OPRD1,Efficacy,-1,oxycodone,1451121723.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
981237802,PA166156966,rs992160,,,CDC5L,Efficacy,1,gemcitabine,981237806.0,East Asian
1448613452,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,deferasirox,1448613531.0,"Multiple groups, 95% Caucasian (Italy)"
1448613452,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,1,deferasirox,1448613454.0,"Multiple groups, 95% Caucasian (Italy)"
1450826733,PA166156991,rs1799971,,,OPRM1,Other,-1,nicotine,1450826738.0,"Multiple groups, Caucasian, African American and 'other'"
1449188368,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,1,cotinine,1449188370.0,East Asian
1449188368,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,1,cotinine,1449188370.0,East Asian
1450826739,PA166154339,rs1800497,,,DRD2,Other,-1,nicotine,1450826745.0,"Multiple groups, Caucasian, African American and 'other'"
1451138043,PA166205781,rs769395,,,GAD1,Dosage,-1,methadone,1451138008.0,East Asian
1184754650,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,acenocoumarol,1184754665.0,European
1184754650,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,acenocoumarol,1184754665.0,European
1184754650,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,acenocoumarol,1184754665.0,European
981352439,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,infliximab,981352446.0,European
1450826746,PA166154339,rs1800497,,,DRD2,Other,-1,nicotine,1450826751.0,"Multiple groups, Caucasian, African American and 'other'"
1449188376,PA166177787,rs12209447,,,OPRM1,Metabolism/PK,1,cotinine,1449188378.0,East Asian
827863356,PA166155196,rs1979277,,,SHMT1,Efficacy,-1,methotrexate,827863365.0,European
981483523,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,981483528.0,European
981483523,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,981483528.0,European
981483523,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,981483528.0,European
981483523,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,981483528.0,European
981483523,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,981483528.0,European
981483523,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,981483528.0,European
1447990832,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1447990834.0,Sub-Saharan African
1447990832,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,debrisoquine,1447990834.0,Sub-Saharan African
1447990832,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1447990834.0,Sub-Saharan African
1450826752,PA166154339,rs1800497,,,DRD2,Other,-1,nicotine,1450826757.0,Unknown
1449188382,PA166156924,rs510769,,,OPRM1,Metabolism/PK,1,cotinine,1449188384.0,East Asian
1449188382,PA166156924,rs510769,,,OPRM1,Metabolism/PK,1,cotinine,1449188384.0,East Asian
1183689711,PA166156999,rs1800750,,,TNF,Efficacy,-1,infliximab,1183689713.0,European
981237767,PA166153880,rs35687416,,,CMPK1,Efficacy,1,gemcitabine,981237774.0,East Asian
981237767,PA166153880,rs35687416,,,CMPK1,Efficacy,1,gemcitabine,981237776.0,East Asian
981483529,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981483534.0,East Asian
981483529,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981483534.0,East Asian
981483529,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981483534.0,East Asian
827863341,PA166155986,rs1051266,,,SLC19A1,Efficacy,-1,methotrexate,827863347.0,European
1183689719,PA166156915,rs361525,,,TNF,Efficacy,-1,infliximab,1183689721.0,European
1449188394,PA166177789,rs553202,,,OPRM1,Metabolism/PK,1,cotinine,1449188396.0,East Asian
981237838,PA166154769,rs944050,,,ESR2,Efficacy,1,gemcitabine,981237846.0,East Asian
1448613418,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613421.0,Unknown
1448613418,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613420.0,European
1448613418,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613422.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613418,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613423.0,Multiple groups
1447990816,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,debrisoquine,1447990818.0,Sub-Saharan African
1447990816,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,debrisoquine,1447990818.0,Sub-Saharan African
1447990816,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,debrisoquine,1447990818.0,Sub-Saharan African
1444697587,PA166156528,rs1870377,,,KDR,Efficacy,-1,clopidogrel,1444697589.0,East Asian
1449172013,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1449172025.0,East Asian
1449172013,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1449172025.0,East Asian
1449188388,PA166177788,rs3798676,,,OPRM1,Metabolism/PK,1,cotinine,1449188390.0,East Asian
1448285727,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448285737.0,Latino
1448285727,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448285737.0,Latino
1444697594,PA166156624,rs7667298,,,KDR,Efficacy,-1,clopidogrel,1444697596.0,East Asian
1449188406,PA166177791,rs7748401,,,OPRM1,Metabolism/PK,1,cotinine,1449188408.0,East Asian
827601694,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827601887.0,Multiple groups
1447990796,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,0,debrisoquine,1447990803.0,Unknown
1448613398,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613403.0,European
1448613398,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613409.0,Multiple groups
1448613398,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613405.0,Unknown
1448613398,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613407.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1183689806,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tolterodine,1183689820.0,European
1183689806,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,tolterodine,1183689820.0,European
1183689806,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tolterodine,1183689820.0,European
1448613393,PA166156418,rs6809699,,,P2RY12,Efficacy,1,clopidogrel,1448613395.0,East Asian
1447990805,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,debrisoquine,1447990814.0,Sub-Saharan African
1447990805,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,debrisoquine,1447990814.0,Sub-Saharan African
1449188412,PA166177792,rs495491,,,OPRM1,Metabolism/PK,1,cotinine,1449188414.0,East Asian
1449188424,PA166177794,rs589046,,,OPRM1,Metabolism/PK,1,cotinine,1449188426.0,East Asian
981237807,PA166153814,rs10916852,,,SH2D5,Efficacy,1,gemcitabine,981237813.0,East Asian
1445402137,PA166155923,rs2236196,,,CHRNA4,Efficacy,-1,varenicline,1445402139.0,Multiple groups
1449188442,PA166157015,rs2075572,,,OPRM1,Metabolism/PK,1,cotinine,1449188444.0,East Asian
981237814,PA166153761,rs3925058,,,CMPK1,Efficacy,-1,gemcitabine,981237818.0,East Asian
1183624260,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,citalopram,1183624270.0,European
1183624260,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,citalopram,1183624270.0,European
1183624260,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,mianserin,1183624270.0,European
1183624260,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,mianserin,1183624270.0,European
1183624260,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,mirtazapine,1183624270.0,European
1183624260,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,mirtazapine,1183624270.0,European
1183624260,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,nortriptyline,1183624270.0,European
1183624260,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,nortriptyline,1183624270.0,European
1183624260,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,paroxetine,1183624270.0,European
1183624260,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,paroxetine,1183624270.0,European
1183624260,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,venlafaxine,1183624270.0,European
1183624260,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,venlafaxine,1183624270.0,European
1448613376,PA166156412,rs6785930,,,P2RY12,Efficacy,1,clopidogrel,1448613381.0,East Asian
981237819,PA166153793,rs7543016,,,CMPK1,Efficacy,1,gemcitabine,981237827.0,East Asian
637879752,PA166153643,rs1801131,,,MTHFR,,-1,methotrexate,637879754.0,European
1450826813,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1450826822.0,European
1450826813,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1450826826.0,European
1450826813,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1450826825.0,European
1450826813,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1450826824.0,European
1450826813,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1450826818.0,European
1450826813,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,morphine,1450826823.0,European
1449188436,PA166177796,rs563649,,,OPRM1,Metabolism/PK,1,cotinine,1449188438.0,East Asian
1451121728,PA166175994,rs678849,,,OPRD1,Efficacy,-1,oxycodone,1451121732.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
1447679474,PA166154263,rs6356,,,TH,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679476.0,East Asian
1447990776,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,sparteine,1447990787.0,East Asian
1447990776,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1447990787.0,East Asian
1447990776,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,sparteine,1447990787.0,East Asian
1447679482,PA166154499,rs723672,,,CACNA1C,Efficacy,-1,olanzapine,1447679502.0,East Asian
1447679482,PA166154499,rs723672,,,CACNA1C,Efficacy,-1,quetiapine,1447679502.0,East Asian
1447679482,PA166154499,rs723672,,,CACNA1C,Efficacy,-1,risperidone,1447679502.0,East Asian
1184754854,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,simvastatin acid,1184754858.0,Unknown
637879832,PA166154334,rs1799732,,,DRD2,Efficacy,0,clozapine,637879836.0,East Asian
637879832,PA166154334,rs1799732,,,DRD2,Efficacy,0,clozapine,637879834.0,European
1451121724,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,oxycodone,1451121705.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
1447679454,PA166156803,rs2550956,,,SLC6A3,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679456.0,East Asian
1447679460,PA166154433,rs10743152,,,TH,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679462.0,East Asian
1447679466,PA166154434,rs10770141,,,TH,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679469.0,East Asian
1449172092,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449172104.0,Unknown
1449172092,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449172104.0,Unknown
1183624342,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183624348.0,Unknown
981483674,PA166154632,rs11045872,,,SLCO1B1,Efficacy,-1,methotrexate,1451401580.0,Multiple groups
981483674,PA166154632,rs11045872,,,SLCO1B1,Efficacy,-1,methotrexate,981483685.0,Multiple groups
981483674,PA166154632,rs11045872,,,SLCO1B1,Toxicity,-1,methotrexate,1451401580.0,Multiple groups
981483674,PA166154632,rs11045872,,,SLCO1B1,Toxicity,-1,methotrexate,981483685.0,Multiple groups
981483674,PA166154632,rs11045872,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1451401580.0,Multiple groups
981483674,PA166154632,rs11045872,,,SLCO1B1,Metabolism/PK,-1,methotrexate,981483685.0,Multiple groups
637879842,PA166154334,rs1799732,,,DRD2,Efficacy,0,clozapine,637879845.0,European
637879842,PA166154334,rs1799732,,,DRD2,Efficacy,0,clozapine,637879847.0,African American/Afro-Caribbean
637879838,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,637879844.0,"Multiple groups, Asians (n = 1103), blacks (n = 670), and whites (n = 3113)"
1447679420,PA166155036,rs2242446,,,SLC6A2,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679422.0,East Asian
1445402071,PA166155912,rs1044396,,,CHRNA4,Efficacy,1,varenicline,1445402118.0,Multiple groups
1445402071,PA166155912,rs1044396,,,CHRNA4,Efficacy,1,varenicline,1445402124.0,Multiple groups
1447679428,PA166154970,rs5564,,,SLC6A2,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679430.0,East Asian
981483686,PA166154633,rs11045879,,,SLCO1B1,Efficacy,1,methotrexate,1451401591.0,Multiple groups
981483686,PA166154633,rs11045879,,,SLCO1B1,Efficacy,1,methotrexate,981483691.0,Multiple groups
981483686,PA166154633,rs11045879,,,SLCO1B1,Toxicity,1,methotrexate,1451401591.0,Multiple groups
981483686,PA166154633,rs11045879,,,SLCO1B1,Toxicity,1,methotrexate,981483691.0,Multiple groups
981483686,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401591.0,Multiple groups
981483686,PA166154633,rs11045879,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483691.0,Multiple groups
1448285628,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448285630.0,East Asian
1447679434,PA166156045,rs140504,,,BCR,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679437.0,East Asian
1448926357,PA166169977,rs10040363,,,XRCC4,Efficacy,1,fluorouracil,1448926375.0,East Asian
1448926357,PA166169977,rs10040363,,,XRCC4,Efficacy,1,fluorouracil,1448926359.0,East Asian
1448926357,PA166169977,rs10040363,,,XRCC4,Efficacy,1,Platinum compounds,1448926375.0,East Asian
1448926357,PA166169977,rs10040363,,,XRCC4,Efficacy,1,Platinum compounds,1448926359.0,East Asian
1448926357,PA166169977,rs10040363,,,XRCC4,Efficacy,1,radiotherapy,1448926375.0,East Asian
1448926357,PA166169977,rs10040363,,,XRCC4,Efficacy,1,radiotherapy,1448926359.0,East Asian
1448613303,PA166153961,rs1058930,,,CYP2C8,Metabolism/PK,-1,imatinib,1448613305.0,Unknown
1447679410,PA166155012,rs1362621,,,SLC6A2,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679412.0,East Asian
1183624311,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183624333.0,Unknown
1183624311,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183624333.0,Unknown
1183624311,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183624333.0,Unknown
1448285615,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448285627.0,East Asian
1448285615,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448285627.0,East Asian
1448613297,PA166154110,rs10509681,,,CYP2C8,Metabolism/PK,-1,imatinib,1448613299.0,Unknown
1448613297,PA166154110,rs10509681,,,CYP2C8,Metabolism/PK,-1,imatinib,1448613299.0,Unknown
1444697577,PA166156553,rs2305948,,,KDR,Efficacy,1,clopidogrel,1444697585.0,East Asian
1447990710,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,debrisoquine,1447990712.0,European
1447990710,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1447990712.0,European
1447990710,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,debrisoquine,1447990712.0,European
1447990710,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,debrisoquine,1447990712.0,European
1447679388,PA166154423,rs7131056,,,DRD2,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679390.0,East Asian
1448613291,PA166154140,rs11572080,,,CYP2C8,Metabolism/PK,-1,imatinib,1448613293.0,Unknown
1449565369,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenytoin,1449565376.0,East Asian
1449565369,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenytoin,1449565376.0,East Asian
1449565369,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,phenytoin,1449565376.0,East Asian
1449565369,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,phenytoin,1449565376.0,East Asian
827863717,PA166157345,rs2242480,,,CYP3A4,Other,0,warfarin,827863725.0,Unknown
827863717,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,0,warfarin,827863725.0,Unknown
1448613285,PA166154160,rs17110453,,,CYP2C8,Metabolism/PK,-1,imatinib,1448613287.0,Unknown
1449270454,PA166157316,rs2032582,,,ABCB1,Efficacy,1,iguratimod,1449270456.0,East Asian
1449270454,PA166157316,rs2032582,,,ABCB1,Efficacy,1,iguratimod,1449270456.0,East Asian
1451138265,PA166184204,rs204047,,,OPRD1,Dosage,1,methadone,1451138269.0,Unknown
1449270444,PA166156544,rs2231142,,,ABCG2,Efficacy,1,iguratimod,1449270446.0,East Asian
1448613278,PA166154085,rs7909236,,,CYP2C8,Metabolism/PK,-1,imatinib,1448613284.0,Unknown
1447679401,PA166154353,rs2234689,,,DRD2,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679403.0,East Asian
1447679373,PA166156823,rs3863145,,,SLC6A3,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679375.0,East Asian
1448285601,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,fluoxetine,1448285603.0,Central/South Asian
1448285601,,,PA166117147,SLC6A4 L allele-rs25531C,SLC6A4,Efficacy,-1,fluoxetine,1448285603.0,Central/South Asian
1448285601,,,PA166117146,SLC6A4 L allele-rs25531T,SLC6A4,Efficacy,-1,fluoxetine,1448285603.0,Central/South Asian
1451138275,PA166206021,rs797397,,,OPRD1,Metabolism/PK,1,methadone,1451138279.0,Unknown
1448926403,PA166156345,rs2228001,,,XPC,Efficacy,-1,fluorouracil,1448926409.0,East Asian
1448926403,PA166156345,rs2228001,,,XPC,Efficacy,-1,Platinum compounds,1448926409.0,East Asian
1448926403,PA166156345,rs2228001,,,XPC,Efficacy,-1,radiotherapy,1448926409.0,East Asian
827863702,PA166154042,rs3814637,,,CYP2C19,Other,0,warfarin,827863709.0,Unknown
827863702,PA166154042,rs3814637,,,CYP2C19,Metabolism/PK,0,warfarin,827863709.0,Unknown
1448285592,PA166157286,rs1057868,,,POR,Metabolism/PK,-1,tacrolimus,1448285600.0,Multiple groups
1451138270,PA166184204,rs204047,,,OPRD1,Metabolism/PK,1,methadone,1451138274.0,Unknown
1447679379,PA166154412,rs4963126,,,DEAF1,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679382.0,East Asian
981844189,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,midazolam,981844199.0,Unknown
1447679358,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,Selective serotonin reuptake inhibitors,1447679372.0,East Asian
1448285579,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluoxetine,1448285598.0,Central/South Asian
1448285579,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1448285598.0,Central/South Asian
1448285579,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1448285598.0,Central/South Asian
1448926423,PA166155343,rs13181,,,ERCC2,Efficacy,-1,fluorouracil,1448926425.0,East Asian
1448926423,PA166155343,rs13181,,,ERCC2,Efficacy,-1,Platinum compounds,1448926425.0,East Asian
1448926423,PA166155343,rs13181,,,ERCC2,Efficacy,-1,radiotherapy,1448926425.0,East Asian
1449270476,PA166177971,rs11940694,,,KLB,Toxicity,1,ethanol,1449270483.0,European
981483700,PA166154629,rs11045821,,,SLCO1B1,Efficacy,1,methotrexate,1451401620.0,Multiple groups
981483700,PA166154629,rs11045821,,,SLCO1B1,Efficacy,1,methotrexate,981483705.0,Multiple groups
981483700,PA166154629,rs11045821,,,SLCO1B1,Toxicity,1,methotrexate,1451401620.0,Multiple groups
981483700,PA166154629,rs11045821,,,SLCO1B1,Toxicity,1,methotrexate,981483705.0,Multiple groups
981483700,PA166154629,rs11045821,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401620.0,Multiple groups
981483700,PA166154629,rs11045821,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483705.0,Multiple groups
981483693,PA166154581,rs4149081,,,SLCO1B1,Efficacy,1,methotrexate,1451401585.0,Multiple groups
981483693,PA166154581,rs4149081,,,SLCO1B1,Efficacy,1,methotrexate,981483698.0,Multiple groups
981483693,PA166154581,rs4149081,,,SLCO1B1,Toxicity,1,methotrexate,1451401585.0,Multiple groups
981483693,PA166154581,rs4149081,,,SLCO1B1,Toxicity,1,methotrexate,981483698.0,Multiple groups
981483693,PA166154581,rs4149081,,,SLCO1B1,Metabolism/PK,1,methotrexate,1451401585.0,Multiple groups
981483693,PA166154581,rs4149081,,,SLCO1B1,Metabolism/PK,1,methotrexate,981483698.0,Multiple groups
1448926417,PA166169985,rs1870134,,,XPC,Efficacy,-1,fluorouracil,1448926419.0,East Asian
1448926417,PA166169985,rs1870134,,,XPC,Efficacy,-1,Platinum compounds,1448926419.0,East Asian
1448926417,PA166169985,rs1870134,,,XPC,Efficacy,-1,radiotherapy,1448926419.0,East Asian
1448926429,PA166155349,rs238406,,,ERCC2,Efficacy,-1,fluorouracil,1448926431.0,East Asian
1448926429,PA166155349,rs238406,,,ERCC2,Efficacy,-1,Platinum compounds,1448926431.0,East Asian
1448926429,PA166155349,rs238406,,,ERCC2,Efficacy,-1,radiotherapy,1448926431.0,East Asian
1448926435,PA166155361,rs1052555,,,ERCC2,Efficacy,-1,fluorouracil,1448926437.0,East Asian
1448926435,PA166155361,rs1052555,,,ERCC2,Efficacy,-1,Platinum compounds,1448926437.0,East Asian
1448926435,PA166155361,rs1052555,,,ERCC2,Efficacy,-1,radiotherapy,1448926437.0,East Asian
1184754864,PA166154465,rs12422149,,,SLCO2B1,Metabolism/PK,0,simvastatin,1184754868.0,Unknown
1448613226,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,tacrolimus,1448613228.0,East Asian
1183771932,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1183772379.0,Sub-Saharan African
1183771932,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1183772379.0,Sub-Saharan African
1448613220,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,tacrolimus,1448613222.0,East Asian
1184754871,PA166156105,rs4253728,,,PPARA,Metabolism/PK,0,simvastatin,1184754875.0,Unknown
1448926448,PA166169991,rs3810366,,,ERCC2,Efficacy,-1,fluorouracil,1448926450.0,East Asian
1448926448,PA166169991,rs3810366,,,ERCC2,Efficacy,-1,Platinum compounds,1448926450.0,East Asian
1448926448,PA166169991,rs3810366,,,ERCC2,Efficacy,-1,radiotherapy,1448926450.0,East Asian
1447990611,PA166154313,rs1076560,,,DRD2,Efficacy,1,rasagiline,1447990613.0,"Multiple groups, Patients from 129 centers across 14 countries"
1448613208,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,tacrolimus,1448613210.0,East Asian
1448926460,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,fluorouracil,1448926462.0,East Asian
1448926460,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,Platinum compounds,1448926462.0,East Asian
1448926460,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,radiotherapy,1448926462.0,East Asian
1448926466,PA166155342,rs11615,,,ERCC1,Efficacy,-1,fluorouracil,1448926468.0,East Asian
1448926466,PA166155342,rs11615,,,ERCC1,Efficacy,-1,Platinum compounds,1448926468.0,East Asian
1448926466,PA166155342,rs11615,,,ERCC1,Efficacy,-1,radiotherapy,1448926468.0,East Asian
1448613202,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,tacrolimus,1448613204.0,East Asian
1448613202,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,1,tacrolimus,1448613204.0,East Asian
1447990618,PA166155928,rs2585428,,,CYP24A1,Metabolism/PK,1,telaprevir,1447990626.0,Unknown
1449188612,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,0,apixaban,1449188618.0,East Asian
1447679317,PA166157414,rs6942609,,,ACHE,Efficacy,-1,donepezil,1447679319.0,East Asian
1447679317,PA166157414,rs6942609,,,ACHE,Efficacy,-1,galantamine,1447679319.0,East Asian
1447679317,PA166157414,rs6942609,,,ACHE,Efficacy,-1,rivastigmine,1447679319.0,East Asian
1451138340,PA166175994,rs678849,,,OPRD1,Dosage,-1,methadone,1451138344.0,Unknown
1449188622,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,methotrexate,1449188628.0,Unknown
1448926477,PA166169996,rs2276464,,,ERCC4,Efficacy,-1,fluorouracil,1448926479.0,East Asian
1448926477,PA166169996,rs2276464,,,ERCC4,Efficacy,-1,Platinum compounds,1448926479.0,East Asian
1448926477,PA166169996,rs2276464,,,ERCC4,Efficacy,-1,radiotherapy,1448926479.0,East Asian
1448926477,PA166169996,rs2276464,,,ERCC4,Efficacy,-1,radiotherapy,1448926479.0,East Asian
1448613188,PA166155730,rs4553808,,,CTLA4,Metabolism/PK,1,tacrolimus,1448613190.0,East Asian
1449172248,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,tacrolimus,1449172260.0,
1449172248,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,tacrolimus,1449172260.0,
1449172236,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tacrolimus,1449172238.0,Unknown
1449172236,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tacrolimus,1449172238.0,Unknown
1449188641,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,methotrexate,1449188643.0,Unknown
981483776,PA166157428,rs7787082,,,ABCB1,Efficacy,1,clozapine,981483783.0,East Asian
1451138300,PA166206021,rs797397,,,OPRD1,Dosage,-1,methadone,1451138304.0,Unknown
1448926488,PA166169998,rs2276466,,,ERCC4,Efficacy,-1,fluorouracil,1448926490.0,East Asian
1448926488,PA166169998,rs2276466,,,ERCC4,Efficacy,-1,Platinum compounds,1448926490.0,East Asian
1448926488,PA166169998,rs2276466,,,ERCC4,Efficacy,-1,radiotherapy,1448926490.0,East Asian
1447990584,PA166154364,rs2283265,,,DRD2,Efficacy,1,rasagiline,1447990609.0,"Multiple groups, Patients from 129 centers across 14 countries"
981483784,PA166157440,rs10248420,,,ABCB1,Efficacy,1,clozapine,981483791.0,East Asian
1448926507,PA166154693,rs1047768,,,ERCC5,Efficacy,-1,fluorouracil,1448926509.0,East Asian
1448926507,PA166154693,rs1047768,,,ERCC5,Efficacy,-1,Platinum compounds,1448926509.0,East Asian
1448926507,PA166154693,rs1047768,,,ERCC5,Efficacy,-1,radiotherapy,1448926509.0,East Asian
1449188647,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,1,methotrexate,1449188873.0,European
1449188647,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,1,methotrexate,1449188655.0,European
1448926501,PA166170000,rs6498486,,,ERCC4,Efficacy,-1,fluorouracil,1448926503.0,East Asian
1448926501,PA166170000,rs6498486,,,ERCC4,Efficacy,-1,Platinum compounds,1448926503.0,East Asian
1448926501,PA166170000,rs6498486,,,ERCC4,Efficacy,-1,radiotherapy,1448926503.0,East Asian
1449188656,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,methotrexate,1449188664.0,European
1449188656,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,methotrexate,1449188664.0,European
1184165220,PA166155055,rs3785143,,,SLC6A2,Efficacy,1,atomoxetine,1184165224.0,East Asian
1447679260,PA166154081,rs7094421,,,CHAT,Efficacy,-1,donepezil,1447679262.0,East Asian
1447679260,PA166154081,rs7094421,,,CHAT,Efficacy,-1,galantamine,1447679262.0,East Asian
1447679260,PA166154081,rs7094421,,,CHAT,Efficacy,-1,rivastigmine,1447679262.0,East Asian
1448613158,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,imatinib,1448613160.0,Central/South Asian
1448926513,PA166154677,rs17655,,,ERCC5,Efficacy,-1,fluorouracil,1448926515.0,East Asian
1448926513,PA166154677,rs17655,,,ERCC5,Efficacy,-1,Platinum compounds,1448926515.0,East Asian
1448926513,PA166154677,rs17655,,,ERCC5,Efficacy,-1,radiotherapy,1448926515.0,East Asian
1183690079,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,1183690081.0,East Asian
1183690079,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,warfarin,1183690081.0,East Asian
1448613152,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,imatinib,1448613154.0,Central/South Asian
1449188665,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,methotrexate,1449188672.0,European
1450417472,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,propafenone,1450417483.0,East Asian
1450417472,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,propafenone,1450417483.0,East Asian
981481812,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,981481825.0,East Asian
981481812,PA166155381,rs2108622,,,CYP4F2,Efficacy,1,warfarin,981481825.0,East Asian
1448613146,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,imatinib,1448613148.0,Central/South Asian
1448926524,PA166170004,rs751402,,,ERCC5,Efficacy,-1,fluorouracil,1448926526.0,East Asian
1448926524,PA166170004,rs751402,,,ERCC5,Efficacy,-1,Platinum compounds,1448926526.0,East Asian
1448926524,PA166170004,rs751402,,,ERCC5,Efficacy,-1,radiotherapy,1448926526.0,East Asian
1448926535,PA166170006,rs2094258,,,ERCC5,Efficacy,-1,fluorouracil,1448926537.0,East Asian
1448926535,PA166170006,rs2094258,,,ERCC5,Efficacy,-1,Platinum compounds,1448926537.0,East Asian
1448926535,PA166170006,rs2094258,,,ERCC5,Efficacy,-1,radiotherapy,1448926537.0,East Asian
1450417453,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,pioglitazone,1450417464.0,Unknown
1450417453,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,pioglitazone,1450417464.0,Unknown
981481830,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,981481837.0,East Asian
981481830,PA166155381,rs2108622,,,CYP4F2,Efficacy,1,warfarin,981481837.0,East Asian
1448613138,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,imatinib,1448613140.0,Central/South Asian
1448613132,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,imatinib,1448613134.0,Central/South Asian
1448613132,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,imatinib,1448613134.0,Central/South Asian
981481774,PA166154971,rs5568,,,SLC6A2,Efficacy,-1,methylphenidate,981481782.0,East Asian
1183690069,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1183690078.0,East Asian
1448926546,PA166170008,rs2296147,,,ERCC5,Efficacy,-1,fluorouracil,1448926548.0,East Asian
1448926546,PA166170008,rs2296147,,,ERCC5,Efficacy,-1,Platinum compounds,1448926548.0,East Asian
1448926546,PA166170008,rs2296147,,,ERCC5,Efficacy,-1,radiotherapy,1448926548.0,East Asian
1448613124,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,imatinib,1448613126.0,Central/South Asian
1451138360,PA166206041,rs482387,,,OPRD1,Dosage,-1,methadone,1451138364.0,Unknown
981481784,PA166154972,rs5569,,,SLC6A2,Efficacy,-1,methylphenidate,981481793.0,East Asian
1450368353,PA166181801,rs3842761,,,INS-IGF2,Efficacy,1,Platinum compounds,1450368364.0,East Asian
1448613117,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,imatinib,1448613123.0,Central/South Asian
981481795,PA166155000,rs998424,,,SLC6A2,Efficacy,-1,methylphenidate,981481803.0,East Asian
1183690032,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183690034.0,Unknown
1183690032,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,tacrolimus,1183690034.0,Unknown
769166457,PA166155331,rs45445694,,,TYMS,Efficacy,1,capecitabine,769166459.0,Unknown
769166457,PA166155331,rs45445694,,,TYMS,Efficacy,1,raltitrexed,769166459.0,Unknown
769166457,PA166155331,rs45445694,,,TYMS,Efficacy,1,raltitrexed,769166459.0,Unknown
1448926557,PA166170010,rs873601,,,ERCC5,Efficacy,-1,fluorouracil,1448926559.0,East Asian
1448926557,PA166170010,rs873601,,,ERCC5,Efficacy,-1,Platinum compounds,1448926559.0,East Asian
1448926557,PA166170010,rs873601,,,ERCC5,Efficacy,-1,radiotherapy,1448926559.0,East Asian
1183690042,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1183690044.0,Unknown
1183690042,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,tacrolimus,1183690044.0,Unknown
1447679217,PA166154126,rs11101193,,,CHAT,Efficacy,-1,donepezil,1447679219.0,East Asian
1447679217,PA166154126,rs11101193,,,CHAT,Efficacy,-1,galantamine,1447679219.0,East Asian
1447679217,PA166154126,rs11101193,,,CHAT,Efficacy,-1,rivastigmine,1447679219.0,East Asian
1451138451,PA166184212,rs508448,,,OPRD1,Dosage,-1,methadone,1451138426.0,Unknown
1448269030,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448269037.0,East Asian
1448269030,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448269037.0,East Asian
981481869,PA166156948,rs760761,,,DTNBP1,Efficacy,-1,aripiprazole,981481876.0,East Asian
1448926577,PA166170014,rs174538,,,FEN1,Efficacy,-1,fluorouracil,1448926579.0,East Asian
1448926577,PA166170014,rs174538,,,FEN1,Efficacy,-1,Platinum compounds,1448926579.0,East Asian
1448926577,PA166170014,rs174538,,,FEN1,Efficacy,-1,radiotherapy,1448926579.0,East Asian
1451138446,PA166184211,rs2298895,,,OPRD1,Dosage,-1,methadone,1451138450.0,Unknown
1451138455,PA166153773,rs4654327,,,OPRD1,Dosage,-1,methadone,1451138459.0,Unknown
1450253685,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1450253697.0,East Asian
1450253685,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1450253699.0,East Asian
1450253685,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1450253697.0,East Asian
1450253685,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1450253699.0,East Asian
1450253685,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1450253697.0,East Asian
1450253685,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1450253699.0,East Asian
1184165275,PA166157084,rs3804454,,,MAPK14,Efficacy,-1,bevacizumab,1184165277.0,European
1184165275,PA166157084,rs3804454,,,MAPK14,Efficacy,-1,ranibizumab,1184165277.0,European
1448926588,PA166170016,rs4462560,,,NEIL1,Efficacy,-1,fluorouracil,1448926590.0,East Asian
1448926588,PA166170016,rs4462560,,,NEIL1,Efficacy,-1,Platinum compounds,1448926590.0,East Asian
1448926588,PA166170016,rs4462560,,,NEIL1,Efficacy,-1,radiotherapy,1448926590.0,East Asian
1184165271,PA166153567,rs323719,,,YBX1,Efficacy,-1,bevacizumab,1184165273.0,European
1184165271,PA166153567,rs323719,,,YBX1,Efficacy,-1,ranibizumab,1184165273.0,European
1184165267,PA166155821,rs12712973,,,EPAS1,Efficacy,-1,bevacizumab,1184165269.0,European
1184165267,PA166155821,rs12712973,,,EPAS1,Efficacy,-1,ranibizumab,1184165269.0,European
1448926597,PA166170018,rs7402844,,,NEIL1,Efficacy,-1,fluorouracil,1448926599.0,East Asian
1448926597,PA166170018,rs7402844,,,NEIL1,Efficacy,-1,Platinum compounds,1448926599.0,East Asian
1448926597,PA166170018,rs7402844,,,NEIL1,Efficacy,-1,radiotherapy,1448926599.0,East Asian
1448613071,PA166157366,rs2687116,,,CYP3A4,Efficacy,1,carbamazepine,1448613073.0,Unknown
1448613071,PA166157366,rs2687116,,,CYP3A4,Efficacy,1,lamotrigine,1448613073.0,Unknown
1448613071,PA166157366,rs2687116,,,CYP3A4,Efficacy,1,phenytoin,1448613073.0,Unknown
1448613071,PA166157366,rs2687116,,,CYP3A4,Efficacy,1,primidone,1448613073.0,Unknown
1448613071,PA166157366,rs2687116,,,CYP3A4,Efficacy,1,valproic acid,1448613073.0,Unknown
1184165262,PA166153828,rs11580141,,,RGS5,Efficacy,-1,bevacizumab,1184165264.0,European
1184165262,PA166153828,rs11580141,,,RGS5,Efficacy,-1,ranibizumab,1184165264.0,European
1449155973,PA166153666,rs2072661,,,CHRNB2,Efficacy,-1,bupropion,1449155980.0,European
1449155973,PA166153666,rs2072661,,,CHRNB2,Efficacy,-1,nicotine,1449155980.0,European
1449155973,PA166153666,rs2072661,,,CHRNB2,Efficacy,-1,varenicline,1449155980.0,European
1184165258,PA166154750,rs12877323,,,FLT1,Efficacy,-1,bevacizumab,1184165260.0,European
1184165258,PA166154750,rs12877323,,,FLT1,Efficacy,-1,ranibizumab,1184165260.0,European
1448613065,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,carbamazepine,1448613067.0,Unknown
1448613065,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,lamotrigine,1448613067.0,Unknown
1448613065,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,phenytoin,1448613067.0,Unknown
1448613065,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,primidone,1448613067.0,Unknown
1448613065,PA166157367,rs2740574,,,CYP3A4,Efficacy,1,valproic acid,1448613067.0,Unknown
981481839,PA166157074,rs3213207,,,DTNBP1,Efficacy,-1,aripiprazole,981481850.0,East Asian
1184165254,PA166155753,rs6726454,,,EPAS1,Efficacy,-1,bevacizumab,1184165256.0,European
1184165254,PA166155753,rs6726454,,,EPAS1,Efficacy,-1,ranibizumab,1184165256.0,European
1184165250,PA166155775,rs9679290,,,EPAS1,Efficacy,-1,bevacizumab,1184165252.0,European
1184165250,PA166155775,rs9679290,,,EPAS1,Efficacy,-1,ranibizumab,1184165252.0,European
1448613059,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,carbamazepine,1448613061.0,Unknown
1448613059,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,lamotrigine,1448613061.0,Unknown
1448613059,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,phenytoin,1448613061.0,Unknown
1448613059,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,primidone,1448613061.0,Unknown
1448613059,PA166156104,rs3892097,,,CYP2D6,Efficacy,1,valproic acid,1448613061.0,Unknown
1448613053,PA166154099,rs9332120,,,CYP2C9,Efficacy,1,carbamazepine,1448613055.0,Unknown
1448613053,PA166154099,rs9332120,,,CYP2C9,Efficacy,1,lamotrigine,1448613055.0,Unknown
1448613053,PA166154099,rs9332120,,,CYP2C9,Efficacy,1,phenytoin,1448613055.0,Unknown
1448613053,PA166154099,rs9332120,,,CYP2C9,Efficacy,1,primidone,1448613055.0,Unknown
1448613053,PA166154099,rs9332120,,,CYP2C9,Efficacy,1,valproic acid,1448613055.0,Unknown
1451138433,PA166184211,rs2298895,,,OPRD1,Metabolism/PK,-1,methadone,1451138521.0,Unknown
1184165242,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1184165244.0,European
1184165242,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1184165244.0,European
1451138429,PA166184210,rs12749204,,,OPRD1,Metabolism/PK,-1,methadone,1451138520.0,Unknown
1448613046,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,carbamazepine,1448613052.0,Unknown
1448613046,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,lamotrigine,1448613052.0,Unknown
1448613046,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,phenytoin,1448613052.0,Unknown
1448613046,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,primidone,1448613052.0,Unknown
1448613046,PA166156062,rs1065852,,,CYP2D6,Efficacy,1,valproic acid,1448613052.0,Unknown
1449156003,PA166175853,rs55781567,,,CHRNA5,Efficacy,-1,bupropion,1449156005.0,European
1449156003,PA166175853,rs55781567,,,CHRNA5,Efficacy,-1,nicotine,1449156005.0,European
1449156003,PA166175853,rs55781567,,,CHRNA5,Efficacy,-1,varenicline,1449156005.0,European
1449156003,PA166175853,rs55781567,,,CHRNA5,Efficacy,-1,varenicline,1449156005.0,European
769166388,PA166153644,rs1801133,,,MTHFR,Efficacy,1,fluorouracil,769166390.0,Unknown
769166388,PA166153644,rs1801133,,,MTHFR,Efficacy,1,leucovorin,769166390.0,Unknown
769166388,PA166153644,rs1801133,,,MTHFR,Efficacy,1,oxaliplatin,769166390.0,Unknown
1184165232,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1184165241.0,European
1184165232,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1184165241.0,European
1184165232,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1184165241.0,European
1184755051,PA166156787,rs2216711,,,GDNF,Efficacy,1,paroxetine,1184755053.0,East Asian
769166385,PA166153643,rs1801131,,,MTHFR,Efficacy,1,fluorouracil,769166387.0,Unknown
769166385,PA166153643,rs1801131,,,MTHFR,Efficacy,1,leucovorin,769166387.0,Unknown
769166385,PA166153643,rs1801131,,,MTHFR,Efficacy,1,oxaliplatin,769166387.0,Unknown
1449156009,PA166154938,rs16969968,,,CHRNA3,Efficacy,-1,bupropion,1449156011.0,European
1449156009,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,bupropion,1449156011.0,European
1449156009,PA166154938,rs16969968,,,CHRNA3,Efficacy,-1,nicotine,1449156011.0,European
1449156009,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,nicotine,1449156011.0,European
1449156009,PA166154938,rs16969968,,,CHRNA3,Efficacy,-1,varenicline,1449156011.0,European
1449156009,PA166154938,rs16969968,,,CHRNA5,Efficacy,-1,varenicline,1449156011.0,European
1446909124,PA166154658,rs61764370,,,KRAS,Efficacy,-1,cetuximab,1446909130.0,"Multiple groups, 4 studies all listed as Caucasian; Italy, Spain, Norway, USA"
1446909124,PA166154658,rs61764370,,,KRAS,Efficacy,-1,panitumumab,1446909130.0,"Multiple groups, 4 studies all listed as Caucasian; Italy, Spain, Norway, USA"
1448268979,PA166156978,rs1142345,,,TPMT,Efficacy,1,mercaptopurine,1448275770.0,"Multiple groups, White, Black, Hispanic, Asian, Other"
1448926630,PA166170024,rs1863332,,,MSH2,Efficacy,-1,fluorouracil,1448926632.0,East Asian
1448926630,PA166170024,rs1863332,,,MSH2,Efficacy,-1,Platinum compounds,1448926632.0,East Asian
1448926630,PA166170024,rs1863332,,,MSH2,Efficacy,-1,radiotherapy,1448926632.0,East Asian
1449188786,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449188792.0,Unknown
1449156016,PA166155923,rs2236196,,,CHRNA4,Efficacy,-1,bupropion,1449156018.0,European
1449156016,PA166155923,rs2236196,,,CHRNA4,Efficacy,-1,nicotine,1449156018.0,European
1449156016,PA166155923,rs2236196,,,CHRNA4,Efficacy,-1,varenicline,1449156018.0,European
1448613027,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,sulindac,1448613029.0,East Asian
1448926639,PA166170026,rs863221,,,MSH3,Efficacy,-1,fluorouracil,1448926641.0,East Asian
1448926639,PA166170026,rs863221,,,MSH3,Efficacy,-1,Platinum compounds,1448926641.0,East Asian
1448926639,PA166170026,rs863221,,,MSH3,Efficacy,-1,radiotherapy,1448926641.0,East Asian
1448613020,PA166153688,rs2266782,,,FMO3,Metabolism/PK,1,sulindac,1448613025.0,East Asian
1448268948,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1448268957.0,Multiple groups
1448268948,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448268957.0,Multiple groups
1451138480,PA166184213,rs204076,,,OPRD1,Dosage,-1,methadone,1451138484.0,Unknown
1448926660,PA166170030,rs1346044,,,WRN,Efficacy,-1,fluorouracil,1448926662.0,East Asian
1448926660,PA166170030,rs1346044,,,WRN,Efficacy,-1,Platinum compounds,1448926662.0,East Asian
1448926660,PA166170030,rs1346044,,,WRN,Efficacy,-1,radiotherapy,1448926662.0,East Asian
1448613000,PA166163521,rs7968606,,,ANKS1B,Efficacy,1,amisulpride,1448613010.0,East Asian
827832192,PA166154341,rs1801028,,,DRD2,Efficacy,-1,aripiprazole,827832207.0,East Asian
1445205151,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1445205945.0,African American/Afro-Caribbean
1445205151,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1445205705.0,African American/Afro-Caribbean
1445205151,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1445205945.0,African American/Afro-Caribbean
1445205151,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1445205705.0,African American/Afro-Caribbean
1451138505,PA166184213,rs204076,,,OPRD1,Metabolism/PK,-1,methadone,1451138493.0,Unknown
1448926678,PA166170034,rs1801320,,,RAD51,Efficacy,-1,fluorouracil,1448926680.0,East Asian
1448926678,PA166170034,rs1801320,,,RAD51,Efficacy,-1,Platinum compounds,1448926680.0,East Asian
1448926678,PA166170034,rs1801320,,,RAD51,Efficacy,-1,radiotherapy,1448926680.0,East Asian
1448612973,PA166157284,rs1045642,,,ABCB1,Dosage,-1,morphine,1448612975.0,Near Eastern
1449188836,PA166156991,rs1799971,,,OPRM1,Other,1,naloxone,1449188841.0,"Multiple groups, Participants were of Caucasian, African American or Asian background. Study carried out in Baltimore, Maryland."
1449188836,PA166156991,rs1799971,,,OPRM1,Other,1,naloxone,1449188841.0,"Multiple groups, Participants were of Caucasian, African American or Asian background. Study carried out in Baltimore, Maryland."
769248365,PA166157288,rs1128503,,,ABCB1,Other,1,tipifarnib,769248367.0,European
769248365,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,tipifarnib,769248367.0,European
1448926698,PA166170038,rs1478486,,,XRCC4,Efficacy,-1,fluorouracil,1448926700.0,East Asian
1448926698,PA166170038,rs1478486,,,XRCC4,Efficacy,-1,Platinum compounds,1448926700.0,East Asian
1448926698,PA166170038,rs1478486,,,XRCC4,Efficacy,-1,radiotherapy,1448926700.0,East Asian
1451138500,PA166175994,rs678849,,,OPRD1,Metabolism/PK,-1,methadone,1451138427.0,Unknown
1449713146,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,bupropion,1449713155.0,European
1448612967,PA166156024,rs4680,,,COMT,Dosage,-1,morphine,1448612969.0,Near Eastern
769248368,PA166157284,rs1045642,,,ABCB1,Other,-1,tipifarnib,769248370.0,European
769248368,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tipifarnib,769248370.0,European
769248371,PA166157367,rs2740574,,,CYP3A,Other,-1,tipifarnib,769248373.0,European
769248371,PA166157367,rs2740574,,,CYP3A4,Other,-1,tipifarnib,769248373.0,European
769248371,PA166157367,rs2740574,,,CYP3A,Metabolism/PK,-1,tipifarnib,769248373.0,European
769248371,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,tipifarnib,769248373.0,European
1449188859,PA166156991,rs1799971,,,OPRM1,Dosage,1,morphine,1449188865.0,Unknown
1449188859,PA166156991,rs1799971,,,OPRM1,Efficacy,1,morphine,1449188865.0,Unknown
1451122200,PA166156357,rs2461817,,,NR1I2,Metabolism/PK,1,voriconazole,1451122175.0,East Asian
769248374,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2a,769248377.0,East Asian
769248374,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2b,769248377.0,East Asian
769248374,PA166155469,rs12980275,,,IFNL3,Efficacy,1,ribavirin,769248377.0,East Asian
1448612958,PA166156991,rs1799971,,,OPRM1,Dosage,1,morphine,1448612966.0,Near Eastern
769248378,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,769248381.0,East Asian
769248378,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,769248381.0,East Asian
769248378,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,769248381.0,East Asian
1449713162,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713185.0,European
1449713162,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713183.0,European
1449713162,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713172.0,East Asian
1449713162,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713174.0,East Asian
1449713162,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713185.0,European
1449713162,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713183.0,European
1449713162,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713172.0,East Asian
1449713162,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713174.0,East Asian
1447679078,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679080.0,European
1447679078,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679081.0,European
1447679078,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679082.0,European
1447679078,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679080.0,European
1447679078,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679081.0,European
1447679078,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679082.0,European
1447679078,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679080.0,European
1447679078,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679081.0,European
1447679078,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1447679082.0,European
1451122204,PA166156423,rs7643645,,,NR1I2,Metabolism/PK,1,voriconazole,1451122176.0,East Asian
1451122204,PA166156423,rs7643645,,,NR1I2,Metabolism/PK,1,voriconazole,1451122176.0,East Asian
1447990337,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,debrisoquine,1447990346.0,Unknown
1447990337,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1447990346.0,Unknown
1447990337,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,sparteine,1447990346.0,Unknown
1447990337,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1447990346.0,Unknown
1451122160,PA166156384,rs3814057,,,NR1I2,Metabolism/PK,1,voriconazole,1451122164.0,East Asian
1451122160,PA166156384,rs3814057,,,NR1I2,Metabolism/PK,1,voriconazole,1451122164.0,East Asian
1451138540,PA166153773,rs4654327,,,OPRD1,Metabolism/PK,-1,methadone,1451138437.0,Unknown
1448612933,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,-1,phenytoin,1448612935.0,Central/South Asian
1448612933,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,-1,phenytoin,1448612935.0,Central/South Asian
1444713552,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444713565.0,Central/South Asian
1444713552,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444713565.0,Central/South Asian
1444713552,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1444713565.0,Central/South Asian
1449188881,PA166177853,rs3732361,,,GSK3B,Metabolism/PK,1,methotrexate,1449188887.0,European
1449188891,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,1,methotrexate,1449188897.0,European
1451122165,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,voriconazole,1451122169.0,East Asian
1449713195,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713200.0,European
1449713195,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713198.0,East Asian
1449713195,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713199.0,European
1449713195,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713197.0,East Asian
1449713195,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713200.0,European
1449713195,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713198.0,East Asian
1449713195,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713199.0,European
1449713195,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1449713197.0,East Asian
1451122177,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,1,voriconazole,1451122184.0,East Asian
1448612922,,,PA165816542,CYP2C9*1,CYP2C9,Toxicity,1,phenytoin,1448612932.0,Central/South Asian
1448612922,,,PA165816544,CYP2C9*3,CYP2C9,Toxicity,1,phenytoin,1448612932.0,Central/South Asian
1448612922,,,PA165816544,CYP2C9*3,CYP2C9,Toxicity,1,phenytoin,1448612932.0,Central/South Asian
1449713186,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713191.0,European
1449713186,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713189.0,East Asian
1449713186,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713190.0,European
1449713186,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1449713188.0,East Asian
1451122180,PA166200543,rs10954732,,,POR,Metabolism/PK,1,voriconazole,1451122174.0,East Asian
827816234,PA166155409,rs3745274,,,CYP2B6,Dosage,1,methadone,827816242.0,East Asian
827816234,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,methadone,827816242.0,East Asian
1444713578,,,PA165981641,SLCO1B1*1,SLCO1B1,Metabolism/PK,1,lovastatin acid,1444714169.0,European
1444713578,,,PA165819255,SLCO1B1*5,SLCO1B1,Metabolism/PK,1,lovastatin acid,1444714169.0,European
1444713578,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,lovastatin acid,1444714169.0,European
1450827343,PA166185207,rs2075652,,,DRD2,Toxicity,-1,heroin,1450827347.0,East Asian
1444828143,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1444828150.0,European
827783461,PA166157143,rs9340799,,,ESR1,Efficacy,1,leflunomide,827783480.0,Unknown
1444828153,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1444828160.0,Latino
1450827348,PA166154407,rs4436578,,,DRD2,Toxicity,-1,heroin,1450827352.0,East Asian
1447679007,PA166154063,rs4838392,,,CHAT,Efficacy,-1,donepezil,1447679009.0,East Asian
1447679007,PA166154063,rs4838392,,,CHAT,Efficacy,-1,galantamine,1447679009.0,East Asian
1447679007,PA166154063,rs4838392,,,CHAT,Efficacy,-1,rivastigmine,1447679009.0,East Asian
1451105880,PA166154084,rs7903146,,,TCF7L2,Efficacy,1,glipizide,1451105884.0,"Multiple groups, Boston, USA ""Over 35% of the participants came from ethnic minority populations"""
1450827353,PA166184000,rs4648318,,,DRD2,Toxicity,-1,heroin,1450827357.0,East Asian
1444828163,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1444828170.0,Sub-Saharan African
1444828163,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1444828170.0,Sub-Saharan African
1450827358,PA166184212,rs508448,,,OPRD1,Toxicity,-1,heroin,1450827362.0,East Asian
1451335271,PA166157440,rs10248420,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335275.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1450827363,PA166185218,rs12574471,,,DRD2,Toxicity,-1,heroin,1450827367.0,East Asian
1451335261,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335265.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
981858915,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,981858923.0,"Multiple groups, USA: 73% White, 18.9% African American, 8.1% Asian"
1450827368,PA166185233,rs6985606,,,OPRK1,Toxicity,-1,heroin,1450827372.0,East Asian
1451335266,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335270.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451138662,PA166206221,rs3802281,,,OPRK1,Dosage,1,methadone,1451138667.0,East Asian
1451105843,PA166154084,rs7903146,,,TCF7L2,Efficacy,1,metformin,1451105860.0,"Multiple groups, Boston, USA ""Over 35% of the participants came from ethnic minority populations"""
1451138607,PA166206202,rs3802279,,,OPRK1,Dosage,1,methadone,1451138642.0,East Asian
1451138607,PA166206202,rs3802279,,,OPRK1,Dosage,1,methadone,1451138642.0,East Asian
1447678987,PA166154034,rs3793790,,,CHAT,Efficacy,1,donepezil,1447678989.0,East Asian
1447678987,PA166154034,rs3793790,,,CHAT,Efficacy,1,galantamine,1447678989.0,East Asian
1447678987,PA166154034,rs3793790,,,CHAT,Efficacy,1,rivastigmine,1447678989.0,East Asian
827848963,PA166155409,rs3745274,,,CYP2B6,Toxicity,1,nevirapine,827848973.0,Multiple groups
827848963,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,827848973.0,Multiple groups
1447678959,PA166153998,rs2177370,,,CHAT,Efficacy,1,donepezil,1447678985.0,East Asian
1447678959,PA166153998,rs2177370,,,CHAT,Efficacy,1,galantamine,1447678985.0,East Asian
1447678959,PA166153998,rs2177370,,,CHAT,Efficacy,1,rivastigmine,1447678985.0,East Asian
1448612847,PA166156544,rs2231142,,,ABCG2,Dosage,-1,sulfasalazine,1448612849.0,East Asian
827848942,PA166155405,rs3211371,,,CYP2B6,Toxicity,-1,nevirapine,827848987.0,Multiple groups
827848942,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,-1,nevirapine,827848987.0,Multiple groups
1451138701,PA166206201,rs16918842,,,OPRK1,Dosage,-1,methadone,1451138720.0,East Asian
1448612852,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,rosuvastatin,1448612854.0,East Asian
1451122240,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1451122300.0,Sub-Saharan African
1451122240,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1451122284.0,Sub-Saharan African
1451335320,PA166156141,rs13306278,,,COMT,Metabolism/PK,-1,olanzapine,1451335324.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
769182565,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,769182567.0,"Multiple groups, Singapore: 131 Chinese, 81 Malays and 36 Asian Indians"
1450827414,PA166185235,rs7813478,,,OPRK1,Toxicity,-1,heroin,1450827418.0,East Asian
769182559,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,769182561.0,"Multiple groups, Singapore: 131 Chinese, 81 Malays and 36 Asian Indians"
1451335313,PA166154250,rs4520,,,APOC3,Metabolism/PK,-1,olanzapine,1451335317.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451138721,PA166206241,rs3808627,,,OPRK1,Dosage,-1,methadone,1451138740.0,East Asian
769182562,PA166155079,rs7196161,,,VKORC1,Dosage,1,warfarin,769182564.0,"Multiple groups, Singapore: 131 Chinese, 81 Malays and 36 Asian Indians"
827848927,PA166157267,rs776746,,,CYP3A5,Toxicity,-1,nevirapine,827848981.0,Multiple groups
827848927,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,nevirapine,827848981.0,Multiple groups
1449565832,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenytoin,1449565845.0,Central/South Asian
1449565832,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,phenytoin,1449565845.0,Central/South Asian
1449565832,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenytoin,1449565845.0,Central/South Asian
827848921,PA166157367,rs2740574,,,CYP3A4,Toxicity,-1,nevirapine,827848983.0,Multiple groups
827848921,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,nevirapine,827848983.0,Multiple groups
1448432602,PA166155684,rs2372536,,,ATIC,Efficacy,1,methotrexate,1448432608.0,European
1444828093,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,flurbiprofen,1444828106.0,Unknown
1444828093,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,flurbiprofen,1444828106.0,Unknown
827848916,PA166157288,rs1128503,,,ABCB1,Toxicity,-1,nevirapine,827848979.0,Multiple groups
827848916,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,nevirapine,827848979.0,Multiple groups
1447678931,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,ambrisentan,1447678953.0,"Multiple groups, 17 Caucasians, 2 Hispanics, 1 Asian"
1447678931,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,ambrisentan,1447678953.0,"Multiple groups, 17 Caucasians, 2 Hispanics, 1 Asian"
1447678931,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,ambrisentan,1447678953.0,"Multiple groups, 17 Caucasians, 2 Hispanics, 1 Asian"
1447678931,,,PA165980637,CYP2C19*4,CYP2C19,Metabolism/PK,1,ambrisentan,1447678953.0,"Multiple groups, 17 Caucasians, 2 Hispanics, 1 Asian"
1447678931,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,ambrisentan,1447678953.0,"Multiple groups, 17 Caucasians, 2 Hispanics, 1 Asian"
1450827424,PA166179883,rs2236857,,,OPRD1,Toxicity,-1,heroin,1450827428.0,East Asian
1444828107,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,flurbiprofen,1444828119.0,Unknown
1444828107,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,flurbiprofen,1444828119.0,Unknown
1450827434,PA166154437,rs10835210,,,BDNF,Toxicity,-1,heroin,1450827438.0,East Asian
1450827374,PA166185237,rs16918909,,,OPRK1,Toxicity,-1,heroin,1450827378.0,East Asian
1451335288,PA166157458,rs12720067,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335292.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
981858976,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859037.0,East Asian
981858976,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981859035.0,East Asian
981858976,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,981858993.0,East Asian
1449565846,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,phenytoin,1449565848.0,Central/South Asian
1449565846,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,phenytoin,1449565848.0,Central/South Asian
1450827379,PA166154423,rs7131056,,,DRD2,Toxicity,-1,heroin,1450827383.0,East Asian
1451335276,PA166157445,rs10280101,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335282.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335276,PA166157445,rs10280101,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335282.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
827848898,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,nevirapine,827848975.0,Multiple groups
827848898,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,nevirapine,827848975.0,Multiple groups
1450827384,PA166185231,rs6669447,,,OPRD1,Toxicity,-1,heroin,1450827388.0,East Asian
1451138668,PA166176247,rs963549,,,OPRK1,Dosage,1,methadone,1451138700.0,East Asian
1448432576,PA166161545,rs2373586,,,ABCB1,Metabolism/PK,-1,SN-38,1448432578.0,"Multiple groups, Caucasian and African-American"
981858924,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,981858928.0,"Multiple groups, USA: 73% White, 18.9% African American, 8.1% Asian"
981858924,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,981858928.0,"Multiple groups, USA: 73% White, 18.9% African American, 8.1% Asian"
981858924,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,981858928.0,"Multiple groups, USA: 73% White, 18.9% African American, 8.1% Asian"
981858924,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,981858928.0,"Multiple groups, USA: 73% White, 18.9% African American, 8.1% Asian"
1451335283,PA166157453,rs11983225,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335287.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1449172643,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449173177.0,European
1449172643,PA166156991,rs1799971,,,OPRM1,Dosage,-1,morphine,1449172863.0,European
1450827389,PA166154313,rs1076560,,,DRD2,Toxicity,-1,heroin,1450827393.0,East Asian
981858954,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,981858973.0,East Asian
981858954,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,981858975.0,East Asian
1450827394,PA166183998,rs1079596,,,DRD2,Toxicity,-1,heroin,1450827398.0,East Asian
1446695874,PA166156553,rs2305948,,,KDR,Efficacy,-1,sunitinib,1446698465.0,"Multiple groups, Chinese, Malay, Indian"
1447678899,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cyclophosphamide,1447678913.0,Multiple groups
1447678899,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cyclophosphamide,1447678910.0,"Multiple groups, Britain 90% White, 4% Asian/Indian/Pakistani, 6% mixed background"
1447678899,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cyclophosphamide,1447678913.0,Multiple groups
1447678899,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cyclophosphamide,1447678910.0,"Multiple groups, Britain 90% White, 4% Asian/Indian/Pakistani, 6% mixed background"
1184509540,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,sertraline,1184509820.0,Unknown
1184509540,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,sertraline,1184509820.0,Unknown
1451335293,PA166157385,rs4148737,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335297.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1449565855,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,phenytoin,1449565857.0,Central/South Asian
1449565855,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,phenytoin,1449565857.0,Central/South Asian
1449565855,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,phenytoin,1449565857.0,Central/South Asian
1451335298,PA166157398,rs4728709,,,ABCB1,Metabolism/PK,-1,olanzapine,1451335302.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1448432559,PA166161543,rs35621,,,ABCC1,Metabolism/PK,1,SN-38,1448432561.0,"Multiple groups, Caucasian and African-American"
981482193,PA166157163,rs9471077,,,KIF6,Efficacy,1,atorvastatin,981482199.0,European
981482193,PA166157163,rs9471077,,,KIF6,Efficacy,1,atorvastatin,981482198.0,European
981482193,PA166157163,rs9471077,,,KIF6,Efficacy,1,atorvastatin,981482197.0,European
981482193,PA166157163,rs9471077,,,KIF6,Efficacy,1,pravastatin,981482199.0,European
981482193,PA166157163,rs9471077,,,KIF6,Efficacy,1,pravastatin,981482198.0,European
981482193,PA166157163,rs9471077,,,KIF6,Efficacy,1,pravastatin,981482197.0,European
1447678879,PA166157153,rs9380142,,,HLA-G,Efficacy,1,capecitabine,1447678881.0,European
1447678879,PA166157153,rs9380142,,,HLA-G,Efficacy,1,capecitabine,1447678882.0,European
1447678879,PA166157153,rs9380142,,,HLA-G,Efficacy,1,fluorouracil,1447678881.0,European
1447678879,PA166157153,rs9380142,,,HLA-G,Efficacy,1,fluorouracil,1447678882.0,European
1447678879,PA166157153,rs9380142,,,HLA-G,Efficacy,1,fluorouracil,1447678881.0,European
1447678879,PA166157153,rs9380142,,,HLA-G,Efficacy,1,fluorouracil,1447678882.0,European
1451138764,PA166206221,rs3802281,,,OPRK1,Dosage,-1,heroin,1451138800.0,East Asian
1451138764,PA166206221,rs3802281,,,OPRK1,Dosage,-1,heroin,1451138800.0,East Asian
1449565868,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,phenytoin,1449565870.0,Central/South Asian
1449565868,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,phenytoin,1449565870.0,Central/South Asian
1451138773,PA166206241,rs3808627,,,OPRK1,Dosage,-1,heroin,1451138778.0,East Asian
1448612764,PA166154899,rs2606345,,,CYP1A1,Metabolism/PK,1,deferasirox,1448613449.0,"Multiple groups, 95% Caucasian (Italy)"
1448612764,PA166154899,rs2606345,,,CYP1A1,Metabolism/PK,1,deferasirox,1448613451.0,"Multiple groups, 95% Caucasian (Italy)"
1447678861,PA166156592,rs4627835,,,GABRB1,Dosage,1,antipsychotics,1447678863.0,European
1451138786,PA166206201,rs16918842,,,OPRK1,Dosage,-1,heroin,1451138801.0,East Asian
1451138786,PA166206201,rs16918842,,,OPRK1,Dosage,-1,heroin,1451138801.0,East Asian
1184165591,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1184165601.0,East Asian
1184165591,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1184165601.0,East Asian
827783312,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,827783315.0,East Asian
827783312,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,827783315.0,East Asian
1183690453,PA166155331,rs45445694,,,None,Efficacy,-1,methotrexate,1183690826.0,Unknown
1451335348,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,olanzapine,1451335352.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1450811055,PA166156991,rs1799971,,,OPRM1,Efficacy,1,nicotine,1450811060.0,European
1448432529,PA166161538,rs12720066,,,ABCB1,Metabolism/PK,1,SN-38,1448432535.0,"Multiple groups, Caucasian and African-American"
1451138791,PA166180104,rs12205732,,,OPRM1,Dosage,-1,heroin,1451138796.0,East Asian
1448612748,PA166163480,rs13144136,,,CLNK,Efficacy,1,Antihypertensives,1448612756.0,Multiple groups
1448612748,PA166163480,rs13144136,,,CLNK,Efficacy,1,Antihypertensives,1448612758.0,European
1450827439,PA166185222,rs16917234,,,BDNF,Toxicity,-1,heroin,1450827443.0,East Asian
1184165572,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,midazolam,1184165586.0,"Multiple groups, Chinese, Malay, Indian"
1184165572,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,midazolam,1184165586.0,"Multiple groups, Chinese, Malay, Indian"
827783301,PA166155091,rs9923231,,,VKORC1,Dosage,-1,warfarin,827783310.0,East Asian
1447678850,PA166156666,rs16860087,,,GABRB1,Dosage,1,antipsychotics,1447678859.0,European
1184165568,PA166155770,rs7589621,,,EPAS1,Efficacy,-1,bevacizumab,1184165570.0,European
1184165568,PA166155770,rs7589621,,,EPAS1,Efficacy,-1,ranibizumab,1184165570.0,European
1451335340,PA166156024,rs4680,,,COMT,Metabolism/PK,-1,olanzapine,1451335344.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451138747,PA166177786,rs6912029,,,OPRM1,Dosage,-1,methadone,1451138752.0,East Asian
1184165564,PA166153568,rs323720,,,YBX1,Efficacy,-1,bevacizumab,1184165566.0,European
1184165564,PA166153568,rs323720,,,YBX1,Efficacy,-1,ranibizumab,1184165566.0,European
1450811064,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,nicotine,1450811069.0,European
1451138741,PA166180104,rs12205732,,,OPRM1,Dosage,-1,methadone,1451138746.0,East Asian
1451335345,,,PA165819171,CYP1A2*1A,CYP1A2,Metabolism/PK,-1,olanzapine,1451335360.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335345,,,PA165819172,CYP1A2*1B,CYP1A2,Metabolism/PK,-1,olanzapine,1451335360.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335345,,,PA165819173,CYP1A2*1C,CYP1A2,Metabolism/PK,-1,olanzapine,1451335360.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335345,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,-1,olanzapine,1451335360.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1184165560,PA166154295,rs671976,,,BAD,Efficacy,-1,bevacizumab,1184165562.0,European
1184165560,PA166154295,rs671976,,,BAD,Efficacy,-1,ranibizumab,1184165562.0,European
1451138753,PA166206203,rs9322453,,,OPRM1,Dosage,-1,methadone,1451138758.0,East Asian
1450827454,PA166185213,rs4936274,,,DRD2,Toxicity,-1,heroin,1450827458.0,East Asian
981482176,PA166157161,rs9462535,,,KIF6,Efficacy,1,atorvastatin,981482181.0,European
981482176,PA166157161,rs9462535,,,KIF6,Efficacy,1,atorvastatin,981482182.0,European
981482176,PA166157161,rs9462535,,,KIF6,Efficacy,1,atorvastatin,981482180.0,European
981482176,PA166157161,rs9462535,,,KIF6,Efficacy,1,pravastatin,981482181.0,European
981482176,PA166157161,rs9462535,,,KIF6,Efficacy,1,pravastatin,981482182.0,European
981482176,PA166157161,rs9462535,,,KIF6,Efficacy,1,pravastatin,981482180.0,European
1450827459,PA166153773,rs4654327,,,OPRD1,Toxicity,-1,heroin,1450827463.0,East Asian
1450827459,PA166153773,rs4654327,,,OPRD1,Toxicity,-1,heroin,1450827463.0,East Asian
1450827459,PA166153773,rs4654327,,,OPRD1,Toxicity,-1,heroin,1450827463.0,East Asian
1451335361,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,-1,olanzapine,1451335365.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451138759,PA166206202,rs3802279,,,OPRK1,Dosage,-1,heroin,1451138780.0,East Asian
1448612713,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,imatinib,1448612715.0,Central/South Asian
981482185,PA166157161,rs9462535,,,KIF6,Efficacy,-1,atorvastatin,981482191.0,European
981482185,PA166157161,rs9462535,,,KIF6,Efficacy,-1,atorvastatin,981482190.0,European
981482185,PA166157161,rs9462535,,,KIF6,Efficacy,-1,atorvastatin,981482189.0,European
981482185,PA166157161,rs9462535,,,KIF6,Efficacy,-1,pravastatin,981482191.0,European
981482185,PA166157161,rs9462535,,,KIF6,Efficacy,-1,pravastatin,981482190.0,European
981482185,PA166157161,rs9462535,,,KIF6,Efficacy,-1,pravastatin,981482189.0,European
1444827950,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1444827963.0,East Asian
1444827950,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1444827963.0,East Asian
1444827950,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,voriconazole,1444827963.0,East Asian
1444827950,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,voriconazole,1444827963.0,East Asian
1448612701,PA166157284,rs1045642,,,ABCB1,Efficacy,1,imatinib,1448612703.0,Central/South Asian
1448530779,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1448530781.0,Central/South Asian
1448530779,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1448530781.0,Central/South Asian
1448530779,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,ribavirin,1448530781.0,Central/South Asian
1184755389,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184755401.0,European
1184755389,,,PA165971559,CYP2D6*7,CYP2D6,Metabolism/PK,0,sparteine,1184755401.0,European
1451335464,PA166154675,rs6313,,,HTR2A,Metabolism/PK,-1,olanzapine,1451335500.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1448530773,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1448530775.0,Central/South Asian
1448530773,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1448530775.0,Central/South Asian
1448530773,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1448530775.0,Central/South Asian
1448530773,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1448530775.0,Central/South Asian
1448530773,PA166155435,rs8099917,,,IFNL3,Efficacy,-1,ribavirin,1448530775.0,Central/South Asian
1448530773,PA166155435,rs8099917,,,IFNL4,Efficacy,-1,ribavirin,1448530775.0,Central/South Asian
1448612707,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,imatinib,1448612709.0,Central/South Asian
1444827966,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444841888.0,East Asian
1444827966,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444841888.0,East Asian
1444827966,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1444841888.0,East Asian
1444827966,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1444841888.0,East Asian
1448612688,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,lenalidomide,1448612690.0,European
1448612688,PA166157061,rs3025039,,,VEGFA,Efficacy,-1,thalidomide,1448612690.0,European
1184165651,PA166157283,rs1043550,,,CALU,Dosage,-1,warfarin,1184165655.0,"Multiple groups, predominantly Caucasian"
1184165651,PA166157283,rs1043550,,,CALU,Dosage,-1,warfarin,1184165657.0,"Multiple groups, predominantly Caucasian"
1448530766,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1448530772.0,Central/South Asian
1448530766,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1448530772.0,Central/South Asian
1448530766,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1448530772.0,Central/South Asian
1448530766,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1448530772.0,Central/South Asian
1448530766,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,1448530772.0,Central/South Asian
1448530766,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,1448530772.0,Central/South Asian
1447678780,PA166157191,rs17179108,,,HLA-G,Efficacy,1,capecitabine,1447678783.0,European
1447678780,PA166157191,rs17179108,,,HLA-G,Efficacy,1,capecitabine,1447678782.0,European
1447678780,PA166157191,rs17179108,,,HLA-G,Efficacy,1,fluorouracil,1447678783.0,European
1447678780,PA166157191,rs17179108,,,HLA-G,Efficacy,1,fluorouracil,1447678782.0,European
1449189139,PA166155024,rs1967309,,,None,Efficacy,-1,evacetrapib,1449189147.0,Unknown
827603022,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827603285.0,Unknown
1444827984,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,carisoprodol,1444827993.0,Unknown
1444827984,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,carisoprodol,1444827997.0,Unknown
1444827984,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,carisoprodol,1444827993.0,Unknown
1444827984,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,carisoprodol,1444827997.0,Unknown
1451138802,PA166206203,rs9322453,,,OPRM1,Dosage,-1,heroin,1451138822.0,East Asian
1448530758,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,sunitinib,1448530760.0,East Asian
1451138797,PA166177786,rs6912029,,,OPRM1,Dosage,-1,heroin,1451138840.0,East Asian
1448612673,PA166163497,rs308395,,,FGF2,Efficacy,1,lenalidomide,1448612681.0,European
1448612673,PA166163497,rs308395,,,FGF2,Efficacy,1,thalidomide,1448612681.0,European
1449713428,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,pioglitazone,1449713439.0,European
1449713428,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,pioglitazone,1449713439.0,European
1449713428,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,pioglitazone,1449713439.0,European
1449713428,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,pioglitazone,1449713439.0,European
1447678770,PA166157235,rs371194629,,,HLA-G,Efficacy,1,capecitabine,1447678772.0,European
1447678770,PA166157235,rs371194629,,,HLA-G,Efficacy,1,capecitabine,1447678773.0,European
1447678770,PA166157235,rs371194629,,,HLA-G,Efficacy,1,fluorouracil,1447678772.0,European
1447678770,PA166157235,rs371194629,,,HLA-G,Efficacy,1,fluorouracil,1447678773.0,European
1448530742,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,sunitinib,1448530744.0,East Asian
1451335420,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,olanzapine,1451335423.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335420,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,olanzapine,1451335423.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1450942212,PA166155341,rs7412,,,APOE,Dosage,1,warfarin,1450942219.0,East Asian
1448612656,PA166156530,rs1902023,,,UGT2B15,Efficacy,-1,oxcarbazepine,1448612658.0,East Asian
1451335424,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,olanzapine,1451335440.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335424,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,olanzapine,1451335440.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1448530735,PA166156561,rs2622604,,,ABCG2,Metabolism/PK,-1,sunitinib,1448530737.0,East Asian
1451335427,PA166154334,rs1799732,,,DRD2,Metabolism/PK,-1,olanzapine,1451335415.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1448530729,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,sunitinib,1448530731.0,East Asian
1448530729,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,sunitinib,1448530731.0,East Asian
981859157,PA166156023,rs4633,,,COMT,Efficacy,-1,risperidone,981859167.0,East Asian
1184755565,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,debrisoquine,1184755573.0,Unknown
1184755565,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,debrisoquine,1184755573.0,Unknown
1184755565,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,0,debrisoquine,1184755573.0,Unknown
1448612644,PA166155662,rs2011425,,,UGT1A4,Efficacy,-1,oxcarbazepine,1448612646.0,East Asian
1447678756,PA166156976,rs1063320,,,HLA-G,Efficacy,-1,capecitabine,1447678758.0,European
1447678756,PA166156976,rs1063320,,,HLA-G,Efficacy,-1,capecitabine,1447678759.0,European
1447678756,PA166156976,rs1063320,,,HLA-G,Efficacy,-1,fluorouracil,1447678758.0,European
1447678756,PA166156976,rs1063320,,,HLA-G,Efficacy,-1,fluorouracil,1447678759.0,European
1447678756,PA166156976,rs1063320,,,HLA-G,Efficacy,-1,fluorouracil,1447678758.0,European
1447678756,PA166156976,rs1063320,,,HLA-G,Efficacy,-1,fluorouracil,1447678759.0,European
769182369,PA166153683,rs2239622,,,NGF,Dosage,1,methadone,769182372.0,"Multiple groups, Israeli, 62 Jewish subjects and 10 subjects that are either Caucasians or Arabs. For simplicity, the Jewish subjects are divided into two main groups: Ashkenazi and ¿non-Ashkenazi¿. The ¿non-Ashkenazi¿ group includes Moroccan, Yemenite, Iraqi, Turkish, Iranian, Libyan, Syrian, Greek subjects and subjects with mixed origin or unknown origin. Five subjects are Jewish of mixed or unknown origin."
1448530723,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,sunitinib,1448530725.0,East Asian
1448612637,PA166155690,rs2741049,,,UGT1A9,Efficacy,1,oxcarbazepine,1448612643.0,East Asian
1447678763,PA166156986,rs1610696,,,HLA-G,Efficacy,-1,capecitabine,1447678765.0,European
1447678763,PA166156986,rs1610696,,,HLA-G,Efficacy,-1,capecitabine,1447678766.0,European
1447678763,PA166156986,rs1610696,,,HLA-G,Efficacy,-1,fluorouracil,1447678765.0,European
1447678763,PA166156986,rs1610696,,,HLA-G,Efficacy,-1,fluorouracil,1447678766.0,European
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,sirolimus,1449140042.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,sirolimus,1449140037.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140042.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140037.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140042.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140037.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140042.0,Unknown
1449140035,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140037.0,Unknown
1449140029,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,temsirolimus,1449140031.0,Unknown
1184755593,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,itopride,1184755595.0,East Asian
1184755593,PA166153687,rs2266780,,,FMO3,Metabolism/PK,1,itopride,1184755595.0,East Asian
1451106148,PA166196763,rs45545233,,,SLC4A1,Efficacy,1,atenolol,1451106153.0,European
1451106148,PA166196763,rs45545233,,,SLC4A1,Efficacy,1,atenolol,1451106180.0,European
1451106148,PA166196763,rs45545233,,,SLC4A1,Efficacy,1,metoprolol,1451106153.0,European
1451106148,PA166196763,rs45545233,,,SLC4A1,Efficacy,1,metoprolol,1451106180.0,European
769182345,PA166154177,rs28399504,,,CYP2C19,Other,-1,clopidogrel,769182347.0,European
769182345,PA166154177,rs28399504,,,CYP2C19,Other,-1,clopidogrel,769182349.0,European
1449140043,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,temsirolimus,1449140045.0,Unknown
1449271127,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1449271129.0,European
1449271127,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,1449271129.0,European
1447990018,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1447990020.0,European
1447990018,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1447990021.0,European
1447990018,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1447990022.0,East Asian
1447990018,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1447990023.0,East Asian
1447990018,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1447990024.0,East Asian
1447990018,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,atorvastatin,1447990025.0,East Asian
1184509840,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluvoxamine,1184509846.0,East Asian
1449140049,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,sirolimus,1449140051.0,Unknown
1449140049,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,temsirolimus,1449140051.0,Unknown
981859123,PA166156134,rs9606186,,,COMT,Efficacy,1,risperidone,981859132.0,East Asian
981859123,PA166156134,rs9606186,,,COMT,Efficacy,1,risperidone,981859130.0,East Asian
1450942260,PA166157284,rs1045642,,,ABCB1,Dosage,-1,warfarin,1450942280.0,East Asian
1448530690,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448530700.0,European
1448530690,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448530700.0,European
1449271120,PA166154261,rs6277,,,DRD2,Dosage,-1,methadone,1449271122.0,European
1444827924,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444827933.0,European
1444827924,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444827933.0,European
1448530681,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,sunitinib,1448530687.0,East Asian
1448530681,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,sunitinib,1448530687.0,East Asian
1448530681,PA166157267,rs776746,,,ZSCAN25,Metabolism/PK,-1,sunitinib,1448530687.0,East Asian
1184509852,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184509862.0,Near Eastern
1184509852,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184509862.0,Near Eastern
1184509852,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184509862.0,Near Eastern
1184755616,PA166155718,rs3832043,,,UGT1A9,Metabolism/PK,1,mycophenolic acid,1184755621.0,East Asian
1450401621,PA166154083,rs7902257,,,CYP2C19,Metabolism/PK,0,omeprazole,1450401631.0,Multiple groups
1449271143,PA166175997,rs2234918,,,OPRD1,Dosage,-1,methadone,1449271145.0,European
1448104687,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448104689.0,Unknown
1448612598,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,simvastatin,1448612603.0,East Asian
1449271133,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1449271135.0,European
827864562,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827864563.0,Near Eastern
981859133,PA166156024,rs4680,,,COMT,Efficacy,-1,risperidone,981859148.0,East Asian
827864558,PA166155381,rs2108622,,,CYP4F2,,-1,warfarin,827864559.0,Near Eastern
1184755622,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,mycophenolic acid,1184755628.0,East Asian
1184755622,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,1,mycophenolic acid,1184755628.0,East Asian
1448104673,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1448104675.0,Unknown
1448104673,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1448104675.0,Unknown
827864550,PA166157254,rs339097,,,CALU,Dosage,-1,warfarin,827864551.0,Near Eastern
1451335577,PA166157432,rs7799039,,,LEP,Metabolism/PK,-1,olanzapine,1451335581.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1449271149,PA166156706,rs4532,,,DRD1,Dosage,-1,methadone,1449271151.0,European
827864552,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827864553.0,Near Eastern
827864546,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,827864547.0,Near Eastern
1447989994,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1447989999.0,European
1447989994,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1447990001.0,European
1447989994,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1447990003.0,East Asian
1447989994,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1447990005.0,East Asian
1447989994,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1447990007.0,East Asian
1447989994,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,rosuvastatin,1447990009.0,East Asian
1449271155,PA166154339,rs1800497,,,DRD2,Dosage,-1,methadone,1449271157.0,European
1448104659,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1448104668.0,Unknown
1448104659,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1448104668.0,Unknown
1449271175,PA166154339,rs1800497,,,DRD2,Efficacy,-1,methadone,1449271177.0,European
1448530650,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,risperidone,1448530663.0,East Asian
1448530650,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,risperidone,1448530663.0,East Asian
1448530650,,,PA165816576,CYP2D6*1,CYP2D6,Toxicity,-1,risperidone,1448530663.0,East Asian
1448530650,,,PA165816582,CYP2D6*10,CYP2D6,Toxicity,-1,risperidone,1448530663.0,East Asian
1449271168,PA166156706,rs4532,,,DRD1,Efficacy,-1,methadone,1449271170.0,European
1451155365,PA166155794,rs10929302,,,UGT1A1,Efficacy,-1,fluorouracil,1451155370.0,Multiple groups
1451155365,PA166155794,rs10929302,,,UGT1A1,Efficacy,-1,irinotecan,1451155370.0,Multiple groups
1451155365,PA166155794,rs10929302,,,UGT1A1,Efficacy,-1,oxaliplatin,1451155370.0,Multiple groups
1447989974,PA166154759,rs116855232,,,NUDT15,Dosage,0,mercaptopurine,1447989980.0,Unknown
1451335587,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,olanzapine,1451335600.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335587,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,olanzapine,1451335600.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1451335540,PA166157862,rs1414334,,,HTR2C,Metabolism/PK,-1,olanzapine,1451335544.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1448612553,PA166156091,rs2267076,,,ADORA2A,Efficacy,-1,regadenoson,1448612555.0,"Multiple groups, 71% Caucasian"
1448612553,PA166156091,rs2267076,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612555.0,"Multiple groups, 71% Caucasian"
1451138980,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,dipyrone,1451138984.0,European
1451138980,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,dipyrone,1451138984.0,European
1451138980,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,dipyrone,1451138984.0,European
1451138980,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,dipyrone,1451138984.0,European
1451138980,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,dipyrone,1451138984.0,European
1448530624,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448530634.0,European
1448530624,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448530634.0,European
1448530620,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1448530644.0,East Asian
1448530620,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1448530644.0,East Asian
1448612543,PA166156099,rs2298383,,,ADORA2A,Efficacy,-1,regadenoson,1448612545.0,"Multiple groups, 71% Caucasian"
1448612543,PA166156099,rs2298383,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612545.0,"Multiple groups, 71% Caucasian"
1448612543,PA166156099,rs2298383,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612545.0,"Multiple groups, 71% Caucasian"
1448612543,PA166156099,rs2298383,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612545.0,"Multiple groups, 71% Caucasian"
982023021,PA166154340,rs1800532,,,TPH1,Efficacy,1,citalopram,982023028.0,European
827815352,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,827815356.0,East Asian
827815352,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,827815356.0,East Asian
827815352,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,827815356.0,East Asian
827815352,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,827815356.0,East Asian
1451335560,PA166157875,rs3813929,,,HTR2C,Metabolism/PK,-1,olanzapine,1451335564.0,"Multiple groups, ""36 Caucasians, 42 Latin-Americans and 2 Blacks"""
1448612534,PA166156117,rs5751862,,,ADORA2A,Efficacy,-1,regadenoson,1448612541.0,"Multiple groups, 71% Caucasian"
1447678642,PA166157190,rs17179101,,,HLA-G,Efficacy,-1,capecitabine,1447678644.0,European
1447678642,PA166157190,rs17179101,,,HLA-G,Efficacy,-1,capecitabine,1447678645.0,European
1447678642,PA166157190,rs17179101,,,HLA-G,Efficacy,-1,fluorouracil,1447678644.0,European
1447678642,PA166157190,rs17179101,,,HLA-G,Efficacy,-1,fluorouracil,1447678645.0,European
1448530601,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1448530616.0,European
1448530601,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1448530616.0,European
1448530601,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1448530616.0,European
1448530601,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,risperidone,1448530616.0,European
1447678621,PA166156896,rs1707,,,HLA-G,Efficacy,-1,capecitabine,1447678629.0,European
1447678621,PA166156896,rs1707,,,HLA-G,Efficacy,-1,capecitabine,1447678631.0,European
1447678621,PA166156896,rs1707,,,HLA-G,Efficacy,-1,fluorouracil,1447678629.0,European
1447678621,PA166156896,rs1707,,,HLA-G,Efficacy,-1,fluorouracil,1447678631.0,European
827864486,PA166154001,rs2230345,,,GRK5,Efficacy,0,Beta Blocking Agents,827864492.0,African American/Afro-Caribbean
827864486,PA166154001,rs2230345,,,GRK5,Efficacy,0,Beta Blocking Agents,827864492.0,African American/Afro-Caribbean
827864486,PA166154001,rs2230345,,,GRK5,Efficacy,0,Beta Blocking Agents,827864492.0,African American/Afro-Caribbean
1450123149,PA166164933,rs12456693,,,SLC14A2,Efficacy,1,clopidogrel,1450123151.0,East Asian
1445401203,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1445401239.0,Unknown
1445401203,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1445401241.0,Unknown
1445401203,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1445401239.0,Unknown
1445401203,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1445401241.0,Unknown
1445401203,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1445401239.0,Unknown
1445401203,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1445401241.0,Unknown
1445401203,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1445401239.0,Unknown
1445401203,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1445401241.0,Unknown
1445401203,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1445401239.0,Unknown
1445401203,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,endoxifen,1445401241.0,Unknown
1445401203,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1445401239.0,Unknown
1445401203,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1445401241.0,Unknown
1450942421,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450942447.0,"Multiple groups, Brazil: ""51% Caucasian,  16% African, 32% Intermediate, 1% other"""
1450942421,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450942447.0,"Multiple groups, Brazil: ""51% Caucasian,  16% African, 32% Intermediate, 1% other"""
1451253720,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1451253760.0,East Asian
1451253720,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1451253760.0,East Asian
1451253720,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1451253760.0,East Asian
1451253720,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1451253760.0,East Asian
1451253720,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1451253760.0,East Asian
982006735,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,982006743.0,European
1447678633,PA166156897,rs1710,,,HLA-G,Efficacy,-1,capecitabine,1447678635.0,European
1447678633,PA166156897,rs1710,,,HLA-G,Efficacy,-1,capecitabine,1447678636.0,European
1447678633,PA166156897,rs1710,,,HLA-G,Efficacy,-1,fluorouracil,1447678635.0,European
1447678633,PA166156897,rs1710,,,HLA-G,Efficacy,-1,fluorouracil,1447678636.0,European
827815322,PA166153680,rs2234922,,,EPHX1,Dosage,1,carbamazepine,827815332.0,Unknown
827815322,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,827815332.0,Unknown
1451253729,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1451253744.0,East Asian
1451253729,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1451253744.0,East Asian
1451253729,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1451253744.0,East Asian
1449271238,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,buprenorphine,1449271244.0,Multiple groups
1449271238,PA166153974,rs1800544,,,ADRA2A,Efficacy,-1,methadone,1449271244.0,Multiple groups
1449713604,PA166155183,rs1136201,,,ERBB2,Efficacy,1,carboplatin,1449713610.0,Unknown
1449713604,PA166155183,rs1136201,,,ERBB2,Efficacy,1,docetaxel,1449713610.0,Unknown
1449713604,PA166155183,rs1136201,,,ERBB2,Efficacy,1,trastuzumab,1449713610.0,Unknown
1449713604,PA166155183,rs1136201,,,ERBB2,Efficacy,1,trastuzumab,1449713610.0,Unknown
982006752,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,982006754.0,European
1450811368,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,1,bupropion,1450811375.0,European
1450811368,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,bupropion,1450811375.0,European
827815311,PA166153612,rs1051740,,,EPHX1,Dosage,1,carbamazepine,827815321.0,Unknown
827815311,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,827815321.0,Unknown
1447989908,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989910.0,East Asian
1447989908,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989911.0,East Asian
1447989908,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989912.0,East Asian
1447989908,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989910.0,East Asian
1447989908,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989911.0,East Asian
1447989908,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989912.0,East Asian
1451253733,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,rabeprazole,1451253737.0,East Asian
1451253733,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,rabeprazole,1451253737.0,East Asian
1451253733,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,rabeprazole,1451253737.0,East Asian
981859299,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,981859309.0,Near Eastern
1451253680,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1451253700.0,East Asian
1451253680,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1451253700.0,East Asian
1184755725,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184755734.0,Unknown
1184755725,,,PA165971565,CYP2D6*12,CYP2D6,Metabolism/PK,0,sparteine,1184755734.0,Unknown
827815301,PA166154141,rs11572103,,,CYP2C8,Efficacy,-1,amodiaquine,827815308.0,Sub-Saharan African
827815301,PA166154141,rs11572103,,,CYP2C8,Metabolism/PK,-1,amodiaquine,827815308.0,Sub-Saharan African
827815301,PA166154141,rs11572103,,,CYP2C8,Efficacy,-1,artesunate,827815308.0,Sub-Saharan African
827815301,PA166154141,rs11572103,,,CYP2C8,Metabolism/PK,-1,artesunate,827815308.0,Sub-Saharan African
1449271245,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,buprenorphine,1449271247.0,Multiple groups
1449271245,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,methadone,1449271247.0,Multiple groups
1449713624,PA166179817,rs2284922,,,RNF8,Efficacy,1,carboplatin,1449713626.0,Unknown
1449713624,PA166179817,rs2284922,,,RNF8,Efficacy,1,docetaxel,1449713626.0,Unknown
1449713624,PA166179817,rs2284922,,,RNF8,Efficacy,1,trastuzumab,1449713626.0,Unknown
1451139000,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,dipyrone,1451139004.0,European
1451139000,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,dipyrone,1451139004.0,European
1449271273,PA166154673,rs6311,,,HTR2A,Efficacy,-1,buprenorphine,1449271275.0,Multiple groups
1449271273,PA166154673,rs6311,,,HTR2A,Efficacy,-1,methadone,1449271275.0,Multiple groups
1449713641,PA166179819,rs2229571,,,BARD1,Efficacy,-1,carboplatin,1449713643.0,Unknown
1449713641,PA166179819,rs2229571,,,BARD1,Efficacy,-1,docetaxel,1449713643.0,Unknown
1449713641,PA166179819,rs2229571,,,BARD1,Efficacy,-1,trastuzumab,1449713643.0,Unknown
982006724,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,982006734.0,European
1450811334,PA166156991,rs1799971,,,OPRM1,Efficacy,0,naltrexone,1450811339.0,European
1449271267,PA166156024,rs4680,,,COMT,Efficacy,-1,buprenorphine,1449271269.0,Multiple groups
1449271267,PA166156024,rs4680,,,COMT,Efficacy,-1,methadone,1449271269.0,Multiple groups
1451221008,PA166156024,rs4680,,,COMT,Dosage,1,opioids,1451221014.0,"Multiple groups, Caucasian and African American"
1448612457,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,0,colchicine,1448612467.0,Near Eastern
1448612457,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,colchicine,1448612467.0,Near Eastern
1184755634,PA166155857,rs17868323,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1184755636.0,East Asian
1450942480,PA166157367,rs2740574,,,CYP3A,Metabolism/PK,-1,tacrolimus,1450942485.0,"Multiple groups, Brazil: ""51% Caucasian,  16% African, 32% Intermediate, 1% other"""
1450942480,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,tacrolimus,1450942485.0,"Multiple groups, Brazil: ""51% Caucasian,  16% African, 32% Intermediate, 1% other"""
827848035,PA166155478,rs28399499,,,CYP2B6,Toxicity,1,nevirapine,827848533.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827848035,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,nevirapine,827848533.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
1184509880,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluoxetine,1184509888.0,East Asian
1184509880,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1184509888.0,East Asian
1184509880,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,sertraline,1184509888.0,East Asian
1184509880,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,sertraline,1184509888.0,East Asian
1184755639,PA166155853,rs17863778,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1184755641.0,East Asian
1184755639,PA166155853,rs17863778,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1184755641.0,East Asian
1184755639,PA166155853,rs17863778,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1184755641.0,East Asian
827700577,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,tegafur,827700579.0,East Asian
827700577,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,tegafur,827700579.0,East Asian
982006805,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,-1,ondansetron,982006807.0,Unknown
982006805,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,-1,ondansetron,982006807.0,Unknown
982006805,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,ondansetron,982006807.0,Unknown
1184755649,PA166155686,rs2741045,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1184755651.0,East Asian
1184755644,PA166155687,rs2741046,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1184755646.0,East Asian
1184509891,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,escitalopram,1184509899.0,East Asian
1184509891,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,escitalopram,1184509899.0,East Asian
1448612434,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,talinolol,1448612436.0,Unknown
1184755659,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,mycophenolic acid,1184755661.0,East Asian
827848013,PA166155409,rs3745274,,,CYP2B6,Toxicity,1,nevirapine,827848529.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827848013,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,827848529.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
1448530511,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1448530530.0,East Asian
1448530511,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,risperidone,1448530530.0,East Asian
1448530511,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,risperidone,1448530530.0,East Asian
1448530511,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,risperidone,1448530530.0,East Asian
1448530511,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,risperidone,1448530530.0,East Asian
1448530511,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,risperidone,1448530530.0,East Asian
1448612429,PA166156543,rs2231137,,,ABCG2,Metabolism/PK,-1,talinolol,1448612431.0,Unknown
1184755654,PA166156695,rs73823859,,,UGT2B7,Metabolism/PK,-1,mycophenolic acid,1184755656.0,East Asian
1451237363,PA166156978,rs1142345,,,TPMT,Dosage,1,azathioprine,1451237369.0,Unknown
1184755664,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,mycophenolic acid,1184755666.0,East Asian
1448612419,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,talinolol,1448612421.0,Unknown
827848004,PA166155467,rs12721655,,,CYP2B6,Toxicity,-1,nevirapine,827848527.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827848004,PA166155467,rs12721655,,,CYP2B6,Metabolism/PK,-1,nevirapine,827848527.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
1184755674,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,mycophenolic acid,1184755676.0,East Asian
1184755669,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,mycophenolic acid,1184755671.0,East Asian
1449156631,PA166175907,rs199670311,,,TMEM8A,Efficacy,1,fentanyl,1449156658.0,East Asian
1449156631,PA166175907,rs199670311,,,TMEM8A,Efficacy,1,fentanyl,1449156649.0,East Asian
1449156631,PA166175907,rs199670311,,,TMEM8A,Efficacy,1,remifentanil,1449156658.0,East Asian
1449156631,PA166175907,rs199670311,,,TMEM8A,Efficacy,1,remifentanil,1449156649.0,East Asian
827602228,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827602363.0,Multiple groups
1448612409,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,talinolol,1448612411.0,Unknown
1451237374,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,azathioprine,1451237379.0,Unknown
1451237374,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,azathioprine,1451237379.0,Unknown
1451106300,PA166196842,rs17817449,,,FTO,Dosage,-1,ethanol,1451106307.0,Unknown
1451106300,PA166196842,rs17817449,,,FTO,Dosage,-1,ethanol,1451106306.0,Unknown
1448530486,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1448530510.0,East Asian
1448530486,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,risperidone,1448530510.0,East Asian
1448530486,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1448530510.0,East Asian
1448530486,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1448530510.0,East Asian
1448530486,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1448530510.0,East Asian
1448612403,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,talinolol,1448612408.0,Unknown
1451155460,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,oxycodone,1451155463.0,"Multiple groups, Caucasian and African American"
982006874,PA166154346,rs1967554,,,BDNF,Efficacy,1,methadone,982006896.0,European
982006874,PA166154346,rs1967554,,,BDNF-AS,Efficacy,1,methadone,982006896.0,European
1447678493,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,carbamazepine,1447678495.0,European
1446908428,PA166154658,rs61764370,,,KRAS,Efficacy,1,capecitabine,1446908438.0,Unknown
1446908428,PA166154658,rs61764370,,,KRAS,Efficacy,1,cetuximab,1446908438.0,Unknown
1446908428,PA166154658,rs61764370,,,KRAS,Efficacy,1,oxaliplatin,1446908438.0,Unknown
1450811473,PA166155174,rs1045280,,,ARRB2,Efficacy,-1,nicotine,1450811478.0,European
1450811473,PA166155174,rs1045280,,,ARRB2,Efficacy,-1,nicotine,1450811480.0,European
1450811473,PA166155174,rs1045280,,,ARRB2,Efficacy,-1,nicotine,1450811481.0,European
1450811473,PA166155174,rs1045280,,,ARRB2,Efficacy,-1,nicotine,1450811479.0,European
981793872,PA166157058,rs3025000,,,VEGFA,Efficacy,1,bevacizumab,981793898.0,Unknown
981793872,PA166157058,rs3025000,,,VEGFA,Efficacy,1,bevacizumab,982009729.0,Unknown
981793872,PA166157058,rs3025000,,,VEGFA,Efficacy,1,bevacizumab,982009799.0,Unknown
981793872,PA166157058,rs3025000,,,VEGFA,Efficacy,1,ranibizumab,981793898.0,Unknown
981793872,PA166157058,rs3025000,,,VEGFA,Efficacy,1,ranibizumab,982009729.0,Unknown
981793872,PA166157058,rs3025000,,,VEGFA,Efficacy,1,ranibizumab,982009799.0,Unknown
1449713713,PA166154502,rs767455,,,TNFRSF1A,Efficacy,-1,etanercept,1449713719.0,Unknown
1184886901,PA166154249,rs1695,,,GSTP1,Efficacy,-1,fluorouracil,1184886903.0,Unknown
1184886901,PA166154249,rs1695,,,GSTP1,Efficacy,-1,leucovorin,1184886903.0,Unknown
1184886901,PA166154249,rs1695,,,GSTP1,Efficacy,-1,oxaliplatin,1184886903.0,Unknown
1450811485,PA166155215,rs3786047,,,ARRB2,Efficacy,-1,nicotine,1450811490.0,European
1450811485,PA166155215,rs3786047,,,ARRB2,Efficacy,-1,nicotine,1450811491.0,European
1446908451,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,1,nilotinib,1446908469.0,East Asian
1446908451,,,PA166115858,UGT1A1*6,UGT1A1,Dosage,1,nilotinib,1446908469.0,East Asian
1446908451,,,PA166115865,UGT1A1*27,UGT1A1,Dosage,1,nilotinib,1446908469.0,East Asian
1446908451,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,1,nilotinib,1446908469.0,East Asian
1449156665,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,efavirenz,1449156671.0,Multiple groups
1447678481,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,carbamazepine,1447678483.0,European
981793894,PA166153610,rs1048977,,,CDA,Efficacy,-1,gemcitabine,981793943.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981793894,PA166153610,rs1048977,,,CDA,Toxicity,-1,gemcitabine,981793943.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981793894,PA166153610,rs1048977,,,CDA,Toxicity,-1,gemcitabine,981793943.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1448612369,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,simvastatin acid,1448612374.0,East Asian
1183690838,PA166154264,rs9344,,,None,Efficacy,-1,methotrexate,1183690840.0,Unknown
1183690838,PA166154264,rs9344,,,None,Toxicity,-1,methotrexate,1183690840.0,Unknown
1184886917,PA166155343,rs13181,,,ERCC2,Efficacy,-1,fluorouracil,1184886919.0,Unknown
1184886917,PA166155343,rs13181,,,ERCC2,Efficacy,-1,leucovorin,1184886919.0,Unknown
1184886917,PA166155343,rs13181,,,ERCC2,Efficacy,-1,oxaliplatin,1184886919.0,Unknown
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cotinine,1450811513.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cotinine,1450811512.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cotinine,1450811508.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cotinine,1450811509.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cotinine,1450811510.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,cotinine,1450811511.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cotinine,1450811513.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cotinine,1450811512.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cotinine,1450811508.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cotinine,1450811509.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cotinine,1450811510.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,cotinine,1450811511.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,nicotine,1450811513.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,nicotine,1450811512.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,nicotine,1450811508.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,nicotine,1450811509.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,nicotine,1450811510.0,European
1450811499,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,nicotine,1450811511.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,nicotine,1450811513.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,nicotine,1450811512.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,nicotine,1450811508.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,nicotine,1450811509.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,nicotine,1450811510.0,European
1450811499,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,nicotine,1450811511.0,European
982006840,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,982006848.0,Unknown
1444827662,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1444827670.0,"Multiple groups, mostly white"
1447678461,PA166155680,rs2298771,,,SCN1A,Metabolism/PK,-1,carbamazepine,1447678463.0,European
827815680,PA166157487,rs35599367,,,CYP3A4,Toxicity,1,cyclosporine,827815688.0,European
827815680,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,cyclosporine,827815688.0,European
1447678444,PA166153612,rs1051740,,,EPHX1,Dosage,-1,carbamazepine,1447678446.0,East Asian
1447678444,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,-1,carbamazepine,1447678446.0,East Asian
1184510108,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184510110.0,Latino
1184510108,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184510110.0,Latino
1184510108,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184510110.0,Latino
1184510108,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1184510110.0,Latino
1447678447,PA166153680,rs2234922,,,EPHX1,Efficacy,-1,carbamazepine,1447678449.0,European
827815666,PA166157487,rs35599367,,,CYP3A4,Dosage,1,tacrolimus,827815679.0,European
1450811453,PA166179948,rs3852209,,,HINT1,Efficacy,1,nicotine,1450811461.0,European
1450811453,PA166179948,rs3852209,,,HINT1,Efficacy,1,nicotine,1450811459.0,European
1450811453,PA166179948,rs3852209,,,HINT1,Efficacy,1,nicotine,1450811460.0,European
1450811453,PA166179948,rs3852209,,,HINT1,Efficacy,1,nicotine,1450811458.0,European
982006849,PA166154422,rs7127507,,,BDNF,Efficacy,1,methadone,982006873.0,European
982006849,PA166154422,rs7127507,,,BDNF-AS,Efficacy,1,methadone,982006873.0,European
1184755882,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,dextromethorphan,1184755900.0,European
1184755882,,,PA165988481,CYP2D6*13,CYP2D6,Metabolism/PK,0,dextromethorphan,1184755900.0,European
1448530413,PA166156352,rs2276707,,,NR1I2,Dosage,-1,sunitinib,1448530415.0,"Multiple groups, 95% Caucasian"
1448530413,PA166156352,rs2276707,,,NR1I2,Toxicity,-1,sunitinib,1448530415.0,"Multiple groups, 95% Caucasian"
1450811465,PA166183817,rs2278060,,,HINT1,Efficacy,-1,nicotine,1450811471.0,European
1450811465,PA166183817,rs2278060,,,HINT1,Efficacy,-1,nicotine,1450811470.0,European
1450811465,PA166183817,rs2278060,,,HINT1,Efficacy,-1,nicotine,1450811472.0,European
981793945,PA166153667,rs2072671,,,CDA,Efficacy,1,gemcitabine,981793950.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1448104418,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,methadone,1448104420.0,European
1448104418,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,methadone,1448104420.0,European
1183690913,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,celecoxib,1183690917.0,Unknown
769247726,PA166154850,rs762551,,,CYP1A2,Other,1,caffeine,769247730.0,European
769247726,PA166154850,rs762551,,,CYP1A2,Other,1,caffeine,769247728.0,European
769247726,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,769247730.0,European
769247726,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,caffeine,769247728.0,European
1449713783,PA166156991,rs1799971,,,OPRM1,Dosage,1,fentanyl,1449713789.0,Unknown
1449713783,PA166156991,rs1799971,,,OPRM1,Efficacy,1,fentanyl,1449713789.0,Unknown
1445401015,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,endoxifen,1445401025.0,Unknown
1445401015,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,endoxifen,1445401025.0,Unknown
982006932,PA166154446,rs11030119,,,BDNF,Efficacy,1,methadone,982006941.0,European
1447678435,PA166153612,rs1051740,,,EPHX1,Efficacy,-1,carbamazepine,1447678437.0,European
1183690922,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,-1,celecoxib,1183690926.0,European
982023314,PA166155680,rs2298771,,,SCN1A,Efficacy,1,carbamazepine,982023326.0,East Asian
1448612320,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448612331.0,East Asian
1448612320,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448612331.0,East Asian
827832031,PA166156760,rs1364043,,,HTR1A,Efficacy,1,fluvoxamine,827832035.0,East Asian
827832031,PA166156760,rs1364043,,,HTR1A,Efficacy,1,milnacipran,827832035.0,East Asian
827832031,PA166156760,rs1364043,,,HTR1A,Efficacy,1,paroxetine,827832035.0,East Asian
1183690897,PA166157094,rs3957357,,,GSTA1,Metabolism/PK,1,busulfan,1183690899.0,Unknown
1448104400,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,methadone,1448104402.0,European
1184886844,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,1184886852.0,Unknown
1184886844,PA166155331,rs45445694,,,TYMS,Efficacy,1,leucovorin,1184886852.0,Unknown
1184886844,PA166155331,rs45445694,,,TYMS,Efficacy,1,oxaliplatin,1184886852.0,Unknown
1449156732,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,efavirenz,,
1449156732,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,efavirenz,,
1449156732,,,PA166117278,CYP2B6*38,CYP2B6,Metabolism/PK,-1,efavirenz,,
1184510021,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184510025.0,East Asian
1445401027,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,4-hydroxytamoxifen,1445401040.0,Unknown
1445401027,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,4-hydroxytamoxifen,1445401029.0,Unknown
1445401027,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,4-hydroxytamoxifen,1445401040.0,Unknown
1445401027,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,4-hydroxytamoxifen,1445401029.0,Unknown
1445401027,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,4-hydroxytamoxifen,1445401040.0,Unknown
1445401027,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,4-hydroxytamoxifen,1445401029.0,Unknown
1445401027,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,endoxifen,1445401040.0,Unknown
1445401027,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,endoxifen,1445401029.0,Unknown
1445401027,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,endoxifen,1445401040.0,Unknown
1445401027,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,endoxifen,1445401029.0,Unknown
1445401027,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,endoxifen,1445401040.0,Unknown
1445401027,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,endoxifen,1445401029.0,Unknown
1448104407,PA166157286,rs1057868,,,POR,Metabolism/PK,1,methadone,1448104409.0,European
1448530382,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1448530470.0,East Asian
1448530382,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,risperidone,1448530470.0,East Asian
1448530382,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1448530470.0,East Asian
1448530382,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,risperidone,1448530470.0,East Asian
1448530382,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1448530470.0,East Asian
1448530382,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,risperidone,1448530470.0,East Asian
1445401050,PA166155136,rs72547529,,,VKORC1,Dosage,0,warfarin,1445401055.0,Sub-Saharan African
982023290,PA166156796,rs2290732,,,GABRA1,Efficacy,1,carbamazepine,982023303.0,East Asian
1449713816,PA166157284,rs1045642,,,ABCB1,Dosage,1,opioids,1449713826.0,East Asian
1449713816,PA166157284,rs1045642,,,ABCB1,Dosage,1,opioids,1449713818.0,East Asian
1449713816,PA166157284,rs1045642,,,ABCB1,Efficacy,1,opioids,1449713826.0,East Asian
1449713816,PA166157284,rs1045642,,,ABCB1,Efficacy,1,opioids,1449713818.0,East Asian
982006898,PA166154445,rs11030118,,,BDNF,Efficacy,1,methadone,982006908.0,European
982006898,PA166154445,rs11030118,,,BDNF-AS,Efficacy,1,methadone,982006908.0,European
1184510039,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184510041.0,East Asian
1445401042,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1445401047.0,Multiple groups
1184886873,PA166155346,rs25487,,,XRCC1,Efficacy,-1,fluorouracil,1184886875.0,Unknown
1184886873,PA166155346,rs25487,,,XRCC1,Efficacy,-1,leucovorin,1184886875.0,Unknown
1184886873,PA166155346,rs25487,,,XRCC1,Efficacy,-1,oxaliplatin,1184886875.0,Unknown
1449713808,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1449713815.0,East Asian
1449713808,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1449713815.0,East Asian
1184510043,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1184510045.0,East Asian
1183690865,PA166157303,rs1799983,,,NOS3,Efficacy,-1,enalapril,1183690867.0,Multiple groups
1448530360,PA166157288,rs1128503,,,ABCB1,Dosage,1,sunitinib,1448530366.0,"Multiple groups, 95% Caucasian"
1448530360,PA166157288,rs1128503,,,ABCB1,Toxicity,1,sunitinib,1448530366.0,"Multiple groups, 95% Caucasian"
1184510047,PA166157354,rs2290228,,,CALU,Dosage,-1,warfarin,1184510049.0,East Asian
982006921,PA166154348,rs2030324,,,BDNF,Efficacy,1,methadone,982006930.0,European
982023304,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,982023313.0,East Asian
982023304,PA166155715,rs3812718,,,SCN1A,Dosage,1,carbamazepine,982023328.0,East Asian
1445401065,PA166155136,rs72547529,,,VKORC1,Dosage,0,warfarin,1445401070.0,African American/Afro-Caribbean
981793920,PA166157058,rs3025000,,,VEGFA,Efficacy,1,bevacizumab,981793953.0,Unknown
981793920,PA166157058,rs3025000,,,VEGFA,Efficacy,1,bevacizumab,981793951.0,Unknown
981793920,PA166157058,rs3025000,,,VEGFA,Efficacy,1,bevacizumab,981793955.0,Unknown
981793920,PA166157058,rs3025000,,,VEGFA,Efficacy,1,ranibizumab,981793953.0,Unknown
981793920,PA166157058,rs3025000,,,VEGFA,Efficacy,1,ranibizumab,981793951.0,Unknown
981793920,PA166157058,rs3025000,,,VEGFA,Efficacy,1,ranibizumab,981793955.0,Unknown
1449156764,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1449156769.0,European
1445401057,PA166155136,rs72547529,,,VKORC1,Dosage,0,warfarin,1445401063.0,African American/Afro-Caribbean
982006910,PA166154305,rs988748,,,BDNF,Efficacy,1,methadone,982006919.0,European
1183690869,PA166154785,rs1799722,,,BDKRB2,Efficacy,1,enalapril,1183690871.0,Multiple groups
1184755954,PA166157036,rs2444933,,,POU2F2,Efficacy,-1,platinum,1184755956.0,East Asian
1447678392,PA166155715,rs3812718,,,SCN1A,Dosage,-1,carbamazepine,1447678412.0,East Asian
1447678392,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,-1,carbamazepine,1447678412.0,East Asian
1447678392,PA166155715,rs3812718,,,SCN1A,Metabolism/PK,-1,carbamazepine,1447678412.0,East Asian
1450811601,PA166157341,rs2235067,,,ABCB1,Dosage,-1,methadone,1450811606.0,Near Eastern
1451237580,,,PA165819268,TPMT*1,TPMT,Dosage,-1,azathioprine,1451237600.0,Unknown
1451237580,,,PA165819269,TPMT*2,TPMT,Dosage,-1,azathioprine,1451237600.0,Unknown
1451237580,,,PA165819270,TPMT*3A,TPMT,Dosage,-1,azathioprine,1451237600.0,Unknown
1451237580,,,PA165819272,TPMT*3C,TPMT,Dosage,-1,azathioprine,1451237600.0,Unknown
1450811607,PA166157317,rs2032583,,,ABCB1,Dosage,-1,methadone,1450811612.0,Near Eastern
981793996,PA166154265,rs9937,,,RRM1,Efficacy,1,gemcitabine,981794000.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1184755959,PA166157002,rs1883306,,,POU2F2,Efficacy,-1,platinum,1184755961.0,East Asian
1449713837,PA166156024,rs4680,,,COMT,Dosage,1,sufentanil,1449713842.0,Unknown
1449713837,PA166156024,rs4680,,,COMT,Efficacy,1,sufentanil,1449713842.0,Unknown
1449713837,PA166156024,rs4680,,,COMT,Efficacy,1,sufentanil,1449713842.0,Unknown
1450811619,PA166157312,rs1922242,,,ABCB1,Dosage,-1,methadone,1450811624.0,Near Eastern
1184755977,PA166155430,rs7251786,,,TMEM205,Efficacy,-1,platinum,1184755979.0,East Asian
1450811613,PA166157316,rs2032582,,,ABCB1,Dosage,-1,methadone,1450811618.0,Near Eastern
1450811613,PA166157316,rs2032582,,,ABCB1,Dosage,-1,methadone,1450811618.0,Near Eastern
1450811613,PA166157316,rs2032582,,,ABCB1,Dosage,-1,methadone,1450811618.0,Near Eastern
1450811625,PA166157380,rs3789243,,,ABCB1,Dosage,-1,methadone,1450811630.0,Near Eastern
1184755972,PA166157001,rs1869641,,,POU2F2,Efficacy,-1,platinum,1184755974.0,East Asian
1447678334,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,-1,carbamazepine,1447678336.0,European
1447711105,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,paclitaxel,1447711849.0,European
1447711105,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,paclitaxel,1447713753.0,European
1447711105,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,paclitaxel,1447714249.0,European
1447711105,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,paclitaxel,1447711849.0,European
1447711105,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,paclitaxel,1447713753.0,European
1447711105,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,paclitaxel,1447714249.0,European
1447711105,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,Platinum compounds,1447711849.0,European
1447711105,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,Platinum compounds,1447713753.0,European
1447711105,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,Platinum compounds,1447714249.0,European
1447711105,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,Platinum compounds,1447711849.0,European
1447711105,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,Platinum compounds,1447713753.0,European
1447711105,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,Platinum compounds,1447714249.0,European
981793968,PA166156595,rs4694362,,,DCK,Efficacy,-1,gemcitabine,981793973.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1447678341,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,-1,carbamazepine,1447678343.0,European
1450811573,PA166157284,rs1045642,,,ABCB1,Dosage,-1,methadone,1450811578.0,Near Eastern
1184755994,PA166155358,rs896412,,,TMEM205,Efficacy,-1,platinum,1184755996.0,East Asian
1184510232,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1184510243.0,East Asian
1184510232,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1184510243.0,East Asian
1184510232,,,PA165816554,CYP2C9*13,CYP2C9,Dosage,0,warfarin,1184510243.0,East Asian
1450811579,PA166157288,rs1128503,,,ABCB1,Dosage,1,methadone,1450811584.0,Near Eastern
1183690931,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,celecoxib,1183690935.0,European
1447678320,PA166155680,rs2298771,,,SCN1A,Metabolism/PK,-1,carbamazepine,1447678322.0,European
981793989,PA166154309,rs1042858,,,RRM1,Efficacy,-1,gemcitabine,981793993.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981793989,PA166154309,rs1042858,,,RRM1,Toxicity,-1,gemcitabine,981793993.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1184755999,PA166155348,rs172731,,,TMEM205,Efficacy,-1,platinum,1184756001.0,East Asian
1450811587,PA166183843,rs2520464,,,ABCB1,Dosage,-1,methadone,1450811592.0,Near Eastern
1184756011,PA166154561,rs3759125,,,AQP2,Efficacy,-1,platinum,1184756013.0,East Asian
1447678328,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,carbamazepine,1447678330.0,European
1184756005,PA166154496,rs461872,,,AQP2,Efficacy,-1,platinum,1184756007.0,East Asian
1448268147,PA166155964,rs7270101,,,ITPA,Toxicity,1,azathioprine,1448268161.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Toxicity,1,azathioprine,1448268163.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Metabolism/PK,1,azathioprine,1448268161.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Metabolism/PK,1,azathioprine,1448268163.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Toxicity,1,mercaptopurine,1448268161.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Toxicity,1,mercaptopurine,1448268163.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Metabolism/PK,1,mercaptopurine,1448268161.0,Unknown
1448268147,PA166155964,rs7270101,,,ITPA,Metabolism/PK,1,mercaptopurine,1448268163.0,Unknown
981793982,PA166156662,rs12648166,,,DCK,Efficacy,-1,gemcitabine,981793987.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981793982,PA166156662,rs12648166,,,DCK,Toxicity,-1,gemcitabine,981793987.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1444712755,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,paroxetine,1444712757.0,East Asian
1444712755,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,paroxetine,1444712757.0,East Asian
1444712755,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,paroxetine,1444712757.0,East Asian
1444712755,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,paroxetine,1444712757.0,East Asian
1444712755,,,PA166181185,CYP2D6*14,CYP2D6,Metabolism/PK,1,paroxetine,1444712757.0,East Asian
1444712755,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,paroxetine,1444712757.0,East Asian
1447678304,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,carbamazepine,1447678306.0,European
1446908239,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,citalopram,1446908241.0,Unknown
1446908239,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,citalopram,1446908241.0,Unknown
1449173229,PA166157284,rs1045642,,,ABCB1,Dosage,-1,morphine,1449173231.0,European
1449173229,PA166157284,rs1045642,,,ABCB1,Dosage,-1,morphine,1449173232.0,European
1449271546,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,0,methadone,1449271548.0,Unknown
1184166178,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,bleomycin,1184166189.0,Unknown
1184166178,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,bleomycin,1184166189.0,Unknown
1184166178,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,dacarbazine,1184166189.0,Unknown
1184166178,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,dacarbazine,1184166189.0,Unknown
1184166178,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,doxorubicin,1184166189.0,Unknown
1184166178,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,doxorubicin,1184166189.0,Unknown
1184166178,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,1,vinblastine,1184166189.0,Unknown
1184166178,,,PA166048675,GSTM1 null,GSTM1,Efficacy,1,vinblastine,1184166189.0,Unknown
1447678311,PA166155680,rs2298771,,,SCN1A,Metabolism/PK,-1,carbamazepine,1447678313.0,European
1184510136,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184510144.0,Multiple groups
1184510136,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184510140.0,European
1184510136,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184510142.0,East Asian
1449271538,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,methadone,1449271545.0,Unknown
1449271538,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,methadone,1449271545.0,Unknown
1449713930,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,norfentanyl,1449713932.0,East Asian
1449713930,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,norfentanyl,1449713932.0,East Asian
1449713930,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,norfentanyl,1449713932.0,East Asian
1448268118,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1448268120.0,Multiple groups
1448268118,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448268120.0,Multiple groups
1447678288,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,1447678290.0,European
1447678288,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,1447678291.0,European
1184166166,PA166157060,rs3025033,,,VEGFA,Efficacy,-1,bevacizumab,1184166168.0,European
1184166162,PA166157019,rs2146323,,,VEGFA,Efficacy,-1,bevacizumab,1184166164.0,European
827815502,PA166155196,rs1979277,,,SHMT1,Efficacy,1,bevacizumab,827815511.0,Unknown
827815502,PA166155196,rs1979277,,,SHMT1,Efficacy,1,fluorouracil,827815511.0,Unknown
827815502,PA166155196,rs1979277,,,SHMT1,Efficacy,1,irinotecan,827815511.0,Unknown
827815502,PA166155196,rs1979277,,,SHMT1,Efficacy,1,leucovorin,827815511.0,Unknown
1448268112,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1448268117.0,Multiple groups
1184755911,PA166155081,rs7204252,,,LRP1,Efficacy,-1,platinum,1184755917.0,East Asian
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811697.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811702.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811696.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811708.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811710.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811694.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811703.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811709.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811698.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811695.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811706.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811707.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811700.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811699.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811690,PA166183702,rs524731,,,OPRM1,Efficacy,1,ethanol,1450811701.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1184510155,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1184510160.0,East Asian
1447678268,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,1447678270.0,European
1447678268,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,1447678271.0,European
1447678268,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,1447678406.0,European
1184755919,PA166155070,rs4788186,,,LRP1,Efficacy,-1,platinum,1184755921.0,East Asian
1184755929,PA166155006,rs1057451,,,LRP1,Efficacy,-1,platinum,1184755931.0,East Asian
1449271568,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,S-EDDP,1449271570.0,Unknown
1449271568,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,S-EDDP,1449271570.0,Unknown
1184166141,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1184166143.0,European
1184755924,PA166155069,rs4788184,,,LRP1,Efficacy,-1,platinum,1184755926.0,East Asian
1449271593,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1449271656.0,European
1184166132,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1184166136.0,European
827815479,PA166157304,rs1800795,,,IL6,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,827815485.0,Unknown
1446908220,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,citalopram,1446908232.0,Unknown
1446908220,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,citalopram,1446908232.0,Unknown
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811657.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811665.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811668.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811663.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811658.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811669.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811655.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811664.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811662.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811660.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811659.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811666.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811667.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811656.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1450811650,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,ethanol,1450811661.0,"Multiple groups, Participants were of mixed heritage but were at least one sixteenth Native American. 60% of the sample had over 50% Native American heritage."
1184755934,PA166156911,rs195862,,,POU2F2,Efficacy,-1,platinum,1184755936.0,East Asian
1184755946,PA166157088,rs3823036,,,POU2F2,Efficacy,-1,platinum,1184755948.0,East Asian
1184755940,PA166156910,rs195854,,,POU2F2,Efficacy,-1,platinum,1184755942.0,East Asian
1446908230,PA166157527,rs121434568,,,EGFR,Efficacy,1,erlotinib,1446908249.0,Unknown
1446908230,PA166157527,rs121434568,,,EGFR,Efficacy,1,erlotinib,1446908257.0,Unknown
1446908230,PA166157527,rs121434568,,,EGFR,Efficacy,1,gefitinib,1446908249.0,Unknown
1446908230,PA166157527,rs121434568,,,EGFR,Efficacy,1,gefitinib,1446908257.0,Unknown
1184166127,PA166156478,rs4073,,,CXCL8,Efficacy,1,bevacizumab,1184166131.0,European
1451250000,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,1451250040.0,East Asian
1451250000,PA166155187,rs1799752,,,ACE,Efficacy,1,lisinopril,1451250040.0,East Asian
1184510186,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1184510188.0,East Asian
1450824016,PA166156991,rs1799971,,,OPRM1,Other,1,ethanol,1450824020.0,"Multiple groups, ""The sample consisted predominantly of Caucasian participants (n=40); others reported Asian (n=6), East Indian (n=4), African (n=2), Native (n=1), mixed (n=2), or “other” (n=5) racial backgrounds. One participant endorsed Hispanic ethnicity without indicating race."""
1448108305,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1448108307.0,East Asian
1448255771,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448255779.0,Unknown
1448255771,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448255779.0,Unknown
982037860,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,982037867.0,African American/Afro-Caribbean
827784211,PA166155409,rs3745274,,,CYP2B6,Other,0,nevirapine,827784243.0,Multiple groups
827784211,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,nevirapine,827784243.0,Multiple groups
1446895857,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,escitalopram,1446895872.0,Multiple groups
1446895857,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,escitalopram,1446895872.0,Multiple groups
1449005403,PA166169464,rs11503014,,,GABRA2,Other,1,propofol,1449005408.0,East Asian
1448108296,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1448108298.0,East Asian
1183703365,PA166157284,rs1045642,,,ABCB1,Efficacy,1,antiepileptics,1183703367.0,Central/South Asian
827784189,PA166154155,rs12768009,,,CYP2C19,Other,0,nevirapine,827784210.0,Multiple groups
827784189,PA166154155,rs12768009,,,CYP2C19,Metabolism/PK,0,nevirapine,827784210.0,Multiple groups
1447682270,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1447682276.0,East Asian
1447682270,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1447682276.0,East Asian
1447682270,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1447682276.0,East Asian
981939609,PA166153781,rs6427528,,,CD84,Efficacy,-1,etanercept,981939619.0,European
1183621538,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,trimipramine,1183621540.0,Unknown
1444700343,PA166157734,rs1611115,,,DBH,Efficacy,1,naltrexone,1444700351.0,European
1445585092,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,daptomycin,1445585108.0,European
1450807702,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,omeprazole,1450807721.0,East Asian
1450807702,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,omeprazole,1450807721.0,East Asian
1450807702,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,omeprazole,1450807721.0,East Asian
1446895835,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,escitalopram,1446895855.0,"Multiple groups, African American/African American/Hispanic Asian/White/Hispanic White/Non-Hispanic"
1446895835,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,escitalopram,1446895847.0,"Multiple groups, African American/African American/Hispanic Asian/White/Hispanic White/Non-Hispanic"
1446895835,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,escitalopram,1446895855.0,"Multiple groups, African American/African American/Hispanic Asian/White/Hispanic White/Non-Hispanic"
1446895835,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,escitalopram,1446895847.0,"Multiple groups, African American/African American/Hispanic Asian/White/Hispanic White/Non-Hispanic"
981939599,PA166153847,rs12082710,,,TGFBR3,Efficacy,1,antidepressants,981939607.0,Unknown
1449005428,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,imatinib,1449005434.0,Near Eastern
1445585099,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,0,daptomycin,1445585110.0,European
1449005441,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,imatinib,1449005443.0,Near Eastern
1448255703,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,1448255705.0,Unknown
1448255703,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1448255705.0,Unknown
1448255703,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,1448255705.0,Unknown
982037919,PA166155042,rs2884737,,,VKORC1,Dosage,1,warfarin,982037925.0,African American/Afro-Caribbean
1183621485,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,trimipramine,1183621492.0,Unknown
1183621485,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,trimipramine,1183621492.0,Unknown
1183621485,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,trimipramine,1183621492.0,Unknown
1183621485,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,trimipramine,1183621492.0,Unknown
1183621485,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,1,trimipramine,1183621492.0,Unknown
1451151740,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,phenytoin,1451151723.0,Unknown
982037888,PA166155123,rs17880887,,,VKORC1,Dosage,-1,warfarin,982037892.0,African American/Afro-Caribbean
1183621496,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1183621532.0,European
1183621496,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1183621532.0,European
1183621496,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,pantoprazole,1183621532.0,European
982037894,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982037902.0,African American/Afro-Caribbean
1449005482,PA166154102,rs9332131,,,CYP2C9,Dosage,0,warfarin,1449005484.0,African American/Afro-Caribbean
1449005482,PA166154102,rs9332131,,,CYP2C9,Efficacy,0,warfarin,1449005484.0,African American/Afro-Caribbean
1183703414,PA166156997,rs1800629,,,TNF,Efficacy,1,adalimumab,1183703418.0,Unknown
1183703414,PA166156997,rs1800629,,,TNF,Efficacy,1,etanercept,1183703418.0,Unknown
1183703414,PA166156997,rs1800629,,,TNF,Efficacy,1,infliximab,1183703418.0,Unknown
1449005488,PA166154176,rs28371686,,,CYP2C9,Dosage,0,warfarin,1449005490.0,African American/Afro-Caribbean
1449005488,PA166154176,rs28371686,,,CYP2C9,Efficacy,0,warfarin,1449005490.0,African American/Afro-Caribbean
1447944355,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,methadone,1447944357.0,Multiple groups
1447944355,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,methadone,1447944357.0,Multiple groups
1447944355,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,methadone,1447944357.0,Multiple groups
1450807761,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807772.0,East Asian
1450807761,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807805.0,East Asian
1450807761,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807772.0,East Asian
1450807761,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807805.0,East Asian
1450807761,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807772.0,East Asian
1450807761,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807805.0,East Asian
1448108212,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448108218.0,Multiple groups
1183703531,PA166156750,rs1050152,,,SLC22A4,Efficacy,1,imatinib,1183703535.0,"Multiple groups, Caucasian, Asian, Other"
827784097,PA166153656,rs1877724,,,EPHX1,Dosage,1,warfarin,827784112.0,"Multiple groups, Chinese, Indian, Malay and 'other' participants from Singapore"
982037995,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982038001.0,European
982037995,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982038003.0,European
982037995,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982038001.0,European
982037995,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982038003.0,European
1449005494,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1449005496.0,African American/Afro-Caribbean
1449005494,PA166155091,rs9923231,,,VKORC1,Efficacy,0,warfarin,1449005496.0,African American/Afro-Caribbean
1450807773,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807775.0,East Asian
1450807773,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807814.0,East Asian
1450807773,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807775.0,East Asian
1450807773,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807814.0,East Asian
1450807773,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807775.0,East Asian
1450807773,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807814.0,East Asian
1450807773,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807775.0,East Asian
1450807773,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807814.0,East Asian
1184997887,,,PA166117680,UGT1A9*3a,UGT1A9,Metabolism/PK,1,raltegravir,1184997897.0,Unknown
1184997887,,,PA166117680,UGT1A9*3a,UGT1A9,Metabolism/PK,1,raltegravir,1184997902.0,Unknown
1450807784,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807821.0,East Asian
1450807784,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450807786.0,East Asian
1450807784,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807821.0,East Asian
1450807784,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450807786.0,East Asian
1450807784,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807821.0,East Asian
1450807784,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807786.0,East Asian
1450807784,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807821.0,East Asian
1450807784,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450807786.0,East Asian
1450824161,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,0,nicotine,1450824167.0,Unknown
1450824161,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,0,nicotine,1450824167.0,Unknown
1184997889,PA166153711,rs2501873,,,NR1I3,Dosage,1,warfarin,1184997910.0,East Asian
982037980,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037992.0,European
982037980,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037994.0,European
1448632458,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,olanzapine,1448632465.0,European
1448632458,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,1,olanzapine,1448632460.0,European
982037942,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,982037949.0,African American/Afro-Caribbean
982037942,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,982037949.0,African American/Afro-Caribbean
1448632450,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,olanzapine,1448632452.0,European
1447944325,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,methadone,1447944354.0,Multiple groups
1447944325,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,methadone,1447944354.0,Multiple groups
1448108161,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448108179.0,Multiple groups
1448108161,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448108187.0,African American/Afro-Caribbean
1448108161,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448108183.0,European
1448108161,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1448108190.0,Latino
982037960,PA166155341,rs7412,,,APOE,Dosage,-1,warfarin,982037967.0,African American/Afro-Caribbean
1184997918,PA166155934,rs3212198,,,HNF4A,Dosage,1,warfarin,1184997920.0,East Asian
982037951,PA166155351,rs429358,,,APOE,Dosage,-1,warfarin,982037958.0,African American/Afro-Caribbean
982037951,PA166155351,rs429358,,,APOE,Dosage,-1,warfarin,982037958.0,African American/Afro-Caribbean
1183621560,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,trimipramine,1183621562.0,Unknown
1183621560,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,trimipramine,1446901729.0,Unknown
1183621560,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,trimipramine,1446901727.0,Unknown
1183621560,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,trimipramine,1183621562.0,Unknown
1183621560,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,trimipramine,1446901729.0,Unknown
1183621560,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,trimipramine,1446901727.0,Unknown
982038036,PA166154253,rs5104,,,APOA4,Efficacy,-1,fenofibrate,982038042.0,European
982038036,PA166154253,rs5104,,,APOA4,Efficacy,-1,fenofibrate,982038043.0,European
1183703589,PA166157284,rs1045642,,,ABCB1,Efficacy,1,imatinib,1183703591.0,European
1183703569,PA166157032,rs2282143,,,SLC22A1,Efficacy,-1,imatinib,1183703571.0,European
1448255577,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,,
1448255577,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,,
982038053,PA166154251,rs5090,,,APOA4,Efficacy,-1,fenofibrate,982038058.0,European
982038053,PA166154251,rs5090,,,APOA4,Efficacy,-1,fenofibrate,982038057.0,European
1183703573,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,imatinib,1183703575.0,European
1449005569,PA166170923,rs56240334,,,ADCK1,Efficacy,-1,paliperidone,1449005574.0,European
982038045,PA166154252,rs5092,,,APOA4,Efficacy,-1,fenofibrate,982038050.0,European
982038045,PA166154252,rs5092,,,APOA4,Efficacy,-1,fenofibrate,982038051.0,European
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824368.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824367.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824371.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824261.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824260.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824259.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824372.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824262.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824369.0,Unknown
1450824235,PA166184666,rs3778150,,,OPRM1,,1,ethanol,1450824370.0,Unknown
1446895666,PA166157298,rs1468412,,,GRM3,Efficacy,1,antipsychotics,1446895668.0,Central/South Asian
1446895666,PA166157298,rs1468412,,,GRM3,Efficacy,1,antipsychotics,1446895669.0,Central/South Asian
1446895666,PA166157298,rs1468412,,,GRM3,Efficacy,1,antipsychotics,1446895670.0,Central/South Asian
1444929615,PA166157431,rs7794356,,,GALNT17,Efficacy,-1,montelukast,1444929618.0,Multiple groups
982038004,PA166154326,rs1263177,,,APOA4,Efficacy,-1,fenofibrate,982038008.0,European
982038004,PA166154326,rs1263177,,,APOA4,Efficacy,-1,fenofibrate,982038009.0,European
1447944264,PA166155336,rs183205964,,,TYMS,Toxicity,1,capecitabine,1447944286.0,Unknown
1447944264,PA166155336,rs183205964,,,TYMS,Toxicity,1,fluorouracil,1447944286.0,Unknown
1447944264,PA166155336,rs183205964,,,TYMS,Toxicity,1,tegafur,1447944286.0,Unknown
1183703560,PA166156750,rs1050152,,,SLC22A4,Efficacy,-1,imatinib,1183703562.0,"Multiple groups, Caucasian, Asian, Other"
982038027,PA166154248,rs675,,,APOA4,Efficacy,-1,fenofibrate,982038033.0,European
982038027,PA166154248,rs675,,,APOA4,Efficacy,-1,fenofibrate,982038034.0,European
1183703536,PA166157373,rs3213619,,,ABCB1,Efficacy,-1,imatinib,1183703554.0,"Multiple groups, Caucasian, Asian, Other"
1183703536,PA166157373,rs3213619,,,ABCB1,Efficacy,-1,imatinib,1183703538.0,"Multiple groups, Caucasian, Asian, Other"
1183703536,PA166157373,rs3213619,,,ABCB1,Efficacy,-1,imatinib,1183703556.0,"Multiple groups, Caucasian, Asian, Other"
1447944241,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,endoxifen,1447944243.0,"Multiple groups, Brazil, 85% White, 15% Others"
1447944241,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,endoxifen,1447944243.0,"Multiple groups, Brazil, 85% White, 15% Others"
1184997863,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,raltegravir,1184997873.0,Unknown
1184997863,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,raltegravir,1184997873.0,Unknown
1448255545,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1448255547.0,Central/South Asian
1448255545,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1448255547.0,Central/South Asian
1448255545,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1448255547.0,Central/South Asian
1183703546,PA166157032,rs2282143,,,SLC22A1,Efficacy,-1,imatinib,1183703548.0,"Multiple groups, Caucasian, Asian, Other"
1183703542,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,imatinib,1183703544.0,"Multiple groups, Caucasian, Asian, Other"
1448255537,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1448255543.0,Central/South Asian
1183703648,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,venlafaxine,1183703660.0,European
1183703648,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,venlafaxine,1183703662.0,European
1183703648,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,venlafaxine,1183703658.0,European
1183703648,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,venlafaxine,1183703656.0,European
982038105,PA166154247,rs670,,,APOA1,Efficacy,-1,fenofibrate,982038110.0,European
982038105,PA166154247,rs670,,,APOA1,Efficacy,-1,fenofibrate,982038109.0,European
1448632358,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,1,olanzapine,1448632364.0,Unknown
1448632358,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,1,olanzapine,1448632367.0,Unknown
982038097,PA166154254,rs5128,,,APOC3,Efficacy,-1,fenofibrate,982038102.0,European
982038097,PA166154254,rs5128,,,APOC3,Efficacy,-1,fenofibrate,982038103.0,European
982038097,PA166154254,rs5128,,,APOC3,Efficacy,-1,fenofibrate,982038102.0,European
982038097,PA166154254,rs5128,,,APOC3,Efficacy,-1,fenofibrate,982038103.0,European
1447944228,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,4-hydroxytamoxifen,1447944230.0,"Multiple groups, Brazil, 85% White, 15% Others"
1447944228,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,4-hydroxytamoxifen,1447944230.0,"Multiple groups, Brazil, 85% White, 15% Others"
1447944228,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,4-hydroxytamoxifen,1447944230.0,"Multiple groups, Brazil, 85% White, 15% Others"
1446895651,PA166156048,rs165854,,,PI4KA,Efficacy,1,antipsychotics,1446895659.0,Central/South Asian
1446895651,PA166156048,rs165854,,,PI4KA,Efficacy,1,antipsychotics,1446895661.0,Central/South Asian
1446895651,PA166156048,rs165854,,,PI4KA,Efficacy,1,antipsychotics,1446895663.0,Central/South Asian
982038119,PA166154382,rs2727784,,,APOA1,Efficacy,-1,fenofibrate,982038124.0,European
982038119,PA166154382,rs2727784,,,APOA1,Efficacy,-1,fenofibrate,982038123.0,European
1447944217,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tamoxifen,1447944227.0,"Multiple groups, Brazil, 85% White, 15% Others"
1447944217,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,tamoxifen,1447944227.0,"Multiple groups, Brazil, 85% White, 15% Others"
1448124443,PA166153889,rs56038477,,,DPYD,Dosage,1,capecitabine,1448124445.0,Unknown
1448124443,PA166153889,rs56038477,,,DPYD,Dosage,1,fluorouracil,1448124445.0,Unknown
982038112,PA166154286,rs613808,,,APOA1,Efficacy,-1,fenofibrate,982038117.0,European
982038112,PA166154286,rs613808,,,APOA1,Efficacy,-1,fenofibrate,982038116.0,European
982038075,PA166154391,rs2854117,,,APOC3,Efficacy,-1,fenofibrate,982038079.0,European
982038075,PA166154391,rs2854117,,,APOC3,Efficacy,-1,fenofibrate,982038080.0,European
1446895600,PA166157357,rs2299214,,,GRM3,Efficacy,1,risperidone,1446895611.0,Central/South Asian
1450807854,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450807869.0,Unknown
1450807854,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450807873.0,Unknown
1450807854,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450807867.0,Unknown
1450807854,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450807869.0,Unknown
1450807854,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450807873.0,Unknown
1450807854,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450807867.0,Unknown
1450807854,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450807869.0,Unknown
1450807854,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450807873.0,Unknown
1450807854,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450807867.0,Unknown
769165185,PA166155331,rs45445694,,,C18orf56,Dosage,-1,irinotecan,827699102.0,"Multiple groups, USA, about 80% White, 10-20% African American, a couple of Asian and HIspanic subjects"
769165185,PA166155331,rs45445694,,,TYMS,Dosage,-1,irinotecan,827699102.0,"Multiple groups, USA, about 80% White, 10-20% African American, a couple of Asian and HIspanic subjects"
982038060,PA166154376,rs2542051,,,APOC3,Efficacy,-1,fenofibrate,982038065.0,European
982038060,PA166154376,rs2542051,,,APOC3,Efficacy,-1,fenofibrate,982038066.0,European
769165179,PA166155331,rs45445694,,,TYMS,Efficacy,1,fluorouracil,769165181.0,Unknown
1183703603,PA166156750,rs1050152,,,SLC22A4,Efficacy,1,imatinib,1183703605.0,European
1183703597,PA166157373,rs3213619,,,ABCB1,Efficacy,-1,imatinib,1183703599.0,European
1447944175,PA166156043,rs138337,,,ST13,Efficacy,1,corticosteroids,1447944177.0,Unknown
982038082,PA166154390,rs2854116,,,APOC3,Efficacy,-1,fenofibrate,982038087.0,European
982038082,PA166154390,rs2854116,,,APOC3,Efficacy,-1,fenofibrate,982038086.0,European
1183703611,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,imatinib,1183703613.0,European
1448665077,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448665079.0,Sub-Saharan African
1183703607,PA166156750,rs1050152,,,SLC22A4,Efficacy,-1,imatinib,1183703609.0,European
1183703607,PA166156750,rs1050152,,,SLC22A4,Efficacy,-1,imatinib,1183703609.0,European
1448108002,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1448108017.0,"Multiple groups, 8 studies"
1448108002,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1448108014.0,European
769165161,PA166155331,rs45445694,,,TYMS,Metabolism/PK,-1,FOLFIRI,,
1447944162,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1447944164.0,East Asian
1447944162,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1447944164.0,East Asian
1447944162,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,voriconazole,1447944164.0,East Asian
1445584831,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1445584860.0,East Asian
1445584831,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1445584860.0,East Asian
1445584831,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,voriconazole,1445584860.0,East Asian
1445584831,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1445584860.0,East Asian
1446895571,PA166157411,rs6465084,,,GRM3,Efficacy,1,antipsychotics,1446895574.0,Central/South Asian
1446895571,PA166157411,rs6465084,,,GRM3,Efficacy,1,antipsychotics,1446895575.0,Central/South Asian
1446895571,PA166157411,rs6465084,,,GRM3,Efficacy,1,antipsychotics,1446895573.0,Central/South Asian
1446895571,PA166157411,rs6465084,,,GRM3,Efficacy,1,antipsychotics,1446895574.0,Central/South Asian
1446895571,PA166157411,rs6465084,,,GRM3,Efficacy,1,antipsychotics,1446895575.0,Central/South Asian
1446895571,PA166157411,rs6465084,,,GRM3,Efficacy,1,antipsychotics,1446895573.0,Central/South Asian
1444929453,PA166156781,rs2053044,,,ADRB2,Efficacy,1,ramipril,1444929721.0,African American/Afro-Caribbean
1451135636,PA166205221,rs3733829,,,EGLN2,Metabolism/PK,1,3-hydroxycotinine,1451135661.0,Unknown
1184473659,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1184473667.0,Central/South Asian
1184473659,,,PA165816555,CYP2C9*14,CYP2C9,Dosage,0,warfarin,1184473667.0,Central/South Asian
1183703697,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,efavirenz,1183703699.0,East Asian
827784411,PA166156561,rs2622604,,,ABCG2,Efficacy,-1,gefitinib,827784447.0,Unknown
1448107984,PA166155915,rs1127354,,,ITPA,Efficacy,1,azathioprine,1448108015.0,East Asian
1183703693,PA166155471,rs28399433,,,CYP2A6,Metabolism/PK,-1,efavirenz,1183703695.0,East Asian
1183703705,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1183703707.0,East Asian
1448107993,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1448108012.0,"Multiple groups, 8 studies"
1448107993,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1448108010.0,European
1183703701,PA166157481,rs28371759,,,CYP3A4,Metabolism/PK,-1,efavirenz,1183703703.0,East Asian
1447944149,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447944161.0,East Asian
1447944149,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447944161.0,East Asian
1447944149,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1447944161.0,East Asian
1446895589,PA166155786,rs10211524,,,SLC1A4,Efficacy,1,antipsychotics,1446895592.0,Central/South Asian
1446895589,PA166155786,rs10211524,,,SLC1A4,Efficacy,1,antipsychotics,1446895591.0,Central/South Asian
1446895589,PA166155786,rs10211524,,,SLC1A4,Efficacy,1,antipsychotics,1446895593.0,Central/South Asian
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,fluorouracil,1446895542.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,fluorouracil,1446895543.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,fluorouracil,1446895544.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,irinotecan,1446895542.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,irinotecan,1446895543.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,irinotecan,1446895544.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,oxaliplatin,1446895542.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,oxaliplatin,1446895543.0,Multiple groups
1446895539,PA166155298,rs4939827,,,SMAD7,Efficacy,-1,oxaliplatin,1446895544.0,Multiple groups
1446748136,PA166157316,rs2032582,,,ABCB1,Efficacy,1,sunitinib,1450985860.0,"Multiple groups, Chinese, Indian, Malay"
1446748136,PA166157316,rs2032582,,,ABCB1,Efficacy,1,sunitinib,1446748138.0,"Multiple groups, Chinese, Indian, Malay"
1446748136,PA166157316,rs2032582,,,ABCB1,Efficacy,1,sunitinib,1446753930.0,"Multiple groups, Chinese, Indian, Malay"
1446748136,PA166157316,rs2032582,,,ABCB1,Efficacy,1,sunitinib,1446749790.0,"Multiple groups, Chinese, Indian, Malay"
1448632263,PA166157286,rs1057868,,,POR,Dosage,-1,acenocoumarol,1448632265.0,European
827784391,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,gefitinib,827784433.0,Unknown
1447944137,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447944139.0,East Asian
1447944137,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447944139.0,East Asian
1447944137,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1447944139.0,East Asian
1183703687,PA166155395,rs2279345,,,CYP2B6,Metabolism/PK,1,efavirenz,1183703691.0,East Asian
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169561.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169563.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169565.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169567.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169577.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169561.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169563.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169565.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169567.0,Latino
1449169556,PA166153539,rs699,,,AGT,Metabolism/PK,-1,atorvastatin,1449169577.0,Latino
1447944114,PA166156042,rs138335,,,ST13,Efficacy,1,corticosteroids,1447944174.0,Unknown
982038152,PA166155967,rs62205366,,,GNAS,Efficacy,1,dobutamine,982038288.0,East Asian
982038152,PA166155967,rs62205366,,,GNAS,Efficacy,1,dobutamine,982038192.0,East Asian
982038152,PA166155967,rs62205366,,,GNAS,Efficacy,1,dobutamine,982038290.0,East Asian
1446895550,PA166156764,rs1529461,,,SLC1A3,Efficacy,1,antipsychotics,1446895560.0,Central/South Asian
1446895550,PA166156764,rs1529461,,,SLC1A3,Efficacy,1,antipsychotics,1446895556.0,Central/South Asian
1446895550,PA166156764,rs1529461,,,SLC1A3,Efficacy,1,antipsychotics,1446895558.0,Central/South Asian
1448615861,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,hydroxyamitriptyline,1448615863.0,East Asian
1448615861,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,hydroxyamitriptyline,1448615863.0,East Asian
982038144,PA166153972,rs1799853,,,CYP2C9,Dosage,0,warfarin,,
1446895561,PA166157357,rs2299214,,,GRM3,Efficacy,1,antipsychotics,1446895566.0,Central/South Asian
1446895561,PA166157357,rs2299214,,,GRM3,Efficacy,1,antipsychotics,1446895564.0,Central/South Asian
1446895561,PA166157357,rs2299214,,,GRM3,Efficacy,1,antipsychotics,1446895565.0,Central/South Asian
1444929392,PA166157785,rs6475448,,,MLLT3,Efficacy,1,montelukast,1444929406.0,Multiple groups
1444929392,PA166157785,rs6475448,,,MLLT3,Efficacy,1,montelukast,1444929406.0,Multiple groups
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169586.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169589.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169590.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169585.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169587.0,Latino
1449169583,PA166154785,rs1799722,,,BDKRB2,Metabolism/PK,1,atorvastatin,1449169588.0,Latino
1448615842,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1448615860.0,East Asian
1448615842,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1448615860.0,East Asian
1448615842,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,amitriptyline,1448615860.0,East Asian
1447223182,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1447223184.0,Multiple groups
1447223182,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1447223184.0,Multiple groups
1448107943,PA166157269,rs854547,,,PON1,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448107956.0,European
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,3-hydroxycotinine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,3-hydroxycotinine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,3-hydroxycotinine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,3-hydroxycotinine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,3-hydroxycotinine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,3-hydroxycotinine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,cotinine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,cotinine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,cotinine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,cotinine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,cotinine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,cotinine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA3,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135720.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135705.0,Unknown
1451135700,PA166154938,rs16969968,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135721.0,Unknown
1184998169,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998179.0,Unknown
1184998169,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998179.0,Unknown
1451135662,PA166205221,rs3733829,,,EGLN2,Metabolism/PK,-1,cotinine,1451135680.0,Unknown
1451135662,PA166205221,rs3733829,,,EGLN2,Metabolism/PK,-1,cotinine,1451135667.0,Unknown
1451135662,PA166205221,rs3733829,,,EGLN2,Metabolism/PK,-1,nicotine,1451135680.0,Unknown
1451135662,PA166205221,rs3733829,,,EGLN2,Metabolism/PK,-1,nicotine,1451135667.0,Unknown
1448632196,PA166154516,rs1544410,,,VDR,Metabolism/PK,1,rifampin,1448632198.0,"Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)"
1184998157,PA166154345,rs1954787,,,GRIK4,Efficacy,1,antidepressants,1184998244.0,Multiple groups
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824388.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824387.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824386.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824383.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824389.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824384.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824390.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824385.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824382.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824388.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824387.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824386.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824383.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824389.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824384.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824390.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824385.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824382.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824388.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824387.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824386.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824383.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824389.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824384.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824390.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824385.0,Unknown
1450824374,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450824382.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,3-hydroxycotinine,1451135681.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,3-hydroxycotinine,1451135644.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,3-hydroxycotinine,1451135682.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,3-hydroxycotinine,1451135681.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,3-hydroxycotinine,1451135644.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,3-hydroxycotinine,1451135682.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,cotinine,1451135681.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,cotinine,1451135644.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,cotinine,1451135682.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,cotinine,1451135681.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,cotinine,1451135644.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,cotinine,1451135682.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,nicotine,1451135681.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,nicotine,1451135644.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA3,Metabolism/PK,-1,nicotine,1451135682.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135681.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135644.0,Unknown
1451135674,PA166154840,rs578776,,,CHRNA5,Metabolism/PK,-1,nicotine,1451135682.0,Unknown
1448632188,PA166165040,rs4646536,,,CYP27B1,Metabolism/PK,1,rifampin,1448632190.0,"Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)"
1448632188,PA166165040,rs4646536,,,CYP27B1,Metabolism/PK,1,rifampin,1448632190.0,"Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)"
1448632188,PA166165040,rs4646536,,,CYP27B1,Metabolism/PK,1,rifampin,1448632190.0,"Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)"
1448632188,PA166165040,rs4646536,,,CYP27B1,Metabolism/PK,1,rifampin,1448632190.0,"Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)"
1447223171,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447223180.0,Multiple groups
1447223171,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447223180.0,Multiple groups
1447944033,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1447944055.0,East Asian
1447944033,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1447944055.0,East Asian
1447944033,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,voriconazole,1447944055.0,East Asian
982038292,PA166155967,rs62205366,,,GNAS,Efficacy,-1,dobutamine,982038313.0,East Asian
982038292,PA166155967,rs62205366,,,GNAS,Efficacy,-1,dobutamine,982038315.0,East Asian
1184998180,PA166157267,rs776746,,,CYP3A5,Dosage,-1,tacrolimus,1184998186.0,Unknown
1184998180,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1184998186.0,Unknown
1450808090,PA166157164,rs9479757,,,OPRM1,Dosage,1,heroin,1450808092.0,East Asian
1448107856,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,docetaxel,1448107872.0,Unknown
1183703811,PA166154249,rs1695,,,GSTP1,Metabolism/PK,1,olanzapine,1183703813.0,European
1449251596,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449251598.0,Central/South Asian
1444929377,PA166154526,rs2069705,,,IFNG,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444929401.0,European
1444929377,PA166154526,rs2069705,,,IFNG,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1444929395.0,European
769165237,PA166156008,rs4920037,,,CBS,Toxicity,1,Arsenic compounds,769165244.0,Latino
769165237,PA166156008,rs4920037,,,CBS,Metabolism/PK,1,Arsenic compounds,769165244.0,Latino
769181620,PA166155331,rs45445694,,,C18orf56,Efficacy,1,methotrexate,769181630.0,Unknown
769181620,PA166155331,rs45445694,,,TYMS,Efficacy,1,methotrexate,769181630.0,Unknown
769165235,PA166155977,rs234709,,,CBS,Toxicity,1,Arsenic compounds,769165242.0,Latino
769165235,PA166155977,rs234709,,,CBS,Metabolism/PK,1,Arsenic compounds,769165242.0,Latino
981939971,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,0,isoniazid,981939977.0,East Asian
1450824453,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450824457.0,Unknown
1183703802,PA166159214,rs1799735,,,GSTM3,Metabolism/PK,1,olanzapine,1183703806.0,European
1450824458,PA166184666,rs3778150,,,OPRM1,Dosage,1,ethanol,1450824462.0,Unknown
769164968,PA166154979,rs9597,,,UBE2I,Efficacy,1,cisplatin,769164971.0,East Asian
769164968,PA166154979,rs9597,,,UBE2I,Efficacy,1,irinotecan,769164971.0,East Asian
981940056,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,981940066.0,European
1450971980,PA166154482,rs671,,,ALDH2,Other,1,ethanol,1450971944.0,East Asian
827783711,PA166157325,rs2070744,,,NOS3,Efficacy,1,sildenafil,827783717.0,"Multiple groups, Brazil"
1183703910,PA166155608,rs889895,,,CREB1,Efficacy,1,antidepressants,1183703933.0,"Multiple groups, 95% Caucasian"
981940067,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,acenocoumarol,981940073.0,European
1448632071,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rifampin,1448632182.0,"Multiple groups, Italy, Caucasian (n=11), African (n=7), Asian (n=3), Latin American (n=3)"
1448632071,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,rifampin,1448632205.0,Multiple groups
827849230,PA166155409,rs3745274,,,CYP2B6,Toxicity,1,nevirapine,827849238.0,Central/South Asian
827849230,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,nevirapine,827849238.0,Central/South Asian
1449169755,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,1449169766.0,Latino
1449169755,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,1449169768.0,Latino
1449169755,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,1449169764.0,Latino
1449169755,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,1449169762.0,Latino
1449169769,PA166153953,rs717620,,,ABCC2,Efficacy,-1,atorvastatin,1449169771.0,Latino
1444880046,PA166154847,rs700518,,,CYP19A1,Other,1,Enzyme inhibitors,1444892751.0,Unknown
1444880046,PA166154847,rs700518,,,CYP19A1,Other,1,Enzyme inhibitors,1444893188.0,Unknown
1184998312,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998318.0,Latino
1449169787,PA166153953,rs717620,,,ABCC2,Efficacy,-1,atorvastatin,1449169789.0,Latino
1449169781,PA166153953,rs717620,,,ABCC2,Efficacy,-1,atorvastatin,1449169783.0,Latino
1183622039,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622041.0,East Asian
1183622039,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1183622041.0,East Asian
1447681725,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1447681727.0,East Asian
1447681725,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,risperidone,1447681727.0,East Asian
1447681725,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,risperidone,1447681727.0,East Asian
1447681725,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,risperidone,1447681727.0,East Asian
982022009,PA166156708,rs6295,,,HTR1A,Dosage,1,risperidone,982022014.0,East Asian
982022009,PA166156708,rs6295,,,HTR1A,Efficacy,1,risperidone,982022014.0,East Asian
1449251734,PA166154671,rs6046,,,F7,Dosage,-1,warfarin,1449251737.0,Central/South Asian
827816402,PA166154409,rs4648317,,,DRD2,Dosage,-1,methadone,827816446.0,East Asian
827816402,PA166154409,rs4648317,,,DRD2,Metabolism/PK,-1,methadone,827816446.0,East Asian
1183703934,PA166156028,rs6928,,,MAPK1,Efficacy,-1,antidepressants,1183704064.0,"Multiple groups, 95% Caucasian"
1183703934,PA166156028,rs6928,,,MAPK1,Efficacy,-1,antidepressants,1183703938.0,"Multiple groups, 95% Caucasian"
1184998246,PA166154345,rs1954787,,,GRIK4,Efficacy,1,antidepressants,1184998248.0,Multiple groups
1447681711,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1447681713.0,East Asian
1447681711,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,risperidone,1447681713.0,East Asian
1447681711,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,risperidone,1447681713.0,East Asian
1447681711,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,risperidone,1447681713.0,East Asian
1448124080,PA166154759,rs116855232,,,NUDT15,Dosage,1,azathioprine,1448124087.0,Central/South Asian
1444699877,PA166156819,rs3836790,,,SLC6A3,Efficacy,1,levodopa,1444699879.0,Unknown
1444699877,PA166156819,rs3836790,,,SLC6A3,Efficacy,1,methylphenidate,1444699879.0,Unknown
1448435381,PA166161567,rs212082,,,ABCC1,Metabolism/PK,-1,SN-38,1448435383.0,"Multiple groups, Caucasian and African-American"
1447681693,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1447681710.0,East Asian
1447681693,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,risperidone,1447681710.0,East Asian
1447681693,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,risperidone,1447681710.0,East Asian
1183704035,PA166156030,rs13515,,,MAPK1,Efficacy,-1,antidepressants,1183704068.0,"Multiple groups, 95% Caucasian"
1183704035,PA166156030,rs13515,,,MAPK1,Efficacy,-1,antidepressants,1183704037.0,"Multiple groups, 95% Caucasian"
1447943838,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943838,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,atomoxetine,1447943840.0,"Multiple groups, White, African-American, Native Hawaiian"
981940181,,,PA165816546,CYP2C9*5,CYP2C9,Efficacy,-1,acenocoumarol,981940183.0,Sub-Saharan African
1183704043,PA166155755,rs6740584,,,CREB1,Efficacy,-1,antidepressants,1183704060.0,"Multiple groups, 95% Caucasian"
1183704043,PA166155755,rs6740584,,,CREB1,Efficacy,-1,antidepressants,1183704045.0,"Multiple groups, 95% Caucasian"
1448435370,PA166161565,rs215095,,,ABCC1,Metabolism/PK,-1,SN-38,1448435372.0,"Multiple groups, Caucasian and African-American"
1183704039,PA166156130,rs8136867,,,MAPK1,Efficacy,-1,antidepressants,1183704041.0,"Multiple groups, 95% Caucasian"
827816346,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,827816421.0,European
827816346,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,carvedilol,827816421.0,European
827816346,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,diltiazem,827816421.0,European
827816346,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,metoprolol,827816421.0,European
827816346,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,verapamil,827816421.0,European
1449595846,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,voriconazole,1449595848.0,"Multiple groups, Italy, specified 37.5% Caucasian, 62.5% Other."
1184654330,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184654336.0,Unknown
1184654330,PA166155091,rs9923231,,,VKORC1,Efficacy,1,warfarin,1184654336.0,Unknown
827816353,PA166154486,rs5443,,,GNB3,Dosage,-1,methadone,827816451.0,East Asian
827816353,PA166154486,rs5443,,,GNB3,Metabolism/PK,-1,methadone,827816451.0,East Asian
1448435351,PA166155049,rs3743527,,,ABCC1,Metabolism/PK,-1,SN-38,1448435353.0,"Multiple groups, Caucasian and African-American"
1447681685,PA166157653,rs17716295,,,NRG1,Efficacy,1,antipsychotics,1447681687.0,Central/South Asian
1184998398,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998404.0,European
1448615563,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448615806.0,East Asian
1448615563,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448615569.0,East Asian
1448615563,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1448615571.0,East Asian
1447681665,PA166156766,rs1544938,,,ADCY2,Efficacy,1,antipsychotics,1447681667.0,Central/South Asian
1444667028,PA166156308,rs1063538,,,ADIPOQ,Efficacy,-1,pioglitazone,1444667030.0,East Asian
1184654356,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184654358.0,Unknown
1184654356,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184654358.0,Unknown
1184654356,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,1184654358.0,Unknown
1184654356,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,warfarin,1184654358.0,Unknown
1447681671,PA166157643,rs13250975,,,NRG1,Efficacy,1,antipsychotics,1447681674.0,Central/South Asian
1448615540,PA166163676,rs142410335,,,MIR133B,Dosage,-1,warfarin,1448615545.0,East Asian
1448615546,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1448615552.0,East Asian
1448615546,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1448615691.0,East Asian
1448615546,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1448615693.0,East Asian
1447681648,PA166155151,rs4586,,,CCL2,Efficacy,1,antipsychotics,1447681650.0,Central/South Asian
827816315,PA166155393,rs2279343,,,CYP2B6,Dosage,-1,methadone,827816467.0,East Asian
827816315,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,methadone,827816467.0,East Asian
1444699815,PA166156819,rs3836790,,,SLC6A3,Efficacy,1,levodopa,1444699832.0,Unknown
1444699815,PA166156819,rs3836790,,,SLC6A3,Efficacy,1,levodopa,1444699834.0,Unknown
981940163,,,PA165816549,CYP2C9*8,CYP2C9,Efficacy,-1,acenocoumarol,981940165.0,Sub-Saharan African
1184654374,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1184654376.0,Unknown
1184654374,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1184654376.0,Unknown
1184654374,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1184654376.0,Unknown
1184654374,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,0,warfarin,1184654376.0,Unknown
1184654374,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,0,warfarin,1184654376.0,Unknown
1184654374,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,0,warfarin,1184654376.0,Unknown
1184654374,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,0,warfarin,1184654376.0,Unknown
1448107619,PA166155196,rs1979277,,,SHMT1,Efficacy,-1,methotrexate,1448107627.0,Unknown
1448615525,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1448615527.0,East Asian
1448615525,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1448615560.0,East Asian
1448615525,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1448615562.0,East Asian
1448615525,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1448615527.0,East Asian
1448615525,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1448615560.0,East Asian
1448615525,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1448615562.0,East Asian
1448615516,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448615522.0,East Asian
1448615516,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448615749.0,East Asian
1448615516,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448615825.0,East Asian
1444666932,PA166156282,rs266729,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666934.0,East Asian
1447681639,PA166155227,rs4795893,,,CCL2,Efficacy,1,antipsychotics,1447681645.0,Central/South Asian
1447943783,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA166123455,CYP2D6*4xN,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165948318,CYP2D6*29,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1447943783,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,atomoxetine,1447943815.0,"Multiple groups, White, African-American, Native Hawaiian"
1447943783,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,atomoxetine,1447943836.0,Multiple groups
1447943783,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,1,atomoxetine,1447943882.0,Multiple groups
1444666944,PA166156459,rs16861194,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666946.0,East Asian
827783502,PA166154776,rs1256049,,,ESR2,Efficacy,-1,leflunomide,827783513.0,Unknown
827816268,PA166154260,rs6275,,,DRD2,Dosage,1,methadone,827816275.0,East Asian
827816268,PA166154260,rs6275,,,DRD2,Metabolism/PK,1,methadone,827816275.0,East Asian
1183491069,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,losartan,1183491071.0,East Asian
1183491069,,,PA165816574,CYP2C9*30,CYP2C9,Efficacy,-1,losartan,1183491071.0,East Asian
981481458,PA166156947,rs760370,,,SLC29A1,Efficacy,1,peginterferon alfa-2a,981481471.0,"Multiple groups, mostly White patients(95% were White) patients at a Spanish hospital."
981481458,PA166156947,rs760370,,,SLC29A1,Efficacy,1,peginterferon alfa-2b,981481471.0,"Multiple groups, mostly White patients(95% were White) patients at a Spanish hospital."
981481458,PA166156947,rs760370,,,SLC29A1,Efficacy,1,ribavirin,981481471.0,"Multiple groups, mostly White patients(95% were White) patients at a Spanish hospital."
1184998356,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998362.0,European
1448107584,PA166154938,rs16969968,,,CHRNA5,Other,1,nicotine,1448107590.0,"Multiple groups, Caucasian (n=52), African American (n=12) or American Indian or Alaskan native (n=1). One participant did not identify a racial background. Seven participants self identified their ethnicity as Hispanic"
1444666960,PA166156307,rs1063537,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666962.0,East Asian
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,atenolol,827816314.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,atenolol,827824835.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,carvedilol,827816314.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,carvedilol,827824835.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,diltiazem,827816314.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,diltiazem,827824835.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,metoprolol,827816314.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,metoprolol,827824835.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,verapamil,827816314.0,European
827816261,PA166153977,rs1801253,,,ADRB1,Efficacy,1,verapamil,827824835.0,European
1184998363,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998365.0,European
1444666966,PA166156342,rs2082940,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666968.0,East Asian
1183491076,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,losartan,1183491078.0,East Asian
1183491076,,,PA165816561,CYP2C9*33,CYP2C9,Efficacy,-1,losartan,1183491078.0,East Asian
827783488,PA166154805,rs4986938,,,ESR2,Efficacy,-1,leflunomide,827783510.0,Unknown
1450415126,PA166157284,rs1045642,,,ABCB1,Efficacy,1,methotrexate,1450415149.0,Unknown
1448107570,PA166157487,rs35599367,,,CYP3A4,Efficacy,1,simvastatin,1448107576.0,Unknown
981481472,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481477.0,European
981481472,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981481477.0,European
981481472,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981481477.0,European
981481472,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981481477.0,European
981481472,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981481477.0,European
981481472,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981481477.0,European
1184998375,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998377.0,European
827816247,PA166154337,rs1799978,,,DRD2,Dosage,1,methadone,827816253.0,East Asian
827816247,PA166154337,rs1799978,,,DRD2,Metabolism/PK,1,methadone,827816253.0,East Asian
1183704047,PA166154357,rs2254237,,,NAV2,Efficacy,-1,antidepressants,1183704062.0,"Multiple groups, 95% Caucasian"
1183704047,PA166154357,rs2254237,,,NAV2,Efficacy,-1,antidepressants,1183704049.0,"Multiple groups, 95% Caucasian"
981481478,PA166157851,rs179008,,,TLR7,Efficacy,-1,"interferon alfa-2a, recombinant",981481487.0,European
1183704054,PA166155608,rs889895,,,CREB1,Efficacy,-1,antidepressants,1183704058.0,"Multiple groups, 95% White"
981481554,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481559.0,East Asian
981481554,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981481559.0,East Asian
981481554,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981481559.0,East Asian
1184998369,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998371.0,European
981481560,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481563.0,East Asian
981481560,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981481563.0,East Asian
1444666874,PA166156320,rs1501299,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666876.0,East Asian
1445125617,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1445125683.0,Unknown
1445125617,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1445125622.0,Unknown
1448107552,PA166157267,rs776746,,,CYP3A5,Efficacy,1,rosuvastatin,1448107554.0,Unknown
1444699635,PA166155079,rs7196161,,,VKORC1,Dosage,-1,acenocoumarol,1444699640.0,Central/South Asian
1444699642,PA166155042,rs2884737,,,VKORC1,Dosage,-1,acenocoumarol,1444699644.0,Central/South Asian
1184654456,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1184654458.0,Unknown
1184654456,PA166155381,rs2108622,,,CYP4F2,Efficacy,-1,warfarin,1184654458.0,Unknown
827816731,PA166154591,rs4512905,,,SCN8A,Efficacy,-1,lithium,827816739.0,Unknown
981481567,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481572.0,East Asian
981481567,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981481572.0,East Asian
981481567,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981481572.0,East Asian
1184998539,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998545.0,Unknown
1184998539,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998545.0,Unknown
1184998539,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998545.0,Unknown
1183622207,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622209.0,East Asian
1183622207,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,mephenytoin,1183622209.0,East Asian
981481521,PA166156331,rs1801282,,,PPARG,Efficacy,1,rosiglitazone,981481533.0,East Asian
827816713,PA166156024,rs4680,,,COMT,Efficacy,1,fluvoxamine,827816737.0,Unknown
1448631815,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,clomipramine,,
1448631815,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,clomipramine,,
1448631815,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,desmethyl clomipramine,,
1448631815,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,desmethyl clomipramine,,
1444699652,PA166155040,rs2359612,,,VKORC1,Dosage,-1,acenocoumarol,1444699654.0,Central/South Asian
827816704,PA166154469,rs16909440,,,OR52E2,Efficacy,1,lithium,827816712.0,Unknown
1183622217,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622219.0,East Asian
1183622217,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1183622219.0,East Asian
1183622217,,,PA165980638,CYP2C19*5,CYP2C19,Metabolism/PK,0,mephenytoin,1183622219.0,East Asian
827816699,PA166154371,rs2499984,,,OR52J3,Efficacy,1,lithium,827816703.0,Unknown
981481534,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481539.0,"Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American)."
981481534,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981481539.0,"Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American)."
981481534,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981481539.0,"Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American)."
981481534,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981481539.0,"Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American)."
981481534,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981481539.0,"Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American)."
981481534,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981481539.0,"Multiple groups, North American (treated in Boston).  The 25 were a subset of the study cohort of 61(38 White,5 Hispanic,5 Asian,12 African American)."
1448631796,PA166156750,rs1050152,,,SLC22A4,Efficacy,-1,metformin,1448631798.0,European
1449645155,PA166156913,rs316019,,,SLC22A2,Efficacy,1,metformin,1449645161.0,Central/South Asian
1184998546,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,tacrolimus,1184998552.0,Unknown
1450415186,PA166182830,rs293983,,,ANO3,Efficacy,-1,belimumab,1450415193.0,Unknown
1184998561,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atazanavir,1184998564.0,"Multiple groups, Non-African-American"
1184998561,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atazanavir,1184998563.0,"Multiple groups, African-American and non-African-American"
1184998561,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atazanavir,1184998565.0,African American/Afro-Caribbean
1184998561,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atazanavir,1184998564.0,"Multiple groups, Non-African-American"
1184998561,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atazanavir,1184998563.0,"Multiple groups, African-American and non-African-American"
1184998561,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atazanavir,1184998565.0,African American/Afro-Caribbean
1184998561,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,atazanavir,1184998564.0,"Multiple groups, Non-African-American"
1184998561,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,atazanavir,1184998563.0,"Multiple groups, African-American and non-African-American"
1184998561,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,atazanavir,1184998565.0,African American/Afro-Caribbean
1184998561,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,atazanavir,1184998564.0,"Multiple groups, Non-African-American"
1184998561,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,atazanavir,1184998563.0,"Multiple groups, African-American and non-African-American"
1184998561,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,atazanavir,1184998565.0,African American/Afro-Caribbean
981481540,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481545.0,Unknown
981481540,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981481545.0,Unknown
981481540,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981481545.0,Unknown
1448631790,PA166165000,rs272893,,,SLC22A4,Efficacy,-1,metformin,1448631792.0,European
1183622300,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622302.0,East Asian
1183622300,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622302.0,East Asian
1183622300,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622302.0,East Asian
827816679,PA166156783,rs2107506,,,LECT2,Efficacy,-1,lithium,827816698.0,Unknown
1183491237,PA166156873,rs11960832,,,SV2C,Efficacy,-1,quetiapine,1183491239.0,European
1183622310,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622318.0,East Asian
1183622310,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183622318.0,East Asian
1448631778,PA166155251,rs12943590,,,SLC47A2,Efficacy,-1,metformin,1448631780.0,European
1448107497,PA166156544,rs2231142,,,ABCG2,Efficacy,1,rosuvastatin,1448107520.0,Unknown
1449645164,PA166155251,rs12943590,,,SLC47A2,Efficacy,1,metformin,1449645171.0,Central/South Asian
1449645164,PA166155251,rs12943590,,,SLC47A2,Efficacy,1,metformin,1449645166.0,Central/South Asian
1184654392,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184654394.0,Unknown
1184654392,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184654394.0,Unknown
1184654392,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,1184654394.0,Unknown
1184654392,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,warfarin,1184654394.0,Unknown
1448631772,PA166155204,rs2252281,,,SLC47A1,Efficacy,-1,metformin,1448631774.0,European
1448615387,PA166156679,rs34231037,,,KDR,Efficacy,-1,sunitinib,1448615389.0,Unknown
1183622290,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622292.0,East Asian
1183622290,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622292.0,East Asian
1183622290,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622292.0,East Asian
1448631766,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,metformin,1448631768.0,European
1184998473,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,simvastatin,1184998491.0,Unknown
1184654401,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184654403.0,Unknown
1184654401,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184654403.0,Unknown
1184654401,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,1184654403.0,Unknown
1184654401,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,warfarin,1184654403.0,Unknown
1444666816,PA166156347,rs2241766,,,ADIPOQ,Efficacy,1,pioglitazone,1444666854.0,East Asian
1448615381,PA166156679,rs34231037,,,KDR,Efficacy,1,sunitinib,1448615386.0,Unknown
1183491220,PA166156861,rs10214163,,,SV2C,Efficacy,-1,quetiapine,1183491222.0,European
1448631760,PA166156913,rs316019,,,SLC22A2,Efficacy,-1,metformin,1448631762.0,European
1183491224,PA166156785,rs2134227,,,SV2C,Efficacy,-1,quetiapine,1183491226.0,European
1448615370,PA166155187,rs1799752,,,ACE,Efficacy,-1,interferon beta-1a,1448615372.0,European
1448631754,PA166156932,rs622342,,,SLC22A1,Efficacy,-1,metformin,1448631756.0,European
1183491199,PA166156780,rs1995381,,,SV2C,Efficacy,-1,olanzapine,1183491201.0,European
1444699595,PA166155091,rs9923231,,,VKORC1,Dosage,1,acenocoumarol,1444699600.0,Central/South Asian
1450415269,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,acenocoumarol,1450415276.0,European
1450415269,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,acenocoumarol,1450415276.0,European
1183491203,PA166156793,rs2270927,,,SV2C,Efficacy,-1,olanzapine,1183491205.0,European
1448631748,PA166157216,rs72552763,,,SLC22A1,Efficacy,-1,metformin,1448631750.0,European
1448615363,PA166155187,rs1799752,,,ACE,Efficacy,1,interferon beta-1a,1448615369.0,European
1183491207,PA166156839,rs6874435,,,SV2C,Efficacy,-1,olanzapine,1183491209.0,European
1444699605,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1444699607.0,Central/South Asian
1444699610,PA166155805,rs11676382,,,GGCX,Dosage,1,acenocoumarol,1444699613.0,Central/South Asian
1183491211,PA166156784,rs2112865,,,SV2C,Efficacy,-1,olanzapine,1183491213.0,European
1448631741,PA166157178,rs12208357,,,SLC22A1,Efficacy,-1,metformin,1448631747.0,European
827816637,PA166156369,rs2811332,,,TMCC1,Efficacy,-1,lithium,827816644.0,Unknown
1448615355,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1448615361.0,East Asian
1448615355,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1448615556.0,East Asian
1448615355,PA166155598,rs699664,,,GGCX,Dosage,-1,warfarin,1448615558.0,East Asian
1445125604,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445125606.0,Unknown
1445125604,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445125606.0,Unknown
827816630,PA166155820,rs12693402,,,ZNF804A,Efficacy,-1,lithium,827816634.0,Unknown
1183491185,PA166156829,rs4580760,,,SV2C,Efficacy,-1,olanzapine,1183491194.0,European
1444699618,PA166154977,rs7294,,,VKORC1,Dosage,1,acenocoumarol,1444699620.0,Central/South Asian
1183622261,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183622289.0,East Asian
1183622261,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183622289.0,East Asian
1183491195,PA166156861,rs10214163,,,SV2C,Efficacy,-1,olanzapine,1183491197.0,European
827816621,PA166155249,rs11869731,,,ASIC2,Efficacy,1,lithium,827816629.0,Unknown
1448123818,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1448123841.0,Unknown
1448123818,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1448123841.0,Unknown
1448123818,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,voriconazole,1448123841.0,Unknown
1183491305,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,1,memantine,1183491309.0,"Multiple groups, 98% Caucasian and 2% Asian"
1183491305,PA166156323,rs1523130,,,NR1I2,Metabolism/PK,1,memantine,1183491309.0,"Multiple groups, 98% Caucasian and 2% Asian"
1450808537,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450808548.0,East Asian
1450808537,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450808548.0,East Asian
769246523,PA166154874,rs2069514,,,CYP1A2,Other,1,theophylline,769246526.0,East Asian
769246523,PA166154874,rs2069514,,,CYP1A2,Metabolism/PK,1,theophylline,769246526.0,East Asian
1183491287,PA166156879,rs12655684,,,SV2C,Efficacy,-1,ziprasidone,1183491289.0,European
1450415284,PA166155096,rs9934438,,,VKORC1,Dosage,-1,acenocoumarol,1450415289.0,European
1183622336,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622338.0,East Asian
1183622336,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183622338.0,East Asian
1183622336,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183622338.0,East Asian
1183491271,PA166156841,rs6882321,,,SV2C,Efficacy,-1,risperidone,1183491273.0,European
1448631680,PA166153600,rs928655,,,GBP6,Efficacy,1,etanercept,1448631688.0,Unknown
1183622346,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622381.0,European
1183622346,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1183622381.0,European
1183622346,,,PA165816522,CYP2C19*6,CYP2C19,Metabolism/PK,0,mephenytoin,1183622381.0,European
1183491245,PA166156849,rs7732173,,,SV2C,Efficacy,-1,risperidone,1183491247.0,European
1448598925,PA166162981,rs7512462,,,SLC26A9,Efficacy,1,ivacaftor,1448599823.0,European
1448598925,PA166162981,rs7512462,,,SLC26A9,Efficacy,1,ivacaftor,1448599825.0,European
1448123760,PA166159627,rs2535629,,,ITIH3,Efficacy,1,clozapine,1448123816.0,"Multiple groups, Caucasian (n=188); African-American (n=68)"
1183491249,PA166156865,rs10514062,,,SV2C,Efficacy,-1,risperidone,1183491251.0,European
1444699553,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444699588.0,Central/South Asian
1444699553,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444699590.0,Central/South Asian
1444699553,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444699588.0,Central/South Asian
1444699553,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444699590.0,Central/South Asian
1444699553,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444699588.0,Central/South Asian
1444699553,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444699590.0,Central/South Asian
1451250880,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250920.0,European
1451250880,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250888.0,European
1451250880,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250887.0,European
1451250880,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250900.0,European
1451250880,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250886.0,European
1451250880,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250901.0,European
1451250880,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250920.0,European
1451250880,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250888.0,European
1451250880,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250887.0,European
1451250880,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250900.0,European
1451250880,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250886.0,European
1451250880,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,-1,tacrolimus,1451250901.0,European
827783799,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,827783835.0,European
1184998684,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine,1184998705.0,Multiple groups
1184998684,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine,1184998703.0,Multiple groups
1184998684,PA166155225,rs4793665,,,ABCC3,Metabolism/PK,1,morphine,1184998707.0,Multiple groups
1183491254,PA166156800,rs2358531,,,SV2C,Efficacy,-1,risperidone,1183491256.0,European
1183491258,PA166156779,rs1995380,,,SV2C,Efficacy,-1,risperidone,1183491260.0,European
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622658.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622660.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622662.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622664.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622665.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622668.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622658.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622660.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622662.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622664.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622665.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622668.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622658.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622660.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622662.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622664.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622665.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622668.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622658.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622660.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622662.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622664.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622665.0,Unknown
1183622435,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622668.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622658.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622660.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622662.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622664.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622665.0,Unknown
1183622435,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622668.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622658.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622660.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622662.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622664.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622665.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622668.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622658.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622660.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622662.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622664.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622665.0,Unknown
1183622435,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622668.0,Unknown
769164773,PA166156618,rs7438284,,,UGT2B7,Efficacy,1,lorazepam,769164775.0,East Asian
769164773,PA166156618,rs7438284,,,UGT2B7,Efficacy,1,valproic acid,769164775.0,East Asian
769164773,PA166156618,rs7438284,,,UGT2B7,Efficacy,1,valproic acid,769164775.0,East Asian
769246583,PA166154874,rs2069514,,,CYP1A2,Other,1,caffeine,769246585.0,East Asian
769246583,PA166154874,rs2069514,,,CYP1A2,Metabolism/PK,1,caffeine,769246585.0,East Asian
1447681357,PA166156513,rs1449683,,,FGF2,Efficacy,1,fluvoxamine,1447681360.0,East Asian
1450415351,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450415368.0,"Multiple groups, USA ""90% Caucasian, 8.4% African American, 1.6% Other"""
1450415351,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450415364.0,"Multiple groups, USA ""90% Caucasian, 8.4% African American, 1.6% Other"""
1450415351,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450415368.0,"Multiple groups, USA ""90% Caucasian, 8.4% African American, 1.6% Other"""
1450415351,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450415364.0,"Multiple groups, USA ""90% Caucasian, 8.4% African American, 1.6% Other"""
1447959890,PA166154583,rs4149117,,,SLCO1B3,Efficacy,1,imatinib,1447959892.0,Unknown
1447959896,PA166154985,rs150929,,,ABCA3,Efficacy,1,imatinib,1447959904.0,Unknown
1448123726,PA166159625,rs4148776,,,ABCB11,Efficacy,1,glyburide,1448123728.0,Unknown
1183622426,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,famotidine,1183622432.0,Unknown
1450808617,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,pantoprazole,1450808634.0,East Asian
1450808617,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,pantoprazole,1450808634.0,East Asian
1450808617,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,pantoprazole,1450808634.0,East Asian
981481765,PA166155036,rs2242446,,,SLC6A2,Efficacy,-1,methylphenidate,981481773.0,East Asian
1447681340,PA166156708,rs6295,,,HTR1A,Efficacy,1,milnacipran,1447681346.0,East Asian
1183622397,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622425.0,Unknown
1183622397,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622401.0,Unknown
1183622397,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622400.0,Unknown
1183622397,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622399.0,Unknown
1183622397,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622421.0,Unknown
1183622397,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622423.0,Unknown
1183622397,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622425.0,Unknown
1183622397,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622401.0,Unknown
1183622397,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622400.0,Unknown
1183622397,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622399.0,Unknown
1183622397,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622421.0,Unknown
1183622397,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622423.0,Unknown
1183622397,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622425.0,Unknown
1183622397,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622401.0,Unknown
1183622397,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622400.0,Unknown
1183622397,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622399.0,Unknown
1183622397,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622421.0,Unknown
1183622397,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622423.0,Unknown
1183491329,PA166155187,rs1799752,,,ACE,Efficacy,1,captopril,1183491331.0,Near Eastern
747980551,PA166154982,rs35592,,,ABCC1,Efficacy,1,methotrexate,747989553.0,Unknown
1450808566,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1450808579.0,Unknown
1450808566,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1450808579.0,Unknown
1450808566,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1450808579.0,Unknown
1447681351,PA166153974,rs1800544,,,ADRA2A,Efficacy,1,milnacipran,1447681353.0,East Asian
1448123709,PA166159622,rs1054097,,,CHST13,Efficacy,1,glyburide,1448123711.0,Unknown
1447959879,PA166154602,rs7311358,,,SLCO1B3,Efficacy,1,imatinib,1447959885.0,Unknown
1183622382,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622419.0,Unknown
1183622382,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622396.0,Unknown
1183622382,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622394.0,Unknown
1183622382,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622392.0,Unknown
1183622382,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622415.0,Unknown
1183622382,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622417.0,Unknown
1183622382,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622419.0,Unknown
1183622382,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622396.0,Unknown
1183622382,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622394.0,Unknown
1183622382,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622392.0,Unknown
1183622382,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622415.0,Unknown
1183622382,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622417.0,Unknown
1183622382,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622419.0,Unknown
1183622382,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622396.0,Unknown
1183622382,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622394.0,Unknown
1183622382,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622392.0,Unknown
1183622382,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622415.0,Unknown
1183622382,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622417.0,Unknown
1449170208,PA166155342,rs11615,,,ERCC1,Efficacy,-1,granisetron,1449170217.0,East Asian
1449170208,PA166155342,rs11615,,,ERCC1,Efficacy,-1,granisetron,1449170215.0,East Asian
1449170208,PA166155342,rs11615,,,ERCC1,Efficacy,-1,palonosetron,1449170217.0,East Asian
1449170208,PA166155342,rs11615,,,ERCC1,Efficacy,-1,palonosetron,1449170215.0,East Asian
1448123697,PA166159620,rs1803545,,,MAPK1,Efficacy,1,glyburide,1448123699.0,Unknown
1183491316,PA166155187,rs1799752,,,ACE,Efficacy,1,losartan,1183491328.0,Near Eastern
1444699493,PA166156024,rs4680,,,COMT,Efficacy,1,clozapine,1444699501.0,Unknown
1444699493,PA166156024,rs4680,,,COMT,Efficacy,1,clozapine,1444699501.0,Unknown
1448123702,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,voriconazole,1448123729.0,Unknown
1448123702,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1448123729.0,Unknown
1448123702,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,voriconazole,1448123729.0,Unknown
1449170220,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,granisetron,1449170223.0,East Asian
1449170220,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,granisetron,1449170222.0,East Asian
1449170220,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,palonosetron,1449170223.0,East Asian
1449170220,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,palonosetron,1449170222.0,East Asian
981479756,PA166156132,rs9306356,,,None,Metabolism/PK,-1,olanzapine,981479761.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479756,PA166156132,rs9306356,,,None,Metabolism/PK,-1,olanzapine,981479761.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1183491430,PA166155442,rs8192709,,,CYP2B6,Metabolism/PK,-1,efavirenz,1183491432.0,East Asian
1183491421,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491423.0,East Asian
1183491421,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491423.0,East Asian
1183491434,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491436.0,East Asian
1183491434,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491436.0,East Asian
1449170236,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,granisetron,1449170238.0,East Asian
1449170236,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,granisetron,1449170239.0,East Asian
1449170236,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,palonosetron,1449170238.0,East Asian
1449170236,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,palonosetron,1449170239.0,East Asian
1449170228,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,granisetron,1449170231.0,East Asian
1449170228,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,granisetron,1449170230.0,East Asian
1449170228,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,palonosetron,1449170231.0,East Asian
1449170228,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,palonosetron,1449170230.0,East Asian
1183491412,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491416.0,East Asian
981479783,PA166153601,rs929087,,,None,Metabolism/PK,-1,olanzapine,981479788.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1449170244,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,granisetron,1449170246.0,East Asian
1449170244,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,granisetron,1449170247.0,East Asian
1449170244,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,palonosetron,1449170246.0,East Asian
1449170244,PA166156543,rs2231137,,,ABCG2,Efficacy,-1,palonosetron,1449170247.0,East Asian
981479730,PA166154877,rs2069526,,,CYP1A2,Metabolism/PK,-1,olanzapine,981479735.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479724,PA166154876,rs2069522,,,CYP1A2,Metabolism/PK,-1,olanzapine,981479728.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1183491417,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491419.0,East Asian
1183622464,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,-1,escitalopram,1183622466.0,East Asian
1449170252,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,granisetron,1449170255.0,East Asian
1449170252,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,granisetron,1449170254.0,East Asian
1449170252,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,palonosetron,1449170255.0,East Asian
1449170252,PA166156544,rs2231142,,,ABCG2,Efficacy,-1,palonosetron,1449170254.0,East Asian
1449170266,PA166177542,rs45460698,,,HTR3B,Efficacy,-1,granisetron,1449170269.0,East Asian
1449170266,PA166177542,rs45460698,,,HTR3B,Efficacy,-1,granisetron,1449170268.0,East Asian
1449170266,PA166177542,rs45460698,,,HTR3B,Efficacy,-1,palonosetron,1449170269.0,East Asian
1449170266,PA166177542,rs45460698,,,HTR3B,Efficacy,-1,palonosetron,1449170268.0,East Asian
981479737,PA166154909,rs4646425,,,CYP1A2,Metabolism/PK,-1,olanzapine,981479742.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1447959818,PA166156324,rs1533682,,,ABCC5,Metabolism/PK,1,doxorubicin,1447959824.0,"Multiple groups, Singapore (Chinese, Malay, Indian)"
1448123633,PA166159615,rs3729910,,,MAPK1,Efficacy,1,glyburide,1448123635.0,Unknown
1448123633,PA166159615,rs3729910,,,MAPK1,Efficacy,1,glyburide,1448123635.0,Unknown
1183622452,PA166154877,rs2069526,,,CYP1A2,Metabolism/PK,1,escitalopram,1183622454.0,East Asian
1183622452,PA166154877,rs2069526,,,CYP1A2,Metabolism/PK,1,escitalopram,1183622454.0,East Asian
1183622456,PA166154909,rs4646425,,,CYP1A2,Metabolism/PK,1,escitalopram,1183622458.0,East Asian
1444699432,PA166157805,rs10465180,,,NTRK2,Efficacy,1,clozapine,1444699438.0,European
1448123619,PA166155370,rs1799782,,,XRCC1,Efficacy,1,Platinum compounds,1448123622.0,Multiple groups
1449170281,PA166177545,rs6766410,,,HTR3C,Efficacy,-1,granisetron,1449170283.0,East Asian
1449170281,PA166177545,rs6766410,,,HTR3C,Efficacy,-1,granisetron,1449170284.0,East Asian
1449170281,PA166177545,rs6766410,,,HTR3C,Efficacy,-1,palonosetron,1449170283.0,East Asian
1449170281,PA166177545,rs6766410,,,HTR3C,Efficacy,-1,palonosetron,1449170284.0,East Asian
981479826,PA166157259,rs651430,,,CYP3A,Metabolism/PK,-1,olanzapine,981479838.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479826,PA166157259,rs651430,,,CYP3A43,Metabolism/PK,-1,olanzapine,981479838.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1184998709,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,morphine,1184998711.0,Multiple groups
1184998709,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,morphine,1184998712.0,Multiple groups
1184998709,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,morphine,1184998713.0,Multiple groups
982036882,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,carvedilol,982036896.0,East Asian
1183491496,PA166153724,rs2932538,,,MOV10,Efficacy,-1,atenolol,1183491498.0,European
1183491496,PA166153724,rs2932538,,,MOV10,Efficacy,-1,atenolol,1183491499.0,European
978614496,PA166155598,rs699664,,,GGCX,Dosage,0,warfarin,978614505.0,Central/South Asian
978614496,PA166155598,rs699664,,,GGCX,Dosage,0,warfarin,978614507.0,Central/South Asian
978614496,PA166155598,rs699664,,,GGCX,Metabolism/PK,0,warfarin,978614505.0,Central/South Asian
978614496,PA166155598,rs699664,,,GGCX,Metabolism/PK,0,warfarin,978614507.0,Central/South Asian
1449170293,PA166177547,rs6807362,,,HTR3C,Efficacy,-1,granisetron,1449170296.0,East Asian
1449170293,PA166177547,rs6807362,,,HTR3C,Efficacy,-1,granisetron,1449170295.0,East Asian
1449170293,PA166177547,rs6807362,,,HTR3C,Efficacy,-1,palonosetron,1449170296.0,East Asian
1449170293,PA166177547,rs6807362,,,HTR3C,Efficacy,-1,palonosetron,1449170295.0,East Asian
1183491471,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,-1,efavirenz,1183491473.0,East Asian
1184998726,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,raltegravir,1184998733.0,"Multiple groups, Asian, Caucasian, Africa-American"
981479840,PA166157455,rs12535293,,,CYP3A,Metabolism/PK,-1,olanzapine,981479849.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479840,PA166157455,rs12535293,,,CYP3A43,Metabolism/PK,-1,olanzapine,981479849.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
982036901,PA166153972,rs1799853,,,CYP2C9,Dosage,0,warfarin,982036908.0,Multiple groups
1183491475,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1183491481.0,East Asian
981479851,PA166157257,rs472660,,,CYP3A43,Metabolism/PK,-1,olanzapine,981479860.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
769164370,PA166157824,rs10975641,,,GLDC,Efficacy,1,citalopram,769164379.0,European
769164370,PA166157824,rs10975641,,,GLDC,Efficacy,1,citalopram,769164377.0,"Multiple groups, 293 African American,1245 White Non-Hispanic, 241 White Hispanic."
769164370,PA166157824,rs10975641,,,GLDC,Efficacy,1,citalopram,769164375.0,Unknown
769164370,PA166157824,rs10975641,,,GLDC,Efficacy,1,escitalopram,769164379.0,European
769164370,PA166157824,rs10975641,,,GLDC,Efficacy,1,escitalopram,769164377.0,"Multiple groups, 293 African American,1245 White Non-Hispanic, 241 White Hispanic."
769164370,PA166157824,rs10975641,,,GLDC,Efficacy,1,escitalopram,769164375.0,Unknown
1183491483,PA166156514,rs1458038,,,FGF5,Efficacy,-1,atenolol,1183491493.0,European
1183491483,PA166156514,rs1458038,,,FGF5,Efficacy,-1,atenolol,1183491487.0,European
1183491483,PA166156514,rs1458038,,,FGF5,Efficacy,-1,atenolol,1183491493.0,European
1183491483,PA166156514,rs1458038,,,FGF5,Efficacy,-1,atenolol,1183491487.0,European
1151429461,PA166156276,rs5186,,,AGTR1,Efficacy,1,losartan,1151848668.0,European
1449170308,PA166177550,rs6443930,,,HTR3D,Efficacy,-1,granisetron,1449170310.0,East Asian
1449170308,PA166177550,rs6443930,,,HTR3D,Efficacy,-1,granisetron,1449170311.0,East Asian
1449170308,PA166177550,rs6443930,,,HTR3D,Efficacy,-1,palonosetron,1449170310.0,East Asian
1449170308,PA166177550,rs6443930,,,HTR3D,Efficacy,-1,palonosetron,1449170311.0,East Asian
981479790,PA166153800,rs10458360,,,None,Metabolism/PK,-1,olanzapine,981479795.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479790,PA166153800,rs10458360,,,None,Metabolism/PK,-1,olanzapine,981479795.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
978614465,PA166155381,rs2108622,,,CYP4F2,Dosage,0,warfarin,978614513.0,Central/South Asian
978614465,PA166155381,rs2108622,,,CYP4F2,Dosage,0,warfarin,978614515.0,Central/South Asian
978614465,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,0,warfarin,978614513.0,Central/South Asian
978614465,PA166155381,rs2108622,,,CYP4F2,Metabolism/PK,0,warfarin,978614515.0,Central/South Asian
1183491467,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1183491469.0,East Asian
1450415520,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,thalidomide,1450415532.0,Unknown
1450415520,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,thalidomide,1450415532.0,Unknown
1449170319,PA166177552,rs2111375,,,TACR1,Efficacy,-1,granisetron,1449170321.0,East Asian
1449170319,PA166177552,rs2111375,,,TACR1,Efficacy,-1,granisetron,1449170322.0,East Asian
1449170319,PA166177552,rs2111375,,,TACR1,Efficacy,-1,palonosetron,1449170321.0,East Asian
1449170319,PA166177552,rs2111375,,,TACR1,Efficacy,-1,palonosetron,1449170322.0,East Asian
1448123581,PA166159609,rs5224,,,BDKRB2,Efficacy,1,glyburide,1448123583.0,Unknown
982036874,PA166153959,rs1057910,,,CYP2C9,Dosage,0,warfarin,982036894.0,Multiple groups
1448107184,PA166155855,rs17868320,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1448107189.0,Unknown
981479807,PA166157360,rs2525557,,,None,Metabolism/PK,-1,olanzapine,981479810.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479807,PA166157360,rs2525557,,,None,Metabolism/PK,-1,olanzapine,981479810.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1446534354,PA166154105,rs9332238,,,CYP2C9,Dosage,1,warfarin,1446534356.0,"Multiple groups, Brazilian"
978614455,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,978614509.0,Central/South Asian
978614455,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,978614511.0,Central/South Asian
978614455,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,0,warfarin,978614509.0,Central/South Asian
978614455,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,0,warfarin,978614511.0,Central/South Asian
1448107192,PA166155777,rs10187694,,,UGT1A10,Metabolism/PK,-1,mycophenolic acid,1448107200.0,Unknown
1448107192,PA166155777,rs10187694,,,UGT1A10,Metabolism/PK,-1,mycophenolic acid,1448107200.0,Unknown
1449170340,PA166155407,rs3212986,,,ERCC1,Efficacy,1,granisetron,1449170353.0,East Asian
1449170340,PA166155407,rs3212986,,,ERCC1,Efficacy,1,granisetron,1449170342.0,East Asian
1449170340,PA166155407,rs3212986,,,ERCC1,Efficacy,1,granisetron,1449170343.0,East Asian
1449170340,PA166155407,rs3212986,,,ERCC1,Efficacy,1,palonosetron,1449170353.0,East Asian
1449170340,PA166155407,rs3212986,,,ERCC1,Efficacy,1,palonosetron,1449170342.0,East Asian
1449170340,PA166155407,rs3212986,,,ERCC1,Efficacy,1,palonosetron,1449170343.0,East Asian
1448123553,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1448123589.0,Multiple groups
1448123553,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1448123567.0,East Asian
978614436,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,978614521.0,Central/South Asian
978614436,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,978614523.0,Central/South Asian
978614436,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,warfarin,978614521.0,Central/South Asian
978614436,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,warfarin,978614523.0,Central/South Asian
982036951,PA166154176,rs28371686,,,CYP2C9,Dosage,0,warfarin,982036956.0,Multiple groups
981479884,PA166157365,rs2572023,,,CYP3A,Metabolism/PK,-1,olanzapine,981479890.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1448107164,PA166155748,rs6714486,,,UGT1A9,Metabolism/PK,-1,mycophenolic acid,1448107178.0,Unknown
1450939860,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1450939880.0,East Asian
1450939860,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1450939880.0,East Asian
1450939860,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1450939880.0,East Asian
1183491533,PA166153845,rs12069113,,,MOV10,Efficacy,-1,atenolol,1183491535.0,African American/Afro-Caribbean
978614420,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,0,warfarin,978614424.0,Central/South Asian
978614420,,,PA165816549,CYP2C9*8,CYP2C9,Dosage,0,warfarin,978614426.0,Central/South Asian
978614420,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,0,warfarin,978614424.0,Central/South Asian
978614420,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,0,warfarin,978614426.0,Central/South Asian
1183491537,PA166153846,rs12076902,,,CAPZA1,Efficacy,-1,atenolol,1183491539.0,African American/Afro-Caribbean
982036966,PA166154176,rs28371686,,,CYP2C9,Dosage,0,warfarin,982036971.0,Multiple groups
982036966,PA166154176,rs28371686,,,CYP2C9,Dosage,0,warfarin,982036971.0,Multiple groups
982036958,PA166154184,rs56165452,,,CYP2C9,Dosage,0,warfarin,982036964.0,Multiple groups
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491569.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491571.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491563.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491559.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491575.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491561.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491567.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491573.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,bevacizumab,1183491565.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491569.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491571.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491563.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491559.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491575.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491561.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491567.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491573.0,Unknown
1183491546,PA166153617,rs1061170,,,CFH,Efficacy,-1,ranibizumab,1183491565.0,Unknown
1450808749,PA166154339,rs1800497,,,DRD2,Efficacy,-1,venlafaxine,1450808754.0,"Multiple groups, White, black, Hispanic and other ethnicities"
1183491516,PA166156828,rs4551053,,,EBF1,Efficacy,-1,hydrochlorothiazide,1183491518.0,European
1183491516,PA166156828,rs4551053,,,EBF1,Efficacy,-1,hydrochlorothiazide,1183491519.0,European
1183491516,PA166156828,rs4551053,,,EBF1,Efficacy,-1,hydrochlorothiazide,1183491518.0,European
1183491516,PA166156828,rs4551053,,,EBF1,Efficacy,-1,hydrochlorothiazide,1183491519.0,European
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959680.0,Unknown
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959678.0,European
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959679.0,"Multiple groups, Majority Caucasian"
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959681.0,European
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959680.0,Unknown
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959678.0,European
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959679.0,"Multiple groups, Majority Caucasian"
1447959676,PA166157750,rs2291858,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959681.0,European
1449170380,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449170392.0,Unknown
1449170380,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449170392.0,Unknown
982036914,PA166154679,rs510317,,,F7,Dosage,1,warfarin,982036920.0,Multiple groups
982036911,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,carvedilol,982036913.0,East Asian
982036911,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,carvedilol,982036913.0,East Asian
982036911,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,carvedilol,982036913.0,East Asian
981479862,PA166157473,rs17161981,,,CYP3A,Metabolism/PK,-1,olanzapine,981479871.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479862,PA166157473,rs17161981,,,CYP3A43,Metabolism/PK,-1,olanzapine,981479871.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1183491528,PA166154560,rs3184504,,,SH2B3,Efficacy,-1,hydrochlorothiazide,1183491532.0,African American/Afro-Caribbean
1183491501,PA166156989,rs1799945,,,HFE,Efficacy,-1,atenolol,1183491504.0,European
1183491501,PA166156989,rs1799945,,,HFE,Efficacy,-1,atenolol,1183491503.0,European
981479873,PA166157474,rs17161983,,,CYP3A,Metabolism/PK,-1,olanzapine,981479882.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
981479873,PA166157474,rs17161983,,,CYP3A43,Metabolism/PK,-1,olanzapine,981479882.0,"Multiple groups, subset of CATIE-SZ.  multiple U.S. sites. 161 White, 74  African American."
1448123507,PA166159602,rs7793861,,,CYP51A1,Efficacy,1,glyburide,1448123509.0,Unknown
1448123507,PA166159602,rs7793861,,,CYP51A1,Efficacy,1,glyburide,1448123509.0,Unknown
1448123507,PA166159602,rs7793861,,,CYP51A1,Efficacy,1,glyburide,1448123509.0,Unknown
1183491506,PA166156514,rs1458038,,,FGF5,Efficacy,-1,hydrochlorothiazide,1183491509.0,European
1183491506,PA166156514,rs1458038,,,FGF5,Efficacy,-1,hydrochlorothiazide,1183491508.0,European
1183491511,PA166154560,rs3184504,,,SH2B3,Efficacy,-1,hydrochlorothiazide,1183491513.0,European
1183491511,PA166154560,rs3184504,,,SH2B3,Efficacy,-1,hydrochlorothiazide,1183491514.0,European
982036934,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,982036942.0,Multiple groups
982036934,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,982036942.0,Multiple groups
1449170406,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1449170412.0,Unknown
982036924,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,carvedilol,982036926.0,East Asian
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1a,1447959653.0,Unknown
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1a,1447959651.0,European
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1a,1447959652.0,"Multiple groups, Majority Caucasian"
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1a,1447959654.0,European
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1b,1447959653.0,Unknown
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1b,1447959651.0,European
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1b,1447959652.0,"Multiple groups, Majority Caucasian"
1447959649,PA166153801,rs10494227,,,ZNF697,Efficacy,1,interferon beta-1b,1447959654.0,European
1447681119,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681123.0,Unknown
1447681119,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681136.0,Unknown
1447681119,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681121.0,Unknown
1447681119,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681138.0,Unknown
1447681119,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681134.0,Unknown
1447681119,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681122.0,Unknown
1447681119,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681123.0,Unknown
1447681119,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681136.0,Unknown
1447681119,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681121.0,Unknown
1447681119,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681138.0,Unknown
1447681119,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681134.0,Unknown
1447681119,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681122.0,Unknown
1448123498,PA166156583,rs4148269,,,UGT2B15,Efficacy,1,glyburide,1448123500.0,Unknown
1451152920,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,dihydrocodeine,1451152940.0,
1451152920,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dihydrocodeine,1451152940.0,
1451152920,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dihydrocodeine,1451152940.0,
1451152920,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dihydrocodeine,1451152940.0,
982037006,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037014.0,East Asian
982037006,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037018.0,East Asian
982037006,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037016.0,East Asian
982037006,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037021.0,East Asian
1448123493,PA166159599,rs7515157,,,FMO2,Efficacy,1,glyburide,1448123495.0,Unknown
1451120160,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1451120180.0,Unknown
1451120160,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1451120180.0,Unknown
1451120160,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1451120180.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622671.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622672.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622673.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622674.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622675.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,famotidine,1183622676.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622671.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622672.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622673.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622674.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622675.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,famotidine,1183622676.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622671.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622672.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622673.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622674.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622675.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,famotidine,1183622676.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622671.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622672.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622673.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622674.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622675.0,Unknown
1183622669,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183622676.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622671.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622672.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622673.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622674.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622675.0,Unknown
1183622669,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183622676.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622671.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622672.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622673.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622674.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622675.0,Unknown
1183622669,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183622676.0,Unknown
1448615000,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,anastrozole,1448615002.0,European
1450989080,PA166157316,rs2032582,,,ABCB1,Toxicity,1,erlotinib,1450989045.0,East Asian
1450989080,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,erlotinib,1450989045.0,East Asian
1449170428,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449170440.0,African American/Afro-Caribbean
1449170428,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449170440.0,African American/Afro-Caribbean
1449170428,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,tacrolimus,1449170440.0,African American/Afro-Caribbean
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959644.0,Unknown
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959642.0,European
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959643.0,"Multiple groups, Majority Caucasian"
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959645.0,European
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959644.0,Unknown
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959642.0,European
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959643.0,"Multiple groups, Majority Caucasian"
1447959640,PA166157811,rs10760397,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959645.0,European
1448614994,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,anastrozole,1448614996.0,European
1448614994,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,anastrozole,1448614996.0,European
981479921,PA166154673,rs6311,,,HTR2A,Efficacy,-1,Selective serotonin reuptake inhibitors,981479927.0,European
1450989040,PA166157288,rs1128503,,,ABCB1,Toxicity,1,erlotinib,1450989060.0,East Asian
1450989040,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,erlotinib,1450989060.0,East Asian
981479928,PA166154726,rs7997012,,,HTR2A,Efficacy,-1,Selective serotonin reuptake inhibitors,981479934.0,European
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491600.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491601.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491598.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491603.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491599.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491595.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491596.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491602.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,bevacizumab,1183491597.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491600.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491601.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491598.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491603.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491599.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491595.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491596.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491602.0,Unknown
1183491593,PA166154135,rs11200638,,,HTRA1,Efficacy,-1,ranibizumab,1183491597.0,Unknown
982036973,PA166154175,rs28371685,,,CYP2C9,Dosage,0,warfarin,982036979.0,Multiple groups
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1a,1447959615.0,Unknown
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1a,1447959611.0,European
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1a,1447959613.0,"Multiple groups, Majority Caucasian"
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1a,1447959624.0,European
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1b,1447959615.0,Unknown
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1b,1447959611.0,European
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1b,1447959613.0,"Multiple groups, Majority Caucasian"
1447959603,PA166156293,rs760316,,,FHIT,Efficacy,1,interferon beta-1b,1447959624.0,European
1447681077,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681118.0,Unknown
1447681077,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681080.0,Unknown
1447681077,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681079.0,Unknown
1447681077,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447681118.0,Unknown
1447681077,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447681080.0,Unknown
1447681077,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447681079.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491584.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491585.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491583.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491582.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491579.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491580.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491587.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491586.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1183491581.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491584.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491585.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491583.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491582.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491579.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491580.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491587.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491586.0,Unknown
1183491577,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,ranibizumab,1183491581.0,Unknown
1444666354,PA166154270,rs187238,,,IL18,Metabolism/PK,-1,tacrolimus,1444666365.0,East Asian
1183491684,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1183491686.0,European
1448107049,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1448107055.0,Multiple groups
1448107049,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1448107055.0,Multiple groups
1448107049,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1448107055.0,Multiple groups
1448107049,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1448107055.0,Multiple groups
1448107049,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1448107055.0,Multiple groups
1448107049,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1448107055.0,Multiple groups
1450989140,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,crizotinib,1450989144.0,East Asian
1183491688,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1183491690.0,European
1450972760,PA166155341,rs7412,,,APOE,Efficacy,1,fluvastatin,1450972766.0,Unknown
1450972760,PA166155341,rs7412,,,APOE,Efficacy,1,fluvastatin,1450972780.0,Unknown
1450972760,PA166155341,rs7412,,,APOE,Efficacy,1,fluvastatin,1450972781.0,Unknown
1450972760,PA166155341,rs7412,,,APOE,Efficacy,1,fluvastatin,1450972782.0,Unknown
1448107024,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1448107031.0,European
1448107024,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1448107031.0,European
1448107024,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1448107031.0,European
1448107024,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1448107031.0,European
1448107024,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1448107031.0,European
1448107024,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1448107031.0,European
1183491664,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,1183491668.0,European
1444666368,PA166154344,rs1946518,,,IL18,Metabolism/PK,1,tacrolimus,1444666399.0,East Asian
1444666368,PA166154344,rs1946518,,,IL18,Metabolism/PK,1,tacrolimus,1444666409.0,East Asian
1183491673,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,1183491675.0,European
1183491669,PA166157288,rs1128503,,,ABCB1,Dosage,-1,tacrolimus,1183491671.0,European
1183704662,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1185235662.0,Central/South Asian
1183704662,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183704686.0,Central/South Asian
1183704662,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1185235662.0,Central/South Asian
1183704662,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183704686.0,Central/South Asian
1183704662,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1185235662.0,Central/South Asian
1183704662,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183704686.0,Central/South Asian
1450989160,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,crizotinib,1450989180.0,East Asian
1447681020,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681022.0,Unknown
1447681020,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681023.0,Unknown
1447681020,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681022.0,Unknown
1447681020,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447681023.0,Unknown
1183622726,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183622764.0,East Asian
1183622726,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183622728.0,East Asian
1183622726,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183622762.0,East Asian
1183622726,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183622764.0,East Asian
1183622726,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183622728.0,East Asian
1183622726,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183622762.0,East Asian
1183622726,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183622764.0,East Asian
1183622726,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183622728.0,East Asian
1183622726,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,lansoprazole,1183622762.0,East Asian
1448123412,PA166159597,rs7512785,,,FMO2,Efficacy,1,glyburide,1448123482.0,Unknown
1183491645,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183491647.0,European
1183491645,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183491648.0,European
981479989,PA166156445,rs11716445,,,RHOA,Efficacy,1,pravastatin,981479995.0,"Multiple groups, CAP: White; PRINCE: African American and Caucasian"
981479989,PA166156445,rs11716445,,,RHOA,Efficacy,1,simvastatin,981479995.0,"Multiple groups, CAP: White; PRINCE: African American and Caucasian"
982037057,PA166156447,rs12487736,,,SCAP,Efficacy,-1,fluvastatin,982037064.0,Multiple groups
1183491630,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183491644.0,European
1183491630,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1183491642.0,European
1183622712,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183622757.0,East Asian
1183622712,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183622722.0,East Asian
1183622712,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183622755.0,East Asian
1183622712,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183622757.0,East Asian
1183622712,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183622722.0,East Asian
1183622712,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183622755.0,East Asian
1183622712,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183622757.0,East Asian
1183622712,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183622722.0,East Asian
1183622712,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183622755.0,East Asian
1183622820,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183622822.0,East Asian
1183622820,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183622822.0,East Asian
1183622820,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183622822.0,East Asian
1450186374,,,PA165819255,SLCO1B1*5,SLCO1B1,Metabolism/PK,1,paclitaxel,1450186376.0,"Multiple groups, ""93.2% Caucasian"""
1450186374,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,paclitaxel,1450186376.0,"Multiple groups, ""93.2% Caucasian"""
1183491726,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,talinolol,1183491732.0,East Asian
1183491726,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,talinolol,1183491734.0,East Asian
1183491726,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,talinolol,1183491730.0,East Asian
1183491726,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,talinolol,1183491740.0,East Asian
1183491726,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,talinolol,1183491738.0,East Asian
1183491726,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,talinolol,1183491736.0,East Asian
613977249,PA166155040,rs2359612,,,PRSS53,Dosage,1,warfarin,613977253.0,Multiple groups
613977249,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,613977253.0,Multiple groups
1450186361,,,PA165958686,CYP2C8*4,CYP2C8,Metabolism/PK,-1,paclitaxel,1450186363.0,"Multiple groups, ""93.2% Caucasian"""
1183622809,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183622819.0,East Asian
1183622809,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183622819.0,East Asian
1183622809,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183622819.0,East Asian
1183622781,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,imipramine,1183622783.0,East Asian
1183622781,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,imipramine,1183622783.0,East Asian
1183622781,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,imipramine,1183622783.0,East Asian
1183704700,PA166155805,rs11676382,,,GGCX,Dosage,1,warfarin,1185235658.0,Central/South Asian
1183704700,PA166155805,rs11676382,,,GGCX,Dosage,1,warfarin,1183704704.0,Central/South Asian
1447959492,PA166156748,rs1042713,,,ADRB2,Efficacy,1,propranolol,1447959494.0,Unknown
1448663995,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448664887.0,Sub-Saharan African
1448663995,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448664887.0,Sub-Saharan African
1183704687,PA166155042,rs2884737,,,VKORC1,Dosage,1,warfarin,1183704694.0,Central/South Asian
1183622774,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183622799.0,East Asian
1183622774,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,haloperidol,1183622799.0,East Asian
1450415756,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atazanavir / ritonavir,1450415759.0,Unknown
1450415756,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,atazanavir / ritonavir,1450415758.0,Unknown
1444666225,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1444666227.0,European
1444666225,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1444666227.0,European
1183622885,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183622895.0,East Asian
1183622885,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183622919.0,East Asian
1183622885,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183622895.0,East Asian
1183622885,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183622919.0,East Asian
1183622885,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183622895.0,East Asian
1183622885,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183622919.0,East Asian
613977311,PA166155183,rs1136201,,,ERBB2,Toxicity,1,trastuzumab,613977314.0,European
982037196,PA166153545,rs4762,,,AGT,Efficacy,1,benazepril,982037206.0,East Asian
982037196,PA166153545,rs4762,,,AGT,Efficacy,1,benazepril,982037204.0,East Asian
982037196,PA166153545,rs4762,,,AGT,Efficacy,1,benazepril,982037208.0,East Asian
1444666244,PA166155351,rs429358,,,APOE,Dosage,1,warfarin,1444666246.0,European
1444666251,PA166157284,rs1045642,,,ABCB1,Dosage,1,warfarin,1444666253.0,European
1450186421,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1450186460.0,European
1450186421,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1450186462.0,"Multiple groups, Asian"
1450186421,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1450186464.0,African American/Afro-Caribbean
1450186421,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1450186460.0,European
1450186421,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1450186462.0,"Multiple groups, Asian"
1450186421,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1450186464.0,African American/Afro-Caribbean
1444666236,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1444666238.0,European
1448106881,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,1,tacrolimus,1448106890.0,European
1448614780,PA166154639,rs11568563,,,SLCO1A2,Metabolism/PK,-1,rocuronium,1448614782.0,Unknown
1449563874,PA166155206,rs2289669,,,SLC47A1,Efficacy,1,metformin,1449563880.0,European
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037504.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037461.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037293.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037500.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037457.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037502.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037459.0,Unknown
982037275,PA166154293,rs662799,,,APOA5,Efficacy,-1,fenofibrate,982037291.0,Unknown
1448614761,PA166154564,rs3764043,,,SLCO1A2,Metabolism/PK,-1,rocuronium,1448614763.0,Unknown
1447680865,PA166156305,rs1054190,,,NR1I2,Metabolism/PK,-1,efavirenz,1447680867.0,Sub-Saharan African
1448614791,PA166163603,rs750165758,,,SLCO1A2,Metabolism/PK,-1,rocuronium,1448614793.0,Unknown
1448614755,PA166154572,rs4148978,,,SLCO1A2,Metabolism/PK,-1,rocuronium,1448614760.0,Unknown
1183704872,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1183704882.0,Central/South Asian
1183704872,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1185235652.0,Central/South Asian
1447680871,PA166156306,rs1054191,,,NR1I2,Metabolism/PK,-1,efavirenz,1447680873.0,Sub-Saharan African
1183491878,PA166154380,rs2587550,,,ANKK1,Efficacy,-1,haloperidol,1183491882.0,European
1183622953,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183622955.0,Unknown
1183622953,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183622955.0,Unknown
1183622953,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183622955.0,Unknown
1183491853,PA166156276,rs5186,,,AGTR1,Efficacy,1,angiotensin II,1183491855.0,European
613977365,PA166156277,rs6280,,,DRD3,Efficacy,1,pramipexole,613977367.0,East Asian
1183622935,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,rabeprazole,1183622945.0,Unknown
1183622935,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,rabeprazole,1183622945.0,Unknown
1183622935,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,rabeprazole,1183622945.0,Unknown
1183704846,PA166155079,rs7196161,,,VKORC1,Dosage,1,warfarin,1183704850.0,Central/South Asian
1183491839,PA166155187,rs1799752,,,ACE,Efficacy,-1,angiotensin II,1183491850.0,European
1183491842,PA166155187,rs1799752,,,ACE,Efficacy,-1,angiotensin II,1183491852.0,European
1183491842,PA166155187,rs1799752,,,ACE,Efficacy,-1,losartan,1183491852.0,European
1183704839,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1183704843.0,Central/South Asian
1183704839,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1185235660.0,Central/South Asian
982037228,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,digoxin,982037238.0,Unknown
1183704858,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1185235648.0,Central/South Asian
1183704858,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1183704862.0,Central/South Asian
982037259,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037274.0,Unknown
982037259,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037451.0,Unknown
982037259,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037272.0,Unknown
1447680819,PA166155360,rs1042389,,,CYP2B6,Metabolism/PK,-1,efavirenz,1447680821.0,Sub-Saharan African
1183622896,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183622898.0,East Asian
1183622896,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183622924.0,East Asian
1183622896,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183622898.0,East Asian
1183622896,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183622924.0,East Asian
1183622896,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183622898.0,East Asian
1183622896,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,pantoprazole,1183622924.0,East Asian
1447680825,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,efavirenz,1447680827.0,Sub-Saharan African
1183491834,PA166155187,rs1799752,,,ACE,Efficacy,-1,bradykinin,1183491848.0,European
1444698865,PA166154698,rs1412125,,,HMGB1,Efficacy,1,Platinum compounds,1444698873.0,East Asian
982037339,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982037351.0,East Asian
982037339,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,982037351.0,East Asian
1444666097,PA166153748,rs3753380,,,PTGFR,Efficacy,-1,latanoprost,1444666099.0,East Asian
1444666097,PA166153748,rs3753380,,,PTGFR,Efficacy,-1,latanoprost,1444666150.0,East Asian
1444666097,PA166153748,rs3753380,,,PTGFR,Efficacy,-1,latanoprost,1444666100.0,East Asian
1444666097,PA166153748,rs3753380,,,PTGFR,Efficacy,-1,latanoprost,1444666143.0,East Asian
982037327,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037337.0,Unknown
982037327,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037453.0,Unknown
982037327,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037338.0,Unknown
982037327,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037455.0,Unknown
982037327,PA166154395,rs3135506,,,APOA5,Efficacy,1,fenofibrate,982037352.0,Unknown
1444698874,PA166154706,rs2249825,,,HMGB1,Efficacy,1,Platinum compounds,1444698880.0,East Asian
1183622993,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622998.0,Unknown
1444698889,PA166154692,rs1045411,,,HMGB1,Efficacy,-1,Platinum compounds,1444698895.0,East Asian
1447680794,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1447680818.0,Unknown
1447680794,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1447680816.0,Unknown
1447680794,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1447680818.0,Unknown
1447680794,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1447680816.0,Unknown
1183622976,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622989.0,Unknown
1183622976,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622985.0,Unknown
1183622976,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622983.0,Unknown
1183622976,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622987.0,Unknown
1183704894,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1183704898.0,Central/South Asian
1183704894,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1185235655.0,Central/South Asian
1447680776,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447680791.0,Unknown
1447680776,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681009.0,Unknown
1447680776,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447681006.0,Unknown
1447680776,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447680791.0,Unknown
1447680776,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447681009.0,Unknown
1447680776,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1447681006.0,Unknown
1447680778,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1447680780.0,Sub-Saharan African
1444698904,PA166156630,rs7686909,,,HMGB2,Efficacy,-1,Platinum compounds,1444698906.0,East Asian
1184819093,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1184819734.0,European
1184819093,,,PA165971621,CYP2D6*69,CYP2D6,Metabolism/PK,0,dextromethorphan,1184819734.0,European
1449563982,PA166179249,rs797044887,,,PDGFRB,Efficacy,-1,imatinib,1449563987.0,Unknown
1447680752,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1447680754.0,Sub-Saharan African
1447680755,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447680773.0,Unknown
1447680755,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447680990.0,Unknown
1447680755,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1447680852.0,Unknown
1447680755,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447680773.0,Unknown
1447680755,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447680990.0,Unknown
1447680755,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1447680852.0,Unknown
1183704889,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,1183704893.0,Central/South Asian
1183622965,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622975.0,Unknown
1183622965,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622975.0,Unknown
1183622965,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,rabeprazole,1183622975.0,Unknown
1450809160,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,tolbutamide,1450809167.0,Unknown
1450809160,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,tolbutamide,1450809167.0,Unknown
1450809160,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,tolbutamide,1450809167.0,Unknown
1450973000,PA166155351,rs429358,,,APOE,Efficacy,-1,donepezil,1450973060.0,European
1447680733,PA166155496,rs35303484,,,CYP2B6,Metabolism/PK,-1,efavirenz,1447680735.0,Sub-Saharan African
982037396,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,-1,fluvastatin,982037403.0,Unknown
1447680740,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,efavirenz,1447680742.0,Sub-Saharan African
1449564017,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1449564029.0,Multiple groups
1449564017,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1449564029.0,Multiple groups
1444698809,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,everolimus,1444698818.0,"Multiple groups, Mainly Caucasian, 2 Hispanic, 1 African-American and 1 American Indian"
1444698809,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,everolimus,1444698818.0,"Multiple groups, Mainly Caucasian, 2 Hispanic, 1 African-American and 1 American Indian"
1447680746,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1447680748.0,Sub-Saharan African
1446533819,PA166154994,rs749671,,,VKORC1,Dosage,1,warfarin,1446534310.0,"Multiple groups, Brazilian"
1447680719,PA166154948,rs45564134,,,CYP1A2,Metabolism/PK,-1,efavirenz,1447680721.0,Sub-Saharan African
1444666054,PA166157767,rs3842787,,,PTGS1,Efficacy,-1,latanoprost,1444666056.0,East Asian
1447680725,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,-1,efavirenz,1447680727.0,Sub-Saharan African
1449564030,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1449564032.0,Multiple groups
1449564030,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,bupropion,1449564032.0,Multiple groups
1449564030,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1449564032.0,Multiple groups
982037405,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,-1,fluvastatin,982037412.0,Unknown
1451120506,PA166199981,rs28404156,,,BST1,Efficacy,1,"Beta blocking agents, selective",1451120560.0,European
1451120506,PA166199981,rs28404156,,,BST1,Efficacy,1,"Beta blocking agents, selective",1451120520.0,European
1451120506,PA166199981,rs28404156,,,BST1,Efficacy,1,"Beta blocking agents, selective",1451120511.0,European
1449564044,PA166157286,rs1057868,,,POR,Metabolism/PK,1,bupropion,1449564046.0,Multiple groups
1449564044,PA166157286,rs1057868,,,POR,Metabolism/PK,1,bupropion,1449564046.0,Multiple groups
982037386,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,fluvastatin,982037395.0,Unknown
1444698851,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1444698861.0,Unknown
1444698851,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1444698859.0,Unknown
1444698851,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1444698861.0,Unknown
1444698851,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1444698859.0,Unknown
1184753650,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184753657.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753650,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184753652.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753650,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184753657.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753650,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184753652.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1447680695,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,-1,efavirenz,1447680718.0,Sub-Saharan African
1448123039,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,zafirlukast,1448123041.0,East Asian
1448123039,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,zafirlukast,1448123041.0,East Asian
1448123039,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,zafirlukast,1448123041.0,East Asian
1451136987,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,dexlansoprazole,1451137000.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698746.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698748.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698768.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698764.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698762.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698760.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698766.0,East Asian
1444698740,PA166155210,rs2857657,,,CCL2,Efficacy,1,risperidone,1444698770.0,East Asian
827784609,PA166154602,rs7311358,,,SLCO1B3,Other,1,docetaxel,827784615.0,East Asian
827784609,PA166154602,rs7311358,,,SLCO1B3,Metabolism/PK,1,docetaxel,827784615.0,East Asian
1449564081,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1449564083.0,European
1184753658,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184753661.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753658,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184753660.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753658,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184753661.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753658,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184753660.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1451136980,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,dexlansoprazole,1451136986.0,East Asian
1451136980,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,dexlansoprazole,1451136986.0,East Asian
1451136980,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,dexlansoprazole,1451136986.0,East Asian
827784603,PA166154584,rs4149118,,,SLCO1B3,Other,1,docetaxel,827784608.0,East Asian
827784603,PA166154584,rs4149118,,,SLCO1B3,Metabolism/PK,1,docetaxel,827784608.0,East Asian
1448123026,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,zafirlukast,1448123037.0,East Asian
1448123026,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,zafirlukast,1448123037.0,East Asian
1448123026,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,zafirlukast,1448123037.0,East Asian
1449564102,PA166170863,rs2248359,,,CYP24A1,Metabolism/PK,1,daclatasvir,1449564104.0,Unknown
1449564102,PA166170863,rs2248359,,,CYP24A1,Metabolism/PK,1,daclatasvir,1449564104.0,Unknown
1449564095,PA166154640,rs11568820,,,VDR,Metabolism/PK,1,daclatasvir,1449564101.0,Unknown
1184753676,PA166157316,rs2032582,,,ABCB1,Dosage,1,tacrolimus,1184753678.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1184753676,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,tacrolimus,1184753678.0,"Multiple groups, The majority of donors were Asian, the majority of recipients were Caucasian."
1449269204,PA166153959,rs1057910,,,CYP2C9,Dosage,0,warfarin,1449269206.0,Multiple groups
1448123009,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1448123017.0,Near Eastern
1448123009,PA166154450,rs11212617,,,ATM,Efficacy,-1,metformin,1448123017.0,Near Eastern
1447680639,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,corticosteroids,1447680641.0,Unknown
1447680639,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,Leukotriene receptor antagonists,1447680641.0,Unknown
1447680639,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680641.0,Unknown
1448123019,PA166156933,rs628031,,,SLC22A1,Efficacy,-1,metformin,1448123021.0,Near Eastern
1447680645,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,corticosteroids,1447680647.0,Unknown
1447680645,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,Leukotriene receptor antagonists,1447680647.0,Unknown
1449269199,PA166153972,rs1799853,,,CYP2C9,Dosage,0,warfarin,1449269201.0,Multiple groups
1445206674,PA166155416,rs4803217,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1445206677.0,African American/Afro-Caribbean
1445206674,PA166155416,rs4803217,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1445206676.0,African American/Afro-Caribbean
1445206674,PA166155416,rs4803217,,,IFNL3,Efficacy,1,ribavirin,1445206677.0,African American/Afro-Caribbean
1445206674,PA166155416,rs4803217,,,IFNL3,Efficacy,1,ribavirin,1445206676.0,African American/Afro-Caribbean
1448122994,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,losartan,1448122996.0,Unknown
1447680625,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680627.0,Unknown
1447680625,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680627.0,Unknown
1447680625,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680627.0,Unknown
1447680625,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680627.0,Unknown
1447680625,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680627.0,Unknown
1447680625,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,selective beta-2-adrenoreceptor agonists,1447680627.0,Unknown
1447680633,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,corticosteroids,1447680635.0,Unknown
1184753704,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1184753710.0,Unknown
1184753704,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1184753710.0,Unknown
1184753704,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1184753710.0,Unknown
1184753704,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1184753710.0,Unknown
982037525,PA166157865,rs2106809,,,ACE2,Efficacy,-1,captopril,982037532.0,East Asian
1447680610,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,photodynamic therapy,1447680612.0,Unknown
1444698677,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,nelfinavir,1444698686.0,Unknown
1444698677,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,nelfinavir,1444698686.0,Unknown
1448106601,PA166155915,rs1127354,,,ITPA,Metabolism/PK,1,mercaptopurine,1448106607.0,Multiple groups
1448106601,PA166155915,rs1127354,,,ITPA,Metabolism/PK,1,mercaptopurine,1448106609.0,Multiple groups
982037542,PA166157865,rs2106809,,,ACE2,Efficacy,-1,atenolol,982037548.0,East Asian
982037542,PA166157865,rs2106809,,,ACE2,Efficacy,-1,atenolol,982037547.0,East Asian
1447680594,PA166153617,rs1061170,,,CFH,Efficacy,-1,photodynamic therapy,1447680603.0,Unknown
1444698694,PA166155227,rs4795893,,,CCL2,Efficacy,1,risperidone,1444698700.0,East Asian
1444698694,PA166155227,rs4795893,,,CCL2,Efficacy,1,risperidone,1444698704.0,East Asian
1444698694,PA166155227,rs4795893,,,CCL2,Efficacy,1,risperidone,1444698702.0,East Asian
1444698694,PA166155227,rs4795893,,,CCL2,Efficacy,1,risperidone,1444698706.0,East Asian
1448122968,PA166157284,rs1045642,,,ABCB1,Efficacy,1,losartan,1448122974.0,Unknown
982037533,PA166157865,rs2106809,,,ACE2,Efficacy,-1,nifedipine,982037541.0,East Asian
982037533,PA166157865,rs2106809,,,ACE2,Efficacy,-1,nifedipine,982037538.0,East Asian
1447680618,PA166156748,rs1042713,,,ADRB2,Efficacy,1,corticosteroids,1447680624.0,Unknown
1447680618,PA166156748,rs1042713,,,ADRB2,Efficacy,1,selective beta-2-adrenoreceptor agonists,1447680624.0,Unknown
981349362,PA166156938,rs699947,,,VEGFA,Efficacy,1,sildenafil,981349370.0,"Multiple groups, Brazil approximately half White half non-white"
981349362,PA166156938,rs699947,,,VEGFA,Efficacy,1,sildenafil,981349368.0,"Multiple groups, Brazil approximately half White half non-white"
1444698707,PA166155151,rs4586,,,CCL2,Efficacy,1,risperidone,1444698710.0,East Asian
1444698707,PA166155151,rs4586,,,CCL2,Efficacy,1,risperidone,1444698712.0,East Asian
1444698707,PA166155151,rs4586,,,CCL2,Efficacy,1,risperidone,1444698711.0,East Asian
1444698707,PA166155151,rs4586,,,CCL2,Efficacy,1,risperidone,1444698713.0,East Asian
1451350020,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,hydroxybupropion,1451350026.0,European
1451350020,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,hydroxybupropion,1451350026.0,European
982037510,PA166157865,rs2106809,,,ACE2,Efficacy,1,captopril,982037524.0,East Asian
1447680563,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1447680565.0,Unknown
1183623160,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,0,amitriptyline,1183623162.0,European
1183623160,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,0,amitriptyline,1446903379.0,European
1183623160,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,0,amitriptyline,1183623162.0,European
1183623160,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,0,amitriptyline,1446903379.0,European
1183623160,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,amitriptyline,1183623162.0,European
1183623160,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,amitriptyline,1446903379.0,European
1183623160,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,amitriptyline,1183623162.0,European
1183623160,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,amitriptyline,1446903379.0,European
1444698605,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,nelfinavir,1444698615.0,European
1444698605,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,nelfinavir,1444698615.0,European
1447959074,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,adalimumab,1447959174.0,European
1447959074,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,etanercept,1447959174.0,European
1447959074,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,infliximab,1447959174.0,European
1447959074,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,ustekinumab,1447959174.0,European
1447680551,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447680553.0,Unknown
1447680551,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447680553.0,Unknown
1447680551,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447680553.0,Unknown
827784991,PA166156406,rs6438552,,,GSK3B,Efficacy,1,lithium,827785066.0,European
1183606890,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,carbamazepine,1183607724.0,Multiple groups
1183606890,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,valproic acid,1183607724.0,Multiple groups
827784987,PA166155199,rs2071427,,,NR1D1,Efficacy,1,lithium,827785072.0,European
827784987,PA166155199,rs2071427,,,THRA,Efficacy,1,lithium,827785072.0,European
827784981,PA166156406,rs6438552,,,GSK3B,Efficacy,-1,lithium,827785063.0,European
1447680533,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447680542.0,Unknown
1447680533,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447680542.0,Unknown
827784977,PA166155199,rs2071427,,,NR1D1,Efficacy,-1,lithium,827785070.0,European
827784977,PA166155199,rs2071427,,,THRA,Efficacy,-1,lithium,827785070.0,European
827784977,PA166155199,rs2071427,,,THRA,Efficacy,-1,lithium,827785070.0,European
827784973,PA166154610,rs8192440,,,CRY1,Efficacy,-1,lithium,827785068.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444667951.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444665878.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444667951.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444665878.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444667951.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444665878.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,telaprevir,1444667951.0,European
1444665876,PA166155435,rs8099917,,,IFNL3,Efficacy,1,telaprevir,1444665878.0,European
1445403153,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1445403173.0,African American/Afro-Caribbean
1445403153,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,bupropion,1445403173.0,African American/Afro-Caribbean
1445403153,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,1,bupropion,1445403173.0,African American/Afro-Caribbean
1445403153,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1445403173.0,African American/Afro-Caribbean
1445403153,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,bupropion,1445403173.0,African American/Afro-Caribbean
1445403153,,,PA165818809,CYP2B6*22,CYP2B6,Metabolism/PK,1,bupropion,1445403173.0,African American/Afro-Caribbean
982037550,PA166157865,rs2106809,,,ACE2,Efficacy,-1,hydrochlorothiazide,982037555.0,East Asian
982037550,PA166157865,rs2106809,,,ACE2,Efficacy,-1,hydrochlorothiazide,982037556.0,East Asian
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154650.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154653.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154677.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154682.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154650.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154653.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154677.0,Multiple groups
1449154644,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154682.0,Multiple groups
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444665888.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444667943.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444665888.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1444667943.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444665888.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1444667943.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,telaprevir,1444665888.0,European
1444665886,PA166190881,rs11322783,,,IFNL4,Efficacy,1,telaprevir,1444667943.0,European
1445403174,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1445403176.0,African American/Afro-Caribbean
1445403174,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1445403195.0,African American/Afro-Caribbean
1445403174,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,bupropion,1445403176.0,African American/Afro-Caribbean
1445403174,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,1,bupropion,1445403195.0,African American/Afro-Caribbean
1445403174,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,1,bupropion,1445403176.0,African American/Afro-Caribbean
1445403174,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,1,bupropion,1445403195.0,African American/Afro-Caribbean
1445403174,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1445403176.0,African American/Afro-Caribbean
1445403174,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,bupropion,1445403195.0,African American/Afro-Caribbean
1445403174,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,bupropion,1445403176.0,African American/Afro-Caribbean
1445403174,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,bupropion,1445403195.0,African American/Afro-Caribbean
1445403174,,,PA165818809,CYP2B6*22,CYP2B6,Metabolism/PK,1,bupropion,1445403176.0,African American/Afro-Caribbean
1445403174,,,PA165818809,CYP2B6*22,CYP2B6,Metabolism/PK,1,bupropion,1445403195.0,African American/Afro-Caribbean
1449171049,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,1,methadone,1449171054.0,European
1449171059,PA166155442,rs8192709,,,CYP2B6,Metabolism/PK,1,S-EDDP,1449171061.0,European
613976745,PA166153680,rs2234922,,,EPHX1,Dosage,1,carbamazepine,613976749.0,East Asian
613976745,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,1,carbamazepine,613976749.0,East Asian
827784936,PA166155470,rs28364072,,,FCER2,Dosage,1,corticosteroids,827784941.0,European
1449171064,PA166155394,rs2279344,,,CYP2B6,Metabolism/PK,-1,methadone,1449171066.0,European
1449171064,PA166155394,rs2279344,,,CYP2B6,Metabolism/PK,-1,methadone,1449171066.0,European
982037675,PA166154586,rs4238001,,,SCARB1,Efficacy,1,fenofibrate,982037684.0,European
982037675,PA166154586,rs4238001,,,SCARB1,Efficacy,1,fenofibrate,982037686.0,European
1447680461,PA166154548,rs2307024,,,ABCC9,Metabolism/PK,-1,efavirenz,1447680464.0,"Multiple groups, 90% Caucasian, Italy"
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154706.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154708.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154710.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154712.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154706.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154708.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154710.0,Multiple groups
1449154699,PA166157525,rs113993960,,,CFTR,Efficacy,1,tezacaftor,1449154712.0,Multiple groups
769245704,PA166155133,rs61162043,,,VKORC1,Dosage,1,warfarin,769245707.0,African American/Afro-Caribbean
1184753733,PA166156024,rs4680,,,COMT,Dosage,-1,morphine,1184753735.0,"Multiple groups, Majority Caucasian patients."
1449171079,PA166155442,rs8192709,,,CYP2B6,Metabolism/PK,-1,methadone,1449171081.0,European
1183688854,PA166154284,rs588076,,,PICALM,Efficacy,1,calcium channel blockers,1183688923.0,East Asian
769245708,PA166154078,rs7089580,,,CYP2C9,Dosage,1,warfarin,769245711.0,African American/Afro-Caribbean
1449171089,PA166155394,rs2279344,,,CYP2B6,Metabolism/PK,-1,S-EDDP,1449171091.0,European
1449171069,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,methadone,1449171071.0,European
1447680448,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,efavirenz,1447680450.0,"Multiple groups, 90% Caucasian, Italy"
1447680448,PA166156619,rs7439366,,,UGT2B7,Metabolism/PK,-1,efavirenz,1447680450.0,"Multiple groups, 90% Caucasian, Italy"
1183623301,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623303.0,East Asian
1183623301,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623303.0,East Asian
1183623301,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,omeprazole,1183623303.0,East Asian
1449171099,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,S-EDDP,1449171101.0,European
1447680454,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,-1,efavirenz,1447680456.0,"Multiple groups, 90% Caucasian, Italy"
1449171094,PA166155405,rs3211371,,,CYP2B6,Metabolism/PK,-1,S-EDDP,1449171096.0,European
1448122820,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,warfarin,1448122822.0,East Asian
1448122820,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,warfarin,1448122822.0,East Asian
1448122820,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,1,warfarin,1448122822.0,East Asian
1447680428,PA166155447,rs8192726,,,CYP2A6,Metabolism/PK,-1,efavirenz,1447680430.0,"Multiple groups, 90% Caucasian, Italy"
1449171104,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,S-EDDP,1449171106.0,European
1447680436,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,-1,efavirenz,1447680438.0,"Multiple groups, 90% Caucasian, Italy"
1449171109,PA166155444,rs8192719,,,CYP2B6,Metabolism/PK,-1,S-EDDP,1449171111.0,European
1447680442,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,-1,efavirenz,1447680444.0,"Multiple groups, 90% Caucasian, Italy"
1183623395,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,lansoprazole,1183623403.0,European
1183623395,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,lansoprazole,1183623410.0,European
1183623395,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,lansoprazole,1183623403.0,European
1183623395,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,lansoprazole,1183623410.0,European
1183623395,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183623403.0,European
1183623395,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183623410.0,European
1183623395,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,omeprazole,1183623403.0,European
1183623395,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,omeprazole,1183623410.0,European
982037714,PA166156276,rs5186,,,AGTR1,Efficacy,1,candesartan,982037727.0,European
982037714,PA166156276,rs5186,,,AGTR1,Efficacy,1,candesartan,982037725.0,European
1450809558,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,tolbutamide,1450809564.0,Unknown
1450809558,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,tolbutamide,1450809564.0,Unknown
1444698493,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1444698506.0,East Asian
1444698493,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1444698502.0,Multiple groups
1444698493,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1444698508.0,Multiple groups
1444698493,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1444698510.0,Multiple groups
1444698493,PA166155346,rs25487,,,XRCC1,Efficacy,1,Platinum compounds,1444698504.0,European
1449269428,PA166157345,rs2242480,,,CYP3A4,Efficacy,-1,oxycodone,1449269430.0,East Asian
1449269421,PA166157345,rs2242480,,,CYP3A4,Efficacy,-1,oxycodone,1449269423.0,East Asian
1447680398,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,efavirenz,1447680400.0,"Multiple groups, 90% Caucasian, Italy"
1447680404,PA166155918,rs1884613,,,HNF4A,Metabolism/PK,1,efavirenz,1447680406.0,"Multiple groups, 90% Caucasian, Italy"
1450809573,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,tolbutamide,1450809582.0,Unknown
1450809573,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,-1,tolbutamide,1450809582.0,Unknown
1450809573,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,tolbutamide,1450809582.0,Unknown
982037728,PA166156276,rs5186,,,AGTR1,Efficacy,1,candesartan,982037739.0,European
1448122772,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,warfarin,1448122800.0,East Asian
1448122772,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,warfarin,1448122800.0,East Asian
1448122772,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,1,warfarin,1448122800.0,East Asian
1447680386,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,efavirenz,1447680388.0,"Multiple groups, 90% Caucasian, Italy"
1183688895,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,atomoxetine,1183688907.0,East Asian
1183688895,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,atomoxetine,1183688907.0,East Asian
1183688895,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,atomoxetine,1183688907.0,East Asian
1449269466,PA166156619,rs7439366,,,UGT2B7,Efficacy,1,oxycodone,1449269468.0,East Asian
1449269452,PA166156619,rs7439366,,,UGT2B7,Efficacy,-1,oxycodone,1449269454.0,East Asian
1183492294,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,tacrolimus,1183492298.0,"Multiple groups, Native American (n=20) and Caucasian (n=11)"
1449269459,PA166156619,rs7439366,,,UGT2B7,Efficacy,-1,oxycodone,1449269461.0,East Asian
1447680365,,,PA165816525,CYP2C19*9,CYP2C19,Metabolism/PK,0,omeprazole,1447680367.0,Multiple groups
1447680392,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,efavirenz,1447680394.0,"Multiple groups, 90% Caucasian, Italy"
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492285.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492279.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492293.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492281.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492283.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492287.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492289.0,East Asian
1183492275,PA166155296,rs4483927,,,HRH4,Efficacy,1,risperidone,1183492291.0,East Asian
1444698532,PA166157047,rs2760118,,,ALDH5A1,Efficacy,1,methadone,1444698540.0,European
1184999713,PA166154007,rs2273697,,,ABCC2,Efficacy,1,carbamazepine,1184999715.0,East Asian
1184999713,PA166154007,rs2273697,,,ABCC2,Efficacy,1,oxcarbazepine,1184999715.0,East Asian
1447680349,,,PA165816531,CYP2C19*15,CYP2C19,Metabolism/PK,0,omeprazole,1447680351.0,Multiple groups
1447680376,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1447680382.0,"Multiple groups, 90% Caucasian, Italy"
1184999606,PA166155715,rs3812718,,,SCN1A,Efficacy,1,carbamazepine,1184999612.0,East Asian
1184999606,PA166155715,rs3812718,,,SCN1A,Efficacy,1,oxcarbazepine,1184999612.0,East Asian
1449171185,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1449171203.0,African American/Afro-Caribbean
1449171185,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1449171203.0,African American/Afro-Caribbean
1449171185,,,PA166128233,CYP3A5*6,CYP3A5,Dosage,1,tacrolimus,1449171203.0,African American/Afro-Caribbean
1451284760,PA166191043,rs405509,,,APOE,Efficacy,1,Selective serotonin reuptake inhibitors,1451284783.0,East Asian
1451284760,PA166191043,rs405509,,,APOE,Efficacy,1,Selective serotonin reuptake inhibitors,1451284783.0,East Asian
1450809629,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1450809631.0,East Asian
1450809629,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1450809631.0,East Asian
1450809629,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,lansoprazole,1450809631.0,East Asian
1447680341,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,omeprazole,1447680348.0,Multiple groups
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183623458.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183623461.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183623476.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183623474.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183623458.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183623461.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183623476.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,lansoprazole,1183623474.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623458.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623461.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623476.0,European
1183623444,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623474.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623458.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623461.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623476.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623474.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623458.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623461.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623476.0,European
1183623444,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623474.0,European
1449154836,PA166175767,rs12917707,,,UMOD,Efficacy,1,cyclosporine,1449154842.0,European
1183688944,PA166154441,rs10898815,,,NUMA1,Efficacy,1,calcium channel blockers,1183688946.0,East Asian
1447680300,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,venlafaxine,1447680302.0,Unknown
1449171233,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449171239.0,African American/Afro-Caribbean
1450809598,PA166154486,rs5443,,,GNB3,Efficacy,1,sibutramine,1450809603.0,Unknown
1450809598,PA166154486,rs5443,,,GNB3,Efficacy,1,sibutramine,1450809650.0,Unknown
1450809598,PA166154486,rs5443,,,GNB3,Efficacy,1,sibutramine,1450809603.0,Unknown
1450809598,PA166154486,rs5443,,,GNB3,Efficacy,1,sibutramine,1450809650.0,Unknown
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183623432.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183623413.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183623436.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183623414.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,omeprazole,1183623432.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,omeprazole,1183623413.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,omeprazole,1183623436.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,omeprazole,1183623414.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623432.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623413.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623436.0,European
1183623411,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623414.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623432.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623413.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623436.0,European
1183623411,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,pantoprazole,1183623414.0,European
1183688940,PA166155209,rs2429427,,,TANC2,Efficacy,1,calcium channel blockers,1183688942.0,East Asian
1183688940,PA166155209,rs2429427,,,TANC2,Efficacy,1,calcium channel blockers,1183688942.0,East Asian
1183688940,PA166155209,rs2429427,,,TANC2,Efficacy,1,calcium channel blockers,1183688942.0,East Asian
1450809604,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1450809621.0,East Asian
1450809604,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1450809621.0,East Asian
1450809604,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1450809621.0,East Asian
1184999651,PA166155715,rs3812718,,,SCN1A,Efficacy,1,carbamazepine,1184999653.0,East Asian
1184999651,PA166155715,rs3812718,,,SCN1A,Efficacy,1,oxcarbazepine,1184999653.0,East Asian
1448257194,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448257199.0,"Multiple groups, mostly Caucasians"
637879876,PA166157254,rs339097,,,CALU,Dosage,1,warfarin,637879878.0,African American/Afro-Caribbean
1444695613,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1444695618.0,Multiple groups
827649690,PA166154977,rs7294,,,PRSS53,Dosage,1,warfarin,827650842.0,European
827649690,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,827650842.0,European
1449157667,PA166176073,rs1143671,,,SLC15A2,Dosage,1,warfarin,1449157672.0,East Asian
769250083,PA166153959,rs1057910,,,CYP2C9,Other,-1,phenytoin,,
769250083,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,-1,phenytoin,,
982033533,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,982033543.0,Unknown
731462495,PA166156991,rs1799971,,,OPRM1,Efficacy,1,morphine,731479968.0,European
769277920,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,769277922.0,East Asian
827807158,,,PA165980635,CYP2C19*2,CYP2C19,Other,-1,carvedilol,827807171.0,Multiple groups
827807158,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,carvedilol,827807171.0,Multiple groups
827807158,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,carvedilol,827807171.0,Multiple groups
1451138105,PA166163138,rs2236418,,,GAD2,Dosage,-1,methadone,1451138123.0,East Asian
1449715975,PA166180147,rs3845744,,,ATF2,Efficacy,-1,fentanyl,1449715977.0,East Asian
1447952622,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447952625.0,European
1447952622,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447952625.0,European
1447680801,PA166155355,rs707265,,,CYP2B6,Metabolism/PK,-1,efavirenz,1447680803.0,Sub-Saharan African
1444608101,PA166154078,rs7089580,,,CYP2C9,Dosage,1,warfarin,1444608103.0,African American/Afro-Caribbean
982037879,PA166153972,rs1799853,,,CYP2C9,Dosage,1,warfarin,982037886.0,African American/Afro-Caribbean
1451134841,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,oxycodone,1451134860.0,East Asian
1451134841,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,oxycodone,1451134860.0,East Asian
981474995,PA166154163,rs17222723,,,ABCC2,Metabolism/PK,-1,methotrexate,981475003.0,Unknown
1448639969,PA166155584,rs8330,,,UGT1A,Metabolism/PK,-1,acetaminophen,1448639974.0,"Multiple groups, Black, White"
1447680859,PA166156375,rs3732360,,,NR1I2,Metabolism/PK,-1,efavirenz,1447680861.0,Sub-Saharan African
1449165203,PA166155204,rs2252281,,,SLC47A1,Metabolism/PK,-1,metformin,1449165205.0,"Multiple groups, Brazil"
1449310942,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1449310944.0,European
1449310942,PA166154053,rs4244285,,,CYP2C19,Other,1,clopidogrel,1449310944.0,European
1449269209,PA166155381,rs2108622,,,CYP4F2,Dosage,0,warfarin,1449269211.0,Multiple groups
981481851,PA166156968,rs1011313,,,DTNBP1,Efficacy,-1,aripiprazole,981481858.0,East Asian
981481878,PA166157042,rs2619522,,,DTNBP1,Efficacy,-1,aripiprazole,981481885.0,East Asian
1449157694,PA166154602,rs7311358,,,SLCO1B3,Dosage,1,warfarin,1449157696.0,East Asian
1449157694,PA166154602,rs7311358,,,SLCO1B3,Dosage,1,warfarin,1449157696.0,East Asian
1447681848,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1447681857.0,Central/South Asian
1447681848,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1447681857.0,Central/South Asian
1450045085,PA166154027,rs3740065,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045087.0,Unknown
1450814759,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814766.0,Unknown
1450814759,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814763.0,Unknown
1450814759,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814765.0,Unknown
1450814759,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814768.0,Unknown
1450814759,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814764.0,Unknown
1450814759,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,-1,pitavastatin,1450814767.0,Unknown
982032955,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,982032964.0,European
982035432,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,bepridil,982035467.0,East Asian
1451129611,PA166157239,rs3842,,,ABCB1,Metabolism/PK,-1,efavirenz,1451129624.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
982032947,PA166154066,rs4917639,,,CYP2C9,Dosage,1,warfarin,982032954.0,European
982033113,PA166154109,rs10509680,,,CYP2C9,Dosage,1,warfarin,982033130.0,East Asian
1447573633,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1447573635.0,Multiple groups
1446907672,PA166155325,rs12969154,,,TNFRSF11A,Efficacy,-1,alendronate,1446907678.0,East Asian
1445402189,PA166153666,rs2072661,,,CHRNB2,Efficacy,-1,varenicline,1445402191.0,Multiple groups
1448530349,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,sunitinib,1448530357.0,East Asian
1448994001,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448994003.0,Multiple groups
1448994001,,,PA165818808,CYP2B6*18,CYP2B6,Metabolism/PK,1,efavirenz,1448994003.0,Multiple groups
1447519319,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1447519324.0,Central/South Asian
1449557881,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methotrexate,1449557890.0,European
1449557881,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,methotrexate,1449558063.0,European
981478739,PA166156903,rs6296,,,HTR1B,Efficacy,-1,methylphenidate,981478791.0,European
1449165138,PA166156932,rs622342,,,SLC22A1,Metabolism/PK,-1,metformin,1449165140.0,"Multiple groups, Brazil"
1449188418,PA166177793,rs10457090,,,OPRM1,Metabolism/PK,1,cotinine,1449188420.0,East Asian
1449271581,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,0,S-EDDP,1449271583.0,Unknown
699642174,PA166154514,rs1487278,,,TPH2,Efficacy,1,mirtazapine,699642176.0,European
699642174,PA166154514,rs1487278,,,TPH2,Efficacy,1,venlafaxine,699642176.0,European
1447680877,PA166156384,rs3814057,,,NR1I2,Metabolism/PK,-1,efavirenz,1447680879.0,Sub-Saharan African
769255171,PA166154070,rs4986893,,,CYP2C19,Efficacy,-1,ticlopidine,769255173.0,East Asian
1449157006,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,efavirenz,1449157008.0,Multiple groups
1449157006,,,PA165818753,CYP2B6*2,CYP2B6,Metabolism/PK,-1,efavirenz,1449157008.0,Multiple groups
827783823,,,PA165818757,CYP2B6*4,CYP2B6,Other,-1,propofol,827783838.0,Unknown
827783823,,,PA165818757,CYP2B6*4,CYP2B6,Metabolism/PK,-1,propofol,827783838.0,Unknown
827864560,PA166155341,rs7412,,,APOC1,Dosage,1,warfarin,827864561.0,Near Eastern
827864560,PA166155341,rs7412,,,APOE,Dosage,1,warfarin,827864561.0,Near Eastern
982044357,PA166155042,rs2884737,,,VKORC1,Dosage,1,warfarin,982044363.0,European
827690626,PA166153772,rs4653436,,,EPHX1,Dosage,-1,warfarin,827690631.0,Unknown
827807173,,,PA165816542,CYP2C9*1,CYP2C9,Other,-1,carvedilol,827807190.0,Multiple groups
827807173,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,carvedilol,827807190.0,Multiple groups
827567338,PA166155104,rs11150606,,,VKORC1,Dosage,1,warfarin,827567351.0,European
827567321,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,827567328.0,European
827783818,,,PA165818762,CYP2B6*6,CYP2B6,Other,-1,propofol,827783836.0,Unknown
827783818,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,propofol,827783836.0,Unknown
1448993700,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448993706.0,Central/South Asian
655387805,PA166157731,rs1544105,,,FPGS,Efficacy,1,methotrexate,655387808.0,Central/South Asian
981420009,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,acenocoumarol,981420011.0,"Multiple groups, Reported that approximately 99% of patients were Caucasian in this cohort."
827807187,,,PA165816542,CYP2C9*1,CYP2C9,Other,-1,carvedilol,827807196.0,Multiple groups
827807187,,,PA165816543,CYP2C9*2,CYP2C9,Other,-1,carvedilol,827807196.0,Multiple groups
827807187,,,PA165816544,CYP2C9*3,CYP2C9,Other,-1,carvedilol,827807196.0,Multiple groups
827807187,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,carvedilol,827807196.0,Multiple groups
827807187,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,carvedilol,827807196.0,Multiple groups
827807187,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,carvedilol,827807196.0,Multiple groups
827807184,,,PA165816542,CYP2C9*1,CYP2C9,Other,-1,carvedilol,827807198.0,Multiple groups
827807184,,,PA165816544,CYP2C9*3,CYP2C9,Other,-1,carvedilol,827807198.0,Multiple groups
827807184,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,carvedilol,827807198.0,Multiple groups
827807184,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,carvedilol,827807198.0,Multiple groups
827807179,,,PA165816542,CYP2C9*1,CYP2C9,Other,-1,carvedilol,827807194.0,Multiple groups
827807179,,,PA165816543,CYP2C9*2,CYP2C9,Other,-1,carvedilol,827807194.0,Multiple groups
827807179,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,carvedilol,827807194.0,Multiple groups
827807179,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,carvedilol,827807194.0,Multiple groups
1449144250,PA166171044,rs62200793,,,ZNF804A,Efficacy,1,lithium,1449144252.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
1449144286,PA166171051,rs79403677,,,FAM177A1,Efficacy,1,lithium,1449144288.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
827863309,PA166157634,rs11545078,,,GGH,Efficacy,-1,methotrexate,827863315.0,European
827806085,,,PA165948045,CYP3A7*1A,CYP3A7,Dosage,1,cortisone acetate,827806099.0,Unknown
827806085,,,PA165948047,CYP3A7*1C,CYP3A7,Dosage,1,cortisone acetate,827806099.0,Unknown
1447520009,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447520014.0,European
1183701883,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,0,warfarin,1183701889.0,Unknown
1448573551,PA166155135,rs71647871,,,CES1,Metabolism/PK,1,methylphenidate,1448573560.0,European
608431732,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,608431734.0,European
1448993691,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448993697.0,Sub-Saharan African
1444705817,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444705819.0,Latino
1444705817,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705819.0,Latino
1444843741,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843747.0,Near Eastern
1444843741,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843747.0,Near Eastern
1444843741,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444843747.0,Near Eastern
981501267,PA166155468,rs12979860,,,IFNL3,Dosage,1,peginterferon alfa-2a,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL4,Dosage,1,peginterferon alfa-2a,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL3,Dosage,1,peginterferon alfa-2b,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL4,Dosage,1,peginterferon alfa-2b,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL3,Dosage,1,ribavirin,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL4,Dosage,1,ribavirin,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981501272.0,European
981501267,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981501272.0,European
1183634033,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lafutidine,1183634044.0,East Asian
1183685450,,,PA165947827,G6PD A- 202A_376G,G6PD,Metabolism/PK,1,daunorubicin,1183685458.0,Unknown
769278041,PA166155422,rs5031016,,,CYP2A6,Other,-1,nicotine,981201933.0,East Asian
769278041,PA166155422,rs5031016,,,CYP2A6,Metabolism/PK,-1,nicotine,981201933.0,East Asian
769278041,PA166155422,rs5031016,,,CYP2A6,Metabolism/PK,-1,nicotine,981201933.0,East Asian
769278041,PA166155422,rs5031016,,,CYP2A6,Metabolism/PK,-1,nicotine,981201933.0,East Asian
827700537,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,tegafur,1451822940.0,East Asian
827700537,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,tegafur,1451822960.0,East Asian
827700537,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,tegafur,827700546.0,East Asian
827704840,PA166154249,rs1695,,,GSTP1,Efficacy,1,cyclophosphamide,827704847.0,East Asian
827704840,PA166154249,rs1695,,,GSTP1,Efficacy,1,epirubicin,827704847.0,East Asian
827863348,PA166155331,rs45445694,,,C18orf56,Efficacy,-1,methotrexate,827863351.0,European
827863348,PA166155331,rs45445694,,,TYMS,Efficacy,-1,methotrexate,827863351.0,European
827807118,,,PA165816576,CYP2D6*1,CYP2D6,Other,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816578,CYP2D6*3,CYP2D6,Other,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816579,CYP2D6*4,CYP2D6,Other,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816581,CYP2D6*6,CYP2D6,Other,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,carvedilol,827807121.0,Multiple groups
827807118,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,carvedilol,827807121.0,Multiple groups
827803602,,,PA165924719,CYP2A6*2,CYP2A6,Other,1,efavirenz,827803615.0,Near Eastern
827803602,,,PA165924719,CYP2A6*2,CYP2A6,Metabolism/PK,1,efavirenz,827803615.0,Near Eastern
827892687,PA166153648,rs1801265,,,DPYD,Toxicity,-1,fluorouracil,827892696.0,European
827892687,PA166153648,rs1801265,,,DPYD,Metabolism/PK,-1,fluorouracil,827892696.0,European
827783832,,,PA165818765,CYP2B6*7,CYP2B6,Other,-1,propofol,827783844.0,Unknown
827783832,,,PA165818765,CYP2B6*7,CYP2B6,Metabolism/PK,-1,propofol,827783844.0,Unknown
1449173347,PA166156024,rs4680,,,COMT,Dosage,-1,morphine,1449173350.0,European
1449173347,PA166156024,rs4680,,,COMT,Dosage,-1,morphine,1449173349.0,European
1450821476,PA166184628,rs1718136,,,P2RX7,Efficacy,-1,fentanyl,1450821481.0,Unknown
981478844,PA166155937,rs3746544,,,SNAP25,Efficacy,-1,methylphenidate,981478849.0,European
981501896,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,981501900.0,East Asian
981501896,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,981501900.0,East Asian
1448616501,PA166163735,rs3212227,,,IL12B,Other,-1,methotrexate,1448616507.0,Central/South Asian
1448616501,PA166163735,rs3212227,,,IL12B,Other,-1,methotrexate,1448616507.0,Central/South Asian
1448616501,PA166163735,rs3212227,,,IL12B,Other,-1,methotrexate,1448616507.0,Central/South Asian
981344990,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,-1,dexmedetomidine,981345007.0,"Multiple groups, 38 Whites; 2 Blacks"
1184513495,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513497.0,Unknown
1184513495,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513499.0,Unknown
1184513495,PA166156565,rs2725252,,,ABCG2,Efficacy,1,imatinib,1184513498.0,Unknown
981483998,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,981484000.0,East Asian
981483998,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,981484000.0,East Asian
981483998,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,warfarin,981484000.0,East Asian
981483998,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,warfarin,981484000.0,East Asian
981474986,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,methotrexate,981474994.0,Unknown
978639678,PA166155595,rs295137,,,SPATS2L,Efficacy,-1,salbutamol,978639682.0,European
978639678,PA166155595,rs295137,,,SPATS2L,Efficacy,-1,salbutamol,978639687.0,European
981420013,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,acenocoumarol,981420015.0,"Multiple groups, Reported that approximately 99% of patients were Caucasian in this cohort."
981501607,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501609.0,European
981501607,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501628.0,European
981501607,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,sulfapyridine,981501609.0,European
981501607,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,sulfapyridine,981501628.0,European
981848260,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,0,isoniazid,981848267.0,European
982010231,PA166154264,rs9344,,,CCND1,Efficacy,-1,lapatinib,982010237.0,Unknown
982010231,PA166154264,rs9344,,,CCND1,Efficacy,-1,lapatinib,982010235.0,Unknown
981940074,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,981940076.0,European
981862303,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,ibuprofen,,
981862003,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,ibuprofen,981862019.0,Unknown
981862003,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,ibuprofen,981862007.0,Unknown
1451104860,PA166196167,rs1139916,,,GABRE,Efficacy,-1,botulinum toxin type a,1451104868.0,European
1451104881,PA166196169,rs2201169,,,GABRA3,Efficacy,-1,botulinum toxin type a,1451104886.0,European
1451117367,PA166199021,rs10224002,,,PRKAG2,Efficacy,1,hydrochlorothiazide,1451117397.0,"Multiple groups, See Figure 1A for genetic ancestry data"
769248355,PA166157267,rs776746,,,CYP3A,Other,-1,tipifarnib,769248357.0,European
769248355,PA166157267,rs776746,,,CYP3A5,Other,-1,tipifarnib,769248357.0,European
769248355,PA166157267,rs776746,,,CYP3A,Metabolism/PK,-1,tipifarnib,769248357.0,European
769248355,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tipifarnib,769248357.0,European
981940169,,,PA165816547,CYP2C9*6,CYP2C9,Efficacy,-1,acenocoumarol,981940171.0,Sub-Saharan African
1043818082,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1043818088.0,European
1043818082,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1043818088.0,European
1134736215,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,losartan,1134736217.0,Sub-Saharan African
1134736215,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,-1,losartan,1134736217.0,Sub-Saharan African
1043818268,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,1043818270.0,European
981501615,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,sulfapyridine,981501617.0,European
981501615,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,sulfapyridine,981501632.0,European
1451129584,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,efavirenz,1451129600.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
1451129584,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,efavirenz,1451129600.0,"Multiple groups, 46 Caucasian subjects, one Latino subject"
981482129,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,981482164.0,European
981482129,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,981482166.0,European
981482129,PA166156905,rs20455,,,KIF6,Efficacy,1,atorvastatin,981482134.0,European
981482129,PA166156905,rs20455,,,KIF6,Efficacy,1,pravastatin,981482164.0,European
981482129,PA166156905,rs20455,,,KIF6,Efficacy,1,pravastatin,981482166.0,European
981482129,PA166156905,rs20455,,,KIF6,Efficacy,1,pravastatin,981482134.0,European
981477278,PA166155046,rs3024530,,,IL4R,Efficacy,1,pitrakinra,981477284.0,European
982043913,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,982043915.0,European
981501880,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,carbamazepine,981501886.0,African American/Afro-Caribbean
981501880,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,1,carbamazepine,981501887.0,European
1041237161,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1041237373.0,East Asian
1041237161,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1041237373.0,East Asian
1040863313,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,atorvastatin,1040863315.0,East Asian
1040863313,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,atorvastatin,1040863315.0,East Asian
1133417241,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,1133680521.0,Sub-Saharan African
1133417241,,,PA165816546,CYP2C9*5,CYP2C9,Metabolism/PK,1,losartan,1133680521.0,Sub-Saharan African
1133417241,,,PA165816547,CYP2C9*6,CYP2C9,Metabolism/PK,1,losartan,1133680521.0,Sub-Saharan African
1043859014,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,metoprolol,1043859016.0,East Asian
982047048,PA166155374,rs1800471,,,TGFB1,Efficacy,-1,adalimumab,982047052.0,European
982047048,PA166155374,rs1800471,,,TGFB1,Efficacy,-1,etanercept,982047052.0,European
982047048,PA166155374,rs1800471,,,TGFB1,Efficacy,-1,infliximab,982047052.0,European
982031278,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,acenocoumarol,982031280.0,Multiple groups
982031278,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,acenocoumarol,982031280.0,Multiple groups
982037353,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,982037355.0,East Asian
982037353,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,982037355.0,East Asian
982037353,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,982037355.0,East Asian
981501404,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,-1,sulfasalazine,981501406.0,East Asian
1183631242,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,clozapine,1183631248.0,European
981747509,PA166155276,rs1008899,,,NEDD4L,Efficacy,-1,hydrochlorothiazide,981747520.0,African American/Afro-Caribbean
1183618465,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183618477.0,East Asian
1183618465,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183618477.0,East Asian
1183618465,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183618477.0,East Asian
1451133740,PA166154675,rs6313,,,HTR2A,Efficacy,-1,morphine,1451133745.0,European
1451133740,PA166154675,rs6313,,,HTR2A,Efficacy,-1,nortriptyline,1451133745.0,European
981483891,,,PA165952269,HLA-DRB1*15:01:01:01,HLA-DRB1,Efficacy,1,glatiramer acetate,981483899.0,European
981483891,,,PA165952269,HLA-DRB1*15:01:01:01,HLA-DRB1,Efficacy,1,glatiramer acetate,981483897.0,European
981483891,,,PA165952269,HLA-DRB1*15:01:01:01,HLA-DRB1,Efficacy,1,glatiramer acetate,981483893.0,European
981934182,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,981934226.0,Unknown
981344548,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,981344552.0,East Asian
981344548,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,isoniazid,981344552.0,East Asian
981344548,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,isoniazid,981344552.0,East Asian
981344548,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,isoniazid,981344552.0,East Asian
981501514,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,sulfapyridine,981501516.0,East Asian
981501514,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,1,sulfapyridine,981501516.0,East Asian
981934319,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,981934325.0,Unknown
981934319,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,981934325.0,Unknown
981934319,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,981934325.0,Unknown
981344716,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,981344727.0,European
981344716,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,981344727.0,European
981344716,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,981344727.0,European
981344716,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,981344727.0,European
981345093,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,981345097.0,European
981482201,PA166157163,rs9471077,,,KIF6,Efficacy,-1,atorvastatin,981482205.0,European
981482201,PA166157163,rs9471077,,,KIF6,Efficacy,-1,atorvastatin,981482207.0,European
981482201,PA166157163,rs9471077,,,KIF6,Efficacy,-1,atorvastatin,981482206.0,European
981482201,PA166157163,rs9471077,,,KIF6,Efficacy,-1,pravastatin,981482205.0,European
981482201,PA166157163,rs9471077,,,KIF6,Efficacy,-1,pravastatin,981482207.0,European
981482201,PA166157163,rs9471077,,,KIF6,Efficacy,-1,pravastatin,981482206.0,European
981419313,PA166156055,rs737865,,,COMT,Efficacy,1,bupropion,981419321.0,African American/Afro-Caribbean
1451135060,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,oxycodone,1451135064.0,East Asian
1451135060,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,-1,oxycodone,1451135064.0,East Asian
1451135060,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,-1,sufentanil,1451135064.0,East Asian
1451135060,,,PA165816582,CYP2D6*10,CYP2D6,Dosage,-1,sufentanil,1451135064.0,East Asian
1183622033,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622035.0,East Asian
1451104961,PA166196172,rs1718119,,,P2RX7,Efficacy,-1,botulinum toxin type a,1451104966.0,European
1183623462,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183623464.0,East Asian
1183623462,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,haloperidol,1183623464.0,East Asian
982015573,PA166157647,rs13280604,,,CHRNB3,Efficacy,1,nicotine,982015577.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015573,PA166157647,rs13280604,,,CHRNB3,Efficacy,1,nicotine,982015578.0,"Multiple groups, Caucasian: 69%, African American: 20%, Asian: 7.7%, Native American: 1.7% and Unknown: 1.9%."
982015573,PA166157647,rs13280604,,,CHRNB3,Other,1,nicotine,982015577.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015573,PA166157647,rs13280604,,,CHRNB3,Other,1,nicotine,982015578.0,"Multiple groups, Caucasian: 69%, African American: 20%, Asian: 7.7%, Native American: 1.7% and Unknown: 1.9%."
981954037,PA166156525,rs1801260,,,CLOCK,Efficacy,-1,lithium,981954041.0,European
982034045,PA166157566,rs1799998,,,CYP11B2,Efficacy,1,candesartan,982034051.0,Unknown
981785684,PA166154934,rs11854484,,,SLC28A2,Efficacy,1,gemcitabine,981785691.0,East Asian
982028611,PA166154259,rs6265,,,BDNF,Efficacy,1,antidepressants,982028657.0,Multiple groups
1183679290,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1183679292.0,European
1183679290,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,rabeprazole,1183679299.0,European
1183679290,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1183679292.0,European
1183679290,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,rabeprazole,1183679299.0,European
1183681446,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1183681478.0,East Asian
1183681446,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1183681478.0,East Asian
1183681446,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1183681478.0,East Asian
1183681446,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1183681478.0,East Asian
1183679273,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,esomeprazole,1183679286.0,European
1183679273,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,esomeprazole,1183679286.0,European
1183689285,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,olanzapine,1183689293.0,Central/South Asian
1183689285,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,olanzapine,1183689293.0,Central/South Asian
1450943742,PA166186681,rs36217263,,,KL,Efficacy,1,Beta Blocking Agents,1450943760.0,East Asian
981940175,,,PA165816552,CYP2C9*11,CYP2C9,Efficacy,-1,acenocoumarol,981940177.0,Sub-Saharan African
981940156,,,PA165816550,CYP2C9*9,CYP2C9,Efficacy,-1,acenocoumarol,981940162.0,Sub-Saharan African
981934149,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,981934156.0,Unknown
981785622,PA166154926,rs8187758,,,SLC28A1,Efficacy,-1,gemcitabine,981785627.0,East Asian
982047409,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,982047411.0,Multiple groups
982047409,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,warfarin,982047411.0,Multiple groups
981954058,PA166155683,rs2304672,,,PER2,Efficacy,-1,lithium,981954063.0,European
1451138380,PA166184210,rs12749204,,,OPRD1,Dosage,-1,methadone,1451138384.0,Unknown
1451098100,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,sumatriptan,1451098120.0,Unknown
1449713140,PA166154339,rs1800497,,,ANKK1,Efficacy,-1,bupropion,1449713145.0,Unknown
981785779,PA166155331,rs45445694,,,C18orf56,Efficacy,-1,gemcitabine,981785781.0,East Asian
981785779,PA166155331,rs45445694,,,TYMS,Efficacy,-1,gemcitabine,981785781.0,East Asian
1451101175,PA166195564,rs79983226,,,HCN1,Metabolism/PK,0,tramadol,1451101200.0,Unknown
1451101175,PA166195564,rs79983226,,,HCN1,Metabolism/PK,0,tramadol,1451101179.0,Unknown
608431785,PA166154102,rs9332131,,,CYP2C9,Dosage,1,warfarin,608431787.0,African American/Afro-Caribbean
1184468799,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,1184468809.0,Multiple groups
1451098090,PA166157197,rs34130495,,,SLC22A1,Metabolism/PK,1,fenoterol,1451098108.0,Unknown
982023773,,,PA165949099,NAT2*5A,NAT2,Metabolism/PK,0,caffeine,982023775.0,European
982023773,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,0,caffeine,982023775.0,European
982023773,,,PA165949101,NAT2*5C,NAT2,Metabolism/PK,0,caffeine,982023775.0,European
982023773,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,0,caffeine,982023775.0,European
982023773,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,0,caffeine,982023775.0,European
982023773,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,0,caffeine,982023775.0,European
1451138001,PA166205843,rs769404,,,GAD1,Dosage,1,methadone,1451138006.0,East Asian
1183700033,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1183700054.0,European
1448266722,PA166157393,rs4646440,,,CYP3A4,Metabolism/PK,-1,carbamazepine,1448266724.0,East Asian
982023752,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,caffeine,982023760.0,European
982023752,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,caffeine,982023758.0,East Asian
1183634353,PA166155633,rs1374385,,,HES6,Efficacy,-1,citalopram,1183634360.0,Unknown
1183634353,PA166155633,rs1374385,,,HES6,Efficacy,-1,fluoxetine,1183634360.0,Unknown
1183634353,PA166155633,rs1374385,,,HES6,Efficacy,-1,paroxetine,1183634360.0,Unknown
1449557898,PA166153876,rs17602729,,,AMPD1,Efficacy,-1,methotrexate,1449557900.0,European
1449557898,PA166153876,rs17602729,,,AMPD1,Efficacy,-1,methotrexate,1449558067.0,European
981794086,PA166156479,rs4742,,,DCTD,Efficacy,-1,gemcitabine,981794094.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794086,PA166156479,rs4742,,,DCTD,Toxicity,-1,gemcitabine,981794094.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
1451147943,PA166156658,rs12233719,,,UGT2B7,Efficacy,-1,fentanyl,1451147948.0,Unknown
1451148543,PA166154340,rs1800532,,,TPH1,Efficacy,1,escitalopram,1451148560.0,Multiple groups
655388073,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,655388075.0,European
655388073,PA166154977,rs7294,,,VKORC1,Metabolism/PK,1,warfarin,655388075.0,European
1448998441,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,efavirenz,1448998447.0,Unknown
1183689318,,,PA165819171,CYP1A2*1A,CYP1A2,Efficacy,-1,olanzapine,1183689320.0,Central/South Asian
1183689318,,,PA165819173,CYP1A2*1C,CYP1A2,Efficacy,-1,olanzapine,1183689320.0,Central/South Asian
1040387995,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,atorvastatin,1040387997.0,East Asian
1040387995,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,atorvastatin,1040387997.0,East Asian
655386848,PA166157302,rs1799889,,,SERPINE1,Efficacy,1,citalopram,655386851.0,East Asian
655386848,PA166157302,rs1799889,,,SERPINE1,Efficacy,1,fluoxetine,655386851.0,East Asian
655388076,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,655388078.0,European
655388076,PA166155096,rs9934438,,,VKORC1,Metabolism/PK,1,warfarin,655388078.0,European
1444703287,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,tenofovir,1444703289.0,East Asian
1448104256,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448104317.0,East Asian
1449168211,PA166177193,rs17786394,,,ANO2,Efficacy,1,duloxetine,1449168213.0,European
1449168223,PA166177195,rs17786412,,,ANO2,Efficacy,1,duloxetine,1449168225.0,European
608431741,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,,
608431764,PA166153680,rs2234922,,,EPHX1,,-1,warfarin,,
699639145,PA166156045,rs140504,,,BCR,Efficacy,0,lithium,699639150.0,East Asian
1183688829,,,PA165980634,CYP2C19*1,CYP2C19,Other,1,diazepam,1183688839.0,East Asian
1183688829,,,PA165980635,CYP2C19*2,CYP2C19,Other,1,diazepam,1183688839.0,East Asian
1183688829,,,PA165980636,CYP2C19*3,CYP2C19,Other,1,diazepam,1183688839.0,East Asian
1183688829,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,diazepam,1183688839.0,East Asian
1183688829,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,diazepam,1183688839.0,East Asian
1183688829,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,diazepam,1183688839.0,East Asian
1449188852,PA166156991,rs1799971,,,OPRM1,Dosage,1,morphine,1449188858.0,Unknown
1449188852,PA166156991,rs1799971,,,OPRM1,Efficacy,1,morphine,1449188858.0,Unknown
1184510035,PA166154053,rs4244285,,,CYP2C19,Dosage,-1,warfarin,1184510037.0,East Asian
769165182,PA166155346,rs25487,,,XRCC1,Efficacy,1,fluorouracil,769165184.0,Unknown
769170863,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,0,efavirenz,769170866.0,Sub-Saharan African
827848042,PA166155500,rs35979566,,,CYP2B6,Toxicity,-1,nevirapine,827848535.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827848042,PA166155500,rs35979566,,,CYP2B6,Metabolism/PK,-1,nevirapine,827848535.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
769170865,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,0,pravastatin,769170876.0,East Asian
1449576782,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,cyclophosphamide,1449576784.0,Central/South Asian
1449576782,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,doxorubicin,1449576784.0,Central/South Asian
1444705593,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705595.0,Multiple groups
1444705593,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705595.0,Multiple groups
769170797,PA166157593,rs3758149,,,GGH,Efficacy,1,methotrexate,769170799.0,East Asian
769170720,PA166155331,rs45445694,,,C18orf56,Toxicity,-1,methotrexate,,
769170720,PA166155331,rs45445694,,,TYMS,Toxicity,-1,methotrexate,,
981844204,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,erythromycin,981844213.0,Unknown
769171488,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,fluvoxamine,769171490.0,East Asian
769171479,PA166158926,rs57098334,,,SLC6A4,Efficacy,1,fluoxetine,769171483.0,East Asian
769171479,PA166158926,rs57098334,,,SLC6A4,Efficacy,1,paroxetine,769171483.0,East Asian
1449271551,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,0,methadone,1449271553.0,Unknown
1449715034,PA166180036,rs7208257,,,ARRB2,Dosage,-1,opioids,1449715037.0,European
1449715034,PA166180036,rs7208257,,,ARRB2,Dosage,-1,opioids,1449715036.0,European
769173647,PA166156710,rs7387,,,DHFR,Efficacy,-1,methotrexate,,
982048046,PA166155460,rs11666735,,,FCAR,Efficacy,-1,pravastatin,982048048.0,European
981862045,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,ibuprofen,981862098.0,European
981862045,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,ibuprofen,981862300.0,European
981862045,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,ibuprofen,981862302.0,European
982029511,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,venlafaxine,982029517.0,European
1447680853,PA166156625,rs7668258,,,UGT2B7,Metabolism/PK,-1,efavirenz,1447680855.0,Sub-Saharan African
827816329,PA166155505,rs45482602,,,CYP2B6,Dosage,-1,methadone,827816456.0,East Asian
827816329,PA166155505,rs45482602,,,CYP2B6,Metabolism/PK,-1,methadone,827816456.0,East Asian
1448106937,PA166156383,rs3814055,,,NR1I2,Efficacy,1,pazopanib,1448106995.0,"Multiple groups, 84% white"
769180270,PA166157132,rs8187725,,,SLC22A3,Other,1,catecholamines,769180273.0,Unknown
769180270,PA166157132,rs8187725,,,SLC22A3,Metabolism/PK,1,catecholamines,769180273.0,Unknown
769180270,PA166157132,rs8187725,,,SLC22A3,Other,1,metformin,769180273.0,Unknown
769180270,PA166157132,rs8187725,,,SLC22A3,Metabolism/PK,1,metformin,769180273.0,Unknown
1449156661,PA166175908,rs4839603,,,SLC9A9,Efficacy,1,fentanyl,1449156664.0,East Asian
1449156661,PA166175908,rs4839603,,,SLC9A9,Efficacy,1,fentanyl,1449156663.0,East Asian
1449156661,PA166175908,rs4839603,,,SLC9A9,Efficacy,1,remifentanil,1449156664.0,East Asian
1449156661,PA166175908,rs4839603,,,SLC9A9,Efficacy,1,remifentanil,1449156663.0,East Asian
769250034,PA166154053,rs4244285,,,CYP2C19,Other,1,phenytoin,769250037.0,Unknown
769250034,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,1,phenytoin,769250037.0,Unknown
769250082,PA166153972,rs1799853,,,CYP2C9,Other,-1,phenytoin,,
769250082,PA166153972,rs1799853,,,CYP2C9,Metabolism/PK,-1,phenytoin,,
769246303,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,769246305.0,Multiple groups
981481546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481551.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981481553.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981481551.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,981481553.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981481551.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981481553.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981481551.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981481553.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981481551.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981481553.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981481551.0,East Asian
981481546,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981481553.0,East Asian
827848049,PA166156104,rs3892097,,,CYP2D6,Toxicity,-1,nevirapine,827848537.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
827848049,PA166156104,rs3892097,,,CYP2D6,Metabolism/PK,-1,nevirapine,827848537.0,"Multiple groups, population comprised whites, african american, asian and hispanics"
769235413,PA166154877,rs2069526,,,CYP1A2,Other,-1,leflunomide,769235417.0,European
769235413,PA166154877,rs2069526,,,CYP1A2,Metabolism/PK,-1,leflunomide,769235417.0,European
769218883,PA166154850,rs762551,,,CYP1A2,Other,-1,clozapine,769218889.0,"Multiple groups, 39 men and 36 women; 73 white, 1 Asian, and 1 black African"
769218883,PA166154850,rs762551,,,CYP1A2,Metabolism/PK,-1,clozapine,769218889.0,"Multiple groups, 39 men and 36 women; 73 white, 1 Asian, and 1 black African"
981851608,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,0,isoniazid,981851610.0,Unknown
981851608,,,PA165949099,NAT2*5A,NAT2,Metabolism/PK,0,isoniazid,981851610.0,Unknown
981851608,,,PA165949115,NAT2*6A,NAT2,Metabolism/PK,0,isoniazid,981851610.0,Unknown
981851608,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,0,isoniazid,981851610.0,Unknown
981851608,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,0,isoniazid,981851610.0,Unknown
769245465,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,aspirin,769245467.0,Multiple groups
769245465,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,769245467.0,Multiple groups
1449271162,PA166175997,rs2234918,,,OPRD1,Efficacy,-1,methadone,1449271164.0,European
1183633740,PA166157576,rs2432742,,,CSMD3,Efficacy,-1,diuretics,1183633742.0,European
1183633740,PA166157576,rs2432742,,,CSMD3,Efficacy,-1,diuretics,1183633743.0,European
1183633740,PA166157576,rs2432742,,,CSMD3,Efficacy,-1,hydrochlorothiazide,1183633742.0,European
1183633740,PA166157576,rs2432742,,,CSMD3,Efficacy,-1,hydrochlorothiazide,1183633743.0,European
1183633740,PA166157576,rs2432742,,,CSMD3,Efficacy,-1,"Thiazides, plain",1183633742.0,European
1183633740,PA166157576,rs2432742,,,CSMD3,Efficacy,-1,"Thiazides, plain",1183633743.0,European
827641446,PA166154256,rs5219,,,KCNJ11,Efficacy,-1,"sulfonamides, urea derivatives",,
982036545,PA166157568,rs1801177,,,LPL,Efficacy,-1,fenofibrate,982036554.0,Unknown
982036545,PA166157568,rs1801177,,,LPL,Efficacy,-1,fenofibrate,982036563.0,Unknown
827566674,PA166156532,rs2018417,,,ADH1B,Toxicity,1,ethanol,827566680.0,European
827566674,PA166156532,rs2018417,,,ADH1B,Metabolism/PK,1,ethanol,827566680.0,European
1448105627,PA166155972,rs9024,,,CBR1,Metabolism/PK,1,doxorubicin,1448105629.0,"Multiple groups, Chinese; Malay; Indian"
1444698141,PA166155468,rs12979860,,,IFNL3,Efficacy,0,peginterferon alfa-2b,1444698148.0,Multiple groups
1444698141,PA166155468,rs12979860,,,IFNL4,Efficacy,0,peginterferon alfa-2b,1444698148.0,Multiple groups
1444698141,PA166155468,rs12979860,,,IFNL3,Efficacy,0,ribavirin,1444698148.0,Multiple groups
1444698141,PA166155468,rs12979860,,,IFNL4,Efficacy,0,ribavirin,1444698148.0,Multiple groups
827698457,,,PA165819176,CYP1A2*1F,CYP1A2,Metabolism/PK,1,caffeine,827698459.0,Unknown
827698390,,,PA165819179,CYP1A2*1K,CYP1A2,Metabolism/PK,1,caffeine,827698392.0,Sub-Saharan African
827698390,,,PA165819179,CYP1A2*1K,CYP1A2,Metabolism/PK,1,caffeine,827698392.0,Sub-Saharan African
827698390,,,PA165819179,CYP1A2*1K,CYP1A2,Metabolism/PK,1,caffeine,827698392.0,Sub-Saharan African
827698390,,,PA165819179,CYP1A2*1K,CYP1A2,Metabolism/PK,1,caffeine,827698392.0,Sub-Saharan African
827698390,,,PA165819179,CYP1A2*1K,CYP1A2,Metabolism/PK,1,caffeine,827698392.0,Sub-Saharan African
981954118,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,acenocoumarol,981954133.0,Unknown
827690709,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,nifedipine,827690711.0,Unknown
827690709,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,-1,nifedipine,827690711.0,Unknown
827690709,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,-1,nifedipine,827690711.0,Unknown
827690709,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,-1,nifedipine,827690711.0,Unknown
827690709,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,-1,nifedipine,827690711.0,Unknown
1450930674,PA166154842,rs615470,,,CHRNA5,Other,-1,nicotine,1450930678.0,East Asian
1450930674,PA166154842,rs615470,,,CHRNA5,Other,-1,nicotine,1450930678.0,East Asian
1450930674,PA166154842,rs615470,,,CHRNA5,Other,-1,nicotine,1450930678.0,East Asian
827700554,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,-1,tegafur,827700562.0,East Asian
827700554,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,-1,tegafur,827700562.0,East Asian
827700554,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,-1,tegafur,827700562.0,East Asian
827700554,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,-1,tegafur,827700562.0,East Asian
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,cyclophosphamide,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,cyclophosphamide,827704820.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,epirubicin,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,epirubicin,827704820.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704820.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704820.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704820.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704820.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704822.0,"Multiple groups, Brazil: white and black"
827704813,PA166154249,rs1695,,,GSTP1,Efficacy,1,fluorouracil,827704820.0,"Multiple groups, Brazil: white and black"
827699118,PA166155331,rs45445694,,,C18orf56,Efficacy,-1,carboplatin,827699121.0,European
827699118,PA166155331,rs45445694,,,TYMS,Efficacy,-1,carboplatin,827699121.0,European
827699118,PA166155331,rs45445694,,,C18orf56,Efficacy,-1,pemetrexed,827699121.0,European
827699118,PA166155331,rs45445694,,,TYMS,Efficacy,-1,pemetrexed,827699121.0,European
827699118,PA166155331,rs45445694,,,TYMS,Efficacy,-1,pemetrexed,827699121.0,European
827698978,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,1,nicotine,827698980.0,East Asian
1448258061,PA166160154,rs4980524,,,STIP1,Efficacy,-1,corticosteroids,1448258063.0,Unknown
827783868,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827783887.0,European
827783868,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,827783887.0,European
827783860,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827783883.0,European
827783860,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,827783883.0,European
827807099,,,PA165816576,CYP2D6*1,CYP2D6,Other,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816578,CYP2D6*3,CYP2D6,Other,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816579,CYP2D6*4,CYP2D6,Other,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816581,CYP2D6*6,CYP2D6,Other,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,carvedilol,827807116.0,Multiple groups
827807099,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,carvedilol,827807116.0,Multiple groups
1183689255,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1183689265.0,East Asian
1183689255,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1183689265.0,East Asian
1183689255,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1183689265.0,East Asian
827789188,PA166157830,rs11146020,,,GRIN1,Efficacy,-1,clozapine,827789193.0,European
827789188,PA166157830,rs11146020,,,GRIN1,Efficacy,-1,clozapine,827789195.0,African American/Afro-Caribbean
827807143,,,PA165816533,CYP2C19*17,CYP2C19,Other,-1,carvedilol,827807161.0,Multiple groups
827807143,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,carvedilol,827807161.0,Multiple groups
827807126,,,PA165816576,CYP2D6*1,CYP2D6,Other,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816578,CYP2D6*3,CYP2D6,Other,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816579,CYP2D6*4,CYP2D6,Other,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816581,CYP2D6*6,CYP2D6,Other,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,carvedilol,827807134.0,Multiple groups
827807126,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,carvedilol,827807134.0,Multiple groups
827783872,,,PA165860685,CYP4F2*1,CYP4F2,Dosage,1,warfarin,827783876.0,European
827783872,,,PA165860687,CYP4F2*3,CYP4F2,Dosage,1,warfarin,827783876.0,European
827783863,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827783885.0,European
827783863,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,827783885.0,European
827783863,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,827783885.0,European
827807176,,,PA165816542,CYP2C9*1,CYP2C9,Other,-1,carvedilol,827807192.0,Unknown
827807176,,,PA165816543,CYP2C9*2,CYP2C9,Other,-1,carvedilol,827807192.0,Unknown
827807176,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,carvedilol,827807192.0,Unknown
827807176,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,carvedilol,827807192.0,Unknown
827922780,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,1,paclitaxel,827922786.0,"Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5."
827922780,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,1,paclitaxel,827922823.0,European
827922780,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,1,paclitaxel,827922786.0,"Multiple groups, An original 111 patients self-reported as Caucasian 79;African-American 27 and Other 5."
827922780,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,1,paclitaxel,827922823.0,European
827807123,,,PA165816576,CYP2D6*1,CYP2D6,Other,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816578,CYP2D6*3,CYP2D6,Other,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816579,CYP2D6*4,CYP2D6,Other,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165948092,CYP2D6*5,CYP2D6,Other,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816581,CYP2D6*6,CYP2D6,Other,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,carvedilol,827807136.0,Multiple groups
827807123,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,carvedilol,827807136.0,Multiple groups
827812172,PA166155739,rs5009910,,,GALNT14,Efficacy,1,cisplatin,827812177.0,Unknown
827812172,PA166155739,rs5009910,,,GALNT14,Efficacy,1,fluorouracil,827812177.0,Unknown
827812172,PA166155739,rs5009910,,,GALNT14,Efficacy,1,mitoxantrone,827812177.0,Unknown
827812172,PA166155739,rs5009910,,,GALNT14,Efficacy,1,mitoxantrone,827812177.0,Unknown
827813144,,,PA165924731,CYP2A6*7,CYP2A6,Other,0,caffeine,,
827813144,,,PA165924735,CYP2A6*10,CYP2A6,Other,0,caffeine,,
827813144,,,PA165924736,CYP2A6*11,CYP2A6,Other,0,caffeine,,
827813144,,,PA165924736,CYP2A6*11,CYP2A6,Other,0,caffeine,,
827813144,,,PA165924731,CYP2A6*7,CYP2A6,Metabolism/PK,0,caffeine,,
827813144,,,PA165924735,CYP2A6*10,CYP2A6,Metabolism/PK,0,caffeine,,
827813144,,,PA165924736,CYP2A6*11,CYP2A6,Metabolism/PK,0,caffeine,,
1447963349,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1447963358.0,East Asian
1447963349,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1447963358.0,East Asian
1447963349,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1447963358.0,East Asian
1447963349,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1447963358.0,East Asian
827812881,,,PA165980914,CYP2A6*9,CYP2A6,Other,1,caffeine,827812885.0,Unknown
827812881,,,PA165980914,CYP2A6*9,CYP2A6,Other,1,caffeine,827812885.0,Unknown
827812881,,,PA165980914,CYP2A6*9,CYP2A6,Other,1,caffeine,827812885.0,Unknown
827812881,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,caffeine,827812885.0,Unknown
827812881,,,PA165980914,CYP2A6*9,CYP2A6,Metabolism/PK,1,caffeine,827812885.0,Unknown
827827685,,,PA165980915,CYP2A6*12,CYP2A6,Other,0,coumarin,827827692.0,European
827827685,,,PA165980915,CYP2A6*12,CYP2A6,Other,0,coumarin,827827703.0,"Custom, COS-1 cells"
827827685,,,PA165980915,CYP2A6*12,CYP2A6,Other,0,coumarin,827827692.0,European
827827685,,,PA165980915,CYP2A6*12,CYP2A6,Other,0,coumarin,827827703.0,"Custom, COS-1 cells"
827827685,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,0,coumarin,827827692.0,European
827827685,,,PA165980915,CYP2A6*12,CYP2A6,Metabolism/PK,0,coumarin,827827703.0,"Custom, COS-1 cells"
827925130,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827925133.0,East Asian
827925130,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,827925133.0,East Asian
827925130,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,827925133.0,East Asian
827925130,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,warfarin,827925133.0,East Asian
1448995815,PA166170292,rs2236416,,,MMP9,Efficacy,-1,bevacizumab,1448995818.0,European
1448995815,PA166170292,rs2236416,,,MMP9,Efficacy,-1,bevacizumab,1448995817.0,African American/Afro-Caribbean
1448995815,PA166170292,rs2236416,,,MMP9,Efficacy,-1,bevacizumab,1448995818.0,European
1448995815,PA166170292,rs2236416,,,MMP9,Efficacy,-1,bevacizumab,1448995817.0,African American/Afro-Caribbean
1448995815,PA166170292,rs2236416,,,MMP9,Efficacy,-1,bevacizumab,1448995818.0,European
1448995815,PA166170292,rs2236416,,,MMP9,Efficacy,-1,bevacizumab,1448995817.0,African American/Afro-Caribbean
1449144280,PA166171050,rs1521470,,,ADCY1,Efficacy,1,lithium,1449144282.0,"Multiple groups, 2366 patients were of European descent. The remaining 220 patients were of Asian descent"
827823561,PA166155589,rs231775,,,CTLA4,Efficacy,-1,glatiramer acetate,827823609.0,European
827822925,PA166154500,rs731236,,,VDR,Efficacy,-1,zoledronate,827822950.0,Unknown
1450934482,PA166185919,rs190347120,,,GLA,Efficacy,0,migalastat,1450934487.0,Unknown
1444706524,PA166157592,rs3735814,,,GATA4,Dosage,-1,phenprocoumon,1444706526.0,Multiple groups
1449714818,PA166179997,rs7122246,,,DRD2,Dosage,-1,opioids,1449714821.0,European
1449714818,PA166179997,rs7122246,,,DRD2,Dosage,-1,opioids,1449714820.0,European
827824071,PA166153680,rs2234922,,,EPHX1,Dosage,-1,carbamazepine,827824212.0,East Asian
827824071,PA166153680,rs2234922,,,EPHX1,Metabolism/PK,-1,carbamazepine,827824212.0,East Asian
827806117,PA166155164,rs391300,,,SRR,Efficacy,1,metformin,827806131.0,East Asian
827806117,PA166155164,rs391300,,,SRR,Efficacy,1,metformin,827806144.0,East Asian
827806117,PA166155164,rs391300,,,SRR,Efficacy,1,metformin,827806141.0,East Asian
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,827813348.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,827813344.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,atorvastatin,827813346.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813348.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813344.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813346.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813348.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813344.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813346.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813348.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813344.0,European
827813338,PA166153953,rs717620,,,ABCC2,Efficacy,1,simvastatin,827813346.0,European
1449295921,PA166156024,rs4680,,,COMT,Dosage,-1,morphine,1449295923.0,European
1449295921,PA166156024,rs4680,,,COMT,Efficacy,-1,morphine,1449295923.0,European
827845854,PA166154932,rs11636419,,,CYP1A2,Dosage,-1,warfarin,827845860.0,East Asian
981239471,PA166155139,rs104894541,,,VKORC1,Dosage,0,warfarin,1184136139.0,Unknown
981238760,PA166155650,rs1869295,,,AGAP1,Efficacy,1,risperidone,981238766.0,European
827845898,PA166157481,rs28371759,,,CYP3A4,Dosage,-1,warfarin,827845907.0,East Asian
827845898,PA166157481,rs28371759,,,CYP3A4,Dosage,-1,warfarin,827845907.0,East Asian
827827892,PA166157642,rs13250096,,,GFRA2,Efficacy,-1,clozapine,827827899.0,"Multiple groups, USA, Caucasians (n = 114) and African American (n = 26)"
981865137,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,acenocoumarol,981865141.0,European
1449715478,PA166180070,rs11931604,,,UGT2B7,Efficacy,-1,fentanyl,1449715480.0,East Asian
1449715544,PA166180070,rs11931604,,,UGT2B7,Dosage,-1,fentanyl,1449715546.0,East Asian
981238701,PA166157636,rs11774231,,,None,Efficacy,1,perphenazine,981238706.0,European
827823858,PA166156358,rs2472677,,,NR1I2,Dosage,-1,nevirapine,827823866.0,Sub-Saharan African
827823858,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,-1,nevirapine,827823866.0,Sub-Saharan African
1448612694,PA166157288,rs1128503,,,ABCB1,Efficacy,1,imatinib,1448612700.0,Central/South Asian
981238713,PA166157652,rs17570753,,,MCPH1,Efficacy,1,perphenazine,981238719.0,European
981238789,PA166157562,rs1546519,,,LYN,Efficacy,1,ziprasidone,981238795.0,European
1450045199,PA166181281,rs2900476,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045201.0,Unknown
981238675,PA166157087,rs3819811,,,PLAGL1,Efficacy,1,olanzapine,981238688.0,European
1448519661,PA166161803,rs1731017,,,ABAT,Efficacy,-1,valproic acid,1448519667.0,East Asian
1450045223,PA166181284,rs2417955,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045225.0,Unknown
1450045235,PA166181286,rs10444413,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045237.0,Unknown
1450045229,PA166181285,rs4149035,,,SLCO1B1,Metabolism/PK,-1,methotrexate,1450045231.0,Unknown
981238655,PA166157651,rs17070785,,,CSMD1,Efficacy,1,olanzapine,981238660.0,European
1449271576,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,0,S-EDDP,1449271578.0,Unknown
827824096,PA166157316,rs2032582,,,ABCB1,Dosage,-1,carbamazepine,827824216.0,East Asian
827824096,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,carbamazepine,827824216.0,East Asian
827922827,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,-1,cyclophosphamide,827922833.0,Multiple groups
827922827,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,-1,cyclophosphamide,827922833.0,Multiple groups
827922827,,,PA166242948,CYP2C8*1,CYP2C8,Efficacy,-1,doxorubicin,827922833.0,Multiple groups
827922827,,,PA165958685,CYP2C8*3,CYP2C8,Efficacy,-1,doxorubicin,827922833.0,Multiple groups
1449733189,PA166154161,rs17216177,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733191.0,Sub-Saharan African
1449733152,PA166180522,rs16980091,,,FOXA3,Metabolism/PK,1,rosuvastatin,1449733154.0,Sub-Saharan African
1449733162,PA166180524,rs17216198,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733164.0,Sub-Saharan African
1449733162,PA166180524,rs17216198,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733164.0,Sub-Saharan African
1449733162,PA166180524,rs17216198,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733164.0,Sub-Saharan African
827824618,,,PA165924731,CYP2A6*7,CYP2A6,Efficacy,-1,tegafur,827824623.0,East Asian
827824618,,,PA165980914,CYP2A6*9,CYP2A6,Efficacy,-1,tegafur,827824623.0,East Asian
827824618,,,PA165924735,CYP2A6*10,CYP2A6,Efficacy,-1,tegafur,827824623.0,East Asian
827824618,,,PA165924736,CYP2A6*11,CYP2A6,Efficacy,-1,tegafur,827824623.0,East Asian
827807419,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,827807423.0,"Multiple groups, 89.2% White, 9.8% Black, 1% Hispanic"
1449167930,PA166177138,rs3889402,,,MIEF2,Efficacy,1,duloxetine,1449167932.0,European
827813426,PA166156330,rs1801019,,,UMPS,Efficacy,-1,fluorouracil,827813436.0,European
1451100046,PA166195023,rs324498,,,PTPRD,Efficacy,-1,Antihypertensives,1451100052.0,"Multiple groups, White and Hispanic patients"
1451100046,PA166195023,rs324498,,,PTPRD,Efficacy,-1,Antihypertensives,1451100003.0,"Multiple groups, White and Hispanic patients"
1451100046,PA166195023,rs324498,,,PTPRD,Efficacy,-1,Antihypertensives,1451100051.0,"Multiple groups, White and Hispanic patients"
1039730449,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,atorvastatin,1040301452.0,East Asian
1039730449,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,atorvastatin,1040301452.0,East Asian
1449557975,PA166163751,rs699517,,,TYMS,Efficacy,-1,methotrexate,1449557977.0,European
1449557975,PA166163751,rs699517,,,TYMS,Efficacy,-1,methotrexate,1449558085.0,European
827827900,PA166157599,rs4567028,,,GFRA2,Efficacy,-1,clozapine,827827908.0,"Multiple groups, USA, Caucasians (n = 114) and African American (n = 26)"
1041015512,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1041015722.0,East Asian
1041015512,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1041015722.0,East Asian
1449269193,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1449269198.0,Multiple groups
1449269193,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1449269198.0,Multiple groups
827863698,,,PA165816542,CYP2C9*1,CYP2C9,Other,0,warfarin,827863701.0,Unknown
827863698,,,PA165816543,CYP2C9*2,CYP2C9,Other,0,warfarin,827863701.0,Unknown
827863698,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,warfarin,827863701.0,Unknown
827863698,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,0,warfarin,827863701.0,Unknown
827863693,,,PA165816542,CYP2C9*1,CYP2C9,Other,0,warfarin,827863696.0,Unknown
827863693,,,PA165816544,CYP2C9*3,CYP2C9,Other,0,warfarin,827863696.0,Unknown
827863693,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,warfarin,827863696.0,Unknown
827863693,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,0,warfarin,827863696.0,Unknown
1449716717,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,sufentanil,1449716727.0,East Asian
1449716717,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,-1,sufentanil,1449716727.0,East Asian
978639890,PA166157378,rs3750117,,,NT5C3A,Other,1,gemcitabine,978639900.0,European
978639890,PA166157378,rs3750117,,,NT5C3A,Metabolism/PK,1,gemcitabine,978639900.0,European
827814740,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,827814748.0,Near Eastern
827807933,PA166157645,rs13266634,,,SLC30A8,Efficacy,1,repaglinide,827807949.0,East Asian
827920114,PA166154373,rs2511989,,,SERPING1,Efficacy,-1,bevacizumab,827920146.0,East Asian
827783829,,,PA165818760,CYP2B6*5,CYP2B6,Other,-1,propofol,827783842.0,Unknown
827783829,,,PA165818760,CYP2B6*5,CYP2B6,Metabolism/PK,-1,propofol,827783842.0,Unknown
827783826,,,PA165818807,CYP2B6*9,CYP2B6,Other,-1,propofol,827783840.0,Unknown
827783826,,,PA165818807,CYP2B6*9,CYP2B6,Metabolism/PK,-1,propofol,827783840.0,Unknown
1449714354,PA166179919,rs3773679,,,DRD3,Dosage,-1,opioids,1449714356.0,European
1449714354,PA166179919,rs3773679,,,DRD3,Dosage,-1,opioids,1449714357.0,European
827824182,PA166156676,rs28365062,,,UGT2B7,Dosage,-1,carbamazepine,827824233.0,East Asian
827824182,PA166156676,rs28365062,,,UGT2B7,Metabolism/PK,-1,carbamazepine,827824233.0,East Asian
1450813963,PA166156024,rs4680,,,COMT,Efficacy,1,modafinil,1450813968.0,Latino
1450928217,PA166153653,rs1805054,,,HTR6,Efficacy,-1,risperidone,1450928224.0,Unknown
1450928217,PA166153653,rs1805054,,,HTR6,Efficacy,-1,risperidone,1450928223.0,East Asian
1450928217,PA166153653,rs1805054,,,HTR6,Efficacy,-1,risperidone,1450928222.0,East Asian
1450928312,PA166156134,rs9606186,,,COMT,Efficacy,-1,risperidone,1450928319.0,East Asian
1450928312,PA166156134,rs9606186,,,COMT,Efficacy,-1,risperidone,1450928317.0,East Asian
1450928312,PA166156134,rs9606186,,,COMT,Efficacy,-1,risperidone,1450928318.0,East Asian
827830265,PA166157284,rs1045642,,,ABCB1,Dosage,-1,tacrolimus,827830274.0,Multiple groups
827830265,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,827830274.0,Multiple groups
827777175,PA166157650,rs17060812,,,SLC39A14,Efficacy,1,nortriptyline,827777183.0,European
827777175,PA166157650,rs17060812,,,SLC39A14,Efficacy,1,nortriptyline,827777183.0,European
827864335,,,PA165924756,CYP2A6*26,CYP2A6,Metabolism/PK,0,letrozole,827864409.0,Multiple groups
1183849194,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,paroxetine,1183849198.0,European
1183849194,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,paroxetine,1183849198.0,European
827844985,PA166154162,rs17222589,,,ABCC2,Efficacy,-1,antiepileptics,827844992.0,East Asian
827844958,PA166154019,rs2804398,,,ABCC2,Efficacy,-1,antiepileptics,827844964.0,East Asian
827844958,PA166154019,rs2804398,,,ABCC2,Efficacy,-1,antiepileptics,827844964.0,East Asian
827864338,,,PA165980920,CYP2A6*35,CYP2A6,,0,letrozole,827864411.0,Multiple groups
1450823501,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,fluvastatin,1450823507.0,European
1450823501,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,fluvastatin,1450823507.0,European
827784616,PA166154626,rs11045585,,,SLCO1B3,Other,1,docetaxel,827784621.0,East Asian
827784616,PA166154626,rs11045585,,,SLCO1B3,Metabolism/PK,1,docetaxel,827784621.0,East Asian
1184483448,PA166157699,rs17650,,,ORM1,Dosage,1,warfarin,1184483452.0,East Asian
981417557,PA166157169,rs10499194,,,SH3BP2,Efficacy,-1,adalimumab,981417713.0,European
981417557,PA166157169,rs10499194,,,SH3BP2,Efficacy,-1,etanercept,981417713.0,European
981417557,PA166157169,rs10499194,,,SH3BP2,Efficacy,-1,infliximab,981417713.0,European
981417557,PA166157169,rs10499194,,,SH3BP2,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417713.0,European
981417565,PA166157580,rs2736340,,,BLK,Efficacy,-1,adalimumab,981417719.0,European
981417565,PA166157580,rs2736340,,,BLK,Efficacy,-1,etanercept,981417719.0,European
981417565,PA166157580,rs2736340,,,BLK,Efficacy,-1,infliximab,981417719.0,European
981417565,PA166157580,rs2736340,,,BLK,Efficacy,-1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,981417719.0,European
981502885,PA166154355,rs2237895,,,KCNQ1,Efficacy,1,repaglinide,981502893.0,East Asian
981477848,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,sulfamethoxazole,981477850.0,East Asian
981477848,,,PA165949102,NAT2*5D,NAT2,Metabolism/PK,1,sulfamethoxazole,981477850.0,East Asian
981477848,,,PA165949116,NAT2*6B,NAT2,Metabolism/PK,1,sulfamethoxazole,981477850.0,East Asian
981477848,,,PA165949130,NAT2*7A,NAT2,Metabolism/PK,1,sulfamethoxazole,981477850.0,East Asian
981750822,PA166154513,rs1386494,,,TPH2,Efficacy,-1,citalopram,981750827.0,European
981750822,PA166154513,rs1386494,,,TPH2,Efficacy,-1,fluoxetine,981750827.0,European
981750822,PA166154513,rs1386494,,,TPH2,Efficacy,-1,paroxetine,981750827.0,European
981750795,PA166154673,rs6311,,,HTR2A,Efficacy,-1,citalopram,981750799.0,European
981750795,PA166154673,rs6311,,,HTR2A,Efficacy,-1,fluoxetine,981750799.0,European
981750795,PA166154673,rs6311,,,HTR2A,Efficacy,-1,paroxetine,981750799.0,European
1449714533,PA166179950,rs3864283,,,HINT1,Dosage,-1,opioids,1449714536.0,European
1449714533,PA166179950,rs3864283,,,HINT1,Dosage,-1,opioids,1449714535.0,European
1449557344,PA166179077,rs11574077,,,VDR,Metabolism/PK,1,irinotecan,1449557351.0,European
1449557344,PA166179077,rs11574077,,,VDR,Metabolism/PK,1,irinotecan,1449557355.0,European
981479632,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2a,981479638.0,East Asian
981479632,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981479638.0,East Asian
981479632,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,981479638.0,East Asian
1183620362,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,risperidone,1183620381.0,East Asian
1448567737,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,sirolimus,1448567739.0,Unknown
981502166,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,1,mirtazapine,981502170.0,Unknown
981502148,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,mirtazapine,981502165.0,Unknown
981500957,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,antipsychotics,981500961.0,European
981500957,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,haloperidol,981500961.0,European
981500957,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,olanzapine,981500961.0,European
981500957,PA166155159,rs25531,,,SLC6A4,Efficacy,-1,risperidone,981500961.0,European
981501598,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501602.0,European
981501598,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501624.0,European
981478337,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,naproxen,981478341.0,East Asian
981478337,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,naproxen,981478341.0,East Asian
981501603,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501605.0,European
981501603,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501626.0,European
981501603,,,PA165949101,NAT2*5C,NAT2,Metabolism/PK,1,sulfapyridine,981501605.0,European
981501603,,,PA165949101,NAT2*5C,NAT2,Metabolism/PK,1,sulfapyridine,981501626.0,European
981501611,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501613.0,European
981501611,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501630.0,European
981501611,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,sulfapyridine,981501613.0,European
981501611,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,sulfapyridine,981501630.0,European
981501619,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,sulfapyridine,981501621.0,European
981501619,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,sulfapyridine,981501634.0,European
1184756997,PA166153772,rs4653436,,,EPHX1,Dosage,-1,warfarin,1184756999.0,East Asian
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,citalopram,981500806.0,European
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,citalopram,981500805.0,Multiple groups
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,fluoxetine,981500806.0,European
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,fluoxetine,981500805.0,Multiple groups
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,mirtazapine,981500806.0,European
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,mirtazapine,981500805.0,Multiple groups
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,paroxetine,981500806.0,European
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,paroxetine,981500805.0,Multiple groups
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,Selective serotonin reuptake inhibitors,981500806.0,European
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,Selective serotonin reuptake inhibitors,981500805.0,Multiple groups
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,venlafaxine,981500806.0,European
981500798,PA166157083,rs3800373,,,FKBP5,Efficacy,-1,venlafaxine,981500805.0,Multiple groups
981239981,PA166153612,rs1051740,,,EPHX1,Dosage,1,carbamazepine,981239991.0,East Asian
981239981,PA166153612,rs1051740,,,EPHX1,Metabolism/PK,1,carbamazepine,981239991.0,East Asian
981238818,PA166155096,rs9934438,,,VKORC1,Dosage,0,acenocoumarol,981238832.0,"Multiple groups, Reported that approximately 99% of patients were Caucasian in this cohort."
827864080,PA166156568,rs2960306,,,GRK4,Efficacy,1,metoprolol,827864091.0,African American/Afro-Caribbean
1184821109,PA166155599,rs724710,,,BCL2L11,Efficacy,1,imatinib,1184825577.0,Unknown
1451116362,PA166154628,rs11045819,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451116367.0,European
1451116362,PA166154628,rs11045819,,,SLCO1B1,Metabolism/PK,-1,lopinavir,1451116368.0,European
1451121689,PA166156055,rs737865,,,COMT,Efficacy,-1,oxycodone,1451121693.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
981345416,PA166156748,rs1042713,,,ADRB2,Metabolism/PK,-1,terbutaline,981345424.0,Unknown
981479950,PA166157645,rs13266634,,,SLC30A8,Efficacy,-1,metformin,981479966.0,"Multiple groups, White,African American,Hispanic,Asian/Pacific Islanders,American Indians."
981240151,PA166157603,rs4646244,,,NAT2,Toxicity,1,isoniazid,981240156.0,East Asian
981240151,PA166157603,rs4646244,,,NAT2,Metabolism/PK,1,isoniazid,981240156.0,East Asian
981861796,PA166157306,rs1800797,,,IL6,Efficacy,1,peginterferon alfa-2a,981861803.0,European
981501518,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,sulfapyridine,981501520.0,East Asian
981501518,,,PA165949100,NAT2*5B,NAT2,Metabolism/PK,1,sulfapyridine,981501520.0,East Asian
981501499,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,sulfapyridine,981501501.0,East Asian
981501499,,,PA165949131,NAT2*7B,NAT2,Metabolism/PK,1,sulfapyridine,981501501.0,East Asian
1184166980,PA166156610,rs6822844,,,IL2,Efficacy,1,rituximab,1184166984.0,European
769164776,PA166156619,rs7439366,,,UGT2B7,Efficacy,1,lorazepam,769164778.0,East Asian
769164776,PA166156619,rs7439366,,,UGT2B7,Efficacy,1,valproic acid,769164778.0,East Asian
981475614,PA166154855,rs1048943,,,CYP1A1,Efficacy,1,capecitabine,981475618.0,East Asian
981475614,PA166154855,rs1048943,,,CYP1A1,Efficacy,1,docetaxel,981475618.0,East Asian
981477269,PA166155008,rs1110470,,,IL4R,Efficacy,1,pitrakinra,981477277.0,European
827864556,PA166155351,rs429358,,,APOC1,Dosage,1,warfarin,827864557.0,Near Eastern
827864556,PA166155351,rs429358,,,APOE,Dosage,1,warfarin,827864557.0,Near Eastern
827864548,PA166154082,rs7900194,,,CYP2C9,Dosage,1,warfarin,827864549.0,Near Eastern
981747571,PA166155333,rs75982813,,,NEDD4L,Efficacy,-1,atenolol,981747574.0,European
1449716606,PA166156991,rs1799971,,,OPRM1,Dosage,1,fentanyl,1449716612.0,East Asian
1449716606,PA166156991,rs1799971,,,OPRM1,Efficacy,1,fentanyl,1449716612.0,East Asian
982046448,PA166155407,rs3212986,,,ERCC1,Efficacy,-1,Platinum compounds,982046450.0,"Multiple groups, Asian and Caucasian"
981419964,PA166157316,rs2032582,,,ABCB1,Dosage,1,antipsychotics,981419974.0,Central/South Asian
981419964,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,antipsychotics,981419974.0,Central/South Asian
1184483453,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1184483455.0,East Asian
1449716512,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,fentanyl,1449716518.0,"Multiple groups, Caucasian, African American, Asian and Hispanic participants."
981502459,PA166154851,rs809736,,,RORA,Efficacy,-1,citalopram,981502463.0,"Multiple groups, African American, non-Hispanic Caucasian and Hispanic Caucasian"
981344709,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,981344713.0,European
981344709,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,981344713.0,European
981344709,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,warfarin,981344713.0,European
981344709,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,981344713.0,European
981345061,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,warfarin,981345092.0,European
981237893,PA166154882,rs2242047,,,SLC28A1,Efficacy,-1,gemcitabine,981237899.0,East Asian
981939860,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,981939903.0,Unknown
981939860,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,981939903.0,Unknown
981794008,PA166154269,rs183484,,,RRM1,Efficacy,1,gemcitabine,981794012.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981794008,PA166154269,rs183484,,,RRM1,Toxicity,1,gemcitabine,981794012.0,"Multiple groups, 136/149 subjects were white, 9 were Hispanic, 2 were African American, and 2 were ""other"""
981419341,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,981419345.0,European
981419341,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,981419345.0,European
981483885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,981483888.0,East Asian
981483885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,981483888.0,East Asian
981483885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,981483888.0,East Asian
981483885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,981483888.0,East Asian
981483885,PA166155468,rs12979860,,,IFNL3,Efficacy,1,telaprevir,981483888.0,East Asian
981483885,PA166155468,rs12979860,,,IFNL4,Efficacy,1,telaprevir,981483888.0,East Asian
1447586762,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447586764.0,Near Eastern
981750833,PA166154856,rs1051730,,,CHRNA3,Metabolism/PK,1,nicotine,981750842.0,European
981934332,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,phenprocoumon,981934334.0,Unknown
981934332,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,phenprocoumon,981934334.0,Unknown
981934332,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenprocoumon,981934334.0,Unknown
1184468829,PA166157243,rs15524,,,CYP3A5,Dosage,1,tacrolimus,1184468831.0,Multiple groups
982010010,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,982010016.0,Near Eastern
1451104700,PA166196241,rs8065082,,,SLC47A1,Efficacy,1,metformin,1451104705.0,"Multiple groups, ""27-center randomized clinical trial in the U.S.: 56% white, 20% African American, 17% Hispanic, 4% Asian/Pacific Islander, 3% American Indian"""
981851591,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,981851593.0,East Asian
981851586,,,PA165949098,NAT2*4,NAT2,Metabolism/PK,1,isoniazid,981851590.0,East Asian
981934227,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,981934229.0,Unknown
981785635,PA166154883,rs2242048,,,SLC28A1,Efficacy,-1,gemcitabine,981785639.0,East Asian
637879873,PA166157254,rs339097,,,CALU,Dosage,1,warfarin,637879875.0,Multiple groups
981934157,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,981934159.0,Unknown
981862010,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,ibuprofen,981862014.0,Unknown
981954065,PA166153566,rs228729,,,PER3,Efficacy,-1,lithium,981954069.0,European
981848084,PA166156291,rs701265,,,P2RY1,Efficacy,-1,clopidogrel,981848090.0,"Multiple groups, White, African-American, Asian, and Hispanic origin"
981862049,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,ibuprofen,981862080.0,European
981862049,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,ibuprofen,981862106.0,European
981862049,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,ibuprofen,981862082.0,European
982006745,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,982006751.0,European
981848218,PA166156024,rs4680,,,COMT,Efficacy,-1,venlafaxine,981848233.0,European
981848218,PA166156024,rs4680,,,COMT,Efficacy,-1,venlafaxine,981848235.0,European
1451117386,PA166199006,rs8068318,,,TBX2,Efficacy,1,atenolol,1451117366.0,"Multiple groups, See Figure 1A for genetic ancestry data"
981865171,PA166154344,rs1946518,,,IL18,Efficacy,1,"interferon alfa-2a, recombinant",981865176.0,European
981865171,PA166154344,rs1946518,,,IL18,Efficacy,1,"interferon alfa-2b, recombinant",981865176.0,European
981865171,PA166154344,rs1946518,,,IL18,Efficacy,1,interferons,981865176.0,European
981865171,PA166154344,rs1946518,,,IL18,Efficacy,1,peginterferon alfa-2a,981865176.0,European
981865171,PA166154344,rs1946518,,,IL18,Efficacy,1,peginterferon alfa-2b,981865176.0,European
981865171,PA166154344,rs1946518,,,IL18,Efficacy,1,ribavirin,981865176.0,European
981954438,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,acenocoumarol,981954444.0,Central/South Asian
827785547,PA166157267,rs776746,,,CYP3A,Dosage,1,tacrolimus,827785588.0,European
827785547,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,827785588.0,European
827785547,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,tacrolimus,827785588.0,European
827785547,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,827785588.0,European
982010082,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,982010089.0,Near Eastern
827699040,PA166157267,rs776746,,,CYP3A5,Efficacy,0,tacrolimus,827699077.0,"Multiple groups, Mostly White.  14/16 receiving tacrolimus once daily were white.  12/15 receiving tacrolimus twice daily were white."
827699040,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,0,tacrolimus,827699077.0,"Multiple groups, Mostly White.  14/16 receiving tacrolimus once daily were white.  12/15 receiving tacrolimus twice daily were white."
982015587,PA166157647,rs13280604,,,CHRNB3,Dosage,-1,ethanol,982015591.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015587,PA166157647,rs13280604,,,CHRNB3,Efficacy,-1,ethanol,982015591.0,"Multiple groups, 74% Caucasian;16% Hispanic;4% African American;6% other."
982015075,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,982015086.0,Central/South Asian
827813960,PA166157267,rs776746,,,CYP3A5,Dosage,-1,cyclosporine,827813980.0,"Multiple groups, Brazilian"
827813960,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827813980.0,"Multiple groups, Brazilian"
827813960,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827813980.0,"Multiple groups, Brazilian"
827813960,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827813980.0,"Multiple groups, Brazilian"
827813960,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,cyclosporine,827813980.0,"Multiple groups, Brazilian"
982028876,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antidepressants,982028884.0,Multiple groups
1134807206,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,losartan,1134807349.0,Sub-Saharan African
1134807206,,,PA165816552,CYP2C9*11,CYP2C9,Metabolism/PK,-1,losartan,1134807349.0,Sub-Saharan African
982046197,PA166155265,rs60282872,,,SREBF1,Efficacy,-1,atorvastatin,982046201.0,Multiple groups
1134049001,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,losartan,1134052957.0,Sub-Saharan African
1134049001,,,PA165816547,CYP2C9*6,CYP2C9,Metabolism/PK,0,losartan,1134052957.0,Sub-Saharan African
1451126286,PA166202221,rs616147,,,MOBP,Efficacy,-1,valproic acid,1451126291.0,Unknown
982043919,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,982043921.0,European
1043880897,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,losartan,1043880899.0,Near Eastern
1043880897,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,losartan,1043880899.0,Near Eastern
982031571,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,982031601.0,European
982031571,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,982031601.0,European
982031571,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2b,982031601.0,European
982031571,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2b,982031601.0,European
982031571,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,982031601.0,European
982031571,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,982031601.0,European
1451126300,PA166202201,rs12608932,,,UNC13A,Efficacy,-1,valproic acid,1451126305.0,Unknown
1444714172,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,voriconazole,1444842050.0,Unknown
1444714172,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1444842050.0,Unknown
1183490988,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,losartan,1183490990.0,European
1183490988,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,losartan,1183490990.0,European
1183490988,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,losartan,1183490990.0,European
982028496,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028503.0,East Asian
982028496,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028518.0,East Asian
982028496,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028521.0,East Asian
982028496,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,losartan,982028503.0,East Asian
982028496,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,losartan,982028518.0,East Asian
982028496,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,losartan,982028521.0,East Asian
982043900,PA166157595,rs3808607,,,CYP7A1,Efficacy,0,atorvastatin,982043904.0,Unknown
982046735,PA166156808,rs2631372,,,SLC22A5,Efficacy,1,imatinib,982046737.0,European
982036983,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982037002.0,East Asian
982036983,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982037004.0,East Asian
982036983,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,amlodipine,982037000.0,East Asian
982045328,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,carvedilol,982045330.0,Unknown
982045328,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,carvedilol,982045330.0,Unknown
982045328,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,carvedilol,982045330.0,Unknown
982045328,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,metoprolol,982045330.0,Unknown
982045328,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,-1,metoprolol,982045330.0,Unknown
982045328,,,PA165816581,CYP2D6*6,CYP2D6,Efficacy,-1,metoprolol,982045330.0,Unknown
982046088,PA166156447,rs12487736,,,SCAP,Efficacy,1,simvastatin,982046119.0,European
982030363,PA166157872,rs3761555,,,GRIA3,Efficacy,1,Selective serotonin reuptake inhibitors,982030367.0,East Asian
982030363,PA166157872,rs3761555,,,GRIA3,Efficacy,1,venlafaxine,982030367.0,East Asian
982046831,PA166154030,rs3740556,,,EIF3A,Efficacy,-1,carboplatin,982046840.0,East Asian
982046831,PA166154030,rs3740556,,,EIF3A,Efficacy,-1,cisplatin,982046840.0,East Asian
982030340,PA166156777,rs1992647,,,GABRA6,Efficacy,-1,Selective serotonin reuptake inhibitors,982030343.0,East Asian
982030340,PA166156777,rs1992647,,,GABRA6,Efficacy,-1,venlafaxine,982030343.0,East Asian
982045579,PA166154543,rs2291073,,,SLCO1B1,Efficacy,1,lovastatin,982045584.0,European
982045810,PA166155351,rs429358,,,APOE,Efficacy,-1,lovastatin,982045817.0,European
981954738,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,1,tropisetron,981954744.0,Unknown
982038089,PA166154250,rs4520,,,APOC3,Efficacy,-1,fenofibrate,982038094.0,European
982038089,PA166154250,rs4520,,,APOC3,Efficacy,-1,fenofibrate,982038095.0,European
982045824,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,atorvastatin,982045830.0,European
1043859395,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,metoprolol,1043859403.0,East Asian
982032665,PA166153683,rs2239622,,,NGF,Dosage,-1,methadone,982032670.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
982034671,PA166156748,rs1042713,,,ADRB2,Efficacy,1,benazepril,982034717.0,East Asian
982034671,PA166156748,rs1042713,,,ADRB2,Efficacy,1,benazepril,982034679.0,East Asian
982037581,PA166153626,rs1137101,,,LEPR,Efficacy,1,simvastatin,982037595.0,Unknown
982045854,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,atorvastatin,982045862.0,European
1183490976,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,1,losartan,1183490987.0,European
1183490976,,,PA165816543,CYP2C9*2,CYP2C9,Efficacy,1,losartan,1183490987.0,European
1183490976,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,1,losartan,1183490987.0,European
982045488,PA166154975,rs5882,,,CETP,Efficacy,-1,fluvastatin,982045494.0,Unknown
982038068,PA166154377,rs2542052,,,APOC3,Efficacy,-1,fenofibrate,982038073.0,European
982038068,PA166154377,rs2542052,,,APOC3,Efficacy,-1,fenofibrate,982038072.0,European
1027521661,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenprocoumon,1028166824.0,European
1027521661,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,phenprocoumon,1028166824.0,European
1027521661,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenprocoumon,1028166824.0,European
982047473,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,982047485.0,Central/South Asian
1043859002,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,metoprolol,1043859004.0,East Asian
1043858738,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,olmesartan,1043858744.0,East Asian
1043858738,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,olmesartan,1043858744.0,East Asian
1043859008,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,metoprolol,1043859010.0,East Asian
982047183,PA166157267,rs776746,,,CYP3A5,Dosage,-1,tacrolimus,982047185.0,European
982047143,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,tacrolimus,982047149.0,European
982047143,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,tacrolimus,982047149.0,European
1184509867,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,sertraline,1184509875.0,East Asian
1184509867,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,sertraline,1184509875.0,East Asian
1043858995,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,metoprolol,1043859001.0,East Asian
982047169,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,-1,tacrolimus,982047175.0,European
982047169,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,tacrolimus,982047175.0,European
982047486,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,clopidogrel,982047488.0,Central/South Asian
982046870,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,adalimumab,982046874.0,European
982046870,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,adalimumab,982046876.0,European
982046870,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,etanercept,982046874.0,European
982046870,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,etanercept,982046876.0,European
982046870,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,infliximab,982046874.0,European
982046870,PA166157545,rs20575,,,TNFRSF10A,Efficacy,1,infliximab,982046876.0,European
1043737589,PA166155096,rs9934438,,,VKORC1,Dosage,1,acenocoumarol,1043737593.0,European
1043737589,PA166155096,rs9934438,,,VKORC1,Toxicity,1,acenocoumarol,1043737593.0,European
1043737589,PA166155096,rs9934438,,,VKORC1,Dosage,1,phenprocoumon,1043737593.0,European
1043737589,PA166155096,rs9934438,,,VKORC1,Toxicity,1,phenprocoumon,1043737593.0,European
1184470178,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184470182.0,East Asian
1184470178,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184470193.0,East Asian
982045934,PA166157595,rs3808607,,,CYP7A1,Efficacy,-1,atorvastatin,982045938.0,European
982033292,PA166153972,rs1799853,,,CYP2C9,Dosage,0,warfarin,982033299.0,Unknown
982033292,PA166153972,rs1799853,,,CYP2C9,Efficacy,0,warfarin,982033299.0,Unknown
982033292,PA166153972,rs1799853,,,CYP2C9,Toxicity,0,warfarin,982033299.0,Unknown
1183701031,PA166156727,rs307805,,,FLT4,Efficacy,-1,cisplatin,1183701033.0,Unknown
1183701031,PA166156727,rs307805,,,FLT4,Efficacy,-1,fluorouracil,1183701033.0,Unknown
1183701031,PA166156727,rs307805,,,FLT4,Efficacy,-1,oxaliplatin,1183701033.0,Unknown
982043801,,,PA165819265,SLCO1B1*15,SLCO1B1,Metabolism/PK,1,rosuvastatin,982043803.0,East Asian
982043801,,,PA165819251,SLCO1B1*37,SLCO1B1,Metabolism/PK,1,rosuvastatin,982043803.0,East Asian
982044365,PA166155084,rs8050894,,,VKORC1,Dosage,1,warfarin,982044371.0,European
1444705070,PA166155462,rs11881222,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705072.0,European
1444705070,PA166155462,rs11881222,,,IFNL3,Efficacy,1,ribavirin,1444705072.0,European
982045166,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,1,simvastatin,982045172.0,Unknown
982045166,,,PA165819222,CYP3A4*4,CYP3A4,Efficacy,1,simvastatin,982045172.0,Unknown
982028504,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028510.0,East Asian
982028504,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028527.0,East Asian
982028504,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028512.0,East Asian
982028504,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028514.0,East Asian
982028504,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,losartan,982028525.0,East Asian
982028504,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,losartan,982028510.0,East Asian
982028504,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,losartan,982028527.0,East Asian
982028504,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,losartan,982028512.0,East Asian
982028504,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,losartan,982028514.0,East Asian
982028504,,,PA165816554,CYP2C9*13,CYP2C9,Metabolism/PK,1,losartan,982028525.0,East Asian
1444705133,PA166155435,rs8099917,,,IFNL3,Efficacy,1,interferon alfa-n1,1444705135.0,Unknown
1444705133,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705135.0,Unknown
1444705133,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705135.0,Unknown
1444705262,PA166155435,rs8099917,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444705264.0,European
1444705262,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444705264.0,European
982046660,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,phenprocoumon,982046662.0,European
982046660,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,phenprocoumon,982046662.0,European
982046660,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,phenprocoumon,982046662.0,European
982006758,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,ondansetron,982006767.0,Unknown
982006758,,,PA165988479,CYP2D6*1xN,CYP2D6,Efficacy,1,ondansetron,982006767.0,Unknown
982006758,,,PA165988480,CYP2D6*2xN,CYP2D6,Efficacy,1,ondansetron,982006767.0,Unknown
1043859140,,,PA165816577,CYP2D6*2,CYP2D6,Toxicity,-1,metoprolol,1043859142.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1043859140,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,metoprolol,1043859142.0,"Multiple groups, Predominantly White (78%), 18% Black, 4% Latino-Hispanic"
1041119744,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1041119958.0,East Asian
1041119744,,,PA165819201,CYP3A4*1,CYP3A4,Efficacy,-1,simvastatin,1041119958.0,East Asian
982047452,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,nateglinide,982047461.0,East Asian
982047452,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,nateglinide,982047461.0,East Asian
981954763,,,PA165816577,CYP2D6*2,CYP2D6,Efficacy,-1,metoclopramide,981954769.0,East Asian
981954763,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,-1,metoclopramide,981954769.0,East Asian
982034970,PA166154184,rs56165452,,,CYP2C9,Dosage,1,warfarin,982034976.0,Near Eastern
1043818258,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenprocoumon,1043818260.0,European
1043818092,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,phenprocoumon,1043818095.0,European
1043818092,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,phenprocoumon,1043818095.0,European
1043818092,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,phenprocoumon,1043818095.0,European
1451132020,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,progesterone,1451132026.0,Unknown
1451132020,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,progesterone,1451132026.0,Unknown
1183619945,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183619974.0,East Asian
1183619945,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1183619974.0,East Asian
1183630106,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183630108.0,East Asian
1183630106,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,haloperidol,1183630108.0,East Asian
1183620832,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183620859.0,East Asian
1183620832,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1183620859.0,East Asian
1183617585,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,clozapine,1183617617.0,Unknown
1183619871,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,omeprazole,1183619887.0,East Asian
982044931,PA166154545,rs2301339,,,GNB3,Efficacy,1,atenolol,982044937.0,European
982044931,PA166154545,rs2301339,,,GNB3,Efficacy,1,atenolol,982044936.0,European
1183629618,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183629626.0,East Asian
1183629618,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,haloperidol,1183629626.0,East Asian
1183629465,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,0,debrisoquine,1183629471.0,European
1183629560,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1183629562.0,Unknown
1183629560,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,debrisoquine,1183629562.0,Unknown
1183629560,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629562.0,Unknown
1183629560,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629562.0,Unknown
1183618528,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,famotidine,1183618530.0,East Asian
1183618528,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,famotidine,1183618530.0,East Asian
1183618528,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,famotidine,1183618530.0,East Asian
1183618478,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183618480.0,East Asian
1183618478,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183618480.0,East Asian
1183618478,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183618480.0,East Asian
1183620682,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183620698.0,East Asian
1183620682,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183620701.0,East Asian
1183620682,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183620698.0,East Asian
1183620682,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183620701.0,East Asian
1183620682,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183620698.0,East Asian
1183620682,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183620701.0,East Asian
982044314,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,carvedilol,982044320.0,East Asian
982044314,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,carvedilol,982044320.0,East Asian
1183619427,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183619437.0,European
1183619427,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183619437.0,European
1183619427,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183619437.0,European
1446900797,PA166154249,rs1695,,,GSTP1,Metabolism/PK,-1,gemcitabine,1446900799.0,Unknown
1451133560,PA166157284,rs1045642,,,ABCB1,Efficacy,1,morphine,1451133565.0,European
1451133560,PA166157284,rs1045642,,,ABCB1,Efficacy,1,morphine,1451133620.0,"Multiple groups, Majority white British"
1451133560,PA166157284,rs1045642,,,ABCB1,Efficacy,1,nortriptyline,1451133565.0,European
1451133560,PA166157284,rs1045642,,,ABCB1,Efficacy,1,nortriptyline,1451133620.0,"Multiple groups, Majority white British"
1183623682,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1183623688.0,East Asian
1184514835,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514837.0,East Asian
1183621536,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183621555.0,European
1183621536,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183621555.0,European
1183621536,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,pantoprazole,1183621555.0,European
1183619401,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183619414.0,East Asian
1183619401,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183619414.0,East Asian
1183619401,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183619414.0,East Asian
1183619401,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183619414.0,East Asian
982036394,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,amlodipine,982036418.0,East Asian
1184510180,PA166155364,rs1126757,,,IL11,Efficacy,1,escitalopram,1184510185.0,European
1184510370,PA166157355,rs2293347,,,EGFR,Efficacy,1,fluorouracil,1184510374.0,Unknown
1183624295,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,esomeprazole,1183624305.0,European
1183624295,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,esomeprazole,1183624303.0,European
1183624295,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,esomeprazole,1183624305.0,European
1183624295,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,esomeprazole,1183624303.0,European
1183621475,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183621481.0,East Asian
1183618316,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,escitalopram,1183618356.0,European
1183618316,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,escitalopram,1183618356.0,European
982046974,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,citalopram,982046976.0,European
982046974,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,-1,citalopram,982046976.0,European
1183622326,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183622328.0,East Asian
1183622326,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,rabeprazole,1183622328.0,East Asian
1183622326,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183622328.0,East Asian
1183622326,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,rabeprazole,1183622328.0,East Asian
982045318,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,carvedilol,982045320.0,Unknown
982045318,,,PA165948092,CYP2D6*5,CYP2D6,Dosage,1,carvedilol,982045320.0,Unknown
982045318,,,PA165816581,CYP2D6*6,CYP2D6,Dosage,1,carvedilol,982045320.0,Unknown
1183491857,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1183491863.0,Unknown
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623483.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623482.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623484.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183623481.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623483.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623482.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623484.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,omeprazole,1183623481.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,omeprazole,1183623483.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,omeprazole,1183623482.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,omeprazole,1183623484.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,omeprazole,1183623481.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1183623483.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1183623482.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1183623484.0,European
1183623479,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,pantoprazole,1183623481.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1183623483.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1183623482.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1183623484.0,European
1183623479,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,pantoprazole,1183623481.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,pantoprazole,1183623483.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,pantoprazole,1183623482.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,pantoprazole,1183623484.0,European
1183623479,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,pantoprazole,1183623481.0,European
982043089,PA166156901,rs5370,,,EDN1,Efficacy,1,atenolol,982043110.0,European
982043089,PA166156901,rs5370,,,EDN1,Efficacy,1,irbesartan,982043110.0,European
982044801,PA166157745,rs2230808,,,ABCA1,Efficacy,1,fenofibrate,982044811.0,European
982044801,PA166157745,rs2230808,,,ABCA1,Efficacy,1,fenofibrate,982044809.0,European
1183620957,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183620977.0,European
1183620957,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183620977.0,European
1183620957,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,pantoprazole,1183620977.0,European
1183620957,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,pantoprazole,1183620977.0,European
982044327,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,carvedilol,982044329.0,East Asian
982043679,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,amlodipine,982043685.0,African American/Afro-Caribbean
982044321,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,carvedilol,982044323.0,East Asian
982044321,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,carvedilol,982044323.0,East Asian
982043670,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,amlodipine,982043677.0,African American/Afro-Caribbean
982043670,PA166157367,rs2740574,,,CYP3A4,Efficacy,-1,amlodipine,982043676.0,African American/Afro-Caribbean
982044891,PA166156748,rs1042713,,,ADRB2,Efficacy,-1,atenolol,982044897.0,European
982044875,PA166153977,rs1801253,,,ADRB1,Efficacy,-1,atenolol,982044882.0,European
1183618939,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,aripiprazole,1183618943.0,East Asian
1183618939,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,aripiprazole,1183618943.0,East Asian
982043031,PA166153547,rs5051,,,AGT,Efficacy,-1,irbesartan,982043037.0,European
982043031,PA166153547,rs5051,,,AGT,Efficacy,-1,irbesartan,982043036.0,European
1183618318,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183618347.0,East Asian
1183618318,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183618351.0,East Asian
1183618318,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183618349.0,East Asian
1183618318,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183618353.0,East Asian
1183618318,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183618355.0,East Asian
1183618318,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183618347.0,East Asian
1183618318,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183618351.0,East Asian
1183618318,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183618349.0,East Asian
1183618318,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183618353.0,East Asian
1183618318,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183618355.0,East Asian
1183618318,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183618347.0,East Asian
1183618318,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183618351.0,East Asian
1183618318,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183618349.0,East Asian
1183618318,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183618353.0,East Asian
1183618318,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,rabeprazole,1183618355.0,East Asian
1448997449,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997455.0,Multiple groups
982043452,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,carvedilol,982043458.0,East Asian
982043452,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,carvedilol,982043461.0,East Asian
982043452,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,carvedilol,982043458.0,East Asian
982043452,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,carvedilol,982043461.0,East Asian
982043452,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,carvedilol,982043458.0,East Asian
982043452,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,carvedilol,982043461.0,East Asian
1184515029,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184515031.0,European
1184515029,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515031.0,European
1451134629,PA166156991,rs1799971,,,OPRM1,Efficacy,1,oxycodone,1451134640.0,East Asian
982044712,PA166154293,rs662799,,,APOA5,Efficacy,0,fenofibrate,982044716.0,European
1183617247,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,zuclopenthixol,1183617293.0,European
1183617247,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,zuclopenthixol,1183617293.0,European
1451134687,PA166156991,rs1799971,,,OPRM1,Dosage,-1,oxycodone,1451134692.0,East Asian
1451134687,PA166156991,rs1799971,,,OPRM1,Dosage,-1,sufentanil,1451134692.0,East Asian
1183491053,,,PA165816542,CYP2C9*1,CYP2C9,Efficacy,-1,losartan,1183491068.0,East Asian
1183491053,,,PA165816544,CYP2C9*3,CYP2C9,Efficacy,-1,losartan,1183491068.0,East Asian
1183620420,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,risperidone,1183620422.0,European
1183620420,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,risperidone,1183620422.0,European
1183533905,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183533909.0,East Asian
1183533905,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1183533911.0,East Asian
1183615619,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,risperidone,1183615632.0,Unknown
1183615619,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,risperidone,1183615632.0,Unknown
1183624182,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183624206.0,European
1183624182,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183624204.0,European
1183624182,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183624184.0,European
1183624182,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183624185.0,European
1183624182,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1183624206.0,European
1183624182,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1183624204.0,European
1183624182,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1183624184.0,European
1183624182,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,esomeprazole,1183624185.0,European
1183630934,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183630936.0,Multiple groups
1183630934,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,haloperidol,1183630936.0,Multiple groups
1183630934,,,PA165816583,CYP2D6*17,CYP2D6,Metabolism/PK,-1,haloperidol,1183630936.0,Multiple groups
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,amitriptyline,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,amitriptyline,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,amitriptyline,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,amitriptyline,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,amitriptyline,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,amitriptyline,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,amitriptyline,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,amitriptyline,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,clomipramine,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,clomipramine,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,clomipramine,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,clomipramine,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,clomipramine,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,clomipramine,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,clomipramine,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,clomipramine,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,doxepin,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,doxepin,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,doxepin,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,doxepin,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,doxepin,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,doxepin,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,doxepin,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,doxepin,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,imipramine,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,imipramine,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,imipramine,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,imipramine,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,imipramine,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,imipramine,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,imipramine,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,imipramine,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,maprotiline,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,maprotiline,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,maprotiline,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,maprotiline,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,maprotiline,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,maprotiline,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,maprotiline,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,maprotiline,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,nortriptyline,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,nortriptyline,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,nortriptyline,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,nortriptyline,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,nortriptyline,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,nortriptyline,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,nortriptyline,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,nortriptyline,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,opipramol,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Dosage,1,opipramol,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,opipramol,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,1,opipramol,1446903862.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,opipramol,1183617428.0,European
1183617426,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,opipramol,1446903862.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,opipramol,1183617428.0,European
1183617426,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,opipramol,1446903862.0,European
1451135000,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,oxycodone,1451135004.0,East Asian
1451135000,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,oxycodone,1451135004.0,East Asian
1451134983,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,sufentanil,1451134990.0,East Asian
1451134983,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,sufentanil,1451134990.0,East Asian
1184515181,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515183.0,European
982046981,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,citalopram,982046987.0,European
982046981,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,citalopram,982046987.0,European
982046981,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,citalopram,982046987.0,European
982046960,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,citalopram,982046973.0,European
982046960,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,citalopram,982046973.0,European
982046960,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,citalopram,982046973.0,European
1183621939,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1183621957.0,East Asian
1183621939,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,risperidone,1183621957.0,East Asian
1183622066,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1183622068.0,East Asian
1183622066,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,mephenytoin,1183622068.0,East Asian
1183619675,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,risperidone,1183619677.0,European
1183619675,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,-1,risperidone,1183619677.0,European
1183620508,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,-1,risperidone,1183620516.0,Unknown
1183620508,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,risperidone,1183620516.0,Unknown
1183620508,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,-1,risperidone,1183620516.0,Unknown
1183622172,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622206.0,East Asian
1183622172,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,mephenytoin,1183622206.0,East Asian
1183622460,PA166154910,rs4646427,,,CYP1A2,Metabolism/PK,1,escitalopram,1183622462.0,East Asian
1183620517,,,PA165816576,CYP2D6*1,CYP2D6,Efficacy,1,risperidone,1183620525.0,East Asian
1183620517,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,risperidone,1183620525.0,East Asian
1183620517,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183620525.0,East Asian
1183620517,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,risperidone,1183620525.0,East Asian
1446903458,PA166153864,rs13376631,,,FMO1,Efficacy,-1,metformin,1446903460.0,Unknown
1183622057,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,mephenytoin,1183622059.0,East Asian
1183622057,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,mephenytoin,1183622059.0,East Asian
1183623082,,,PA165816579,CYP2D6*4,CYP2D6,Toxicity,0,amitriptyline,1183623089.0,European
1183623082,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,amitriptyline,1183623089.0,European
1183623471,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183623473.0,East Asian
1183623471,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,haloperidol,1183623473.0,East Asian
1183629566,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1183629568.0,Unknown
1183629566,,,PA165971568,CYP2D6*15,CYP2D6,Metabolism/PK,0,debrisoquine,1183629568.0,Unknown
1183629566,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629568.0,Unknown
1183629566,,,PA165971568,CYP2D6*15,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629568.0,Unknown
1448995859,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448995869.0,Sub-Saharan African
1448995859,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448995869.0,Sub-Saharan African
1450932005,PA166157288,rs1128503,,,ABCB1,Dosage,1,sufentanil,1450932011.0,East Asian
1183620440,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,risperidone,1183620442.0,European
1183620440,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,risperidone,1183620442.0,European
1183491171,PA166156873,rs11960832,,,SV2C,Efficacy,1,olanzapine,1183491180.0,European
1183623437,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,haloperidol,1183623460.0,East Asian
1183623437,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,haloperidol,1183623460.0,East Asian
1183623172,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,debrisoquine,1183623182.0,East Asian
1183623172,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,debrisoquine,1183623182.0,East Asian
1183624136,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,mephenytoin,1183624138.0,European
1183624136,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,mephenytoin,1183624138.0,European
1183624136,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,mephenytoin,1183624138.0,European
1183624136,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,omeprazole,1183624138.0,European
1183624136,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,omeprazole,1183624138.0,European
1183624136,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,omeprazole,1183624138.0,European
1183629749,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,haloperidol,1183629765.0,East Asian
1183629749,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,haloperidol,1183629765.0,East Asian
1183629536,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,debrisoquine,1183629545.0,Unknown
1183629536,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1183629545.0,Unknown
1184514498,PA166157267,rs776746,,,CYP3A5,Other,1,tacrolimus,1184514500.0,East Asian
1184514498,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514500.0,East Asian
1183620411,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,risperidone,1183620419.0,European
1183620411,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,risperidone,1183620419.0,European
1183617637,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,clozapine,1183617649.0,European
1183491275,PA166156877,rs12522597,,,SV2C,Efficacy,-1,ziprasidone,1183491277.0,European
1183690117,PA166155381,rs2108622,,,CYP4F2,Efficacy,-1,warfarin,1183690119.0,East Asian
1183703250,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,lornoxicam,1183703281.0,East Asian
1183703250,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,lornoxicam,1183703281.0,East Asian
1183623283,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183623293.0,East Asian
1183623283,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183623293.0,East Asian
1183623283,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183623293.0,East Asian
1184515270,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184515272.0,East Asian
1183623799,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,lansoprazole,1183623809.0,Multiple groups
1183623799,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,lansoprazole,1183623809.0,Multiple groups
1183623799,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,lansoprazole,1183623809.0,Multiple groups
1183699179,PA166154833,rs74090038,,,AKT1,Efficacy,-1,carboplatin,1183699181.0,East Asian
1183699179,PA166154833,rs74090038,,,AKT1,Efficacy,-1,cisplatin,1183699181.0,East Asian
1183680182,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183680184.0,East Asian
1184514537,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514539.0,Multiple groups
1184514537,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514539.0,Multiple groups
1183700614,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1183700616.0,European
1183700614,PA166153959,rs1057910,,,CYP2C9,Efficacy,1,warfarin,1183700616.0,European
1183679247,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679251.0,European
1183679247,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,rabeprazole,1183679250.0,European
1183679247,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679251.0,European
1183679247,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,rabeprazole,1183679250.0,European
1183679483,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183679527.0,Multiple groups
1183679483,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183679529.0,Multiple groups
1183679483,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,esomeprazole,1183679485.0,Multiple groups
1183679229,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183679237.0,European
1183679229,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183679244.0,European
1183679229,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,esomeprazole,1183679246.0,European
1183679229,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183679237.0,European
1183679229,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183679244.0,European
1183679229,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,esomeprazole,1183679246.0,European
1183679635,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183679637.0,Unknown
1183680395,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,tramadol,1183680425.0,European
1183680395,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,tramadol,1183680425.0,European
1183680395,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1183680425.0,European
1183680395,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,tramadol,1183680425.0,European
1183690860,PA166157325,rs2070744,,,NOS3,Efficacy,1,enalapril,1183690864.0,Multiple groups
1183681642,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1183681655.0,East Asian
1183681642,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1183681655.0,East Asian
1183681642,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1183681655.0,East Asian
1183681642,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1183681655.0,East Asian
1183629838,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1183629840.0,Near Eastern
1183629838,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183629840.0,Near Eastern
1183629838,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183629840.0,Near Eastern
1183680124,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183680126.0,East Asian
1183680124,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183680127.0,East Asian
1451136960,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,dexlansoprazole,1451136965.0,East Asian
1451136960,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,dexlansoprazole,1451136965.0,East Asian
1183700228,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1183700237.0,Unknown
1183623842,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183623844.0,Multiple groups
1183623842,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183623844.0,Multiple groups
1183623842,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183623844.0,Multiple groups
1183623842,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183623844.0,Multiple groups
1183697705,PA166155096,rs9934438,,,VKORC1,Dosage,1,warfarin,1183697707.0,European
1183690829,PA166157634,rs11545078,,,GGH,Efficacy,-1,methotrexate,1183690831.0,Unknown
1183690829,PA166157634,rs11545078,,,GGH,Toxicity,-1,methotrexate,1183690831.0,Unknown
1183690873,PA166159014,rs61722009,,,None,Efficacy,-1,enalapril,1183690875.0,Multiple groups
1183689298,,,PA165819171,CYP1A2*1A,CYP1A2,Efficacy,-1,olanzapine,1183689300.0,Central/South Asian
1183689298,,,PA165819176,CYP1A2*1F,CYP1A2,Efficacy,-1,olanzapine,1183689300.0,Central/South Asian
1451138100,PA166205821,rs2839670,,,GAD2,Dosage,-1,methadone,1451138122.0,East Asian
1183697377,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,lovastatin,1183697387.0,East Asian
1183697377,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,lovastatin,1183697387.0,East Asian
1183697377,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,lovastatin,1183697387.0,East Asian
1447520644,PA166154486,rs5443,,,GNB3,Efficacy,1,hydralazine / isosorbide dinitrate,1447520650.0,African American/Afro-Caribbean
1451137985,PA166205843,rs769404,,,GAD1,Dosage,-1,methadone,1451138007.0,East Asian
1451137970,PA166205744,rs3749034,,,GAD1,Dosage,1,methadone,1451138000.0,East Asian
1183680188,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,benzbromarone,1183680196.0,East Asian
1183680188,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,benzbromarone,1183680196.0,East Asian
1184754437,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,1,lamotrigine,1184754455.0,East Asian
1183682115,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,sibutramine,1183682127.0,Unknown
1183682115,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,-1,sibutramine,1183682123.0,Unknown
1183682115,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,sibutramine,1183682127.0,Unknown
1183682115,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,-1,sibutramine,1183682123.0,Unknown
1183680808,PA166157284,rs1045642,,,ABCB1,Efficacy,1,highly active antiretroviral therapy (haart),1183680812.0,"Multiple groups, Brazilian."
1183701586,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,-1,warfarin,1183701588.0,African American/Afro-Caribbean
1183682257,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,labetalol,1183682267.0,East Asian
1183682257,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,labetalol,1183682267.0,East Asian
1183680745,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,celecoxib,1183680747.0,"Multiple groups, 23 White and 1 African"
1183680745,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,1,celecoxib,1183680747.0,"Multiple groups, 23 White and 1 African"
1183680624,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,codeine,1183680626.0,European
1183680624,,,PA165988479,CYP2D6*1xN,CYP2D6,Metabolism/PK,0,codeine,1183680626.0,European
1183680606,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,0,codeine,1183680608.0,European
1183680606,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,codeine,1183680608.0,European
1183693363,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,icotinib,1183693374.0,East Asian
1183693363,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,icotinib,1183693374.0,East Asian
1183693363,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,icotinib,1183693374.0,East Asian
1183693363,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,icotinib,1183693374.0,East Asian
1183693363,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,icotinib,1183693374.0,East Asian
1183679613,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183679619.0,Unknown
1183701549,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1183701564.0,European
1183701549,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,-1,warfarin,1183701564.0,European
1183679601,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,omeprazole,1183679607.0,Unknown
1183679601,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679607.0,Unknown
1451138485,PA166206041,rs482387,,,OPRD1,Metabolism/PK,-1,methadone,1451138428.0,Unknown
1451138489,PA166184212,rs508448,,,OPRD1,Metabolism/PK,-1,methadone,1451138504.0,Unknown
1183701320,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,1183701322.0,"Multiple groups, 94% White"
1183701320,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1183701322.0,"Multiple groups, 94% White"
1183700648,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700664.0,European
1183700648,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700664.0,European
1183700648,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700664.0,European
1183700730,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700738.0,"Multiple groups, 84.4% Caucasian;9.8% African ancestry;2.9% Asian;2.9% other."
1183700730,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700738.0,"Multiple groups, 84.4% Caucasian;9.8% African ancestry;2.9% Asian;2.9% other."
1183682332,PA166156913,rs316019,,,SLC22A2,Metabolism/PK,1,metformin,1183682350.0,East Asian
1183682332,PA166156913,rs316019,,,SLC22A2,Metabolism/PK,1,metformin,1183682336.0,East Asian
1183682332,PA166156913,rs316019,,,SLC22A2,Metabolism/PK,1,metformin,1183682338.0,East Asian
1183681894,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,hydromorphone,1183681900.0,European
1183681894,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,ketorolac,1183681900.0,European
1183681894,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,morphine,1183681900.0,European
1183681894,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,opioids,1183681900.0,European
1183681894,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,oxycodone,1183681900.0,European
1183681894,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,0,oxycodone,1183681900.0,European
1183697419,PA166157316,rs2032582,,,ABCB1,Dosage,1,tacrolimus,1183697421.0,East Asian
1183700669,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1183700671.0,European
1183700669,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1183700671.0,European
1183700669,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1183700671.0,European
1183699139,PA166154795,rs2494752,,,AKT1,Efficacy,1,carboplatin,1183699150.0,East Asian
1183699139,PA166154795,rs2494752,,,AKT1,Efficacy,1,cisplatin,1183699150.0,East Asian
1183679628,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lafutidine,1183679634.0,Unknown
1183680085,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183680096.0,Unknown
1183679411,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,omeprazole,1183679413.0,Multiple groups
1183679411,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,omeprazole,1183679413.0,Multiple groups
1183679411,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,omeprazole,1183679413.0,Multiple groups
1447963480,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1447963493.0,European
1447963480,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,bupropion,1447963495.0,European
1447963480,,,PA165818809,CYP2B6*22,CYP2B6,Metabolism/PK,1,bupropion,1447963493.0,European
1447963480,,,PA165818809,CYP2B6*22,CYP2B6,Metabolism/PK,1,bupropion,1447963495.0,European
1444706064,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1444706066.0,East Asian
1183682248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,nifedipine,1183682252.0,"Multiple groups, African American (n=4), Caucasian (n=7), Hispanic (n=2)"
1183682248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,nifedipine,1183682256.0,"Multiple groups, African American (n=4), Caucasian (n=7), Hispanic (n=2)"
1183682248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,nifedipine,1183682254.0,"Multiple groups, African American (n=4), Caucasian (n=7), Hispanic (n=2)"
1183682248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,nifedipine,1183682252.0,"Multiple groups, African American (n=4), Caucasian (n=7), Hispanic (n=2)"
1183682248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,nifedipine,1183682256.0,"Multiple groups, African American (n=4), Caucasian (n=7), Hispanic (n=2)"
1183682248,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,nifedipine,1183682254.0,"Multiple groups, African American (n=4), Caucasian (n=7), Hispanic (n=2)"
1183679975,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,famotidine,1183679981.0,East Asian
1183679975,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,lansoprazole,1183679981.0,East Asian
1183680817,PA166157239,rs3842,,,ABCB1,Efficacy,-1,lamivudine,1183680821.0,"Multiple groups, Brazilian."
1183680817,PA166157239,rs3842,,,ABCB1,Efficacy,-1,lopinavir,1183680821.0,"Multiple groups, Brazilian."
1183680817,PA166157239,rs3842,,,ABCB1,Efficacy,-1,ritonavir,1183680821.0,"Multiple groups, Brazilian."
1183680817,PA166157239,rs3842,,,ABCB1,Efficacy,-1,zidovudine,1183680821.0,"Multiple groups, Brazilian."
1183697697,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1183697699.0,European
1183679621,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,rabeprazole,1183679623.0,Unknown
1183697428,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,axitinib,1183697430.0,Multiple groups
1183697428,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,axitinib,1183697430.0,Multiple groups
1183685442,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1183685475.0,European
1183685442,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1183685475.0,European
1183697432,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,axitinib,1183697434.0,Multiple groups
1183697432,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,-1,axitinib,1183697434.0,Multiple groups
1183697432,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,-1,axitinib,1183697434.0,Multiple groups
1183697477,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,axitinib,1183697479.0,Multiple groups
1183629846,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,lansoprazole,1183629848.0,Near Eastern
1183629846,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,lansoprazole,1183629848.0,Near Eastern
1183699447,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,-1,risperidone,1183699451.0,"Multiple groups, Caucasian, African, Unknown"
1184166145,PA166157301,rs1617640,,,EPO,Efficacy,-1,bevacizumab,1184166147.0,European
1184166137,PA166154107,rs10490924,,,ARMS2,Efficacy,-1,bevacizumab,1184166139.0,European
1184168878,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1184168880.0,East Asian
1184168878,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,clopidogrel,1184168880.0,East Asian
1448107849,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,docetaxel,1448107855.0,Unknown
1184998389,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184998395.0,European
1184998389,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184998395.0,European
1184167098,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,fludarabine,1184167100.0,Unknown
1184167098,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,-1,fludarabine,1184167100.0,Unknown
1184510172,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184510182.0,East Asian
1184510172,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184510182.0,East Asian
1184483514,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,bevacizumab,1184483526.0,East Asian
1184483514,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,bevacizumab,1184483526.0,East Asian
1184483514,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,bevacizumab,1184483526.0,East Asian
1184483514,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,fluorouracil,1184483526.0,East Asian
1184483514,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,fluorouracil,1184483526.0,East Asian
1184483514,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,fluorouracil,1184483526.0,East Asian
1184483514,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1184483526.0,East Asian
1184483514,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,irinotecan,1184483526.0,East Asian
1184483514,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1184483526.0,East Asian
1184483514,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,leucovorin,1184483526.0,East Asian
1184483514,,,PA166115858,UGT1A1*6,UGT1A1,Efficacy,-1,leucovorin,1184483526.0,East Asian
1184483514,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,leucovorin,1184483526.0,East Asian
1183704875,PA166154628,rs11045819,,,SLCO1B1,Metabolism/PK,0,rifampin,1183704877.0,"Multiple groups, 6 Caucasians, 5 African-Americans."
1184165246,PA166154440,rs10898563,,,FZD4,Efficacy,-1,bevacizumab,1184165248.0,European
1184165246,PA166154440,rs10898563,,,FZD4,Efficacy,-1,ranibizumab,1184165248.0,European
1184174521,,,PA165949102,NAT2*5D,NAT2,Efficacy,1,hydralazine,1184174553.0,Unknown
1184174521,,,PA165949116,NAT2*6B,NAT2,Efficacy,1,hydralazine,1184174553.0,Unknown
1184174521,,,PA165949130,NAT2*7A,NAT2,Efficacy,1,hydralazine,1184174553.0,Unknown
1184174521,,,PA165949150,NAT2*14A,NAT2,Efficacy,1,hydralazine,1184174553.0,Unknown
1447680210,PA166157600,rs4645943,,,MYC,Dosage,1,warfarin,1447680212.0,East Asian
1184484028,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluoxetine,1184484045.0,East Asian
1184484028,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1184484045.0,East Asian
1184484028,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1184484045.0,East Asian
1183849138,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,-1,paroxetine,1183849148.0,East Asian
1183849138,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,-1,paroxetine,1183849148.0,East Asian
982047415,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,0,warfarin,982047417.0,Multiple groups
982047415,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,0,warfarin,982047417.0,Multiple groups
1184086246,PA166156595,rs4694362,,,DCK,Efficacy,-1,gemcitabine,1184086248.0,East Asian
1184086246,PA166156595,rs4694362,,,DCK,Toxicity,-1,gemcitabine,1184086248.0,East Asian
1184086246,PA166156595,rs4694362,,,DCK,Efficacy,-1,paclitaxel,1184086248.0,East Asian
1184086246,PA166156595,rs4694362,,,DCK,Toxicity,-1,paclitaxel,1184086248.0,East Asian
1183852291,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1183854391.0,European
1183852291,,,PA165980634,CYP2C19*1,CYP2C19,Dosage,1,voriconazole,1183863823.0,European
1183852291,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1183854391.0,European
1183852291,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,1,voriconazole,1183863823.0,European
1183852291,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1183854391.0,European
1183852291,,,PA165816533,CYP2C19*17,CYP2C19,Dosage,1,voriconazole,1183863823.0,European
1184508133,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1184508912.0,Unknown
1184508133,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1184508912.0,Unknown
1184086183,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,gemcitabine,1184086187.0,East Asian
1184086183,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,gemcitabine,1184086187.0,East Asian
1184086183,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,paclitaxel,1184086187.0,East Asian
1184086183,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,paclitaxel,1184086187.0,East Asian
1449171084,PA166155444,rs8192719,,,CYP2B6,Metabolism/PK,-1,methadone,1449171086.0,European
1183960616,PA166154298,rs720106,,,RRM1,Efficacy,1,cisplatin,1183960620.0,East Asian
1183960616,PA166154298,rs720106,,,RRM1,Efficacy,1,gemcitabine,1183960620.0,East Asian
1451104980,PA166196174,rs222747,,,TRPV1,Efficacy,-1,botulinum toxin type a,1451105000.0,European
1184086234,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,gemcitabine,1184086236.0,East Asian
1184086234,PA166157267,rs776746,,,CYP3A5,Toxicity,-1,gemcitabine,1184086236.0,East Asian
1184086234,PA166157267,rs776746,,,CYP3A5,Efficacy,-1,paclitaxel,1184086236.0,East Asian
1184086234,PA166157267,rs776746,,,CYP3A5,Toxicity,-1,paclitaxel,1184086236.0,East Asian
1451148582,PA166156024,rs4680,,,COMT,Efficacy,-1,escitalopram,1451148587.0,Multiple groups
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959634.0,Unknown
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959632.0,European
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959633.0,"Multiple groups, Majority Caucasian"
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1a,1447959635.0,European
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959634.0,Unknown
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959632.0,European
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959633.0,"Multiple groups, Majority Caucasian"
1447959629,PA166157818,rs10819043,,,GAPVD1,Efficacy,1,interferon beta-1b,1447959635.0,European
1184472857,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184472859.0,Multiple groups
1184472857,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1184472859.0,Multiple groups
982047403,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,982047405.0,Multiple groups
982047403,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,warfarin,982047405.0,Multiple groups
1183960004,PA166154673,rs6311,,,HTR2A,Efficacy,-1,fluvoxamine,1183960008.0,East Asian
1183960004,PA166154673,rs6311,,,HTR2A,Efficacy,-1,paroxetine,1183960008.0,East Asian
1183944237,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1183944243.0,East Asian
1183944237,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1183944243.0,East Asian
1183704865,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,0,rifampin,1183704874.0,"Multiple groups, 6 Caucasians, 5 African-Americans."
1183704865,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,0,rifampin,1183704874.0,"Multiple groups, 6 Caucasians, 5 African-Americans."
1448997218,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997224.0,Sub-Saharan African
1448997218,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997224.0,Sub-Saharan African
1451104869,PA166157873,rs3810651,,,GABRQ,Efficacy,-1,botulinum toxin type a,1451104874.0,European
1184136036,PA166156092,rs2269577,,,XBP1,Efficacy,1,Platinum compounds,1184136040.0,East Asian
1183704069,PA166156130,rs8136867,,,MAPK1,Efficacy,1,antidepressants,1183704073.0,"Multiple groups, 95% Caucasian"
1184472379,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,aspirin,1184472381.0,Unknown
1184472379,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,aspirin,1184472381.0,Unknown
1184472379,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1184472381.0,Unknown
1184472379,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,clopidogrel,1184472381.0,Unknown
1184472508,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1184472512.0,Unknown
1184473233,PA166155442,rs8192709,,,CYP2B6,Metabolism/PK,1,efavirenz,1184473235.0,East Asian
1184473587,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1184473591.0,European
1184473587,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1184473591.0,European
1184510382,PA166153588,rs800292,,,CFH,Efficacy,-1,ranibizumab,1184510384.0,East Asian
1184510402,PA166153627,rs1329424,,,CFH,Efficacy,-1,ranibizumab,1184510404.0,East Asian
1184472059,PA166155381,rs2108622,,,CYP4F2,Efficacy,-1,vitamin e,1184472829.0,Unknown
1184472059,PA166155381,rs2108622,,,CYP4F2,Efficacy,-1,vitamin e,1184472087.0,Unknown
1184510348,PA166154257,rs5896,,,F2,Dosage,-1,warfarin,1184510350.0,European
1448098938,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,lamotrigine,1448098940.0,East Asian
1448099041,PA166155453,rs10423928,,,GIPR,Efficacy,-1,sitagliptin,1448099044.0,European
1448099041,PA166155453,rs10423928,,,GIPR,Efficacy,-1,vildagliptin,1448099044.0,European
1184511588,PA166155805,rs11676382,,,GGCX,Dosage,1,warfarin,1184511590.0,European
1184472114,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184472124.0,"Multiple groups, mostly Caucasian.  Individual studies were conducted in Europe or North America."
1184472114,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1184472124.0,"Multiple groups, mostly Caucasian.  Individual studies were conducted in Europe or North America."
1184510745,PA166156646,rs11568993,,,EGF,Efficacy,-1,cetuximab,1184510747.0,Unknown
1184510745,PA166156646,rs11568993,,,EGF,Efficacy,-1,panitumumab,1184510747.0,Unknown
1184473580,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1184473586.0,European
1184349353,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,-1,nevirapine,1184349355.0,East Asian
1184469816,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1184469835.0,East Asian
1184469816,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1184469835.0,East Asian
1184469816,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1184469835.0,East Asian
1184469816,,,PA165980634,CYP2C19*1,CYP2C19,Toxicity,1,clopidogrel,1184469835.0,East Asian
1184469816,,,PA165980635,CYP2C19*2,CYP2C19,Toxicity,1,clopidogrel,1184469835.0,East Asian
1184469816,,,PA165980636,CYP2C19*3,CYP2C19,Toxicity,1,clopidogrel,1184469835.0,East Asian
1184349374,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1184349376.0,East Asian
1184349374,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1184349377.0,East Asian
1184349374,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,nevirapine,1184349376.0,East Asian
1184349374,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,nevirapine,1184349377.0,East Asian
1451141783,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451141792.0,"Multiple groups, Predominantly European American patients."
1451141783,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451141803.0,"Multiple groups, Predominantly European American patients."
1451141783,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451141802.0,"Multiple groups, Predominantly European American patients."
1451141783,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451141801.0,"Multiple groups, Predominantly European American patients."
1451141783,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451141791.0,"Multiple groups, Predominantly European American patients."
1451141783,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1451141800.0,"Multiple groups, Predominantly European American patients."
1448602097,PA166153688,rs2266782,,,FMO3,Metabolism/PK,-1,nicotine,1448602099.0,African American/Afro-Caribbean
1448602091,PA166153688,rs2266782,,,FMO3,Metabolism/PK,-1,cotinine,1448602093.0,African American/Afro-Caribbean
1448602091,PA166153688,rs2266782,,,FMO3,Metabolism/PK,-1,cotinine,1448602093.0,African American/Afro-Caribbean
1184468543,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,nortriptyline,1184468553.0,East Asian
1184468543,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,0,nortriptyline,1184468553.0,East Asian
1184470351,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1184470353.0,East Asian
1184483230,PA166153679,rs2228145,,,IL6R,Efficacy,-1,tocilizumab,1184483232.0,Unknown
1184470358,PA166156110,rs4823613,,,PPARA,Metabolism/PK,1,tacrolimus,1184470367.0,Unknown
1184467472,PA166153643,rs1801131,,,MTHFR,Efficacy,-1,methotrexate,1184467476.0,Unknown
1449713390,,,PA166242948,CYP2C8*1,CYP2C8,Metabolism/PK,1,pioglitazone,1449713411.0,Unknown
1449713390,,,PA165958685,CYP2C8*3,CYP2C8,Metabolism/PK,1,pioglitazone,1449713411.0,Unknown
1184468139,,,PA165952609,HLA-A*01:01:01:01,HLA-A,Efficacy,1,peginterferon alfa-2a,1184468145.0,Near Eastern
1184468139,,,PA165952609,HLA-A*01:01:01:01,HLA-A,Efficacy,1,peginterferon alfa-2b,1184468145.0,Near Eastern
1184468139,,,PA165952609,HLA-A*01:01:01:01,HLA-A,Efficacy,1,ribavirin,1184468145.0,Near Eastern
1184471526,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,prasugrel,1184471529.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471526,,,PA165818750,CYP2B6*1,CYP2B6,Efficacy,-1,prasugrel,1184471528.0,Unknown
1184471526,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,-1,prasugrel,1184471529.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471526,,,PA165818762,CYP2B6*6,CYP2B6,Efficacy,-1,prasugrel,1184471528.0,Unknown
1184471526,,,PA165818807,CYP2B6*9,CYP2B6,Efficacy,-1,prasugrel,1184471529.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471526,,,PA165818807,CYP2B6*9,CYP2B6,Efficacy,-1,prasugrel,1184471528.0,Unknown
1184471526,,,PA165818773,CYP2B6*13,CYP2B6,Efficacy,-1,prasugrel,1184471529.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184471526,,,PA165818773,CYP2B6*13,CYP2B6,Efficacy,-1,prasugrel,1184471528.0,Unknown
1184470393,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1184470393,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1184470393,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1184470393,,,PA165980637,CYP2C19*4,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165980637,CYP2C19*4,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1184470393,,,PA165980638,CYP2C19*5,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165980638,CYP2C19*5,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1184470393,,,PA165816524,CYP2C19*8,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165816524,CYP2C19*8,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1184470393,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,prasugrel,1184470462.0,"Multiple groups, mostly Caucasian (1429) with a few Hispanic(19),African(9),Asian(4) and Other(5)"
1184470393,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,-1,prasugrel,1184470449.0,Unknown
1296666938,PA166154748,rs11568668,,,ABCC4,Efficacy,-1,latanoprost,1296666940.0,East Asian
1296666938,PA166154748,rs11568668,,,ABCC4,Efficacy,-1,latanoprost,1296666958.0,East Asian
1444696719,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,mephenytoin,1444696727.0,European
1444696719,,,PA165816524,CYP2C19*8,CYP2C19,Metabolism/PK,-1,mephenytoin,1444696727.0,European
1184653974,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,methylphenobarbital,1184653983.0,East Asian
1184653974,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,methylphenobarbital,1184653983.0,East Asian
1184653974,,,PA165816532,CYP2C19*16,CYP2C19,Metabolism/PK,-1,methylphenobarbital,1184653983.0,East Asian
1448568106,PA166162507,rs3774959,,,NFKB1,Efficacy,1,flupenthixol,1448568108.0,"Multiple groups, 82 South African Colored (SAC), 13 Xhosa and eight Caucasian individuals"
1448568106,PA166162507,rs3774959,,,NFKB1,Efficacy,1,flupenthixol,1448568113.0,"Multiple groups, 82 South African Colored (SAC), 13 Xhosa and eight Caucasian individuals"
1451146211,PA166209223,rs775887911,,,ADRA2A,Efficacy,1,dexmedetomidine,1451146216.0,East Asian
1451146211,PA166209223,rs775887911,,,ADRA2A,Efficacy,1,dexmedetomidine,1451146240.0,East Asian
1184512692,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,citalopram,1184512707.0,East Asian
1184512692,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,citalopram,1184512707.0,East Asian
1184512692,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,fluoxetine,1184512707.0,East Asian
1184512692,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,fluoxetine,1184512707.0,East Asian
1184512692,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,paroxetine,1184512707.0,East Asian
1184512692,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1184512707.0,East Asian
1184512692,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,paroxetine,1184512707.0,East Asian
1451147629,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,amlodipine,1451147632.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147629,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,amlodipine,1451147632.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147629,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,0,amlodipine,1451147632.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147629,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,0,amlodipine,1451147632.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147584,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,ambrisentan,1451147571.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147584,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,aripiprazole,1451147571.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147584,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,atorvastatin,1451147571.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147584,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,donepezil,1451147571.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1451147584,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,-1,olanzapine,1451147571.0,"Multiple groups, Caucasian, Latin-American, Black and Arab subjects"
1184747491,PA166154007,rs2273697,,,ABCC2,Toxicity,-1,tenofovir,1184747493.0,"Multiple groups, 80% Caucasian"
1184512426,PA166157792,rs7856096,,,FPGS,Dosage,1,warfarin,1184512428.0,African American/Afro-Caribbean
1451147960,PA166156619,rs7439366,,,UGT2B7,Efficacy,-1,fentanyl,1451147942.0,Unknown
1451147960,PA166156619,rs7439366,,,UGT2B7,Efficacy,-1,fentanyl,1451147965.0,Unknown
1184747531,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,atazanavir,1184747533.0,"Multiple groups, 80% Caucasian"
1184747531,PA166157284,rs1045642,,,ABCB1,Toxicity,-1,ritonavir,1184747533.0,"Multiple groups, 80% Caucasian"
1444936331,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,1444936333.0,East Asian
1184754582,PA166156385,rs3814058,,,NR1I2,Metabolism/PK,1,repaglinide,1184754584.0,East Asian
1447813829,PA166154782,rs1629140,,,EGLN3,Efficacy,-1,anthracyclines and related substances,1447813832.0,Unknown
1447813829,PA166154782,rs1629140,,,EGLN3,Efficacy,-1,bevacizumab,1447813832.0,Unknown
1447813829,PA166154782,rs1629140,,,EGLN3,Efficacy,-1,cyclophosphamide,1447813832.0,Unknown
1447813829,PA166154782,rs1629140,,,EGLN3,Efficacy,-1,docetaxel,1447813832.0,Unknown
1447813829,PA166154782,rs1629140,,,EGLN3,Efficacy,-1,epirubicin,1447813832.0,Unknown
1447813829,PA166154782,rs1629140,,,EGLN3,Efficacy,-1,taxanes,1447813832.0,Unknown
1448266521,PA166157334,rs2229109,,,ABCB1,Metabolism/PK,-1,risperidone,1448266523.0,"Multiple groups, 81% Caucasian"
1449576772,PA166178428,rs74743371,,,DOP1B,Efficacy,-1,cyclophosphamide,1449576774.0,Central/South Asian
1449576772,PA166178428,rs74743371,,,DOP1B,Efficacy,-1,doxorubicin,1449576774.0,Central/South Asian
1184754833,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,sunitinib,1184754843.0,"Multiple groups, Mostly white"
1184754833,,,PA166048680,CYP3A4*22,CYP3A4,Metabolism/PK,1,sunitinib,1184754843.0,"Multiple groups, Mostly white"
1184754844,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,sunitinib,1184754846.0,"Multiple groups, Mostly white"
1451148974,PA166209942,rs7224199,,,SLC6A4,Dosage,-1,morphine,1451148980.0,Unknown
1184754433,PA166155662,rs2011425,,,UGT1A4,Efficacy,1,lamotrigine,1184754462.0,East Asian
1449557938,PA166179160,rs2295553,,,DDRGK1,Efficacy,-1,methotrexate,1449557940.0,European
1449557938,PA166179160,rs2295553,,,DDRGK1,Efficacy,-1,methotrexate,1449558078.0,European
1184755514,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,debrisoquine,1184755562.0,Unknown
1184755514,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,0,debrisoquine,1184755562.0,Unknown
1184755450,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,debrisoquine,1184755458.0,European
1184755450,,,PA165971560,CYP2D6*8,CYP2D6,Metabolism/PK,0,debrisoquine,1184755458.0,European
1184755450,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184755458.0,European
1184755450,,,PA165971560,CYP2D6*8,CYP2D6,Metabolism/PK,0,sparteine,1184755458.0,European
1447680321,PA166154486,rs5443,,,GNB3,Efficacy,1,telmisartan,1447680329.0,East Asian
1446899495,PA166154823,rs11623866,,,FNTB,Efficacy,1,carboplatin,1446899506.0,Unknown
1446899495,PA166154823,rs11623866,,,FNTB,Efficacy,1,carboplatin,1446899508.0,Unknown
1446899495,PA166154823,rs11623866,,,FNTB,Efficacy,1,lonafarnib,1446899506.0,Unknown
1446899495,PA166154823,rs11623866,,,FNTB,Efficacy,1,lonafarnib,1446899508.0,Unknown
1446899495,PA166154823,rs11623866,,,FNTB,Efficacy,1,paclitaxel,1446899506.0,Unknown
1446899495,PA166154823,rs11623866,,,FNTB,Efficacy,1,paclitaxel,1446899508.0,Unknown
1183959847,PA166157316,rs2032582,,,ABCB1,Toxicity,-1,tacrolimus,1183959849.0,East Asian
1183959847,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1183959849.0,East Asian
1184470196,PA166153830,rs11584174,,,NR1I3,Metabolism/PK,-1,tacrolimus,1184470200.0,East Asian
1184470196,PA166153830,rs11584174,,,NR1I3,Metabolism/PK,-1,tacrolimus,1184470202.0,East Asian
1184470208,PA166153887,rs55802895,,,NR1I3,Metabolism/PK,-1,tacrolimus,1184470210.0,East Asian
1184470208,PA166153887,rs55802895,,,NR1I3,Metabolism/PK,-1,tacrolimus,1184470211.0,East Asian
1185002375,PA166155140,rs104894542,,,VKORC1,Dosage,0,acenocoumarol,,
1185002294,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1185002299.0,Sub-Saharan African
1185002301,PA166155080,rs7200749,,,VKORC1,Dosage,1,warfarin,1185002303.0,Sub-Saharan African
1185002324,PA166155080,rs7200749,,,VKORC1,Dosage,1,acenocoumarol,1185002326.0,European
1185002340,PA166155134,rs61742245,,,VKORC1,Dosage,1,acenocoumarol,1185002342.0,European
1185002333,PA166155122,rs17878544,,,VKORC1,Dosage,1,acenocoumarol,1185002335.0,European
1447949678,PA166154547,rs2306283,,,SLCO1B1,Efficacy,1,atorvastatin,1447949680.0,Central/South Asian
769257607,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,antiepileptics,769257611.0,East Asian
827816224,PA166157284,rs1045642,,,ABCB1,Dosage,1,methadone,827816233.0,East Asian
827816224,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,methadone,827816233.0,East Asian
1184755585,PA166153688,rs2266782,,,FMO3,Metabolism/PK,1,itopride,1184755589.0,East Asian
1184757079,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1184757087.0,African American/Afro-Caribbean
1184757079,,,PA165816581,CYP2D6*6,CYP2D6,Metabolism/PK,0,dextromethorphan,1184757087.0,African American/Afro-Caribbean
1184757079,,,PA165971594,CYP2D6*40,CYP2D6,Metabolism/PK,0,dextromethorphan,1184757087.0,African American/Afro-Caribbean
1184756116,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184756130.0,East Asian
1184756116,,,PA165971569,CYP2D6*18,CYP2D6,Metabolism/PK,0,sparteine,1184756130.0,East Asian
1184757143,,,PA165971594,CYP2D6*40,CYP2D6,Metabolism/PK,0,dextromethorphan,1184757149.0,African American/Afro-Caribbean
1184757143,,,PA165971595,CYP2D6*42,CYP2D6,Metabolism/PK,0,dextromethorphan,1184757149.0,African American/Afro-Caribbean
981954829,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,carbamazepine,981954837.0,Central/South Asian
981954829,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,phenobarbital,981954837.0,Central/South Asian
981954829,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,phenytoin,981954837.0,Central/South Asian
981954829,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,valproic acid,981954837.0,Central/South Asian
1448099986,PA166157435,rs9282564,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448099988.0,European
982035840,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,verapamil,982036219.0,East Asian
1184886879,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,fluorouracil,1184886881.0,Unknown
1184886879,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,leucovorin,1184886881.0,Unknown
1184886879,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,oxaliplatin,1184886881.0,Unknown
1447683030,PA166154331,rs1529909,,,SLC22A12,Efficacy,1,losartan,1447683039.0,East Asian
1184757252,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,sparteine,1184757273.0,European
1184757252,,,PA165971617,CYP2D6*62,CYP2D6,Metabolism/PK,0,sparteine,1184757273.0,European
1184755702,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,sparteine,1184755709.0,Unknown
1184755702,,,PA165971564,CYP2D6*11,CYP2D6,Metabolism/PK,0,sparteine,1184755709.0,Unknown
1184764296,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,sparteine,1184764298.0,European
1184764296,,,PA165971559,CYP2D6*7,CYP2D6,Metabolism/PK,0,sparteine,1184764298.0,European
1184514719,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514721.0,East Asian
1449188430,PA166177795,rs3778152,,,OPRM1,Metabolism/PK,1,cotinine,1449188432.0,East Asian
1183703357,PA166157284,rs1045642,,,ABCB1,Efficacy,1,antiepileptics,1183703364.0,Central/South Asian
1183703357,PA166157284,rs1045642,,,ABCB1,Efficacy,1,antiepileptics,1451337587.0,Central/South Asian
1183703357,PA166157284,rs1045642,,,ABCB1,Efficacy,1,antiepileptics,1451337600.0,Central/South Asian
1184511088,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,donepezil,1184511090.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184511088,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,donepezil,1184511090.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184511088,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,donepezil,1184511090.0,"Multiple groups, n=1 Arabian patient, the rest were Caucasian."
1184514528,PA166157267,rs776746,,,CYP3A5,Dosage,1,tacrolimus,1184514530.0,Multiple groups
1184514528,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,tacrolimus,1184514530.0,Multiple groups
1449566942,PA166179489,rs12138564,,,CCT3,Efficacy,-1,bevacizumab,1449566948.0,Multiple groups
1449566942,PA166179489,rs12138564,,,CCT3,Efficacy,-1,bevacizumab,1449566961.0,Multiple groups
1449566942,PA166179489,rs12138564,,,CCT3,Efficacy,-1,bevacizumab,1449566950.0,Multiple groups
1449566942,PA166179489,rs12138564,,,CCT3,Efficacy,-1,ranibizumab,1449566948.0,Multiple groups
1449566942,PA166179489,rs12138564,,,CCT3,Efficacy,-1,ranibizumab,1449566961.0,Multiple groups
1449566942,PA166179489,rs12138564,,,CCT3,Efficacy,-1,ranibizumab,1449566950.0,Multiple groups
1184514665,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,tacrolimus,1184514667.0,Unknown
1451114040,PA166184213,rs204076,,,OPRD1,Efficacy,-1,naltrexone,1451114008.0,"Multiple groups, Caucasian, African American and Other ethnicities."
1184472517,PA166157284,rs1045642,,,ABCB1,Efficacy,-1,clopidogrel,1184472519.0,Unknown
1448997587,PA166170426,rs70950385,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997592.0,Unknown
1449163317,PA166176416,rs4253730,,,PPARA,Metabolism/PK,-1,tacrolimus,1449163319.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1448257695,PA166160077,rs38010,,,GLCCI1,Efficacy,-1,corticosteroids,1448257697.0,Unknown
1449164090,PA166157578,rs2645400,,,GATA4,Dosage,-1,warfarin,1449164093.0,European
1445297339,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,atazanavir,1445297348.0,Unknown
1445297339,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,bilirubin,1445297348.0,Unknown
1444936339,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,aspirin,1444936351.0,Unknown
1444936339,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,aspirin,1444936351.0,Unknown
1444936339,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1444936351.0,Unknown
1444936339,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1444936351.0,Unknown
1444936339,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1444936351.0,Unknown
1444936339,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1444936351.0,Unknown
1444705641,PA166156417,rs6806020,,,None,Efficacy,1,peginterferon alfa-2b,1444705643.0,Multiple groups
1444705641,PA166156417,rs6806020,,,None,Efficacy,1,ribavirin,1444705643.0,Multiple groups
1444704705,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1444704719.0,East Asian
1444704705,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1444704719.0,East Asian
1444704705,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,1,clopidogrel,1444704719.0,East Asian
1444705790,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1444705792.0,European
1444705790,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1444705792.0,European
1444705790,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,ribavirin,1444705792.0,European
1444705790,PA166155468,rs12979860,,,IFNL4,Efficacy,-1,ribavirin,1444705792.0,European
1444706944,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444706955.0,Unknown
1444706944,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444706955.0,Unknown
1444706944,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444706955.0,Unknown
1444696308,PA166155135,rs71647871,,,CES1,Metabolism/PK,1,clopidogrel,1444696313.0,European
1444696308,PA166155135,rs71647871,,,CES1,Metabolism/PK,1,clopidogrel,1444696313.0,European
1444707144,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444707159.0,European
1444707144,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444707159.0,European
1444707144,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444707159.0,European
1185234754,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,clopidogrel,1185234759.0,European
1185023386,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,tacrolimus,1185023388.0,European
1185023386,PA166156105,rs4253728,,,PPARA,Metabolism/PK,-1,tacrolimus,1185023389.0,European
1444828207,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,voriconazole,1444828216.0,European
1444694858,PA166156900,rs4880,,,SOD2,Efficacy,0,epirubicin,1444694860.0,East Asian
1444694858,PA166156900,rs4880,,,SOD2,Efficacy,0,fluorouracil,1444694860.0,East Asian
1444694858,PA166156900,rs4880,,,SOD2,Efficacy,0,oxaliplatin,1444694860.0,East Asian
1444665914,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,"interferon alfa-2b, recombinant",1444665920.0,European
1444665914,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,"interferon alfa-2b, recombinant",1444665924.0,European
1444665914,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,"interferon alfa-2b, recombinant",1444665926.0,Unknown
1444665914,PA166155468,rs12979860,,,IFNL3,Efficacy,-1,"interferon alfa-2b, recombinant",1444665922.0,European
1444843603,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843609.0,Multiple groups
1444843603,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843609.0,Multiple groups
1444843603,PA166155469,rs12980275,,,IFNL3,Efficacy,1,ribavirin,1444843609.0,Multiple groups
1444706383,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1444706385.0,European
1444706383,PA166155469,rs12980275,,,IFNL3,Efficacy,-1,ribavirin,1444706385.0,European
1448612336,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448612338.0,East Asian
1447519671,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1447519696.0,African American/Afro-Caribbean
1447519671,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1447519673.0,European
1448573364,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448573366.0,East Asian
1444694633,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1444694646.0,East Asian
1449171488,PA166157284,rs1045642,,,ABCB1,Dosage,1,opioids,1449171502.0,Unknown
1449171488,PA166157284,rs1045642,,,ABCB1,Efficacy,1,opioids,1449171502.0,Unknown
1444694879,PA166154249,rs1695,,,GSTP1,Efficacy,0,epirubicin,1444694881.0,East Asian
1444694879,PA166154249,rs1695,,,GSTP1,Efficacy,0,fluorouracil,1444694881.0,East Asian
1444694879,PA166154249,rs1695,,,GSTP1,Efficacy,0,oxaliplatin,1444694881.0,East Asian
1444694818,PA166155017,rs1800566,,,NQO1,Efficacy,1,epirubicin,1444694825.0,East Asian
1444694818,PA166155017,rs1800566,,,NQO1,Efficacy,1,epirubicin,1444694827.0,East Asian
1444694818,PA166155017,rs1800566,,,NQO1,Efficacy,1,fluorouracil,1444694825.0,East Asian
1444694818,PA166155017,rs1800566,,,NQO1,Efficacy,1,fluorouracil,1444694827.0,East Asian
1444694818,PA166155017,rs1800566,,,NQO1,Efficacy,1,oxaliplatin,1444694825.0,East Asian
1444694818,PA166155017,rs1800566,,,NQO1,Efficacy,1,oxaliplatin,1444694827.0,East Asian
1444668556,PA166155435,rs8099917,,,IFNL3,Efficacy,1,"interferon alfa-2a, recombinant",1444668558.0,European
1444668556,PA166155435,rs8099917,,,IFNL3,Efficacy,1,"interferon alfa-2b, recombinant",1444668558.0,European
1444668556,PA166155435,rs8099917,,,IFNL3,Efficacy,1,ribavirin,1444668558.0,European
1444695486,PA166154147,rs12248560,,,CYP2C19,Dosage,-1,methadone,1444695488.0,"Multiple groups, Caucasian (85%), African-descent (10%), Asian-descent (5%)"
1444706170,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444706189.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1445183238.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1444706189.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1445183238.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1444706189.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL3,Efficacy,1,ribavirin,1445183238.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1444706189.0,Unknown
1444706170,PA166155468,rs12979860,,,IFNL4,Efficacy,1,ribavirin,1445183238.0,Unknown
1444698898,PA166156611,rs6832850,,,HMGB2,Efficacy,-1,Platinum compounds,1444698900.0,East Asian
1444936127,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444936233.0,East Asian
1444936127,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444936233.0,East Asian
1444936127,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,4-hydroxytamoxifen,1444936233.0,East Asian
1444936127,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,endoxifen,1444936233.0,East Asian
1444936127,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,endoxifen,1444936233.0,East Asian
1444936127,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,endoxifen,1444936233.0,East Asian
1446767176,PA166155045,rs2917677,,,NQO1,Dosage,-1,warfarin,1446767178.0,East Asian
1447024584,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447024599.0,Unknown
1447024584,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447024599.0,Unknown
1447024584,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447024599.0,Unknown
1444828173,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,0,voriconazole,1444828204.0,Unknown
1444935576,PA166153745,rs3738046,,,EPHX1,Metabolism/PK,1,carbamazepine,1444935582.0,East Asian
1444934680,PA166156656,rs11942466,,,AREG,Efficacy,1,capecitabine,1444934682.0,Unknown
1444934680,PA166156656,rs11942466,,,AREG,Efficacy,1,radiotherapy,1444934682.0,Unknown
1444695622,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,warfarin,1444695635.0,European
1444695622,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,warfarin,1444695635.0,European
1444695622,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,warfarin,1444695635.0,European
1444695230,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,0,clobazam,1444695244.0,East Asian
1444695230,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,0,clobazam,1444695244.0,East Asian
1444695230,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,0,clobazam,1444695244.0,East Asian
1445296627,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296638.0,Multiple groups
1445296627,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296642.0,European
1445296627,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296646.0,African American/Afro-Caribbean
1445296627,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1445296638.0,Multiple groups
1445296627,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1445296642.0,European
1445296627,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1445296646.0,African American/Afro-Caribbean
1185235188,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,SN-38,1185235200.0,"Multiple groups, White, Black, Hispanic"
1185235188,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,SN-38,1185235200.0,"Multiple groups, White, Black, Hispanic"
1446765670,PA166157284,rs1045642,,,ABCB1,Efficacy,1,sunitinib,1450985820.0,"Multiple groups, Chinese, Indian, Malay"
1446765670,PA166157284,rs1045642,,,ABCB1,Efficacy,1,sunitinib,1446765672.0,"Multiple groups, Chinese, Indian, Malay"
1446765670,PA166157284,rs1045642,,,ABCB1,Efficacy,1,sunitinib,1446765678.0,"Multiple groups, Chinese, Indian, Malay"
1446765670,PA166157284,rs1045642,,,ABCB1,Efficacy,1,sunitinib,1446765681.0,"Multiple groups, Chinese, Indian, Malay"
1185235201,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,-1,irinotecan,1185235218.0,"Multiple groups, White, Black, Hispanic"
1185235201,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,-1,irinotecan,1185235218.0,"Multiple groups, White, Black, Hispanic"
1444608095,PA166154078,rs7089580,,,CYP2C9,Dosage,1,warfarin,1444608100.0,African American/Afro-Caribbean
1445296671,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296673.0,Multiple groups
1445296671,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296674.0,European
1445296671,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1445296675.0,African American/Afro-Caribbean
1445296671,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1445296673.0,Multiple groups
1445296671,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1445296674.0,European
1445296671,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1445296675.0,African American/Afro-Caribbean
1444705825,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1444705840.0,Unknown
1444705825,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1444705840.0,Unknown
1444705825,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,acenocoumarol,1444705840.0,Unknown
1296598796,PA166156105,rs4253728,,,PPARA,Dosage,1,phenprocoumon,1296598857.0,"Multiple groups, mostly White (81%)"
1185012177,,,PA165955628,HLA-B*40:01:01,HLA-B,Efficacy,1,lamivudine,1185012185.0,East Asian
1185012177,,,PA165955628,HLA-B*40:01:01,HLA-B,Efficacy,1,nevirapine,1185012185.0,East Asian
1185012177,,,PA165955628,HLA-B*40:01:01,HLA-B,Efficacy,1,stavudine,1185012185.0,East Asian
1444705851,PA166155381,rs2108622,,,CYP4F2,Dosage,1,acenocoumarol,1444705853.0,Unknown
1444706610,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,acenocoumarol,1444706621.0,Sub-Saharan African
1444706610,,,PA165816546,CYP2C9*5,CYP2C9,Metabolism/PK,-1,acenocoumarol,1444706621.0,Sub-Saharan African
1444706610,,,PA165816549,CYP2C9*8,CYP2C9,Metabolism/PK,-1,acenocoumarol,1444706621.0,Sub-Saharan African
1444706610,,,PA165816550,CYP2C9*9,CYP2C9,Metabolism/PK,-1,acenocoumarol,1444706621.0,Sub-Saharan African
1444706610,,,PA165816552,CYP2C9*11,CYP2C9,Metabolism/PK,-1,acenocoumarol,1444706621.0,Sub-Saharan African
1185003533,PA166153571,rs396991,,,FCGR3A,Efficacy,1,trastuzumab,1185003539.0,Unknown
1444707383,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1444707398.0,Unknown
1444707383,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1444707398.0,Unknown
1444707383,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1444707398.0,Unknown
1184483601,PA166158926,rs57098334,,,SLC6A4,Efficacy,-1,sertraline,1184483603.0,Unknown
981238227,PA166157288,rs1128503,,,ABCB1,Dosage,1,antipsychotics,981238233.0,Central/South Asian
981238227,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,antipsychotics,981238233.0,Central/South Asian
1447674478,PA166155986,rs1051266,,,SLC19A1,Efficacy,1,methotrexate,1447674480.0,Central/South Asian
981954797,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,carbamazepine,981954804.0,Central/South Asian
981954797,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,phenobarbital,981954804.0,Central/South Asian
981954797,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,phenytoin,981954804.0,Central/South Asian
981954797,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,valproic acid,981954804.0,Central/South Asian
1448636673,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,everolimus,1448636675.0,European
1445296596,PA166157288,rs1128503,,,ABCB1,Efficacy,1,imatinib,1445296606.0,East Asian
1449310654,PA166153972,rs1799853,,,CYP2C9,Efficacy,-1,"sulfonamides, urea derivatives",1449310656.0,Latino
1444935858,PA166153595,rs846908,,,HSD11B1,Metabolism/PK,1,tacrolimus,1444935866.0,East Asian
1446754341,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,sunitinib,1446765321.0,"Multiple groups, Chinese, Indian, Malay"
1446754341,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,sunitinib,1446765667.0,"Multiple groups, Chinese, Indian, Malay"
1446754341,PA166157288,rs1128503,,,ABCB1,Efficacy,-1,sunitinib,1446754343.0,"Multiple groups, Chinese, Indian, Malay"
1444705811,PA166155469,rs12980275,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444705813.0,Latino
1444705811,PA166155469,rs12980275,,,IFNL3,Efficacy,1,ribavirin,1444705813.0,Latino
1444827994,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1444828005.0,"Multiple groups, White, Latino, African American, Asian"
1444827994,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1444828005.0,"Multiple groups, White, Latino, African American, Asian"
1444608478,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,-1,valproic acid,1444608513.0,East Asian
1444608478,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,valproic acid,1444608513.0,East Asian
1444666116,PA166153751,rs3766355,,,PTGFR,Efficacy,-1,latanoprost,1444666118.0,East Asian
1444666116,PA166153751,rs3766355,,,PTGFR,Efficacy,-1,latanoprost,1444666159.0,East Asian
1444666116,PA166153751,rs3766355,,,PTGFR,Efficacy,-1,latanoprost,1444666119.0,East Asian
1444666116,PA166153751,rs3766355,,,PTGFR,Efficacy,-1,latanoprost,1444666157.0,East Asian
1444842399,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,bevacizumab,1444842401.0,"Multiple groups, Asian and Caucasians were studied"
1444842399,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,capecitabine,1444842401.0,"Multiple groups, Asian and Caucasians were studied"
1444842399,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,fluorouracil,1444842401.0,"Multiple groups, Asian and Caucasians were studied"
1444842399,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,irinotecan,1444842401.0,"Multiple groups, Asian and Caucasians were studied"
1444842399,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,leucovorin,1444842401.0,"Multiple groups, Asian and Caucasians were studied"
1444842399,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,oxaliplatin,1444842401.0,"Multiple groups, Asian and Caucasians were studied"
981861804,PA166157305,rs1800796,,,IL6,Efficacy,1,peginterferon alfa-2a,981861809.0,European
1444666926,PA166156380,rs3774261,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666928.0,East Asian
1444666909,PA166156348,rs2241767,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666911.0,East Asian
1444666920,PA166156386,rs3821799,,,ADIPOQ,Efficacy,-1,pioglitazone,1444666922.0,East Asian
982045481,PA166157312,rs1922242,,,ABCB1,Efficacy,1,fluvastatin,982045486.0,Unknown
1444843589,PA166155437,rs8103142,,,IFNL3,Efficacy,1,peginterferon alfa-2a,1444843591.0,East Asian
1444843589,PA166155437,rs8103142,,,IFNL3,Efficacy,1,peginterferon alfa-2b,1444843591.0,East Asian
1444843589,PA166155437,rs8103142,,,IFNL3,Efficacy,1,ribavirin,1444843591.0,East Asian
1444843860,PA166155468,rs12979860,,,IFNL3,Efficacy,1,deleobuvir,1444843868.0,European
1444843860,PA166155468,rs12979860,,,IFNL3,Efficacy,1,deleobuvir,1444843866.0,"Multiple groups, 77 white, 1 black"
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,deleobuvir,1444843868.0,European
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,deleobuvir,1444843866.0,"Multiple groups, 77 white, 1 black"
1444843860,PA166155468,rs12979860,,,IFNL3,Efficacy,1,faldaprevir,1444843868.0,European
1444843860,PA166155468,rs12979860,,,IFNL3,Efficacy,1,faldaprevir,1444843866.0,"Multiple groups, 77 white, 1 black"
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,faldaprevir,1444843868.0,European
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,faldaprevir,1444843866.0,"Multiple groups, 77 white, 1 black"
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,faldaprevir,1444843868.0,European
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,faldaprevir,1444843866.0,"Multiple groups, 77 white, 1 black"
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,faldaprevir,1444843868.0,European
1444843860,PA166155468,rs12979860,,,IFNL4,Efficacy,1,faldaprevir,1444843866.0,"Multiple groups, 77 white, 1 black"
1447519684,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1447519686.0,European
1447519684,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1447519701.0,African American/Afro-Caribbean
1447672753,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,belinostat,1447673292.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672753,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,belinostat,1447672772.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672753,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,1,belinostat,1447673292.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672753,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,1,belinostat,1447672772.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672760,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,belinostat,1447673226.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672760,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,belinostat,1447672778.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672760,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,1,belinostat,1447673226.0,"Multiple groups, White, African American, Hispanic, Asian"
1447672760,,,PA166115845,UGT1A1*60,UGT1A1,Metabolism/PK,1,belinostat,1447672778.0,"Multiple groups, White, African American, Hispanic, Asian"
1447680831,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,efavirenz,1447680833.0,Sub-Saharan African
982045444,PA166157316,rs2032582,,,ABCB1,Efficacy,0,lamivudine,982045454.0,East Asian
982045444,PA166157316,rs2032582,,,ABCB1,Efficacy,0,nevirapine,982045454.0,East Asian
982045444,PA166157316,rs2032582,,,ABCB1,Efficacy,0,zidovudine,982045454.0,East Asian
1447946367,PA166157288,rs1128503,,,ABCB1,Dosage,1,tacrolimus,1447946373.0,European
1183491680,PA166157316,rs2032582,,,ABCB1,Dosage,-1,tacrolimus,1183491682.0,European
1447678071,PA166154522,rs1899663,,,HOTAIR,Efficacy,-1,Platinum compounds,1447678073.0,East Asian
1184483099,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,cyclosporine,1184483101.0,European
1446896579,PA166154898,rs2472304,,,CYP1A2,Metabolism/PK,1,erlotinib,1446896586.0,East Asian
1446900422,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,enalapril,1446900425.0,Unknown
1446900422,PA166157006,rs2010963,,,VEGFA,Efficacy,-1,enalapril,1446900424.0,"Multiple groups, Brazil"
1446767367,PA166153691,rs2291834,,,MIA3,Metabolism/PK,-1,vancomycin,1446767369.0,European
1448820619,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,tacrolimus,1448820625.0,East Asian
1447679448,PA166156797,rs2292023,,,SLC6A3,Efficacy,-1,Selective serotonin reuptake inhibitors,1447679450.0,East Asian
1448427752,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,granisetron,1448427754.0,East Asian
1448427752,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,palonosetron,1448427754.0,East Asian
1448573370,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448573372.0,East Asian
1446897132,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897139.0,African American/Afro-Caribbean
1446897132,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897139.0,African American/Afro-Caribbean
1446897132,,,PA165988488,CYP2D6*36,CYP2D6,Metabolism/PK,0,dextromethorphan,1446897139.0,African American/Afro-Caribbean
1446896603,PA166154259,rs6265,,,BDNF,Efficacy,1,olanzapine,1446896611.0,European
1446896603,PA166154259,rs6265,,,BDNF,Efficacy,1,olanzapine,1446896617.0,European
1449173236,PA166157316,rs2032582,,,ABCB1,Dosage,-1,morphine,1449173239.0,European
1449173236,PA166157316,rs2032582,,,ABCB1,Dosage,-1,morphine,1449173238.0,European
1446896493,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1446896495.0,Latino
1446896493,,,PA165980636,CYP2C19*3,CYP2C19,Efficacy,-1,clopidogrel,1446896495.0,Latino
1446896483,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,-1,clopidogrel,1446896485.0,Latino
1446896483,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,-1,clopidogrel,1446896485.0,Latino
1447674967,PA166153797,rs7552841,,,PCSK9,Efficacy,-1,atorvastatin,1447674978.0,Latino
1446899459,PA166155135,rs71647871,,,CES1,Metabolism/PK,-1,enalapril,1446899461.0,European
1450928150,PA166156023,rs4633,,,COMT,Efficacy,-1,risperidone,1450928155.0,East Asian
1450928225,PA166154793,rs2494732,,,AKT1,Efficacy,-1,risperidone,1450928232.0,East Asian
1450928225,PA166154793,rs2494732,,,AKT1,Efficacy,-1,risperidone,1450928231.0,East Asian
1450928225,PA166154793,rs2494732,,,AKT1,Efficacy,-1,risperidone,1450928230.0,East Asian
1444707745,PA166154623,rs10877012,,,CYP27B1,Efficacy,1,peginterferon alfa-2b,1444707751.0,European
1444707745,PA166154623,rs10877012,,,CYP27B1,Efficacy,1,ribavirin,1444707751.0,European
1444707745,PA166154623,rs10877012,,,CYP27B1,Efficacy,1,ribavirin,1444707751.0,European
1447715709,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,paclitaxel,1447715712.0,European
1447715709,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,paclitaxel,1447715711.0,European
1447715709,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,paclitaxel,1447715712.0,European
1447715709,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,paclitaxel,1447715711.0,European
1447715709,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,Platinum compounds,1447715712.0,European
1447715709,,,PA166048679,GSTT1 non-null,GSTT1,Efficacy,-1,Platinum compounds,1447715711.0,European
1447715709,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,Platinum compounds,1447715712.0,European
1447715709,,,PA166048678,GSTT1 null,GSTT1,Efficacy,-1,Platinum compounds,1447715711.0,European
1446905865,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,doxepin,1446905874.0,European
1446905865,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,doxepin,1446905877.0,European
1446905865,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,doxepin,1446905874.0,European
1446905865,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,doxepin,1446905877.0,European
1446906141,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,voriconazole,1446906147.0,East Asian
1446904458,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,nortriptyline,1446904486.0,"Multiple groups, mostly White"
1446904458,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,1,nortriptyline,1446904486.0,"Multiple groups, mostly White"
1446904458,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,1,nortriptyline,1446904486.0,"Multiple groups, mostly White"
1446904458,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,1,nortriptyline,1446904486.0,"Multiple groups, mostly White"
1446904458,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,1,nortriptyline,1446904486.0,"Multiple groups, mostly White"
1446904458,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,nortriptyline,1446904486.0,"Multiple groups, mostly White"
1446907896,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,-1,cyclophosphamide,1446907898.0,East Asian
1447682460,PA166190881,rs11322783,,,IFNL4,Efficacy,1,boceprevir,1447682462.0,European
1447682460,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2a,1447682462.0,European
1447682460,PA166190881,rs11322783,,,IFNL4,Efficacy,1,peginterferon alfa-2b,1447682462.0,European
1447682460,PA166190881,rs11322783,,,IFNL4,Efficacy,1,ribavirin,1447682462.0,European
1447682460,PA166190881,rs11322783,,,IFNL4,Efficacy,1,telaprevir,1447682462.0,European
1447519652,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447519663.0,European
1447519652,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447519705.0,African American/Afro-Caribbean
1447519652,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447519663.0,European
1447519652,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447519705.0,African American/Afro-Caribbean
1447519652,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447519663.0,European
1447519652,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447519705.0,African American/Afro-Caribbean
1447519652,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1447519663.0,European
1447519652,,,PA165816546,CYP2C9*5,CYP2C9,Dosage,1,warfarin,1447519705.0,African American/Afro-Caribbean
1447519652,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1447519663.0,European
1447519652,,,PA165816547,CYP2C9*6,CYP2C9,Dosage,1,warfarin,1447519705.0,African American/Afro-Caribbean
1447519652,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1447519663.0,European
1447519652,,,PA165816552,CYP2C9*11,CYP2C9,Dosage,1,warfarin,1447519705.0,African American/Afro-Caribbean
1447680419,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,efavirenz,1447680421.0,"Multiple groups, 90% Caucasian, Italy"
1447947823,PA166154194,rs72558187,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947838.0,East Asian
1447947823,PA166154194,rs72558187,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947825.0,East Asian
1447520623,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447520634.0,Multiple groups
1447520623,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447520636.0,European
1447520623,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447520638.0,African American/Afro-Caribbean
1447520623,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447520634.0,Multiple groups
1447520623,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447520636.0,European
1447520623,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447520638.0,African American/Afro-Caribbean
1447520623,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447520634.0,Multiple groups
1447520623,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447520636.0,European
1447520623,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447520638.0,African American/Afro-Caribbean
1447676158,PA166154990,rs246221,,,ABCC1,Efficacy,-1,cyclophosphamide,1447676201.0,East Asian
1447676158,PA166154990,rs246221,,,ABCC1,Toxicity,-1,cyclophosphamide,1447676201.0,East Asian
1447676158,PA166154990,rs246221,,,ABCC1,Metabolism/PK,-1,cyclophosphamide,1447676201.0,East Asian
1449167906,PA166177132,rs7035619,,,TEX10,Efficacy,1,duloxetine,1449167908.0,European
1447675725,PA166156920,rs462779,,,REV3L,Efficacy,1,cisplatin,1447675735.0,European
1446899759,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,nortriptyline,1446899761.0,East Asian
1446899759,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,nortriptyline,1446899761.0,East Asian
1447991285,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,0,sparteine,1447991305.0,Unknown
1447991285,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,sparteine,1447991305.0,Unknown
1447991285,,,PA165988480,CYP2D6*2xN,CYP2D6,Metabolism/PK,0,sparteine,1447991305.0,Unknown
1447991285,,,PA165971588,CYP2D6*35xN,CYP2D6,Metabolism/PK,0,sparteine,1447991305.0,Unknown
1447520846,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,sirolimus,1447520852.0,East Asian
1447520846,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,tacrolimus,1447520852.0,East Asian
1446848557,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,-1,warfarin,1446848559.0,East Asian
1446848557,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,warfarin,1446848559.0,East Asian
1446908196,PA166157527,rs121434568,,,EGFR,Efficacy,-1,afatinib,1446908198.0,Unknown
1446908196,PA166157527,rs121434568,,,EGFR,Efficacy,-1,afatinib,1446908199.0,Unknown
1446908196,PA166157527,rs121434568,,,EGFR,Efficacy,-1,afatinib,1446908198.0,Unknown
1446908196,PA166157527,rs121434568,,,EGFR,Efficacy,-1,afatinib,1446908199.0,Unknown
1447946352,PA166157316,rs2032582,,,ABCB1,Dosage,1,tacrolimus,1447946362.0,European
1446901519,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,amitriptyline,1446901543.0,East Asian
1446901519,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,amitriptyline,1446901543.0,East Asian
1446901519,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,amitriptyline,1446901543.0,East Asian
1446905079,PA166155023,rs1805015,,,IL4R,Efficacy,1,Hepatitis vaccines,1446905086.0,East Asian
1446896031,PA166156763,rs1438692,,,AFAP1L1,Efficacy,-1,Selective serotonin reuptake inhibitors,1446896034.0,Multiple groups
1447952414,PA166157512,rs74597325,,,CFTR,Efficacy,-1,ataluren,1447952416.0,Unknown
1448258935,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,0,acenocoumarol,1448258946.0,Unknown
1448258935,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,0,acenocoumarol,1448258944.0,Unknown
1448258935,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,0,acenocoumarol,1448258946.0,Unknown
1448258935,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,0,acenocoumarol,1448258944.0,Unknown
1448258935,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,0,phenprocoumon,1448258946.0,Unknown
1448258935,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,0,phenprocoumon,1448258944.0,Unknown
1448258935,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,0,phenprocoumon,1448258946.0,Unknown
1448258935,,,PA165980636,CYP2C19*3,CYP2C19,Dosage,0,phenprocoumon,1448258944.0,Unknown
1184470054,PA166154053,rs4244285,,,CYP2C19,Dosage,1,clopidogrel,1184470056.0,"Multiple groups, out of an initial 40 patients(2 of whom did not complete the study), there were 35 Caucasian,2 Maori,2 Fijian Indian and 1 Chinese from the Australian New Zealand Clinical Trials registry."
1184470054,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,1184470056.0,"Multiple groups, out of an initial 40 patients(2 of whom did not complete the study), there were 35 Caucasian,2 Maori,2 Fijian Indian and 1 Chinese from the Australian New Zealand Clinical Trials registry."
1448115881,PA166156412,rs6785930,,,P2RY12,Efficacy,-1,clopidogrel,1448115883.0,European
1448267948,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448267950.0,East Asian
1448266503,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,risperidone,1448266505.0,"Multiple groups, 81% Caucasian"
1448112553,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1448112564.0,Unknown
1448112553,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1448112564.0,Unknown
1448266474,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,-1,risperidone,1448266476.0,"Multiple groups, 81% Caucasian"
1448276433,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,0,warfarin,1448276452.0,Multiple groups
1448276433,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,0,warfarin,1448276452.0,Multiple groups
1448276496,PA166155091,rs9923231,,,VKORC1,Dosage,0,warfarin,1448276502.0,Unknown
1448266530,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,risperidone,1448266532.0,"Multiple groups, 81% Caucasian"
1448266728,PA166157345,rs2242480,,,CYP3A4,Metabolism/PK,-1,carbamazepine,1448266730.0,East Asian
1448276172,PA166155040,rs2359612,,,VKORC1,Dosage,1,warfarin,1448276174.0,East Asian
1448123402,PA166153895,rs67376798,,,DPYD,Dosage,1,capecitabine,1448123404.0,Unknown
1448259006,PA166153571,rs396991,,,FCGR3A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448259018.0,Multiple groups
1448259006,PA166153571,rs396991,,,FCGR3A,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448259055.0,Multiple groups
1447980312,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,tolperisone,1447980316.0,European
1447980312,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,tolperisone,1447983896.0,European
1447980312,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,tolperisone,1447983898.0,European
1447980312,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,tolperisone,1447980314.0,European
1447980312,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,-1,tolperisone,1447980315.0,European
1447980312,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,tolperisone,1447980316.0,European
1447980312,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,tolperisone,1447983896.0,European
1447980312,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,tolperisone,1447983898.0,European
1447980312,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,tolperisone,1447980314.0,European
1447980312,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,tolperisone,1447980315.0,European
1447680253,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447680255.0,Multiple groups
1447680253,PA166156988,rs1799724,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1447680256.0,European
1447678102,PA166154835,rs116907618,,,MEG3,Efficacy,-1,Platinum compounds,1447678104.0,East Asian
1447943994,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,hmg coa reductase inhibitors,1447944000.0,European
1447943994,PA166154579,rs4149056,,,SLCO1B1,Efficacy,1,hmg coa reductase inhibitors,1447944000.0,European
1448104199,,,PA165924730,CYP2A6*6,CYP2A6,Metabolism/PK,0,coumarin,1448104206.0,Unknown
1447986082,PA166157367,rs2740574,,,CYP3A4,Metabolism/PK,-1,lopinavir,1447986088.0,Sub-Saharan African
1449154515,PA166154836,rs4646,,,CYP19A1,Efficacy,1,tamoxifen,1449154517.0,East Asian
1448254963,PA166159897,rs28362491,,,NFKB1,Efficacy,-1,etanercept,1448254972.0,Unknown
1448265740,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,azithromycin,1448265745.0,East Asian
1447986186,PA166157168,rs10455872,,,LPA,Efficacy,1,hmg coa reductase inhibitors,1447986188.0,European
1448109250,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,1,3,1448109252.0,European
1448109250,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,3,1448109252.0,European
1448109250,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,3,1448109252.0,European
1448109250,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,1,3,1448109252.0,European
1448109250,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,3,1448109252.0,European
1448109250,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,3,1448109252.0,European
1448109250,,,PA165816578,CYP2D6*3,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109252.0,European
1448109250,,,PA165816579,CYP2D6*4,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109252.0,European
1448109250,,,PA165948092,CYP2D6*5,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109252.0,European
1448109250,,,PA165948317,CYP2D6*9,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109252.0,European
1448109250,,,PA165816582,CYP2D6*10,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109252.0,European
1448109250,,,PA165816584,CYP2D6*41,CYP2D6,Efficacy,1,4-methylenedioxymethamphetamine,1448109252.0,European
1450933226,PA166154850,rs762551,,,CYP1A2,Dosage,1,imatinib,1450933241.0,Unknown
1450933226,PA166154850,rs762551,,,CYP1A2,Dosage,1,imatinib,1450933231.0,Unknown
1450933226,PA166154850,rs762551,,,CYP1A2,Dosage,1,imatinib,1450933240.0,Unknown
1183622472,PA166154902,rs3743484,,,CYP1A2,Metabolism/PK,-1,escitalopram,1183622474.0,East Asian
1184473337,PA166155475,rs28399454,,,CYP2A6,Metabolism/PK,-1,efavirenz,1184473339.0,Latino
1447677450,PA166154884,rs2289105,,,CYP19A1,Other,1,hdl cholesterol,1447677452.0,Unknown
827848949,PA166155478,rs28399499,,,CYP2B6,Toxicity,-1,nevirapine,827848985.0,Multiple groups
827848949,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,-1,nevirapine,827848985.0,Multiple groups
1447988501,PA166155272,rs594445,,,MOCOS,Dosage,1,azathioprine,1447988504.0,Unknown
981861789,PA166157100,rs4305746,,,TAAR6,Efficacy,1,aripiprazole,981861795.0,East Asian
1448258044,PA166160151,rs2701528,,,STIP1,Efficacy,-1,corticosteroids,1448258046.0,Unknown
1448258082,PA166160158,rs2282490,,,STIP1,Efficacy,-1,corticosteroids,1448258084.0,Unknown
1448262588,,,PA166048676,GSTM1 non-null,GSTM1,Efficacy,-1,azathioprine,1448262599.0,Unknown
1448262588,,,PA166048675,GSTM1 null,GSTM1,Efficacy,-1,azathioprine,1448262599.0,Unknown
1447814549,PA166157848,rs121913459,,,ABL1,Efficacy,-1,nilotinib,1447814555.0,Unknown
1448262619,PA166155915,rs1127354,,,ITPA,Metabolism/PK,1,azathioprine,1448262625.0,Unknown
1448258435,PA166160230,rs2532292,,,KANSL1,Efficacy,-1,corticosteroids,1448258437.0,Unknown
1448258411,PA166160225,rs1052587,,,MAPT,Efficacy,-1,corticosteroids,1448258413.0,Unknown
1450936706,PA166186238,rs17376019,,,SRPRB,Metabolism/PK,-1,acetaldehyde,1450936710.0,East Asian
1184512504,PA166153729,rs3003596,,,NR1I3,Metabolism/PK,1,efavirenz,1184512518.0,Sub-Saharan African
1447959918,,,PA166115841,UGT1A1*1,UGT1A1,Metabolism/PK,1,deferasirox,1447959930.0,Unknown
1447959918,,,PA166115842,UGT1A1*28,UGT1A1,Metabolism/PK,1,deferasirox,1447959930.0,Unknown
1449164918,PA166176810,rs35511654,,,ADORA3,Toxicity,-1,methotrexate,1449164920.0,European
1447814556,PA166157848,rs121913459,,,ABL1,Efficacy,-1,homoharringtonine,1447814558.0,Unknown
1447814556,PA166157848,rs121913459,,,ABL1,Efficacy,-1,homoharringtonine,1447814558.0,Unknown
1449717757,,,PA165816579,CYP2D6*4,CYP2D6,Dosage,-1,carvedilol,1449717759.0,"Multiple groups, Caucasian and African American patients."
1448122976,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,losartan,1448122978.0,Unknown
1447964466,PA166156275,rs5182,,,AGTR1,Efficacy,1,perindopril,1447964468.0,European
1448104433,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,1,methadone,1448104439.0,East Asian
1448109658,PA166155096,rs9934438,,,VKORC1,Dosage,0,warfarin,,
1446906519,PA166157267,rs776746,,,CYP3A5,Dosage,1,sunitinib,1446906525.0,"Multiple groups, 96% white"
1449713612,PA166179815,rs2229046,,,ERBB3,Efficacy,1,carboplatin,1449713614.0,Unknown
1449713612,PA166179815,rs2229046,,,ERBB3,Efficacy,1,docetaxel,1449713614.0,Unknown
1449713612,PA166179815,rs2229046,,,ERBB3,Efficacy,1,trastuzumab,1449713614.0,Unknown
1448254981,PA166159900,rs696,,,NFKBIA,Efficacy,-1,etanercept,1448254983.0,Unknown
1450933234,PA166185792,rs28656907,,,ABCB1,Dosage,-1,imatinib,1450933243.0,Unknown
1450933234,PA166185792,rs28656907,,,ABCB1,Dosage,-1,imatinib,1450933239.0,Unknown
1450933234,PA166185792,rs28656907,,,ABCB1,Dosage,-1,imatinib,1450933242.0,Unknown
1450928170,PA166154322,rs1176713,,,HTR3A,Efficacy,-1,risperidone,1450928180.0,East Asian
1450928170,PA166154322,rs1176713,,,HTR3A,Efficacy,-1,risperidone,1450928176.0,East Asian
1450928170,PA166154322,rs1176713,,,HTR3A,Efficacy,-1,risperidone,1450928175.0,East Asian
1450933171,PA166185788,rs2236599,,,KLF4,Efficacy,1,hydroxyurea,1450933178.0,European
1450933171,PA166185788,rs2236599,,,KLF4,Efficacy,1,hydroxyurea,1450933178.0,European
1448123636,PA166154768,rs861539,,,XRCC3,Efficacy,1,Platinum compounds,1448123638.0,Multiple groups
1448123675,PA166159618,rs3749442,,,ABCC5,Efficacy,1,glyburide,1448123677.0,Unknown
1448123598,PA166159611,rs2303070,,,SPINK5,Efficacy,1,glyburide,1448123600.0,Unknown
1448123605,PA166157017,rs2077647,,,ESR1,Efficacy,1,glyburide,1448123607.0,Unknown
1448109526,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,clopidogrel,,
1448109526,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,prasugrel,,
1448109526,PA166154053,rs4244285,,,CYP2C19,Efficacy,1,ticagrelor,,
1447989858,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989900.0,East Asian
1447989858,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989902.0,East Asian
1447989858,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989904.0,East Asian
1447989858,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989900.0,East Asian
1447989858,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989902.0,East Asian
1447989858,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,1,dextromethorphan,1447989904.0,East Asian
1448109688,PA166154102,rs9332131,,,CYP2C9,Dosage,0,warfarin,,
1447988330,PA166157151,rs9373839,,,ATG5,Efficacy,1,adalimumab,1447988333.0,Unknown
1448124372,PA166153874,rs17376848,,,DPYD,Metabolism/PK,1,fluorouracil,1448124375.0,"Multiple groups, Malay, Chinese, Indian"
1448124372,PA166153874,rs17376848,,,DPYD,Metabolism/PK,1,fluorouracil,1448124374.0,"Multiple groups, Malay, Chinese, Indian"
1448109696,PA166154175,rs28371685,,,CYP2C9,Dosage,0,warfarin,,
1448634117,PA166165137,rs1427407,,,BCL11A,Efficacy,1,hydroxyurea,1448634123.0,Near Eastern
1448423969,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1448423971.0,Latino
1449003516,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,-1,lumefantrine,1449003518.0,Sub-Saharan African
1448997246,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,0,efavirenz,1448997256.0,Sub-Saharan African
1448997246,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,0,efavirenz,1448997256.0,Sub-Saharan African
1448635307,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,1,sorafenib,1448635309.0,Unknown
1448604391,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1448604402.0,European
1448604391,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1448604402.0,European
1448997456,PA166155393,rs2279343,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997458.0,Multiple groups
1448997462,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997468.0,Unknown
1448636654,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,-1,everolimus,1448636660.0,European
1448636667,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,-1,everolimus,1448636669.0,European
1448258274,PA166160196,rs1396862,,,CRHR1,Efficacy,-1,corticosteroids,1448258276.0,Unknown
1448613164,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,imatinib,1448613166.0,Central/South Asian
1448613164,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,imatinib,1448613166.0,Central/South Asian
1448612414,PA166157469,rs17143212,,,ABCB5,Metabolism/PK,-1,talinolol,1448612416.0,Unknown
1448603797,PA166161252,rs1439050,,,NTRK2,Efficacy,-1,antidepressants,1448603803.0,"Multiple groups, 92% Caucasian"
1448997381,PA166157267,rs776746,,,CYP3A,Metabolism/PK,1,cyclosporine,1448997386.0,East Asian
1448997381,PA166157267,rs776746,,,CYP3A5,Metabolism/PK,1,cyclosporine,1448997386.0,East Asian
1448997408,PA166157347,rs2257401,,,CYP3A7,Metabolism/PK,1,cyclosporine,1448997411.0,East Asian
1448995884,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448995886.0,Sub-Saharan African
1448995884,,,PA165818770,CYP2B6*11,CYP2B6,Metabolism/PK,1,efavirenz,1448995886.0,Sub-Saharan African
1448603909,PA166163355,rs3824519,,,NTRK2,Efficacy,-1,antidepressants,1448603911.0,"Multiple groups, 92% Caucasian"
1448997416,PA166157391,rs4646437,,,CYP3A4,Metabolism/PK,1,cyclosporine,1448997418.0,East Asian
1448426798,PA166154007,rs2273697,,,ABCC2,Efficacy,-1,antiepileptics,1448426800.0,Multiple groups
1448601802,PA166155036,rs2242446,,,SLC6A2,Efficacy,1,venlafaxine,1448601807.0,"Multiple groups, 88.9% European, 9.4% African American, 1.4% Asian, 0.3% admixed"
1448428115,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,valproic acid,1448428158.0,Unknown
1448428115,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,valproic acid,1448428158.0,Unknown
1448428115,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,valproic acid,1448428158.0,Unknown
1448495164,PA166154899,rs2606345,,,CYP1A1,Metabolism/PK,-1,exemestane,1448495166.0,Multiple groups
1448492087,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,exemestane,1448492089.0,Multiple groups
1448492087,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,-1,exemestane,1448492089.0,Multiple groups
1448493593,PA166161792,rs17134592,,,AKR1C4,Metabolism/PK,-1,exemestane,1448493595.0,Multiple groups
1448995964,PA166170320,rs7234029,,,PTPN2,Efficacy,-1,adalimumab,1448995966.0,European
1448995964,PA166170320,rs7234029,,,PTPN2,Efficacy,-1,adalimumab,1448995966.0,European
1449004334,PA166170800,rs6498169,,,CLEC16A,Efficacy,1,glatiramer acetate,1449004336.0,European
1448612558,PA166156118,rs5751876,,,ADORA2A,Efficacy,-1,regadenoson,1448612560.0,"Multiple groups, 71% Caucasian"
1448612558,PA166156118,rs5751876,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612560.0,"Multiple groups, 71% Caucasian"
1448612548,PA166156103,rs3761422,,,ADORA2A,Efficacy,-1,regadenoson,1448612550.0,"Multiple groups, 71% Caucasian"
1448612548,PA166156103,rs3761422,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612550.0,"Multiple groups, 71% Caucasian"
1448612548,PA166156103,rs3761422,,,ADORA2A-AS1,Efficacy,-1,regadenoson,1448612550.0,"Multiple groups, 71% Caucasian"
1448603676,PA166163329,rs11646054,,,SLC5A2,Efficacy,-1,empagliflozin,1448603678.0,Unknown
1448522700,PA166161859,rs6908425,,,CDKAL1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448522702.0,European
1448522700,PA166161859,rs6908425,,,CDKAL1,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1448522702.0,European
1449005435,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,imatinib,1449005437.0,Near Eastern
1448604042,PA166157288,rs1128503,,,ABCB1,Efficacy,1,risperidone,1448604044.0,East Asian
1448530379,PA166157316,rs2032582,,,ABCB1,Dosage,1,sunitinib,1448530381.0,"Multiple groups, 95% Caucasian"
1448530379,PA166157316,rs2032582,,,ABCB1,Toxicity,1,sunitinib,1448530381.0,"Multiple groups, 95% Caucasian"
1448603564,PA166153639,rs1800871,,,IL10,Metabolism/PK,-1,tacrolimus,1448603566.0,East Asian
1448424049,PA166154899,rs2606345,,,CYP1A1,Efficacy,1,antiepileptics,1448424056.0,Central/South Asian
1448613410,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613415.0,Multiple groups
1448613410,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613414.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613410,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613412.0,European
1448613410,PA166154070,rs4986893,,,CYP2C19,Metabolism/PK,-1,selumetinib,1448613413.0,Unknown
1448624859,PA166164927,rs2254638,,,N6AMT1,Metabolism/PK,1,clopidogrel,1448624864.0,East Asian
1448568024,PA166156958,rs833061,,,VEGFA,Efficacy,1,pazopanib,1448568026.0,"Multiple groups, 84% white"
1448634923,PA166157250,rs255100,,,CRHR2,Efficacy,-1,salbutamol,1448634925.0,European
1448612424,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,talinolol,1448612426.0,Unknown
1448431572,PA166156544,rs2231142,,,ABCG2,Toxicity,-1,n-desethyl sunitinib,1448431578.0,East Asian
1448431572,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,n-desethyl sunitinib,1448431578.0,East Asian
1448431572,PA166156544,rs2231142,,,ABCG2,Toxicity,-1,sunitinib,1448431578.0,East Asian
1448431572,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,sunitinib,1448431578.0,East Asian
1448632254,PA166157370,rs2868177,,,POR,Dosage,-1,acenocoumarol,1448632262.0,European
1449002176,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,clopidogrel,1449002178.0,European
1449002176,PA166154147,rs12248560,,,CYP2C19,Metabolism/PK,-1,clopidogrel thiol metabolite H4,1449002178.0,European
1448637116,PA166165401,rs1000940,,,RABEP1,Other,1,glucose,1448637121.0,European
1448637116,PA166165401,rs1000940,,,RABEP1,Other,1,glucose,1448637123.0,European
1448639044,PA166154053,rs4244285,,,CYP2C19,Metabolism/PK,-1,bupropion,1448639046.0,Unknown
1449002579,PA166157316,rs2032582,,,ABCB1,Dosage,-1,opioids,1449002581.0,"Multiple groups, Studies include Asian, Caucasian, African-American, Hispanic and Polynesian participants and participants of unreported ethnicity."
1449002579,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,opioids,1449002581.0,"Multiple groups, Studies include Asian, Caucasian, African-American, Hispanic and Polynesian participants and participants of unreported ethnicity."
1448428843,PA166161456,rs34650714,,,UGT1A1,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A10,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A3,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A4,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A5,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A6,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A7,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A8,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A9,Dosage,1,allopurinol,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A1,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A10,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A3,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A4,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A5,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A6,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A7,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A8,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448428843,PA166161456,rs34650714,,,UGT1A9,Dosage,1,febuxostat,1448428845.0,"Multiple groups, 22 African American, 2 Asian, 77 Caucasian, 1 Pacific Islander"
1448530748,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,sunitinib,1448530750.0,East Asian
1448603760,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,pantoprazole,1448603768.0,Near Eastern
1448603760,PA166157316,rs2032582,,,ABCB1,Efficacy,-1,pantoprazole,1448603768.0,Near Eastern
1448995983,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448995995.0,Multiple groups
1448995983,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448995995.0,Multiple groups
1448926568,PA166170012,rs4246215,,,FEN1,Efficacy,-1,fluorouracil,1448926570.0,East Asian
1448926568,PA166170012,rs4246215,,,FEN1,Efficacy,-1,Platinum compounds,1448926570.0,East Asian
1448926568,PA166170012,rs4246215,,,FEN1,Efficacy,-1,radiotherapy,1448926570.0,East Asian
1448633794,PA166157238,rs662,,,PON1,Efficacy,-1,clopidogrel,1448633796.0,Near Eastern
1449005218,PA166155381,rs2108622,,,CYP4F2,Dosage,1,warfarin,1449005220.0,East Asian
1448997158,PA166155478,rs28399499,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997164.0,Unknown
1448632439,PA166154944,rs35694136,,,CYP1A2,Metabolism/PK,1,olanzapine,1448632447.0,European
1448522373,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,fluorouracil,1448522375.0,Multiple groups
1448522373,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,fluorouracil,1448522375.0,Multiple groups
1448522373,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,irinotecan,1448522375.0,Multiple groups
1448522373,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,irinotecan,1448522375.0,Multiple groups
1448522373,,,PA166115841,UGT1A1*1,UGT1A1,Efficacy,-1,oxaliplatin,1448522375.0,Multiple groups
1448522373,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,oxaliplatin,1448522375.0,Multiple groups
1448522373,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,oxaliplatin,1448522375.0,Multiple groups
1448522373,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,oxaliplatin,1448522375.0,Multiple groups
1448522373,,,PA166115842,UGT1A1*28,UGT1A1,Efficacy,-1,oxaliplatin,1448522375.0,Multiple groups
1448531852,PA166162370,rs4661012,,,PEAR1,Efficacy,1,ticagrelor,1448531854.0,East Asian
1448634657,PA166156553,rs2305948,,,KDR,Efficacy,1,carfilzomib,1448634659.0,Unknown
1448634657,PA166156553,rs2305948,,,KDR,Efficacy,1,dexamethasone,1448634659.0,Unknown
1448634657,PA166156553,rs2305948,,,KDR,Efficacy,1,lenalidomide,1448634659.0,Unknown
1448999777,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,metformin,1448999808.0,Unknown
1448999777,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,metformin,1448999808.0,Unknown
1448999777,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,metformin,1448999808.0,Unknown
1448999777,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,metformin,1448999808.0,Unknown
1448530787,PA166155429,rs7248668,,,IFNL3,Efficacy,-1,peginterferon alfa-2a,1448530789.0,Central/South Asian
1448530787,PA166155429,rs7248668,,,IFNL3,Efficacy,-1,peginterferon alfa-2b,1448530789.0,Central/South Asian
1448530787,PA166155429,rs7248668,,,IFNL3,Efficacy,-1,ribavirin,1448530789.0,Central/South Asian
1448994017,,,PA165818750,CYP2B6*1,CYP2B6,Metabolism/PK,1,efavirenz,1448994035.0,European
1448994017,,,PA165818762,CYP2B6*6,CYP2B6,Metabolism/PK,1,efavirenz,1448994035.0,European
1449140022,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,1,sirolimus,1449140028.0,Unknown
1449140022,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,1,temsirolimus,1449140028.0,Unknown
1448281118,,,PA166115841,UGT1A1*1,UGT1A1,Dosage,0,irinotecan,1448281131.0,Multiple groups
1448281118,,,PA166115842,UGT1A1*28,UGT1A1,Dosage,0,irinotecan,1448281131.0,Multiple groups
1449716064,PA166156991,rs1799971,,,OPRM1,Dosage,1,fentanyl,1449716070.0,"Multiple groups, Asian and Caucasian participants"
1449713618,PA166179816,rs773123,,,ERBB3,Efficacy,1,carboplatin,1449713620.0,Unknown
1449713618,PA166179816,rs773123,,,ERBB3,Efficacy,1,docetaxel,1449713620.0,Unknown
1449713618,PA166179816,rs773123,,,ERBB3,Efficacy,1,trastuzumab,1449713620.0,Unknown
1449575733,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449575736.0,"Multiple groups, Brazil"
1449575733,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449575735.0,"Multiple groups, Brazil"
1449575733,PA166155381,rs2108622,,,CYP4F2,Dosage,-1,warfarin,1449575737.0,"Multiple groups, Brazil"
1449575721,PA166157284,rs1045642,,,ABCB1,Dosage,-1,warfarin,1449575726.0,"Multiple groups, Brazil"
1449575721,PA166157284,rs1045642,,,ABCB1,Dosage,-1,warfarin,1449575728.0,"Multiple groups, Brazil"
1449575721,PA166157284,rs1045642,,,ABCB1,Dosage,-1,warfarin,1449575730.0,"Multiple groups, Brazil"
1449713726,PA166179835,rs2234649,,,TNFRSF1A,Efficacy,-1,etanercept,1449713728.0,Unknown
1449165208,PA166155206,rs2289669,,,SLC47A1,Metabolism/PK,-1,metformin,1449165210.0,"Multiple groups, Brazil"
1449713732,PA166153618,rs1061622,,,TNFRSF1B,Efficacy,1,etanercept,1449713734.0,Unknown
1449713797,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,fentanyl,1449713806.0,"Multiple groups, Study carried out in hospitals in Miami, Florida and Jerusalem, Israel. Participants were predominantly of Jewish, Arab, Black or Hispanic ethnicities."
1449713797,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,fentanyl,1449713803.0,"Multiple groups, Study carried out in hospitals in Miami, Florida and Jerusalem, Israel. Participants were predominantly of Jewish, Arab, Black or Hispanic ethnicities."
1449714442,PA166179935,rs6808122,,,HTR3C,Dosage,-1,opioids,1449714444.0,European
1449714442,PA166179935,rs6808122,,,HTR3C,Dosage,-1,opioids,1449714445.0,European
1449714485,PA166179942,rs7627615,,,HTR3E,Dosage,-1,opioids,1449714488.0,European
1449714485,PA166179942,rs7627615,,,HTR3E,Dosage,-1,opioids,1449714487.0,European
1449188252,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,acenocoumarol,1449188262.0,Near Eastern
1449188252,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,acenocoumarol,1449188262.0,Near Eastern
1449166128,PA166176952,rs11559290,,,ETFDH,Efficacy,-1,methylphenidate,1449166130.0,"Multiple groups, 173 Caucasian pediatric patients from Spain and 189 adult patients from Brazil"
1449749382,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449749388.0,Unknown
1449749382,PA166156383,rs3814055,,,NR1I2,Metabolism/PK,-1,tacrolimus,1449749388.0,Unknown
1449163533,PA166176608,rs4646450,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449163541.0,European
1449163533,PA166176608,rs4646450,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449163535.0,African American/Afro-Caribbean
1449192323,PA166178193,rs397508602,,,CFTR,Efficacy,0,ivacaftor,1449192329.0,Unknown
1449733121,PA166155677,rs2287622,,,ABCB11,Metabolism/PK,1,rosuvastatin,1449733124.0,Sub-Saharan African
1449165805,,,PA165819201,CYP3A4*1,CYP3A4,Metabolism/PK,1,tacrolimus,1449165817.0,East Asian
1449165805,,,PA165819240,CYP3A4*18,CYP3A4,Metabolism/PK,1,tacrolimus,1449165817.0,East Asian
1449295782,PA166178579,rs57081354,,,NBEA,Efficacy,1,metformin,1449295788.0,Multiple groups
1449295782,PA166178579,rs57081354,,,NBEA,Efficacy,1,metformin,1449295788.0,Multiple groups
1449295963,PA166156625,rs7668258,,,UGT2B7,Dosage,-1,morphine,1449295965.0,European
1449295963,PA166156625,rs7668258,,,UGT2B7,Efficacy,-1,morphine,1449295965.0,European
1449295963,PA166156625,rs7668258,,,UGT2B7,Efficacy,-1,morphine,1449295965.0,European
1449192891,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,methadone,1449192893.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192891,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,methadone,1449192893.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192891,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,-1,methadone,1449192893.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192891,,,PA165816582,CYP2D6*10,CYP2D6,Metabolism/PK,-1,methadone,1449192893.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192891,,,PA165971584,CYP2D6*33,CYP2D6,Metabolism/PK,-1,methadone,1449192893.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192891,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,-1,methadone,1449192893.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192908,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,-1,methadone,1449192910.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192908,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,-1,methadone,1449192910.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192908,,,PA165816578,CYP2D6*3,CYP2D6,Metabolism/PK,-1,methadone,1449192910.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192908,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,-1,methadone,1449192910.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192908,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,-1,methadone,1449192910.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449192908,,,PA165971584,CYP2D6*33,CYP2D6,Metabolism/PK,-1,methadone,1449192910.0,"Multiple groups, Caucasian, Indigenous Australian and Asian participants"
1449295957,PA166156617,rs7438135,,,UGT2B7,Dosage,-1,morphine,1449295959.0,European
1449295957,PA166156617,rs7438135,,,UGT2B7,Efficacy,-1,morphine,1449295959.0,European
1449295969,PA166156695,rs73823859,,,UGT2B7,Dosage,-1,morphine,1449295971.0,European
1449295969,PA166156695,rs73823859,,,UGT2B7,Efficacy,-1,morphine,1449295971.0,European
1449295969,PA166156695,rs73823859,,,UGT2B7,Efficacy,-1,morphine,1449295971.0,European
1449295969,PA166156695,rs73823859,,,UGT2B7,Efficacy,-1,morphine,1449295971.0,European
1449171322,,,PA165816542,CYP2C9*1,CYP2C9,Metabolism/PK,1,celecoxib,1449171336.0,East Asian
1449171322,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,1,celecoxib,1449171336.0,East Asian
1449714932,PA166154322,rs1176713,,,HTR3A,Dosage,-1,opioids,1449714935.0,European
1449714932,PA166154322,rs1176713,,,HTR3A,Dosage,-1,opioids,1449714934.0,European
1449165091,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,1,warfarin,1449165093.0,European
1449165085,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,1,warfarin,1449165090.0,European
1449165085,PA166155091,rs9923231,,,VKORC1,Metabolism/PK,1,warfarin,1449165090.0,European
1449311424,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,conjugated estrogens,1449311434.0,Unknown
1449311424,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,conjugated estrogens,1449311432.0,Unknown
1449311424,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,conjugated estrogens,1449311430.0,Unknown
1449168217,PA166177194,rs17786400,,,ANO2,Efficacy,1,duloxetine,1449168219.0,European
1449168246,PA166177198,rs61908404,,,ANO2,Efficacy,1,duloxetine,1449168248.0,European
1449168252,PA166177199,rs61908405,,,ANO2,Efficacy,1,duloxetine,1449168254.0,European
1449168252,PA166177199,rs61908405,,,ANO2,Efficacy,1,duloxetine,1449168254.0,European
1449560356,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,lamotrigine,1449560362.0,European
1449560356,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,lamotrigine,1449560362.0,European
1449560356,PA166155662,rs2011425,,,UGT1A4,Metabolism/PK,-1,lamotrigine,1449560362.0,European
1449246784,PA166153612,rs1051740,,,EPHX1,Dosage,-1,warfarin,1449246786.0,Central/South Asian
1449250615,PA166155805,rs11676382,,,GGCX,Dosage,-1,warfarin,1449250617.0,Central/South Asian
1449189944,,,PA165816577,CYP2D6*2,CYP2D6,Metabolism/PK,0,hydrocodone,1449189951.0,Sub-Saharan African
1449189944,,,PA165816584,CYP2D6*41,CYP2D6,Metabolism/PK,0,hydrocodone,1449189951.0,Sub-Saharan African
1449262642,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1449262776.0,Near Eastern
1449565316,,,PA165980635,CYP2C19*2,CYP2C19,Dosage,-1,phenytoin,1449565318.0,European
1449565316,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,-1,phenytoin,1449565318.0,European
1449310630,PA166154301,rs757110,,,ABCC8,Efficacy,1,"sulfonamides, urea derivatives",1449310638.0,Latino
1449565307,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,-1,phenytoin,1449565314.0,European
1449565307,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,phenytoin,1449565314.0,European
1449310602,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,1,axitinib,1449310604.0,East Asian
1449576379,PA166170105,rs1799836,,,MAOB,Dosage,-1,levodopa,1449576381.0,Latino
1449576323,PA166156024,rs4680,,,COMT,Dosage,-1,levodopa,1449576349.0,Latino
1449266467,,,PA165816543,CYP2C9*2,CYP2C9,Metabolism/PK,-1,methadone,1449266477.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266467,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,methadone,1449266477.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449266467,,,PA165816544,CYP2C9*3,CYP2C9,Metabolism/PK,-1,methadone,1449266477.0,"Multiple groups, 96% of participants were Caucasian. Study carried out in Switzerland."
1449166167,PA166156637,rs10011796,,,ABCG2,Dosage,-1,allopurinol,1449166169.0,Unknown
1449166167,PA166156637,rs10011796,,,ABCG2,Dosage,-1,allopurinol,1449166169.0,Unknown
1449166167,PA166156637,rs10011796,,,ABCG2,Dosage,-1,allopurinol,1449166169.0,Unknown
1449576749,PA166157783,rs6151031,,,ALDH1A1,Efficacy,1,cyclophosphamide,1449576755.0,Central/South Asian
1449576749,PA166157783,rs6151031,,,ALDH1A1,Efficacy,1,doxorubicin,1449576755.0,Central/South Asian
1449271251,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,buprenorphine,1449271253.0,Multiple groups
1449271251,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,buprenorphine,1449271253.0,Multiple groups
1449271251,,,PA166116465,SLC6A4 HTTLPR long form (L allele),SLC6A4,Efficacy,1,methadone,1449271253.0,Multiple groups
1449271251,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,methadone,1449271253.0,Multiple groups
1449271251,,,PA166116466,SLC6A4 HTTLPR short form (S allele),SLC6A4,Efficacy,1,methadone,1449271253.0,Multiple groups
1449162638,,,PA166169821,CYP2D6*99,CYP2D6,Metabolism/PK,0,desvenlafaxine,,
1448258104,PA166160163,rs2236647,,,STIP1,Efficacy,-1,corticosteroids,1448258106.0,Unknown
1449163088,PA166157288,rs1128503,,,ABCB1,Metabolism/PK,-1,tacrolimus,1449163090.0,"Multiple groups, 1560 EA and 363 AA kidney allograft recipients"
1449716693,PA166156023,rs4633,,,COMT,Dosage,-1,fentanyl,1449716695.0,East Asian
1449716693,PA166156023,rs4633,,,COMT,Dosage,-1,fentanyl,1449716696.0,East Asian
1449162960,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,morphine,1449162962.0,Unknown
1449162960,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,morphine-3-glucuronide,1449162962.0,Unknown
1449162960,PA166156619,rs7439366,,,UGT2B7,Dosage,-1,morphine-3-glucuronide,1449162962.0,Unknown
1449164037,PA166176702,rs11168293,,,VDR,Dosage,1,warfarin,1449164039.0,European
1444843660,PA166190881,rs11322783,,,IFNL4,Efficacy,-1,peginterferon alfa-2a,1444843662.0,"Multiple groups, mostly white"
1444843660,PA166190881,rs11322783,,,IFNL4,Efficacy,-1,peginterferon alfa-2b,1444843662.0,"Multiple groups, mostly white"
1444843660,PA166190881,rs11322783,,,IFNL4,Efficacy,-1,ribavirin,1444843662.0,"Multiple groups, mostly white"
1449733079,PA166180508,rs56903885,,,SLC10A1,Metabolism/PK,1,rosuvastatin,1449733081.0,Sub-Saharan African
1449733079,PA166180508,rs56903885,,,SLC10A1,Metabolism/PK,1,rosuvastatin,1449733081.0,Sub-Saharan African
1449733079,PA166180508,rs56903885,,,SLC10A1,Metabolism/PK,1,rosuvastatin,1449733081.0,Sub-Saharan African
1449733054,PA166180502,rs11045873,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733056.0,Sub-Saharan African
1449733062,PA166180504,rs11045874,,,SLCO1B1,Metabolism/PK,1,rosuvastatin,1449733064.0,Sub-Saharan African
1449164912,PA166176809,rs3393,,,ADORA3,Toxicity,-1,methotrexate,1449164914.0,European
1449164974,PA166176825,rs73598374,,,ADA,Toxicity,-1,methotrexate,1449164976.0,European
1449192335,PA166161188,rs121909011,,,CFTR,Efficacy,0,ivacaftor / lumacaftor,1449192337.0,"Custom, Not applicable - study was carried out using rectal organoids"
1449160237,PA166176143,rs36029,,,SLC6A2,Other,1,3,1449160240.0,European
1449160237,PA166176143,rs36029,,,SLC6A2,Other,1,3,1449160239.0,European
1449160237,PA166176143,rs36029,,,SLC6A2,Other,1,3,1449160241.0,European
1449160237,PA166176143,rs36029,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160240.0,European
1449160237,PA166176143,rs36029,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160239.0,European
1449160237,PA166176143,rs36029,,,SLC6A2,Other,1,4-methylenedioxymethamphetamine,1449160241.0,European
1449155451,PA166175800,rs8177374,,,TIRAP,Efficacy,1,ustekinumab,1449155454.0,Unknown
1449155997,PA166175852,rs55853698,,,CHRNA5,Efficacy,-1,bupropion,1449155999.0,European
1449155997,PA166175852,rs55853698,,,CHRNA5,Efficacy,-1,nicotine,1449155999.0,European
1449155997,PA166175852,rs55853698,,,CHRNA5,Efficacy,-1,varenicline,1449155999.0,European
1449171074,PA166155420,rs4803419,,,CYP2B6,Metabolism/PK,-1,methadone,1449171076.0,European
1447520031,,,PA165816542,CYP2C9*1,CYP2C9,Dosage,1,warfarin,1447520042.0,European
1447520031,,,PA165816543,CYP2C9*2,CYP2C9,Dosage,1,warfarin,1447520042.0,European
1447520031,,,PA165816544,CYP2C9*3,CYP2C9,Dosage,1,warfarin,1447520042.0,European
1450811595,PA166183845,rs6949448,,,ABCB1,Dosage,-1,methadone,1450811600.0,Near Eastern
1450933253,PA166156807,rs2631367,,,SLC22A5,Dosage,-1,imatinib,1450933260.0,Unknown
1450933253,PA166156807,rs2631367,,,SLC22A5,Dosage,-1,imatinib,1450933259.0,Unknown
1450933253,PA166156807,rs2631367,,,SLC22A5,Dosage,-1,imatinib,1450933258.0,Unknown
1450933458,PA166185813,rs1800810,,,PDGFRA,Dosage,-1,imatinib,1450933464.0,Unknown
1450933458,PA166185813,rs1800810,,,PDGFRA,Dosage,-1,imatinib,1450933463.0,Unknown
1450933458,PA166185813,rs1800810,,,PDGFRA,Dosage,-1,imatinib,1450933465.0,Unknown
1450821968,PA166154856,rs1051730,,,CHRNA3,Dosage,1,nicotine,1450821979.0,European
1450821968,PA166154856,rs1051730,,,CHRNA3,Dosage,1,nicotine,1450821977.0,European
1450821968,PA166154856,rs1051730,,,CHRNA3,Dosage,1,nicotine,1450821976.0,European
1450821968,PA166154856,rs1051730,,,CHRNA3,Dosage,1,nicotine,1450821978.0,European
1450821968,PA166154856,rs1051730,,,CHRNA3,Dosage,1,nicotine,1450821981.0,European
1450821968,PA166154856,rs1051730,,,CHRNA3,Dosage,1,nicotine,1450821980.0,European
1450823212,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1450823219.0,Unknown
1450823212,,,PA165819201,CYP3A4*1,CYP3A4,Dosage,1,fentanyl,1450823219.0,Unknown
1450933577,PA166156840,rs6877011,,,FLT4,Dosage,-1,imatinib,1450933582.0,Unknown
1450933577,PA166156840,rs6877011,,,FLT4,Dosage,-1,imatinib,1450933583.0,Unknown
1450933577,PA166156840,rs6877011,,,FLT4,Dosage,-1,imatinib,1450933584.0,Unknown
1450827399,PA166185216,rs11214607,,,DRD2,Toxicity,-1,heroin,1450827403.0,East Asian
1450044766,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,ceftriaxone,1450044768.0,Unknown
1446904186,PA166156687,rs56061981,,,CXCL10,Efficacy,1,peginterferon alfa-2a,1446904197.0,East Asian
1446904186,PA166156687,rs56061981,,,CXCL10,Efficacy,1,peginterferon alfa-2a,1446904194.0,East Asian
1446904186,PA166156687,rs56061981,,,CXCL10,Efficacy,1,peginterferon alfa-2b,1446904197.0,East Asian
1446904186,PA166156687,rs56061981,,,CXCL10,Efficacy,1,peginterferon alfa-2b,1446904194.0,East Asian
1184175118,PA166156697,rs80143932,,,DCK,Efficacy,1,cytarabine,1184175123.0,Unknown
1184175118,PA166156697,rs80143932,,,DCK,Efficacy,1,cytarabine,1184472860.0,Unknown
1184175118,PA166156697,rs80143932,,,DCK,Efficacy,1,idarubicin,1184175123.0,Unknown
1184175118,PA166156697,rs80143932,,,DCK,Efficacy,1,idarubicin,1184472860.0,Unknown
1450928334,PA166155376,rs1801272,,,CYP2A6,Efficacy,-1,varenicline,1450928339.0,
1450928579,PA166153716,rs2768759,,,PEAR1,Efficacy,1,aspirin,1450928589.0,"Multiple groups, European, African American and East Asian ancestries"
1450928579,PA166153716,rs2768759,,,PEAR1,Efficacy,1,aspirin,1450928588.0,"Multiple groups, European, African American and East Asian ancestries"
1450928579,PA166153716,rs2768759,,,PEAR1,Efficacy,1,aspirin,1450928590.0,"Multiple groups, European, African American and East Asian ancestries"
1450928579,PA166153716,rs2768759,,,PEAR1,Efficacy,1,prasugrel,1450928589.0,"Multiple groups, European, African American and East Asian ancestries"
1450928579,PA166153716,rs2768759,,,PEAR1,Efficacy,1,prasugrel,1450928588.0,"Multiple groups, European, African American and East Asian ancestries"
1450928579,PA166153716,rs2768759,,,PEAR1,Efficacy,1,prasugrel,1450928590.0,"Multiple groups, European, African American and East Asian ancestries"
1183491228,PA166156715,rs31244,,,SV2C,Efficacy,-1,quetiapine,1183491230.0,European
1444699502,PA166156708,rs6295,,,HTR1A,Efficacy,1,clozapine,1444699505.0,Unknown
1444699502,PA166156708,rs6295,,,HTR1A,Efficacy,1,clozapine,1444699505.0,Unknown
1444699502,PA166156708,rs6295,,,HTR1A,Efficacy,1,clozapine,1444699505.0,Unknown
1450370871,,,PA165980634,CYP2C19*1,CYP2C19,Efficacy,1,clopidogrel,1450370888.0,European
1450370871,,,PA165980635,CYP2C19*2,CYP2C19,Efficacy,1,clopidogrel,1450370888.0,European
1450370871,,,PA165816533,CYP2C19*17,CYP2C19,Efficacy,1,clopidogrel,1450370888.0,European
1450931743,PA166157288,rs1128503,,,ABCB1,PD,-1,fentanyl,1450931747.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931743,PA166157288,rs1128503,,,ABCB1,PD,-1,fentanyl,1450931747.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450931743,PA166157288,rs1128503,,,ABCB1,PD,-1,fentanyl,1450931747.0,"Multiple groups, Volunteers of European or Latino ethnicity."
1450933294,PA166175783,rs2631370,,,SLC22A5,Dosage,-1,imatinib,1450933301.0,Unknown
1450933294,PA166175783,rs2631370,,,SLC22A5,Dosage,-1,imatinib,1450933300.0,Unknown
1450933294,PA166175783,rs2631370,,,SLC22A5,Dosage,-1,imatinib,1450933299.0,Unknown
1450933294,PA166175783,rs2631370,,,SLC22A5,Dosage,-1,imatinib,1450933301.0,Unknown
1450933294,PA166175783,rs2631370,,,SLC22A5,Dosage,-1,imatinib,1450933300.0,Unknown
1450933294,PA166175783,rs2631370,,,SLC22A5,Dosage,-1,imatinib,1450933299.0,Unknown
1450935725,PA166186019,rs61311738,,,CYP2C19,Metabolism/PK,1,mephenytoin,1450935729.0,
1450935708,PA166186017,rs149158426,,,CYP2C9,Metabolism/PK,-1,tolbutamide,1450935712.0,
1450813976,PA166154259,rs6265,,,BDNF,Efficacy,-1,modafinil,1450813981.0,"Multiple groups, ""Non-Hispanic Caucasian"" and ""Hispanic Caucasian"" subjects"
1450375599,PA166156582,rs4148157,,,ABCG2,Efficacy,-1,allopurinol,1450375601.0,European
1450375599,PA166156582,rs4148157,,,ABCG2,Efficacy,-1,allopurinol,1450375634.0,"Multiple groups, Non-Hispanic White, Asian, African American and Latino"
1450372517,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1450372532.0,East Asian
1450372517,,,PA165980634,CYP2C19*1,CYP2C19,Metabolism/PK,1,voriconazole,1450372530.0,East Asian
1450372517,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1450372532.0,East Asian
1450372517,,,PA165980635,CYP2C19*2,CYP2C19,Metabolism/PK,1,voriconazole,1450372530.0,East Asian
1450372517,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372532.0,East Asian
1450372517,,,PA165980636,CYP2C19*3,CYP2C19,Metabolism/PK,1,voriconazole,1450372530.0,East Asian
1450372517,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1450372532.0,East Asian
1450372517,,,PA165816533,CYP2C19*17,CYP2C19,Metabolism/PK,1,voriconazole,1450372530.0,East Asian
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371636.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371638.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371634.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371615.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371613.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371566.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371627.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371595.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371623.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371597.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371611.0,European
1450371564,PA166153652,rs1801274,,,FCGR2A,Efficacy,-1,tocilizumab,1450371625.0,European
1450934565,PA166154579,rs4149056,,,SLCO1B1,PD,1,grazoprevir,1450934570.0,"Multiple groups, This is a retrospective pharmacogenetic analysis of a pooled dataset of selected HCV GT1- or GT4-infected participants enrolled in ten Phase II/III clinical trials of EBR/GZR: C-WORTHY (MSD Protocol, 5172-035; ClinicalTrials. gov identifier NCT01717326), C-SCAPE (5172-047; NCT01932762), C-SALVAGE (5172-048; NCT02105454), C-SURFER (5172-052; NCT02092350), Japan Phase II/III study (5172-058; NCT02203149), C-SALT (5172-059; NCT02115321), C-EDGE Treatment-Naive (5172-060; NCT02105467), C-EDGE CO-INFECTION (5172-061; NCT02105662), C-EDGE CO-STAR (5172-062; NCT02105688), C-EDGE Treatment-Experienced (5172-068; NCT02105701)"
1450934565,PA166154579,rs4149056,,,SLCO1B1,PD,1,grazoprevir,1450934571.0,"Multiple groups, This is a retrospective pharmacogenetic analysis of a pooled dataset of selected HCV GT1- or GT4-infected participants enrolled in ten Phase II/III clinical trials of EBR/GZR: C-WORTHY (MSD Protocol, 5172-035; ClinicalTrials. gov identifier NCT01717326), C-SCAPE (5172-047; NCT01932762), C-SALVAGE (5172-048; NCT02105454), C-SURFER (5172-052; NCT02092350), Japan Phase II/III study (5172-058; NCT02203149), C-SALT (5172-059; NCT02115321), C-EDGE Treatment-Naive (5172-060; NCT02105467), C-EDGE CO-INFECTION (5172-061; NCT02105662), C-EDGE CO-STAR (5172-062; NCT02105688), C-EDGE Treatment-Experienced (5172-068; NCT02105701)"
1449733134,PA166180518,rs3212207,,,HNF4A,Metabolism/PK,1,rosuvastatin,1449733136.0,Sub-Saharan African
1450935691,PA166186014,rs762081829,,,CYP2C9,Metabolism/PK,1,tolbutamide,1450935695.0,
1450368365,PA166181802,rs4244809,,,IGF2,Efficacy,1,Platinum compounds,1450368367.0,East Asian
1450368365,PA166181802,rs4244809,,,IGF2-AS,Efficacy,1,Platinum compounds,1450368367.0,East Asian
1450368365,PA166181802,rs4244809,,,INS-IGF2,Efficacy,1,Platinum compounds,1450368367.0,East Asian
1450045067,PA166181273,rs2756109,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045069.0,Unknown
1450045073,PA166154007,rs2273697,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045075.0,Unknown
1450045079,PA166153953,rs717620,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045081.0,Unknown
1450045091,PA166181274,rs3740074,,,ABCC2,Metabolism/PK,-1,methotrexate,1450045093.0,Unknown
1450374150,PA166155409,rs3745274,,,CYP2B6,Dosage,-1,methadone,1450374152.0,"Multiple groups, ""All subjects were Caucasians with the exception of two Africans"""
1450827429,PA166154384,rs2734833,,,DRD2,Toxicity,-1,heroin,1450827433.0,East Asian
1450930694,PA166185491,rs3827020,,,CHRNA4,Other,-1,nicotine,1450930698.0,East Asian
1451105117,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,letermovir,1451105161.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1451105117,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,letermovir,1451105161.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1450342113,PA166181494,rs162561,,,CYP1B1,Efficacy,-1,docetaxel,1450342119.0,European
1448258402,PA166160223,rs9468,,,MAPT,Efficacy,-1,corticosteroids,1448258404.0,Unknown
1450821075,PA166153623,rs1126742,,,CYP4A11,Efficacy,1,amiloride,1450821080.0,African American/Afro-Caribbean
1450821075,PA166153623,rs1126742,,,CYP4A11,Efficacy,1,spironolactone,1450821080.0,African American/Afro-Caribbean
1448123395,PA166153760,rs3918290,,,DPYD,Dosage,1,capecitabine,1448123401.0,Unknown
1448123395,PA166153760,rs3918290,,,DPYD,Dosage,1,capecitabine,1448123401.0,Unknown
1450112752,PA166156621,rs7662029,,,UGT2B7,Metabolism/PK,1,mycophenolic acid,1450112763.0,Unknown
1450822114,PA166156924,rs510769,,,OPRM1,Dosage,-1,ethanol,1450822118.0,European
1450823261,PA166157316,rs2032582,,,ABCB1,Dosage,-1,opioids,1450823266.0,Unknown
1450812289,PA166154261,rs6277,,,DRD2,Efficacy,-1,nicotine,1450812293.0,European
1450823635,PA166154375,rs2514218,,,DRD2,Efficacy,1,aripiprazole,1450823640.0,"Multiple groups, Asian, African American, Hispanic, Caucasian and Other ethnicities."
1450823635,PA166154375,rs2514218,,,DRD2,Efficacy,1,risperidone,1450823640.0,"Multiple groups, Asian, African American, Hispanic, Caucasian and Other ethnicities."
1450928201,PA166154339,rs1800497,,,DRD2,Efficacy,-1,risperidone,1450928208.0,East Asian
1450928201,PA166154339,rs1800497,,,DRD2,Efficacy,-1,risperidone,1450928207.0,East Asian
1450928201,PA166154339,rs1800497,,,DRD2,Efficacy,-1,risperidone,1450928206.0,East Asian
1450811492,PA166155198,rs2036657,,,ARRB2,Efficacy,-1,nicotine,1450811497.0,European
1450811492,PA166155198,rs2036657,,,ARRB2,Efficacy,-1,nicotine,1450811498.0,European
1184512540,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,-1,efavirenz,1184512542.0,Sub-Saharan African
1184512544,PA166156411,rs6785049,,,NR1I2,Metabolism/PK,-1,efavirenz,1184512546.0,Sub-Saharan African
1450814114,PA166156991,rs1799971,,,OPRM1,Dosage,-1,ethanol,1450814118.0,"Multiple groups, Majority of participants were Caucasian"
1450814619,PA166184252,rs363226,,,SLC18A2,Efficacy,1,bupropion,1450814624.0,European
1450372692,PA166182096,rs7905446,,,HTR7,Efficacy,1,antidepressants,1450372694.0,European
1450373027,PA166153585,rs689466,,,PTGS2,Efficacy,1,celecoxib,1450373033.0,East Asian
1450930657,PA166154938,rs16969968,,,CHRNA5,Other,-1,nicotine,1450930661.0,East Asian
1450930622,PA166185482,rs667282,,,CHRNA5,Other,-1,nicotine,1450930626.0,East Asian
1450930622,PA166185482,rs667282,,,CHRNA5,Other,-1,nicotine,1450930626.0,East Asian
1450368707,,,PA165816579,CYP2D6*4,CYP2D6,Metabolism/PK,0,clomipramine,,
1450368707,,,PA165948092,CYP2D6*5,CYP2D6,Metabolism/PK,0,clomipramine,,
982035533,PA166154535,rs2239128,,,CACNA1C,Efficacy,1,calcium channel blockers,982035562.0,European
1450989200,PA166157316,rs2032582,,,ABCB1,Metabolism/PK,-1,crizotinib,1450989204.0,East Asian
1450989046,PA166157284,rs1045642,,,ABCB1,Toxicity,1,erlotinib,1450989051.0,East Asian
1450989046,PA166157284,rs1045642,,,ABCB1,Metabolism/PK,1,erlotinib,1450989051.0,East Asian
1449749531,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449749533.0,Multiple groups
1449749531,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449749533.0,Multiple groups
1451094960,PA166156023,rs4633,,,COMT,Dosage,1,morphine,1451094967.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094960,PA166156023,rs4633,,,COMT,Dosage,1,morphine,1451094966.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094960,PA166156023,rs4633,,,COMT,Efficacy,1,morphine,1451094967.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094960,PA166156023,rs4633,,,COMT,Efficacy,1,morphine,1451094966.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094980,PA166156024,rs4680,,,COMT,Dosage,1,morphine,1451095001.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094980,PA166156024,rs4680,,,COMT,Dosage,1,morphine,1451095000.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094980,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1451095001.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451094980,PA166156024,rs4680,,,COMT,Efficacy,1,morphine,1451095000.0,"Multiple groups, Netherlands: 62 Caucasian, 1 Asian"
1451122208,PA166156374,rs3732359,,,NR1I2,Metabolism/PK,1,voriconazole,1451122212.0,East Asian
1184757055,PA166153792,rs7542281,,,F5,Dosage,-1,warfarin,1184757057.0,East Asian
1451097945,PA166157178,rs12208357,,,SLC22A1,Metabolism/PK,1,cycloguanil,1451097905.0,Unknown
1451098246,PA166157196,rs34059508,,,SLC22A1,Metabolism/PK,1,o-desmethyltramadol,1451098251.0,"Multiple groups, The majority of patients were from Central Europe, with 9 patients from Turkey and one patient each from the Ukraine, Syria, Tunisia, Dubai and Asia"
1184998461,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atazanavir,1184998509.0,European
1184998461,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atazanavir,1184998492.0,"Multiple groups, African-American and non-African-American"
1184998461,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,atazanavir,1184998513.0,African American/Afro-Caribbean
1184998461,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atazanavir,1184998509.0,European
1184998461,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atazanavir,1184998492.0,"Multiple groups, African-American and non-African-American"
1184998461,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,atazanavir,1184998513.0,African American/Afro-Caribbean
1184998461,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,atazanavir,1184998509.0,European
1184998461,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,atazanavir,1184998492.0,"Multiple groups, African-American and non-African-American"
1184998461,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,1,atazanavir,1184998513.0,African American/Afro-Caribbean
1184998461,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,atazanavir,1184998509.0,European
1184998461,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,atazanavir,1184998492.0,"Multiple groups, African-American and non-African-American"
1184998461,,,PA166128234,CYP3A5*7,CYP3A5,Metabolism/PK,1,atazanavir,1184998513.0,African American/Afro-Caribbean
1449146864,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,clozapine,1449146885.0,Unknown
1449146864,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,clozapine,1449146885.0,Unknown
982036531,,,PA166128233,CYP3A5*6,CYP3A5,Efficacy,-1,verapamil,982036538.0,"Multiple groups, Black, Hispanic, and White"
1184514634,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514638.0,European
1184514634,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514639.0,European
1184514634,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514640.0,European
1184514634,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514641.0,European
1184514634,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514638.0,European
1184514634,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514639.0,European
1184514634,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514640.0,European
1184514634,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514641.0,European
769174165,PA166156744,rs881152,,,DUSP1,Efficacy,-1,salbutamol,769174167.0,Sub-Saharan African
1450806320,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,clopidogrel,1450806322.0,European
1450806320,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,clopidogrel,1450806322.0,European
1449170393,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1449170405.0,Unknown
1449170393,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1449170405.0,Unknown
982036539,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,verapamil,982036541.0,"Multiple groups, Black, Hispanic, and White"
1444843349,PA166154454,rs11231809,,,SLC22A11,Efficacy,1,methotrexate,1444843355.0,Multiple groups
1448263056,PA166156748,rs1042713,,,ADRB2,Metabolism/PK,-1,ephedrine,1448263062.0,European
1448263056,PA166156748,rs1042713,,,ADRB2,Metabolism/PK,-1,phenylephrine,1448263062.0,European
1449714503,PA166156743,rs878567,,,HTR1A,Dosage,-1,opioids,1449714505.0,European
1449714503,PA166156743,rs878567,,,HTR1A,Dosage,-1,opioids,1449714506.0,European
1450823248,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,fentanyl,1450823254.0,Unknown
1450823248,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,fentanyl,1450823254.0,Unknown
1448427598,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448427610.0,Unknown
1448427598,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448427610.0,Unknown
982036485,PA166156749,rs1042714,,,ADRB2,Efficacy,1,atenolol,982036493.0,European
1447520826,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,sirolimus,1447520838.0,East Asian
1447520826,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,sirolimus,1447520845.0,East Asian
1447520826,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,sirolimus,1447520838.0,East Asian
1447520826,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,sirolimus,1447520845.0,East Asian
1447520826,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447520838.0,East Asian
1447520826,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447520845.0,East Asian
1447520826,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447520838.0,East Asian
1447520826,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447520845.0,East Asian
1449563883,PA166154450,rs11212617,,,ATM,Metabolism/PK,-1,metformin,1449564080.0,European
1448573323,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,0,tacrolimus,1448573333.0,East Asian
1448573323,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,0,tacrolimus,1448573333.0,East Asian
1450935937,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,fluticasone propionate,1450935942.0,
1450935937,PA166156773,rs1800888,,,ADRB2,Efficacy,-1,salmeterol,1450935942.0,
982038126,PA166154452,rs11216158,,,APOA1,Efficacy,-1,fenofibrate,982038130.0,European
982038126,PA166154452,rs11216158,,,APOA1,Efficacy,-1,fenofibrate,982038131.0,European
1184514971,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,-1,tacrolimus,1184514976.0,European
1184514971,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,-1,tacrolimus,1184514976.0,European
1445125156,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445125603.0,Unknown
1445125156,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445125603.0,Unknown
1184470953,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,cyclosporine,1184470978.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,cyclosporine,1184470976.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,cyclosporine,1184470978.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,cyclosporine,1184470976.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,everolimus,1184470978.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,everolimus,1184470976.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,everolimus,1184470978.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470953,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,everolimus,1184470976.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1447949204,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447949243.0,European
1447949204,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447949243.0,European
1447674939,PA166157438,rs10242595,,,IL6,Efficacy,-1,duloxetine,1447674941.0,European
981501901,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,-1,simvastatin,981501903.0,East Asian
981501901,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,-1,simvastatin,981501903.0,East Asian
1450812359,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,nimodipine,1450812366.0,Unknown
1450812359,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,nimodipine,1450812367.0,Unknown
1450812359,,,PA166128213,CYP3A5*1,CYP3A5,Efficacy,1,nimodipine,1450812365.0,Unknown
1450812359,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,nimodipine,1450812366.0,Unknown
1450812359,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,nimodipine,1450812367.0,Unknown
1450812359,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,nimodipine,1450812365.0,Unknown
1450377052,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1450377069.0,Unknown
1450377052,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1450377069.0,Unknown
1444708907,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamoxifen,1444708918.0,"Multiple groups, mostly White"
1444708907,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamoxifen,1444708918.0,"Multiple groups, mostly White"
1445584925,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1445584937.0,East Asian
1445584925,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1445584937.0,East Asian
1183685478,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,voriconazole,1183685484.0,European
1449749453,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449749465.0,East Asian
1449749453,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449749465.0,East Asian
1184514946,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184514951.0,East Asian
1184514946,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184514951.0,East Asian
1184470932,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470974.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1184470932,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470974.0,"Multiple groups, Caucasian, Mediterranean, Asian, Black"
1447520665,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1447520680.0,East Asian
1447520665,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1447520680.0,East Asian
1449748903,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1449748915.0,East Asian
1449748903,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1449748915.0,East Asian
1184514901,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184514906.0,"Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% ""other""."
1184514901,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184514906.0,"Multiple groups, 100% Caucasian for *3/*3 patients; 56% for *1/*1 or *1/*3, 44% ""other""."
1184565781,PA166154183,rs55948420,,,CYP2C19,Metabolism/PK,-1,mephenytoin,1184642601.0,Unknown
1184565781,PA166154183,rs55948420,,,CYP2C19,Metabolism/PK,-1,mephenytoin,1184642603.0,Unknown
1184565781,PA166154183,rs55948420,,,CYP2C19,Metabolism/PK,-1,omeprazole,1184642601.0,Unknown
1184565781,PA166154183,rs55948420,,,CYP2C19,Metabolism/PK,-1,omeprazole,1184642603.0,Unknown
1444936677,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,sunitinib,1444936689.0,"Multiple groups, Chinese, Malay, Indian"
1444936677,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,sunitinib,1444936689.0,"Multiple groups, Chinese, Malay, Indian"
1450933374,PA166156936,rs683369,,,SLC22A1,Dosage,-1,imatinib,1450933380.0,Unknown
1450933374,PA166156936,rs683369,,,SLC22A1,Dosage,-1,imatinib,1450933379.0,Unknown
1450933374,PA166156936,rs683369,,,SLC22A1,Dosage,-1,imatinib,1450933381.0,Unknown
981501747,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,carbamazepine,981501750.0,African American/Afro-Caribbean
981501747,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,carbamazepine,981501751.0,European
981501747,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,carbamazepine,981501750.0,African American/Afro-Caribbean
981501747,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,carbamazepine,981501751.0,European
1450933561,PA166156938,rs699947,,,VEGFA,Dosage,-1,imatinib,1450933568.0,Unknown
1450933561,PA166156938,rs699947,,,VEGFA,Dosage,-1,imatinib,1450933567.0,Unknown
1450933561,PA166156938,rs699947,,,VEGFA,Dosage,-1,imatinib,1450933566.0,Unknown
1449161179,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,naltrexone,1449161181.0,European
981844214,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,erythromycin,981844216.0,Unknown
981844214,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,erythromycin,981844216.0,Unknown
1449713910,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1449713923.0,East Asian
1449713910,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1449713923.0,East Asian
1447674595,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1447674607.0,"Multiple groups, White, Hispanic, Asian/Pacific Islander, Other"
1447674595,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1447674607.0,"Multiple groups, White, Hispanic, Asian/Pacific Islander, Other"
1449576683,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576698.0,East Asian
1449576683,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576700.0,East Asian
1449576683,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576702.0,East Asian
1449576683,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576704.0,East Asian
1449576683,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576685.0,East Asian
1449576683,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576686.0,East Asian
1449576683,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576698.0,East Asian
1449576683,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576700.0,East Asian
1449576683,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576702.0,East Asian
1449576683,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576704.0,East Asian
1449576683,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576685.0,East Asian
1449576683,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,tamsulosin,1449576686.0,East Asian
1449716462,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1449716476.0,East Asian
1449716462,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,fentanyl,1449716464.0,East Asian
1449716462,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1449716476.0,East Asian
1449716462,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,fentanyl,1449716464.0,East Asian
1449716450,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,norfentanyl,1449716452.0,East Asian
1449716450,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,norfentanyl,1449716452.0,East Asian
1449716754,PA166156991,rs1799971,,,OPRM1,Dosage,1,fentanyl,1449716756.0,East Asian
981844200,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,midazolam,981844202.0,Unknown
981844200,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,midazolam,981844202.0,Unknown
1449188815,PA166156991,rs1799971,,,OPRM1,Efficacy,1,naltrexone,1449188821.0,European
1183689326,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1183689338.0,Multiple groups
1183689326,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1183689330.0,"Multiple groups, Not stated: studies in Belgium, Switzerland, Denmark, Czech, China and Greece."
1183689326,PA166156997,rs1800629,,,TNF,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1183689369.0,Multiple groups
1451105120,PA166154547,rs2306283,,,SLCO1B1,Metabolism/PK,-1,letermovir,1451105112.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1184470237,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1184470247.0,"Multiple groups, White, Japanese, Korean, Iranian, Chinese"
1184470237,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1184470247.0,"Multiple groups, White, Japanese, Korean, Iranian, Chinese"
1448358509,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448358521.0,Unknown
1448358509,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448358521.0,Unknown
1447948600,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,gefitinib,1447948607.0,European
1447948600,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,gefitinib,1447948607.0,European
1449716657,PA166156991,rs1799971,,,OPRM1,Dosage,-1,fentanyl,1449716663.0,East Asian
1447948379,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,gefitinib,1447948381.0,East Asian
1447948379,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,-1,gefitinib,1447948381.0,East Asian
1183689883,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,cyclosporine,1183689894.0,European
1183689883,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,cyclosporine,1183689894.0,European
1448427616,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448427618.0,Unknown
1448427616,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448427618.0,Unknown
1451117373,PA166199042,rs9306160,,,RRP1B,Efficacy,1,atenolol,1451117399.0,"Multiple groups, See Figure 1A for genetic ancestry data"
982044254,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,atorvastatin,982044256.0,Latino
982044254,,,PA166128219,CYP3A5*3,CYP3A5,Efficacy,1,atorvastatin,982044257.0,Sub-Saharan African
1448567961,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,-1,sirolimus,1448567963.0,Unknown
1448567961,,,PA166128233,CYP3A5*6,CYP3A5,Metabolism/PK,-1,sirolimus,1448567963.0,Unknown
1184989793,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1184989803.0,European
1184989793,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1184989803.0,European
1451099067,,,PA165816576,CYP2D6*1,CYP2D6,Metabolism/PK,1,fentanyl,1451099073.0,Unknown
1451099067,,,PA165948317,CYP2D6*9,CYP2D6,Metabolism/PK,1,fentanyl,1451099073.0,Unknown
1448276167,PA166154977,rs7294,,,VKORC1,Dosage,1,warfarin,1448276169.0,East Asian
1448308421,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,1,tacrolimus,1448308433.0,East Asian
1448308421,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,1,tacrolimus,1448308433.0,East Asian
1184515187,,,PA166128213,CYP3A5*1,CYP3A5,Metabolism/PK,0,tacrolimus,1184515191.0,East Asian
1184515187,,,PA166128219,CYP3A5*3,CYP3A5,Metabolism/PK,0,tacrolimus,1184515191.0,East Asian
1448285878,,,PA166128213,CYP3A5*1,CYP3A5,Dosage,1,tacrolimus,1448285880.0,Near Eastern
1448285878,,,PA166128219,CYP3A5*3,CYP3A5,Dosage,1,tacrolimus,1448285880.0,Near Eastern
1451104645,PA166196173,rs222749,,,TRPV1,Efficacy,1,botulinum toxin type a,1451104650.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,atenolol,1451107120.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,atenolol,1451107107.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,atenolol,1451107105.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,atenolol,1451107106.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,metoprolol,1451107120.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,metoprolol,1451107107.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,metoprolol,1451107105.0,European
1451107100,PA166156748,rs1042713,,,ADRB2,Efficacy,1,metoprolol,1451107106.0,European
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,atenolol,1451107140.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,atenolol,1451107142.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,atenolol,1451107143.0,Latino
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,atenolol,1451107139.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,atenolol,1451107141.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,metoprolol,1451107140.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,metoprolol,1451107142.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,metoprolol,1451107143.0,Latino
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,metoprolol,1451107139.0,African American/Afro-Caribbean
1451107134,PA166156749,rs1042714,,,ADRB2,Efficacy,-1,metoprolol,1451107141.0,African American/Afro-Caribbean
1449714361,PA166156280,rs167771,,,DRD3,Dosage,-1,opioids,1449714364.0,European
1449714361,PA166156280,rs167771,,,DRD3,Dosage,-1,opioids,1449714363.0,European
1043880431,PA166156276,rs5186,,,AGTR1,Efficacy,1,losartan,1043880459.0,European
1449169568,PA166156276,rs5186,,,AGTR1,Metabolism/PK,1,atorvastatin,1449169571.0,Latino
1449169568,PA166156276,rs5186,,,AGTR1,Metabolism/PK,1,atorvastatin,1449169580.0,Latino
1449169568,PA166156276,rs5186,,,AGTR1,Metabolism/PK,1,atorvastatin,1449169582.0,Latino
1449169568,PA166156276,rs5186,,,AGTR1,Metabolism/PK,1,atorvastatin,1449169570.0,Latino
1449169568,PA166156276,rs5186,,,AGTR1,Metabolism/PK,1,atorvastatin,1449169572.0,Latino
1449169568,PA166156276,rs5186,,,AGTR1,Metabolism/PK,1,atorvastatin,1449169573.0,Latino
1296666803,PA166156288,rs352139,,,TLR9,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666805.0,European
1296666803,PA166156288,rs352139,,,TLR9,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1296666952.0,European
1451114623,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,lopinavir,1451114640.0,"Multiple groups, Brazilian patients (white, brown or black, according to Brazilian census categories)"
699639266,PA166156287,rs334558,,,GSK3B,Efficacy,0,lithium,699639303.0,European
1184755040,PA166156811,rs2973049,,,GDNF,Efficacy,1,paroxetine,1184755042.0,East Asian
1184747871,PA166156802,rs2550948,,,SLC6A3,Efficacy,-1,venlafaxine,1184747873.0,"Multiple groups, European Americans, African Americans, Other"
699639070,PA166156885,rs17238540,,,HMGCR,Efficacy,-1,fluvastatin,699639072.0,"Multiple groups, White 97.00%,; Asian 2.30%,; Black 0.40%; other 0.30%"
769152897,PA166156885,rs17238540,,,HMGCR,Efficacy,-1,pravastatin,769152899.0,European
1450826531,PA166156991,rs1799971,,,OPRM1,Other,-1,ethanol,1450826537.0,"Multiple groups, Asian, African American, White or 'Other' ethnicities"
1184166157,PA166156938,rs699947,,,VEGFA,Efficacy,-1,bevacizumab,1184166159.0,European
1448613196,PA166155730,rs4553808,,,CTLA4,Metabolism/PK,1,tacrolimus,1448613198.0,East Asian
1447987295,PA166157501,rs62471956,,,CYP3A43,Metabolism/PK,1,ticagrelor,1447987297.0,European
981478948,PA166155715,rs3812718,,,SCN1A,Dosage,-1,carbamazepine,981478957.0,European
981478948,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,carbamazepine,981478957.0,European
981478948,PA166155715,rs3812718,,,SCN1A,Dosage,-1,oxcarbazepine,981478957.0,European
981478948,PA166155715,rs3812718,,,SCN1A,Efficacy,-1,oxcarbazepine,981478957.0,European
982023280,PA166155715,rs3812718,,,SCN1A,Efficacy,1,carbamazepine,982023289.0,East Asian
981843956,PA166155718,rs3832043,,,UGT1A9,Dosage,-1,irinotecan,981843965.0,East Asian
1449165223,PA166154504,rs784892,,,AMHR2,Metabolism/PK,-1,metformin,1449165225.0,"Multiple groups, Brazil"
1448636647,PA166157487,rs35599367,,,CYP3A4,Metabolism/PK,1,everolimus,1448636653.0,European
1449163518,PA166157490,rs41303343,,,CYP3A5,Metabolism/PK,1,tacrolimus,1449163520.0,African American/Afro-Caribbean
1448613514,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613519.0,Multiple groups
1448613514,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613518.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613514,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613516.0,European
1448613514,PA166155721,rs4148323,,,UGT1A1,Metabolism/PK,-1,selumetinib,1448613517.0,Unknown
769173673,PA166155733,rs4673993,,,ATIC,Efficacy,1,methotrexate,769173675.0,European
1449192709,PA166157516,rs75527207,,,CFTR,Efficacy,0,ivacaftor,1449192715.0,Unknown
1450821553,PA166180936,rs11280056,,,TYMS,Efficacy,-1,methotrexate,1450821558.0,European
1448612650,PA166155760,rs6759892,,,UGT1A6,Efficacy,-1,oxcarbazepine,1448612652.0,East Asian
1448612650,PA166155760,rs6759892,,,UGT1A6,Efficacy,-1,oxcarbazepine,1448612652.0,East Asian
1450930602,PA166185409,rs6495307,,,CHRNA3,Other,-1,nicotine,1450930606.0,East Asian
1447952179,PA166157518,rs77010898,,,CFTR,Efficacy,1,ataluren,1447952181.0,Unknown
827812184,PA166155772,rs7608731,,,GALNT14,Efficacy,1,cisplatin,827812189.0,Unknown
827812184,PA166155772,rs7608731,,,GALNT14,Efficacy,1,fluorouracil,827812189.0,Unknown
827812184,PA166155772,rs7608731,,,GALNT14,Efficacy,1,mitoxantrone,827812189.0,Unknown
982042960,PA166155145,rs4331,,,ACE,Efficacy,-1,atenolol,982042972.0,European
982042960,PA166155145,rs4331,,,ACE,Efficacy,-1,atenolol,982042970.0,European
1448102384,PA166155147,rs4343,,,ACE,Efficacy,-1,sertraline,1448102386.0,Near Eastern
1448266865,PA166155173,rs1042522,,,TP53,Efficacy,1,capecitabine,1448266871.0,East Asian
1448266865,PA166155173,rs1042522,,,TP53,Efficacy,1,capecitabine,1448266874.0,East Asian
1448266865,PA166155173,rs1042522,,,TP53,Efficacy,1,capecitabine,1448266876.0,East Asian
1448266865,PA166155173,rs1042522,,,TP53,Efficacy,1,paclitaxel,1448266871.0,East Asian
1448266865,PA166155173,rs1042522,,,TP53,Efficacy,1,paclitaxel,1448266874.0,East Asian
1448266865,PA166155173,rs1042522,,,TP53,Efficacy,1,paclitaxel,1448266876.0,East Asian
1449567013,PA166155162,rs242939,,,CRHR1,Efficacy,-1,bevacizumab,1449567015.0,Multiple groups
1449567013,PA166155162,rs242939,,,CRHR1,Efficacy,-1,bevacizumab,1449567017.0,Multiple groups
1449567013,PA166155162,rs242939,,,CRHR1,Efficacy,-1,bevacizumab,1449567016.0,Multiple groups
1449567013,PA166155162,rs242939,,,CRHR1,Efficacy,-1,ranibizumab,1449567015.0,Multiple groups
1449567013,PA166155162,rs242939,,,CRHR1,Efficacy,-1,ranibizumab,1449567017.0,Multiple groups
1449567013,PA166155162,rs242939,,,CRHR1,Efficacy,-1,ranibizumab,1449567016.0,Multiple groups
1448258238,PA166155162,rs242939,,,CRHR1,Efficacy,-1,corticosteroids,1448258240.0,Unknown
1448107229,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor / lumacaftor,1448107262.0,Unknown
982034681,PA166155187,rs1799752,,,ACE,Efficacy,1,acetylcholine,982034859.0,European
982034681,PA166155187,rs1799752,,,ACE,Efficacy,1,nitroprusside,982034859.0,European
982036510,PA166155187,rs1799752,,,ACE,Efficacy,1,fluvastatin,982036518.0,Multiple groups
1449154713,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154715.0,Multiple groups
1449154713,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154716.0,Multiple groups
1449154713,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154717.0,Multiple groups
1449154713,PA166157525,rs113993960,,,CFTR,Efficacy,1,ivacaftor,1449154718.0,Multiple groups
982041046,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982041056.0,"Multiple groups, 80% White, remaining unspecified"
982041046,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982041058.0,"Multiple groups, 80% White, remaining unspecified"
982041046,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982041056.0,"Multiple groups, 80% White, remaining unspecified"
982041046,PA166155187,rs1799752,,,ACE,Efficacy,1,enalapril,982041058.0,"Multiple groups, 80% White, remaining unspecified"
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,tipiracil hydrochloride,1449146813.0,East Asian
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,tipiracil hydrochloride,1449146816.0,European
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,tipiracil hydrochloride,1449146815.0,European
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,tipiracil hydrochloride,1449146814.0,East Asian
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,trifluridine,1449146813.0,East Asian
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,trifluridine,1449146816.0,European
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,trifluridine,1449146815.0,European
1449146811,PA166155206,rs2289669,,,SLC47A1,Efficacy,-1,trifluridine,1449146814.0,East Asian
1183960659,PA166154403,rs3817657,,,RRM1,Efficacy,-1,cisplatin,1183960663.0,East Asian
1183960659,PA166154403,rs3817657,,,RRM1,Efficacy,-1,gemcitabine,1183960663.0,East Asian
1183960659,PA166154403,rs3817657,,,RRM1,Efficacy,-1,gemcitabine,1183960663.0,East Asian
1183960659,PA166154403,rs3817657,,,RRM1,Efficacy,-1,gemcitabine,1183960663.0,East Asian
1447683043,PA166154404,rs3825016,,,SLC22A12,Efficacy,1,losartan,1447683045.0,East Asian
1449752066,PA166154447,rs11030918,,,RRM1,Metabolism/PK,1,ara-CTP,1449752069.0,"Multiple groups, USA St Jude, specified 43 white, 13 black and 12 other."
982017795,PA166154457,rs11568482,,,SLC22A8,Metabolism/PK,1,cefotaxime,982017919.0,Unknown
1296666475,PA166154476,rs61734430,,,FOLR3,Efficacy,1,pemetrexed,1296666482.0,"Multiple groups, Caucasian, African, Asian, Other, Not stated"
655387194,PA166154478,rs61888800,,,BDNF,Efficacy,0,antidepressants,655387197.0,Latino
655387194,PA166154478,rs61888800,,,BDNF,Efficacy,0,desipramine,655387197.0,Latino
655387194,PA166154478,rs61888800,,,BDNF,Efficacy,0,fluoxetine,655387197.0,Latino
1184756037,PA166154494,rs296766,,,AQP2,Efficacy,-1,platinum,1184756039.0,East Asian
982046897,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,adalimumab,982046904.0,European
982046897,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,etanercept,982046904.0,European
982046897,PA166154502,rs767455,,,TNFRSF1A,Efficacy,1,infliximab,982046904.0,European
769169630,PA166155228,rs4796793,,,STAT3,Efficacy,1,interferons,769169633.0,East Asian
769168963,PA166155822,rs12714145,,,GGCX,Dosage,-1,warfarin,769168965.0,Multiple groups
981728486,PA166155293,rs4149601,,,NEDD4L,Efficacy,1,hydrochlorothiazide,981730231.0,European
1446907728,PA166155328,rs17069895,,,TNFRSF11A,Efficacy,-1,alendronate,1446907734.0,East Asian
1446907687,PA166155320,rs11877530,,,TNFRSF11A,Efficacy,-1,alendronate,1446907699.0,East Asian
981785789,PA166155331,rs45445694,,,C18orf56,Efficacy,-1,gemcitabine,981785791.0,East Asian
981785789,PA166155331,rs45445694,,,TYMS,Efficacy,-1,gemcitabine,981785791.0,East Asian
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,bevacizumab,1448568266.0,Unknown
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,capecitabine,1448568266.0,Unknown
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,cisplatin,1448568266.0,Unknown
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,docetaxel,1448568266.0,Unknown
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,epirubicin,1448568266.0,Unknown
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,oxaliplatin,1448568266.0,Unknown
1448568253,PA166155331,rs45445694,,,TYMS,Efficacy,1,trastuzumab,1448568266.0,Unknown
1184748858,PA166155781,rs10197559,,,ATIC,Toxicity,-1,methotrexate,1184748860.0,Unknown
1448435387,PA166155794,rs10929302,,,UGT1A1,Metabolism/PK,-1,SN-38,1448435389.0,"Multiple groups, Caucasian and African-American"
1184511609,PA166155805,rs11676382,,,GGCX,Dosage,-1,acenocoumarol,1184511611.0,European
827822867,PA166156478,rs4073,,,CXCL8,Efficacy,1,bevacizumab,827822872.0,"Multiple groups, Forty-five patients were Caucasian, 3 Asian, 3 African-American and 2 Hispanic"
827822867,PA166156478,rs4073,,,CXCL8,Efficacy,1,cyclophosphamide,827822872.0,"Multiple groups, Forty-five patients were Caucasian, 3 Asian, 3 African-American and 2 Hispanic"
827864069,PA166156499,rs1024323,,,GRK4,Efficacy,-1,metoprolol,827864079.0,African American/Afro-Caribbean
1183491488,PA166156494,rs871606,,,CHIC2,Efficacy,-1,atenolol,1183491490.0,European
1183491488,PA166156494,rs871606,,,CHIC2,Efficacy,-1,atenolol,1183491495.0,European
1183491521,PA166156494,rs871606,,,CHIC2,Efficacy,-1,atenolol,1183491525.0,African American/Afro-Caribbean
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,epirubicin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,fluorouracil,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1444694865,PA166156522,rs1799895,,,SOD3,Efficacy,0,oxaliplatin,1444694867.0,East Asian
1449750697,PA166156978,rs1142345,,,TPMT,Metabolism/PK,-1,thioguanine,1449750699.0,East Asian
1449714597,PA166156973,rs1049353,,,CNR1,Dosage,-1,opioids,1449714600.0,European
1449714597,PA166156973,rs1049353,,,CNR1,Dosage,-1,opioids,1449714599.0,European
1450827419,PA166154261,rs6277,,,DRD2,Toxicity,-1,heroin,1450827423.0,East Asian
1444699407,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,clozapine,1444699417.0,European
827707457,PA166156985,rs1570360,,,VEGFA,Efficacy,1,bevacizumab,827707462.0,Unknown
827707457,PA166156985,rs1570360,,,VEGFA,Efficacy,1,irinotecan,827707462.0,Unknown
982015355,PA166156983,rs1360780,,,FKBP5,Efficacy,-1,citalopram,982015363.0,European
981349353,PA166156985,rs1570360,,,VEGFA,Efficacy,1,sildenafil,981349361.0,"Multiple groups, Brazil approximately half White half non-white"
981349353,PA166156985,rs1570360,,,VEGFA,Efficacy,1,sildenafil,981349359.0,"Multiple groups, Brazil approximately half White half non-white"
1184175240,PA166154265,rs9937,,,RRM1,Efficacy,-1,carboplatin,1184175296.0,East Asian
1184175240,PA166154265,rs9937,,,RRM1,Efficacy,-1,gemcitabine,1184175296.0,East Asian
1183960654,PA166154269,rs183484,,,RRM1,Efficacy,-1,cisplatin,1183960658.0,East Asian
1183960654,PA166154269,rs183484,,,RRM1,Efficacy,-1,gemcitabine,1183960658.0,East Asian
1450821902,PA166156991,rs1799971,,,OPRM1,Other,1,ethanol,1450821906.0,Unknown
1450821902,PA166156991,rs1799971,,,OPRM1,Other,1,ethanol,1450821907.0,Unknown
827816359,PA166156991,rs1799971,,,OPRM1,Dosage,-1,methadone,827816423.0,East Asian
827816359,PA166156991,rs1799971,,,OPRM1,Metabolism/PK,-1,methadone,827816423.0,East Asian
981865177,PA166154270,rs187238,,,IL18,Efficacy,1,"interferon alfa-2a, recombinant",981865180.0,European
981865177,PA166154270,rs187238,,,IL18,Efficacy,1,"interferon alfa-2b, recombinant",981865180.0,European
981865177,PA166154270,rs187238,,,IL18,Efficacy,1,interferons,981865180.0,European
981865177,PA166154270,rs187238,,,IL18,Efficacy,1,peginterferon alfa-2a,981865180.0,European
981865177,PA166154270,rs187238,,,IL18,Efficacy,1,peginterferon alfa-2b,981865180.0,European
981865177,PA166154270,rs187238,,,IL18,Efficacy,1,ribavirin,981865180.0,European
655387630,PA166154334,rs1799732,,,DRD2,,-1,risperidone,655387632.0,East Asian
1450826727,PA166156991,rs1799971,,,OPRM1,Other,1,nicotine,1450826732.0,"Multiple groups, Caucasian, African American and 'other'"
1450812282,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,nicotine,1450812286.0,European
1450812611,PA166156991,rs1799971,,,OPRM1,Efficacy,1,ethanol,1450812616.0,"Multiple groups, The majority of study participants were Caucasian"
1450812611,PA166156991,rs1799971,,,OPRM1,Efficacy,1,ethanol,1450812615.0,"Multiple groups, The majority of study participants were Caucasian"
1450812611,PA166156991,rs1799971,,,OPRM1,Efficacy,1,ethanol,1450812617.0,"Multiple groups, The majority of study participants were Caucasian"
1450808082,PA166156991,rs1799971,,,OPRM1,Dosage,-1,heroin,1450808089.0,East Asian
1450821136,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1450821144.0,"Multiple groups, Caucasian and Asian patients"
1450821136,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1450821145.0,Unknown
1450821136,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1450821146.0,European
1450821136,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1450821144.0,"Multiple groups, Caucasian and Asian patients"
1450821136,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1450821145.0,Unknown
1450821136,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1450821146.0,European
1451118400,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1451118381.0,Multiple groups
1451118400,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1451118420.0,Multiple groups
1451118400,PA166156991,rs1799971,,,OPRM1,Dosage,1,opioids,1451118406.0,Multiple groups
1451118400,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1451118381.0,Multiple groups
1451118400,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1451118420.0,Multiple groups
1451118400,PA166156991,rs1799971,,,OPRM1,Efficacy,1,opioids,1451118406.0,Multiple groups
1451121680,PA166156991,rs1799971,,,OPRM1,Efficacy,-1,oxycodone,1451121684.0,"Multiple groups, ""12 African-American/Black, 18 Caucasian/White, 3 Multiracial, 1 Native-American or Alaskan, 2 chose not to report.; Ethnically, 22% of the sample identified as Hispanic or Latino."""
982047080,PA166156997,rs1800629,,,TNF,Efficacy,-1,rituximab,982047082.0,European
1183689715,PA166156997,rs1800629,,,TNF,Efficacy,-1,infliximab,1183689717.0,European
1444668588,PA166156997,rs1800629,,,TNF,Efficacy,-1,infliximab,1444668594.0,Unknown
1444693775,PA166156997,rs1800629,,,TNF,Efficacy,-1,adalimumab,1444693777.0,European
1184511734,PA166155037,rs2244613,,,CES1,Dosage,-1,methylphenidate,1184511736.0,Unknown
981481860,PA166157005,rs2005976,,,DTNBP1,Efficacy,-1,aripiprazole,981481867.0,East Asian
1448995956,PA166157025,rs2233945,,,PSORS1C1,Efficacy,-1,adalimumab,1448995959.0,European
1448995971,PA166157025,rs2233945,,,PSORS1C1,Efficacy,1,etanercept,1448995973.0,European
827783469,PA166157026,rs2234693,,,ESR1,Efficacy,1,leflunomide,827783478.0,Unknown
1449191808,PA166178138,rs397508453,,,CFTR,Efficacy,1,ivacaftor,1449191810.0,"Multiple groups, Majority of patients were Caucasian and not of Hispanic/Latino origin"
827698061,PA166153958,rs1049550,,,ANXA11,Efficacy,-1,bevacizumab,827698071.0,East Asian
1184086208,PA166153893,rs60369023,,,CDA,Efficacy,-1,gemcitabine,1184086210.0,East Asian
1184086208,PA166153893,rs60369023,,,CDA,Toxicity,-1,gemcitabine,1184086210.0,East Asian
1184086208,PA166153893,rs60369023,,,CDA,Efficacy,-1,paclitaxel,1184086210.0,East Asian
1184086208,PA166153893,rs60369023,,,CDA,Toxicity,-1,paclitaxel,1184086210.0,East Asian
1447680544,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1447680549.0,Unknown
981794122,PA166154579,rs4149056,,,SLCO1B1,Dosage,1,SN-38,981794130.0,East Asian
1448257083,PA166155091,rs9923231,,,VKORC1,Dosage,1,warfarin,1448257088.0,East Asian
769170744,PA166153644,rs1801133,,,MTHFR,Toxicity,-1,methotrexate,769170746.0,East Asian
769170744,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,-1,methotrexate,769170746.0,East Asian
1448634598,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634600.0,Unknown
1448634598,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634605.0,Unknown
1448634590,PA166153953,rs717620,,,ABCC2,Metabolism/PK,1,mycophenolic acid,1448634592.0,Unknown
1448426774,PA166153953,rs717620,,,ABCC2,Efficacy,1,antiepileptics,1448426787.0,Multiple groups
1450812380,PA166154535,rs2239128,,,CACNA1C,Efficacy,1,nimodipine,1450812384.0,Unknown
1444706633,PA166154531,rs2228570,,,VDR,Efficacy,1,peginterferon alfa-2b,1444706635.0,European
1444706633,PA166154531,rs2228570,,,VDR,Efficacy,1,peginterferon alfa-2b,1444706648.0,European
1444706633,PA166154531,rs2228570,,,VDR,Efficacy,1,ribavirin,1444706635.0,European
1444706633,PA166154531,rs2228570,,,VDR,Efficacy,1,ribavirin,1444706648.0,European
982035781,PA166154533,rs2238032,,,CACNA1C,Efficacy,1,lacidipine,982035811.0,European
982035781,PA166154533,rs2238032,,,CACNA1C,Efficacy,1,nifedipine,982035811.0,European
982035781,PA166154533,rs2238032,,,CACNA1C,Efficacy,1,nitrendipine,982035811.0,European
982035861,PA166154534,rs2239050,,,CACNA1C,Efficacy,-1,lacidipine,982035890.0,European
982035861,PA166154534,rs2239050,,,CACNA1C,Efficacy,-1,nifedipine,982035890.0,European
982035861,PA166154534,rs2239050,,,CACNA1C,Efficacy,-1,nitrendipine,982035890.0,European
982035593,PA166154533,rs2238032,,,CACNA1C,Efficacy,1,calcium channel blockers,982035622.0,European
1184997439,PA166154557,rs2900478,,,SLCO1B1,Efficacy,1,hmg coa reductase inhibitors,1184997443.0,Multiple groups
1184997439,PA166154557,rs2900478,,,SLCO1B1,Efficacy,1,hmg coa reductase inhibitors,1184997441.0,Multiple groups
1184997439,PA166154557,rs2900478,,,SLCO1B1,Efficacy,1,hmg coa reductase inhibitors,1184997442.0,Multiple groups
1451105105,PA166154575,rs4149032,,,SLCO1B1,Metabolism/PK,1,letermovir,1451105109.0,"Multiple groups, Asian, Black, Other and White ethnicities"
1183681930,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,atorvastatin,1183681938.0,East Asian
1183681930,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,simvastatin,1183681938.0,East Asian
769170766,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,769170773.0,European
1448260874,PA166154579,rs4149056,,,SLCO1B1,Dosage,1,atazanavir,1448260876.0,Unknown
1448624730,PA166154579,rs4149056,,,SLCO1B1,Efficacy,-1,simvastatin,1451354945.0,African American/Afro-Caribbean
1450823509,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,1,fluvastatin,1450823513.0,European
1451115920,PA166154579,rs4149056,,,SLCO1B1,Metabolism/PK,-1,saquinavir,1451115940.0,European
1444703731,PA166155903,rs113095083,,,ILKAP,Efficacy,-1,hydrochlorothiazide,1444703734.0,European
1448105647,PA166155974,rs20572,,,CBR1,Metabolism/PK,1,doxorubicin,1448105649.0,"Multiple groups, Chinese; Malay; Indian"
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613430.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613428.0,European
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613431.0,Multiple groups
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613429.0,Unknown
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613430.0,"Multiple groups, Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects)"
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613428.0,European
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613431.0,Multiple groups
1448613426,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,selumetinib,1448613429.0,Unknown
1184228585,PA166156536,rs2070950,,,NR3C2,Efficacy,-1,enalapril,1184228587.0,East Asian
1184747642,PA166156544,rs2231142,,,ABCG2,Other,-1,sulfasalazine,1184747647.0,Multiple groups
1296598942,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1296598944.0,East Asian
1296598942,PA166156544,rs2231142,,,ABCG2,Metabolism/PK,-1,methotrexate,1296598945.0,East Asian
1450933039,PA166157114,rs6920220,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1450933047.0,Unknown
1450933039,PA166157114,rs6920220,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1450933045.0,Unknown
1450933039,PA166157114,rs6920220,,,TNFAIP3,Efficacy,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,1450933046.0,Unknown
1183698994,PA166157708,rs496503,,,KCNT1,Efficacy,-1,antiepileptics,1183698996.0,East Asian
982032460,PA166157739,rs1948308,,,NTRK2,Dosage,-1,methadone,982032466.0,"Multiple groups, 93% Jewish patients, the rest of the population were Arabic patients or non-Jewish European."
1185235766,PA166157747,rs2250242,,,ORM2,Metabolism/PK,-1,atrasentan,1185235768.0,"Multiple groups, Caucasian (primarily), and African-American"
1446899416,PA166155135,rs71647871,,,CES1,Metabolism/PK,1,enalapril,1446899447.0,European
1446899416,PA166155135,rs71647871,,,CES1,Metabolism/PK,1,enalapril,1446899445.0,European
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,trandolapril,1446902896.0,"Multiple groups, USA"
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,trandolapril,1446902890.0,European
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,trandolapril,1446902892.0,Latino
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,trandolapril,1446902894.0,African American/Afro-Caribbean
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,verapamil,1446902896.0,"Multiple groups, USA"
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,verapamil,1446902890.0,European
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,verapamil,1446902892.0,Latino
1446902880,PA166157776,rs4742610,,,PTPRD,Efficacy,1,verapamil,1446902894.0,African American/Afro-Caribbean
1184512419,PA166157792,rs7856096,,,FPGS,Dosage,1,warfarin,1184512423.0,African American/Afro-Caribbean
1184512419,PA166157792,rs7856096,,,FPGS,Dosage,1,warfarin,1184512425.0,African American/Afro-Caribbean
982037219,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037225.0,East Asian
982037219,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037224.0,East Asian
982037219,PA166153556,rs7079,,,AGT,Efficacy,1,benazepril,982037226.0,East Asian
1444934874,PA166153615,rs1056515,,,RGS5,Efficacy,1,bevacizumab,1444934880.0,Unknown
1444934874,PA166153615,rs1056515,,,RGS5,Efficacy,1,fluorouracil,1444934880.0,Unknown
1444934874,PA166153615,rs1056515,,,RGS5,Efficacy,1,irinotecan,1444934880.0,Unknown
1444934874,PA166153615,rs1056515,,,RGS5,Efficacy,1,leucovorin,1444934880.0,Unknown
769171568,PA166153571,rs396991,,,FCGR3A,Efficacy,1,cetuximab,769171570.0,Unknown
769171565,PA166153571,rs396991,,,FCGR3A,Efficacy,1,infliximab,769171567.0,East Asian
1184513720,PA166153574,rs529520,,,OPRD1,Efficacy,1,buprenorphine,1184513723.0,"Multiple groups, European American - mainly White but some Latino/White."
1184513720,PA166153574,rs529520,,,OPRD1,Efficacy,1,buprenorphine,1184513725.0,"Multiple groups, European American - mainly White but some Latino/White."
1184513720,PA166153574,rs529520,,,OPRD1,Efficacy,1,buprenorphine,1184513724.0,"Multiple groups, European American - mainly White but some Latino/White."
1184513720,PA166153574,rs529520,,,OPRD1,Efficacy,1,buprenorphine,1184513722.0,"Multiple groups, European American - mainly White but some Latino/White."
769170664,PA166153643,rs1801131,,,MTHFR,,-1,methotrexate,,
982043429,PA166153643,rs1801131,,,MTHFR,Efficacy,1,benazepril,982043441.0,East Asian
982043429,PA166153643,rs1801131,,,MTHFR,Efficacy,1,benazepril,982043439.0,East Asian
769173655,PA166155684,rs2372536,,,ATIC,Efficacy,1,folic acid,769173657.0,"Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients."
769173655,PA166155684,rs2372536,,,ATIC,Efficacy,1,methotrexate,769173657.0,"Multiple groups, 93% Caucasian (n = 191), 2.4% Asian (n = 5), 1.0% African (n = 2), and 3.4% other (n = 3 Hindustani, 3 Surinamese, 1 Israeli). All results remained similar when performed with and without inclusion of non-Caucasian patients."
1448109930,PA166153644,rs1801133,,,MTHFR,Metabolism/PK,1,methotrexate,1448109936.0,East Asian
1448108623,PA166153644,rs1801133,,,MTHFR,Efficacy,-1,methotrexate,1448108630.0,Unknown
1296599938,PA166153644,rs1801133,,,MTHFR,Toxicity,1,methotrexate,1296600044.0,"Multiple groups, Mixed, Caucasian, Egyptian"
1296599938,PA166153644,rs1801133,,,MTHFR,Toxicity,1,methotrexate,1296599944.0,"Multiple groups, Caucasian, Egyptian, Mixed"
1296599938,PA166153644,rs1801133,,,MTHFR,Toxicity,1,methotrexate,1296600029.0,"Multiple groups, Caucasian, Egyptian"
1450814406,PA166153644,rs1801133,,,MTHFR,Efficacy,1,"Vitamin B-complex, Incl. Combinations",1450814411.0,Unknown
1449147078,PA166153644,rs1801133,,,MTHFR,Efficacy,1,fluorouracil,1449147084.0,Central/South Asian
982037209,PA166153539,rs699,,,AGT,Efficacy,1,benazepril,982037216.0,East Asian
982037209,PA166153539,rs699,,,AGT,Efficacy,1,benazepril,982037215.0,East Asian
982037209,PA166153539,rs699,,,AGT,Efficacy,1,benazepril,982037217.0,East Asian
1183699320,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,1183699322.0,"Multiple groups, patients at Washington University Medical Center.  79 White;13 African-American."
982036698,PA166153959,rs1057910,,,CYP2C9,Dosage,1,warfarin,982036705.0,Near Eastern
1447947806,PA166153959,rs1057910,,,CYP2C9,Metabolism/PK,1,irbesartan,1447947808.0,East Asian
1451094340,PA166153976,rs1801252,,,ADRB1,Efficacy,1,carvedilol,1451094346.0,Multiple groups
655387640,PA166153976,rs1801252,,,ADRB1,Efficacy,-1,atenolol,655387642.0,European
1448997496,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448997504.0,"Multiple groups, Mostly white"
981476550,PA166153977,rs1801253,,,ADRB1,Efficacy,1,metoprolol,981476559.0,East Asian
1449733168,PA166154028,rs3740066,,,ABCC2,Metabolism/PK,1,rosuvastatin,1449733170.0,Sub-Saharan African
1450973700,PA166155351,rs429358,,,APOE,Efficacy,1,donepezil,1450973705.0,"Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)"
1450973700,PA166155351,rs429358,,,APOE,Efficacy,1,galantamine,1450973705.0,"Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)"
1450973700,PA166155351,rs429358,,,APOE,Efficacy,1,rivastigmine,1450973705.0,"Multiple groups, 81.8% European origin, 5.3% African, 12.9% Asian (in Brazil)"
1444936362,PA166155381,rs2108622,,,CYP4F2,Efficacy,1,aspirin,1444936364.0,Unknown
1444936362,PA166155381,rs2108622,,,CYP4F2,Efficacy,1,clopidogrel,1444936364.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491607.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491613.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491615.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491610.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491608.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491611.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491612.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491609.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,bevacizumab,1183491614.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491607.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491613.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491615.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491610.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491608.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491611.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491612.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491609.0,Unknown
1183491605,PA166155386,rs2230199,,,C3,Efficacy,-1,ranibizumab,1183491614.0,Unknown
1184757008,PA166155402,rs3093105,,,CYP4F2,Dosage,-1,warfarin,1184757010.0,East Asian
1184757018,PA166155403,rs3093158,,,CYP4F2,Dosage,-1,warfarin,1184757020.0,East Asian
1448997209,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,1,efavirenz,1448997215.0,Unknown
1448617505,PA166155409,rs3745274,,,CYP2B6,Efficacy,1,efavirenz,1448617511.0,Sub-Saharan African
1448998426,PA166155409,rs3745274,,,CYP2B6,Metabolism/PK,0,efavirenz,1448998432.0,Unknown
1448107499,PA166155409,rs3745274,,,CYP2B6,Dosage,0,efavirenz,1448107504.0,East Asian
1450807575,PA166156358,rs2472677,,,NR1I2,Metabolism/PK,1,isoniazid,1450807577.0,Sub-Saharan African
